Psyllid ID: psy10212
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 444 | 2.2.26 [Sep-21-2011] | |||||||
| P49841 | 420 | Glycogen synthase kinase- | yes | N/A | 0.718 | 0.759 | 0.646 | 1e-117 | |
| Q9WV60 | 420 | Glycogen synthase kinase- | yes | N/A | 0.718 | 0.759 | 0.646 | 1e-117 | |
| Q5YJC2 | 420 | Glycogen synthase kinase- | N/A | N/A | 0.718 | 0.759 | 0.646 | 1e-117 | |
| Q91757 | 420 | Glycogen synthase kinase- | N/A | N/A | 0.718 | 0.759 | 0.649 | 1e-117 | |
| P18266 | 420 | Glycogen synthase kinase- | yes | N/A | 0.718 | 0.759 | 0.643 | 1e-117 | |
| P18431 | 514 | Protein kinase shaggy OS= | no | N/A | 0.698 | 0.603 | 0.658 | 1e-115 | |
| P49840 | 483 | Glycogen synthase kinase- | no | N/A | 0.734 | 0.674 | 0.607 | 1e-110 | |
| P18265 | 483 | Glycogen synthase kinase- | no | N/A | 0.734 | 0.674 | 0.607 | 1e-109 | |
| Q2NL51 | 490 | Glycogen synthase kinase- | no | N/A | 0.729 | 0.661 | 0.605 | 1e-107 | |
| A8X5H5 | 359 | Glycogen synthase kinase- | N/A | N/A | 0.698 | 0.863 | 0.594 | 1e-102 |
| >sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens GN=GSK3B PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 214/331 (64%), Positives = 259/331 (78%), Gaps = 12/331 (3%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9WV60|GSK3B_MOUSE Glycogen synthase kinase-3 beta OS=Mus musculus GN=Gsk3b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 214/331 (64%), Positives = 259/331 (78%), Gaps = 12/331 (3%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5YJC2|GSK3B_SPECI Glycogen synthase kinase-3 beta OS=Spermophilus citellus GN=GSK3B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 214/331 (64%), Positives = 258/331 (77%), Gaps = 12/331 (3%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDVVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Spermophilus citellus (taxid: 9997) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91757|GSK3B_XENLA Glycogen synthase kinase-3 beta OS=Xenopus laevis GN=gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 215/331 (64%), Positives = 257/331 (77%), Gaps = 12/331 (3%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDR QE++YT+T+V +G +V K+ T I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+PET
Sbjct: 135 VPETVYRVARHYSRAKQALPIIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPETA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP+SR++PL + + F ELR
Sbjct: 315 ALCSRLLEYTPTSRLTPLDACAHS-FFDELR 344
|
Plays a role in the organization of the formation of the main body axis of developing embryo. Acts as an inhibitor of differentiation of primary neurons. Inhibits the ability of ectopically expressed NEUROD1 and other bHLH factors to promote early retinal cell differentiation. May participate in the Wnt signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P18266|GSK3B_RAT Glycogen synthase kinase-3 beta OS=Rattus norvegicus GN=Gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-117, Method: Compositional matrix adjust.
Identities = 213/331 (64%), Positives = 259/331 (78%), Gaps = 12/331 (3%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ ID+WSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDMWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18431|SGG_DROME Protein kinase shaggy OS=Drosophila melanogaster GN=sgg PE=1 SV=3 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-115, Method: Compositional matrix adjust.
Identities = 212/322 (65%), Positives = 250/322 (77%), Gaps = 12/322 (3%)
Query: 112 NKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171
+K+TTVVATPGQG DR QE+SYT+T+V +G +V K+ T I+++ +
Sbjct: 33 SKITTVVATPGQGTDRVQEVSYTDTKVIGNGSFGVVFQAKLCDTGELVAIKKV---LQDR 89
Query: 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVA 231
+F + K+ I +LL + SS +VFLNLVLE++PETVYKVA
Sbjct: 90 RFKNRELQIMRKLEHCN--------IVKLLYFFYSSGEKRDEVFLNLVLEYIPETVYKVA 141
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
+ Y+K+KQ P + +LY+YQLFRSLAYIH LGICHRDIKPQNLLL+PET VLKLCDFGS
Sbjct: 142 RQYAKTKQTIPINFIRLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPETAVLKLCDFGS 201
Query: 292 AKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
AK L+ GEPNVSYICSRYYRAPELIFGAI+YTTKIDVWSAGCVLAELLLGQP+FPGDSGV
Sbjct: 202 AKQLLHGEPNVSYICSRYYRAPELIFGAINYTTKIDVWSAGCVLAELLLGQPIFPGDSGV 261
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
DQLVE+IKVLGTPTREQIREMNPNYTEFKFPQIKSHPW KVFR+RTP +AI+L+S LLEY
Sbjct: 262 DQLVEVIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWQKVFRIRTPTEAINLVSLLLEY 321
Query: 412 TPSSRISPLQVRSITPFLIELR 433
TPS+RI+PL+ PF ELR
Sbjct: 322 TPSARITPLKA-CAHPFFDELR 342
|
Required for several developmental events such as synctial blastoderm formation and embryonic segmentation. Is involved in transcriptional regulation. Required for Arm phosphorylation. Wg signaling operates by inactivating the Sgg repression of en autoactivation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49840|GSK3A_HUMAN Glycogen synthase kinase-3 alpha OS=Homo sapiens GN=GSK3A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 207/341 (60%), Positives = 259/341 (75%), Gaps = 15/341 (4%)
Query: 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLG 154
T++PP +K+ S KVTTVVAT GQGP+R QE++YT+ +V +G +V ++
Sbjct: 84 TSFPP-PGVKLGRDS--GKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAE 140
Query: 155 TPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 214
T I+++ + FK ++ ++ D +++ RL + SS ++
Sbjct: 141 TRELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEL 189
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+LNLVLE++PETVY+VA+H++K+K P Y K+Y+YQLFRSLAYIH G+CHRDIKPQN
Sbjct: 190 YLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQN 249
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL++P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCV
Sbjct: 250 LLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 309
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
LAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVF+
Sbjct: 310 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFK 369
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435
RTPP+AI L S LLEYTPSSR+SPL+ + + F ELR +
Sbjct: 370 SRTPPEAIALCSSLLEYTPSSRLSPLEACAHS-FFDELRCL 409
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transctiption factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1. Requires primed phosphorylation of the majority of its substrates. Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. Regulates glycogen metabolism in liver, but not in muscle. May also mediate the development of insulin resistance by regulating activation of transcription factors. In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin. Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease. May be involved in the regulation of replication in pancreatic beta-cells. Is necessary for the establishment of neuronal polarity and axon outgrowth. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18265|GSK3A_RAT Glycogen synthase kinase-3 alpha OS=Rattus norvegicus GN=Gsk3a PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-109, Method: Compositional matrix adjust.
Identities = 207/341 (60%), Positives = 260/341 (76%), Gaps = 15/341 (4%)
Query: 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLG 154
T++PP +K+ S KVTTVVAT GQGP+R QE++YT+ +V +G +V ++
Sbjct: 84 TSFPP-PGVKLGRDS--GKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAE 140
Query: 155 TPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 214
T I+++ + FK ++ ++ D +++ RL + SS ++
Sbjct: 141 TRELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEL 189
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+LNLVLE++PETVY+VA+H++K+K P Y K+Y+YQLFRSLAYIH G+CHRDIKPQN
Sbjct: 190 YLNLVLEYVPETVYRVARHFTKAKLIIPIIYVKVYMYQLFRSLAYIHSQGVCHRDIKPQN 249
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL++P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCV
Sbjct: 250 LLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 309
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
LAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVF+
Sbjct: 310 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFK 369
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435
RTPP+AI L S LLEYTPSSR+SPL+ + + F ELR++
Sbjct: 370 SRTPPEAIALCSSLLEYTPSSRLSPLEACAHS-FFDELRSL 409
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transctiption factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1. Requires primed phosphorylation of the majority of its substrates. Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. Regulates glycogen metabolism in liver, but not in muscle. May also mediate the development of insulin resistance by regulating activation of transcription factors. In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin. May be involved in the regulation of replication in pancreatic beta-cells. Is necessary for the establishment of neuronal polarity and axon outgrowth. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2NL51|GSK3A_MOUSE Glycogen synthase kinase-3 alpha OS=Mus musculus GN=Gsk3a PE=1 SV=2 | Back alignment and function description |
|---|
Score = 390 bits (1001), Expect = e-107, Method: Compositional matrix adjust.
Identities = 206/340 (60%), Positives = 258/340 (75%), Gaps = 16/340 (4%)
Query: 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLG 154
T++PP +K+ S KVTTVVAT GQGP+R QE++YT+ +V +G +V ++
Sbjct: 84 TSFPP-PGVKLGRDS--GKVTTVVATVGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAE 140
Query: 155 TPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 214
T I+++ + FK ++ ++ D +++ RL + SS ++
Sbjct: 141 TRELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEL 189
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+LNLVLE++PETVY+VA+H++K+K P Y K+Y+YQLFRSLAYIH G+CHRDIKPQN
Sbjct: 190 YLNLVLEYVPETVYRVARHFTKAKLITPIIYIKVYMYQLFRSLAYIHSQGVCHRDIKPQN 249
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL++P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCV
Sbjct: 250 LLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 309
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
LAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVF+
Sbjct: 310 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFK 369
Query: 395 -VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
+TPP+AI L S LLEYTPSSR+SPL+ + + F ELR
Sbjct: 370 SSKTPPEAIALCSSLLEYTPSSRLSPLEACAHS-FFDELR 408
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transctiption factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1. Requires primed phosphorylation of the majority of its substrates. Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. Regulates glycogen metabolism in liver, but not in muscle. May also mediate the development of insulin resistance by regulating activation of transcription factors. In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin. May be involved in the regulation of replication in pancreatic beta-cells. Is necessary for the establishment of neuronal polarity and axon outgrowth. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8X5H5|GSK3_CAEBR Glycogen synthase kinase-3 OS=Caenorhabditis briggsae GN=gsk-3 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (952), Expect = e-102, Method: Compositional matrix adjust.
Identities = 192/323 (59%), Positives = 241/323 (74%), Gaps = 13/323 (4%)
Query: 113 KVTTVVATPG-QGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171
+VT VVA+ G D+ EISY + +V +G +V + K+ T I+++ + F
Sbjct: 15 QVTMVVASVATDGVDQQVEISYYDQKVIGNGSFGVVFLAKLSTTNEMVAIKKVLQD-KRF 73
Query: 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVA 231
K +++ + R P+ I +L + SS +++LNL+LE++PETVY+VA
Sbjct: 74 KNRELQ------IMRKLNHPN----IVKLKYFFYSSGDKKDELYLNLILEYVPETVYRVA 123
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
+HYSK +Q+ P Y KLY+YQL RSLAYIH +GICHRDIKPQNLL++PETG+LKLCDFGS
Sbjct: 124 RHYSKQRQSIPMIYVKLYMYQLLRSLAYIHSIGICHRDIKPQNLLIDPETGILKLCDFGS 183
Query: 292 AKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
AK+LVR EPNVSYICSRYYRAPELIFGA +YT IDVWSAG V+AELLLGQP+FPGDSGV
Sbjct: 184 AKYLVRNEPNVSYICSRYYRAPELIFGATNYTNSIDVWSAGTVIAELLLGQPIFPGDSGV 243
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
DQLVEIIKVLGTPTREQI+ MNPNY EFKFPQIK+HPW+KVFRV TP +AIDLIS+++EY
Sbjct: 244 DQLVEIIKVLGTPTREQIQSMNPNYKEFKFPQIKAHPWNKVFRVHTPAEAIDLISKIIEY 303
Query: 412 TPSSRISPLQVRSITPFLIELRA 434
TP+SR +P Q F ELR+
Sbjct: 304 TPTSRPTP-QAACQHAFFDELRS 325
|
Phosphorylates oma-1, a regulator of the oocyte-to-embryo transition, enabling its degradation. Phosphorylates skn-1, preventing it from accumulating in nuclei and thus inhibiting phase II gene expression in the oxidative stress defense. Involved in mesendoderm specification and mitotic spindle orientation in EMS blastomeres. Thought to be a branch point in these processes as proteins downstream are not required. Negatively regulates Wnt signaling in vulval precursor cells and acts as a Wnt-independent repressor of med-1 and med-2 in the C lineage inhibiting mesoderm development. Required for normal lifespan and LiCl-induced lifespan extension. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 444 | ||||||
| 47226970 | 496 | unnamed protein product [Tetraodon nigro | 0.867 | 0.776 | 0.613 | 1e-130 | |
| 346654995 | 415 | shaggy [Tribolium castaneum] | 0.740 | 0.792 | 0.662 | 1e-121 | |
| 340719007 | 448 | PREDICTED: protein kinase shaggy-like [B | 0.779 | 0.772 | 0.619 | 1e-119 | |
| 328788094 | 447 | PREDICTED: protein kinase shaggy isoform | 0.779 | 0.774 | 0.616 | 1e-119 | |
| 380012417 | 447 | PREDICTED: protein kinase shaggy-like [A | 0.779 | 0.774 | 0.616 | 1e-119 | |
| 91081055 | 494 | PREDICTED: similar to mck1 [Tribolium ca | 0.684 | 0.615 | 0.685 | 1e-118 | |
| 383847865 | 448 | PREDICTED: protein kinase shaggy-like [M | 0.779 | 0.772 | 0.613 | 1e-118 | |
| 332018301 | 481 | Protein kinase shaggy [Acromyrmex echina | 0.698 | 0.644 | 0.670 | 1e-117 | |
| 307197001 | 435 | Protein kinase shaggy [Harpegnathos salt | 0.698 | 0.712 | 0.673 | 1e-117 | |
| 321461564 | 439 | glycogen synthase kinase 3 beta [Daphnia | 0.698 | 0.706 | 0.680 | 1e-117 |
| >gi|47226970|emb|CAG05862.1| unnamed protein product [Tetraodon nigroviridis] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 259/422 (61%), Positives = 299/422 (70%), Gaps = 37/422 (8%)
Query: 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKY 82
S VIGNGSFG+VYQAKL DSGELVAIKKVLQDKRFKNRE+QIMR+L+H NIV+L+Y
Sbjct: 64 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 123
Query: 83 FFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSG 142
FFYSSGDK D N P S N + TV +P T RV+ +G
Sbjct: 124 FFYSSGDKPDRRANRPS---------SVVNSMVTVGELSQWLRCKPCS-QLTRARVAQAG 173
Query: 143 VDQLVEIIKVLGT-PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 201
Q E I+ G P + R + T + K RV P + R
Sbjct: 174 GSQ--EPIRPSGNQPGKWLCRGRKRSLTFLRESANK--------RVDIP----QPVPRSR 219
Query: 202 EYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261
++ S S +V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH
Sbjct: 220 GHSVRSG-SKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPMVYVKLYMYQLFRSLAYIH 278
Query: 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID 321
GICHRDIKPQNLLL+PET VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA D
Sbjct: 279 SFGICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 338
Query: 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK----------VLGTPTREQIRE 371
YT+ IDVWSAGCVLAELLLGQP+FPGDSGVDQLVEIIK VLGTPTREQIRE
Sbjct: 339 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKRQNAAFRSPQVLGTPTREQIRE 398
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431
MNPNYTEFKFPQIK+HPW+KVFR RTPP+AI L SRLLEYTP++R++PL+ + + F E
Sbjct: 399 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDE 457
Query: 432 LR 433
LR
Sbjct: 458 LR 459
|
Source: Tetraodon nigroviridis Species: Tetraodon nigroviridis Genus: Tetraodon Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|346654995|gb|AEO44887.1| shaggy [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 234/353 (66%), Positives = 270/353 (76%), Gaps = 24/353 (6%)
Query: 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVD 144
++ G+K +P N PPL MKIS+ +KVTTVVATPGQGPDRPQE+SYT+T+V +G
Sbjct: 10 FAEGNK--QPLN-PPLGGMKISS-KDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGS- 64
Query: 145 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL----ISRL 200
G + ++ E N +F IK K F+ R L I +L
Sbjct: 65 --------FGVVYQAKLCETN------EFVAIKKVLQDKRFKNRELQIMRKLEHCNIVKL 110
Query: 201 LEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260
+ SS +V+LNLVLE++PETVY+VA+HYSKSKQ P + KLY+YQLFRSLAYI
Sbjct: 111 KYFFYSSGDKKDEVYLNLVLEYIPETVYRVARHYSKSKQTIPIIFIKLYMYQLFRSLAYI 170
Query: 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320
H LGICHRDIKPQNLLL+P TG+LKLCDFGSAKHLV+GEPNVSYICSRYYRAPELIFGAI
Sbjct: 171 HSLGICHRDIKPQNLLLDPGTGILKLCDFGSAKHLVKGEPNVSYICSRYYRAPELIFGAI 230
Query: 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 380
DYTTKIDVWSAGCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPT+EQI+EMNPNYTEFK
Sbjct: 231 DYTTKIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTKEQIKEMNPNYTEFK 290
Query: 381 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
FPQIKSHPW +VFR RTPP+AI+L++RLLEYTPSSRISPLQ F ELR
Sbjct: 291 FPQIKSHPWQQVFRARTPPEAIELVARLLEYTPSSRISPLQA-CAHAFFNELR 342
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340719007|ref|XP_003397950.1| PREDICTED: protein kinase shaggy-like [Bombus terrestris] gi|350396122|ref|XP_003484448.1| PREDICTED: protein kinase shaggy-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1117), Expect = e-119, Method: Compositional matrix adjust.
Identities = 223/360 (61%), Positives = 270/360 (75%), Gaps = 14/360 (3%)
Query: 86 SSGDKKDEPTNYPPLEDMKISTFSPR----------NKVTTVVATPGQGPDRPQEISYTN 135
S D + PTN PPL M++S+ NKVTTVVATPG GPDRPQEISYT+
Sbjct: 9 SFADCTNAPTN-PPLGGMRVSSHPAGGVTLKKDRDGNKVTTVVATPGAGPDRPQEISYTD 67
Query: 136 TRVSDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDA 193
T+V +G +V + K+ T I+++ + + + ++ + +++ +
Sbjct: 68 TKVIGNGSFGVVYLAKLCDTEELVAIKKVLQDKRFKNRELQIMRRLEHCNIVKLKYFFYS 127
Query: 194 IDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253
+ L P + +V+LNLVLE++PETVYKVA+HY+KSKQ P + KLY+YQL
Sbjct: 128 SGDKNILNATNPVFHVDKDEVYLNLVLEYIPETVYKVARHYNKSKQTIPINFIKLYMYQL 187
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
FRSLAYIH LGICHRDIKPQNLLL+PE+GVLKLCDFGSAKHLV+GEPNVSYICSRYYRAP
Sbjct: 188 FRSLAYIHSLGICHRDIKPQNLLLDPESGVLKLCDFGSAKHLVKGEPNVSYICSRYYRAP 247
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
ELIFGAIDYTTKIDVWSAGCV+AELLLGQP+FPGDSGVDQLVEIIKVLGTPTR+QIREMN
Sbjct: 248 ELIFGAIDYTTKIDVWSAGCVVAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRDQIREMN 307
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
PNYTEFKFPQIK+HPW KVFR RTPP+A++L++ LLEYTPS RI+PL+ PF ELR
Sbjct: 308 PNYTEFKFPQIKAHPWQKVFRARTPPEAMELVAGLLEYTPSGRITPLEA-CAHPFFDELR 366
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328788094|ref|XP_392504.3| PREDICTED: protein kinase shaggy isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1116), Expect = e-119, Method: Compositional matrix adjust.
Identities = 222/360 (61%), Positives = 270/360 (75%), Gaps = 14/360 (3%)
Query: 86 SSGDKKDEPTNYPPLEDMKISTFSPR----------NKVTTVVATPGQGPDRPQEISYTN 135
S D + P+N PPL M++S+ NKVTTVVATPG GPDRPQEISYT+
Sbjct: 9 SFADCTNAPSN-PPLGGMRVSSHPAGGVTLKKDRDGNKVTTVVATPGAGPDRPQEISYTD 67
Query: 136 TRVSDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDA 193
T+V +G +V + K+ T I+++ + + + ++ + +++ +
Sbjct: 68 TKVIGNGSFGVVYLAKLCDTEELVAIKKVLQDKRFKNRELQIMRRLEHCNIVKLKYFFYS 127
Query: 194 IDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253
+ L P + +V+LNLVLE++PETVYKVA+HY+KSKQ P + KLY+YQL
Sbjct: 128 SGDKNILNATNPVFHVDKDEVYLNLVLEYIPETVYKVARHYNKSKQTIPINFIKLYMYQL 187
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
FRSLAYIH LGICHRDIKPQNLLL+PE+GVLKLCDFGSAKHLV+GEPNVSYICSRYYRAP
Sbjct: 188 FRSLAYIHSLGICHRDIKPQNLLLDPESGVLKLCDFGSAKHLVKGEPNVSYICSRYYRAP 247
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
ELIFGAIDYTTKIDVWSAGCV+AELLLGQP+FPGDSGVDQLVEIIKVLGTPTR+QIREMN
Sbjct: 248 ELIFGAIDYTTKIDVWSAGCVVAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRDQIREMN 307
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
PNYTEFKFPQIK+HPW KVFR RTPP+A++L++ LLEYTPS RI+PL+ PF ELR
Sbjct: 308 PNYTEFKFPQIKAHPWQKVFRARTPPEAMELVAGLLEYTPSGRITPLEA-CAHPFFDELR 366
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380012417|ref|XP_003690280.1| PREDICTED: protein kinase shaggy-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1116), Expect = e-119, Method: Compositional matrix adjust.
Identities = 222/360 (61%), Positives = 270/360 (75%), Gaps = 14/360 (3%)
Query: 86 SSGDKKDEPTNYPPLEDMKISTFSPR----------NKVTTVVATPGQGPDRPQEISYTN 135
S D + P+N PPL M++S+ NKVTTVVATPG GPDRPQEISYT+
Sbjct: 9 SFADCTNAPSN-PPLGGMRVSSHPAGGVTLKKDRDGNKVTTVVATPGAGPDRPQEISYTD 67
Query: 136 TRVSDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDA 193
T+V +G +V + K+ T I+++ + + + ++ + +++ +
Sbjct: 68 TKVIGNGSFGVVYLAKLCDTEELVAIKKVLQDKRFKNRELQIMRRLEHCNIVKLKYFFYS 127
Query: 194 IDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253
+ L P + +V+LNLVLE++PETVYKVA+HY+KSKQ P + KLY+YQL
Sbjct: 128 SGDKNILNATNPVFHVDKDEVYLNLVLEYIPETVYKVARHYNKSKQTIPINFIKLYMYQL 187
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
FRSLAYIH LGICHRDIKPQNLLL+PE+GVLKLCDFGSAKHLV+GEPNVSYICSRYYRAP
Sbjct: 188 FRSLAYIHSLGICHRDIKPQNLLLDPESGVLKLCDFGSAKHLVKGEPNVSYICSRYYRAP 247
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
ELIFGAIDYTTKIDVWSAGCV+AELLLGQP+FPGDSGVDQLVEIIKVLGTPTR+QIREMN
Sbjct: 248 ELIFGAIDYTTKIDVWSAGCVVAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRDQIREMN 307
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
PNYTEFKFPQIK+HPW KVFR RTPP+A++L++ LLEYTPS RI+PL+ PF ELR
Sbjct: 308 PNYTEFKFPQIKAHPWQKVFRARTPPEAMELVAGLLEYTPSGRITPLEA-CAHPFFDELR 366
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91081055|ref|XP_975399.1| PREDICTED: similar to mck1 [Tribolium castaneum] gi|270006440|gb|EFA02888.1| shaggy [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1110), Expect = e-118, Method: Compositional matrix adjust.
Identities = 222/324 (68%), Positives = 252/324 (77%), Gaps = 20/324 (6%)
Query: 114 VTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173
VTTVVATPGQGPDRPQE+SYT+T+V +G G + ++ E N +F
Sbjct: 114 VTTVVATPGQGPDRPQEVSYTDTKVIGNGS---------FGVVYQAKLCETN------EF 158
Query: 174 PQIKSHPWSKVFRVRTPPDAIDL----ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYK 229
IK K F+ R L I +L + SS +V+LNLVLE++PETVY+
Sbjct: 159 VAIKKVLQDKRFKNRELQIMRKLEHCNIVKLKYFFYSSGDKKDEVYLNLVLEYIPETVYR 218
Query: 230 VAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDF 289
VA+HYSKSKQ P + KLY+YQLFRSLAYIH LGICHRDIKPQNLLL+P TG+LKLCDF
Sbjct: 219 VARHYSKSKQTIPIIFIKLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPGTGILKLCDF 278
Query: 290 GSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS 349
GSAKHLV+GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP+FPGDS
Sbjct: 279 GSAKHLVKGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPIFPGDS 338
Query: 350 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409
GVDQLVEIIKVLGTPT+EQI+EMNPNYTEFKFPQIKSHPW +VFR RTPP+AI+L++RLL
Sbjct: 339 GVDQLVEIIKVLGTPTKEQIKEMNPNYTEFKFPQIKSHPWQQVFRARTPPEAIELVARLL 398
Query: 410 EYTPSSRISPLQVRSITPFLIELR 433
EYTPSSRISPLQ F ELR
Sbjct: 399 EYTPSSRISPLQA-CAHAFFNELR 421
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383847865|ref|XP_003699573.1| PREDICTED: protein kinase shaggy-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 221/360 (61%), Positives = 269/360 (74%), Gaps = 14/360 (3%)
Query: 86 SSGDKKDEPTNYPPLEDMKISTF----------SPRNKVTTVVATPGQGPDRPQEISYTN 135
S D P+N PPL M++S+ NKVTTVVATPG GPDRPQEISYT+
Sbjct: 9 SFADCTIAPSN-PPLGGMRVSSHPMGGVMYNADRDGNKVTTVVATPGAGPDRPQEISYTD 67
Query: 136 TRVSDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDA 193
T+V +G +V + K+ T I+++ + + + ++ + +++ +
Sbjct: 68 TKVIGNGSFGVVYLAKLCDTEELVAIKKVLQDKRFKNRELQIMRRLEHCNIVKLKYFFYS 127
Query: 194 IDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253
+ L P + +V+LNLVLE++PETVYKVA+HY+K+KQ P + KLY+YQL
Sbjct: 128 SGDKNILNATNPVFHVDKDEVYLNLVLEYIPETVYKVARHYNKNKQTIPINFIKLYMYQL 187
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
FRSLAYIH LGICHRDIKPQNLLL+PE+GVLKLCDFGSAKHLV+GEPNVSYICSRYYRAP
Sbjct: 188 FRSLAYIHSLGICHRDIKPQNLLLDPESGVLKLCDFGSAKHLVKGEPNVSYICSRYYRAP 247
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
ELIFGAIDYTTKIDVWSAGCV+AELLLGQP+FPGDSGVDQLVEIIKVLGTPTR+QIREMN
Sbjct: 248 ELIFGAIDYTTKIDVWSAGCVVAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRDQIREMN 307
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
PNYTEFKFPQIK+HPW KVFR RTPP+A++L++ LLEYTPS RI+PL+ PF ELR
Sbjct: 308 PNYTEFKFPQIKAHPWQKVFRARTPPEAMELVAGLLEYTPSGRITPLEA-CAHPFFDELR 366
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332018301|gb|EGI58906.1| Protein kinase shaggy [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1102), Expect = e-117, Method: Compositional matrix adjust.
Identities = 216/322 (67%), Positives = 259/322 (80%), Gaps = 12/322 (3%)
Query: 112 NKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171
+KVTTVVATPG GPDRPQE++YT+T+V +G +V K+ + I+++ + F
Sbjct: 67 SKVTTVVATPGAGPDRPQEVAYTDTKVIGNGSFGVVYQAKLCDSGEMVAIKKVLQD-KRF 125
Query: 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVA 231
K ++ ++ + +++ +L + SS +V+LNLVLE++PETVYKVA
Sbjct: 126 K---------NRELQIMRRLEHCNIV-KLKYFFYSSGDKKDEVYLNLVLEYIPETVYKVA 175
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
+HYSKSKQ P + KLY+YQLFRSLAYIH LGICHRDIKPQNLLL+P+TGVLKLCDFGS
Sbjct: 176 RHYSKSKQTIPISFIKLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPDTGVLKLCDFGS 235
Query: 292 AKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
AKHLV+GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP+FPGDSGV
Sbjct: 236 AKHLVKGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPIFPGDSGV 295
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
DQLVEIIKVLGTPTR+QIREMNPNYTEFKFPQIKSHPW KVFR RTPP+A+DL++RLLEY
Sbjct: 296 DQLVEIIKVLGTPTRDQIREMNPNYTEFKFPQIKSHPWQKVFRARTPPEAMDLVARLLEY 355
Query: 412 TPSSRISPLQVRSITPFLIELR 433
TPS R++PLQ + + F ELR
Sbjct: 356 TPSLRMTPLQACAHS-FFNELR 376
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307197001|gb|EFN78376.1| Protein kinase shaggy [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 217/322 (67%), Positives = 256/322 (79%), Gaps = 12/322 (3%)
Query: 112 NKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171
+KVTTVVATPG GPDRPQE++YT+T+V +G +V K+ + I+++
Sbjct: 13 SKVTTVVATPGAGPDRPQEVAYTDTKVIGNGSFGVVYQAKLCDSGEMVAIKKV------L 66
Query: 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVA 231
+ + K+ + R+ I +L + SS +V+LNLVLE++PETVYKVA
Sbjct: 67 QDKRFKNRELQIMRRLEHCN-----IVKLKYFFYSSGDKKDEVYLNLVLEYIPETVYKVA 121
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
+HYSKSKQ P + KLY+YQLFRSLAYIH LGICHRDIKPQNLLL+P+TGVLKLCDFGS
Sbjct: 122 RHYSKSKQTIPISFIKLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPDTGVLKLCDFGS 181
Query: 292 AKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
AKHLV+GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP+FPGDSGV
Sbjct: 182 AKHLVKGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPIFPGDSGV 241
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
DQLVEIIKVLGTPTR+QIREMNPNYTEFKFPQIKSHPW KVFR RTPP+A+DL++RLLEY
Sbjct: 242 DQLVEIIKVLGTPTRDQIREMNPNYTEFKFPQIKSHPWQKVFRARTPPEAMDLVARLLEY 301
Query: 412 TPSSRISPLQVRSITPFLIELR 433
TPS R++PLQ + + F ELR
Sbjct: 302 TPSLRMTPLQACAHS-FFHELR 322
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|321461564|gb|EFX72595.1| glycogen synthase kinase 3 beta [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-117, Method: Compositional matrix adjust.
Identities = 219/322 (68%), Positives = 256/322 (79%), Gaps = 12/322 (3%)
Query: 112 NKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171
+KVTTVVATPGQGPDR QE++YT+ +V +G +V K+ T I+++ + F
Sbjct: 25 SKVTTVVATPGQGPDRAQEVAYTDAKVIGNGSFGVVYQAKLCETGELVAIKKVLQD-KRF 83
Query: 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVA 231
K +++ + R + + L + Y+ + + +VFLNLVLEF+PETVYKVA
Sbjct: 84 KNRELQ------IMRRLEHCNIVKL--KYFFYSSGEKAN--EVFLNLVLEFIPETVYKVA 133
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
+HYSKSKQ P + KLY+YQLFRSLAYIH LGICHRDIKPQNLLL+PE+GVLKLCDFGS
Sbjct: 134 RHYSKSKQTIPISFIKLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPESGVLKLCDFGS 193
Query: 292 AKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
AKHLV+GEPNVSYICSRYYRAPELIFGA DYTT IDVWSAGCVLAELLLGQP+FPGDSGV
Sbjct: 194 AKHLVQGEPNVSYICSRYYRAPELIFGATDYTTNIDVWSAGCVLAELLLGQPIFPGDSGV 253
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW KVFR RTP +AIDL+SRLLEY
Sbjct: 254 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWQKVFRARTPLEAIDLVSRLLEY 313
Query: 412 TPSSRISPLQVRSITPFLIELR 433
TPS+RISPL+ + T F ELR
Sbjct: 314 TPSARISPLEACAHT-FFEELR 334
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 444 | ||||||
| UNIPROTKB|K7GSV4 | 326 | GSK3B "Uncharacterized protein | 0.531 | 0.723 | 0.767 | 9.1e-109 | |
| ZFIN|ZDB-GENE-090312-2 | 419 | si:dkeyp-80c12.7 "si:dkeyp-80c | 0.720 | 0.763 | 0.647 | 1.5e-108 | |
| UNIPROTKB|E2R4Y4 | 420 | GSK3B "Uncharacterized protein | 0.740 | 0.783 | 0.631 | 4.9e-108 | |
| UNIPROTKB|P49841 | 420 | GSK3B "Glycogen synthase kinas | 0.740 | 0.783 | 0.631 | 4.9e-108 | |
| MGI|MGI:1861437 | 420 | Gsk3b "glycogen synthase kinas | 0.740 | 0.783 | 0.631 | 4.9e-108 | |
| UNIPROTKB|F1SPD2 | 395 | GSK3B "Uncharacterized protein | 0.718 | 0.807 | 0.646 | 8.1e-108 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.718 | 0.757 | 0.646 | 1e-107 | |
| RGD|70982 | 420 | Gsk3b "glycogen synthase kinas | 0.740 | 0.783 | 0.628 | 1e-107 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.740 | 0.783 | 0.634 | 1e-107 | |
| UNIPROTKB|Q5YJC2 | 420 | GSK3B "Glycogen synthase kinas | 0.740 | 0.783 | 0.631 | 1.3e-107 |
| UNIPROTKB|K7GSV4 GSK3B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 9.1e-109, Sum P(2) = 9.1e-109
Identities = 182/237 (76%), Positives = 207/237 (87%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
I RL + SS +V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRS
Sbjct: 15 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 74
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
LAYIH GICHRDIKPQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELI
Sbjct: 75 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 134
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
FGA DYT+ IDVWSAGCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNY
Sbjct: 135 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 194
Query: 377 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
TEFKFPQIK+HPW+KVFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 195 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 250
|
|
| ZFIN|ZDB-GENE-090312-2 si:dkeyp-80c12.7 "si:dkeyp-80c12.7" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.5e-108, P = 1.5e-108
Identities = 215/332 (64%), Positives = 259/332 (78%)
Query: 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQI 161
+MK+S +KVTTV ATPGQGPDRPQE+SYT+T+V +G +V K+ T I
Sbjct: 25 NMKVSRDKDGSKVTTVAATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDTGELVAI 84
Query: 162 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLE 221
+++ + FK ++ ++ D +++ RL + SS +V+LNLV++
Sbjct: 85 KKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGDKKDEVYLNLVMD 133
Query: 222 FMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET 281
++PE VY+VA+HYSK+KQN P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+PET
Sbjct: 134 YVPENVYRVARHYSKAKQNLPMVYVKLYMYQLFRSLAYIHSYGICHRDIKPQNLLLDPET 193
Query: 282 GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ ID+WSAGCVLAELLLG
Sbjct: 194 AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDIWSAGCVLAELLLG 253
Query: 342 QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401
QP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+A
Sbjct: 254 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 313
Query: 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
I L SRLLEYTP++R++PL+ + T F ELR
Sbjct: 314 IALCSRLLEYTPTARLTPLEACAHT-FFDELR 344
|
|
| UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 216/342 (63%), Positives = 262/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ + I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDSGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
+V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSA
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
| UNIPROTKB|P49841 GSK3B "Glycogen synthase kinase-3 beta" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 216/342 (63%), Positives = 262/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ + I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDSGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
+V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSA
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
| MGI|MGI:1861437 Gsk3b "glycogen synthase kinase 3 beta" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 216/342 (63%), Positives = 262/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ + I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDSGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
+V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSA
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
| UNIPROTKB|F1SPD2 GSK3B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 214/331 (64%), Positives = 259/331 (78%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 1 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 60
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 61 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDY 109
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 110 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 169
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 170 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 229
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 230 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 289
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 290 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 319
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 214/331 (64%), Positives = 259/331 (78%)
Query: 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162
MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K+ + I+
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF 222
++ + FK ++ ++ D +++ RL + SS +V+LNLVL++
Sbjct: 86 KVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGDKKDEVYLNLVLDY 134
Query: 223 MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG 282
+PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P+T
Sbjct: 135 VPETVYRVARHYSRAKQTLPMVYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 283 VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELLLGQ
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
Query: 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
P+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP+AI
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433
L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
| RGD|70982 Gsk3b "glycogen synthase kinase 3 beta" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 215/342 (62%), Positives = 262/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ + I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDSGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
+V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ ID+WSA
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDMWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 217/342 (63%), Positives = 260/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDR QE++YT+T+V +G +V K
Sbjct: 15 KPVQQPSSFGSMKVSRDKDGSKVTTVVATPGQGPDRQQEVTYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ T I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDTGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
+V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQALPIIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+PET VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSA
Sbjct: 184 PQNLLLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP+SR++PL + + F ELR
Sbjct: 304 VFRARTPPEAIALCSRLLEYTPTSRLTPLDACAHS-FFDELR 344
|
|
| UNIPROTKB|Q5YJC2 GSK3B "Glycogen synthase kinase-3 beta" [Spermophilus citellus (taxid:9997)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 216/342 (63%), Positives = 261/342 (76%)
Query: 93 EPTNYPP-LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIK 151
+P P MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V +G +V K
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 152 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211
+ + I+++ + FK ++ ++ D +++ RL + SS
Sbjct: 75 LCDSGELVAIKKVLQD-KRFK---------NRELQIMRKLDHCNIV-RLRYFFYSSGEKK 123
Query: 212 LQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIK
Sbjct: 124 DVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
PQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSA
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+K
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VFR RTPP+AI L SRLLEYTP++R++PL+ + + F ELR
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS-FFDELR 344
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5377 | 0.6599 | 0.7571 | yes | N/A |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.4585 | 0.6734 | 0.8081 | yes | N/A |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6465 | 0.7184 | 0.7595 | yes | N/A |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6801 | 0.4954 | 0.4710 | yes | N/A |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5962 | 0.6959 | 0.8535 | yes | N/A |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6435 | 0.7184 | 0.7595 | yes | N/A |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5579 | 0.6846 | 0.7414 | yes | N/A |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6465 | 0.7184 | 0.7595 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 444 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-94 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-62 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-62 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-59 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-57 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-53 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-53 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-52 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-51 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-48 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-48 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-47 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-47 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-47 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-46 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-45 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-45 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-45 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-45 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-43 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-42 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-41 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-41 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-41 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-39 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-39 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-39 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-39 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-38 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-37 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-37 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-37 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-37 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-37 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-36 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-36 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-36 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-36 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-36 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-35 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-35 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-35 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-35 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-34 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-28 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-25 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-23 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-21 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-14 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-12 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-11 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-10 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-08 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-07 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.001 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.001 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.001 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.002 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.002 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.002 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.003 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.003 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.003 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.003 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.004 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 1e-94
Identities = 129/231 (55%), Positives = 172/231 (74%), Gaps = 1/231 (0%)
Query: 203 YTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV 262
YT + + +FLN+V+EF+P+TV+K KHY+++ P F KLY YQL R+LAYIH
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDY 322
ICHRD+KPQNLL++P T LKLCDFGSAK+L+ G+ +VSYICSR+YRAPEL+ GA +Y
Sbjct: 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNY 248
Query: 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 382
TT ID+WS GC++AE++LG P+F G S VDQLV II+VLGTPT +Q++EMNPNY + KFP
Sbjct: 249 TTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFP 308
Query: 383 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
+K KVF TP DAI+ IS+ L+Y P R++P++ + PF +LR
Sbjct: 309 DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA-DPFFDDLR 358
|
Length = 440 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-62
Identities = 96/230 (41%), Positives = 129/230 (56%), Gaps = 13/230 (5%)
Query: 197 ISRLLEYTPSSRISPLQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251
I L E + I L VF L LV EFM +YK+ K + P K Y+Y
Sbjct: 49 IKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG---LPESLIKSYLY 105
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYY 310
QL + LA+ H GI HRD+KP+NLL+N GVLKL DFG A+ P Y+ +R+Y
Sbjct: 106 QLLQGLAFCHSHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWY 164
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
RAPEL+ G Y+T +D+WS GC+ AELL +P+FPG S +DQL +I + LGTP E
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224
Query: 371 EMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ +F FP+ P K+F P A+DL+S++L Y P RI+
Sbjct: 225 KFTSLARNYKFSFPKKAGMPLPKLFP-NASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 6e-62
Identities = 82/206 (39%), Positives = 123/206 (59%), Gaps = 11/206 (5%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV+E+MP + +V + + P K Y+ L + +AY+H GI HRD+KP NLL+
Sbjct: 76 LVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+ GVLK+ DFG A+ L E Y + +R+YRAPEL++GA Y +D+W+ GC+
Sbjct: 133 SA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKV 392
AELL G P+FPG++ ++QL + + LGTP E + P+Y + FP+ K P ++
Sbjct: 191 FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI 250
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRIS 418
F P+A+DL+ LL Y PS R+S
Sbjct: 251 FP-DASPEALDLLKGLLVYDPSKRLS 275
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-59
Identities = 86/206 (41%), Positives = 122/206 (59%), Gaps = 13/206 (6%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV E+ + K+ K K +YQL R LAY H I HRD+KPQN+L+
Sbjct: 75 LVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
N GVLKL DFG A+ G P +Y + + +YRAPE++ G+ Y+T +D+WS GC+
Sbjct: 132 N-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI 188
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKV 392
AE++ G+P+FPGDS +DQL +I ++LGTPT E + P+Y FP+ KV
Sbjct: 189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP-TFPKFPPKDLEKV 247
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRIS 418
R P+ IDL+S++L+Y P+ RIS
Sbjct: 248 LP-RLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-57
Identities = 91/214 (42%), Positives = 118/214 (55%), Gaps = 24/214 (11%)
Query: 215 FLNLVLEFMPETVYKVAKH----YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDI 270
+NLV EFM + KV K + + K Y+ R L Y+H I HRD+
Sbjct: 76 NINLVFEFMETDLEKVIKDKSIVLTPA-------DIKSYMLMTLRGLEYLHSNWILHRDL 128
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC---SRYYRAPELIFGAIDYTTKID 327
KP NLL+ + GVLKL DFG A+ G PN +R+YRAPEL+FGA Y +D
Sbjct: 129 KPNNLLIASD-GVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVD 185
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK-FPQI 384
+WS GC+ AELLL P PGDS +DQL +I + LGTPT E + P+Y EFK FP
Sbjct: 186 MWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPT 245
Query: 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
P ++F DA+DL+ RLL P+ RI+
Sbjct: 246 ---PLKQIFPAA-SDDALDLLQRLLTLNPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 5e-56
Identities = 81/223 (36%), Positives = 125/223 (56%), Gaps = 14/223 (6%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E M ++KV K S Q + + ++YQ+ R L Y+H + HRD+KP N+L+
Sbjct: 81 IVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS----YICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N LK+CDFG A+ + E Y+ +R+YRAPEL+ + YT ID+WS GC
Sbjct: 137 N-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI-REMNPNYTEF--KFPQIKSHPWS 390
+ AELL +P+FPG +DQL I++VLGTP+ E + + + P+ P S
Sbjct: 196 IFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
K+F P+AIDL+ ++L + P RI+ + + P+L +L
Sbjct: 256 KLFP-GASPEAIDLLEKMLVFDPKKRITADEALA-HPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV+E+ Y K Q+ R L Y+H GI HRD+KP+N+
Sbjct: 73 LYLVMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENI 129
Query: 276 LLNPETGVLKLCDFGSAK-HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL+ E GV+K+ DFG AK L +++ + +Y APE++ G Y K+DVWS G +
Sbjct: 130 LLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
L ELL G+P F G++ +DQL I ++LG P + +
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG------------------- 229
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQV 422
+A DLI + L PS R + ++
Sbjct: 230 ---SEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 78/228 (34%), Positives = 118/228 (51%), Gaps = 16/228 (7%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
I RL E S + + +V E+M + + F K Y+ QL
Sbjct: 60 IVRLKEIV----TSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEG 112
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAP 313
L Y+H GI HRDIK N+L+N + GVLKL DFG A+ + Y + + +YR P
Sbjct: 113 LQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYT-KRNSADYTNRVITLWYRPP 170
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE---QIR 370
EL+ GA Y ++D+WS GC+LAEL LG+P+F G + ++QL +I ++ G+PT E +
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
++ P + K + + F+ P A+DL+ +LL P RIS
Sbjct: 231 KL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 5e-53
Identities = 84/208 (40%), Positives = 120/208 (57%), Gaps = 13/208 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV E++ T+ ++ + S P + YI+QL +++AY H I HRDIKP+N+
Sbjct: 75 LYLVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L++ E+GVLKLCDFG A+ L R P Y+ +R+YRAPEL+ G +Y +DVW+ G
Sbjct: 132 LVS-ESGVLKLCDFGFARAL-RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG 189
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGT-PTREQIREM-NPNYTEFKFPQIKSHPWS 390
C++AELL G+P+FPGDS +DQL I K LG P Q NP + FP+ S P S
Sbjct: 190 CIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP-SQPES 248
Query: 391 --KVFRVRTPPDAIDLISRLLEYTPSSR 416
+ + + A+D + L P R
Sbjct: 249 LERRYPGKVSSPALDFLKACLRMDPKER 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-52
Identities = 73/182 (40%), Positives = 110/182 (60%), Gaps = 12/182 (6%)
Query: 247 KLYI-YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-- 303
K YI YQL ++L YIH + HRD+KP N+LLN + V KL DFG A+ L E N
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV-KLADFGLARSLSELEENPENP 167
Query: 304 ----YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
Y+ +R+YRAPE++ G+ YT +D+WS GC+L E+LLG+P+FPG S ++QL +II+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 360 VLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
V+G P+ E I + + P P ++ + DA+DL+ +LL + P+ R
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKR 286
Query: 417 IS 418
++
Sbjct: 287 LT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-52
Identities = 75/214 (35%), Positives = 118/214 (55%), Gaps = 16/214 (7%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L V E+M +Y++ K F + IYQ+ + LA+IH G HRD+KP+NL
Sbjct: 73 LYFVFEYMEGNLYQLMKDRKGKP--FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL 130
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
L++ V+K+ DFG A+ + P Y+ +R+YRAPE++ + Y++ +D+W+ GC++
Sbjct: 131 LVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIM 189
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE-------MNPNYTEFKFPQIKSHP 388
AEL +P+FPG S +DQL +I VLGTPT++ E + F+FPQ
Sbjct: 190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG-----FRFPQFAPTS 244
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
++ P+AIDLI +L + P R + Q
Sbjct: 245 LHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-51
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV+E+ K + + Y+ Q+ +L Y+H GI HRD+KP+N
Sbjct: 71 KLYLVMEYCE---GGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPEN 127
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+LL+ E G +KL DFG A+ L GE +++ + Y APE++ G Y +D+WS G +
Sbjct: 128 ILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVI 185
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
L ELL G+P FPGD DQL+E+ K +G P S
Sbjct: 186 LYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEW--------------DIS---- 224
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQV 422
P+A DLI +LL P R++ +
Sbjct: 225 ----PEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 79/209 (37%), Positives = 119/209 (56%), Gaps = 16/209 (7%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E M +YK+ K ++ N Y ++YQ+ R L YIH + HRD+KP NLLL
Sbjct: 85 IVQELMETDLYKLIK--TQHLSNDHIQY---FLYQILRGLKYIHSANVLHRDLKPSNLLL 139
Query: 278 NPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N LK+CDFG A+ + Y+ +R+YRAPE++ + YT ID+WS GC
Sbjct: 140 N-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NP---NYTEFKFPQIKSHPW 389
+LAE+L +P+FPG + QL I+ VLGTP++E + + + NY + P PW
Sbjct: 199 ILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK-SLPFKPKVPW 257
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+K+F P A+DL+ ++L + P RI+
Sbjct: 258 NKLFP-NADPKALDLLDKMLTFNPHKRIT 285
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 82/234 (35%), Positives = 123/234 (52%), Gaps = 15/234 (6%)
Query: 186 RVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFY 245
R+ P+ + LI L + L LV E M +Y++ K K+ P
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGR--------LALVFELMDMNLYELIK---GRKRPLPEKR 101
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
K Y+YQL +SL ++H GI HRDIKP+N+L+ + LKL DFGS + + P YI
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYI 159
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+R+YRAPE + Y K+D+W+ GCV E+L P+FPG + +DQ+ +I VLGTP
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 366 REQIREMNP-NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
E +++ + + FP K K+ + +DL+ +LL Y P RI+
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLL-PNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 77/210 (36%), Positives = 121/210 (57%), Gaps = 16/210 (7%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V++ M ++ H S Q + + ++YQL R L YIH + HRD+KP NLL+
Sbjct: 85 VVMDLMESDLH----HIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV 140
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS-----YICSRYYRAPELIFGAIDYTTKIDVWSAG 332
N E L++ DFG A+ L Y+ +R+YRAPEL+ +YTT ID+WS G
Sbjct: 141 N-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKSHP 388
C+ AE+L + +FPG + V QL I+ VLG+P+ E + + Y + P+ + P
Sbjct: 200 CIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVP 258
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
WSK+F + P+A+DL+S++L++ P RI+
Sbjct: 259 WSKIFPKAS-PEALDLLSQMLQFDPEERIT 287
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 91/242 (37%), Positives = 130/242 (53%), Gaps = 23/242 (9%)
Query: 190 PPDAIDLISRLLEYTPSSRISPLQVF-----LNLVLEFMPETVYKVAKHY--SKSKQNFP 242
P AI IS L E + + L V L LV EF+ + K Y S
Sbjct: 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLD 97
Query: 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV 302
K Y+YQL + +AY H + HRD+KPQNLL++ G LKL DFG A+ G P
Sbjct: 98 PPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVR 154
Query: 303 SY---ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
+Y + + +YRAPE++ G+ Y+T +D+WS GC+ AE++ +P+FPGDS +DQL I +
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214
Query: 360 VLGTPTREQ---IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
LGTP + + + P+Y FP+ SKV D +DL+S++L Y P+ R
Sbjct: 215 TLGTPDEDVWPGVTSL-PDYKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKR 271
Query: 417 IS 418
IS
Sbjct: 272 IS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 8e-47
Identities = 79/226 (34%), Positives = 123/226 (54%), Gaps = 15/226 (6%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
I L +TP+S + Q LV M + + K S + + +YQ+ R
Sbjct: 77 IGLLDVFTPASSLEDFQDVY-LVTHLMGADLNNIVKCQKLSDD-----HIQFLVYQILRG 130
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
L YIH GI HRD+KP N+ +N E LK+ DFG A+H + Y+ +R+YRAPE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIM 187
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP-- 374
+ Y +D+WS GC++AELL G+ +FPG +DQL I+ ++GTP E +++++
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 375 --NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
NY + PQ+ + +VF P AIDL+ ++L P RI+
Sbjct: 248 ARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRIT 291
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 83/232 (35%), Positives = 128/232 (55%), Gaps = 20/232 (8%)
Query: 197 ISRLL--EYTPSSRISPLQVFLNLVLEFMPETVYK-VAKHYSKSKQNFPCFYTKLYIYQL 253
I RLL E+ P L LV E++ + K + + + P K ++YQL
Sbjct: 63 IVRLLDVEHVEEKNGKPS---LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYY 310
+ +A+ H G+ HRD+KPQNLL++ + G+LK+ D G + P SY I + +Y
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWY 177
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
RAPE++ G+ Y+T +D+WS GC+ AE+ QP+FPGDS + QL+ I K+LGTPT +
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW- 236
Query: 371 EMNPNYTEFK----FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
P ++ + FPQ K S+ P+ +DL+ ++L Y P+ RIS
Sbjct: 237 ---PGVSKLRDWHEFPQWKPQDLSRAVP-DLSPEGLDLLQKMLRYDPAKRIS 284
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 76/192 (39%), Positives = 106/192 (55%), Gaps = 12/192 (6%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG----- 290
+S Q + + +IYQ+ L YIH + HRD+KP NLL+N + LK+CDFG
Sbjct: 97 RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGF 155
Query: 291 SAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG 350
S Y+ +R+YRAPE++ YT IDVWS GC+LAELL +P+F G
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215
Query: 351 VDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406
VDQL +I++VLGTP E + + NY P I P+ +F P A+DL+
Sbjct: 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYI-RSLPNIPKKPFESIF-PNANPLALDLLE 273
Query: 407 RLLEYTPSSRIS 418
+LL + P+ RIS
Sbjct: 274 KLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 70/179 (39%), Positives = 106/179 (59%), Gaps = 10/179 (5%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
+L+++QL R LAY H + HRD+KPQNLL++ E G LKL DFG A+ + P+ +Y
Sbjct: 106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLAR--AKSVPSKTYSN 162
Query: 305 -ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLG 362
+ + +YR P+++ G+ +Y+T +D+W GC+ E+ G+P+FPG + V DQL +I +VLG
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG 222
Query: 363 TPTREQIR--EMNPNYTEFKFPQIKSHPWSKVF-RVRTPPDAIDLISRLLEYTPSSRIS 418
TPT E NP + + FP P R+ P +L + L+Y P RIS
Sbjct: 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 79/205 (38%), Positives = 120/205 (58%), Gaps = 10/205 (4%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E M ++++ + S++ + C Y ++YQL R L YIH + HRD+KP NLLL
Sbjct: 86 IVYELMDTDLHQIIRS-SQTLSDDHCQY---FLYQLLRGLKYIHSANVLHRDLKPSNLLL 141
Query: 278 NPETGVLKLCDFGSAK-HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336
N LK+CDFG A+ +G+ Y+ +R+YRAPEL+ +YTT IDVWS GC+ A
Sbjct: 142 N-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200
Query: 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVF 393
ELL +P+FPG V QL I ++LG+P+ E + + N + P ++++F
Sbjct: 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF 260
Query: 394 RVRTPPDAIDLISRLLEYTPSSRIS 418
P AIDL+ ++L + PS RI+
Sbjct: 261 P-HANPLAIDLLEKMLVFDPSKRIT 284
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-45
Identities = 85/218 (38%), Positives = 123/218 (56%), Gaps = 26/218 (11%)
Query: 213 QVFLNLVLEFMPETVYKVAKHYSKS-----KQNFPCFYTKLYIYQLFRSLAYIHVLGICH 267
++++ V+E++ +H KS KQ F K + QL +A++H I H
Sbjct: 80 KIYM--VMEYV--------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 268 RDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTT 324
RD+K NLLLN G+LK+CDFG A+ G P Y + + +YRAPEL+ GA +Y+T
Sbjct: 130 RDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKF 381
ID+WS GC+ AELL +P+FPG S +DQL +I K+LGTPT + E+ P + F
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL-PGAKKKTF 245
Query: 382 PQIKSHPWSKVFRVRTPPDA-IDLISRLLEYTPSSRIS 418
+ + K F + D DL++RLL Y P+ RIS
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 81/216 (37%), Positives = 121/216 (56%), Gaps = 14/216 (6%)
Query: 212 LQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGIC 266
++VF L LV EF+ TV + Y + Y++Q+ R + + H I
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 267 HRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTK 325
HRDIKP+N+L++ +GV+KLCDFG A+ L GE Y+ +R+YRAPEL+ G Y
Sbjct: 123 HRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT--PTREQIREMNPNYTEFKFPQ 383
+D+W+ GC++ E+L G+P+FPGDS +DQL IIK LG P ++I + NP + + P+
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241
Query: 384 IKS-HPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+K P K F + +DL + L P R S
Sbjct: 242 VKEIEPLEKRF-PKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 84/240 (35%), Positives = 132/240 (55%), Gaps = 16/240 (6%)
Query: 189 TPPDAIDLISRLLEYTPSSRISPLQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPC 243
TP AI IS + E + + V L LV E+M + + K + +
Sbjct: 41 TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHG-VRGALDP 99
Query: 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS 303
K + YQL + +A+ H + HRD+KPQNLL+N + G LKL DFG A+ G P +
Sbjct: 100 NTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN-KRGELKLADFGLARAF--GIPVNT 156
Query: 304 Y---ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV 360
+ + + +YRAP+++ G+ Y+T ID+WS GC++AE++ G+P+FPG + DQL++I ++
Sbjct: 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
Query: 361 LGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+GTPT ++ P Y + FP+ ++F P IDL+ RLL+ P RIS
Sbjct: 217 MGTPTESTWPGISQLPEY-KPTFPRYPPQDLQQLFP-HADPLGIDLLHRLLQLNPELRIS 274
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 91/243 (37%), Positives = 131/243 (53%), Gaps = 25/243 (10%)
Query: 190 PPDAIDLISRLLEYTPSSRISPLQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPCF 244
P AI IS L E + + L V L LV EF+ + + K + P
Sbjct: 43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASPLSGIPLP 100
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
K Y++QL + LA+ H + HRD+KPQNLL+N E G +KL DFG A+ G P +Y
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAF--GVPVRTY 157
Query: 305 ---ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ + +YRAPE++ G Y+T +D+WS GC+ AE++ + +FPGDS +DQL I + L
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217
Query: 362 GTPTREQ---IREMNPNYTEFKFPQIKSHPWSKVFRVRTPP---DAIDLISRLLEYTPSS 415
GTP + + P+Y FP+ +SKV PP D DL+S++L Y P+
Sbjct: 218 GTPDEVVWPGVTSL-PDYKP-SFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNK 271
Query: 416 RIS 418
RIS
Sbjct: 272 RIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-41
Identities = 72/178 (40%), Positives = 110/178 (61%), Gaps = 11/178 (6%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
K Y+YQ+ R +AY H + HRD+KPQNLL++ T LKL DFG A+ G P ++
Sbjct: 105 KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTH 162
Query: 305 -ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
+ + +YRAPE++ G+ Y+T +D+WS GC+ AE++ +P+FPGDS +D+L +I ++LGT
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT 222
Query: 364 PTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRT-PPDAIDLISRLLEYTPSSRIS 418
P E + P+Y FP+ + V V T P +DL+S++L PS RI+
Sbjct: 223 PNEETWPGVTSLPDYKS-AFPKWPPKDLATV--VPTLEPAGVDLLSKMLRLDPSKRIT 277
|
Length = 294 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-41
Identities = 78/213 (36%), Positives = 124/213 (58%), Gaps = 13/213 (6%)
Query: 209 ISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHR 268
ISPL+ + V E + ++++ KQ + + ++YQ+ R L Y+H G+ HR
Sbjct: 79 ISPLED-IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQILRGLKYVHSAGVVHR 132
Query: 269 DIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328
D+KP N+L+N E LK+CDFG A+ ++ Y+ +RYYRAPE++ Y ++D+
Sbjct: 133 DLKPSNILIN-ENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIK 385
WSAGC+ AE+L G+P+FPG V+Q I +LGTP + I + + N F P+ +
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249
Query: 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
P+S+ F+ P AIDL+ ++L + P RIS
Sbjct: 250 PVPFSEKFK-NADPSAIDLLEKMLVFDPQKRIS 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 75/216 (34%), Positives = 113/216 (52%), Gaps = 14/216 (6%)
Query: 212 LQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGIC 266
++VF L+LV E+ TV + + P K I+Q +++ + H
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 267 HRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYYRAPELIFGAIDYTTK 325
HRD+KP+N+L+ + G +KLCDFG A+ L + + Y+ +R+YRAPEL+ G Y
Sbjct: 123 HRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLG--TPTREQIREMNPNYTEFKFPQ 383
+DVW+ GCV AELL GQP++PG S VDQL I K LG P +QI N + P+
Sbjct: 182 VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241
Query: 384 IKS-HPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
++ P F A+ + L+ P+ R+S
Sbjct: 242 PETREPLESKFP-NISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 79/228 (34%), Positives = 128/228 (56%), Gaps = 15/228 (6%)
Query: 195 DLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
++I L +TP + F LV+ FM + K+ KH S+ + +YQ+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFY-LVMPFMGTDLGKLMKHEKLSEDRI-----QFLVYQML 128
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
+ L YIH GI HRD+KP NL +N E LK+ DFG A+ Y+ +R+YRAPE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQ--TDSEMTGYVVTRWYRAPE 185
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
+I + YT +D+WS GC++AE+L G+P+F G +DQL+EI+KV GTP++E ++++
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 375 ----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
NY + K P+ + + + P A++++ ++L SRI+
Sbjct: 246 EDAKNYVK-KLPRFRKKDFRSLLP-NANPLAVNVLEKMLVLDAESRIT 291
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 73/179 (40%), Positives = 104/179 (58%), Gaps = 13/179 (7%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
K +++QL + LA+ H + HRD+KPQNLL+N + G LKL DFG A+ G P Y
Sbjct: 102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAF--GIPVRCYSA 158
Query: 305 -ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLG 362
+ + +YR P+++FGA Y+T ID+WSAGC+ AEL G+P+FPG+ DQL I ++LG
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
Query: 363 TPTREQIREMN--PNYTEF-KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
TPT E ++ P+Y + +P S V + DL+ LL P RIS
Sbjct: 219 TPTEESWPGVSKLPDYKPYPMYPATTS--LVNVVP-KLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 84/211 (39%), Positives = 124/211 (58%), Gaps = 18/211 (8%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYT-KLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV E++ + K Y + N + K++++QL R L+Y H I HRD+KPQN
Sbjct: 78 LTLVFEYLDSDL----KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSA 331
LL+N E G LKL DFG A+ + P +Y + + +YR P+++ G+ +Y+T ID+W
Sbjct: 134 LLIN-EKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK---FPQIKSHP 388
GC+L E+ G+PMFPG + ++L I ++LGTPT E + N EF+ FPQ ++ P
Sbjct: 191 GCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN-EEFRSYLFPQYRAQP 249
Query: 389 W-SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ R+ T D IDL+S LL Y SRIS
Sbjct: 250 LINHAPRLDT--DGIDLLSSLLLYETKSRIS 278
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 83/246 (33%), Positives = 127/246 (51%), Gaps = 40/246 (16%)
Query: 209 ISPLQVFLN-------LVLEFMPETVYKVAKHYSKSK-QNFPCFYTKLYIYQLFRSLAYI 260
+S ++VFL L+ ++ ++++ K + ++K + P K ++Q+ + Y+
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 261 HVLGICHRDIKPQNLLL---NPETGVLKLCDFGSA-------KHLVRGEPNVSYICSRYY 310
H + HRD+KP N+L+ PE GV+K+ D G A K L +P V I +Y
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---WY 181
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG---------VDQLVEIIKVL 361
RAPEL+ GA YT ID+W+ GC+ AELL +P+F G DQL I +VL
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 362 GTPTREQ---IREMNPNY----TEFKFPQIKSHPWSKVFRVRTPPD--AIDLISRLLEYT 412
GTPT + I++M P Y +FK S+ +K PD DL+ +LLEY
Sbjct: 242 GTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 413 PSSRIS 418
P+ RI+
Sbjct: 301 PTKRIT 306
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 68/182 (37%), Positives = 103/182 (56%), Gaps = 12/182 (6%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
+ K+++YQ+ R L Y+H GI HRDIKP NLL+N VLK+CDFG A+ EP+ S
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLAR---VEEPDESK 159
Query: 305 -----ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
+ ++YYRAPE++ G+ YT+ +D+WS GC+ AELL + +F S + QL I
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219
Query: 360 VLGTPTREQIREMNPNYTEFKFPQIKSHP-WSKVFRVRTPP--DAIDLISRLLEYTPSSR 416
+LGTP+ E +R P ++ + + +A+ L+ R+L + P R
Sbjct: 220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279
Query: 417 IS 418
IS
Sbjct: 280 IS 281
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 82/210 (39%), Positives = 120/210 (57%), Gaps = 13/210 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L V E+M +A++ + + +L+++QL R LAYIH I HRD+KPQNL
Sbjct: 78 LTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L++ G LKL DFG A+ + P+ +Y + + +YR P+++ GA DY++ +D+W AG
Sbjct: 135 LIS-YLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG 191
Query: 333 CVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPW 389
C+ E+L GQP FPG S V +QL +I VLG PT + ++ PNY F K
Sbjct: 192 CIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQL 251
Query: 390 SKVF-RVRTPPDAIDLISRLLEYTPSSRIS 418
V+ R+ PP A DL S++L P RIS
Sbjct: 252 RVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 77/224 (34%), Positives = 115/224 (51%), Gaps = 27/224 (12%)
Query: 213 QVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
F+NLV++ M + KV K K + Q+ L +H HRD+ P
Sbjct: 92 GDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147
Query: 273 QNLLLNPETGVLKLCDFGSA---------------KHLVRGEPNVSYICSRYYRAPELIF 317
N+ +N + G+ K+ DFG A + + R E S + + +YRAPEL+
Sbjct: 148 ANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM 206
Query: 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE---QIREMNP 374
GA Y +D+WS GC+ AELL G+P+FPG++ +DQL I ++LGTP + Q +++ P
Sbjct: 207 GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-P 265
Query: 375 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
YTEF + K +F + DAIDL+ LL+ P RIS
Sbjct: 266 LYTEFTPRKPKD--LKTIFPNAS-DDAIDLLQSLLKLNPLERIS 306
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-37
Identities = 76/176 (43%), Positives = 107/176 (60%), Gaps = 9/176 (5%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSY 304
+ YIYQL +++ + H I HRDIKP+NLL++ VLKLCDFG A++L G Y
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEY 161
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ +R+YR+PEL+ GA Y +D+WS GC+L EL GQP+FPG+S +DQL I KVLG
Sbjct: 162 VATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL 220
Query: 365 TREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDAI--DLISRLLEYTPSSR 416
EQ++ NP + +FP + +HP S R + DL+ LL+ P+ R
Sbjct: 221 PAEQMKLFYSNPRFHGLRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 65/196 (33%), Positives = 96/196 (48%), Gaps = 30/196 (15%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
K Y+ QL + Y+H I HRDIK N+L++ G+LK+ DFG A+ PN
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 305 ----------ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQL 354
+ +R+YR PEL+ G YTT +D+W GCV AE+ +P+ G S +DQL
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 355 VEIIKVLGTPTREQIREMNPNYT-------EFKFPQIKSHP--WSKVFRVRTPPDAIDLI 405
I K+ GTPT E P + F ++P + F + P+ +DL+
Sbjct: 237 HLIFKLCGTPTEETW----PGWRSLPGCEGVHSFT---NYPRTLEERFG-KLGPEGLDLL 288
Query: 406 SRLLEYTPSSRISPLQ 421
S+LL P R++
Sbjct: 289 SKLLSLDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 67/177 (37%), Positives = 106/177 (59%), Gaps = 9/177 (5%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
KL+++QL R L Y H + HRD+KPQNLL+N E G LKL DFG A+ + P +Y
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLAR--AKSIPTKTYSN 163
Query: 305 -ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
+ + +YR P+++ G+ DY+T+ID+W GC+ E+ G+P+FPG + +QL I ++LGT
Sbjct: 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT 223
Query: 364 PTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
PT E + N + + +P+ ++ R D +L+S+LL++ RIS
Sbjct: 224 PTEETWPGILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRIS 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 85/247 (34%), Positives = 130/247 (52%), Gaps = 23/247 (9%)
Query: 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFP 242
K+ R+ PD +++ +L P SR +++ V E M +++V K + +
Sbjct: 51 KLLRLLRHPDIVEIKHIML---PPSRREFKDIYV--VFELMESDLHQVIK----ANDDLT 101
Query: 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGEPN 301
+ + ++YQL R+L YIH + HRD+KP+N+L N + LK+CDFG A+
Sbjct: 102 PEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTA 160
Query: 302 V---SYICSRYYRAPEL---IFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLV 355
+ Y+ +R+YRAPEL F YT ID+WS GC+ AE+L G+P+FPG + V QL
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218
Query: 356 EIIKVLGTPTREQI-REMNPNYTEFKFPQIKSHP--WSKVFRVRTPPDAIDLISRLLEYT 412
I +LGTP+ E I R N + K P +S+ F P A+ L+ RLL +
Sbjct: 219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFD 277
Query: 413 PSSRISP 419
P R +
Sbjct: 278 PKDRPTA 284
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 73/196 (37%), Positives = 103/196 (52%), Gaps = 29/196 (14%)
Query: 240 NFPCFYT----KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL 295
N P ++ K + QL R L Y+H I HRD+K NLLL + G LK+ DFG A+
Sbjct: 100 NMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLAR-- 156
Query: 296 VRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD 352
G P + + +YRAPEL+ G YTT ID+W+ GC+LAELL +P+ PG S ++
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
Query: 353 QLVEIIKVLGTPTREQI----REMNPNYTEFKFPQ-----IKSH-PWSKVFRVRTPPDAI 402
QL II++LGTP E I ++ P +F P+ +K PW +
Sbjct: 217 QLDLIIQLLGTPN-ESIWPGFSDL-PLVGKFTLPKQPYNNLKHKFPWLS-------EAGL 267
Query: 403 DLISRLLEYTPSSRIS 418
L++ LL Y P R +
Sbjct: 268 RLLNFLLMYDPKKRAT 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 7e-36
Identities = 77/243 (31%), Positives = 126/243 (51%), Gaps = 20/243 (8%)
Query: 197 ISRLLE-YTPSSRISPLQVFLNLVLEFMPETVYKV-AKHYSKSKQNFPCFYTKLYIYQLF 254
+ LL+ +T + Q F LV+ +M + K+ S+ K + +YQ+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFY-LVMPYMQTDLQKIMGHPLSEDKVQY-------LVYQML 127
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
L YIH GI HRD+KP NL +N E LK+ DFG A+H Y+ +R+YRAPE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN- 373
+I + Y +D+WS GC++AE+L G+ +F G +DQL +I+KV G P E ++++
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 374 ---PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430
+Y + P+ +S +F + P A+DL+ ++LE R++ + P+
Sbjct: 245 KAAKSYIK-SLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALE-HPYFD 301
Query: 431 ELR 433
R
Sbjct: 302 SFR 304
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 67/181 (37%), Positives = 107/181 (59%), Gaps = 9/181 (4%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
+ + IYQ+ R L YIH I HRD+KP NL +N E LK+ DFG A+H + Y
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARH--TDDEMTGY 177
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ +R+YRAPE++ + Y +D+WS GC++AELL G+ +FPG +DQL I++++GTP
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 365 TREQIREMNP----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 420
E +++++ NY + Q+ ++ VF + P A+DL+ ++L RI+
Sbjct: 238 GAELLKKISSESARNYIQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAA 295
Query: 421 Q 421
Q
Sbjct: 296 Q 296
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 67/177 (37%), Positives = 105/177 (59%), Gaps = 7/177 (3%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
+ + IYQL R L YIH GI HRD+KP N+ +N E L++ DFG A+ + Y
Sbjct: 119 HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQ--ADDEMTGY 175
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ +R+YRAPE++ + Y +D+WS GC++AELL G+ +FPG+ +DQL I++V+GTP
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
Query: 365 TREQIREMNPNYTEFKF---PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ E +++++ + P + K+FR P AIDL+ ++L RIS
Sbjct: 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPL-AIDLLEKMLVLDSDKRIS 291
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 82/243 (33%), Positives = 124/243 (51%), Gaps = 24/243 (9%)
Query: 190 PPDAIDLISRLLEYTPSSRISPLQVF-----LNLVLEFMPETVYKVAKHYSKSKQNFPCF 244
P AI IS L E + + V L L+ EF+ + K K +
Sbjct: 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-MDAE 101
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
K Y+YQ+ + + + H + HRD+KPQNLL++ GV+KL DFG A+ G P Y
Sbjct: 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVY 158
Query: 305 ---ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ + +YRAPE++ G+ Y+T +D+WS G + AE+ +P+F GDS +DQL I ++L
Sbjct: 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL 218
Query: 362 GTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPP----DAIDLISRLLEYTPSS 415
GTPT + + P+Y FP+ W K D +DL+ ++L Y P+
Sbjct: 219 GTPTEDVWPGVTSLPDYKN-TFPK-----WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK 272
Query: 416 RIS 418
RIS
Sbjct: 273 RIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 75/209 (35%), Positives = 120/209 (57%), Gaps = 14/209 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYT-KLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV E++ + + K Y N + K+++YQ+ R LAY H + HRD+KPQN
Sbjct: 79 LTLVFEYLDKDL----KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSA 331
LL+N E G LKL DFG A+ + P +Y + + +YR P+++ G+ +Y+T+ID+W
Sbjct: 135 LLIN-ERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV 191
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPW 389
GC+ E+ G+P+FPG + D+L I ++LGTPT E ++ N + + FP+ K P
Sbjct: 192 GCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPL 251
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
R + I+L+++ L+Y RIS
Sbjct: 252 IN-HAPRLDTEGIELLTKFLQYESKKRIS 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 47/270 (17%)
Query: 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETV 227
Y E ++ +H ++I L +TP + Q + LV+E M +
Sbjct: 63 YRELVLMKLVNHK--------------NIIGLLNVFTPQKSLEEFQD-VYLVMELMDANL 107
Query: 228 YKVAK----HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGV 283
+V + H S +YQ+ + ++H GI HRD+KP N+++ +
Sbjct: 108 CQVIQMDLDHERMS----------YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-T 156
Query: 284 LKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
LK+ DFG A+ Y+ +RYYRAPE+I G + Y +D+WS GC++ E++ G
Sbjct: 157 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTV 215
Query: 344 MFPGDSGVDQLVEIIKVLGTPTREQIREMNP---NYTEFKFPQIKSHPWSKVF-RVRTPP 399
+FPG +DQ +II+ LGTP+ E + + P NY E + P+ + + ++F V PP
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPP 274
Query: 400 D-----------AIDLISRLLEYTPSSRIS 418
D A DL+S++L P RIS
Sbjct: 275 DSESHNKLKASQARDLLSKMLVIDPEKRIS 304
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 61/180 (33%), Positives = 95/180 (52%), Gaps = 26/180 (14%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY 309
+ QL R + ++H I HRD+KPQN+L+ + G +K+ DFG A+ S + + +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTSVVVTLW 171
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
YRAPE++ + Y T +D+WS GC+ AEL +P+F G S DQL +I V+G P+ E+
Sbjct: 172 YRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE- 229
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTP-----------PDAIDLISRLLEYTPSSRIS 418
+P+ S P S F TP + +DL+ ++L + P RIS
Sbjct: 230 -----------WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 61/211 (28%), Positives = 114/211 (54%), Gaps = 20/211 (9%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E+M + V + + +L++YQL R L YIH + HRD+KP N+ +
Sbjct: 93 IVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSY-------ICSRYYRAPELIFGAIDYTTKIDVWS 330
N E VLK+ DFG A+ + +P+ S+ + +++YR+P L+ +YT ID+W+
Sbjct: 148 NTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204
Query: 331 AGCVLAELLLGQPMFPGDSGVDQL---VEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
AGC+ AE+L G+P+F G ++Q+ +E + V+ R ++ + P++ + +
Sbjct: 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPR-R 263
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
P + P+A+D + ++L + P R++
Sbjct: 264 PLRDLL-PGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+E+ ++ + K + Q+ L Y+H GI HRD+KP+
Sbjct: 65 HLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ + G +KL DFG +K L + + I + Y APE++ G Y+ K D+WS G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 333 CVLAEL 338
+L EL
Sbjct: 182 VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 60/214 (28%), Positives = 87/214 (40%), Gaps = 36/214 (16%)
Query: 207 SRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGI 265
S + LN+ LE++ ++ K P + Y Q+ LAY+H GI
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSL----SSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 266 CHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR---YYRAPELIFGAIDY 322
HRDIK N+L++ + GV+KL DFG AK L E R Y+ APE+I G +Y
Sbjct: 123 VHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EY 180
Query: 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 382
D+WS GC + E+ G+P + + I G P P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-----------------P 223
Query: 383 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
+I H +A D + + L P R
Sbjct: 224 EIPEH---------LSEEAKDFLRKCLRRDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 72/292 (24%), Positives = 113/292 (38%), Gaps = 51/292 (17%)
Query: 142 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 201
D+ + +KVL + +E+ E + +HP + I +L
Sbjct: 19 ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN--------------IVKLY 64
Query: 202 EYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261
++ L LV+E++ + K + Q+ +L Y+H
Sbjct: 65 DFFQDEG------SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-------SYICSRYYRAPE 314
GI HRDIKP+N+LL+ + V+KL DFG AK L + + + Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 315 LIFG--AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQI 369
++ G ++ D+WS G L ELL G P F G+ Q ++II L TP
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----- 233
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
+ P S A DL+ +LL P +R+S
Sbjct: 234 --------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 68/182 (37%), Positives = 107/182 (58%), Gaps = 16/182 (8%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-- 304
KL+++QL R L+YIH I HRD+KPQNLL++ +TG LKL DFG A+ + P+ +Y
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLAR--AKSVPSHTYSN 162
Query: 305 -ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLG 362
+ + +YR P+++ G+ +Y+T +D+W GC+ E++ G FPG + DQL I VLG
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222
Query: 363 TPTREQIREMN--PNYTEFKFPQIKS----HPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
TP + ++ P++ +F W+K+ V A DL S+LL+ P +R
Sbjct: 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNR 279
Query: 417 IS 418
+S
Sbjct: 280 LS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 61/176 (34%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRY 309
QL L Y H HRDIK N+LLN G +KL DFG A+ E P + + + +
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
YR PEL+ G Y IDVWS GC+L EL +P+F + + QL I ++ G+P
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC---- 238
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVR-------TPPDAIDLISRLLEYTPSSRIS 418
+ P+ K P + K +R R P A+DL+ +L PS R +
Sbjct: 239 PAVWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/239 (31%), Positives = 123/239 (51%), Gaps = 26/239 (10%)
Query: 195 DLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
++IS L +TP + Q + LV+E M + +V H + +YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQD-VYLVMELMDANLCQVI-HMELDHERM-----SYLLYQML 133
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
+ ++H GI HRD+KP N+++ + LK+ DFG A+ Y+ +RYYRAPE
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
+I G + Y +D+WS GC++ EL+ G +F G +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 375 ---NYTEFKFPQIKSHPWSKVF------------RVRTPPDAIDLISRLLEYTPSSRIS 418
NY E + PQ + ++F +++T A DL+S++L P RIS
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKT-SQARDLLSKMLVIDPDKRIS 308
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 73/238 (30%), Positives = 124/238 (52%), Gaps = 24/238 (10%)
Query: 195 DLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
++I L +TP + Q + +V+E M + +V + ++ +YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQD-VYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
+ ++H GI HRD+KP N+++ + LK+ DFG A+ Y+ +RYYRAPE
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
+I G + Y +D+WS GC++ E++ G +FPG +DQ ++I+ LGTP E ++++ P
Sbjct: 196 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 375 ---NYTEFKFPQIKSHPWSKVF-RVRTPPD----------AIDLISRLLEYTPSSRIS 418
Y E + P+ + + K+F V P D A DL+S++L S RIS
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 73/238 (30%), Positives = 124/238 (52%), Gaps = 24/238 (10%)
Query: 195 DLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
++IS L +TP + Q + LV+E M + +V + ++ +YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQD-VYLVMELMDANLCQVIQMELDHER------MSYLLYQML 129
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
+ ++H GI HRD+KP N+++ + LK+ DFG A+ Y+ +RYYRAPE
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
+I G + Y +D+WS GC++ E++ + +FPG +DQ ++I+ LGTP E ++++ P
Sbjct: 189 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 375 ---NYTEFKFPQIKSHPWSKVFRVRTPP-----------DAIDLISRLLEYTPSSRIS 418
NY E + P+ + K+F P A DL+S++L P+ RIS
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 19/185 (10%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV---RGEPN-- 301
K + L L YIH I HRD+K N+L+ + G+LKL DFG A+ +PN
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 302 VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ + + +YR PEL+ G DY ID+W AGC++AE+ P+ G++ QL I ++
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240
Query: 362 GTPTRE---QIREMNPNYTEFKFPQ-----IKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
G+ T E + ++ + + + PQ +K V P A+DLI +LL P
Sbjct: 241 GSITPEVWPGVDKL-ELFKKMELPQGQKRKVKERLKPYV----KDPHALDLIDKLLVLDP 295
Query: 414 SSRIS 418
+ RI
Sbjct: 296 AKRID 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+V+EF ++ + K +++ +L + L Y+H GI HRDIK N+L
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336
L G +KL DFG + L + + + + Y+ APE+I G Y K D+WS G
Sbjct: 131 LT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAI 188
Query: 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396
EL G+P + + + + I G P WS F+
Sbjct: 189 ELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR--NPEKWSDEFK-- 228
Query: 397 TPPDAIDLISRLLEYTPSSRISPLQ 421
D + + L+ P R + Q
Sbjct: 229 ------DFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 39/209 (18%)
Query: 213 QVFLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDI 270
+ L LVLE+ P E + H SK + F + Y ++ +L Y+H LGI +RD+
Sbjct: 65 EEKLYLVLEYAPGGE----LFSHLSKEGR-FSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVW 329
KP+N+LL+ G +KL DFG AK L + C + Y APE++ G Y +D W
Sbjct: 120 KPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWW 177
Query: 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389
S G +L E+L G+P F + ++ E I +FP+ S
Sbjct: 178 SLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPLRFPEFLS--- 217
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
P+A DLIS LL+ P+ R+
Sbjct: 218 ---------PEARDLISGLLQKDPTKRLG 237
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 43/211 (20%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV+E++P + + ++ + ++YI ++ +L Y+H GI HRD+KP N
Sbjct: 68 LYLVMEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 275 LLLNPETGVLKLCDFG---------SAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
+L++ G LKL DFG + + + + Y APE+I G ++
Sbjct: 124 ILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-GHSKT 181
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385
+D WS GC+L E L+G P F G+ T E+I + N K
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGE----------------TPEEIFQ---NILNGKI---- 218
Query: 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
W + V +AIDLIS+LL P R
Sbjct: 219 --EWPEDVEV--SDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 8/171 (4%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY 309
++QL R L ++H + HRD+KPQN+L+ +G +KL DFG A+ S + + +
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLW 174
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
YRAPE++ + Y T +D+WS GC+ AE+ +P+F G S VDQL +I+ V+G P E
Sbjct: 175 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI--DLISRLLEYTPSSRIS 418
P S + + T D + DL+ + L + P+ RIS
Sbjct: 234 ----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 22/160 (13%)
Query: 194 IDLISRL--------LEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCF 244
IDL+ L + +S L ++LE+ ++ ++ K + FP
Sbjct: 50 IDLLKNLKHPNIVKYIGSIETSD------SLYIILEYAENGSLRQIIKKFGP----FPES 99
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVS 303
+Y+YQ+ + LAY+H G+ HRDIK N+L + GV+KL DFG A L + + S
Sbjct: 100 LVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDAS 158
Query: 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
+ + Y+ APE+I + +T D+WS GC + ELL G P
Sbjct: 159 VVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 7e-23
Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 4/170 (2%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
Q R L ++H I HRD+KP+N+L+ G +KL DFG A+ + + +YR
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
APE++ + Y T +D+WS GC+ AE+ +P+F G+S DQL +I ++G P +
Sbjct: 175 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW-P 232
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
+ F P V A L+ +L + P RIS +
Sbjct: 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGA-QLLLEMLTFNPHKRISAFR 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 43/265 (16%)
Query: 197 ISRLLEYTPSSRISPLQVFLN-------LVLEFMPETVYKVAKHYSKSKQN-----FPCF 244
I+ L E + IS +VFL+ L+ ++ ++ + K + SK N P
Sbjct: 49 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSA-------KH 294
K +YQ+ + Y+H + HRD+KP N+L+ PE G +K+ D G A K
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 295 LVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF--------- 345
L +P + + +YRAPEL+ GA YT ID+W+ GC+ AELL +P+F
Sbjct: 169 LADLDP---VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225
Query: 346 PGDSGVDQLVEIIKVLGTPTR---EQIREMNPNYTEFK------FPQIKSHPWSKVFRVR 396
DQL I V+G P E I++M + T K + + + +V+
Sbjct: 226 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 285
Query: 397 TPPDAIDLISRLLEYTPSSRISPLQ 421
A L+ +LL P RI+ Q
Sbjct: 286 PDSKAFHLLQKLLTMDPIKRITSEQ 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 54/176 (30%), Positives = 79/176 (44%), Gaps = 27/176 (15%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+ YI + + Y+H GI +RD+KP+NLLL+ G +KL DFG AK L G+ ++
Sbjct: 95 ARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFC 153
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ Y APE+I Y +D WS G +L ELL G+P F D + + G
Sbjct: 154 GTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-- 210
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
++ +FP A DLI +LL P R+ L+
Sbjct: 211 -GKL----------EFPNYID------------KAAKDLIKQLLRRNPEERLGNLK 243
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 63/228 (27%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L VLE+ P E + + K+ S C T+ Y ++ +L Y+H GI HRD+KP+
Sbjct: 77 LYFVLEYAPNGELLQYIRKYGSLD---EKC--TRFYAAEILLALEYLHSKGIIHRDLKPE 131
Query: 274 NLLLNPETGVLKLCDFGSAKHL----VRGEPNVSYICSRY-----------------YRA 312
N+LL+ + +K+ DFG+AK L Y +
Sbjct: 132 NILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190
Query: 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLV--EIIKVLGTPTREQIR 370
PEL+ D+W+ GC++ ++L G+P F G + + L +I+K
Sbjct: 191 PELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKILK----------- 236
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
E+ FP PPDA DLI +LL P R+
Sbjct: 237 ------LEYSFPPN------------FPPDAKDLIEKLLVLDPQDRLG 266
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQN 274
+++ +E+M + K + + P + + L Y+H I HRD+KP N
Sbjct: 74 ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+L+N G +KLCDFG + LV +++ + Y APE I G DY+ K D+WS G
Sbjct: 132 ILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLS 188
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
L EL G+ FP D I ++L + I P P++ S +S
Sbjct: 189 LIELATGR--FPYPPENDPPDGIFELL-----QYIVNEPP-------PRLPSGKFS---- 230
Query: 395 VRTPPDAIDLISRLLEYTPSSRISP 419
PD D ++ L P R S
Sbjct: 231 ----PDFQDFVNLCLIKDPRERPSY 251
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 43/96 (44%), Positives = 62/96 (64%)
Query: 141 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 200
S VDQLV II+VLGTPT +Q++EMNPNY + KFP +K KVF TP DAI+ IS+
Sbjct: 275 SSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQF 334
Query: 201 LEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK 236
L+Y P R++P++ + + + + K+ K+ K
Sbjct: 335 LKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDK 370
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 82/275 (29%), Positives = 122/275 (44%), Gaps = 63/275 (22%)
Query: 197 ISRLLEYTPSSRISPLQVFLN-------LVLEFMPETVYKVAKHYSKSKQN-----FPCF 244
I+ L E + I+ +VFL+ L+ ++ ++ + K + SK N P
Sbjct: 49 IALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSA-------KH 294
K +YQ+ + Y+H + HRD+KP N+L+ PE G +K+ D G A K
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 295 LVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF--------- 345
L +P + + +YRAPEL+ GA YT ID+W+ GC+ AELL +P+F
Sbjct: 169 LADLDP---VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225
Query: 346 PGDSGVDQLVEIIKVLGTPTR---EQIREMNPNYTEFK----------------FPQIKS 386
DQL I V+G P E IR+M P Y + + K
Sbjct: 226 SNPFHHDQLDRIFSVMGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKV 284
Query: 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
P SKVF L+ +LL P+ RI+ Q
Sbjct: 285 KPDSKVFL---------LLQKLLTMDPTKRITSEQ 310
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 33/202 (16%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L + LE +P ++ K+ K Y +FP +LY Q+ L Y+H HRDIK N
Sbjct: 77 LYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGAN 132
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+L++ GV+KL DFG AK +V S+ S Y+ APE+I Y D+WS GC
Sbjct: 133 ILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
+ E+ G+P + S ++ + + K+ + P I H
Sbjct: 192 VLEMATGKPPW---SQLEGVAAVFKIGRSKE---------------LPPIPDH------- 226
Query: 395 VRTPPDAIDLISRLLEYTPSSR 416
+A D I + L+ PS R
Sbjct: 227 --LSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L +V+E+ + + K K + FP + QL +L Y+H I HRDIKPQN
Sbjct: 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR----YYRAPELIFGAIDYTTKIDVWS 330
+ L G++KL DFG +K L V + YY +PEL Y K D+WS
Sbjct: 134 IFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWS 188
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
GCVL EL + F G++ + +L K+L + Q + Y
Sbjct: 189 LGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQY-------------- 227
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ +L+S LL+ P R S Q+
Sbjct: 228 -------SSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 58/197 (29%), Positives = 83/197 (42%), Gaps = 46/197 (23%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-----GEP 300
++Y QL LAY+H GI HRDIKP N+ L+ GV+KL DFG A L GE
Sbjct: 101 IRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 301 NVSYICSRYYRAPELIFGA--IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
S + Y APE+I G + D+WS GCV+ E+ G+ + S +D +I+
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIM 216
Query: 359 KVLG------TPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412
+G P Q+ P+ D + R LE
Sbjct: 217 FHVGAGHKPPIPDSLQLS----------------------------PEGKDFLDRCLESD 248
Query: 413 PSSRISPLQVRSITPFL 429
P R + ++ PF+
Sbjct: 249 PKKRPTASELLQ-HPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 41/207 (19%)
Query: 215 FLNLVLEFMP----ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDI 270
+L LV+E++ ++ K P + K YI ++ + +H GI HRDI
Sbjct: 71 YLYLVMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330
KP+NLL++ +TG LKL DFG +++ G N ++ + Y APE I G + D WS
Sbjct: 124 KPENLLID-QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILG-VGDDKMSDWWS 178
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
GCV+ E L G P F ++ D + + I +I N+ E
Sbjct: 179 LGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEVKEFCS----- 221
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRI 417
P+A+DLI+RLL P+ R+
Sbjct: 222 --------PEAVDLINRLLCMDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 50/173 (28%), Positives = 73/173 (42%), Gaps = 28/173 (16%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
K +I ++ +L Y+H GI HRDIKP N+LL+ E G + + DF A + S
Sbjct: 102 VKFWICEIVLALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTS 160
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ Y APE++ Y+ +D WS G E L G+ + G S
Sbjct: 161 GTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTI 206
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
R+QIR +P +AID I++LLE P R+
Sbjct: 207 RDQIRAKQETADV-LYP------------ATWSTEAIDAINKLLERDPQKRLG 246
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 31/195 (15%)
Query: 216 LNLVLEFMP----ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDI 270
+++VLE+M + K + Q+ + L Y+H I HRDI
Sbjct: 74 ISIVLEYMDGGSLADLLKKVGKIPEP-------VLAYIARQILKGLDYLHTKRHIIHRDI 126
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329
KP NLL+N G +K+ DFG +K L + +++ + Y +PE I G Y+ D+W
Sbjct: 127 KPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIW 184
Query: 330 SAGCVLAELLLGQ-PM-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF------KF 381
S G L E LG+ P PG +L++ I G P E +P + +F K
Sbjct: 185 SLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRDFISACLQKD 243
Query: 382 P-------QIKSHPW 389
P ++ HP+
Sbjct: 244 PKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 69/225 (30%), Positives = 92/225 (40%), Gaps = 60/225 (26%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV+E+MP + + K FP + YI +L +L +H LG HRDIKP N
Sbjct: 75 HLYLVMEYMPGG--DLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDN 131
Query: 275 LLLNPETGVLKLCDFGSAK-----------------------HLVRGEPNVSYICSRY-- 309
+L++ G +KL DFG K LVR +
Sbjct: 132 ILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 310 -----YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
Y APE++ G Y + D WS G +L E+L G P F D+ L E
Sbjct: 191 VGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT----LQE-------- 237
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409
T +I +N +FP P S P+AIDLI RLL
Sbjct: 238 TYNKI--INWK-ESLRFPP--DPPVS--------PEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 47/137 (34%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS- 303
Y + I ++ +L YIH +G+ HRDIK N+L+ TG +KLCDFG A L + S
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRST 160
Query: 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
++ + Y+ APE+I Y TK D+WS G + E+ G P + S VD ++ + +
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKS 217
Query: 364 -PTREQIREMNPNYTEF 379
P R + + EF
Sbjct: 218 KPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 30/179 (16%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
+ + Y+ ++F ++ +H LG HRD+KP+N L++ +G +KL DFG +K +V S
Sbjct: 102 HARFYMAEMFEAVDALHELGYIHRDLKPENFLID-ASGHIKLTDFGLSKGIV--TYANSV 158
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ S Y APE++ G Y +D WS GC+L E L G P F G + ++ E +K
Sbjct: 159 VGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGST-PNETWENLK----- 211
Query: 365 TREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
+E P Y + +F S +A DLI++L+ PS R L+
Sbjct: 212 ---YWKETLQRPVYDDPRF------NLSD--------EAWDLITKLIN-DPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 57/176 (32%), Positives = 81/176 (46%), Gaps = 38/176 (21%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS----YICSRYY 310
+ L+Y+H I HRDIKP N+LL + G +KLCDFG V GE S + + +Y
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFG-----VSGELVNSLAGTFTGTSFY 169
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE I G Y+ DVWS G L E+ + FP + + + I++L I
Sbjct: 170 MAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEG--EPPLGPIELL-----SYIV 221
Query: 371 EMNPNYTEFKFPQIKSHP-----WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
M P++K P WS+ F+ D I + LE P+ R +P
Sbjct: 222 NMPN-------PELKDEPGNGIKWSEEFK--------DFIKQCLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 61/185 (32%), Positives = 88/185 (47%), Gaps = 32/185 (17%)
Query: 257 LAYIH-VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPEL 315
L Y++ V I HRDIKP N+L+N G +KLCDFG + L+ + +++ + Y +PE
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINSIAD-TFVGTSTYMSPER 173
Query: 316 IFGAIDYTTKIDVWSAGCVLAELLLGQPMFP------GDSGVDQLVEIIKVLGTPTREQI 369
I G YT K DVWS G + EL LG+ FP D G D + I+ +L
Sbjct: 174 IQGG-KYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLL-------- 222
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
QI P ++ P D D + L P+ R +P Q+ ++ PF+
Sbjct: 223 ------------QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
Query: 430 IELRA 434
LRA
Sbjct: 271 QALRA 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 37/65 (56%), Positives = 51/65 (78%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
+IGNGSFG+VY+A +D+ E VAIKKVLQD ++KNRE+ IM+ L H NI+ LK ++Y+
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 89 DKKDE 93
KK+E
Sbjct: 133 FKKNE 137
|
Length = 440 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 29/165 (17%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYYRAP 313
+ L Y+H + HRDIK N+LL+ + G +KL DFG A L + + S + + Y+ AP
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
E+I DY K+D+WS G + E+ G+P + + + L I G P ++
Sbjct: 186 EVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLKN-- 238
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
WS F+ D +++ L P R S
Sbjct: 239 ------------PEKWSPEFK--------DFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 52/143 (36%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
LN+VLE + ++ KH+ K K+ P Y QL +L ++H I HRDIKP N
Sbjct: 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN 136
Query: 275 LLLNPETGVLKLCDFG---------SAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
+ + TGV+KL D G +A H + G P YY +PE I Y K
Sbjct: 137 VFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP--------YYMSPERIHEN-GYNFK 186
Query: 326 IDVWSAGCVLAELLLGQPMFPGD 348
D+WS GC+L E+ Q F GD
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 43/112 (38%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL 295
K + FYTK Q+ L Y+H I HRDIK N+L+N +GV+K+ DFG++K L
Sbjct: 104 KDNEQTIIFYTK----QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159
Query: 296 VRGEPNV-SYICSRYYRAPELI-FGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
P ++ + Y APE+I G Y D+WS GC + E+ G+P F
Sbjct: 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L++ +E+MP +V K Y + T+ Y Q+ + Y+H I HRDIK N
Sbjct: 79 LSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVEYLHSNMIVHRDIKGAN 134
Query: 275 LLLNPETGVLKLCDFGSAKHL----VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330
+L + G +KL DFG++K L G S + Y+ +PE+I G Y K DVWS
Sbjct: 135 ILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWS 192
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
GC + E+L +P + + + + I K+ PT PQ+ SH
Sbjct: 193 VGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------------PQLPSH--- 231
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
PDA + + R R S ++
Sbjct: 232 ------VSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 42/204 (20%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+E++P E + + FP + Y Q+ +L Y+H L I +RD+KP+
Sbjct: 76 LYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPE 130
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
NLLL+ G +K+ DFG AK + + +C + Y APE+I Y +D W+ G
Sbjct: 131 NLLLD-SDGYIKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILSK-GYGKAVDWWALG 185
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ E+L G P F D Q+ E K+L + +FP S
Sbjct: 186 ILIYEMLAGYPPF-FDDNPIQIYE--KILE--------------GKVRFPSFFS------ 222
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
PDA DLI LL+ + R
Sbjct: 223 ------PDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-- 295
Q F Y++Q+ +++YIH GI HRDIK N+ L + G++KL DFG +K L
Sbjct: 95 GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGS 153
Query: 296 -------VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD 348
V G P YY +PEL G Y K D+W+ GCVL ELL + F
Sbjct: 154 EYSMAETVVGTP--------YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDAT 204
Query: 349 SGVDQLVEIIKVLGTPTREQ 368
+ ++ +V+I++ TP
Sbjct: 205 NPLNLVVKIVQGNYTPVVSV 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 58/206 (28%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 217 NLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
NL +E+M +V + Y K+ Y QL R L+Y+H I HRD+K NL
Sbjct: 79 NLFVEWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLHENQIIHRDVKGANL 134
Query: 276 LLNPETGVLKLCDFGSAKHLVR-----GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330
L++ L++ DFG+A L GE + + + APE++ G Y DVWS
Sbjct: 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWS 193
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
GCV+ E+ +P + + + L I K+ T P I H
Sbjct: 194 VGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---------------PSIPEH--- 235
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSR 416
P D+ R LE P R
Sbjct: 236 ------LSPGLRDVTLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
LN+ LE++P +V + +Y F + ++ Q+ + L Y+H GI HRDIK
Sbjct: 80 HLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGA 135
Query: 274 NLLLNPETGVLKLCDFGSAKHL-------VRGEPNVSYICSRYYRAPELIFGAIDYTTKI 326
N+L++ G +K+ DFG +K L S S ++ APE++ YT K
Sbjct: 136 NILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKA 193
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV 360
D+WS GC++ E+L G+ FP QL I K+
Sbjct: 194 DIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 30/144 (20%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+++ +EF+P ++ + + + C YTK Q+ +AY+H + HRDIK N
Sbjct: 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK----QILDGVAYLHNNCVVHRDIKGNN 132
Query: 275 LLLNPETGVLKLCDFGSAKHL---------------VRGEPNVSYICSRYYRAPELIFGA 319
++L P G++KL DFG A+ L + G P Y+ APE+I
Sbjct: 133 VMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP--------YWMAPEVI-NE 182
Query: 320 IDYTTKIDVWSAGCVLAELLLGQP 343
Y K D+WS GC + E+ G+P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 199 RLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257
R+++Y R P++ L++ +E MP ++ K Y +N T+ Y Q+ +
Sbjct: 65 RIVQYYGCLR-DPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGV 119
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL----VRGEPNVSYICSRYYRAP 313
+Y+H I HRDIK N+L + G +KL DFG++K L + G S + Y+ +P
Sbjct: 120 SYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
E+I G Y K D+WS GC + E+L +P + + + + I K+ PT +
Sbjct: 179 EVISGE-GYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 50/173 (28%), Positives = 68/173 (39%), Gaps = 36/173 (20%)
Query: 252 QLFRSLAYIHVLG-----ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYI 305
QL +L H + HRD+KP N+ L+ +KL DFG AK L +Y+
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ YY +PE + Y K D+WS GC++ EL P F QL IK
Sbjct: 172 GTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK------ 223
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
E KF +I S++ V I +L P R S
Sbjct: 224 ------------EGKFRRIPYRYSSELNEV---------IKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 29/184 (15%)
Query: 237 SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV 296
+++F ++YI ++ +L ++H LGI +RDIK +N+LL+ E G + L DFG +K +
Sbjct: 98 QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156
Query: 297 RGEPNVSY-ICSRY-YRAPELIFGAID-YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ 353
E +Y C Y APE+I G + +D WS G + ELL G F D +
Sbjct: 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216
Query: 354 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
EI + +I + P FP+ S +A D I +LLE P
Sbjct: 217 QSEISR--------RILKSKP-----PFPKTMS------------AEARDFIQKLLEKDP 251
Query: 414 SSRI 417
R+
Sbjct: 252 KKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 46/126 (36%), Positives = 71/126 (56%), Gaps = 4/126 (3%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL 295
+ K F + Y ++ L ++H GI +RD+K N++L+ + G +K+ DFG K
Sbjct: 88 QDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKEN 146
Query: 296 VRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQL 354
V G+ S C + Y APE++ G + YT +D WS G +L E+L+GQ F GD D+L
Sbjct: 147 VFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DEL 204
Query: 355 VEIIKV 360
E I+V
Sbjct: 205 FESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 51/173 (29%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--GEPNVSYICSR 308
YQ + L Y+H HRDIK N+LLN E G KL DFG + L + N + I +
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTP 163
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQ 368
++ APE+I I Y K D+WS G E+ G+P + + + I
Sbjct: 164 FWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------- 213
Query: 369 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
P T P WS F D + + L P R S +Q
Sbjct: 214 ----KPPPT-LSDP----EKWSPEF--------NDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 32/186 (17%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ +S F + Y ++ L ++H GI +RD+K N+LL+ + G +K+ DFG
Sbjct: 85 FHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMC 143
Query: 293 KHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
K + GE S C + Y APE++ G Y +D WS G +L E+L+GQ F G+
Sbjct: 144 KENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGE-DE 201
Query: 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411
D+L + I P F +A D +S+L E
Sbjct: 202 DELFDSILN-------------------------DRPH---FPRWISKEAKDCLSKLFER 233
Query: 412 TPSSRI 417
P+ R+
Sbjct: 234 DPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 52/178 (29%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 199 RLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257
R+++Y R P + L++ +E+MP ++ K Y +N T+ Y Q+ + +
Sbjct: 65 RIVQYYGCLR-DPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGV 119
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL----VRGEPNVSYICSRYYRAP 313
+Y+H I HRDIK N+L + G +KL DFG++K + + G S + Y+ +P
Sbjct: 120 SYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
E+I G Y K DVWS C + E+L +P + + + + I K+ PT+ + +
Sbjct: 179 EVISGE-GYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 44/132 (33%), Positives = 78/132 (59%), Gaps = 10/132 (7%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L++ LE++P ++ + Y + ++ F+T+ Q+ LAY+H GI HRD+K N
Sbjct: 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE----QVLEGLAYLHSKGILHRDLKADN 138
Query: 275 LLLNPETGVLKLCDFGSAKH---LVRGEPNVSYICSRYYRAPELIFG-AIDYTTKIDVWS 330
LL++ + G+ K+ DFG +K + + N+S S ++ APE+I + Y+ K+D+WS
Sbjct: 139 LLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWS 197
Query: 331 AGCVLAELLLGQ 342
GCV+ E+ G+
Sbjct: 198 LGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 25/67 (37%), Positives = 38/67 (56%), Gaps = 6/67 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
+G+GSFG VY+AK +G++VA+K + + RE++I+RRL H NIV+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 83 FFYSSGD 89
F
Sbjct: 66 AFEDKDH 72
|
Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
+ Q+ +L ++H I HRD+K QN+LL+ V+K+ DFG +K L + + +
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTP 165
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
Y +PEL G Y K D+W+ GCVL EL
Sbjct: 166 CYISPELCEGK-PYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L + +E+MP +V K Y ++ T+ Y Q+ ++Y+H I HRDIK N
Sbjct: 81 LTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSYLHSNMIVHRDIKGAN 136
Query: 275 LLLNPETGVLKLCDFGSAKHL----VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330
+L + G +KL DFG++K L + G S + Y+ +PE+I G Y K DVWS
Sbjct: 137 ILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWS 194
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
GC + E+L +P + + + + I K+ PT Q+
Sbjct: 195 LGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 8e-14
Identities = 26/66 (39%), Positives = 40/66 (60%), Gaps = 5/66 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
+G GSFG VY A+ +G+LVAIK + + K K+ RE++I+++L+H NIV+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 84 FYSSGD 89
F
Sbjct: 66 FEDEDK 71
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
+ L Y+ L I HRD+KP N+L+N G +KLCDFG + LV +Y+ + Y APE
Sbjct: 106 KGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPE 163
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQ---PMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
I G Y DVWS G EL LG+ P + G +++++ I +
Sbjct: 164 RISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVD 214
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419
+P P + +S+ F + I++ + P R +P
Sbjct: 215 EDP-------PVLPVGQFSEKF--------VHFITQCMRKQPKERPAP 247
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 49/146 (33%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 225 ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI-HVLGICHRDIKPQNLLLNPETGV 283
+ YK Y K P ++L Y+ L I HRD+KP N+LL+ G
Sbjct: 90 DKFYKYV--YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGN 146
Query: 284 LKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI--FGAIDYTTKIDVWSAGCVLAELLLG 341
+KLCDFG + LV R Y APE I Y + DVWS G L E+ G
Sbjct: 147 IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 342 QPMFPG-DSGVDQLVEIIKVLGTPTR 366
+ +P +S DQL +++K G P
Sbjct: 207 KFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 27/147 (18%)
Query: 213 QVFLNLVLEFMPE----TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHR 268
Q FL +++E++P + + + +S S F Y ++ +L Y+H I +R
Sbjct: 73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-------YASEIVCALEYLHSKEIVYR 125
Query: 269 DIKPQNLLLNPETGVLKLCDFGSAKHLVR------GEPNVSYICSRYYRAPELIFGAIDY 322
D+KP+N+LL+ E G +KL DFG AK L G P Y APE+I + +
Sbjct: 126 DLKPENILLDKE-GHIKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEVI-QSKGH 175
Query: 323 TTKIDVWSAGCVLAELLLGQPMFPGDS 349
+D W+ G ++ E+L+G P F D+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 41/85 (48%), Positives = 51/85 (60%), Gaps = 8/85 (9%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
LAY+H HRDIK N+LL E G +KL DFGSA LV P S++ + Y+ APE+I
Sbjct: 128 LAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSAS-LV--SPANSFVGTPYWMAPEVI 183
Query: 317 FGAID---YTTKIDVWSAGCVLAEL 338
A+D Y K+DVWS G EL
Sbjct: 184 L-AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 51/143 (35%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
LN+VLE + ++ KH+ K K+ P Y QL +L ++H + HRDIKP N
Sbjct: 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 136
Query: 275 LLLNPETGVLKLCDFG---------SAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
+ + TGV+KL D G +A H + G P YY +PE I Y K
Sbjct: 137 VFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP--------YYMSPERIHEN-GYNFK 186
Query: 326 IDVWSAGCVLAELLLGQPMFPGD 348
D+WS GC+L E+ Q F GD
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 220 LEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLN 278
+E M ++ K K P + ++L Y+H L + HRD+KP N+L+N
Sbjct: 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN 138
Query: 279 PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID---YTTKIDVWSAGCVL 335
G +KLCDFG + +LV + Y APE I ++ Y K DVWS G +
Sbjct: 139 -RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 336 AELLLGQPMFPGDSGVD---QLVEIIKVLGTPTREQIREMNPNYTEF------------- 379
EL G+ FP DS QL ++++ + + +P + +F
Sbjct: 198 IELATGR--FPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPEFQDFVNKCLKKNYKERP 253
Query: 380 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410
+P++ HP+ ++ + D +S +L
Sbjct: 254 NYPELLQHPFFELHLSKN-TDVASFVSLILG 283
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 44/135 (32%), Positives = 72/135 (53%), Gaps = 6/135 (4%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
H+ + + F + Y +L +L +H + +RD+KP+N+LL+ G + LCDFG
Sbjct: 82 HHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD-YQGHIALCDFGLC 140
Query: 293 KHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
K ++ + + C + Y APEL+ G YT +D W+ G +L E+L G P F D V
Sbjct: 141 KLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY-DENV 198
Query: 352 DQLVEIIKVLGTPTR 366
+++ K+L P R
Sbjct: 199 NEMYR--KILQEPLR 211
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 23/174 (13%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
K Y+ +L +L ++H LGI +RD+KP+N+LL+ E G +KL DFG +K + E C
Sbjct: 101 KFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFC 159
Query: 307 SRY-YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV-LGTP 364
Y APE++ +T D WS G ++ E+L G F G + + I+K LG P
Sbjct: 160 GTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
Query: 365 ---TRE------QIREMNPNYTEFKFPQ----IKSHP------WSKVFRVRTPP 399
+ E + + NP P IK HP W+K++R P
Sbjct: 219 QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 19/112 (16%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--- 297
Y + ++ L Y+H G HRDIK N+LL+ E G +KL DFG + L
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMS 153
Query: 298 ------GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
G P ++ APE+I + Y K D+WS G EL G+P
Sbjct: 154 KRNTFVGTP--------FWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 43/106 (40%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 249 YI-YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--GEPNVSYI 305
YI + R LAY+H + HRDIK QN+LL V KL DFG + L G N ++I
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV-KLVDFGVSAQLDSTLGRRN-TFI 174
Query: 306 CSRYYRAPELIFGAID------YTTKIDVWSAGCVLAELLLGQPMF 345
+ Y+ APE+I A D Y + DVWS G EL G+P
Sbjct: 175 GTPYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 57/206 (27%), Positives = 82/206 (39%), Gaps = 60/206 (29%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-- 293
K+ P ++Y + +L Y+H GI HRD+KP NLL+ G +KL DFG +K
Sbjct: 93 KNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIG 151
Query: 294 -----------HL-----------VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
H+ V G P Y APE+I Y +D W+
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPE--------YIAPEVILRQ-GYGKPVDWWAM 202
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G +L E L+G F GD+ + ++I + ++P+
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISD-----------------DIEWPEGDEAL--- 242
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRI 417
P DA DLISRLL P R+
Sbjct: 243 ------PADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 216 LNLVLEFMPET-VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L +V+E+ P + K K ++ P QL R L +H I HRD+K N
Sbjct: 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+LL ++K+ D G +K L + + I + +Y APE ++ Y+ K D+WS GC+
Sbjct: 134 ILLV-ANDLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPYSYKSDIWSLGCL 190
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
L E+ P F S D KV K+P I +S+
Sbjct: 191 LYEMATFAPPFEARSMQDLRY---KVQRG----------------KYPPI-PPIYSQ--- 227
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQV 422
D + I +L+ P R + ++
Sbjct: 228 -----DLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 52/181 (28%), Positives = 91/181 (50%), Gaps = 32/181 (17%)
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYYR 311
+ ++L Y+H G+ HRDIK ++LL + G +KL DFG + + P S + + Y+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
APE+I Y T++D+WS G ++ E++ G+P + DS V + +++R+
Sbjct: 185 APEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRD 231
Query: 372 MNPNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430
P P++K +H S V R D + R+L P R + ++ PFL+
Sbjct: 232 SPP-------PKLKNAHKISPVLR--------DFLERMLTREPQERATAQELLD-HPFLL 275
Query: 431 E 431
+
Sbjct: 276 Q 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
F + Y ++ L ++H GI +RD+K N+LL+ E G +K+ DFG K + G
Sbjct: 93 FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGV 151
Query: 301 NVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
S C + Y APE++ Y +D W+ G +L E+L GQ F GD D+L + I
Sbjct: 152 TTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 49/143 (34%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
LN+VLE + ++ K++ K K+ P Y QL ++ ++H + HRDIKP N
Sbjct: 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136
Query: 275 LLLNPETGVLKLCDFG---------SAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
+ + TGV+KL D G +A H + G P YY +PE I Y K
Sbjct: 137 VFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP--------YYMSPERIHEN-GYNFK 186
Query: 326 IDVWSAGCVLAELLLGQPMFPGD 348
D+WS GC+L E+ Q F GD
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 43/114 (37%), Positives = 65/114 (57%), Gaps = 10/114 (8%)
Query: 253 LFRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
+ R LAY+ I HRD+KP N+L+N G +KLCDFG + L+ N S++ +R Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMAN-SFVGTRSYM 169
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTP 364
+PE + G Y+ + D+WS G L EL +G+ P+ P D+ E+ + G P
Sbjct: 170 SPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 55/204 (26%), Positives = 75/204 (36%), Gaps = 68/204 (33%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL---------- 295
T+ YI + ++ IH LG HRDIKP NLLL+ G +KL DFG L
Sbjct: 103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 296 ----VRGEPNVSYICSRY-------------------------YRAPELIFGAIDYTTKI 326
+ +I Y APE +F Y +
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKEC 220
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE-FKFPQIK 385
D WS G ++ E+L+G P F D+ + +II N+ E +FP
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSDNPQETYRKII----------------NWKETLQFPD-- 262
Query: 386 SHPWSKVFRVRTPPDAIDLISRLL 409
V P+A DLI RL
Sbjct: 263 --------EVPLSPEAKDLIKRLC 278
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 251 YQLFRSLAYIH-VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY 309
+ R L Y+ I HRD+KP N+L+N G +KLCDFG + L+ N S++ +R
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMAN-SFVGTRS 163
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFP 346
Y +PE + G YT + D+WS G L E+ +G +P
Sbjct: 164 YMSPERLQGT-HYTVQSDIWSLGLSLVEMAIG--RYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 49/147 (33%), Positives = 77/147 (52%), Gaps = 20/147 (13%)
Query: 215 FLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
+L +V+E+MP + V + S + P + + Y ++ +L IH +G HRD+KP
Sbjct: 117 YLYMVMEYMPGGDLVNLM------SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170
Query: 273 QNLLLNPETGVLKLCDFGS-----AKHLVRGEPNVSYICSRYYRAPELIF---GAIDYTT 324
N+LL+ ++G LKL DFG+ A +VR + V + Y +PE++ G Y
Sbjct: 171 DNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVG---TPDYISPEVLKSQGGDGYYGR 226
Query: 325 KIDVWSAGCVLAELLLGQPMFPGDSGV 351
+ D WS G L E+L+G F DS V
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 36/175 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAKHLVRGEPNVSYICSRY 309
Q+ +L ++H + HRD+K N+LL + V KL DFG SAK+ + ++I + Y
Sbjct: 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDV-KLADFGVSAKNKSTLQKRDTFIGTPY 168
Query: 310 YRAPELI----FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT-- 363
+ APE++ F Y K D+WS G L EL M P ++ + ++K+L +
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIEL---AQMEPPHHELNPMRVLLKILKSEP 225
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
PT +Q WS F D + L P R +
Sbjct: 226 PTLDQ-----------------PSKWSSSFN--------DFLKSCLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 24/123 (19%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
+ Q+ R + Y+ HRD+ +N L+ E V+K+ DFG ++ L +
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD--------- 157
Query: 309 YYR-----------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVE 356
YY+ APE + +T+K DVWS G +L E+ LG+ +PG S +++E
Sbjct: 158 YYKVKGGKLPIRWMAPESLKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLE 215
Query: 357 IIK 359
+K
Sbjct: 216 YLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/170 (35%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
+ LAY+H + HRDIK N+LL E G +KL DFGSA + P S++ + Y+ AP
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSAS---KSSPANSFVGTPYWMAP 186
Query: 314 ELIFGAID---YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
E+I A+D Y K+DVWS G EL +P + + L I + +PT Q
Sbjct: 187 EVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTL-QSN 243
Query: 371 EMNPNYTEF------KFPQIKSHPWSK-------VFRVRTPPDAIDLISR 407
E ++ F K PQ P S V R R IDLI R
Sbjct: 244 EWTDSFRGFVDYCLQKIPQ--ERPASAELLRHDFVRRDRPARVLIDLIQR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 30/156 (19%)
Query: 218 LVLEFMPETVYKVA-KHYSKSKQNFPCFYTKL-YIYQLFRSLAYIHVLGICHRDIKPQNL 275
+V+E+M Y + + L + Q+ R + Y+ HRD+ +N
Sbjct: 78 IVMEYME----GGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC 133
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APELIFGAIDYTT 324
L+ E V+K+ DFG ++ L + YYR APE + +T+
Sbjct: 134 LVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGKLPIRWMAPESLKEGK-FTS 182
Query: 325 KIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
K DVWS G +L E+ LG+ +PG S ++++E +K
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 47/157 (29%), Positives = 67/157 (42%), Gaps = 34/157 (21%)
Query: 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI-----F 317
I HRD+KP N+L+N G +KLCDFG + +LV + C Y APE I
Sbjct: 122 HNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPN 179
Query: 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD---QLVEIIKVLGTPTR-------- 366
YT + DVWS G + E+ LG+ +P ++ + QL I+ G P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPTLPSGYSDD 237
Query: 367 ---------EQIREMNPNYTEFKFPQIKSHPWSKVFR 394
+I P Y Q+ HPW ++
Sbjct: 238 AQDFVAKCLNKIPNRRPTY-----AQLLEHPWLVKYK 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 37/185 (20%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-- 306
+ Q+ L +IH I HRDIK QN+ L+ V KL DFG A+ L ++Y C
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVG 164
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ YY +PE I Y K D+WS GCVL EL + F G++ + QLV I +
Sbjct: 165 TPYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI------CQ 216
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI- 425
++PN++ D LIS+L + +P R S + SI
Sbjct: 217 GYFAPISPNFSR---------------------DLRSLISQLFKVSPRDRPS---ITSIL 252
Query: 426 -TPFL 429
PFL
Sbjct: 253 KRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC- 306
Y ++ L ++H GI +RD+K N+LL+ + G +K+ DFG K + G+ C
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCG 158
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPG 347
+ Y APE++ G Y T +D WS G +L E+L+GQ F G
Sbjct: 159 TPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 25/183 (13%)
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLN-PETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
L +LAY+H GI HRD+K +N+ L+ PE VL DFG+A L + C +
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKL--DAHPDTPQCYGWSG 249
Query: 310 ---YRAPELIFGAID-YTTKIDVWSAGCVLAELLLGQPMFPG---DSGVDQLVEIIKVLG 362
+PEL+ A+D Y K D+WSAG VL E+ + G S QL II+ +
Sbjct: 250 TLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307
Query: 363 TPTREQIREMNPNYT-EFK-FPQIKSHPWS--KVFRVRTPP-DAIDLISRLL----EYTP 413
E + + N FK + + P++ V R D LI+++L E+ P
Sbjct: 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367
Query: 414 SSR 416
S++
Sbjct: 368 SAQ 370
|
Length = 392 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 51/168 (30%), Positives = 71/168 (42%), Gaps = 34/168 (20%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--GEPNVSYICSRYYRA 312
+ LAY+H G HRDIK N+LL E G +KL DFG + L + S+I + Y+ A
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRK-SFIGTPYWMA 169
Query: 313 PELIF--GAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQI 369
PE+ Y K D+W+ G EL Q PMF + ++ L ++
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS-- 219
Query: 370 REMNPNYTEFKFPQIKS-HPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
F P++K WS VF D I + L P R
Sbjct: 220 --------NFPPPKLKDKEKWSPVF--------HDFIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 42/166 (25%), Positives = 82/166 (49%), Gaps = 29/166 (17%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYY 310
+ ++L+++H G+ HRDIK ++LL + G +KL DFG + + P S + + Y+
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE+I + Y T++D+WS G ++ E++ G+P + + + + ++IR
Sbjct: 182 MAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIR 228
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
+ P P++K+ + P + R+L P+ R
Sbjct: 229 DNLP-------PKLKNL-------HKVSPRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 42/213 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+E+ P + + + ++ + ++ FY + +L ++ +H +G HRDIKP+
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----LAELVLAIHSVHQMGYVHRDIKPE 131
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSY--ICSRYYRAPELI-----FGAIDYTTKI 326
N+L++ TG +KL DFGSA L + S + + Y APE++ G Y +
Sbjct: 132 NVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF-KFPQIK 385
D WS G + E++ G+ F + I+ N+ F KFP+
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM----------------NFQRFLKFPE-- 232
Query: 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ D +DLI LL R+
Sbjct: 233 --------DPKVSSDFLDLIQSLL-CGQKERLG 256
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 17/182 (9%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
Q+ L Y+H I HRD+K +N+ +N V + D G+A+ V + +
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVC-IGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLL----------GQPMFPGDSGVDQLVEIIKVL 361
APE++ Y +K D+WSAG VL E+L P S L++II L
Sbjct: 224 APEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 362 GTPTREQIRE----MNPNYTEFKFPQIKSHP-WSKVFRVRTPPDAIDLISRLLEYTPSSR 416
E R+ + + E+ + + + + RV P D L+ ++L + + R
Sbjct: 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMR 342
Query: 417 IS 418
S
Sbjct: 343 PS 344
|
Length = 357 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y +Q+ R + ++ HRD+ +N+LL+ E V+K+CDFG A+ + + V +R
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 309 Y---YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTP 364
+ APE IF + YTT+ DVWS G +L E+ LG +PG V+I +
Sbjct: 238 LPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQR 289
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVR-TPPDAIDLISRLLE 410
++ R P + +I W + R T ++++ LL+
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 28/182 (15%)
Query: 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR 297
+ NF + Y ++ +L ++H LGI +RDIK +N+LL+ E G + L DFG +K +
Sbjct: 99 RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS 157
Query: 298 GEPNVSY-IC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLV 355
E +Y C + Y APE+I G + +D WS G ++ ELL G F + +
Sbjct: 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 356 EIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415
E+ + +I + +P FP P+A DL+ +LL P
Sbjct: 218 EVSR--------RILKCDP-----PFPSFIG------------PEAQDLLHKLLRKDPKK 252
Query: 416 RI 417
R+
Sbjct: 253 RL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 34/174 (19%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGEPNVSY 304
Y+ ++ +L ++H GI +RD+KP+N+LL+ + G +KL DFG K + G ++
Sbjct: 102 ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTF 160
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV-LGT 363
+ Y APE I + +D WS G ++ ++L G P F ++ + +I+K L
Sbjct: 161 CGTIEYMAPE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
P P T P+A DL+ +LL+ PSSR+
Sbjct: 220 P---------PYLT---------------------PEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 2/106 (1%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGE 299
F K YI +L +L ++H I +RD+KP+N+LL+ TG + LCDFG +K +L +
Sbjct: 93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNK 151
Query: 300 PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
++ + Y APE++ YT +D WS G ++ E+ G F
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 5/62 (8%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYFF 84
+G G FG VY A+ +G+ VAIK + ++ RE++I+++L H NIVKL F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 85 YS 86
Sbjct: 61 ED 62
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 29/75 (38%), Positives = 43/75 (57%), Gaps = 12/75 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKN-----REMQIMRRLEHSNIVKLKY 82
++G GSFG VY A D+GEL+A+K V L + RE++I+ L+H NIV +Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--RY 64
Query: 83 FFYSSGDKKDEPTNY 97
+ G ++DE N
Sbjct: 65 Y----GSERDEEKNT 75
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 32/179 (17%)
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYYR 311
+ R+L+Y+H G+ HRDIK ++LL + G +KL DFG + + P S + + Y+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
APE+I + Y T++D+WS G ++ E++ G+P + P + +R
Sbjct: 186 APEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRR 229
Query: 372 MNPNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
+ N P++K SH S V R + +L PS R + ++ PFL
Sbjct: 230 IRDNLP----PRVKDSHKVSSVLRG--------FLDLMLVREPSQRATAQELLQ-HPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 64/194 (32%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
+ LAY+H + HRDIK N+LL E G +KL DFGSA P S++ + Y+ AP
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAP 190
Query: 314 ELIFGAID---YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
E+I A+D Y K+DVWS G EL +P + + L I + +PT Q
Sbjct: 191 EVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTL-QSN 247
Query: 371 EMNPNYTEF------KFPQIKSHPWSK-----VFRVRTPPDA--IDLISRLLEYTPSSRI 417
E + + F K PQ P S+ +F +R P+ IDLI R + +
Sbjct: 248 EWSDYFRNFVDSCLQKIPQ--DRPTSEELLKHMFVLRERPETVLIDLIQRTKDAV--REL 303
Query: 418 SPLQVRSITPFLIE 431
LQ R + L +
Sbjct: 304 DNLQYRKMKKLLFQ 317
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 265 ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324
I HRD+KP N+L+N G +KLCDFG + L+ N S++ +R Y +PE + G Y+
Sbjct: 125 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT-HYSV 181
Query: 325 KIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383
+ D+WS G L E+ +G+ P+ P D+ +L+ V G P E +P P+
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES---ETSPR------PR 232
Query: 384 IKSHPWSKVFRVRTPPDAIDLISRLLEY 411
P S PP A I LL+Y
Sbjct: 233 PPGRPLSSYGPDSRPPMA---IFELLDY 257
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 2/112 (1%)
Query: 234 YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
Y+ + FP Y Q+ L ++H I +RD+KP+N+LL+ + G +++ D G A
Sbjct: 85 YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAV 143
Query: 294 HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
L G+ + Y APE++ G + Y +D ++ GC L E++ G+ F
Sbjct: 144 ELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 3/106 (2%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
FP + Y ++ +L Y+H L I +RD+KP+N+LL+ + G + L DFG K +
Sbjct: 93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSK 151
Query: 301 NVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
S C + Y APE++ Y +D W G VL E+L G P F
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAKHLVRGEPNVSYICSRYY 310
Q+ +L Y+H + I HRD+K N+LL + G +KL DFG SAK++ + S+I + Y+
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 311 RAPELIFGAI----DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
APE++ Y K D+WS G L E+ +P + + L++I K PT
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTL 235
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405
Q + + + +F + HP T P A L+
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHP-------ETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 71/297 (23%)
Query: 148 EIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA-IDLISRLLEYTPS 206
E++KVLGT ++ F ++ H K++ ++ A I ++ E+T +
Sbjct: 3 ELLKVLGTGAYGKV---------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 207 SRISPLQVFLNLVLEFMPETVYKVAKHYS-----------------------KSKQNFPC 243
R VLE + ++ + V HY+ ++ F
Sbjct: 54 ER---------QVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE 104
Query: 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS 303
++Y ++ +L ++H LGI +RDIK +N+LL+ G + L DFG +K E +
Sbjct: 105 QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERA 163
Query: 304 Y-ICSRY-YRAPELIFGA-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV 360
Y C Y AP+++ G + +D WS G ++ ELL G F D + EI
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--- 220
Query: 361 LGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
+I + P Y PQ S A D+I RLL P R+
Sbjct: 221 -----SRRILKSEPPY-----PQEMS------------ALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELI---FGA 319
G+ HRD+KP N+LL+ +G +KLCDFG + LV + S C+ Y APE I
Sbjct: 135 GVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDPN 192
Query: 320 IDYTTKIDVWSAGCVLAELLLGQPMFPG 347
Y + DVWS G L EL GQ +
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
LN+V+E+ ++K+ K + + +I Q+ LA++H I HRDIK N
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVW-RFFI-QILLGLAHLHSKKILHRDIKSLN 131
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSY----ICSRYYRAPELIFGAIDYTTKIDVWS 330
L L+ V K+ D G AK L N ++ + + YY +PEL Y K DVW+
Sbjct: 132 LFLDAYDNV-KIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWA 186
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
G VL E G+ F ++ +++II+
Sbjct: 187 LGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 40/112 (35%), Positives = 63/112 (56%), Gaps = 4/112 (3%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGEPNVSYIC 306
Y ++ L ++H GI +RD+K N++L+ E G +K+ DFG K H+V G ++
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTTRTFCG 163
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
+ Y APE+I Y +D W+ G +L E+L GQP F G+ D+L + I
Sbjct: 164 TPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 18/153 (11%)
Query: 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
+L +V+E+MP + + +Y + P + + Y ++ +L IH +G HRD+KP
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 171
Query: 274 NLLLNPETGVLKLCDFGSA-----KHLVRGEPNVSYICSRYYRAPELIF---GAIDYTTK 325
N+LL+ ++G LKL DFG+ + +VR + V + Y +PE++ G Y +
Sbjct: 172 NMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVG---TPDYISPEVLKSQGGDGYYGRE 227
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
D WS G L E+L+G F DS V +I+
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 27/144 (18%)
Query: 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
+ LAY+H + HRD+K N+LL+ E G++KL DFGSA + P ++ + Y+ AP
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAP 180
Query: 314 ELIFGAID---YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
E+I A+D Y K+DVWS G EL +P + + L I
Sbjct: 181 EVIL-AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------- 226
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFR 394
+ + P ++S WS+ FR
Sbjct: 227 ------AQNESPALQSGHWSEYFR 244
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 30/73 (41%), Positives = 43/73 (58%), Gaps = 4/73 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
DS +DQL +I ++LGTPT E + P+Y FP+ KV R P+ IDL+
Sbjct: 202 DSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP-TFPKFPPKDLEKVLP-RLDPEGIDLL 259
Query: 198 SRLLEYTPSSRIS 210
S++L+Y P+ RIS
Sbjct: 260 SKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L+ +L+ M + Y +++H S+ + Y ++ L ++H + +RD+KP
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLEHMHNRFVVYRDLKPA 126
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N+LL+ E G +++ D G A + +P+ S + + Y APE++ + Y + D +S GC
Sbjct: 127 NILLD-EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGC 184
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-----------------Y 376
+L +LL G F D+ EI ++ T E +P
Sbjct: 185 MLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 243
Query: 377 TEFKFPQ-IKSHP------WSKVFRVRTPPDAI 402
+ Q +K HP W VF + PP I
Sbjct: 244 CLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 36/88 (40%), Positives = 52/88 (59%), Gaps = 3/88 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYY 310
Q+ + +IH + HRDIK +N+ L + G +KL DFGSA+ L G +Y+ + YY
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAEL 338
PE I+ + Y K D+WS GC+L EL
Sbjct: 167 VPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 3/111 (2%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL 295
+ +++FP + Y ++ +L Y+H + I +RD+KP+N+LL+ + G + L DFG K
Sbjct: 88 QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEG 146
Query: 296 VRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
+ + C + Y APE+I Y +D W G VL E+L G P F
Sbjct: 147 IAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 25/66 (37%), Positives = 39/66 (59%), Gaps = 6/66 (9%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKR---FKN---REMQIMRRLEHSNIVKLKYF 83
IG G++G+VY+A+ +GE+VAIKK+ RE+++++ L H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 84 FYSSGD 89
F GD
Sbjct: 67 FRHKGD 72
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 18/153 (11%)
Query: 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
+L +V+E+MP + + +Y + P + K Y ++ +L IH +G+ HRD+KP
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPD 171
Query: 274 NLLLNPETGVLKLCDFGSAKH-----LVRGEPNVSYICSRYYRAPELIF---GAIDYTTK 325
N+LL+ + G LKL DFG+ +VR + V + Y +PE++ G Y +
Sbjct: 172 NMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVG---TPDYISPEVLKSQGGDGYYGRE 227
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
D WS G L E+L+G F DS V +I+
Sbjct: 228 CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 41/185 (22%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
FP K Y +L + Y+H I +RD+KP+NLLL+ + G +K+ DFG AK + P
Sbjct: 115 FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKV----P 169
Query: 301 NVSY-IC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
+ ++ +C + Y APE+I + + +D W+ G +L E + G P F D
Sbjct: 170 DRTFTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---------- 218
Query: 359 KVLGTPTR--EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
TP R E+I KFP W F R A DL+ LL+ + R
Sbjct: 219 ----TPFRIYEKILA-----GRLKFPN-----W---FDGR----ARDLVKGLLQTDHTKR 257
Query: 417 ISPLQ 421
+ L+
Sbjct: 258 LGTLK 262
|
Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/124 (36%), Positives = 62/124 (50%), Gaps = 5/124 (4%)
Query: 229 KVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCD 288
K K K F + L YQ+ +L +H + HRD+K N+ L P TG++KL D
Sbjct: 154 KQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGD 212
Query: 289 FGSAKHL---VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
FG +K V + S+ + YY APEL + Y+ K D+WS G +L ELL F
Sbjct: 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 346 PGDS 349
G S
Sbjct: 272 KGPS 275
|
Length = 478 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPEL 315
L Y+H I +RD+K NLLL+ E G +K+ DFG K + S C + + APE+
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 316 IFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD 348
+ YT +D W G ++ E+L+G+ FPGD
Sbjct: 173 LTET-SYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y +Q+ + + ++ HRD+ +N+LL+ E V+K+CDFG A+ + + V +R
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 309 Y---YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTP 364
+ APE IF + YT + DVWS G +L E+ LG +PG V+I +
Sbjct: 243 LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRR 294
Query: 365 TREQIREMNPNYTEFKFPQIKSHPW 389
+E R P+YT + Q W
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCW 319
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 37/129 (28%), Positives = 70/129 (54%), Gaps = 4/129 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYY 310
+ ++L ++H + HRDIK N+LL + G +KL DFG + + S + + Y+
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE++ Y K+D+WS G + E++ G+P + ++ + L +I GTP +
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 371 EMNPNYTEF 379
+++P + +F
Sbjct: 240 KLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 31/74 (41%), Positives = 42/74 (56%), Gaps = 7/74 (9%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK-FPQIKSHPWSKVFRVRTPPDAIDL 196
DS +DQL +I + LGTPT E + P+Y EFK FP P ++F DA+DL
Sbjct: 206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPT---PLKQIFPAA-SDDALDL 261
Query: 197 ISRLLEYTPSSRIS 210
+ RLL P+ RI+
Sbjct: 262 LQRLLTLNPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 38/103 (36%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y +Q+ R + ++ HRD+ +N+LL+ E V+K+CDFG A+ + + V +R
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 309 Y---YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE IF + YTT+ DVWS G +L E+ LG +PG
Sbjct: 237 LPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 75/216 (34%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG---------S 291
FP + YI +L ++ +H +G HRDIKP N+L++ + G +KL DFG +
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN 156
Query: 292 AKHLVRG--------EPN-------------------------------VSYICSRYYRA 312
+K+ +G EP+ S + + Y A
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216
Query: 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM 372
PE++ YT D WS G +L E+L+GQP F + TPT Q++ +
Sbjct: 217 PEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVI 261
Query: 373 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408
N T PQ+K P+A+DLI++L
Sbjct: 262 NWENTLHIPPQVK-----------LSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 40/134 (29%), Positives = 70/134 (52%), Gaps = 11/134 (8%)
Query: 234 YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
+ + ++ P + + Y ++ +L Y+H GI +RD+K N+LL+ E G +KL D+G K
Sbjct: 86 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK 144
Query: 294 HLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF------- 345
+R S C + Y APE++ G DY +D W+ G ++ E++ G+ F
Sbjct: 145 EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
Query: 346 -PGDSGVDQLVEII 358
P + D L ++I
Sbjct: 204 NPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 59/201 (29%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDF------GSAKHLVR--- 297
+ Y ++ +L Y+H+LGI +RD+KP+N+LL+ E+G + L DF V
Sbjct: 106 RFYAAEVLLALEYLHLLGIVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 298 ---------------------GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336
+ S++ + Y APE+I G + + +D W+ G +L
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLY 223
Query: 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396
E+L G F G + + I+K E FP S P S R
Sbjct: 224 EMLYGTTPFKGSNRDETFSNILK-----------------KEVTFP--GSPPVSSSAR-- 262
Query: 397 TPPDAIDLISRLLEYTPSSRI 417
DLI +LL PS R+
Sbjct: 263 ------DLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 50/150 (33%), Positives = 70/150 (46%), Gaps = 31/150 (20%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--GEPNVSYICSRY 309
++ R LA++H + HRDIK QN+LL E +KL DFG + L R G N ++I + Y
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPY 186
Query: 310 YRAPELIFGAID------YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
+ APE+I A D Y + D+WS G E+ G P + L I +
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---- 240
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
NP P++KS WSK F
Sbjct: 241 ---------NPP------PKLKSKKWSKKF 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 28/144 (19%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKL-YIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+V E+MP + + L Q+ + + Y+ HRD+ +N L
Sbjct: 78 IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCL 134
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APELIFGAIDYTT 324
+ E V+K+ DFG ++ + + YYR APE + +T+
Sbjct: 135 VT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGKLPIKWMAPESLKDGK-FTS 183
Query: 325 KIDVWSAGCVLAELL-LGQPMFPG 347
K DVWS G +L E+ LG+ +PG
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 196
++ ++QL + + LGTP E + P+Y + FP+ K P ++F P+A+DL
Sbjct: 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP-DASPEALDL 261
Query: 197 ISRLLEYTPSSRIS 210
+ LL Y PS R+S
Sbjct: 262 LKGLLVYDPSKRLS 275
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 243 CFY---TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE 299
CF + Y ++ +L Y+H L I +RD+KP+N+LL+ + G + L DFG K +
Sbjct: 92 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHN 150
Query: 300 PNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
S C + Y APE++ Y +D W G VL E+L G P F
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 34/151 (22%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTK--------LYIYQLFRSLAYIHVLGICHRD 269
LVLE+M + KS+ FP + Q+ + + Y+ HRD
Sbjct: 73 LVLEYMEGGDLL--DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130
Query: 270 IKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APELIF 317
+ +N L+ E V+K+ DFG ++ + + YYR APE +
Sbjct: 131 LAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKKTGGKLPIRWMAPESLK 180
Query: 318 GAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
I +T+K DVWS G +L E+ LG +PG
Sbjct: 181 DGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ Y ++ ++ Y+H L I +RD+KP+N+LL+ + V+ L DFG K V E S C
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFC 157
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
+ Y APE + Y +D W G VL E+L G P F
Sbjct: 158 GTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 5e-10
Identities = 22/65 (33%), Positives = 40/65 (61%), Gaps = 8/65 (12%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLKY 82
+G G++G+VY+A+ +GE+VA+KK+ D + RE+ +++ L+H NIVKL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 83 FFYSS 87
++
Sbjct: 66 VIHTE 70
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 8/70 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
IG G FG VY+A+ +G+ VAIK + + K E+QI+++ +H NIVK +
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK----Y 62
Query: 85 YSSGDKKDEP 94
Y S KKDE
Sbjct: 63 YGSYLKKDEL 72
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 38/114 (33%), Positives = 62/114 (54%), Gaps = 4/114 (3%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
++ Y ++ +L ++H G+ +RD+K N+LL+ E G KL DFG K + +
Sbjct: 98 SRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTF 156
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
C + Y APE I ++Y +D W+ G ++ E++ GQP F D+ D L E I
Sbjct: 157 CGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 7e-10
Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 9/61 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSG----ELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
+G G+FG VY+ KL G VA+K + +D + RE +IMR+L+H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 80 L 80
L
Sbjct: 66 L 66
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 55/186 (29%), Positives = 83/186 (44%), Gaps = 41/186 (22%)
Query: 235 SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294
SK + P + Y+ ++ ++ +H LG HRDIKP N+LL+ + G ++L DFGS
Sbjct: 93 SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLR 151
Query: 295 LVR----------GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPM 344
L+ G P+ YI +A E G Y + D WS G + E+L G+
Sbjct: 152 LLADGTVQSNVAVGTPD--YISPEILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETP 207
Query: 345 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE-FKFPQIKSHPWSKVFRVRTPPDAID 403
F +S V+ +I+ N+ E F+FP V V +A D
Sbjct: 208 FYAESLVETYGKIM----------------NHKEHFQFP-------PDVTDV--SEEAKD 242
Query: 404 LISRLL 409
LI RL+
Sbjct: 243 LIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 3/109 (2%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYY 310
Q+ +L ++H I HRDIK QN+ L + G +KL DFG A+ L E + I + YY
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
+PE I Y K D+W+ GCVL E+ + F + + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 10/137 (7%)
Query: 216 LNLVLEFMPE-TVYKVAKH-YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+ ++ ++ + K Y + + T L ++ + L Y+H G HRDIK
Sbjct: 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK--EVLKGLEYLHSNGQIHRDIKAG 131
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVS-----YICSRYYRAPELIFGAIDYTTKIDV 328
N+LL E G +K+ DFG + L G ++ + + APE++ Y K D+
Sbjct: 132 NILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADI 190
Query: 329 WSAGCVLAELLLGQPMF 345
WS G EL G +
Sbjct: 191 WSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 4/74 (5%)
Query: 143 VDQLVEIIKVLGTPTREQI-REMNPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL I++VLGTP+ E + + + P+ P SK+F P+AIDL+ +
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP-GASPEAIDLLEK 271
Query: 200 LLEYTPSSRISPLQ 213
+L + P RI+ +
Sbjct: 272 MLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-10
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 9/61 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSG----ELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
+G G+FG VY+ L G VA+K + +D + RE +IMR+L+H NIVK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 80 L 80
L
Sbjct: 66 L 66
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 6/66 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKN---REMQIMRRLEHSNIVKLKY 82
V+G G++G+V + + +GE+VAIKK + D+ K RE++++R+L H NIV LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 83 FFYSSG 88
F G
Sbjct: 68 AFRRKG 73
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 39/95 (41%), Positives = 53/95 (55%), Gaps = 17/95 (17%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLN-PETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
QL ++ YIH GI HRDIK +N+L+N PE + L DFG+A RG S+ +Y
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAA-CFARG----SWSTPFHY 320
Query: 311 --------RAPELIFGAIDYTTKIDVWSAGCVLAE 337
APE++ G YT +D+WSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 30/177 (16%)
Query: 252 QLFRSLAYIHVLG-ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ +L Y+H I HRD+ P N++L + V + DFG AK S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT-ITDFGLAKQKQPESKLTSVVGTILY 179
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
PE++ Y K DVW+ GC+L ++ QP F + + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM- 237
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITP 427
+S+ D D+I+ L +R +QV ++
Sbjct: 238 ------------------YSE--------DVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 31/151 (20%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR--GEPNVSYICSRY 309
++ R L+++H + HRDIK QN+LL E +KL DFG + L R G N ++I + Y
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPY 176
Query: 310 YRAPELIFGAID------YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
+ APE+I A D Y K D+WS G E+ G P + L I +
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---- 230
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
NP P++KS WSK F+
Sbjct: 231 ---------NPA------PRLKSKKWSKKFQ 246
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 36/129 (27%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYY 310
+ ++L ++H + HRDIK N+LL + G +KL DFG + + S + + Y+
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE++ Y K+D+WS G + E++ G+P + ++ + L +I GTP +
Sbjct: 182 MAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 371 EMNPNYTEF 379
+++ + +F
Sbjct: 240 KLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 6/74 (8%)
Query: 140 DSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 196
DS +DQL I + LGTP + + + P+Y FP+ SKV D +DL
Sbjct: 203 DSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYKP-TFPKWARQDLSKVVP-NLDEDGLDL 259
Query: 197 ISRLLEYTPSSRIS 210
+S++L Y P+ RIS
Sbjct: 260 LSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGEPNVSYICSRYYRAPEL 315
L ++H GI +RD+K N++L+ E G +K+ DFG K ++ G+ ++ + Y APE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172
Query: 316 IFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD 348
I Y +D W+ G +L E+L GQP F G+
Sbjct: 173 IAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y Q+ + ++H + I +RD+KP+N+LL+ + G +L D G A L G+ +
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTN 158
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
Y APE++ Y+ +D ++ GC + E++ G+ F
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAKHLVRGEPNVSYICSRYY 310
Q +L Y+H I HRD+K N+L + G +KL DFG SAK+ + S+I + Y+
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 311 RAPELIFGAID----YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
APE++ Y K DVWS G L E+ +P + + L++I K PT
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTL 228
Query: 367 EQIREMNPNYTEF 379
Q + + +F
Sbjct: 229 AQPSRWSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 33/151 (21%)
Query: 252 QLFRSLAYIHVLG-------ICHRDIKPQNLLLNPETGV------------------LKL 286
QL +LAY H L + HRD+KPQN+ L+ TG+ K+
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS--TGIRHIGKITAQANNLNGRPIAKI 183
Query: 287 CDFGSAKHLVRGEPNVSYIC--SRYYRAPELIFGAI-DYTTKIDVWSAGCVLAELLLGQP 343
DFG +K++ G ++++ C + YY +PEL+ Y K D+W+ GC++ EL G+
Sbjct: 184 GDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 344 MFPGDSGVDQLV-EIIKVLGTPTREQIREMN 373
F + QL+ E+ + P + + +E+N
Sbjct: 242 PFHKANNFSQLISELKRGPDLPIKGKSKELN 272
|
Length = 1021 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 32/94 (34%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYYR 311
+ ++L+ +H G+ HRDIK ++LL + G +KL DFG + + P S + + Y+
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWM 183
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
APELI + Y ++D+WS G ++ E++ G+P +
Sbjct: 184 APELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE- 299
F F + ++ + L Y+H HRDIK N+LL+ E G +KL DFG A L +
Sbjct: 98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQI 156
Query: 300 PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
+++ + ++ APE+I + Y +K D+WS G EL G+P
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 36/129 (27%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYY 310
+ ++L ++H + HRDIK N+LL + G +KL DFG + + S + + Y+
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE++ Y K+D+WS G + E++ G+P + ++ + L +I GTP +
Sbjct: 183 MAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 371 EMNPNYTEF 379
+++ + +F
Sbjct: 241 KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 28/60 (46%), Positives = 42/60 (70%), Gaps = 10/60 (16%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRL-EHSNIVKLK 81
+G+G+FG VY A+ ++GELVAIKK+ + +F + RE++ +R+L EH NIVKLK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 40/208 (19%)
Query: 250 IYQLFRSLAYIHV-LGICHRDIKPQNLLLN---------------PETGVLKLCDFGSA- 292
I+Q +L Y H L + H D+KP+N+L+ P+ +++CD G
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296
Query: 293 --KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG 350
+H + + +R+YR+PE++ G + + D+WS GC++ EL G+ ++
Sbjct: 297 DERH-----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350
Query: 351 VDQLVEIIKVLGT-PTR-------EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402
++ L + K LG P+ E+ R + + + + P +++ R R + I
Sbjct: 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR-PCTDPKHLARIARARPVREVI 409
Query: 403 ------DLISRLLEYTPSSRISPLQVRS 424
DLI LL Y R++ Q+ +
Sbjct: 410 RDDLLCDLIYGLLHYDRQKRLNARQMTT 437
|
Length = 467 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 3/73 (4%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
S +DQL +I + LGTP E + +F FP+ P K+F P A+DL+
Sbjct: 202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP-NASPQALDLL 260
Query: 198 SRLLEYTPSSRIS 210
S++L Y P RI+
Sbjct: 261 SQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 43/127 (33%), Positives = 64/127 (50%), Gaps = 5/127 (3%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
H KS++ F + Y ++ +L ++H GI +RD+K N+LL+ E G KL DFG
Sbjct: 86 HIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMC 143
Query: 293 KHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
K + S C + Y APE I + Y +D W+ G +L E+L G F ++
Sbjct: 144 KEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE- 201
Query: 352 DQLVEII 358
D L E I
Sbjct: 202 DDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 35/188 (18%)
Query: 234 YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
Y + F Y ++ L +H I +RD+KP+N+LL+ + G +++ D G A
Sbjct: 92 YHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAV 150
Query: 294 HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ 353
H+ G+ + + Y APE++ YT D W+ GC+L E++ GQ F Q
Sbjct: 151 HVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPF------QQ 203
Query: 354 LVEIIKVLGTPTREQ----IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409
+ IK RE+ ++E+ Y+E + PDA L LL
Sbjct: 204 RKKKIK------REEVERLVKEVQEEYSE-----------------KFSPDARSLCKMLL 240
Query: 410 EYTPSSRI 417
P R+
Sbjct: 241 CKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 10/65 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
IG+G++G+V A +G VAIKK+ F + RE++++R L H NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKIS--NVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 81 KYFFY 85
Sbjct: 65 LDILR 69
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 34/174 (19%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+ Y ++ +L Y+H + +RD+K +NL+L+ + G +K+ DFG K + +
Sbjct: 97 ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGT 363
C + Y APE++ DY +D W G V+ E++ G+ P + D ++L E+I +
Sbjct: 156 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM--- 209
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
E +FP+ P+A L++ LL+ P R+
Sbjct: 210 -------------EEIRFPR------------TLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 9e-09
Identities = 36/129 (27%), Positives = 68/129 (52%), Gaps = 4/129 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYY 310
+ ++L ++H + HRDIK N+LL + G +KL DFG + + S + + Y+
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE++ Y K+D+WS G + E++ G+P + ++ + L +I GTP +
Sbjct: 182 MAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 371 EMNPNYTEF 379
++ + +F
Sbjct: 240 RLSAVFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
IG G++GIVY+A+ SGE+VA+KKV D RE+ ++ L H NIV+LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 25/56 (44%), Positives = 37/56 (66%), Gaps = 6/56 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKN-----REMQIMRRLEHSNIVK 79
IG G+FG VY A LD+GEL+A+K++ +QD K EM+++ L+H N+VK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 8/60 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKNR-----EMQIMRRLEHSNIVKL 80
+G G+FG VY+ KL VA+K + +D + R E ++M++L H N+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 6/101 (5%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY- 309
YQ+ + +A++ HRD+ +N+LL ++K+CDFG A+ ++ V +R
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 310 --YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE IF + YT + DVWS G +L E+ LG +PG
Sbjct: 207 VKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 215 FLNLVLEF-MPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
+L LVLEF + + + + + CFY Q+ Y+ L I +RD+KP+
Sbjct: 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA----QIVLIFEYLQSLNIVYRDLKPE 160
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
NLLL+ + G +K+ DFG AK + + +C + Y APE++ + + D W+ G
Sbjct: 161 NLLLDKD-GFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN-VGHGKAADWWTLG 215
Query: 333 CVLAELLLGQPMF 345
+ E+L+G P F
Sbjct: 216 IFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 32/113 (28%), Positives = 62/113 (54%), Gaps = 3/113 (2%)
Query: 234 YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
+ + ++ P + + Y ++ +L ++H GI +RD+K N+LL+ + G +KL D+G K
Sbjct: 86 HMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCK 144
Query: 294 HLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
+ S C + Y APE++ G +Y +D W+ G ++ E++ G+ F
Sbjct: 145 EGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 235 SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294
SK + P + YI ++ ++ IH L HRDIKP N+LL+ G ++L DFGS
Sbjct: 93 SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLK 151
Query: 295 LVRGEPNVSYIC--SRYYRAPELIFGAID----YTTKIDVWSAGCVLAELLLGQPMFPGD 348
+ + S + + Y +PE++ D Y + D WS G + E+L G+ F +
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 349 SGVDQLVEIIKVLGTPTREQIREMNPNYTE-FKFPQIKSHPWSKVFRVRTPPDAIDLISR 407
S V+ +I+ N+ E F+FP S + V +A DLI R
Sbjct: 212 SLVETYGKIM----------------NHEERFQFP-------SHITDVSE--EAKDLIQR 246
Query: 408 LL 409
L+
Sbjct: 247 LI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 33/112 (29%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICS 307
+ QL + Y+H I HRD+K +N+ L + +LK+ DFG ++ L+ + ++ +
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
YY +PE + Y +K D+WS GC+L E+ F G + + ++ I++
Sbjct: 169 PYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 3/109 (2%)
Query: 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR 297
++ P + + Y ++ +L ++H GI +RD+K N+LL+ E G +KL D+G K +R
Sbjct: 90 QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIR 148
Query: 298 GEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
S C + Y APE++ G DY +D W+ G ++ E++ G+ F
Sbjct: 149 PGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
K +K+ + F L Q+ ++ ++H + HRDIK N+LL G++KL DFG
Sbjct: 131 KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-SNGLVKLGDFGF 189
Query: 292 AKHL---VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD 348
+K V + ++ + YY APE I+ Y+ K D++S G +L ELL + F G+
Sbjct: 190 SKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 349 S 349
+
Sbjct: 249 N 249
|
Length = 496 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/58 (36%), Positives = 34/58 (58%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
IG G+ GIV++AK ++GE VA+KKV + RE++ ++ +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 22/68 (32%), Positives = 41/68 (60%), Gaps = 6/68 (8%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKN-----REMQIMRRLEHSNIVKL 80
+IG G+FG+VY+ L++G+ VAIK++ L+ + + +E+ +++ L+H NIVK
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 81 KYFFYSSG 88
+S
Sbjct: 65 IGSIETSD 72
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 23/63 (36%), Positives = 35/63 (55%), Gaps = 7/63 (11%)
Query: 28 TVIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKN--REMQIMRRLEHSNIVKLKYFF 84
IG G+ G VY+A +G+ VAIKK+ L+ + + E+ IM+ +H NIV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVD----Y 80
Query: 85 YSS 87
Y S
Sbjct: 81 YDS 83
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 7/118 (5%)
Query: 228 YKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLC 287
Y +++H S++ + Y ++ L ++H + +RD+KP N+LL+ E G +++
Sbjct: 86 YHLSQHGVFSEKEM-----RFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRIS 139
Query: 288 DFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
D G A + +P+ S + + Y APE++ Y + D +S GC+L +LL G F
Sbjct: 140 DLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 8/68 (11%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +L +H GI HRD+KPQN++ + +G K+ D G+A L G ++YI +
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFLL 319
Query: 310 ---YRAPE 314
Y APE
Sbjct: 320 DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYY 310
++ + L Y+H HRDIK N+LL+ E G +KL DFG A L + + ++ + ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
APE+I + Y +K D+WS G EL G+P
Sbjct: 168 MAPEVIKQSA-YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 52/221 (23%), Positives = 79/221 (35%), Gaps = 72/221 (32%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCD------------ 288
F + YI +L ++ +H +G HRDIKP N+L++ + G +KL D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156
Query: 289 ---FGSAKH--------------LVRGEPNV---------------SYICSRYYRAPELI 316
+ H + R S + + Y APE++
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
YT D WS G +L E+L+GQP F D TP Q++ +N
Sbjct: 217 L-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE- 260
Query: 377 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
T P + + +A DLI RL R+
Sbjct: 261 TTLHIP----------SQAKLSREASDLILRLCC-GAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVS 303
Y + ++ + L Y+H HRDIK N+LL+ E G +KL DFG A L + +
Sbjct: 102 YIATILREILKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNT 160
Query: 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
++ + ++ APE+I + Y K D+WS G EL G+P
Sbjct: 161 FVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 34/173 (19%)
Query: 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ Y ++ +L Y+H + +RDIK +NL+L+ + G +K+ DFG K + + C
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTP 364
+ Y APE++ DY +D W G V+ E++ G+ P + D ++L E+I +
Sbjct: 157 GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM---- 209
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
E+IR FP+ S P+A L++ LL+ P R+
Sbjct: 210 --EEIR----------FPRTLS------------PEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 3e-08
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
+G G+FG VY+ L GE VA+K + + + E IM++L H NIV+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 80 L 80
L
Sbjct: 66 L 66
|
Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y ++ L +H +RD+KP+N+LL+ + G +++ D G A + GE + +
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGT 164
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPG 347
Y APE++ YT D W GC++ E++ GQ F G
Sbjct: 165 VGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICS 307
+ Q+ +L Y+H I HRD+K QN+ L T ++K+ D G A+ L S I +
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGT 165
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338
YY +PEL F Y K DVW+ GC + E+
Sbjct: 166 PYYMSPEL-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 46/163 (28%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGV---LKLCDFG----------------SA 292
Q+ +LA H GI HRD+KPQN++++ +TGV K+ DFG +
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVS-QTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 293 KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD 352
V G P Y APE + G T D+++ G + E L GQ + G S
Sbjct: 146 TTEVLGTPT--------YCAPEQLRGE-PVTPNSDLYAWGLIFLECLTGQRVVQGAS--- 193
Query: 353 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQ-IKSHPWSKVFR 394
+ EI+ ++++P + P I HP +V R
Sbjct: 194 -VAEILY----------QQLSPV--DVSLPPWIAGHPLGQVLR 223
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 23/71 (32%), Positives = 41/71 (57%), Gaps = 6/71 (8%)
Query: 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMR 70
F D + + IG G+FG V++A+ + ++VA+KKVL + + RE++I++
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ 66
Query: 71 RLEHSNIVKLK 81
L+H N+V L
Sbjct: 67 LLKHENVVNLI 77
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 50/167 (29%)
Query: 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG---------- 290
FP + YI +L ++ +H +G HRDIKP N+L++ + G +KL DFG
Sbjct: 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156
Query: 291 -----SAKHLVR---------GEPNV------------------------SYICSRYYRA 312
S H+ + G+P S + + Y A
Sbjct: 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA 216
Query: 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
PE++ YT D WS G +L E+L+GQP F + ++ +++I
Sbjct: 217 PEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 71/286 (24%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L L++EF+P + + + K + S++ T+ YI + ++ IH LG HRDIKP
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQLGFIHRDIKPD 130
Query: 274 NLLLNPETGVLKLCDFGSA------------KHLVRGEPN-------------------- 301
NLLL+ + G +KL DFG ++L P+
Sbjct: 131 NLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189
Query: 302 ----VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEI 357
S + + Y APE +F Y D WS G ++ E+L+G P F ++ + ++
Sbjct: 190 RQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
Query: 358 IKVLGT-------PTREQIREMNPNY---TEFKF-----PQIKSHPWSKVF---RVRTPP 399
+ T P E+ +++ + +E + +IKSHP+ + +R P
Sbjct: 249 MNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERP 308
Query: 400 DA-------IDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438
A ID S E+ S + P + +I P VF N
Sbjct: 309 AAIPIEIKSIDDTSNFDEFPESDILQPAEN-TIEPDYKSKDWVFLN 353
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y ++ L +H I +RD+KP+N+LL+ + G +++ D G A + GE + +
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTV 165
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
Y APE++ YT D W GC++ E++ G+ F
Sbjct: 166 GYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYI 305
+ YQ+ R + ++ HRD+ +N+LL + ++K+CDFG A+ ++ V S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE IF + YTT DVWS G +L E+ LG +PG
Sbjct: 301 LPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 39/122 (31%), Positives = 64/122 (52%), Gaps = 25/122 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQ+ R + ++ HRD+ +N+L+ E V+K+ DFG A+ ++ +I YY
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI--DYY 188
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
R APE +F + YT + DVWS G +L E+ LG +PG V++L ++
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 246
Query: 358 IK 359
+K
Sbjct: 247 LK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 38/130 (29%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 235 SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294
SK + P + Y+ ++ ++ +H L HRDIKP N+L++ G ++L DFGS
Sbjct: 93 SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLK 151
Query: 295 LVRGEPNVSYIC--SRYYRAPELIFGAID----YTTKIDVWSAGCVLAELLLGQPMFPGD 348
L+ S + + Y +PE++ D Y + D WS G + E+L G+ F +
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 349 SGVDQLVEII 358
S V+ +I+
Sbjct: 212 SLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 44/131 (33%), Positives = 61/131 (46%), Gaps = 25/131 (19%)
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY-- 310
+ R++ Y+H I HRDIK +N+ +N G + L DFG+A V N +YY
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGW 243
Query: 311 ------RAPELIFGAID-YTTKIDVWSAGCVLAELLLGQPMFPGDSGVD-------QLVE 356
APEL+ A D Y +D+WSAG VL E+ G+D Q+
Sbjct: 244 AGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 357 IIKVLGTPTRE 367
II+ GT E
Sbjct: 302 IIRRSGTHPNE 312
|
Length = 391 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-HLVRGEPNVSYIC 306
Y ++ L ++H GI +RD+K N++L+ E G +K+ DFG K ++ G ++
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCG 163
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358
+ Y APE+I Y +D W+ G +L E+L GQ F G+ D+L + I
Sbjct: 164 TPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 38/100 (38%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAKHLVRGEPNVSYICSRYY 310
+ + LAY+H G HRDIK N+LL + G +KL DFG +AK S+I + Y+
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 311 RAPELIFGAID----YTTKIDVWSAGCVLAELL-LGQPMF 345
APE+ A++ Y D+W+ G EL L PMF
Sbjct: 173 MAPEV--AAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 20/71 (28%), Positives = 36/71 (50%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 199
++QL +I ++ G+PT E + ++ P + K + + F+ P A+DL+ +
Sbjct: 208 LEQLEKIFELCGSPTDENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 200 LLEYTPSSRIS 210
LL P RIS
Sbjct: 267 LLTLDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 25/71 (35%), Positives = 33/71 (46%), Gaps = 3/71 (4%)
Query: 143 VDQLVEIIKVLGTPTREQIR--EMNPNYTEFKFPQIKSHPWSKVF-RVRTPPDAIDLISR 199
DQL +I +VLGTPT E NP + + FP P R+ P +L +
Sbjct: 211 EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALK 270
Query: 200 LLEYTPSSRIS 210
L+Y P RIS
Sbjct: 271 FLQYEPKKRIS 281
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 12/102 (11%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYY 310
Q+ +AY+H I HRDIKP NLL+N V K+ DFG ++ L + +P S + + Y
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNV-KIADFGVSRILAQTMDPCNSSVGTIAY 234
Query: 311 RAPELI-----FGAID-YTTKIDVWSAGCVLAELLLGQPMFP 346
+PE I GA D Y D+WS G + E LG+ FP
Sbjct: 235 MSPERINTDLNHGAYDGYAG--DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 34/174 (19%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
T+ Y ++ +L Y+H I +RD+K +NL+L+ + G +K+ DFG K + +
Sbjct: 97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTF 155
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGT 363
C + Y APE++ DY +D W G V+ E++ G+ P + D ++L E+I +
Sbjct: 156 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM--- 209
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
+ KFP+ S DA L+S LL P+ R+
Sbjct: 210 -------------EDIKFPRTLS------------ADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 6/103 (5%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
+ +Q+ R + Y+ + + HRD+ +N+L+ E +K+ DFG ++ + + V R
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKRSKGR 190
Query: 309 Y---YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ A E +F I YTT+ DVWS G +L E++ LG +PG
Sbjct: 191 IPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 80/256 (31%)
Query: 215 FLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
+L L++EF+P + + + K+ F T+ Y+ + ++ +H LG HRDIKP
Sbjct: 75 YLYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129
Query: 273 QNLLLNPETGVLKLCDFG------------SAKHLVRGEPNVSYICSRY----------- 309
N+L++ G +KL DFG + L++G+ N + I +R
Sbjct: 130 DNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188
Query: 310 -------------------------YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPM 344
Y APE IF Y + D WS G ++ E L+G P
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFECLIGWPP 247
Query: 345 FPGDSGVDQLVEIIK-----------VLGTPTREQIREMNPNYTEFKF-----PQIKSHP 388
F ++ + +II L + IR + N E + +IKSHP
Sbjct: 248 FCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITN-AENRLGRGGAHEIKSHP 306
Query: 389 ------WSKVFRVRTP 398
W + ++R P
Sbjct: 307 FFRGVDWDTIRQIRAP 322
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 19/60 (31%), Positives = 38/60 (63%), Gaps = 9/60 (15%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVKL 80
+G G++ +VY+A+ ++G +VAIKK+ +R + RE+++++ L+H NI+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 9e-08
Identities = 25/62 (40%), Positives = 40/62 (64%), Gaps = 14/62 (22%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLEHSNIVK 79
IG G++G VY+A+ +GELVA+KK+ R +N RE++++++L H NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 80 LK 81
LK
Sbjct: 63 LK 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 4/73 (5%)
Query: 141 SGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLI 197
S ++QL +II+V+G P+ E I + + P P ++ + DA+DL+
Sbjct: 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLL 275
Query: 198 SRLLEYTPSSRIS 210
+LL + P+ R++
Sbjct: 276 KKLLVFNPNKRLT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 13/82 (15%)
Query: 141 SGVDQLVEIIKVLGTPTREQIRE-------MNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 193
S +DQL +I VLGTPT++ E + F+FPQ ++ P+A
Sbjct: 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLG-----FRFPQFAPTSLHQLIP-NASPEA 256
Query: 194 IDLISRLLEYTPSSRISPLQVF 215
IDLI +L + P R + Q
Sbjct: 257 IDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 6/72 (8%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 198
VDQL +I++VLGTP E + + NY P I P+ +F P A+DL+
Sbjct: 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYI-RSLPNIPKKPFESIF-PNANPLALDLLE 273
Query: 199 RLLEYTPSSRIS 210
+LL + P+ RIS
Sbjct: 274 KLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 28/59 (47%), Positives = 39/59 (66%), Gaps = 6/59 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
IG G++G VY+A+ D+GELVA+KKV D + RE++I+R+L H NIV LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 7/62 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--REMQIMRRLEHSNIVKLKY 82
+G GSFG V + D+G+L A+K K+++ K ++ E I+ R+ H IVKL Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 83 FF 84
F
Sbjct: 61 AF 62
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 18/59 (30%), Positives = 32/59 (54%), Gaps = 6/59 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVKLK 81
IG GSFG VY + G+L +K++ +++ E++I+++L H NI+K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 25/72 (34%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 198
V QL I+ VLG+P+ E + + Y + P+ + PWSK+F +P +A+DL+S
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASP-EALDLLS 275
Query: 199 RLLEYTPSSRIS 210
++L++ P RI+
Sbjct: 276 QMLQFDPEERIT 287
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 15/117 (12%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY- 309
YQ+ R + Y+ HRD+ +N+L+ E V+K+ DFG L R N+ Y
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFG----LARDVNNIDYYKKTTN 198
Query: 310 ------YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
+ APE +F + YT + DVWS G ++ E+ LG +PG V++L +++K
Sbjct: 199 GRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS---YI 305
+ YQ+ + ++ HRD+ +N+L+ E ++K+CDFG A+ ++R +S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTP 364
+ APE IF + YTT DVWS G +L E+ LG +P +Q IK
Sbjct: 303 LPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK----- 356
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398
R P + + +I W + F +R
Sbjct: 357 --RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 19/146 (13%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQ+ + ++++ HRD+ +N+LL + K+CDFG A+ +R + N Y+
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD-IRNDSN--YVVKGNA 276
Query: 311 R------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGT 363
R APE IF + YT + DVWS G +L E+ LG +PG + ++IK
Sbjct: 277 RLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK---- 331
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPW 389
E R ++P + I W
Sbjct: 332 ---EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 30/194 (15%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y +L L + I +RD+KP+N+LL+ + G +++ D G A + GE + +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
Y APE+I YT D W GC++ E++ GQ F +V
Sbjct: 165 VGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKE--------RVKREEVDR 215
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITP 427
+++E Y+E KF + DA + LL P R L R
Sbjct: 216 RVKEDQEEYSE-KFSE----------------DAKSICRMLLTKNPKER---LGCRGNGA 255
Query: 428 FLIELRAVFENICF 441
++ +F+NI F
Sbjct: 256 AGVKQHPIFKNINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 24/69 (34%), Positives = 41/69 (59%), Gaps = 8/69 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLKY 82
+G G+FG VY+A+ + +G +VA+KK+L K+ RE++I+++L+H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 83 FFYSSGDKK 91
DK
Sbjct: 75 MAVERPDKS 83
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 6/101 (5%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY- 309
Q+ + + ++ HRD+ +N+LL + V K+CDFG A+ ++ V +R
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 310 --YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE IF + YT + DVWS G +L E+ LG+ +PG
Sbjct: 278 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 38/113 (33%), Positives = 62/113 (54%), Gaps = 7/113 (6%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK---HLVRGEPNVSYICS 307
YQ+ R + Y+ HRD+ +N+L+ E V+K+ DFG A+ H+ + +
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
+ APE +F I YT + DVWS G +L E+ LG +PG V++L +++K
Sbjct: 206 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 45/168 (26%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L L++EF+P + + + K + +++ T+ YI + ++ IH LG HRDIKP
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 274 NLLLNPETGVLKLCDFGSAKHLV------------------------------------R 297
NLLL+ + G +KL DFG L R
Sbjct: 131 NLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189
Query: 298 GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345
+ S + + Y APE +F Y D WS G ++ E+L+G P F
Sbjct: 190 RQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 37/100 (37%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV--RGEPNVSYICS 307
+Y L ++H I HRD+K N+LL E GV KL DFG + L R N S + +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV-KLVDFGVSAQLTSTRLRRNTS-VGT 191
Query: 308 RYYRAPELIFGA----IDYTTKIDVWSAGCVLAELLLGQP 343
++ APE+I Y + DVWS G EL G P
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 23/57 (40%), Positives = 37/57 (64%), Gaps = 6/57 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKL 80
IG G++G+VY+A+ +GE+VA+KK+ D + RE+ +++ L H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 9/71 (12%)
Query: 30 IGNGSFGIVYQAKLLDS--GELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKL 80
IG G++G VY+AK + G+ AIKK DK RE+ ++R L+H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 81 KYFFYSSGDKK 91
F DK
Sbjct: 68 VEVFLEHADKS 78
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK 236
KS +S+ R+ P + + L +Y +S VFL VL+ K+ H SK
Sbjct: 28 KSSEYSRE-RLTIIPHCVPNMVCLHKYI----VSEDSVFL--VLQHAEGG--KLWSHISK 78
Query: 237 SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV 296
N P K + ++ +L +H GI RD+ P N+LL+ + G ++L F +
Sbjct: 79 -FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEV- 135
Query: 297 RGEPNV-SYICSRYYRAPELIFGAI-DYTTKIDVWSAGCVLAELLLGQPMF---PGDSGV 351
E + Y APE+ G I + T D WS G +L ELL G+ + P
Sbjct: 136 --EDSCDGEAVENMYCAPEV--GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT 191
Query: 352 DQLVEIIKVLGTPTR---EQIREMNP----NYTEFKFPQIKSHPW 389
+ I + + R +Q+ + NP IKSHP+
Sbjct: 192 HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 21/61 (34%), Positives = 41/61 (67%), Gaps = 6/61 (9%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYF 83
IG GS+G+V++ + ++G++VAIKK ++ K+ RE++++++L+H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 84 F 84
F
Sbjct: 69 F 69
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 25/66 (37%), Positives = 39/66 (59%), Gaps = 7/66 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKV-LQDK---RFKNREMQIMRRLEHSNIVKLKYF-F 84
IG+G++G VY+A+ + +GELVAIK + L+ +E+ +++ H NIV YF
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV--AYFGS 68
Query: 85 YSSGDK 90
Y DK
Sbjct: 69 YLRRDK 74
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 35/174 (20%)
Query: 247 KLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+ Y ++ +L Y+H + +RD+K +NL+L+ + G +K+ DFG K ++ +
Sbjct: 98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGT 363
C + Y APE++ DY +D W G V+ E++ G+ P + D ++L E+I +
Sbjct: 157 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM--- 210
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
E+IR FP+ S P+A L+S LL+ P R+
Sbjct: 211 ---EEIR----------FPRTLS------------PEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 42/127 (33%), Positives = 61/127 (48%), Gaps = 16/127 (12%)
Query: 225 ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVL 284
+ +Y V S+S+ + T + L Y+H G HRDIK N+LL + G +
Sbjct: 94 QDIYHVTGPLSESQIAYVSRET-------LQGLYYLHSKGKMHRDIKGANILLT-DNGHV 145
Query: 285 KLCDFG-SAKHLVRGEPNVSYICSRYYRAPELIFGAID----YTTKIDVWSAGCVLAELL 339
KL DFG SA+ S+I + Y+ APE+ A++ Y D+W+ G EL
Sbjct: 146 KLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKGGYNQLCDIWAVGITAIELA 203
Query: 340 -LGQPMF 345
L PMF
Sbjct: 204 ELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 31/121 (25%), Positives = 56/121 (46%), Gaps = 25/121 (20%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
++ +AY+ HRD+ +N ++ E +K+ DFG + + + YYR
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETD---------YYR 176
Query: 312 ------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEII 358
APE + + +TTK DVWS G VL E+ L + + G S +++++ +
Sbjct: 177 KGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFV 234
Query: 359 K 359
Sbjct: 235 I 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 15/117 (12%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY- 309
YQ+ R + Y+ HRD+ +N+L+ E V+K+ DFG L R N+ Y
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFG----LARDVHNIDYYKKTTN 195
Query: 310 ------YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
+ APE +F + YT + DVWS G +L E+ LG +PG V++L +++K
Sbjct: 196 GRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 9/75 (12%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK----FPQIKSHPWSKVFRVRTPPDAID 195
DS + QL+ I K+LGTPT + P ++ + FPQ K S+ P+ +D
Sbjct: 215 DSELQQLLHIFKLLGTPTEQVW----PGVSKLRDWHEFPQWKPQDLSRAVP-DLSPEGLD 269
Query: 196 LISRLLEYTPSSRIS 210
L+ ++L Y P+ RIS
Sbjct: 270 LLQKMLRYDPAKRIS 284
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 24/64 (37%), Positives = 37/64 (57%), Gaps = 17/64 (26%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLE---HSN 76
IG G++G VY+A+ L++G VA+KKV R RE+ ++++LE H N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 77 IVKL 80
IV+L
Sbjct: 63 IVRL 66
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 24/71 (33%), Positives = 39/71 (54%), Gaps = 6/71 (8%)
Query: 144 DQLVEIIKVLGTPTREQIREM-NP---NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 199
QL I+ VLGTP++E + + + NY + P PW+K+F P A+DL+ +
Sbjct: 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIK-SLPFKPKVPWNKLFP-NADPKALDLLDK 274
Query: 200 LLEYTPSSRIS 210
+L + P RI+
Sbjct: 275 MLTFNPHKRIT 285
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 24/69 (34%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 144 DQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 201
DQL++I +++GTPT ++ P Y + FP+ ++F P IDL+ RLL
Sbjct: 208 DQLLKIFRIMGTPTESTWPGISQLPEY-KPTFPRYPPQDLQQLFP-HADPLGIDLLHRLL 265
Query: 202 EYTPSSRIS 210
+ P RIS
Sbjct: 266 QLNPELRIS 274
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 21/67 (31%), Positives = 39/67 (58%), Gaps = 6/67 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFYS 86
+G GS+G VY+A ++G++VAIK V ++ + +E+ I+++ + IVK +Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK----YYG 65
Query: 87 SGDKKDE 93
S K +
Sbjct: 66 SYFKNTD 72
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV 302
CFYT Q+ L ++H I +RD+KP+N+LL+ + G +++ D G A L G+
Sbjct: 100 CFYTA----QIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT 154
Query: 303 -SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
Y + + APEL+ G +Y +D ++ G L E++
Sbjct: 155 KGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 216 LNLVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LV+E++P Y + Y K ++ LY Q+ + + Y+ HRD+ +N
Sbjct: 82 LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN 138
Query: 275 LLLNPETGVLKLCDFGSAKHL--------VRGEPNVSYICSRYYRAPELIFGAIDYTTKI 326
+L+ E V K+ DFG K L VR EP S I ++ APE + + ++
Sbjct: 139 ILVESENRV-KIGDFGLTKVLPQDKEYYKVR-EPGESPI---FWYAPESLTESK-FSVAS 192
Query: 327 DVWSAGCVLAEL 338
DVWS G VL EL
Sbjct: 193 DVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 22/58 (37%), Positives = 38/58 (65%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
I G++G+VY+A+ +GE+VA+KK+ +K + RE+ I+ +L+H NIV +K
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
K I QL +L +H I H DIK +N+L + + LCD+G K G P+ Y
Sbjct: 111 VKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSC-YD 167
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG----VDQL------- 354
+ Y +PE I G +Y D W+ G + ELL G+ F D ++ L
Sbjct: 168 GTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226
Query: 355 VEIIKVLGTPTREQIREM---NPNYTEFKFPQIKSHPW 389
+ IK + + ++ M N NY + +I HP+
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL--VRGEPNVSYICS 307
+++ L ++HV HRD+K N+LL E GV KL DFG + L R N S + +
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV-KLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 308 RYYRAPELIF--GAID--YTTKIDVWSAGCVLAELLLGQP 343
++ APE+I +D Y + DVWS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 15/117 (12%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY- 309
YQ+ R + Y+ HRD+ +N+L+ E V+K+ DFG L RG ++ Y
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVT-EDNVMKIADFG----LARGVHDIDYYKKTSN 195
Query: 310 ------YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
+ APE +F + YT + DVWS G ++ E+ LG +PG V++L ++++
Sbjct: 196 GRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 2/69 (2%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNP-NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 201
+DQ+ +I VLGTP E +++ + + FP K K+ + +DL+ +LL
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLL-PNASAEGLDLLKKLL 263
Query: 202 EYTPSSRIS 210
Y P RI+
Sbjct: 264 AYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 6/72 (8%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNP----NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 198
+DQL I+ ++GTP E +++++ NY + PQ+ + +VF P AIDL+
Sbjct: 222 IDQLKRIMNLVGTPDEELLQKISSESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLE 279
Query: 199 RLLEYTPSSRIS 210
++L P RI+
Sbjct: 280 KMLVLDPDKRIT 291
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 10/60 (16%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKLK 81
IG G++GIV AK ++ E VAIKK+ F N RE++++R L+H N++ +K
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 21/57 (36%), Positives = 36/57 (63%), Gaps = 6/57 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKL 80
IG G++G V++AK ++ E+VA+K+V D RE+ +++ L+H NIV+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 25/57 (43%), Positives = 37/57 (64%), Gaps = 1/57 (1%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
YI ++ +L Y+H GI HRD+KP N+L++ E G +KL DFG +K + E N+ I
Sbjct: 109 YISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 29/76 (38%), Positives = 40/76 (52%), Gaps = 10/76 (13%)
Query: 144 DQLVEIIKVLGTPTREQ---IREMNPNY----TEFKFPQIKSHPWSKVFRVRTPPD--AI 194
DQL I +VLGTPT + I++M P Y +FK S+ +K PD
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 195 DLISRLLEYTPSSRIS 210
DL+ +LLEY P+ RI+
Sbjct: 291 DLLRKLLEYDPTKRIT 306
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 9/70 (12%)
Query: 30 IGNGSFGIVYQAKLL----DSGELVAIKK-----VLQDKRFKNREMQIMRRLEHSNIVKL 80
+G G FG V + ++GE VA+K Q + RE++I+R L+H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 81 KYFFYSSGDK 90
K G +
Sbjct: 72 KGVCEKPGGR 81
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 24/135 (17%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L L++E++P + + + K K N L+ Q+ +AY+H HRD+ +N+
Sbjct: 83 LQLIMEYVP--LGSLRDYLPKHKLNLAQLL--LFAQQICEGMAYLHSQHYIHRDLAARNV 138
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE-----LIFGAID------YTT 324
LL+ + ++K+ DFG AK + G YYR E + + A++ ++
Sbjct: 139 LLDNDR-LVKIGDFGLAKAVPEGH--------EYYRVREDGDSPVFWYAVECLKENKFSY 189
Query: 325 KIDVWSAGCVLAELL 339
DVWS G L ELL
Sbjct: 190 ASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ + ++Y+ + HRD+ +N+L+ V K+ DFG AK L E +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 310 -YRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
+ A E I I YT K DVWS G + EL+ G + G V+ L+E
Sbjct: 176 KWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 12/66 (18%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREM---------QIMRRLE-HSNIV 78
+IG GSF V AK ++ + AI K+L DKR +E +++ RL H I+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAI-KIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 79 KLKYFF 84
KL Y F
Sbjct: 66 KLYYTF 71
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 21/58 (36%), Positives = 37/58 (63%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
IG G++G+VY+A+ +GE+VA+KK+ + + RE+ +++ L H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 22/67 (32%), Positives = 35/67 (52%), Gaps = 6/67 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKK------VLQDKRFKNREMQIMRRLEHSNIVKLKY 82
IG+G++G+V A SG+ VAIKK V + RE++I+R +H NI+ ++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 83 FFYSSGD 89
G
Sbjct: 72 ILRPPGA 78
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 29/77 (37%), Positives = 40/77 (51%), Gaps = 12/77 (15%)
Query: 140 DSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKSHPWSKVFRVRTPP---DA 193
DS +DQL I + LGTP + + P+Y FP+ +SKV PP D
Sbjct: 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSL-PDYKP-SFPKWARQDFSKV----VPPLDEDG 257
Query: 194 IDLISRLLEYTPSSRIS 210
DL+S++L Y P+ RIS
Sbjct: 258 RDLLSQMLHYDPNKRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 19/59 (32%), Positives = 34/59 (57%), Gaps = 9/59 (15%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVL---QDKRFK------NREMQIMRRLEHSNIVK 79
+G+GSFG VY+ LD G+ A+K+V + + +E+ ++ +L+H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 23/67 (34%), Positives = 39/67 (58%), Gaps = 8/67 (11%)
Query: 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNR---EMQIMRRL 72
L N +K IG G F +VY+A L G +VA+KKV + D + + E+ ++++L
Sbjct: 1 LGNFKIEKK-IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL 59
Query: 73 EHSNIVK 79
+H N++K
Sbjct: 60 DHPNVIK 66
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 40/148 (27%), Positives = 60/148 (40%), Gaps = 25/148 (16%)
Query: 234 YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
Y K ++ P K +Q+ +AY+ HRD+ +N+LL K+ DFG ++
Sbjct: 85 YLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA-KISDFGMSR 143
Query: 294 HLVRGEPNVSYICSRYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL-L 340
L G S YYR APE I +++K DVWS G L E
Sbjct: 144 ALGAG--------SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSY 194
Query: 341 GQPMFPGDSGVD--QLVEIIKVLGTPTR 366
G + G + ++E + L P
Sbjct: 195 GAKPYGEMKGAEVIAMLESGERLPRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 23/141 (16%)
Query: 218 LVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+V+E P + Y +K + LY YQL +LAY+ HRDI +N+L
Sbjct: 83 IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139
Query: 277 L-NPETGVLKLCDFGSAKHLVRGEPNVSYICSR-----YYRAPELIFGAIDY---TTKID 327
+ +P+ +KL DFG +++L E Y S+ + APE +I++ T+ D
Sbjct: 140 VSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPE----SINFRRFTSASD 190
Query: 328 VWSAG-CVLAELLLGQPMFPG 347
VW G C+ L+LG F G
Sbjct: 191 VWMFGVCMWEILMLGVKPFQG 211
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AY+ HRD+ +N+L+ E V K+ DFG A+ L+ + + +++
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR-LIEDDEYTAREGAKFPI 168
Query: 310 -YRAPELIFGAIDY---TTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE A +Y T K DVWS G +L E++ G+ +PG
Sbjct: 169 KWTAPE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 16/75 (21%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLE-HSNIVKLK 81
IG G+F V +A+ +G+ AIK + K FK+ RE+Q +RRL H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 82 YFFYSSGDKKDEPTN 96
+ D T
Sbjct: 65 EVLF------DRKTG 73
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 23/58 (39%), Positives = 40/58 (68%), Gaps = 6/58 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKN---REMQIMRRLEHSNIVKL 80
++G GS+G+V + K ++G++VAIKK L+ DK K RE++++++L H N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 6/60 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVKLKY 82
VIG GS+G+V A +GE VAIKK+ + D RE++++R L H +IV++K+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 28/63 (44%), Positives = 40/63 (63%), Gaps = 4/63 (6%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKK-VLQDKR-FKN--REMQIMRRLEHSNIVKLKYFFY 85
+G GS G+V+ A D + VA+KK VL D + K+ RE++I+RRL+H NIVK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 86 SSG 88
SG
Sbjct: 73 PSG 75
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 9/77 (11%)
Query: 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR-----EMQIMRRL 72
SDL+ V+G GS G+VY+ + +G++ A+KK+ D + R E++ +R
Sbjct: 1 SDLER----VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC 56
Query: 73 EHSNIVKLKYFFYSSGD 89
E +VK FY G+
Sbjct: 57 ESPYVVKCYGAFYKEGE 73
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 27/67 (40%), Positives = 40/67 (59%), Gaps = 8/67 (11%)
Query: 30 IGNGSFGIVYQAK---LLDS-GELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLK 81
+G G+FG V + L D+ GE+VA+KK+ R RE++I++ L+H NIVK K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 82 YFFYSSG 88
YS+G
Sbjct: 72 GVCYSAG 78
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
+ ++ Y+ G HRD+ +N L+ E V+K+ DFG A++++ + Y S+ +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTK 162
Query: 312 -----APELIFGAIDYTTKIDVWSAGCVLAEL 338
AP +F +++K DVWS G ++ E+
Sbjct: 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 7/121 (5%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL--VRGEPNVS 303
T+ + QL ++ YIH + HRDIK +N+ LN + G + L DFG+A R +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYG 327
Query: 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD---QLVEIIKV 360
++ + +PE++ G Y D+WS G +L ++L GD G QL++II
Sbjct: 328 WVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 361 L 361
L
Sbjct: 387 L 387
|
Length = 501 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
++ EFM + ++ K SKQ P + Q+ +A+I HRD++ N+L
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEGMAFIEQRNYIHRDLRAANIL 134
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY---YRAPELI-FGAIDYTTKIDVWSAG 332
++ V K+ DFG A+ ++ + +++ + APE I FG+ +T K DVWS G
Sbjct: 135 VSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFG 190
Query: 333 CVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
+L E++ G+ +PG S E+I+ L R E P
Sbjct: 191 ILLMEIVTYGRIPYPGMSN----PEVIRALERGYRMPRPENCP 229
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 37/121 (30%), Positives = 65/121 (53%), Gaps = 9/121 (7%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AYI HRD++ N+L++ E+ + K+ DFG A+ ++ + +++
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLAR-VIEDNEYTAREGAKFPI 168
Query: 310 -YRAPELI-FGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ APE I FG+ +T K DVWS G +L E++ G+ +PG S D + + + P
Sbjct: 169 KWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226
Query: 367 E 367
E
Sbjct: 227 E 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 26/74 (35%), Positives = 40/74 (54%), Gaps = 6/74 (8%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRT-PPDAIDL 196
DS +D+L +I ++LGTP E + P+Y FP+ + V V T P +DL
Sbjct: 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKS-AFPKWPPKDLATV--VPTLEPAGVDL 263
Query: 197 ISRLLEYTPSSRIS 210
+S++L PS RI+
Sbjct: 264 LSKMLRLDPSKRIT 277
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/71 (38%), Positives = 39/71 (54%), Gaps = 7/71 (9%)
Query: 143 VDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL I ++LGTP + Q +++ P YTEF + K +F + DAIDL+
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNASD-DAIDLLQS 295
Query: 200 LLEYTPSSRIS 210
LL+ P RIS
Sbjct: 296 LLKLNPLERIS 306
|
Length = 335 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 45.9 bits (107), Expect = 3e-05
Identities = 26/68 (38%), Positives = 35/68 (51%), Gaps = 11/68 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRL-EHSNIVKL 80
+G GSFG VY A+ +LVA+K + + K+ RE+QI+ L NIVKL
Sbjct: 7 KLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 81 KYFFYSSG 88
FF G
Sbjct: 64 YDFFQDEG 71
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 47/220 (21%)
Query: 216 LNLVLEFMPETVYKVAKHY---SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
L L++E++P + Y + + N L+ Q+ + + Y+ HRD+
Sbjct: 83 LRLIMEYLP---SGSLRDYLQRHRDQINLKRLL--LFSSQICKGMDYLGSQRYIHRDLAA 137
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRG-------EPNVSYICSRYYRAPELIFGAIDYTTK 325
+N+L+ E V K+ DFG AK L EP S I +Y APE + + +++
Sbjct: 138 RNILVESEDLV-KISDFGLAKVLPEDKDYYYVKEPGESPI--FWY-APECLRTSK-FSSA 192
Query: 326 IDVWSAGCVLAELL-LGQPMF--PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 382
DVWS G L EL G P P + L I G ++ E+
Sbjct: 193 SDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQMIVTRLLEL---------- 238
Query: 383 QIKSHPWSKVFRVRTPP----DAIDLISRLLEYTPSSRIS 418
+K R+ PP + DL+ E P R S
Sbjct: 239 -LKEGE-----RLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 27/113 (23%)
Query: 259 YIHVLGICHRDIKPQNLLLNPETG----VLKLCDFGSAKHLVRGEPNVSYICSRYYR--- 311
Y+ + HRD+ +N L++ + V+K+ DFG A+ + + S YYR
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SDYYRKEG 171
Query: 312 ---------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQL 354
APE + +TT+ DVWS G ++ E+L LGQ +P + + L
Sbjct: 172 EGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 15/104 (14%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR--- 308
Q+ +A+I HRD++ N+L++ ET K+ DFG A+ + E Y
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAK 164
Query: 309 ---YYRAPELI-FGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE I +G +T K DVWS G +L E++ G+ +PG
Sbjct: 165 FPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 21/71 (29%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
V QL I ++LG+P+ E + + N + P ++++F P AIDL+ +
Sbjct: 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP-HANPLAIDLLEK 273
Query: 200 LLEYTPSSRIS 210
+L + PS RI+
Sbjct: 274 MLVFDPSKRIT 284
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 4e-05
Identities = 18/63 (28%), Positives = 32/63 (50%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
+G GSFG V + SG+ A+K K+++ K+ + E +I++ + H +V L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 82 YFF 84
F
Sbjct: 68 GSF 70
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ L++EF+P K +K+K N Y Q+ + + Y+ HRD+ +N+
Sbjct: 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLK--YAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR-------YYRAPELIFGAIDYTTKIDV 328
L+ E +K+ DFG K + E + Y + ++ APE + + Y DV
Sbjct: 141 LVESE-HQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS-DV 195
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI---REMNPNYTEFKFPQIK 385
WS G L ELL DS + +K++G PT Q+ R + + P+
Sbjct: 196 WSFGVTLYELLT-----YCDSESSPMTLFLKMIG-PTHGQMTVTRLVRVLEEGKRLPR-- 247
Query: 386 SHPWSKVFRVRTPPDAIDLISRLL----EYTPSSRIS 418
PP+ + + +L+ E+ PS R +
Sbjct: 248 ------------PPNCPEEVYQLMRKCWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 4/68 (5%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---EPNVSYICSR 308
Q+ L +H +GI HRDIKP+NLL+ + G +K+ DFG+A + G P + R
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375
Query: 309 YYRAPELI 316
Y EL+
Sbjct: 376 YSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 6/57 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVK 79
IG GSFG V + + G+++ K++ ++K+ E+ I+R L+H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 143 VDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA-IDLIS 198
+DQL +I K+LGTPT + E+ P + F + + K F + D DL++
Sbjct: 213 IDQLNKIFKLLGTPTEKIWPGFSEL-PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLN 271
Query: 199 RLLEYTPSSRIS 210
RLL Y P+ RIS
Sbjct: 272 RLLTYDPAKRIS 283
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 35/104 (33%), Positives = 46/104 (44%), Gaps = 25/104 (24%)
Query: 259 YIHVLGICHRDIKPQNLLLN-PETG-VLKLCDFGSAKHLVRGEPNVSYICSRYYR----- 311
Y+ HRDI +N LL G V K+ DFG A+ + R + YYR
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASYYRKGGRA 181
Query: 312 -------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
PE I +T+K DVWS G +L E+ LG +PG
Sbjct: 182 MLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPG 224
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AYI + HRD++ N+L+ + V K+ DFG A+ L+ + +++
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPI 167
Query: 310 -YRAPEL-IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPG 347
+ APE ++G +T K DVWS G +L EL+ G+ +PG
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 48/202 (23%), Positives = 75/202 (37%), Gaps = 58/202 (28%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
++ + + Y+ HRD+ +N +LN V + DFG +K + G+ Y R
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC-VADFGLSKKIYNGD---YYRQGR 172
Query: 309 YYRAPELIFGAID------YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVL 361
+ P + + AI+ YTTK DVWS G + E+ GQ +PG V
Sbjct: 173 IAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG------------VE 219
Query: 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID----LISRLLEYTPSSRI 417
+ + +R+ N R++ PPD +D L+S P R
Sbjct: 220 NSEIYDYLRQGN--------------------RLKQPPDCLDGLYSLMSSCWLLNPKDR- 258
Query: 418 SPLQVRSITPFLIELRAVFENI 439
P LR E
Sbjct: 259 ---------PSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 14/71 (19%)
Query: 23 SLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-------KRFKNREMQIMR 70
++ K +G G+FG V+ + + ELVA+K L++ K F+ RE +++
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFE-REAELLT 63
Query: 71 RLEHSNIVKLK 81
+H NIVK
Sbjct: 64 NFQHENIVKFY 74
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 12/77 (15%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPP----DA 193
DS +DQL I ++LGTPT + + P+Y FP+ W K D
Sbjct: 205 DSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN-TFPK-----WKKGSLRSAVKNLDEDG 258
Query: 194 IDLISRLLEYTPSSRIS 210
+DL+ ++L Y P+ RIS
Sbjct: 259 LDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 20/61 (32%), Positives = 37/61 (60%), Gaps = 14/61 (22%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLEHSNIVK 79
IG G++G+VY+ + +G++VA+KK+ R ++ RE+ +++ L+H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 80 L 80
L
Sbjct: 64 L 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 17/64 (26%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLE---HSN 76
IG G++G VY+A+ SG VA+K V R + RE+ +++RLE H N
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 77 IVKL 80
IV+L
Sbjct: 64 IVRL 67
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 13/64 (20%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-------QDKRFKN------REMQIMRRLEHS 75
+IG+GSFG VY SGEL+A+K+V R ++ RE+ +++ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 76 NIVK 79
NIV+
Sbjct: 67 NIVQ 70
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 14/109 (12%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR------YY 310
+ Y+ HRD+ +N L++ TGV+K+ DFG ++++ E Y S +
Sbjct: 113 MEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEII 358
PE +F Y++K DVWS G ++ E+ G+ F S ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 16/90 (17%)
Query: 267 HRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-------APE-LIFG 318
HRD+ +N L+ E VLK+ DFG + R E Y S + APE L +G
Sbjct: 116 HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 319 AIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
YT++ DVWS G +L E LG +PG
Sbjct: 171 R--YTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AY+ + HRD++ N+L+ E V K+ DFG A+ L+ + +++
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 167
Query: 310 -YRAPE-LIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPG 347
+ APE ++G +T K DVWS G +L EL G+ +PG
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AYI + HRD++ N+L+ + V K+ DFG A+ L+ + +++
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLAR-LIEDNEYTARQGAKFPI 167
Query: 310 -YRAPEL-IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPG 347
+ APE ++G +T K DVWS G +L EL+ G+ +PG
Sbjct: 168 KWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 15/114 (13%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AY+ HRD+ +N+L+ E + K+ DFG A+ + + +++
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYE-AREGAKFPI 168
Query: 310 -YRAPELIFGAIDY---TTKIDVWSAGCVLAELL-LGQPMFPGDSG--VDQLVE 356
+ APE A Y + K DVWS G +L E++ G+ +PG + V Q V+
Sbjct: 169 KWTAPE----AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/62 (33%), Positives = 35/62 (56%), Gaps = 11/62 (17%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIV 78
+ IG G++G+V A +G VAIKK+ F++ RE++I+RR +H NI+
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKI---SPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 79 KL 80
+
Sbjct: 67 GI 68
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--REMQIMRRLEHSNIVKLK 81
VIG G+FG V + D+ ++ A+K K ++ +N E +I++ L H +V L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 82 YFF 84
Y F
Sbjct: 67 YSF 69
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 7/59 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG+GSFG VY A+ + + E+VAIKK+ + N +E++ +++L H N ++ K
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY---YRAP 313
+ Y+ HRD+ +N+L++ E V K+ DFG AK E + + + AP
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP 168
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAEL 338
E + ++TK DVWS G +L E+
Sbjct: 169 EALREKK-FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 19/63 (30%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKYF 83
IG G++G+VY+A+ + E +A+KK+ ++ + RE+ +++ ++H NIV+L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 84 FYS 86
+S
Sbjct: 70 VHS 72
|
Length = 294 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 22/86 (25%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKLK 81
+G G+FG+V A+ +G+ VAIKK++ K F RE+++++ L H NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM--KPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 82 YFFYSSGDKKDEPTNYPPLEDMKIST 107
F S PLED+ T
Sbjct: 76 DIFIS------------PLEDIYFVT 89
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 16/83 (19%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNP---NYTEFKFPQIKSHPWSKVF-RVRTPPD------ 192
+DQ +II+ LGTP+ E + + P NY E + P+ + + ++F V PPD
Sbjct: 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNK 281
Query: 193 -----AIDLISRLLEYTPSSRIS 210
A DL+S++L P RIS
Sbjct: 282 LKASQARDLLSKMLVIDPEKRIS 304
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 31/76 (40%), Positives = 38/76 (50%), Gaps = 16/76 (21%)
Query: 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR------EMQIMRR 71
S LDN IG GS GIV A +G VA+KK+ D R + R E+ IMR
Sbjct: 19 SYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRD 72
Query: 72 LEHSNIVKLKYFFYSS 87
+H NIV+ YSS
Sbjct: 73 YQHPNIVE----MYSS 84
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 47/168 (27%), Positives = 68/168 (40%), Gaps = 43/168 (25%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY------Y 310
+AY+ HRD+ +N L+ E VLK+ DFG + R E + Y S +
Sbjct: 106 MAYLESKNCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKW 160
Query: 311 RAPE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQ 368
APE L +G Y+++ DVWS G +L E LG +PG T +Q
Sbjct: 161 TAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPG----------------MTNQQ 202
Query: 369 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
RE PQ + P D ++ R +Y P +R
Sbjct: 203 AREQVEKGYRMSCPQ------------KCPDDVYKVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 26/85 (30%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY---YRAP 313
+AY+ + HRD+ +N L+ E V+K+ DFG + V + S +++ + +P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVG-ENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSP 170
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAEL 338
E +F Y++K DVWS G ++ E+
Sbjct: 171 E-VFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 19/102 (18%)
Query: 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK-------HLVRGEPNVSYICSR 308
++ Y+H G+ HRD+KP N+LL V+ L D+G+A L+ + + IC
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 309 YYRAPELIFGAIDY-----------TTKIDVWSAGCVLAELL 339
P I G DY + D+++ G +L ++L
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 14/64 (21%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR--------------EMQIMRRLEH 74
+IG G++G VY A + +GE++A+K+V R E++ ++ L+H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 75 SNIV 78
NIV
Sbjct: 68 LNIV 71
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 12/78 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR-----EMQIMRRL-EHSNIVKLKY 82
VIG G++G VY+A+ +G+LVAIK + D E I+R+ H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIAT--- 67
Query: 83 FFYSSGDKKDEPTNYPPL 100
FY + KK+ P N L
Sbjct: 68 -FYGAFIKKNPPGNDDQL 84
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 23/94 (24%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRA---- 312
+AY+ HRD+ +N L+ E V+K+ DFG ++++ + YY+A
Sbjct: 143 MAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSAD---------YYKASEND 192
Query: 313 --------PELIFGAIDYTTKIDVWSAGCVLAEL 338
PE IF YTT+ DVW+ G VL E+
Sbjct: 193 AIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 245 YTKLYIYQLFRSLA----YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
+T + + + R +A Y+ +G HRD+ +N+L+N V K+ DFG ++ ++ +P
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSR-VLEDDP 160
Query: 301 NVSYICSR-----YYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
+Y + APE I +T+ DVWS G V+ E++
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 29/121 (23%), Positives = 53/121 (43%), Gaps = 14/121 (11%)
Query: 238 KQNFPCFYTKLYIYQLFR----SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
K +FP +L I + + +L YIH G HR +K ++LL+ + V L +
Sbjct: 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV-VLSGLRYSV 149
Query: 294 HLVRG--------EPNVSYICSRYYRAPELIFGAID-YTTKIDVWSAGCVLAELLLGQPM 344
+++ + S + + + +PE++ + Y K D++S G EL G
Sbjct: 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
Query: 345 F 345
F
Sbjct: 210 F 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 6/66 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKY 82
V+G G++G+V + + ++ E+VAIKK K RE++++R L+ NIV+LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 83 FFYSSG 88
F G
Sbjct: 68 AFRRRG 73
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 5/56 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
VIG G+ +VY A L + E VAIK++ +K + +E+Q M + H N+VK
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 13/90 (14%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY------ICSRYY 310
+ Y+ + HRD+ +N+L+N V K+ DFG ++ L + +Y I R+
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174
Query: 311 RAPELI-FGAIDYTTKIDVWSAGCVLAELL 339
APE I + +T+ DVWS G V+ E++
Sbjct: 175 TAPEAIAYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 23/68 (33%), Positives = 37/68 (54%), Gaps = 10/68 (14%)
Query: 23 SLAQKTVIGNGSFGIVYQAKL----LDSGELVAIKKVLQDKRFKN------REMQIMRRL 72
+L + T +G G FG V+ AK + GE + + K LQ + +N RE+ + R+L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 73 EHSNIVKL 80
H N+V+L
Sbjct: 66 SHKNVVRL 73
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 11/60 (18%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRL-EHSNIVKL 80
+G G++GIV++A + E+VA+KK+ F+N RE+ ++ L +H NIVKL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFD--AFRNATDAQRTFREIMFLQELGDHPNIVKL 72
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 8/59 (13%)
Query: 30 IGNGSFGIVYQAKLLDS-GEL--VAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKL 80
+G+GSFG+V + + S G++ VA+K + DK +E IM L+H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 14/104 (13%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
Q+ + + Y+ HRD+ +N +L+ E+ +K+ DFG A+ + E Y +
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHT 160
Query: 312 APEL--IFGAID------YTTKIDVWSAGCVLAELLL-GQPMFP 346
+L + A++ +TTK DVWS G +L EL+ G P +P
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 23/73 (31%), Positives = 31/73 (42%), Gaps = 5/73 (6%)
Query: 140 DSGVDQLVEIIKVLGT-PTREQIREM-NPNYTEFKFPQIKSHPWS--KVFRVRTPPDAID 195
DS +DQL I K LG P Q NP + FP+ S P S + + + A+D
Sbjct: 205 DSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP-SQPESLERRYPGKVSSPALD 263
Query: 196 LISRLLEYTPSSR 208
+ L P R
Sbjct: 264 FLKACLRMDPKER 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 19/56 (33%), Positives = 34/56 (60%), Gaps = 5/56 (8%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKL 80
+G G++ VY+ + +GE+VA+K++ D RE+ +M+ L+H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL 63
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 17/62 (27%), Positives = 35/62 (56%), Gaps = 10/62 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLEHSNIV 78
+G G+F YQA+ + +G L+A+K+V + + +E+++M RL H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 79 KL 80
++
Sbjct: 67 RM 68
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 17/56 (30%), Positives = 27/56 (48%), Gaps = 5/56 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV-----LQDKRFKNREMQIMRRLEHSNIVK 79
IG GSFG VY+A + ++VAIK + + +E+Q + + I K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 29/67 (43%), Positives = 40/67 (59%), Gaps = 9/67 (13%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR------EMQIMRRLEHSNIVKLKYF 83
IG GS GIV A + SG+LVA+KK+ D R + R E+ IMR +H N+V++ Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEM-YN 84
Query: 84 FYSSGDK 90
Y GD+
Sbjct: 85 SYLVGDE 91
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 24 LAQKTVIGNGSFGIV----YQAKLLDSGELVAIKKVLQDKRFKNR-----EMQIMRRLEH 74
L + V+G G FG V Y +GE+VA+K + ++ +N E+ I++ L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 75 SNIVKLKYFFYSSGDKKDE-PTNYPPLEDMKISTFSPRNKV 114
NIVK K G K + Y PL ++ + P++K+
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR--DYLPKHKL 104
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 14/99 (14%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC----- 306
Q+ ++Y+H G+ H+DI +N +++ E V K+ D ++ L + Y C
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQV-KITDNALSRDLFPMD----YHCLGDNE 179
Query: 307 SRYYR--APELIFGAIDYTTKIDVWSAGCVLAELL-LGQ 342
+R + A E + +Y++ DVWS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
+ Y+ + HRD+ +N+L++ E GV K+ DFG A+ G N + APE +
Sbjct: 113 MEYLESKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL 169
Query: 317 FGAIDYTTKIDVWSAGCVLAELL-LGQPMFP 346
+++K DVWS G +L E+ G+ +P
Sbjct: 170 KHK-KFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 12/105 (11%)
Query: 245 YTKLYIYQLFRSLA----YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
+T + + + R +A Y+ + HRD+ +N+L+N V K+ DFG ++ L
Sbjct: 103 FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTS 161
Query: 301 NVSYICSR------YYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
+ +Y S + APE I +T+ DVWS G V+ E++
Sbjct: 162 DPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
V+Q I +LGTP + I + + N F P+ + P+S+ F+ P AIDL+ +
Sbjct: 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK-NADPSAIDLLEK 270
Query: 200 LLEYTPSSRIS 210
+L + P RIS
Sbjct: 271 MLVFDPQKRIS 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 6/70 (8%)
Query: 144 DQLVEIIKVLGTPTREQIREMN--PNYTEF-KFPQIKSHPWSKVFRVRTPPDAIDLISRL 200
DQL I ++LGTPT E ++ P+Y + +P S V + DL+ L
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTS--LVNVVP-KLNSTGRDLLQNL 264
Query: 201 LEYTPSSRIS 210
L P RIS
Sbjct: 265 LVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 22/68 (32%), Positives = 41/68 (60%), Gaps = 5/68 (7%)
Query: 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFK---NREMQIMRR 71
Y + D + ++ V+G G++GIVY A+ L + +AIK++ +D R+ + E+ +
Sbjct: 3 YEYEYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 72 LEHSNIVK 79
L+H NIV+
Sbjct: 62 LKHRNIVQ 69
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 20/59 (33%), Positives = 36/59 (61%), Gaps = 7/59 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG+GSFG VY A+ + + E+VAIKK+ + N +E++ +++L H N ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 24/62 (38%), Positives = 40/62 (64%), Gaps = 6/62 (9%)
Query: 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSN 76
D L Q+ IG+G++G VY+A+ +++GEL AIK + +D +E+ +M+ +HSN
Sbjct: 10 DFELIQR--IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 77 IV 78
IV
Sbjct: 68 IV 69
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 19/62 (30%), Positives = 25/62 (40%), Gaps = 5/62 (8%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR---EMQIMRRLEHSNIV 78
L IG G FG V G+ VA+K + D E +M L H N+V
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 79 KL 80
+L
Sbjct: 64 QL 65
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 8/61 (13%)
Query: 28 TVIGNGSFGIVYQAKLLDSGE---LVAIKKV---LQDKRFKN--REMQIMRRLEHSNIVK 79
VIG G FG V + +L G+ VAIK + DK+ + E IM + +H NI++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 80 L 80
L
Sbjct: 70 L 70
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 11/110 (10%)
Query: 266 CHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
HR K N+LL + G+LKL GS + Y+ APE+I G YT K
Sbjct: 33 LHRQAKSGNILLTWD-GLLKL--DGS--VAFKTPEQ--SRPDPYFMAPEVIQG-QSYTEK 84
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 375
D++S G L E L + + +L I+++L N
Sbjct: 85 ADIYSLGITLYEALDYE---LPYNEERELSAILEILLNGMPADDPRDRSN 131
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 34/114 (29%), Positives = 50/114 (43%), Gaps = 24/114 (21%)
Query: 239 QNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR 297
F T LY+ Q+ + Y+ L HRD+ +N L+ + K+ DFG +++L
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI-KIADFGMSRNL-- 180
Query: 298 GEPNVSYICSRYY----RAP--------ELIFGAIDYTTKIDVWSAGCVLAELL 339
Y YY RAP E + +TTK DVW+ G L E+L
Sbjct: 181 ------YSSD-YYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-- 309
Q+ +AY+ HRD+ +N+L+ + V K+ DFG A+ + E Y+ S
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKI 166
Query: 310 ---YRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPG 347
+ APE ++TK DVWS G +L E+ GQ +PG
Sbjct: 167 PYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 24/82 (29%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP--------- 190
S DQL +I V+G P+ E+ +P+ S P S F TP
Sbjct: 209 TSEADQLDKIFDVIGLPSEEE------------WPRNVSLPRSS-FPSYTPRSFKSFVPE 255
Query: 191 --PDAIDLISRLLEYTPSSRIS 210
+ +DL+ ++L + P RIS
Sbjct: 256 ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 25/66 (37%), Positives = 32/66 (48%), Gaps = 10/66 (15%)
Query: 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIM-------RRLEHSNIV 78
VIG GSFG V AK G+ A+ KVLQ K K + IM + ++H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 79 KLKYFF 84
L Y F
Sbjct: 60 GLHYSF 65
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 22/56 (39%), Positives = 32/56 (57%), Gaps = 6/56 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKK-----VLQDKRFKNREMQIMRRLEHSNIVKL 80
IG G+FG VY+ L + E VA+K KR +E +I+++ +H NIVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 245 YTKLYIYQLFRSLA----YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP 300
++ + + R +A Y+ + HRD+ +N+L+N K+ DFG ++ ++ +P
Sbjct: 104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSR-VLEDDP 161
Query: 301 NVSYICSR-----YYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
+Y S + APE I +T+ DVWS G V+ E++
Sbjct: 162 EGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 25/101 (24%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ + Y+ HRD+ +N L+ V K+ DFG ++ + + YY
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV-KISDFGLSRDIYSAD---------YY 180
Query: 311 R------------APELI-FGAIDYTTKIDVWSAGCVLAEL 338
R PE I +G +TT+ D+WS G VL E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 25/133 (18%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
Q+ + Y+ L HRD+ +N L+ E +K+ DFG +++L G+ YYR
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGD---------YYR 195
Query: 312 ------------APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
A E I +TT DVW+ G L E+L+ P D+ ++I+
Sbjct: 196 IQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPYGELTDE--QVIE 252
Query: 360 VLGTPTREQIREM 372
G R+Q R++
Sbjct: 253 NAGEFFRDQGRQV 265
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 444 | |||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| KOG4257|consensus | 974 | 99.98 | ||
| KOG4250|consensus | 732 | 99.98 | ||
| KOG0696|consensus | 683 | 99.98 | ||
| KOG1006|consensus | 361 | 99.98 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG4278|consensus | 1157 | 99.97 | ||
| KOG0614|consensus | 732 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0695|consensus | 593 | 99.97 | ||
| KOG1094|consensus | 807 | 99.97 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151|consensus | 775 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| KOG0608|consensus | 1034 | 99.97 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| KOG1025|consensus | 1177 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576|consensus | 829 | 99.95 | ||
| KOG3653|consensus | 534 | 99.95 | ||
| KOG2052|consensus | 513 | 99.94 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1024|consensus | 563 | 99.94 | ||
| KOG1152|consensus | 772 | 99.93 | ||
| KOG1345|consensus | 378 | 99.93 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164|consensus | 322 | 99.9 | ||
| KOG1163|consensus | 341 | 99.9 | ||
| KOG1165|consensus | 449 | 99.88 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590|consensus | 601 | 99.88 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1033|consensus | 516 | 99.85 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240|consensus | 1431 | 99.81 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0603|consensus | 612 | 99.77 | ||
| KOG0195|consensus | 448 | 99.76 | ||
| KOG0606|consensus | 1205 | 99.76 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1166|consensus | 974 | 99.7 | ||
| KOG4158|consensus | 598 | 99.7 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| KOG1023|consensus | 484 | 99.6 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG0601|consensus | 524 | 99.51 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0590|consensus | 601 | 99.43 | ||
| KOG1266|consensus | 458 | 99.35 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG1243|consensus | 690 | 99.09 | ||
| KOG0601|consensus | 524 | 99.08 | ||
| KOG3741|consensus | 655 | 99.05 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| KOG0606|consensus | 1205 | 99.02 | ||
| KOG3087|consensus | 229 | 98.87 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| KOG2137|consensus | 700 | 98.74 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.64 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| KOG0576|consensus | 829 | 97.99 | ||
| KOG1035|consensus | 1351 | 97.99 | ||
| KOG0658|consensus | 364 | 97.88 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.85 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.81 | |
| KOG1235|consensus | 538 | 97.71 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.34 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.26 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.73 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.46 | |
| KOG2268|consensus | 465 | 96.45 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 96.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.35 | |
| KOG2270|consensus | 520 | 95.97 | ||
| KOG1093|consensus | 725 | 95.93 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.29 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.28 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.04 | |
| KOG1826|consensus | 2724 | 94.14 | ||
| PLN02236 | 344 | choline kinase | 93.28 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.01 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.34 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.2 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 89.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 89.62 | |
| KOG2269|consensus | 531 | 87.4 | ||
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 86.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 86.19 | |
| KOG1236|consensus | 565 | 85.42 | ||
| PTZ00296 | 442 | choline kinase; Provisional | 85.32 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.1 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 84.43 |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=418.57 Aligned_cols=301 Identities=68% Similarity=1.170 Sum_probs=283.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
..-.|.-.+.+|.|+||.||+|+...+++.||||++.++++..++|+++|+++.|||||++..+|.+...+ +
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~-d------- 93 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTES-D------- 93 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCC-c-------
Confidence 44578889999999999999999999999999999999999999999999999999999999999887642 1
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (364)
T KOG0658|consen 94 -------------------------------------------------------------------------------- 93 (364)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
..++.+|||||+.+|...++++...+..++...++-+..||+.||+|
T Consensus 94 ---------------------------------~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~y 140 (364)
T KOG0658|consen 94 ---------------------------------EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAY 140 (364)
T ss_pred ---------------------------------hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHH
Confidence 15688999999999999999988899999999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl 339 (444)
||+.||+||||||.|+|+|.+.+.+||+|||.++....+.......+|..|.|||++.+...|+.+.|+||.||++.||+
T Consensus 141 Lh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl 220 (364)
T KOG0658|consen 141 LHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL 220 (364)
T ss_pred HHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh
Confidence 99999999999999999998889999999999999988888888899999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH
Q psy10212 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419 (444)
Q Consensus 340 tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~ 419 (444)
.|++.|+|.+..+++..|++.+|.|..+++..+++.+....+|.+....|...+....+++..+|+.++|.++|.+|.++
T Consensus 221 ~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~ 300 (364)
T KOG0658|consen 221 KGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA 300 (364)
T ss_pred cCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence 99999999999999999999999999999999999999999999999999998899999999999999999999999999
Q ss_pred HHHhccCchhhhhhhhhhccccC
Q psy10212 420 LQVRSITPFLIELRAVFENICFG 442 (444)
Q Consensus 420 ~elL~~hpwf~~~~~~~~~~~~~ 442 (444)
.|+|. ||||.++|..-...-.|
T Consensus 301 ~~~l~-h~fFdelr~~~~~l~~g 322 (364)
T KOG0658|consen 301 LEALA-HPFFDELRDPNTKLPNG 322 (364)
T ss_pred HHHhc-chhhHHhhCcCccCcCC
Confidence 99999 99999999885444444
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=412.27 Aligned_cols=285 Identities=36% Similarity=0.651 Sum_probs=259.7
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|.++++||.|+||.||+|+.+.+|+.||||++..+- ..-.||++.|++|+ ||||+++.+.+.+...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~---- 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR---- 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----
Confidence 5689999999999999999999999999999999985442 23338999999998 9999999988877652
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (538)
T KOG0661|consen 84 -------------------------------------------------------------------------------- 83 (538)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||+..|+.+++. .++.+++..++.|+.||
T Consensus 84 -----------------------------------------~L~fVfE~Md~NLYqLmK~---R~r~fse~~irnim~Qi 119 (538)
T KOG0661|consen 84 -----------------------------------------ILYFVFEFMDCNLYQLMKD---RNRLFSESDIRNIMYQI 119 (538)
T ss_pred -----------------------------------------eEeeeHHhhhhhHHHHHhh---cCCcCCHHHHHHHHHHH
Confidence 4999999999999999984 47899999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
++||+|+|.+|+.|||+||+|||+. ....+||+|||+++........+....|++|.|||++.....|+.+.|+||+||
T Consensus 120 lqGL~hiHk~GfFHRDlKPENiLi~-~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~Gc 198 (538)
T KOG0661|consen 120 LQGLAHIHKHGFFHRDLKPENILIS-GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGC 198 (538)
T ss_pred HHHHHHHHhcCcccccCChhheEec-ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHH
Confidence 9999999999999999999999998 678999999999999988888889999999999999988779999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhh--CCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|++|+.+-++.|+|.+..|++.+|.+.+|+|....|.+. -....++++|......+...++. +++++.+||.+||.+
T Consensus 199 I~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~W 277 (538)
T KOG0661|consen 199 IMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAW 277 (538)
T ss_pred HHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999888772 24556788899888888888875 999999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||.+||||.|+|+ ||||+.-.+.
T Consensus 278 DP~kRpTA~~al~-~pffq~~~~~ 300 (538)
T KOG0661|consen 278 DPDKRPTASQALQ-HPFFQVGRAS 300 (538)
T ss_pred CCccCccHHHHhc-Cccccccccc
Confidence 9999999999999 9999985544
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=378.59 Aligned_cols=283 Identities=33% Similarity=0.626 Sum_probs=250.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+.|+.+.++|.|+||.||++++++||+.||||++...+ +...||+++|++|+|+|+|.+++.|--.+.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk------ 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK------ 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce------
Confidence 57999999999999999999999999999999995443 456699999999999999999888876654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (396)
T KOG0593|consen 76 -------------------------------------------------------------------------------- 75 (396)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+++|+|||+-++++.+.+ ....++.+.++.++.|++.
T Consensus 76 ----------------------------------------lhLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ 112 (396)
T KOG0593|consen 76 ----------------------------------------LHLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLK 112 (396)
T ss_pred ----------------------------------------eEEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHH
Confidence 999999999999888864 5667899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+.|+|+++++||||||+||+++ .++.+||||||+++... .++..+....|.+|.|||.+.+...|..+.||||+||+
T Consensus 113 ai~~cHk~n~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv 191 (396)
T KOG0593|consen 113 AIHFCHKNNCIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCV 191 (396)
T ss_pred HhhhhhhcCeecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHH
Confidence 99999999999999999999999 89999999999998876 56666777889999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHh--hCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+.||++|.+.|++.++.+++..|++.+|..++..+.- .++-|....+|.....+-.+.-=++++..+.+|+..||..|
T Consensus 192 ~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 192 FAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD 271 (396)
T ss_pred HHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999988876553 46777777888766544322222467889999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+|++.+|+|. |+||..+.+.
T Consensus 272 P~~R~sc~qll~-H~yFd~~~er 293 (396)
T KOG0593|consen 272 PDDRLSCEQLLH-HPYFDGFIER 293 (396)
T ss_pred ccccccHHHHhc-ChHHHHHHHH
Confidence 999999999999 9999886654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=401.75 Aligned_cols=297 Identities=55% Similarity=0.984 Sum_probs=261.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
.++|.+.++||+|+||+||+|++..+++.||||++........+|+.+|++++||||++++++++...-..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~--------- 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKK--------- 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeeccccc---------
Confidence 35799999999999999999999999999999999877777778999999999999999999887653100
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 136 -------------------------------------------------------------------------------- 135 (440)
T PTZ00036 136 -------------------------------------------------------------------------------- 135 (440)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL 260 (444)
.....++++|||||+++|.+++.........+++..++.++.||+.||+||
T Consensus 136 -----------------------------~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL 186 (440)
T PTZ00036 136 -----------------------------NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186 (440)
T ss_pred -----------------------------CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 011246889999999999999877666778899999999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
|++|++||||||+||+++...+.++|+|||+++............+++.|+|||.+.+...++.++|+|||||++|+|++
T Consensus 187 H~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred HHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999855567999999999876554444556779999999998776578999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHH
Q psy10212 341 GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 420 (444)
Q Consensus 341 G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~ 420 (444)
|.+||.+.+..+.+.++.+.++.+....+....+.+..+.+|......+...++...++++.+||.+||++||.+|||+.
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 99999999999999999999999999999888888888888877777777778888899999999999999999999999
Q ss_pred HHhccCchhhhhhhhh
Q psy10212 421 QVRSITPFLIELRAVF 436 (444)
Q Consensus 421 elL~~hpwf~~~~~~~ 436 (444)
|+|. ||||++++...
T Consensus 347 e~l~-hp~f~~~~~~~ 361 (440)
T PTZ00036 347 EALA-DPFFDDLRDPC 361 (440)
T ss_pred HHhC-ChhHHhhhccc
Confidence 9999 99999987643
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=362.85 Aligned_cols=282 Identities=39% Similarity=0.708 Sum_probs=247.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+|..+++||+|.||.||+|++..+|+.||||++... ..+..||+++|+.++|+||+.+.+.|-..+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~------ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN------ 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc------
Confidence 5899999999999999999999999999999999443 2455699999999999999999999977654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (318)
T KOG0659|consen 76 -------------------------------------------------------------------------------- 75 (318)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+.||+||++.+|...|+ +..-.++...++.|+.++++
T Consensus 76 ----------------------------------------l~lVfEfm~tdLe~vIk---d~~i~l~pa~iK~y~~m~Lk 112 (318)
T KOG0659|consen 76 ----------------------------------------LSLVFEFMPTDLEVVIK---DKNIILSPADIKSYMLMTLK 112 (318)
T ss_pred ----------------------------------------eEEEEEeccccHHHHhc---ccccccCHHHHHHHHHHHHH
Confidence 88999999999999986 56778999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc-ccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|++|||++.|.||||||.|++++ ++|.+||+|||+++.+........ ...|.+|.|||.+.|...|....|+||.||+
T Consensus 113 Gl~y~H~~~IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI 191 (318)
T KOG0659|consen 113 GLAYCHSKWILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCI 191 (318)
T ss_pred HHHHHHhhhhhcccCCccceEEc-CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHH
Confidence 99999999999999999999999 899999999999988765543332 3679999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCccc-CCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK-FPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~-~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+.||+.+.+.|+|.++.+++..|++.+|+|.+..|+++. +++..++ +|. ......|+ -++++..||+.+||.+
T Consensus 192 ~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~---~~~~~lf~-aas~d~ldLl~~m~~y 267 (318)
T KOG0659|consen 192 FAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPK---PPLNNLFP-AASSDALDLLSKMLTY 267 (318)
T ss_pred HHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCC---Cccccccc-cccHHHHHHHHhhhcc
Confidence 999999999999999999999999999999999999875 4555544 333 22233343 4688889999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
||.+|+|+.|+|+ |+||++++....+
T Consensus 268 nP~~Rita~qaL~-~~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 268 NPKKRITASQALK-HPYFKSLPLPTPP 293 (318)
T ss_pred CchhcccHHHHhc-chhhhcCCCCCCh
Confidence 9999999999999 9999987665544
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=389.46 Aligned_cols=289 Identities=35% Similarity=0.580 Sum_probs=244.6
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
-|...-.+.|+.+++||+|.||.||+|++..+|+.||+|++..+ ..+..|||++|++|.||||+++.+.+.++.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 45566778999999999999999999999999999999999443 245669999999999999999999998873
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 190 ~------------------------------------------------------------------------------- 190 (560)
T KOG0600|consen 190 S------------------------------------------------------------------------------- 190 (560)
T ss_pred C-------------------------------------------------------------------------------
Confidence 2
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
..+|+|+|||+-+|.-++. ..+-.|++..+++
T Consensus 191 ---------------------------------------------~siYlVFeYMdhDL~GLl~---~p~vkft~~qIKc 222 (560)
T KOG0600|consen 191 ---------------------------------------------GSIYLVFEYMDHDLSGLLS---SPGVKFTEPQIKC 222 (560)
T ss_pred ---------------------------------------------ceEEEEEecccchhhhhhc---CCCcccChHHHHH
Confidence 3499999999999888874 4567899999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcch
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
+++||+.||+|+|++||.|||||.+|||+| ++|.+||+|||+++.+.... ..+....|++|.|||++.|...|+++.
T Consensus 223 ~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aV 301 (560)
T KOG0600|consen 223 YMKQLLEGLEYCHSRGVLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAV 301 (560)
T ss_pred HHHHHHHHHHHHhhcCeeeccccccceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccce
Confidence 999999999999999999999999999999 89999999999998664433 345567799999999999999999999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC-CCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||.|||+.||+.|+++|++.+..+++..|.+.+|+|...-|+... |.+...+-...-...+.+. -..+++...+|+
T Consensus 302 DlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll 380 (560)
T KOG0600|consen 302 DLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLL 380 (560)
T ss_pred eehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHH
Confidence 99999999999999999999999999999999999999998887321 1111111111111122222 245799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..||..||.+|.||.++|. |+||..-+
T Consensus 381 ~~lL~ldP~kR~tA~~aL~-seyF~t~p 407 (560)
T KOG0600|consen 381 EKLLSLDPDKRGTASSALQ-SEYFTTEP 407 (560)
T ss_pred HHHhccCccccccHHHHhc-CcccccCC
Confidence 9999999999999999999 99995533
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=384.98 Aligned_cols=265 Identities=31% Similarity=0.452 Sum_probs=221.3
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----------cchhhHHHHhhhcCCCceeEee
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----------RFKNREMQIMRRLEHSNIVKLK 81 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~ 81 (444)
+-.+-..+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.. ...++|+++|++|+|||||+++
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 34445668899999999999999999999999999999999994432 2234899999999999999999
Q ss_pred eEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhh
Q psy10212 82 YFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQI 161 (444)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (444)
++|.....
T Consensus 243 d~f~~~ds------------------------------------------------------------------------ 250 (475)
T KOG0615|consen 243 DFFEVPDS------------------------------------------------------------------------ 250 (475)
T ss_pred eeeecCCc------------------------------------------------------------------------
Confidence 99987653
Q ss_pred hhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCC
Q psy10212 162 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQN 240 (444)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~ 240 (444)
.|+||||++| .|.+.+. ..+.
T Consensus 251 ------------------------------------------------------~YmVlE~v~GGeLfd~vv----~nk~ 272 (475)
T KOG0615|consen 251 ------------------------------------------------------SYMVLEYVEGGELFDKVV----ANKY 272 (475)
T ss_pred ------------------------------------------------------eEEEEEEecCccHHHHHH----hccc
Confidence 7999999995 8888885 4567
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhcc
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~ 318 (444)
+.+..-+.+++||+.|+.|||++||+||||||+|||++.+ .-.+||+|||+++.........+.+||+.|.|||++.+
T Consensus 273 l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 273 LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheec
Confidence 8888889999999999999999999999999999999732 25789999999999887778889999999999999965
Q ss_pred C--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhH-HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 319 A--IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD-QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 319 ~--~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
. ..+..+.|+|||||++|-+++|.+||.+..... ...+|.+..-...+..| .
T Consensus 353 kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w--------------------~----- 407 (475)
T KOG0615|consen 353 KGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW--------------------D----- 407 (475)
T ss_pred CCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh--------------------h-----
Confidence 4 123448899999999999999999999865544 55555553211112222 1
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.++++..+||.+||.+||++|||+.|+|+ ||||++..
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~-hpW~~~~~ 444 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALN-HPWFKDAP 444 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhc-Chhhhccc
Confidence 35999999999999999999999999999 99999754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=391.82 Aligned_cols=248 Identities=33% Similarity=0.537 Sum_probs=224.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+|...+.||+|||++||++++..+|+.||+|++.++ ++...+||++-++|+|||||+++++|.++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~------ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN------ 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC------
Confidence 6799999999999999999999999999999999542 356668999999999999999999998875
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (592)
T KOG0575|consen 92 -------------------------------------------------------------------------------- 91 (592)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.|||+|+|. ++|..+.+ ..++++|.+++.+++||
T Consensus 92 ----------------------------------------nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QI 127 (592)
T KOG0575|consen 92 ----------------------------------------NVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQI 127 (592)
T ss_pred ----------------------------------------ceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHH
Confidence 3999999999 57777764 46789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||+++|+|||||..|+|++ ++-++||+|||++...... ..+.+.+||+-|+|||++... ..+..+||||+|
T Consensus 128 v~GlkYLH~~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlG 205 (592)
T KOG0575|consen 128 VEGLKYLHSLGIIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLG 205 (592)
T ss_pred HHHHHHHHhcCceecccchhheeec-CcCcEEecccceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhh
Confidence 9999999999999999999999999 7889999999999888644 667788999999999999877 889999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|+||-|+.|++||...+..+.+.+|.. .++.+| .++|.++++||.+||+.|
T Consensus 206 cvmYtLL~G~PPFetk~vkety~~Ik~-----------------~~Y~~P------------~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 206 CVMYTLLVGRPPFETKTVKETYNKIKL-----------------NEYSMP------------SHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred hHHHhhhhCCCCcccchHHHHHHHHHh-----------------cCcccc------------cccCHHHHHHHHHHhcCC
Confidence 999999999999999999999988887 344444 367999999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|.+|||+.++|. |+||+.
T Consensus 257 P~~Rpsl~~vL~-h~Ff~~ 274 (592)
T KOG0575|consen 257 PSERPSLDEVLD-HPFFKS 274 (592)
T ss_pred cccCCCHHHHhc-CHhhhC
Confidence 999999999999 999944
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=366.58 Aligned_cols=288 Identities=33% Similarity=0.545 Sum_probs=250.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecccc------chhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR------FKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.-.++|+.+..|+.|+||.||+|+|+.+++.||+|++.-+++ +..|||.+|.+++|||||.+.+...-+.-
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~--- 149 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM--- 149 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---
Confidence 345789999999999999999999999999999999955432 34499999999999999999888765432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 150 -------------------------------------------------------------------------------- 149 (419)
T KOG0663|consen 150 -------------------------------------------------------------------------------- 149 (419)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
--.|||||||+-+|.+++.. -.+++...+++.++.|
T Consensus 150 -----------------------------------------d~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~Q 185 (419)
T KOG0663|consen 150 -----------------------------------------DKIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQ 185 (419)
T ss_pred -----------------------------------------ceeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHH
Confidence 11899999999999999874 3479999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
++.|++|||.+.|+|||||++|+|++ ..|.+||+|||+++.+.... ..+...-|.+|.|||++.+...|+.+.|+||+
T Consensus 186 lL~glk~lH~~wilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv 264 (419)
T KOG0663|consen 186 LLRGLKHLHDNWILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV 264 (419)
T ss_pred HHHHHHHHhhceeEecccchhheeec-cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence 99999999999999999999999999 89999999999999876553 34555679999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccccCC-CChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVR-TPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~-~s~~l~~LI~~~ 408 (444)
|||+.||+++++.|++.+..+++.+|++.+|.|....|+.+. +....+.++...-..+...|+.. +++...+|+..+
T Consensus 265 GCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~l 344 (419)
T KOG0663|consen 265 GCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKL 344 (419)
T ss_pred HHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHH
Confidence 999999999999999999999999999999999999988753 33334555555555566666544 789999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+||.+|.||.|.|+ |+||.+.+..
T Consensus 345 lt~dP~kR~tA~~~L~-h~~F~e~P~p 370 (419)
T KOG0663|consen 345 LTYDPGKRITAEDGLK-HEYFRETPLP 370 (419)
T ss_pred hccCccccccHHHhhc-ccccccCCCC
Confidence 9999999999999999 9999995543
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=367.59 Aligned_cols=252 Identities=31% Similarity=0.531 Sum_probs=217.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+.+.++.||+|.-|+||+|+++.+++.+|+|++... .+.+.+|++++++.+||+||++++.|++.+.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~------- 151 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE------- 151 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-------
Confidence 3678899999999999999999999999999999322 3556799999999999999999999999862
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 152 -------------------------------------------------------------------------------- 151 (364)
T KOG0581|consen 152 -------------------------------------------------------------------------------- 151 (364)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
-..|+||||++ ||.++.+. .+++++.....++.++++
T Consensus 152 --------------------------------------~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~ 189 (364)
T KOG0581|consen 152 --------------------------------------EISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLR 189 (364)
T ss_pred --------------------------------------eEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHH
Confidence 17899999995 77777653 378999999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.|||. ++|+||||||+|||++ ..|++||+|||.+...... ...+..||..|||||.+.+. .|+.++||||||++
T Consensus 190 GL~YLh~~~~IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLs 266 (364)
T KOG0581|consen 190 GLSYLHEERKIIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLS 266 (364)
T ss_pred HHHHHhhccCeeeccCCHHHeeec-cCCCEEeccccccHHhhhh-hcccccccccccChhhhcCC-cCCcccceecccHH
Confidence 9999995 9999999999999999 7999999999999887666 56778999999999999998 89999999999999
Q ss_pred HHHHHhCCCCCCCC-----ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC-CCChhHHHHHHHh
Q psy10212 335 LAELLLGQPMFPGD-----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV-RTPPDAIDLISRL 408 (444)
Q Consensus 335 l~eLltG~~Pf~~~-----~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~s~~l~~LI~~~ 408 (444)
++|+.+|+.||... +..+++..|+.. ++ |. ++. .+|+++++||..|
T Consensus 267 llE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---pp----------------P~---------lP~~~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 267 LLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PP----------------PR---------LPEGEFSPEFRSFVSCC 318 (364)
T ss_pred HHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CC----------------CC---------CCcccCCHHHHHHHHHH
Confidence 99999999999874 344555555441 11 11 122 2699999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++||.+|||+.|++. |||+++...
T Consensus 319 L~Kdp~~R~s~~qLl~-Hpfi~~~~~ 343 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQ-HPFIKKFED 343 (364)
T ss_pred hcCCcccCCCHHHHhc-CHHHhhccc
Confidence 9999999999999999 999998654
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=364.40 Aligned_cols=294 Identities=37% Similarity=0.668 Sum_probs=252.8
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeec------cccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ------DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.-++...|..++.||.|+||.|..|.++.+|+.||||++.. ......||+++|++++|+||+.+++.+.....
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~- 95 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR- 95 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc-
Confidence 34566788889999999999999999999999999999951 12344589999999999999999988865211
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
+++
T Consensus 96 -----------------------------------------------------------------------~~f------ 98 (359)
T KOG0660|consen 96 -----------------------------------------------------------------------DKF------ 98 (359)
T ss_pred -----------------------------------------------------------------------ccc------
Confidence 001
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.-.|+|+|+|+..|.+.++ +++.+++..+..++
T Consensus 99 -------------------------------------------~DvYiV~elMetDL~~iik----~~~~L~d~H~q~f~ 131 (359)
T KOG0660|consen 99 -------------------------------------------NDVYLVFELMETDLHQIIK----SQQDLTDDHAQYFL 131 (359)
T ss_pred -------------------------------------------ceeEEehhHHhhHHHHHHH----cCccccHHHHHHHH
Confidence 1289999999999999985 56669999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC---CCCCccccccccccCchhhccCCCCCcchh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR---GEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
.||+.||.|+|+.+++||||||+|++++ .+-.+||+|||+++.... ....+....|.+|.|||++.....|+.+.|
T Consensus 132 YQiLrgLKyiHSAnViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiD 210 (359)
T KOG0660|consen 132 YQILRGLKYIHSANVIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAID 210 (359)
T ss_pred HHHHHhcchhhcccccccccchhheeec-cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhh
Confidence 9999999999999999999999999999 777889999999988753 333456677999999999988779999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC---CCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN---YTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
|||+|||+.||++|++.|+|.+..+++..|...+|+|.++.+...... ..-...|......+...|+ +.++.+.+|
T Consensus 211 iWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidL 289 (359)
T KOG0660|consen 211 IWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDL 289 (359)
T ss_pred hhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHH
Confidence 999999999999999999999999999999999999998888776521 1223577777888888887 899999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+++||.+||.+|+|++|+|. |||+..+....++
T Consensus 290 lekmL~fdP~kRita~eAL~-hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 290 LEKMLVFDPKKRITAEEALA-HPYLAPYHDPEDE 322 (359)
T ss_pred HHHHhccCccccCCHHHHhc-ChhhhhhcCCccC
Confidence 99999999999999999999 9999998766554
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=356.43 Aligned_cols=244 Identities=32% Similarity=0.476 Sum_probs=210.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeec------cccchhhHHHHhhhcCCCceeEeee-EEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ------DKRFKNREMQIMRRLEHSNIVKLKY-FFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~~~~~~ 94 (444)
..|+|+++||+|+||+||+|++..+|+.+|.|.+.- .+...-.|+.+|++|+|||||+|+. .|..+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~------ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN------ 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc------
Confidence 569999999999999999999999999999999942 2334447999999999999999987 443332
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (375)
T KOG0591|consen 93 -------------------------------------------------------------------------------- 92 (375)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.-++||||||+ |+|...|++++..++.+++..+|.++.|+
T Consensus 93 ---------------------------------------evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL 133 (375)
T KOG0591|consen 93 ---------------------------------------EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQL 133 (375)
T ss_pred ---------------------------------------hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHH
Confidence 12789999999 69999999999999999999999999999
Q ss_pred HHHHHHHHH--CC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhh
Q psy10212 254 FRSLAYIHV--LG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs--~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||.++|+ .+ +.||||||.|||++ .+|.+||+|||+++....... .....|||.||+||.+.+. .|+.+|||
T Consensus 134 ~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDi 211 (375)
T KOG0591|consen 134 CRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDI 211 (375)
T ss_pred HHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhH
Confidence 999999999 55 99999999999999 899999999999988754432 3456899999999999998 99999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+||++|||+..++||.+.+-.++-.+|.+.--.|.+ ...+|.++..+|..|
T Consensus 212 WslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---------------------------~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 212 WSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---------------------------DEHYSTDLRELINMC 264 (375)
T ss_pred HHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---------------------------HHHhhhHHHHHHHHH
Confidence 99999999999999999999877777777763111111 124689999999999
Q ss_pred cccCCCCCCCH
Q psy10212 409 LEYTPSSRISP 419 (444)
Q Consensus 409 L~~DP~kRPs~ 419 (444)
+.+||+.||+.
T Consensus 265 i~vd~~~RP~t 275 (375)
T KOG0591|consen 265 IAVDPEQRPDT 275 (375)
T ss_pred ccCCcccCCCc
Confidence 99999999985
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=351.76 Aligned_cols=276 Identities=33% Similarity=0.616 Sum_probs=229.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|+++++||.|+||+||+|++..+++.||+|++... ...+.+|+.++++++||||+++++++...+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 76 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-------- 76 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--------
Confidence 5699999999999999999999999999999998532 234558999999999999999998886543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (288)
T cd07871 77 -------------------------------------------------------------------------------- 76 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+++|.+++.. .+..+++..++.++.||+.|
T Consensus 77 --------------------------------------~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~a 115 (288)
T cd07871 77 --------------------------------------CLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRG 115 (288)
T ss_pred --------------------------------------eEEEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 3899999999999988753 34567899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++
T Consensus 116 L~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 194 (288)
T cd07871 116 LSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194 (288)
T ss_pred HHHHHhCCcccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999986543222 223346688999999987655789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|++|+.||.+.+..+.+..+.+..+.+....|+.... .+....+|......+.. ..+.+++++++||.+||++||
T Consensus 195 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 195 YEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCc
Confidence 999999999999998899999999999998888776432 22223333333223222 234578999999999999999
Q ss_pred CCCCCHHHHhccCchh
Q psy10212 414 SSRISPLQVRSITPFL 429 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf 429 (444)
.+|||+.|+|+ ||||
T Consensus 274 ~~R~t~~~~l~-hp~f 288 (288)
T cd07871 274 KSRISAEAALR-HSYF 288 (288)
T ss_pred ccCCCHHHHhc-CCCC
Confidence 99999999999 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=351.57 Aligned_cols=294 Identities=36% Similarity=0.671 Sum_probs=246.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCc-eeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSN-IVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~ 93 (444)
...|+.+++||.|+||+||+|+++.+|+.||+|++..+ ..+..||+.++++|+|+| |+.+.+++..+...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~--- 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH--- 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc---
Confidence 45688999999999999999999999999999999443 245579999999999999 99999999886520
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (323)
T KOG0594|consen 87 -------------------------------------------------------------------------------- 86 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....+++|+||++..|..++.........++...++.++.||
T Consensus 87 -------------------------------------~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Ql 129 (323)
T KOG0594|consen 87 -------------------------------------RGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQL 129 (323)
T ss_pred -------------------------------------cccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHH
Confidence 0013499999999999999997655433567779999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||+++|+||||||.||+++ +.|.+||+|||+++... +....+....|.+|.|||++.+...|+...||||+|
T Consensus 130 l~gl~~~H~~~IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G 208 (323)
T KOG0594|consen 130 LRGLAFLHSHGILHRDLKPQNLLIS-SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG 208 (323)
T ss_pred HHHHHHHHhCCeecccCCcceEEEC-CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH
Confidence 9999999999999999999999999 79999999999998765 333456667899999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCcc-CCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~-~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||++||++++..|++.++.+++..|.+.+|+|....|+... +++.. .++... ...+...+ ++.+++..+++.+||
T Consensus 209 cIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 209 CIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHh
Confidence 99999999999999999999999999999999998887743 23222 344433 22223332 344689999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+.+|.+|.|+..+|. ||||.++......
T Consensus 287 ~y~p~~R~Sa~~al~-h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 287 QYDPAKRISAKGALT-HPYFSELPEKSSQ 314 (323)
T ss_pred ccCcccCcCHHHHhc-Chhhcccccchhh
Confidence 999999999999999 9999998665443
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=357.31 Aligned_cols=254 Identities=30% Similarity=0.532 Sum_probs=222.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.|++++.||+|+||.||+|+.+++++.||+|++.+. .+....|..+|.+++||.||+++..|.+.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k---- 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK---- 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe----
Confidence 47899999999999999999999999999999998543 2344479999999999999999999988875
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (357)
T KOG0598|consen 100 -------------------------------------------------------------------------------- 99 (357)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
+|+|+||+.| .|...+. ..+.+++..++.++.+
T Consensus 100 ------------------------------------------LylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaE 133 (357)
T KOG0598|consen 100 ------------------------------------------LYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAE 133 (357)
T ss_pred ------------------------------------------EEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHH
Confidence 9999999996 7877774 5788999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc-cCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||.|||++||+||||||+|||+| ..|+++|+|||+++.. ..+....+.+||+.|||||++.+. .++.++|.|||
T Consensus 134 i~lAL~~LH~~gIiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsL 211 (357)
T KOG0598|consen 134 IVLALGYLHSKGIIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSL 211 (357)
T ss_pred HHHHHHHHHhCCeeeccCCHHHeeec-CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhH
Confidence 99999999999999999999999999 8999999999999854 334556667999999999999998 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|.+||.+.+......+|.+.-. ...+..++++++++|+++|..
T Consensus 212 GillYeML~G~pPF~~~~~~~~~~~I~~~k~----------------------------~~~p~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 212 GILLYEMLTGKPPFYAEDVKKMYDKILKGKL----------------------------PLPPGYLSEEARDLLKKLLKR 263 (357)
T ss_pred HHHHHHHhhCCCCCcCccHHHHHHHHhcCcC----------------------------CCCCccCCHHHHHHHHHHhcc
Confidence 9999999999999999998888888876210 011223689999999999999
Q ss_pred CCCCCC----CHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRI----SPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRP----s~~elL~~hpwf~~~~~~ 435 (444)
||++|. .+.++-+ ||||+++...
T Consensus 264 dp~~RLg~~~d~~~ik~-HpfF~~inW~ 290 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKR-HPFFKGINWE 290 (357)
T ss_pred CHHHhcCCCCChHHhhc-CcccccCCHH
Confidence 999996 4677777 9999987543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=367.48 Aligned_cols=252 Identities=32% Similarity=0.566 Sum_probs=223.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.|...++||.|+|++|++|+++.+++.||||++.+. .....+|-..|.+| .||.|++++..|.+...
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s--- 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES--- 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc---
Confidence 46799999999999999999999999999999998432 34555788899999 89999999999988764
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 149 -------------------------------------------------------------------------------- 148 (604)
T KOG0592|consen 149 -------------------------------------------------------------------------------- 148 (604)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
||+|+||++ |.|+++|.+ -+.+++..++.++.
T Consensus 149 -------------------------------------------LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAA 181 (604)
T KOG0592|consen 149 -------------------------------------------LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAA 181 (604)
T ss_pred -------------------------------------------eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHH
Confidence 999999999 699999974 37899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--------------CccccccccccCchhhc
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------------NVSYICSRYYRAPELIF 317 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------------~~~~~gt~~y~aPE~l~ 317 (444)
||+.||+|||++||+||||||+|||++ .+++++|+|||.++.+..... .....||..|.+||++.
T Consensus 182 eIldAleylH~~GIIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 182 EILDALEYLHSNGIIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred HHHHHHHHHHhcCceeccCChhheeEc-CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 999999999999999999999999999 899999999999976643221 13468899999999999
Q ss_pred cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
.+ ..++++|+|+|||++|.|+.|++||.+.+..-+.++|++. .+. |+.+.
T Consensus 261 ~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-----------------~y~------------fp~~f 310 (604)
T KOG0592|consen 261 DS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-----------------DYE------------FPEGF 310 (604)
T ss_pred CC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-----------------ccc------------CCCCC
Confidence 88 8999999999999999999999999999999999998883 222 34567
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
++.+++||.++|..||.+|+|++||-+ ||||..+..
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~-HpFF~~Vdw 346 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKA-HPFFEGVDW 346 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhh-CcccccCCh
Confidence 999999999999999999999999999 999998754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=347.83 Aligned_cols=283 Identities=31% Similarity=0.557 Sum_probs=221.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||.|+||.||+|+++.+++.||+|++.... ....+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 76 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-------- 76 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--------
Confidence 78999999999999999999999999999999985332 24558999999999999999999887653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (303)
T cd07869 77 -------------------------------------------------------------------------------- 76 (303)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+++|.+++.. ....+++..++.++.||+.|
T Consensus 77 --------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~a 115 (303)
T cd07869 77 --------------------------------------TLTLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRG 115 (303)
T ss_pred --------------------------------------eEEEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHH
Confidence 3899999999999888753 34668999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++
T Consensus 116 l~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 194 (303)
T cd07869 116 LSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIF 194 (303)
T ss_pred HHHHHHCCeecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999 7889999999998643222 1223346788999999987654688999999999999
Q ss_pred HHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccc-cCCCChhHHHHHHHhccc
Q psy10212 336 AELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVF-RVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~-~~~~s~~l~~LI~~~L~~ 411 (444)
|+|++|..||.+..+ .+.+..+....+.+....+.... +.+....+.......+...+ ....+..+.+||.+||++
T Consensus 195 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 274 (303)
T cd07869 195 VEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQC 274 (303)
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhcc
Confidence 999999999987644 45566666666666655443321 11111111111111111111 113467899999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||++|||+.|+|+ ||||+++...
T Consensus 275 dp~~R~s~~~~l~-h~~f~~~~~~ 297 (303)
T cd07869 275 FPKNRLSAQAALS-HEYFSDLPPR 297 (303)
T ss_pred CchhccCHHHHhc-CcccccCChh
Confidence 9999999999999 9999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=359.63 Aligned_cols=253 Identities=33% Similarity=0.490 Sum_probs=220.7
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcC-CCceeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLE-HSNIVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 87 (444)
....++|.+.+.||.|+||+|++|++..+|+.||+|.+... .....+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35678999999999999999999999999999999966442 223348999999998 99999999999876
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
..
T Consensus 93 ~~------------------------------------------------------------------------------ 94 (370)
T KOG0583|consen 93 TK------------------------------------------------------------------------------ 94 (370)
T ss_pred Ce------------------------------------------------------------------------------
Confidence 53
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i 246 (444)
+|+|||||.| .|.+++. ..+++.+..+
T Consensus 95 ------------------------------------------------~~ivmEy~~gGdL~~~i~----~~g~l~E~~a 122 (370)
T KOG0583|consen 95 ------------------------------------------------IYIVMEYCSGGDLFDYIV----NKGRLKEDEA 122 (370)
T ss_pred ------------------------------------------------EEEEEEecCCccHHHHHH----HcCCCChHHH
Confidence 9999999996 8999885 2688999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC-CeEEEeecCCcccc-cCCCCCccccccccccCchhhccCCCC-C
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET-GVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDY-T 323 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~-~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~-s 323 (444)
+.++.||+.|++|+|++||+||||||+||+++ .+ +++||+|||++... .......+.+|++.|+|||++.+...| .
T Consensus 123 r~~F~Qlisav~y~H~~gi~HRDLK~ENilld-~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g 201 (370)
T KOG0583|consen 123 RKYFRQLISAVAYCHSRGIVHRDLKPENILLD-GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSG 201 (370)
T ss_pred HHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec-CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCC
Confidence 99999999999999999999999999999999 55 99999999999887 456667788999999999999887424 5
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC-ChhHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT-PPDAI 402 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-s~~l~ 402 (444)
.++|+||+|+++|.|++|+.||.+.+...+..++.+ ..+.+ +..+ |++++
T Consensus 202 ~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~-----------------~~~~~------------p~~~~S~~~~ 252 (370)
T KOG0583|consen 202 KAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK-----------------GEFKI------------PSYLLSPEAR 252 (370)
T ss_pred chhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------CCccC------------CCCcCCHHHH
Confidence 899999999999999999999999777777776554 12222 2345 89999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
+||.+||..||.+|+|+.++++ ||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~-h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILE-HPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhh-Chhhcc
Confidence 9999999999999999999998 999996
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=350.83 Aligned_cols=286 Identities=35% Similarity=0.611 Sum_probs=226.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||+|+||.||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++.......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~----- 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE----- 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC-----
Confidence 589999999999999999999999999999998532 234568999999999999999998886543200
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (338)
T cd07859 76 -------------------------------------------------------------------------------- 75 (338)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
...+|+|||||+++|.+++. ....+++..++.++.||+.|
T Consensus 76 ------------------------------------~~~~~lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~a 115 (338)
T cd07859 76 ------------------------------------FKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRA 115 (338)
T ss_pred ------------------------------------CceEEEEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHH
Confidence 02489999999999998875 34569999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccC-CCCCcchhhhhH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGA-IDYTTKIDVWSA 331 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwSL 331 (444)
|+|||++|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||++.+. ..++.++|+|||
T Consensus 116 L~~LH~~~ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl 194 (338)
T cd07859 116 LKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194 (338)
T ss_pred HHHHHHCCeecCCCCHHHeEEC-CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence 9999999999999999999999 788999999999865422211 1234678999999998652 268899999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||++|+|++|+.||.+.+....+..+.+..+.+....+.......... .+...........+ +.+++.+.++|.+|
T Consensus 195 Gvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~ 273 (338)
T cd07859 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERL 273 (338)
T ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHH
Confidence 999999999999999988888888888888888776665432211000 00000011111111 34688999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
|+.||++|||+.|+|+ ||||+.+....
T Consensus 274 l~~~P~~Rpt~~e~l~-hp~f~~~~~~~ 300 (338)
T cd07859 274 LAFDPKDRPTAEEALA-DPYFKGLAKVE 300 (338)
T ss_pred cCcCcccCCCHHHHhc-CchhhhcCccc
Confidence 9999999999999999 99999977654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=345.66 Aligned_cols=283 Identities=30% Similarity=0.604 Sum_probs=232.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|.+++.||+|+||.||+|+++.+++.+|+|.+.... ..+.+|+.++++++||||+++++++...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-------- 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--------
Confidence 67999999999999999999999999999999985332 34568999999999999999999887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (309)
T cd07872 78 -------------------------------------------------------------------------------- 77 (309)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||++++|.+++.. .+..++...++.++.||+.|
T Consensus 78 --------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~a 116 (309)
T cd07872 78 --------------------------------------SLTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRG 116 (309)
T ss_pred --------------------------------------eEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 3899999999999888753 34568899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||++|++||||+|+||+++ ..+.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++
T Consensus 117 L~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (309)
T cd07872 117 LAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 195 (309)
T ss_pred HHHHHHCCeecCCCCHHHEEEC-CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999986543222 122345688999999987655789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|++|+.||.+.+..+....+.+..+.+....|+.... .+.+..++......+.. ..+.+++++.+||.+||+.||
T Consensus 196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCCh
Confidence 999999999999999999999999999888877765432 11222333322222222 124578999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+|||+.|+|+ ||||+.+....
T Consensus 275 ~~R~t~~e~l~-h~~~~~~~~~~ 296 (309)
T cd07872 275 KKRISAEEAMK-HAYFRSLGTRI 296 (309)
T ss_pred hhCCCHHHHhc-Chhhhhccccc
Confidence 99999999999 99999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=341.47 Aligned_cols=276 Identities=37% Similarity=0.684 Sum_probs=221.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++.+.||+|+||+||+|+++.+++.||+|++... ...+.+|+.++++++||||+++.+.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG------- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-------
Confidence 5799999999999999999999999999999998543 234568999999999999999988876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (287)
T cd07848 74 -------------------------------------------------------------------------------- 73 (287)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++|||||++++.+.+.. ....+++..++.++.||+.
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~ 111 (287)
T cd07848 74 ---------------------------------------KLYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIK 111 (287)
T ss_pred ---------------------------------------EEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHH
Confidence 3899999999887776642 3457899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+||
T Consensus 112 ~L~~lH~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGv 189 (287)
T cd07848 112 AIHWCHKNDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGC 189 (287)
T ss_pred HHHHHHHCCeecCCCCHHHEEEc-CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHH
Confidence 99999999999999999999999 78899999999987653322 12234678999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccC-CCCcccccCCCChhHHHHHHHhcc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKS-HPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~-~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
++|+|++|+.||.+.+..+....+....+..+...+.... +.+.....+.... ..+.......+|.++.+||.+||+
T Consensus 190 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~ 269 (287)
T cd07848 190 ILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLK 269 (287)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHcc
Confidence 9999999999999988877777777776666655554321 1111111221111 111122233478999999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
+||++|||+.|+|+ ||||
T Consensus 270 ~~P~~R~s~~~~l~-hp~f 287 (287)
T cd07848 270 LNPTDRYLTEQCLN-HPAF 287 (287)
T ss_pred CCcccCCCHHHHhc-CCCC
Confidence 99999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.74 Aligned_cols=280 Identities=31% Similarity=0.531 Sum_probs=221.8
Q ss_pred cccchhheecccceeEEEEeEecC-CCceeeeeeeeccc------cchhhHHHHhhhc---CCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD-SGELVAIKKVLQDK------RFKNREMQIMRRL---EHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~------~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~ 91 (444)
++|++++.||+|+||.||+|++.. .++.||+|.+.... ..+.+|+.+++++ .||||+++++++......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~- 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD- 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC-
Confidence 479999999999999999999854 47889999885321 2344677777766 699999999988643210
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (290)
T cd07862 80 -------------------------------------------------------------------------------- 79 (290)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
....+++||||++++|.+++... ....+++..++.++.
T Consensus 80 ----------------------------------------~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~ 117 (290)
T cd07862 80 ----------------------------------------RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMF 117 (290)
T ss_pred ----------------------------------------CCCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHH
Confidence 01248899999999999988532 334589999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++.............+++.|+|||.+.+. .++.++|+|||
T Consensus 118 qi~~aL~~lH~~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl 195 (290)
T cd07862 118 QLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSV 195 (290)
T ss_pred HHHHHHHHHHHCCeeeCCCCHHHEEEc-CCCCEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHH
Confidence 999999999999999999999999999 7889999999998765444444455679999999999776 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|++||.+.++.+.+..+.+..+.+.+..+..... .....+...... ....+.+.+++.+.+||.+||+.
T Consensus 196 G~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 273 (290)
T cd07862 196 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA-LPRQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTF 273 (290)
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc-ccchhccCCCCC-CHHHHccCCCHHHHHHHHHHhcc
Confidence 9999999999999999999999999999888877666543211 000001111111 11122345789999999999999
Q ss_pred CCCCCCCHHHHhccCchh
Q psy10212 412 TPSSRISPLQVRSITPFL 429 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf 429 (444)
||++|||+.|+|+ ||||
T Consensus 274 ~P~~R~s~~~~l~-hp~f 290 (290)
T cd07862 274 NPAKRISAYSALS-HPYF 290 (290)
T ss_pred CchhcCCHHHHhc-CCCC
Confidence 9999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=364.40 Aligned_cols=283 Identities=37% Similarity=0.640 Sum_probs=234.6
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchh---hHHHHhhhcC------CCceeEeeeEEeecCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLE------HSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 90 (444)
+--+|+|++.||+|+||.|.+|.|..+++.||||++..++..+. .|+++|.+|+ --|||+++++|...+
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-- 261 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-- 261 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--
Confidence 34499999999999999999999999999999999988776655 5899999886 359999999998875
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 262 -------------------------------------------------------------------------------- 261 (586)
T KOG0667|consen 262 -------------------------------------------------------------------------------- 261 (586)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
|+|||+|+++.+|+++++. ..-..++...++.++
T Consensus 262 --------------------------------------------HlciVfELL~~NLYellK~--n~f~Glsl~~ir~~~ 295 (586)
T KOG0667|consen 262 --------------------------------------------HLCIVFELLSTNLYELLKN--NKFRGLSLPLVRKFA 295 (586)
T ss_pred --------------------------------------------ceeeeehhhhhhHHHHHHh--cCCCCCCHHHHHHHH
Confidence 5999999999999999975 344559999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLN-PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~-~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
.||+.||..||+.+|||+||||+|||+. .....+||+|||.++..... ..+...+..|.|||++.|. +|+.+.|||
T Consensus 296 ~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILGl-pY~~~IDmW 372 (586)
T KOG0667|consen 296 QQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILGL-PYDTAIDMW 372 (586)
T ss_pred HHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc--ceeeeeccccccchhhccC-CCCCcccee
Confidence 9999999999999999999999999994 23448999999999775333 3377889999999999999 999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC---Cc-ccCCCc---------------------
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY---TE-FKFPQI--------------------- 384 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~---~~-~~~p~~--------------------- 384 (444)
|||||++||++|.++|++.+..+++..|++.+|.|+...+....... .. ..++..
T Consensus 373 SLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~ 452 (586)
T KOG0667|consen 373 SLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRK 452 (586)
T ss_pred ehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhh
Confidence 99999999999999999999999999999999999988776532111 11 001110
Q ss_pred ---------cCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 385 ---------KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 385 ---------~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
....+...+.......+.+||.+||.+||.+|+|+.|+|+ ||||+....
T Consensus 453 ~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~-Hpfl~~~~~ 510 (586)
T KOG0667|consen 453 ARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN-HPFLTGTSL 510 (586)
T ss_pred hcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc-Ccccccccc
Confidence 1111111222233567899999999999999999999999 999996443
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.94 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=221.2
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+...+|++.+.||.|+||+||+|+++.++..||||.+..+ .+-...|+++|+.|+|||||.++++.+..+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~---- 82 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD---- 82 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC----
Confidence 4567899999999999999999999999999999999554 245568999999999999999999998875
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (429)
T KOG0595|consen 83 -------------------------------------------------------------------------------- 82 (429)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
++|+|||||. |+|.+++.+ .+.+++.+++.++.
T Consensus 83 ------------------------------------------~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~ 116 (429)
T KOG0595|consen 83 ------------------------------------------FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQ 116 (429)
T ss_pred ------------------------------------------eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHH
Confidence 4999999999 699999863 45899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCC--C---CeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPE--T---GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~--~---~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
||+.||++||+++|+||||||.|||++.. . ..+||+|||+++.........+.+|++.|||||++... .|+.++
T Consensus 117 QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKA 195 (429)
T KOG0595|consen 117 QLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKA 195 (429)
T ss_pred HHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchh
Confidence 99999999999999999999999999743 1 46899999999999888888899999999999999877 899999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||+|+++|+|++|+.||...+..+....+.+.- . ....++..++...++++.
T Consensus 196 DLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-----------------~---------~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 196 DLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-----------------E---------IVPVLPAELSNPLRELLI 249 (429)
T ss_pred hHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-----------------c---------ccCchhhhccCchhhhhh
Confidence 99999999999999999999999998888665521 1 111122345777889999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
..|+.+|..|.+..+-+. |+++..
T Consensus 250 ~ll~~~~~~~~~~~~~~~-~~~l~~ 273 (429)
T KOG0595|consen 250 SLLQRNPKDRISFEDFFD-HPFLAA 273 (429)
T ss_pred HHHhcCccccCchHHhhh-hhhccc
Confidence 999999999999998888 887764
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=334.46 Aligned_cols=249 Identities=28% Similarity=0.489 Sum_probs=221.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+|+.++.||.|+||+|-+++.+.+|..||+|++.+.+ +...+|..+|+.+.||.++++...|.+.+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~------ 117 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS------ 117 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC------
Confidence 57999999999999999999999999999999995542 45558999999999999999988887664
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 118 -------------------------------------------------------------------------------- 117 (355)
T KOG0616|consen 118 -------------------------------------------------------------------------------- 117 (355)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+||||++| .|.++++ ..+++++..++.++.||
T Consensus 118 ----------------------------------------~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAei 153 (355)
T KOG0616|consen 118 ----------------------------------------NLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEI 153 (355)
T ss_pred ----------------------------------------eEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHH
Confidence 49999999996 7888874 56789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||+++|++|||||+|||+| .+|.+||+|||.++..... .-+.+||+.|+|||.+... .+..++|.||||+
T Consensus 154 vlAleylH~~~iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGV 229 (355)
T KOG0616|consen 154 VLALEYLHSLDIIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGV 229 (355)
T ss_pred HHHHHHHHhcCeeeccCChHHeeec-cCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHH
Confidence 9999999999999999999999999 8999999999999886433 6678999999999999888 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|||+.|.+||.+.++..++.+|+.. +..+ |..+++++++||..+|++|-
T Consensus 230 LIYEMlaG~pPF~~~~~~~iY~KI~~~-----------------~v~f------------P~~fs~~~kdLl~~LL~vD~ 280 (355)
T KOG0616|consen 230 LIYEMLAGYPPFYDDNPIQIYEKILEG-----------------KVKF------------PSYFSSDAKDLLKKLLQVDL 280 (355)
T ss_pred HHHHHHcCCCCCcCCChHHHHHHHHhC-----------------cccC------------CcccCHHHHHHHHHHHhhhh
Confidence 999999999999999999999999872 3333 44679999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~~~ 434 (444)
.+|. ...++.. ||||+++..
T Consensus 281 t~R~gnlknG~~dIk~-H~wF~~v~W 305 (355)
T KOG0616|consen 281 TKRFGNLKNGVEDIKN-HPWFKGVDW 305 (355)
T ss_pred HhhhcCcCCCcccccc-CcccccccH
Confidence 9993 4678999 999998643
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.46 Aligned_cols=253 Identities=32% Similarity=0.499 Sum_probs=227.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.=|++.+-||.|+.|.|-+|++..||+..|||++.+. ...+.+|+-+|+-|.||||+.+++.|....
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~------ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ------ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc------
Confidence 4588999999999999999999999999999999766 466779999999999999999999998875
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (786)
T KOG0588|consen 86 -------------------------------------------------------------------------------- 85 (786)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+|+||++ |.|.+++. ..+++++.++.++++||
T Consensus 86 ----------------------------------------~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QI 121 (786)
T KOG0588|consen 86 ----------------------------------------HLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQI 121 (786)
T ss_pred ----------------------------------------eEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHH
Confidence 4999999998 58888885 46899999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.|+.|+|..+|+||||||+|++++ ..++|||+|||++.....+....+.+|+++|.+||++.|...-..++||||+||
T Consensus 122 i~gv~yCH~~~icHRDLKpENlLLd-~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGV 200 (786)
T KOG0588|consen 122 LDGVSYCHAFNICHRDLKPENLLLD-VKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGV 200 (786)
T ss_pred HHHHHHHhhhcceeccCCchhhhhh-cccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHH
Confidence 9999999999999999999999999 666699999999988878888888999999999999999866689999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|.|++|++||++.+-..++.++.++. + .+|.++|+++++||.+||.+||
T Consensus 201 ILfALLtG~LPFdDdNir~LLlKV~~G~-----------------f------------~MPs~Is~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 201 ILFALLTGKLPFDDDNIRVLLLKVQRGV-----------------F------------EMPSNISSEAQDLLRRMLDVDP 251 (786)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHHcCc-----------------c------------cCCCcCCHHHHHHHHHHhccCc
Confidence 9999999999999888777777776631 1 2345789999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~ 435 (444)
++|.|.+|+++ |||+......
T Consensus 252 ~~RiT~~eI~k-HP~l~g~~~~ 272 (786)
T KOG0588|consen 252 STRITTEEILK-HPFLSGYTSL 272 (786)
T ss_pred cccccHHHHhh-CchhhcCCCC
Confidence 99999999999 9999876543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=344.81 Aligned_cols=258 Identities=31% Similarity=0.501 Sum_probs=209.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..+|...+.||+|+||+||++.+..+|+..|+|.+... .+.+++|+++|++|+|||||++++.......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~------- 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN------- 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC-------
Confidence 45688999999999999999999999999999999665 4557899999999999999998776433321
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (313)
T KOG0198|consen 89 -------------------------------------------------------------------------------- 88 (313)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++|.||||+ |+|.+++.. .++++++..++.+..||++
T Consensus 89 -------------------------------------~~~~i~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~ 128 (313)
T KOG0198|consen 89 -------------------------------------DEYNIFMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILE 128 (313)
T ss_pred -------------------------------------eeeEeeeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHH
Confidence 24889999999 599999864 3337999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC----CCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR----GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||.|||++|++|+||||+|||++..++.+||+|||.+..... ........||+.|||||++..+....+++|||||
T Consensus 129 GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl 208 (313)
T KOG0198|consen 129 GLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL 208 (313)
T ss_pred HHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence 999999999999999999999993378999999999876543 1223356789999999999854244569999999
Q ss_pred HHHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||++.||+||+.||... ...+.+..+... . ..| .++..+|++.++||.+||.
T Consensus 209 GCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----------------~-~~P---------~ip~~ls~~a~~Fl~~C~~ 261 (313)
T KOG0198|consen 209 GCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----------------D-SLP---------EIPDSLSDEAKDFLRKCFK 261 (313)
T ss_pred CCEEEeccCCCCcchhhcchHHHHHHHhcc-----------------C-CCC---------CCCcccCHHHHHHHHHHhh
Confidence 99999999999999873 222222222210 0 111 3445689999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||++||||.++|+ |||.+.-.
T Consensus 262 ~~p~~Rpta~eLL~-hpf~~~~~ 283 (313)
T KOG0198|consen 262 RDPEKRPTAEELLE-HPFLKQNS 283 (313)
T ss_pred cCcccCcCHHHHhh-Chhhhccc
Confidence 99999999999999 99997743
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=347.27 Aligned_cols=285 Identities=30% Similarity=0.514 Sum_probs=225.1
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++......
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL-- 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc--
Confidence 3568999999999999999999999999999999998432 23455899999999999999999887654310
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 96 -------------------------------------------------------------------------------- 95 (359)
T cd07876 96 -------------------------------------------------------------------------------- 95 (359)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....+|+||||++++|.+.+. ..+++..+..++.|
T Consensus 96 --------------------------------------~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~q 131 (359)
T cd07876 96 --------------------------------------EEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQ 131 (359)
T ss_pred --------------------------------------cccceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHH
Confidence 0002378999999999888763 34788999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++.............+++.|+|||.+.+. .++.++|+||||
T Consensus 132 i~~~L~~LH~~~ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 209 (359)
T cd07876 132 MLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVG 209 (359)
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEEC-CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHH
Confidence 99999999999999999999999999 7889999999998765444334455778999999999876 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC----------CCCCcccCCCccCCCC----cccccCCCC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN----------PNYTEFKFPQIKSHPW----SKVFRVRTP 398 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~----------~~~~~~~~p~~~~~~~----~~~~~~~~s 398 (444)
|++|+|++|+.||.+.+..+....+.+.++.+....+.... +......+... ...| ........+
T Consensus 210 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 288 (359)
T cd07876 210 CIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL-FPDWIFPSESERDKLKT 288 (359)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh-ccccccccccccccccc
Confidence 99999999999999988888888888888877655433221 11111100000 0000 001122357
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.+++||.+||+.||++|||+.|+|. ||||+...
T Consensus 289 ~~~~~li~~mL~~dP~~R~t~~e~l~-hp~~~~~~ 322 (359)
T cd07876 289 SQARDLLSKMLVIDPDKRISVDEALR-HPYITVWY 322 (359)
T ss_pred hhHHHHHHHHhccCcccCCCHHHHhc-Cchhhhhc
Confidence 88999999999999999999999999 99998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.23 Aligned_cols=279 Identities=29% Similarity=0.498 Sum_probs=221.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhc---CCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRL---EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|++.+.||+|+||+||+|+++.+|+.||+|.+.... ....+|+.+++++ +||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~--- 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD--- 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC---
Confidence 5899999999999999999999999999999885321 2344677777665 799999999887654310
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (288)
T cd07863 78 -------------------------------------------------------------------------------- 77 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....+++||+++++|.+++... ....+++..++.++.||
T Consensus 78 --------------------------------------~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi 117 (288)
T cd07863 78 --------------------------------------RETKVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQF 117 (288)
T ss_pred --------------------------------------CCceEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHH
Confidence 01358899999999999888542 23458999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||
T Consensus 118 ~~al~~lH~~~ivH~dikp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~ 195 (288)
T cd07863 118 LRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGC 195 (288)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHH
Confidence 9999999999999999999999999 7889999999998765444333445678899999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|++||.+.+..+.+.++....+.+....+...... ....+...... ....+.+.++..+.++|.+||+.||
T Consensus 196 ~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP 273 (288)
T cd07863 196 IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL-PRGAFSPRGPR-PVQSVVPEIEESGAQLLLEMLTFNP 273 (288)
T ss_pred HHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc-cccccCCCCCC-chHHhCcCcCHHHHHHHHHHhccCc
Confidence 999999999999998888888888888877766555432100 00001111111 1122234678999999999999999
Q ss_pred CCCCCHHHHhccCchh
Q psy10212 414 SSRISPLQVRSITPFL 429 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf 429 (444)
++|||+.|++. ||||
T Consensus 274 ~~R~t~~~~l~-hp~f 288 (288)
T cd07863 274 HKRISAFRALQ-HPFF 288 (288)
T ss_pred ccCCCHHHHhc-CCCC
Confidence 99999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.84 Aligned_cols=283 Identities=31% Similarity=0.592 Sum_probs=229.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||.|+||.||+|++..+++.||+|.+.... ..+.+|+.++++++||||+++++++...+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-------- 77 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-------- 77 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--------
Confidence 67999999999999999999999999999999985332 34568999999999999999999987654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (301)
T cd07873 78 -------------------------------------------------------------------------------- 77 (301)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||++++|.+++.. ....+++..++.++.||+.|
T Consensus 78 --------------------------------------~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~a 116 (301)
T cd07873 78 --------------------------------------SLTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRG 116 (301)
T ss_pred --------------------------------------eEEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 3899999999999888753 34568899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||||+++
T Consensus 117 L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l 195 (301)
T cd07873 117 LNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 195 (301)
T ss_pred HHHHHhCCeeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999986543222 122335688899999987765688999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|++|++||.+.+..+....+...++.+....|...... +.....+..... .......++++.+.+||.+||+.||
T Consensus 196 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp 274 (301)
T cd07873 196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD-CLHNHAPRLDSDGAELLSKLLQFEG 274 (301)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccc-cHHhhcCCCCHHHHHHHHHHhcCCc
Confidence 9999999999998888888888888887776665543211 111112221111 1112335678999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+|||+.|+|. ||||+.+.+..
T Consensus 275 ~~R~t~~eil~-h~~f~~~~~~~ 296 (301)
T cd07873 275 RKRISAEEAMK-HPYFHCLGERI 296 (301)
T ss_pred ccCcCHHHHhc-Ccccccccchh
Confidence 99999999999 99999877543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.79 Aligned_cols=287 Identities=29% Similarity=0.500 Sum_probs=227.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.++|++.+.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.++||||+++++.+.......
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~- 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE- 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc-
Confidence 3568999999999999999999999999999999998532 234558999999999999999988775433100
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (364)
T cd07875 100 -------------------------------------------------------------------------------- 99 (364)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....|+||||++++|.+.+. ..+++..++.++.|
T Consensus 100 ---------------------------------------~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~q 134 (364)
T cd07875 100 ---------------------------------------EFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQ 134 (364)
T ss_pred ---------------------------------------ccCeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHH
Confidence 002489999999999988774 24788899999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
++.||+|||++|++||||||+||+++ .++.++|+|||++.............++..|+|||.+.+. .++.++|+||||
T Consensus 135 i~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG 212 (364)
T cd07875 135 MLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVG 212 (364)
T ss_pred HHHHHHHHhhCCeecCCCCHHHEEEC-CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHH
Confidence 99999999999999999999999999 7889999999999765444334455789999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC----------CCcccCCCcc---CCCCcccccCCCCh
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN----------YTEFKFPQIK---SHPWSKVFRVRTPP 399 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~----------~~~~~~p~~~---~~~~~~~~~~~~s~ 399 (444)
|++|+|++|+.||.+.+..+...++....+.+.+..+..+.+. +....+.... ...+........+.
T Consensus 213 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (364)
T cd07875 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292 (364)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccH
Confidence 9999999999999999999999999888888877655543221 1111100000 00011111222467
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+++||.+||+.||.+|||+.|+|. ||||.....
T Consensus 293 ~~~dll~~mL~~dP~~R~t~~e~L~-hp~~~~~~~ 326 (364)
T cd07875 293 QARDLLSKMLVIDASKRISVDEALQ-HPYINVWYD 326 (364)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhc-CcccccccC
Confidence 8999999999999999999999999 999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=338.61 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=209.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++.+.||+|+||+||+|+++.+|+.||+|++... ...+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR------ 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC------
Confidence 4789999999999999999999999999999998532 234668999999999999999877665443
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (291)
T cd05612 75 -------------------------------------------------------------------------------- 74 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++++|||||+ ++|.+++.. .+.+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi 110 (291)
T cd05612 75 ----------------------------------------FLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEI 110 (291)
T ss_pred ----------------------------------------eEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 4899999998 488888753 4578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++|++|+||+|+||+++ .++.++|+|||++...... .....+++.|+|||.+.+. .++.++|+|||||
T Consensus 111 ~~~l~~lH~~~i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 186 (291)
T cd05612 111 VCALEYLHSKEIVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGI 186 (291)
T ss_pred HHHHHHHHHCCeeecCCCHHHeEEC-CCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHH
Confidence 9999999999999999999999999 7889999999998765322 2345689999999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+....+... .. .++..+++.+++||.+||+.||
T Consensus 187 il~~l~~g~~pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 187 LIYEMLVGYPPFFDDNPFGIYEKILAG-----------------KL------------EFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------Cc------------CCCccCCHHHHHHHHHHcCCCH
Confidence 999999999999988776665555431 01 1233468899999999999999
Q ss_pred CCCCC-----HHHHhccCchhhhhhh
Q psy10212 414 SSRIS-----PLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRPs-----~~elL~~hpwf~~~~~ 434 (444)
.+||+ +.++++ ||||+.+..
T Consensus 238 ~~R~~~~~~~~~~~l~-h~~~~~~~~ 262 (291)
T cd05612 238 TRRLGNMKNGADDVKN-HRWFKSVDW 262 (291)
T ss_pred HHccCCccCCHHHHhc-CccccCCCH
Confidence 99995 999999 999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.36 Aligned_cols=276 Identities=33% Similarity=0.529 Sum_probs=220.4
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||+|+||.||+|+++.+|+.+|+|.+... ...+.+|+.++++++|+||+++.+++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-------- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-------- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--------
Confidence 588999999999999999999999999999998543 234568999999999999999988876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (284)
T cd07839 73 -------------------------------------------------------------------------------- 72 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+++++|||+++|.+++.. ....+++..++.++.||+.|
T Consensus 73 --------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~a 111 (284)
T cd07839 73 --------------------------------------KLTLVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKG 111 (284)
T ss_pred --------------------------------------ceEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 3899999999999888753 34679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.|||+++++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+...++.++|+|||||++
T Consensus 112 l~~LH~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 190 (284)
T cd07839 112 LAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190 (284)
T ss_pred HHHHHHCCEecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999986543221 122335678899999987764678999999999999
Q ss_pred HHHHhCCCC-CCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLLGQPM-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLltG~~P-f~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++|..| |.+.+..+.+..+.+..+.+....++...........+............+.+++++.++|.+||+.||.
T Consensus 191 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 270 (284)
T cd07839 191 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV 270 (284)
T ss_pred HHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChh
Confidence 999998877 5566667777777777777766655543221111122222222211223356799999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 271 ~R~t~~~il~-h~~f 284 (284)
T cd07839 271 QRISAEEALQ-HPYF 284 (284)
T ss_pred hcCCHHHHhc-CCCC
Confidence 9999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.31 Aligned_cols=284 Identities=30% Similarity=0.517 Sum_probs=226.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|++++.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.++||||+++++.+.......
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-- 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE-- 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc--
Confidence 568999999999999999999999999999999998532 234557999999999999999998886543100
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (355)
T cd07874 93 -------------------------------------------------------------------------------- 92 (355)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....++|||||++++.+.+. ..+++..++.++.||
T Consensus 93 --------------------------------------~~~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi 128 (355)
T cd07874 93 --------------------------------------EFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQM 128 (355)
T ss_pred --------------------------------------ccceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHH
Confidence 002378999999999888764 258889999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++.............++..|+|||.+.+. .++.++|+|||||
T Consensus 129 ~~aL~~LH~~givHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~ 206 (355)
T cd07874 129 LCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 206 (355)
T ss_pred HHHHHHHHhCCcccCCCChHHEEEC-CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHH
Confidence 9999999999999999999999999 7889999999999765444444456789999999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC----------CCcccCCCccCC---CCcccccCCCChh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN----------YTEFKFPQIKSH---PWSKVFRVRTPPD 400 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~----------~~~~~~p~~~~~---~~~~~~~~~~s~~ 400 (444)
++|+|++|+.||.+.+..+....+.+.++.+.+..+..+.+. +....++..... ..........+..
T Consensus 207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T cd07874 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286 (355)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchH
Confidence 999999999999998888888888888888776655443321 111111111000 0011122335678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+++||.+||+.||++|||+.|+|. ||||...
T Consensus 287 ~~~li~~mL~~dP~~Rps~~ell~-hp~~~~~ 317 (355)
T cd07874 287 ARDLLSKMLVIDPAKRISVDEALQ-HPYINVW 317 (355)
T ss_pred HHHHHHHHhcCCchhcCCHHHHhc-Ccchhcc
Confidence 999999999999999999999999 9999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=354.37 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=219.9
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeec----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
=...|....+||+|..|.||.|+...+++.||||++.. .++.+.+|+.+|+..+|+|||.+++.|+..+.
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de------ 344 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE------ 344 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce------
Confidence 34678899999999999999999999999999999943 45677799999999999999999999988754
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 345 -------------------------------------------------------------------------------- 344 (550)
T KOG0578|consen 345 -------------------------------------------------------------------------------- 344 (550)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
++.||||++| +|.+.+.. ..++|..+..++++++
T Consensus 345 ----------------------------------------LWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l 379 (550)
T KOG0578|consen 345 ----------------------------------------LWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREIL 379 (550)
T ss_pred ----------------------------------------eEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHH
Confidence 9999999995 88888853 4599999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+||+|||.+||+|+|||.+||+++ .++.+||+|||++....... ...+..||++|||||+.... .|.++.||||||+
T Consensus 380 ~aL~fLH~~gIiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGI 457 (550)
T KOG0578|consen 380 QGLKFLHARGIIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGI 457 (550)
T ss_pred HHHHHHHhcceeeeccccceeEec-cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhc-ccCccccchhhhh
Confidence 999999999999999999999999 78899999999987765544 56778999999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++.||+-|++||-..++..-+..|... |.| ....+..+|+.+++||.+||+.|+
T Consensus 458 MaIEMveGEPPYlnE~PlrAlyLIa~n-g~P-------------------------~lk~~~klS~~~kdFL~~cL~~dv 511 (550)
T KOG0578|consen 458 MAIEMVEGEPPYLNENPLRALYLIATN-GTP-------------------------KLKNPEKLSPELKDFLDRCLVVDV 511 (550)
T ss_pred HHHHHhcCCCCccCCChHHHHHHHhhc-CCC-------------------------CcCCccccCHHHHHHHHHHhhcch
Confidence 999999999999887776666555541 211 111234679999999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
.+|++|.|||+ ||||+.
T Consensus 512 ~~RasA~eLL~-HpFl~~ 528 (550)
T KOG0578|consen 512 EQRASAKELLE-HPFLKM 528 (550)
T ss_pred hcCCCHHHHhc-Chhhhh
Confidence 99999999999 999965
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=348.43 Aligned_cols=284 Identities=33% Similarity=0.542 Sum_probs=225.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++++.||+|+||.||+|++..+|+.||||++... ...+.+|+++++.++|+||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID------ 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc------
Confidence 478999999999999999999999999999988432 23456899999999999999998887654310
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (372)
T cd07853 75 -------------------------------------------------------------------------------- 74 (372)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
....+|+||||++++|.+.+. ....+++..++.++.||+.|
T Consensus 75 -----------------------------------~~~~~~lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~a 115 (372)
T cd07853 75 -----------------------------------PFEEIYVVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRG 115 (372)
T ss_pred -----------------------------------ccceEEEEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHH
Confidence 002489999999999988874 45679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|.|||++|++|+||||+||+++ .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+||+
T Consensus 116 L~~LH~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 194 (372)
T cd07853 116 LKYLHSAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCI 194 (372)
T ss_pred HHHHHhCCeeCCCCChHHEEEC-CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHH
Confidence 9999999999999999999999 78899999999986543221 12234568889999999876468899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccC--CC-ccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF--PQ-IKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~--p~-~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+|+|++|+.||.+.+..+.+..+.+.+|.+....+............ +. .........+....++.+.+||.+||+.
T Consensus 195 l~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 274 (372)
T cd07853 195 FAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274 (372)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCC
Confidence 99999999999999999999999999998887665432211000000 00 0000000112345689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||.+|||+.|+|+ ||||+..+
T Consensus 275 dP~~R~t~~e~l~-hp~~~~~~ 295 (372)
T cd07853 275 DPDKRISAADALA-HPYLDEGR 295 (372)
T ss_pred ChhhCcCHHHHhc-CHhhCCCc
Confidence 9999999999999 99999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=329.29 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=219.2
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++++|++.+.||+|.|+.||++.+..+|+.+|+|.+... -+.+.+|+++++.|+||||+++.+.+-+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~----- 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE----- 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----
Confidence 4678999999999999999999999999999999998433 25566999999999999999997766554
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (355)
T KOG0033|consen 83 -------------------------------------------------------------------------------- 82 (355)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.|.|+|+|+|+| .|..-|-.. .-+++..+..++.
T Consensus 83 -----------------------------------------~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~r 117 (355)
T KOG0033|consen 83 -----------------------------------------SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQ 117 (355)
T ss_pred -----------------------------------------ceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHH
Confidence 479999999997 554444211 3478888999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
||+++|.|+|.+||+|||+||+|+++-+ ...-+||+|||++.....+.......|||.|||||++... +++..+|||
T Consensus 118 QiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW 196 (355)
T KOG0033|consen 118 QILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIW 196 (355)
T ss_pred HHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhh
Confidence 9999999999999999999999999942 2346899999999888766666777899999999999887 899999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
+.|+++|-|+.|.+||-+.+...++++|.++. ++++. ..| +++++..++|+++||
T Consensus 197 ~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-----------------yd~~~---~~w-----~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 197 ACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-----------------YDYPS---PEW-----DTVTPEAKSLIRRML 251 (355)
T ss_pred hhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-----------------cCCCC---ccc-----CcCCHHHHHHHHHHh
Confidence 99999999999999999999999999998742 22221 222 246999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~ 431 (444)
..||.+|+|+.|+|+ |||+++
T Consensus 252 ~~dP~kRIta~EAL~-HpWi~~ 272 (355)
T KOG0033|consen 252 TVNPKKRITADEALK-HPWICN 272 (355)
T ss_pred ccChhhhccHHHHhC-Cchhcc
Confidence 999999999999999 999987
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.10 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=209.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.|++.+.||+|+||.||+|.++.+|+.||+|.+.... ..+.+|++++++++|++|+++.+.+...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~------- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD------- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-------
Confidence 3788999999999999999999999999999985321 24557999999999999999988886654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (285)
T cd05631 74 -------------------------------------------------------------------------------- 73 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||||++ +|.+.+.. .....+++..++.++.|++
T Consensus 74 ---------------------------------------~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~ 112 (285)
T cd05631 74 ---------------------------------------ALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELC 112 (285)
T ss_pred ---------------------------------------eEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHH
Confidence 38999999985 77766643 2334689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||+|||+++++|+||||+||+++ .++.++|+|||++.............++..|+|||.+.+. .++.++|+|||||+
T Consensus 113 ~~l~~lH~~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvi 190 (285)
T cd05631 113 CGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCL 190 (285)
T ss_pred HHHHHHHhCCEEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHH
Confidence 999999999999999999999999 7889999999998765443333445689999999999877 78999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+.......+...... ....++..+++++.+||.+||+.||.
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~s~~~~~li~~~l~~~P~ 245 (285)
T cd05631 191 IYEMIQGQSPFRKRKERVKREEVDRRVKE-------------------------DQEEYSEKFSEDAKSICRMLLTKNPK 245 (285)
T ss_pred HHHHHhCCCCCCCCCcchhHHHHHHHhhc-------------------------ccccCCccCCHHHHHHHHHHhhcCHH
Confidence 99999999999876554333333221110 00112335689999999999999999
Q ss_pred CCCC-----HHHHhccCchhhhhhh
Q psy10212 415 SRIS-----PLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs-----~~elL~~hpwf~~~~~ 434 (444)
+||+ ++++++ ||||+++..
T Consensus 246 ~R~~~~~~~~~~~~~-h~~~~~~~~ 269 (285)
T cd05631 246 ERLGCRGNGAAGVKQ-HPIFKNINF 269 (285)
T ss_pred HhcCCCCCCHHHHhc-CHhhcCCCH
Confidence 9997 899999 999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.64 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=221.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.--.+.|++..+||.|..++||+|+++-+++.||||++..++ +.+.+|++.|+.++||||++++.+|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-- 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-- 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce--
Confidence 3334678999999999999999999999999999999995543 567799999999999999999999998764
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 99 -------------------------------------------------------------------------------- 98 (516)
T KOG0582|consen 99 -------------------------------------------------------------------------------- 98 (516)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
+++||+||. ||+.++++.+. ...+.+..+..++
T Consensus 99 --------------------------------------------LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iL 132 (516)
T KOG0582|consen 99 --------------------------------------------LWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATIL 132 (516)
T ss_pred --------------------------------------------eEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHH
Confidence 999999998 69999997644 3459999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-----ccccccccccCchhhc-cCCCCCc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-----VSYICSRYYRAPELIF-GAIDYTT 324 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~l~-~~~~~s~ 324 (444)
+++++||.|||.+|.+|||||+.|||++ ++|.++|+|||.+..+...... ....++++|||||++. ....|+.
T Consensus 133 re~LkaL~YLH~~G~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdf 211 (516)
T KOG0582|consen 133 REVLKALDYLHQNGHIHRDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDF 211 (516)
T ss_pred HHHHHHHHHHHhcCceecccccccEEEc-CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccc
Confidence 9999999999999999999999999999 8999999999987655444322 3457899999999953 3346899
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++||||||++..||.+|..||....+...+...++ +.|+.... ......-.+.++..++.+
T Consensus 212 KaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~t-----------------~~~~~d~~k~~~ksf~e~ 272 (516)
T KOG0582|consen 212 KADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLLT-----------------SGLDKDEDKKFSKSFREM 272 (516)
T ss_pred hhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCccc-----------------ccCChHHhhhhcHHHHHH
Confidence 99999999999999999999999888776654443 33331111 001111112357799999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|..||+.||.+|||+.++|+ |+||+..+
T Consensus 273 i~~CL~kDP~kRptAskLlk-h~FFk~~k 300 (516)
T KOG0582|consen 273 IALCLVKDPSKRPTASKLLK-HAFFKKAK 300 (516)
T ss_pred HHHHhhcCcccCCCHHHHhc-cHHHhhcc
Confidence 99999999999999999999 99999854
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=345.79 Aligned_cols=256 Identities=31% Similarity=0.466 Sum_probs=215.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------------cchhhHHHHhhhcCCCceeEe
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------------RFKNREMQIMRRLEHSNIVKL 80 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------~~~~~E~~~l~~l~h~~i~~~ 80 (444)
+.-|+|++++.||+|.||.|-+|++..+++.||||++.+.+ +...+||.+|++|+|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34589999999999999999999999999999999995432 244589999999999999999
Q ss_pred eeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 81 KYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
++..-+...
T Consensus 174 iEvLDDP~s----------------------------------------------------------------------- 182 (576)
T KOG0585|consen 174 IEVLDDPES----------------------------------------------------------------------- 182 (576)
T ss_pred EEeecCccc-----------------------------------------------------------------------
Confidence 887744332
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCC
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQN 240 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~ 240 (444)
-.+|||+|||...-..|. ...++
T Consensus 183 -----------------------------------------------------~~~YlVley~s~G~v~w~----p~d~~ 205 (576)
T KOG0585|consen 183 -----------------------------------------------------DKLYLVLEYCSKGEVKWC----PPDKP 205 (576)
T ss_pred -----------------------------------------------------CceEEEEEeccCCccccC----CCCcc
Confidence 349999999996544544 23445
Q ss_pred -CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC------CCccccccccccCc
Q psy10212 241 -FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE------PNVSYICSRYYRAP 313 (444)
Q Consensus 241 -l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~------~~~~~~gt~~y~aP 313 (444)
+++.+++.++.++..||+|||.+||+||||||+|+|++ +.|++||+|||.+..+..+. ......||+.|+||
T Consensus 206 els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 206 ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 89999999999999999999999999999999999999 78999999999997663321 12235789999999
Q ss_pred hhhccC---CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 314 ELIFGA---IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 314 E~l~~~---~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|.+.+. ...+.+.||||+||++|.|+.|+.||-+..-.++..+|+. ....+|...
T Consensus 285 E~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn-----------------~pL~fP~~p----- 342 (576)
T KOG0585|consen 285 ELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN-----------------DPLEFPENP----- 342 (576)
T ss_pred HhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc-----------------CcccCCCcc-----
Confidence 999773 2457899999999999999999999999988899988887 334444422
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+.+++++||.+||.+||++|.+..++.. |||...
T Consensus 343 -----e~~e~~kDli~~lL~KdP~~Ri~l~~ik~-Hpwvt~ 377 (576)
T KOG0585|consen 343 -----EINEDLKDLIKRLLEKDPEQRITLPDIKL-HPWVTR 377 (576)
T ss_pred -----cccHHHHHHHHHHhhcChhheeehhhhee-cceecc
Confidence 35899999999999999999999999999 999876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.20 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=210.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+... ...+.+|+.++++++||||+++++.+...+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN----- 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----
Confidence 37899999999999999999999999999999998543 234668999999999999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (329)
T PTZ00263 92 -------------------------------------------------------------------------------- 91 (329)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..|+|||||.+ +|.+++. ..+.+++..++.++.|
T Consensus 92 -----------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~q 126 (329)
T PTZ00263 92 -----------------------------------------RVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAE 126 (329)
T ss_pred -----------------------------------------EEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHH
Confidence 38999999985 8888775 3457899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++|++|+||||+||+++ .++.++|+|||++...... .....+++.|+|||.+.+. .++.++|+||||
T Consensus 127 i~~aL~~LH~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 202 (329)
T PTZ00263 127 LVLAFEYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMG 202 (329)
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechH
Confidence 99999999999999999999999999 7889999999998765332 2345689999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|..||.+.+..+....+... ... ++..++..+.+||.+||+.|
T Consensus 203 ~il~elltg~~pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 203 VLLYEFIAGYPPFFDDTPFRIYEKILAG-----------------RLK------------FPNWFDGRARDLVKGLLQTD 253 (329)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------CcC------------CCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999887766555544331 111 12346889999999999999
Q ss_pred CCCCCC-----HHHHhccCchhhhh
Q psy10212 413 PSSRIS-----PLQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs-----~~elL~~hpwf~~~ 432 (444)
|.+||+ +.++++ ||||++.
T Consensus 254 P~~R~~~~~~~~~~ll~-hp~f~~~ 277 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKN-HPYFHGA 277 (329)
T ss_pred HHHcCCCCCCCHHHHhc-CCccCCC
Confidence 999997 799999 9999873
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=375.43 Aligned_cols=357 Identities=24% Similarity=0.279 Sum_probs=242.2
Q ss_pred chhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 14 YTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
..-+|.+.+.|++++.||+||||.||+|+++-+|++||||+|.... ..+.+|++++.+|+|||||+|+..|+++.
T Consensus 471 ~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 471 QRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred ccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 3445889999999999999999999999999999999999995542 34458999999999999999999999966
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccC--CChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSD--SGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.. ..+.+..++ ..+++++......+ .-..++..-.+.++.-.++.-...++
T Consensus 551 ~~---~~~~ei~~~------------------------~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~ss 603 (1351)
T KOG1035|consen 551 AE---LTVLEIVAS------------------------DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSS 603 (1351)
T ss_pred Cc---ccccccccc------------------------chhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccc
Confidence 42 111111111 11111111111111 00011111112222222222222333
Q ss_pred CCcc---------------cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCC----cccceEEEEeccCCCcH
Q psy10212 167 NYTE---------------FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS----PLQVFLNLVLEFMPETV 227 (444)
Q Consensus 167 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~iv~e~~~~~l 227 (444)
.|++ .++.+. +.+..+.++.++..+..+..+.....+....+. .+..++||+||||+.++
T Consensus 604 s~~~~~~~~~~~~d~e~~d~dedg~-~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~l 682 (1351)
T KOG1035|consen 604 SYTTRKASYESSTDEENDDSDEDGR-NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTL 682 (1351)
T ss_pred ccccccccccccCCccccccccccc-ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhH
Confidence 3221 111111 116677788888888888777777666555542 45689999999999877
Q ss_pred HHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-----------
Q psy10212 228 YKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV----------- 296 (444)
Q Consensus 228 ~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~----------- 296 (444)
+.++.+.. ...-.....|++++||+.||+|+|++|++||||||.|||++ +...+||+|||++....
T Consensus 683 l~~iI~~N--~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~ 759 (1351)
T KOG1035|consen 683 LRDIIRRN--HFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLS 759 (1351)
T ss_pred HHHHHHhc--ccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccC
Confidence 76664311 11115788999999999999999999999999999999999 88999999999986511
Q ss_pred --------CCCCCccccccccccCchhhccCC--CCCcchhhhhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCC
Q psy10212 297 --------RGEPNVSYICSRYYRAPELIFGAI--DYTTKIDVWSAGCVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPT 365 (444)
Q Consensus 297 --------~~~~~~~~~gt~~y~aPE~l~~~~--~~s~~sDiwSLGvil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~ 365 (444)
.....+...||..|+|||++.+.. .|+.++|+||||++++||+. ||... .....+..+.+
T Consensus 760 ~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~------ 830 (1351)
T KOG1035|consen 760 FSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK------ 830 (1351)
T ss_pred ccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc------
Confidence 011234557899999999997764 69999999999999999994 45432 22222222221
Q ss_pred HHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 366 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
..+|.. ..|..+--+.-.++|..||+.||.+||||.|+|+ +.||-
T Consensus 831 -------------g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~-s~llp 875 (1351)
T KOG1035|consen 831 -------------GSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN-SELLP 875 (1351)
T ss_pred -------------CCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh-ccCCC
Confidence 111111 1111122456778999999999999999999999 99998
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.53 Aligned_cols=248 Identities=32% Similarity=0.497 Sum_probs=217.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-cc-----hhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RF-----KNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~-----~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|.+.+.||+|+||+||+|+.+.+.+.||||.+.+.. .+ ..+|++++++|+||||+.++++|..+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~------- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA------- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-------
Confidence 68999999999999999999999999999999995543 22 568999999999999999999887764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (808)
T KOG0597|consen 75 -------------------------------------------------------------------------------- 74 (808)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
++++|+|||.|+|..++. +.+.++++.+..+..|+..
T Consensus 75 ---------------------------------------~~~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVs 111 (808)
T KOG0597|consen 75 ---------------------------------------HLWVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVS 111 (808)
T ss_pred ---------------------------------------eEEEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHH
Confidence 499999999999998884 6789999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.|||+.+|.|+|+||.||+++ ..+.+|++|||+++.+.... ..+...||+.|||||+..+. +|+..+|+|||||+
T Consensus 112 aL~yLhs~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGci 189 (808)
T KOG0597|consen 112 ALYYLHSNRILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCI 189 (808)
T ss_pred HHHHHHhcCcccccCCcceeeec-CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHH
Confidence 99999999999999999999999 88999999999998876543 24456899999999999987 99999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+||++.|++||-..+-......|... +.. .+...+..+.+||..+|.+||.
T Consensus 190 lYE~~~G~PPF~a~si~~Lv~~I~~d-----------------~v~------------~p~~~S~~f~nfl~gLL~kdP~ 240 (808)
T KOG0597|consen 190 LYELYVGQPPFYARSITQLVKSILKD-----------------PVK------------PPSTASSSFVNFLQGLLIKDPA 240 (808)
T ss_pred HHHHhcCCCCchHHHHHHHHHHHhcC-----------------CCC------------CcccccHHHHHHHHHHhhcChh
Confidence 99999999999876666655555541 111 1225689999999999999999
Q ss_pred CCCCHHHHhccCchhhh
Q psy10212 415 SRISPLQVRSITPFLIE 431 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~ 431 (444)
+|.|+.+++. |||.+.
T Consensus 241 ~RltW~~Ll~-HpF~k~ 256 (808)
T KOG0597|consen 241 QRLTWTDLLG-HPFWKG 256 (808)
T ss_pred hcccHHHHhc-ChHHhh
Confidence 9999999999 999987
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.38 Aligned_cols=288 Identities=31% Similarity=0.568 Sum_probs=229.5
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
-++.++|.+++.||+|+||+||+|++..+++.||+|++... ...+.+|++++++++||||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI- 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc-
Confidence 35778999999999999999999999999999999998532 23455899999999999999998877543210
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (343)
T cd07878 90 -------------------------------------------------------------------------------- 89 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
......++++++++++|.+++. ...+++..++.++.
T Consensus 90 ---------------------------------------~~~~~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~ 125 (343)
T cd07878 90 ---------------------------------------ENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIY 125 (343)
T ss_pred ---------------------------------------cccCcEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHH
Confidence 0012378999999999988764 35699999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++..... ......+++.|+|||.+.+...++.++|+|||
T Consensus 126 qi~~aL~~LH~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 126 QLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHHHHHHCCeecccCChhhEEEC-CCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhH
Confidence 999999999999999999999999999 788999999999876432 23345678999999999775478999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||++|+|++|+.||.+.+..+.+..+....+.+....+......... ...+......+...+ ..+++.+.+||.+|
T Consensus 203 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~m 281 (343)
T cd07878 203 GCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHH
Confidence 99999999999999998888888888888887776655443221110 011111222222222 24578899999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|+.||.+|||+.|+|. ||||......
T Consensus 282 L~~dp~~R~s~~ell~-hp~~~~~~~~ 307 (343)
T cd07878 282 LVLDSDKRISASEALA-HPYFSQYHDP 307 (343)
T ss_pred cCCChhhCCCHHHHhc-CcchhccCCC
Confidence 9999999999999999 9999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=332.51 Aligned_cols=278 Identities=29% Similarity=0.531 Sum_probs=212.6
Q ss_pred hheecccceeEEEEeEecC--CCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 27 KTVIGNGSFGIVYQAKLLD--SGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
.++||+|+||+||+|+++. +++.||+|.+... .....+|++++++++||||+++.+.+.+..+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------------- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHAD------------- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC-------------
Confidence 4689999999999999764 6789999998543 2456789999999999999999988876543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (317)
T cd07868 73 -------------------------------------------------------------------------------- 72 (317)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhh-----cCCCCChHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK-----SKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~-----~~~~l~~~~i~~i~~QIl~aL 257 (444)
...+++|||++++|.+++..... ....+++..++.++.||+.||
T Consensus 73 -------------------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 121 (317)
T cd07868 73 -------------------------------RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121 (317)
T ss_pred -------------------------------cEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence 35889999999999988854221 223588999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEc---CCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 258 AYIHVLGICHRDIKPQNLLLN---PETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~---~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.|||++|++|+||||+||++. ...+.++|+|||++....... ......+++.|+|||.+.+...++.++|+||
T Consensus 122 ~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred HHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 999999999999999999994 245789999999987653321 1234467899999999987546899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh---------hHHHHHHHHHhCCCCHHHHHhhCCCCCc---------ccCCCccCCCCccc
Q psy10212 331 AGCVLAELLLGQPMFPGDSG---------VDQLVEIIKVLGTPTREQIREMNPNYTE---------FKFPQIKSHPWSKV 392 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~---------~e~~~~i~~~~g~~~~~~~~~~~~~~~~---------~~~p~~~~~~~~~~ 392 (444)
+||++|+|++|++||..... .+.+..+...++.+....|......... ..............
T Consensus 202 lG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07868 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHh
Confidence 99999999999999975432 3567778888888877766553211000 00000000000001
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
.....+..+.+||.+||++||.+|||+.|+|+ ||||
T Consensus 282 ~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~-hp~f 317 (317)
T cd07868 282 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ-DPYF 317 (317)
T ss_pred cCCCCChHHHHHHHHHhccCcccCCCHHHHhc-CCCC
Confidence 11234678999999999999999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=326.15 Aligned_cols=277 Identities=32% Similarity=0.589 Sum_probs=219.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.|++++.||.|++|.||+|++..+++.||+|++... ...+.+|+.++++++||||+++++++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-------- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--------
Confidence 488999999999999999999999999999998432 134668999999999999999999987654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (285)
T cd07861 73 -------------------------------------------------------------------------------- 72 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+++|.+++.... .+..+++..++.++.||+.|
T Consensus 73 --------------------------------------~~~~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~ 113 (285)
T cd07861 73 --------------------------------------RLYLIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQG 113 (285)
T ss_pred --------------------------------------eEEEEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHH
Confidence 389999999999988875422 34678999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+...++.++|+||||+++
T Consensus 114 L~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 192 (285)
T cd07861 114 ILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIF 192 (285)
T ss_pred HHHHHhCCeeecCCCHHHEEEc-CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999986543221 112234578899999987664678999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC-CcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++|+.||.+.+..+....+....+.+....|....... ....++........ .....+++++.++|.+||+.||.
T Consensus 193 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~ 271 (285)
T cd07861 193 AEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPA 271 (285)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChh
Confidence 99999999999888777777777777766655543321000 00011111111111 11235799999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 272 ~Rpt~~~ll~-~~~~ 285 (285)
T cd07861 272 KRISAKKALN-HPYF 285 (285)
T ss_pred hCCCHHHHhc-CCCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=337.88 Aligned_cols=244 Identities=24% Similarity=0.441 Sum_probs=203.4
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||.||+|+++.+|+.||||++.... ..+.+|++++++++||||+++.+.+...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~------------ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD------------ 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC------------
Confidence 46999999999999999999999999985431 34457999999999999999988886654
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (323)
T cd05571 69 -------------------------------------------------------------------------------- 68 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.+|+|||||++ +|.+.+. ....+++..++.++.||+.||+|
T Consensus 69 ----------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~ 110 (323)
T cd05571 69 ----------------------------------RLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALGY 110 (323)
T ss_pred ----------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Confidence 48999999985 7877774 34678999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
||++|++||||||+||+++ .++.++|+|||++..... ........|++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus 111 lH~~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 188 (323)
T cd05571 111 LHSCDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHhCCeEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCC-CCCccccCcccchhhhhh
Confidence 9999999999999999999 788999999999865322 2223345689999999999877 789999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC-
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI- 417 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP- 417 (444)
++|+.||.+.+.......+... .. .++..+++.+.+||.+||+.||++||
T Consensus 189 ltg~~Pf~~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 189 MCGRLPFYNQDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred hcCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999877665544433320 11 12345789999999999999999999
Q ss_pred ----CHHHHhccCchhhhhh
Q psy10212 418 ----SPLQVRSITPFLIELR 433 (444)
Q Consensus 418 ----s~~elL~~hpwf~~~~ 433 (444)
++.++++ ||||+.+.
T Consensus 240 ~~~~~~~~ll~-h~~f~~~~ 258 (323)
T cd05571 240 GGPEDAKEIME-HRFFASIN 258 (323)
T ss_pred CCCCCHHHHHc-CCCcCCCC
Confidence 8999999 99998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.27 Aligned_cols=255 Identities=32% Similarity=0.587 Sum_probs=215.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.|++++.||+|+||.||+|+.++||+.||+|++.+.. +....|-.+|....+|+||++++.|.+..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~----- 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE----- 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-----
Confidence 367999999999999999999999999999999995542 33335777888889999999999998875
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 215 -------------------------------------------------------------------------------- 214 (550)
T KOG0605|consen 215 -------------------------------------------------------------------------------- 214 (550)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
++||||||++| .+..++. ..+.+++..++.++.+
T Consensus 215 -----------------------------------------~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE 249 (550)
T KOG0605|consen 215 -----------------------------------------YLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAE 249 (550)
T ss_pred -----------------------------------------eeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHH
Confidence 49999999996 6777764 5688999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC----------------------CC-C-----Cc--
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR----------------------GE-P-----NV-- 302 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~----------------------~~-~-----~~-- 302 (444)
++.|++.||++|++||||||+|+|+| ..|++||+|||++..... .. . ..
T Consensus 250 ~vlAI~~iH~~gyIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (550)
T KOG0605|consen 250 TVLAIESIHQLGYIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTM 328 (550)
T ss_pred HHHHHHHHHHcCcccccCChhheeec-CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchh
Confidence 99999999999999999999999999 899999999999842210 00 0 00
Q ss_pred ------------------cccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCC
Q psy10212 303 ------------------SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364 (444)
Q Consensus 303 ------------------~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~ 364 (444)
...|||.|+|||++.+. .|...+|.||||||+|||+.|.+||.+.++.++..+|+.....
T Consensus 329 ~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~- 406 (550)
T KOG0605|consen 329 SRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET- 406 (550)
T ss_pred hHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-
Confidence 12679999999999998 7999999999999999999999999999999999999874211
Q ss_pred CHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhhh
Q psy10212 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELRA 434 (444)
Q Consensus 365 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~~ 434 (444)
..+|. ...+++++.|||.+||. ||.+|.. +.||-+ ||||+.+..
T Consensus 407 --------------l~fP~----------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~-HPfF~~v~W 453 (550)
T KOG0605|consen 407 --------------LKFPE----------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK-HPFFKGVDW 453 (550)
T ss_pred --------------ccCCC----------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc-CCccccCCc
Confidence 11221 12458999999999999 9999986 788888 999998654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=346.68 Aligned_cols=274 Identities=24% Similarity=0.310 Sum_probs=214.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCcc
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLE 101 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 101 (444)
++|++++.||.|+||.||+|++..+++.||+|... ...+.+|++++++|+||||+++++++....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------------- 156 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTYNK------------- 156 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-------------
Confidence 67999999999999999999999999999999754 344678999999999999999999887653
Q ss_pred ccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCC
Q psy10212 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 181 (444)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (444)
T Consensus 157 -------------------------------------------------------------------------------- 156 (391)
T PHA03212 157 -------------------------------------------------------------------------------- 156 (391)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 182 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
+.++|||++.++|..++.. ...+++..++.++.||+.||+|||
T Consensus 157 ---------------------------------~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH 199 (391)
T PHA03212 157 ---------------------------------FTCLILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLH 199 (391)
T ss_pred ---------------------------------eeEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3889999999999888742 356889999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC--CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG--EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl 339 (444)
++||+||||||+||+++ ..+.++|+|||++...... .......||+.|+|||++.+. .++.++|+|||||++|+|+
T Consensus 200 ~~~IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 200 ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred hCCcccCCCChHhEEEc-CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999 7889999999998653222 122345689999999999876 7899999999999999999
Q ss_pred hCCCCCCCC-------ChhHHHHHHHHHhCCCCHHHH-------H----hhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 340 LGQPMFPGD-------SGVDQLVEIIKVLGTPTREQI-------R----EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 340 tG~~Pf~~~-------~~~e~~~~i~~~~g~~~~~~~-------~----~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
+|+.||-.. +....+..++...|.++.... . ...... ...+. ....|... ..++.++
T Consensus 278 tg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~--~~~~~~l 352 (391)
T PHA03212 278 TCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS--SRKPG-SRPLWTNL--YELPIDL 352 (391)
T ss_pred HCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhcc--CCCCC-CCCCHHHH--hhhhhhH
Confidence 999876432 233456666666665432110 0 000000 00000 00111111 1357789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+||.+||++||.+|||+.|+|+ ||||+++...
T Consensus 353 ~~Li~~mL~~dP~~Rpta~elL~-hp~f~~~~~~ 385 (391)
T PHA03212 353 EYLICKMLAFDAHHRPSAEALLD-FAAFQDIPDP 385 (391)
T ss_pred HHHHHHHhcCChhhCCCHHHHhc-ChhhccCCCC
Confidence 99999999999999999999999 9999987654
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.25 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=228.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|+.++.+|+|+||.+++++++.+++.||+|++... ++...+|+.++++++|||||.|++.|+.++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~------- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG------- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-------
Confidence 6899999999999999999999999999999999433 346678999999999999999999999887
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (426)
T KOG0589|consen 77 -------------------------------------------------------------------------------- 76 (426)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||+||+| ++.+.|...+ +..++++.+..|+.||+
T Consensus 77 --------------------------------------~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~ 116 (426)
T KOG0589|consen 77 --------------------------------------QLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQIL 116 (426)
T ss_pred --------------------------------------ceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHH
Confidence 369999999995 8888887543 68899999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.|+.|||+++|.|||||+.|||++ .++.++|+|||+++...... ...+..||+.|++||.+.+. +|..++|+|||||
T Consensus 117 ~av~ylH~~~iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC 194 (426)
T KOG0589|consen 117 LAVNYLHENRVLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGC 194 (426)
T ss_pred HHHHHHHhhhhhcccchhhhhhcc-ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcc
Confidence 999999999999999999999999 66777999999999887766 66778999999999999988 9999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|||++-+++|.+.+...+..+|.+....|. +..++.+++.+|..||..+|
T Consensus 195 ~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl----------------------------p~~ys~el~~lv~~~l~~~P 246 (426)
T KOG0589|consen 195 CLYEMCTLKPAFKASNMSELILKINRGLYSPL----------------------------PSMYSSELRSLVKSMLRKNP 246 (426)
T ss_pred hHHHHHhcccccCccchHHHHHHHhhccCCCC----------------------------CccccHHHHHHHHHHhhcCC
Confidence 99999999999999999999999988653332 34569999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~ 433 (444)
..||++.++|. +|.+.-+.
T Consensus 247 ~~RPsa~~LL~-~P~l~~~~ 265 (426)
T KOG0589|consen 247 EHRPSALELLR-RPHLLRYL 265 (426)
T ss_pred ccCCCHHHHhh-ChhhhhHH
Confidence 99999999999 99888655
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=335.05 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=212.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||.||+|++..+++.||||++... ...+.+|++++.+++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~------ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE------ 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC------
Confidence 4799999999999999999999999999999998543 234557999999999999999998886553
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (333)
T cd05600 75 -------------------------------------------------------------------------------- 74 (333)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.|+|||||++ +|.+++. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi 110 (333)
T cd05600 75 ----------------------------------------YLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEM 110 (333)
T ss_pred ----------------------------------------EEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHH
Confidence 48999999985 8888874 34578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++|++|+||+|+||+++ ..+.++|+|||++..... ......+++.|+|||.+.+. .++.++|+|||||
T Consensus 111 ~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~ 186 (333)
T cd05600 111 FEAVDALHELGYIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGC 186 (333)
T ss_pred HHHHHHHHHCCccccCCCHHHEEEC-CCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchH
Confidence 9999999999999999999999999 788999999999865433 23455789999999999887 8899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|..||.+.+..+....+...... ...|.... ....+++++.++|.+||..+|
T Consensus 187 il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~------~~~~~s~~~~~li~~~l~~~~ 245 (333)
T cd05600 187 MLYEFLCGFPPFSGSTPNETWENLKYWKET---------------LQRPVYDD------PRFNLSDEAWDLITKLINDPS 245 (333)
T ss_pred HHhhhhhCCCCCCCCCHHHHHHHHHhcccc---------------ccCCCCCc------cccccCHHHHHHHHHHhhChh
Confidence 999999999999988776666555432110 00010000 012468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
.+||++.++++ ||||+++
T Consensus 246 ~rr~s~~~ll~-h~~~~~~ 263 (333)
T cd05600 246 RRFGSLEDIKN-HPFFKEV 263 (333)
T ss_pred hhcCCHHHHHh-CcccCCC
Confidence 99999999999 9999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=338.03 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=211.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.+++.||+|+||+||+|++..+|+.||||++... ...+.+|++++..++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE------ 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC------
Confidence 4799999999999999999999999999999998542 234668999999999999999988776543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (350)
T cd05573 75 -------------------------------------------------------------------------------- 74 (350)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++++|||||+ ++|.+++.. .+.+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi 110 (350)
T cd05573 75 ----------------------------------------HLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAEL 110 (350)
T ss_pred ----------------------------------------eEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 4899999997 488888753 2679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC------------------------------CCcc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE------------------------------PNVS 303 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~------------------------------~~~~ 303 (444)
+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ....
T Consensus 111 ~~aL~~LH~~giiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (350)
T cd05573 111 VLALDSVHKLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189 (350)
T ss_pred HHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999 78899999999987654332 1233
Q ss_pred ccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCC
Q psy10212 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383 (444)
Q Consensus 304 ~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~ 383 (444)
..+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+...++..... ...+|.
T Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~ 253 (350)
T cd05573 190 TVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE---------------SLRFPP 253 (350)
T ss_pred cccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCC---------------cccCCC
Confidence 4679999999999887 889999999999999999999999998876665555443110 011111
Q ss_pred ccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC-HHHHhccCchhhhhhh
Q psy10212 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS-PLQVRSITPFLIELRA 434 (444)
Q Consensus 384 ~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs-~~elL~~hpwf~~~~~ 434 (444)
...+++.+.+||.+||. ||.+||+ +.++|+ ||||++...
T Consensus 254 ----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~-hp~~~~~~~ 293 (350)
T cd05573 254 ----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS-HPFFKGIDW 293 (350)
T ss_pred ----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc-CCCcCCCCH
Confidence 11258999999999998 9999999 999999 999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=326.36 Aligned_cols=278 Identities=29% Similarity=0.546 Sum_probs=210.6
Q ss_pred hheecccceeEEEEeEecC--CCceeeeeeeeccc--cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 27 KTVIGNGSFGIVYQAKLLD--SGELVAIKKVLQDK--RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
..+||+|+||+||+|+++. +++.||+|.+.... ..+.+|++++++++||||+++.+++....+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------------- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSD------------- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC-------------
Confidence 4689999999999999764 56889999985432 356689999999999999999998876543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (317)
T cd07867 73 -------------------------------------------------------------------------------- 72 (317)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhh-----cCCCCChHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK-----SKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~-----~~~~l~~~~i~~i~~QIl~aL 257 (444)
...++||||++++|.+++..... ....+++..++.++.||+.||
T Consensus 73 -------------------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 73 -------------------------------RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred -------------------------------CeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 34889999999999998853221 223578899999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEc---CCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhh
Q psy10212 258 AYIHVLGICHRDIKPQNLLLN---PETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~---~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.|||+++++|+||||+||++. ...+.++|+|||++........ .....++..|+|||.+.+...++.++|+||
T Consensus 122 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 201 (317)
T cd07867 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred HHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence 999999999999999999993 2567899999999976533221 223466889999999877546899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh---------hHHHHHHHHHhCCCCHHHHHhhCCC--CCcc-------cCCCccCCCCccc
Q psy10212 331 AGCVLAELLLGQPMFPGDSG---------VDQLVEIIKVLGTPTREQIREMNPN--YTEF-------KFPQIKSHPWSKV 392 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~---------~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~-------~~p~~~~~~~~~~ 392 (444)
+||++|+|++|++||..... .....++...++.+....|...... +... .............
T Consensus 202 lG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07867 202 IGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhc
Confidence 99999999999999975432 3456667777777766665543211 0000 0000000001111
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
.....+..+.+||.+||+.||.+|||+.|+|+ ||||
T Consensus 282 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~-hp~f 317 (317)
T cd07867 282 HKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ-DPYF 317 (317)
T ss_pred ccCCCChHHHHHHHHHhccCcccccCHHHHhc-CCCC
Confidence 12334678999999999999999999999999 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.93 Aligned_cols=241 Identities=30% Similarity=0.527 Sum_probs=201.7
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||+||+|+++.+++.||+|++... ...+.+|+.++++++||||+++.+.+...+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-------------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--------------
Confidence 79999999999999999999999998542 134457999999999999999988876553
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (312)
T cd05585 67 -------------------------------------------------------------------------------- 66 (312)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
.+++|||||++ +|.+++.. .+.+++..++.++.||+.||.|||
T Consensus 67 --------------------------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH 110 (312)
T cd05585 67 --------------------------------KLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLH 110 (312)
T ss_pred --------------------------------eEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 38999999985 88888752 457899999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
++|++||||||+||+++ .++.++|+|||++...... .......|++.|+|||.+.+. .++.++|+||+||++|+|++
T Consensus 111 ~~~i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~t 188 (312)
T cd05585 111 KFNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLT 188 (312)
T ss_pred hCCeEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHh
Confidence 99999999999999999 7889999999998653222 223345689999999999877 78999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC---
Q psy10212 341 GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI--- 417 (444)
Q Consensus 341 G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP--- 417 (444)
|+.||.+.+..+....+... .. .++..+++.+.++|.+||+.||.+||
T Consensus 189 g~~pf~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 189 GLPPFYDENVNEMYRKILQE-----------------PL------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CCCCcCCCCHHHHHHHHHcC-----------------CC------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 99999887766555444321 11 12335689999999999999999997
Q ss_pred CHHHHhccCchhhhh
Q psy10212 418 SPLQVRSITPFLIEL 432 (444)
Q Consensus 418 s~~elL~~hpwf~~~ 432 (444)
++.++|+ ||||++.
T Consensus 240 ~~~e~l~-hp~~~~~ 253 (312)
T cd05585 240 GAQEIKN-HPFFSQL 253 (312)
T ss_pred CHHHHHc-CCCcCCC
Confidence 5799999 9999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.05 Aligned_cols=285 Identities=22% Similarity=0.393 Sum_probs=216.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCC------ceeEeeeEEeecC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHS------NIVKLKYFFYSSG 88 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~ 88 (444)
+...++|+++++||+|+||+||+|.+..+++.||||++... .....+|+.+++.++|. +++++.+++....
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 33468999999999999999999999999999999998532 23445688888777554 5788877775443
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 205 -------------------------------------------------------------------------------- 204 (467)
T PTZ00284 205 -------------------------------------------------------------------------------- 204 (467)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.++++||++++++|.+++.. .+.+++..++.
T Consensus 205 ---------------------------------------------~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~ 235 (467)
T PTZ00284 205 ---------------------------------------------GHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQ 235 (467)
T ss_pred ---------------------------------------------ceEEEEEeccCCCHHHHHHH----cCCCCHHHHHH
Confidence 35899999999999998853 35799999999
Q ss_pred HHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCC---------------CeEEEeecCCcccccCCCCCccccccccccC
Q psy10212 249 YIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPET---------------GVLKLCDFGSAKHLVRGEPNVSYICSRYYRA 312 (444)
Q Consensus 249 i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~---------------~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~a 312 (444)
++.||+.||.|||+ .||+||||||+||+++... ..+||+|||.+... ........+|+.|+|
T Consensus 236 i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~A 313 (467)
T PTZ00284 236 IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRS 313 (467)
T ss_pred HHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccccC
Confidence 99999999999998 5999999999999997332 15999999987542 222345678999999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC-----CCcc--cCCCcc
Q psy10212 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-----YTEF--KFPQIK 385 (444)
Q Consensus 313 PE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~-----~~~~--~~p~~~ 385 (444)
||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|..+.......... +... ..+...
T Consensus 314 PE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (467)
T PTZ00284 314 PEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD 392 (467)
T ss_pred cHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCC
Confidence 9999887 7999999999999999999999999998888888888888887654332111000 0000 000000
Q ss_pred CCCCc-----ccc-cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 386 SHPWS-----KVF-RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 386 ~~~~~-----~~~-~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
...+. ..+ ....++.+.+||.+||++||.+|||+.|+|+ ||||++....
T Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~-Hp~~~~~~~~ 447 (467)
T PTZ00284 393 PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT-HPYVLKYYPE 447 (467)
T ss_pred HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc-CccccccCCc
Confidence 00000 000 0012577899999999999999999999999 9999986543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=326.04 Aligned_cols=285 Identities=34% Similarity=0.543 Sum_probs=227.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.++++++|+||+++.+++.....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL----- 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC-----
Confidence 467999999999999999999999999999999985432 123479999999999999999998875431
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (309)
T cd07845 81 -------------------------------------------------------------------------------- 80 (309)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..+++||||++++|.+++... ...+++..++.++.||+
T Consensus 81 ---------------------------------------~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~ 118 (309)
T cd07845 81 ---------------------------------------DSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLL 118 (309)
T ss_pred ---------------------------------------CeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHH
Confidence 137899999999998888642 36789999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++|++|+||+|+||+++ ..+.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+
T Consensus 119 ~~l~~lH~~~i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~ 197 (309)
T cd07845 119 RGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGC 197 (309)
T ss_pred HHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHH
Confidence 999999999999999999999999 78899999999987654332 1222344778999999876546889999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
++|+|++|+.||.+.++.+.+..+.+..+.+....++.... .......+......+...+ ...++.+.++|.+||++
T Consensus 198 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~ 276 (309)
T cd07845 198 ILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMY 276 (309)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcC
Confidence 99999999999999999999999998888777655543221 1111111111111111111 23589999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||++|||+.|+|. ||||++....
T Consensus 277 dp~~R~t~~~il~-h~~f~~~~~~ 299 (309)
T cd07845 277 DPKKRATAEEALE-SSYFKEKPLP 299 (309)
T ss_pred ChhhCcCHHHHhc-ChhhccCCCC
Confidence 9999999999999 9999875444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=321.48 Aligned_cols=279 Identities=36% Similarity=0.617 Sum_probs=227.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++.+.||.|+||.||+|+++.+++.+|+|.+.... ..+.+|+.++++++||||+++.+++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL------ 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC------
Confidence 57999999999999999999999999999999995432 134579999999999999999998876531
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (293)
T cd07843 79 -------------------------------------------------------------------------------- 78 (293)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
...|+||||++++|.+++.. ....+++..++.++.||+.
T Consensus 79 --------------------------------------~~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~ 117 (293)
T cd07843 79 --------------------------------------DKIYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLS 117 (293)
T ss_pred --------------------------------------CcEEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHH
Confidence 24899999999999888753 2236899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++|++|+||+|+||+++ .++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|++
T Consensus 118 aL~~LH~~~i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 196 (293)
T cd07843 118 GVAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196 (293)
T ss_pred HHHHHHHCCeeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHH
Confidence 99999999999999999999999 7899999999998765443 222334567889999998766467899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCC-CChhHHHHHHHhccc
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVR-TPPDAIDLISRLLEY 411 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~-~s~~l~~LI~~~L~~ 411 (444)
+|+|++|..||...+..+...++....+.+....|+.... ..............+...++.. +++.+.++|.+||+.
T Consensus 197 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (293)
T cd07843 197 FAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTY 276 (293)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhcc
Confidence 9999999999999998888898988888888777765321 1111111122222233334443 689999999999999
Q ss_pred CCCCCCCHHHHhccCchh
Q psy10212 412 TPSSRISPLQVRSITPFL 429 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf 429 (444)
||++|||+.|+|. ||||
T Consensus 277 ~p~~R~t~~ell~-~~~f 293 (293)
T cd07843 277 DPAKRISAEDALK-HPYF 293 (293)
T ss_pred CccccCCHHHHhc-CCCC
Confidence 9999999999999 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=338.42 Aligned_cols=253 Identities=32% Similarity=0.546 Sum_probs=208.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|++..+|+.||||++... ...+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~------ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN------ 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC------
Confidence 4799999999999999999999999999999999543 134557999999999999999998887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (364)
T cd05599 75 -------------------------------------------------------------------------------- 74 (364)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+|||||++ +|.+++. ..+.+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi 110 (364)
T cd05599 75 ----------------------------------------YLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAET 110 (364)
T ss_pred ----------------------------------------eEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHH
Confidence 48999999985 7888774 34579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---------------------------------- 299 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---------------------------------- 299 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++.......
T Consensus 111 ~~aL~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (364)
T cd05599 111 ILAIDSIHKLGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189 (364)
T ss_pred HHHHHHHHHCCeEeccCCHHHeEEC-CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchh
Confidence 9999999999999999999999999 78999999999886432111
Q ss_pred -----CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC
Q psy10212 300 -----PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374 (444)
Q Consensus 300 -----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~ 374 (444)
......||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+.+..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~------------- 255 (364)
T cd05599 190 RNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWK------------- 255 (364)
T ss_pred hcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 00123589999999999877 78999999999999999999999999887766555544311
Q ss_pred CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhh
Q psy10212 375 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELR 433 (444)
Q Consensus 375 ~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~ 433 (444)
....+|. ...+++.+.++|.+||. +|.+|++ +.|++. ||||+...
T Consensus 256 --~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~-h~~~~~~~ 303 (364)
T cd05599 256 --ETLQFPD----------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS-HPFFKGVD 303 (364)
T ss_pred --CccCCCC----------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc-CCCcCCCC
Confidence 0011111 11358999999999997 9999998 999999 99998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.83 Aligned_cols=258 Identities=33% Similarity=0.581 Sum_probs=225.3
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcC-CCceeEeeeEEeecC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLE-HSNIVKLKYFFYSSG 88 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 88 (444)
...+...|++.++||+|.||.||+++.+.+|+.+|+|.+.+.. ....+|+.+|++|. ||||+.+.+.|.+..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 4667889999999999999999999999999999999995442 36779999999998 999999999998875
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 110 ~------------------------------------------------------------------------------- 110 (382)
T KOG0032|consen 110 S------------------------------------------------------------------------------- 110 (382)
T ss_pred e-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
+++|||+|. |.|.+.+... .+++..+.
T Consensus 111 -----------------------------------------------~~lvmEL~~GGeLfd~i~~~-----~~sE~da~ 138 (382)
T KOG0032|consen 111 -----------------------------------------------VYLVMELCEGGELFDRIVKK-----HYSERDAA 138 (382)
T ss_pred -----------------------------------------------EEEEEEecCCchHHHHHHHc-----cCCHHHHH
Confidence 999999999 5899988654 39999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE---TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~---~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
.++.|++.++.|||+.|++|+||||+|+++... .+.++++|||++............+||+.|+|||.+... .++.
T Consensus 139 ~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~ 217 (382)
T KOG0032|consen 139 GIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGD 217 (382)
T ss_pred HHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCC-CCCc
Confidence 999999999999999999999999999999643 248999999999988776667788999999999999876 8999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
.+|+||+|+++|.|++|..||.+.+.......+... ++ .+....|. +++..+.++
T Consensus 218 ~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-----------------~~---~f~~~~w~-----~is~~akd~ 272 (382)
T KOG0032|consen 218 EVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-----------------DF---DFTSEPWD-----DISESAKDF 272 (382)
T ss_pred ccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----------------CC---CCCCCCcc-----ccCHHHHHH
Confidence 999999999999999999999998887777766552 11 12223333 459999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|..||..||.+|+|+.++|. |||++..
T Consensus 273 i~~ll~~dp~~R~ta~~~L~-HpWi~~~ 299 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQ-HPWIKSI 299 (382)
T ss_pred HHHhcccCcccCCCHHHHhc-CccccCC
Confidence 99999999999999999999 9999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.06 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=209.7
Q ss_pred ccccchhheecccceeEEEEeEecCCC-ceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG-ELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++++.||+|+||.||+|++..++ +.||+|.+... ...+.+|+.+++.++||||+++++++...+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~---- 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES---- 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence 367999999999999999999976654 78999998432 234557999999999999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 105 -------------------------------------------------------------------------------- 104 (340)
T PTZ00426 105 -------------------------------------------------------------------------------- 104 (340)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
++|+|||||+ ++|.+++. ....+++..++.++.
T Consensus 105 ------------------------------------------~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~ 138 (340)
T PTZ00426 105 ------------------------------------------YLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAA 138 (340)
T ss_pred ------------------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHH
Confidence 4899999997 58888875 345789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.||.|||++|++||||||+||+++ .++.++|+|||++..... ......|++.|+|||.+.+. .++.++|+||+
T Consensus 139 qi~~aL~~LH~~~ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSl 214 (340)
T PTZ00426 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTL 214 (340)
T ss_pred HHHHHHHHHHHCCeEccCCCHHHEEEC-CCCCEEEecCCCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccch
Confidence 999999999999999999999999998 789999999999876532 23345789999999999876 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|..||.+.+.......+... .. .++..+++.+.++|.+||+.
T Consensus 215 Gvil~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 215 GIFIYEILVGCPPFYANEPLLIYQKILEG-----------------II------------YFPKFLDNNCKHLMKKLLSH 265 (340)
T ss_pred hhHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHccc
Confidence 99999999999999987776655555431 00 12345688999999999999
Q ss_pred CCCCCC-----CHHHHhccCchhhhhh
Q psy10212 412 TPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
||.+|+ ++.++++ ||||+++.
T Consensus 266 dp~~R~~~~~~~~~~~~~-hp~f~~~~ 291 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKE-HPWFGNID 291 (340)
T ss_pred CHHHcCCCCCCCHHHHHc-CCCcCCCC
Confidence 999995 8999999 99999754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=317.19 Aligned_cols=275 Identities=36% Similarity=0.635 Sum_probs=219.1
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++++.||+|+||.||+|++..+++.||+|++.... ....+|+..+.++. |+||+++.+++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-------- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKT-------- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCC--------
Confidence 678999999999999999999999999999985432 12236888888885 9999999999876521
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (282)
T cd07831 73 -------------------------------------------------------------------------------- 72 (282)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++||||+++++.+.+.. ....+++..++.++.||+.||
T Consensus 73 ------------------------------------~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L 113 (282)
T cd07831 73 ------------------------------------GRLALVFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSL 113 (282)
T ss_pred ------------------------------------CcEEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHH
Confidence 13899999999999988753 235789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||++|++|+||+|+||+++ . +.++|+|||.+.............++..|+|||.+.+...++.++|+||+||++|+
T Consensus 114 ~~LH~~~i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~e 191 (282)
T cd07831 114 DHMHRNGIFHRDIKPENILIK-D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFE 191 (282)
T ss_pred HHHHHCCceecccCHHHEEEc-C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHH
Confidence 999999999999999999999 5 99999999998765444333445578899999987654467899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC-CcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
|++|..||.+.+..+....+.+..+.+............ ....++....... ..+...++..+.++|.+||+.||++|
T Consensus 192 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R 270 (282)
T cd07831 192 ILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDER 270 (282)
T ss_pred HHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccc
Confidence 999999999998888888888888777765433322111 1111221111111 11223568999999999999999999
Q ss_pred CCHHHHhccCchh
Q psy10212 417 ISPLQVRSITPFL 429 (444)
Q Consensus 417 Ps~~elL~~hpwf 429 (444)
|++.+++. ||||
T Consensus 271 ~~~~~~l~-~~~~ 282 (282)
T cd07831 271 ITAKQALR-HPYF 282 (282)
T ss_pred cCHHHHhh-CCCC
Confidence 99999999 9997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.55 Aligned_cols=277 Identities=25% Similarity=0.336 Sum_probs=226.9
Q ss_pred ccccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeE
Q psy10212 10 FAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYF 83 (444)
Q Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (444)
|+.+........++|.+.+.||+|+||+||+|++..+|+.||||.+... ...+.+|+.++..++|+||+++...
T Consensus 20 ~~~d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 20 FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred cCCCcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 5667777788889999999999999999999999999999999998543 2345679999999999999998776
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+........
T Consensus 100 ~~~~~~~~~----------------------------------------------------------------------- 108 (496)
T PTZ00283 100 FAKKDPRNP----------------------------------------------------------------------- 108 (496)
T ss_pred eecccccCc-----------------------------------------------------------------------
Confidence 654432000
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCC
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFP 242 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~ 242 (444)
....++++||||++ ++|.+++.........++
T Consensus 109 -----------------------------------------------~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~ 141 (496)
T PTZ00283 109 -----------------------------------------------ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141 (496)
T ss_pred -----------------------------------------------ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCC
Confidence 01135889999998 589998876555667899
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC---CCCccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---EPNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~l~~~ 319 (444)
+..++.++.|++.||.|||+++++||||||+||+++ .++.++|+|||+++..... .......|++.|+|||.+.+.
T Consensus 142 e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe-CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence 999999999999999999999999999999999999 7889999999998764322 123345689999999999877
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+|||||++|+|++|+.||.+.+..+....+.... ...++..+++
T Consensus 221 -~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 271 (496)
T PTZ00283 221 -PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR----------------------------YDPLPPSISP 271 (496)
T ss_pred -CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCCCCCCH
Confidence 78999999999999999999999998877665555443210 0113346789
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+.++|.+||+.||.+||++.++|+ |||++.+...
T Consensus 272 ~l~~li~~~L~~dP~~RPs~~ell~-~p~~~~~~~~ 306 (496)
T PTZ00283 272 EMQEIVTALLSSDPKRRPSSSKLLN-MPICKLFISG 306 (496)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHh-CHHHHHhhhh
Confidence 9999999999999999999999999 9999876543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=329.70 Aligned_cols=280 Identities=25% Similarity=0.399 Sum_probs=211.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|++++.||+|+||.||++++..+|..+|+|.+... ...+.+|++++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------- 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-------
Confidence 47899999999999999999999999999999998543 245678999999999999999999987764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (331)
T cd06649 77 -------------------------------------------------------------------------------- 76 (331)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..++|||||++ +|.+++.. ...+++..++.++.|++
T Consensus 77 ---------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~ 113 (331)
T cd06649 77 ---------------------------------------EISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVL 113 (331)
T ss_pred ---------------------------------------EEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHH
Confidence 38899999985 88888753 34689999999999999
Q ss_pred HHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++ +++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||.+.+. .++.++|+|||||
T Consensus 114 ~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~ 190 (331)
T cd06649 114 RGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGL 190 (331)
T ss_pred HHHHHHhhcCCEEcCCCChhhEEEc-CCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHH
Confidence 999999986 699999999999999 7889999999998655332 23345688999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC----------cccCCCc---------cCCCCccccc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT----------EFKFPQI---------KSHPWSKVFR 394 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~----------~~~~p~~---------~~~~~~~~~~ 394 (444)
++|+|++|+.||...+..+....+................+... ....+.. ..........
T Consensus 191 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
T cd06649 191 SLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN 270 (331)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCC
Confidence 99999999999987665543322111000000000000000000 0000000 0000000001
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..+++++++||.+||++||++|||+.++|+ ||||+....
T Consensus 271 ~~~~~~l~~li~~~L~~~P~~Rpt~~ell~-h~~~~~~~~ 309 (331)
T cd06649 271 GVFTPDFQEFVNKCLIKNPAERADLKMLMN-HTFIKRSEV 309 (331)
T ss_pred ccccHHHHHHHHHHccCCcccCCCHHHHhc-ChHHhhccc
Confidence 246889999999999999999999999999 999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.48 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=206.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+++.||+|++.... ..+.+|+.++.+++|++|+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~------ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL------ 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Confidence 47899999999999999999999999999999985421 34567999999999999999998887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (363)
T cd05628 75 -------------------------------------------------------------------------------- 74 (363)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++. ..+++++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi 110 (363)
T cd05628 75 ----------------------------------------NLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAET 110 (363)
T ss_pred ----------------------------------------eEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHH
Confidence 38999999985 8888875 34679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---------------------------------- 299 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---------------------------------- 299 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++.......
T Consensus 111 ~~aL~~lH~~givHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (363)
T cd05628 111 VLAIDSIHQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189 (363)
T ss_pred HHHHHHHHhCCeEecCCCHHHeEEC-CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhcc
Confidence 9999999999999999999999999 78899999999986432110
Q ss_pred --CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC
Q psy10212 300 --PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 377 (444)
Q Consensus 300 --~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~ 377 (444)
......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...++.....
T Consensus 190 ~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 253 (363)
T cd05628 190 RQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKE--------------- 253 (363)
T ss_pred ccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC---------------
Confidence 01234689999999999877 789999999999999999999999998887776666554210
Q ss_pred cccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC---CCCCHHHHhccCchhhhhh
Q psy10212 378 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS---SRISPLQVRSITPFLIELR 433 (444)
Q Consensus 378 ~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~---kRPs~~elL~~hpwf~~~~ 433 (444)
...+|. ...+++++.++|.+|+. +|. .||++.|+++ ||||+...
T Consensus 254 ~~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~-hp~f~~~~ 300 (363)
T cd05628 254 TLIFPP----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT-NPFFEGVD 300 (363)
T ss_pred cccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC-CCCCCCCC
Confidence 011111 01358899999999875 555 4589999999 99998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.65 Aligned_cols=283 Identities=32% Similarity=0.590 Sum_probs=223.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++.+.||.|++|.||+|+++.+|+.||+|++... ...+.+|++++++++|+||+++.+++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-------
Confidence 5799999999999999999999999999999988432 234668999999999999999999987654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (294)
T PLN00009 75 -------------------------------------------------------------------------------- 74 (294)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+.++||||++++|.+.+.. .....+++..++.++.||+.
T Consensus 75 ---------------------------------------~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~ 113 (294)
T PLN00009 75 ---------------------------------------RLYLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILR 113 (294)
T ss_pred ---------------------------------------eEEEEEecccccHHHHHHh--CCCCCcCHHHHHHHHHHHHH
Confidence 3899999999998888753 22334678889999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||+++++|+||+|+||+++..++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|++
T Consensus 114 aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i 193 (294)
T PLN00009 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCI 193 (294)
T ss_pred HHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 99999999999999999999998556789999999986543221 12233557889999998765467899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+|+|++|+.||...+..+...++....+.+....|..... ++ ....+..... ......+.+++.+.++|.+||+.|
T Consensus 194 ~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~ 271 (294)
T PLN00009 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY-KSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLD 271 (294)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh-hhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCC
Confidence 9999999999998888888888877777766555432110 00 0001110110 111123457899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|++||++.++|+ ||||++++++
T Consensus 272 P~~Rps~~~~l~-~~~~~~~~~~ 293 (294)
T PLN00009 272 PSKRITARAALE-HEYFKDLGDA 293 (294)
T ss_pred hhhCcCHHHHhc-CchHhHHhcC
Confidence 999999999999 9999998764
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=320.81 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=202.5
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||+||+++++.+|+.||+|++.... ..+..|++++++++|+||+++.+.+....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-------------- 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-------------- 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--------------
Confidence 799999999999999999999999985432 33457999999999999999988876653
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (280)
T cd05608 67 -------------------------------------------------------------------------------- 66 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
.+++|||||++ +|.+.+.........+++..++.++.||+.||.|||
T Consensus 67 --------------------------------~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 114 (280)
T cd05608 67 --------------------------------DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114 (280)
T ss_pred --------------------------------eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 38999999985 787777544445667999999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
+++++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus 115 ~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~ 192 (280)
T cd05608 115 QRRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIA 192 (280)
T ss_pred HCCcccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHh
Confidence 99999999999999999 788999999999876543322 2234678999999999877 78999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC---
Q psy10212 341 GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI--- 417 (444)
Q Consensus 341 G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP--- 417 (444)
|+.||...+.......+...... . ...++..+++.+.+++.+||+.||++||
T Consensus 193 g~~pf~~~~~~~~~~~~~~~~~~-------------~------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 193 ARGPFRARGEKVENKELKQRILN-------------D------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred CCCCCCCCCcchhHHHHHHhhcc-------------c------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 99999865433222222221100 0 0012235689999999999999999999
Q ss_pred --CHHHHhccCchhhhhhh
Q psy10212 418 --SPLQVRSITPFLIELRA 434 (444)
Q Consensus 418 --s~~elL~~hpwf~~~~~ 434 (444)
++.++++ ||||+++..
T Consensus 248 ~~~~~~~l~-h~~~~~~~~ 265 (280)
T cd05608 248 DGNCDGLRT-HPLFRDLNW 265 (280)
T ss_pred CCCHHHHhc-ChhhhcCCH
Confidence 8899999 999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=318.19 Aligned_cols=276 Identities=37% Similarity=0.699 Sum_probs=226.3
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||.|+||.||+|++..+|+.||+|++.... ..+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-------- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--------
Confidence 5899999999999999999999999999999985432 35668999999999999999998886643
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (286)
T cd07832 73 -------------------------------------------------------------------------------- 72 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.++||||++++|.+++.. ...++++..++.++.||+.|
T Consensus 73 --------------------------------------~~~~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~ 111 (286)
T cd07832 73 --------------------------------------GFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKG 111 (286)
T ss_pred --------------------------------------eeEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 4899999998899998863 23679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||++|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+...++.++|+||+|++
T Consensus 112 l~~lH~~~i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 190 (286)
T cd07832 112 VAYMHANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190 (286)
T ss_pred HHHHHHCCeecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence 9999999999999999999999 688999999999876543321 2334678899999998765467899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|++|++||.+.++......+....+.+....++.... ......++......+.. +.++.+..+.++|.+||+.|
T Consensus 191 l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~ 269 (286)
T cd07832 191 FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYD 269 (286)
T ss_pred HHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccC
Confidence 9999999999998888888888888888877766655321 11222222222222222 22456899999999999999
Q ss_pred CCCCCCHHHHhccCchhh
Q psy10212 413 PSSRISPLQVRSITPFLI 430 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~ 430 (444)
|++|||+.++|+ ||||.
T Consensus 270 p~~R~~~~~~l~-h~~~~ 286 (286)
T cd07832 270 PSKRLSAAEALR-HPYFT 286 (286)
T ss_pred hhhCCCHHHHhh-CcCcC
Confidence 999999999999 99983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=330.99 Aligned_cols=244 Identities=25% Similarity=0.437 Sum_probs=202.8
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||.||+|+++.+|+.||+|++... ...+.+|++++++++||||+++.+.+...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------------ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------------ 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC------------
Confidence 4799999999999999999999999998543 123457999999999999999988886654
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (323)
T cd05595 69 -------------------------------------------------------------------------------- 68 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.+|+|||||++ +|..++. ....+++..++.++.||+.||+|
T Consensus 69 ----------------------------------~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~ 110 (323)
T cd05595 69 ----------------------------------RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 110 (323)
T ss_pred ----------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Confidence 38999999985 7776664 34578999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus 111 LH~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~el 188 (323)
T cd05595 111 LHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHHCCeEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHH
Confidence 9999999999999999999 7889999999987653222 222345689999999999877 789999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC-
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI- 417 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP- 417 (444)
++|+.||...+.......+... .. .++..+++.+.++|.+||+.||.+||
T Consensus 189 l~g~~Pf~~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 189 MCGRLPFYNQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HhCCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 9999999887766555444321 11 12335789999999999999999998
Q ss_pred ----CHHHHhccCchhhhhh
Q psy10212 418 ----SPLQVRSITPFLIELR 433 (444)
Q Consensus 418 ----s~~elL~~hpwf~~~~ 433 (444)
++.++++ ||||....
T Consensus 240 ~~~~~~~~~l~-h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVME-HRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHc-CCCcCCCC
Confidence 8999999 99998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.70 Aligned_cols=254 Identities=31% Similarity=0.431 Sum_probs=209.9
Q ss_pred ccccchhheecccceeEEEEeEecCCCce-eeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGEL-VAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.....+...||.|+||+||+|.. .|+. +|+|++... .+.+.+|+.+|++|+|||||++++.+.+...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 45566777799999999999999 4666 999999543 3478899999999999999999999977641
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 114 -------------------------------------------------------------------------------- 113 (362)
T KOG0192|consen 114 -------------------------------------------------------------------------------- 113 (362)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+.|||||++ |+|..++... ....++...+..|+.|
T Consensus 114 -----------------------------------------~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~ald 150 (362)
T KOG0192|consen 114 -----------------------------------------SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALD 150 (362)
T ss_pred -----------------------------------------ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHH
Confidence 2889999999 5888887542 5788999999999999
Q ss_pred HHHHHHHHHHCC-cccCCCCCCcEEEcCCCC-eEEEeecCCcccccCC-CCCccccccccccCchhhcc-CCCCCcchhh
Q psy10212 253 LFRSLAYIHVLG-ICHRDIKPQNLLLNPETG-VLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG-AIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~g-ivH~dLkp~NIll~~~~~-~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~s~~sDi 328 (444)
|+.||.|||+++ |+|+|||++|||++ ... ++||+|||+++..... .......||..|||||++.+ ...++.++|+
T Consensus 151 iArGm~YLH~~~~iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dv 229 (362)
T KOG0192|consen 151 IARGMEYLHSEGPIIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDV 229 (362)
T ss_pred HHHHHHHHhcCCCeeecccChhhEEEc-CCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchh
Confidence 999999999999 99999999999999 665 9999999999776544 33344688999999999984 2389999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+|+++|||+||+.||.+.........++... .+..++..+++.+.+++.+|
T Consensus 230 ySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~---------------------------~Rp~~p~~~~~~l~~l~~~C 282 (362)
T KOG0192|consen 230 YSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG---------------------------LRPPIPKECPPHLSSLMERC 282 (362)
T ss_pred hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC---------------------------CCCCCCccCCHHHHHHHHHh
Confidence 999999999999999999988855555444311 11122334799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|..||.+||+..+++. -++.+..
T Consensus 283 W~~dp~~RP~f~ei~~---~l~~~~~ 305 (362)
T KOG0192|consen 283 WLVDPSRRPSFLEIVS---RLESIMS 305 (362)
T ss_pred CCCCCCcCCCHHHHHH---HHHHHHH
Confidence 9999999999999988 5554433
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=321.06 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=207.8
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.|++.+.||+|+||+||++.+..+++.||+|++.... ..+.+|+.++++++||||+++.+.+....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD------- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-------
Confidence 4889999999999999999999899999999985421 33557999999999999999988776543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (285)
T cd05605 74 -------------------------------------------------------------------------------- 73 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
++++|||||++ +|.+.+.. .....+++..+..++.|++
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~ 112 (285)
T cd05605 74 ---------------------------------------ALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEIT 112 (285)
T ss_pred ---------------------------------------eEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHH
Confidence 38999999985 77777643 2335689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||.|||+.|++|+||+|+||+++ +++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 113 ~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~ 190 (285)
T cd05605 113 CGLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCL 190 (285)
T ss_pred HHHHHHHHCCcEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHH
Confidence 999999999999999999999999 7889999999998765433333345678999999999876 78999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+.......+...+.. ....++..+++.+.+||.+||+.||.
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05605 191 IYEMIEGKSPFRQRKEKVKREEVERRVKE-------------------------DQEEYSEKFSEAARSICRQLLTKDPG 245 (285)
T ss_pred HHHHHHCCCCCCCCchhhHHHHHHHHhhh-------------------------cccccCcccCHHHHHHHHHHccCCHH
Confidence 99999999999876654443333321100 00112234689999999999999999
Q ss_pred CCC-----CHHHHhccCchhhhh
Q psy10212 415 SRI-----SPLQVRSITPFLIEL 432 (444)
Q Consensus 415 kRP-----s~~elL~~hpwf~~~ 432 (444)
+|| ++.++++ ||||.+.
T Consensus 246 ~R~~~~~~~~~~l~~-~~~~~~~ 267 (285)
T cd05605 246 FRLGCRGEGAEEVKA-HPFFRTA 267 (285)
T ss_pred HhcCCCCCCHHHHhc-CcCccCC
Confidence 999 8999999 9999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=330.34 Aligned_cols=243 Identities=25% Similarity=0.428 Sum_probs=201.5
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||.||+++++.+|+.||+|++... ...+.+|++++++++||||+++.+.+...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------------ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD------------ 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC------------
Confidence 4699999999999999999999999998543 134557999999999999999988876654
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (328)
T cd05593 69 -------------------------------------------------------------------------------- 68 (328)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.+++|||||++ +|.+++. ....+++..++.++.||+.||+|
T Consensus 69 ----------------------------------~~~lv~Ey~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~ 110 (328)
T cd05593 69 ----------------------------------RLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDY 110 (328)
T ss_pred ----------------------------------EEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Confidence 38999999985 7877764 34578999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus 111 LH~~~ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el 188 (328)
T cd05593 111 LHSGKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEM 188 (328)
T ss_pred HHhCCeEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHH
Confidence 9999999999999999999 7889999999998653221 222344689999999999877 789999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC-
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI- 417 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP- 417 (444)
++|+.||.+.+..+....+.. ... .++..+++++.+||.+||+.||.+|+
T Consensus 189 ltG~~Pf~~~~~~~~~~~~~~-----------------~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 189 MCGRLPFYNQDHEKLFELILM-----------------EDI------------KFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred hhCCCCCCCCCHHHHHHHhcc-----------------CCc------------cCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999987765554433321 011 12345689999999999999999997
Q ss_pred ----CHHHHhccCchhhhh
Q psy10212 418 ----SPLQVRSITPFLIEL 432 (444)
Q Consensus 418 ----s~~elL~~hpwf~~~ 432 (444)
++.++++ ||||...
T Consensus 240 ~~~~~~~~il~-h~~~~~~ 257 (328)
T cd05593 240 GGPDDAKEIMR-HSFFTGV 257 (328)
T ss_pred CCCCCHHHHhc-CCCcCCC
Confidence 8999999 9999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=328.33 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=203.4
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHH---hhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQI---MRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~---l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
|++++.||+|+||.||+|+++.+|+.||||++.... ..+.+|+++ +++++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence 678999999999999999999999999999985431 233455544 45678999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (324)
T cd05589 76 -------------------------------------------------------------------------------- 75 (324)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||++ +|...+. ...+++..++.++.|
T Consensus 76 -----------------------------------------~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~q 109 (324)
T cd05589 76 -----------------------------------------HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAAC 109 (324)
T ss_pred -----------------------------------------EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHH
Confidence 38999999996 6666553 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||+|||++|++|+||+|+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||
T Consensus 110 i~~al~~lH~~~ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Diwsl 187 (324)
T cd05589 110 VVLGLQYLHENKIVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGL 187 (324)
T ss_pred HHHHHHHHHhCCeEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhH
Confidence 99999999999999999999999999 788999999998764322 2223345689999999999877 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+....+... .. .++..+++.+.++|.+||+.
T Consensus 188 G~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 188 GVLIYEMLVGESPFPGDDEEEVFDSIVND-----------------EV------------RYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCCCCCHHHHHHHHHHhhc
Confidence 99999999999999988776665554431 00 12335689999999999999
Q ss_pred CCCCCC-----CHHHHhccCchhhhhh
Q psy10212 412 TPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
||.+|| ++.++++ ||||+++.
T Consensus 239 dP~~R~~~~~~~~~~l~~-~~~f~~~~ 264 (324)
T cd05589 239 NPERRLGSGEKDAEDVKK-QPFFRDIN 264 (324)
T ss_pred CHhHcCCCCCCCHHHHhh-CCCcCCCC
Confidence 999999 6899999 99998854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=336.03 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=207.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|+++++||+|+||+||+|+++.+++.||+|++... ...+.+|++++++++|+||+++++.+....
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~------ 74 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD------ 74 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC------
Confidence 3689999999999999999999999999999998543 235668999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (382)
T cd05625 75 -------------------------------------------------------------------------------- 74 (382)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++.+ .+.+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi 110 (382)
T cd05625 75 ----------------------------------------NLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAEL 110 (382)
T ss_pred ----------------------------------------EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHH
Confidence 38999999985 88888753 3568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----------------------------------- 298 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~----------------------------------- 298 (444)
+.||+|||++||+||||||+||+++ .++.++|+|||++......
T Consensus 111 ~~al~~lH~~~ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (382)
T cd05625 111 TCAVESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189 (382)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999 7889999999986422100
Q ss_pred -------------CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCC
Q psy10212 299 -------------EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365 (444)
Q Consensus 299 -------------~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~ 365 (444)
.......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+...++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 265 (382)
T cd05625 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT--- 265 (382)
T ss_pred cchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---
Confidence 001123578999999999877 789999999999999999999999998877665555543110
Q ss_pred HHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhhh
Q psy10212 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELRA 434 (444)
Q Consensus 366 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~~ 434 (444)
...+|. ...+++++.++|.+|+ .||.+|++ +.++++ ||||+.+..
T Consensus 266 ------------~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~-hp~f~~~~~ 313 (382)
T cd05625 266 ------------SLHIPP----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA-HPFFKTIDF 313 (382)
T ss_pred ------------CcCCCC----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc-CCCcCCcCh
Confidence 001111 1246899999999986 59999998 999999 999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=319.15 Aligned_cols=276 Identities=36% Similarity=0.621 Sum_probs=219.3
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++++.||.|++|.||+|++..+|+.||||++..+. ..+.+|++++++++||||+++.+++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-------- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--------
Confidence 4889999999999999999999999999999885432 34668999999999999999988876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (284)
T cd07860 73 -------------------------------------------------------------------------------- 72 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+.++|.+++.. .....+++..++.++.|++.|
T Consensus 73 --------------------------------------~~~~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~ 112 (284)
T cd07860 73 --------------------------------------KLYLVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQG 112 (284)
T ss_pred --------------------------------------cEEEEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHH
Confidence 3899999999998888753 234568999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||+++++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+...++.++|+||||+++
T Consensus 113 l~~lh~~~i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 191 (284)
T cd07860 113 LAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 191 (284)
T ss_pred HHHHHHCCeecCCCCHHHEEEC-CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999 788999999999865432221 12234577899999887654568899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC-CCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++|+.||.+.+..+...++.+..+.+....++....- .....++......... ..+.+++.+.++|.+||+.||.
T Consensus 192 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~ 270 (284)
T cd07860 192 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPN 270 (284)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcc
Confidence 9999999999998888888888888777765444321100 0001122211111111 1235789999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++|+ ||||
T Consensus 271 ~Rpt~~~~l~-~~~f 284 (284)
T cd07860 271 KRISAKAALA-HPFF 284 (284)
T ss_pred cCCCHHHHhc-CCCC
Confidence 9999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.89 Aligned_cols=277 Identities=32% Similarity=0.609 Sum_probs=215.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||.||+|+++.+|+.||+|++.... ..+.+|++++++++|+||+++.+++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR------- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-------
Confidence 47999999999999999999999999999999885332 33568999999999999999999887654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (286)
T cd07847 74 -------------------------------------------------------------------------------- 73 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+++++++.+. .....+++..++.++.||+.
T Consensus 74 ---------------------------------------~~~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~ 111 (286)
T cd07847 74 ---------------------------------------KLHLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQ 111 (286)
T ss_pred ---------------------------------------EEEEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHH
Confidence 388999999987666553 23456899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++|++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|++
T Consensus 112 ~l~~LH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i 190 (286)
T cd07847 112 AVNFCHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCV 190 (286)
T ss_pred HHHHHHHCCceecCCChhhEEEc-CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHH
Confidence 99999999999999999999999 78899999999987654433 22234567889999998765468899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+|+|++|..||.+.+..+....+....+............ .......+......-....-..++..+.+||.+||+.|
T Consensus 191 ~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07847 191 FAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMD 270 (286)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCC
Confidence 9999999999998887777777666655544322111100 00111111111100001111346899999999999999
Q ss_pred CCCCCCHHHHhccCchh
Q psy10212 413 PSSRISPLQVRSITPFL 429 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf 429 (444)
|++||++.|++. ||||
T Consensus 271 p~~Rp~~~eil~-~~~f 286 (286)
T cd07847 271 PTERLSCEELLE-HPYF 286 (286)
T ss_pred ccccCCHHHHhc-CCCC
Confidence 999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=328.18 Aligned_cols=245 Identities=29% Similarity=0.475 Sum_probs=202.8
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||+||+|+++.+++.||+|++... ...+.+|+.++..+ +||||+++++++...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----------- 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----------- 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----------
Confidence 4799999999999999999999999998543 13344688888776 6999999998886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (320)
T cd05590 70 -------------------------------------------------------------------------------- 69 (320)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|.+++. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~iv~Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~ 110 (320)
T cd05590 70 -----------------------------------RLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALM 110 (320)
T ss_pred -----------------------------------EEEEEEcCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877764 3457999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........|++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 188 (320)
T cd05590 111 FLHDKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYE 188 (320)
T ss_pred HHHHCCeEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHH
Confidence 99999999999999999999 788999999999865322 2223345689999999999876 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... .. .++..++.++.++|.+||+.||.+||
T Consensus 189 l~~g~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 189 MLCGHAPFEAENEDDLFEAILND-----------------EV------------VYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred HhhCCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999988776666555431 01 11234689999999999999999999
Q ss_pred CH------HHHhccCchhhhhhh
Q psy10212 418 SP------LQVRSITPFLIELRA 434 (444)
Q Consensus 418 s~------~elL~~hpwf~~~~~ 434 (444)
++ .++++ ||||+.+..
T Consensus 240 ~~~~~~~~~~~~~-h~~f~~~~~ 261 (320)
T cd05590 240 GSLTLGGEEAILR-HPFFKELDW 261 (320)
T ss_pred CCCCCCCHHHHHc-CCCcCCCCH
Confidence 98 89999 999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.88 Aligned_cols=286 Identities=32% Similarity=0.571 Sum_probs=221.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++++. |+||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~---- 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN---- 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC----
Confidence 47999999999999999999999999999999885432 34567999999995 69999998888654320
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (295)
T cd07837 77 -------------------------------------------------------------------------------- 76 (295)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhc-CCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKS-KQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~-~~~l~~~~i~~i~~QI 253 (444)
.....|+|||||+++|.+++...... ...+++..++.++.||
T Consensus 77 -------------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi 119 (295)
T cd07837 77 -------------------------------------GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119 (295)
T ss_pred -------------------------------------CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHH
Confidence 00248899999999999988644332 4578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++|++|+||+|+||+++..++.++|+|||.+....... ......+++.|+|||.+.+...++.++|+||||
T Consensus 120 ~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 199 (295)
T cd07837 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199 (295)
T ss_pred HHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHH
Confidence 9999999999999999999999999448899999999886543221 122234578899999887654678999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|..||.+.+..+...++...++.+....+...........++....... ....+.+++.+.++|.+||..|
T Consensus 200 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~ 278 (295)
T cd07837 200 CIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYD 278 (295)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCC
Confidence 999999999999999888888888877776665544432211111111111111111 1122357899999999999999
Q ss_pred CCCCCCHHHHhccCchhh
Q psy10212 413 PSSRISPLQVRSITPFLI 430 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~ 430 (444)
|.+||++.|+|. ||||+
T Consensus 279 P~~R~~~~eil~-~~~~~ 295 (295)
T cd07837 279 PAKRISAKAALT-HPYFD 295 (295)
T ss_pred hhhcCCHHHHhc-CCCcC
Confidence 999999999999 99985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.58 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=217.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.++++||+|+||.|+++..+.+++.||||.+.++. +-.+.|.+++... +||.++.++..|..++
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~----- 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE----- 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-----
Confidence 67999999999999999999999999999999985542 3444677777766 5999999999997765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 443 -------------------------------------------------------------------------------- 442 (694)
T KOG0694|consen 443 -------------------------------------------------------------------------------- 442 (694)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+||||+.|+....+ ...+.+++..++.++..|
T Consensus 443 -----------------------------------------~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev 477 (694)
T KOG0694|consen 443 -----------------------------------------HLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEV 477 (694)
T ss_pred -----------------------------------------eEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHH
Confidence 49999999998642221 345789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++||++||||.+|||+| ..|.+||+|||+++..- .+....+.+||+.|+|||++.+. .|+.+.|.||||
T Consensus 478 ~l~L~fLH~~~IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lG 555 (694)
T KOG0694|consen 478 VLGLQFLHENGIIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLG 555 (694)
T ss_pred HHHHHHHHhcCceeeecchhheEEc-ccCcEEecccccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHH
Confidence 9999999999999999999999999 89999999999997654 55667788999999999999998 899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|+||+|+.|+.||.+.+.++....|+. ++..+ |..+|.+..+++.++|..|
T Consensus 556 VLlyeML~Gq~PF~gddEee~FdsI~~-----------------d~~~y------------P~~ls~ea~~il~~ll~k~ 606 (694)
T KOG0694|consen 556 VLLYEMLVGESPFPGDDEEEVFDSIVN-----------------DEVRY------------PRFLSKEAIAIMRRLLRKN 606 (694)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHhc-----------------CCCCC------------CCcccHHHHHHHHHHhccC
Confidence 999999999999999999888888776 22222 3467999999999999999
Q ss_pred CCCCCCH----HHHhccCchhhhhhh
Q psy10212 413 PSSRISP----LQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~----~elL~~hpwf~~~~~ 434 (444)
|++|..+ ++.++.||||+.+..
T Consensus 607 p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 607 PEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred cccccCCCCCCchhhhhCCccccCCH
Confidence 9999997 555555999999754
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.78 Aligned_cols=276 Identities=34% Similarity=0.627 Sum_probs=223.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+|++.+.||.|++|.||+|++..+|+.||||++... ...+.+|+.++++++|+||+++.+++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK-------- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc--------
Confidence 588999999999999999999999999999998543 2345579999999999999999999887653
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (284)
T cd07836 73 -------------------------------------------------------------------------------- 72 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++||||++++|.+++.... ...++++..+..++.||+.||
T Consensus 73 --------------------------------------~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l 113 (284)
T cd07836 73 --------------------------------------LMLVFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGI 113 (284)
T ss_pred --------------------------------------EEEEEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHH
Confidence 88999999999998885422 235689999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
+|||++|++|+||+|+||+++ +++.++|+|||.+....... ......++..|++||.+.+...++.++|+||||+++|
T Consensus 114 ~~lH~~~i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~ 192 (284)
T cd07836 114 AFCHENRVLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMA 192 (284)
T ss_pred HHHHHCCeeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999 78899999999986543221 1223345788999999876546789999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc--ccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE--FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|++|+.||.+.+..+...++.+..+.+....+..+. .... ..++....... ..+.+.+++.+.++|.+||+.||.
T Consensus 193 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~ 270 (284)
T cd07836 193 EMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPE 270 (284)
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcc
Confidence 9999999999998888888888888777776665443 1111 11111111111 122235689999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.++++ ||||
T Consensus 271 ~R~~~~~~l~-~~~f 284 (284)
T cd07836 271 LRISAHDALQ-HPWF 284 (284)
T ss_pred cCCCHHHHhc-CCCC
Confidence 9999999999 9998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.23 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=206.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.|++++.||+|+||+||+|+++.+++.||||++... ...+.+|++++++++|+||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~------ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD------ 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC------
Confidence 4699999999999999999999999999999998432 234568999999999999999998887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (376)
T cd05598 75 -------------------------------------------------------------------------------- 74 (376)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||+ ++|.+++.. .+.+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi 110 (376)
T cd05598 75 ----------------------------------------NLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAEL 110 (376)
T ss_pred ----------------------------------------EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHH
Confidence 4899999998 588888753 4568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----------------------------------- 298 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~----------------------------------- 298 (444)
+.||+|||++||+||||||+||+++ ..+.++|+|||++......
T Consensus 111 ~~al~~lH~~~ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (376)
T cd05598 111 TCAIESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189 (376)
T ss_pred HHHHHHHHHCCeEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchh
Confidence 9999999999999999999999999 7889999999986422100
Q ss_pred ---------CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHH
Q psy10212 299 ---------EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369 (444)
Q Consensus 299 ---------~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~ 369 (444)
.......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.....
T Consensus 190 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------- 261 (376)
T cd05598 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET------- 261 (376)
T ss_pred hhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc-------
Confidence 001123689999999999877 789999999999999999999999998876665544432100
Q ss_pred HhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC---CHHHHhccCchhhhhh
Q psy10212 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI---SPLQVRSITPFLIELR 433 (444)
Q Consensus 370 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP---s~~elL~~hpwf~~~~ 433 (444)
...++ ....+++.+.++|.+|+ .+|.+|+ ++.++++ ||||+.+.
T Consensus 262 --------~~~~~----------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~-h~~~~~~~ 308 (376)
T cd05598 262 --------TLHIP----------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA-HPFFKGID 308 (376)
T ss_pred --------cccCC----------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC-CCCcCCCC
Confidence 00011 01246899999999977 5999999 9999999 99998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=326.98 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=204.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCC-ceeEeeeEEeecCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHS-NIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~ 94 (444)
+|++++.||+|+||.||+|+++.+++.||+|++... ...+..|++++..+.|+ +|+++.+++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD------ 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Confidence 488999999999999999999999999999998542 23455788889888764 5788877776543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (324)
T cd05587 75 -------------------------------------------------------------------------------- 74 (324)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi 110 (324)
T cd05587 75 ----------------------------------------RLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEI 110 (324)
T ss_pred ----------------------------------------EEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHH
Confidence 38999999985 8877774 34568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++|+||||+||+++ .++.++|+|||++..... ........|++.|+|||.+.+. .++.++|+||+|
T Consensus 111 ~~al~~lH~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 188 (324)
T cd05587 111 AIGLFFLHSKGIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFG 188 (324)
T ss_pred HHHHHHHHHCCeEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhH
Confidence 9999999999999999999999999 788999999998864321 2223345689999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+... .. .++..+++.+.++|.+||..|
T Consensus 189 vil~elltG~~pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 189 VLLYEMLAGQPPFDGEDEDELFQSIMEH-----------------NV------------SYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999988776666555431 01 122346899999999999999
Q ss_pred CCCCCCH-----HHHhccCchhhhhh
Q psy10212 413 PSSRISP-----LQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~-----~elL~~hpwf~~~~ 433 (444)
|.+|++. .++++ ||||+.+.
T Consensus 240 P~~R~~~~~~~~~~~~~-hp~~~~~~ 264 (324)
T cd05587 240 PAKRLGCGPTGERDIRE-HAFFRRID 264 (324)
T ss_pred HHHcCCCCCCCHHHHhc-CCCcCCCC
Confidence 9999986 78999 99998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.58 Aligned_cols=281 Identities=33% Similarity=0.609 Sum_probs=217.2
Q ss_pred ccchhheecccceeEEEEeEecC--CCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLD--SGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|++.+.||+|+||.||+|+++. +++.||+|.+.... ....+|+.++++++||||+++.+++.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 76 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---- 76 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC----
Confidence 58899999999999999999988 89999999996532 345579999999999999999999876532
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (316)
T cd07842 77 -------------------------------------------------------------------------------- 76 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcC-CCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSK-QNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~-~~l~~~~i~~i~~Q 252 (444)
..+++|||||++++.+++....... ..+++..++.++.|
T Consensus 77 ----------------------------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~q 116 (316)
T cd07842 77 ----------------------------------------KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116 (316)
T ss_pred ----------------------------------------ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHH
Confidence 2489999999999998886544433 37899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCC----CCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCc
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPE----TGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~----~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
|+.||+|||+++++|+||+|+||+++ . .+.++|+|||++........ .....++..|+|||.+.+...++.
T Consensus 117 i~~~l~~lH~~~i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (316)
T cd07842 117 ILNGVHYLHSNWVLHRDLKPANILVM-GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTK 195 (316)
T ss_pred HHHHHHHHHhCCEeeCCCCHHHEEEc-CCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCc
Confidence 99999999999999999999999998 6 78999999999875433221 223356788999998877546889
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChh---------HHHHHHHHHhCCCCHHHHHhhC--CCCCc----ccCCCccCCCC
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGV---------DQLVEIIKVLGTPTREQIREMN--PNYTE----FKFPQIKSHPW 389 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~---------e~~~~i~~~~g~~~~~~~~~~~--~~~~~----~~~p~~~~~~~ 389 (444)
++|+||||+++++|++|+.||.+.... ..+..++..++.+.+..+.... +.+.. ...........
T Consensus 196 ~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (316)
T cd07842 196 AIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSL 275 (316)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccH
Confidence 999999999999999999999865433 3455666666666555443221 11110 00000110111
Q ss_pred ccccc--CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 390 SKVFR--VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 390 ~~~~~--~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
...+. ...+..+.++|.+||+.||++|||+.|++. ||||
T Consensus 276 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~-~~~f 316 (316)
T cd07842 276 AKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE-HPYF 316 (316)
T ss_pred HHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc-CCCC
Confidence 11111 156889999999999999999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=331.97 Aligned_cols=275 Identities=23% Similarity=0.334 Sum_probs=207.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
...|++++.||+|+||.||+|++..+++.||+|... .....+|+.++++++|+||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ--KGTTLIEAMLLQNVNHPSVIRMKDTLVSGA------------ 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCC--ccccHHHHHHHHhCCCCCCcChhheEEeCC------------
Confidence 457999999999999999999999999999999753 233457999999999999999999887654
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 131 -------------------------------------------------------------------------------- 130 (357)
T PHA03209 131 -------------------------------------------------------------------------------- 130 (357)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL 260 (444)
+.++|||++.++|.+++.. ...++++..++.++.||+.||.||
T Consensus 131 ----------------------------------~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L 173 (357)
T PHA03209 131 ----------------------------------ITCMVLPHYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYL 173 (357)
T ss_pred ----------------------------------eeEEEEEccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3889999999999988753 456789999999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
|++|++||||||+||+++ ..+.++|+|||.+.............++..|+|||.+.+. .++.++|+|||||++|+|++
T Consensus 174 H~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 174 HAQRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred HHCCeecCCCCHHHEEEC-CCCCEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999 7889999999998654333333445689999999999877 78999999999999999997
Q ss_pred CC-CCCCCCCh---------hHHHHHHHHHhCCCCHHHH--------HhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 341 GQ-PMFPGDSG---------VDQLVEIIKVLGTPTREQI--------REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 341 G~-~Pf~~~~~---------~e~~~~i~~~~g~~~~~~~--------~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+. .+|..... ...+.++...++..+.... ............| ...+...-..+++.++.
T Consensus 252 ~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 328 (357)
T PHA03209 252 YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQP---YTRYPCFQRVNLPIDGE 328 (357)
T ss_pred cCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCc---ccccHHHhccCCCchHH
Confidence 54 44443221 1223333333332211100 0000000000000 00000011235688899
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+||.+||+.||.+|||+.|+|+ ||||+++
T Consensus 329 ~li~~mL~~dP~~Rpta~e~l~-hp~f~~~ 357 (357)
T PHA03209 329 FLVHKMLTFDAAMRPSAEEILN-YPMFAQL 357 (357)
T ss_pred HHHHHHHcCCcccCcCHHHHhc-CchhccC
Confidence 9999999999999999999999 9999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=334.51 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=205.0
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.|++++.||+|+||+||+|+++.+++.||||++.... ..+.+|++++++++|+||+++++.+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~------- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD------- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-------
Confidence 6899999999999999999999999999999995431 34568999999999999999999887654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (381)
T cd05626 75 -------------------------------------------------------------------------------- 74 (381)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||||++ +|.+++. ....+++..++.++.||+
T Consensus 75 ---------------------------------------~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~ 111 (381)
T cd05626 75 ---------------------------------------NLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELT 111 (381)
T ss_pred ---------------------------------------EEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHH
Confidence 49999999985 8888875 345689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----------------------------------
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----------------------------------- 299 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----------------------------------- 299 (444)
.||.|||++||+||||||+||+++ ..+.++|+|||++.......
T Consensus 112 ~aL~~LH~~givHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (381)
T cd05626 112 LAIESVHKMGFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190 (381)
T ss_pred HHHHHHHhCCeeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccc
Confidence 999999999999999999999999 78899999999864321000
Q ss_pred -------------CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCH
Q psy10212 300 -------------PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366 (444)
Q Consensus 300 -------------~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~ 366 (444)
......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---- 265 (381)
T cd05626 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---- 265 (381)
T ss_pred hhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc----
Confidence 01124689999999999876 789999999999999999999999988776665554443110
Q ss_pred HHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc--CCCCCCCHHHHhccCchhhhhhh
Q psy10212 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY--TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 367 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~--DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
...+|. ...+++++.+||.+|+.. +|..||++.++++ ||||+++..
T Consensus 266 -----------~~~~~~----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~-hp~f~~~~~ 313 (381)
T cd05626 266 -----------TLHIPP----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA-HPFFSEVDF 313 (381)
T ss_pred -----------ccCCCC----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc-CcccCCCCh
Confidence 001111 124689999999996654 5555999999999 999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.26 Aligned_cols=252 Identities=28% Similarity=0.515 Sum_probs=205.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.++++||+|+||+||+|+++.+|+.||||++.... ..+.+|++++++++||||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~------ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ------ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC------
Confidence 47899999999999999999999999999999985431 34567999999999999999998887653
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (377)
T cd05629 75 -------------------------------------------------------------------------------- 74 (377)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+|||||+ ++|.+++. ....+++..++.++.|+
T Consensus 75 ----------------------------------------~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql 110 (377)
T cd05629 75 ----------------------------------------YLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAEC 110 (377)
T ss_pred ----------------------------------------eeEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHH
Confidence 4999999997 58888875 34678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------------------------------- 300 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------------------------------- 300 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++........
T Consensus 111 ~~aL~~LH~~givHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (377)
T cd05629 111 VLAIEAVHKLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189 (377)
T ss_pred HHHHHHHHhCCeeccCCCHHHEEEC-CCCCEEEeeccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999 788999999998853211000
Q ss_pred ---------------CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCC
Q psy10212 301 ---------------NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365 (444)
Q Consensus 301 ---------------~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~ 365 (444)
.....||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---- 264 (377)
T cd05629 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---- 264 (377)
T ss_pred chhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC----
Confidence 0023588999999999877 78999999999999999999999998877766655554310
Q ss_pred HHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC---CCHHHHhccCchhhhh
Q psy10212 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR---ISPLQVRSITPFLIEL 432 (444)
Q Consensus 366 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR---Ps~~elL~~hpwf~~~ 432 (444)
....+|. ...++.++.+||.+||. +|.+| +++.|++. ||||+..
T Consensus 265 -----------~~~~~p~----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~-hp~~~~~ 311 (377)
T cd05629 265 -----------ETLYFPD----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS-HPFFRGV 311 (377)
T ss_pred -----------CccCCCC----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc-CCCcCCC
Confidence 0111111 12368999999999998 77775 59999999 9999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=329.51 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=209.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.+.+.||+|+||+||+|+++.+|+.||+|++... ...+.+|+.+++.++|+||+++.+.+....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~------ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD------ 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC------
Confidence 4799999999999999999999999999999998543 235668999999999999999988876643
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (330)
T cd05601 75 -------------------------------------------------------------------------------- 74 (330)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||+ ++|.+++.. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi 111 (330)
T cd05601 75 ----------------------------------------NLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAEL 111 (330)
T ss_pred ----------------------------------------eEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHH
Confidence 3899999997 588888753 34579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc-----CCCCCcch
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG-----AIDYTTKI 326 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~-----~~~~s~~s 326 (444)
+.||.|||+++++||||+|+||+++ ..+.++|+|||++........ .....+++.|+|||.+.. ...++.++
T Consensus 112 ~~aL~~lH~~~i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 190 (330)
T cd05601 112 VLAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190 (330)
T ss_pred HHHHHHHHHCCeEcccCchHheEEC-CCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcc
Confidence 9999999999999999999999999 789999999999876533322 122357899999999863 23678999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+|||||++|+|++|+.||...+......++.... ....+|. ...+++.+.+||.
T Consensus 191 DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~~~~~~~li~ 245 (330)
T cd05601 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ---------------RFLKFPE----------DPKVSSDFLDLIQ 245 (330)
T ss_pred eeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHH
Confidence 99999999999999999998877766655554310 0011111 1246899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||+ ||.+|||+.+++. ||||+.+.
T Consensus 246 ~ll~-~p~~R~t~~~l~~-h~~~~~~~ 270 (330)
T cd05601 246 SLLC-GQKERLGYEGLCC-HPFFSKID 270 (330)
T ss_pred HHcc-ChhhCCCHHHHhC-CCCcCCCC
Confidence 9998 9999999999999 99998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.80 Aligned_cols=280 Identities=37% Similarity=0.614 Sum_probs=222.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+|++++++++|+||+++.+++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence 5888999999999999999999999999999995432 23457999999999999999998887643
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (298)
T cd07841 76 -------------------------------------------------------------------------------- 75 (298)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++||||+.++|.+++.. ....+++..++.++.||
T Consensus 76 -----------------------------------------~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi 111 (298)
T cd07841 76 -----------------------------------------NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMT 111 (298)
T ss_pred -----------------------------------------EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHH
Confidence 4899999998899998853 22479999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
++||+|||++|++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|
T Consensus 112 ~~al~~lH~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 190 (298)
T cd07841 112 LRGLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190 (298)
T ss_pred HHHHHHHHhCCeeecCCChhhEEEc-CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHH
Confidence 9999999999999999999999999 78999999999987654332 222334577899999986654688999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|.+||.+.++.+...++....+.+....+.................... .....+.+..+.++|.+||++|
T Consensus 191 ~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 269 (298)
T cd07841 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLN 269 (298)
T ss_pred HHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcch-hhhcccccHHHHHHHHHHhcCC
Confidence 999999999999998888888888877777666555443211100000000001111 1122456889999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++|||+.|+|+ |+||++-..
T Consensus 270 P~~R~s~~e~l~-~~~~~~~~~ 290 (298)
T cd07841 270 PNKRITARQALE-HPYFSNDPA 290 (298)
T ss_pred cccCcCHHHHhh-CccccCCCC
Confidence 999999999999 999998544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=328.38 Aligned_cols=244 Identities=25% Similarity=0.438 Sum_probs=201.7
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||+||+|++..+|+.||+|++... ...+.+|++++++++||||+++.+.+...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~------------ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD------------ 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC------------
Confidence 4699999999999999999999999998542 133457899999999999999988876654
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (325)
T cd05594 69 -------------------------------------------------------------------------------- 68 (325)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.+++|||||++ +|..++. ....+++..++.++.||+.||+|
T Consensus 69 ----------------------------------~~~lv~E~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~ 110 (325)
T cd05594 69 ----------------------------------RLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDY 110 (325)
T ss_pred ----------------------------------EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Confidence 38999999985 7776664 34578999999999999999999
Q ss_pred HHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 260 IHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 260 LHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
||+ +|++|+||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 lH~~~~ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 188 (325)
T cd05594 111 LHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYE 188 (325)
T ss_pred HHhcCCEEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC-CCCCccccccccceeee
Confidence 997 7999999999999999 788999999999865322 2222345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... .. .++..+++++.++|.+||+.||++|+
T Consensus 189 l~tG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 189 MMCGRLPFYNQDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred eccCCCCCCCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 99999999887665544433320 11 12335689999999999999999997
Q ss_pred -----CHHHHhccCchhhhhh
Q psy10212 418 -----SPLQVRSITPFLIELR 433 (444)
Q Consensus 418 -----s~~elL~~hpwf~~~~ 433 (444)
++.++++ ||||+...
T Consensus 240 ~~~~~~~~~il~-h~~~~~~~ 259 (325)
T cd05594 240 GGGPDDAKEIMQ-HKFFAGIV 259 (325)
T ss_pred CCCCCCHHHHhc-CCCcCCCC
Confidence 8999999 99999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.28 Aligned_cols=284 Identities=30% Similarity=0.523 Sum_probs=224.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|++++.||+|+||.||+|++..+|+.||||.+... ...+.+|+.++++++|+||+++++++.......
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-- 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE-- 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc--
Confidence 568999999999999999999999999999999998432 234557999999999999999998886543200
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (353)
T cd07850 92 -------------------------------------------------------------------------------- 91 (353)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....|+|||||+++|.+.+.. .+++..++.++.||
T Consensus 92 --------------------------------------~~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql 127 (353)
T cd07850 92 --------------------------------------EFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQM 127 (353)
T ss_pred --------------------------------------ccCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHH
Confidence 0024789999999999988742 28899999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++|++|+||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. .++.++|+|||||
T Consensus 128 ~~aL~~LH~~gi~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 205 (353)
T cd07850 128 LCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 205 (353)
T ss_pred HHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHH
Confidence 9999999999999999999999999 7889999999999765443333344678889999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCccc--CCCccCCCCccc------------ccCCCCh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKSHPWSKV------------FRVRTPP 399 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~------------~~~~~s~ 399 (444)
++|+|++|+.||...+..+....+...++.+....+..+........ .+......+... .....++
T Consensus 206 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
T cd07850 206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS 285 (353)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchh
Confidence 99999999999999888888888888888877655444321111000 000000000000 0223577
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.++++|.+||+.||++|||+.|+|. ||||+..
T Consensus 286 ~~~~li~~~L~~dP~~R~t~~eiL~-~~~~~~~ 317 (353)
T cd07850 286 QARDLLSKMLVIDPEKRISVDDALQ-HPYINVW 317 (353)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc-ChhHhhc
Confidence 8999999999999999999999999 9999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=314.87 Aligned_cols=276 Identities=32% Similarity=0.630 Sum_probs=217.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||+|++|.||+|+++.+++.||||.+.... ..+.+|++++++++|+||+++.+++....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 76 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-------- 76 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--------
Confidence 67999999999999999999999999999999985432 34457999999999999999999886543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (291)
T cd07844 77 -------------------------------------------------------------------------------- 76 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.++||||++++|.+++.. ....+++..++.++.|++.|
T Consensus 77 --------------------------------------~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~a 115 (291)
T cd07844 77 --------------------------------------TLTLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRG 115 (291)
T ss_pred --------------------------------------eEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHH
Confidence 4899999999999988753 33478999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.|||+++++|+||+|+||+++ .++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++
T Consensus 116 l~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il 194 (291)
T cd07844 116 LAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIF 194 (291)
T ss_pred HHHHHhCCeecccCCHHHEEEc-CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHH
Confidence 9999999999999999999999 7889999999988543221 1122234577899999987654688999999999999
Q ss_pred HHHHhCCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccccCCCC--hhHHHHHHHhcc
Q psy10212 336 AELLLGQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTP--PDAIDLISRLLE 410 (444)
Q Consensus 336 ~eLltG~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~s--~~l~~LI~~~L~ 410 (444)
|+|++|+.||.+.. ..+....+.+.++.+.+..++..... +.....+..........+ ..++ ..+.++|.+||+
T Consensus 195 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~ 273 (291)
T cd07844 195 YEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQ 273 (291)
T ss_pred HHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhc
Confidence 99999999998765 56667777787777776665543211 111111111111111111 1233 889999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
.||.+|||+.++|. ||||
T Consensus 274 ~~p~~Rps~~e~l~-~~~f 291 (291)
T cd07844 274 YEPKKRISAAEAMK-HPYF 291 (291)
T ss_pred cCcccccCHHHHhc-CCCC
Confidence 99999999999999 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.10 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=210.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
-.++|+++++||+|+||+||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++.+++....
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~---- 116 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK---- 116 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 357899999999999999999999999999999998532 234568999999999999999998876543
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 117 -------------------------------------------------------------------------------- 116 (370)
T cd05596 117 -------------------------------------------------------------------------------- 116 (370)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
++|+|||||++ +|.+++.. ..+++..+..++.
T Consensus 117 ------------------------------------------~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~ 149 (370)
T cd05596 117 ------------------------------------------YLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTA 149 (370)
T ss_pred ------------------------------------------EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHH
Confidence 49999999984 78887742 3588999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccC---CCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGA---IDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~s~~s 326 (444)
||+.||+|||++|++||||||+||+++ .++.++|+|||.+....... ......|++.|+|||.+.+. ..++.++
T Consensus 150 qi~~aL~~LH~~~ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 228 (370)
T cd05596 150 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (370)
T ss_pred HHHHHHHHHHHCCeeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCce
Confidence 999999999999999999999999999 78999999999986653322 12345689999999998653 1478899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+|||||++|+|++|+.||.+.+......++..... ...+|. ...+|.++.+||.
T Consensus 229 DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~ 283 (370)
T cd05596 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---------------SLTFPD----------DIEISKQAKDLIC 283 (370)
T ss_pred eeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---------------cCCCCC----------cCCCCHHHHHHHH
Confidence 999999999999999999998877666655543110 011111 1246899999999
Q ss_pred HhcccCCCC--CCCHHHHhccCchhhhhhh
Q psy10212 407 RLLEYTPSS--RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 407 ~~L~~DP~k--RPs~~elL~~hpwf~~~~~ 434 (444)
+||+.+|.+ |+|+.++++ ||||++...
T Consensus 284 ~~L~~~p~r~~R~s~~ell~-h~~~~~~~~ 312 (370)
T cd05596 284 AFLTDREVRLGRNGVDEIKS-HPFFKNDQW 312 (370)
T ss_pred HHccChhhccCCCCHHHHhc-CcccCCCCh
Confidence 999999998 999999999 999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.20 Aligned_cols=243 Identities=26% Similarity=0.472 Sum_probs=202.3
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||.||+|+++.+++.||+|++.... ..+..|.+++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----------- 69 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----------- 69 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----------
Confidence 46999999999999999999999999985431 2344688888766 8999999999887654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (321)
T cd05591 70 -------------------------------------------------------------------------------- 69 (321)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~ 110 (321)
T cd05591 70 -----------------------------------RLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALM 110 (321)
T ss_pred -----------------------------------eEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877774 3457899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~LH~~~ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e 188 (321)
T cd05591 111 FLHRHGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYE 188 (321)
T ss_pred HHHHCCeeccCCCHHHeEEC-CCCCEEEeecccceecccCCccccccccCccccCHHHHcCC-CCCCccceechhHHHHH
Confidence 99999999999999999999 7889999999998653222 223345689999999999876 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... .. .++..+++++.++|.+||+.||++||
T Consensus 189 l~tg~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 189 MMAGQPPFEADNEDDLFESILHD-----------------DV------------LYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 99999999988877666555431 01 11234689999999999999999999
Q ss_pred -------CHHHHhccCchhhhh
Q psy10212 418 -------SPLQVRSITPFLIEL 432 (444)
Q Consensus 418 -------s~~elL~~hpwf~~~ 432 (444)
++.++++ ||||+.+
T Consensus 240 ~~~~~~~~~~~~~~-hp~~~~~ 260 (321)
T cd05591 240 GCVASQGGEDAIKQ-HPFFKEI 260 (321)
T ss_pred CCCCCCCCHHHHhc-CCccCCC
Confidence 8999999 9999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=327.16 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=202.3
Q ss_pred ccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
+|++++.||+|+||+||+|++. .+++.||+|++... .+.+.+|+.+++++ +|++|+++.+.+...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 4889999999999999999874 47899999998532 12355799999999 5999999988876554
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (332)
T cd05614 79 -------------------------------------------------------------------------------- 78 (332)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+++|||||++ +|.+++. ....+++..++.+
T Consensus 79 --------------------------------------------~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~ 110 (332)
T cd05614 79 --------------------------------------------KLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFY 110 (332)
T ss_pred --------------------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHH
Confidence 38999999985 8888874 3457899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+.||+.||.|||++|++||||||+||+++ .++.++|+|||++....... ......|++.|+|||.+.+...++.++|
T Consensus 111 ~~qi~~~l~~lH~~~ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 189 (332)
T cd05614 111 SGEIILALEHLHKLGIVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVD 189 (332)
T ss_pred HHHHHHHHHHHHHCCcEecCCCHHHeEEC-CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccc
Confidence 99999999999999999999999999999 78899999999987543322 2223468999999999987645788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|||||++|+|++|+.||...........+..... . ....++..+++.+.++|.+
T Consensus 190 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~-----------------~~~~~~~~~~~~~~~li~~ 244 (332)
T cd05614 190 WWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--------K-----------------CDPPFPSFIGPEAQDLLHK 244 (332)
T ss_pred cccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--------c-----------------CCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999975433222222211100 0 0011233568999999999
Q ss_pred hcccCCCCCC-----CHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
||+.||++|| +++++++ ||||++..
T Consensus 245 ~l~~dp~~R~~~~~~~~~~~l~-h~~~~~~~ 274 (332)
T cd05614 245 LLRKDPKKRLGAGPQGASEIKE-HPFFKGLD 274 (332)
T ss_pred HcCCCHHHcCCCCCCCHHHHHc-CCCcCCCC
Confidence 9999999999 7889999 99998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.18 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=225.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhc-CCCceeEeeeEE
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRL-EHSNIVKLKYFF 84 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (444)
..+.+.|+-.++||.|..+.|-++..+.+|+++|+|++.... +.-.+|+.+|+++ -||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 346678999999999999999999999999999999993221 2223799999998 699999999999
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
.++
T Consensus 93 es~----------------------------------------------------------------------------- 95 (411)
T KOG0599|consen 93 ESD----------------------------------------------------------------------------- 95 (411)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 775
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCCh
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPC 243 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~ 243 (444)
.|+|+|+|+|+ |.|.|++ ++...+++
T Consensus 96 -------------------------------------------------sF~FlVFdl~prGELFDyL----ts~VtlSE 122 (411)
T KOG0599|consen 96 -------------------------------------------------AFVFLVFDLMPRGELFDYL----TSKVTLSE 122 (411)
T ss_pred -------------------------------------------------chhhhhhhhcccchHHHHh----hhheeecH
Confidence 47999999999 6899988 46778999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc-----
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG----- 318 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~----- 318 (444)
..++.+++|+++|++|||.++|+||||||+||+++ ++-+++|+|||.++...++......+||++|+|||.+..
T Consensus 123 K~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~ 201 (411)
T KOG0599|consen 123 KETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYEN 201 (411)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccC
Confidence 99999999999999999999999999999999999 899999999999999999998999999999999999853
Q ss_pred CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 319 AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 319 ~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
...|+...|+||+|++||-|+.|-+||=.....-++.-|.++.-+. .+.+|. ++|
T Consensus 202 ~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF--------------------~speWa-----dis 256 (411)
T KOG0599|consen 202 HPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF--------------------RSPEWA-----DIS 256 (411)
T ss_pred CCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc--------------------CCcchh-----hcc
Confidence 2468999999999999999999999997666555555555532211 223333 348
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
...++||.+||++||.+|.|+.|+|. ||||..+-.+.+
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~La-Hpff~q~~~~~~ 294 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALA-HPFFIQIAQQQA 294 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhc-ChHHHHHHHhcc
Confidence 99999999999999999999999999 999988765544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.00 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=217.2
Q ss_pred ccccchhheecccceeEEEEeEecCC-Cceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDS-GELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
...|.+.+.||+|+||.||+|.+..+ ++.+|+|.+.... ..+.+|+.++++++||||+++++++...+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------- 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD------- 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-------
Confidence 34599999999999999999999877 7889999874332 34557999999999999999999987764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 139 -------------------------------------------------------------------------------- 138 (478)
T PTZ00267 139 -------------------------------------------------------------------------------- 138 (478)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+ ++|.+++........++++..+..++.||+
T Consensus 139 ---------------------------------------~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 179 (478)
T PTZ00267 139 ---------------------------------------KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV 179 (478)
T ss_pred ---------------------------------------EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHH
Confidence 3999999997 589888865555567899999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
.||.|||+++++||||||+||+++ ..+.++|+|||++....... ......||+.|+|||.+.+. .++.++|+|||
T Consensus 180 ~aL~~lH~~~ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~sl 257 (478)
T PTZ00267 180 LALDEVHSRKMMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSL 257 (478)
T ss_pred HHHHHHHhCCEEECCcCHHhEEEC-CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHH
Confidence 999999999999999999999999 78899999999997654332 12344689999999999876 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+....+..... ..++..++..+.++|.+||..
T Consensus 258 G~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~ 309 (478)
T PTZ00267 258 GVILYELLTLHRPFKGPSQREIMQQVLYGKY----------------------------DPFPCPVSSGMKALLDPLLSK 309 (478)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------------------CCCCccCCHHHHHHHHHHhcc
Confidence 9999999999999988776665554443100 011235689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
||++||++.++|. |+|++.+...++.
T Consensus 310 dP~~Rps~~~~l~-~~~~~~~~~~~~~ 335 (478)
T PTZ00267 310 NPALRPTTQQLLH-TEFLKYVANLFQD 335 (478)
T ss_pred ChhhCcCHHHHHh-CHHHHHHHHHHHH
Confidence 9999999999999 9999886655443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.83 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=205.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+|.+++.||+|+||.||+|+++.+++.||+|++.... .....|..++..+ +|++|+++.+++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD------ 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC------
Confidence 4889999999999999999999999999999985432 2344577777776 5899999888876654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (323)
T cd05616 75 -------------------------------------------------------------------------------- 74 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||+ ++|.+.+. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi 110 (323)
T cd05616 75 ----------------------------------------RLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEI 110 (323)
T ss_pred ----------------------------------------EEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHH
Confidence 3899999998 58887774 33568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++..... ........|++.|+|||.+.+. .++.++|+||||
T Consensus 111 ~~aL~~LH~~~ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG 188 (323)
T cd05616 111 AIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFG 188 (323)
T ss_pred HHHHHHHHHCCEEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchh
Confidence 9999999999999999999999999 788999999999865332 2223345689999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+... .. .++..+++++.++|.+||+.|
T Consensus 189 vil~elltg~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 189 VLLYEMLAGQAPFEGEDEDELFQSIMEH-----------------NV------------AYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCCcCCHHHHHHHHHHcccC
Confidence 9999999999999988776666555431 11 123356899999999999999
Q ss_pred CCCCCCH-----HHHhccCchhhhhh
Q psy10212 413 PSSRISP-----LQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~-----~elL~~hpwf~~~~ 433 (444)
|.+|++. .++++ ||||+.+.
T Consensus 240 p~~R~~~~~~~~~~i~~-h~~~~~~~ 264 (323)
T cd05616 240 PGKRLGCGPEGERDIKE-HAFFRYID 264 (323)
T ss_pred HHhcCCCCCCCHHHHhc-CCCcCCCC
Confidence 9999984 78999 99998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.05 Aligned_cols=244 Identities=29% Similarity=0.525 Sum_probs=201.7
Q ss_pred hheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 27 KTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++.||+|+||.||+|++. .+++.||+|.+... ...+.+|+.++++++||||+++++.+..++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~------- 73 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG------- 73 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-------
Confidence 468999999999999874 46889999998532 123457999999999999999998887654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (323)
T cd05584 74 -------------------------------------------------------------------------------- 73 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..|+|||||++ +|.+++. ....+++..++.++.||+
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~ 110 (323)
T cd05584 74 ---------------------------------------KLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEIS 110 (323)
T ss_pred ---------------------------------------eEEEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHH
Confidence 38999999985 8877774 345788999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+|||||
T Consensus 111 ~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 188 (323)
T cd05584 111 LALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGA 188 (323)
T ss_pred HHHHHHHHCCeecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHH
Confidence 999999999999999999999999 7889999999998643222 223345689999999999876 7889999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+.......+... . ..++..+++.+.++|.+||+.||
T Consensus 189 il~ell~G~~pf~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 189 LMYDMLTGAPPFTAENRKKTIDKILKG-----------------K------------LNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------C------------CCCCCCCCHHHHHHHHHHcccCH
Confidence 999999999999887766555544431 0 01233568999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~ 432 (444)
++|| ++.++++ ||||+..
T Consensus 240 ~~R~~~~~~~~~~l~~-h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQS-HPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhc-CCCcCCC
Confidence 9999 8999999 9999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.65 Aligned_cols=274 Identities=36% Similarity=0.646 Sum_probs=219.2
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++++.||.|++|.||+|.++.+|+.||+|++.... ..+.+|++++++++|+||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--------- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--------- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC---------
Confidence 688999999999999999999999999999985432 34668999999999999999998876543
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (283)
T cd07835 72 -------------------------------------------------------------------------------- 71 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++|||++++|.+++.... ...+++..++.++.|++.||
T Consensus 72 -------------------------------------~~~iv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L 112 (283)
T cd07835 72 -------------------------------------KLYLVFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGI 112 (283)
T ss_pred -------------------------------------eEEEEEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHH
Confidence 389999999999999885322 24689999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
+|||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|
T Consensus 113 ~~lH~~~~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 191 (283)
T cd07835 113 AYCHSHRVLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFA 191 (283)
T ss_pred HHHHHCCeeCCCCCHHHEEEc-CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHH
Confidence 999999999999999999999 68899999999986543221 1122345788999998876546789999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|++|+.||...++.+...++.+..+.+....+.... +++ ...++........ ....++++.+.++|.+||+.||.
T Consensus 192 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~ 269 (283)
T cd07835 192 EMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY-KPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPA 269 (283)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh-hhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChh
Confidence 9999999999988888888888877777665543321 010 0111111111111 12346789999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.|++. ||||
T Consensus 270 ~Rpt~~~il~-~~~~ 283 (283)
T cd07835 270 KRISAKAALQ-HPYF 283 (283)
T ss_pred hCcCHHHHhc-CCCC
Confidence 9999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.12 Aligned_cols=251 Identities=35% Similarity=0.562 Sum_probs=205.3
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeecccc------chhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR------FKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++++.||+|+||+||+++++.+++.||+|.+..... ...+|+.++++++||||+++.+++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--------- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS---------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc---------
Confidence 7899999999999999999999999999999965431 2235899999999999999999998754
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (260)
T PF00069_consen 72 -------------------------------------------------------------------------------- 71 (260)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||+|++ +|.+++. ....++...++.++.||+.|
T Consensus 72 -------------------------------------~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~ 110 (260)
T PF00069_consen 72 -------------------------------------YLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEA 110 (260)
T ss_dssp -------------------------------------EEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHH
T ss_pred -------------------------------------ccccccccccccccccccc----cccccccccccccccccccc
Confidence 48899999998 8998886 45778999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc-cCCCCCccccccccccCchhhc-cCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIF-GAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~-~~~~~s~~sDiwSLGvi 334 (444)
|.+||+++++|+||+|+||+++ .++.++|+|||.+... ..........++..|+|||.+. +. .++.++|+||||++
T Consensus 111 L~~Lh~~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~i 188 (260)
T PF00069_consen 111 LAYLHSKGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGK-KYTRKSDIWSLGII 188 (260)
T ss_dssp HHHHHHTTEEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTS-SBSTHHHHHHHHHH
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc-cccccccccccccc
Confidence 9999999999999999999999 8999999999998653 2223334456788999999988 44 88999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|..||......+....+.+............ ....+..+.++|.+||+.||+
T Consensus 189 l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~~p~ 246 (260)
T PF00069_consen 189 LYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ----------------------SREKSEELRDLIKKMLSKDPE 246 (260)
T ss_dssp HHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----------------------HTTSHHHHHHHHHHHSSSSGG
T ss_pred cccccccccccccccchhhhhhhhhcccccccccccc----------------------cchhHHHHHHHHHHHccCChh
Confidence 9999999999998744444443333221111111000 001137999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 247 ~R~~~~~l~~-~~~~ 260 (260)
T PF00069_consen 247 QRPSAEELLK-HPWF 260 (260)
T ss_dssp GSTTHHHHHT-SGGG
T ss_pred HCcCHHHHhc-CCCC
Confidence 9999999999 9998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=324.24 Aligned_cols=287 Identities=33% Similarity=0.597 Sum_probs=225.9
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.++|++.++||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++|+||+++++++...+..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 78 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE---- 78 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc----
Confidence 457899999999999999999999999999999998532 12345799999999999999998876544310
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (336)
T cd07849 79 -------------------------------------------------------------------------------- 78 (336)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.....++++||+++++.+.+. ..++++..++.++.|++
T Consensus 79 -------------------------------------~~~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~ 116 (336)
T cd07849 79 -------------------------------------SFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQIL 116 (336)
T ss_pred -------------------------------------ccceEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHH
Confidence 002488999999998887764 35799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||++||++|++|+||+|+||+++ ..+.++|+|||++........ .....++..|+|||.+.+...++.++|+||
T Consensus 117 ~aL~~LH~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 195 (336)
T cd07849 117 RGLKYIHSANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWS 195 (336)
T ss_pred HHHHHHHhCCeeccCCCHHHEEEC-CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHH
Confidence 999999999999999999999999 788999999999865433221 122456888999998766546889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|+++|+|++|+.||.+.+.......+...++.+....+.......... ..+......+. ...+++++.+.++|.+
T Consensus 196 lGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 274 (336)
T cd07849 196 VGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWN-KLFPNADPKALDLLDK 274 (336)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHH-HHhcccCcHHHHHHHH
Confidence 9999999999999999888888888888888887776654432111100 01111111111 1123468899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||+.||++|||+.|+++ ||||+.+...
T Consensus 275 ~l~~dP~~Rpt~~e~l~-hp~~~~~~~~ 301 (336)
T cd07849 275 MLTFNPHKRITVEEALA-HPYLEQYHDP 301 (336)
T ss_pred HcCCChhhCcCHHHHhc-CccccccCCC
Confidence 99999999999999999 9999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=322.91 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=202.0
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||+||+|+++.+++.||||++... ...+.+|++++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----------- 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----------- 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----------
Confidence 4799999999999999999999999998643 23445788888877 7999999999886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (318)
T cd05570 70 -------------------------------------------------------------------------------- 69 (318)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+++|||||++ +|...+. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~ 110 (318)
T cd05570 70 -----------------------------------RLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQ 110 (318)
T ss_pred -----------------------------------EEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7777764 3457999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++|+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~ 188 (318)
T cd05570 111 FLHERGIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYE 188 (318)
T ss_pred HHHhCCeEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHH
Confidence 99999999999999999999 7889999999988643222 222334678999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... .. .++..++..+.+||.+||+.||.+||
T Consensus 189 l~~G~~pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 189 MLAGQSPFEGDDEDELFQSILED-----------------EV------------RYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred HhhCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 99999999887766554443321 00 12234689999999999999999999
Q ss_pred CH-----HHHhccCchhhhhh
Q psy10212 418 SP-----LQVRSITPFLIELR 433 (444)
Q Consensus 418 s~-----~elL~~hpwf~~~~ 433 (444)
|+ .++++ ||||+...
T Consensus 240 s~~~~~~~~ll~-~~~~~~~~ 259 (318)
T cd05570 240 GCLPTGEQDIKG-HPFFREID 259 (318)
T ss_pred CCCCCCHHHHhc-CCCcCCCC
Confidence 99 99999 99998854
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=324.21 Aligned_cols=289 Identities=35% Similarity=0.603 Sum_probs=227.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|.+.+.||+|+||+||+|++..+++.||||.+... ...+.+|+.++++++|+||+++.+++......
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~--- 79 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE--- 79 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc---
Confidence 567899999999999999999999999999999988432 22345799999999999999998877643210
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (337)
T cd07858 80 -------------------------------------------------------------------------------- 79 (337)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....|+||||++++|.+++. ...++++..++.++.||
T Consensus 80 --------------------------------------~~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi 117 (337)
T cd07858 80 --------------------------------------AFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQL 117 (337)
T ss_pred --------------------------------------ccCcEEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHH
Confidence 002489999999999988875 34679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||+++++|+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+...++.++|+||||
T Consensus 118 ~~aL~~LH~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (337)
T cd07858 118 LRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG 196 (337)
T ss_pred HHHHHHHHhCCEecCCCCHHHEEEc-CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHH
Confidence 9999999999999999999999999 7889999999998765333 2223345688899999887643688999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
+++|+|++|+.||.+.+.......+....+.+.+..+......... ...+........ ...+.+++.+.++|.+||
T Consensus 197 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l 275 (337)
T cd07858 197 CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKML 275 (337)
T ss_pred HHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHh
Confidence 9999999999999988887888888888777766554321110000 001111111111 123467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.||++|||+.++|+ ||||+.++...
T Consensus 276 ~~~P~~Rps~~ell~-h~~~~~~~~~~ 301 (337)
T cd07858 276 VFDPSKRITVEEALA-HPYLASLHDPS 301 (337)
T ss_pred cCChhhccCHHHHHc-CcchhhhcCcc
Confidence 999999999999999 99999876554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.82 Aligned_cols=244 Identities=27% Similarity=0.492 Sum_probs=199.5
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHH-HhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQ-IMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||+||+|+++.+|+.||||++.... ..+.+|.. +++.++||||+++++.+...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----------- 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----------- 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----------
Confidence 47999999999999999999999999985431 12223433 567899999999988886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (323)
T cd05575 70 -------------------------------------------------------------------------------- 69 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++|||||++ +|..++. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~ 110 (323)
T cd05575 70 -----------------------------------KLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALG 110 (323)
T ss_pred -----------------------------------EEEEEEcCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877774 3457899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||+|+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~givH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e 188 (323)
T cd05575 111 YLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYE 188 (323)
T ss_pred HHHHCCeEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCC-CCCccccccccchhhhh
Confidence 99999999999999999999 788999999999865322 2223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... . ..+++.+++.+.++|.+||+.||.+||
T Consensus 189 ll~g~~pf~~~~~~~~~~~i~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 189 MLYGLPPFYSRDTAEMYDNILNK-----------------P------------LRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcC-----------------C------------CCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 99999999887766655544431 0 012235689999999999999999999
Q ss_pred CH----HHHhccCchhhhhh
Q psy10212 418 SP----LQVRSITPFLIELR 433 (444)
Q Consensus 418 s~----~elL~~hpwf~~~~ 433 (444)
++ .++++ ||||....
T Consensus 240 ~~~~~~~~il~-~~~~~~~~ 258 (323)
T cd05575 240 GAKDDFLEIKN-HVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHc-CCCcCCCC
Confidence 98 59999 99997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=322.02 Aligned_cols=292 Identities=33% Similarity=0.625 Sum_probs=233.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|++... ...+.+|+.+++++ +|+||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~- 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND- 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC-
Confidence 35778999999999999999999999989999999988432 23455799999999 99999999988765432
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (337)
T cd07852 82 -------------------------------------------------------------------------------- 81 (337)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..+++||||++++|.+++.. ..+.+..++.++
T Consensus 82 -------------------------------------------~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~ 113 (337)
T cd07852 82 -------------------------------------------KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIM 113 (337)
T ss_pred -------------------------------------------ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHH
Confidence 34899999999999888742 277888999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC------CCccccccccccCchhhccCCCCCc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE------PNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
.||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.
T Consensus 114 ~qi~~~L~~LH~~~i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (337)
T cd07852 114 YQLLKALKYIHSGNVIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTK 192 (337)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccc
Confidence 9999999999999999999999999999 78999999999987553322 1123356888999998866546889
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccC---CCccCCCCcccccCCCChhH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~~~~~~~s~~l 401 (444)
++|+||||+++|+|++|+.||.+.+..+...++....+.+....+..+......... +.......... .++++..+
T Consensus 193 ~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 271 (337)
T cd07852 193 GVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDA 271 (337)
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh-ccCCCHHH
Confidence 999999999999999999999998888888888888777776655544322111111 11111111122 23478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhcccc
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENICF 441 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~~~ 441 (444)
.++|.+||+.||++|||+.++++ ||||+.+....+...+
T Consensus 272 ~~li~~~l~~~P~~Rps~~~il~-~~~~~~~~~~~~~~~~ 310 (337)
T cd07852 272 LDLLKKLLVFNPNKRLTAEEALE-HPYVAQFHNPSDEPVL 310 (337)
T ss_pred HHHHHHhccCCcccccCHHHHhh-ChhhhhhccCCCCCCC
Confidence 99999999999999999999999 9999998776665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=324.78 Aligned_cols=290 Identities=34% Similarity=0.625 Sum_probs=231.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+..+|++.+.||+|+||.||+|+++.+|+.||+|++.... ..+.+|+.++++++||||+++.+++.....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 78 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA---- 78 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC----
Confidence 4588999999999999999999999999999999985432 234579999999999999998877654321
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (334)
T cd07855 79 -------------------------------------------------------------------------------- 78 (334)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
....+++||||++++|.+++. ....+++..++.++.||
T Consensus 79 --------------------------------------~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi 116 (334)
T cd07855 79 --------------------------------------DFKDVYVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQL 116 (334)
T ss_pred --------------------------------------CCceEEEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHH
Confidence 013489999999999888874 34569999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCCCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||+|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+...++.++|+
T Consensus 117 ~~aL~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 195 (334)
T cd07855 117 LRGLKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDM 195 (334)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEEc-CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccch
Confidence 9999999999999999999999999 789999999999865432221 1234678889999998664468899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
||+|+++|+|++|+.||.+.+....+..+....|.++...+......... ...+......+.. +.+.+++.+.++|
T Consensus 196 ~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 274 (334)
T cd07855 196 WSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLL 274 (334)
T ss_pred HHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHH
Confidence 99999999999999999998888888888888888877665543321110 0111112222221 2245689999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.+||+.||.+|||+.+++. ||||+.......+
T Consensus 275 ~~~l~~~P~~Rpt~~~~l~-~~~~~~~~~~~~~ 306 (334)
T cd07855 275 SQMLQFDPEERITVEQALQ-HPFLAQYHDPDDE 306 (334)
T ss_pred HHHccCChhhCcCHHHHHh-ChhhhhccCCccc
Confidence 9999999999999999999 9999988776643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.05 Aligned_cols=244 Identities=31% Similarity=0.528 Sum_probs=202.1
Q ss_pred hheecccceeEEEEeEec---CCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 27 KTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
++.||+|+||.||++++. .+|+.||+|++... .....+|++++++++||||+++++.+...+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 71 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--------- 71 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC---------
Confidence 468999999999999873 57899999998542 223457999999999999999998887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (318)
T cd05582 72 -------------------------------------------------------------------------------- 71 (318)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+|+|||||+ ++|.+++. ....+++..++.++.||+.|
T Consensus 72 -------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~ 110 (318)
T cd05582 72 -------------------------------------KLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALA 110 (318)
T ss_pred -------------------------------------EEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHH
Confidence 3899999998 58888774 34578999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||++|++|+||+|+||+++ .++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+|||||++
T Consensus 111 l~~lH~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il 188 (318)
T cd05582 111 LDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLM 188 (318)
T ss_pred HHHHHHCCEecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEe
Confidence 9999999999999999999999 7889999999998664333 223345678999999999876 788999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|+.||.+.+..+....+... .. .++..+++.+.++|.+||+.||.+
T Consensus 189 ~el~tg~~p~~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 189 FEMLTGSLPFQGKDRKETMTMILKA-----------------KL------------GMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcCHhH
Confidence 9999999999887766655544331 01 122346899999999999999999
Q ss_pred CCC-----HHHHhccCchhhhh
Q psy10212 416 RIS-----PLQVRSITPFLIEL 432 (444)
Q Consensus 416 RPs-----~~elL~~hpwf~~~ 432 (444)
||+ +.++++ ||||+.+
T Consensus 240 R~~a~~~~~~~~~~-~~~~~~~ 260 (318)
T cd05582 240 RLGAGPDGVEEIKR-HPFFSTI 260 (318)
T ss_pred cCCCCCCCHHHHhC-CCCcCCC
Confidence 999 677999 9999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.45 Aligned_cols=248 Identities=24% Similarity=0.430 Sum_probs=197.7
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||.||+|+++.+++.||+|++... ...+.+|..+++++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----------- 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----------- 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----------
Confidence 4799999999999999999999999999542 13355788899888 7999999998886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (329)
T cd05588 70 -------------------------------------------------------------------------------- 69 (329)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|.+++. ..+++++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~ 110 (329)
T cd05588 70 -----------------------------------RLFFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALN 110 (329)
T ss_pred -----------------------------------EEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877764 3467999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||+|+||+++ ..+.++|+|||++.... .........|++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~e 188 (329)
T cd05588 111 FLHERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 188 (329)
T ss_pred HHHHCCeEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccccccCCccccCHHHHcCC-CCCCccceechHHHHHH
Confidence 99999999999999999999 78899999999986432 22233445789999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhH-----HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 338 LLLGQPMFPGDSGVD-----QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 338 LltG~~Pf~~~~~~e-----~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+.||......+ ....+.+.+ .. ... .++..+++.+.++|.+||+.|
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~-----~~~------------~~p~~~~~~~~~li~~~L~~d 243 (329)
T cd05588 189 MMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LE-----KQI------------RIPRSLSVKASSVLKGFLNKD 243 (329)
T ss_pred HHHCCCCcccccccccccccchHHHHHHH--------Hc-----CCC------------CCCCCCCHHHHHHHHHHhccC
Confidence 999999996422111 000011100 00 001 123456899999999999999
Q ss_pred CCCCCC------HHHHhccCchhhhhh
Q psy10212 413 PSSRIS------PLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs------~~elL~~hpwf~~~~ 433 (444)
|.+||+ +.++++ ||||+.+.
T Consensus 244 P~~R~~~~~~~~~~~i~~-hp~~~~~~ 269 (329)
T cd05588 244 PKERLGCHPQTGFRDIKS-HPFFRNID 269 (329)
T ss_pred HHHcCCCCCCCCHHHHhc-CCCCCCCC
Confidence 999997 789999 99998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=321.10 Aligned_cols=244 Identities=29% Similarity=0.493 Sum_probs=198.5
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhh-cCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRR-LEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|++..+++.||+|.+.... .....|..++.. ++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----------- 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----------- 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----------
Confidence 46999999999999999999999999985431 223356666654 48999999988876543
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (316)
T cd05592 70 -------------------------------------------------------------------------------- 69 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
++++|||||++ +|.+++. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~ 110 (316)
T cd05592 70 -----------------------------------HLFFVMEYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQ 110 (316)
T ss_pred -----------------------------------EEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 48999999985 8877774 3457999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||+|+||+++ .++.++|+|||++...... .......|++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~LH~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e 188 (316)
T cd05592 111 FLHKKGIIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYE 188 (316)
T ss_pred HHHHCCEEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHH
Confidence 99999999999999999999 7889999999998654222 223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... . ..++..++.++.++|.+||+.||.+||
T Consensus 189 ll~G~~Pf~~~~~~~~~~~i~~~-----------------~------------~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 189 MLIGQSPFHGEDEDELFDSILND-----------------R------------PHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcC-----------------C------------CCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999988776655544321 0 012234688999999999999999999
Q ss_pred CHH-HHhccCchhhhhh
Q psy10212 418 SPL-QVRSITPFLIELR 433 (444)
Q Consensus 418 s~~-elL~~hpwf~~~~ 433 (444)
++. +++. ||||+.+.
T Consensus 240 ~~~~~l~~-h~~~~~~~ 255 (316)
T cd05592 240 GVDGDIRQ-HPFFRGID 255 (316)
T ss_pred CChHHHHc-CcccCCCC
Confidence 965 7778 99998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=312.02 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=197.8
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||.||+++++.+|+.||+|.+..+ ......|++++++++||||+++.+.+....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-------------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-------------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--------------
Confidence 79999999999999999999999998532 223446999999999999999988886543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (277)
T cd05607 67 -------------------------------------------------------------------------------- 66 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
+.++||||+++ +|.+++.. .....+++..+..++.||+.||+|||
T Consensus 67 --------------------------------~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH 112 (277)
T cd05607 67 --------------------------------HLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH 112 (277)
T ss_pred --------------------------------eEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 48999999985 78777643 23345888999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
++|++|+||+|+||+++ .++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||++|+|++|
T Consensus 113 ~~~ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 113 SMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred HCCEEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhC
Confidence 99999999999999999 7889999999998765444333345678999999999877 699999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH--
Q psy10212 342 QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP-- 419 (444)
Q Consensus 342 ~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~-- 419 (444)
+.||...........+..... . ..... ....+++++.+||.+||+.||.+||++
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~----------~---~~~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 191 RTPFKDHKEKVAKEELKRRTL----------E---DEVKF-----------EHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred CCCCCCCcchhhHHHHHHHhh----------c---ccccc-----------ccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 999976543222222211100 0 00000 012468999999999999999999999
Q ss_pred --HHHhccCchhhhhh
Q psy10212 420 --LQVRSITPFLIELR 433 (444)
Q Consensus 420 --~elL~~hpwf~~~~ 433 (444)
.++++ ||||+.+.
T Consensus 247 ~~~~~~~-h~~f~~~~ 261 (277)
T cd05607 247 KNDDPRK-HEFFKTIN 261 (277)
T ss_pred chhhhhc-ChhhcCCC
Confidence 67889 99998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.57 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=205.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.|++.+.||+|++|.||+|.+..+++.+|+|.+.... ..+.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 56999999999999999999999999999999885321 24567999999999999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (263)
T cd06625 78 -------------------------------------------------------------------------------- 77 (263)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++|+||+++ +|.+++.. ...+++..++.++.
T Consensus 78 ------------------------------------------~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ 111 (263)
T cd06625 78 ------------------------------------------TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTR 111 (263)
T ss_pred ------------------------------------------eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHH
Confidence 38999999985 88888753 35688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+......... ....++..|+|||.+.+. .++.++|
T Consensus 112 ~l~~~l~~lH~~~i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 189 (263)
T cd06625 112 QILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKAD 189 (263)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhh
Confidence 999999999999999999999999999 7889999999998654322111 234567889999999887 6899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||...+......++... .....++..++..+.++|.+
T Consensus 190 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~ 242 (263)
T cd06625 190 VWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---------------------------PTNPQLPSHVSPDARNFLRR 242 (263)
T ss_pred hHHHHHHHHHHHhCCCCccccchHHHHHHHhcc---------------------------CCCCCCCccCCHHHHHHHHH
Confidence 999999999999999999876555443332221 01112234578999999999
Q ss_pred hcccCCCCCCCHHHHhccCchh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf 429 (444)
||..+|.+|||+.++|+ |+||
T Consensus 243 ~l~~~p~~Rpt~~~ll~-~~~~ 263 (263)
T cd06625 243 TFVENAKKRPSAEELLR-HFFV 263 (263)
T ss_pred HhhcCcccCCCHHHHhh-CCCC
Confidence 99999999999999999 9997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.43 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=214.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
...|..+..||+|+||.||+|.+..+++.||||++..+ .+.+++|+.++.+++++||.+|++.|+.+..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~------ 85 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK------ 85 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc------
Confidence 35677889999999999999999999999999999544 3566789999999999999999999998753
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (467)
T KOG0201|consen 86 -------------------------------------------------------------------------------- 85 (467)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
++|+||||.| ++.+.++ .+..+.+..+..++++++
T Consensus 86 ----------------------------------------LwiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l 121 (467)
T KOG0201|consen 86 ----------------------------------------LWIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVL 121 (467)
T ss_pred ----------------------------------------HHHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHH
Confidence 9999999995 8888874 455569999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||+++.+|+|||+.||++. ..|.++|+|||.+....... ...+..||+.|||||++.+. .|+.++||||||+
T Consensus 122 ~~l~ylH~~~kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGI 199 (467)
T KOG0201|consen 122 KGLDYLHSEKKIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGI 199 (467)
T ss_pred HHhhhhhhcceecccccccceeEe-ccCcEEEEecceeeeeechhhccccccccccccchhhhccc-cccchhhhhhhhH
Confidence 999999999999999999999999 56999999999987665443 33678999999999999976 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+.+||.+|.+|+....+...+..| |...-..+. .++++.+++|+..||+.||
T Consensus 200 TaiEla~GePP~s~~hPmrvlflI------------------------pk~~PP~L~----~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 200 TAIELAKGEPPHSKLHPMRVLFLI------------------------PKSAPPRLD----GDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred HHHHHhcCCCCCcccCcceEEEec------------------------cCCCCCccc----cccCHHHHHHHHHHhhcCc
Confidence 999999999999987764333222 111112222 2468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
+.||||.++|+ |+|++..
T Consensus 252 ~~RpsA~~LLK-h~FIk~a 269 (467)
T KOG0201|consen 252 EFRPSAKELLK-HKFIKRA 269 (467)
T ss_pred ccCcCHHHHhh-hHHHHhc
Confidence 99999999999 9999983
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.46 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=205.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.|++.+.||+|+||+||++.+..+++.||+|.+.... ..+.+|+.++++++|++|+++.+.+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~------- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD------- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-------
Confidence 3778899999999999999999999999999985431 23457999999999999999988886653
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (285)
T cd05630 74 -------------------------------------------------------------------------------- 73 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
+.++||||+++ +|.+.+.. .....+++..+..++.|++
T Consensus 74 ---------------------------------------~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~ 112 (285)
T cd05630 74 ---------------------------------------ALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEIC 112 (285)
T ss_pred ---------------------------------------EEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHH
Confidence 48999999985 78777743 2334689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||.|||+++++|+||+|+||+++ ..+.++|+|||++.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 113 ~~l~~lH~~~iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~ 190 (285)
T cd05630 113 CGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCL 190 (285)
T ss_pred HHHHHHHhCCEEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHH
Confidence 999999999999999999999999 7889999999998665433333345678999999999877 78999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||................. . ....++..+++.+.+||.+||+.||+
T Consensus 191 l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 245 (285)
T cd05630 191 LYEMIAGQSPFQQRKKKIKREEVERLVK-E------------------------VQEEYSEKFSPDARSLCKMLLCKDPK 245 (285)
T ss_pred HHHHHhCCCCCCCCCccchHHHHHhhhh-h------------------------hhhhcCccCCHHHHHHHHHHhhcCHH
Confidence 9999999999986543211111111000 0 00112234688999999999999999
Q ss_pred CCCC-----HHHHhccCchhhhhh
Q psy10212 415 SRIS-----PLQVRSITPFLIELR 433 (444)
Q Consensus 415 kRPs-----~~elL~~hpwf~~~~ 433 (444)
+||| +.|+++ ||||+.+.
T Consensus 246 ~R~s~~~~~~~~~~~-h~~~~~~~ 268 (285)
T cd05630 246 ERLGCQGGGAREVKE-HPLFKQIN 268 (285)
T ss_pred HccCCCCCchHHHHc-ChhhhccC
Confidence 9999 899999 99998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=320.33 Aligned_cols=244 Identities=28% Similarity=0.483 Sum_probs=199.3
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|+++.+|+.||+|.+... ......|..++..+ +||+|+++++.+...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----------- 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----------- 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----------
Confidence 4799999999999999999999999998543 12344677777654 8999999998887654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (316)
T cd05620 70 -------------------------------------------------------------------------------- 69 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
++|+|||||.+ +|...+. ...++++..+..++.||+.||+
T Consensus 70 -----------------------------------~~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~ 110 (316)
T cd05620 70 -----------------------------------HLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQ 110 (316)
T ss_pred -----------------------------------EEEEEECCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 48999999985 7877774 3467899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~e 188 (316)
T cd05620 111 FLHSKGIIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYE 188 (316)
T ss_pred HHHHCCeEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHH
Confidence 99999999999999999999 788999999998864322 1223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... . ..++..++.++.++|.+||+.||++||
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 189 MLIGQSPFHGDDEDELFESIRVD-----------------T------------PHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhC-----------------C------------CCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999999887765544433321 0 011224689999999999999999999
Q ss_pred CH-HHHhccCchhhhhh
Q psy10212 418 SP-LQVRSITPFLIELR 433 (444)
Q Consensus 418 s~-~elL~~hpwf~~~~ 433 (444)
++ .++++ ||||+...
T Consensus 240 ~~~~~~~~-h~~f~~~~ 255 (316)
T cd05620 240 GVVGNIRG-HPFFKTIN 255 (316)
T ss_pred CChHHHHc-CCCcCCCC
Confidence 98 47888 99998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=304.75 Aligned_cols=250 Identities=33% Similarity=0.523 Sum_probs=224.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.|++.+.||+|-||.||+|+.+.++-.+|+|++.++ ...+.||+++-+.|+||||++++++|+++..
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r----- 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR----- 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce-----
Confidence 6799999999999999999999999999999999544 3566689999999999999999999998865
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 97 -------------------------------------------------------------------------------- 96 (281)
T KOG0580|consen 97 -------------------------------------------------------------------------------- 96 (281)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.|+++||.+ |++++.+.. ....++++..++.++.|+
T Consensus 97 -----------------------------------------iyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~ 133 (281)
T KOG0580|consen 97 -----------------------------------------IYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQL 133 (281)
T ss_pred -----------------------------------------eEEEEEecCCchHHHHHHh--cccccccccchhHHHHHH
Confidence 999999998 688888752 245679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|+|.++++||||||+|+|++ ..+.+|++|||-+...+ .....+.+||..|.+||...+. ..+...|+|++|+
T Consensus 134 A~Al~y~h~k~VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgv 210 (281)
T KOG0580|consen 134 ANALLYCHLKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGV 210 (281)
T ss_pred HHHHHHhccCCcccCCCCHHHhccC-CCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHH
Confidence 9999999999999999999999999 78999999999997765 5667788999999999999888 8899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+.||++.|.+||...+..+.+.+|.+. ++.+ +..++..+.|+|.+||.++|
T Consensus 211 l~yeflvg~ppFes~~~~etYkrI~k~-----------------~~~~------------p~~is~~a~dlI~~ll~~~p 261 (281)
T KOG0580|consen 211 LCYEFLVGLPPFESQSHSETYKRIRKV-----------------DLKF------------PSTISGGAADLISRLLVKNP 261 (281)
T ss_pred HHHHHHhcCCchhhhhhHHHHHHHHHc-----------------cccC------------CcccChhHHHHHHHHhccCc
Confidence 999999999999999988888888873 2222 34689999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
.+|.+..|++. |||+...
T Consensus 262 ~~r~~l~~v~~-hpwI~a~ 279 (281)
T KOG0580|consen 262 IERLALTEVMD-HPWIVAN 279 (281)
T ss_pred cccccHHHHhh-hHHHHhc
Confidence 99999999999 9999764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.17 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=206.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.|++++.||+|+||+||+|+++.+++.||+|++... ...+.+|+.++.+++|++|+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR------ 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC------
Confidence 4689999999999999999999999999999998532 234557999999999999999998886654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (360)
T cd05627 75 -------------------------------------------------------------------------------- 74 (360)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+|||||++ +|.+++. ....+++..++.++.|+
T Consensus 75 ----------------------------------------~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi 110 (360)
T cd05627 75 ----------------------------------------NLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAET 110 (360)
T ss_pred ----------------------------------------EEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHH
Confidence 48999999985 8888874 34678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---------------------------------- 299 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---------------------------------- 299 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++.......
T Consensus 111 ~~~L~~lH~~givHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (360)
T cd05627 111 VLAIDAIHQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189 (360)
T ss_pred HHHHHHHHHCCeEccCCCHHHEEEC-CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccc
Confidence 9999999999999999999999999 78999999999876432110
Q ss_pred --CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC
Q psy10212 300 --PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 377 (444)
Q Consensus 300 --~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~ 377 (444)
......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.... .
T Consensus 190 ~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~---------------~ 253 (360)
T cd05627 190 RQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWK---------------E 253 (360)
T ss_pred cccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCC---------------C
Confidence 01123689999999999877 78999999999999999999999999887766655554310 0
Q ss_pred cccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhh
Q psy10212 378 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELR 433 (444)
Q Consensus 378 ~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~ 433 (444)
...+|. ...+++.+.++|.+|+ .||.+|++ +.++++ ||||+.+.
T Consensus 254 ~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~-hp~f~~~~ 300 (360)
T cd05627 254 TLVFPP----------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS-HPFFEGVD 300 (360)
T ss_pred ceecCC----------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc-CCCCCCCC
Confidence 011111 0135889999999987 49999995 789999 99998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=321.66 Aligned_cols=282 Identities=24% Similarity=0.392 Sum_probs=210.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|++.++||+|+||.||++++..+++.+|+|.+... ...+.+|++++++++|+||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------- 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-------
Confidence 47899999999999999999999999999999988543 235668999999999999999999998764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (333)
T cd06650 77 -------------------------------------------------------------------------------- 76 (333)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
++++|||||.+ +|.+++.. ...+++..++.++.|++
T Consensus 77 ---------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~ 113 (333)
T cd06650 77 ---------------------------------------EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVI 113 (333)
T ss_pred ---------------------------------------EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHH
Confidence 38999999975 89888753 45688999999999999
Q ss_pred HHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++ +++|+||||+||+++ .++.++|+|||++...... ......++..|+|||.+.+. .++.++|+|||||
T Consensus 114 ~~l~~lH~~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 190 (333)
T cd06650 114 KGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGL 190 (333)
T ss_pred HHHHHHHhcCCEEecCCChhhEEEc-CCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHH
Confidence 999999985 799999999999998 7889999999998654322 22344678899999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHH-HhCCCCHHHHHh-hC------CCCCcccCCCcc--------CCCCcccc-cCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIK-VLGTPTREQIRE-MN------PNYTEFKFPQIK--------SHPWSKVF-RVR 396 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~-~~g~~~~~~~~~-~~------~~~~~~~~p~~~--------~~~~~~~~-~~~ 396 (444)
++|+|++|+.||......+....+.. ..+.+....... .. ..+.....|... .......+ ...
T Consensus 191 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (333)
T cd06650 191 SLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGV 270 (333)
T ss_pred HHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCC
Confidence 99999999999987654333221110 000000000000 00 000000000000 00000001 112
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
++.++.+||.+||+.||++|||+.|++. ||||+...+..
T Consensus 271 ~~~~~~~li~~~L~~~P~~Rpt~~ell~-h~~~~~~~~~~ 309 (333)
T cd06650 271 FGAEFQDFVNKCLIKNPAERADLKQLMV-HAFIKRSEAEE 309 (333)
T ss_pred cCHHHHHHHHHhccCCcccCcCHHHHhh-CHHHhcCcccc
Confidence 5788999999999999999999999999 99999865543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.99 Aligned_cols=287 Identities=29% Similarity=0.496 Sum_probs=217.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.-++|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--- 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc---
Confidence 3457999999999999999999999999999999885432 1234799999999999999999988765320
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (310)
T cd07865 87 -------------------------------------------------------------------------------- 86 (310)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
........++|||||+++|.+.+.. ....+++..++.++.||
T Consensus 87 -----------------------------------~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi 128 (310)
T cd07865 87 -----------------------------------YNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKML 128 (310)
T ss_pred -----------------------------------ccCCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHH
Confidence 0000134899999999999888752 33468999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-----ccccccccccCchhhccCCCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-----VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||+|||++|++|+||+|+||+++ ..+.++|+|||.+......... ....++..|+|||.+.+...++.++|+
T Consensus 129 ~~al~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 207 (310)
T cd07865 129 LNGLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDM 207 (310)
T ss_pred HHHHHHHHHCCeeccCCCHHHEEEC-CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhh
Confidence 9999999999999999999999999 7889999999998655332211 223457789999988765457889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccc-cCCCChhHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVF-RVRTPPDAIDLI 405 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~-~~~~s~~l~~LI 405 (444)
||+|+++|+|++|+.||.+.+.......+....+..++..++... ..+....++..........+ +...+..+.++|
T Consensus 208 ~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli 287 (310)
T cd07865 208 WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLI 287 (310)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHH
Confidence 999999999999999999887777666666665555444332211 00111111111111111111 112467899999
Q ss_pred HHhcccCCCCCCCHHHHhccCchh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
.+||..||.+|||+.++|+ ||||
T Consensus 288 ~~~l~~~P~~R~t~~e~l~-h~~f 310 (310)
T cd07865 288 DKLLVLDPAKRIDADTALN-HDFF 310 (310)
T ss_pred HHHhcCChhhccCHHHHhc-CCCC
Confidence 9999999999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.94 Aligned_cols=283 Identities=34% Similarity=0.569 Sum_probs=224.0
Q ss_pred hhccccchh-heecccceeEEEEeEecCCCceeeeeeeecccc------------------chhhHHHHhhhcCCCceeE
Q psy10212 19 DLDNSLAQK-TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR------------------FKNREMQIMRRLEHSNIVK 79 (444)
Q Consensus 19 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------~~~~E~~~l~~l~h~~i~~ 79 (444)
.+.++|..+ +.||+|+||+||+|+++.+++.||||++..... .+.+|++++++++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 356888764 779999999999999999999999999843311 3568999999999999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+.+++...+
T Consensus 85 ~~~~~~~~~----------------------------------------------------------------------- 93 (335)
T PTZ00024 85 LVDVYVEGD----------------------------------------------------------------------- 93 (335)
T ss_pred eeEEEecCC-----------------------------------------------------------------------
Confidence 999887654
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCC
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQ 239 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~ 239 (444)
+.++||||++++|.+++. ...
T Consensus 94 -------------------------------------------------------~~~lv~e~~~~~l~~~l~----~~~ 114 (335)
T PTZ00024 94 -------------------------------------------------------FINLVMDIMASDLKKVVD----RKI 114 (335)
T ss_pred -------------------------------------------------------cEEEEEeccccCHHHHHH----hcC
Confidence 389999999999998885 345
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC---------------CCCccc
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---------------EPNVSY 304 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~---------------~~~~~~ 304 (444)
.+++..+..++.|++.||.+||++|++|+||+|+||+++ ..+.++|+|||.+...... ......
T Consensus 115 ~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (335)
T PTZ00024 115 RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193 (335)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC-CCCCEEECCccceeeccccccccccccccccccccccccc
Confidence 689999999999999999999999999999999999999 7889999999988654311 111122
Q ss_pred cccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCC
Q psy10212 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFP 382 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p 382 (444)
.++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.++.+.+..+....+.+....|+... +.+......
T Consensus 194 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
T PTZ00024 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR 273 (335)
T ss_pred ccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC
Confidence 457789999998775467899999999999999999999999999888888888888777655443321 001000000
Q ss_pred CccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 383 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 383 ~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
..... ......++..+.++|.+||+.||++|||+.|+|. ||||+.-....
T Consensus 274 --~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~-~~~~~~~~~~~ 323 (335)
T PTZ00024 274 --KPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALK-HEYFKSDPLPC 323 (335)
T ss_pred --CcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc-CcccCCCCCCC
Confidence 00001 1112356889999999999999999999999999 99999755443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=327.75 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=208.7
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
...++|++++.||+|+||.||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++++.+....
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--- 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--- 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence 3457899999999999999999999999999999998532 234568999999999999999998886653
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 117 -------------------------------------------------------------------------------- 116 (370)
T cd05621 117 -------------------------------------------------------------------------------- 116 (370)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
++|+|||||+ ++|.+++.. ..+++..++.++
T Consensus 117 -------------------------------------------~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~ 148 (370)
T cd05621 117 -------------------------------------------YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYT 148 (370)
T ss_pred -------------------------------------------EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHH
Confidence 4999999998 488888742 358899999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccC---CCCCcc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGA---IDYTTK 325 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~---~~~s~~ 325 (444)
.||+.||+|||++|++||||||+||+++ ..+.++|+|||++........ .....||+.|+|||.+.+. ..++.+
T Consensus 149 ~qil~aL~~LH~~~IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 227 (370)
T cd05621 149 AEVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227 (370)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHEEEC-CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcc
Confidence 9999999999999999999999999999 789999999999876533221 2345689999999998653 137889
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|+||+||++|+|++|+.||.+.+......++..... ...+|. ...++..+.++|
T Consensus 228 ~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li 282 (370)
T cd05621 228 CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---------------SLNFPE----------DVEISKHAKNLI 282 (370)
T ss_pred cCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------------ccCCCC----------cccCCHHHHHHH
Confidence 9999999999999999999998877666665554211 011111 123589999999
Q ss_pred HHhcccCCCC--CCCHHHHhccCchhhhh
Q psy10212 406 SRLLEYTPSS--RISPLQVRSITPFLIEL 432 (444)
Q Consensus 406 ~~~L~~DP~k--RPs~~elL~~hpwf~~~ 432 (444)
..||..++.+ |+++.|+++ ||||+..
T Consensus 283 ~~~L~~~~~r~~R~~~~e~l~-hp~~~~~ 310 (370)
T cd05621 283 CAFLTDREVRLGRNGVEEIKQ-HPFFKND 310 (370)
T ss_pred HHHccCchhccCCCCHHHHhc-CcccCCC
Confidence 9999865544 899999999 9999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.35 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=206.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHH-hhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQI-MRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||.||+|+++.+|+.||||.+.... ..+..|+.. ++.++||||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~------ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD------ 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc------
Confidence 47899999999999999999999999999999885432 223345554 666799999999999876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (283)
T cd06617 75 -------------------------------------------------------------------------------- 74 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||++++|.+++.........+++..++.++.||+.
T Consensus 75 ----------------------------------------~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~ 114 (283)
T cd06617 75 ----------------------------------------VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114 (283)
T ss_pred ----------------------------------------EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHH
Confidence 8999999999999988765555578999999999999999
Q ss_pred HHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC---CCCCcchhhhhH
Q psy10212 256 SLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA---IDYTTKIDVWSA 331 (444)
Q Consensus 256 aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~s~~sDiwSL 331 (444)
||+|||++ +++|+||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. ..++.++|+||+
T Consensus 115 ~l~~lH~~~~i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 193 (283)
T cd06617 115 ALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193 (283)
T ss_pred HHHHHhhcCCeecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhh
Confidence 99999997 999999999999999 7889999999998765433333334578889999988542 246889999999
Q ss_pred HHHHHHHHhCCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++|+.||.... ..+.+..+.... ...++ ...+|.++.++|.+||.
T Consensus 194 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------~~~~~-----------~~~~~~~l~~li~~~l~ 246 (283)
T cd06617 194 GITMIELATGRFPYDSWKTPFQQLKQVVEEP----------------SPQLP-----------AEKFSPEFQDFVNKCLK 246 (283)
T ss_pred HHHHHHHHhCCCCCCccccCHHHHHHHHhcC----------------CCCCC-----------ccccCHHHHHHHHHHcc
Confidence 999999999999996532 223332222210 00000 12358999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+|.+||++.++++ ||||+.-...
T Consensus 247 ~~p~~Rp~~~~il~-~~~~~~~~~~ 270 (283)
T cd06617 247 KNYKERPNYPELLQ-HPFFELHLSK 270 (283)
T ss_pred CChhhCcCHHHHhc-Cchhhhcccc
Confidence 99999999999999 9999985533
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=310.70 Aligned_cols=274 Identities=41% Similarity=0.755 Sum_probs=223.2
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++.+.||+|++|.||+|++..+|+.+|+|.+.... ..+.+|++++++++|+||+++.+++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--------- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC---------
Confidence 678899999999999999999899999999985432 34568999999999999999988776543
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (283)
T cd05118 72 -------------------------------------------------------------------------------- 71 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++|||+++++.+.+.. ....+++..++.++.||+.||
T Consensus 72 -------------------------------------~~~~v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l 111 (283)
T cd05118 72 -------------------------------------DLYLVFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGL 111 (283)
T ss_pred -------------------------------------CEEEEEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHH
Confidence 3889999999998888753 336789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
.|||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|
T Consensus 112 ~~LH~~~i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~ 190 (283)
T cd05118 112 AFCHSHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190 (283)
T ss_pred HHHHHCCeeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHH
Confidence 999999999999999999999 78899999999986654432 2223456788999999876546889999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|++|+.||...+..+....+...++.+.+..+..... ......++....... ....+.++..+.++|.+||+.||.
T Consensus 191 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~ 269 (283)
T cd05118 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPH 269 (283)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcc
Confidence 99999999999988888888888888777666555332 111222222222222 122345789999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.+++. ||||
T Consensus 270 ~Rp~~~~ll~-~~~~ 283 (283)
T cd05118 270 KRITAEQALA-HPYF 283 (283)
T ss_pred cCcCHHHHhh-CCCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.85 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=213.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeec---cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
..+..++.||+|-||.||.|..+. ...||+|.+.. ..+.|.+|+++|++|+|++||++++.+...++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p--------- 275 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP--------- 275 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc---------
Confidence 456779999999999999999953 34799998854 35777899999999999999999999988765
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 276 -------------------------------------------------------------------------------- 275 (468)
T KOG0197|consen 276 -------------------------------------------------------------------------------- 275 (468)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+|||||||+ |+|.++++. ..+..+.......++.|||+|+
T Consensus 276 -------------------------------------iyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM 316 (468)
T KOG0197|consen 276 -------------------------------------IYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGM 316 (468)
T ss_pred -------------------------------------eEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHH
Confidence 999999999 799999975 4667789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc--ccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS--YICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+||+++++|||||...||||+ ++..+||+|||+++...+...... ..-...|.|||.+..+ .++.+|||||||++|
T Consensus 317 ~YLes~~~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL 394 (468)
T KOG0197|consen 317 AYLESKNYIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLL 394 (468)
T ss_pred HHHHhCCccchhhhhhheeec-cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhH
Confidence 999999999999999999999 888999999999985433322211 1225669999999988 899999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|||+| |+.||.+.+..+.+..+.++.+ +|. |.+||+.+.+++..||..+|+
T Consensus 395 ~E~fT~G~~py~~msn~ev~~~le~GyR------------------lp~----------P~~CP~~vY~lM~~CW~~~P~ 446 (468)
T KOG0197|consen 395 WELFTYGRVPYPGMSNEEVLELLERGYR------------------LPR----------PEGCPDEVYELMKSCWHEDPE 446 (468)
T ss_pred HHHhccCCCCCCCCCHHHHHHHHhccCc------------------CCC----------CCCCCHHHHHHHHHHhhCCcc
Confidence 99996 9999999999998888876432 222 356899999999999999999
Q ss_pred CCCCHHHHhccCchhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~ 434 (444)
+|||+..+.. .+.++..
T Consensus 447 ~RPtF~~L~~---~l~~~~~ 463 (468)
T KOG0197|consen 447 DRPTFETLRE---VLEDFFT 463 (468)
T ss_pred cCCCHHHHHH---HHHHhhh
Confidence 9999998777 6666543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=306.57 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=206.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+..+.|++.+.||+|+||.||+|+++.+++.+|+|.+... ...+.+|+.+++++ +|+||+++.+++.......
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~-- 79 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG-- 79 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC--
Confidence 45678999999999999999999999999999999998543 34566899999998 7999999999987654200
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (272)
T cd06637 80 -------------------------------------------------------------------------------- 79 (272)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...+.+++||||++ +|.+++.. .....+++..++.++.|
T Consensus 80 --------------------------------------~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~q 119 (272)
T cd06637 80 --------------------------------------MDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICRE 119 (272)
T ss_pred --------------------------------------CCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHH
Confidence 01358899999985 88888753 23456889999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhcc----CCCCCcchh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG----AIDYTTKID 327 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~s~~sD 327 (444)
++.||+|||+++++|+||+|+||+++ +++.++|+|||++...... .......++..|+|||.+.+ ...++.++|
T Consensus 120 i~~~l~~LH~~~ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~D 198 (272)
T cd06637 120 ILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 198 (272)
T ss_pred HHHHHHHHHHCCCccCCCCHHHEEEC-CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhh
Confidence 99999999999999999999999999 7889999999998654322 12234467889999999853 225788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||+||++|+|++|+.||............... . ........++..+.+||.+
T Consensus 199 v~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~~~~~li~~ 251 (272)
T cd06637 199 LWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-------------------P--------APRLKSKKWSKKFQSFIES 251 (272)
T ss_pred HHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-------------------C--------CCCCCCCCcCHHHHHHHHH
Confidence 999999999999999999765443322211110 0 0001112457899999999
Q ss_pred hcccCCCCCCCHHHHhccCchh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf 429 (444)
||..||.+|||+.++++ ||||
T Consensus 252 ~l~~~p~~Rpt~~~il~-~~~~ 272 (272)
T cd06637 252 CLVKNHSQRPTTEQLMK-HPFI 272 (272)
T ss_pred HcCCChhhCCCHHHHhh-CCCC
Confidence 99999999999999999 9997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.13 Aligned_cols=277 Identities=35% Similarity=0.630 Sum_probs=219.6
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++.+.||.|+||.||+|++..+|+.+|+|.+.... ..+.+|++++++++|+|++++.+++...+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-------- 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK-------- 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC--------
Confidence 678999999999999999999999999999996542 345679999999999999999998876521
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (287)
T cd07840 73 -------------------------------------------------------------------------------- 72 (287)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
...++||||++++|.+++.. ....+++..++.++.||+.||
T Consensus 73 ------------------------------------~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al 113 (287)
T cd07840 73 ------------------------------------GSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGL 113 (287)
T ss_pred ------------------------------------CcEEEEeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHH
Confidence 23899999999998888753 235789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
++||++|++|+||+|+||+++ +++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++
T Consensus 114 ~~LH~~~~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l 192 (287)
T cd07840 114 QYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCIL 192 (287)
T ss_pred HHHHHCCceeccCcHHHeEEc-CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHH
Confidence 999999999999999999999 78999999999987654332 122335577899999887654688999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|++|+.||...+.......+.+..+.+....+...... .................+...+++.+.++|.+||+.||
T Consensus 193 ~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 272 (287)
T cd07840 193 AELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP 272 (287)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCCh
Confidence 9999999999998888888888887777766555432110 00000000000111122222248999999999999999
Q ss_pred CCCCCHHHHhccCchh
Q psy10212 414 SSRISPLQVRSITPFL 429 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf 429 (444)
.+||++.++++ ||||
T Consensus 273 ~~Rp~~~~~l~-~~~~ 287 (287)
T cd07840 273 KKRISADQALQ-HEYF 287 (287)
T ss_pred hhCcCHHHHhh-CcCC
Confidence 99999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.59 Aligned_cols=278 Identities=35% Similarity=0.604 Sum_probs=215.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+.|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+|+.+++.++|+||+++.+++...+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------- 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE------- 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-------
Confidence 478999999999999999999999999999999985432 24568999999999999999999886543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (291)
T cd07870 77 -------------------------------------------------------------------------------- 76 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+.+++.+++.. ....+++..++.++.||+.
T Consensus 77 ---------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~ 114 (291)
T cd07870 77 ---------------------------------------TLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLR 114 (291)
T ss_pred ---------------------------------------eEEEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHH
Confidence 3889999999999887742 3356788889999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.|||++|++|+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+...++.++|+||||++
T Consensus 115 ~L~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 193 (291)
T cd07870 115 GLAYIHGQHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCI 193 (291)
T ss_pred HHHHHHhCCcccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHH
Confidence 99999999999999999999998 7889999999988653222 122333568889999998765467889999999999
Q ss_pred HHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCccccc-CCCChhHHHHHHHhcc
Q psy10212 335 LAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFR-VRTPPDAIDLISRLLE 410 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~-~~~s~~l~~LI~~~L~ 410 (444)
+|+|++|..||.+.++ .+.+.++....+.+....+.... +.+.....+............ ...++.+.++|.+||.
T Consensus 194 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 273 (291)
T cd07870 194 FIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLM 273 (291)
T ss_pred HHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhC
Confidence 9999999999986543 46666777777766655544321 111111111100001111000 1236789999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
.||.+|||+.|++. ||||
T Consensus 274 ~dp~~R~t~~~~l~-h~~~ 291 (291)
T cd07870 274 MFPKDRISAQDALL-HPYF 291 (291)
T ss_pred cCcccCcCHHHHhc-CCCC
Confidence 99999999999999 9997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=318.80 Aligned_cols=244 Identities=28% Similarity=0.488 Sum_probs=199.6
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhh-cCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRR-LEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|++..+++.||+|.+... ......|..++.. ++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----------- 69 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----------- 69 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----------
Confidence 4699999999999999999999999998543 1234457777775 48999999999887654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (316)
T cd05619 70 -------------------------------------------------------------------------------- 69 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+++|||||+ ++|.+++. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~ 110 (316)
T cd05619 70 -----------------------------------NLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQ 110 (316)
T ss_pred -----------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 3899999998 48888774 2457899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++|+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+. .++.++|+||+||++|+
T Consensus 111 ~LH~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e 188 (316)
T cd05619 111 FLHSKGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYE 188 (316)
T ss_pred HHHhCCeEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHH
Confidence 99999999999999999999 7889999999998643222 223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... .. .++..++.++.++|.+||+.||++||
T Consensus 189 l~~G~~pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 189 MLIGQSPFHGHDEEELFQSIRMD-----------------NP------------CYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCccCCHHHHHHHHHHhccCHhhcC
Confidence 99999999887766554443220 00 01223588999999999999999999
Q ss_pred CHH-HHhccCchhhhhh
Q psy10212 418 SPL-QVRSITPFLIELR 433 (444)
Q Consensus 418 s~~-elL~~hpwf~~~~ 433 (444)
++. +++. ||||+++.
T Consensus 240 ~~~~~l~~-h~~~~~~~ 255 (316)
T cd05619 240 GVKGDIRQ-HPFFREID 255 (316)
T ss_pred CChHHHHc-CcccCCCC
Confidence 996 8888 99998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=324.37 Aligned_cols=251 Identities=28% Similarity=0.388 Sum_probs=198.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|+.+++||+|+||+||+|++..+|+.||||++... ...+.+|++++++++|+||+++++++...+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG------- 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-------
Confidence 46788999999999999999999999999999998543 245668999999999999999999886654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 146 -------------------------------------------------------------------------------- 145 (353)
T PLN00034 146 -------------------------------------------------------------------------------- 145 (353)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||||.+ +|.+ .....+..+..++.||+
T Consensus 146 ---------------------------------------~~~lv~e~~~~~~L~~--------~~~~~~~~~~~i~~qi~ 178 (353)
T PLN00034 146 ---------------------------------------EIQVLLEFMDGGSLEG--------THIADEQFLADVARQIL 178 (353)
T ss_pred ---------------------------------------eEEEEEecCCCCcccc--------cccCCHHHHHHHHHHHH
Confidence 38899999996 5533 23456778889999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccC----CCCCcchhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGA----IDYTTKIDVW 329 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~s~~sDiw 329 (444)
.||.|||++|++|+||||+||+++ .++.++|+|||++....... ......++..|+|||.+... ...+.++|||
T Consensus 179 ~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw 257 (353)
T PLN00034 179 SGIAYLHRRHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIW 257 (353)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEc-CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHH
Confidence 999999999999999999999999 78899999999987653322 22345689999999987431 1345689999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||||++|+|++|+.||......+....+...... .....+..++..+.+||.+||
T Consensus 258 slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l 312 (353)
T PLN00034 258 SLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-------------------------QPPEAPATASREFRHFISCCL 312 (353)
T ss_pred HHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-------------------------CCCCCCCccCHHHHHHHHHHc
Confidence 9999999999999999744332222211111000 000112356899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+.||++|||+.|+|+ ||||..-
T Consensus 313 ~~~P~~Rpt~~ell~-hp~~~~~ 334 (353)
T PLN00034 313 QREPAKRWSAMQLLQ-HPFILRA 334 (353)
T ss_pred cCChhhCcCHHHHhc-CcccccC
Confidence 999999999999999 9999884
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.72 Aligned_cols=277 Identities=38% Similarity=0.699 Sum_probs=219.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++.+.||+|+||.||+|.++.+++.||+|++... ...+.+|++++++++|+||+++.+++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG------- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-------
Confidence 4799999999999999999999999999999988542 245668999999999999999999987754
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (288)
T cd07833 74 -------------------------------------------------------------------------------- 73 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++|||+++++.+.+. .....+++..++.++.||+.
T Consensus 74 ---------------------------------------~~~iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~ 111 (288)
T cd07833 74 ---------------------------------------RLYLVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQ 111 (288)
T ss_pred ---------------------------------------EEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHH
Confidence 389999999988776654 23456899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+
T Consensus 112 ~l~~LH~~~i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~ 190 (288)
T cd07833 112 AIAYCHSHNIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGC 190 (288)
T ss_pred HHHHHHHCCeecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHH
Confidence 99999999999999999999999 78999999999987654433 2233456788999999877657889999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCC-CCcccccCCCChhHHHHHHHhcc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSH-PWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~-~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
++|+|++|+.||.+.+..+.+..+....+...+....... +......++..... .+...++..+++.+.+||.+||.
T Consensus 191 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 270 (288)
T cd07833 191 IMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270 (288)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhc
Confidence 9999999999999887777777776666654443222211 11111111111111 11122344568999999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
.||++|||+.++++ ||||
T Consensus 271 ~~p~~Rps~~~il~-~~~f 288 (288)
T cd07833 271 MDPKERLTCDELLQ-HPYF 288 (288)
T ss_pred cCchhcccHHHHhc-CCCC
Confidence 99999999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.24 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=199.4
Q ss_pred cccchhheecccceeEEEEeEe-----cCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.++||+|+||.||+|.+ ..+++.||+|++... ...+.+|+.++.++ +||||+++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG- 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC-
Confidence 6899999999999999999985 234578999998532 23566899999999 89999999988765431
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (338)
T cd05102 86 -------------------------------------------------------------------------------- 85 (338)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS------------ 237 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~------------ 237 (444)
.++++||||+ |+|.+++......
T Consensus 86 --------------------------------------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 121 (338)
T cd05102 86 --------------------------------------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQR 121 (338)
T ss_pred --------------------------------------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhh
Confidence 3789999998 5888888642211
Q ss_pred ----------------------------------------------CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q psy10212 238 ----------------------------------------------KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271 (444)
Q Consensus 238 ----------------------------------------------~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLk 271 (444)
..++++..+..++.||+.||+|||++|++|+|||
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiK 201 (338)
T cd05102 122 GRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLA 201 (338)
T ss_pred hhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCc
Confidence 2357788899999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCC
Q psy10212 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPG 347 (444)
Q Consensus 272 p~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~ 347 (444)
|+||+++ .++.++|+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus 202 p~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 202 ARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred cceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 788999999999875432211 1122345789999999877 78999999999999999996 9999987
Q ss_pred CChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCc
Q psy10212 348 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITP 427 (444)
Q Consensus 348 ~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hp 427 (444)
....+........ + .. ...+..+++.+.++|.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~-~--------------~~------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~--- 329 (338)
T cd05102 280 VQINEEFCQRLKD-G--------------TR------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE--- 329 (338)
T ss_pred CCccHHHHHHHhc-C--------------CC------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH---
Confidence 6543333222210 0 00 0112356899999999999999999999999998
Q ss_pred hhhhhh
Q psy10212 428 FLIELR 433 (444)
Q Consensus 428 wf~~~~ 433 (444)
.++++.
T Consensus 330 ~l~~~~ 335 (338)
T cd05102 330 ILGDLL 335 (338)
T ss_pred HHHHHH
Confidence 666643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.34 Aligned_cols=275 Identities=23% Similarity=0.320 Sum_probs=208.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
...|.+.+.||+|+||.||+|++..+++.||||... ...+.+|++++++|+|+||+++++++...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~------------ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVVGG------------ 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEECC------------
Confidence 457999999999999999999999999999999643 234568999999999999999999887664
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 234 -------------------------------------------------------------------------------- 233 (461)
T PHA03211 234 -------------------------------------------------------------------------------- 233 (461)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL 260 (444)
..++|||++.++|.+++.. ....+++..++.++.||+.||.||
T Consensus 234 ----------------------------------~~~lv~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yL 276 (461)
T PHA03211 234 ----------------------------------LTCLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYI 276 (461)
T ss_pred ----------------------------------EEEEEEEccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3889999999999988753 334799999999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|++||+|+||||+||+++ ..+.++|+|||+++....... .....||..|+|||++.+. .++.++|+|||||++|+
T Consensus 277 H~~gIvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~E 354 (461)
T PHA03211 277 HGEGIIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354 (461)
T ss_pred HHCCEEECcCCHHHEEEC-CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHH
Confidence 999999999999999999 788999999999875432211 1234589999999999877 78999999999999999
Q ss_pred HHhCCCCC-CCCC------hhHHHHHHHHHhCCCCH--------HHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 338 LLLGQPMF-PGDS------GVDQLVEIIKVLGTPTR--------EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 338 LltG~~Pf-~~~~------~~e~~~~i~~~~g~~~~--------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
|++|..++ .... ....+.++++..+.... .....+.........+......|.... .++.++.
T Consensus 355 l~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 432 (461)
T PHA03211 355 AAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVE 432 (461)
T ss_pred HHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHH
Confidence 99877543 3211 12334444443322110 011111000001111222222233221 3577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
+||.+||+.||.+|||+.|+|+ ||||++
T Consensus 433 dli~~mL~~DP~~RPsa~elL~-hp~f~~ 460 (461)
T PHA03211 433 YLVCRALTFDGARRPSAAELLR-LPLFQS 460 (461)
T ss_pred HHHHHHcccChhhCcCHHHHhh-CcccCC
Confidence 9999999999999999999999 999974
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.31 Aligned_cols=281 Identities=20% Similarity=0.307 Sum_probs=204.5
Q ss_pred chhheeccc--ceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 25 AQKTVIGNG--SFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 25 ~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+++++||+| +||+||+++++.+|+.||+|.+... ...+.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-------- 72 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-------- 72 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--------
Confidence 467899999 7899999999999999999998543 245668999999999999999999987764
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (327)
T cd08227 73 -------------------------------------------------------------------------------- 72 (327)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||||+ ++|.+++... ....+++..++.++.||+.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~ 112 (327)
T cd08227 73 --------------------------------------ELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLK 112 (327)
T ss_pred --------------------------------------EEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHH
Confidence 3899999998 5888887532 2345899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccC-CCCCcch
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGA-IDYTTKI 326 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~s~~s 326 (444)
||+|||+++++|+||||+||+++ .++.++++||+.......... .....++..|+|||.+.+. ..++.++
T Consensus 113 ~L~~LH~~~iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 191 (327)
T cd08227 113 ALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191 (327)
T ss_pred HHHHHHHCCEecCCCChhhEEEe-cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchh
Confidence 99999999999999999999999 778999999976433211110 1122356679999998753 2588999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCC-------CCHHHHHhhCCCCC--c--c----c---CCCccCCC
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT-------PTREQIREMNPNYT--E--F----K---FPQIKSHP 388 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~-------~~~~~~~~~~~~~~--~--~----~---~p~~~~~~ 388 (444)
|+||+||++|+|++|+.||.................. .....+. ..+... + . . ........
T Consensus 192 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (327)
T cd08227 192 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGES 270 (327)
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCC
Confidence 9999999999999999999876554433332221000 0000000 000000 0 0 0 00000000
Q ss_pred CcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 389 ~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
....+...+++.+.+||.+||+.||++|||++|+|+ ||||+++....
T Consensus 271 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~-~p~f~~~~~~~ 317 (327)
T cd08227 271 SSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN-HSFFKQIKRRA 317 (327)
T ss_pred cccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc-Chhhhhcchhh
Confidence 111123346889999999999999999999999999 99999876443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=309.00 Aligned_cols=277 Identities=34% Similarity=0.644 Sum_probs=213.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++++++||||+++.+++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK------- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-------
Confidence 47899999999999999999999899999999884322 34568999999999999999988876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (286)
T cd07846 74 -------------------------------------------------------------------------------- 73 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+++++.+.+. .....+++..++.++.||+.
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~ 111 (286)
T cd07846 74 ---------------------------------------RLYLVFEFVDHTVLDDLE---KYPNGLDESRVRKYLFQILR 111 (286)
T ss_pred ---------------------------------------eEEEEEecCCccHHHHHH---hccCCCCHHHHHHHHHHHHH
Confidence 389999999986555432 23345899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||+.|++|+||+|+||+++ +++.++|+|||++........ .....++..|+|||.+.+...++.++|+||||++
T Consensus 112 ~l~~LH~~~i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 190 (286)
T cd07846 112 GIEFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190 (286)
T ss_pred HHHHHHHCCccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence 99999999999999999999999 788999999999865433221 2234568889999998765467889999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+|+|++|++||...+..+....+....+........... +.......+......-.....+.++..+.+|+.+||+.|
T Consensus 191 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07846 191 VTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID 270 (286)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCC
Confidence 999999999998877777777776655543322111110 000111122211111111123467899999999999999
Q ss_pred CCCCCCHHHHhccCchh
Q psy10212 413 PSSRISPLQVRSITPFL 429 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf 429 (444)
|++||++.++++ ||||
T Consensus 271 P~~Rp~~~~il~-~~~~ 286 (286)
T cd07846 271 PDDRPSSSQLLH-HEFF 286 (286)
T ss_pred cccchhHHHHhc-CCCC
Confidence 999999999999 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.40 Aligned_cols=266 Identities=25% Similarity=0.338 Sum_probs=211.3
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
.++.+..++|++++.||+|+||.||+|++..+++.+|+|++... ...+.+|+.+++++ +|+||+++++++......
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45788999999999999999999999999999999999987542 24566899999999 699999999988654310
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (286)
T cd06638 91 -------------------------------------------------------------------------------- 90 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
...++++|||||++ +|.+++.........+++..++.+
T Consensus 91 -----------------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 129 (286)
T cd06638 91 -----------------------------------------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129 (286)
T ss_pred -----------------------------------------CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHH
Confidence 00248999999985 888887654445567899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccC----CCCCc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGA----IDYTT 324 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~s~ 324 (444)
+.|++.||.|||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+... ..++.
T Consensus 130 ~~~i~~~l~~lH~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 208 (286)
T cd06638 130 LHEALMGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA 208 (286)
T ss_pred HHHHHHHHHHHHhCCccccCCCHHhEEEC-CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccc
Confidence 99999999999999999999999999999 77889999999986653322 22234578899999987532 25788
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++|+||+||++|+|++|+.||...+.......+... . ......+..++..+.++
T Consensus 209 ~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~-----------------------~~~~~~~~~~~~~~~~l 262 (286)
T cd06638 209 RCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P-----------------------PPTLHQPELWSNEFNDF 262 (286)
T ss_pred hhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C-----------------------CCcccCCCCcCHHHHHH
Confidence 999999999999999999999876543332221110 0 00001122357889999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
|.+||+.||++|||+.|+|+ |+||
T Consensus 263 i~~~l~~~p~~Rps~~ell~-~~~~ 286 (286)
T cd06638 263 IRKCLTKDYEKRPTVSDLLQ-HVFI 286 (286)
T ss_pred HHHHccCCcccCCCHHHHhh-cccC
Confidence 99999999999999999999 9997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.31 Aligned_cols=297 Identities=29% Similarity=0.499 Sum_probs=220.7
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++..+|.+.+.||.|+||+||+|++..+|+.||+|++.... +.+.+|+.++++++||||+++++.+...+.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~- 80 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE- 80 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc-
Confidence 35689999999999999999999999999999999985432 3456799999999999999998777654320000
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (342)
T cd07854 81 -------------------------------------------------------------------------------- 80 (342)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
-..........++||||++++|.+++. ..++++..++.++.||+
T Consensus 81 -------------------------------~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~ 124 (342)
T cd07854 81 -------------------------------DVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLL 124 (342)
T ss_pred -------------------------------ccccccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHH
Confidence 000000113589999999998888764 24689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||.|||++|++|+||+|+||+++..++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||
T Consensus 125 ~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred HHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHH
Confidence 999999999999999999999998667789999999986543221 1122356788999998766547889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc-cc-CCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE-FK-FPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~-~~-~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||++|+|++|+.||.+.++.+....+.+................... .. ........ ...+.+.++.++.+||.+|
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 283 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP-LRDLLPGVNPEALDFLEQI 283 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCC-HHHHccCCCHHHHHHHHHH
Confidence 999999999999999988887777766665444333222221000000 00 00000000 1112235789999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.++|+ ||||+.+..
T Consensus 284 L~~dP~~R~t~~ell~-h~~~~~~~~ 308 (342)
T cd07854 284 LTFNPMDRLTAEEALM-HPYMSCYSC 308 (342)
T ss_pred hCCCchhccCHHHHhC-CCccccccC
Confidence 9999999999999999 999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.03 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=204.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.|+..+.||+|+||+||+|+++.+|+.||+|++.... ..+..|+.++..+. |++|+++.+++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD------ 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC------
Confidence 3778899999999999999999999999999985431 23456888888775 577788877776553
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (323)
T cd05615 75 -------------------------------------------------------------------------------- 74 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi 110 (323)
T cd05615 75 ----------------------------------------RLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEI 110 (323)
T ss_pred ----------------------------------------EEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHH
Confidence 38999999984 8877774 34579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+|
T Consensus 111 ~~al~~lH~~~ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 188 (323)
T cd05615 111 SVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYG 188 (323)
T ss_pred HHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhH
Confidence 9999999999999999999999999 78899999999986532222 22344689999999999876 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+.......+... .. .++..++.++.+++.+||+.|
T Consensus 189 vil~elltG~~pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 189 VLLYEMLAGQPPFDGEDEDELFQSIMEH-----------------NV------------SYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCccCCHHHHHHHHHHcccC
Confidence 9999999999999988776665555431 11 122346889999999999999
Q ss_pred CCCCCCH-----HHHhccCchhhhhh
Q psy10212 413 PSSRISP-----LQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~-----~elL~~hpwf~~~~ 433 (444)
|.+|++. .++++ ||||+.+.
T Consensus 240 p~~R~~~~~~~~~~i~~-h~~f~~~~ 264 (323)
T cd05615 240 PSKRLGCGPEGERDIRE-HAFFRRID 264 (323)
T ss_pred HhhCCCCCCCCHHHHhc-CcccCCCC
Confidence 9999984 68888 99999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.16 Aligned_cols=285 Identities=31% Similarity=0.563 Sum_probs=221.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|.+.+.||.|+||.||+|+++.+++.+|+|++.... ..+.+|++++++++|+||+++.+++.......
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--- 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS--- 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc---
Confidence 589999999999999999999999999999999984321 24568999999999999999988776654200
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (311)
T cd07866 84 -------------------------------------------------------------------------------- 83 (311)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
......+++||||+++++.+.+.. ....+++..++.++.||+
T Consensus 84 -----------------------------------~~~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~ 125 (311)
T cd07866 84 -----------------------------------KRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLL 125 (311)
T ss_pred -----------------------------------cccCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHH
Confidence 011135899999999988887642 345799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC------------ccccccccccCchhhccCCCC
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN------------VSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~------------~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+||+|||++|++|+||+|+||+++ +++.++|+|||++......... ....+++.|+|||.+.+...+
T Consensus 126 ~al~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 126 EGINYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHHHhCCeecCCCCHHHEEEC-CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 999999999999999999999999 7899999999998654322211 122457789999998765468
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccccCCCChh
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
+.++|+||+|+++|+|++|++||.+.+.......+....+.+.+..+.... +..................+ ..+++.
T Consensus 205 ~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 283 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPE 283 (311)
T ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChh
Confidence 899999999999999999999999999888888888887777665554321 11111000000001111111 234688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
+.++|.+||+.||.+|||+.+++. ||||
T Consensus 284 ~~~~i~~~l~~~p~~R~t~~ell~-~~~f 311 (311)
T cd07866 284 GLDLLSKLLSLDPYKRLTASDALE-HPYF 311 (311)
T ss_pred HHHHHHHHcccCcccCcCHHHHhc-CCCC
Confidence 999999999999999999999999 9998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=320.18 Aligned_cols=244 Identities=29% Similarity=0.499 Sum_probs=198.8
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHH-HhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQ-IMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|+++.+|+.||+|++.... ..+.+|.. +++.++||||+++++.+...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----------- 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----------- 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----------
Confidence 46999999999999999999999999985431 22334443 567789999999988886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (325)
T cd05604 70 -------------------------------------------------------------------------------- 69 (325)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+++|||||++ +|...+. ...++++..++.++.||+.||+
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~ 110 (325)
T cd05604 70 -----------------------------------KLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALG 110 (325)
T ss_pred -----------------------------------EEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7777664 3467899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~givH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e 188 (325)
T cd05604 111 YLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYE 188 (325)
T ss_pred HHHHCCeeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehh
Confidence 99999999999999999999 788999999999865322 2223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||...+..+....+... . ..+++..+..+.++|.+||+.||.+||
T Consensus 189 l~~G~~pf~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 189 MLYGLPPFYCRDVAEMYDNILHK-----------------P------------LVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcC-----------------C------------ccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 99999999887766655544331 0 011234688999999999999999999
Q ss_pred CH----HHHhccCchhhhhh
Q psy10212 418 SP----LQVRSITPFLIELR 433 (444)
Q Consensus 418 s~----~elL~~hpwf~~~~ 433 (444)
++ .++++ ||||+...
T Consensus 240 ~~~~~~~~i~~-h~~f~~~~ 258 (325)
T cd05604 240 GAKEDFLEIQE-HPFFESLS 258 (325)
T ss_pred CCCCCHHHHhc-CCCcCCCC
Confidence 87 58999 99998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=306.65 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=209.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++.+.||.|+||.||+|++..+++.+|+|.+..+. ..+.+|++++++++|+||+++.+++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-------- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--------
Confidence 47999999999999999999999999999999985432 34568999999999999999999887653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (274)
T cd06609 73 -------------------------------------------------------------------------------- 72 (274)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|+||+++ +|.+++.. .++++..++.++.|++.
T Consensus 73 --------------------------------------~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~ 109 (274)
T cd06609 73 --------------------------------------KLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLL 109 (274)
T ss_pred --------------------------------------eEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHH
Confidence 48999999985 88888752 27899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.+||+++++|+||+|+||+++ +++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||||++
T Consensus 110 ~l~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~i 187 (274)
T cd06609 110 GLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGIT 187 (274)
T ss_pred HHHHHHhCCcccCCCCHHHEEEC-CCCCEEEcccccceeecccccccccccCCccccChhhhccC-CCCchhhHHHHHHH
Confidence 99999999999999999999999 7889999999998766443 223344678889999999877 68999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC-CChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR-TPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|+.||...+.......+.... ...+... +++++.++|.+||..||
T Consensus 188 l~~l~tg~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 188 AIELAKGEPPLSDLHPMRVLFLIPKNN----------------------------PPSLEGNKFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred HHHHHhCCCCcccCchHHHHHHhhhcC----------------------------CCCCcccccCHHHHHHHHHHhhCCh
Confidence 999999999998766444333222210 0001112 58899999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~ 435 (444)
++|||+.++++ ||||+.-...
T Consensus 240 ~~Rpt~~~il~-~~~~~~~~~~ 260 (274)
T cd06609 240 KERPSAKELLK-HKFIKKAKKT 260 (274)
T ss_pred hhCcCHHHHhh-ChhhcCCCcc
Confidence 99999999999 9999885443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=302.32 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=210.0
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++++.||.|+||.||+|.+..+|+.+|+|.+... ...+.+|++++++++|+||+++.+++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN------- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC-------
Confidence 488999999999999999999999999999988532 2345579999999999999999888765432
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (265)
T cd08217 74 -------------------------------------------------------------------------------- 73 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++++|||+++ +|.+++........++++..++.++.||+.
T Consensus 74 -------------------------------------~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~ 116 (265)
T cd08217 74 -------------------------------------QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116 (265)
T ss_pred -------------------------------------CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence 348899999985 899998766666778999999999999999
Q ss_pred HHHHHH-----HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhh
Q psy10212 256 SLAYIH-----VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 256 aL~yLH-----s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
||.+|| +.+++|+||+|+||+++ +++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+|
T Consensus 117 ~l~~lH~~~~~~~~i~h~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~ 194 (265)
T cd08217 117 ALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIW 194 (265)
T ss_pred HHHHHhcCccccCcceecCCCHHHEEEe-cCCCEEEecccccccccCCcccccccccCCCccChhhhcCC-CCCchhHHH
Confidence 999999 89999999999999999 789999999999877644432 3344678899999998776 688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++++|++|+.||...+..+....+... .. ..++.+.+..+.+++.+||
T Consensus 195 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~l~~~~l 246 (265)
T cd08217 195 SLGCLIYELCALSPPFTARNQLQLASKIKEG-------------------KF---------RRIPYRYSSELNEVIKSML 246 (265)
T ss_pred HHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------------------CC---------CCCccccCHHHHHHHHHHc
Confidence 9999999999999999877644433322210 00 1123356899999999999
Q ss_pred ccCCCCCCCHHHHhccCchh
Q psy10212 410 EYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf 429 (444)
+.+|.+||++.++|+ |||+
T Consensus 247 ~~~p~~Rp~~~~il~-~~~~ 265 (265)
T cd08217 247 NVDPDKRPSTEELLQ-LPLI 265 (265)
T ss_pred cCCcccCCCHHHHhh-CCCC
Confidence 999999999999999 9995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.92 Aligned_cols=286 Identities=22% Similarity=0.287 Sum_probs=215.7
Q ss_pred hhccccchhheecccceeEEEEeEecC--CCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLD--SGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+..+|++++.||.|+||.||+|.... +++.||+|.+... ....+|++++++++||||+++++.+....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~~-------- 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKS-------- 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeCC--------
Confidence 345679999999999999999998643 4678999988643 34568999999999999999998876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 160 -------------------------------------------------------------------------------- 159 (392)
T PHA03207 160 -------------------------------------------------------------------------------- 159 (392)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.+++||++.++|.+++. ....+++..++.++.||+.|
T Consensus 160 --------------------------------------~~~lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~a 197 (392)
T PHA03207 160 --------------------------------------TVCMVMPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEA 197 (392)
T ss_pred --------------------------------------EEEEEehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHH
Confidence 489999999999998883 34679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
|.|||++|++||||||+||+++ ..+.++|+|||++........ .....++..|+|||.+.+. .++.++|+|||||
T Consensus 198 L~~LH~~givHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv 275 (392)
T PHA03207 198 LAYLHGRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGL 275 (392)
T ss_pred HHHHHHCCccccCCCHHHEEEc-CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHH
Confidence 9999999999999999999999 788999999999865543322 1234689999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCCh---hHHHHHHHHHhCCCCHHHHHhh----CCCCCcccCCCccCCCCcccc-cCCCChhHHHHH
Q psy10212 334 VLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQIREM----NPNYTEFKFPQIKSHPWSKVF-RVRTPPDAIDLI 405 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~---~e~~~~i~~~~g~~~~~~~~~~----~~~~~~~~~p~~~~~~~~~~~-~~~~s~~l~~LI 405 (444)
++|+|++|+.||.+... ...+..+.+.++..+....... ...+..+.............+ ...++.++.++|
T Consensus 276 il~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 355 (392)
T PHA03207 276 VLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLI 355 (392)
T ss_pred HHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHH
Confidence 99999999999976543 3445555555443321100000 000000000000000000111 123578899999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.+||.+||++|||+.|+|. ||||+......-+
T Consensus 356 ~~ml~~dp~~Rpsa~e~l~-~p~f~~~~~~~~~ 387 (392)
T PHA03207 356 AKMLTFDQEFRPSAQDILS-LPLFTKEPINLLN 387 (392)
T ss_pred HHHhccChhhCCCHHHHhh-Cchhhccchhhhc
Confidence 9999999999999999999 9999986655433
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.09 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=204.8
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.|++++.||.|++|.||+++++.+++.+|+|++..+ ...+.+|+.++++++|+|++++.+.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-------- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC--------
Confidence 489999999999999999999999999999998532 234668999999999999999887764332
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (257)
T cd08223 73 -------------------------------------------------------------------------------- 72 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++|++||||++ +|.+++.. .....+++..++.++.|++.
T Consensus 73 -------------------------------------~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~ 113 (257)
T cd08223 73 -------------------------------------GLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAM 113 (257)
T ss_pred -------------------------------------CEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHH
Confidence 258999999985 88888753 23456899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+++||++|++|+||+|+||+++ ..+.++|+|||++...... .......+++.|+|||.+.+. .++.++|+||+|++
T Consensus 114 ~l~~lH~~~i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i 191 (257)
T cd08223 114 ALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCC 191 (257)
T ss_pred HHHHHHhCCeeccCCCchhEEEe-cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHH
Confidence 99999999999999999999999 7889999999998765322 222334578899999998877 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|+.||...+.......+.... .+ .++..+++.+.++|.+||+.||+
T Consensus 192 l~~l~~g~~~~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~ 243 (257)
T cd08223 192 VYEMATLKHAFNAKDMNSLVYRIIEGK-------------------LP---------PMPKDYSPELGELIATMLSKRPE 243 (257)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcC-------------------CC---------CCccccCHHHHHHHHHHhccCcc
Confidence 999999999998766554443333210 00 11234689999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 244 ~Rp~~~~~l~-~~~~ 257 (257)
T cd08223 244 KRPSVKSILR-QPYI 257 (257)
T ss_pred cCCCHHHHhc-CCCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.15 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=208.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.|++.+.||+|+||+||+|.+..+++.+|+|.+.... ..+.+|++++++++|++|+.+.+.+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~------- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD------- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-------
Confidence 3678899999999999999999999999999985331 23567999999999999999988876653
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (285)
T cd05632 74 -------------------------------------------------------------------------------- 73 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..+++|||+.+ +|.+++.. ....++++..+..++.|++
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~ 112 (285)
T cd05632 74 ---------------------------------------ALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEIL 112 (285)
T ss_pred ---------------------------------------EEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHH
Confidence 38999999996 67766642 2334699999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||.|||++|++|+||+|+||+++ +++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 113 ~~l~~lH~~~iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~ 190 (285)
T cd05632 113 CGLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCL 190 (285)
T ss_pred HHHHHHHhCCeeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHH
Confidence 999999999999999999999999 6789999999998665433333345678999999999776 78999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|..||.+.........+....... ...++..+++.+.+|+..||+.||+
T Consensus 191 l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05632 191 IYEMIEGQSPFRGRKEKVKREEVDRRVLET-------------------------EEVYSAKFSEEAKSICKMLLTKDPK 245 (285)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-------------------------ccccCccCCHHHHHHHHHHccCCHh
Confidence 999999999998766554443333211100 0012234688999999999999999
Q ss_pred CCCC-----HHHHhccCchhhhhhh
Q psy10212 415 SRIS-----PLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs-----~~elL~~hpwf~~~~~ 434 (444)
+||+ +.+++. |+||++...
T Consensus 246 ~R~~~~~~~~~~l~~-~~~~~~~~~ 269 (285)
T cd05632 246 QRLGCQEEGAGEVKR-HPFFRNMNF 269 (285)
T ss_pred HcCCCcccChHHHHc-ChhhhcCCH
Confidence 9999 889999 999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.86 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=206.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+++++.+++.||+|++... ...+.+|+.++..++|+||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN------ 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC------
Confidence 4799999999999999999999999999999998542 233567999999999999999998887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (331)
T cd05597 75 -------------------------------------------------------------------------------- 74 (331)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++|+|||||+ ++|.+++.. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi 111 (331)
T cd05597 75 ----------------------------------------NLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEM 111 (331)
T ss_pred ----------------------------------------eEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHH
Confidence 4899999997 588888853 34578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc----CCCCCcchh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG----AIDYTTKID 327 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~s~~sD 327 (444)
+.||+|||+++++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+ ...++.++|
T Consensus 112 ~~~l~~lH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (331)
T cd05597 112 VLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECD 190 (331)
T ss_pred HHHHHHHHhCCeEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcce
Confidence 9999999999999999999999998 788999999999865433222 122457999999999863 225788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||+||++|+|++|+.||.+.+..+....+..... ...++. ....+++.++++|.+
T Consensus 191 iwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~---------~~~~~~~~~~~li~~ 246 (331)
T cd05597 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---------------HFQFPP---------DVTDVSEEAKDLIRR 246 (331)
T ss_pred eehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------------cccCCC---------ccCCCCHHHHHHHHH
Confidence 99999999999999999988776666555443110 001110 012368999999999
Q ss_pred hcccCCCC--CCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSS--RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~k--RPs~~elL~~hpwf~~~~~ 434 (444)
||..++.+ |+++.++++ ||||.+++.
T Consensus 247 ll~~~~~r~~r~~~~~~l~-hp~~~~~~~ 274 (331)
T cd05597 247 LICSPETRLGRNGLQDFKD-HPFFEGIDW 274 (331)
T ss_pred HccCcccccCCCCHHHHhc-CCCCCCCCH
Confidence 99765544 789999999 999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=308.58 Aligned_cols=291 Identities=32% Similarity=0.494 Sum_probs=223.2
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.+...++|++.+.||.|+||+||+|.++.+|+.||+|++.... ..+.+|++++++++||||+++++++.+..+.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 4556789999999999999999999999999999999985432 2345799999999999999999888765420
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
..
T Consensus 82 ~~------------------------------------------------------------------------------ 83 (302)
T cd07864 82 LD------------------------------------------------------------------------------ 83 (302)
T ss_pred hh------------------------------------------------------------------------------
Confidence 00
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
......++++|+||+++++.+.+.. ....+++..++.++
T Consensus 84 --------------------------------------~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~ 122 (302)
T cd07864 84 --------------------------------------FKKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFM 122 (302)
T ss_pred --------------------------------------ccccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHH
Confidence 0000125899999999988887652 24578999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||+|||+.|++|+||+|+||+++ +++.++|+|||.+........ .....++..|+|||.+.+...++.++|+
T Consensus 123 ~qi~~aL~~LH~~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 123 KQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHH
Confidence 9999999999999999999999999999 788999999999876533321 1222446779999988765467899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|||||++++|++|++||...+..+.+..+.+..+.+.+..++.... .+.......... .........++..+.++|.
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 280 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR-RRLREEFSFIPTPALDLLD 280 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccc-cchhhhcCCCCHHHHHHHH
Confidence 9999999999999999998888888888888777776655433211 110000000000 0111112246899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf 429 (444)
+||+.||.+||++.+++. ||||
T Consensus 281 ~~l~~~P~~Rp~~~~il~-~~~~ 302 (302)
T cd07864 281 HMLTLDPSKRCTAEEALN-SPWL 302 (302)
T ss_pred HHccCChhhCCCHHHHhc-CCCC
Confidence 999999999999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.71 Aligned_cols=286 Identities=35% Similarity=0.602 Sum_probs=228.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++|+||+++.+++......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE------ 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc------
Confidence 589999999999999999999989999999998543 23566899999999999999998877665310
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (330)
T cd07834 75 -------------------------------------------------------------------------------- 74 (330)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
....+|++|||++++|.+++. ...++++..++.++.||+.|
T Consensus 75 -----------------------------------~~~~~~lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~ 115 (330)
T cd07834 75 -----------------------------------DFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRG 115 (330)
T ss_pred -----------------------------------cccceEEEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHH
Confidence 002489999999998888874 33489999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|.+||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|
T Consensus 116 l~~LH~~gi~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG 194 (330)
T cd07834 116 LKYLHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194 (330)
T ss_pred HHHHHhCCeecCCCCHHHEEEc-CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHH
Confidence 9999999999999999999999 77999999999987654432 133445688899999987765789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCccc---CCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK---FPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
+++|+|++|+.||.+.+..+....+....+.+....+........... .+......+.. +.+.+++.+.++|.+||
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l 273 (330)
T cd07834 195 CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKML 273 (330)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHc
Confidence 999999999999999999998988988888877665543211110000 00001111111 12447899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.||.+|||+.+++. ||||+.++...
T Consensus 274 ~~~P~~Rpt~~~ll~-~~~~~~~~~~~ 299 (330)
T cd07834 274 VFDPKKRITADEALA-HPYLAQLHDPE 299 (330)
T ss_pred cCChhhCCCHHHHHh-CccHHhhcccc
Confidence 999999999999999 99999987753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=305.56 Aligned_cols=274 Identities=38% Similarity=0.675 Sum_probs=226.1
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|++.+.||+|++|.||+|++..+++.||+|.+.... ..+.+|+.++++++|+||+++.+++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--------- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--------- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC---------
Confidence 677899999999999999999999999999986531 34457999999999999999988887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (282)
T cd07829 72 -------------------------------------------------------------------------------- 71 (282)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++||||++++|.+++... ...+++..++.++.|++.||
T Consensus 72 -------------------------------------~~~~v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l 111 (282)
T cd07829 72 -------------------------------------KLYLVFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGL 111 (282)
T ss_pred -------------------------------------ceEEEecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHH
Confidence 38899999999999998642 25799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
++||++|++|+||+|+||+++ +++.++|+|||.+....... .......+..|+|||.+.+...++.++|+||||++++
T Consensus 112 ~~LH~~~i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~ 190 (282)
T cd07829 112 AYCHSHRILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA 190 (282)
T ss_pred HHHHHCCcccCCCChheEEEc-CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHH
Confidence 999999999999999999999 78999999999986653332 2223345778999999876657889999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC-CcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
+|++|+.||.+.+..+...++....+.+....|....... ....++..........+ +..+..+.++|.+||+.||++
T Consensus 191 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~ 269 (282)
T cd07829 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAK 269 (282)
T ss_pred HHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCccc
Confidence 9999999999998888888899988888887776543221 23334443333333333 234889999999999999999
Q ss_pred CCCHHHHhccCchh
Q psy10212 416 RISPLQVRSITPFL 429 (444)
Q Consensus 416 RPs~~elL~~hpwf 429 (444)
||++.+++. ||||
T Consensus 270 Rp~~~~~l~-~p~~ 282 (282)
T cd07829 270 RISAKEALK-HPYF 282 (282)
T ss_pred CCCHHHHhh-CcCC
Confidence 999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.95 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=210.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.+++.||+|+||.||++++..+++.+|+|.+... ...+.+|++++++++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS------ 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 4789999999999999999999999999999998532 234568999999999999999999887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (290)
T cd05580 75 -------------------------------------------------------------------------------- 74 (290)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||+ ++|.+++.. ...+++..++.++.||
T Consensus 75 ----------------------------------------~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi 110 (290)
T cd05580 75 ----------------------------------------NLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQV 110 (290)
T ss_pred ----------------------------------------eEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 3899999995 689888753 3679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.+||++|++|+||+|+||+++ .++.++|+|||++...... .....+++.|+|||.+.+. ..+.++|+||||+
T Consensus 111 l~~l~~lH~~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 186 (290)
T cd05580 111 VLALEYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGI 186 (290)
T ss_pred HHHHHHHHHCCEecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHH
Confidence 9999999999999999999999999 7889999999998765433 3344678899999998776 7889999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||...+..+....+... .. .++..+++.+.++|.+||..||
T Consensus 187 il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 187 LIYEMLAGYPPFFDDNPIQIYEKILEG-----------------KV------------RFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------Cc------------cCCccCCHHHHHHHHHHccCCH
Confidence 999999999999877755444443321 00 1223458999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~~ 433 (444)
.+|+ +++|+++ ||||+++.
T Consensus 238 ~~R~~~~~~~~~~l~~-~~~~~~~~ 261 (290)
T cd05580 238 TKRLGNLKNGVNDIKN-HPWFAGID 261 (290)
T ss_pred HHccCcccCCHHHHHc-CcccccCC
Confidence 9999 8999999 99999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.30 Aligned_cols=248 Identities=24% Similarity=0.437 Sum_probs=196.4
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|+++.+++.||+|++.... ..+.+|+.++.++ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----------- 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----------- 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----------
Confidence 47999999999999999999999999985431 2345788888776 8999999999887654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (329)
T cd05618 70 -------------------------------------------------------------------------------- 69 (329)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++|||||++ +|..++. ....+++..++.++.||+.||+
T Consensus 70 -----------------------------------~~~lv~E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~ 110 (329)
T cd05618 70 -----------------------------------RLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALN 110 (329)
T ss_pred -----------------------------------EEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999995 7776664 3457999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........|+..|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 188 (329)
T cd05618 111 YLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 188 (329)
T ss_pred HHHHCCeeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHH
Confidence 99999999999999999999 788999999999865322 2223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChh-----HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 338 LLLGQPMFPGDSGV-----DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 338 LltG~~Pf~~~~~~-----e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+.||...... .....+.+.. .. .. ..++..++..+.++|.+||+.|
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~-----~~------------~~~p~~~~~~~~~ll~~~L~~d 243 (329)
T cd05618 189 MMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LE-----KQ------------IRIPRSLSVKAASVLKSFLNKD 243 (329)
T ss_pred HhhCCCCCccCCCcCCcccccHHHHHHHH--------hc-----CC------------CCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999532110 0011111100 00 00 1133457899999999999999
Q ss_pred CCCCCC------HHHHhccCchhhhhh
Q psy10212 413 PSSRIS------PLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs------~~elL~~hpwf~~~~ 433 (444)
|.+||+ +.++++ ||||++..
T Consensus 244 P~~R~~~~~~~~~~~i~~-hp~f~~~~ 269 (329)
T cd05618 244 PKERLGCHPQTGFADIQG-HPFFRNVD 269 (329)
T ss_pred HHHcCCCCCCCCHHHHhc-CCCCCCCC
Confidence 999998 479999 99998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.50 Aligned_cols=244 Identities=28% Similarity=0.455 Sum_probs=197.1
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHH-HHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREM-QIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||.||+|++..+|+.||+|++.... ..+.+|. .+++.++||||+++.+.+...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----------- 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----------- 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----------
Confidence 47999999999999999999999999985321 1223344 3678899999999988876553
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (321)
T cd05603 70 -------------------------------------------------------------------------------- 69 (321)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..|+|||||++ +|...+. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~ 110 (321)
T cd05603 70 -----------------------------------KLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIG 110 (321)
T ss_pred -----------------------------------EEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7776664 3467899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 188 (321)
T cd05603 111 YLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYE 188 (321)
T ss_pred HHHHCCeEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhh
Confidence 99999999999999999999 788999999999865322 2223345679999999999876 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+.......+... . ..++...+..+.++|.+||+.||.+||
T Consensus 189 l~~g~~pf~~~~~~~~~~~i~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 189 MLYGLPPFYSRDVSQMYDNILHK-----------------P------------LQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred hhcCCCCCCCCCHHHHHHHHhcC-----------------C------------CCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 99999999887665544443320 0 012234688999999999999999999
Q ss_pred CH----HHHhccCchhhhhh
Q psy10212 418 SP----LQVRSITPFLIELR 433 (444)
Q Consensus 418 s~----~elL~~hpwf~~~~ 433 (444)
++ .++++ |+||..+.
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~ 258 (321)
T cd05603 240 GAKADFLEIKN-HVFFSPIN 258 (321)
T ss_pred CCCCCHHHHhC-CCCcCCCC
Confidence 86 49999 99998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.39 Aligned_cols=268 Identities=28% Similarity=0.382 Sum_probs=217.9
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
...+.+.++|++++.||.|+||+||+|+++.+++.+|+|.+... ...+.+|+.++++|+||||++++++|....
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 33456778999999999999999999999999999999998532 245668999999999999999999987654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 86 ~------------------------------------------------------------------------------- 86 (1021)
T PTZ00266 86 N------------------------------------------------------------------------------- 86 (1021)
T ss_pred C-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..+|||||||+ ++|.+++.........+++..++
T Consensus 87 ---------------------------------------------~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il 121 (1021)
T PTZ00266 87 ---------------------------------------------QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121 (1021)
T ss_pred ---------------------------------------------CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHH
Confidence 35899999998 59999997666666789999999
Q ss_pred HHHHHHHHHHHHHHHC-------CcccCCCCCCcEEEcC----------------CCCeEEEeecCCcccccCCCCCccc
Q psy10212 248 LYIYQLFRSLAYIHVL-------GICHRDIKPQNLLLNP----------------ETGVLKLCDFGSAKHLVRGEPNVSY 304 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~-------givH~dLkp~NIll~~----------------~~~~ikL~Dfg~s~~~~~~~~~~~~ 304 (444)
.|+.||+.||+|||+. +|+|+||||+|||++. ....++|+|||++............
T Consensus 122 ~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~ 201 (1021)
T PTZ00266 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC 201 (1021)
T ss_pred HHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccccccc
Confidence 9999999999999985 4999999999999962 1235899999999765444444455
Q ss_pred cccccccCchhhccC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCC
Q psy10212 305 ICSRYYRAPELIFGA-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~-~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~ 383 (444)
.+++.|+|||++.+. ..++.++|||||||++|+|++|+.||...+....+...+... + ..+
T Consensus 202 vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p---------------~lp- 263 (1021)
T PTZ00266 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--P---------------DLP- 263 (1021)
T ss_pred CCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--C---------------CCC-
Confidence 789999999998643 257899999999999999999999998765544433332210 0 000
Q ss_pred ccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 384 ~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
....+.++.+||..||+.+|.+||++.|+|. |+||+.+...
T Consensus 264 ----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~-h~~ik~i~~p 304 (1021)
T PTZ00266 264 ----------IKGKSKELNILIKNLLNLSAKERPSALQCLG-YQIIKNVGPP 304 (1021)
T ss_pred ----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc-cHHHhhcCCC
Confidence 0235889999999999999999999999999 9999987654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.08 Aligned_cols=290 Identities=31% Similarity=0.560 Sum_probs=226.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
-.+.++|.+.+.||+|+||.||+|+++.+|+.||+|++... ...+.+|+.++++++|+||+++.+++.......
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 34568999999999999999999999999999999998532 123568999999999999999998886543200
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (342)
T cd07879 91 -------------------------------------------------------------------------------- 90 (342)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.....++||||+..+|.+.. +..+++..++.++.
T Consensus 91 ----------------------------------------~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~ 124 (342)
T cd07879 91 ----------------------------------------EFQDFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVY 124 (342)
T ss_pred ----------------------------------------CCceEEEEecccccCHHHHH------cCCCCHHHHHHHHH
Confidence 00237899999998776654 24689999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|++.||+|||++|++|+||+|+||+++ .++.++|+|||++..... ......++..|+|||.+.+...++.++|+|||
T Consensus 125 qi~~aL~~LH~~~i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 201 (342)
T cd07879 125 QMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201 (342)
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHH
Confidence 999999999999999999999999999 788999999999865422 22334567889999998765468899999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|+++|+|++|+.||.+.+....+..+....+.+.+..+.......... ..+......+... .+.+++.+.+||.+|
T Consensus 202 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~ 280 (342)
T cd07879 202 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKM 280 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHH
Confidence 999999999999999888888888888877777665554432111000 1111111111111 134688999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
|+.||.+||++.++|. ||||+.++...+.
T Consensus 281 l~~dP~~R~~~~e~l~-h~~f~~~~~~~~~ 309 (342)
T cd07879 281 LELDVDKRLTATEALE-HPYFDSFRDADEE 309 (342)
T ss_pred cCCChhhCcCHHHHhc-Ccchhhccccccc
Confidence 9999999999999999 9999998865443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.76 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=207.2
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
-.++|++.+.||+|+||.||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++++.+...+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~---- 116 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR---- 116 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC----
Confidence 348999999999999999999999999999999998532 234568999999999999999998886543
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 117 -------------------------------------------------------------------------------- 116 (371)
T cd05622 117 -------------------------------------------------------------------------------- 116 (371)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
++++|||||+ ++|.+++.. ..+++..++.++.
T Consensus 117 ------------------------------------------~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~ 149 (371)
T cd05622 117 ------------------------------------------YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTA 149 (371)
T ss_pred ------------------------------------------EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHH
Confidence 4999999998 478887742 3588999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccC---CCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGA---IDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~s~~s 326 (444)
||+.||.|||++|++||||||+||+++ .++.++|+|||++....... ......||+.|+|||.+.+. ..++.++
T Consensus 150 qi~~aL~~LH~~~ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~ 228 (371)
T cd05622 150 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228 (371)
T ss_pred HHHHHHHHHHHCCEEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCcc
Confidence 999999999999999999999999999 78899999999987653322 12345689999999998653 1378999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+|||||++|+|++|+.||.+.+.......+..... ...+|. ...++..+.++|.
T Consensus 229 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~ 283 (371)
T cd05622 229 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------------SLTFPD----------DNDISKEAKNLIC 283 (371)
T ss_pred ceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------cccCCC----------cCCCCHHHHHHHH
Confidence 999999999999999999998777665555543110 011111 1246899999999
Q ss_pred HhcccCCCC--CCCHHHHhccCchhhhhh
Q psy10212 407 RLLEYTPSS--RISPLQVRSITPFLIELR 433 (444)
Q Consensus 407 ~~L~~DP~k--RPs~~elL~~hpwf~~~~ 433 (444)
.||..++.+ |+++.++++ |+||++..
T Consensus 284 ~~L~~~~~r~~r~~~~ei~~-h~~~~~~~ 311 (371)
T cd05622 284 AFLTDREVRLGRNGVEEIKR-HLFFKNDQ 311 (371)
T ss_pred HHcCChhhhcCCCCHHHHhc-CcccCCCC
Confidence 999844433 789999999 99998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.56 Aligned_cols=243 Identities=25% Similarity=0.460 Sum_probs=198.4
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHH-HHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREM-QIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||+||+|+++.+++.||+|++.... ..+.+|. .+++.++|+||+++++.+...+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----------- 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----------- 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----------
Confidence 46999999999999999999999999985432 1222333 3567889999999988886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (325)
T cd05602 70 -------------------------------------------------------------------------------- 69 (325)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|.+++. ....+++..++.++.||+.||.
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~ 110 (325)
T cd05602 70 -----------------------------------KLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALG 110 (325)
T ss_pred -----------------------------------eEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999986 7877774 3456889999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++||||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~giiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 188 (325)
T cd05602 111 YLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYE 188 (325)
T ss_pred HHHHCCeEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHH
Confidence 99999999999999999999 788999999999865322 2223345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... . ..++++++..+.++|.+||+.||.+||
T Consensus 189 l~~g~~pf~~~~~~~~~~~i~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 189 MLYGLPPFYSRNTAEMYDNILNK-----------------P------------LQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred HhcCCCCCCCCCHHHHHHHHHhC-----------------C------------cCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999999887766655554431 0 012235789999999999999999999
Q ss_pred CHH----HHhccCchhhhh
Q psy10212 418 SPL----QVRSITPFLIEL 432 (444)
Q Consensus 418 s~~----elL~~hpwf~~~ 432 (444)
++. ++++ |+||..+
T Consensus 240 ~~~~~~~~i~~-~~~~~~~ 257 (325)
T cd05602 240 GAKDDFMEIKN-HIFFSPI 257 (325)
T ss_pred CCCCCHHHHhc-CcccCCC
Confidence 976 8889 9999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=306.54 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=207.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
++|++++.||.|+||.||+|++..+++.+|+|.+.... ..+.+|++++++++|+||+++.+.+....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--------- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC---------
Confidence 67999999999999999999998899999999985432 35668999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (280)
T cd06611 76 -------------------------------------------------------------------------------- 75 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++ +|.+++.. .+.++++..++.++.|++.|
T Consensus 76 -------------------------------------~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~ 115 (280)
T cd06611 76 -------------------------------------KLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEA 115 (280)
T ss_pred -------------------------------------eEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHH
Confidence 38999999986 77777642 34579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhcc----CCCCCcchhhhhH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFG----AIDYTTKIDVWSA 331 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~s~~sDiwSL 331 (444)
|.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|++||.+.. ...++.++|+|||
T Consensus 116 l~~lh~~~i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl 194 (280)
T cd06611 116 LNFLHSHKVIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194 (280)
T ss_pred HHHHHHCCcccCCCChhhEEEC-CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence 9999999999999999999999 78899999999875543222 2233457888999998752 2257789999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|+.||...+......++.... .+. ...+..++..+.++|.+||+.
T Consensus 195 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~-------~~~~~~~~~~~~~li~~~l~~ 248 (280)
T cd06611 195 GITLIELAQMEPPHHELNPMRVLLKILKSE-------------------PPT-------LDQPSKWSSSFNDFLKSCLVK 248 (280)
T ss_pred HHHHHHHHhCCCCcccCCHHHHHHHHhcCC-------------------CCC-------cCCcccCCHHHHHHHHHHhcc
Confidence 999999999999998776554443332210 000 001234688999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||.+||++.++|+ ||||++..
T Consensus 249 ~p~~Rps~~~il~-~~~~~~~~ 269 (280)
T cd06611 249 DPDDRPTAAELLK-HPFVSDQS 269 (280)
T ss_pred ChhhCcCHHHHhc-Chhhcccc
Confidence 9999999999999 99999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=306.73 Aligned_cols=267 Identities=27% Similarity=0.356 Sum_probs=213.0
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
.-+.+..++|.+.+.||+|+||.||+|.++.+++.+|+|.+... ...+.+|+.+++++ +||||+++++++...+..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34667889999999999999999999999999999999998543 24556799999999 899999999998754320
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (291)
T cd06639 95 -------------------------------------------------------------------------------- 94 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.....++||||+++ +|.+++.........+++..++.+
T Consensus 95 -----------------------------------------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 133 (291)
T cd06639 95 -----------------------------------------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133 (291)
T ss_pred -----------------------------------------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHH
Confidence 00248899999985 888888655555678999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCC----CCCc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAI----DYTT 324 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~----~~s~ 324 (444)
+.|++.||.+||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.... .++.
T Consensus 134 ~~qi~~al~~lH~~~ivH~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 212 (291)
T cd06639 134 LYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212 (291)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEEc-CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCC
Confidence 99999999999999999999999999998 78889999999986543322 122345678899999875431 3678
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++|+||+||++|+|++|+.||...+....+.++.+.. . +.. ..+...+..+.++
T Consensus 213 ~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~----------------~~~-------~~~~~~~~~l~~l 266 (291)
T cd06639 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---P----------------PTL-------LHPEKWCRSFNHF 266 (291)
T ss_pred ccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---C----------------CCC-------CcccccCHHHHHH
Confidence 9999999999999999999998776554444332210 0 000 0112356789999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
|.+||+.||++||++.+++. ||||+
T Consensus 267 i~~~l~~~p~~Rps~~~il~-~~~~~ 291 (291)
T cd06639 267 ISQCLIKDFEARPSVTHLLE-HPFIK 291 (291)
T ss_pred HHHHhhcChhhCcCHHHHhc-CcccC
Confidence 99999999999999999999 99995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.90 Aligned_cols=275 Identities=37% Similarity=0.682 Sum_probs=221.0
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
|.+.+.||+|++|+||+|++..+++.+|||++.... ....+|+..+++++ |+||+++++++...+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--------- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND--------- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC---------
Confidence 678999999999999999999899999999985432 23346899999999 999999988876643
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (283)
T cd07830 72 -------------------------------------------------------------------------------- 71 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++||||++++|.+.+... ....+++..++.++.|++.+|
T Consensus 72 -------------------------------------~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l 112 (283)
T cd07830 72 -------------------------------------ELYFVFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGL 112 (283)
T ss_pred -------------------------------------cEEEEEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHH
Confidence 38999999999999887532 235789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||++|++|+||+|+||+++ ..+.++|+|||.+.............++..|+|||.+.+...++.++|+||||+++++
T Consensus 113 ~~Lh~~~i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~e 191 (283)
T cd07830 113 AHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191 (283)
T ss_pred HHHHHCCcccCCCChhhEEEc-CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHH
Confidence 999999999999999999999 7899999999998766444344445678889999988655468899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|++|+.||...+..+...++...++.+....+...... .....++..........+ ...+..+.++|.+||+.||++
T Consensus 192 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~ 270 (283)
T cd07830 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKK 270 (283)
T ss_pred HHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCccc
Confidence 99999999999888888888888888776555432110 111111111111111112 234789999999999999999
Q ss_pred CCCHHHHhccCchh
Q psy10212 416 RISPLQVRSITPFL 429 (444)
Q Consensus 416 RPs~~elL~~hpwf 429 (444)
|||+.|++. ||||
T Consensus 271 Rpt~~ei~~-~~~~ 283 (283)
T cd07830 271 RPTASQALQ-HPYF 283 (283)
T ss_pred CCCHHHHhh-CCCC
Confidence 999999999 9997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=302.95 Aligned_cols=263 Identities=29% Similarity=0.371 Sum_probs=210.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+..++|++.+.||+|++|.||+|+++.+++.+|+|.+.... ..+.+|+.+++++ .|+||+++++++......
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~---- 78 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP---- 78 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC----
Confidence 45689999999999999999999999899999999985442 4566899999999 799999999998775420
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (275)
T cd06608 79 -------------------------------------------------------------------------------- 78 (275)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
....++++|||||++ +|.+++......+.++++..++.++.|+
T Consensus 79 ------------------------------------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql 122 (275)
T cd06608 79 ------------------------------------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122 (275)
T ss_pred ------------------------------------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHH
Confidence 001358999999996 8888887655556789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccC----CCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGA----IDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~s~~sDi 328 (444)
+.||+|||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+... ..++.++|+
T Consensus 123 ~~al~~lH~~~i~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 123 LRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHHHHhcCCcccCCCCHHHEEEc-cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999999999999999999999 78899999999886543222 22334578889999987532 246789999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|+.||..........++.... .+.. ..+..++..+.++|.+|
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~-------~~~~~~~~~~~~li~~~ 255 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMRALFKIPRNP-------------------PPTL-------KSPENWSKKFNDFISEC 255 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHHHHHHhhccC-------------------CCCC-------CchhhcCHHHHHHHHHH
Confidence 999999999999999998665544444332210 0000 00123578999999999
Q ss_pred cccCCCCCCCHHHHhccCchh
Q psy10212 409 LEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf 429 (444)
|..||++|||+.++++ |||+
T Consensus 256 l~~dp~~Rpt~~~ll~-~~~~ 275 (275)
T cd06608 256 LIKNYEQRPFMEELLE-HPFI 275 (275)
T ss_pred hhcChhhCcCHHHHhc-CCCC
Confidence 9999999999999999 9996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.74 Aligned_cols=244 Identities=28% Similarity=0.505 Sum_probs=196.7
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc---CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL---EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
||+|+||+||+|+++.+|+.||+|++.... ....+|..++.++ .||+|+++.+.+....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----------- 69 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----------- 69 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----------
Confidence 799999999999999999999999985431 1222455566555 6999999988886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (330)
T cd05586 70 -------------------------------------------------------------------------------- 69 (330)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|.+.+. ....+++..++.++.||+.||+
T Consensus 70 -----------------------------------~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~ 110 (330)
T cd05586 70 -----------------------------------DLYLVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALE 110 (330)
T ss_pred -----------------------------------eEEEEEcCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877764 3567999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++|+||||+||+++ .++.++|+|||++...... .......|+..|+|||.+.+...++.++|+|||||++|+
T Consensus 111 ~LH~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~e 189 (330)
T cd05586 111 HLHKYDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189 (330)
T ss_pred HHHHCCeEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEE
Confidence 99999999999999999999 7889999999998654222 223345689999999998765468899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+... ...++. ..+++.+.++|.+||+.||.+||
T Consensus 190 lltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 190 MCCGWSPFYAEDTQQMYRNIAFG-----------------KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcC-----------------CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCC
Confidence 99999999887765554444321 111111 13588999999999999999998
Q ss_pred ----CHHHHhccCchhhhhh
Q psy10212 418 ----SPLQVRSITPFLIELR 433 (444)
Q Consensus 418 ----s~~elL~~hpwf~~~~ 433 (444)
++.++++ ||||++..
T Consensus 242 ~~~~~~~~ll~-h~~~~~~~ 260 (330)
T cd05586 242 GAHRDAVELKE-HPFFADID 260 (330)
T ss_pred CCCCCHHHHhc-CccccCCC
Confidence 6899999 99998743
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=286.42 Aligned_cols=276 Identities=36% Similarity=0.651 Sum_probs=237.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|.-.++||.|.||+||+|++..+++.||+|.+..+ .....||+-+++.|.|.|||++++...++..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk------- 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK------- 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce-------
Confidence 577789999999999999999999999999999543 2456699999999999999999988877653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (292)
T KOG0662|consen 76 -------------------------------------------------------------------------------- 75 (292)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+-+|+|||...|..++. .-++.++.+.++.++.|++.|
T Consensus 76 ---------------------------------------ltlvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrg 113 (292)
T KOG0662|consen 76 ---------------------------------------LTLVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRG 113 (292)
T ss_pred ---------------------------------------eEEeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhh
Confidence 88999999999998886 356789999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.++|++++.|||+||.|++++ .+|.+||.|||+++.++-.- ..+....|.+|.+|.++.+..-|+.+.|+||.||++
T Consensus 114 l~fchshnvlhrdlkpqnllin-~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcif 192 (292)
T KOG0662|consen 114 LGFCHSHNVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_pred hhhhhhhhhhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHH
Confidence 9999999999999999999999 89999999999998764332 223345689999999999987899999999999999
Q ss_pred HHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCcc-CCCCcccccCCCChhHHHHHHHhccc
Q psy10212 336 AELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 336 ~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~-~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
.|+. .|++.|++.+..+++.+|+..+|.+....|+.+. +++. ..|... ...|.+.. ++++..-++++..+|..
T Consensus 193 aelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk--~yp~ypattswsqiv-p~lns~grdllqkll~c 269 (292)
T KOG0662|consen 193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK--PYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKC 269 (292)
T ss_pred HHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc--ccCCccccchHHHHh-hhhcchhHHHHHHHhcc
Confidence 9999 6999999999999999999999999999888754 3332 233333 23344443 46788899999999999
Q ss_pred CCCCCCCHHHHhccCchhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~ 432 (444)
+|.+|++++.+|. ||||.+.
T Consensus 270 np~qrisaeaalq-hpyf~d~ 289 (292)
T KOG0662|consen 270 NPAQRISAEAALQ-HPYFSDF 289 (292)
T ss_pred CcccccCHHHHhc-Ccccccc
Confidence 9999999999999 9999874
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=315.19 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=197.8
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|++..+++.||+|++... ...+.+|+.++.++ +||+|+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----------- 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----------- 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----------
Confidence 4799999999999999999999999999643 13355788888888 6999999998886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (327)
T cd05617 70 -------------------------------------------------------------------------------- 69 (327)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+|+|||||++ +|...+. ....+++..++.++.||+.||+
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~ 110 (327)
T cd05617 70 -----------------------------------RLFLVIEYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALN 110 (327)
T ss_pred -----------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 38999999985 7877664 3457999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||++|++|+||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+|||||++|+
T Consensus 111 ~lH~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~e 188 (327)
T cd05617 111 FLHERGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFE 188 (327)
T ss_pred HHHHCCeeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHH
Confidence 99999999999999999999 788999999999865322 2233345689999999999877 78999999999999999
Q ss_pred HHhCCCCCCCCCh------hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 338 LLLGQPMFPGDSG------VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 338 LltG~~Pf~~~~~------~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|++|+.||..... .+...+.... .. ..++..+++.+.++|.+||+.
T Consensus 189 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------~~------------~~~p~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 189 MMAGRSPFDIITDNPDMNTEDYLFQVILE----------------KP------------IRIPRFLSVKASHVLKGFLNK 240 (327)
T ss_pred HHhCCCCCCccCCCcccccHHHHHHHHHh----------------CC------------CCCCCCCCHHHHHHHHHHhcc
Confidence 9999999964321 1112211110 00 112335689999999999999
Q ss_pred CCCCCCCH------HHHhccCchhhhhh
Q psy10212 412 TPSSRISP------LQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRPs~------~elL~~hpwf~~~~ 433 (444)
||.+|+++ .++++ ||||+.+.
T Consensus 241 dP~~R~~~~~~~~~~~i~~-h~~f~~~~ 267 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKS-HTFFRSID 267 (327)
T ss_pred CHHHcCCCCCCCCHHHHHc-CCCCCCCC
Confidence 99999984 69999 99998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.71 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=204.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||+|+||.||+|++..+++.||+|.+..+ ...+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-------- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--------
Confidence 4688999999999999999999999999999998543 234668999999999999999999987764
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (279)
T cd06619 73 -------------------------------------------------------------------------------- 72 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++...+.. ..+++..+..++.|++.|
T Consensus 73 --------------------------------------~~~lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~ 107 (279)
T cd06619 73 --------------------------------------RISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKG 107 (279)
T ss_pred --------------------------------------EEEEEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHH
Confidence 37899999997443322 357888999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
|+|||+.|++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||||+++|
T Consensus 108 l~~lH~~~i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ 184 (279)
T cd06619 108 LTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFM 184 (279)
T ss_pred HHHHHHCCEeeCCCCHHHEEEC-CCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHH
Confidence 9999999999999999999999 7899999999998665332 23345678899999999877 7899999999999999
Q ss_pred HHHhCCCCCCCCChhHH---HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 337 ELLLGQPMFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|++|+.||......+. ........... . . ........++++.++|.+||+.||
T Consensus 185 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~---~--------~~~~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------------D---P--------PVLPVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred HHHhCCCCchhhcccccccchHHHHHHHhcc------------C---C--------CCCCCCcCCHHHHHHHHHHhhCCh
Confidence 99999999975332110 01111110000 0 0 000112357899999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhhhhcc
Q psy10212 414 SSRISPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~~~~~ 439 (444)
.+||++.++++ ||||+.......++
T Consensus 242 ~~Rp~~~eil~-~~~~~~~~~~~~~~ 266 (279)
T cd06619 242 KERPAPENLMD-HPFIVQYNDGNAEV 266 (279)
T ss_pred hhCCCHHHHhc-CcccccccCccHHH
Confidence 99999999999 99999876554443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=298.60 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=206.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++|++.+.||+|+||.||+|++..+++.+|+|.+... ...+.+|++++++++|+||+++.+++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----------- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT----------- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----------
Confidence 6899999999999999999999988999999998644 356778999999999999999999887654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (256)
T cd06612 72 -------------------------------------------------------------------------------- 71 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
++++++||+++ +|.+++. .....+++..++.++.|++.||.
T Consensus 72 -----------------------------------~~~l~~e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~ 113 (256)
T cd06612 72 -----------------------------------DLWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLE 113 (256)
T ss_pred -----------------------------------cEEEEEecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHH
Confidence 38999999995 8888774 23467899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
|||+.+++|+||+|+||+++ +++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus 114 ~lh~~~i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 114 YLHSNKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIE 191 (256)
T ss_pred HHHHCCcccCCCCcceEEEC-CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHH
Confidence 99999999999999999999 78899999999987654333 22334568889999998877 78999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||...+.......+... ..+ ....+..++..+.++|.+||+.||.+||
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 245 (256)
T cd06612 192 MAEGKPPYSDIHPMRAIFMIPNK-------------------PPP-------TLSDPEKWSPEFNDFVKKCLVKDPEERP 245 (256)
T ss_pred HHhCCCCCCCcchhhhhhhhccC-------------------CCC-------CCCchhhcCHHHHHHHHHHHhcChhhCc
Confidence 99999999876544322211110 000 0001234678999999999999999999
Q ss_pred CHHHHhccCchh
Q psy10212 418 SPLQVRSITPFL 429 (444)
Q Consensus 418 s~~elL~~hpwf 429 (444)
|+.|+|. ||||
T Consensus 246 s~~~il~-~~~~ 256 (256)
T cd06612 246 SAIQLLQ-HPFI 256 (256)
T ss_pred CHHHHhc-CCCC
Confidence 9999999 9997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.10 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=205.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+.|++++.||+|+||.||+|++..+++.+|+|.+.... ..+.+|+.+++++.|+||+++.+.+..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--------- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC---------
Confidence 67999999999999999999999999999999985432 34557999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (292)
T cd06644 83 -------------------------------------------------------------------------------- 82 (292)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++ +|...+. .....+++..++.++.|++.+
T Consensus 83 -------------------------------------~~~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~ 122 (292)
T cd06644 83 -------------------------------------KLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEA 122 (292)
T ss_pred -------------------------------------eEEEEEecCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHH
Confidence 38999999996 5555543 234568999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhcc----CCCCCcchhhhhH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG----AIDYTTKIDVWSA 331 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~s~~sDiwSL 331 (444)
|++||+++++|+||+|+||+++ .++.++|+|||.+...... .......++..|+|||.+.+ ...++.++|+|||
T Consensus 123 l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 123 LQYLHSMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred HHHHhcCCeeecCCCcceEEEc-CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 9999999999999999999998 7889999999987653222 12233456888999998852 2257889999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|..||...+......++... .. + ....+..++.++.++|.+||..
T Consensus 202 G~il~el~~g~~p~~~~~~~~~~~~~~~~---~~----------------~-------~~~~~~~~~~~~~~li~~~l~~ 255 (292)
T cd06644 202 GITLIEMAQIEPPHHELNPMRVLLKIAKS---EP----------------P-------TLSQPSKWSMEFRDFLKTALDK 255 (292)
T ss_pred HHHHHHHhcCCCCCccccHHHHHHHHhcC---CC----------------c-------cCCCCcccCHHHHHHHHHHhcC
Confidence 99999999999999876654444333221 00 0 0011234678999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||++||++.++++ ||||+.+..
T Consensus 256 ~p~~Rp~~~~il~-~~~~~~~~~ 277 (292)
T cd06644 256 HPETRPSAAQLLE-HPFVSSVTS 277 (292)
T ss_pred CcccCcCHHHHhc-Ccccccccc
Confidence 9999999999999 999987543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=299.06 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=205.8
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|.+.+.||+|++|.||+|+++.+++.||+|.+... ...+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-------- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--------
Confidence 478899999999999999999999999999998532 345568999999999999999998887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd08529 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||++ ++|.+++... ....+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~ 112 (256)
T cd08529 73 --------------------------------------KLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILL 112 (256)
T ss_pred --------------------------------------EEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHH
Confidence 3899999997 4898888642 3467899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||...+. .++.++|+||||++
T Consensus 113 al~~lH~~~i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i 190 (256)
T cd08529 113 GLAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVV 190 (256)
T ss_pred HHHHHHHCCcccCCCCcceEEEe-CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHH
Confidence 99999999999999999999999 788999999998876543322 2234578889999999877 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|+.||...+..+....+.... .+ .++..++..+.++|.+||+.+|+
T Consensus 191 l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08529 191 LYECCTGKHPFDANNQGALILKIIRGV-------------------FP---------PVSQMYSQQLAQLIDQCLTKDYR 242 (256)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------CC---------CCccccCHHHHHHHHHHccCCcc
Confidence 999999999998777555444333210 00 11124588999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.++++ |||+
T Consensus 243 ~Rp~~~~ll~-~~~~ 256 (256)
T cd08529 243 QRPDTFQLLR-NPSL 256 (256)
T ss_pred cCcCHHHHhh-CCCC
Confidence 9999999999 9995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=306.89 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=206.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.|+..+.||+|+||.||++++..+++.+|+|.+... ...+.+|+.++.++. |+||+++++++..++.
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~------- 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD------- 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc-------
Confidence 567889999999999999999999999999998532 234567999999996 9999999998876542
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (288)
T cd06616 78 -------------------------------------------------------------------------------- 77 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhh-hcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYS-KSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~-~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||++.++.++..... .....+++..+..++.|++.
T Consensus 78 ---------------------------------------~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~ 118 (288)
T cd06616 78 ---------------------------------------CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118 (288)
T ss_pred ---------------------------------------EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence 78999999988777654322 23467999999999999999
Q ss_pred HHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC--CCCCcchhhhhHH
Q psy10212 256 SLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA--IDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~s~~sDiwSLG 332 (444)
||+|||+. +++|+||+|+||+++ ..+.++|+|||++.............++..|+|||.+.+. ..++.++|+||+|
T Consensus 119 ~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 119 ALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred HHHHHhhcCCeeccCCCHHHEEEc-cCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 99999974 999999999999999 7889999999998765444333444678889999998765 3688999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||.... .....+.+..... .+. ........++..+.+||.+||+.|
T Consensus 198 ~il~el~~g~~p~~~~~--~~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~~l~~li~~~l~~~ 254 (288)
T cd06616 198 ITLYEVATGKFPYPKWN--SVFDQLTQVVKGD----------------PPI-----LSNSEEREFSPSFVNFINLCLIKD 254 (288)
T ss_pred HHHHHHHhCCCCchhcc--hHHHHHhhhcCCC----------------CCc-----CCCcCCCccCHHHHHHHHHHccCC
Confidence 99999999999997654 1222222211100 000 011111346899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|++|||+.++++ ||||++....
T Consensus 255 p~~Rpt~~~i~~-~~~~~~~~~~ 276 (288)
T cd06616 255 ESKRPKYKELLE-HPFIKDYEER 276 (288)
T ss_pred hhhCcCHHHHhc-Chhhhchhhc
Confidence 999999999999 9999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.41 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=210.3
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.....+|++.+.||.|+||+||+|++..+|+.||+|.+... .+.+.+|+..+++++||||+++.+++....
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 89 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD----- 89 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----
Confidence 34446899999999999999999999999999999998433 245567999999999999999999887653
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (296)
T cd06655 90 -------------------------------------------------------------------------------- 89 (296)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|+||+.+ +|..++. ...+++..+..++.|
T Consensus 90 -----------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~ 123 (296)
T cd06655 90 -----------------------------------------ELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRE 123 (296)
T ss_pred -----------------------------------------eEEEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHH
Confidence 38999999985 7777764 246899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
++.||++||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+|||
T Consensus 124 l~~al~~LH~~~i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl 201 (296)
T cd06655 124 CLQALEFLHANQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSL 201 (296)
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCC-CCCchhhHHHH
Confidence 99999999999999999999999998 788999999998765433322 2234578889999998776 78899999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||...+..+....+... +.+ ....+..+++.+.++|.+||..
T Consensus 202 Gvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 202 GIMAIEMVEGEPPYLNENPLRALYLIATN-GTP-------------------------ELQNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc-------------------------ccCCcccCCHHHHHHHHHHhhc
Confidence 99999999999999887665444333220 000 0001234688999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||.+|||+.+++. ||||+..+.
T Consensus 256 dp~~Rpt~~~il~-~~~~~~~~~ 277 (296)
T cd06655 256 DVEKRGSAKELLQ-HPFLKLAKP 277 (296)
T ss_pred ChhhCCCHHHHhh-ChHhhhccc
Confidence 9999999999999 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.70 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=207.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++++.||+|+||.||+|.+..+++.+|+|.+... ...+.+|++++++++||||+++.+.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-------- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--------
Confidence 589999999999999999999999999999998543 235668999999999999999988876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd08220 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+++ +|.+++.. .....+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~ 112 (256)
T cd08220 73 --------------------------------------ALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILL 112 (256)
T ss_pred --------------------------------------EEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHH
Confidence 38999999985 89888853 22456899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|+|||++|++|+||+|+||+++.+++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|+++
T Consensus 113 ~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l 191 (256)
T cd08220 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVL 191 (256)
T ss_pred HHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCC-CCCcccchHHHHHHH
Confidence 9999999999999999999999855667899999998766544433445678899999999876 788999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|..||...+.......+..... ..++..+++.+.++|.+||..||++
T Consensus 192 ~~l~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 243 (256)
T cd08220 192 YELASLKRAFEAANLPALVLKIMSGTF----------------------------APISDRYSPDLRQLILSMLNLDPSK 243 (256)
T ss_pred HHHHhCCCCcccCchHHHHHHHHhcCC----------------------------CCCCCCcCHHHHHHHHHHccCChhh
Confidence 999999999987765554443332100 0112346899999999999999999
Q ss_pred CCCHHHHhccCchh
Q psy10212 416 RISPLQVRSITPFL 429 (444)
Q Consensus 416 RPs~~elL~~hpwf 429 (444)
|||+.|++. ||||
T Consensus 244 Rpt~~~ll~-~p~~ 256 (256)
T cd08220 244 RPQLSQIMA-QPIC 256 (256)
T ss_pred CCCHHHHhh-CCCC
Confidence 999999999 9996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.90 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=201.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE--- 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---
Confidence 5789999999999999999999999999999988432 1345679999999999999999988765432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (266)
T cd06651 79 -------------------------------------------------------------------------------- 78 (266)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++++|||+++ +|.+++. ....+++..++.++.
T Consensus 79 -----------------------------------------~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~ 113 (266)
T cd06651 79 -----------------------------------------KTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTR 113 (266)
T ss_pred -----------------------------------------CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHH
Confidence 248899999985 8888875 234688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
|++.||+|||+++++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+. .++.++|
T Consensus 114 qi~~~l~~LH~~~i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 191 (266)
T cd06651 114 QILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKAD 191 (266)
T ss_pred HHHHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC-CCCchhh
Confidence 999999999999999999999999999 78899999999986543211 11223467889999999876 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||+|+++|+|++|+.||...+......++... + ....++..+++.+.++| +
T Consensus 192 v~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~~~~li-~ 243 (266)
T cd06651 192 VWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---P------------------------TNPQLPSHISEHARDFL-G 243 (266)
T ss_pred hHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---C------------------------CCCCCchhcCHHHHHHH-H
Confidence 999999999999999999876544433322210 0 00112234688899999 6
Q ss_pred hcccCCCCCCCHHHHhccCchhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
||..+|++||++.|+++ ||||+
T Consensus 244 ~~~~~p~~Rp~~~eil~-hp~~~ 265 (266)
T cd06651 244 CIFVEARHRPSAEELLR-HPFAQ 265 (266)
T ss_pred HhcCChhhCcCHHHHhc-Ccccc
Confidence 88899999999999999 99996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.86 Aligned_cols=281 Identities=33% Similarity=0.658 Sum_probs=224.7
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.++|++++.||.|+||.||+|+++.+++.||+|++... ...+.+|+.++++++||||+++.+++...+.
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 83 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE--- 83 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC---
Confidence 4689999999999999999999999999999999987432 2345579999999999999999998876432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (328)
T cd07856 84 -------------------------------------------------------------------------------- 83 (328)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..+++|||++++|.+++. ..++++..+..++.|
T Consensus 84 ------------------------------------------~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~q 116 (328)
T cd07856 84 ------------------------------------------DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQ 116 (328)
T ss_pred ------------------------------------------cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHH
Confidence 378999999999887764 346888999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||+++++|+||+|+||+++ +.+.++|+|||.+..... ......++..|+|||.+.+...++.++|+||||
T Consensus 117 l~~aL~~LH~~~iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 193 (328)
T cd07856 117 ILRGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193 (328)
T ss_pred HHHHHHHHHhCCcccCCCCHHHEeEC-CCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHH
Confidence 99999999999999999999999999 788999999999865322 223345678899999887644789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCccc----CCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK----FPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
+++|+|++|+.||...........+.+.++.++...+....... ... .+........ ...+.+++.+.++|.+|
T Consensus 194 ~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 271 (328)
T cd07856 194 CIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-TLRFVQSLPKREPVPFS-EKFKNADPSAIDLLEKM 271 (328)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-hHHHHhhccccCCCcHH-HHcCCCCHHHHHHHHHH
Confidence 99999999999999888877777788888877765544321110 000 0000000111 11235689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|+.+|++|||+.+++. ||||+..+.+
T Consensus 272 l~~~P~~R~t~~ell~-~~~~~~~~~~ 297 (328)
T cd07856 272 LVFDPQKRISAAEALA-HPYLAPYHDP 297 (328)
T ss_pred cCCChhhCCCHHHHhc-CCccccccCC
Confidence 9999999999999999 9999876655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=313.92 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=206.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|+++++||+|+||.||+++++.+++.||+|.+... ...+.+|+.++..++|++|+++.+.+....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN------ 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC------
Confidence 4789999999999999999999999999999998532 123567899999999999999988886553
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (332)
T cd05623 75 -------------------------------------------------------------------------------- 74 (332)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||+ ++|.+++.. ....+++..++.++.||
T Consensus 75 ----------------------------------------~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi 111 (332)
T cd05623 75 ----------------------------------------NLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEM 111 (332)
T ss_pred ----------------------------------------EEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHH
Confidence 3899999997 588888853 34578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc----CCCCCcchh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG----AIDYTTKID 327 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~s~~sD 327 (444)
+.||.|||++|++||||||+||+++ .++.++|+|||++........ .....|++.|+|||.+.+ ...++.++|
T Consensus 112 ~~al~~lH~~~iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (332)
T cd05623 112 VIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190 (332)
T ss_pred HHHHHHHHHCCeEecCCCHHHEEEC-CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCC
Confidence 9999999999999999999999999 788999999999865432221 223468999999999862 235789999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|||||++|+|++|+.||...+..+....+.... ....+|. ....+++++.+||.+
T Consensus 191 vwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~---------~~~~~s~~~~~li~~ 246 (332)
T cd05623 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK---------------ERFQFPA---------QVTDVSEDAKDLIRR 246 (332)
T ss_pred EEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------------ccccCCC---------ccccCCHHHHHHHHH
Confidence 9999999999999999998877766665554310 0111111 012468999999999
Q ss_pred hcccCCCC--CCCHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSS--RISPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~k--RPs~~elL~~hpwf~~~~ 433 (444)
||..++.+ |+++.++++ ||||+.+.
T Consensus 247 ll~~~~~r~~r~~~~~~~~-h~~f~~~~ 273 (332)
T cd05623 247 LICSREHRLGQNGIEDFKQ-HPFFTGID 273 (332)
T ss_pred HccChhhhcCCCCHHHHhC-CCCcCCCC
Confidence 99765554 789999999 99998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.57 Aligned_cols=254 Identities=28% Similarity=0.372 Sum_probs=205.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+.|++++.||+|+||.||+|++..+++.+|+|.+... ...+.+|++++++++||||+++.+++...+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--------- 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--------- 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC---------
Confidence 4589999999999999999999999999999998543 235668999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (282)
T cd06643 76 -------------------------------------------------------------------------------- 75 (282)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++ +|..++. ....++++..+..++.|++.|
T Consensus 76 -------------------------------------~~~~v~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~~ 115 (282)
T cd06643 76 -------------------------------------NLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEA 115 (282)
T ss_pred -------------------------------------EEEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHH
Confidence 38999999996 5555543 234578999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhc----cCCCCCcchhhhhH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIF----GAIDYTTKIDVWSA 331 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~----~~~~~s~~sDiwSL 331 (444)
|.|||+.|++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+. ....++.++|+||+
T Consensus 116 L~~LH~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 116 LNYLHENKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred HHHHHHCCeeecCCCcccEEEc-cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 9999999999999999999998 78899999999986543221 122345788999999874 22257789999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||...+..+....+...... ....+..++..+.++|.+||+.
T Consensus 195 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~ 248 (282)
T cd06643 195 GITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------------------------TLAQPSRWSSEFKDFLKKCLEK 248 (282)
T ss_pred HHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------------------------CCCCccccCHHHHHHHHHHccC
Confidence 99999999999999887765555444331100 0001224688999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~ 432 (444)
||.+||++.++++ ||||+..
T Consensus 249 ~p~~Rp~~~~il~-~~~~~~~ 268 (282)
T cd06643 249 NVDARWTTTQLLQ-HPFVTVN 268 (282)
T ss_pred ChhhCcCHHHHhc-CCCEecc
Confidence 9999999999999 9999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.51 Aligned_cols=289 Identities=31% Similarity=0.588 Sum_probs=228.2
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
..++.++|++.+.||+|++|.||+|++..+++.||+|++... ...+.+|+.++++++|+||+++.+++......
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 456788999999999999999999999999999999988432 13345799999999999999987766543310
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (343)
T cd07851 90 -------------------------------------------------------------------------------- 89 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.....+++|+||++++|.+++.. .++++..++.++
T Consensus 90 ----------------------------------------~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~ 124 (343)
T cd07851 90 ----------------------------------------EDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLV 124 (343)
T ss_pred ----------------------------------------cccccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHH
Confidence 00124899999999999998852 579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||++||++|++|+||+|+||+++ +++.++|+|||.+...... .....++..|+|||.+.+...++.++|+||
T Consensus 125 ~ql~~aL~~LH~~gi~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (343)
T cd07851 125 YQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201 (343)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHeEEC-CCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHH
Confidence 9999999999999999999999999999 7889999999998765332 233456788999999876546789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||+++|+|++|+.||.+.+..+.+..+.+..+.+.+..+..+...... ...+......+... ...+++.+.++|.+
T Consensus 202 lGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~ 280 (343)
T cd07851 202 VGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHH
Confidence 999999999999999988888888888887777776655543321110 00111111111111 13458999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||+.||++|||+.++++ ||||++....
T Consensus 281 ~l~~~P~~Rpt~~ell~-h~~~~~~~~~ 307 (343)
T cd07851 281 MLVLDPDKRITAAEALA-HPYLAEYHDP 307 (343)
T ss_pred hCCCChhhCCCHHHHhc-CCCccccCCC
Confidence 99999999999999999 9999986544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.99 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=209.7
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.+...+|++++.||+|+||.||+|+++.+++.||+|.+... ...+.+|+.+++.+.|+||+++.+.+....
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~---- 90 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC----
Confidence 345668999999999999999999999999999999998543 245668999999999999999999887653
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (296)
T cd06654 91 -------------------------------------------------------------------------------- 90 (296)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++||||+++ +|.+++. ...+++..+..++.
T Consensus 91 ------------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ 123 (296)
T cd06654 91 ------------------------------------------ELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123 (296)
T ss_pred ------------------------------------------EEEEeecccCCCCHHHHHH-----hcCCCHHHHHHHHH
Confidence 38999999985 8888774 24588999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|++.||+|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||
T Consensus 124 ql~~aL~~LH~~gi~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s 201 (296)
T cd06654 124 ECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWS 201 (296)
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCEEECccccchhccccccccCcccCCccccCHHHHcCC-CCCccchHHH
Confidence 999999999999999999999999998 78899999999886543222 12234678899999998876 7889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||...+.......+.. .+. + ....+..+++.+.++|.+||.
T Consensus 202 ~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~------------------~-------~~~~~~~~~~~l~~li~~~l~ 255 (296)
T cd06654 202 LGIMAIEMIEGEPPYLNENPLRALYLIAT-NGT------------------P-------ELQNPEKLSAIFRDFLNRCLD 255 (296)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCC------------------C-------CCCCccccCHHHHHHHHHHCc
Confidence 99999999999999987655433222111 000 0 001123468899999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.||++|||+.+++. ||||+..+.
T Consensus 256 ~~p~~Rpt~~eil~-~~~~~~~~~ 278 (296)
T cd06654 256 MDVEKRGSAKELLQ-HQFLKIAKP 278 (296)
T ss_pred CCcccCcCHHHHhh-ChhhhccCC
Confidence 99999999999999 999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.71 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=202.8
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc----------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+|+..+.||+|+||.||+|.+..+++.+|+|++.... ..+.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS---- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence 4788899999999999999999999999999985432 35668999999999999999998886554
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (268)
T cd06630 77 -------------------------------------------------------------------------------- 76 (268)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++||||+.+ +|.+++.. .+++++..++.++.
T Consensus 77 ------------------------------------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ 110 (268)
T cd06630 77 ------------------------------------------HFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTE 110 (268)
T ss_pred ------------------------------------------eEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHH
Confidence 38899999995 78887752 35789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCCCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
||+.||++||++|++|+||+|+||+++.....++|+|||.+........ .....++..|+|||.+.+. .++.++
T Consensus 111 ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~ 189 (268)
T cd06630 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSC 189 (268)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC-CCCccc
Confidence 9999999999999999999999999984445799999999866533211 1233567889999998776 788999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||+|+++++|++|..||...........+.+... ......++..+++++.++|.
T Consensus 190 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS------------------------ATTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred chHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc------------------------cCCCCCCchhhCHHHHHHHH
Confidence 999999999999999999976543333222222100 00011123356899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
+||+.||.+||++.++++ ||||+
T Consensus 246 ~~l~~~p~~R~~~~~ll~-~~~~~ 268 (268)
T cd06630 246 RCLELQPEDRPPSRELLK-HPVFR 268 (268)
T ss_pred HHcCCCcccCcCHHHHhc-CcccC
Confidence 999999999999999999 99985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.39 Aligned_cols=255 Identities=28% Similarity=0.530 Sum_probs=208.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++.+.||+|+||+||+|++..+++.||+|.+.... ..+.+|++++++++|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET------ 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC------
Confidence 47899999999999999999999999999999996432 23567999999999999999988876543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (316)
T cd05574 75 -------------------------------------------------------------------------------- 74 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.++|||||.+ +|.+++.. .....+++..++.++.|+
T Consensus 75 ----------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi 112 (316)
T cd05574 75 ----------------------------------------YLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEV 112 (316)
T ss_pred ----------------------------------------EEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHH
Confidence 48999999985 88888752 234678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC------------------------------Ccc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP------------------------------NVS 303 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~------------------------------~~~ 303 (444)
+.||+|||+.|++|+||+|+||+++ .++.++|+|||++........ ...
T Consensus 113 ~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (316)
T cd05574 113 LLALEYLHLLGIVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNS 191 (316)
T ss_pred HHHHHHHHHCCeeccCCChHHeEEc-CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCC
Confidence 9999999999999999999999999 788999999998754422110 112
Q ss_pred ccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCC
Q psy10212 304 YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383 (444)
Q Consensus 304 ~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~ 383 (444)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.......+... ....+.
T Consensus 192 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~~~~~ 253 (316)
T cd05574 192 FVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK-----------------EVTFPG 253 (316)
T ss_pred CcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcC-----------------CccCCC
Confidence 3467889999999877 7899999999999999999999999887766555443321 001111
Q ss_pred ccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC----HHHHhccCchhhhhhh
Q psy10212 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS----PLQVRSITPFLIELRA 434 (444)
Q Consensus 384 ~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs----~~elL~~hpwf~~~~~ 434 (444)
...+++.+.++|.+||..||++||| +.|+|. ||||+..+.
T Consensus 254 ----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~-~~~~~~~~~ 297 (316)
T cd05574 254 ----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ-HPFFRGVNW 297 (316)
T ss_pred ----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc-CchhhcCCh
Confidence 0125899999999999999999999 999999 999998653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.96 Aligned_cols=291 Identities=29% Similarity=0.540 Sum_probs=227.7
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.++++++||||+++.+++......
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 355779999999999999999999999999999999998532 23455799999999999999999887654320
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
.
T Consensus 92 ~------------------------------------------------------------------------------- 92 (345)
T cd07877 92 E------------------------------------------------------------------------------- 92 (345)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.....++++++++++|.+++. ...+++..++.++
T Consensus 93 -----------------------------------------~~~~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~ 126 (345)
T cd07877 93 -----------------------------------------EFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLI 126 (345)
T ss_pred -----------------------------------------ccccEEEEehhcccCHHHHHh-----cCCCCHHHHHHHH
Confidence 002378999999999988764 2468999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||+|||++|++|+||+|+||+++ .++.++|+|||++..... ......++..|+|||.+.+...++.++|+||
T Consensus 127 ~qi~~aL~~LH~~~ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 127 YQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHHHHHHHHHHHCCeeecCCChHHEEEc-CCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 9999999999999999999999999999 788999999999865422 2234466888999999876446889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||++|+|++|+.||...+.......+.+..+.+.+.....+....... ..+......+... ....++.+.++|.+
T Consensus 204 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ 282 (345)
T cd07877 204 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHH
Confidence 9999999999999999888888888888877777666554432211000 0011111111111 12458899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
||+.||.+||++.++|+ ||||+++.....
T Consensus 283 ~L~~dp~~R~t~~e~l~-h~~f~~~~~~~~ 311 (345)
T cd07877 283 MLVLDSDKRITAAQALA-HAYFAQYHDPDD 311 (345)
T ss_pred HcCCChhhcCCHHHHhc-ChhhhhcCCCCc
Confidence 99999999999999999 999998665443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.00 Aligned_cols=267 Identities=26% Similarity=0.430 Sum_probs=208.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|+.++.||.|++|.||+|.+..+++.+|+|.+... ...+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------- 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS------- 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC-------
Confidence 4789999999999999999999999999999998643 2356689999999999999999998876542
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (287)
T cd06621 74 -------------------------------------------------------------------------------- 73 (287)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++|||||++ +|.+++.........+++..+..++.||+.
T Consensus 74 -------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 116 (287)
T cd06621 74 -------------------------------------SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116 (287)
T ss_pred -------------------------------------CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 248899999985 888887665556677899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
||+|||+.|++|+||+|+||+++ ..+.++|+|||++....... .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 117 ~L~~lH~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il 193 (287)
T cd06621 117 GLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTL 193 (287)
T ss_pred HHHHHHHCCcccCCCCHHHEEEe-cCCeEEEeeccccccccccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHH
Confidence 99999999999999999999999 78899999999986543322 2234567889999998776 789999999999999
Q ss_pred HHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++|+.||...... ....+....+..... +....... .....++.+.++|.+||..||.
T Consensus 194 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~ 255 (287)
T cd06621 194 LEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN---------------PELKDEPG---NGIKWSEEFKDFIKQCLEKDPT 255 (287)
T ss_pred HHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---------------hhhccCCC---CCCchHHHHHHHHHHHcCCCcc
Confidence 9999999999865320 000111111110000 00000000 0012367899999999999999
Q ss_pred CCCCHHHHhccCchhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~ 434 (444)
+|||+.|+++ ||||+....
T Consensus 256 ~Rpt~~eil~-~~~~~~~~~ 274 (287)
T cd06621 256 RRPTPWDMLE-HPWIKAQMK 274 (287)
T ss_pred cCCCHHHHHh-Ccccccccc
Confidence 9999999999 999987554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=308.95 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=210.1
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.+..++|.+++.||+|+||.||+|++..+++.||+|.+... .+.+.+|+.+++.++|+||+++++++...+
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---- 89 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 89 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 356678999999999999999999999999999999998532 245668999999999999999999887654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (297)
T cd06656 90 -------------------------------------------------------------------------------- 89 (297)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++||||+++ +|.+++. ...+++..+..++.
T Consensus 90 ------------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ 122 (297)
T cd06656 90 ------------------------------------------ELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 122 (297)
T ss_pred ------------------------------------------EEEEeecccCCCCHHHHHH-----hCCCCHHHHHHHHH
Confidence 38999999985 8888774 24578899999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||
T Consensus 123 ~l~~~L~~LH~~~i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s 200 (297)
T cd06656 123 ECLQALDFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWS 200 (297)
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCC-CCCcHHHHHH
Confidence 999999999999999999999999998 788999999998865433221 2234678889999999876 7889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
+|+++|+|++|..||...+.......+.. .+. .....+..+++.+.++|.+||.
T Consensus 201 lGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~~~li~~~l~ 254 (297)
T cd06656 201 LGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT-------------------------PELQNPERLSAVFRDFLNRCLE 254 (297)
T ss_pred HHHHHHHHHhCCCCCCCCCcchheeeecc-CCC-------------------------CCCCCccccCHHHHHHHHHHcc
Confidence 99999999999999976554332211110 000 0001123468899999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.||.+||++.++++ ||||+..+..
T Consensus 255 ~~p~~Rps~~~il~-~~~~~~~~~~ 278 (297)
T cd06656 255 MDVDRRGSAKELLQ-HPFLKLAKPL 278 (297)
T ss_pred CChhhCcCHHHHhc-Cchhcccccc
Confidence 99999999999999 9999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.43 Aligned_cols=264 Identities=28% Similarity=0.389 Sum_probs=207.2
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
.-+....+.|++.+.||+|+||.||+|+++.+++.+|+|.+.... ..+.+|+.+++++ +|+||++++++++.....
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 344556789999999999999999999999999999999985442 3556788889988 799999999988754310
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (282)
T cd06636 89 -------------------------------------------------------------------------------- 88 (282)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
+...+.+++||||++ +|.+++... ....+++..++.+
T Consensus 89 ----------------------------------------~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ 126 (282)
T cd06636 89 ----------------------------------------GHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYI 126 (282)
T ss_pred ----------------------------------------CCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHH
Confidence 001358999999985 888887542 2346888899999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhcc----CCCCCc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG----AIDYTT 324 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~s~ 324 (444)
+.||+.||+|||++|++|+||+|+||+++ +.+.++|+|||.+...... .......++..|+|||.+.. ...++.
T Consensus 127 ~~qi~~al~~LH~~~ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~ 205 (282)
T cd06636 127 CREILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205 (282)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCc
Confidence 99999999999999999999999999999 7889999999998654322 12233467889999998752 225788
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++|+||||+++|+|++|..||....+......+... .........++..+.+|
T Consensus 206 ~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~l 258 (282)
T cd06636 206 RSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---------------------------PPPKLKSKKWSKKFIDF 258 (282)
T ss_pred ccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---------------------------CCCCCcccccCHHHHHH
Confidence 999999999999999999999765543332221110 00001112468999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
|.+||+.||.+||++.|+|+ ||||
T Consensus 259 i~~cl~~~p~~Rp~~~ell~-~~~~ 282 (282)
T cd06636 259 IEGCLVKNYLSRPSTEQLLK-HPFI 282 (282)
T ss_pred HHHHhCCChhhCcCHHHHhc-CCCC
Confidence 99999999999999999999 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.28 Aligned_cols=289 Identities=31% Similarity=0.585 Sum_probs=225.6
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
+..+.++|.+++.||+|+||+||+|.+..+|+.||+|++... ...+.+|++++++++|+||+++.+.+.....-
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 345788999999999999999999999999999999988432 12455899999999999999998887654320
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (343)
T cd07880 90 -------------------------------------------------------------------------------- 89 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
......++||||++++|.+++. ..++++..++.++
T Consensus 90 ----------------------------------------~~~~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~ 124 (343)
T cd07880 90 ----------------------------------------DRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLV 124 (343)
T ss_pred ----------------------------------------cccceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHH
Confidence 0012478999999888888774 2568999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||.|||++|++|+||+|+||+++ +++.++|+|||.+...... .....++..|++||.+.+...++.++|+||
T Consensus 125 ~qi~~al~~LH~~gi~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 201 (343)
T cd07880 125 YQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWS 201 (343)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHH
Confidence 9999999999999999999999999999 7889999999998764322 223456888999999876446889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||+++|+|++|+.||.+.+.......+.+..+.+.......+...... ...+......+ ..+..++++.+.++|.+
T Consensus 202 lG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 280 (343)
T cd07880 202 VGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEK 280 (343)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHH
Confidence 999999999999999988877777777776655554433332211100 01111111111 12234678999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||+.||.+|||+.+++. ||||+..+..
T Consensus 281 ~l~~dP~~R~t~~~~l~-~~~~~~~~~~ 307 (343)
T cd07880 281 MLVLDAESRITAAEALA-HPYFEEFHDP 307 (343)
T ss_pred HcCCChhhCCCHHHHhc-CccHhhhcCc
Confidence 99999999999999999 9999987554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=313.38 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=206.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+++++.+++.||+|.+... ...+.+|+.++..++|++|+++.+++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~------ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN------ 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC------
Confidence 5799999999999999999999999999999998542 133557889999999999999998886653
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (331)
T cd05624 75 -------------------------------------------------------------------------------- 74 (331)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.|+|||||. ++|.+++.. ....+++..++.++.|+
T Consensus 75 ----------------------------------------~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi 111 (331)
T cd05624 75 ----------------------------------------YLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEM 111 (331)
T ss_pred ----------------------------------------EEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHH
Confidence 4899999997 588888853 34578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccC----CCCCcchh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGA----IDYTTKID 327 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~----~~~s~~sD 327 (444)
+.||.|||++|++|+||||+||+++ .++.++|+|||++........ .....|++.|+|||.+.+. ..++.++|
T Consensus 112 ~~~L~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (331)
T cd05624 112 VLAIHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190 (331)
T ss_pred HHHHHHHHHCCeeeccCchHHEEEc-CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCccc
Confidence 9999999999999999999999999 788999999999866543322 1234689999999998652 25788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||+|+++|+|++|+.||...+..+....+.... ....+|. . ...+++.+.++|.+
T Consensus 191 iwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~--------~-~~~~~~~~~~li~~ 246 (331)
T cd05624 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE---------------ERFQFPS--------H-ITDVSEEAKDLIQR 246 (331)
T ss_pred EEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---------------CcccCCC--------c-cccCCHHHHHHHHH
Confidence 9999999999999999998877666555444310 0011111 0 12468999999999
Q ss_pred hcccCCCC--CCCHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSS--RISPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~k--RPs~~elL~~hpwf~~~~ 433 (444)
||..++.+ |+++.++++ ||||+.+.
T Consensus 247 ll~~~~~~~~~~~~~~~~~-h~~f~~~~ 273 (331)
T cd05624 247 LICSRERRLGQNGIEDFKK-HAFFEGID 273 (331)
T ss_pred HccCchhhcCCCCHHHHhc-CCCcCCCC
Confidence 99976655 578999999 99998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=310.47 Aligned_cols=256 Identities=27% Similarity=0.480 Sum_probs=217.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.|++++.||+|.-|+||+|+...++..+|+|++.+.. ...+-|-++|+.++||.+..++..|.++.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~------ 150 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK------ 150 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc------
Confidence 56899999999999999999999999999999995432 23345888999999999999999987763
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 151 -------------------------------------------------------------------------------- 150 (459)
T KOG0610|consen 151 -------------------------------------------------------------------------------- 150 (459)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.|++||||+| .|..+.+ +..+..+++..++.++.++
T Consensus 151 ----------------------------------------~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEv 188 (459)
T KOG0610|consen 151 ----------------------------------------YSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEV 188 (459)
T ss_pred ----------------------------------------eeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHH
Confidence 69999999996 6766654 3567789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC---------------------------------CCC
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR---------------------------------GEP 300 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~---------------------------------~~~ 300 (444)
+.||+|||..||+.|||||+|||+. ++|+|.|+||.++..+.. ...
T Consensus 189 l~ALEYLHmlGivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~ 267 (459)
T KOG0610|consen 189 LLALEYLHMLGIVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSK 267 (459)
T ss_pred HHHHHHHHhhceeeccCCcceeEEe-cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccc
Confidence 9999999999999999999999999 899999999998743211 000
Q ss_pred ------------------------CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHH
Q psy10212 301 ------------------------NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVE 356 (444)
Q Consensus 301 ------------------------~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~ 356 (444)
.....||-.|+|||++.|. .-+.+.|+|+||+++|||+.|.-||.+.+..+++..
T Consensus 268 ~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N 346 (459)
T KOG0610|consen 268 KRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN 346 (459)
T ss_pred ccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH
Confidence 0112567889999999988 788999999999999999999999999999999988
Q ss_pred HHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC----HHHHhccCchhhhh
Q psy10212 357 IIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS----PLQVRSITPFLIEL 432 (444)
Q Consensus 357 i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs----~~elL~~hpwf~~~ 432 (444)
++. .+..+|.. ++++..++|||+++|.+||++|.. |+||-+ ||||+.+
T Consensus 347 Iv~-----------------~~l~Fp~~----------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~-HpFF~gV 398 (459)
T KOG0610|consen 347 IVG-----------------QPLKFPEE----------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR-HPFFEGV 398 (459)
T ss_pred Hhc-----------------CCCcCCCC----------CcchhHHHHHHHHHhccChhhhhccccchHHhhc-CccccCC
Confidence 876 23333331 246899999999999999999999 999999 9999998
Q ss_pred hhh
Q psy10212 433 RAV 435 (444)
Q Consensus 433 ~~~ 435 (444)
.+.
T Consensus 399 nWa 401 (459)
T KOG0610|consen 399 NWA 401 (459)
T ss_pred Chh
Confidence 765
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=297.00 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=209.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++.+.||+|++|.||+|++..+++.||+|++... ...+.+|+..+++++|+||+++.+++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-------- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--------
Confidence 4789999999999999999999999999999998554 346678999999999999999999887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (264)
T cd06623 73 -------------------------------------------------------------------------------- 72 (264)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++||||++ ++|.+++.. ...+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~ 110 (264)
T cd06623 73 --------------------------------------EISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILK 110 (264)
T ss_pred --------------------------------------eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHH
Confidence 3899999999 689888853 367899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc-cccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||++||+ .+++|+||+|+||+++ .++.++|+|||.+.......... ...++..|+|||.+.+. .++.++|+||||+
T Consensus 111 ~l~~lh~~~~~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~ 188 (264)
T cd06623 111 GLDYLHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGL 188 (264)
T ss_pred HHHHHhccCCCccCCCCHHHEEEC-CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHH
Confidence 9999999 9999999999999999 78999999999987654433322 44568889999998777 7899999999999
Q ss_pred HHHHHHhCCCCCCCCCh---hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC-CChhHHHHHHHhc
Q psy10212 334 VLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR-TPPDAIDLISRLL 409 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~---~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~s~~l~~LI~~~L 409 (444)
++|+|++|+.||..... .+....+... . . ..++.. ++..+.++|.+||
T Consensus 189 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~----------------~---------~~~~~~~~~~~l~~li~~~l 240 (264)
T cd06623 189 TLLECALGKFPFLPPGQPSFFELMQAICDG---P----------------P---------PSLPAEEFSPEFRDFISACL 240 (264)
T ss_pred HHHHHHhCCCCCccccccCHHHHHHHHhcC---C----------------C---------CCCCcccCCHHHHHHHHHHc
Confidence 99999999999987642 2222222110 0 0 011223 6899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..+|++|||+.++++ ||||+...
T Consensus 241 ~~~p~~R~~~~~ll~-~~~~~~~~ 263 (264)
T cd06623 241 QKDPKKRPSAAELLQ-HPFIKKAD 263 (264)
T ss_pred cCChhhCCCHHHHHh-CHHHHhcc
Confidence 999999999999999 99998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.15 Aligned_cols=246 Identities=31% Similarity=0.534 Sum_probs=201.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------------cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------------RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+.... ..+.+|+.++++++||||+++.+++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4788899999999999999999899999999884321 34568999999999999999999887654
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (267)
T cd06628 80 -------------------------------------------------------------------------------- 79 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
+.+++|||+++ +|.+++. ..+.+++..++.
T Consensus 80 ---------------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~ 110 (267)
T cd06628 80 ---------------------------------------------HLNIFLEYVPGGSVAALLN----NYGAFEETLVRN 110 (267)
T ss_pred ---------------------------------------------ccEEEEEecCCCCHHHHHH----hccCccHHHHHH
Confidence 38899999985 8888874 335788999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-------CCccccccccccCchhhccCCC
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-------PNVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~ 321 (444)
++.|++.||++||++|++|+||+|+||+++ +++.++|+|||.+....... ......++..|+|||.+.+. .
T Consensus 111 ~~~~l~~~l~~lH~~~ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~ 188 (267)
T cd06628 111 FVRQILKGLNYLHNRGIIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-S 188 (267)
T ss_pred HHHHHHHHHHHHHhcCcccccCCHHHEEEc-CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-C
Confidence 999999999999999999999999999998 78899999999886653211 11123467889999998776 7
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
++.++|+||+|+++|+|++|+.||...+....+..+... ....++..++..+
T Consensus 189 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~ 240 (267)
T cd06628 189 YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN----------------------------ASPEIPSNISSEA 240 (267)
T ss_pred CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc----------------------------CCCcCCcccCHHH
Confidence 889999999999999999999999876554433322210 0011223468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
.++|.+||+.||.+||++.++++ ||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~-~~~~ 267 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLK-HPFL 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhh-CCCC
Confidence 99999999999999999999999 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.74 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=228.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.++-.=|.+.+.||+|-|+.|-+|++..+|+.||||++.+.+ ..+.+|++.|+-.+|||||++++..-..
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ---- 89 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ---- 89 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc----
Confidence 457778999999999999999999999999999999996543 4556899999999999999997665322
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (864)
T KOG4717|consen 90 -------------------------------------------------------------------------------- 89 (864)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.-+|+|+|+=.+ .|.++|.. ....+.++.+++++
T Consensus 90 ------------------------------------------TKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF 124 (864)
T KOG4717|consen 90 ------------------------------------------TKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYF 124 (864)
T ss_pred ------------------------------------------ceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHH
Confidence 239999999885 99999963 45679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.|+.|+|+..++||||||+|+.+-..-|-+||+|||++..+.++....+.+|+..|-|||++.|...-.++.||||
T Consensus 125 ~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWS 204 (864)
T KOG4717|consen 125 AQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWS 204 (864)
T ss_pred HHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhH
Confidence 99999999999999999999999988865788999999999999999999999999999999999999866678999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||||+|.|++|++||...++.+.+..|++. .+.+ |.+++.++++||.+||.
T Consensus 205 LGVILyMLVCGq~PFqeANDSETLTmImDC-----------------KYtv------------PshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 205 LGVILYMLVCGQPPFQEANDSETLTMIMDC-----------------KYTV------------PSHVSKECRDLIQSMLV 255 (864)
T ss_pred HHHHHHHHHhCCCccccccchhhhhhhhcc-----------------cccC------------chhhhHHHHHHHHHHHh
Confidence 999999999999999999999999988873 3333 34789999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
-||.+|.|.+++.. |+|++-..
T Consensus 256 RdPkkRAslEeI~s-~~Wlq~~D 277 (864)
T KOG4717|consen 256 RDPKKRASLEEIVS-TSWLQAGD 277 (864)
T ss_pred cCchhhccHHHHhc-cccccCCC
Confidence 99999999999999 99998754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=308.65 Aligned_cols=284 Identities=35% Similarity=0.570 Sum_probs=223.7
Q ss_pred ccchhheecccceeEEEEeEecCC--Cceeeeeeeecc------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDS--GELVAIKKVLQD------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|.+.+.||+|+||.||+|++..+ ++.||+|++... ...+.+|+.+++++ +||||+++.+........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~--- 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN--- 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc---
Confidence 588999999999999999999888 899999988532 23456799999999 599999998765432110
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (332)
T cd07857 78 -------------------------------------------------------------------------------- 77 (332)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
....++++++++++|.+++. ....+++..++.++.||
T Consensus 78 ---------------------------------------~~~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi 114 (332)
T cd07857 78 ---------------------------------------FNELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQI 114 (332)
T ss_pred ---------------------------------------CCcEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHH
Confidence 02378999999999988874 35678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCCCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+...++.++|+
T Consensus 115 ~~aL~~LH~~givH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 115 LCGLKYIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred HHHHHHHHhCCcccCCCCHHHeEEc-CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 9999999999999999999999999 788999999999875432211 1234678889999988765478999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
||+|+++|+|++|+.||.+.+.......++..++.+....+..+....... .........+. ...+.++..+.++|
T Consensus 194 ~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 272 (332)
T cd07857 194 WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLL 272 (332)
T ss_pred HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHH
Confidence 999999999999999999999889999999998888766554432110000 00000111111 11234688999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+||+.||.+|||+.+++. ||||++.+..
T Consensus 273 ~~~l~~~P~~R~t~~~ll~-~~~~~~~~~~ 301 (332)
T cd07857 273 EKLLAFDPTKRISVEEALE-HPYLAIWHDP 301 (332)
T ss_pred HHHccCCcccCCCHHHHhc-ChhhhhhcCc
Confidence 9999999999999999999 9999987754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.61 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=206.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++.+.||.|+||+||+|.+..+++.+|+|++... ...+.+|++.++.++|+||+++.+.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-------- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--------
Confidence 4799999999999999999999989999999998543 245668999999999999999988886654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (267)
T cd06610 73 -------------------------------------------------------------------------------- 72 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++||+|++ +|.+.+.... ....+++..++.++.|++.
T Consensus 73 --------------------------------------~~~iv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~ 113 (267)
T cd06610 73 --------------------------------------ELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLK 113 (267)
T ss_pred --------------------------------------EEEEEEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHH
Confidence 38899999985 8888875322 2356899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-----ccccccccccCchhhccCCCCCcchhhhh
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-----VSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||++||++|++|+||+|+||+++ +++.++|+|||++......... ....++..|++||.+.....++.++|+||
T Consensus 114 al~~lh~~~i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~s 192 (267)
T cd06610 114 GLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWS 192 (267)
T ss_pred HHHHHHhCCeecCCCCHHhEEEc-CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHh
Confidence 99999999999999999999999 7889999999998665433221 23357888999999876556889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++++|++|+.||...+......+.... ... ..+ .. .....+++.+.++|.+||.
T Consensus 193 lG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-------------~~~---~~----~~~~~~~~~~~~li~~~l~ 249 (267)
T cd06610 193 FGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP-------------SLE---TG----ADYKKYSKSFRKMISLCLQ 249 (267)
T ss_pred HhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC-------------CcC---Cc----cccccccHHHHHHHHHHcC
Confidence 999999999999999877665444433321 000 000 00 0012468999999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
.||++||++.++++ ||||
T Consensus 250 ~~p~~Rp~~~~ll~-~p~~ 267 (267)
T cd06610 250 KDPSKRPTAEELLK-HKFF 267 (267)
T ss_pred CChhhCcCHHHHhh-CCCC
Confidence 99999999999999 9998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.48 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=200.4
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc----------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+|.+.+.||+|+||.||+|.+. +|+.+|+|.+..+. ..+.+|+.++++++|+||+++.+++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN---- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence 5889999999999999999874 68999999885432 34568999999999999999999887654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (265)
T cd06631 76 -------------------------------------------------------------------------------- 75 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..+++|||+++ +|.+++.. ..++++..++.++.
T Consensus 76 ------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ 109 (265)
T cd06631 76 ------------------------------------------TISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTK 109 (265)
T ss_pred ------------------------------------------eEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHH
Confidence 38999999985 88888742 35688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-------CCCccccccccccCchhhccCCCCCc
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-------EPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
|++.||++||+.+++|+||+|+||+++ +.+.++|+|||.+...... .......++..|+|||.+.+. .++.
T Consensus 110 qi~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~ 187 (265)
T cd06631 110 QILDGVAYLHNNCVVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGR 187 (265)
T ss_pred HHHHHHHHHHhCCcccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcc
Confidence 999999999999999999999999999 7889999999988654211 111234568889999998876 7889
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++|+||||+++|+|++|..||...+.......+....+ ....++..++..+.++
T Consensus 188 ~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~ 241 (265)
T cd06631 188 KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--------------------------LMPRLPDSFSAAAIDF 241 (265)
T ss_pred hhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--------------------------CCCCCCCCCCHHHHHH
Confidence 99999999999999999999986554433222221100 0011233568999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
|.+||..+|.+||++.++|+ ||||
T Consensus 242 i~~~l~~~p~~Rp~~~~~l~-~~~~ 265 (265)
T cd06631 242 VTSCLTRDQHERPSALQLLR-HDFL 265 (265)
T ss_pred HHHHhcCCcccCCCHHHHhc-CCCC
Confidence 99999999999999999999 9997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=306.88 Aligned_cols=285 Identities=33% Similarity=0.581 Sum_probs=228.7
Q ss_pred ccccchhheecccceeEEEEeEecCCC----ceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG----ELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
...|++++.||+|.||.||+|..+.++ +.||||++...+ -...||+.+++.|+|+||+.+...|++.+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d-- 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD-- 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence 357999999999999999999765543 379999996552 35569999999999999999988888753
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (438)
T KOG0666|consen 101 -------------------------------------------------------------------------------- 100 (438)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCC-CCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQ-NFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~-~l~~~~i~~i 249 (444)
...++++||.+-.|+..|+..+.+.. .++...++.+
T Consensus 101 -------------------------------------------~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsi 137 (438)
T KOG0666|consen 101 -------------------------------------------KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSI 137 (438)
T ss_pred -------------------------------------------ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHH
Confidence 23899999999999999987776544 4778899999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCC
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLN---PETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~---~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+.||+.|+.|||++=+.||||||.||++- ++.|.+||+|+|+++.+...-.. .....|.+|.|||++.|...|
T Consensus 138 lwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hY 217 (438)
T KOG0666|consen 138 LWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHY 217 (438)
T ss_pred HHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccc
Confidence 99999999999999999999999999995 23489999999999877544222 233558999999999999899
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcc
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGD---------SGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSK 391 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~---------~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~ 391 (444)
+++.|+||+|||+.||++..+.|.+. -..+++.+|++.+|.|....|+.+. |.+... +..+....+..
T Consensus 218 T~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~-ls~f~~~~~~n 296 (438)
T KOG0666|consen 218 TKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTL-LSDFRRHYYDN 296 (438)
T ss_pred cchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHH-HHHhHHhhcCc
Confidence 99999999999999999999999752 2467899999999999999887653 222100 00011111111
Q ss_pred -----cc--cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 392 -----VF--RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 392 -----~~--~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+ ...-++...+|+.+||.+||-+|.|+.++|+ |+||++-
T Consensus 297 ~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle-h~yF~~d 343 (438)
T KOG0666|consen 297 VSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE-HPYFTED 343 (438)
T ss_pred chHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc-ccccccC
Confidence 11 1223666999999999999999999999999 9999984
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.19 Aligned_cols=279 Identities=24% Similarity=0.380 Sum_probs=207.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++.+.||+|+||.||++++..+++.+|+|.+..+ ...+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-------- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--------
Confidence 4699999999999999999999999999999988543 134568999999999999999999987754
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (308)
T cd06615 73 -------------------------------------------------------------------------------- 72 (308)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++||||+++ +|.+++.. .+++++..+..++.|++.
T Consensus 73 --------------------------------------~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~ 110 (308)
T cd06615 73 --------------------------------------EISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLR 110 (308)
T ss_pred --------------------------------------EEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHH
Confidence 38999999985 88888753 367899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.|||+ .+++|+||+|+||+++ .++.++|+|||.+...... ......++..|+|||.+.+. .++.++|+||||++
T Consensus 111 ~l~~lH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~ 187 (308)
T cd06615 111 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLS 187 (308)
T ss_pred HHHHHHhhCCEEECCCChHHEEEe-cCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHH
Confidence 9999997 5999999999999999 7889999999988654322 22345678899999998776 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCC----------ccCCCCcccccCCCChhHHHH
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ----------IKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~----------~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+|++|+.||...+.... ...........................+. .........-...++.++.++
T Consensus 188 l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (308)
T cd06615 188 LVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF 266 (308)
T ss_pred HHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHH
Confidence 9999999999976553332 22221110000000000000000000000 000000000011367899999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+||..||++|||+.+++. ||||+.....
T Consensus 267 i~~~l~~~P~~Rpt~~~ll~-~~~~~~~~~~ 296 (308)
T cd06615 267 VDKCLKKNPKERADLKELTK-HPFIKRAELE 296 (308)
T ss_pred HHHHccCChhhCcCHHHHhc-Chhhhhcccc
Confidence 99999999999999999999 9999885444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=295.04 Aligned_cols=248 Identities=31% Similarity=0.508 Sum_probs=203.8
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.++++++|+||+++.+++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence 5788899999999999999999889999999985432 34668999999999999999998876553
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (258)
T cd06632 76 -------------------------------------------------------------------------------- 75 (258)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.++++|||+++ +|.+++.. ..++++..++.++.|
T Consensus 76 -----------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~ 110 (258)
T cd06632 76 -----------------------------------------NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQ 110 (258)
T ss_pred -----------------------------------------eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHH
Confidence 38899999985 88888753 356889999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||++||+.|++|+||+|+||+++ .++.++|+|||.+.............++..|++||.+.....++.++|+||+|
T Consensus 111 i~~~l~~lH~~~i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG 189 (258)
T cd06632 111 ILLGLEYLHDRNTVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189 (258)
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHH
Confidence 99999999999999999999999999 78899999999987654433334456788899999987652388999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||......+....+.... .. ..++..+++.+.++|.+||+.+
T Consensus 190 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------------~~---------~~~~~~~~~~~~~li~~~l~~~ 242 (258)
T cd06632 190 CTVLEMATGKPPWSQLEGVAAVFKIGRSK------------------EL---------PPIPDHLSDEAKDFILKCLQRD 242 (258)
T ss_pred HHHHHHHhCCCCcccCcHHHHHHHHHhcc------------------cC---------CCcCCCcCHHHHHHHHHHhhcC
Confidence 99999999999997765443333222100 00 1122356899999999999999
Q ss_pred CCCCCCHHHHhccCchh
Q psy10212 413 PSSRISPLQVRSITPFL 429 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf 429 (444)
|.+||++.++|. |||+
T Consensus 243 p~~Rp~~~~~l~-~~~~ 258 (258)
T cd06632 243 PSLRPTAAELLE-HPFV 258 (258)
T ss_pred cccCcCHHHHhc-CCCC
Confidence 999999999999 9996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.84 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=205.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||+|+||.||+|++..+|+.||+|.+... ...+.+|++++++++|+||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-------- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--------
Confidence 4799999999999999999999989999999988542 235668999999999999999988776643
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (286)
T cd06622 73 -------------------------------------------------------------------------------- 72 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
++++|||||++ +|..++... .....+++..++.++.||+.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 113 (286)
T cd06622 73 --------------------------------------AVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVK 113 (286)
T ss_pred --------------------------------------eEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHH
Confidence 48999999996 776666432 12347899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC-----CCCcchhhh
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI-----DYTTKIDVW 329 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~s~~sDiw 329 (444)
||.|||+ .+++|+||+|+||+++ .++.++|+|||.+...... ......++..|+|||.+.+.. .++.++|+|
T Consensus 114 ~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diw 191 (286)
T cd06622 114 GLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191 (286)
T ss_pred HHHHHHhcCCEeeCCCCHHHEEEC-CCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchH
Confidence 9999997 5999999999999999 6889999999998654322 222345678899999885431 357899999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|+||++|+|++|+.||...........+....... ...++..+++++.++|.+||
T Consensus 192 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l 246 (286)
T cd06622 192 SLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-------------------------PPTLPSGYSDDAQDFVAKCL 246 (286)
T ss_pred hHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-------------------------CCCCCcccCHHHHHHHHHHc
Confidence 99999999999999997655443333222211000 01122346899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.+|.+||++.+++. ||||...+..
T Consensus 247 ~~~p~~Rp~~~~l~~-~~~~~~~~~~ 271 (286)
T cd06622 247 NKIPNRRPTYAQLLE-HPWLVKYKNA 271 (286)
T ss_pred ccCcccCCCHHHHhc-ChhhhhccCC
Confidence 999999999999999 9999886543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.17 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=202.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.++|.+.+.||+|+||.||+|++..+++.||+|.+.... ..+.+|+.+++.++||||+++.+.+...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-------- 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-------- 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--------
Confidence 368999999999999999999999999999999985432 34567999999999999999999887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (267)
T cd06645 80 -------------------------------------------------------------------------------- 79 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++|||||++ +|.+++. ..+.+++..++.++.|++.
T Consensus 80 --------------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~ 117 (267)
T cd06645 80 --------------------------------------KLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQ 117 (267)
T ss_pred --------------------------------------EEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHH
Confidence 38999999985 8888774 3457999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhc--cCCCCCcchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIF--GAIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~--~~~~~s~~sDiwSLG 332 (444)
||+|||++|++|+||+|+||+++ ..+.++|+|||.+....... ......++..|+|||.+. ....++.++|+||||
T Consensus 118 ~l~~lH~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG 196 (267)
T cd06645 118 GLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG 196 (267)
T ss_pred HHHHHHHCCeecCCCCHHHEEEC-CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHH
Confidence 99999999999999999999999 78899999999986543222 223446788999999874 222578899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|..||............... ....+ .+.. ...++..+.++|.+||..|
T Consensus 197 ~il~~l~~~~~p~~~~~~~~~~~~~~~~-----------------~~~~~-----~~~~--~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06645 197 ITAIELAELQPPMFDLHPMRALFLMTKS-----------------NFQPP-----KLKD--KMKWSNSFHHFVKMALTKN 252 (267)
T ss_pred HHHHHHhcCCCCcccccchhhHHhhhcc-----------------CCCCC-----cccc--cCCCCHHHHHHHHHHccCC
Confidence 9999999999999765543332222110 00000 0000 1235788999999999999
Q ss_pred CCCCCCHHHHhccCch
Q psy10212 413 PSSRISPLQVRSITPF 428 (444)
Q Consensus 413 P~kRPs~~elL~~hpw 428 (444)
|++|||+.+++. |||
T Consensus 253 P~~R~~~~~ll~-~~~ 267 (267)
T cd06645 253 PKKRPTAEKLLQ-HPF 267 (267)
T ss_pred chhCcCHHHHhc-CCC
Confidence 999999999999 998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=298.32 Aligned_cols=278 Identities=32% Similarity=0.577 Sum_probs=216.6
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhc---CCCceeEeeeEEeecCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRL---EHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
|++.+.||+|+||.||+|+++.+++.||+|.+.... ..+.+|+.+++++ .|+||+++.+++......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~---- 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD---- 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC----
Confidence 678999999999999999999889999999995321 2344677777666 699999999998875420
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (287)
T cd07838 77 -------------------------------------------------------------------------------- 76 (287)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.....+++|||+.++|.+++... ....+++..++.++.|++
T Consensus 77 -------------------------------------~~~~~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~ 117 (287)
T cd07838 77 -------------------------------------RELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLL 117 (287)
T ss_pred -------------------------------------CCceeEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHH
Confidence 01348899999999998887542 223689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||.|||+.+++|+||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 118 ~al~~LH~~~i~h~~l~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~ 195 (287)
T cd07838 118 RGVDFLHSHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCI 195 (287)
T ss_pred HHHHHHHHCCeeeccCChhhEEEc-cCCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHH
Confidence 999999999999999999999999 6799999999998765444333344568889999999877 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|.+||.+.+..+...++.+..+.+....+..... .....++....... ....+.+++.+.++|.+||+.||.
T Consensus 196 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~ 273 (287)
T cd07838 196 FAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS-LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPH 273 (287)
T ss_pred HHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc-cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCc
Confidence 9999999999999888888888887666554433321110 00011111111111 111234578899999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.+++. ||||
T Consensus 274 ~Rp~~~~il~-~~~~ 287 (287)
T cd07838 274 KRISAFEALQ-HPYF 287 (287)
T ss_pred cCCCHHHHhc-CcCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.43 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=221.7
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.+.-+|++.+.||+|.||.|-+|+....|+.||||.|.+++ -.+.||+++|+.|+||||+.+++.|..++.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-- 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-- 127 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce--
Confidence 46789999999999999999999998899999999995442 233489999999999999999999877654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 128 -------------------------------------------------------------------------------- 127 (668)
T KOG0611|consen 128 -------------------------------------------------------------------------------- 127 (668)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
++|||||.+ |.|+++|. ..+.+++.+++.++
T Consensus 128 --------------------------------------------IvivMEYaS~GeLYDYiS----er~~LsErEaRhfF 159 (668)
T KOG0611|consen 128 --------------------------------------------IVIVMEYASGGELYDYIS----ERGSLSEREARHFF 159 (668)
T ss_pred --------------------------------------------EEEEEEecCCccHHHHHH----HhccccHHHHHHHH
Confidence 889999998 58999995 35789999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+||..|+.|+|.++++|||||.+|||+| .++++||.|||++..+.......+++|++.|.+||+..|...-.+..|.||
T Consensus 160 RQIvSAVhYCHknrVvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWs 238 (668)
T KOG0611|consen 160 RQIVSAVHYCHKNRVVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWS 238 (668)
T ss_pred HHHHHHHHHHhhccceecccchhheeec-CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhh
Confidence 9999999999999999999999999999 899999999999999888888889999999999999999866689999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++|-|+.|..||++.+...++.+|-.+ .+ +.+..+.+..-||+.||.
T Consensus 239 LGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-----------------aY-------------rEP~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 239 LGVLLYTLVYGTMPFDGRDHKRLVRQISRG-----------------AY-------------REPETPSDASGLIRWMLM 288 (668)
T ss_pred HHHHHHHHhhcccccCCchHHHHHHHhhcc-----------------cc-------------cCCCCCchHHHHHHHHHh
Confidence 999999999999999999887777766652 11 112347788999999999
Q ss_pred cCCCCCCCHHHHhccCchhh
Q psy10212 411 YTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~ 430 (444)
+||++|.|+.++-. |=|..
T Consensus 289 VNP~RRATieDiAs-HWWvN 307 (668)
T KOG0611|consen 289 VNPERRATIEDIAS-HWWVN 307 (668)
T ss_pred cCcccchhHHHHhh-hheee
Confidence 99999999999999 87753
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=300.31 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=204.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.... ..+.+|++++++++||||+++.+.+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-------- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--------
Confidence 46899999999999999999999999999999985432 34668999999999999999988887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (265)
T cd06605 73 -------------------------------------------------------------------------------- 72 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++++||++ ++|.+++... ...+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~ 111 (265)
T cd06605 73 --------------------------------------DISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLK 111 (265)
T ss_pred --------------------------------------EEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHH
Confidence 3899999999 5898887642 267899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||++||+ .|++|+||+|+||+++ ..+.++|+|||.+......... ...++..|+|||.+.+. .++.++|+||+|++
T Consensus 112 ~l~~lH~~~~i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~ 188 (265)
T cd06605 112 GLTYLHEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLS 188 (265)
T ss_pred HHHHHcCCCCeecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHH
Confidence 9999999 9999999999999999 6889999999988654322211 25678889999999777 88999999999999
Q ss_pred HHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC-CCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV-RTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~s~~l~~LI~~~L~~D 412 (444)
+|+|++|+.||...+. .+......+..... ..+. ++. .+++.+.++|.+||..|
T Consensus 189 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 189 LIELATGRFPYPPENDPPDGIFELLQYIVNE---------------PPPR---------LPSGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred HHHHHhCCCCCCccccccccHHHHHHHHhcC---------------CCCC---------CChhhcCHHHHHHHHHHcCCC
Confidence 9999999999975421 11111111111000 0000 111 15889999999999999
Q ss_pred CCCCCCHHHHhccCchhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~ 432 (444)
|.+|||+.+++. ||||+.+
T Consensus 245 p~~Rpt~~~ll~-~~~~~~~ 263 (265)
T cd06605 245 PRERPSYKELLE-HPFIKKY 263 (265)
T ss_pred chhCcCHHHHhh-Cchhhcc
Confidence 999999999999 9999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.54 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=201.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.++|++++.||+|+||.||+|++..+++.||+|++... ...+.+|+.++++++||||+++.+++...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-------- 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-------- 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--------
Confidence 46899999999999999999999999999999998543 234568999999999999999999887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (267)
T cd06646 80 -------------------------------------------------------------------------------- 79 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+++ +|.+++. ...++++..+..++.|++.
T Consensus 80 --------------------------------------~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~ 117 (267)
T cd06646 80 --------------------------------------KLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQ 117 (267)
T ss_pred --------------------------------------EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHH
Confidence 38899999995 7877774 2457899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhcc--CCCCCcchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFG--AIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~s~~sDiwSLG 332 (444)
||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||+|
T Consensus 118 ~l~~lH~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G 196 (267)
T cd06646 118 GLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG 196 (267)
T ss_pred HHHHHHHCCccccCCCHHHEEEC-CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHH
Confidence 99999999999999999999998 78899999999987653322 2233457888999998742 22578899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||...++.+....+... ....+. +. ....++..+.++|.+||+.|
T Consensus 197 ~il~el~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06646 197 ITAIELAELQPPMFDLHPMRALFLMSKS-----------------NFQPPK-----LK--DKTKWSSTFHNFVKISLTKN 252 (267)
T ss_pred HHHHHHHhCCCCccccchhhhheeeecC-----------------CCCCCC-----Cc--cccccCHHHHHHHHHHhhCC
Confidence 9999999999999655433222111110 000000 00 01245889999999999999
Q ss_pred CCCCCCHHHHhccCch
Q psy10212 413 PSSRISPLQVRSITPF 428 (444)
Q Consensus 413 P~kRPs~~elL~~hpw 428 (444)
|++|||+.++|+ |+|
T Consensus 253 P~~Rp~~~~il~-~l~ 267 (267)
T cd06646 253 PKKRPTAERLLT-HLF 267 (267)
T ss_pred hhhCcCHHHHhc-CCC
Confidence 999999999999 987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=303.97 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=197.4
Q ss_pred ccccchhheecccceeEEEEeEecC----------------CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeE
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD----------------SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVK 79 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~ 79 (444)
.++|.+.++||+|+||.||+|++.. ++..||+|.+... ...+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3689999999999999999998632 3457999988543 235678999999999999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+++++...+.
T Consensus 84 ~~~~~~~~~~---------------------------------------------------------------------- 93 (304)
T cd05096 84 LLGVCVDEDP---------------------------------------------------------------------- 93 (304)
T ss_pred EEEEEecCCc----------------------------------------------------------------------
Confidence 9998876542
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh--
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK-- 236 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~-- 236 (444)
.++|||||++ +|.+++.....
T Consensus 94 --------------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~ 117 (304)
T cd05096 94 --------------------------------------------------------LCMITEYMENGDLNQFLSSHHLDD 117 (304)
T ss_pred --------------------------------------------------------eEEEEecCCCCcHHHHHHhccccc
Confidence 8899999984 88888754211
Q ss_pred -------------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---
Q psy10212 237 -------------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--- 300 (444)
Q Consensus 237 -------------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--- 300 (444)
....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~ 196 (304)
T cd05096 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRI 196 (304)
T ss_pred cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEc-CCccEEECCCccceecccCceeEe
Confidence 123467788999999999999999999999999999999999 788999999999865432221
Q ss_pred CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc
Q psy10212 301 NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL--GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 378 (444)
Q Consensus 301 ~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt--G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~ 378 (444)
.....++..|+|||.+.+. .++.++|+||||+++|+|++ +..||...+..+....+........
T Consensus 197 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------- 262 (304)
T cd05096 197 QGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG------------- 262 (304)
T ss_pred cCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc-------------
Confidence 1122346789999998877 78999999999999999986 6678887766655544333211000
Q ss_pred ccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 379 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 379 ~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.......++.++..+.+||.+||+.||.+|||+.++..
T Consensus 263 --------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 263 --------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred --------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 00001112356899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=295.84 Aligned_cols=244 Identities=30% Similarity=0.488 Sum_probs=201.1
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||.|++|.||+|++..+++.+|+|.+.... ..+.+|++++++++||||+++.+.+.+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------------- 66 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-------------- 66 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--------------
Confidence 699999999999999889999999985432 34668999999999999999999876554
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (262)
T cd05572 67 -------------------------------------------------------------------------------- 66 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
.++++|||++ ++|.+++.. ...+++..+..++.||+.||.|||
T Consensus 67 --------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH 110 (262)
T cd05572 67 --------------------------------YIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH 110 (262)
T ss_pred --------------------------------ccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3889999998 589888853 346899999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
+++++|+||+|+||+++ .++.++|+|||.+.............++..|++||.+.+. .++.++|+||+|+++|+|++|
T Consensus 111 ~~~~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 111 NRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred hCCcccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhC
Confidence 99999999999999999 7889999999998776544333344678889999998766 789999999999999999999
Q ss_pred CCCCCCCC--hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC-
Q psy10212 342 QPMFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS- 418 (444)
Q Consensus 342 ~~Pf~~~~--~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs- 418 (444)
..||.... ..+....+... .....++..+++.+.++|.+||+.||++||+
T Consensus 189 ~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 189 RPPFGEDDEDPMEIYNDILKG---------------------------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred CCCcCCCCCCHHHHHHHHhcc---------------------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCC
Confidence 99998765 33333322210 0011122345789999999999999999999
Q ss_pred ----HHHHhccCchhhhhh
Q psy10212 419 ----PLQVRSITPFLIELR 433 (444)
Q Consensus 419 ----~~elL~~hpwf~~~~ 433 (444)
+.|+++ ||||+++.
T Consensus 242 ~~~~~~~l~~-~~~~~~~~ 259 (262)
T cd05572 242 LKGGIKDIKK-HKWFNGFD 259 (262)
T ss_pred cccCHHHHhc-ChhhhCCC
Confidence 999999 99999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=296.89 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=204.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||+|+||.||++++..+|+.||+|.+... ...+.+|+.++++++||||+++.+++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-------- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--------
Confidence 589999999999999999999999999999998532 235668999999999999999988876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd08218 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+.++||||+.+ +|.+.+.. .....+++..+..++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~ 112 (256)
T cd08218 73 --------------------------------------NLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICL 112 (256)
T ss_pred --------------------------------------eEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHH
Confidence 48999999975 88887753 22346789999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.+||+++++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||++
T Consensus 113 ~l~~lh~~~i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i 190 (256)
T cd08218 113 ALKHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCV 190 (256)
T ss_pred HHHHHHhCCEecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHH
Confidence 99999999999999999999998 788999999999866533221 1223567889999998776 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|+.||...+..+....+.... .+ ..+..++.++.++|.+||+.+|.
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08218 191 LYEMCTLKHAFEAGNMKNLVLKIIRGS-------------------YP---------PVSSHYSYDLRNLVSQLFKRNPR 242 (256)
T ss_pred HHHHHcCCCCccCCCHHHHHHHHhcCC-------------------CC---------CCcccCCHHHHHHHHHHhhCChh
Confidence 999999999998776665554443310 00 11234688999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.++|+ ||||
T Consensus 243 ~Rp~~~~vl~-~~~~ 256 (256)
T cd08218 243 DRPSVNSILE-KNFI 256 (256)
T ss_pred hCcCHHHHhh-CcCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=295.48 Aligned_cols=255 Identities=29% Similarity=0.414 Sum_probs=205.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++.+.||+|+||.||+|+++.+++.||||.+... ...+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN------ 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC------
Confidence 5799999999999999999999999999999987431 134568999999999999999999887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (267)
T cd08228 76 -------------------------------------------------------------------------------- 75 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..+++|||+++ +|.+++.........+++..++.++.||
T Consensus 76 ----------------------------------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i 115 (267)
T cd08228 76 ----------------------------------------ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115 (267)
T ss_pred ----------------------------------------eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHH
Confidence 38899999995 8888887665566678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||+++++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|
T Consensus 116 ~~~l~~LH~~~i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG 193 (267)
T cd08228 116 CSAVEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLG 193 (267)
T ss_pred HHHHHHHhhCCeeCCCCCHHHEEEc-CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHH
Confidence 9999999999999999999999998 788999999998876533221 1234577889999999876 788999999999
Q ss_pred HHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|+|++|+.||...... ......+...+ .+. .....++..+.++|.+||..
T Consensus 194 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~--------~~~~~~~~~~~~li~~cl~~ 247 (267)
T cd08228 194 CLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------------------YPP--------LPTEHYSEKLRELVSMCIYP 247 (267)
T ss_pred HHHHHHhcCCCCCccccccHHHHHHHHhcCC------------------CCC--------CChhhcCHHHHHHHHHHCCC
Confidence 9999999999999654321 11222221111 000 01123578899999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+|++||++.++++ .++.++
T Consensus 248 ~p~~Rp~~~~vl~---~~~~~~ 266 (267)
T cd08228 248 DPDQRPDIGYVHQ---IAKQMH 266 (267)
T ss_pred CcccCcCHHHHHH---HHHHhc
Confidence 9999999999999 777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.37 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=201.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++.+.||+|+||.||+|++..+|+.||||.+... ...+.+|++++++++||||+++.+++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME--- 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---
Confidence 5789999999999999999999999999999988432 1345679999999999999999988765432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (265)
T cd06652 79 -------------------------------------------------------------------------------- 78 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++++|||+++ +|.+++. ....+++..++.++.
T Consensus 79 -----------------------------------------~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ 113 (265)
T cd06652 79 -----------------------------------------RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTR 113 (265)
T ss_pred -----------------------------------------ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHH
Confidence 248899999985 8888875 234688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
|++.||.+||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|
T Consensus 114 ~l~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 191 (265)
T cd06652 114 QILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKAD 191 (265)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEec-CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC-CCCcchh
Confidence 999999999999999999999999999 78899999999886543211 12233578889999998776 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||...+......++.. .+. ...++..++..+.++|.+
T Consensus 192 v~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~~~i~~ 244 (265)
T cd06652 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT------------------------NPVLPPHVSDHCRDFLKR 244 (265)
T ss_pred HHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC------------------------CCCCchhhCHHHHHHHHH
Confidence 99999999999999999986654443322211 110 011223457889999999
Q ss_pred hcccCCCCCCCHHHHhccCchhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
|+. +|++||++.+++. |||+.
T Consensus 245 ~l~-~p~~Rp~~~~il~-~~~~~ 265 (265)
T cd06652 245 IFV-EAKLRPSADELLR-HTFVH 265 (265)
T ss_pred Hhc-ChhhCCCHHHHhc-CcccC
Confidence 995 9999999999999 99974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=302.21 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=208.2
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.+..++|++.+.||+|+||+||+|++..+|+.||+|++.... ..+.+|+.++++++||||+++.+++.....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~- 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT- 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe-
Confidence 456678999999999999999999999899999999985321 245689999999999999999999887643
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (307)
T cd06607 90 -------------------------------------------------------------------------------- 89 (307)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.++||||+.+++.+++.. ...++++..+..++
T Consensus 90 ---------------------------------------------~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~ 121 (307)
T cd06607 90 ---------------------------------------------AWLVMEYCLGSASDILEV---HKKPLQEVEIAAIC 121 (307)
T ss_pred ---------------------------------------------EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHH
Confidence 889999999999887753 23568999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDi 328 (444)
.||+.||.|||+.|++|+||+|+||+++ .++.++|+|||.+..... .....++..|+|||.+.+ ...++.++|+
T Consensus 122 ~ql~~~L~~LH~~~i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv 197 (307)
T cd06607 122 HGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (307)
T ss_pred HHHHHHHHHHHHCCceecCCCcccEEEC-CCCCEEEeecCcceecCC---CCCccCCccccCceeeeccCCCCCCcccch
Confidence 9999999999999999999999999999 788999999998865422 233456788999998742 2367889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|+.||.+.+.......+... . .+.. ....++..+.++|.+|
T Consensus 198 ~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----------------~~~~--------~~~~~~~~~~~li~~~ 250 (307)
T cd06607 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQN--D-----------------SPTL--------SSNDWSDYFRNFVDSC 250 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C-----------------CCCC--------CchhhCHHHHHHHHHH
Confidence 99999999999999999877655443332210 0 0000 0112578899999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|+.||++||++.+++. ||||..-+
T Consensus 251 l~~~p~~Rp~~~~il~-~~~~~~~~ 274 (307)
T cd06607 251 LQKIPQDRPSSEELLK-HRFVLRER 274 (307)
T ss_pred hcCChhhCcCHHHHhc-ChhhcccC
Confidence 9999999999999999 99997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.77 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=203.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+|++.+.||+|+||.||+|++..+++.||+|.+... .+.+.+|++++++++||||+++.+++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE------- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-------
Confidence 588999999999999999999999999999999543 245568999999999999999877765433
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (258)
T cd05578 74 -------------------------------------------------------------------------------- 73 (258)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|+||+.+ +|.+.+.. ..++++..++.++.||+
T Consensus 74 ---------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~ 110 (258)
T cd05578 74 ---------------------------------------NMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIV 110 (258)
T ss_pred ---------------------------------------eEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHH
Confidence 38999999985 88887742 36899999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
+||.|||+++++|+||+|+||+++ +++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 111 ~~l~~lh~~~i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~ 188 (258)
T cd05578 111 LALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVT 188 (258)
T ss_pred HHHHHHHhCCeeccCCCHHHeEEc-CCCCEEEeecccccccCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHH
Confidence 999999999999999999999999 7889999999998765444333445678889999999876 68999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||...+.. ....+...... ....++..++..+.++|.+||+.||.
T Consensus 189 l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 189 AYECLRGKRPYRGHSRT-IRDQIRAKQET-------------------------ADVLYPATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred HHHHHhCCCCCCCCCcc-HHHHHHHHhcc-------------------------ccccCcccCcHHHHHHHHHHccCChh
Confidence 99999999999876642 11111111100 01112335689999999999999999
Q ss_pred CCCCH--HHHhccCchh
Q psy10212 415 SRISP--LQVRSITPFL 429 (444)
Q Consensus 415 kRPs~--~elL~~hpwf 429 (444)
+||++ .|+++ ||||
T Consensus 243 ~R~~~~~~~l~~-~~~~ 258 (258)
T cd05578 243 KRLGDNLKDLKN-HPYF 258 (258)
T ss_pred HcCCccHHHHhc-CCCC
Confidence 99999 99999 9998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.08 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=206.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|++++++++||||+++.+++....
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 75 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT------- 75 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-------
Confidence 467889999999999999999999899999999885332 34668999999999999999988876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (277)
T cd06642 76 -------------------------------------------------------------------------------- 75 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..++|||||++ +|.+++. ..++++..++.++.||+
T Consensus 76 ---------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~ 111 (277)
T cd06642 76 ---------------------------------------KLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREIL 111 (277)
T ss_pred ---------------------------------------ceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHH
Confidence 38999999995 7777763 35689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.|+.|||+++++|+||+|+||+++ +++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||||+
T Consensus 112 ~~l~~lH~~~ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~ 189 (277)
T cd06642 112 KGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGI 189 (277)
T ss_pred HHHHHHhcCCeeccCCChheEEEe-CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHH
Confidence 999999999999999999999998 788999999999866533221 1223567889999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||...........+... ....+...++..+.++|.+||+.+|
T Consensus 190 il~el~tg~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 190 TAIELAKGEPPNSDLHPMRVLFLIPKN----------------------------SPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred HHHHHHhCCCCCcccchhhHHhhhhcC----------------------------CCCCCCcccCHHHHHHHHHHccCCc
Confidence 999999999999765544332211110 0011122457899999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+||++.++++ ||||+......
T Consensus 242 ~~Rp~~~~il~-~~~~~~~~~~~ 263 (277)
T cd06642 242 RFRPTAKELLK-HKFITRYTKKT 263 (277)
T ss_pred ccCcCHHHHHH-hHHHHHHhhhH
Confidence 99999999999 99999766543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=298.42 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=200.0
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||+||+|.+..+|+.||+|.+... ...+.+|++++++++||||+++.+.+...+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------------- 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-------------- 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--------------
Confidence 69999999999999999999999998532 223457999999999999999988886654
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (277)
T cd05577 67 -------------------------------------------------------------------------------- 66 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
..|+||||+++ +|.+++... ....+++..++.++.|++.||.|||
T Consensus 67 --------------------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH 112 (277)
T cd05577 67 --------------------------------DLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLH 112 (277)
T ss_pred --------------------------------eEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 38999999985 888887532 2247899999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
++|++|+||+|+||+++ +++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|
T Consensus 113 ~~~i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 113 QRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred hCCcccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhC
Confidence 99999999999999999 7889999999988665433333344567889999998877 688999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC----
Q psy10212 342 QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI---- 417 (444)
Q Consensus 342 ~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP---- 417 (444)
+.||...........+..... .....++..+++.+.++|.+||+.||.+||
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTL-------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCCCCCCcccccHHHHHhccc-------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 999976554222222211100 001112234689999999999999999999
Q ss_pred -CHHHHhccCchhhhhhh
Q psy10212 418 -SPLQVRSITPFLIELRA 434 (444)
Q Consensus 418 -s~~elL~~hpwf~~~~~ 434 (444)
++.+++. ||||+++..
T Consensus 246 ~~~~~ll~-h~~~~~~~~ 262 (277)
T cd05577 246 GSADEVRE-HPLFKDLNW 262 (277)
T ss_pred ccHHHHHh-ChhhhcCCh
Confidence 8888999 999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=293.29 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=207.4
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++++.||.|+||.||.+++..+++.+++|.+.... ..+.+|+.++++++|+||+++.+++.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-------- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-------- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--------
Confidence 5899999999999999999999999999999885331 34668999999999999999999997754
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd08221 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++++||||++ +|.+++... ....+++..+..++.|++.
T Consensus 73 --------------------------------------~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~ 112 (256)
T cd08221 73 --------------------------------------TLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVS 112 (256)
T ss_pred --------------------------------------eEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHH
Confidence 38999999984 899888632 2456899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
+|.|||+.|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||||++
T Consensus 113 ~l~~lh~~~i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i 190 (256)
T cd08221 113 AVSYIHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCV 190 (256)
T ss_pred HHHHHHhCCccccCCChHhEEEe-CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHH
Confidence 99999999999999999999999 78899999999986653332 22344678899999998876 68899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|..||...+..+....+... ... ..+..++..+.++|.+||..||.
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08221 191 LYELLTLKRTFDATNPLNLVVKIVQG--NYT--------------------------PVVSVYSSELISLVHSLLQQDPE 242 (256)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHcC--CCC--------------------------CCccccCHHHHHHHHHHcccCcc
Confidence 99999999999877666655544321 000 00134688999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+||++.++|+ |+|+
T Consensus 243 ~R~s~~~ll~-~~~l 256 (256)
T cd08221 243 KRPTADEVLD-QPLL 256 (256)
T ss_pred cCCCHHHHhh-CcCC
Confidence 9999999999 9986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=312.75 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=196.5
Q ss_pred cccchhheecccceeEEEEeEecCCC-----ceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSG-----ELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||.||+|++...| +.||+|.+.... ..+.+|+++++++ +|+||+++++.+...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~- 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP- 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC-
Confidence 46999999999999999999865433 579999985432 3466899999999 89999999998866543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 117 -------------------------------------------------------------------------------- 116 (374)
T cd05106 117 -------------------------------------------------------------------------------- 116 (374)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh--------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS-------------- 235 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~-------------- 235 (444)
.++|||||+ ++|.+++....
T Consensus 117 ---------------------------------------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 151 (374)
T cd05106 117 ---------------------------------------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEIS 151 (374)
T ss_pred ---------------------------------------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccc
Confidence 778888887 47777774321
Q ss_pred ----------------------------------------------------hcCCCCChHHHHHHHHHHHHHHHHHHHC
Q psy10212 236 ----------------------------------------------------KSKQNFPCFYTKLYIYQLFRSLAYIHVL 263 (444)
Q Consensus 236 ----------------------------------------------------~~~~~l~~~~i~~i~~QIl~aL~yLHs~ 263 (444)
....++++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 231 (374)
T cd05106 152 ETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK 231 (374)
T ss_pred cccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 1123578888999999999999999999
Q ss_pred CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 264 givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
|++||||||+||+++ +++.++|+|||++......... ....++..|+|||.+.+. .++.++|+|||||++|+|++
T Consensus 232 giiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt 309 (374)
T cd05106 232 NCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 309 (374)
T ss_pred CEEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHh
Confidence 999999999999999 7889999999998654322211 112235679999999776 78999999999999999997
Q ss_pred -CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH
Q psy10212 341 -GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419 (444)
Q Consensus 341 -G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~ 419 (444)
|+.||................ .....+..+++++.++|.+||+.||.+|||+
T Consensus 310 ~G~~Pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 310 LGKSPYPGILVNSKFYKMVKRG---------------------------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred CCCCCCccccccHHHHHHHHcc---------------------------cCccCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999998765444333333210 0001122358999999999999999999999
Q ss_pred HHHhccCchhhhh
Q psy10212 420 LQVRSITPFLIEL 432 (444)
Q Consensus 420 ~elL~~hpwf~~~ 432 (444)
.++++ .|+++
T Consensus 363 ~~l~~---~l~~~ 372 (374)
T cd05106 363 SQISQ---LIQRQ 372 (374)
T ss_pred HHHHH---HHHHH
Confidence 99998 55553
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=309.38 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=213.0
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc--cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
-|.++++||.|+||.||+|.++.+|+.+|||++..+. ..+.+|+.+|+++..++||+|+++|....+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----------- 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----------- 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----------
Confidence 4889999999999999999999999999999996543 566689999999999999999999998876
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 103 -------------------------------------------------------------------------------- 102 (502)
T KOG0574|consen 103 -------------------------------------------------------------------------------- 102 (502)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
++||||||+ |+..+.++ ....++++.++..++..-+.||+|
T Consensus 103 -----------------------------------LWIVMEYCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~Y 144 (502)
T KOG0574|consen 103 -----------------------------------LWIVMEYCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQY 144 (502)
T ss_pred -----------------------------------eEeehhhcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHH
Confidence 999999999 68888775 356789999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
||...-+|||||..||+++ ..|..||.|||.+-..... ....+..||+.|||||++... .|...+||||||++..||
T Consensus 145 LH~~~KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEM 222 (502)
T KOG0574|consen 145 LHDLKKIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEM 222 (502)
T ss_pred HHHHHHHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhh
Confidence 9999999999999999999 7899999999998654332 345677899999999999877 789999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs 418 (444)
..|++||.+..+..-+. . +|..+-..++. +..-|.++.+++++||.++|++|-|
T Consensus 223 AEG~PPYsDIHPMRAIF---M---------------------IPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~T 276 (502)
T KOG0574|consen 223 AEGRPPYSDIHPMRAIF---M---------------------IPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKT 276 (502)
T ss_pred hcCCCCcccccccceeE---e---------------------ccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHH
Confidence 99999998866543211 1 11111111000 1123788999999999999999999
Q ss_pred HHHHhccCchhhhh
Q psy10212 419 PLQVRSITPFLIEL 432 (444)
Q Consensus 419 ~~elL~~hpwf~~~ 432 (444)
+.++++ |||+++.
T Consensus 277 A~~L~~-H~FiknA 289 (502)
T KOG0574|consen 277 ALRLCE-HTFIKNA 289 (502)
T ss_pred HHHHhh-hhhhcCC
Confidence 999999 9999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=293.49 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=204.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.++|++.+.||.|+||.||+|++..+++.+|+|.+... ...+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-------- 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-------- 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--------
Confidence 36899999999999999999999999999999998543 345678999999999999999999887754
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (262)
T cd06613 74 -------------------------------------------------------------------------------- 73 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++++|||+++ +|.+++.. ...++++..++.++.|++.
T Consensus 74 --------------------------------------~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~ 112 (262)
T cd06613 74 --------------------------------------KLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLK 112 (262)
T ss_pred --------------------------------------EEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHH
Confidence 38999999996 77777642 2357899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccC--CCCCcchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGA--IDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~--~~~s~~sDiwSLG 332 (444)
||+|||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. ..++.++|+||+|
T Consensus 113 ~l~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG 191 (262)
T cd06613 113 GLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191 (262)
T ss_pred HHHHHHhCCceecCCChhhEEEC-CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHH
Confidence 99999999999999999999999 78899999999986653322 22334567889999988543 2577899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||...+.......+.... ...+. . ......+.++.++|.+||..|
T Consensus 192 ~~l~~~~tg~~p~~~~~~~~~~~~~~~~~-----------------~~~~~-----~--~~~~~~~~~~~~li~~~l~~~ 247 (262)
T cd06613 192 ITAIELAELQPPMFDLHPMRALFLISKSN-----------------FPPPK-----L--KDKEKWSPVFHDFIKKCLTKD 247 (262)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------CCCcc-----c--cchhhhhHHHHHHHHHHcCCC
Confidence 99999999999998776555444332210 00000 0 011234788999999999999
Q ss_pred CCCCCCHHHHhccCch
Q psy10212 413 PSSRISPLQVRSITPF 428 (444)
Q Consensus 413 P~kRPs~~elL~~hpw 428 (444)
|.+|||+.++++ |+|
T Consensus 248 p~~Rpt~~~il~-~~~ 262 (262)
T cd06613 248 PKKRPTATKLLQ-HPF 262 (262)
T ss_pred hhhCCCHHHHhc-CCC
Confidence 999999999999 998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.83 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=207.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
....|+.++.||+|+||.||+|.+..+++.+|||.+.... ..+.+|+++++++.|+||+++.+.+..+.
T Consensus 2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (277)
T cd06640 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT------ 75 (277)
T ss_pred hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC------
Confidence 3467899999999999999999999899999999885432 34568999999999999999999987754
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (277)
T cd06640 76 -------------------------------------------------------------------------------- 75 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++||||+++ +|.+++. ..++++..+..++.|+
T Consensus 76 ----------------------------------------~~~lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l 110 (277)
T cd06640 76 ----------------------------------------KLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEI 110 (277)
T ss_pred ----------------------------------------EEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHH
Confidence 48999999985 8888774 2468899999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||++||+.+++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||
T Consensus 111 ~~~l~~lh~~~ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG 188 (277)
T cd06640 111 LKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLG 188 (277)
T ss_pred HHHHHHHHhCCccCcCCChhhEEEc-CCCCEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHH
Confidence 9999999999999999999999999 788999999999866543321 2233567789999998877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||...+.......+... ....+...++..+.++|.+||+.+
T Consensus 189 ~il~el~tg~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 189 ITAIELAKGEPPNSDMHPMRVLFLIPKN----------------------------NPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred HHHHHHHHCCCCCCCcChHhHhhhhhcC----------------------------CCCCCchhhhHHHHHHHHHHcccC
Confidence 9999999999999876654333221110 001122345789999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++||++.+++. |+||.....
T Consensus 241 p~~Rp~~~~il~-~~~~~~~~~ 261 (277)
T cd06640 241 PSFRPTAKELLK-HKFIVKNAK 261 (277)
T ss_pred cccCcCHHHHHh-ChHhhhcch
Confidence 999999999999 999987554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=290.67 Aligned_cols=250 Identities=32% Similarity=0.484 Sum_probs=208.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||.|+||.||++.+..+++.||+|++... ...+.+|++++++++|+|++++.+.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-------- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-------- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC--------
Confidence 588999999999999999999988999999998543 245668999999999999999998886653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (258)
T cd08215 73 -------------------------------------------------------------------------------- 72 (258)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++++|++++ +|.+.+.........+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~ 114 (258)
T cd08215 73 --------------------------------------KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114 (258)
T ss_pred --------------------------------------EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHH
Confidence 38899999985 898888765444678999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.+||++|++|+||+|+||+++ +++.++|+|||.+....... ......+++.|+|||...+. .++.++|+||+|++
T Consensus 115 ~l~~lh~~~~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~ 192 (258)
T cd08215 115 ALKYLHSRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCV 192 (258)
T ss_pred HHHHHHhCCEecccCChHHeEEc-CCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHH
Confidence 99999999999999999999999 78899999999986654332 22334678889999998777 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|..||...+..+......... ...++..++..+.++|.+||..+|+
T Consensus 193 ~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~ 244 (258)
T cd08215 193 LYELCTLKHPFEGENLLELALKILKGQ----------------------------YPPIPSQYSSELRNLVSSLLQKDPE 244 (258)
T ss_pred HHHHHcCCCCCCCCcHHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChh
Confidence 999999999998776554444332210 0011224689999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++|+ ||||
T Consensus 245 ~Rp~~~~ll~-~~~~ 258 (258)
T cd08215 245 ERPSIAQILQ-SPFI 258 (258)
T ss_pred hCcCHHHHhc-CCCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.93 Aligned_cols=246 Identities=17% Similarity=0.189 Sum_probs=198.7
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
..+|+|++|.||+|.. +|+.||||.+.... +.+.+|+.+|++++||||+++++++.+....
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~---------- 93 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD---------- 93 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC----------
Confidence 6799999999999998 79999999985431 3455899999999999999999998762110
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (283)
T PHA02988 94 -------------------------------------------------------------------------------- 93 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
...+++|||||++ +|.+++. ....+++.....++.|++.||.|
T Consensus 94 --------------------------------~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~ 137 (283)
T PHA02988 94 --------------------------------LPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYN 137 (283)
T ss_pred --------------------------------CCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHH
Confidence 0248899999995 7888875 34578899999999999999999
Q ss_pred HHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC-CCCCcchhhhhHHHHHHH
Q psy10212 260 IHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA-IDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 260 LHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwSLGvil~e 337 (444)
||+. +++|+||+|+||+++ .++.++|+|||++...... .....++..|+|||.+.+. ..++.++|+|||||++|+
T Consensus 138 lH~~~~~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~e 214 (283)
T PHA02988 138 LYKYTNKPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214 (283)
T ss_pred HHhcCCCCCCcCChhhEEEC-CCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHH
Confidence 9984 999999999999999 7889999999998754322 2334578899999998751 278999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||.+.+..+....+..... ...++..+++.+.++|.+||+.||++||
T Consensus 215 l~~g~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rp 267 (283)
T PHA02988 215 IFTGKIPFENLTTKEIYDLIINKNN---------------------------SLKLPLDCPLEIKCIVEACTSHDSIKRP 267 (283)
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcCC---------------------------CCCCCCcCcHHHHHHHHHHhcCCcccCc
Confidence 9999999998776665554443110 0012234689999999999999999999
Q ss_pred CHHHHhccCchhhhhhh
Q psy10212 418 SPLQVRSITPFLIELRA 434 (444)
Q Consensus 418 s~~elL~~hpwf~~~~~ 434 (444)
|+.++++ -|+.+..
T Consensus 268 s~~ell~---~l~~~~~ 281 (283)
T PHA02988 268 NIKEILY---NLSLYKF 281 (283)
T ss_pred CHHHHHH---HHHHHHh
Confidence 9999998 6666554
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.42 Aligned_cols=253 Identities=29% Similarity=0.473 Sum_probs=205.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||.||++++..+++.||+|.+... ...+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR------ 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC------
Confidence 4789999999999999999999999999999988543 234557999999999999999998886543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (305)
T cd05609 75 -------------------------------------------------------------------------------- 74 (305)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++++||||+++ +|.+++.. ...+++..+..++.|+
T Consensus 75 ----------------------------------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i 110 (305)
T cd05609 75 ----------------------------------------HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAET 110 (305)
T ss_pred ----------------------------------------EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 48999999985 88888743 3578999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------CCccccccccccCchhhc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----------------PNVSYICSRYYRAPELIF 317 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----------------~~~~~~gt~~y~aPE~l~ 317 (444)
+.||.|||+++++|+||+|+||+++ ..+.++|+|||.++...... ......++..|+|||.+.
T Consensus 111 ~~~l~~lH~~~i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (305)
T cd05609 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189 (305)
T ss_pred HHHHHHHHHCCccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhcc
Confidence 9999999999999999999999999 78899999999875321000 011234577899999987
Q ss_pred cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
+. .++.++|+||||+++|+|++|..||.+.+..+....+.... ...|. ....+
T Consensus 190 ~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~~---------~~~~~ 242 (305)
T cd05609 190 RQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-----------------IEWPE---------GDEAL 242 (305)
T ss_pred CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------cCCCC---------ccccC
Confidence 76 78999999999999999999999998776665555443310 00110 01146
Q ss_pred ChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELR 433 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~ 433 (444)
++.+.++|.+||+.||++||+ +.++|+ ||||+..+
T Consensus 243 ~~~~~~li~~~l~~~P~~R~~~~~~~~ll~-~~~~~~~~ 280 (305)
T cd05609 243 PADAQDLISRLLRQNPLERLGTGGAFEVKQ-HRFFLGLD 280 (305)
T ss_pred CHHHHHHHHHHhccChhhccCccCHHHHHh-CccccCCC
Confidence 889999999999999999998 799999 99997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.63 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=203.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcC---CCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLE---HSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.|++++.||+|+||.||+|++..+++.||+|.+..+ ...+.+|+.++++++ ||||+++.+++....
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~----- 75 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP----- 75 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----
Confidence 3588999999999999999999999999999988532 234668999999996 999999999886653
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (277)
T cd06917 76 -------------------------------------------------------------------------------- 75 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++||||+++ +|.+++.. ..+++..++.++.|
T Consensus 76 -----------------------------------------~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~ 109 (277)
T cd06917 76 -----------------------------------------RLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIRE 109 (277)
T ss_pred -----------------------------------------EEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHH
Confidence 38899999985 78777642 37899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
++.||.|||+.|++|+||+|+||+++ ..+.++|+|||.+....... ......++..|+|||.+.+...++.++|+|||
T Consensus 110 i~~~l~~lh~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (277)
T cd06917 110 VLVALKYIHKVGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188 (277)
T ss_pred HHHHHHHHHhCCcccCCcCHHHEEEc-CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHH
Confidence 99999999999999999999999999 78899999999887654332 22334578889999998765467899999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|..||.+.+.......+.. ...+... ...++.++.++|.+||+.
T Consensus 189 G~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------------~~~~~~~--------~~~~~~~~~~~i~~~l~~ 241 (277)
T cd06917 189 GITIYEMATGNPPYSDVDAFRAMMLIPK-------------------SKPPRLE--------DNGYSKLLREFVAACLDE 241 (277)
T ss_pred HHHHHHHHhCCCCCCCCChhhhhhcccc-------------------CCCCCCC--------cccCCHHHHHHHHHHcCC
Confidence 9999999999999986554322211100 0000000 012578999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||++||++.++++ |+||++..+
T Consensus 242 ~p~~R~~~~~il~-~~~~~~~~~ 263 (277)
T cd06917 242 EPKERLSAEELLK-SKWIKAHSK 263 (277)
T ss_pred CcccCcCHHHHhh-ChHhhcccc
Confidence 9999999999999 999988654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=302.69 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=207.3
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+..+.|.....||+|+||.||++.+..+++.||||++... .+.+.+|+.++++++|+||+++.+.+...+
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~------ 92 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD------ 92 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC------
Confidence 3446677778899999999999999999999999998432 245668999999999999999988876543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (292)
T cd06658 93 -------------------------------------------------------------------------------- 92 (292)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.++||||+++ +|.+++. .+.+++..++.++.||
T Consensus 93 ----------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi 127 (292)
T cd06658 93 ----------------------------------------ELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSV 127 (292)
T ss_pred ----------------------------------------eEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHH
Confidence 38999999986 6777663 2468999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||+++++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|
T Consensus 128 ~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG 205 (292)
T cd06658 128 LRALSYLHNQGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLG 205 (292)
T ss_pred HHHHHHHHHCCEeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccC-CCCchhhHHHHH
Confidence 9999999999999999999999999 77899999999886543222 12234578899999998776 788999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||...+.......+...... ..+ ....++..+.++|.+||..|
T Consensus 206 vil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~----------~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 206 IMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP----------------RVK----------DSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------ccc----------cccccCHHHHHHHHHHccCC
Confidence 9999999999999877665544433221100 000 01235889999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+|||+.++++ ||||+.....
T Consensus 260 P~~Rpt~~~il~-~~~~~~~~~~ 281 (292)
T cd06658 260 PSQRATAQELLQ-HPFLKLAGPP 281 (292)
T ss_pred hhHCcCHHHHhh-ChhhhccCCc
Confidence 999999999999 9999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.42 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=199.6
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
-.+.+.....||+|+||.||+|++..+++.||+|.+... ...+.+|++++++++|+||+++++++...+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 78 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG------- 78 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-------
Confidence 345566667999999999999999989999999988543 245678999999999999999998876654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (268)
T cd06624 79 -------------------------------------------------------------------------------- 78 (268)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCC--ChHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNF--PCFYTKLYIYQ 252 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l--~~~~i~~i~~Q 252 (444)
..++++||+++ +|.+++... ..++ ++..+..++.|
T Consensus 79 ---------------------------------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~q 116 (268)
T cd06624 79 ---------------------------------------FFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQ 116 (268)
T ss_pred ---------------------------------------EEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHH
Confidence 38899999985 888887532 2344 78888999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccC-CCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGA-IDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwS 330 (444)
|+.||+|||++|++|+||+|+||+++...+.++|+|||.+........ .....++..|+|||.+.+. ..++.++|+||
T Consensus 117 i~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~s 196 (268)
T cd06624 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196 (268)
T ss_pred HHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHH
Confidence 999999999999999999999999985578999999999865433222 2233568899999998654 24788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
+|+++|+|++|+.||............... ......++..+++.+.+++.+||+
T Consensus 197 lGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~ 250 (268)
T cd06624 197 LGCTIVEMATGKPPFIELGEPQAAMFKVGM--------------------------FKIHPEIPESLSAEAKNFILRCFE 250 (268)
T ss_pred HHHHHHHHHhCCCCCccccChhhhHhhhhh--------------------------hccCCCCCcccCHHHHHHHHHHcC
Confidence 999999999999999754332211100000 000111234568999999999999
Q ss_pred cCCCCCCCHHHHhccCchh
Q psy10212 411 YTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf 429 (444)
.+|.+|||+.|++. ||||
T Consensus 251 ~~p~~Rpt~~~ll~-~~~~ 268 (268)
T cd06624 251 PDPDKRASAHDLLQ-DPFL 268 (268)
T ss_pred CCchhCCCHHHHHh-CCCC
Confidence 99999999999999 9997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.31 Aligned_cols=249 Identities=31% Similarity=0.426 Sum_probs=203.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|.+.+.||+|+||.||+|.++.+|+.+|+|.+... .+.+.+|++++++++|+||+++.+.+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-------- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-------- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--------
Confidence 588999999999999999999999999999998542 345668999999999999999988776543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (257)
T cd08225 73 -------------------------------------------------------------------------------- 72 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++++||+++ +|.+++.. .....+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~ 112 (257)
T cd08225 73 --------------------------------------RLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISL 112 (257)
T ss_pred --------------------------------------eEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHH
Confidence 48999999975 88888753 23345789999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-ccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||+.+++|+||+|+||+++.+...++|+|||.+......... ....++..|+|||.+.+. .++.++|+||+|++
T Consensus 113 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~i 191 (257)
T cd08225 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCV 191 (257)
T ss_pred HHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHH
Confidence 9999999999999999999999844456799999988665433221 223568889999998776 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|..||...+..+....+.... . ....+.++.++.++|.+||..+|+
T Consensus 192 l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~~i~~~l~~~p~ 243 (257)
T cd08225 192 LYELCTLKHPFEGNNLHQLVLKICQGY-------------------F---------APISPNFSRDLRSLISQLFKVSPR 243 (257)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHhccc-------------------C---------CCCCCCCCHHHHHHHHHHhccChh
Confidence 999999999998766555444332210 0 011234688999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 244 ~Rpt~~~ll~-~~~~ 257 (257)
T cd08225 244 DRPSITSILK-RPFL 257 (257)
T ss_pred hCcCHHHHhh-CCCC
Confidence 9999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.29 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=196.1
Q ss_pred eecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHH---hhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQI---MRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~---l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.||+|+||.||++.+..+++.+|+|.+.... ..+.+|..+ +...+||+|+.+.+.+...+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---------- 70 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD---------- 70 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC----------
Confidence 4899999999999999999999999885431 122344433 33347999999988887654
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 71 -------------------------------------------------------------------------------- 70 (279)
T cd05633 71 -------------------------------------------------------------------------------- 70 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++||||+++ +|.+++. ..+.+++..+..++.|++.||
T Consensus 71 ------------------------------------~~~lv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al 110 (279)
T cd05633 71 ------------------------------------KLCFILDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGL 110 (279)
T ss_pred ------------------------------------eEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Confidence 38899999985 7777764 345699999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
+|||+++++|+||+|+||+++ .++.++|+|||++....... .....++..|+|||.+.+...++.++|+||+||++|+
T Consensus 111 ~~lH~~~ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 188 (279)
T cd05633 111 EHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188 (279)
T ss_pred HHHHHCCcCCCCCCHHHEEEC-CCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHH
Confidence 999999999999999999999 78899999999986543222 2334678999999998754468899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|..||.......... +.... ......++..+++++.++|.+||+.||.+||
T Consensus 189 l~~g~~pf~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 242 (279)
T cd05633 189 LLRGHSPFRQHKTKDKHE-IDRMT-------------------------LTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242 (279)
T ss_pred HHhCCCCcCCCCCcCHHH-HHHHh-------------------------hcCCcCCccccCHHHHHHHHHHhcCCHHHhc
Confidence 999999997654322111 11100 0011112345689999999999999999999
Q ss_pred -----CHHHHhccCchhhhhhhhhhcc
Q psy10212 418 -----SPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 418 -----s~~elL~~hpwf~~~~~~~~~~ 439 (444)
|++++++ ||||+.+....+.+
T Consensus 243 ~~~~~~~~~~~~-h~~~~~~~~~~~~~ 268 (279)
T cd05633 243 GCLGRGAQEVKE-HVFFKGIDWQQVYL 268 (279)
T ss_pred CCCCCCHHHHHh-CccccCCCHhHHhc
Confidence 6999999 99999977665544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.37 Aligned_cols=252 Identities=27% Similarity=0.520 Sum_probs=200.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc--------------cchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--------------RFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
+|.+.+.||+|+||.||+|++..+|+.+|+|.+.... +.+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999999899999999884311 23557999999999999999998876543
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (272)
T cd06629 82 -------------------------------------------------------------------------------- 81 (272)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..++||||+.+ +|.+.+.. .+++++..++
T Consensus 82 ----------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~ 111 (272)
T cd06629 82 ----------------------------------------------YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVR 111 (272)
T ss_pred ----------------------------------------------ceEEEEecCCCCcHHHHHhh----ccCCCHHHHH
Confidence 38899999975 88888753 2578999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCC-CCC
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAI-DYT 323 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~s 323 (444)
.++.||+.||.+||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.... .++
T Consensus 112 ~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 190 (272)
T cd06629 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS 190 (272)
T ss_pred HHHHHHHHHHHHHhhCCeeecCCChhhEEEc-CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCC
Confidence 9999999999999999999999999999999 78999999999986543221 122345678899999987652 478
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+||||++++++++|..||...+..+...++... .... .........++..+.+
T Consensus 191 ~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------~~~~--------~~~~~~~~~~~~~~~~ 247 (272)
T cd06629 191 AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK---------------RSAP--------PIPPDVSMNLSPVALD 247 (272)
T ss_pred ccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc---------------ccCC--------cCCccccccCCHHHHH
Confidence 9999999999999999999999755443322221110 0000 0111122346899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
+|.+||..||.+|||+.++|+ ||||
T Consensus 248 li~~~l~~~p~~Rps~~~il~-~~~~ 272 (272)
T cd06629 248 FLNACFTINPDNRPTARELLQ-HPFI 272 (272)
T ss_pred HHHHHhcCChhhCCCHHHHhh-CCCC
Confidence 999999999999999999999 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.29 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=200.5
Q ss_pred cccchhheecccceeEEEEeEecCCC-----ceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSG-----ELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.|++.+.||+|+||.||+|.+...+ +.+|+|.+.... ..+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-- 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP-- 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc--
Confidence 57999999999999999999986655 679999885432 346689999999999999999998876542
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (283)
T cd05048 83 -------------------------------------------------------------------------------- 82 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------cC
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------SK 238 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~~ 238 (444)
.+++|||++ ++|.+++..... ..
T Consensus 83 --------------------------------------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 118 (283)
T cd05048 83 --------------------------------------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118 (283)
T ss_pred --------------------------------------------eEEEEecCCCCcHHHHHHhcCCCccccccccccccc
Confidence 889999998 589888864321 11
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchh
Q psy10212 239 QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPEL 315 (444)
Q Consensus 239 ~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~ 315 (444)
..+++..++.++.||+.||.|||++|++|+||+|+||+++ +++.++|+|||++....... ......+++.|+|||.
T Consensus 119 ~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (283)
T cd05048 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA 197 (283)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc-CCCcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence 4678889999999999999999999999999999999999 78899999999986543222 1223345778999999
Q ss_pred hccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 316 IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 316 l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.... ....+
T Consensus 198 ~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~ 248 (283)
T cd05048 198 ILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ----------------------------LLPCP 248 (283)
T ss_pred hccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------cCCCc
Confidence 8776 78999999999999999997 999998877665544333210 00113
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..+|+.+.+|+.+||+.||.+||++.|+++
T Consensus 249 ~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 249 EDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 457999999999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=291.78 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=201.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+|++.+.||.|+||.||+++++.+++.+|+|.+... .+.+.+|+.++++++|+||+++.+.+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--------- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC---------
Confidence 588999999999999999999999999999998432 234557999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (255)
T cd08219 72 -------------------------------------------------------------------------------- 71 (255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+++++|||+++ +|.+++.. .....+++..++.++.||+.|
T Consensus 72 -------------------------------------~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~a 112 (255)
T cd08219 72 -------------------------------------HLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLG 112 (255)
T ss_pred -------------------------------------EEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHH
Confidence 48999999984 88887753 234568999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.+||++|++|+||+|+||+++ +++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 113 l~~lH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~ 190 (255)
T cd08219 113 VQHIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCIL 190 (255)
T ss_pred HHHHhhCCcccCCCCcceEEEC-CCCcEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhh
Confidence 9999999999999999999998 78899999999986553322 22334678889999998776 789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|..||...+.......+.... ...++..++..+.++|.+||+.||++
T Consensus 191 ~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~ 242 (255)
T cd08219 191 YELCTLKHPFQANSWKNLILKVCQGS----------------------------YKPLPSHYSYELRSLIKQMFKRNPRS 242 (255)
T ss_pred eehhhccCCCCCCCHHHHHHHHhcCC----------------------------CCCCCcccCHHHHHHHHHHHhCCccc
Confidence 99999999998766554444333210 00112346889999999999999999
Q ss_pred CCCHHHHhc
Q psy10212 416 RISPLQVRS 424 (444)
Q Consensus 416 RPs~~elL~ 424 (444)
|||+.+++.
T Consensus 243 Rp~~~~il~ 251 (255)
T cd08219 243 RPSATTILS 251 (255)
T ss_pred CCCHHHHhh
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=293.55 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=206.4
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+-|++++.||.|+||.||+|.+..+++.+|||.+.... ..+.+|+.++++++||||+++++++..+.
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 75 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT------- 75 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-------
Confidence 466889999999999999999999899999999875322 35668999999999999999999987654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (277)
T cd06641 76 -------------------------------------------------------------------------------- 75 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
+.++||||+++ +|.+++. ...+++..+..++.|++
T Consensus 76 ---------------------------------------~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~ 111 (277)
T cd06641 76 ---------------------------------------KLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREIL 111 (277)
T ss_pred ---------------------------------------eEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHH
Confidence 38999999985 7777764 24688999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.++.+||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|+
T Consensus 112 ~~l~~lh~~~i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ 189 (277)
T cd06641 112 KGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGI 189 (277)
T ss_pred HHHHHHccCCeecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhccccCCccccChhhhccC-CCCchhhHHHHHH
Confidence 999999999999999999999999 788999999998865433221 2233567889999998776 7889999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|..||...+.......+... . ...+...++..+.++|.+||+.+|
T Consensus 190 ~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 190 TAIELAKGEPPHSELHPMKVLFLIPKN-------------------N---------PPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred HHHHHHcCCCCCCccchHHHHHHHhcC-------------------C---------CCCCCcccCHHHHHHHHHHccCCh
Confidence 999999999999876544333322110 0 001223468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+||++.++++ ||||.....
T Consensus 242 ~~Rp~~~~~l~-~~~~~~~~~ 261 (277)
T cd06641 242 SFRPTAKELLK-HKFIVRFAK 261 (277)
T ss_pred hhCcCHHHHHh-CHHHhhhhh
Confidence 99999999999 999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.78 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=193.6
Q ss_pred cccchhheecccceeEEEEeEe-----cCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||.||+|++ ..++..||+|++... ...+.+|+++++.+ +||||+++++++...+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~- 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP- 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc-
Confidence 3799999999999999999974 345678999998533 23466899999999 89999999998866543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 114 -------------------------------------------------------------------------------- 113 (375)
T cd05104 114 -------------------------------------------------------------------------------- 113 (375)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh--------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS-------------- 235 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~-------------- 235 (444)
.++|||||+ |+|.+++....
T Consensus 114 ---------------------------------------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 148 (375)
T cd05104 114 ---------------------------------------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEA 148 (375)
T ss_pred ---------------------------------------------ceeeehhccCCcHHHHHHhcccccccccccchhhh
Confidence 778888887 47877775321
Q ss_pred ---------------------------------------------------------hcCCCCChHHHHHHHHHHHHHHH
Q psy10212 236 ---------------------------------------------------------KSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 236 ---------------------------------------------------------~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.....+++..++.++.||+.||+
T Consensus 149 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~ 228 (375)
T cd05104 149 ALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMS 228 (375)
T ss_pred HHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 11235778889999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|||++|++|+||||+||+++ ..+.++|+|||++........ .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 229 ~lH~~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l 306 (375)
T cd05104 229 FLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILL 306 (375)
T ss_pred HHHHCCeeccCCchhhEEEE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHH
Confidence 99999999999999999999 788999999999875533221 1112335679999999877 789999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |..||..........+.+... . ....+...+.++.+||.+||+.||+
T Consensus 307 ~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------~----------~~~~~~~~~~~l~~li~~cl~~dP~ 359 (375)
T cd05104 307 WEIFSLGSSPYPGMPVDSKFYKMIKEG-----------------Y----------RMLSPECAPSEMYDIMKSCWDADPL 359 (375)
T ss_pred HHHHhcCCCCCCCCCchHHHHHHHHhC-----------------c----------cCCCCCCCCHHHHHHHHHHccCChh
Confidence 99997 899998765443333332210 0 0001123578999999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+|||+.|+++
T Consensus 360 ~RPs~~eil~ 369 (375)
T cd05104 360 KRPTFKQIVQ 369 (375)
T ss_pred HCcCHHHHHH
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.11 Aligned_cols=244 Identities=20% Similarity=0.257 Sum_probs=196.1
Q ss_pred cccchhheecccceeEEEEeEec---CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||.||+|.++ ..+..||+|.+... ...+.+|+..+++++||||+++.+++....
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----- 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-----
Confidence 57999999999999999999875 34568999988543 235668999999999999999999886543
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (266)
T cd05064 80 -------------------------------------------------------------------------------- 79 (266)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++||||+++ +|.+++.. ....+++..++.++.|
T Consensus 80 -----------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~ 115 (266)
T cd05064 80 -----------------------------------------TMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPG 115 (266)
T ss_pred -----------------------------------------CcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHH
Confidence 38899999996 67777642 3457899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc--cccccccccCchhhccCCCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|+.||+|||++|++|+||+|+||+++ .++.++++|||.+.......... ...++..|+|||.+.+. .++.++|+||
T Consensus 116 i~~al~~lH~~~iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s 193 (266)
T cd05064 116 LASGMKYLSEMGYVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWS 193 (266)
T ss_pred HHHHHHHHHHCCEeeccccHhhEEEc-CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHH
Confidence 99999999999999999999999999 78899999999875432221111 12335679999998776 8899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
+||++|++++ |..||.+.+..+....+.+.. .. ..+..++..+.+++.+||
T Consensus 194 lG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~li~~c~ 245 (266)
T cd05064 194 FGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------------RL----------PAPRNCPNLLHQLMLDCW 245 (266)
T ss_pred HHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------------CC----------CCCCCCCHHHHHHHHHHc
Confidence 9999999774 999998877665544432210 00 112457899999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy10212 410 EYTPSSRISPLQVRS 424 (444)
Q Consensus 410 ~~DP~kRPs~~elL~ 424 (444)
+.+|.+||++.++++
T Consensus 246 ~~~p~~RP~~~~i~~ 260 (266)
T cd05064 246 QKERGERPRFSQIHS 260 (266)
T ss_pred CCCchhCCCHHHHHH
Confidence 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.09 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=207.2
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.++||.|+||.||+++++.+++.+|+|.+... ...+.+|++++++++|+||+++.+++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-------- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--------
Confidence 588999999999999999999999999999998532 234558999999999999999988776653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd08530 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++||||+++ +|.+++.........+++..++.++.|++.
T Consensus 73 --------------------------------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 114 (256)
T cd08530 73 --------------------------------------KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114 (256)
T ss_pred --------------------------------------EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence 38999999975 899988765555677899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
||++||+.|++|+||+|+||+++ +.+.++|+|||.+...... ......++..|++||.+.+. .++.++|+||+|+++
T Consensus 115 al~~lh~~~i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~ 191 (256)
T cd08530 115 GLQALHEQKILHRDLKSANILLV-ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLL 191 (256)
T ss_pred HHHHHhhCCcccCCCCcceEEEe-cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHH
Confidence 99999999999999999999999 6889999999998765443 23334578899999999776 788999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
++|++|+.||...+..+....+... .++ .++..++.++.++|.+||+.+|.+
T Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~ 243 (256)
T cd08530 192 YEMATFAPPFEARSMQDLRYKVQRG-------------------KYP---------PIPPIYSQDLQNFIRSMLQVKPKL 243 (256)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCC---------CCchhhCHHHHHHHHHHcCCCccc
Confidence 9999999999877655443332221 000 112245889999999999999999
Q ss_pred CCCHHHHhccCchh
Q psy10212 416 RISPLQVRSITPFL 429 (444)
Q Consensus 416 RPs~~elL~~hpwf 429 (444)
|||+.+++. ||++
T Consensus 244 Rp~~~~~l~-~p~~ 256 (256)
T cd08530 244 RPNCDKILA-SPAV 256 (256)
T ss_pred CCCHHHHhc-CCCC
Confidence 999999999 9974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=285.16 Aligned_cols=250 Identities=32% Similarity=0.493 Sum_probs=205.0
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|.+.+.||+|++|.||+|++..+++.+++|++.... ..+.+|+.++++++|+||+++.+.+.....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK------- 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC-------
Confidence 4788899999999999999999899999999985443 456689999999999999999988876521
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (260)
T cd06606 74 -------------------------------------------------------------------------------- 73 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
...++++|+++ ++|.+++.. ...+++..++.++.|++.
T Consensus 74 -------------------------------------~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~ 112 (260)
T cd06606 74 -------------------------------------NTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILE 112 (260)
T ss_pred -------------------------------------CeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHH
Confidence 24889999996 588888753 238999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
||+|||+.+++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. ..+.++|+||||
T Consensus 113 ~l~~lh~~~~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG 190 (260)
T cd06606 113 GLAYLHSNGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLG 190 (260)
T ss_pred HHHHHHHCCccccCCCHHHEEEc-CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHH
Confidence 99999999999999999999999 688999999999877654432 3445678899999998777 689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++++|++|..||...+... ....... .......++..++..+.++|.+||..|
T Consensus 191 ~il~~l~~g~~p~~~~~~~~--~~~~~~~------------------------~~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 191 CTVIEMATGKPPWSELGNPM--AALYKIG------------------------SSGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred HHHHHHHhCCCCCCCCCchH--HHHHhcc------------------------ccCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 99999999999998765211 1111110 001111223455899999999999999
Q ss_pred CCCCCCHHHHhccCchh
Q psy10212 413 PSSRISPLQVRSITPFL 429 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf 429 (444)
|.+||++.+++. ||||
T Consensus 245 p~~Rp~~~~ll~-~~~~ 260 (260)
T cd06606 245 PKKRPTADELLQ-HPFL 260 (260)
T ss_pred hhhCCCHHHHhh-CCCC
Confidence 999999999999 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=298.31 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=207.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+..+.|...+.||+|+||+||+|++..+|+.||+|++.... ..+.+|++++++++|||++++.+++.+..
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 34556888899999999999999999999999999985321 24568999999999999999999987754
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (313)
T cd06633 95 -------------------------------------------------------------------------------- 94 (313)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|||||.+++.+++.. ...++++..++.++.
T Consensus 95 -------------------------------------------~~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~ 128 (313)
T cd06633 95 -------------------------------------------TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITH 128 (313)
T ss_pred -------------------------------------------EEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHH
Confidence 3889999999998888753 345789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDVW 329 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDiw 329 (444)
||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+.... ......++..|+|||.+.. ...++.++|+|
T Consensus 129 qi~~al~~LH~~gi~H~dl~p~nili~-~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~ 204 (313)
T cd06633 129 GALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 204 (313)
T ss_pred HHHHHHHHHHHCCeecCCCChhhEEEC-CCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHH
Confidence 999999999999999999999999998 78899999999875432 2234567888999999742 22678899999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|..||...+.......+.... .+. .....++..+.+||.+||
T Consensus 205 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~--------~~~~~~~~~l~~li~~~l 257 (313)
T cd06633 205 SLGITCIELAERKPPLFNMNAMSALYHIAQND-------------------SPT--------LQSNEWTDSFRGFVDYCL 257 (313)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------------CCC--------CCccccCHHHHHHHHHHc
Confidence 99999999999999998776655554433210 000 011235778999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+.+|.+||++.+++. ||||+..+.
T Consensus 258 ~~~P~~Rp~~~~~l~-~~~~~~~~~ 281 (313)
T cd06633 258 QKIPQERPASAELLR-HDFVRRDRP 281 (313)
T ss_pred cCChhhCcCHHHHhc-CcccCCCch
Confidence 999999999999999 999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.85 Aligned_cols=285 Identities=21% Similarity=0.293 Sum_probs=202.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCC-ceeeee------------------eeec---cccchhhHHHHhhhcCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSG-ELVAIK------------------KVLQ---DKRFKNREMQIMRRLEHS 75 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK------------------~~~~---~~~~~~~E~~~l~~l~h~ 75 (444)
..+.++|++++.||+|+||+||+|..+... +..++| .+.. ....+.+|++++++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345688999999999999999998764432 222222 1111 123456899999999999
Q ss_pred ceeEeeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCC
Q psy10212 76 NIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGT 155 (444)
Q Consensus 76 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (444)
||+++++++...+
T Consensus 224 nIv~l~~~~~~~~------------------------------------------------------------------- 236 (501)
T PHA03210 224 NILKIEEILRSEA------------------------------------------------------------------- 236 (501)
T ss_pred CcCcEeEEEEECC-------------------------------------------------------------------
Confidence 9999999987764
Q ss_pred CchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhh
Q psy10212 156 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYS 235 (444)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~ 235 (444)
..|+|++++.++|.+++....
T Consensus 237 -----------------------------------------------------------~~~lv~e~~~~~l~~~l~~~~ 257 (501)
T PHA03210 237 -----------------------------------------------------------NTYMITQKYDFDLYSFMYDEA 257 (501)
T ss_pred -----------------------------------------------------------eeEEEEeccccCHHHHHhhcc
Confidence 388999999999988874322
Q ss_pred h-cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccC
Q psy10212 236 K-SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRA 312 (444)
Q Consensus 236 ~-~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~a 312 (444)
. .........++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++........ .....|+..|+|
T Consensus 258 ~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~a 336 (501)
T PHA03210 258 FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS 336 (501)
T ss_pred ccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEEEeCCCceecCcccccccccccCCcCCCC
Confidence 1 123345677889999999999999999999999999999999 788999999999976543322 223568999999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHHhCCC-CCCCC--ChhHHHHHHHHHhCCCCHHHHHh----hCCCCCcccCCCcc
Q psy10212 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQP-MFPGD--SGVDQLVEIIKVLGTPTREQIRE----MNPNYTEFKFPQIK 385 (444)
Q Consensus 313 PE~l~~~~~~s~~sDiwSLGvil~eLltG~~-Pf~~~--~~~e~~~~i~~~~g~~~~~~~~~----~~~~~~~~~~p~~~ 385 (444)
||.+.+. .++.++|+|||||++|+|++|.. |+... .....+.+++..++..... ++. +........+....
T Consensus 337 PE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~ 414 (501)
T PHA03210 337 PEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAG 414 (501)
T ss_pred chhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCc
Confidence 9999877 78999999999999999999875 44432 3345555555544432211 100 00000000000000
Q ss_pred CCCCcccc-cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 386 SHPWSKVF-RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 386 ~~~~~~~~-~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
......+ ...++.++.++|.+||++||.+|||+.|+|. ||||....
T Consensus 415 -~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~-hp~f~~~~ 461 (501)
T PHA03210 415 -HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA-LPLFSAEE 461 (501)
T ss_pred -cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh-ChhhhcCC
Confidence 0000001 1245788999999999999999999999999 99998744
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=288.75 Aligned_cols=245 Identities=34% Similarity=0.572 Sum_probs=195.7
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHH-hhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQI-MRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|.+..+|+.||+|.+.... ..+..|..+ ...++|+||+++++++....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----------- 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----------- 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----------
Confidence 57899999999999999999999999985421 112234433 44558999999998887653
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 71 -------------------------------------------------------------------------------- 70 (260)
T cd05611 71 -------------------------------------------------------------------------------- 70 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
+.|+|||||++ +|.+++. ....+++..+..++.||+.||.
T Consensus 71 -----------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~ 111 (260)
T cd05611 71 -----------------------------------YLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVE 111 (260)
T ss_pred -----------------------------------eEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Confidence 48999999985 8888874 3357899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
|||+.+++|+||+|+||+++ ..+.++|+|||.+..... .....++..|++||.+.+. .++.++|+||+|+++|+|
T Consensus 112 ~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l 186 (260)
T cd05611 112 DLHQRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEF 186 (260)
T ss_pred HHHHCCeecCCCCHHHeEEC-CCCcEEEeecccceeccc---cccCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHH
Confidence 99999999999999999999 788999999998865432 2234567889999999877 588999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs 418 (444)
++|..||...+..+....+.... . .+.......+++.+.++|.+||+.||++||+
T Consensus 187 ~~g~~p~~~~~~~~~~~~~~~~~-----------------~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 241 (260)
T cd05611 187 LFGYPPFHAETPDAVFDNILSRR-----------------I--------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLG 241 (260)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcc-----------------c--------CCCCcccccCCHHHHHHHHHHccCCHHHccC
Confidence 99999998777655444333210 0 0111112346899999999999999999995
Q ss_pred H---HHHhccCchhhhhh
Q psy10212 419 P---LQVRSITPFLIELR 433 (444)
Q Consensus 419 ~---~elL~~hpwf~~~~ 433 (444)
+ +|+|+ ||||+++.
T Consensus 242 ~~~~~~~l~-~~~~~~~~ 258 (260)
T cd05611 242 ANGYQEIKS-HPFFKSIN 258 (260)
T ss_pred CCcHHHHHc-ChHhhcCC
Confidence 5 79999 99998864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.65 Aligned_cols=283 Identities=21% Similarity=0.297 Sum_probs=203.9
Q ss_pred hhheeccc--ceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 26 QKTVIGNG--SFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 26 ~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+...||+| +||+||+|++..+|+.||+|.+.... +.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--------- 72 (328)
T cd08226 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--------- 72 (328)
T ss_pred hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC---------
Confidence 34567777 99999999999999999999985432 44568999999999999999999987754
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (328)
T cd08226 73 -------------------------------------------------------------------------------- 72 (328)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.++||||+.+ ++.+++... ....+++..++.++.||+.|
T Consensus 73 -------------------------------------~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~a 113 (328)
T cd08226 73 -------------------------------------WLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRG 113 (328)
T ss_pred -------------------------------------ceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHH
Confidence 38999999995 888887643 23458899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--------ccccccccccCchhhccC-CCCCcchh
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--------VSYICSRYYRAPELIFGA-IDYTTKID 327 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--------~~~~gt~~y~aPE~l~~~-~~~s~~sD 327 (444)
|+|||++|++|+||||+||+++ ..+.++++||+........... ....++..|+|||.+.+. ..++.++|
T Consensus 114 L~~lH~~~ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (328)
T cd08226 114 LNYLHQNGYIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192 (328)
T ss_pred HHHHHhCCeecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhh
Confidence 9999999999999999999999 7789999999754322111110 011235569999998764 25789999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHH------HHHhhC---CCCC----cccC-----CCccCCCC
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE------QIREMN---PNYT----EFKF-----PQIKSHPW 389 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~------~~~~~~---~~~~----~~~~-----p~~~~~~~ 389 (444)
+||+||++|+|++|+.||...................+.. .-.... .... .... .......+
T Consensus 193 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T cd08226 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL 272 (328)
T ss_pred HHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccc
Confidence 9999999999999999998776555444333311100000 000000 0000 0000 00001111
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.......+++.+.+||.+||+.||++|||+.|+|+ ||||+.++.+..+
T Consensus 273 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~-~~~~~~~~~~~~~ 320 (328)
T cd08226 273 RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS-HAFFKQVKEQTQG 320 (328)
T ss_pred cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh-CHHHHHHHHhccc
Confidence 11223346789999999999999999999999999 9999998886544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.71 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=201.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|+++++||+|+||.||+|.+. +++.||+|.+... .+.+.+|+.++++++|+||+++++.+...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 74 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--------- 74 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC---------
Confidence 368999999999999999999975 4678999988543 345668999999999999999988876543
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (261)
T cd05072 75 -------------------------------------------------------------------------------- 74 (261)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..+++|||++ ++|.+++.. .....++...+..++.|++.|
T Consensus 75 -------------------------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~ 115 (261)
T cd05072 75 -------------------------------------PIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEG 115 (261)
T ss_pred -------------------------------------CcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHH
Confidence 2889999997 589888853 234578889999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||+++++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||++
T Consensus 116 l~~LH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~ 193 (261)
T cd05072 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGIL 193 (261)
T ss_pred HHHHHHCCeeccccchhhEEec-CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHH
Confidence 9999999999999999999999 788999999999976543221 1122345679999998776 78899999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||...+..+....+.... .. .....++.++.+++.+||..||
T Consensus 194 l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p 245 (261)
T cd05072 194 LYEIVTYGKIPYPGMSNSDVMSALQRGY------------------RM----------PRMENCPDELYDIMKTCWKEKA 245 (261)
T ss_pred HHHHHccCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCCCCCHHHHHHHHHHccCCc
Confidence 999998 999998876665544433210 00 0112468899999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
++||++.++++ ++++
T Consensus 246 ~~Rp~~~~i~~---~l~~ 260 (261)
T cd05072 246 EERPTFDYLQS---VLDD 260 (261)
T ss_pred ccCcCHHHHHH---HHhc
Confidence 99999999988 6654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=290.90 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=198.8
Q ss_pred hhhhhccccchhhee--cccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 16 YFSDLDNSLAQKTVI--GNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 16 ~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
...++.+.|++.+.+ |+|+||.||+++++.+++.+|+|.+....- ...|+.....+ +|+||+++++.+....
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~~---- 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLK---- 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecCC----
Confidence 345667788888887 999999999999999999999999855321 11233333222 7999999999987754
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (267)
T PHA03390 83 -------------------------------------------------------------------------------- 82 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++||||++ ++|.+++.. ..++++..++.++.
T Consensus 83 ------------------------------------------~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ 116 (267)
T PHA03390 83 ------------------------------------------GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIR 116 (267)
T ss_pred ------------------------------------------eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHH
Confidence 3899999997 589888852 34899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.||.|||+.|++|+||+|+||+++...+.++|+|||.+...... ....++..|+|||.+.+. .++.++|+||+
T Consensus 117 qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Dvwsl 192 (267)
T PHA03390 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAV 192 (267)
T ss_pred HHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCC-CCCchhhHHHH
Confidence 99999999999999999999999999943339999999988654322 234578899999999876 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHH-HHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQL-VEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~-~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++|+.||......+.. ........ . .......+++.+.++|.+||+
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~------------~~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--------------K------------KLPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred HHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--------------c------------cCCcccccCHHHHHHHHHHhc
Confidence 99999999999999865443321 11111100 0 001112468999999999999
Q ss_pred cCCCCCCC-HHHHhccCchhhh
Q psy10212 411 YTPSSRIS-PLQVRSITPFLIE 431 (444)
Q Consensus 411 ~DP~kRPs-~~elL~~hpwf~~ 431 (444)
.||.+||+ +.++|+ ||||++
T Consensus 247 ~~p~~R~~~~~~~l~-h~~~~~ 267 (267)
T PHA03390 247 YNINYRLTNYNEIIK-HPFLKI 267 (267)
T ss_pred cChhhCCchHHHHhc-CCcccC
Confidence 99999996 599999 999974
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=287.26 Aligned_cols=250 Identities=31% Similarity=0.517 Sum_probs=200.6
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.++++++|+||++++++....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-------- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-------- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--------
Confidence 6889999999999999999999899999999985432 35568999999999999999988765543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (264)
T cd06626 73 -------------------------------------------------------------------------------- 72 (264)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++|+||+++ +|.+++. ....+++..++.++.|++.
T Consensus 73 --------------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~ 110 (264)
T cd06626 73 --------------------------------------KVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLE 110 (264)
T ss_pred --------------------------------------EEEEEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHH
Confidence 38899999985 8888774 3456889999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc-----cccccccccCchhhccCC--CCCcchhh
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-----SYICSRYYRAPELIFGAI--DYTTKIDV 328 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~-----~~~gt~~y~aPE~l~~~~--~~s~~sDi 328 (444)
||.|||++|++|+||+|+||+++ +.+.++|+|||.+.......... ...++..|+|||.+.+.. ..+.++|+
T Consensus 111 ~l~~lh~~~i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv 189 (264)
T cd06626 111 GLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189 (264)
T ss_pred HHHHHHHCCcccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccch
Confidence 99999999999999999999999 68899999999987654332211 235678899999987652 37899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+|++++++++|+.||...+........... +. ...+|. ...+++.+.++|.+|
T Consensus 190 ~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~~~~~----------~~~~~~~~~~li~~~ 244 (264)
T cd06626 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH--------------KPPIPD----------SLQLSPEGKDFLDRC 244 (264)
T ss_pred HHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC--------------CCCCCc----------ccccCHHHHHHHHHH
Confidence 99999999999999999765433222211111 00 000111 113488999999999
Q ss_pred cccCCCCCCCHHHHhccCchh
Q psy10212 409 LEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf 429 (444)
|+.||.+|||+.+++. |||+
T Consensus 245 l~~~p~~R~~~~~i~~-~~~~ 264 (264)
T cd06626 245 LESDPKKRPTASELLQ-HPFV 264 (264)
T ss_pred ccCCcccCCCHHHHhc-CCCC
Confidence 9999999999999999 9996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=281.78 Aligned_cols=248 Identities=30% Similarity=0.474 Sum_probs=204.3
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.|++.+.||+|++|.||++++..+++.+++|++.... ..+.+|+.++++++|++|+++.+.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--------- 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE--------- 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe---------
Confidence 3788899999999999999999889999999995543 466789999999999999999998876542
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (253)
T cd05122 72 -------------------------------------------------------------------------------- 71 (253)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++++||++ ++|.+++.. ....+++..+..++.|++.||
T Consensus 72 -------------------------------------~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l 111 (253)
T cd05122 72 -------------------------------------LWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGL 111 (253)
T ss_pred -------------------------------------EEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHH
Confidence 889999999 588888753 226789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.+||++|++|+||+|+||+++ +++.++|+|||.+.............++..|+|||.+.+. .++.++|+||||+++++
T Consensus 112 ~~lh~~~i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~ 189 (253)
T cd05122 112 EYLHSNGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIE 189 (253)
T ss_pred HHhhcCCEecCCCCHHHEEEc-cCCeEEEeeccccccccccccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHH
Confidence 999999999999999999999 7889999999998766444323445678889999999877 68899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||...+........... . .+.. .....++..+.++|.+||+.||++||
T Consensus 190 l~~g~~p~~~~~~~~~~~~~~~~-~------------------~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~ 243 (253)
T cd05122 190 LAEGKPPYSELPPMKALFKIATN-G------------------PPGL-------RNPEKWSDEFKDFLKKCLQKNPEKRP 243 (253)
T ss_pred HHhCCCCCCCCchHHHHHHHHhc-C------------------CCCc-------CcccccCHHHHHHHHHHccCChhhCC
Confidence 99999999876544333322210 0 0000 00112478999999999999999999
Q ss_pred CHHHHhccCch
Q psy10212 418 SPLQVRSITPF 428 (444)
Q Consensus 418 s~~elL~~hpw 428 (444)
|+.|+|+ |||
T Consensus 244 t~~~~l~-~~~ 253 (253)
T cd05122 244 TAEQLLK-HPF 253 (253)
T ss_pred CHHHHhc-CCC
Confidence 9999999 998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=292.30 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=213.4
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..+..+.|++.+.||+|++|.||+|.+..+++.+|+|++... ...+.+|++++++++|+||+++.+.+....
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 88 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD----- 88 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----
Confidence 456788999999999999999999999988999999999654 345668999999999999999999987764
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (286)
T cd06614 89 -------------------------------------------------------------------------------- 88 (286)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++++||++ ++|.+++... ...++...+..++.|
T Consensus 89 -----------------------------------------~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~ 124 (286)
T cd06614 89 -----------------------------------------ELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCRE 124 (286)
T ss_pred -----------------------------------------EEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHH
Confidence 3899999999 5999988642 247999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
++.||++||+.|++|+||+|+||+++ .++.++|+|||.+....... ......++..|++||.+.+. .++.++|+|||
T Consensus 125 i~~~L~~lH~~gi~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~sl 202 (286)
T cd06614 125 VLQGLEYLHSQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSL 202 (286)
T ss_pred HHHHHHHHHhCCeeeCCCChhhEEEc-CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCC-CCCCccccHHH
Confidence 99999999999999999999999999 78899999999875543221 11233467889999998776 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|+.||...+.......+... +. +. .....+++..+.++|.+||+.
T Consensus 203 Gvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------------~~-------~~~~~~~~~~l~~li~~~l~~ 256 (286)
T cd06614 203 GIMCIEMAEGEPPYLREPPLRALFLITTK-GI------------------PP-------LKNPEKWSPEFKDFLNKCLVK 256 (286)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC------------------CC-------CcchhhCCHHHHHHHHHHhcc
Confidence 99999999999999876655444333221 00 00 000123688999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+|.+|||+.++|+ |+||+....
T Consensus 257 ~p~~Rpt~~~il~-~~~~~~~~~ 278 (286)
T cd06614 257 DPEKRPSAEELLQ-HPFLKKACP 278 (286)
T ss_pred ChhhCcCHHHHhh-ChHhhccCc
Confidence 9999999999999 999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=289.67 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=199.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+|.+.+.||+|+||.||+|.++.+++.+|+|.+..+. ..+.+|++++++++|+||+++++++...+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--------- 76 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--------- 76 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC---------
Confidence 56889999999999999999999999999999985443 356789999999999999999988766542
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (263)
T cd05052 77 -------------------------------------------------------------------------------- 76 (263)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
++++|||++ ++|.+++.. .....+++..++.++.|++.||
T Consensus 77 -------------------------------------~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l 117 (263)
T cd05052 77 -------------------------------------FYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAM 117 (263)
T ss_pred -------------------------------------cEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHH
Confidence 789999997 588888753 2245688999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++|+||+|+||+++ +++.++|+|||.+......... .....+..|+|||.+.+. .++.++|+||||+++
T Consensus 118 ~~lH~~~i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il 195 (263)
T cd05052 118 EYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLL 195 (263)
T ss_pred HHHHhCCEeecccCcceEEEc-CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHH
Confidence 999999999999999999998 7889999999998665332211 112235679999998776 789999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |..||.+.+..+....+... .....+..++..+.++|.+||+.||+
T Consensus 196 ~el~t~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~ 247 (263)
T cd05052 196 WEIATYGMSPYPGIDLSQVYELLEKG----------------------------YRMERPEGCPPKVYELMRACWQWNPS 247 (263)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCC----------------------------CCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 99998 99999887655443333210 00112235689999999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+|||+.++++
T Consensus 248 ~Rp~~~~l~~ 257 (263)
T cd05052 248 DRPSFAEIHQ 257 (263)
T ss_pred cCCCHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.92 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=207.6
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.+..++|++.+.||+|+||+||++++..+++.||+|.+... .+.+.+|+.++++++||||+++.+++....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~---- 89 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD---- 89 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC----
Confidence 455668999999999999999999999889999999998432 245568999999999999999988886654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (293)
T cd06647 90 -------------------------------------------------------------------------------- 89 (293)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|+||+++ +|.+++.. ..+++..+..++.
T Consensus 90 ------------------------------------------~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~ 122 (293)
T cd06647 90 ------------------------------------------ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 122 (293)
T ss_pred ------------------------------------------cEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHH
Confidence 28899999985 88887742 3578889999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|++.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|++||.+.+. .++.++|+||
T Consensus 123 ~l~~al~~LH~~gi~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~s 200 (293)
T cd06647 123 ECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWS 200 (293)
T ss_pred HHHHHHHHHHhCCEeeccCCHHHEEEc-CCCCEEEccCcceecccccccccccccCChhhcCchhhccC-CCCchhhHHH
Confidence 999999999999999999999999999 78899999999876543322 22234577889999998776 7889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
+|+++|++++|+.||...+..+....+... +. + ....+..++..+.++|.+||.
T Consensus 201 lG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~------------------~-------~~~~~~~~~~~l~~li~~~l~ 254 (293)
T cd06647 201 LGIMAIEMVEGEPPYLNENPLRALYLIATN-GT------------------P-------ELQNPEKLSAIFRDFLNRCLE 254 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChhhheeehhcC-CC------------------C-------CCCCccccCHHHHHHHHHHcc
Confidence 999999999999999876543322211110 00 0 000122357889999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+|++||++.+++. |+||+..+
T Consensus 255 ~~p~~Rp~~~~il~-h~~~~~~~ 276 (293)
T cd06647 255 MDVEKRGSAKELLQ-HPFLKIAK 276 (293)
T ss_pred CChhhCcCHHHHhc-CHHHhcCc
Confidence 99999999999999 99999866
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=289.89 Aligned_cols=250 Identities=30% Similarity=0.440 Sum_probs=201.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.+.+.||+|+||.||+|+++.+++.+|||.+... ...+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN------ 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC------
Confidence 5799999999999999999999999999999987432 235568999999999999999999887764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (267)
T cd08229 76 -------------------------------------------------------------------------------- 75 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..+++|||+++ +|.+++.........+++..++.++.||
T Consensus 76 ----------------------------------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i 115 (267)
T cd08229 76 ----------------------------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115 (267)
T ss_pred ----------------------------------------eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHH
Confidence 38899999985 8998887655556778999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|
T Consensus 116 ~~~l~~LH~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG 193 (267)
T cd08229 116 CSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLG 193 (267)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEEc-CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHH
Confidence 9999999999999999999999999 788999999998866533221 2234578889999999776 788999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|..||.+..... ....+.+. ....+. ..+..+++.+.++|.+||..|
T Consensus 194 ~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------------~~~~~~--------~~~~~~~~~~~~li~~~l~~~ 248 (267)
T cd08229 194 CLLYEMAALQSPFYGDKMNL--YSLCKKIE---------------QCDYPP--------LPSDHYSEELRQLVNMCINPD 248 (267)
T ss_pred HHHHHHHhCCCCcccccchH--HHHhhhhh---------------cCCCCC--------CCcccccHHHHHHHHHhcCCC
Confidence 99999999999997543221 11111000 000000 011246889999999999999
Q ss_pred CCCCCCHHHHhc
Q psy10212 413 PSSRISPLQVRS 424 (444)
Q Consensus 413 P~kRPs~~elL~ 424 (444)
|.+|||+.++++
T Consensus 249 p~~Rpt~~~i~~ 260 (267)
T cd08229 249 PEKRPDITYVYD 260 (267)
T ss_pred cccCCCHHHHHH
Confidence 999999998877
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.36 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=199.5
Q ss_pred cccchhheecccceeEEEEeEecC-----CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
++|.+++.||+|+||.||+|++.. +++.||+|.+... ...+.+|++++++++|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP-- 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC--
Confidence 579999999999999999998753 3678999998543 2456789999999999999999998877643
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (280)
T cd05049 83 -------------------------------------------------------------------------------- 82 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh----------hcCCC
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS----------KSKQN 240 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~----------~~~~~ 240 (444)
.++||||++ ++|.+++.... .....
T Consensus 83 --------------------------------------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~ 118 (280)
T cd05049 83 --------------------------------------------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118 (280)
T ss_pred --------------------------------------------eEEEEecCCCCCHHHHHHhcCCchhhhccccccccc
Confidence 899999998 48988885431 12345
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhc
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIF 317 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~ 317 (444)
+++..+..++.||+.||.+||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.
T Consensus 119 l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-CCCeEEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 78889999999999999999999999999999999999 78999999999986532221 112223467899999998
Q ss_pred cCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
+. .++.++|+||||+++|+|++ |..||.+.+..+....+.... . ...+..
T Consensus 198 ~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~ 248 (280)
T cd05049 198 YR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR-------------------L---------LQRPRT 248 (280)
T ss_pred cC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------c---------CCCCCC
Confidence 77 78999999999999999998 999998777665544433210 0 001124
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
++..+.++|.+||+.||.+||++.|+++
T Consensus 249 ~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 249 CPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6899999999999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.17 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=204.8
Q ss_pred cccchhheecccceeEEEEeEec-----CCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+|.+.+.||.|+||.||++.+. .++..+|+|.+... ...+.+|+.++++++||||+++.+++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 57899999999999999999863 34567999988543 235678999999999999999999887654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (288)
T cd05093 81 -------------------------------------------------------------------------------- 80 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh---------hcCCCCC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS---------KSKQNFP 242 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~---------~~~~~l~ 242 (444)
..++||||++ ++|.+++.... .....++
T Consensus 81 ------------------------------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~ 118 (288)
T cd05093 81 ------------------------------------------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118 (288)
T ss_pred ------------------------------------------ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCC
Confidence 3889999998 58988886432 1223589
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~ 319 (444)
+..++.++.||+.||+|||++|++|+||+|+||+++ +.+.++|+|||.+........ .....++..|+|||.+.+.
T Consensus 119 ~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 197 (288)
T cd05093 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 197 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence 999999999999999999999999999999999999 788999999999865432211 1122346679999998776
Q ss_pred CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
.++.++|+||||+++|+|++ |..||...+..+....+.... .+ ..+..++
T Consensus 198 -~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-------------------~~---------~~~~~~~ 248 (288)
T cd05093 198 -KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-------------------VL---------QRPRTCP 248 (288)
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------cC---------CCCCCCC
Confidence 78999999999999999998 999998877665554443310 00 0122468
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.++.+++.+||+.||.+|||+.++++ .++++....
T Consensus 249 ~~l~~li~~~l~~~p~~Rpt~~~v~~---~l~~~~~~~ 283 (288)
T cd05093 249 KEVYDLMLGCWQREPHMRLNIKEIHS---LLQNLAKAS 283 (288)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH---HHHHHHHhc
Confidence 89999999999999999999999988 788876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.95 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=197.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++.+.||+|+||.||+|+.+. +..+|+|.+... ...+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--------- 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP--------- 73 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC---------
Confidence 568899999999999999998864 568999987543 3466789999999999999999988866542
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (256)
T cd05114 74 -------------------------------------------------------------------------------- 73 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++||||++ ++|.+++.. ....+++..++.++.|++.||
T Consensus 74 -------------------------------------~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l 113 (256)
T cd05114 74 -------------------------------------LYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGM 113 (256)
T ss_pred -------------------------------------EEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHH
Confidence 899999998 588887753 234688999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
.|||++|++|+||+|+||+++ .++.++|+|||.+......... ....++..|+|||.+.+. .++.++|+||+|+++
T Consensus 114 ~~lH~~~i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l 191 (256)
T cd05114 114 EYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLM 191 (256)
T ss_pred HHHHHCCccccccCcceEEEc-CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHH
Confidence 999999999999999999999 7889999999988654322211 122345679999998766 789999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |+.||...+..+....+.+... ...+...+..+.+++.+||+.||.
T Consensus 192 ~el~~~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~~~~li~~c~~~~p~ 243 (256)
T cd05114 192 WEVFTEGKMPFEKKSNYEVVEMISRGFR----------------------------LYRPKLASMTVYEVMYSCWHEKPE 243 (256)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcc
Confidence 99999 9999988776665555443100 001122478899999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+|||+.+++.
T Consensus 244 ~Rps~~~l~~ 253 (256)
T cd05114 244 GRPTFAELLR 253 (256)
T ss_pred cCcCHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=294.82 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=203.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|++++.||+|+||+||++++..+|+.||+|++... ...+.+|+++++.++||||+++.+++....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-------- 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--------
Confidence 6899999999999999999999999999999988543 245668999999999999999999887654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (284)
T cd06620 77 -------------------------------------------------------------------------------- 76 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++||||+++ +|.+++. ..+++++..+..++.|++.
T Consensus 77 --------------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~ 114 (284)
T cd06620 77 --------------------------------------NICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVE 114 (284)
T ss_pred --------------------------------------EEEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHH
Confidence 38999999986 7777664 2357899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
+|.|||+ ++++|+||+|+||+++ +.+.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||+
T Consensus 115 ~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~ 191 (284)
T cd06620 115 GLTYLYNVHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGIS 191 (284)
T ss_pred HHHHHHHhcCeeccCCCHHHEEEC-CCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHH
Confidence 9999997 6899999999999999 7889999999987654222 22344678899999998776 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHH----HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 335 LAELLLGQPMFPGDSGVDQ----LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~----~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
+|+|++|..||......+. ...+.... ...+... ...++ ...++..+.+||.+||+
T Consensus 192 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----~~~~~-----------~~~~~~~~~~li~~~l~ 251 (284)
T cd06620 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLL----QQIVQEP-----PPRLP-----------SSDFPEDLRDFVDACLL 251 (284)
T ss_pred HHHHHhCCCCCcccchhhhhhhhhhHHHHHH----HHHhhcc-----CCCCC-----------chhcCHHHHHHHHHHhc
Confidence 9999999999986554311 11111100 0000000 00000 01257889999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||.+|||+.|+++ |+||.+..
T Consensus 252 ~dp~~Rpt~~e~~~-~~~~~~~~ 273 (284)
T cd06620 252 KDPTERPTPQQLCA-MPPFIQAL 273 (284)
T ss_pred CCcccCcCHHHHhc-Cccccccc
Confidence 99999999999999 99997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=286.95 Aligned_cols=254 Identities=31% Similarity=0.472 Sum_probs=204.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... ...+.+|++++++++|+||+++++++...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~------ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN------ 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC------
Confidence 6899999999999999999999989999999988431 345668999999999999999999887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (267)
T cd08224 76 -------------------------------------------------------------------------------- 75 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++||||+++ +|.+++.........+++..++.++.|+
T Consensus 76 ----------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l 115 (267)
T cd08224 76 ----------------------------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115 (267)
T ss_pred ----------------------------------------eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHH
Confidence 38899999985 8988887655566778999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.+||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||||
T Consensus 116 ~~~l~~lh~~~i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG 193 (267)
T cd08224 116 CSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLG 193 (267)
T ss_pred HHHHHHHHhCCEecCCcChhhEEEC-CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHH
Confidence 9999999999999999999999999 78899999999986543322 12234578889999998776 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChh--HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 333 CVLAELLLGQPMFPGDSGV--DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~--e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
+++|+|++|+.||...... +....+... ..+. .....++..+.++|.+||.
T Consensus 194 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~--------~~~~~~~~~~~~~i~~cl~ 246 (267)
T cd08224 194 CLLYEMAALQSPFYGDKMNLYSLCKKIEKC-------------------DYPP--------LPADHYSEELRDLVSRCIN 246 (267)
T ss_pred HHHHHHHHCCCCcccCCccHHHHHhhhhcC-------------------CCCC--------CChhhcCHHHHHHHHHHcC
Confidence 9999999999999654311 111111110 0000 0011457899999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+|++|||+.++++ -++++.
T Consensus 247 ~~p~~Rp~~~~il~---~~~~~~ 266 (267)
T cd08224 247 PDPEKRPDISYVLQ---VAKEMH 266 (267)
T ss_pred CCcccCCCHHHHHH---HHHHhc
Confidence 99999999999998 555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=290.40 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=200.2
Q ss_pred hccccchhheecccceeEEEEeEecCC-----Cceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
..++|.+.+.||+|+||.||+|.++.. ++.||+|.+.... ..+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ- 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC-
Confidence 457899999999999999999998643 3789999985432 34568999999999999999999887654
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (277)
T cd05032 83 -------------------------------------------------------------------------------- 82 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc------CCCCC
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS------KQNFP 242 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~------~~~l~ 242 (444)
+.++||||++ ++|.+++...... ...++
T Consensus 83 ---------------------------------------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 117 (277)
T cd05032 83 ---------------------------------------------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117 (277)
T ss_pred ---------------------------------------------CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCC
Confidence 3889999997 5999888643321 23478
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~ 319 (444)
+..+..++.||+.||.|||+++++|+||+|+||+++ .++.++|+|||+++....... .....++..|+|||.+.+.
T Consensus 118 ~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05032 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc-CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence 889999999999999999999999999999999999 789999999999865433221 1223456789999998776
Q ss_pred CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
.++.++|+||||+++|++++ |..||.+.+..+....+... . ...++..++
T Consensus 197 -~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~ 247 (277)
T cd05032 197 -VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG--G--------------------------HLDLPENCP 247 (277)
T ss_pred -CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC--C--------------------------CCCCCCCCC
Confidence 78999999999999999998 99999877665544433210 0 001223458
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..+.++|.+||+.+|++|||+.++++
T Consensus 248 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 248 DKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.87 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=215.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+-|+|++.||-|.||.||+|+++.++-..|-|.|..+. +.+.-||.+|..+.||+||++++.|+.++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-------- 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-------- 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--------
Confidence 56999999999999999999999888889999984432 456679999999999999999998888765
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 104 -------------------------------------------------------------------------------- 103 (1187)
T KOG0579|consen 104 -------------------------------------------------------------------------------- 103 (1187)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
++|.+|||+|+--+.|. ..-+..+++..+..+++|++.||
T Consensus 104 --------------------------------------LwiliEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldAL 143 (1187)
T KOG0579|consen 104 --------------------------------------LWILIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDAL 143 (1187)
T ss_pred --------------------------------------eEEEEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHH
Confidence 99999999987666553 25567899999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhcc----CCCCCcchhhhhHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFG----AIDYTTKIDVWSAG 332 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~----~~~~s~~sDiwSLG 332 (444)
.|||+++|+|||||..|||+. -+|.++|.|||.+..... ......+.||++|||||+... ..+|+.++||||||
T Consensus 144 n~LHs~~iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlG 222 (1187)
T KOG0579|consen 144 NWLHSQNIIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLG 222 (1187)
T ss_pred HHHhhcchhhhhccccceEEE-ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhh
Confidence 999999999999999999999 789999999999854322 223446789999999998742 24799999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++.+|..+.+|....++...+.+|.+.- ++.++ . |.+-+..+.|||.+||..|
T Consensus 223 ITLIEMAqiEPPHhelnpMRVllKiaKSe---PPTLl----------------q-------PS~Ws~~F~DfLk~cL~Kn 276 (1187)
T KOG0579|consen 223 ITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLL----------------Q-------PSHWSRSFSDFLKRCLVKN 276 (1187)
T ss_pred hHHHHHhccCCCccccchHHHHHHHhhcC---CCccc----------------C-------cchhhhHHHHHHHHHHhcC
Confidence 99999999999999999888888777631 11111 0 1233678999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~ 433 (444)
|..||+++++|+ |||+++..
T Consensus 277 p~~Rp~aaqll~-Hpfv~~~~ 296 (1187)
T KOG0579|consen 277 PRNRPPAAQLLK-HPFVQNAP 296 (1187)
T ss_pred CccCCCHHHHhh-CcccccCC
Confidence 999999999999 99999643
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=295.57 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=205.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+.|++.+.||+|+||.||+|++..+++.||||.+.... ..+.+|+.++.++. |+||+++++++....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------- 87 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS------- 87 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-------
Confidence 77999999999999999999999889999999985432 22345776666664 999999999887654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (296)
T cd06618 88 -------------------------------------------------------------------------------- 87 (296)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++++|||+++.+.+++.. ....+++..+..++.||+.
T Consensus 88 ---------------------------------------~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~ 125 (296)
T cd06618 88 ---------------------------------------DVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVK 125 (296)
T ss_pred ---------------------------------------eEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHH
Confidence 3899999999988887754 2347899999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC---CCCCcchhhhhH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA---IDYTTKIDVWSA 331 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~s~~sDiwSL 331 (444)
||+|||+ .|++|+||+|+||+++ +++.++|+|||.+.............++..|+|||.+.+. ..++.++|+|||
T Consensus 126 ~l~~lH~~~~i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 126 ALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred HHHHHHhhCCEecCCCcHHHEEEc-CCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 9999997 5999999999999999 7889999999998765443333344567889999998654 247889999999
Q ss_pred HHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++|+.||..... .+.+..+.... .+... ....+++.+.+||.+||.
T Consensus 205 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~~~~~l~~li~~~l~ 258 (296)
T cd06618 205 GISLVELATGQFPYKNCKTEFEVLTKILQEE-------------------PPSLP-------PNEGFSPDFCSFVDLCLT 258 (296)
T ss_pred HHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-------------------CCCCC-------CCCCCCHHHHHHHHHHcc
Confidence 9999999999999975432 22222222210 00000 011358899999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.||.+||++.+++. ||||+..+.....
T Consensus 259 ~~p~~Rp~~~~il~-~~~~~~~~~~~~~ 285 (296)
T cd06618 259 KDHRKRPKYRELLQ-HPFIRRYETAEVD 285 (296)
T ss_pred CChhhCCCHHHHhc-ChhhhccchhHHH
Confidence 99999999999999 9999997766553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=286.75 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=199.6
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..++|+++++||+|+||.||+|.+. ++..+|+|.+... ...+.+|+.++++++|++|+++++++.. .
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-------- 73 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-E-------- 73 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-C--------
Confidence 3468999999999999999999876 4677999988543 3457789999999999999999876632 1
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (260)
T cd05070 74 -------------------------------------------------------------------------------- 73 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++|||+++ +|.+++.. .....+++..++.++.|++.
T Consensus 74 --------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~ 113 (260)
T cd05070 74 --------------------------------------PIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAA 113 (260)
T ss_pred --------------------------------------CcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHH
Confidence 26799999985 88888753 22346889999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||+++++|+||+|+||+++ +++.++|+|||.+......... ....++..|+|||.+.+. .++.++|+||||+
T Consensus 114 al~~lH~~~i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 191 (260)
T cd05070 114 GMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGI 191 (260)
T ss_pred HHHHHHHCCcccCCCccceEEEe-CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHH
Confidence 99999999999999999999999 7889999999998765332211 112335679999998776 7889999999999
Q ss_pred HHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 334 VLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 334 il~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
++|+|++ |..||.+.+..+....+..... ...+..++..+.+++.+||..|
T Consensus 192 ~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05070 192 LLTELVTKGRVPYPGMNNREVLEQVERGYR----------------------------MPCPQDCPISLHELMLQCWKKD 243 (260)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcccC
Confidence 9999998 9999988766655544332100 0112346889999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|++|||+.++++ ++++
T Consensus 244 p~~Rpt~~~l~~---~l~~ 259 (260)
T cd05070 244 PEERPTFEYLQS---FLED 259 (260)
T ss_pred cccCcCHHHHHH---HHhc
Confidence 999999999988 6664
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.68 Aligned_cols=246 Identities=31% Similarity=0.559 Sum_probs=203.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.+.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++++. |+||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----- 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE----- 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----
Confidence 4799999999999999999999999999999988542 234567899999998 999999887765543
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (280)
T cd05581 76 -------------------------------------------------------------------------------- 75 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||+++ ++|.+++.. ...+++..++.++.|
T Consensus 76 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~q 110 (280)
T cd05581 76 -----------------------------------------NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAE 110 (280)
T ss_pred -----------------------------------------eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 3889999995 689888853 347999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---------------------Ccccccccccc
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---------------------NVSYICSRYYR 311 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---------------------~~~~~gt~~y~ 311 (444)
++.||.+||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+
T Consensus 111 l~~~l~~Lh~~~~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (280)
T cd05581 111 ILLALEYLHSKGIIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189 (280)
T ss_pred HHHHHHHHHHCCeeecCCCHHHeEEC-CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCcccc
Confidence 99999999999999999999999998 788999999999865533221 11234578899
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 391 (444)
|||...+. .++.++|+||||++++++++|+.||...+.......+... ..
T Consensus 190 ~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~ 239 (280)
T cd05581 190 SPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-----------------------------EY 239 (280)
T ss_pred CHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-----------------------------CC
Confidence 99998776 6889999999999999999999999877654444433321 01
Q ss_pred cccCCCChhHHHHHHHhcccCCCCCCCH----HHHhccCchh
Q psy10212 392 VFRVRTPPDAIDLISRLLEYTPSSRISP----LQVRSITPFL 429 (444)
Q Consensus 392 ~~~~~~s~~l~~LI~~~L~~DP~kRPs~----~elL~~hpwf 429 (444)
.++..+++.+.++|.+||+.||.+||++ .++++ ||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~-~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA-HPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc-CCCC
Confidence 1223458899999999999999999999 99999 9997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.62 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=214.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
-+.|.-++.||.|+||.||-|+|..+.+.||||++.-. -..+.+||++|++|.|||++.|.++|+.+..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T---- 100 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT---- 100 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch----
Confidence 35688899999999999999999999999999999432 2455589999999999999999999987653
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (948)
T KOG0577|consen 101 -------------------------------------------------------------------------------- 100 (948)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.++|||||=||-.|++... ..++.+..+..|+.+.
T Consensus 101 ------------------------------------------aWLVMEYClGSAsDlleVh---kKplqEvEIAAi~~ga 135 (948)
T KOG0577|consen 101 ------------------------------------------AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGA 135 (948)
T ss_pred ------------------------------------------HHHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHH
Confidence 7899999999988888754 3689999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDiwSL 331 (444)
++||+|||+++.+|||||..||+++ +.|.+||+|||.+... .+...+.|||+|||||++.. ...|+-++|||||
T Consensus 136 L~gLaYLHS~~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSL 211 (948)
T KOG0577|consen 136 LQGLAYLHSHNRIHRDIKAGNILLS-EPGLVKLADFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 211 (948)
T ss_pred HHHHHHHHHhhHHhhhccccceEec-CCCeeeeccccchhhc---CchhcccCCccccchhHheeccccccCCccceeec
Confidence 9999999999999999999999999 8999999999998664 44567899999999999842 2368999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|++..+|.-.++|+-..+...-+..|.+. .-|.+.... -|..++.|+.+||++
T Consensus 212 GITCIELAERkPPlFnMNAMSALYHIAQN-------------------esPtLqs~e--------WS~~F~~Fvd~CLqK 264 (948)
T KOG0577|consen 212 GITCIELAERKPPLFNMNAMSALYHIAQN-------------------ESPTLQSNE--------WSDYFRNFVDSCLQK 264 (948)
T ss_pred cchhhhhhhcCCCccCchHHHHHHHHHhc-------------------CCCCCCCch--------hHHHHHHHHHHHHhh
Confidence 99999999999999888887777777652 112222222 367799999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
-|.+|||.+++|+ |+|..-
T Consensus 265 ipqeRptse~ll~-H~fv~R 283 (948)
T KOG0577|consen 265 IPQERPTSEELLK-HRFVLR 283 (948)
T ss_pred CcccCCcHHHHhh-cchhcc
Confidence 9999999999999 999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=290.23 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=196.8
Q ss_pred hccccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
..++|++.+.||+|+||.||+|.++. +++.||+|.+.... ..+.+|+.++++++||||+++.+++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 56889999999999999999998642 35679999885322 23568999999999999999998875543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (277)
T cd05062 83 -------------------------------------------------------------------------------- 82 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc------CCCCC
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS------KQNFP 242 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~------~~~l~ 242 (444)
..++||||++ ++|.+++...+.. ...++
T Consensus 83 ---------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 117 (277)
T cd05062 83 ---------------------------------------------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117 (277)
T ss_pred ---------------------------------------------CeEEEEecCCCCCHHHHHHHcCccccccccccCCC
Confidence 3889999998 4898888643321 23456
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~ 319 (444)
...+..++.|++.||.|||+.+++|+||+|+||+++ +++.++|+|||++........ .....++..|+|||.+.+.
T Consensus 118 ~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05062 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc-CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence 778899999999999999999999999999999999 788999999999865432221 1122346779999999876
Q ss_pred CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
.++.++|+||||+++|+|++ |..||.+.+..+....+.... .+ .++..++
T Consensus 197 -~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~ 247 (277)
T cd05062 197 -VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-------------------LL---------DKPDNCP 247 (277)
T ss_pred -CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------------------cC---------CCCCCCC
Confidence 78999999999999999998 789998776655444333210 00 1123468
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+.+.++|.+||+.||++|||+.|+++
T Consensus 248 ~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 248 DMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.56 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=202.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..|++.+.||+|+||.||+|++..+++.||+|.+... ...+.+|++++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--- 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE--- 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---
Confidence 5799999999999999999999999999999987432 1345679999999999999999998765432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (264)
T cd06653 79 -------------------------------------------------------------------------------- 78 (264)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++++|||+++ +|.+.+. ....+++..++.++.
T Consensus 79 -----------------------------------------~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~ 113 (264)
T cd06653 79 -----------------------------------------KKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTR 113 (264)
T ss_pred -----------------------------------------CEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHH
Confidence 248899999985 8888874 234688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC----CCCccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----EPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||.+||++|++|+||+|+||+++ .++.++|+|||.+...... .......++..|+|||.+.+. .++.++|
T Consensus 114 ~i~~al~~LH~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 191 (264)
T cd06653 114 QILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKAD 191 (264)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEEc-CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCcccc
Confidence 999999999999999999999999999 7889999999998754221 111234578889999999876 7889999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||..........++.. .+ ....++..+++.+.++|.+
T Consensus 192 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~------------------------~~~~~p~~~~~~~~~~i~~ 244 (264)
T cd06653 192 VWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP------------------------TKPMLPDGVSDACRDFLKQ 244 (264)
T ss_pred HHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC------------------------CCCCCCcccCHHHHHHHHH
Confidence 99999999999999999987655443332221 11 1112344578999999999
Q ss_pred hcccCCCCCCCHHHHhccCchh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf 429 (444)
||+ +|..||++.++++ |||.
T Consensus 245 ~l~-~~~~r~~~~~~~~-~~~~ 264 (264)
T cd06653 245 IFV-EEKRRPTAEFLLR-HPFV 264 (264)
T ss_pred Hhc-CcccCccHHHHhc-CCCC
Confidence 999 5799999999999 9983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=287.69 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=202.9
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.-.++|.++++||.|+||.||+|++.. ++.+|+|.+.... ..+.+|+.++++++|+||+++.+++....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 75 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE------ 75 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC------
Confidence 345789999999999999999999987 8999999985442 45668999999999999999988876554
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (261)
T cd05148 76 -------------------------------------------------------------------------------- 75 (261)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||++ +|.+++... .+..+++..++.++.||
T Consensus 76 ----------------------------------------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i 113 (261)
T cd05148 76 ----------------------------------------PVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQV 113 (261)
T ss_pred ----------------------------------------CeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHH
Confidence 28899999985 999988642 34568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++|++|+||+|+||+++ +++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||
T Consensus 114 ~~al~~lH~~~i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG 191 (261)
T cd05148 114 AEGMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFG 191 (261)
T ss_pred HHHHHHHHHCCeeccccCcceEEEc-CCceEEEccccchhhcCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHH
Confidence 9999999999999999999999999 788999999999866533221 1122345679999998776 789999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|+|++ |+.||...+..+....+..... ...+..+++.+.++|.+||+.
T Consensus 192 ~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 192 ILLYEMFTYGQVPYPGMNNHEVYDQITAGYR----------------------------MPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 99999998 8999988776665554443110 011234689999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy10212 412 TPSSRISPLQVRS 424 (444)
Q Consensus 412 DP~kRPs~~elL~ 424 (444)
||.+|||+.++++
T Consensus 244 ~p~~Rpt~~~l~~ 256 (261)
T cd05148 244 EPEDRPSFKALRE 256 (261)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999988
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.52 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=208.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.+..+.|...+.||+|+||.||+|++..+++.+|+|++.... ..+.+|++++++++|+|++++.+++..+.
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 98 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-- 98 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 455677999999999999999999999999999999985321 24557999999999999999999887754
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 99 -------------------------------------------------------------------------------- 98 (317)
T cd06635 99 -------------------------------------------------------------------------------- 98 (317)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++||||+.+++.+.+.. ...++++..+..++
T Consensus 99 --------------------------------------------~~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~ 131 (317)
T cd06635 99 --------------------------------------------TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAIT 131 (317)
T ss_pred --------------------------------------------eEEEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHH
Confidence 3889999999998887642 34568999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDi 328 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++.... ......++..|+|||.+.. ...++.++|+
T Consensus 132 ~~i~~~l~~lH~~~i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 207 (317)
T cd06635 132 HGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDV 207 (317)
T ss_pred HHHHHHHHHHHHCCcccCCCCcccEEEC-CCCCEEEecCCCccccC---CcccccCCccccChhhhhcCCCCCCCccccH
Confidence 9999999999999999999999999998 78899999999876532 2234467888999998742 2257889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+|+++|+|++|+.||...+.......+...... ......+++.+.++|.+|
T Consensus 208 ~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------------------TLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC---------------------------CCCCccccHHHHHHHHHH
Confidence 99999999999999999876655555444431100 000123578899999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|+.+|.+||++.++++ |+|+...+
T Consensus 261 l~~~p~~Rpt~~~il~-~~~~~~~~ 284 (317)
T cd06635 261 LQKIPQDRPTSEELLK-HMFVLRER 284 (317)
T ss_pred ccCCcccCcCHHHHHh-ChhhhccC
Confidence 9999999999999999 99986533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=289.36 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=201.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
...+.|+++++||+|+||.||+|.++ +++.||+|.+.... ..+.+|+.++++++|+||+++.+++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-------- 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-------- 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccC--------
Confidence 35678999999999999999999975 47889999985433 4566899999999999999998775321
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (260)
T cd05067 74 -------------------------------------------------------------------------------- 73 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..+++|||+. ++|.+++.. ..+..++...+..++.|++
T Consensus 74 ---------------------------------------~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~ 112 (260)
T cd05067 74 ---------------------------------------PIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIA 112 (260)
T ss_pred ---------------------------------------CcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHH
Confidence 2789999997 589888753 2345789999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.||+|||+.|++|+||+|+||+++ .++.++|+|||.+......... ....++..|+|||.+.+. .++.++|+||||
T Consensus 113 ~al~~LH~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG 190 (260)
T cd05067 113 EGMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFG 190 (260)
T ss_pred HHHHHHhcCCeecccccHHhEEEc-CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccC-CcCcccchHHHH
Confidence 999999999999999999999999 7889999999998665422211 122345679999998776 788999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|+|++ |+.||.+.+..+....+..... . ..+..++.++.++|.+||+.
T Consensus 191 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 191 ILLTEIVTYGRIPYPGMTNPEVIQNLERGYR------------------M----------PRPDNCPEELYELMRLCWKE 242 (260)
T ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------------------C----------CCCCCCCHHHHHHHHHHccC
Confidence 99999998 9999988776554443322100 0 01124578999999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
||++||++.++++ ++++
T Consensus 243 ~p~~Rp~~~~l~~---~l~~ 259 (260)
T cd05067 243 KPEERPTFEYLRS---VLED 259 (260)
T ss_pred ChhhCCCHHHHHH---Hhhc
Confidence 9999999999998 6664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.09 Aligned_cols=258 Identities=22% Similarity=0.268 Sum_probs=209.6
Q ss_pred cccccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeee
Q psy10212 9 GFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKY 82 (444)
Q Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~ 82 (444)
+-..+.++++...++..+...||+|+||+||+|++ .-.||||++..+ -+.|.+||..+++-+|-||+-+.+
T Consensus 379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cCCccccccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 34455677888889999999999999999999998 345999999544 267779999999999999999999
Q ss_pred EEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhh
Q psy10212 83 FFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162 (444)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (444)
++...+
T Consensus 456 ~~~~p~-------------------------------------------------------------------------- 461 (678)
T KOG0193|consen 456 ACMNPP-------------------------------------------------------------------------- 461 (678)
T ss_pred hhcCCc--------------------------------------------------------------------------
Confidence 987765
Q ss_pred hcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCC
Q psy10212 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNF 241 (444)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l 241 (444)
+.||+.+|+| +|+.++.. ....+
T Consensus 462 -----------------------------------------------------~AIiTqwCeGsSLY~hlHv---~etkf 485 (678)
T KOG0193|consen 462 -----------------------------------------------------LAIITQWCEGSSLYTHLHV---QETKF 485 (678)
T ss_pred -----------------------------------------------------eeeeehhccCchhhhhccc---hhhhh
Confidence 5799999998 88888864 34679
Q ss_pred ChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC---CCCccccccccccCchhhcc
Q psy10212 242 PCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---EPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 242 ~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~l~~ 318 (444)
....+..|+.||++|+.|||.++|+|+|||..|||+. +++.+||+|||++..-..- .......+...|||||++..
T Consensus 486 dm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 486 DMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred hHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc-cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh
Confidence 9999999999999999999999999999999999999 7799999999998553222 22334567888999999964
Q ss_pred C--CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 319 A--IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 319 ~--~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
. -+|++.+||||+|+++|||++|..||...+...++..+-++...+... ....+
T Consensus 565 qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s------------------------~~~s~ 620 (678)
T KOG0193|consen 565 QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS------------------------KIRSN 620 (678)
T ss_pred cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch------------------------hhhcc
Confidence 3 268999999999999999999999999555444443222211111111 11246
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
++.++++|+..||.+++++||+..+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 7889999999999999999999999988
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=291.89 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=206.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.+|...+.||+|++|.||++.+..+++.+|+|++... ...+.+|+.++++++|+||+++.+++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--------- 89 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--------- 89 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC---------
Confidence 4677778999999999999999989999999988432 234568999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (285)
T cd06648 90 -------------------------------------------------------------------------------- 89 (285)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++++||+++ +|.+++.. .++++..++.++.|++.|
T Consensus 90 -------------------------------------~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~ 127 (285)
T cd06648 90 -------------------------------------ELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKA 127 (285)
T ss_pred -------------------------------------eEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHH
Confidence 38899999975 88887753 568999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|++||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 128 l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l 205 (285)
T cd06648 128 LSFLHAQGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMV 205 (285)
T ss_pred HHHHHhCCeecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHH
Confidence 9999999999999999999999 78899999999875543221 12234578899999998876 788999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|+.||...+.......+.... .+... ....+++.+.++|.+||+.||++
T Consensus 206 ~ell~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 206 IEMVDGEPPYFNEPPLQAMKRIRDNL-------------------PPKLK-------NLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHhcC-------------------CCCCc-------ccccCCHHHHHHHHHHcccChhh
Confidence 99999999998766555444333210 00000 01235889999999999999999
Q ss_pred CCCHHHHhccCchhhhhhh
Q psy10212 416 RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 416 RPs~~elL~~hpwf~~~~~ 434 (444)
|||+.++++ ||||+..+.
T Consensus 260 Rpt~~~il~-~~~~~~~~~ 277 (285)
T cd06648 260 RATAAELLN-HPFLAKAGP 277 (285)
T ss_pred CcCHHHHcc-CcccccCCC
Confidence 999999999 999988664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=282.51 Aligned_cols=246 Identities=31% Similarity=0.551 Sum_probs=205.1
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+|++.+.||+|++|.||++++..+++.||+|.+.... ..+.+|++++++++|+|++++.+++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-------- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--------
Confidence 5889999999999999999999999999999985443 35668999999999999999998887653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (254)
T cd06627 73 -------------------------------------------------------------------------------- 72 (254)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++||++++ +|.+++.. ..++++..++.++.|++.
T Consensus 73 --------------------------------------~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~ 110 (254)
T cd06627 73 --------------------------------------SLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQ 110 (254)
T ss_pred --------------------------------------EEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHH
Confidence 38899999986 88888753 267899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||.+||++|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||...+. .++.++|+||+|++
T Consensus 111 ~l~~lH~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~ 188 (254)
T cd06627 111 GLAYLHEQGVIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCT 188 (254)
T ss_pred HHHHHhhCCcccCCCCHHHEEEC-CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCC-CCCcchhHHHHHHH
Confidence 99999999999999999999999 688999999999876544332 2234568889999998776 58899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+++|++|..||...+........... ....++..+++.+.++|.+||..+|+
T Consensus 189 l~~l~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (254)
T cd06627 189 VIELLTGNPPYYDLNPMAALFRIVQD----------------------------DHPPLPEGISPELKDFLMQCFQKDPN 240 (254)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHhcc----------------------------CCCCCCCCCCHHHHHHHHHHHhCChh
Confidence 99999999999876644333322210 00112345689999999999999999
Q ss_pred CCCCHHHHhccCchh
Q psy10212 415 SRISPLQVRSITPFL 429 (444)
Q Consensus 415 kRPs~~elL~~hpwf 429 (444)
+|||+.++++ ||||
T Consensus 241 ~R~~~~~~l~-~~~~ 254 (254)
T cd06627 241 LRPTAKQLLK-HPWI 254 (254)
T ss_pred hCcCHHHHhc-CCCC
Confidence 9999999999 9997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=285.08 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=190.0
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
+.||+|+||.||+|+++.+++.+|+|.+... ...+.+|++++++++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------------- 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-------------- 66 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--------------
Confidence 4699999999999999999999999987432 245678999999999999999999886654
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (252)
T cd05084 67 -------------------------------------------------------------------------------- 66 (252)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||
T Consensus 67 --------------------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH 111 (252)
T cd05084 67 --------------------------------PIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLE 111 (252)
T ss_pred --------------------------------CeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 28899999985 88888742 3446889999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc---cccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
++|++|+||+|+||+++ .++.++|+|||.+.......... ....+..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 112 ~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~ 189 (252)
T cd05084 112 SKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEA 189 (252)
T ss_pred hCCccccccchheEEEc-CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHH
Confidence 99999999999999998 78899999999986543221111 11123469999998777 789999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |..||...+..+....+.... ....+..++..+.+++.+||+.||++||
T Consensus 190 ~~~~~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 190 FSLGAVPYANLSNQQTREAIEQGV----------------------------RLPCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred HhCCCCCccccCHHHHHHHHHcCC----------------------------CCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 97 999997665544332222100 0011234688999999999999999999
Q ss_pred CHHHHhc
Q psy10212 418 SPLQVRS 424 (444)
Q Consensus 418 s~~elL~ 424 (444)
|+.+++.
T Consensus 242 s~~~~~~ 248 (252)
T cd05084 242 SFSTVHQ 248 (252)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=291.46 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=198.8
Q ss_pred cccc-chhheecccceeEEEEeE----ecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSL-AQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++| .+++.||+|+||+||++. ...+++.+|+|.+... ...+.+|++++++++||||+++.+++.....
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG- 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC-
Confidence 4667 999999999999998865 3446889999998543 2456689999999999999999988765432
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (283)
T cd05080 81 -------------------------------------------------------------------------------- 80 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+++++|||+++ +|.+++.. ..+++..++.+
T Consensus 81 -------------------------------------------~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i 112 (283)
T cd05080 81 -------------------------------------------KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLF 112 (283)
T ss_pred -------------------------------------------ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHH
Confidence 348899999985 88888742 35899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
+.|++.||.|||+++++|+||+|+||+++ +++.++|+|||++........ .....++..|+|||.+.+. .++.+
T Consensus 113 ~~~l~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~ 190 (283)
T cd05080 113 AQQICEGMAYLHSQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYA 190 (283)
T ss_pred HHHHHHHHHHHHHCCeeccccChheEEEc-CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcc
Confidence 99999999999999999999999999998 778999999999876543221 1122345679999998776 78999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh-CCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL-GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~-g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++|..||...... ........ +......+... .........+..++..+.++
T Consensus 191 ~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l 256 (283)
T cd05080 191 SDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL------------LERGMRLPCPKNCPQEVYIL 256 (283)
T ss_pred cccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh------------hhcCCCCCCCCCCCHHHHHH
Confidence 99999999999999999998654321 11111100 00000000000 00001111234578999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.+||+.||++|||+.+++. .++++.
T Consensus 257 i~~cl~~~p~~Rps~~~i~~---~l~~~~ 282 (283)
T cd05080 257 MKNCWETEAKFRPTFRSLIP---ILKEMH 282 (283)
T ss_pred HHHHhccChhhCCCHHHHHH---HHHHhh
Confidence 99999999999999999998 776653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=287.46 Aligned_cols=243 Identities=32% Similarity=0.576 Sum_probs=198.4
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||.||+|++..+|+.+|+|.+.... ..+.+|++++++++|+||+++.+.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-------------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-------------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--------------
Confidence 689999999999999899999999985432 35567999999999999999877765543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (265)
T cd05579 67 -------------------------------------------------------------------------------- 66 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
..|++|||+.+ +|.+++.. ...+++..++.++.||+.||++||
T Consensus 67 --------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH 110 (265)
T cd05579 67 --------------------------------NLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH 110 (265)
T ss_pred --------------------------------EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 38999999985 88888753 237899999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---------CCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---------PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.+++|+||+|+||+++ +++.++|+|||++....... ......++..|++||...+. ..+.++|+||||
T Consensus 111 ~~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG 188 (265)
T cd05579 111 SNGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLG 188 (265)
T ss_pred HcCeecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC-CCCcchhhHHHH
Confidence 99999999999999999 78899999999886543321 12233567889999998777 688999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|++++|..||...+..+....+... ....+. . ..++..+.++|.+||+.+
T Consensus 189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~--------~--~~~~~~~~~~i~~~l~~~ 241 (265)
T cd05579 189 CILYEFLVGIPPFHGETPEEIFQNILNG-----------------KIEWPE--------D--VEVSDEAIDLISKLLVPD 241 (265)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------CcCCCc--------c--ccCCHHHHHHHHHHhcCC
Confidence 9999999999999877766554443320 000010 0 114899999999999999
Q ss_pred CCCCCCH---HHHhccCchhhhh
Q psy10212 413 PSSRISP---LQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs~---~elL~~hpwf~~~ 432 (444)
|.+|||+ .++|+ ||||+++
T Consensus 242 p~~Rpt~~~~~~~l~-~~~~~~~ 263 (265)
T cd05579 242 PEKRLGAKSIEEIKN-HPFFKGI 263 (265)
T ss_pred HhhcCCCccHHHHhc-CccccCC
Confidence 9999999 99999 9999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=287.79 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=204.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeec----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+||.+.+.||.|||+-||+++...+++.||+|++.. +.+..++|++..++++||||++++++...+...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D------- 93 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD------- 93 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc-------
Confidence 899999999999999999999999999999999943 346777999999999999999987766554320
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (302)
T KOG2345|consen 94 -------------------------------------------------------------------------------- 93 (302)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
-....||+++|.. |||++.+.+....+..+++..+..|+.+|++|
T Consensus 94 ----------------------------------~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~g 139 (302)
T KOG2345|consen 94 ----------------------------------GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRG 139 (302)
T ss_pred ----------------------------------CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHH
Confidence 0134999999998 78999999888888899999999999999999
Q ss_pred HHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----------CccccccccccCchhhcc--CCCC
Q psy10212 257 LAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----------NVSYICSRYYRAPELIFG--AIDY 322 (444)
Q Consensus 257 L~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----------~~~~~gt~~y~aPE~l~~--~~~~ 322 (444)
|.+||+.. ++|+||||.||+++ +.+.++|.|||.++...-... .....+|..|.|||.+.- ....
T Consensus 140 L~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti 218 (302)
T KOG2345|consen 140 LEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI 218 (302)
T ss_pred HHHHhccCCcccccCCCcceeEec-CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc
Confidence 99999999 99999999999999 789999999998865422111 112356889999999842 3367
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|||||||++|.|+.|..||... .+ .|.... +.-.-..+.+|.. ..+|+.+.
T Consensus 219 ~ertDIWSLGCtLYa~mf~~sPfe~~---------~~-~GgSla-----LAv~n~q~s~P~~----------~~yse~l~ 273 (302)
T KOG2345|consen 219 TERTDIWSLGCTLYAMMFGESPFERI---------YQ-QGGSLA-----LAVQNAQISIPNS----------SRYSEALH 273 (302)
T ss_pred ccccchhhhhHHHHHHHHcCCcchHH---------hh-cCCeEE-----EeeeccccccCCC----------CCccHHHH
Confidence 89999999999999999999999521 11 011000 0000012223321 22699999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy10212 403 DLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~ 424 (444)
++|++||++||.+||++.+++.
T Consensus 274 ~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 274 QLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred HHHHHHhcCCcccCCCHHHHHH
Confidence 9999999999999999999998
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.95 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=206.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.+..+.|...+.||.|+||.||+|+++.+++.+|+|.+... ...+.+|++++++++|+|++++.+++.+..
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 88 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--
Confidence 45678899999999999999999999999999999998532 123457999999999999999999887754
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (308)
T cd06634 89 -------------------------------------------------------------------------------- 88 (308)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++||||+.+++.+.+.. ...++++..+..++
T Consensus 89 --------------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~ 121 (308)
T cd06634 89 --------------------------------------------TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVT 121 (308)
T ss_pred --------------------------------------------eeEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHH
Confidence 3889999999998887642 34568999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDi 328 (444)
.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++..... .....++..|+|||.+.+ ...++.++|+
T Consensus 122 ~~l~~~l~~LH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di 197 (308)
T cd06634 122 HGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (308)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHhEEEC-CCCcEEECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccch
Confidence 9999999999999999999999999998 788999999998865432 223456888999999742 2257889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|..||...+..+....+.... .+ ......++..+.++|.+|
T Consensus 198 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------------SP--------ALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred HHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-------------------CC--------CcCcccccHHHHHHHHHH
Confidence 999999999999999997765544433332210 00 001124578899999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|+.+|.+||++.++++ |||+...
T Consensus 251 l~~~P~~Rp~~~~ll~-~~~~~~~ 273 (308)
T cd06634 251 LQKIPQDRPTSEVLLK-HRFVLRE 273 (308)
T ss_pred hhCCcccCCCHHHHhh-Ccccccc
Confidence 9999999999999999 9998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.35 Aligned_cols=241 Identities=25% Similarity=0.376 Sum_probs=198.9
Q ss_pred heecccceeEEEEeEecCC---Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDS---GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|.+... +..||+|.+... ...+.+|++++++++|+||+++++++...+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----------- 69 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----------- 69 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC-----------
Confidence 4799999999999999866 889999999543 245668999999999999999998887643
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (262)
T cd00192 70 -------------------------------------------------------------------------------- 69 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc-----CCCCChHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS-----KQNFPCFYTKLYIYQL 253 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-----~~~l~~~~i~~i~~QI 253 (444)
..+++|||++ ++|.+++...... ...+++..++.++.|+
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l 114 (262)
T cd00192 70 -----------------------------------PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114 (262)
T ss_pred -----------------------------------ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHH
Confidence 3899999995 6999988653222 4789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.||++||+++++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||
T Consensus 115 ~~al~~lH~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s 192 (262)
T cd00192 115 AKGMEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWS 192 (262)
T ss_pred HHHHHHHHcCCcccCccCcceEEEC-CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHH
Confidence 9999999999999999999999999 77999999999997664432 12234567889999998877 7899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||+++|+|++ |..||...+..+....+... .....+..+|+++.++|.+||
T Consensus 193 lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l 244 (262)
T cd00192 193 FGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----------------------------YRLPKPEYCPDELYELMLSCW 244 (262)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------------------CCCCCCccCChHHHHHHHHHc
Confidence 9999999998 69999888665554444321 011123456899999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy10212 410 EYTPSSRISPLQVRS 424 (444)
Q Consensus 410 ~~DP~kRPs~~elL~ 424 (444)
..||.+|||+.|+++
T Consensus 245 ~~~p~~Rps~~~l~~ 259 (262)
T cd00192 245 QLDPEDRPTFSELVE 259 (262)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=290.25 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=198.3
Q ss_pred ccccchhheecccceeEEEEeEecC-----CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP- 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-
Confidence 3789999999999999999999987 6788999988533 2456789999999999999999998876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (277)
T cd05036 84 -------------------------------------------------------------------------------- 83 (277)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc---CCCCChHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS---KQNFPCFYT 246 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~---~~~l~~~~i 246 (444)
.++||||++ ++|.+++...+.. ...+++..+
T Consensus 84 ---------------------------------------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~ 118 (277)
T cd05036 84 ---------------------------------------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118 (277)
T ss_pred ---------------------------------------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHH
Confidence 689999997 5899998654321 235888999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 321 (444)
..++.||+.||+|||+++++|+||+|+||+++.. ...++|+|||++........ ......+..|+|||.+.+. .
T Consensus 119 ~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~ 197 (277)
T cd05036 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-I 197 (277)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-C
Confidence 9999999999999999999999999999999732 23689999999876532211 1122234679999999877 7
Q ss_pred CCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 322 YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
++.++|+|||||++|+|++ |..||.+.+..+....+.... ...++..++..
T Consensus 198 ~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 249 (277)
T cd05036 198 FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG----------------------------RLDPPKGCPGP 249 (277)
T ss_pred cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------cCCCCCCCCHH
Confidence 9999999999999999996 999998776655433222100 00123456899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+.+++.+||+.||++|||+.++|+
T Consensus 250 ~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 250 VYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=292.45 Aligned_cols=269 Identities=29% Similarity=0.411 Sum_probs=212.8
Q ss_pred ccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 12 KNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
|.|+-.+++.-.+ .+||-|-.|.|-.+.++.+|+.+|+|++... ....||+++--+. .|||||.+++.|...-+.
T Consensus 55 k~~~itedY~is~---qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 55 KEYSITEDYSISW---QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hcccchhhheehh---hhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4444444444333 6899999999999999999999999987543 3345788764333 799999999888554321
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
.
T Consensus 131 r------------------------------------------------------------------------------- 131 (400)
T KOG0604|consen 131 R------------------------------------------------------------------------------- 131 (400)
T ss_pred c-------------------------------------------------------------------------------
Confidence 1
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..+.+|||.++| .|.+.|.. ...+.+++.++..|
T Consensus 132 -------------------------------------------kcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI 166 (400)
T KOG0604|consen 132 -------------------------------------------KCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEI 166 (400)
T ss_pred -------------------------------------------eeeEeeeecccchHHHHHHHH--cccccchHHHHHHH
Confidence 358999999996 78887753 45568999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLN--PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~--~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+.||+.|+.|||+.+|+||||||+|+|.. ..+..+||+|||+++.........+.+.|++|.|||++... .|+...|
T Consensus 167 ~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~e-Kydkscd 245 (400)
T KOG0604|consen 167 MKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPE-KYDKSCD 245 (400)
T ss_pred HHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCch-hcCCCCC
Confidence 99999999999999999999999999995 24557899999999988766667777889999999999776 7999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhH----HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVD----QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e----~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
+||+||+||-|++|.+||-...... +-.+|....- . ++..+|.. +|++.++
T Consensus 246 mwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy-----------------~---FP~pEWs~-----VSe~aKd 300 (400)
T KOG0604|consen 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY-----------------E---FPEPEWSC-----VSEAAKD 300 (400)
T ss_pred ccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-----------------c---CCChhHhH-----HHHHHHH
Confidence 9999999999999999997654321 2222222211 1 22334443 5999999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+|+.+|..+|.+|.|+.++++ |||+...+++
T Consensus 301 lIR~LLkt~PteRlTI~~~m~-hpwi~~~~~v 331 (400)
T KOG0604|consen 301 LIRKLLKTEPTERLTIEEVMD-HPWINQYEAV 331 (400)
T ss_pred HHHHHhcCCchhheeHHHhhc-CchhcccccC
Confidence 999999999999999999999 9999987654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=295.73 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=204.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
..|+....||+|+||.||+|.+..+++.||+|.+... ...+.+|+.++++++||||+++++++....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--------- 91 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--------- 91 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC---------
Confidence 4566677899999999999999999999999998432 234568999999999999999998887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (297)
T cd06659 92 -------------------------------------------------------------------------------- 91 (297)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..+++|||+++ +|.+++. ...+++..++.++.|++.|
T Consensus 92 -------------------------------------~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~ 129 (297)
T cd06659 92 -------------------------------------ELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQA 129 (297)
T ss_pred -------------------------------------eEEEEEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHH
Confidence 38899999985 7776653 2468999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|++||++|++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 130 L~~LH~~~ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il 207 (297)
T cd06659 130 LCYLHSQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMV 207 (297)
T ss_pred HHHHHhCCeecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHH
Confidence 9999999999999999999999 78899999999886543222 12334578899999999876 789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|+.||...+..+....+... +. + .+ .....+++.+.++|.+||+.+|.+
T Consensus 208 ~el~~g~~p~~~~~~~~~~~~~~~~---~~----------------~-----~~--~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 208 IEMVDGEPPYFSDSPVQAMKRLRDS---PP----------------P-----KL--KNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcc---CC----------------C-----Cc--cccCCCCHHHHHHHHHHhcCCccc
Confidence 9999999999876655544332210 00 0 00 011245889999999999999999
Q ss_pred CCCHHHHhccCchhhhhhh
Q psy10212 416 RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 416 RPs~~elL~~hpwf~~~~~ 434 (444)
||++.+++. ||||.+...
T Consensus 262 Rps~~~ll~-~~~~~~~~~ 279 (297)
T cd06659 262 RATAQELLD-HPFLLQTGL 279 (297)
T ss_pred CcCHHHHhh-ChhhccCCC
Confidence 999999999 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.13 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=199.3
Q ss_pred cchhheecccceeEEEEeEecCC---Cceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
|.+.+.||+|+||.||+|.+..+ ++.||+|++..+. ..+.+|+.+++.++|+||+++++++......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL---- 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc----
Confidence 57889999999999999998654 4789999985432 3566899999999999999998887654310
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (273)
T cd05035 77 -------------------------------------------------------------------------------- 76 (273)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh--cCCCCChHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK--SKQNFPCFYTKLYIY 251 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~--~~~~l~~~~i~~i~~ 251 (444)
....+.+++|||+. ++|..++...+. ....+++..++.++.
T Consensus 77 ------------------------------------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 120 (273)
T cd05035 77 ------------------------------------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120 (273)
T ss_pred ------------------------------------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHH
Confidence 00134789999998 488888754332 234689999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|++.||.|||+++++|+||+|+||+++ +++.++|+|||.++....... ......+..|+|||.+.+. .++.++|+
T Consensus 121 ~i~~aL~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv 198 (273)
T cd05035 121 DIALGMEYLSNRNFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDV 198 (273)
T ss_pred HHHHHHHHHHhCCeeccccchheEEEC-CCCeEEECCccceeeccccccccccccccCCccccCHhhcccC-CCCcccch
Confidence 999999999999999999999999999 788999999999876533321 1112345679999998766 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |..||.+.+..+....+.... . ...+..++..+.++|.+
T Consensus 199 ~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~ 250 (273)
T cd05035 199 WAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----------------R------------LKQPEDCLDELYDLMYS 250 (273)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------C------------CCCCcCCCHHHHHHHHH
Confidence 999999999998 999998776655444333210 0 01123568999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
||+.||.+|||+.++++ .|++
T Consensus 251 ~l~~~p~~Rp~~~e~~~---~l~~ 271 (273)
T cd05035 251 CWRADPKDRPTFTKLRE---VLEN 271 (273)
T ss_pred HcCCChhhCcCHHHHHH---HHHh
Confidence 99999999999999998 5544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=288.30 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=198.9
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|.+.++||+|+||.||+|++..+ ..+|+|++... .+.+.+|+.++++++|+||+++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---------- 73 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---------- 73 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCC----------
Confidence 36799999999999999999998765 45999998643 34567899999999999999998765321
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (262)
T cd05071 74 -------------------------------------------------------------------------------- 73 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++ +|.+++.. .....+++..++.++.|++.|
T Consensus 74 -------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~a 114 (262)
T cd05071 74 -------------------------------------PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASG 114 (262)
T ss_pred -------------------------------------CcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHH
Confidence 26899999985 89888853 223467899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||+.+++|+||+|+||+++ +++.++|+|||.+......... ....++..|+|||...+. .++.++|+||||++
T Consensus 115 L~~lH~~~i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~ 192 (262)
T cd05071 115 MAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGIL 192 (262)
T ss_pred HHHHHHCCccccccCcccEEEc-CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHH
Confidence 9999999999999999999999 7889999999998665333221 122345679999988776 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||.+....+....+.... .. ..+..++..+.++|.+||+.||
T Consensus 193 l~ellt~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~l~~li~~~l~~~p 244 (262)
T cd05071 193 LTELTTKGRVPYPGMVNREVLDQVERGY------------------RM----------PCPPECPESLHDLMCQCWRKEP 244 (262)
T ss_pred HHHHHcCCCCCCCCCChHHHHHHHhcCC------------------CC----------CCccccCHHHHHHHHHHccCCc
Confidence 999999 899998776655444332210 00 0123468899999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
++||++.++++ +++++
T Consensus 245 ~~Rp~~~~~~~---~l~~~ 260 (262)
T cd05071 245 EERPTFEYLQA---FLEDY 260 (262)
T ss_pred ccCCCHHHHHH---HHHHh
Confidence 99999999988 66654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.90 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=201.2
Q ss_pred ccccchhheecccceeEEEEeEecCCC----------------ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeE
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG----------------ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVK 79 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~ 79 (444)
.++|++++.||+|+||.||+|++...+ ..||+|.+... ...+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 368999999999999999999886544 56899998543 245668999999999999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+.+++...+
T Consensus 84 ~~~~~~~~~----------------------------------------------------------------------- 92 (296)
T cd05051 84 LLGVCTVDP----------------------------------------------------------------------- 92 (296)
T ss_pred EEEEEecCC-----------------------------------------------------------------------
Confidence 999886654
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh--
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK-- 236 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-- 236 (444)
..+++||++. ++|.+++.....
T Consensus 93 -------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~ 117 (296)
T cd05051 93 -------------------------------------------------------PLCMIMEYMENGDLNQFLQKHVAET 117 (296)
T ss_pred -------------------------------------------------------CcEEEEecCCCCCHHHHHHhccccc
Confidence 2889999998 588888854321
Q ss_pred -----cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccc
Q psy10212 237 -----SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSR 308 (444)
Q Consensus 237 -----~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~ 308 (444)
....+++..++.++.|++.||+|||++|++|+||+|+||+++ ..+.++|+|||.+........ .....++.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 196 (296)
T cd05051 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI 196 (296)
T ss_pred ccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCc
Confidence 223689999999999999999999999999999999999999 778999999999865432221 12233467
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccC
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLL--GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt--G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~ 386 (444)
.|+|||.+.+. .++.++|+||||+++|+|++ +..||...+..+.+.......... .
T Consensus 197 ~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------~ 254 (296)
T cd05051 197 RWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD---------------------G 254 (296)
T ss_pred eecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccc---------------------c
Confidence 89999998876 78999999999999999997 778887766655544443321100 0
Q ss_pred CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 387 ~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
.......+..++.++.++|.+||+.||.+|||+.+++. |++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~---~L~ 295 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL---FLQ 295 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH---Hhc
Confidence 00001122356889999999999999999999999987 654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=295.94 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=195.0
Q ss_pred cccchhheecccceeEEEEeEecCCCce--eeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL--VAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||.||+|+++.+++. +|+|.+... ...+.+|+.++.++ +|+||+++.+++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----- 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-----
Confidence 5789999999999999999999877764 577776432 23456799999999 8999999999886654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (303)
T cd05088 82 -------------------------------------------------------------------------------- 81 (303)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------cCCC
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------SKQN 240 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~~~~ 240 (444)
+.++||||++ ++|.+++..... ....
T Consensus 82 -----------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 120 (303)
T cd05088 82 -----------------------------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120 (303)
T ss_pred -----------------------------------------CceEEEEeCCCCcHHHHHHhcccccccccccccccccCc
Confidence 3889999998 589998864321 2235
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
+++..++.++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||++..............+..|+|||.+.+.
T Consensus 121 l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 198 (303)
T cd05088 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS- 198 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec-CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-
Confidence 78999999999999999999999999999999999999 7889999999998543211111122235679999988776
Q ss_pred CCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|+|++ |..||.+.+..+....+... .....+..+++
T Consensus 199 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 250 (303)
T cd05088 199 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----------------------------YRLEKPLNCDD 250 (303)
T ss_pred CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC----------------------------CcCCCCCCCCH
Confidence 68899999999999999998 99999876655443322110 00001224688
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+.+||.+||+.+|++||++.++|.
T Consensus 251 ~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 251 EVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=287.78 Aligned_cols=243 Identities=20% Similarity=0.286 Sum_probs=196.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
+.|.+++.||+|+||+||+|++.. +..+|+|.+... ...+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---------- 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR---------- 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC----------
Confidence 568999999999999999998754 456999988543 345678999999999999999999886543
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd05113 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++|||+.+ +|.+++.. ....+++..++.++.||+.||
T Consensus 73 ------------------------------------~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l 113 (256)
T cd05113 73 ------------------------------------PIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGM 113 (256)
T ss_pred ------------------------------------CcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Confidence 27899999985 78888753 234689999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++|+||+|+||+++ .++.++|+|||.+......... ....++..|+|||...+. .++.++|+||||+++
T Consensus 114 ~~lH~~~i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l 191 (256)
T cd05113 114 AYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLM 191 (256)
T ss_pred HHHHhCCeeccccCcceEEEc-CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHH
Confidence 999999999999999999999 7889999999998655332211 112345679999999776 688999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |..||...+..+....+.+.... ..+...++.+.+++.+||+.||.
T Consensus 192 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~ 243 (256)
T cd05113 192 WEVYSLGKMPYERFNNSETVEKVSQGLRL----------------------------YRPHLASEKVYAIMYSCWHEKAE 243 (256)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCcc
Confidence 99998 99999877665554444331100 01123578999999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+||++.++++
T Consensus 244 ~Rp~~~~ll~ 253 (256)
T cd05113 244 ERPTFQQLLS 253 (256)
T ss_pred cCCCHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.26 Aligned_cols=269 Identities=31% Similarity=0.388 Sum_probs=208.5
Q ss_pred ccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 12 KNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
-+|..+.+++++|..-++||+||||+||+|.... |+.||||++... ...|.+|+.++.+++|||+|++++||.+.
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 4677889999999999999999999999999864 599999988442 34599999999999999999999999987
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 144 ~~------------------------------------------------------------------------------ 145 (361)
T KOG1187|consen 144 GE------------------------------------------------------------------------------ 145 (361)
T ss_pred Cc------------------------------------------------------------------------------
Confidence 61
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
..+||+|||+ |+|.+.+...... +++|...
T Consensus 146 -----------------------------------------------~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R 176 (361)
T KOG1187|consen 146 -----------------------------------------------HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETR 176 (361)
T ss_pred -----------------------------------------------eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHH
Confidence 2789999999 6999988542222 8899999
Q ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccc-cccccccCchhhccCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLG---ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSY-ICSRYYRAPELIFGAID 321 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~g---ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~-~gt~~y~aPE~l~~~~~ 321 (444)
.+|+.++|.||+|||... |+|||||++|||+| ++.+.||+|||+++.... ....... .||.+|++||++..+ .
T Consensus 177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~ 254 (361)
T KOG1187|consen 177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG-K 254 (361)
T ss_pred HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccC-C
Confidence 999999999999999854 99999999999999 899999999999966544 3222223 789999999999876 8
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCC--hhHHHHHHH-HHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC-CC
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDS--GVDQLVEII-KVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV-RT 397 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~--~~e~~~~i~-~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~ 397 (444)
.+.++||||+|+++.|+++|+.+.+... ....+.... ..+.. .....+..|.+.. ...+. ..
T Consensus 255 lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~----------~~~~eiiD~~l~~----~~~~~~~~ 320 (361)
T KOG1187|consen 255 LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE----------GKLREIVDPRLKE----GEYPDEKE 320 (361)
T ss_pred cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC----------cchhheeCCCccC----CCCChHHH
Confidence 9999999999999999999998887543 111122211 11110 0111222222211 11110 12
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
-..+..+...|++.+|.+||++.|+++
T Consensus 321 ~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 321 VKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 245888999999999999999999877
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=293.49 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=196.1
Q ss_pred cccchhheecccceeEEEEeEecCCCc--eeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE--LVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||.||+|+++.++. .+|+|.+... ...+.+|++++.++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence 679999999999999999999987775 4688877532 23466899999999 7999999998876554
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (297)
T cd05089 77 -------------------------------------------------------------------------------- 76 (297)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------cCCC
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------SKQN 240 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~~~~ 240 (444)
..+++|||++ ++|.+++..... ....
T Consensus 77 -----------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 115 (297)
T cd05089 77 -----------------------------------------YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115 (297)
T ss_pred -----------------------------------------cceEEEEecCCCcHHHHHHhccccccccccccccCccCC
Confidence 2889999998 589998854221 1235
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
+++..++.++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||++..............+..|+|||.+.+.
T Consensus 116 l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 193 (297)
T cd05089 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS- 193 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC-CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-
Confidence 88899999999999999999999999999999999998 7889999999998543221111122234569999998776
Q ss_pred CCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+|||||++|+|++ |..||.+.+..+....+.... ....+..++.
T Consensus 194 ~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 245 (297)
T cd05089 194 VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------------------------RMEKPRNCDD 245 (297)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCCCCCCH
Confidence 78999999999999999997 999998877665544332210 0011235689
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+.+||.+||+.||.+|||+.+++.
T Consensus 246 ~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 246 EVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.91 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=194.8
Q ss_pred cccchhheecccceeEEEEeEecCCCce----eeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL----VAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||.||+|++..+++. ||+|.+... ...+.+|+.+++.++||||+++++++....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~---- 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC----
Confidence 5799999999999999999998766664 899988532 235667999999999999999998886532
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (316)
T cd05108 83 -------------------------------------------------------------------------------- 82 (316)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++++|+. |+|.+++.. ....++...+..++.
T Consensus 83 -------------------------------------------~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~ 116 (316)
T cd05108 83 -------------------------------------------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCV 116 (316)
T ss_pred -------------------------------------------ceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHH
Confidence 568999988 588888753 345688899999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc---cccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++.......... ....+..|+|||.+.+. .++.++|+
T Consensus 117 qi~~~L~~LH~~~iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di 194 (316)
T cd05108 117 QIAKGMNYLEERRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDV 194 (316)
T ss_pred HHHHHHHHHHhcCeeccccchhheEec-CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC-CCCchhhh
Confidence 999999999999999999999999998 78899999999997654332211 12235679999999877 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |..||.+....+.. .+... ....+ .+..++.++.+++.+
T Consensus 195 ~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~-----------------~~~~~----------~~~~~~~~~~~li~~ 246 (316)
T cd05108 195 WSYGVTVWELMTFGSKPYDGIPASEIS-SILEK-----------------GERLP----------QPPICTIDVYMIMVK 246 (316)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhC-----------------CCCCC----------CCCCCCHHHHHHHHH
Confidence 999999999997 99999876655432 22220 00011 123467899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||..||.+||++.+++.
T Consensus 247 cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 247 CWMIDADSRPKFRELII 263 (316)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999999
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.54 Aligned_cols=244 Identities=24% Similarity=0.314 Sum_probs=197.6
Q ss_pred cccchhheecccceeEEEEeEecCC---Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.+.+.||+|+||+||+|+++.. ...+|+|.+... ...+.+|+.++++++||||+++.+++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP---- 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc----
Confidence 6799999999999999999998654 457999988543 2345679999999999999999998866543
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (266)
T cd05033 80 -------------------------------------------------------------------------------- 79 (266)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+++|||+++ +|.+++.. ....+++..++.++.|
T Consensus 80 ------------------------------------------~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ 114 (266)
T cd05033 80 ------------------------------------------VMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRG 114 (266)
T ss_pred ------------------------------------------eEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHH
Confidence 7899999985 88888753 3347899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
++.||+|||+++++|+||+|+||+++ +++.++|+|||++......... ....++..|+|||.+.+. .++.++|+|
T Consensus 115 l~~~l~~Lh~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~ 192 (266)
T cd05033 115 IASGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVW 192 (266)
T ss_pred HHHHHHHHHhCCcccCCCCcceEEEc-CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccC-CCccccchH
Confidence 99999999999999999999999999 7889999999998766421111 112335679999998876 789999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||+++|+|++ |..||......+....+.+.. .. ..+..+++.+.+++.+|
T Consensus 193 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~l~~li~~c 244 (266)
T cd05033 193 SFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------------------RL----------PPPMDCPSALYQLMLDC 244 (266)
T ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCCCCCHHHHHHHHHH
Confidence 99999999997 999998766555444333210 00 01234689999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
|+.||++||++.++++
T Consensus 245 l~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 245 WQKDRNERPTFSQIVS 260 (266)
T ss_pred cCCCcccCcCHHHHHH
Confidence 9999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=289.55 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=198.7
Q ss_pred cccchhheecccceeEEEEeEecCC-----Cceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||.||++.++.. ...+|+|.+.... ..+.+|+.+++++ +|+||+++.+++...+.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~- 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP- 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC-
Confidence 6899999999999999999998643 3789999885432 2456899999999 89999999998866543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (293)
T cd05053 91 -------------------------------------------------------------------------------- 90 (293)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh------------hc
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS------------KS 237 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~------------~~ 237 (444)
++++|||++ ++|.+++.... ..
T Consensus 91 ---------------------------------------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 125 (293)
T cd05053 91 ---------------------------------------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125 (293)
T ss_pred ---------------------------------------------eEEEEEeCCCCcHHHHHHhcCCCcccccccccccc
Confidence 899999998 58888886432 34
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCch
Q psy10212 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPE 314 (444)
Q Consensus 238 ~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE 314 (444)
...+++..++.++.||+.||+|||+++++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||
T Consensus 126 ~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 204 (293)
T cd05053 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE 204 (293)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence 56788999999999999999999999999999999999998 789999999999876533221 11123356799999
Q ss_pred hhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccc
Q psy10212 315 LIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393 (444)
Q Consensus 315 ~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 393 (444)
.+.+. .++.++|+|||||++|+|++ |..||.+....+....+.... ....
T Consensus 205 ~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~ 255 (293)
T cd05053 205 ALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY----------------------------RMEK 255 (293)
T ss_pred HhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------------------cCCC
Confidence 98776 78999999999999999997 999998776655444332210 0011
Q ss_pred cCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 394 ~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+..++..+.+|+.+||..||++|||+.++++
T Consensus 256 ~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 256 PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred CCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 2346889999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=283.83 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=198.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc--cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++|++.+.||+|+||.||++.. .|+.+|+|.+.... ..+.+|+.++++++|+||+++.+++...+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---------- 73 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---------- 73 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC----------
Confidence 5789999999999999999987 48899999885443 356689999999999999999987765432
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (256)
T cd05082 74 -------------------------------------------------------------------------------- 73 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..+++|||++ ++|.+++.. .....+++..++.++.||+.||+
T Consensus 74 -----------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~ 116 (256)
T cd05082 74 -----------------------------------GLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAME 116 (256)
T ss_pred -----------------------------------ceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHH
Confidence 3789999998 489998853 22345889999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
|||++|++|+||+|+||+++ +++.++|+|||++....... .....+..|+|||.+.+. .++.++|+|||||++|+|
T Consensus 117 ~lH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 117 YLEANNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEI 192 (256)
T ss_pred HHHhCCEeccccchheEEEc-CCCcEEecCCccceeccccC--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHH
Confidence 99999999999999999999 78899999999986543222 222345679999998776 789999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |+.||...+..+....+.+. +....+..+++.+.++|.+||+.||++||
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05082 193 YSFGRVPYPRIPLKDVVPRVEKG----------------------------YKMDAPDGCPPVVYDVMKQCWHLDAATRP 244 (256)
T ss_pred HhCCCCCCCCCCHHHHHHHHhcC----------------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 97 99999876654444333220 00112235689999999999999999999
Q ss_pred CHHHHhccCchhhh
Q psy10212 418 SPLQVRSITPFLIE 431 (444)
Q Consensus 418 s~~elL~~hpwf~~ 431 (444)
|+.++++ .+++
T Consensus 245 t~~~l~~---~l~~ 255 (256)
T cd05082 245 SFLQLRE---QLEH 255 (256)
T ss_pred CHHHHHH---HHhc
Confidence 9999988 5543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.32 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=196.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+|++.+.||+|+||.||+|+++ +++.+|+|.+... ...+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---------- 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR---------- 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----------
Confidence 46889999999999999999986 4678999988542 345678999999999999999988875543
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd05059 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+.++||||+++ +|.+++.. ....+++..++.++.||+.||
T Consensus 73 ------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l 113 (256)
T cd05059 73 ------------------------------------PIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAM 113 (256)
T ss_pred ------------------------------------ceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHH
Confidence 38899999975 88888753 234789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc--cccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++|+||+|+||+++ +++.++|+|||.+.......... ...++..|+|||.+.+. .++.++|+||||+++
T Consensus 114 ~~lH~~~i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il 191 (256)
T cd05059 114 EYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLM 191 (256)
T ss_pred HHHHHCCcccccccHhhEEEC-CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHH
Confidence 999999999999999999999 78899999999886543222111 11224579999998876 788999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |+.||...++.+....+.... ....+..+++.+.+++.+||..+|+
T Consensus 192 ~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~ 243 (256)
T cd05059 192 WEVFSEGKMPYERFSNSEVVESVSAGY----------------------------RLYRPKLAPTEVYTIMYSCWHEKPE 243 (256)
T ss_pred HHHhccCCCCCCCCCHHHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHhcCChh
Confidence 99998 899998776655444332210 0011234689999999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+|||+.++++
T Consensus 244 ~Rpt~~~~l~ 253 (256)
T cd05059 244 DRPAFKKLLS 253 (256)
T ss_pred hCcCHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.20 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=199.1
Q ss_pred ccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+|++.+.||+|+||.||+|++.. ..+.+|+|.+.... ..+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP--- 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence 47899999999999999999753 23578999875432 346689999999999999999988765542
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (290)
T cd05045 78 -------------------------------------------------------------------------------- 77 (290)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh---------------
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK--------------- 236 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~--------------- 236 (444)
.+++||||. ++|.+++...+.
T Consensus 78 -------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 114 (290)
T cd05045 78 -------------------------------------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114 (290)
T ss_pred -------------------------------------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccc
Confidence 789999999 589888864321
Q ss_pred -----cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccc
Q psy10212 237 -----SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSR 308 (444)
Q Consensus 237 -----~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~ 308 (444)
...++++..++.++.|++.||.|||+++++|+||+|+||+++ +++.++|+|||.+........ .....++.
T Consensus 115 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 193 (290)
T cd05045 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV 193 (290)
T ss_pred cccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc-CCCcEEeccccccccccCccchhcccCCCCCc
Confidence 224578889999999999999999999999999999999998 788999999999865432221 12223456
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
.|+|||.+.+. .++.++|+||||+++++|++ |..||.+..+.+....+...
T Consensus 194 ~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------------------- 245 (290)
T cd05045 194 KWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG--------------------------- 245 (290)
T ss_pred cccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---------------------------
Confidence 79999998776 78999999999999999998 99999877655443322210
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+....+..++..+.++|.+||+.||++||++.++++ .|+++-
T Consensus 246 -~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~---~l~~~~ 287 (290)
T cd05045 246 -YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK---ELEKMM 287 (290)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH---HHHHHH
Confidence 000112356899999999999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.82 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=198.4
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|++.+.||+|++|.||+|.+.. ++.||+|.+... ...+.+|+.++++++|+||+++.+++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-------- 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC--------
Confidence 4679999999999999999999754 578999998543 3456789999999999999999988766543
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (261)
T cd05068 76 -------------------------------------------------------------------------------- 75 (261)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+++|||++ ++|.+++... .+..+++..+..++.|++.|
T Consensus 76 --------------------------------------~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~ 115 (261)
T cd05068 76 --------------------------------------IYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASG 115 (261)
T ss_pred --------------------------------------eeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHH
Confidence 789999995 6999988532 24568999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc--cccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|.+||++|++|+||+|+||+++ .++.++|+|||++.......... ....+..|+|||.+.+. .++.++|+||||++
T Consensus 116 l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~ 193 (261)
T cd05068 116 MAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGIL 193 (261)
T ss_pred HHHHHhCCeeeccCCcceEEEc-CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHH
Confidence 9999999999999999999999 78899999999987654222111 11223579999988776 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |+.||.+.+.......+.... . ...+..++..+.+++.+||+.||
T Consensus 194 l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~li~~~l~~~P 245 (261)
T cd05068 194 LTEIVTYGRMPYPGMTNAEVLQQVDQGY------------------R----------MPCPPGCPKELYDIMLDCWKEDP 245 (261)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------C----------CCCCCcCCHHHHHHHHHHhhcCc
Confidence 999998 999998776555444332210 0 01123468999999999999999
Q ss_pred CCCCCHHHHhc
Q psy10212 414 SSRISPLQVRS 424 (444)
Q Consensus 414 ~kRPs~~elL~ 424 (444)
.+||++.+++.
T Consensus 246 ~~Rp~~~~l~~ 256 (261)
T cd05068 246 DDRPTFETLQW 256 (261)
T ss_pred ccCCCHHHHHH
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=288.83 Aligned_cols=247 Identities=20% Similarity=0.260 Sum_probs=197.8
Q ss_pred cccchhheecccceeEEEEeEecCC-----Cceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..|++.+.||.|+||.||+|++..+ ++.||+|++.... +.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-- 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP-- 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc--
Confidence 4589999999999999999997543 5789999996432 346689999999999999999998876643
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (283)
T cd05091 83 -------------------------------------------------------------------------------- 82 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh------------hcC
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS------------KSK 238 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~------------~~~ 238 (444)
.++++||+. ++|.+++.... ...
T Consensus 83 --------------------------------------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 118 (283)
T cd05091 83 --------------------------------------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118 (283)
T ss_pred --------------------------------------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccc
Confidence 789999998 47888874211 112
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchh
Q psy10212 239 QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPEL 315 (444)
Q Consensus 239 ~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~ 315 (444)
..+++..++.++.|++.||+|||++|++|+||||+||+++ +++.++|+|||+++....... .....+++.|+|||.
T Consensus 119 ~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (283)
T cd05091 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA 197 (283)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec-CCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence 3578888999999999999999999999999999999998 788999999999865433221 112234678999999
Q ss_pred hccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 316 IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 316 l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.+... ...+
T Consensus 198 ~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~~ 248 (283)
T cd05091 198 IMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV----------------------------LPCP 248 (283)
T ss_pred HhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCC
Confidence 8776 78999999999999999997 8899988776655544443110 0112
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..++..+.+++.+||+.+|.+||++.+++.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 249 DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 357899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=285.12 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=198.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|++.+.||.|++|.||+|.+..+ ..+|+|.+.... +.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------- 73 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE---------- 73 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----------
Confidence 36799999999999999999998654 469999875432 4566899999999999999998766321
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (260)
T cd05069 74 -------------------------------------------------------------------------------- 73 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..+++|||+++ +|.+++.. .....+++..+..++.|++.|
T Consensus 74 -------------------------------------~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~a 114 (260)
T cd05069 74 -------------------------------------PIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADG 114 (260)
T ss_pred -------------------------------------CcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHH
Confidence 26799999985 89998853 223457899999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|.|||+.|++|+||+|+||+++ +++.++|+|||.+........ .....++..|+|||...+. .++.++|+||||++
T Consensus 115 l~~lH~~~i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~ 192 (260)
T cd05069 115 MAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGIL 192 (260)
T ss_pred HHHHHhCCEeecccCcceEEEc-CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHH
Confidence 9999999999999999999999 788999999999865533221 1122346679999988776 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||.+..+.+....+.... .. ..+...+..+.+++.+||..||
T Consensus 193 l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05069 193 LTELVTKGRVPYPGMVNREVLEQVERGY------------------RM----------PCPQGCPESLHELMKLCWKKDP 244 (260)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCcccCHHHHHHHHHHccCCc
Confidence 999999 999998876655444333210 00 1123458899999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
++||++.++++ ++++
T Consensus 245 ~~Rp~~~~i~~---~l~~ 259 (260)
T cd05069 245 DERPTFEYIQS---FLED 259 (260)
T ss_pred ccCcCHHHHHH---HHhc
Confidence 99999999998 7665
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=288.19 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=192.6
Q ss_pred eecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHH---HHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREM---QIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~---~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.||+|+||.||+|++..+++.||+|.+.... ..+..|. +.++...||+|+++.+.+.+.+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---------- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---------- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----------
Confidence 4899999999999999999999999985432 1122333 3445568999999988887654
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 71 -------------------------------------------------------------------------------- 70 (278)
T cd05606 71 -------------------------------------------------------------------------------- 70 (278)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++|||||.+ +|..++. ..+.+++..++.++.|++.||
T Consensus 71 ------------------------------------~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l 110 (278)
T cd05606 71 ------------------------------------KLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGL 110 (278)
T ss_pred ------------------------------------EEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Confidence 38899999985 6766663 345799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||+++++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||.+.+...++.++|+||+|+++|+
T Consensus 111 ~~lH~~~i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~ 188 (278)
T cd05606 111 EHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188 (278)
T ss_pred HHHHHCCEEcCCCCHHHEEEC-CCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHH
Confidence 999999999999999999999 7789999999998654332 22344678999999998765468899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||................ .....++..++..+.++|.+||..||.+||
T Consensus 189 l~~g~~p~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 189 LLRGHSPFRQHKTKDKHEIDRMTL--------------------------TMAVELPDSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred HHhCCCCCCCCCccchHHHHHHhh--------------------------ccCCCCCCcCCHHHHHHHHHHhhcCHHhcc
Confidence 999999998653322111000000 001112334689999999999999999999
Q ss_pred -----CHHHHhccCchhhhhh
Q psy10212 418 -----SPLQVRSITPFLIELR 433 (444)
Q Consensus 418 -----s~~elL~~hpwf~~~~ 433 (444)
++.++++ ||||++..
T Consensus 243 ~~~~~~~~~ll~-~~~~~~~~ 262 (278)
T cd05606 243 GCLGRGAQEVKE-HPFFRSLD 262 (278)
T ss_pred CCCCCCHHHHHh-CccccCCC
Confidence 9999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=281.74 Aligned_cols=241 Identities=26% Similarity=0.368 Sum_probs=197.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecccc---chhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR---FKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
+.|++.+.||+|+||.||+|.. .|+.+|+|.+..... .+.+|+.++++++|+||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---------- 73 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN---------- 73 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC----------
Confidence 6789999999999999999987 489999999965543 5668999999999999999999887643
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (256)
T cd05039 74 -------------------------------------------------------------------------------- 73 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++||||++ ++|.+++.. .....+++..++.++.|++.||
T Consensus 74 ------------------------------------~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l 115 (256)
T cd05039 74 ------------------------------------PLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGM 115 (256)
T ss_pred ------------------------------------CeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHH
Confidence 2889999999 599988853 2223689999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||++|++|+||+|+||+++ .++.++|+|||.+....... .....+..|+|||.+.+. .++.++|+||||+++++
T Consensus 116 ~~lh~~~i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~ 191 (256)
T cd05039 116 EYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWE 191 (256)
T ss_pred HHHHhCCccchhcccceEEEe-CCCCEEEccccccccccccc--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHH
Confidence 999999999999999999999 78899999999987653222 123345679999998776 78899999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 338 LLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 338 Llt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
|++ |..||...+..+....+... +....+..+++.+.++|.+||..+|++|
T Consensus 192 l~~~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05039 192 IYSFGRVPYPRIPLKDVVPHVEKG----------------------------YRMEAPEGCPPEVYKVMKDCWELDPAKR 243 (256)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhcC----------------------------CCCCCccCCCHHHHHHHHHHhccChhhC
Confidence 997 99999877655433322210 0001123468999999999999999999
Q ss_pred CCHHHHhc
Q psy10212 417 ISPLQVRS 424 (444)
Q Consensus 417 Ps~~elL~ 424 (444)
||+.++++
T Consensus 244 p~~~~l~~ 251 (256)
T cd05039 244 PTFKQLRE 251 (256)
T ss_pred cCHHHHHH
Confidence 99999988
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.24 Aligned_cols=237 Identities=27% Similarity=0.407 Sum_probs=205.5
Q ss_pred chhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccccc
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMK 104 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (444)
..++.||.|+.|.||+|+. .++.||||++...++ .+|+.|++|+|+||+.+++.+...-
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~elkE---TdIKHLRkLkH~NII~FkGVCtqsP---------------- 185 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELKE---TDIKHLRKLKHPNIITFKGVCTQSP---------------- 185 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhhhh---hhHHHHHhccCcceeeEeeeecCCc----------------
Confidence 4578999999999999998 689999999966554 4999999999999999999886653
Q ss_pred cccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCccc
Q psy10212 105 ISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 184 (444)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (444)
T Consensus 186 -------------------------------------------------------------------------------- 185 (904)
T KOG4721|consen 186 -------------------------------------------------------------------------------- 185 (904)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHC
Q psy10212 185 FRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVL 263 (444)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~ 263 (444)
.++||||||. |.|...++ .+.+++......|.++|+.|++|||.+
T Consensus 186 ------------------------------cyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h 231 (904)
T KOG4721|consen 186 ------------------------------CYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH 231 (904)
T ss_pred ------------------------------eeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh
Confidence 4899999999 79999885 577899999999999999999999999
Q ss_pred CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCC
Q psy10212 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343 (444)
Q Consensus 264 givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~ 343 (444)
.|+|||||.-|||++ -+..+||+|||.++..........+.||..|||||++... +.+.+.||||+||++|||+||..
T Consensus 232 KIIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~Ei 309 (904)
T KOG4721|consen 232 KIIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEI 309 (904)
T ss_pred hHhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCC
Confidence 999999999999999 6779999999999888777677778999999999999988 89999999999999999999999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q psy10212 344 MFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR 423 (444)
Q Consensus 344 Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL 423 (444)
||.+-+...++. .+| ..-+.-.++..||..+.=||++||+-.|..||++.++|
T Consensus 310 PYkdVdssAIIw----GVG-----------------------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 310 PYKDVDSSAIIW----GVG-----------------------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred CccccchheeEE----ecc-----------------------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHH
Confidence 998765443222 112 22233334567899999999999999999999999998
Q ss_pred ccC
Q psy10212 424 SIT 426 (444)
Q Consensus 424 ~~h 426 (444)
. |
T Consensus 363 ~-H 364 (904)
T KOG4721|consen 363 L-H 364 (904)
T ss_pred H-H
Confidence 8 6
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.19 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=199.1
Q ss_pred hccccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
-.++|++.+.||+|+||.||+|.++. .+..||+|.+.... ..+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999997653 24579999875332 235579999999999999999988765532
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (288)
T cd05061 84 -------------------------------------------------------------------------------- 83 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc------CCCCC
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS------KQNFP 242 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~------~~~l~ 242 (444)
.++|||||+ ++|.+++...... ....+
T Consensus 84 ----------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 117 (288)
T cd05061 84 ----------------------------------------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117 (288)
T ss_pred ----------------------------------------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCC
Confidence 789999998 5999998653321 23346
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~ 319 (444)
...+..++.||+.||.|||+++++|+||+|+||+++ +++.++|+|||+++....... .....++..|+|||.+.+.
T Consensus 118 ~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 196 (288)
T cd05061 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA-HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc-CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC
Confidence 678899999999999999999999999999999999 788999999999865432221 1122345679999998876
Q ss_pred CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
.++.++|+|||||++|+|++ |..||.+.+..+....+.... .+ .++..++
T Consensus 197 -~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~ 247 (288)
T cd05061 197 -VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-------------------YL---------DQPDNCP 247 (288)
T ss_pred -CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------CC---------CCCCCCC
Confidence 78999999999999999998 789998776655444333210 00 0122457
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc-----cCchhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRS-----ITPFLIE 431 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~-----~hpwf~~ 431 (444)
+.+.+++.+||+.||++|||+.++++ .||||++
T Consensus 248 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 248 ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 89999999999999999999999987 2555554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.50 Aligned_cols=279 Identities=20% Similarity=0.262 Sum_probs=198.0
Q ss_pred chhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+.+.+|.|++ ||.+++..+++.||+|++... ...+.+|+.++++++|+||+++++.+....
T Consensus 5 ~i~~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~---------- 72 (314)
T cd08216 5 LIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS---------- 72 (314)
T ss_pred hhhHhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC----------
Confidence 34444455544 555666668999999998543 135668999999999999999998887654
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (314)
T cd08216 73 -------------------------------------------------------------------------------- 72 (314)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++||||+ ++|.+++... ....+++..++.++.|++.||
T Consensus 73 ------------------------------------~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L 114 (314)
T cd08216 73 ------------------------------------ELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNAL 114 (314)
T ss_pred ------------------------------------eEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHH
Confidence 3899999999 5788877532 345688999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccC-CCCCcchhh
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGA-IDYTTKIDV 328 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~s~~sDi 328 (444)
+|||+++++|+||+|+||+++ .++.++|+||+.+........ .....++..|+|||.+.+. ..++.++|+
T Consensus 115 ~~LH~~~ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (314)
T cd08216 115 DYIHSKGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193 (314)
T ss_pred HHHHHCCeecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhH
Confidence 999999999999999999999 788999999998754432211 1223456789999998653 257889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCC--------CccCCCCcccccCCCChh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP--------QIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p--------~~~~~~~~~~~~~~~s~~ 400 (444)
||+||++|+|++|+.||.............. +... ..+............. ..............++++
T Consensus 194 ws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (314)
T cd08216 194 YSVGITACELANGHVPFKDMPATQMLLEKVR--GTVP-CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEH 270 (314)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCc-cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHH
Confidence 9999999999999999987654433322221 1110 0000000000000000 000001111122335678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+.+||.+||+.||++|||+.++|+ ||||+.+++...+
T Consensus 271 ~~~li~~~l~~~P~~Rpt~~~ll~-~p~~~~~~~~~~~ 307 (314)
T cd08216 271 FHQFVELCLQRDPESRPSASQLLN-HSFFKQCKRRNTS 307 (314)
T ss_pred HHHHHHHHhhcCCCcCcCHHHHhc-CchHhhhcccchh
Confidence 999999999999999999999999 9999998765543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=320.78 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=201.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.-+++|.+.|..|||+.||+|++...|..||+|++.... +...+||.+|++|. |+|||.|++.........
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~---- 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN---- 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC----
Confidence 367889999999999999999998878999999985443 34558999999997 999999988432221100
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
..
T Consensus 112 -----------------------------~~------------------------------------------------- 113 (738)
T KOG1989|consen 112 -----------------------------NG------------------------------------------------- 113 (738)
T ss_pred -----------------------------Cc-------------------------------------------------
Confidence 00
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
+ .-..|.||||. |+|.+++..+.. ..+++.++++|+.|++
T Consensus 114 --------~-----------------------------~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~ 154 (738)
T KOG1989|consen 114 --------V-----------------------------WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVC 154 (738)
T ss_pred --------e-----------------------------eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHH
Confidence 0 12779999999 699999964332 3399999999999999
Q ss_pred HHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc----------cccccccccCchhhc--cCC
Q psy10212 255 RSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----------SYICSRYYRAPELIF--GAI 320 (444)
Q Consensus 255 ~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~----------~~~gt~~y~aPE~l~--~~~ 320 (444)
+|+++||... |+|||||-+|||++ .+++.||||||.+.......... ....|+.|.+||.+. .+.
T Consensus 155 ~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~ 233 (738)
T KOG1989|consen 155 EAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGL 233 (738)
T ss_pred HHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCC
Confidence 9999999998 99999999999999 88999999999985443322111 124599999999872 233
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
..+.|+|||||||+||.||....||.......++ . .++.+|.. ++++..
T Consensus 234 pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----n-----------------g~Y~~P~~----------p~ys~~ 282 (738)
T KOG1989|consen 234 PIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----N-----------------GNYSFPPF----------PNYSDR 282 (738)
T ss_pred CCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----e-----------------ccccCCCC----------ccHHHH
Confidence 7899999999999999999999999865332211 1 23344432 357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.+||..||+.||.+||++.|++. .+..+.
T Consensus 283 l~~LI~~mL~~nP~~RPnI~Qv~~---~~~~l~ 312 (738)
T KOG1989|consen 283 LKDLIRTMLQPNPDERPNIYQVLE---EIFELA 312 (738)
T ss_pred HHHHHHHHhccCcccCCCHHHHHH---HHHHHh
Confidence 999999999999999999999998 444443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.63 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=202.4
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..++|.+.++||+|+||.||+|.+. .++.+|+|.+... ...+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 75 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP------- 75 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-------
Confidence 4578999999999999999999986 4678999998543 3457789999999999999999888765432
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (261)
T cd05034 76 -------------------------------------------------------------------------------- 75 (261)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||+++ +|.+++.. ..+..++...+..++.||+.
T Consensus 76 ---------------------------------------~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~ 114 (261)
T cd05034 76 ---------------------------------------IYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAE 114 (261)
T ss_pred ---------------------------------------eEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHH
Confidence 8999999985 89888853 23356899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||+++++|+||+|+||+++ +++.++|+|||.+........ ......+..|+|||.+.+. .++.++|+||+|+
T Consensus 115 al~~lh~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~ 192 (261)
T cd05034 115 GMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGI 192 (261)
T ss_pred HHHHHHhCCcccCCcchheEEEc-CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHH
Confidence 99999999999999999999999 789999999999866533211 1122335679999999876 7899999999999
Q ss_pred HHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 334 VLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 334 il~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
++|+|++ |+.||.+.+.......+..... ...+..++..+.+++.+||+.|
T Consensus 193 il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05034 193 LLTEIVTYGRVPYPGMTNREVLEQVERGYR----------------------------MPRPPNCPEELYDLMLQCWDKD 244 (261)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccC
Confidence 9999998 9999988776655554433110 0112235789999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|++||++.+++. +|++
T Consensus 245 p~~Rp~~~~l~~---~l~~ 260 (261)
T cd05034 245 PEERPTFEYLQS---FLED 260 (261)
T ss_pred cccCCCHHHHHH---HHhc
Confidence 999999999988 6654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=288.94 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=203.2
Q ss_pred cccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+|.+.+.||+|+||.||+|++.. ++..+|+|.+.... ..+.+|+..+++++|+||+++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 568899999999999999998643 45679999885432 45778999999999999999999886543
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (291)
T cd05094 81 -------------------------------------------------------------------------------- 80 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------cCC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------SKQ 239 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~~~ 239 (444)
..++||||++ ++|.+++..... ..+
T Consensus 81 ------------------------------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~ 118 (291)
T cd05094 81 ------------------------------------------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118 (291)
T ss_pred ------------------------------------------ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcC
Confidence 3889999997 589998864321 234
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhh
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELI 316 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l 316 (444)
.+++..++.++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+
T Consensus 119 ~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (291)
T cd05094 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 197 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence 588999999999999999999999999999999999999 78899999999986543321 12223456789999998
Q ss_pred ccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 317 FGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 317 ~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
.+. .++.++|+||||+++|+|++ |+.||...+..+....+.... .+ ..+.
T Consensus 198 ~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------~~---------~~~~ 248 (291)
T cd05094 198 MYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-------------------VL---------ERPR 248 (291)
T ss_pred ccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-------------------CC---------CCCc
Confidence 876 78999999999999999998 999998776655443322200 00 0112
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.++..+.+++.+||+.||++|||+.++++ .++++...
T Consensus 249 ~~~~~~~~li~~~l~~~P~~Rpt~~~v~~---~l~~~~~~ 285 (291)
T cd05094 249 VCPKEVYDIMLGCWQREPQQRLNIKEIYK---ILHALGKA 285 (291)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHHH---HHHHHHhh
Confidence 35889999999999999999999999999 77776543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=287.40 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=199.6
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeec---------cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ---------DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+|.+.++||+|+||.||++++...+..+++|.+.. ....+.+|+.++++++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence 68999999999999999999987777776666532 1123447889999999999999887775543
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (260)
T cd08222 76 -------------------------------------------------------------------------------- 75 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++||||+++ +|.+++.........+++..++.++.|
T Consensus 76 -----------------------------------------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (260)
T cd08222 76 -----------------------------------------AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114 (260)
T ss_pred -----------------------------------------ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHH
Confidence 27899999985 888888665566678999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
++.||.|||++|++|+||+|+||+++ .+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+
T Consensus 115 l~~~l~~lH~~~i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~sl 191 (260)
T cd08222 115 LLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSL 191 (260)
T ss_pred HHHHHHHHHHcCccccCCChhheEee--cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHH
Confidence 99999999999999999999999998 3569999999886553322 22334568889999998765 78889999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|..||...+.......+... . .+ .++..++.++.++|.+||+.
T Consensus 192 G~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~----------------~~---------~~~~~~~~~~~~li~~~l~~ 243 (260)
T cd08222 192 GCILYEMCCLAHAFEGQNFLSVVLRIVEG---P----------------TP---------SLPETYSRQLNSIMQSMLNK 243 (260)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHcC---C----------------CC---------CCcchhcHHHHHHHHHHhcC
Confidence 99999999999999766544433333220 0 00 11234688999999999999
Q ss_pred CCCCCCCHHHHhccCchh
Q psy10212 412 TPSSRISPLQVRSITPFL 429 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf 429 (444)
||++||++.++++ ||||
T Consensus 244 ~p~~Rp~~~~il~-~~~~ 260 (260)
T cd08222 244 DPSLRPSAAEILR-NPFI 260 (260)
T ss_pred ChhhCcCHHHHhh-CCCC
Confidence 9999999999999 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=282.04 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=192.7
Q ss_pred heecccceeEEEEeEecCCC---ceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSG---ELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||.||+|++...+ ..+|+|.+.... ..+.+|+++++++.|+||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------------ 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE------------ 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC------------
Confidence 47999999999999876554 789999985443 3566899999999999999998876422
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (257)
T cd05060 69 -------------------------------------------------------------------------------- 68 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++||||++ ++|.+++.. ...+++..++.++.|++.||+
T Consensus 69 -----------------------------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~ 109 (257)
T cd05060 69 -----------------------------------PLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMA 109 (257)
T ss_pred -----------------------------------ceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Confidence 2689999998 589998853 337899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc----cccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
+||+++++|+||+|+||+++ .++.++|+|||.+.......... ...++..|+|||.+.+. .++.++|+||||++
T Consensus 110 ~lh~~~i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~ 187 (257)
T cd05060 110 YLESKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVT 187 (257)
T ss_pred HHhhcCeeccCcccceEEEc-CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCC-CCCccchHHHHHHH
Confidence 99999999999999999999 78899999999987653332211 11224579999998776 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||...+..+....+.... ....+..++..+.++|.+||..||
T Consensus 188 l~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 188 LWEAFSYGAKPYGEMKGAEVIAMLESGE----------------------------RLPRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHhcCCh
Confidence 999997 999998776655443332210 001123468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
.+||++.++++ .|+.+
T Consensus 240 ~~Rp~~~~l~~---~l~~~ 255 (257)
T cd05060 240 EDRPTFSELES---TFRRD 255 (257)
T ss_pred hhCcCHHHHHH---HHHhc
Confidence 99999999998 66654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=284.76 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=195.7
Q ss_pred cchhheecccceeEEEEeEecCCCc--eeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGE--LVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
|.+.++||+|+||.||+|++..+++ .+|+|.+... ...+.+|+.++++++|+||+++++++.......
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~---- 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE---- 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc----
Confidence 4578899999999999999987775 6999987432 245668999999999999999998775432100
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (272)
T cd05075 77 -------------------------------------------------------------------------------- 76 (272)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh--hcCCCCChHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS--KSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~--~~~~~l~~~~i~~i~~Q 252 (444)
.....+++|||++ ++|.+++...+ .....+++..+..++.|
T Consensus 77 ------------------------------------~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 77 ------------------------------------GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred ------------------------------------CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 0023789999998 58888774322 23345889999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
|+.||+|||+++++|+||||+||+++ .++.++|+|||++........ ......+..|++||...+. .++.++|+|
T Consensus 121 i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~ 198 (272)
T cd05075 121 IASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVW 198 (272)
T ss_pred HHHHHHHHHHCCeeccccchhheEEc-CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHH
Confidence 99999999999999999999999998 788999999999876533221 1122346679999998876 789999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||+++|+|++ |+.||.+....+....+.+.. ....+..++..+.++|.+|
T Consensus 199 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~ 250 (272)
T cd05075 199 SFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN----------------------------RLKQPPDCLDGLYSLMSSC 250 (272)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHH
Confidence 99999999998 899998766655444332210 0011235688999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
|+.||.+|||+.++++
T Consensus 251 l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 251 WLLNPKDRPSFETLRC 266 (272)
T ss_pred cCCCcccCcCHHHHHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.15 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=197.5
Q ss_pred cccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||.||+|++.. +++.||+|++.... ..+.+|+.+++++ +|+||+++++++...+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence 589999999999999999997543 45789999885321 2455799999999 8999999998876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (337)
T cd05054 85 -------------------------------------------------------------------------------- 84 (337)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK------------- 236 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~------------- 236 (444)
..++++|||+++ +|.+++.....
T Consensus 85 -------------------------------------------~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 121 (337)
T cd05054 85 -------------------------------------------GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKR 121 (337)
T ss_pred -------------------------------------------CCEEEEEecCCCCCHHHHHHhcccccccccccccccc
Confidence 237889999985 78877753211
Q ss_pred --------------------------------------------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCC
Q psy10212 237 --------------------------------------------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272 (444)
Q Consensus 237 --------------------------------------------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp 272 (444)
...++++..+..++.||+.||+|||++|++|+||||
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp 201 (337)
T cd05054 122 EMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAA 201 (337)
T ss_pred ccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 123688999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCC
Q psy10212 273 QNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGD 348 (444)
Q Consensus 273 ~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~ 348 (444)
+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.
T Consensus 202 ~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 202 RNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred ceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999 788999999999876533221 1122345679999999887 89999999999999999997 99999875
Q ss_pred ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCch
Q psy10212 349 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPF 428 (444)
Q Consensus 349 ~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpw 428 (444)
...+......... . ....+..+++.+.+++.+||+.+|++||++.|+++ .
T Consensus 280 ~~~~~~~~~~~~~-----------------~----------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~---~ 329 (337)
T cd05054 280 QIDEEFCRRLKEG-----------------T----------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE---I 329 (337)
T ss_pred CccHHHHHHHhcc-----------------C----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH---H
Confidence 4443333222210 0 00012345789999999999999999999999998 5
Q ss_pred hhhh
Q psy10212 429 LIEL 432 (444)
Q Consensus 429 f~~~ 432 (444)
++++
T Consensus 330 l~~~ 333 (337)
T cd05054 330 LGDL 333 (337)
T ss_pred HHHH
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=290.19 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=203.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
..|+-..+||+|+||.||++.++.+|+.+|||++... ...+.+|+.++++++|+||+++.+.+....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------- 90 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--------- 90 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC---------
Confidence 3444568899999999999999999999999998432 234668999999999999999999887654
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (292)
T cd06657 91 -------------------------------------------------------------------------------- 90 (292)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++||||+++ +|.+++. ..++++..++.++.|++.|
T Consensus 91 -------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~ 128 (292)
T cd06657 91 -------------------------------------ELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKA 128 (292)
T ss_pred -------------------------------------EEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHH
Confidence 38999999986 6766553 2468999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|+|||+.|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 129 l~~lH~~givH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil 206 (292)
T cd06657 129 LSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMV 206 (292)
T ss_pred HHHHHHCCeecCCCCHHHEEEC-CCCCEEEcccccceecccccccccccccCccccCHHHhcCC-CCCchhhHHHHHHHH
Confidence 9999999999999999999999 77899999999876543322 12234568889999988766 788999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|..||.+.+..+....+..... .. +. ....+++.+.++|.+||+.||.+
T Consensus 207 ~el~tg~~p~~~~~~~~~~~~~~~~~~----------------~~--------~~--~~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 207 IEMVDGEPPYFNEPPLKAMKMIRDNLP----------------PK--------LK--NLHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhhCC----------------cc--------cC--CcccCCHHHHHHHHHHHhCCccc
Confidence 999999999987665544333222100 00 00 01235889999999999999999
Q ss_pred CCCHHHHhccCchhhhhhh
Q psy10212 416 RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 416 RPs~~elL~~hpwf~~~~~ 434 (444)
||++.++++ ||||.+...
T Consensus 261 R~~~~~ll~-~~~~~~~~~ 278 (292)
T cd06657 261 RATAAELLK-HPFLAKAGP 278 (292)
T ss_pred CcCHHHHhc-ChHHhccCC
Confidence 999999999 999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=285.99 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=193.9
Q ss_pred cccchhheecccceeEEEEeEe----cCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKL----LDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.|++++.||+|+||+||+|+. ..+++.||+|++.... ..+.+|++++++++||||+++.+++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---- 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC----
Confidence 5899999999999999999984 4568899999985432 356789999999999999999888765432
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (284)
T cd05081 80 -------------------------------------------------------------------------------- 79 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..+++||||++ ++|.+++.. ....+++..++.++.|
T Consensus 80 ----------------------------------------~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~ 116 (284)
T cd05081 80 ----------------------------------------RNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQ 116 (284)
T ss_pred ----------------------------------------CceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHH
Confidence 23889999997 589988853 2346899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
++.||+|||++|++|+||+|+||+++ +++.++|+|||++......... ....++..|+|||.+.+. .++.++|+
T Consensus 117 l~~aL~~LH~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 194 (284)
T cd05081 117 ICKGMEYLGSKRYVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDV 194 (284)
T ss_pred HHHHHHHHHHCCceeccCCHhhEEEC-CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHH
Confidence 99999999999999999999999998 7889999999998765332211 111234459999999776 78999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh-CCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL-GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~-g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++++|++|..++...... ....+.... +......+...... ......+..++..+.+||.+
T Consensus 195 ~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~ 261 (284)
T cd05081 195 WSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIELLKN------------NGRLPAPPGCPAEIYAIMKE 261 (284)
T ss_pred HHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHHHhc------------CCcCCCCCCCCHHHHHHHHH
Confidence 99999999999988776433211 110000000 00000000000000 00011234568999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||..+|++|||+.++++
T Consensus 262 cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 262 CWNNDPSQRPSFSELAL 278 (284)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999988
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=279.47 Aligned_cols=286 Identities=29% Similarity=0.570 Sum_probs=234.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeec-cccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-DKRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+.|++++++|+|-++.||.|.+..+++.++||++.. ++..+.||+++|+.|. ||||+++++..-+...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk-------- 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK-------- 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc--------
Confidence 4789999999999999999999999999999999954 5567789999999997 99999998887665431
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 109 -------------------------------------------------------------------------------- 108 (338)
T KOG0668|consen 109 -------------------------------------------------------------------------------- 108 (338)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
...+++||+..+-...+- ..++.-.++.++.|++.||.
T Consensus 109 ------------------------------------tpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALd 146 (338)
T KOG0668|consen 109 ------------------------------------TPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALD 146 (338)
T ss_pred ------------------------------------CchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHh
Confidence 234899999875333331 46888899999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
|+||+||.|||+||.|++++.....++|+|||++...-.+....-...+..|--||++.....+..+-|+|||||++..|
T Consensus 147 yCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 147 YCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred HHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence 99999999999999999999888899999999998876666666667788899999998877899999999999999999
Q ss_pred HhCCCCC-CCCChhHHHHHHHHHhCCCCHHHHHh-----hCCCCCcccCCCccCCCCcccccCC----CChhHHHHHHHh
Q psy10212 339 LLGQPMF-PGDSGVDQLVEIIKVLGTPTREQIRE-----MNPNYTEFKFPQIKSHPWSKVFRVR----TPPDAIDLISRL 408 (444)
Q Consensus 339 ltG~~Pf-~~~~~~e~~~~i~~~~g~~~~~~~~~-----~~~~~~~~~~p~~~~~~~~~~~~~~----~s~~l~~LI~~~ 408 (444)
+..+.|| .+.+..+++.+|.+.+|+......-. +.+.+.++ +....+..|....+.. +++++.|||..+
T Consensus 227 iFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldkl 305 (338)
T KOG0668|consen 227 IFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKL 305 (338)
T ss_pred HhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHH
Confidence 9988765 57788899999999999865443322 23333332 2233444554444322 579999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
|..|..+|+||.|++. ||||..+++...+
T Consensus 306 LrYDHqeRlTakEam~-HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 306 LRYDHQERLTAKEAMA-HPYFAPVREAESS 334 (338)
T ss_pred HhhccccccchHHHhc-CchHHHHHHHhhc
Confidence 9999999999999999 9999999887664
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=286.47 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=196.2
Q ss_pred cccchhheecccceeEEEEeEec----CCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL----DSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.|++.+.||+|+||+||+|++. .+++.+|+|.+.... ..+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP--- 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc---
Confidence 56889999999999999999863 355789999985322 356789999999999999999998866542
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (283)
T cd05090 82 -------------------------------------------------------------------------------- 81 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-------------cC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK-------------SK 238 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~-------------~~ 238 (444)
.++||||+++ +|.+++..... ..
T Consensus 82 -------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 118 (283)
T cd05090 82 -------------------------------------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118 (283)
T ss_pred -------------------------------------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccc
Confidence 8899999984 88888742211 12
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchh
Q psy10212 239 QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPEL 315 (444)
Q Consensus 239 ~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~ 315 (444)
..+++..+..++.||+.||+|||++|++|+||+|+||+++ +.+.++|+|||++....... ......++..|+|||.
T Consensus 119 ~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (283)
T cd05090 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA 197 (283)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc-CCCcEEeccccccccccCCcceecccCCCccceecChHH
Confidence 3477888999999999999999999999999999999999 78899999999987653322 1222334667999999
Q ss_pred hccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 316 IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 316 l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.... ....+
T Consensus 198 ~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~ 248 (283)
T cd05090 198 IMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ----------------------------LLPCS 248 (283)
T ss_pred hccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------cCCCC
Confidence 8776 78999999999999999998 999998766544433332210 00112
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..+++.+.+++.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred CCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 346899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=287.16 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=197.2
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|+++++||+|+||+||+|++..+|+ .||+|.+... ...+.+|+.++++++|+||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST---- 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC----
Confidence 689999999999999999999877776 4899988432 234567999999999999999988875432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (279)
T cd05109 83 -------------------------------------------------------------------------------- 82 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.++++||++ |+|.+++.. ....+++..+..++.
T Consensus 83 -------------------------------------------~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~ 116 (279)
T cd05109 83 -------------------------------------------VQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCV 116 (279)
T ss_pred -------------------------------------------cEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHH
Confidence 668999998 588888752 345789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||+++++|+||+|+||+++ +.+.++|+|||+++........ ....++..|+|||...+. .++.++|+
T Consensus 117 qi~~~L~~lH~~~iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di 194 (279)
T cd05109 117 QIAKGMSYLEEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDV 194 (279)
T ss_pred HHHHHHHHHHHCCeeccccccceEEEc-CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHH
Confidence 999999999999999999999999998 7789999999998765332221 112335679999999776 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||||++|+|++ |..||.......... .+.... . . ..+..++..+.++|.+
T Consensus 195 ~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~-~----------------~----------~~~~~~~~~~~~li~~ 246 (279)
T cd05109 195 WSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGE-R----------------L----------PQPPICTIDVYMIMVK 246 (279)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCC-c----------------C----------CCCccCCHHHHHHHHH
Confidence 999999999998 999997765544332 222100 0 0 0113468899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||..||++||++.++++ -++.+..
T Consensus 247 ~l~~dp~~Rp~~~~l~~---~l~~~~~ 270 (279)
T cd05109 247 CWMIDSECRPRFRELVD---EFSRMAR 270 (279)
T ss_pred HcCCChhhCcCHHHHHH---HHHHhhc
Confidence 99999999999999998 4555433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=281.75 Aligned_cols=236 Identities=25% Similarity=0.303 Sum_probs=188.3
Q ss_pred heecccceeEEEEeEe--cCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKL--LDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||.||+|.. +.+++.+|+|++... .+.+.+|+.+++++.||||+++.+++...
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------------ 68 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------------ 68 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------------
Confidence 3689999999999965 456789999988433 23566899999999999999998776321
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (257)
T cd05116 69 -------------------------------------------------------------------------------- 68 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++||||+++ +|.+++. ....+++..+..++.|++.||+
T Consensus 69 -----------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~ 109 (257)
T cd05116 69 -----------------------------------SWMLVMELAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMK 109 (257)
T ss_pred -----------------------------------CcEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 16799999994 7888874 2346899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
+||++|++|+||+|.||+++ .++.++|+|||.+......... ....++..|+|||.+... .++.++|+||||++
T Consensus 110 ~lH~~~i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~ 187 (257)
T cd05116 110 YLEETNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVL 187 (257)
T ss_pred HHHHCCEeecccchhhEEEc-CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHH
Confidence 99999999999999999999 7889999999998765333221 112234689999988766 78899999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |+.||.+.+..+....+.+.. ....+..+++++.++|.+||+.||
T Consensus 188 l~el~t~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 188 MWEAFSYGQKPYKGMKGNEVTQMIESGE----------------------------RMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHCCC----------------------------CCCCCCCCCHHHHHHHHHHhccCc
Confidence 999997 999998776655544333210 001223578999999999999999
Q ss_pred CCCCCHHHHhc
Q psy10212 414 SSRISPLQVRS 424 (444)
Q Consensus 414 ~kRPs~~elL~ 424 (444)
++||++.+|..
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05116 240 DERPGFAVVEL 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.84 Aligned_cols=161 Identities=26% Similarity=0.442 Sum_probs=125.5
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhh
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELI 316 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l 316 (444)
.+++..+..++.||+.||+|||+++++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 477888899999999999999999999999999999999 788999999999865432221 1223456779999999
Q ss_pred ccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 317 FGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 317 ~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
.+. .++.++|+||||+++|+|++ |..||......+.....+.. .... ..+.
T Consensus 312 ~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~ 363 (400)
T cd05105 312 FDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-----------------GYRM----------AKPD 363 (400)
T ss_pred cCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc-----------------CCCC----------CCCc
Confidence 876 78999999999999999996 99999875443333222221 0000 1123
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.++..+.++|.+||+.||++|||+.++.+ .|+.+
T Consensus 364 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~---~l~~l 397 (400)
T cd05105 364 HATQEVYDIMVKCWNSEPEKRPSFLHLSD---IVESL 397 (400)
T ss_pred cCCHHHHHHHHHHCccCHhHCcCHHHHHH---HHHHH
Confidence 56899999999999999999999999988 55554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=288.35 Aligned_cols=242 Identities=30% Similarity=0.408 Sum_probs=192.4
Q ss_pred chhheecccceeEEEEeEec----CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 25 AQKTVIGNGSFGIVYQAKLL----DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+.+.||.|+||.||+|... ..+..|+||.+... ...+.+|++.+++++||||+++++++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~------ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP------ 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc------
Confidence 36789999999999999997 34578999999432 3566789999999999999999999995543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (259)
T PF07714_consen 76 -------------------------------------------------------------------------------- 75 (259)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.++|||||. ++|.+++... ....++...+..|+.||+
T Consensus 76 ----------------------------------------~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~ 113 (259)
T PF07714_consen 76 ----------------------------------------LFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIA 113 (259)
T ss_dssp ----------------------------------------EEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccccccccccccccc--cccccccccccccccccc
Confidence 889999998 6999998642 356799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
.||+|||+++++|++|+++||+++ .++.+||+|||+......... .........|+|||.+.+. .++.++|||||
T Consensus 114 ~~l~~Lh~~~iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysf 191 (259)
T PF07714_consen 114 EALSYLHSNNIIHGNLSPSNILLD-SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSF 191 (259)
T ss_dssp HHHHHHHHTTEEEST-SGGGEEEE-TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS-EESHHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc
Confidence 999999999999999999999999 788999999999876522211 1223456789999999877 68999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|||++ |+.||.+.+..+...++.+... ...+..++..+.++|.+||.
T Consensus 192 G~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~C~~ 243 (259)
T PF07714_consen 192 GMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----------------------------LPIPDNCPKDIYSLIQQCWS 243 (259)
T ss_dssp HHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----------------------------TTSBTTSBHHHHHHHHHHT-
T ss_pred cccccccccccccccccccccccccccccccc----------------------------ceeccchhHHHHHHHHHHcC
Confidence 999999999 7899988877776665533110 11223578999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy10212 411 YTPSSRISPLQVRS 424 (444)
Q Consensus 411 ~DP~kRPs~~elL~ 424 (444)
.||.+|||+.++++
T Consensus 244 ~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 244 HDPEKRPSFQEILQ 257 (259)
T ss_dssp SSGGGS--HHHHHH
T ss_pred CChhhCcCHHHHHh
Confidence 99999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.23 Aligned_cols=286 Identities=27% Similarity=0.504 Sum_probs=220.4
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeec---cccchhhHHHHhhhcCC--C----ceeEeeeEEeec
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKNREMQIMRRLEH--S----NIVKLKYFFYSS 87 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~---~~~~~~~E~~~l~~l~h--~----~i~~~~~~~~~~ 87 (444)
-+.+.++|.+...||+|.||.|-++.|..++..+|||++.. -++...-|++++++|.+ | -++.+.++|--.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 36679999999999999999999999999999999999843 24555679999999932 1 244444444333
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
T Consensus 164 -------------------------------------------------------------------------------- 163 (415)
T KOG0671|consen 164 -------------------------------------------------------------------------------- 163 (415)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.+.+||+|.++.|+++++.. .+-.+++...++
T Consensus 164 ----------------------------------------------ghiCivfellG~S~~dFlk~--N~y~~fpi~~ir 195 (415)
T KOG0671|consen 164 ----------------------------------------------GHICIVFELLGLSTFDFLKE--NNYIPFPIDHIR 195 (415)
T ss_pred ----------------------------------------------CceEEEEeccChhHHHHhcc--CCccccchHHHH
Confidence 35999999999999999963 455679999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-------------------CCCeEEEeecCCcccccCCCCCccccccc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP-------------------ETGVLKLCDFGSAKHLVRGEPNVSYICSR 308 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~-------------------~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~ 308 (444)
.+..|+++++++||+.+++|.||||+||++.. .+..|+++|||.+... .........|.
T Consensus 196 ~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTR 273 (415)
T KOG0671|consen 196 HMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTR 273 (415)
T ss_pred HHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeecc
Confidence 99999999999999999999999999999931 1346899999998653 34456778899
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CC--CcccCCCc
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NY--TEFKFPQI 384 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~--~~~~~p~~ 384 (444)
.|.|||++.+- .++.++|+||+|||++|+++|..+|++.++.+.++-+...+|..+..-+..... .+ ..++-|..
T Consensus 274 HYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~ 352 (415)
T KOG0671|consen 274 HYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEV 352 (415)
T ss_pred ccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccc
Confidence 99999999998 899999999999999999999999999988888877777778444333333210 00 00000000
Q ss_pred c-----------CCCCccccc--CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 385 K-----------SHPWSKVFR--VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 385 ~-----------~~~~~~~~~--~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
. ..++...+. .....++.|||++||.+||.+|+|+.|+|. ||||..++.
T Consensus 353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~-HpFF~~~~~ 414 (415)
T KOG0671|consen 353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS-HPFFARLTP 414 (415)
T ss_pred cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc-CHHhhcCCC
Confidence 0 001111111 112356999999999999999999999999 999998754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=284.40 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=203.7
Q ss_pred ccccchhheecccceeEEEEeEecC----CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD----SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.++|.+.+.||+|+||.||+|.+.. +++.+|+|.+... ...+.+|+.++++++|+||+++++++...+.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-- 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE-- 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC--
Confidence 3689999999999999999999876 3578999988533 2345579999999999999999998766432
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (280)
T cd05043 83 -------------------------------------------------------------------------------- 82 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc----CCCCChHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS----KQNFPCFYT 246 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~----~~~l~~~~i 246 (444)
..+++++|++ ++|.+++...... +..+++..+
T Consensus 83 -------------------------------------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~ 119 (280)
T cd05043 83 -------------------------------------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119 (280)
T ss_pred -------------------------------------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHH
Confidence 3779999998 6888888654332 256899999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
+.++.||+.||+|||+++++|+||+|+||+++ +.+.++|+|||+++....... .....++..|+|||.+.+. .++
T Consensus 120 ~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~ 197 (280)
T cd05043 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYS 197 (280)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccCHhhEEEc-CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCC
Confidence 99999999999999999999999999999998 789999999999875533221 1122346679999998776 789
Q ss_pred cchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 324 TKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 324 ~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
.++|+||||+++|++++ |+.||...+..+....+... .. ...+..+++.+.
T Consensus 198 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~ 249 (280)
T cd05043 198 SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG------------------YR----------LAQPINCPDELF 249 (280)
T ss_pred chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC------------------CC----------CCCCCcCCHHHH
Confidence 99999999999999998 99999877655543322220 00 001224688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+++.+||+.||++|||+.+++. .++++..
T Consensus 250 ~li~~~l~~~p~~Rps~~~~~~---~l~~~~~ 278 (280)
T cd05043 250 AVMACCWALDPEERPSFSQLVQ---CLTDFHA 278 (280)
T ss_pred HHHHHHcCCChhhCCCHHHHHH---HHHHHHh
Confidence 9999999999999999999999 7877654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=282.08 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=198.4
Q ss_pred cccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|...+.||+|+||.||+|+++.+++ .+|+|.+... ...+.+|++++++++|+||+++.+++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP---- 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC----
Confidence 578889999999999999999976665 6999988543 2345679999999999999999988865542
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (268)
T cd05063 81 -------------------------------------------------------------------------------- 80 (268)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.++||||+++ +|.+++.. ....+++..+..++.|
T Consensus 81 ------------------------------------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ 115 (268)
T cd05063 81 ------------------------------------------AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRG 115 (268)
T ss_pred ------------------------------------------cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHH
Confidence 7899999995 78777742 3457899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc----cccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
++.||+|||++|++|+||+|+||+++ +++.++|+|||++.......... ....+..|+|||.+.+. .++.++|+
T Consensus 116 l~~al~~lH~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv 193 (268)
T cd05063 116 IAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDV 193 (268)
T ss_pred HHHHHHHHHHCCeeccccchhhEEEc-CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHH
Confidence 99999999999999999999999999 78899999999986553322111 11224569999998776 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||...+..+....+..... .| ....++..+.+++.+
T Consensus 194 ~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~------------------~~----------~~~~~~~~~~~li~~ 245 (268)
T cd05063 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR------------------LP----------APMDCPSAVYQLMLQ 245 (268)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC------------------CC----------CCCCCCHHHHHHHHH
Confidence 999999999997 9999987766554444432100 00 012458899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
||..||++||++.++++ .+++
T Consensus 246 c~~~~p~~Rp~~~~i~~---~l~~ 266 (268)
T cd05063 246 CWQQDRARRPRFVDIVN---LLDK 266 (268)
T ss_pred HcCCCcccCcCHHHHHH---HHHh
Confidence 99999999999999998 5554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=287.35 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=195.8
Q ss_pred cccchhheecccceeEEEEeEecCCC--------------ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeee
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSG--------------ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKY 82 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~ 82 (444)
++|++.+.||+|+||.||+|++..++ ..||+|.+... ...+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 68999999999999999999875432 35899998543 235668999999999999999999
Q ss_pred EEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhh
Q psy10212 83 FFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162 (444)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (444)
++.....
T Consensus 85 ~~~~~~~------------------------------------------------------------------------- 91 (295)
T cd05097 85 VCVSDDP------------------------------------------------------------------------- 91 (295)
T ss_pred EEcCCCc-------------------------------------------------------------------------
Confidence 9876542
Q ss_pred hcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-----
Q psy10212 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK----- 236 (444)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~----- 236 (444)
.++|||||.+ +|.+++.....
T Consensus 92 -----------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~ 118 (295)
T cd05097 92 -----------------------------------------------------LCMITEYMENGDLNQFLSQREIESTFT 118 (295)
T ss_pred -----------------------------------------------------cEEEEecCCCCcHHHHHHhcccccccc
Confidence 7899999985 88888753211
Q ss_pred ---cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccccc
Q psy10212 237 ---SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYY 310 (444)
Q Consensus 237 ---~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y 310 (444)
....+++..++.++.|++.||+|||++|++|+||+|+||+++ +++.++|+|||++........ .....++..|
T Consensus 119 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 197 (295)
T cd05097 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197 (295)
T ss_pred ccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceee
Confidence 112467888999999999999999999999999999999999 788999999999865432221 1122335679
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCC
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLL--GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLlt--G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~ 388 (444)
+|||.+.+. .++.++|+||||+++|+|++ +..||...+..+....+.+...... ..
T Consensus 198 ~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------~~ 255 (295)
T cd05097 198 MAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG---------------------RQ 255 (295)
T ss_pred cChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcc---------------------cc
Confidence 999998776 78999999999999999997 6788887766655544433110000 00
Q ss_pred CcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 389 ~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.....+..+++.+.+||.+||+.||++|||+.+++.
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 256 IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000112346899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=278.66 Aligned_cols=238 Identities=34% Similarity=0.592 Sum_probs=196.7
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
||+|+||.||++++..+++.+|+|.+... ...+.+|++++++++|+||+++++.+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------------- 66 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-------------- 66 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--------------
Confidence 69999999999999988999999998543 235668999999999999999887775543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (250)
T cd05123 67 -------------------------------------------------------------------------------- 66 (250)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
..+++|||++ ++|.+++.. ...+++..++.++.|++.||.+||
T Consensus 67 --------------------------------~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh 110 (250)
T cd05123 67 --------------------------------KLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLH 110 (250)
T ss_pred --------------------------------eeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4899999995 689888853 346899999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
+.+++|+||+|+||+++ ..+.++|+|||.+...... .......++..|++||...+. ..+.++|+||||+++|+|++
T Consensus 111 ~~~~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~ 188 (250)
T cd05123 111 SLGIIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLT 188 (250)
T ss_pred HCCceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999 7889999999998765433 223344568889999998776 68899999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH-
Q psy10212 341 GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP- 419 (444)
Q Consensus 341 G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~- 419 (444)
|+.||...+.......+... . ..++..++..+.++|.+||..||++||++
T Consensus 189 g~~p~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 189 GKPPFYAEDRKEIYEKILKD-----------------P------------LRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CCCCCCCCCHHHHHHHHhcC-----------------C------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 99999876654433333220 0 01223458899999999999999999999
Q ss_pred --HHHhccCchh
Q psy10212 420 --LQVRSITPFL 429 (444)
Q Consensus 420 --~elL~~hpwf 429 (444)
.++++ ||||
T Consensus 240 ~~~~l~~-~~~f 250 (250)
T cd05123 240 GAEEIKA-HPFF 250 (250)
T ss_pred cHHHHHh-CCCC
Confidence 89999 9998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.30 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=200.1
Q ss_pred ccccchhheecccceeEEEEeEecC-------CCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeec
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-------SGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSS 87 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (444)
.++|.+.+.||+|+||.||+|++.. ++..+|+|.+.... ..+.+|+.+++++ +|+||+++.+++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998743 23569999986432 2455799999999 799999999988665
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 97 ~~------------------------------------------------------------------------------ 98 (307)
T cd05098 97 GP------------------------------------------------------------------------------ 98 (307)
T ss_pred Cc------------------------------------------------------------------------------
Confidence 42
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh----------
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK---------- 236 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~---------- 236 (444)
.++|||||+ ++|.+++.....
T Consensus 99 ------------------------------------------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 130 (307)
T cd05098 99 ------------------------------------------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130 (307)
T ss_pred ------------------------------------------------eEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 889999998 599999865322
Q ss_pred --cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccccccccc
Q psy10212 237 --SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYR 311 (444)
Q Consensus 237 --~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~ 311 (444)
....++...++.++.|++.||+|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+
T Consensus 131 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~ 209 (307)
T cd05098 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 209 (307)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCcccee
Confidence 123578889999999999999999999999999999999999 778999999999865532211 11122346799
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+... ..
T Consensus 210 aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------------------~~ 260 (307)
T cd05098 210 APEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG----------------------------HR 260 (307)
T ss_pred ChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC----------------------------CC
Confidence 99998876 78999999999999999998 89999776554433322210 00
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
..++..++.++.++|.+||..+|.+|||+.++++ -|+.+.+.
T Consensus 261 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~---~l~~~~~~ 302 (307)
T cd05098 261 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRILAL 302 (307)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH---HHHHHHHH
Confidence 0122356899999999999999999999999998 56555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.72 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=201.6
Q ss_pred ccccchhheecccceeEEEEeEecC-------CCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeec
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-------SGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSS 87 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (444)
..+|.+.+.||+|+||.||+|++.. ....+|+|.+.... ..+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4689999999999999999998632 34579999885432 3456899999999 699999999988665
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 91 ~------------------------------------------------------------------------------- 91 (314)
T cd05099 91 G------------------------------------------------------------------------------- 91 (314)
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh----------
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK---------- 236 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~---------- 236 (444)
..+++|||+. ++|.+++.....
T Consensus 92 -----------------------------------------------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~ 124 (314)
T cd05099 92 -----------------------------------------------PLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124 (314)
T ss_pred -----------------------------------------------ceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 2889999998 589999865322
Q ss_pred --cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccccccccc
Q psy10212 237 --SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYR 311 (444)
Q Consensus 237 --~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~ 311 (444)
....++...+..++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.++....... .....++..|+
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 203 (314)
T cd05099 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM 203 (314)
T ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-CCCcEEEccccccccccccccccccccCCCCcccc
Confidence 234588889999999999999999999999999999999998 788999999999876533211 11122345799
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.... .
T Consensus 204 aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~ 254 (314)
T cd05099 204 APEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH----------------------------R 254 (314)
T ss_pred CHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------------C
Confidence 99998776 78999999999999999998 899998776655444332210 0
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..++..++.++.++|.+||..||++|||+.++++ .++.+..
T Consensus 255 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~---~l~~~~~ 295 (314)
T cd05099 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE---ALDKVLA 295 (314)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH---HHHHHHH
Confidence 0112356889999999999999999999999998 6776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.88 Aligned_cols=243 Identities=27% Similarity=0.389 Sum_probs=197.3
Q ss_pred cchhheecccceeEEEEeEecCCC----ceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSG----ELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+++++.||.|+||.||++++...+ +.+|+|.+.... ..+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP----- 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe-----
Confidence 467899999999999999998766 899999995432 356689999999999999999998876542
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (258)
T smart00219 76 -------------------------------------------------------------------------------- 75 (258)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||+++ +|.+++.... ...+++..++.++.|+
T Consensus 76 -----------------------------------------~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql 112 (258)
T smart00219 76 -----------------------------------------LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQI 112 (258)
T ss_pred -----------------------------------------eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHH
Confidence 8899999985 8888875322 1228999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc--cccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||++||+++++|+||+|+||+++ +.+.++|+|||.+.......... ...++..|+|||.+.+. .++.++|+|||
T Consensus 113 ~~~l~~lh~~~~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~sl 190 (258)
T smart00219 113 ARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSF 190 (258)
T ss_pred HHHHHHHhcCCeeecccccceEEEc-cCCeEEEcccCCceecccccccccccCCCcccccChHHhccC-CCCcchhHHHH
Confidence 9999999999999999999999999 78899999999987654432211 12356789999998665 78999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++++|++ |..||...+..+....+.... ....+..++.++.+++.+||.
T Consensus 191 G~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~ 242 (258)
T smart00219 191 GVLLWEIFTLGESPYPGMSNEEVLEYLKKGY----------------------------RLPKPENCPPEIYKLMLQCWA 242 (258)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCCCcCCHHHHHHHHHHCc
Confidence 999999998 889998766655554443210 001122368999999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy10212 411 YTPSSRISPLQVRS 424 (444)
Q Consensus 411 ~DP~kRPs~~elL~ 424 (444)
.||++|||+.|+++
T Consensus 243 ~~p~~Rpt~~~ll~ 256 (258)
T smart00219 243 EDPEDRPTFSELVE 256 (258)
T ss_pred CChhhCcCHHHHHh
Confidence 99999999999987
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.66 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=202.4
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+|++.+.||+|+||.||+|.++.+|+ .+|+|.+.... ..+.+|+..+++++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~---- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S---- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C----
Confidence 678999999999999999999887765 58999875432 456689999999999999999988865 2
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (279)
T cd05057 82 -------------------------------------------------------------------------------- 81 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++||||++ ++|.+++.. ....+++..+..++.
T Consensus 82 ------------------------------------------~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~ 116 (279)
T cd05057 82 ------------------------------------------QVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCV 116 (279)
T ss_pred ------------------------------------------ceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHH
Confidence 2789999998 588888752 345689999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc---ccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS---YICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||+++++|+||+|+||+++ ..+.++|+|||.+........... ...+..|+|||.+... .++.++|+
T Consensus 117 qi~~~l~~LH~~~i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di 194 (279)
T cd05057 117 QIAKGMSYLEEKRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDV 194 (279)
T ss_pred HHHHHHHHHHhCCEEecccCcceEEEc-CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcC-CcCchhhH
Confidence 999999999999999999999999998 788999999999876543322111 1224679999988766 78899999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|++++ |+.||.+.+..+....+.... ....+..++..+.+++.+
T Consensus 195 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~ 246 (279)
T cd05057 195 WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE----------------------------RLPQPPICTIDVYMVLVK 246 (279)
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHH
Confidence 999999999998 999998877665444333210 001123457899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||..||.+||++.++++ .|+++...
T Consensus 247 ~l~~~p~~Rp~~~~l~~---~l~~~~~~ 271 (279)
T cd05057 247 CWMIDAESRPTFKELIN---EFSKMARD 271 (279)
T ss_pred HcCCChhhCCCHHHHHH---HHHHHHhC
Confidence 99999999999999999 88876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=284.88 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=197.2
Q ss_pred ccccchhheecccceeEEEEeEecC-----CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++++.||+|+||.||+|+++. +++.+|+|.+... ...+.+|+.++++++||||+++.+++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 3689999999999999999999753 5789999988543 245678999999999999999998876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (288)
T cd05050 82 -------------------------------------------------------------------------------- 81 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK------------- 236 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~------------- 236 (444)
..+++|||+++ +|.+++.....
T Consensus 82 --------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 117 (288)
T cd05050 82 --------------------------------------------PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117 (288)
T ss_pred --------------------------------------------ccEEEEecCCCCCHHHHHHHcCcccccccccccccc
Confidence 27899999995 89888853221
Q ss_pred -----cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccc
Q psy10212 237 -----SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSR 308 (444)
Q Consensus 237 -----~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~ 308 (444)
....+++..++.++.||+.||+|||+++++|+||+|+||+++ .++.++|+|||.+........ ......+.
T Consensus 118 ~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 196 (288)
T cd05050 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPI 196 (288)
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec-CCCceEECccccceecccCccccccCCCccCh
Confidence 123477888999999999999999999999999999999998 788999999998865422211 11223356
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.... .+
T Consensus 197 ~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-------------------~~----- 251 (288)
T cd05050 197 RWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-------------------VL----- 251 (288)
T ss_pred hhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------------CC-----
Confidence 79999998776 78999999999999999997 888998777665544333210 00
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..+..++..+.+||.+||+.||.+|||+.|++.
T Consensus 252 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 252 ----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 012346889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.14 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=196.6
Q ss_pred ccccchhheecccceeEEEEeEe-----cCCCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 89 (444)
.++|++.+.||+|+||.||+|.+ ..++..+|+|.+.... ..+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35899999999999999999986 2345689999885432 3466899999999 79999999998866543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 114 -------------------------------------------------------------------------------- 113 (302)
T cd05055 114 -------------------------------------------------------------------------------- 113 (302)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||+. ++|.+++.. .....+++..++.
T Consensus 114 ----------------------------------------------~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~ 145 (302)
T cd05055 114 ----------------------------------------------ILVITEYCCYGDLLNFLRR--KRESFLTLEDLLS 145 (302)
T ss_pred ----------------------------------------------eEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHH
Confidence 889999998 589888853 2223489999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.||+.||+|||+++++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.+
T Consensus 146 i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 223 (302)
T cd05055 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFE 223 (302)
T ss_pred HHHHHHHHHHHHHHCCeehhhhccceEEEc-CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcH
Confidence 999999999999999999999999999998 788999999999875533221 1122346779999998877 78999
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||+|+++|+|++ |..||.+....+...+..... +....+...++.+.++
T Consensus 224 ~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~l 276 (302)
T cd05055 224 SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---------------------------YRMAQPEHAPAEIYDI 276 (302)
T ss_pred hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---------------------------CcCCCCCCCCHHHHHH
Confidence 999999999999998 999998766544333332210 0001122458899999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy10212 405 ISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~ 424 (444)
+.+||+.+|++|||+.|++.
T Consensus 277 i~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 277 MKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=282.42 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=189.3
Q ss_pred heecccceeEEEEeEecCCCc--eeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGE--LVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|+++.+++ .+|+|.+... ...+.+|+++++++ +||||+++++++...+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----------- 69 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----------- 69 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----------
Confidence 468999999999999988776 4688887532 23556799999999 8999999999886654
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (270)
T cd05047 70 -------------------------------------------------------------------------------- 69 (270)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------cCCCCChHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------SKQNFPCFYT 246 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~i 246 (444)
+.++||||++ ++|.+++..... ....+++..+
T Consensus 70 -----------------------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 114 (270)
T cd05047 70 -----------------------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114 (270)
T ss_pred -----------------------------------CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHH
Confidence 3789999998 599998864321 1235788999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcch
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
+.++.|++.||+|||++|++|+||+|+||+++ .++.++|+|||++..............+..|+|||.+.+. .++.++
T Consensus 115 ~~~~~~i~~al~~lH~~~i~H~dikp~nili~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~ 192 (270)
T cd05047 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNS 192 (270)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccccceEEEc-CCCeEEECCCCCccccchhhhccCCCCccccCChHHHccC-CCCchh
Confidence 99999999999999999999999999999999 7889999999998532211111122235679999998776 789999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |..||.+.+..+....+... +....+..++.++.+++
T Consensus 193 Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li 244 (270)
T cd05047 193 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----------------------------YRLEKPLNCDDEVYDLM 244 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----------------------------CCCCCCCcCCHHHHHHH
Confidence 99999999999996 99999876655444332210 00011224688999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy10212 406 SRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~ 424 (444)
.+||+.||.+|||+.+++.
T Consensus 245 ~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 245 RQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHcccChhhCCCHHHHHH
Confidence 9999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=285.48 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=191.9
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||.||+|++..+++ .+|+|.+.... ..+.+|+..+.++.||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence 578999999999999999999987776 47777774321 3445677788999999999998876432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (279)
T cd05111 82 -------------------------------------------------------------------------------- 81 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++++||+. ++|.+++.. ..+.+++..++.++.
T Consensus 82 ------------------------------------------~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~ 116 (279)
T cd05111 82 ------------------------------------------SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCV 116 (279)
T ss_pred ------------------------------------------ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHH
Confidence 1668899988 699988853 345789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||+++++|+||+|+||+++ +++.++|+|||.++....... .....++..|+|||.+.+. .++.++|+
T Consensus 117 qi~~~l~~lH~~~iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv 194 (279)
T cd05111 117 QIAKGMYYLEEHRMVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDV 194 (279)
T ss_pred HHHHHHHHHHHCCEeccccCcceEEEc-CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhH
Confidence 999999999999999999999999999 788999999999876533221 1223456789999999876 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||.+....... +++.. +. ... .+..++.++.+++.+
T Consensus 195 ~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~-~~--------------~~~------------~~~~~~~~~~~li~~ 246 (279)
T cd05111 195 WSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEK-GE--------------RLA------------QPQICTIDVYMVMVK 246 (279)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHC-CC--------------cCC------------CCCCCCHHHHHHHHH
Confidence 999999999998 99999876554332 22220 00 000 012357889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||..||.+|||+.|+++
T Consensus 247 c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 247 CWMIDENVRPTFKELAN 263 (279)
T ss_pred HcCCCcccCcCHHHHHH
Confidence 99999999999999988
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=280.60 Aligned_cols=250 Identities=27% Similarity=0.365 Sum_probs=199.3
Q ss_pred cccchhheecccceeEEEEeEecCC---Cceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.+.+.||+|+||.||+|.+... ...+|||.+.... +.+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP----- 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC-----
Confidence 5688999999999999999998654 3469999885432 35678999999999999999988764321
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (270)
T cd05056 81 -------------------------------------------------------------------------------- 80 (270)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.++|||||+ ++|.+++.. ....+++..++.++.|
T Consensus 81 ------------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~ 115 (270)
T cd05056 81 ------------------------------------------VWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQ 115 (270)
T ss_pred ------------------------------------------cEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHH
Confidence 679999998 589888853 2346899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
++.||+|||+++++|+||+|+||+++ ..+.++|+|||++......... ....++..|+|||.+... .++.++|+||
T Consensus 116 l~~~l~~lH~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s 193 (270)
T cd05056 116 LSTALAYLESKRFVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWM 193 (270)
T ss_pred HHHHHHHHHhCCeeccccChheEEEe-cCCCeEEccCceeeecccccceecCCCCccccccChhhhccC-CCCchhhhHH
Confidence 99999999999999999999999999 7889999999998655333211 112234579999998766 7899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||+++|+|++ |..||.+.+..+....+.... . ...+..+++.+.++|.+||
T Consensus 194 lG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l 245 (270)
T cd05056 194 FGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----------------R------------LPMPPNCPPTLYSLMTKCW 245 (270)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------------c------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999986 999998877655544332210 0 0112356899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..+|.+|||+.++++ .+.+++.
T Consensus 246 ~~~P~~Rpt~~~~~~---~l~~~~~ 267 (270)
T cd05056 246 AYDPSKRPRFTELKA---QLSDILQ 267 (270)
T ss_pred CCChhhCcCHHHHHH---HHHHHHh
Confidence 999999999999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=281.03 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=200.8
Q ss_pred ccchhheecccceeEEEEeEecC-CCceeeeeeeeccc--------------cchhhHHHHhhh-cCCCceeEeeeEEee
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLD-SGELVAIKKVLQDK--------------RFKNREMQIMRR-LEHSNIVKLKYFFYS 86 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~--------------~~~~~E~~~l~~-l~h~~i~~~~~~~~~ 86 (444)
.|++.+.||+|+||.||+|++.. .++.+|+|.+.... ..+.+|+.++.+ ++||||+++.+++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67899999884321 223468877765 799999999998876
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+
T Consensus 81 ~~------------------------------------------------------------------------------ 82 (269)
T cd08528 81 ND------------------------------------------------------------------------------ 82 (269)
T ss_pred CC------------------------------------------------------------------------------
Confidence 54
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHH
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~ 245 (444)
..+++|||+++ +|.+++.........+++..
T Consensus 83 ------------------------------------------------~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~ 114 (269)
T cd08528 83 ------------------------------------------------RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER 114 (269)
T ss_pred ------------------------------------------------eEEEEEecCCCCcHHHHHHHHHhccCCCCHHH
Confidence 38999999985 88888866556667899999
Q ss_pred HHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCc
Q psy10212 246 TKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
++.++.|++.+|.+||+ .+++|+||+|+||+++ ..+.++|+|||.+.............++..|++||.+.+. .++.
T Consensus 115 ~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~ 192 (269)
T cd08528 115 IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGE 192 (269)
T ss_pred HHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-CCCcEEEecccceeecccccccccccCcccCcChhhhcCC-CCch
Confidence 99999999999999996 7899999999999999 7889999999998765444333455678889999999876 7899
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++|+||||+++|+|++|+.||...+.......+......+. ....+++.+.++
T Consensus 193 ~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~l 245 (269)
T cd08528 193 KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDV 245 (269)
T ss_pred HHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC---------------------------CcccCCHHHHHH
Confidence 99999999999999999999977665544443333111000 011357899999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy10212 405 ISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~ 424 (444)
|.+||+.||++||++.|+..
T Consensus 246 i~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 246 ITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHCCCCCccCCCHHHHHH
Confidence 99999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=277.27 Aligned_cols=239 Identities=26% Similarity=0.370 Sum_probs=192.2
Q ss_pred heecccceeEEEEeEecC-CCc--eeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLD-SGE--LVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~-~~~--~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|++|.||+|.+.. .++ .+|||.+.... ..+.+|+.++++++||||+++.+.+.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----------- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----------- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-----------
Confidence 468999999999999865 333 69999985543 356689999999999999999888765 2
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (257)
T cd05040 69 -------------------------------------------------------------------------------- 68 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++||||++ ++|.+++..... ..+++..++.++.|++.||+
T Consensus 69 -----------------------------------~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~ 111 (257)
T cd05040 69 -----------------------------------PLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMR 111 (257)
T ss_pred -----------------------------------eEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHH
Confidence 2889999997 599998864221 56899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||++
T Consensus 112 ~lH~~~i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~ 189 (257)
T cd05040 112 YLESKRFIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVT 189 (257)
T ss_pred HHHhCCccccccCcccEEEe-cCCEEEeccccccccccccccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHH
Confidence 99999999999999999999 679999999999876543221 1123456789999998776 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||...+..+....+... + ... ..+..++..+.+++.+||+.+|
T Consensus 190 l~el~t~g~~p~~~~~~~~~~~~~~~~-~--------------~~~------------~~~~~~~~~~~~li~~~l~~~p 242 (257)
T cd05040 190 LWEMFTYGEEPWAGLSGSQILKKIDKE-G--------------ERL------------ERPEACPQDIYNVMLQCWAHNP 242 (257)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhc-C--------------CcC------------CCCccCCHHHHHHHHHHCCCCc
Confidence 999998 99999877766655444321 0 000 0112358899999999999999
Q ss_pred CCCCCHHHHhc
Q psy10212 414 SSRISPLQVRS 424 (444)
Q Consensus 414 ~kRPs~~elL~ 424 (444)
++|||+.+++.
T Consensus 243 ~~Rps~~~~~~ 253 (257)
T cd05040 243 ADRPTFAALRE 253 (257)
T ss_pred ccCCCHHHHHH
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=283.90 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=196.8
Q ss_pred cccchhheecccceeEEEEeEec-----CCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+|.+.++||+|+||.||+|++. .++..+|+|.+... ...+.+|++++++++|+||+++.+++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP--- 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc---
Confidence 57889999999999999999753 34678999988543 2456789999999999999999988876542
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (280)
T cd05092 82 -------------------------------------------------------------------------------- 81 (280)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh-----------cCCC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK-----------SKQN 240 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-----------~~~~ 240 (444)
.+++|||++ ++|.+++..... ....
T Consensus 82 -------------------------------------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~ 118 (280)
T cd05092 82 -------------------------------------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118 (280)
T ss_pred -------------------------------------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccc
Confidence 789999998 589888864321 1135
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhc
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIF 317 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~ 317 (444)
+++..++.++.||+.||+|||++|++|+||+|+||+++ +++.++|+|||++........ .....+++.|+|||.+.
T Consensus 119 l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05092 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 197 (280)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence 78899999999999999999999999999999999999 788999999999865432211 11223457799999988
Q ss_pred cCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
+. .++.++|+|||||++|+|++ |.+||......+....+.... ....+..
T Consensus 198 ~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~ 248 (280)
T cd05092 198 YR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR----------------------------ELERPRT 248 (280)
T ss_pred cC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc----------------------------cCCCCCC
Confidence 77 78999999999999999998 999998766655544333210 0011234
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+++.+.++|.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 249 CPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.22 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=197.0
Q ss_pred cccchhheecccceeEEEEeEecCC-----Cceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
++|++++.||.|+||.||+|+.+.+ .+.+|+|.+.... ..+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 6789999999999999999997543 4679999885433 34678999999999999999998875543
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (275)
T cd05046 82 -------------------------------------------------------------------------------- 81 (275)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcC-----CCCChHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSK-----QNFPCFY 245 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~-----~~l~~~~ 245 (444)
+.++|||||+ ++|.+++....... ..+++..
T Consensus 82 -------------------------------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~ 118 (275)
T cd05046 82 -------------------------------------------PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118 (275)
T ss_pred -------------------------------------------cceEEEEecCCCcHHHHHHhcccccccccccCCCHHH
Confidence 3789999998 59999886433221 2689999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCC
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
++.++.||+.||+|||+.+++|+||+|+||+++ ..+.++++|||++....... ......++..|+|||.+.+. .++
T Consensus 119 ~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~ 196 (275)
T cd05046 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFS 196 (275)
T ss_pred HHHHHHHHHHHHHHhhhcCcccCcCccceEEEe-CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCC
Confidence 999999999999999999999999999999998 78899999999875432211 12233456779999998776 688
Q ss_pred cchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 324 TKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 324 ~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
.++|+||||+++|+|++ |..||...........+... .+....+..++..+.
T Consensus 197 ~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~ 249 (275)
T cd05046 197 TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG---------------------------KLELPVPEGCPSRLY 249 (275)
T ss_pred chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC---------------------------CcCCCCCCCCCHHHH
Confidence 99999999999999998 88999776655444333210 000011234689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy10212 403 DLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~ 424 (444)
++|.+||+.||.+|||+.|++.
T Consensus 250 ~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 250 KLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=277.97 Aligned_cols=236 Identities=24% Similarity=0.288 Sum_probs=187.2
Q ss_pred eecccceeEEEEeEec--CCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCcc
Q psy10212 29 VIGNGSFGIVYQAKLL--DSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLE 101 (444)
Q Consensus 29 ~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 101 (444)
.||+|+||.||+|.+. ..+..+|+|++.... ..+.+|+.++++++|+||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-------------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-------------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC--------------
Confidence 4899999999999875 345679999885432 3466899999999999999998876322
Q ss_pred ccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCC
Q psy10212 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 181 (444)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (444)
T Consensus 68 -------------------------------------------------------------------------------- 67 (257)
T cd05115 68 -------------------------------------------------------------------------------- 67 (257)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH
Q psy10212 182 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL 260 (444)
..++||||+++ +|.+++.. ....+++..++.++.||+.||+||
T Consensus 68 ---------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 111 (257)
T cd05115 68 ---------------------------------ALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYL 111 (257)
T ss_pred ---------------------------------CeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 27899999985 88887752 345789999999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
|++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||||+++|
T Consensus 112 H~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ 189 (257)
T cd05115 112 EGKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMW 189 (257)
T ss_pred HhcCeeecccchheEEEc-CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHH
Confidence 999999999999999998 788999999999865432211 1111224679999998776 6889999999999999
Q ss_pred HHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 337 ELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 337 eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
++++ |..||.+....+....+.... ...++..+++++.++|.+||+.||++
T Consensus 190 el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~c~~~~~~~ 241 (257)
T cd05115 190 EAFSYGQKPYKKMKGPEVMSFIEQGK----------------------------RLDCPAECPPEMYALMKDCWIYKWED 241 (257)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHCCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9996 999998877655443332210 01123456899999999999999999
Q ss_pred CCCHHHHhc
Q psy10212 416 RISPLQVRS 424 (444)
Q Consensus 416 RPs~~elL~ 424 (444)
||++.++++
T Consensus 242 Rp~~~~i~~ 250 (257)
T cd05115 242 RPNFAKVEE 250 (257)
T ss_pred CcCHHHHHH
Confidence 999999987
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=307.80 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=207.2
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeee-----cc-c--cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVL-----QD-K--RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-----~~-~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.-.+||+|+|-+||+|-|..+|-.||.-.+. +. + ..+..|+.+|+.|+|+||++++++|.+...
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n-------- 115 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN-------- 115 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--------
Confidence 4678999999999999999999999876652 22 2 567789999999999999999999998753
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 116 -------------------------------------------------------------------------------- 115 (632)
T KOG0584|consen 116 -------------------------------------------------------------------------------- 115 (632)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..+.+|+|++. |+|+.+.++ .+.+....++.|++||+.|
T Consensus 116 ------------------------------------~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkG 155 (632)
T KOG0584|consen 116 ------------------------------------KTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKG 155 (632)
T ss_pred ------------------------------------ceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHH
Confidence 23779999998 799998864 4568888999999999999
Q ss_pred HHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|.|||++. |+|||||.+|||++...|.+||+|+|++.....+... ...|||.|||||.+.. .|....||||||++
T Consensus 156 L~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak-svIGTPEFMAPEmYEE--~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 156 LVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK-SVIGTPEFMAPEMYEE--NYNELVDVYAFGMC 232 (632)
T ss_pred hhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc-eeccCccccChHHHhh--hcchhhhhhhhhHH
Confidence 99999997 9999999999999988999999999999876555433 3789999999999974 79999999999999
Q ss_pred HHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|.||+|+.+||..- ++.+++.++..+ ..+ ..+ .+=-.+++++||.+||.. .
T Consensus 233 mLEMvT~eYPYsEC~n~AQIYKKV~SG--iKP-~sl------------------------~kV~dPevr~fIekCl~~-~ 284 (632)
T KOG0584|consen 233 MLEMVTSEYPYSECTNPAQIYKKVTSG--IKP-AAL------------------------SKVKDPEVREFIEKCLAT-K 284 (632)
T ss_pred HHHHHhccCChhhhCCHHHHHHHHHcC--CCH-HHh------------------------hccCCHHHHHHHHHHhcC-c
Confidence 99999999999864 455555555542 111 111 111268999999999999 9
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
++|||+.|+|. ||||..-
T Consensus 285 ~~R~sa~eLL~-d~Ff~~d 302 (632)
T KOG0584|consen 285 SERLSAKELLK-DPFFDED 302 (632)
T ss_pred hhccCHHHHhh-Chhhccc
Confidence 99999999999 9999873
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=290.08 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=216.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.|+.+++||+|.||.|-+++.+.+|+.||||++.+.. ..-..|-++|+..+||.+..+.++|...+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr----- 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR----- 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce-----
Confidence 57899999999999999999999999999999885432 122258889999999999999888876653
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 243 -------------------------------------------------------------------------------- 242 (516)
T KOG0690|consen 243 -------------------------------------------------------------------------------- 242 (516)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+++||||..| .|.-.+. ...-+++..++.+...|
T Consensus 243 -----------------------------------------lCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEI 277 (516)
T KOG0690|consen 243 -----------------------------------------LCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEI 277 (516)
T ss_pred -----------------------------------------EEEEEEEccCceEeeehh----hhhcccchhhhhhhHHH
Confidence 9999999986 4544332 35679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc-cCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||+++|+.||||.+|+++| .+|+|||+|||+++.. ..+....+.+||+.|+|||++... .|..+.|.|.+|
T Consensus 278 vsAL~YLHs~~ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~G 355 (516)
T KOG0690|consen 278 VSALGYLHSRNIVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVG 355 (516)
T ss_pred HHHhhhhhhCCeeeeechhhhheec-cCCceEeeecccchhcccccceeccccCChhhcCchhhccc-cccceeehhhhh
Confidence 9999999999999999999999999 8999999999998654 345566788999999999999988 899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|+||||++|+.||...+...+...|.. .++++ |..++++.+.|+..+|..|
T Consensus 356 VVMYEMmCGRLPFyn~dh~kLFeLIl~-----------------ed~kF------------Pr~ls~eAktLLsGLL~kd 406 (516)
T KOG0690|consen 356 VVMYEMMCGRLPFYNKDHEKLFELILM-----------------EDLKF------------PRTLSPEAKTLLSGLLKKD 406 (516)
T ss_pred HHHHHHHhccCcccccchhHHHHHHHh-----------------hhccC------------CccCCHHHHHHHHHHhhcC
Confidence 999999999999998887777766654 23333 3478999999999999999
Q ss_pred CCCCCC-----HHHHhccCchhhhhhhh
Q psy10212 413 PSSRIS-----PLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs-----~~elL~~hpwf~~~~~~ 435 (444)
|.+|.. +.|+.+ |+||..+..+
T Consensus 407 P~kRLGgGpdDakEi~~-h~FF~~v~W~ 433 (516)
T KOG0690|consen 407 PKKRLGGGPDDAKEIMR-HRFFASVDWE 433 (516)
T ss_pred hHhhcCCCchhHHHHHh-hhhhccCCHH
Confidence 999985 689999 9999987554
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.26 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=201.3
Q ss_pred hccccchhheecccceeEEEEeEec-------CCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEee
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLL-------DSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYS 86 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (444)
-..+|.+.+.||+|+||.||+|++. .++..+|+|.+... ...+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3578999999999999999999853 23457999988532 23466899999999 89999999998866
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+
T Consensus 93 ~~------------------------------------------------------------------------------ 94 (304)
T cd05101 93 DG------------------------------------------------------------------------------ 94 (304)
T ss_pred CC------------------------------------------------------------------------------
Confidence 54
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh---------
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK--------- 236 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~--------- 236 (444)
..+++|||+++ +|.+++...+.
T Consensus 95 ------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 126 (304)
T cd05101 95 ------------------------------------------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126 (304)
T ss_pred ------------------------------------------------ceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 38899999984 89888865322
Q ss_pred ---cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccccc
Q psy10212 237 ---SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYY 310 (444)
Q Consensus 237 ---~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y 310 (444)
....++...+..++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|
T Consensus 127 ~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y 205 (304)
T cd05101 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205 (304)
T ss_pred ccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCcee
Confidence 123577888999999999999999999999999999999998 788999999999876533221 1122345679
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCC
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~ 389 (444)
+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+....
T Consensus 206 ~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------------------- 256 (304)
T cd05101 206 MAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH---------------------------- 256 (304)
T ss_pred eCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------------------------
Confidence 999998776 78999999999999999998 889998776655444332210
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
....+..++..+.++|.+||..+|.+|||+.++++ -++.+-.
T Consensus 257 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~---~l~~~~~ 298 (304)
T cd05101 257 RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE---DLDRILT 298 (304)
T ss_pred cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH---HHHHHHH
Confidence 00112356899999999999999999999999998 5555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.50 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|+++++||+|+||.||+|++..+|+.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~------ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD------ 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC------
Confidence 6899999999999999999999999999999998542 235668999999999999999998887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (932)
T PRK13184 76 -------------------------------------------------------------------------------- 75 (932)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc-------CCCCChHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS-------KQNFPCFYT 246 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~-------~~~l~~~~i 246 (444)
..++|||||+| +|.+++...+.. ....+...+
T Consensus 76 ----------------------------------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~i 115 (932)
T PRK13184 76 ----------------------------------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115 (932)
T ss_pred ----------------------------------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHH
Confidence 38999999985 888888643221 234556778
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-------------------CCcccccc
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-------------------PNVSYICS 307 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-------------------~~~~~~gt 307 (444)
..++.||+.||+|||++|++||||||+||+++ ..+.++|+|||++....... ......||
T Consensus 116 L~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd-~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT 194 (932)
T PRK13184 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGT 194 (932)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCchheEEEc-CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCC
Confidence 89999999999999999999999999999999 78899999999987551110 01123589
Q ss_pred ccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 308 ~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
+.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+....... .....+ ..+ .
T Consensus 195 ~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P--~~~-----------------~ 252 (932)
T PRK13184 195 PDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSP--IEV-----------------A 252 (932)
T ss_pred CCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccCh--hhc-----------------c
Confidence 999999999877 789999999999999999999999987544332211 100000 000 0
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
. ...+++.+.+++.+||+.||++||+..+.|.
T Consensus 253 p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 253 P-----YREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred c-----cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 1246899999999999999999998776665
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.24 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=196.6
Q ss_pred cccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+|++.+.||+|+||.||+|+++.+++ .+|+|.+... ...+.+|+.++++++||||+++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----- 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----
Confidence 578999999999999999999875543 7999988532 245678999999999999999999886544
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (267)
T cd05066 79 -------------------------------------------------------------------------------- 78 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++||||+++ +|.+++.. ....++...+..++.|
T Consensus 79 -----------------------------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~ 114 (267)
T cd05066 79 -----------------------------------------PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRG 114 (267)
T ss_pred -----------------------------------------ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHH
Confidence 27899999985 88888753 3356899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc----cccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
++.||++||+++++|+||+|+||+++ .++.++|+|||.+.......... ....+..|++||.+.+. .++.++|+
T Consensus 115 i~~~l~~lH~~~i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv 192 (267)
T cd05066 115 IASGMKYLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDV 192 (267)
T ss_pred HHHHHHHHHHCCEeehhhchhcEEEC-CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhh
Confidence 99999999999999999999999998 78899999999987654332111 11224579999999876 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|++++ |..||...+..+....+.+.. ..+ .+..+++.+.+++.+
T Consensus 193 ~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~li~~ 244 (267)
T cd05066 193 WSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------------------RLP----------APMDCPAALHQLMLD 244 (267)
T ss_pred HHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC------------------cCC----------CCCCCCHHHHHHHHH
Confidence 999999999886 999998776655444433210 000 123468899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||+.+|.+||++.++++
T Consensus 245 ~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 245 CWQKDRNERPKFEQIVS 261 (267)
T ss_pred HcccCchhCCCHHHHHH
Confidence 99999999999999988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=274.13 Aligned_cols=237 Identities=24% Similarity=0.376 Sum_probs=189.7
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
++||+|+||.||+|... +++.+|+|.+.... ..+.+|+.++++++||||+++.+++...+.
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP------------- 66 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-------------
Confidence 47899999999999865 58899999885432 346689999999999999999998866543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (250)
T cd05085 67 -------------------------------------------------------------------------------- 66 (250)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
.++||||++ ++|.+++.. ....+++..+..++.|++.+|.|||
T Consensus 67 ---------------------------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH 110 (250)
T cd05085 67 ---------------------------------IYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLE 110 (250)
T ss_pred ---------------------------------cEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 789999998 488877642 3346789999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc--cccccccccCchhhccCCCCCcchhhhhHHHHHHHHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl 339 (444)
++|++|+||+|+||+++ .++.++|+|||++.......... ....+..|+|||.+.+. .++.++|+||||+++|+++
T Consensus 111 ~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~ 188 (250)
T cd05085 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETF 188 (250)
T ss_pred hCCeeecccChheEEEc-CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHh
Confidence 99999999999999998 78899999999986543222111 12235669999998776 7899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC
Q psy10212 340 L-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418 (444)
Q Consensus 340 t-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs 418 (444)
+ |..||.+.........+.... ....+..++..+.+++.+||..+|++||+
T Consensus 189 ~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 189 SLGVCPYPGMTNQQAREQVEKGY----------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 8 999998776554433332210 00112356899999999999999999999
Q ss_pred HHHHhc
Q psy10212 419 PLQVRS 424 (444)
Q Consensus 419 ~~elL~ 424 (444)
+.++++
T Consensus 241 ~~~l~~ 246 (250)
T cd05085 241 FSELQK 246 (250)
T ss_pred HHHHHH
Confidence 999987
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=281.49 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=195.5
Q ss_pred cccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.|++.+.||+|+||.||+|+++.+++ .||||.+... ...+.+|+.++++++||||+++.+++..++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---- 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP---- 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc----
Confidence 468899999999999999999987765 5999998543 2356689999999999999999988865542
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (269)
T cd05065 80 -------------------------------------------------------------------------------- 79 (269)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.++||||+++ +|.+++.. ....++...++.++.|
T Consensus 80 ------------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~ 114 (269)
T cd05065 80 ------------------------------------------VMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRG 114 (269)
T ss_pred ------------------------------------------eEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHH
Confidence 7899999985 78777753 2456899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccc---c---ccccccCchhhccCCCCCcch
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---I---CSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~---~---gt~~y~aPE~l~~~~~~s~~s 326 (444)
++.||.|||++|++|+||+|+||+++ .++.++|+|||.+............ . .+..|+|||.+.+. .++.++
T Consensus 115 l~~al~~lH~~g~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~ 192 (269)
T cd05065 115 IAAGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSAS 192 (269)
T ss_pred HHHHHHHHHHCCEeecccChheEEEc-CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccC-cccchh
Confidence 99999999999999999999999998 7889999999988654332211111 1 13469999998776 789999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||+|+++|+|++ |..||...+..+....+... ...+ .+..++..+.+++
T Consensus 193 DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------------------~~~~----------~~~~~~~~~~~li 244 (269)
T cd05065 193 DVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------------------YRLP----------PPMDCPTALHQLM 244 (269)
T ss_pred hhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------------------CcCC----------CcccCCHHHHHHH
Confidence 99999999999886 99999877655544433221 0011 1234688999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy10212 406 SRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~ 424 (444)
.+||..+|.+||++.+++.
T Consensus 245 ~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 245 LDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=284.15 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=195.3
Q ss_pred cccchhheecccceeEEEEeEecC----------------CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEe
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD----------------SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKL 80 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~ 80 (444)
++|++.++||+|+||.||+|.+.. ++..+|+|.+... ...+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 679999999999999999986542 3446999998543 2456789999999999999999
Q ss_pred eeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 81 KYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
++++...+.
T Consensus 85 ~~~~~~~~~----------------------------------------------------------------------- 93 (296)
T cd05095 85 LAVCITSDP----------------------------------------------------------------------- 93 (296)
T ss_pred EEEEecCCc-----------------------------------------------------------------------
Confidence 998866543
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc--
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS-- 237 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-- 237 (444)
.+++|||++ ++|.+++......
T Consensus 94 -------------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~ 118 (296)
T cd05095 94 -------------------------------------------------------LCMITEYMENGDLNQFLSRHEPQEA 118 (296)
T ss_pred -------------------------------------------------------cEEEEEeCCCCcHHHHHHhcCcccc
Confidence 789999998 5898888643221
Q ss_pred -----CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccccccc
Q psy10212 238 -----KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRY 309 (444)
Q Consensus 238 -----~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~ 309 (444)
...+++..+..++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+........ ......+..
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 197 (296)
T cd05095 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197 (296)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccc
Confidence 12467788999999999999999999999999999999998 788999999999865433221 111233567
Q ss_pred ccCchhhccCCCCCcchhhhhHHHHHHHHHh--CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLL--GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 310 y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt--G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
|++||...+. .++.++|+|||||++|+|++ |..||...+..+.......... . .......
T Consensus 198 ~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~--------~---~~~~~~~------ 259 (296)
T cd05095 198 WMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR--------D---QGRQVYL------ 259 (296)
T ss_pred cCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh--------h---ccccccC------
Confidence 9999988776 78999999999999999998 7789987666554433222100 0 0000000
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
..+..+++.+.+|+.+||+.||.+||++.++++
T Consensus 260 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 260 ----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 112346899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=277.68 Aligned_cols=240 Identities=26% Similarity=0.401 Sum_probs=194.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.|++.+.||+|+||.||++.. +++.+|+|.+... ...+.+|+.++++++||||+++.+++...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----------- 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG----------- 72 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-----------
Confidence 5689999999999999999975 7889999998543 345678999999999999999988775432
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (254)
T cd05083 73 -------------------------------------------------------------------------------- 72 (254)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+++|||+. ++|.+++.. .....+++..++.++.|++.||.
T Consensus 73 ------------------------------------~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~ 114 (254)
T cd05083 73 ------------------------------------LYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGME 114 (254)
T ss_pred ------------------------------------cEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHH
Confidence 679999998 499998853 23346889999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
|||++|++|+||+|+||+++ .++.++|+|||.+...... ......+..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 115 ~lH~~~~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el 190 (254)
T cd05083 115 YLESKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEV 190 (254)
T ss_pred HHHhCCeeccccCcceEEEc-CCCcEEECCCccceecccc--CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHH
Confidence 99999999999999999998 7889999999998654222 1222335679999998776 789999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |+.||...+..+....+.+. . ....+..+++.+.+++.+||+.+|.+||
T Consensus 191 ~~~g~~p~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 242 (254)
T cd05083 191 FSYGRAPYPKMSLKEVKECVEKG------------------Y----------RMEPPEGCPADVYVLMTSCWETEPKKRP 242 (254)
T ss_pred HhCCCCCCccCCHHHHHHHHhCC------------------C----------CCCCCCcCCHHHHHHHHHHcCCChhhCc
Confidence 97 99999877654433322210 0 0011234689999999999999999999
Q ss_pred CHHHHhc
Q psy10212 418 SPLQVRS 424 (444)
Q Consensus 418 s~~elL~ 424 (444)
++.+++.
T Consensus 243 ~~~~l~~ 249 (254)
T cd05083 243 SFHKLRE 249 (254)
T ss_pred CHHHHHH
Confidence 9999987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.02 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=194.6
Q ss_pred cccchhheecccceeEEEEeEe----cCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKL----LDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..|++++.||+|+||.||+++. ..+++.||+|.+... ...+.+|+.+++++.||||+++.+++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG--- 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---
Confidence 4579999999999999999984 456889999998533 2456789999999999999999988866532
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (284)
T cd05079 81 -------------------------------------------------------------------------------- 80 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
...++||||++ ++|.+++.. ....+++..+..++.
T Consensus 81 -----------------------------------------~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~ 116 (284)
T cd05079 81 -----------------------------------------NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAV 116 (284)
T ss_pred -----------------------------------------CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHH
Confidence 24789999997 588888742 234689999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||+|||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|
T Consensus 117 ~i~~aL~~lH~~gi~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~D 194 (284)
T cd05079 117 QICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASD 194 (284)
T ss_pred HHHHHHHHHHHCCeeecccchheEEEc-CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCcccc
Confidence 999999999999999999999999998 788999999999876533221 1123456679999998776 7889999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh-CCCC-HHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL-GTPT-REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~-g~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+||||+++|+|+++..|..... ....+..... +... ...+...... .....+..++..+.+||
T Consensus 195 i~slG~il~ellt~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li 259 (284)
T cd05079 195 VWSFGVTLYELLTYCDSESSPM--TLFLKMIGPTHGQMTVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLM 259 (284)
T ss_pred chhhhhhhhhhhcCCCCCcccc--chhhhhcccccccccHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHH
Confidence 9999999999999876643211 1111000000 0000 0000000000 00011235689999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+||+.||.+|||+.++++ .|++
T Consensus 260 ~~~l~~~p~~Rpt~~~il~---~l~~ 282 (284)
T cd05079 260 RKCWEFQPSKRTTFQNLIE---GFEA 282 (284)
T ss_pred HHHccCCcccCcCHHHHHH---HHHh
Confidence 9999999999999999998 5544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=275.38 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=195.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+|++.+.||+|+||.||+|.+.. ++.+|+|.+... ...+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---------- 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS---------- 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC----------
Confidence 478899999999999999999864 778999988543 346778999999999999999988876553
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (256)
T cd05112 73 -------------------------------------------------------------------------------- 72 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++||||+++ +|.+++. .....+++..++.++.|++.+|
T Consensus 73 ------------------------------------~~~~v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l 113 (256)
T cd05112 73 ------------------------------------PICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGM 113 (256)
T ss_pred ------------------------------------ceEEEEEcCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHH
Confidence 37899999985 7777764 2335688999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
++||+++++|+||+|+||+++ .++.++|+|||.+......... .....+..|+|||.+.+. .++.++|+||||+++
T Consensus 114 ~~lH~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l 191 (256)
T cd05112 114 AYLESSNVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLM 191 (256)
T ss_pred HHHHHCCccccccccceEEEc-CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHH
Confidence 999999999999999999998 7889999999988654332211 112335679999998876 788999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |..||......+....+.+.. ....+...+..+.+|+.+||+.+|+
T Consensus 192 ~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~~l~~~p~ 243 (256)
T cd05112 192 WEVFSEGKTPYENRSNSEVVETINAGF----------------------------RLYKPRLASQSVYELMQHCWKERPE 243 (256)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHcccChh
Confidence 99998 999998776655444432210 0001123578999999999999999
Q ss_pred CCCCHHHHhc
Q psy10212 415 SRISPLQVRS 424 (444)
Q Consensus 415 kRPs~~elL~ 424 (444)
+|||+.++++
T Consensus 244 ~Rp~~~~~l~ 253 (256)
T cd05112 244 DRPSFSLLLH 253 (256)
T ss_pred hCCCHHHHHH
Confidence 9999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.59 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=201.1
Q ss_pred ccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
.|++.+.||+|+||.||+|++. .+|+.||+|.+... .+.+.+|+++++++ +|++|+++.+.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-- 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence 4789999999999999999985 47899999998532 23456799999999 5899999987776543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (290)
T cd05613 79 -------------------------------------------------------------------------------- 78 (290)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+++||||+++ +|.+++.. ..++++..+..+
T Consensus 79 --------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~ 110 (290)
T cd05613 79 --------------------------------------------KLHLILDYINGGELFTHLSQ----RERFKEQEVQIY 110 (290)
T ss_pred --------------------------------------------eEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHH
Confidence 38899999995 88888753 356889999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccC-CCCCcch
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGA-IDYTTKI 326 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~-~~~s~~s 326 (444)
+.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. ..++.++
T Consensus 111 ~~qi~~al~~lH~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 189 (290)
T cd05613 111 SGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV 189 (290)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHeEEC-CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccc
Confidence 99999999999999999999999999999 788999999999866533221 1234578889999998653 2467899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||+|+++|+|++|..||...........+.+..... ...++..+++.+.+++.
T Consensus 190 Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~ll~ 244 (290)
T cd05613 190 DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------------------------EPPYPQEMSALAKDIIQ 244 (290)
T ss_pred cHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------------------------CCCCCccCCHHHHHHHH
Confidence 99999999999999999997543332222222211000 00122346889999999
Q ss_pred HhcccCCCCCC-----CHHHHhccCchhhhhhh
Q psy10212 407 RLLEYTPSSRI-----SPLQVRSITPFLIELRA 434 (444)
Q Consensus 407 ~~L~~DP~kRP-----s~~elL~~hpwf~~~~~ 434 (444)
+||+.||++|| ++.++++ ||||+....
T Consensus 245 ~~l~~~p~~R~~~~~~~~~~l~~-~~~~~~~~~ 276 (290)
T cd05613 245 RLLMKDPKKRLGCGPSDADEIKK-HPFFQKINW 276 (290)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHc-CcccccCCH
Confidence 99999999997 8899999 999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.06 Aligned_cols=297 Identities=30% Similarity=0.512 Sum_probs=235.1
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
-+.+..+.|+-+.++|+|.||.||+|+.+.+|+.||+|++.-+ ..+..+|+++|..|.|+|++.+++.+-....
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 3556778999999999999999999999999999999987432 2455699999999999999987665543321
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (376)
T KOG0669|consen 91 -------------------------------------------------------------------------------- 90 (376)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
|.++ +...+|+||++|+-.|.-++. +...+++..+++.+
T Consensus 91 -----------------------------------p~~r---~r~t~ylVf~~cehDLaGlLs---n~~vr~sls~Ikk~ 129 (376)
T KOG0669|consen 91 -----------------------------------PTNR---DRATFYLVFDFCEHDLAGLLS---NRKVRFSLSEIKKV 129 (376)
T ss_pred -----------------------------------Cccc---ccceeeeeHHHhhhhHHHHhc---CccccccHHHHHHH
Confidence 1111 124599999999998888764 45578999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-----ccccccccccCchhhccCCCCCc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-----VSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
+.+++.||.|+|+..++|||+|+.|++++ .++.++|.|||+++.+...... +....|.+|.+||.+.|...+++
T Consensus 130 Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt-~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~ 208 (376)
T KOG0669|consen 130 MKGLMNGLYYIHRNKILHRDMKAANVLIT-KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGP 208 (376)
T ss_pred HHHHHHHHHHHHHhhHHhhcccHhhEEEc-CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCC
Confidence 99999999999999999999999999999 7899999999999766443322 22345899999999999889999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCccc---CCCccCCCCcccccCC-CC
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK---FPQIKSHPWSKVFRVR-TP 398 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~---~p~~~~~~~~~~~~~~-~s 398 (444)
+.|+|+.||++.+|+++.+.+++.+...++..|...+|.-.++-|++.. +-+..+. +|.-........+.+- -+
T Consensus 209 ~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd 288 (376)
T KOG0669|consen 209 PIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKD 288 (376)
T ss_pred cchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCC
Confidence 9999999999999999999999999999999999999998877776532 1111121 1111111111111111 25
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
++..+|+++||..||.+|+.+.++|. |.||..=...
T Consensus 289 ~~a~dLle~ll~~DP~kR~~ad~aln-h~~F~kdp~p 324 (376)
T KOG0669|consen 289 DEALDLLEKLLKLDPTKRIDADQALN-HDFFWKDPMP 324 (376)
T ss_pred hhHHHHHHHHhccCcccCcchHhhhc-hhhhhcCCcc
Confidence 78999999999999999999999999 9999764433
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.85 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=192.4
Q ss_pred cccchhheecccceeEEEEeEe-----cCCCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||.||+|++ ..+++.||||.+..+. ..+.+|+.++.++ +|+||+++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC-
Confidence 6899999999999999999985 3467899999985422 3456899999999 78999999988765432
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (343)
T cd05103 86 -------------------------------------------------------------------------------- 85 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh-------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------- 236 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------- 236 (444)
..+++||||+ ++|.+++.....
T Consensus 86 --------------------------------------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~ 121 (343)
T cd05103 86 --------------------------------------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFR 121 (343)
T ss_pred --------------------------------------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccc
Confidence 3789999998 488888753210
Q ss_pred --------------------------------------------------cCCCCChHHHHHHHHHHHHHHHHHHHCCcc
Q psy10212 237 --------------------------------------------------SKQNFPCFYTKLYIYQLFRSLAYIHVLGIC 266 (444)
Q Consensus 237 --------------------------------------------------~~~~l~~~~i~~i~~QIl~aL~yLHs~giv 266 (444)
....++...+..++.||+.||+|||++|++
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~ 201 (343)
T cd05103 122 QGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCI 201 (343)
T ss_pred cccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 012467778899999999999999999999
Q ss_pred cCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CC
Q psy10212 267 HRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQ 342 (444)
Q Consensus 267 H~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~ 342 (444)
|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |.
T Consensus 202 H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~ 279 (343)
T cd05103 202 HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGA 279 (343)
T ss_pred cCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999999 788999999999865432211 1112335679999998776 78999999999999999996 99
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHH
Q psy10212 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422 (444)
Q Consensus 343 ~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~el 422 (444)
.||............... + ... ..+..+++.+.+++..||+.||.+|||+.++
T Consensus 280 ~p~~~~~~~~~~~~~~~~-~--------------~~~------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 280 SPYPGVKIDEEFCRRLKE-G--------------TRM------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred CCCCCccccHHHHHHHhc-c--------------CCC------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999875433322222110 0 000 0112357899999999999999999999999
Q ss_pred hc
Q psy10212 423 RS 424 (444)
Q Consensus 423 L~ 424 (444)
++
T Consensus 333 l~ 334 (343)
T cd05103 333 VE 334 (343)
T ss_pred HH
Confidence 98
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.94 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=222.3
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
..+.-...|.+++.||+|.|+.|.+|++..++..||||.|.+.. ....+|+++|+.|+|||||+++.++....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~- 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA- 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-
Confidence 44556788999999999999999999999999999999995542 33568999999999999999999888765
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 129 -------------------------------------------------------------------------------- 128 (596)
T KOG0586|consen 129 -------------------------------------------------------------------------------- 128 (596)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+|+||||+.+ .+.+++. ..++..+.+++.
T Consensus 129 ---------------------------------------------~lylV~eya~~ge~~~yl~----~~gr~~e~~ar~ 159 (596)
T KOG0586|consen 129 ---------------------------------------------TLYLVMEYASGGELFDYLV----KHGRMKEKEARA 159 (596)
T ss_pred ---------------------------------------------eeEEEEEeccCchhHHHHH----hcccchhhhhhh
Confidence 39999999985 7888875 456777799999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
++.|+..|++|||+++|+|||||++||+++ .+-++||+|||++..+.......+.+|++.|.|||++.+.....+..|+
T Consensus 160 ~F~q~vsaveYcH~k~ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~ 238 (596)
T KOG0586|consen 160 KFRQIVSAVEYCHSKNIVHRDLKAENILLD-ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDI 238 (596)
T ss_pred hhHHHHHHHHHHhhcceeccccchhhcccc-cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceeh
Confidence 999999999999999999999999999999 7778999999999998888888889999999999999998777899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+|+++|-|+.|.+||.+.+-.+.-.+.+. .++++|. -++.++.++|.++
T Consensus 239 Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----------------gk~rIp~------------~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 239 WSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----------------GKYRIPF------------YMSCDCEDLLRKF 289 (596)
T ss_pred hhhhhhheeeeecccccCCcccccccchhee-----------------eeecccc------------eeechhHHHHHHh
Confidence 9999999999999999998654332222111 1122221 3588999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.++|.+|++..++.+ |.|+-...+.
T Consensus 290 lvl~Pskr~~~dqim~-~~W~n~~~~~ 315 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMK-DRWRNDLLEA 315 (596)
T ss_pred hccCccccCCHHHhhh-hcccchhhhh
Confidence 9999999999999999 9999887766
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=297.11 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=197.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
..|+++++||.||.+.||+|..-+ .+.||+|++... -.-|.+|+..|.+| .|.+|+++++|-.-+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d------- 432 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD------- 432 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-------
Confidence 789999999999999999999743 567777776322 34566999999999 589999999887664
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 433 -------------------------------------------------------------------------------- 432 (677)
T KOG0596|consen 433 -------------------------------------------------------------------------------- 432 (677)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.++|+|||+=+-.|..++.. .......-+++.+..|||
T Consensus 433 ---------------------------------------~~lYmvmE~Gd~DL~kiL~k---~~~~~~~~~lk~ywkqML 470 (677)
T KOG0596|consen 433 ---------------------------------------GYLYMVMECGDIDLNKILKK---KKSIDPDWFLKFYWKQML 470 (677)
T ss_pred ---------------------------------------ceEEEEeecccccHHHHHHh---ccCCCchHHHHHHHHHHH
Confidence 36999999999999999863 334445459999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC----------CC
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA----------ID 321 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~----------~~ 321 (444)
+|+.++|.+||+|.||||.|+++- .|.+||+|||++..+..... .....||+.||+||.+... ..
T Consensus 471 ~aV~~IH~~gIVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~K 548 (677)
T KOG0596|consen 471 LAVKTIHQHGIVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIK 548 (677)
T ss_pred HHHHHHHHhceeecCCCcccEEEE--eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCccee
Confidence 999999999999999999999996 78999999999988755432 3345899999999998432 13
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
.++++||||||||+|+|+.|+.||.... ...+++.. +..|. ..+.+|.... ..++
T Consensus 549 i~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a-I~~P~-----------~~Iefp~~~~-----------~~~l 603 (677)
T KOG0596|consen 549 ISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA-ITDPN-----------HEIEFPDIPE-----------NDEL 603 (677)
T ss_pred ecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh-hcCCC-----------ccccccCCCC-----------chHH
Confidence 6789999999999999999999996432 11222111 11110 1223333221 2349
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.++++.||..||.+|||+.+||. |||++-
T Consensus 604 i~~mK~CL~rdPkkR~si~eLLq-hpFl~~ 632 (677)
T KOG0596|consen 604 IDVMKCCLARDPKKRWSIPELLQ-HPFLQI 632 (677)
T ss_pred HHHHHHHHhcCcccCCCcHHHhc-Cccccc
Confidence 99999999999999999999999 999876
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=308.59 Aligned_cols=249 Identities=29% Similarity=0.468 Sum_probs=204.3
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCcccc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDM 103 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (444)
=+||+|.||+||-|+|.++...+|||.+..+. .-...|+.+-++|+|.|||+|++++-..
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen---------------- 644 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN---------------- 644 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC----------------
Confidence 47999999999999999999999999995543 3344799999999999999999886443
Q ss_pred ccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcc
Q psy10212 104 KISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 183 (444)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (444)
T Consensus 645 -------------------------------------------------------------------------------- 644 (1226)
T KOG4279|consen 645 -------------------------------------------------------------------------------- 644 (1226)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCC--ChHHHHHHHHHHHHHHHHH
Q psy10212 184 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNF--PCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l--~~~~i~~i~~QIl~aL~yL 260 (444)
.|+-|.||-++| ||.++++ ...+++ .+.++..+.+||++||.||
T Consensus 645 ------------------------------Gf~kIFMEqVPGGSLSsLLr---skWGPlKDNEstm~fYtkQILeGLkYL 691 (1226)
T KOG4279|consen 645 ------------------------------GFFKIFMEQVPGGSLSSLLR---SKWGPLKDNESTMNFYTKQILEGLKYL 691 (1226)
T ss_pred ------------------------------CeEEEEeecCCCCcHHHHHH---hccCCCccchhHHHHHHHHHHHHhhhh
Confidence 368899999996 7777765 455777 7899999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhcc-CCCCCcchhhhhHHHHHHHH
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFG-AIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~s~~sDiwSLGvil~eL 338 (444)
|+..|+|||||.+|++++.-.|.+||+|||.+++...-.+ ..+..||..|||||++.. ...|..++|||||||++.||
T Consensus 692 Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM 771 (1226)
T KOG4279|consen 692 HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM 771 (1226)
T ss_pred hhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence 9999999999999999997789999999999988765443 345689999999999954 34699999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC
Q psy10212 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418 (444)
Q Consensus 339 ltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs 418 (444)
.||++||.......-. ++++- | -...| .+|..++.+++.||.+|+.+||.+||+
T Consensus 772 ATGrPPF~ElgspqAA--MFkVG-------m--------yKvHP---------~iPeelsaeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 772 ATGRPPFVELGSPQAA--MFKVG-------M--------YKVHP---------PIPEELSAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred ccCCCCeeecCChhHh--hhhhc-------c--------eecCC---------CCcHHHHHHHHHHHHHHcCCCcccCcc
Confidence 9999999765433221 22210 0 00111 123456899999999999999999999
Q ss_pred HHHHhccCchhhhh
Q psy10212 419 PLQVRSITPFLIEL 432 (444)
Q Consensus 419 ~~elL~~hpwf~~~ 432 (444)
|.++|. .||++.-
T Consensus 826 A~~LL~-DpFlq~~ 838 (1226)
T KOG4279|consen 826 AKDLLQ-DPFLQHN 838 (1226)
T ss_pred HHHhcc-CcccccC
Confidence 999999 9999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.36 Aligned_cols=156 Identities=26% Similarity=0.398 Sum_probs=123.9
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhh
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELI 316 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l 316 (444)
.++...+..++.||+.||+|||+.+++|+||+|+||+++ ..+.++|+|||++....... ......++..|+|||.+
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 356677889999999999999999999999999999999 78899999999987543221 11223457789999999
Q ss_pred ccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 317 FGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 317 ~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
.+. .++.++|+||||+++|+|++ |..||......+.....+.. + +....+.
T Consensus 314 ~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~--------------------------~~~~~p~ 365 (401)
T cd05107 314 FNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-G--------------------------YRMAKPA 365 (401)
T ss_pred cCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-C--------------------------CCCCCCC
Confidence 876 78999999999999999998 89999876555544333321 0 0001123
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.++..+.++|.+||..+|.+||++.++++
T Consensus 366 ~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 366 HASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 56899999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=277.36 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=196.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+... ...+.+|+.++++++|+||+++.+++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-------- 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-------- 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C--------
Confidence 4578999999999999999999865 4667999988543 2456689999999999999999887755 2
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (260)
T cd05073 74 -------------------------------------------------------------------------------- 73 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..+++|||++ ++|.+++.. .....+++..+..++.|++.
T Consensus 74 --------------------------------------~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~ 113 (260)
T cd05073 74 --------------------------------------PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAE 113 (260)
T ss_pred --------------------------------------CeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHH
Confidence 2789999998 599998853 23456788899999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||++|++|+||+|+||+++ ..+.++|+|||.+......... ....++..|+|||.+.+. .++.++|+||||+
T Consensus 114 aL~~lH~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~ 191 (260)
T cd05073 114 GMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGI 191 (260)
T ss_pred HHHHHHhCCccccccCcceEEEc-CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccC-CcCccccchHHHH
Confidence 99999999999999999999998 7889999999988655332211 122345679999999776 7899999999999
Q ss_pred HHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 334 VLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 334 il~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
++|++++ |..||.+.+..+....+.... .. ..+...+..+.+++.+||+.|
T Consensus 192 ~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~~i~~~l~~~ 243 (260)
T cd05073 192 LLMEIVTYGRIPYPGMSNPEVIRALERGY------------------RM----------PRPENCPEELYNIMMRCWKNR 243 (260)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHhCCC------------------CC----------CCcccCCHHHHHHHHHHcccC
Confidence 9999998 999998776655443332210 00 011245889999999999999
Q ss_pred CCCCCCHHHHhc
Q psy10212 413 PSSRISPLQVRS 424 (444)
Q Consensus 413 P~kRPs~~elL~ 424 (444)
|++||++.++++
T Consensus 244 p~~Rp~~~~l~~ 255 (260)
T cd05073 244 PEERPTFEYIQS 255 (260)
T ss_pred cccCcCHHHHHH
Confidence 999999999887
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=274.50 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=190.1
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccc
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLED 102 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (444)
++||+|+||.||+|.+.. ++.||+|.+... ...+.+|++++++++|+||+++.+++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP------------- 66 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC-------------
Confidence 479999999999999987 999999988532 2456689999999999999999988876543
Q ss_pred cccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCc
Q psy10212 103 MKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 182 (444)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (251)
T cd05041 67 -------------------------------------------------------------------------------- 66 (251)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 183 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
.++||||++ ++|.+++.. ....++...+..++.|++.+|.|||
T Consensus 67 ---------------------------------~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH 110 (251)
T cd05041 67 ---------------------------------IYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE 110 (251)
T ss_pred ---------------------------------eEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 889999997 578888753 3446889999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
+++++|+||+|+||+++ .++.++|+|||.+......... .....+..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 111 ~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l 188 (251)
T cd05041 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWET 188 (251)
T ss_pred hCCEehhhcCcceEEEc-CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHH
Confidence 99999999999999999 7889999999998654321111 111224569999998777 789999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |..||...........+.... . ...+..++..+.+++.+||+.+|.+||
T Consensus 189 ~t~~~~p~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 189 FSLGDTPYPGMSNQQTRERIESGY----------------R------------MPAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred HhccCCCCccCCHHHHHHHHhcCC----------------C------------CCCCccCCHHHHHHHHHHhccChhhCc
Confidence 98 889998776544333222100 0 011234588999999999999999999
Q ss_pred CHHHHhc
Q psy10212 418 SPLQVRS 424 (444)
Q Consensus 418 s~~elL~ 424 (444)
|+.|+++
T Consensus 241 ~~~ell~ 247 (251)
T cd05041 241 SFSEIYN 247 (251)
T ss_pred CHHHHHH
Confidence 9999998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=286.71 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=200.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCC-------Cceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEE
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDS-------GELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFF 84 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (444)
+-...+|.+.+.||+|+||.||+|++... +..+|+|.+... ...+.+|+.+++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 33446899999999999999999987432 236899988542 23566899999999 899999999988
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
...+.
T Consensus 88 ~~~~~--------------------------------------------------------------------------- 92 (334)
T cd05100 88 TQDGP--------------------------------------------------------------------------- 92 (334)
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 76543
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-------
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK------- 236 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~------- 236 (444)
.+++|||+++ +|.+++.....
T Consensus 93 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 121 (334)
T cd05100 93 ---------------------------------------------------LYVLVEYASKGNLREYLRARRPPGMDYSF 121 (334)
T ss_pred ---------------------------------------------------eEEEEecCCCCcHHHHHHhcCCccccccc
Confidence 8899999985 89998864321
Q ss_pred -----cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccc
Q psy10212 237 -----SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSR 308 (444)
Q Consensus 237 -----~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~ 308 (444)
....++...+..++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||+++....... .....++.
T Consensus 122 ~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 200 (334)
T cd05100 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200 (334)
T ss_pred ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCc
Confidence 223477888999999999999999999999999999999998 788999999999865433211 11122346
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+....
T Consensus 201 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------------- 253 (334)
T cd05100 201 KWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------------------------- 253 (334)
T ss_pred eEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 79999999876 78999999999999999998 899998776655444332210
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
....+..++..+.++|.+||+.+|.+|||+.++++ -++.+.
T Consensus 254 --~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~---~l~~~~ 294 (334)
T cd05100 254 --RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE---DLDRVL 294 (334)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH---HHHHHh
Confidence 00112346889999999999999999999999999 456554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=276.37 Aligned_cols=241 Identities=23% Similarity=0.336 Sum_probs=190.8
Q ss_pred heecccceeEEEEeEecCCC------ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSG------ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+.||+|+||.||+|+++... +.+|||.+... ...+.+|+.++++++||||+++.+++...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-------- 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--------
Confidence 46899999999999986544 68999988432 345668999999999999999998886554
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (269)
T cd05044 73 -------------------------------------------------------------------------------- 72 (269)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh---cCCCCChHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK---SKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~---~~~~l~~~~i~~i~~Q 252 (444)
..++||||++ ++|.+++..... ....+++..+..++.|
T Consensus 73 --------------------------------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 114 (269)
T cd05044 73 --------------------------------------PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114 (269)
T ss_pred --------------------------------------CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHH
Confidence 2889999998 589988864332 2345788999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCC-----eEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCc
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETG-----VLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~-----~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
++.||.|||+++++|+||+|+||+++ ..+ .++|+|||++........ ......+..|+|||.+.+. .++.
T Consensus 115 l~~~l~~lH~~~i~H~dl~p~nil~~-~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 192 (269)
T cd05044 115 VAKGCVYLEQMHFIHRDLAARNCLVS-EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTT 192 (269)
T ss_pred HHHHHHHHHhCCcccCCCChheEEEe-cCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-Cccc
Confidence 99999999999999999999999998 445 899999999865432221 1122346789999999877 7899
Q ss_pred chhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 325 KIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 325 ~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
++|+||||+++|+|++ |+.||...+..+....+.... ....+..+|..+.+
T Consensus 193 ~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~ 244 (269)
T cd05044 193 QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----------------------------RLQKPENCPDKIYQ 244 (269)
T ss_pred chhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----------------------------ccCCcccchHHHHH
Confidence 9999999999999998 999998776655444332100 00112346889999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy10212 404 LISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~ 424 (444)
+|.+||..+|.+||++.++++
T Consensus 245 li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 245 LMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999987
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=276.58 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=210.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecccc-----chhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR-----FKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
|+.+.++.||.|+-|.||+++.+.+|...|||.+....+ .+..+++++.+.+ +|.||+.+++|+.+.+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d------ 165 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD------ 165 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch------
Confidence 566789999999999999999999999999999954432 2234666666554 8999999999998765
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 166 -------------------------------------------------------------------------------- 165 (391)
T KOG0983|consen 166 -------------------------------------------------------------------------------- 165 (391)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+|-||+|+-=+..+++ ...+++++..+-.+...++.
T Consensus 166 ----------------------------------------V~IcMelMs~C~ekLlk---rik~piPE~ilGk~tva~v~ 202 (391)
T KOG0983|consen 166 ----------------------------------------VFICMELMSTCAEKLLK---RIKGPIPERILGKMTVAIVK 202 (391)
T ss_pred ----------------------------------------HHHHHHHHHHHHHHHHH---HhcCCchHHhhhhhHHHHHH
Confidence 66889999865555554 24578999999999999999
Q ss_pred HHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhhhhHH
Q psy10212 256 SLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDiwSLG 332 (444)
||.||-+ +|++|||+||+|||+| +.|++||+|||++-+..++...+...|.+.|||||.+.- ...|..++|+||||
T Consensus 203 AL~YLKeKH~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlG 281 (391)
T KOG0983|consen 203 ALYYLKEKHGVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLG 281 (391)
T ss_pred HHHHHHHhcceeecccCccceEEc-cCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhc
Confidence 9999986 5899999999999999 899999999999998888888888899999999999843 34688999999999
Q ss_pred HHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
++++||.||+.||.+. .+-+.+.++.+.. |+ . +.. ....|+++++|+..||+.
T Consensus 282 ITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP-----------------~-----L~~--~~gFSp~F~~fv~~CL~k 335 (391)
T KOG0983|consen 282 ITLVELATGQYPYKGCKTDFEVLTKVLNEE--PP-----------------L-----LPG--HMGFSPDFQSFVKDCLTK 335 (391)
T ss_pred cchhhhhcccCCCCCCCccHHHHHHHHhcC--CC-----------------C-----CCc--ccCcCHHHHHHHHHHhhc
Confidence 9999999999999985 4557777776621 11 0 000 123599999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~ 432 (444)
|+.+||...++|+ |||++.+
T Consensus 336 d~r~RP~Y~~Ll~-h~Fi~~y 355 (391)
T KOG0983|consen 336 DHRKRPKYNKLLE-HPFIKRY 355 (391)
T ss_pred CcccCcchHHHhc-Ccceeec
Confidence 9999999999999 9966654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=281.68 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=196.3
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++.+.||+|+||.||+|++..+|+ .+|+|.+.... ..+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~---- 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT---- 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC----
Confidence 678899999999999999999987776 46888875432 24668999999999999999998876432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (303)
T cd05110 83 -------------------------------------------------------------------------------- 82 (303)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.++++||++ ++|.+++.. ....+++..++.++.
T Consensus 83 -------------------------------------------~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~ 116 (303)
T cd05110 83 -------------------------------------------IQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCV 116 (303)
T ss_pred -------------------------------------------ceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHH
Confidence 458899998 588888752 344688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|++.||+|||+++++|+||+|+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++|+
T Consensus 117 qi~~~L~~LH~~~ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di 194 (303)
T cd05110 117 QIAKGMMYLEERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDV 194 (303)
T ss_pred HHHHHHHHHhhcCeeccccccceeeec-CCCceEEccccccccccCcccccccCCCccccccCCHHHhccC-CCChHHHH
Confidence 999999999999999999999999998 6789999999999765332211 122346689999998776 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |..||.+....+.. ++.... ...+ .+..++.++.+++.+
T Consensus 195 wslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~-----------------~~~~----------~~~~~~~~~~~li~~ 246 (303)
T cd05110 195 WSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKG-----------------ERLP----------QPPICTIDVYMVMVK 246 (303)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCC-----------------CCCC----------CCCCCCHHHHHHHHH
Confidence 999999999997 99999876543322 222210 0000 113457899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||..||++||++.++++ -|+.+.
T Consensus 247 c~~~~p~~Rp~~~~l~~---~l~~~~ 269 (303)
T cd05110 247 CWMIDADSRPKFKELAA---EFSRMA 269 (303)
T ss_pred HcCCChhhCcCHHHHHH---HHHHHH
Confidence 99999999999999988 455543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.74 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=215.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.|.+-++||+||||.||-++.+.||+.||.|++.+++ ....+|-++|.+++.+.||.+-+.|...+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~---- 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA---- 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----
Confidence 477899999999999999999999999999999985442 334479999999999999999888887765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 260 -------------------------------------------------------------------------------- 259 (591)
T KOG0986|consen 260 -------------------------------------------------------------------------------- 259 (591)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
+++||.+|.| .|.-.|- ......+++..+..++.+
T Consensus 260 ------------------------------------------LClVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAE 295 (591)
T KOG0986|consen 260 ------------------------------------------LCLVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAE 295 (591)
T ss_pred ------------------------------------------eEEEEEeecCCceeEEee--ccCCCCCchHHHHHHHHH
Confidence 9999999997 4443332 234457999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||++||+.+|+.||+||+|||+| +.|+++|+|+|++..+..+.......||.+|||||++... .|+.+.|.||||
T Consensus 296 i~cGLehlH~~~iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lG 373 (591)
T KOG0986|consen 296 IICGLEHLHRRRIVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLG 373 (591)
T ss_pred HHhhHHHHHhcceeeccCChhheeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCC-cccCCccHHHHH
Confidence 99999999999999999999999999 9999999999999999888888888999999999999988 699999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|+.|+.||........-..+-+... . -...++...|+++++|++.+|..|
T Consensus 374 CllYemi~G~sPFr~~KeKvk~eEvdrr~~-~------------------------~~~ey~~kFS~eakslc~~LL~Kd 428 (591)
T KOG0986|consen 374 CLLYEMIAGHSPFRQRKEKVKREEVDRRTL-E------------------------DPEEYSDKFSEEAKSLCEGLLTKD 428 (591)
T ss_pred hHHHHHHcccCchhhhhhhhhHHHHHHHHh-c------------------------chhhcccccCHHHHHHHHHHHccC
Confidence 999999999999975432211111111100 0 011233456999999999999999
Q ss_pred CCCCCC-----HHHHhccCchhhhhhhhh
Q psy10212 413 PSSRIS-----PLQVRSITPFLIELRAVF 436 (444)
Q Consensus 413 P~kRPs-----~~elL~~hpwf~~~~~~~ 436 (444)
|++|.. ++++-+ ||||+++....
T Consensus 429 p~~RLGcrg~ga~evk~-HpfFk~lnw~r 456 (591)
T KOG0986|consen 429 PEKRLGCRGEGAQEVKE-HPFFKDLNWRR 456 (591)
T ss_pred HHHhccCCCcCcchhhh-CcccccCCHhH
Confidence 999976 568888 99999976543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=277.97 Aligned_cols=235 Identities=19% Similarity=0.243 Sum_probs=183.3
Q ss_pred heecccceeEEEEeEecCCCc-------eeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGE-------LVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~-------~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+.||+|+||+||+|.+...+. .+|+|.+.... +.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~------- 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE------- 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-------
Confidence 469999999999999865544 48999875432 455679999999999999999999877543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (258)
T cd05078 74 -------------------------------------------------------------------------------- 73 (258)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++|||||++ +|.+++.. ....+++..++.++.||+.
T Consensus 74 ---------------------------------------~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~ 111 (258)
T cd05078 74 ---------------------------------------SIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAW 111 (258)
T ss_pred ---------------------------------------cEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHH
Confidence 7899999985 78888753 2346889999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCC-------eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETG-------VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~-------~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+|||++|++|+||+|+||+++.+.. .++++|||.+..... .....++..|+|||.+.+...++.++|+
T Consensus 112 ~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (258)
T cd05078 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADK 188 (258)
T ss_pred HHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhH
Confidence 999999999999999999999973322 379999998865422 2234567889999999775467899999
Q ss_pred hhHHHHHHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++| ..|+...+...... .... . ..++...+.++.++|.+
T Consensus 189 wslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-----------------~------------~~~~~~~~~~~~~li~~ 238 (258)
T cd05078 189 WSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-----------------R------------HQLPAPKWTELANLINQ 238 (258)
T ss_pred HHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-----------------c------------ccCCCCCcHHHHHHHHH
Confidence 9999999999998 46666544433221 1110 0 01122346789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||+.||++|||+.++++
T Consensus 239 ~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 239 CMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HhccChhhCCCHHHHHH
Confidence 99999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=279.78 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=197.8
Q ss_pred ccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
+|++.+.||+|++|.||++++. .+++.||+|.+... ...+.+|+++++++ +||||+++.+.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-- 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-- 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence 4789999999999999999864 46789999988532 13355799999999 6999999987775543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (288)
T cd05583 79 -------------------------------------------------------------------------------- 78 (288)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..++||||+++ +|.+++.. ...+++..++.+
T Consensus 79 --------------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~ 110 (288)
T cd05583 79 --------------------------------------------KLHLILDYVNGGELFTHLYQ----REHFTESEVRVY 110 (288)
T ss_pred --------------------------------------------EEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHH
Confidence 38899999985 88887742 356899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCC-CCCcch
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAI-DYTTKI 326 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~s~~s 326 (444)
+.|++.+|.+||+.+++|+||+|+||+++ .++.++|+|||++........ .....++..|++||.+.+.. ..+.++
T Consensus 111 ~~ql~~~l~~lH~~~~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 189 (288)
T cd05583 111 IAEIVLALDHLHQLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAV 189 (288)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEEC-CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchh
Confidence 99999999999999999999999999999 778999999998865433221 12235688899999986652 368899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||+|+++|+|++|..||...........+.+... . . ....+..++..+.++|.
T Consensus 190 Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------~-----~------------~~~~~~~~~~~l~~li~ 244 (288)
T cd05583 190 DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--------K-----S------------KPPFPKTMSAEARDFIQ 244 (288)
T ss_pred hhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--------c-----c------------CCCCCcccCHHHHHHHH
Confidence 999999999999999999975432222222221100 0 0 00112346889999999
Q ss_pred HhcccCCCCCCC---HHHHhccCchhhhhhh
Q psy10212 407 RLLEYTPSSRIS---PLQVRSITPFLIELRA 434 (444)
Q Consensus 407 ~~L~~DP~kRPs---~~elL~~hpwf~~~~~ 434 (444)
+||+.||++||| +.++|+ ||||+.+..
T Consensus 245 ~~l~~~p~~R~t~~~~~~~l~-~~~~~~~~~ 274 (288)
T cd05583 245 KLLEKDPKKRLGANGADEIKN-HPFFQGIDW 274 (288)
T ss_pred HHhcCCHhhccCcchHHHHhc-CcccccCCH
Confidence 999999999998 567799 999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=274.18 Aligned_cols=246 Identities=22% Similarity=0.262 Sum_probs=187.0
Q ss_pred heecccceeEEEEeEecC--CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLD--SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||.||+|.... ....+|+|.+... ...+.+|+..++.++|+||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----------- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----------- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc-----------
Confidence 368999999999997533 3457899977432 2345689999999999999999998876543
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 70 -------------------------------------------------------------------------------- 69 (269)
T cd05042 70 -------------------------------------------------------------------------------- 69 (269)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc-CCCCChHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS-KQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.++||||++ ++|.+++...... ....++..++.++.||+.||+
T Consensus 70 -----------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 114 (269)
T cd05042 70 -----------------------------------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114 (269)
T ss_pred -----------------------------------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHH
Confidence 899999998 4898888643321 234567888999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhcc------CCCCCcchhhh
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFG------AIDYTTKIDVW 329 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~~~s~~sDiw 329 (444)
|||+++++|+||||+||+++ .++.++|+|||++........ .....++..|+|||.+.. ...++.++|+|
T Consensus 115 ~lH~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05042 115 WLHQADFIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW 193 (269)
T ss_pred HHHhcCEecccccHhheEec-CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence 99999999999999999999 788999999999865322211 112234567999998743 22568899999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||++|+|++ |..||....+.+....+...... ..+. ..++..+++.+.+++..|
T Consensus 194 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----------------~~~~-------~~~~~~~~~~~~~~~~~~ 250 (269)
T cd05042 194 SLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI----------------KLPK-------PQLDLKYSDRWYEVMQFC 250 (269)
T ss_pred HHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc----------------cCCC-------CcccccCCHHHHHHHHHH
Confidence 99999999998 88999887766655554432110 1110 112234688999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
+ .||++|||+.++++
T Consensus 251 ~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 251 W-LDPETRPTAEEVHE 265 (269)
T ss_pred h-cCcccccCHHHHHH
Confidence 8 59999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=272.83 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=184.6
Q ss_pred heecccceeEEEEeEecC---CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLD---SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||.||+|.+.. .+..+|||.+... ...+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---------- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC----------
Confidence 468999999999999754 3457999988432 2456689999999999999999987654331
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 71 -------------------------------------------------------------------------------- 70 (262)
T cd05058 71 -------------------------------------------------------------------------------- 70 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..+++|||+. ++|.+++.. .....+...+..++.||+.||+
T Consensus 71 -----------------------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~ 112 (262)
T cd05058 71 -----------------------------------SPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGME 112 (262)
T ss_pred -----------------------------------CcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Confidence 2679999998 588888752 2344677778889999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
|||+.+++|+||+|+||+++ +.+.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||+
T Consensus 113 ~lH~~~i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 190 (262)
T cd05058 113 YLASKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGV 190 (262)
T ss_pred HHHhCCccccccCcceEEEc-CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHH
Confidence 99999999999999999999 78899999999986543211 11122346679999998776 7899999999999
Q ss_pred HHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 334 VLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 334 il~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
++|+|++ |.+||...+..+....+... .. + ..+..+++.+.+++.+||..+
T Consensus 191 ~l~el~~~~~~~~~~~~~~~~~~~~~~~----------------~~---~---------~~~~~~~~~~~~li~~cl~~~ 242 (262)
T cd05058 191 LLWELMTRGAPPYPDVDSFDITVYLLQG----------------RR---L---------LQPEYCPDPLYEVMLSCWHPK 242 (262)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcC----------------CC---C---------CCCCcCCHHHHHHHHHHcCCC
Confidence 9999999 56778766554433332210 00 0 011235789999999999999
Q ss_pred CCCCCCHHHHhc
Q psy10212 413 PSSRISPLQVRS 424 (444)
Q Consensus 413 P~kRPs~~elL~ 424 (444)
|++||++.++++
T Consensus 243 p~~Rp~~~~il~ 254 (262)
T cd05058 243 PEMRPTFSELVS 254 (262)
T ss_pred hhhCCCHHHHHH
Confidence 999999999998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.46 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=196.5
Q ss_pred cccchhheecccceeEEEEeEecC----CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD----SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..|.+++.||+|+||.||+|+... +++.+|+|.+.... ..+.+|++.++++.|+||+++.+++...+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~--- 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG--- 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC---
Confidence 568889999999999999998643 47899999995443 357789999999999999999988765432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (284)
T cd05038 81 -------------------------------------------------------------------------------- 80 (284)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+.+++|||++ ++|.+++.. ....+++..+..++.
T Consensus 81 -----------------------------------------~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~ 116 (284)
T cd05038 81 -----------------------------------------RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSS 116 (284)
T ss_pred -----------------------------------------CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHH
Confidence 34889999997 589888853 223589999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+......... ....++..|++||.+.+. .++.++|
T Consensus 117 ~l~~aL~~lH~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D 194 (284)
T cd05038 117 QICKGMDYLGSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASD 194 (284)
T ss_pred HHHHHHHHHHhCCeecCCCCHHhEEEc-CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccc
Confidence 999999999999999999999999999 7799999999998765422211 112335569999998776 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh-CCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL-GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~-g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
+||||+++++|++|..|+......... +.... +......+..... .... ...+..++..+.+++.
T Consensus 195 i~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~li~ 260 (284)
T cd05038 195 VWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTRLLELLK--EGER----------LPRPPSCPDEVYDLMK 260 (284)
T ss_pred hHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHHHHHHHH--cCCc----------CCCCccCCHHHHHHHH
Confidence 999999999999999998653221100 00000 0000000000000 0000 0112346789999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+||+.||.+|||+.|+++ .++.+
T Consensus 261 ~cl~~~p~~Rpt~~ei~~---~l~~i 283 (284)
T cd05038 261 LCWEAEPQDRPSFADLIL---IVDRL 283 (284)
T ss_pred HHhccChhhCCCHHHHHH---HHhhc
Confidence 999999999999999998 55543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=280.21 Aligned_cols=257 Identities=18% Similarity=0.162 Sum_probs=190.8
Q ss_pred hhccccchhheecccceeEEEEeEecCC---Cceeeeeeeeccccchhh---------------HHHHhhhcCCCceeEe
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQDKRFKNR---------------EMQIMRRLEHSNIVKL 80 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~---------------E~~~l~~l~h~~i~~~ 80 (444)
-..++|.+.++||+|+||+||+|++..+ ++.+|+|........... +...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3457999999999999999999999877 677888865433322222 2234556789999998
Q ss_pred eeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 81 KYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
++.......
T Consensus 89 ~~~~~~~~~----------------------------------------------------------------------- 97 (294)
T PHA02882 89 YGCGSFKRC----------------------------------------------------------------------- 97 (294)
T ss_pred EEeeeEecC-----------------------------------------------------------------------
Confidence 876544321
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCC
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQN 240 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~ 240 (444)
...+.+++++++..++.+.+.. ...
T Consensus 98 ---------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~----~~~ 122 (294)
T PHA02882 98 ---------------------------------------------------RMYYRFILLEKLVENTKEIFKR----IKC 122 (294)
T ss_pred ---------------------------------------------------CceEEEEEEehhccCHHHHHHh----hcc
Confidence 0135789999998888777643 234
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--------CCccccccccccC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--------PNVSYICSRYYRA 312 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--------~~~~~~gt~~y~a 312 (444)
.++..++.++.|++.||+|||+++++||||||+||+++ ..+.++|+|||+++...... ......+|+.|+|
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a 201 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAG 201 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccC
Confidence 57888999999999999999999999999999999998 77899999999987653221 1122368999999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccc
Q psy10212 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392 (444)
Q Consensus 313 PE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 392 (444)
||...+. .++.++|+|||||++|+|++|+.||.+...........+. ..+..+.. ...
T Consensus 202 pe~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~------~~~~~~~~--~~~------------- 259 (294)
T PHA02882 202 LDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC------DFIKRLHE--GKI------------- 259 (294)
T ss_pred HHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH------HHHHHhhh--hhh-------------
Confidence 9998877 7899999999999999999999999877433322221110 00000000 000
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
...+++..+.+++..|+..+|++||+..++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 260 KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01345889999999999999999999999987
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=271.76 Aligned_cols=246 Identities=22% Similarity=0.237 Sum_probs=185.5
Q ss_pred heecccceeEEEEeEecC--CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLD--SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
+.||+|+||.||+|.... ++..+|+|.+.... ..+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------ 68 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT------------ 68 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC------------
Confidence 468999999999998643 45689999885432 35667999999999999999988776543
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (269)
T cd05087 69 -------------------------------------------------------------------------------- 68 (269)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc-CCCCChHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS-KQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-~~~l~~~~i~~i~~QIl~aL~ 258 (444)
..++|||||+ ++|.+++...... ....++..+..++.|++.||.
T Consensus 69 ----------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~ 114 (269)
T cd05087 69 ----------------------------------PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114 (269)
T ss_pred ----------------------------------CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHH
Confidence 2789999998 5888888543322 234567788899999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC------CCCCcchhhh
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA------IDYTTKIDVW 329 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~~s~~sDiw 329 (444)
|||+++++|+||||+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+. ..++.++|+|
T Consensus 115 ~lH~~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05087 115 HLHKNNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVW 193 (269)
T ss_pred HHHHCCEeccccCcceEEEc-CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhH
Confidence 99999999999999999999 788999999999865432221 1123456789999988542 1357899999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||+++|+|++ |+.||......+.......... ...+ ...+....++.+.+++.+|
T Consensus 194 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------~~~~-------~~~~~~~~~~~~~~l~~~c 250 (269)
T cd05087 194 SLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ----------------LKLP-------KPRLKLPLSDRWYEVMQFC 250 (269)
T ss_pred HHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc----------------CCCC-------CCccCCCCChHHHHHHHHH
Confidence 99999999996 9999987665554333222100 0000 0111123578899999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
+ .+|++|||+.+|+.
T Consensus 251 ~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 251 W-LQPEQRPSAEEVHL 265 (269)
T ss_pred h-cCcccCCCHHHHHH
Confidence 9 68999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.37 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=211.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCc---e-eeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGE---L-VAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
.++-.+.++||.|.||.||+|+.+..+. . ||+|....+ ...+++|.++|++++|||||+++++...+.+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667999999999999999876432 3 899988642 3567799999999999999999999988876
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 236 -------------------------------------------------------------------------------- 235 (474)
T KOG0194|consen 236 -------------------------------------------------------------------------------- 235 (474)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
++||||+|.| +|.++++ +.+..++......
T Consensus 236 ----------------------------------------------l~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~ 266 (474)
T KOG0194|consen 236 ----------------------------------------------LMLVMELCNGGSLDDYLK---KNKKSLPTLEKLR 266 (474)
T ss_pred ----------------------------------------------cEEEEEecCCCcHHHHHH---hCCCCCCHHHHHH
Confidence 9999999995 8999886 3445799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc-cccccccccCchhhccCCCCCcchh
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
++.+.+.||+|||+++++||||..+|+|++ ..+.+||+|||+++......... ...-...|+|||.+... .++.++|
T Consensus 267 ~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTD 344 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKNCIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTD 344 (474)
T ss_pred HHHHHHhHHHHHHHCCCcchhHhHHHheec-CCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccc
Confidence 999999999999999999999999999999 66778999999987643111111 11246789999999888 8999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|||+||++||+++ |..||.+....+...++.. ..++.+ ++...|..+..++.
T Consensus 345 V~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~-----------------~~~r~~----------~~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 345 VWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK-----------------NGYRMP----------IPSKTPKELAKVMK 397 (474)
T ss_pred hhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh-----------------cCccCC----------CCCCCHHHHHHHHH
Confidence 9999999999997 8899999999888887754 111121 12245889999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
+|+..||++|||+.++.+ +++.+....+
T Consensus 398 ~c~~~~p~~R~tm~~i~~---~l~~~~~~~~ 425 (474)
T KOG0194|consen 398 QCWKKDPEDRPTMSTIKK---KLEALEKKKE 425 (474)
T ss_pred HhccCChhhccCHHHHHH---HHHHHHhccc
Confidence 999999999999999988 8888766544
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.51 Aligned_cols=173 Identities=23% Similarity=0.262 Sum_probs=133.2
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC------CCeEEEee
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE------TGVLKLCD 288 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~------~~~ikL~D 288 (444)
.++|||||++ +|..++. .....+++..+..++.||+.||+|||+++++|+||+|+||+++.. ...++++|
T Consensus 91 ~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d 167 (274)
T cd05076 91 NIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167 (274)
T ss_pred eEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecC
Confidence 7899999996 6666553 234578999999999999999999999999999999999999721 23589999
Q ss_pred cCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHH
Q psy10212 289 FGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTRE 367 (444)
Q Consensus 289 fg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~ 367 (444)
||.+...... ....++..|+|||.+.+...++.++|+||||+++|+|+ +|+.||......+........
T Consensus 168 ~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------- 237 (274)
T cd05076 168 PGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK------- 237 (274)
T ss_pred Cccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc-------
Confidence 9987543221 22345778999998876547899999999999999995 799999876554432211110
Q ss_pred HHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 368 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.. ++...++.+.++|.+||+.+|++|||+.++|+
T Consensus 238 -----------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 238 -----------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred -----------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 00 11123578999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.94 Aligned_cols=264 Identities=28% Similarity=0.468 Sum_probs=223.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeec-------cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-------DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
...|+|+++||+|+||.|.+++.+.+++.||.|++.+ +...|..|-.+|..-+.++|+.+.+.|.+..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~----- 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER----- 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-----
Confidence 3679999999999999999999999999999999854 2356678888999889999999998887764
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 149 -------------------------------------------------------------------------------- 148 (1317)
T KOG0612|consen 149 -------------------------------------------------------------------------------- 148 (1317)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
++|+||||++| .|..++. +.+ ++++.+++.++..
T Consensus 149 -----------------------------------------~LYlVMdY~pGGDlltLlS---k~~-~~pE~~ArFY~aE 183 (1317)
T KOG0612|consen 149 -----------------------------------------YLYLVMDYMPGGDLLTLLS---KFD-RLPEDWARFYTAE 183 (1317)
T ss_pred -----------------------------------------ceEEEEecccCchHHHHHh---hcC-CChHHHHHHHHHH
Confidence 59999999985 7777774 344 8999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc---C-CCCCcch
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG---A-IDYTTKI 326 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~---~-~~~s~~s 326 (444)
|..||.-||+.|++||||||+|||+| ..|+++|+|||.+-.+...+. .....|||.|++||++.. + ..|.+.+
T Consensus 184 iVlAldslH~mgyVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ec 262 (1317)
T KOG0612|consen 184 IVLALDSLHSMGYVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGREC 262 (1317)
T ss_pred HHHHHHHHHhccceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCcc
Confidence 99999999999999999999999999 899999999999866643332 334589999999999842 1 3789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|.||+||++|||+.|.-||-..+-.+++.+|+... ....||.. ..+|+..++||.
T Consensus 263 DwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---------------~~l~FP~~----------~~VSeeakdLI~ 317 (1317)
T KOG0612|consen 263 DWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---------------ESLSFPDE----------TDVSEEAKDLIE 317 (1317)
T ss_pred chhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh---------------hhcCCCcc----------cccCHHHHHHHH
Confidence 99999999999999999999999999999998741 12233311 247999999999
Q ss_pred HhcccCCCCCCC---HHHHhccCchhhhhhhhhhccccCCC
Q psy10212 407 RLLEYTPSSRIS---PLQVRSITPFLIELRAVFENICFGVP 444 (444)
Q Consensus 407 ~~L~~DP~kRPs---~~elL~~hpwf~~~~~~~~~~~~~~~ 444 (444)
+++. +|+.|.. +.++-. ||||..+.+ ++|.-+||
T Consensus 318 ~ll~-~~e~RLgrngiedik~-HpFF~g~~W--~~iR~~~p 354 (1317)
T KOG0612|consen 318 ALLC-DREVRLGRNGIEDIKN-HPFFEGIDW--DNIRESVP 354 (1317)
T ss_pred HHhc-ChhhhcccccHHHHHh-CccccCCCh--hhhhhcCC
Confidence 9875 7889999 999999 999999888 77766665
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=270.68 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=194.1
Q ss_pred cchhheecccceeEEEEeEecC---CCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLD---SGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
|.+.+.||+|+||.||+|.+.. +++.+|||++..+. +.+.+|++++++++||||+++++++........
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~-- 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR-- 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc--
Confidence 6788999999999999998643 57899999885432 345689999999999999999998876542100
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (273)
T cd05074 79 -------------------------------------------------------------------------------- 78 (273)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh--cCCCCChHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK--SKQNFPCFYTKLYIY 251 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~--~~~~l~~~~i~~i~~ 251 (444)
....+++++|+. ++|.+++..... ....++...++.++.
T Consensus 79 --------------------------------------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~ 120 (273)
T cd05074 79 --------------------------------------LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120 (273)
T ss_pred --------------------------------------ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 023678899998 577777643222 223578889999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||++|++|+||+|+||+++ +++.++|+|||.+....... ......++..|++||.+.+. .++.++|+
T Consensus 121 ~i~~~l~~lH~~~i~H~dikp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi 198 (273)
T cd05074 121 DIASGMEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDV 198 (273)
T ss_pred HHHHHHHHHHhCCEeecccchhhEEEc-CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhh
Confidence 999999999999999999999999998 78899999999987553222 11223345679999998776 78899999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||.+.+..+....+.... .. ..+..++..+.+++.+
T Consensus 199 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~l~~~ 250 (273)
T cd05074 199 WAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN----------------RL------------KQPPDCLEDVYELMCQ 250 (273)
T ss_pred HHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC----------------cC------------CCCCCCCHHHHHHHHH
Confidence 999999999998 899998776554443333210 00 0112457899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||+.+|++|||+.+++.
T Consensus 251 ~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 251 CWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999988
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.56 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=215.6
Q ss_pred hhccccch--hheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 19 DLDNSLAQ--KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 19 ~~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
++.+-|+| -+.||+|.||+||-|+++.+|+.||||+|.+. ++...+|+.+|++++||.||.+-.-|...+.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er- 637 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER- 637 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-
Confidence 34455665 57899999999999999999999999999443 3556689999999999999998655544432
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 638 -------------------------------------------------------------------------------- 637 (888)
T KOG4236|consen 638 -------------------------------------------------------------------------------- 637 (888)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.|.|||-+.|..+..|.. ...+++++...+.++
T Consensus 638 ---------------------------------------------vFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlv 670 (888)
T KOG4236|consen 638 ---------------------------------------------VFVVMEKLHGDMLEMILS--SEKGRLPERITKFLV 670 (888)
T ss_pred ---------------------------------------------EEEEehhhcchHHHHHHH--hhcccchHHHHHHHH
Confidence 889999999999998853 456789999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||-++|+|+||||+||++.. +..++||+|||.++.+++........||+.|+|||++... .|...-|+
T Consensus 671 tQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDM 749 (888)
T KOG4236|consen 671 TQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDM 749 (888)
T ss_pred HHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc-cccccccc
Confidence 99999999999999999999999999953 3458999999999999888888888999999999999887 89999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||.|+|+|--+.|..||.... ++-.+|.+.. .+.+-.+|.+ +++...|||..+
T Consensus 750 WSVGVIiYVsLSGTFPFNEdE--dIndQIQNAa--------------------FMyPp~PW~e-----is~~AidlIn~L 802 (888)
T KOG4236|consen 750 WSVGVIIYVSLSGTFPFNEDE--DINDQIQNAA--------------------FMYPPNPWSE-----ISPEAIDLINNL 802 (888)
T ss_pred eeeeEEEEEEecccccCCCcc--chhHHhhccc--------------------cccCCCchhh-----cCHHHHHHHHHH
Confidence 999999999999999997543 3333333311 1222344443 489999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|++.-++|-|....|. |||++++
T Consensus 803 LqVkm~kRysvdk~ls-h~Wlq~y 825 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLS-HPWLQDY 825 (888)
T ss_pred HHHHHHHhcchHhhcc-chhhhcc
Confidence 9999999999999999 9999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.20 Aligned_cols=141 Identities=30% Similarity=0.437 Sum_probs=124.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|.++++||.|+||+||+|++..+++.||||++.... ..+.+|+.++..++|+||++++..+....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~------ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN------ 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC------
Confidence 68999999999999999999999999999999985432 45668999999999999999987776543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (669)
T cd05610 78 -------------------------------------------------------------------------------- 77 (669)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.|+|||||. ++|.+++.. .+.+++..++.++.||
T Consensus 78 ----------------------------------------~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qi 113 (669)
T cd05610 78 ----------------------------------------NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEV 113 (669)
T ss_pred ----------------------------------------EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHH
Confidence 4899999997 589888853 3468899999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
+.||.|||+++|+|+||||+||+++ ..+.++|+|||+++
T Consensus 114 l~aL~yLH~~gIiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 114 ALALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHhCCEEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 9999999999999999999999998 78899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=268.42 Aligned_cols=233 Identities=21% Similarity=0.254 Sum_probs=182.7
Q ss_pred heecccceeEEEEeEecCCC----------ceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSG----------ELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~----------~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.||+|+||.||+|.+..++ ..+++|.+... ...+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----- 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----- 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-----
Confidence 46899999999999998766 35888877543 3466789999999999999999988866 32
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (259)
T cd05037 75 -------------------------------------------------------------------------------- 74 (259)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.++||||+++ +|.+++.. ....++...+..++.||
T Consensus 75 -----------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i 110 (259)
T cd05037 75 -----------------------------------------NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQL 110 (259)
T ss_pred -----------------------------------------cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHH
Confidence 6799999985 77777753 22378999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCC-------eEEEeecCCcccccCCCCCccccccccccCchhhccC-CCCCcc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETG-------VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA-IDYTTK 325 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~-------~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~s~~ 325 (444)
+.||+|||++|++|+||+|+||+++ ..+ .++|+|||++..... .....++..|+|||.+.+. ..++.+
T Consensus 111 ~~~l~~LH~~~i~H~dlkp~Nill~-~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~ 186 (259)
T cd05037 111 ASALHYLEDKKLVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIA 186 (259)
T ss_pred HHHHHHHhhCCeecccCccceEEEe-cCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchh
Confidence 9999999999999999999999998 444 799999999876433 2233456779999998664 368899
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++ |..||...+..+....... ... ++......+.++
T Consensus 187 ~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------------------~~~------------~~~~~~~~~~~l 236 (259)
T cd05037 187 ADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------------------QHR------------LPMPDCAELANL 236 (259)
T ss_pred hHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------------------CCC------------CCCCCchHHHHH
Confidence 999999999999998 6888876653322211110 000 001113789999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy10212 405 ISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~ 424 (444)
|.+||..+|.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 237 INQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=270.28 Aligned_cols=246 Identities=18% Similarity=0.217 Sum_probs=186.4
Q ss_pred heecccceeEEEEeEecCC--Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCc
Q psy10212 28 TVIGNGSFGIVYQAKLLDS--GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPL 100 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 100 (444)
++||+|+||.||+|+.... ...+++|.+... .+.+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~------------ 68 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI------------ 68 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC------------
Confidence 3699999999999986443 345677776432 246678999999999999999999886543
Q ss_pred cccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCC
Q psy10212 101 EDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 180 (444)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (444)
T Consensus 69 -------------------------------------------------------------------------------- 68 (268)
T cd05086 69 -------------------------------------------------------------------------------- 68 (268)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 181 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
..++|||||+ ++|.+++..........++..++.++.||+.||+|
T Consensus 69 ----------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~ 114 (268)
T cd05086 69 ----------------------------------PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114 (268)
T ss_pred ----------------------------------ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHH
Confidence 2789999999 58988886543334556778889999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccC------CCCCcchhhhh
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGA------IDYTTKIDVWS 330 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~s~~sDiwS 330 (444)
||+++++|+||+|+||+++ .++.++|+|||++....... ......++..|+|||.+... ..++.++|+||
T Consensus 115 lH~~~i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 115 MHKHNFLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HHHCCeeccCCccceEEEc-CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 9999999999999999998 78899999999875422111 12234567889999987431 14578999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||+++|+|++ |..||...+..+....+...... .. ....+...+++.+.+++..||
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----------------~~-------~~~~~~~~~~~~~~~l~~~c~ 250 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV----------------KL-------FKPQLELPYSERWYEVLQFCW 250 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc----------------cc-------CCCccCCCCcHHHHHHHHHHh
Confidence 9999999996 67899877766655554432110 00 011112235789999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy10212 410 EYTPSSRISPLQVRS 424 (444)
Q Consensus 410 ~~DP~kRPs~~elL~ 424 (444)
.+|.+||++.++++
T Consensus 251 -~~P~~Rp~~~~i~~ 264 (268)
T cd05086 251 -LSPEKRATAEEVHR 264 (268)
T ss_pred -hCcccCCCHHHHHH
Confidence 68999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.00 Aligned_cols=228 Identities=22% Similarity=0.296 Sum_probs=183.2
Q ss_pred cceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccccccccCCCCC
Q psy10212 33 GSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRN 112 (444)
Q Consensus 33 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (444)
|.+|.||+|+++.+++.||+|.+.... ...+|...+....||||+++++++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------ 58 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIVSED------------------------ 58 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhheecCC------------------------
Confidence 899999999999999999999996543 3345666666678999999988876543
Q ss_pred ceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcc
Q psy10212 113 KVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 192 (444)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (444)
T Consensus 59 -------------------------------------------------------------------------------- 58 (237)
T cd05576 59 -------------------------------------------------------------------------------- 58 (237)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q psy10212 193 AIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271 (444)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLk 271 (444)
..+++|||+++ +|.+++.. ..++++..+..++.|++.||+|||++|++|+||+
T Consensus 59 ----------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk 112 (237)
T cd05576 59 ----------------------SVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112 (237)
T ss_pred ----------------------eEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 38999999985 88888753 2458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChh
Q psy10212 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351 (444)
Q Consensus 272 p~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~ 351 (444)
|+||+++ .++.++++|||.+...... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..|+......
T Consensus 113 p~Nil~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~ 188 (237)
T cd05576 113 PNNILLD-DRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG 188 (237)
T ss_pred HHHEEEc-CCCCEEEecccchhccccc--cccCCcCccccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh
Confidence 9999999 7889999999987554332 1223446779999998766 6889999999999999999999887532110
Q ss_pred HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH-----HHHhccC
Q psy10212 352 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP-----LQVRSIT 426 (444)
Q Consensus 352 e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~-----~elL~~h 426 (444)
. . ......++..+++.+.++|.+||+.||++||++ .++++ |
T Consensus 189 ~------~---------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~-h 234 (237)
T cd05576 189 I------N---------------------------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS-H 234 (237)
T ss_pred c------c---------------------------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc-C
Confidence 0 0 000011234568999999999999999999996 99999 9
Q ss_pred chh
Q psy10212 427 PFL 429 (444)
Q Consensus 427 pwf 429 (444)
|||
T Consensus 235 ~~~ 237 (237)
T cd05576 235 PFF 237 (237)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.95 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=214.0
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
..++.++-+|.-..++|.|.||.||-|.+..+|+..|+|.+..-. ....+|++++..|+|||+|+|++.=..++
T Consensus 1228 ~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1228 SSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred HHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 456778889999999999999999999999999999999983321 22338999999999999999988877765
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 1308 k------------------------------------------------------------------------------- 1308 (1509)
T KOG4645|consen 1308 K------------------------------------------------------------------------------- 1308 (1509)
T ss_pred H-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.+|.||||+ |+|.+...+ ++..++...+
T Consensus 1309 -----------------------------------------------v~IFMEyC~~GsLa~ll~~----gri~dE~vt~ 1337 (1509)
T KOG4645|consen 1309 -----------------------------------------------VYIFMEYCEGGSLASLLEH----GRIEDEMVTR 1337 (1509)
T ss_pred -----------------------------------------------HHHHHHHhccCcHHHHHHh----cchhhhhHHH
Confidence 779999999 589888864 4567888899
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccCC--
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGAI-- 320 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~-- 320 (444)
.+..|++.|++|||++||+||||||.||+++ .+|.+|++|||.+....... ......||+.|||||++.+..
T Consensus 1338 vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k 1416 (1509)
T KOG4645|consen 1338 VYTKQLLEGLAYLHEHGIVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK 1416 (1509)
T ss_pred HHHHHHHHHHHHHHhcCceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC
Confidence 9999999999999999999999999999999 78899999999997665442 122447899999999997642
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
.-.-+.|||||||++.||+||+.||...+.+=.+...+.-...| .+|.++|++
T Consensus 1417 G~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P---------------------------q~P~~ls~~ 1469 (1509)
T KOG4645|consen 1417 GHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP---------------------------QIPERLSSE 1469 (1509)
T ss_pred CCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC---------------------------CCchhhhHh
Confidence 34568999999999999999999999877665555444421111 123357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
-++||++||.-||++|+++.|+|+ |.|-+.-
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle-~~f~~~~ 1500 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLE-HAFGKSC 1500 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHH-hhccccc
Confidence 999999999999999999999999 9886653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.97 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=210.5
Q ss_pred cccchhheecccceeEEEEeEecCC-----Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..-+..+.||.|.||.||+|+...- -..||||.+..+ ...|+||++++..|+|||||++++.+..+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P-- 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP-- 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe--
Confidence 3456789999999999999987432 246999999554 3568899999999999999999999999876
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 564 -------------------------------------------------------------------------------- 563 (774)
T KOG1026|consen 564 -------------------------------------------------------------------------------- 563 (774)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------c----CCC
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------S----KQN 240 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------~----~~~ 240 (444)
+++|+|||. |+|..+++.... . ..+
T Consensus 564 --------------------------------------------~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~ 599 (774)
T KOG1026|consen 564 --------------------------------------------LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPP 599 (774)
T ss_pred --------------------------------------------eEEEEEecccccHHHHHHhhCCccccccCCCCCCCC
Confidence 999999999 899999865322 2 233
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc---cccccccccCchhhc
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIF 317 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~l~ 317 (444)
++..+.+.|+.|||.|+.||-++.++||||..+|+||+ ++..+||+|||+++..-..+... ...-..+|||||.+.
T Consensus 600 L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 600 LSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL 678 (774)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence 88899999999999999999999999999999999999 88999999999997653333221 223367899999999
Q ss_pred cCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
.+ .++.+|||||+||++||+++ |+.||-+.+..+.+..+.++-- -.-+.+
T Consensus 679 y~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l----------------------------L~~Pe~ 729 (774)
T KOG1026|consen 679 YG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL----------------------------LSCPEN 729 (774)
T ss_pred cC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc----------------------------ccCCCC
Confidence 88 99999999999999999995 9999999999999888876310 011457
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||..+.+|+..||+.+|.+||++.||-. -++..-
T Consensus 730 CP~~vY~LM~~CW~~~P~~RPsF~eI~~---~L~~~~ 763 (774)
T KOG1026|consen 730 CPTEVYSLMLECWNENPKRRPSFKEIHS---RLQAWA 763 (774)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHH---HHHHHH
Confidence 9999999999999999999999999844 555443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=271.00 Aligned_cols=234 Identities=18% Similarity=0.211 Sum_probs=179.0
Q ss_pred heecccceeEEEEeEecCC------------Cceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDS------------GELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~------------~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.||+|+||.||+|+.... ...+|+|.+.... ..+.+|+.++++++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~-- 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE-- 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence 4689999999999985322 2358899875432 245578899999999999999998876542
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (262)
T cd05077 79 -------------------------------------------------------------------------------- 78 (262)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.++|||||++ +|..++. .....+++..++.++
T Consensus 79 --------------------------------------------~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~ 111 (262)
T cd05077 79 --------------------------------------------NIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVA 111 (262)
T ss_pred --------------------------------------------CEEEEecccCCCHHHHHH---hcCCCCCHHHHHHHH
Confidence 7899999996 5555543 234568999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC-------eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCC
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETG-------VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~-------~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
.||+.||+|||+++++|+||+|+||+++ ..+ .++++|||.+..... .....++..|+|||.+.....++
T Consensus 112 ~qi~~~l~~lH~~~ivH~dlkp~Nill~-~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 187 (262)
T cd05077 112 KQLASALSYLEDKDLVHGNVCTKNILLA-REGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLS 187 (262)
T ss_pred HHHHHHHHHhhhCCeECCCCCcccEEEe-cCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCC
Confidence 9999999999999999999999999997 333 389999998865422 12335677899999887544789
Q ss_pred cchhhhhHHHHHHHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 324 TKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 324 ~~sDiwSLGvil~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
.++|+||||+++|+|+ .|..||......+... .... .. . .....++++.
T Consensus 188 ~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--------------~~-~--------------~~~~~~~~~~ 237 (262)
T cd05077 188 IAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--------------QC-M--------------LVTPSCKELA 237 (262)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc--------------Cc-c--------------CCCCChHHHH
Confidence 9999999999999998 5888887654333211 1110 00 0 0112357899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy10212 403 DLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+||.+||+.||.+||++.++++
T Consensus 238 ~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 238 DLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=294.29 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=201.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
+...|++...+|.|+|+.|-.+.+..+++.+++|++......-.+|+.++... .|+||+++.+.+.+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~---------- 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGK---------- 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCc----------
Confidence 67889999999999999999999999999999999987766667788665555 7999999988876653
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 390 -------------------------------------------------------------------------------- 389 (612)
T KOG0603|consen 390 -------------------------------------------------------------------------------- 389 (612)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCc-HHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPET-VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..|+|||++.|. +.+-+. . .+.....+..|+.||+.|+
T Consensus 390 ------------------------------------~~~~v~e~l~g~ell~ri~----~-~~~~~~e~~~w~~~lv~Av 428 (612)
T KOG0603|consen 390 ------------------------------------EIYLVMELLDGGELLRRIR----S-KPEFCSEASQWAAELVSAV 428 (612)
T ss_pred ------------------------------------eeeeeehhccccHHHHHHH----h-cchhHHHHHHHHHHHHHHH
Confidence 499999999974 444432 2 2333378888999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||++|++||||||+|||++.+.++++|+|||..+..... ....+-|..|.|||++... .++.++|+||||+++|+
T Consensus 429 ~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ 505 (612)
T KOG0603|consen 429 DYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYE 505 (612)
T ss_pred HHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHH
Confidence 99999999999999999999437889999999998775444 3344568889999999866 89999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|+.||...... ..+...++.+. +...+|..+++||.+||++||.+||
T Consensus 506 ML~G~tp~~~~P~~---~ei~~~i~~~~---------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl 555 (612)
T KOG0603|consen 506 MLTGRTLFAAHPAG---IEIHTRIQMPK---------------------------FSECVSDEAKDLLQQLLQVDPALRL 555 (612)
T ss_pred HHhCCCccccCCch---HHHHHhhcCCc---------------------------cccccCHHHHHHHHHhccCChhhCc
Confidence 99999999865544 22222221111 1136799999999999999999999
Q ss_pred CHHHHhccCchh
Q psy10212 418 SPLQVRSITPFL 429 (444)
Q Consensus 418 s~~elL~~hpwf 429 (444)
++.+++. ||||
T Consensus 556 ~~~~i~~-h~w~ 566 (612)
T KOG0603|consen 556 GADEIGA-HPWF 566 (612)
T ss_pred Chhhhcc-Ccch
Confidence 9999999 9999
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=289.13 Aligned_cols=287 Identities=30% Similarity=0.500 Sum_probs=227.4
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcC------CCceeEeeeEEe
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLE------HSNIVKLKYFFY 85 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~------h~~i~~~~~~~~ 85 (444)
..-+-++++|.+....|+|=|++|.+|.+..-|+.||||+|...+ .+=.+|+++|++|+ -.|+++++-.|.
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 344778999999999999999999999999999999999995543 33448999999994 346666655554
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
..
T Consensus 505 hk------------------------------------------------------------------------------ 506 (752)
T KOG0670|consen 505 HK------------------------------------------------------------------------------ 506 (752)
T ss_pred hc------------------------------------------------------------------------------
Confidence 43
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~ 245 (444)
.+||+|+|-+..+|+..++.+.. ...+....
T Consensus 507 ------------------------------------------------nHLClVFE~LslNLRevLKKyG~-nvGL~ika 537 (752)
T KOG0670|consen 507 ------------------------------------------------NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKA 537 (752)
T ss_pred ------------------------------------------------ceeEEEehhhhchHHHHHHHhCc-ccceeehH
Confidence 35999999999999999986543 34588999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcc
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.++.|+..||..|-..||+|+||||+|||++.....+||||||.+....... .+....+..|.|||++.|- +|+..
T Consensus 538 VRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~-~yd~~ 615 (752)
T KOG0670|consen 538 VRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGL-PYDYP 615 (752)
T ss_pred HHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecC-cccCC
Confidence 999999999999999999999999999999999778889999999997665444 3455568889999999998 89999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC-------CCCCcc--cCCCccCC---------
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN-------PNYTEF--KFPQIKSH--------- 387 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~-------~~~~~~--~~p~~~~~--------- 387 (444)
.|+||.||++|||.||+..|++.+..+++...+++.|..+...+..-. .++..+ ..-.....
T Consensus 616 iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~v 695 (752)
T KOG0670|consen 616 IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNV 695 (752)
T ss_pred ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEeccc
Confidence 999999999999999999999999999999999998888776665411 011000 00000000
Q ss_pred --------CCccc--ccC---CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 388 --------PWSKV--FRV---RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 388 --------~~~~~--~~~---~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+... ++. ..-..+++||..||..||++|.|..|+|. ||||+.
T Consensus 696 kPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~-HpFi~~ 751 (752)
T KOG0670|consen 696 KPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK-HPFITE 751 (752)
T ss_pred CcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc-CCcccC
Confidence 00000 010 01256999999999999999999999999 999974
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.87 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=206.3
Q ss_pred cccchhheecccceeEEEEeEecCC-Cc----eeeeeeee-----ccccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-GE----LVAIKKVL-----QDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~----~~aiK~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..-...+.||+|.||.||.|+.... |. .||||.+. ++...|.+|..+|++++|||||++++.+++.++
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 4566789999999999999998653 33 38999883 335778899999999999999999999999765
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 770 -------------------------------------------------------------------------------- 769 (1025)
T KOG1095|consen 770 -------------------------------------------------------------------------------- 769 (1025)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh---cCCCCChHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK---SKQNFPCFYTK 247 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~---~~~~l~~~~i~ 247 (444)
.+|++|||+ |.|.++++..+. +...++.....
T Consensus 770 --------------------------------------------~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl 805 (1025)
T KOG1095|consen 770 --------------------------------------------PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLL 805 (1025)
T ss_pred --------------------------------------------cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHH
Confidence 779999999 589999975432 24568889999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc---ccccccccCchhhccCCCCCc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS---YICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~s~ 324 (444)
.++.|||+|+.||++++++||||..+|+|++ ....+||+|||+++.+-....... ..-...|||||.+..+ .++.
T Consensus 806 ~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~-~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFts 883 (1025)
T KOG1095|consen 806 AFALDVAKGMNYLESKHFVHRDLAARNCLLD-ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTS 883 (1025)
T ss_pred HHHHHHhhhhHHHHhCCCcCcchhhhheeec-ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc-cccc
Confidence 9999999999999999999999999999999 779999999999985433322111 1224679999999987 8999
Q ss_pred chhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 325 KIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 325 ~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
++|||||||++||+++ |..||.+.+..+.+....+.-+ + .-+..||..+.+
T Consensus 884 kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR------------------L----------~~P~~CP~~ly~ 935 (1025)
T KOG1095|consen 884 KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR------------------L----------DPPSYCPEKLYQ 935 (1025)
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc------------------c----------CCCCCCChHHHH
Confidence 9999999999999996 9999999998887776665211 1 114579999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy10212 404 LISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~ 424 (444)
++.+||+.+|++||++..+++
T Consensus 936 lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 936 LMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHccCChhhCccHHHHHh
Confidence 999999999999999999988
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=269.85 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=207.4
Q ss_pred hhhccccch-hheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQ-KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (444)
.+|.+-|.+ .+.||.|.||.|--+....+|+.||||++.+. +...-||++++.+. .|+||+.++++|.++..
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-- 150 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-- 150 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce--
Confidence 345666766 57899999999999999999999999999543 34555899999999 59999999999988765
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 151 -------------------------------------------------------------------------------- 150 (463)
T KOG0607|consen 151 -------------------------------------------------------------------------------- 150 (463)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
+|+|||-|.| +|++.|. ....+++.++.++.
T Consensus 151 --------------------------------------------FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vv 182 (463)
T KOG0607|consen 151 --------------------------------------------FYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVV 182 (463)
T ss_pred --------------------------------------------EEEEEecccCchHHHHHH----HhhhccHHHHHHHH
Confidence 9999999985 8888885 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEeecCCcccccCC--------CCCccccccccccCchhhc---
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETG--VLKLCDFGSAKHLVRG--------EPNVSYICSRYYRAPELIF--- 317 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~Dfg~s~~~~~~--------~~~~~~~gt~~y~aPE~l~--- 317 (444)
++|+.||.+||.+||+||||||+|||-...+. -+||+||.+...+... ....+..|+..|||||+..
T Consensus 183 kdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv 262 (463)
T KOG0607|consen 183 KDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV 262 (463)
T ss_pred HHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc
Confidence 99999999999999999999999999963333 4799999886443221 1123446778899999862
Q ss_pred -cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhH---------------HHHHHHHHhCCCCHHHHHhhCCCCCcccC
Q psy10212 318 -GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD---------------QLVEIIKVLGTPTREQIREMNPNYTEFKF 381 (444)
Q Consensus 318 -~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e---------------~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 381 (444)
....|+.+.|.||||+|+|-|+.|.+||.+....+ +...|.++ .+.+
T Consensus 263 ~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG-----------------kYeF 325 (463)
T KOG0607|consen 263 DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG-----------------KYEF 325 (463)
T ss_pred cccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc-----------------CCcC
Confidence 23468999999999999999999999999755433 22223332 2223
Q ss_pred CCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 382 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 382 p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|. ..|. ++|.+..++|..+|..||..|.++.+++. |||++-...
T Consensus 326 Pd---kdWa-----hIS~eakdlisnLlvrda~~rlsa~~vln-hPw~~~~~~ 369 (463)
T KOG0607|consen 326 PD---KDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLN-HPWVQRCAP 369 (463)
T ss_pred Ch---hhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccC-Cccccccch
Confidence 22 2222 35999999999999999999999999999 999987543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.99 Aligned_cols=208 Identities=21% Similarity=0.267 Sum_probs=138.6
Q ss_pred eEEEEeccCCC-cHHHHHHhhhh----------------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q psy10212 215 FLNLVLEFMPE-TVYKVAKHYSK----------------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277 (444)
Q Consensus 215 ~~~iv~e~~~~-~l~~~~~~~~~----------------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll 277 (444)
.+++||||+++ +|.+++..... .........++.++.||+.||.|||+++|+||||||+||++
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 48899999985 78888753110 01112244577899999999999999999999999999999
Q ss_pred cCCCCeEEEeecCCcccccCC--CCCccccccccccCchhhccCC---------------------CCCcchhhhhHHHH
Q psy10212 278 NPETGVLKLCDFGSAKHLVRG--EPNVSYICSRYYRAPELIFGAI---------------------DYTTKIDVWSAGCV 334 (444)
Q Consensus 278 ~~~~~~ikL~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~l~~~~---------------------~~s~~sDiwSLGvi 334 (444)
+...+.+||+|||++...... .......+++.|+|||.+.... .+..++||||+||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 855689999999999754322 1223456789999999763221 13345699999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccc--cCCCChhHHHHHHHhcccC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF--RVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~s~~l~~LI~~~L~~D 412 (444)
+|+|+++..++ .+........+...+.. ...|....... ........+ ....+....+||.+||++|
T Consensus 369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYD-LVAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHhCcCCC--chHHHHHHHHHHhcCCc-HHHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999876553 23333333333332222 12222211100 000000000 0112456779999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++|||+.|+|+ ||||+....
T Consensus 438 P~kR~ta~e~L~-Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALA-HPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhC-CcCcCCCCc
Confidence 999999999999 999987443
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=270.19 Aligned_cols=281 Identities=31% Similarity=0.544 Sum_probs=230.2
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
...+|.-+..+|.|.- .|.-+-|...+++||||+.... ....++|..++..+.|+||++++.+|.-...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~---- 89 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT---- 89 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc----
Confidence 3478999999999998 8889999999999999998432 3455689999999999999999877754331
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
.+++
T Consensus 90 -------------------------------------------------------------------l~~~--------- 93 (369)
T KOG0665|consen 90 -------------------------------------------------------------------LEEF--------- 93 (369)
T ss_pred -------------------------------------------------------------------HHHH---------
Confidence 0111
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.-.|+|||+|..+|...+. -.++-..+..++.|+
T Consensus 94 ----------------------------------------~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~ 127 (369)
T KOG0665|consen 94 ----------------------------------------QEVYLVMELMDANLCQVIL------MELDHETISYILYQM 127 (369)
T ss_pred ----------------------------------------HhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHH
Confidence 1278999999999999885 356778899999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.|+.|||+.||+||||||+||++. ....+||.|||+++.....-..+....+..|.|||++.+. .+...+||||+||
T Consensus 128 ~~~ik~lhs~~IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGc 205 (369)
T KOG0665|consen 128 LCGIKHLHSAGIIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 205 (369)
T ss_pred HHHHHHHHhcceeecccCcccceec-chhheeeccchhhcccCcccccCchhheeeccCchheecc-CCcccchhhhhhh
Confidence 9999999999999999999999999 7889999999999776555456677789999999999988 5999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc----------cCCC-ccCCCCcccc--cCCCChh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF----------KFPQ-IKSHPWSKVF--RVRTPPD 400 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~----------~~p~-~~~~~~~~~~--~~~~s~~ 400 (444)
++.||++|...|++.+..++..++.+.+|.|.+.-+..+.+....+ .+.. ++...|.... ++--+..
T Consensus 206 i~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ 285 (369)
T KOG0665|consen 206 IMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSL 285 (369)
T ss_pred HHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHH
Confidence 9999999999999999999999999999999998887765322222 1111 1112222221 1123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
+++++.+||..||++|.|+.++|+ ||||+
T Consensus 286 ardll~~MLvi~pe~Risv~daL~-HPY~~ 314 (369)
T KOG0665|consen 286 ARDLLSKMLVIDPEKRISVDDALR-HPYIK 314 (369)
T ss_pred HHHHHHHhhccChhhcccHHHHhc-CCeee
Confidence 999999999999999999999999 99998
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=275.17 Aligned_cols=285 Identities=26% Similarity=0.424 Sum_probs=215.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcC--------CCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLE--------HSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~--------h~~i~~~~~~~~~~~~~ 90 (444)
.+|.+.++||=|-|+|||+|.|....+.||+|+..... ++...||++|++++ ..+||++++.|-..+..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 69999999999999999999999999999999986553 56678999999883 35799999999887752
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
+
T Consensus 158 ---------------------G---------------------------------------------------------- 158 (590)
T KOG1290|consen 158 ---------------------G---------------------------------------------------------- 158 (590)
T ss_pred ---------------------C----------------------------------------------------------
Confidence 1
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+.++|+|+++.+|+.+|.... -+.++...++.|+
T Consensus 159 -------------------------------------------~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~ 193 (590)
T KOG1290|consen 159 -------------------------------------------QHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEIC 193 (590)
T ss_pred -------------------------------------------cEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHH
Confidence 5799999999999999997543 3458889999999
Q ss_pred HHHHHHHHHHHH-CCcccCCCCCCcEEEcCC-------------------------------------------------
Q psy10212 251 YQLFRSLAYIHV-LGICHRDIKPQNLLLNPE------------------------------------------------- 280 (444)
Q Consensus 251 ~QIl~aL~yLHs-~givH~dLkp~NIll~~~------------------------------------------------- 280 (444)
.|||.||.|||. .||+|.||||+|||+...
T Consensus 194 ~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~ 273 (590)
T KOG1290|consen 194 RQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKM 273 (590)
T ss_pred HHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHH
Confidence 999999999996 599999999999999300
Q ss_pred ------------------------------------C-------------------------------------------
Q psy10212 281 ------------------------------------T------------------------------------------- 281 (444)
Q Consensus 281 ------------------------------------~------------------------------------------- 281 (444)
+
T Consensus 274 ~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~ 353 (590)
T KOG1290|consen 274 KKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQ 353 (590)
T ss_pred HHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchh
Confidence 0
Q ss_pred -------------------------------------CeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCc
Q psy10212 282 -------------------------------------GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 282 -------------------------------------~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
-++||.|||.++-.. ..-+.-..|..|.|||++.+. .|++
T Consensus 354 ~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGs-gY~~ 430 (590)
T KOG1290|consen 354 LRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGS-GYST 430 (590)
T ss_pred cccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecC-CCCC
Confidence 012223333222110 001112347889999999998 9999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCC------CChhHHHHHHHHHhCCCCHHHHHhhC--CCCCc--ccCCCccCC---CCcc
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPG------DSGVDQLVEIIKVLGTPTREQIREMN--PNYTE--FKFPQIKSH---PWSK 391 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~------~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~--~~~p~~~~~---~~~~ 391 (444)
.+||||++|++|||.||..+|.- ..+++.++.|++++|..++.....-. .+|.+ ..+..+... .+.+
T Consensus 431 ~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~ 510 (590)
T KOG1290|consen 431 SADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYE 510 (590)
T ss_pred chhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHH
Confidence 99999999999999999998862 45788999999999998877654311 11100 001111110 0111
Q ss_pred c------ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 392 V------FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 392 ~------~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
. |+.....++.+||.-||+++|++||||++.|+ |||+....-
T Consensus 511 VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~-hPwLn~~~~ 558 (590)
T KOG1290|consen 511 VLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK-HPWLNPVAG 558 (590)
T ss_pred HHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc-CccccCCCC
Confidence 1 23334678999999999999999999999999 999986544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=253.14 Aligned_cols=238 Identities=37% Similarity=0.639 Sum_probs=193.4
Q ss_pred ceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccccccccC
Q psy10212 34 SFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTF 108 (444)
Q Consensus 34 ~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (444)
+||.||+|++..+|+.+|+|++... ...+.+|++.+++++|+||+++.+++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-------------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-------------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--------------------
Confidence 6899999999988999999999543 356678999999999999999988876643
Q ss_pred CCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCccccccc
Q psy10212 109 SPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 188 (444)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (444)
T Consensus 61 -------------------------------------------------------------------------------- 60 (244)
T smart00220 61 -------------------------------------------------------------------------------- 60 (244)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCccc
Q psy10212 189 TPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICH 267 (444)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH 267 (444)
..++++|++++ +|.+++.. ...++...++.++.+++.++.+||+.+++|
T Consensus 61 --------------------------~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 61 --------------------------KLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred --------------------------EEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 38899999997 99888753 223889999999999999999999999999
Q ss_pred CCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Q psy10212 268 RDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPG 347 (444)
Q Consensus 268 ~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~ 347 (444)
+||+|+||+++ +++.++|+|||.+.............++..|++||...+. .++.++|+||+|+++++|++|..||..
T Consensus 111 ~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 111 RDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999 6789999999998776554444455678889999998766 788899999999999999999999987
Q ss_pred CChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCc
Q psy10212 348 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITP 427 (444)
Q Consensus 348 ~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hp 427 (444)
....+...+.... .. ... ......++..+.+++.+||..||++||++.++++ ||
T Consensus 189 ~~~~~~~~~~~~~---~~-------------~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~-~~ 242 (244)
T smart00220 189 DDQLLELFKKIGK---PK-------------PPF---------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ-HP 242 (244)
T ss_pred CCcHHHHHHHHhc---cC-------------CCC---------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh-CC
Confidence 4333333222221 00 000 0000015789999999999999999999999999 99
Q ss_pred hh
Q psy10212 428 FL 429 (444)
Q Consensus 428 wf 429 (444)
||
T Consensus 243 ~~ 244 (244)
T smart00220 243 FF 244 (244)
T ss_pred CC
Confidence 97
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=269.34 Aligned_cols=286 Identities=32% Similarity=0.538 Sum_probs=229.3
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeec------cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ------DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.+--+-||.|.||.||-+.|..+|+.||+|++.. ....+-+|++++.-.+|.||+..+++..-...
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~-------- 126 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP-------- 126 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc--------
Confidence 3445789999999999999999999999999832 23445589999999999999976655422110
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
|+-
T Consensus 127 ----------------------------dfF------------------------------------------------- 129 (449)
T KOG0664|consen 127 ----------------------------SFF------------------------------------------------- 129 (449)
T ss_pred ----------------------------hHH-------------------------------------------------
Confidence 000
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.-+|.++|++..+|.+.|. +.++++.+.++.++.||+.||
T Consensus 130 ------------------------------------qEiYV~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGL 169 (449)
T KOG0664|consen 130 ------------------------------------QELYVLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGL 169 (449)
T ss_pred ------------------------------------HHHHHHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhh
Confidence 1277899999999999884 678999999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
.|||+.+|.||||||.|++++ ++-.+||+|||+++....... .+....|-+|.|||++.|...|+.+.||||.|||+
T Consensus 170 KYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 170 KYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred HHHhhcchhhccCCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence 999999999999999999999 777899999999987643322 23445688999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccc---c--cCCCChhHHHHHHHhcc
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV---F--RVRTPPDAIDLISRLLE 410 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---~--~~~~s~~l~~LI~~~L~ 410 (444)
.|++..+..|...++.+++.-|.+.+|+|..+.|+.-+.+...-.++.-.+.+-... + +..-..+...++..||.
T Consensus 249 aELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~ 328 (449)
T KOG0664|consen 249 AELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLH 328 (449)
T ss_pred HHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhC
Confidence 999999999999999999999999999999999887554433222221111111000 1 12335678899999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+||.+|.+.++++. |++..+.|-.+
T Consensus 329 ~d~dkris~~~A~~-~~~~~e~R~r~ 353 (449)
T KOG0664|consen 329 FDPDKRISVEEALQ-HRYLEEGRLRF 353 (449)
T ss_pred CCCcccccHhhhcc-cccccccceee
Confidence 99999999999999 99999877543
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=281.61 Aligned_cols=240 Identities=30% Similarity=0.439 Sum_probs=201.3
Q ss_pred chhheecccceeEEEEeEecC--CCc--eeeeeeeec-----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLD--SGE--LVAIKKVLQ-----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~--~~~--~~aiK~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+.++||.|.||.||+|..-. .|+ -||||.-.. +.+.|..|.-+|++++||||+++++.+.+..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------- 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------- 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-------
Confidence 456789999999999998743 344 388887743 3577889999999999999999999987643
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 465 -------------------------------------------------------------------------------- 464 (974)
T KOG4257|consen 465 -------------------------------------------------------------------------------- 464 (974)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+||||+|+ |.|+.++. .....++......++.||+
T Consensus 465 ----------------------------------------~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~ 501 (974)
T KOG4257|consen 465 ----------------------------------------MWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQIC 501 (974)
T ss_pred ----------------------------------------eeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHH
Confidence 899999999 78999987 3567799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccc--cccccCchhhccCCCCCcchhhhhHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC--SRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.||+|||+.+++||||...||++. ....+||+|||+++............+ ..-|||||.+.-. .++.++|+|.||
T Consensus 502 talaYLeSkrfVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFg 579 (974)
T KOG4257|consen 502 TALAYLESKRFVHRDIAARNILVS-SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFG 579 (974)
T ss_pred HHHHHHHhhchhhhhhhhhheeec-CcceeeecccchhhhccccchhhccccccceeecCccccchh-cccchhhHHHHH
Confidence 999999999999999999999999 778999999999988766544333333 4459999999776 899999999999
Q ss_pred HHHHHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+|||++ .|..||.+-...+.+..+.++-+ -..|++||+.+..|+.+||.+
T Consensus 580 VCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR----------------------------lP~P~nCPp~LYslmskcWay 631 (974)
T KOG4257|consen 580 VCMWEILSLGVKPFQGVKNSDVIGHIENGER----------------------------LPCPPNCPPALYSLMSKCWAY 631 (974)
T ss_pred HHHHHHHHhcCCccccccccceEEEecCCCC----------------------------CCCCCCCChHHHHHHHHHhcc
Confidence 9999998 59999998777776665554321 123578999999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy10212 412 TPSSRISPLQVRS 424 (444)
Q Consensus 412 DP~kRPs~~elL~ 424 (444)
||.+||.+.++..
T Consensus 632 eP~kRPrftei~~ 644 (974)
T KOG4257|consen 632 EPSKRPRFTEIKA 644 (974)
T ss_pred CcccCCcHHHHHH
Confidence 9999999988876
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=290.26 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=194.8
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeec-----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
|..-+.||+|+||.||+++++.+|+.||||.+.. ..+..++|+++|++|+|+|||++.++=.....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~--------- 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL--------- 85 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc---------
Confidence 4567899999999999999999999999999854 34667799999999999999997543322110
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
|-.
T Consensus 86 -------------------------------------------------------~~~---------------------- 88 (732)
T KOG4250|consen 86 -------------------------------------------------------GLV---------------------- 88 (732)
T ss_pred -------------------------------------------------------Ccc----------------------
Confidence 000
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.-.-.+|||||.| +|+..+.. -.....+++.+++.++..+..||
T Consensus 89 ----------------------------------~~~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al 133 (732)
T KOG4250|consen 89 ----------------------------------TRLPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSAL 133 (732)
T ss_pred ----------------------------------cccceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHH
Confidence 0126799999995 88887753 23455699999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCC-CC--eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPE-TG--VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~-~~--~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.|||++||+||||||.||++-.. +| .-||+|||.++.......-....||..|++||.+.....|+...|.|||||+
T Consensus 134 ~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvt 213 (732)
T KOG4250|consen 134 RHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVT 213 (732)
T ss_pred HHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhH
Confidence 99999999999999999999422 23 3499999999999888888888999999999999854489999999999999
Q ss_pred HHHHHhCCCCCCCCC----hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc------CCCChhHHHH
Q psy10212 335 LAELLLGQPMFPGDS----GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR------VRTPPDAIDL 404 (444)
Q Consensus 335 l~eLltG~~Pf~~~~----~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~------~~~s~~l~~L 404 (444)
+|+..||..||-... ..+....+.. +.+....+..- ...+ ....|...+| +..-..+-.+
T Consensus 214 lY~caTG~lPF~p~~~pk~~~~~~~~~~t--kkp~~v~i~~~--~~eN------gpv~~s~~lP~p~~Ls~~l~~~~~kw 283 (732)
T KOG4250|consen 214 LYECATGELPFIPFGGPKNNKEIMWHIIT--KKPSGVAIGAQ--EEEN------GPVEWSSTLPQPNHLSRGLATRLTKW 283 (732)
T ss_pred HHHHhccCCCCCcCCCccccchhhhhhhc--cCCCceeEeee--cccC------CceeeeccCCCcccccHHHHhhhhHH
Confidence 999999999996422 2223333332 11211111000 0001 1122333332 2223557788
Q ss_pred HHHhcccCCCCCCC
Q psy10212 405 ISRLLEYTPSSRIS 418 (444)
Q Consensus 405 I~~~L~~DP~kRPs 418 (444)
+..+|.++|++|..
T Consensus 284 La~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 284 LASMLEWNPRKRGH 297 (732)
T ss_pred HHHHHhhhHHHhCC
Confidence 99999999999994
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=271.54 Aligned_cols=184 Identities=26% Similarity=0.453 Sum_probs=159.3
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
+|+|||||.| .|.-.|. +-+++.+..+..++..|+-||-+||++||+.||||.+||+++ ..|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd-~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec-cCCceEeeecccccc
Confidence 9999999996 6655553 567899999999999999999999999999999999999999 899999999999875
Q ss_pred cc-CCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC
Q psy10212 295 LV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373 (444)
Q Consensus 295 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~ 373 (444)
-- ......+.+||+.|+|||++.-. +|+.+.|.||+|+++|||+.|++||.+.+..++.+.|.+.
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------- 565 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------- 565 (683)
T ss_pred cccCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------
Confidence 43 33445677999999999999877 8999999999999999999999999999998888888762
Q ss_pred CCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH-----HHHhccCchhhhhhhh
Q psy10212 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP-----LQVRSITPFLIELRAV 435 (444)
Q Consensus 374 ~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~-----~elL~~hpwf~~~~~~ 435 (444)
+ -.+++.+|.+..+++..+|.+.|.+|... .++-. ||||+.+...
T Consensus 566 ----n------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~-H~FFR~iDWe 615 (683)
T KOG0696|consen 566 ----N------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIRE-HPFFRRIDWE 615 (683)
T ss_pred ----c------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhh-CcchhhccHH
Confidence 2 22345789999999999999999999875 56666 9999987543
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=265.41 Aligned_cols=263 Identities=29% Similarity=0.391 Sum_probs=211.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHH-HhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQ-IMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
...+-++.||.|+||+|++-.++.+|+..|||+|.... ..+..|.+ .++.-++||||++++...++|+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd------ 137 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD------ 137 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc------
Confidence 45677899999999999999999999999999994432 23334555 3555589999999999999987
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 138 -------------------------------------------------------------------------------- 137 (361)
T KOG1006|consen 138 -------------------------------------------------------------------------------- 137 (361)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHh-hhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKH-YSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~-~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|-||+|.-|+-.+-++ +.-....+++..+-.|..-..
T Consensus 138 ----------------------------------------cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV 177 (361)
T KOG1006|consen 138 ----------------------------------------CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATV 177 (361)
T ss_pred ----------------------------------------eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeeh
Confidence 889999999887655532 445667899999999999999
Q ss_pred HHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC-CCCcchhhhhHH
Q psy10212 255 RSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI-DYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~s~~sDiwSLG 332 (444)
.||.||-. ..++|||+||+|||++ ..|.+||+|||++-....+...+.-.|...|||||.+.... .|..+||+||||
T Consensus 178 ~AL~yLK~~lkiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLG 256 (361)
T KOG1006|consen 178 DALDYLKEELKIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLG 256 (361)
T ss_pred hHHHHHHHHhhhhhccCChhheEEe-cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhc
Confidence 99999985 5899999999999999 78999999999997776666666677889999999986543 489999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++||+.||+.|+.+.+. .+++..++. |.|+ .+ ....- ..+++..+..+|..||.+
T Consensus 257 ITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp-~l----------------~~~~~----~~~~s~~~~~fintCl~K 313 (361)
T KOG1006|consen 257 ITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPP-IL----------------LFDKE----CVHYSFSMVRFINTCLIK 313 (361)
T ss_pred ceEeeeecCCCCcchHHHHHHHHHHHHc--CCCC-ee----------------cCccc----ccccCHHHHHHHHHHhhc
Confidence 999999999999998765 234433332 2221 11 11100 124689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|-++||...++++ +||++.+...
T Consensus 314 d~~~Rpky~~Lk~-~~fyr~y~~~ 336 (361)
T KOG1006|consen 314 DRSDRPKYDDLKK-FPFYRMYAVE 336 (361)
T ss_pred ccccCcchhhhhc-Cchhhhhhhc
Confidence 9999999999999 9999986543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=283.65 Aligned_cols=266 Identities=27% Similarity=0.385 Sum_probs=217.2
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
+-+=+.-|++++.+|+|.+|.||+++.+.+++..|+|+...+ .+..+-|..+++.+ +|||++.++++|.......
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~- 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN- 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC-
Confidence 445567899999999999999999999999999999988544 34555677777766 7999999999998765310
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
+
T Consensus 93 ----------------------------------------------~--------------------------------- 93 (953)
T KOG0587|consen 93 ----------------------------------------------G--------------------------------- 93 (953)
T ss_pred ----------------------------------------------C---------------------------------
Confidence 0
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
--+++|||||+ ||..|+++... +.++.|..+..|++
T Consensus 94 -----------------------------------------DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~r 130 (953)
T KOG0587|consen 94 -----------------------------------------DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILR 130 (953)
T ss_pred -----------------------------------------CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHH
Confidence 13999999999 59999998765 88999999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccC----CCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGA----IDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~s~~s 326 (444)
.++.||++||...++|||||-.||+++ .++.+||+|||.+...... ....+..||++|||||++... ..|+.++
T Consensus 131 e~lrgl~HLH~nkviHRDikG~NiLLT-~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~ 209 (953)
T KOG0587|consen 131 EILRGLAHLHNNKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRS 209 (953)
T ss_pred HHHHHHHHHhhcceeeecccCceEEEe-ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCccccc
Confidence 999999999999999999999999999 8999999999998665332 345677899999999998532 3578899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||||++..||..|.+|+-+..+...+..|. +-|++.+.. +..-+..+.++|.
T Consensus 210 D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPPkLkr-----------------------p~kWs~~FndFIs 263 (953)
T KOG0587|consen 210 DLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPKLKR-----------------------PKKWSKKFNDFIS 263 (953)
T ss_pred chhhccceeehhcCCCCCccCcchhhhhccCC---CCCCccccc-----------------------hhhHHHHHHHHHH
Confidence 99999999999999999998877654443222 122222110 1123788999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||.+|-.+||+..++|+ |||+++..
T Consensus 264 ~cL~Kd~e~RP~~~~ll~-hpFi~e~~ 289 (953)
T KOG0587|consen 264 TCLVKDYEQRPSTEELLK-HPFITEQP 289 (953)
T ss_pred HHHhhccccCcchhhhcc-CCcccccc
Confidence 999999999999999999 99998644
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.61 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=202.8
Q ss_pred ccchhheecccceeEEEEeEecC-CCc--eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLD-SGE--LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
...+.++||+|+||.|++|.+.. .|+ .||||.+..+ -..|.+|+.+|.+|+|+|++++++.....-
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp------ 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP------ 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch------
Confidence 34567899999999999999865 344 5899998443 467889999999999999999999998732
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 185 -------------------------------------------------------------------------------- 184 (1039)
T KOG0199|consen 185 -------------------------------------------------------------------------------- 184 (1039)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+.+|||+|+ |||++-+.. .....+.......++.||
T Consensus 185 -----------------------------------------~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~Qi 221 (1039)
T KOG0199|consen 185 -----------------------------------------AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQI 221 (1039)
T ss_pred -----------------------------------------hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHH
Confidence 669999999 689888764 456778899999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc----ccccccccCchhhccCCCCCcchhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS----YICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~----~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
+.|+.||.+++++||||...|+++- ....+||+|||+.+........-. ..-...|+|||.+... .++.++|+|
T Consensus 222 A~aM~YLeskrlvHRDLAARNllla-sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvW 299 (1039)
T KOG0199|consen 222 AKAMQYLESKRLVHRDLAARNLLLA-SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVW 299 (1039)
T ss_pred HHHHHHHhhhhhhhhhhhhhhheec-ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhh
Confidence 9999999999999999999999998 577999999999987655443221 1225569999999998 899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
++||++|||++ |..||.+....+++.++-+...- + -++.||+++.+++..|
T Consensus 300 myGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL------------------p----------RPk~csedIY~imk~c 351 (1039)
T KOG0199|consen 300 MYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL------------------P----------RPKYCSEDIYQIMKNC 351 (1039)
T ss_pred hhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC------------------C----------CCCCChHHHHHHHHHh
Confidence 99999999996 99999999988877766542111 1 1346899999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
|..+|.+|||+..|.+
T Consensus 352 Wah~paDRptFsair~ 367 (1039)
T KOG0199|consen 352 WAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCccccccHHHHHH
Confidence 9999999999998875
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=275.19 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=216.6
Q ss_pred ccccccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEE
Q psy10212 8 LGFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFF 84 (444)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (444)
+|...|+..++-=.......++||.|.||.||.|.++...-.||||.+..+ .++|..|..+|+.++|||+|++++.|
T Consensus 253 ygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 253 YGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred eeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 566677766666566667789999999999999999988888999998655 47888999999999999999999999
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
..+-+
T Consensus 333 T~EpP--------------------------------------------------------------------------- 337 (1157)
T KOG4278|consen 333 THEPP--------------------------------------------------------------------------- 337 (1157)
T ss_pred ccCCC---------------------------------------------------------------------------
Confidence 87754
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCCh
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPC 243 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~ 243 (444)
+|||+|||. |+|+++++.. ....++.
T Consensus 338 ---------------------------------------------------FYIiTEfM~yGNLLdYLRec--nr~ev~a 364 (1157)
T KOG4278|consen 338 ---------------------------------------------------FYIITEFMCYGNLLDYLREC--NRSEVPA 364 (1157)
T ss_pred ---------------------------------------------------eEEEEecccCccHHHHHHHh--chhhcch
Confidence 999999987 8999999653 3344667
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccc---cccccCchhhccCC
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC---SRYYRAPELIFGAI 320 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~g---t~~y~aPE~l~~~~ 320 (444)
-....++.||..|++||..++++||||...|.|+. ++..+|+.|||+++.+.... .+...| ..-|.|||.+.-.
T Consensus 365 vvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyN- 441 (1157)
T KOG4278|consen 365 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN- 441 (1157)
T ss_pred hHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc-ccceEEeeccchhhhhcCCc-eecccCccCcccccCccccccc-
Confidence 77888899999999999999999999999999999 88899999999998874432 222223 4559999999877
Q ss_pred CCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+|+|||++||+.| |..||++.+..+.+..+.+..+ +.- +..|++
T Consensus 442 tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR----------------M~~------------PeGCPp 493 (1157)
T KOG4278|consen 442 TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR----------------MDG------------PEGCPP 493 (1157)
T ss_pred ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------------ccC------------CCCCCH
Confidence 79999999999999999996 9999999987776665554211 111 346899
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+.+|+..||++.|.+||+++|+-. -|+.
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHq---afEt 522 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQ---AFET 522 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHH---HHHH
Confidence 9999999999999999999998843 5544
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=277.04 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=220.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+++++..||-||||+|=+++.+.....+|+|.+.+. .+....|-++|.+++.|.||+++..|-++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~------- 492 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS------- 492 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-------
Confidence 4677899999999999999998776667999988443 23444688999999999999998777554
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 493 -------------------------------------------------------------------------------- 492 (732)
T KOG0614|consen 493 -------------------------------------------------------------------------------- 492 (732)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+.|+.||-|= |.+|..++ ..+.+.+.+++.++..+
T Consensus 493 ---------------------------------------kyvYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv 529 (732)
T KOG0614|consen 493 ---------------------------------------KYVYMLMEACLGGELWTILR----DRGSFDDYTARFYVACV 529 (732)
T ss_pred ---------------------------------------hhhhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHH
Confidence 35899999986 58998874 46789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
++|++|||++||+.|||||+|++++ ..|.+||.|||.++....+...-+.+||+.|.|||++... .-+.+.|.||||+
T Consensus 530 ~EAfeYLH~k~iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGI 607 (732)
T KOG0614|consen 530 LEAFEYLHRKGIIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGI 607 (732)
T ss_pred HHHHHHHHhcCceeccCChhheeec-cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhcc-CcchhhHHHHHHH
Confidence 9999999999999999999999999 8999999999999999888888889999999999999877 6789999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|||++|.+||.+.++...+..|.+++- .+. ||..++....+||+++-.-+|
T Consensus 608 li~ELL~G~pPFs~~dpmktYn~ILkGid---------------~i~------------~Pr~I~k~a~~Lik~LCr~~P 660 (732)
T KOG0614|consen 608 LIYELLTGSPPFSGVDPMKTYNLILKGID---------------KIE------------FPRRITKTATDLIKKLCRDNP 660 (732)
T ss_pred HHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------hhh------------cccccchhHHHHHHHHHhcCc
Confidence 99999999999999999999999988541 122 334578889999999999999
Q ss_pred CCCCC-----HHHHhccCchhhhhhh
Q psy10212 414 SSRIS-----PLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRPs-----~~elL~~hpwf~~~~~ 434 (444)
.+|.. +.++-+ |.||..+..
T Consensus 661 ~ERLG~~~~gI~DIkk-H~Wf~gfdw 685 (732)
T KOG0614|consen 661 TERLGYQKGGINDIKK-HRWFEGFDW 685 (732)
T ss_pred HhhhccccCChHHHHh-hhhhhcCCh
Confidence 99997 789999 999988544
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=286.65 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=192.7
Q ss_pred ccchhheecccceeE-EEEeEecCCCceeeeeeeeccc-cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGI-VYQAKLLDSGELVAIKKVLQDK-RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~-Vy~~~~~~~~~~~aiK~~~~~~-~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
-|.-.+++|.|+-|+ ||+|.. .|+.||||.+...- ....|||+.++.. .||||+++++.-.+.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~------------ 575 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDR------------ 575 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCC------------
Confidence 344467889999985 899998 79999999996554 5777999999988 699999975332221
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 576 -------------------------------------------------------------------------------- 575 (903)
T KOG1027|consen 576 -------------------------------------------------------------------------------- 575 (903)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.|+||..|+|..+|.+++...............+.++.|++.||++
T Consensus 576 ----------------------------------qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaH 621 (903)
T KOG1027|consen 576 ----------------------------------QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAH 621 (903)
T ss_pred ----------------------------------ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHH
Confidence 6899999999999999997531212222235678899999999999
Q ss_pred HHHCCcccCCCCCCcEEEcC----CCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 260 IHVLGICHRDIKPQNLLLNP----ETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~----~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.+|+||||||.|||++. ....++|.|||+++....+.. .....||-+|+|||++... .-+.+.|||||
T Consensus 622 LHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFsl 700 (903)
T KOG1027|consen 622 LHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSL 700 (903)
T ss_pred HHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhc
Confidence 99999999999999999974 235789999999988754432 3455789999999999887 66789999999
Q ss_pred HHHHHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||++|+.++| ..||.+.-. .-..|+... .-...+.+.-..+..+||.+|+.
T Consensus 701 GCvfyYvltgG~HpFGd~~~--R~~NIl~~~--------------------------~~L~~L~~~~d~eA~dLI~~ml~ 752 (903)
T KOG1027|consen 701 GCVFYYVLTGGSHPFGDSLE--RQANILTGN--------------------------YTLVHLEPLPDCEAKDLISRMLN 752 (903)
T ss_pred CceEEEEecCCccCCCchHH--hhhhhhcCc--------------------------cceeeeccCchHHHHHHHHHhcC
Confidence 9999999975 999975432 223333210 00111111112389999999999
Q ss_pred cCCCCCCCHHHHhccCchhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~ 431 (444)
+||..||+|.++|. ||+|=+
T Consensus 753 ~dP~~RPsa~~VL~-HPlFW~ 772 (903)
T KOG1027|consen 753 PDPQLRPSATDVLN-HPLFWD 772 (903)
T ss_pred CCcccCCCHHHHhC-CCccCC
Confidence 99999999999999 998854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=299.04 Aligned_cols=264 Identities=21% Similarity=0.306 Sum_probs=192.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++++...|...++||+|+||.||+|+++.+++.||+|++........+|++.+++++||||+++++++...+.
T Consensus 685 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~------- 757 (968)
T PLN00113 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG------- 757 (968)
T ss_pred HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCC-------
Confidence 3445567888899999999999999998899999999997655555678999999999999999999976543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 758 -------------------------------------------------------------------------------- 757 (968)
T PLN00113 758 -------------------------------------------------------------------------------- 757 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.++|||||+ ++|.+++. .+++..+..++.||+.
T Consensus 758 ---------------------------------------~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~ 791 (968)
T PLN00113 758 ---------------------------------------AYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAK 791 (968)
T ss_pred ---------------------------------------CEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHH
Confidence 789999998 58888874 3788999999999999
Q ss_pred HHHHHH---HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 256 SLAYIH---VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLH---s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
||+||| +.+++||||||+||+++ .....++. ++...... ......++..|+|||.+.+. .++.++||||+|
T Consensus 792 ~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~G 865 (968)
T PLN00113 792 ALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLC---TDTKCFISSAYVAPETRETK-DITEKSDIYGFG 865 (968)
T ss_pred HHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-eccccccc---cCCCccccccccCcccccCC-CCCcccchhhHH
Confidence 999999 66999999999999998 55665554 44432221 11223568899999998876 799999999999
Q ss_pred HHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|++|||++|+.||...... ....+..+...... ... ....|.... ..........++.+++.+||+.
T Consensus 866 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HLD-------MWIDPSIRG---DVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred HHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--chh-------heeCccccC---CCCccHHHHHHHHHHHHhhCcC
Confidence 9999999999998532211 11111111100000 000 000011000 0001112234688999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||++|||+.|+++ .++.+..
T Consensus 934 ~P~~RPt~~evl~---~L~~~~~ 953 (968)
T PLN00113 934 DPTARPCANDVLK---TLESASR 953 (968)
T ss_pred CchhCcCHHHHHH---HHHHhhc
Confidence 9999999999999 5666543
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=258.20 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=210.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.|.++++||+|+|+.|.+++.+.+.+.||+|++.+. .+..+.|-.++.+. +||.+|-+..+|..+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr--- 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR--- 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce---
Confidence 46899999999999999999999999999999988432 24455677777666 79999998877766543
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 326 -------------------------------------------------------------------------------- 325 (593)
T KOG0695|consen 326 -------------------------------------------------------------------------------- 325 (593)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
+++|.||+.| .|.-.+. ....++++.++.+..
T Consensus 326 -------------------------------------------lffvieyv~ggdlmfhmq----rqrklpeeharfys~ 358 (593)
T KOG0695|consen 326 -------------------------------------------LFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSA 358 (593)
T ss_pred -------------------------------------------EEEEEEEecCcceeeehh----hhhcCcHHHhhhhhH
Confidence 9999999997 4443332 456799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc-cCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.|+.||.|||++||+.||||.+|++++ ..|++||+|+|.++.- ..++..++.+||+.|.|||++.+. .|..+.|.|+
T Consensus 359 ei~lal~flh~rgiiyrdlkldnvlld-aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwa 436 (593)
T KOG0695|consen 359 EICLALNFLHERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWA 436 (593)
T ss_pred HHHHHHHHHhhcCeeeeeccccceEEc-cCCceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHH
Confidence 999999999999999999999999999 8999999999998764 345667788999999999999998 8999999999
Q ss_pred HHHHHHHHHhCCCCCCC-------CChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 331 AGCVLAELLLGQPMFPG-------DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~-------~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
||++|+||+.|+.||+- .+.++.+.+++-. ....++..+|.....
T Consensus 437 lgvlmfemmagrspfdivgm~n~d~ntedylfqvile----------------------------kqiriprslsvkas~ 488 (593)
T KOG0695|consen 437 LGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE----------------------------KQIRIPRSLSVKASH 488 (593)
T ss_pred HHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----------------------------hcccccceeehhhHH
Confidence 99999999999999972 2333444443321 011123356888899
Q ss_pred HHHHhcccCCCCCCC------HHHHhccCchhhhhhhhhhcccc
Q psy10212 404 LISRLLEYTPSSRIS------PLQVRSITPFLIELRAVFENICF 441 (444)
Q Consensus 404 LI~~~L~~DP~kRPs------~~elL~~hpwf~~~~~~~~~~~~ 441 (444)
+++..|++||.+|.. .+++-. |+||+.+.......+-
T Consensus 489 vlkgflnkdp~erlgc~~~~g~~dik~-h~ffr~idwd~leqk~ 531 (593)
T KOG0695|consen 489 VLKGFLNKDPKERLGCRPQTGFSDIKS-HAFFRSIDWDLLEQKQ 531 (593)
T ss_pred HHHHhhcCCcHHhcCCCcccchhhhhc-chhhhhCCHHHHhhcc
Confidence 999999999999875 477888 9999988766544433
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=269.93 Aligned_cols=258 Identities=23% Similarity=0.269 Sum_probs=208.6
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
-.+...+.++||+|-||.|-++.-.. +..||+|.+... ++.|.+|+++|.+|+||||+.+.+.+..+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP----- 609 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP----- 609 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----
Confidence 34677889999999999999998743 589999999543 3678899999999999999999999998775
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 610 -------------------------------------------------------------------------------- 609 (807)
T KOG1094|consen 610 -------------------------------------------------------------------------------- 609 (807)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++++||||+ |.|.+++....... ........|+.||
T Consensus 610 -----------------------------------------icmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqi 646 (807)
T KOG1094|consen 610 -----------------------------------------LCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQI 646 (807)
T ss_pred -----------------------------------------hHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHH
Confidence 889999999 79999986532211 3455566799999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc---cccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.|++||.+.+++||||.+.|+|++ .++++||+|||.++..-.++... ...-..+|||+|.+.-+ .++.++|+|+
T Consensus 647 asgmaYLes~nfVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWa 724 (807)
T KOG1094|consen 647 ASGMAYLESLNFVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWA 724 (807)
T ss_pred HHHHHHHHhhchhhccccccceeec-CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhh
Confidence 9999999999999999999999999 89999999999997543333221 12336789999998877 8999999999
Q ss_pred HHHHHHHHH--hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 331 AGCVLAELL--LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 331 LGvil~eLl--tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
+|+++||++ +...||...++++.....-..+....+.- --..|+-|+..+.++|.+|
T Consensus 725 fgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~---------------------~l~~P~~cp~~lyelml~C 783 (807)
T KOG1094|consen 725 FGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV---------------------VLSRPPACPQGLYELMLRC 783 (807)
T ss_pred hHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---------------------eccCCCcCcHHHHHHHHHH
Confidence 999999988 68899999888877766555433222111 1112456899999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|+.|-.+|||.+++.. +|++.
T Consensus 784 w~~es~~RPsFe~lh~---~lq~~ 804 (807)
T KOG1094|consen 784 WRRESEQRPSFEQLHL---FLQED 804 (807)
T ss_pred hchhhhcCCCHHHHHH---HHHHh
Confidence 9999999999999955 77763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=274.21 Aligned_cols=198 Identities=22% Similarity=0.261 Sum_probs=135.2
Q ss_pred EEEEeccCCC-cHHHHHHhhhh--------------------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSK--------------------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~--------------------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~N 274 (444)
.++||||+++ +|.+++..... ....+++..++.++.|++.+|.|||+++++|+||||+|
T Consensus 260 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~N 339 (507)
T PLN03224 260 QWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPEN 339 (507)
T ss_pred eEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHh
Confidence 7899999994 88888753110 11234567889999999999999999999999999999
Q ss_pred EEEcCCCCeEEEeecCCcccccCCCCCcc--ccccccccCchhhccCC---------------------CCCcchhhhhH
Q psy10212 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVS--YICSRYYRAPELIFGAI---------------------DYTTKIDVWSA 331 (444)
Q Consensus 275 Ill~~~~~~ikL~Dfg~s~~~~~~~~~~~--~~gt~~y~aPE~l~~~~---------------------~~s~~sDiwSL 331 (444)
|+++ .++.++|+|||++........... ...++.|+|||.+.... ....+.|+||+
T Consensus 340 ILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 340 LLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred EEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 9999 678999999999865433322222 23378999999875321 01124699999
Q ss_pred HHHHHHHHhCCC-CCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQP-MFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~-Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||++++|+++.. |+.+........+... .....|..... ..+.-..-..+++...+||.+||.
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~~~~------------~~~~~~~~d~~s~~~~dLi~~LL~ 482 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRMYKG------------QKYDFSLLDRNKEAGWDLACKLIT 482 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHhhcc------------cCCCcccccccChHHHHHHHHHhc
Confidence 999999999875 6654321111100000 00011111100 011111123458999999999999
Q ss_pred cCC---CCCCCHHHHhccCchhhh
Q psy10212 411 YTP---SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 411 ~DP---~kRPs~~elL~~hpwf~~ 431 (444)
.+| .+|+|+.|+|+ ||||..
T Consensus 483 ~~~~~~~~RlSa~eaL~-Hp~f~~ 505 (507)
T PLN03224 483 KRDQANRGRLSVGQALS-HRFFLP 505 (507)
T ss_pred cCCCCcccCCCHHHHhC-CCCcCC
Confidence 876 68999999999 999953
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.00 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=207.5
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----------cchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----------RFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
.+.++|-+++.||+|||+.||+|-|...+++||+|+-...+ ...+||.++-+.|.||-||+++++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 46689999999999999999999999999999999763322 3345899999999999999999999776
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
.+
T Consensus 540 td------------------------------------------------------------------------------ 541 (775)
T KOG1151|consen 540 TD------------------------------------------------------------------------------ 541 (775)
T ss_pred cc------------------------------------------------------------------------------
Confidence 53
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
-++-|+|||+|.-+++.. +...-+++.+++
T Consensus 542 -----------------------------------------------sFCTVLEYceGNDLDFYL---KQhklmSEKEAR 571 (775)
T KOG1151|consen 542 -----------------------------------------------SFCTVLEYCEGNDLDFYL---KQHKLMSEKEAR 571 (775)
T ss_pred -----------------------------------------------cceeeeeecCCCchhHHH---HhhhhhhHHHHH
Confidence 288999999996555542 466789999999
Q ss_pred HHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCC--------CccccccccccCchh
Q psy10212 248 LYIYQLFRSLAYIHVLG--ICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPEL 315 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~g--ivH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~ 315 (444)
.|++||..||.||.+.. |+|.||||.|||+.. ..|.|||+|||+++.+..... .+...||.+|++||.
T Consensus 572 SIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEc 651 (775)
T KOG1151|consen 572 SIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPEC 651 (775)
T ss_pred HHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcce
Confidence 99999999999999876 999999999999952 356899999999988754332 234578999999998
Q ss_pred hcc---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccc
Q psy10212 316 IFG---AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392 (444)
Q Consensus 316 l~~---~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 392 (444)
+.- ....+.+.||||+|||+|..+.|+.||...-.. ++|++.- ..+ ......||.
T Consensus 652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILqeN-----TIl-----kAtEVqFP~--------- 709 (775)
T KOG1151|consen 652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQEN-----TIL-----KATEVQFPP--------- 709 (775)
T ss_pred eecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHhhh-----chh-----cceeccCCC---------
Confidence 743 345789999999999999999999999754322 1222210 000 011222222
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+-++++..+||++||.+.-++|....++-. ||||.-
T Consensus 710 -KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~-dpyllP 746 (775)
T KOG1151|consen 710 -KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC-DPYLLP 746 (775)
T ss_pred -CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc-Cccccc
Confidence 2347999999999999999999999999999 999864
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=277.35 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=210.4
Q ss_pred cccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+...|.++||.|.||.|++|+.+..|+ .||||.+... +..|..|..+|-+.+||||+++-+....+.+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P---- 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP---- 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce----
Confidence 344678999999999999999988775 5999999543 4677789999999999999999999988765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 705 -------------------------------------------------------------------------------- 704 (996)
T KOG0196|consen 705 -------------------------------------------------------------------------------- 704 (996)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..||+|||+ |+|-.+++ ...+.++..+...+++-
T Consensus 705 ------------------------------------------vMIiTEyMENGsLDsFLR---~~DGqftviQLVgMLrG 739 (996)
T KOG0196|consen 705 ------------------------------------------VMIITEYMENGSLDSFLR---QNDGQFTVIQLVGMLRG 739 (996)
T ss_pred ------------------------------------------eEEEhhhhhCCcHHHHHh---hcCCceEeehHHHHHHH
Confidence 789999999 67877775 45577999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc-cccc---cccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYIC---SRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~-~~~g---t~~y~aPE~l~~~~~~s~~sDi 328 (444)
|+.|+.||-+.+++||||...|||++ .+-.+|+.|||+++...+..... +..| ..+|.|||.+... .++.+||+
T Consensus 740 IAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDV 817 (996)
T KOG0196|consen 740 IASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDV 817 (996)
T ss_pred HHHHhHHHhhcCchhhhhhhhheeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhc-ccCchhhc
Confidence 99999999999999999999999999 88999999999998765443211 1111 5789999999888 89999999
Q ss_pred hhHHHHHHHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||+|++|||.+ .|..||=+.+..+.+..|.+..+-|+ |.+||..+..|+..
T Consensus 818 WSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp----------------------------PmDCP~aL~qLMld 869 (996)
T KOG0196|consen 818 WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP----------------------------PMDCPAALYQLMLD 869 (996)
T ss_pred cccceEEEEecccCCCcccccchHHHHHHHHhccCCCC----------------------------CCCCcHHHHHHHHH
Confidence 99999999988 59999999999999988887554443 34789999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||++|-..||.+.|++.
T Consensus 870 CWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 870 CWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHhhcCCCHHHHHH
Confidence 99999999999999998
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=267.71 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=204.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.-|..++-||-|.||.|.+++..++...||.|.+.+.. .....|-++|.....+.||++++.|.+++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn----- 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN----- 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-----
Confidence 46888999999999999999999999999999884432 233358888999999999999999988864
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 704 -------------------------------------------------------------------------------- 703 (1034)
T KOG0608|consen 704 -------------------------------------------------------------------------------- 703 (1034)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
||+||+|++| .+.+++.+ -+-|.++.++.++..+
T Consensus 704 -----------------------------------------LYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEl 738 (1034)
T KOG0608|consen 704 -----------------------------------------LYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAEL 738 (1034)
T ss_pred -----------------------------------------eEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHH
Confidence 9999999995 77776642 4679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc---------CCCC------------------------
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV---------RGEP------------------------ 300 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~---------~~~~------------------------ 300 (444)
..|+++.|..|++||||||+|||+| .+|+|||+|||++.-+. .++.
T Consensus 739 tcAiesVHkmGFIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ 817 (1034)
T KOG0608|consen 739 TCAIESVHKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLER 817 (1034)
T ss_pred HHHHHHHHhccceecccCccceEEc-cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHH
Confidence 9999999999999999999999999 89999999999974321 0000
Q ss_pred ----------CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHH
Q psy10212 301 ----------NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370 (444)
Q Consensus 301 ----------~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~ 370 (444)
.....||+.|+|||++... .++..+|.||.|||+|+|+.|++||...++.+...+++++.
T Consensus 818 ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~--------- 887 (1034)
T KOG0608|consen 818 RAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR--------- 887 (1034)
T ss_pred HHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh---------
Confidence 0013578999999999877 89999999999999999999999999888877666555421
Q ss_pred hhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhhh
Q psy10212 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELRA 434 (444)
Q Consensus 371 ~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~~ 434 (444)
.-+......++|.++.++|.++ ..+++.|.. +.|+-. ||||+.+.-
T Consensus 888 ----------------~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKa-HpfFkgIDf 936 (1034)
T KOG0608|consen 888 ----------------NFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKA-HPFFKGIDF 936 (1034)
T ss_pred ----------------hccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhc-Cccccccch
Confidence 0111122356799999999875 567888886 455666 999997643
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=251.93 Aligned_cols=290 Identities=27% Similarity=0.421 Sum_probs=221.6
Q ss_pred ccccchhhhhhccccchhheecccceeEEEEeEecC---CCceeeeeeee--ccccchhhHHHHhhhc-CCCceeEeeeE
Q psy10212 10 FAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLD---SGELVAIKKVL--QDKRFKNREMQIMRRL-EHSNIVKLKYF 83 (444)
Q Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 83 (444)
+.+-+.++..+.+.|.++++||.|+|++||++.+.. .++.||+|.+. .......+|+++|..+ -+.||+++.+.
T Consensus 24 ~~~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 24 IEQLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HHHHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhh
Confidence 455677888899999999999999999999999987 78899999994 4467788999999999 47899988777
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+-..+.
T Consensus 104 ~rnnd~-------------------------------------------------------------------------- 109 (418)
T KOG1167|consen 104 FRNNDQ-------------------------------------------------------------------------- 109 (418)
T ss_pred hccCCe--------------------------------------------------------------------------
Confidence 655443
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCC
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFP 242 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~ 242 (444)
..+||||++- .-.++.. .++
T Consensus 110 ----------------------------------------------------v~ivlp~~~H~~f~~l~~-------~l~ 130 (418)
T KOG1167|consen 110 ----------------------------------------------------VAIVLPYFEHDRFRDLYR-------SLS 130 (418)
T ss_pred ----------------------------------------------------eEEEecccCccCHHHHHh-------cCC
Confidence 7799999995 5556553 467
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-----------------C--CC----
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-----------------R--GE---- 299 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-----------------~--~~---- 299 (444)
...++.+++.++.||.++|.+||+||||||.|++.+...+.-.|+|||++.... . +.
T Consensus 131 ~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~ 210 (418)
T KOG1167|consen 131 LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC 210 (418)
T ss_pred HHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence 899999999999999999999999999999999999888899999999985110 0 00
Q ss_pred ----------------------CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCC-CCChhHHHHH
Q psy10212 300 ----------------------PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFP-GDSGVDQLVE 356 (444)
Q Consensus 300 ----------------------~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~-~~~~~e~~~~ 356 (444)
......||++|.|||++..-..-+++.|+||.|+|+..+++++.||- ..++.+.+.+
T Consensus 211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e 290 (418)
T KOG1167|consen 211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE 290 (418)
T ss_pred cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHH
Confidence 00012579999999999877678899999999999999999998864 4566677777
Q ss_pred HHHHhCCCCHHHHHhhCCC------------------CCcccCCCccC--C--CCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 357 IIKVLGTPTREQIREMNPN------------------YTEFKFPQIKS--H--PWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 357 i~~~~g~~~~~~~~~~~~~------------------~~~~~~p~~~~--~--~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
++...|...-...+.+.+. +.......... . .+........+..+.+|+.+||..||.
T Consensus 291 i~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~ 370 (418)
T KOG1167|consen 291 IATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ 370 (418)
T ss_pred HHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChh
Confidence 7776665443333322222 00000000000 0 112222334567899999999999999
Q ss_pred CCCCHHHHhccCchhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELR 433 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~ 433 (444)
+|.|++++|+ ||||.+..
T Consensus 371 kRitAEeALk-HpFF~~~~ 388 (418)
T KOG1167|consen 371 KRITAEDALK-HPFFDEAD 388 (418)
T ss_pred hcccHHHHhc-CcCCcchh
Confidence 9999999999 99999754
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=265.21 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=202.8
Q ss_pred hhhhccccchhheecccceeEEEEeEecC---C----Cceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeE
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLD---S----GELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYF 83 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~----~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~ 83 (444)
++--.++..+.+.||.|.||.|++|.... . ...||+|.+... ...+..|+++|+.+ +|+||+.+.+.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33444555677799999999999997531 1 346999988432 45677899999999 69999999999
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+..+++
T Consensus 371 ~t~~~~-------------------------------------------------------------------------- 376 (609)
T KOG0200|consen 371 CTQDGP-------------------------------------------------------------------------- 376 (609)
T ss_pred eccCCc--------------------------------------------------------------------------
Confidence 988554
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh---h--c
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS---K--S 237 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~---~--~ 237 (444)
+++|+|||. |.|.+++++.+ . .
T Consensus 377 ----------------------------------------------------~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~ 404 (609)
T KOG0200|consen 377 ----------------------------------------------------LYVIVEYAEHGDLLEFLRKKRVTESIDG 404 (609)
T ss_pred ----------------------------------------------------eEEEEEeccCCcHHHHHHhccccccccc
Confidence 899999999 79999997655 1 1
Q ss_pred C-------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcc--cc--c
Q psy10212 238 K-------QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS--YI--C 306 (444)
Q Consensus 238 ~-------~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~--~~--g 306 (444)
. ..++......++.||+.|++||++..++||||..+||++. .+..+||+|||+++.......... .. -
T Consensus 405 ~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~L 483 (609)
T KOG0200|consen 405 SGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTL 483 (609)
T ss_pred cCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCcc
Confidence 1 2488889999999999999999999999999999999999 778999999999975433332211 11 2
Q ss_pred cccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCc
Q psy10212 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 384 (444)
Q Consensus 307 t~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~ 384 (444)
...|||||.+... .++.++|+||+|+++||+++ |..||.+.. ..+....+.++
T Consensus 484 P~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G------------------------ 538 (609)
T KOG0200|consen 484 PVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG------------------------ 538 (609)
T ss_pred ceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC------------------------
Confidence 3459999999986 89999999999999999996 899999855 44443322221
Q ss_pred cCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 385 ~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+-..|.+|++++.+++..||+.+|++||+..++.+ +|...
T Consensus 539 ----~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~---~~~~~ 579 (609)
T KOG0200|consen 539 ----NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE---FFEKH 579 (609)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH---HHHHH
Confidence 111124578999999999999999999999999998 77763
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=264.05 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=200.5
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+..-.++||+|.||+||+|...-.|+ +||||++... ...+.+|+..|.+|+|||++++++++..+.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---- 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---- 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence 345567899999999999999865565 6899988433 356678999999999999999999887754
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 772 -------------------------------------------------------------------------------- 771 (1177)
T KOG1025|consen 772 -------------------------------------------------------------------------------- 771 (1177)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
+-||++|++ |.|.++++. ..+++.....+.|+.
T Consensus 772 -------------------------------------------~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~ 805 (1177)
T KOG1025|consen 772 -------------------------------------------LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCY 805 (1177)
T ss_pred -------------------------------------------HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHH
Confidence 559999999 699999874 556788999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccc---cccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC---SRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~s~~sDi 328 (444)
||++||.|||.++++||||..+||||. ....+|++|||+++........-...+ .+-|||-|.+... .+++++||
T Consensus 806 QIAkgM~YLe~qrlVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDV 883 (1177)
T KOG1025|consen 806 QIAKGMKYLEEQRLVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDV 883 (1177)
T ss_pred HHHHHHHHHHhcchhhhhhhhhheeec-CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhcc-CCCchhhh
Confidence 999999999999999999999999998 778999999999987655443322222 4458999988877 89999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||+||++||++| |..|+.+...+++...+.+..+ + .=++.|+-++.-++.+
T Consensus 884 WsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------------L----------sqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 884 WSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------------L----------SQPPICTIDVYMVMVK 935 (1177)
T ss_pred hhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------------------C----------CCCCCccHHHHHHHHH
Confidence 999999999996 9999999887765554443211 1 1135789999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||..|+..||++.++..
T Consensus 936 Cwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAE 952 (1177)
T ss_pred HhccCcccCccHHHHHH
Confidence 99999999999998876
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=227.87 Aligned_cols=216 Identities=25% Similarity=0.420 Sum_probs=185.3
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
|+---+....+..||+|++|.|=+-++..+|+..|+|.+... .....+|+.+..+. .+|.+|.+++.+..+++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd- 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD- 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence 444556677889999999999999999999999999999433 23344677765554 79999999999988876
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 120 -------------------------------------------------------------------------------- 119 (282)
T KOG0984|consen 120 -------------------------------------------------------------------------------- 119 (282)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+|.||.|.-||..+-+..-+.++..++..+-+|+
T Consensus 120 ---------------------------------------------vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa 154 (282)
T KOG0984|consen 120 ---------------------------------------------VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIA 154 (282)
T ss_pred ---------------------------------------------EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhH
Confidence 88999999999999888888899999999999999
Q ss_pred HHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC---CCCCcch
Q psy10212 251 YQLFRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA---IDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~s~~s 326 (444)
..+.+||.|||++ +++|||+||+|||++ ..|++|+||||.+-...++-..+...|...|||||.+... ..|+.++
T Consensus 155 ~Svv~al~~L~~kL~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vks 233 (282)
T KOG0984|consen 155 VSVVHALEFLHSKLSVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKS 233 (282)
T ss_pred HHHHHHHHHHHHHhhhhhccCCcceEEEc-cCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeeh
Confidence 9999999999986 899999999999999 8899999999999887666656656788899999998432 3689999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGD-SGVDQLVEIIK 359 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~-~~~e~~~~i~~ 359 (444)
|+||||+++.||.+++.||+.. ++-+++.++++
T Consensus 234 DvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 234 DVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 9999999999999999999865 56677776665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-27 Score=215.20 Aligned_cols=207 Identities=35% Similarity=0.568 Sum_probs=177.0
Q ss_pred ecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccccc
Q psy10212 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMK 104 (444)
Q Consensus 30 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (444)
||+|++|.||++++..+++.+++|++.... ..+.+|++.++.+.|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---------------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN---------------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----------------
Confidence 689999999999998889999999996654 45889999999999999999988886643
Q ss_pred cccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCccc
Q psy10212 105 ISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 184 (444)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (444)
T Consensus 65 -------------------------------------------------------------------------------- 64 (215)
T cd00180 65 -------------------------------------------------------------------------------- 64 (215)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHC
Q psy10212 185 FRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVL 263 (444)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~ 263 (444)
..+++||+++ ++|.+++.... ..++...++.++.+++.++++||+.
T Consensus 65 ------------------------------~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~ 111 (215)
T cd00180 65 ------------------------------HLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN 111 (215)
T ss_pred ------------------------------eEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3889999999 69998886321 5689999999999999999999999
Q ss_pred CcccCCCCCCcEEEcCC-CCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 264 GICHRDIKPQNLLLNPE-TGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 264 givH~dLkp~NIll~~~-~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
|++|+||+|.||+++ . .+.++|+||+.+....... ......+...|++||........+.++|+|++|+++++|
T Consensus 112 ~~~H~dl~~~ni~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--- 187 (215)
T cd00180 112 GIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--- 187 (215)
T ss_pred CeeccCCCHhhEEEe-CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---
Confidence 999999999999999 5 7899999999987653332 123345678899999886644678899999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHH
Q psy10212 342 QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421 (444)
Q Consensus 342 ~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~e 421 (444)
..+.+++.+|++.||.+||++.+
T Consensus 188 ---------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 188 ---------------------------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred ---------------------------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 24778999999999999999999
Q ss_pred HhccCc
Q psy10212 422 VRSITP 427 (444)
Q Consensus 422 lL~~hp 427 (444)
+++ |+
T Consensus 211 l~~-~~ 215 (215)
T cd00180 211 ILE-HL 215 (215)
T ss_pred Hhh-CC
Confidence 998 64
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=259.60 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=209.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
...|+++..+|.|+||.||+++|+.+++..|+|.+... -...++|+-+++..+||||+.|++.|.....
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk------- 86 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK------- 86 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-------
Confidence 47899999999999999999999999999999999543 3566789999999999999999999988765
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (829)
T KOG0576|consen 87 -------------------------------------------------------------------------------- 86 (829)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
++|.||||++ +|.+.- .-.+++++..+..+++..++
T Consensus 87 ---------------------------------------lwicMEycgggslQdiy----~~TgplselqiayvcRetl~ 123 (829)
T KOG0576|consen 87 ---------------------------------------LWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQ 123 (829)
T ss_pred ---------------------------------------cEEEEEecCCCccccee----eecccchhHHHHHHHhhhhc
Confidence 9999999996 555543 24578999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhc--cCCCCCcchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIF--GAIDYTTKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~--~~~~~s~~sDiwSLG 332 (444)
||+|||+.|-+|||||..||+++ +.+.+++.|||.+..+.- -.+.....||+.|||||+.. ....|...+|+|++|
T Consensus 124 gl~ylhs~gk~hRdiKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~g 202 (829)
T KOG0576|consen 124 GLKYLHSQGKIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG 202 (829)
T ss_pred cchhhhcCCcccccccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccc
Confidence 99999999999999999999999 899999999999865432 23445678999999999872 112689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
++..|+-..++|.-+..+...+.-+-+..-+|+ ..... ..-++.+-+|++.+|..+
T Consensus 203 itAiel~eLqpplfdlhpmr~l~LmTkS~~qpp-----------------~lkDk-------~kws~~fh~fvK~altkn 258 (829)
T KOG0576|consen 203 ITAIELGELQPPLFDLHPMRALFLMTKSGFQPP-----------------TLKDK-------TKWSEFFHNFVKGALTKN 258 (829)
T ss_pred cchhhhhhcCCcccccchHHHHHHhhccCCCCC-----------------cccCC-------ccchHHHHHHHHHHhcCC
Confidence 999999999988766655554444443222221 11111 122678999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|.+|||++-+|. |||...
T Consensus 259 pKkRptaeklL~-h~fvs~ 276 (829)
T KOG0576|consen 259 PKKRPTAEKLLQ-HPFVSQ 276 (829)
T ss_pred CccCCChhhhee-ceeecc
Confidence 999999999999 999865
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=239.59 Aligned_cols=264 Identities=27% Similarity=0.319 Sum_probs=182.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeee-ccccchhhHHH--HhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVL-QDKRFKNREMQ--IMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~~~~~~~E~~--~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
....+++.+|+|.||.||+|+. +++.||||++. ..+..+.+|-. .+..+.|+||+++++.---..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t---------- 277 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT---------- 277 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC----------
Confidence 3456789999999999999998 67999999994 34555555544 455779999998753321111
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 278 -------------------------------------------------------------------------------- 277 (534)
T KOG3653|consen 278 -------------------------------------------------------------------------------- 277 (534)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.+..-+.||++|.+ |+|.++++. ...++....+++..|++||
T Consensus 278 --------------------------------~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGL 320 (534)
T KOG3653|consen 278 --------------------------------ADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGL 320 (534)
T ss_pred --------------------------------ccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHH
Confidence 00123889999999 799999963 5689999999999999999
Q ss_pred HHHHH---------CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCC--
Q psy10212 258 AYIHV---------LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYT-- 323 (444)
Q Consensus 258 ~yLHs---------~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s-- 323 (444)
+|||+ ..|+|||||..|||+. ++..+.|+|||++........ .....||.+|||||++.+...+.
T Consensus 321 a~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~ 399 (534)
T KOG3653|consen 321 AHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDR 399 (534)
T ss_pred HHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccH
Confidence 99996 2499999999999999 899999999999977754432 22357899999999998765444
Q ss_pred ---cchhhhhHHHHHHHHHhCCCCCC-CCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC-CC
Q psy10212 324 ---TKIDVWSAGCVLAELLLGQPMFP-GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR-TP 398 (444)
Q Consensus 324 ---~~sDiwSLGvil~eLltG~~Pf~-~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~s 398 (444)
.+.||||+|+++|||++.=..+. +..++-++.--.+.--.|.-++|.++ ......+..+...+..+ -.
T Consensus 400 ~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~-------VV~kK~RP~~p~~W~~h~~~ 472 (534)
T KOG3653|consen 400 DAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQEL-------VVRKKQRPKIPDAWRKHAGM 472 (534)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHH-------HHhhccCCCChhhhhcCccH
Confidence 57899999999999996322221 11111111111111112333333221 11111222222222222 24
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHH
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQV 422 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~el 422 (444)
..+++.|+.||+.||+.|.|+.=+
T Consensus 473 ~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 473 AVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHHHHcCCchhhhhhhHHH
Confidence 668999999999999999998533
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=234.51 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=191.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeec-cccchhhHHHHhh--hcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-DKRFKNREMQIMR--RLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~E~~~l~--~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+-.+..+++.+|+|.||.||+|+. -|+.||||++.. ++...-||.++.+ .|+|+||+.++..-..+..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g------- 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG------- 279 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC-------
Confidence 446778899999999999999999 599999999954 3455556666655 5699999986543322211
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 280 -------------------------------------------------------------------------------- 279 (513)
T KOG2052|consen 280 -------------------------------------------------------------------------------- 279 (513)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
-...++||++|.+ |||.|++.+ ..++.....+++..++.
T Consensus 280 -----------------------------------s~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~As 319 (513)
T KOG2052|consen 280 -----------------------------------SWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIAS 319 (513)
T ss_pred -----------------------------------ceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhh
Confidence 0145999999999 899999953 67999999999999999
Q ss_pred HHHHHHH-----CC---cccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----CCCccccccccccCchhhccCCCC
Q psy10212 256 SLAYIHV-----LG---ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-----EPNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 256 aL~yLHs-----~g---ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
||++||. +| |+|||||..||+|. .++.+-|+|+|++...... ...+...||.+|||||++......
T Consensus 320 GLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~ 398 (513)
T KOG2052|consen 320 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM 398 (513)
T ss_pred hHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh
Confidence 9999995 22 99999999999999 8999999999998654333 123456899999999998654221
Q ss_pred -----CcchhhhhHHHHHHHHHh-----C-----CCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccC
Q psy10212 323 -----TTKIDVWSAGCVLAELLL-----G-----QPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386 (444)
Q Consensus 323 -----s~~sDiwSLGvil~eLlt-----G-----~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~ 386 (444)
=..+||||||+++||+.. | ++||.+.-+. ....++.+.+- +++++|.. .
T Consensus 399 ~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC------v~~~RP~i---------p 463 (513)
T KOG2052|consen 399 KHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC------VQKLRPNI---------P 463 (513)
T ss_pred hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee------ecccCCCC---------C
Confidence 147999999999999983 2 3677543221 11222222111 01111111 1
Q ss_pred CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 387 ~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.+|... .+-..+..+++.||..||..|.|+.-+-+ -+.++-+..+.
T Consensus 464 nrW~s~---~~l~~m~klMkeCW~~Np~aRltALriKK---tl~~l~~~~ek 509 (513)
T KOG2052|consen 464 NRWKSD---PALRVMAKLMKECWYANPAARLTALRIKK---TLAKLSNSDEK 509 (513)
T ss_pred cccccC---HHHHHHHHHHHHhhcCCchhhhHHHHHHH---HHHHHhcChhh
Confidence 112111 12345788999999999999999987766 67766654443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=212.73 Aligned_cols=206 Identities=33% Similarity=0.553 Sum_probs=170.1
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
|.+.+.||.|++|+||+|.+..+++.+|+|.+... ...+.+|++.+++++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~---------- 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE---------- 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC----------
Confidence 56789999999999999999888999999999643 456668999999999999999988876543
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 71 -------------------------------------------------------------------------------- 70 (225)
T smart00221 71 -------------------------------------------------------------------------------- 70 (225)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++++|++++ +|.+++.... ..+++..++.++.|++.++
T Consensus 71 ------------------------------------~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l 111 (225)
T smart00221 71 ------------------------------------PLYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEAL 111 (225)
T ss_pred ------------------------------------ceEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHH
Confidence 28899999997 9999886422 1188999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
.+||+++++|+||+|+||+++ ..+.++|+|||.+....... ......++..|++||.+.+...++.++|+|+||+++
T Consensus 112 ~~lh~~~i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 112 EYLHSLGIVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred HHHHhCCeecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence 999999999999999999999 67999999999987764442 233456678899999983333778899999999999
Q ss_pred HHHHhCCCCCCC-CChh-HHHHHHHH
Q psy10212 336 AELLLGQPMFPG-DSGV-DQLVEIIK 359 (444)
Q Consensus 336 ~eLltG~~Pf~~-~~~~-e~~~~i~~ 359 (444)
++|++|+.||.. .++. .....+..
T Consensus 191 ~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 191 YELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred HHHHHCCCCccccchhHHHHHHHHhc
Confidence 999999999977 4444 44444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=226.61 Aligned_cols=258 Identities=17% Similarity=0.206 Sum_probs=206.7
Q ss_pred hccccchhheecccceeEEEEeEecCCC-----ceeeeeeeecccc-----chhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSG-----ELVAIKKVLQDKR-----FKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~-----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
...|++..-.+-.|.||+||+|...... +.+-+|.+..... .+..|..++..+.|||++.+.+..++..+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 4567888899999999999999765432 4577777744433 33478888889999999999999988764
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 362 -------------------------------------------------------------------------------- 361 (563)
T KOG1024|consen 362 -------------------------------------------------------------------------------- 361 (563)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh--h--cCCCCChH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS--K--SKQNFPCF 244 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~--~--~~~~l~~~ 244 (444)
+.+..+.+++ |+|..++...+ + ..+.++..
T Consensus 362 ---------------------------------------------~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~ 396 (563)
T KOG1024|consen 362 ---------------------------------------------TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTI 396 (563)
T ss_pred ---------------------------------------------cceEEEeccCcchHHHHHHHhccCCCccccchhHH
Confidence 3567778887 68888886332 1 23346667
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCc---cccccccccCchhhccCCC
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAID 321 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~ 321 (444)
....++.|++.|++|||++|++|.||..+|.+++ +.-++||+|-.+++...+.+..+ .......||+||.+... .
T Consensus 397 qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~ 474 (563)
T KOG1024|consen 397 QLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-H 474 (563)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-h
Confidence 7888999999999999999999999999999999 78899999999998776665443 22346779999999888 8
Q ss_pred CCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 322 YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
|+.++|+||||+++|||++ |+.|+...++.++...+.++-+ +.. |-|||.+
T Consensus 475 yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR----------------laQ------------P~NCPDe 526 (563)
T KOG1024|consen 475 YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR----------------LAQ------------PFNCPDE 526 (563)
T ss_pred hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce----------------ecC------------CCCCcHH
Confidence 9999999999999999996 9999999999998887776321 111 2379999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+..++.-||..+|++||+.+|+.. -+.+...+
T Consensus 527 Lf~vMacCWallpeeRPsf~Qlv~---cLseF~~q 558 (563)
T KOG1024|consen 527 LFTVMACCWALLPEERPSFSQLVI---CLSEFHTQ 558 (563)
T ss_pred HHHHHHHHHhcCcccCCCHHHHHH---HHHHHHHH
Confidence 999999999999999999999987 56555443
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=237.34 Aligned_cols=192 Identities=28% Similarity=0.437 Sum_probs=169.9
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhcC---CCceeEeeeEEeec
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRLE---HSNIVKLKYFFYSS 87 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 87 (444)
.|..+..||.|.||.|++|.++.....|+||.|.+.+ .+.--|+++|..|+ |+||++++++|.+.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4889999999999999999999999999999986543 23336999999997 99999999999876
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 642 d------------------------------------------------------------------------------- 642 (772)
T KOG1152|consen 642 D------------------------------------------------------------------------------- 642 (772)
T ss_pred C-------------------------------------------------------------------------------
Confidence 5
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC--cHHHHHHhhhhcCCCCChHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE--TVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~ 245 (444)
+.||+||-.+. .|.++|. ...++++.+
T Consensus 643 -----------------------------------------------~yyl~te~hg~gIDLFd~IE----~kp~m~E~e 671 (772)
T KOG1152|consen 643 -----------------------------------------------YYYLETEVHGEGIDLFDFIE----FKPRMDEPE 671 (772)
T ss_pred -----------------------------------------------eeEEEecCCCCCcchhhhhh----ccCccchHH
Confidence 59999999985 7888884 567899999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcc
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.|++|++.|+++||+.||+|||||-+|+.++ .+|.+||+|||.+.....+ +--...||..|.|||++.|.......
T Consensus 672 Ak~IFkQV~agi~hlh~~~ivhrdikdenvivd-~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~ 749 (772)
T KOG1152|consen 672 AKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD-SNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKP 749 (772)
T ss_pred HHHHHHHHHhccccccccCceecccccccEEEe-cCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCc
Confidence 999999999999999999999999999999999 8999999999998765433 34567899999999999998677899
Q ss_pred hhhhhHHHHHHHHHhCCCCCC
Q psy10212 326 IDVWSAGCVLAELLLGQPMFP 346 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~ 346 (444)
.|||+||+++|-++....||-
T Consensus 750 qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 750 QDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhhhheeeEEEeccCCCc
Confidence 999999999999998888874
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=217.66 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=193.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
-++.+.|.|.+.||.|-||.+-++.++.+++.+++|.+... .+.|.+|..---.| .|.||+..++......
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----- 94 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----- 94 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-----
Confidence 35678999999999999999999999999999999998543 46677787643334 6899997665554433
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (378)
T KOG1345|consen 95 -------------------------------------------------------------------------------- 94 (378)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
-+.+++||||+ |+|.+-+. ...+.+...+.++.|
T Consensus 95 ----------------------------------------d~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~q 129 (378)
T KOG1345|consen 95 ----------------------------------------DAYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQ 129 (378)
T ss_pred ----------------------------------------ceEEEeeccCccchhhhhcC-----cccccHHHHHHHHHH
Confidence 25889999999 78888763 245788999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEE-cCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc----CCCCCcchh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG----AIDYTTKID 327 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll-~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~s~~sD 327 (444)
+++|+.|||+++++|||||.+|||+ +.+..++||||||.+...+.. -.....+..|.+||.+.. .....+.+|
T Consensus 130 l~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D 207 (378)
T KOG1345|consen 130 LLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTD 207 (378)
T ss_pred HHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEeccccc
Confidence 9999999999999999999999999 445669999999998553221 112233566889987742 224578999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
+|+||+++|..++|..||+.... ..-+.+..+..+...+ ...+.|. .+++.+..+.+
T Consensus 208 ~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---------------------~~P~~F~-~fs~~a~r~Fk 265 (378)
T KOG1345|consen 208 IWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---------------------ALPKKFN-PFSEKALRLFK 265 (378)
T ss_pred chheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---------------------cCchhhc-ccCHHHHHHHH
Confidence 99999999999999999985332 2234444443322111 1111121 25899999999
Q ss_pred HhcccCCCCC---CCHHHHhccCchhhhh
Q psy10212 407 RLLEYTPSSR---ISPLQVRSITPFLIEL 432 (444)
Q Consensus 407 ~~L~~DP~kR---Ps~~elL~~hpwf~~~ 432 (444)
+-|..+|++| .++....+ .-|.+.+
T Consensus 266 k~lt~~~~drcki~~~kk~rk-~~w~E~~ 293 (378)
T KOG1345|consen 266 KSLTPRFKDRCKIWTAKKMRK-CLWKEKL 293 (378)
T ss_pred HhcCCcccccchhHHHHHHHH-HHHHHhh
Confidence 9999999999 66666666 6676653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=253.63 Aligned_cols=184 Identities=18% Similarity=0.208 Sum_probs=135.9
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC----------------
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP---------------- 279 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~---------------- 279 (444)
++.+||+++.+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 55 ~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 55 IVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred hhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 778899999999999852 3456999999999999999999999999999999999999961
Q ss_pred --CCCeEEEeecCCcccccCCC-----------------CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 280 --ETGVLKLCDFGSAKHLVRGE-----------------PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 280 --~~~~ikL~Dfg~s~~~~~~~-----------------~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
..+.++++|||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~sDVwSlGviL~ELl~ 210 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS-SSNCASDVYRLGVLLFELFC 210 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC-CCCchhhhhhHHHHHHHHhh
Confidence 23455666666654321100 00112468889999999877 78999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHH
Q psy10212 341 GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 420 (444)
Q Consensus 341 G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~ 420 (444)
|..|+.... .....+.... .++.. ....+...+++.+||+.||.+||++.
T Consensus 211 ~~~~~~~~~--~~~~~~~~~~--~~~~~--------------------------~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 211 PVSSREEKS--RTMSSLRHRV--LPPQI--------------------------LLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred CCCchhhHH--HHHHHHHHhh--cChhh--------------------------hhcCHHHHHHHHHhCCCChhhCcChH
Confidence 988865321 1111111100 00000 01145677899999999999999999
Q ss_pred HHhccCchhhhhhh
Q psy10212 421 QVRSITPFLIELRA 434 (444)
Q Consensus 421 elL~~hpwf~~~~~ 434 (444)
|+|. ||||.+.+.
T Consensus 261 eil~-h~~~~~~~~ 273 (793)
T PLN00181 261 ELLQ-SEFINEPRE 273 (793)
T ss_pred HHhh-chhhhhhhH
Confidence 9999 999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=195.51 Aligned_cols=170 Identities=20% Similarity=0.199 Sum_probs=129.3
Q ss_pred CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccc
Q psy10212 225 ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304 (444)
Q Consensus 225 ~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~ 304 (444)
|+|.+++.. .+.++++..++.++.||+.||.|||+++ ||+||+++ .++.+++ ||.+...... ..
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~----~~ 64 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT-WDGLLKL--DGSVAFKTPE----QS 64 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc-Cccceee--ccceEeeccc----cC
Confidence 578888752 3567999999999999999999999998 99999998 7888888 9988664332 22
Q ss_pred cccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCC
Q psy10212 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~ 383 (444)
.+++.|+|||.+.+. .++.++||||+||++|+|++|+.||...... .....+........ +.
T Consensus 65 ~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~ 127 (176)
T smart00750 65 RVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR 127 (176)
T ss_pred CCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc
Confidence 578999999999887 7899999999999999999999999765433 22333322111000 00
Q ss_pred ccCCCCcccccCCCCh--hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 384 IKSHPWSKVFRVRTPP--DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 384 ~~~~~~~~~~~~~~s~--~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.......++. .+.++|.+||..||.+||++.|+++ |+|+..-..
T Consensus 128 ------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~-~~~~~~~~~ 173 (176)
T smart00750 128 ------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLA-HCRALFAET 173 (176)
T ss_pred ------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHH-HHHHHHHHH
Confidence 0000011233 6999999999999999999999999 999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-22 Score=201.26 Aligned_cols=256 Identities=21% Similarity=0.226 Sum_probs=195.3
Q ss_pred ccchhheecccceeEEEEeEecCCC-ceeeeeeeeccc----cchhhHHHHhhhcCC----CceeEeeeEEeecCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSG-ELVAIKKVLQDK----RFKNREMQIMRRLEH----SNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~----~~~~~E~~~l~~l~h----~~i~~~~~~~~~~~~~~~~ 93 (444)
+|.+.+.||+|+||.||+|.+..++ +.+|+|...... ..+..|+.++..+.. +++..+.+......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~----- 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE----- 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----
Confidence 8999999999999999999998775 689999875432 256679999998863 46666655443111
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (322)
T KOG1164|consen 94 -------------------------------------------------------------------------------- 93 (322)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+-||||++++.+|.++..... .+.++..++..++.|+
T Consensus 94 ----------------------------------------~~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~ 131 (322)
T KOG1164|consen 94 ----------------------------------------DFNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQN 131 (322)
T ss_pred ----------------------------------------ceeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHH
Confidence 4689999999999999875433 6889999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCC----CeEEEeecCCcc--cccCCC--------C-CccccccccccCchhhcc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPET----GVLKLCDFGSAK--HLVRGE--------P-NVSYICSRYYRAPELIFG 318 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~----~~ikL~Dfg~s~--~~~~~~--------~-~~~~~gt~~y~aPE~l~~ 318 (444)
+.+|.+||+.|++||||||.|+++.... ..+.|.|||+++ ...... . .....||..|.++....+
T Consensus 132 l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 132 LNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred HHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 9999999999999999999999997443 579999999998 321111 1 123458999999999888
Q ss_pred CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 319 AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 319 ~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
. ..+.+.|+||++.++.++..|..||.+........+..+..... .... +....+
T Consensus 212 ~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~~ 266 (322)
T KOG1164|consen 212 I-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL---------------LTDR---------FGDLKP 266 (322)
T ss_pred C-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh---------------cccc---------ccCCCh
Confidence 7 89999999999999999999999998766443333333211000 0000 122346
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..+.++...+-..+...+|....+.. .+++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~Pdy~~~~~---~l~~~~ 298 (322)
T KOG1164|consen 267 EEFAKILEYIDSLDYEDKPDYEKLAE---LLKDVF 298 (322)
T ss_pred HHHHHHHHHhhccCCcCCCCHHHHHH---HHHHHH
Confidence 78888888888899999999988877 455543
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=192.18 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=196.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc--cchhhHHHHhhhcCC-CceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIMRRLEH-SNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
-+.|.++++||.|+||.+|+|....+|+.||||+-..+. .....|.++.+.|+| ..|..+..+..++
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~---------- 83 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEK---------- 83 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccc----------
Confidence 368999999999999999999999999999999885543 445578888888865 4454443333322
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (341)
T KOG1163|consen 84 -------------------------------------------------------------------------------- 83 (341)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
-+-++||++.+.||.+++.- ...+++..+++.++-|++.-+
T Consensus 84 ------------------------------------~ynvlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~Ri 124 (341)
T KOG1163|consen 84 ------------------------------------DYNVLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRI 124 (341)
T ss_pred ------------------------------------ccceeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHH
Confidence 24679999999999998863 446799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEc--CCCCeEEEeecCCcccccCCC--------CCccccccccccCchhhccCCCCCcchh
Q psy10212 258 AYIHVLGICHRDIKPQNLLLN--PETGVLKLCDFGSAKHLVRGE--------PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~--~~~~~ikL~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+|+|.++++||||||+|++.. ....++.|+|||+++...+.. ......||.+|.+-....+. .-+.+.|
T Consensus 125 EyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDD 203 (341)
T KOG1163|consen 125 EYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDD 203 (341)
T ss_pred HHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhh
Confidence 999999999999999999995 334589999999997664332 23355789999999888776 7789999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+-|+|.++.++.-|..||++.......++..+.........+ +.+....|.++.-.|..
T Consensus 204 meSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i---------------------e~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 204 MESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI---------------------EVLCKGFPAEFAMYLNY 262 (341)
T ss_pred hhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH---------------------HHHhCCCcHHHHHHHHH
Confidence 999999999999999999997766555444432221111111 22334558899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
|-..--++-|.-.-+-.
T Consensus 263 ~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 263 CRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred HhhcCCCCCCcHHHHHH
Confidence 99988888888654433
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=192.77 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=201.3
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeeccc--cchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
.|.|.++||.|+||.++.|++.-++++||||.-..+. -.+..|.+..+.|. .++|...++|-.+.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG------------ 96 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG------------ 96 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeecccc------------
Confidence 5999999999999999999999999999999774443 34446888888774 57777654333222
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 97 -------------------------------------------------------------------------------- 96 (449)
T KOG1165|consen 97 -------------------------------------------------------------------------------- 96 (449)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
.+-.+|||+++.||.|++. -.+.+|+..++..++.|++.-+++
T Consensus 97 ----------------------------------~~NiLVidLLGPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~ 139 (449)
T KOG1165|consen 97 ----------------------------------KYNILVIDLLGPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEY 139 (449)
T ss_pred ----------------------------------chhhhhhhhhCcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHH
Confidence 3456999999999999986 467789999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcC----CCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCCcchh
Q psy10212 260 IHVLGICHRDIKPQNLLLNP----ETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~----~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+|++.++.|||||+|+|+.+ ....|.++|||+++...+... .....||.+||+-....|. .-+.+.|
T Consensus 140 vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDD 218 (449)
T KOG1165|consen 140 VHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDD 218 (449)
T ss_pred HHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccc-hhhhhhh
Confidence 99999999999999999963 234789999999987754432 2345789999999999988 8899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChh---HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~---e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+-|||.++++.+-|.+||.+.... +.+++|-+.....+.+.+ ..++|.++..-
T Consensus 219 LEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L------------------------c~g~P~efa~Y 274 (449)
T KOG1165|consen 219 LEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL------------------------CEGFPEEFATY 274 (449)
T ss_pred HHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH------------------------HhcCHHHHHHH
Confidence 999999999999999999986543 334444333333222222 23458899999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+...-+.+-.+-|...-+.+ .|.++-..
T Consensus 275 l~yvR~L~F~E~PDYdylr~---Lf~dvldr 302 (449)
T KOG1165|consen 275 LRYVRRLDFFETPDYDYLRK---LFDDVLDR 302 (449)
T ss_pred HHHHHhcCcccCCCHHHHHH---HHHHHHHh
Confidence 99999999999998877666 66665443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-20 Score=180.75 Aligned_cols=258 Identities=36% Similarity=0.523 Sum_probs=195.2
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCC-ceeEeeeEEeecCCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHS-NIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~ 95 (444)
|.+...||.|+||.||++.+. +.+|+|.+... ...+.+|+.++..+.|+ +|+++.+.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG------- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-------
Confidence 778899999999999999996 88999988433 34566899999999988 7999998884432
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (384)
T COG0515 72 -------------------------------------------------------------------------------- 71 (384)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..+++++++.+ ++.+++...... ..+.......++.|++
T Consensus 72 ---------------------------------------~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~ 111 (384)
T COG0515 72 ---------------------------------------SLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQIL 111 (384)
T ss_pred ---------------------------------------EEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHH
Confidence 16899999996 666454321111 3789999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCC-eEEEeecCCcccccCCC-------CCccccccccccCchhhccC--CCCCc
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETG-VLKLCDFGSAKHLVRGE-------PNVSYICSRYYRAPELIFGA--IDYTT 324 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~-~ikL~Dfg~s~~~~~~~-------~~~~~~gt~~y~aPE~l~~~--~~~s~ 324 (444)
.++.++|+.+++|+|++|+||+++ ..+ .++++|||.+....... ......++..|++||.+.+. ...+.
T Consensus 112 ~~l~~~H~~~~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~ 190 (384)
T COG0515 112 SALEYLHSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASS 190 (384)
T ss_pred HHHHHHHhCCeeccCCCHHHeeec-CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCc
Confidence 999999999999999999999999 455 79999999987554333 23556789999999999873 37899
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~---~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
..|+|++|++++++++|..||..... .............+ ....+...... ......+
T Consensus 191 ~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~------~~~~~~~ 251 (384)
T COG0515 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-------------SLASPLSPSNP------ELISKAA 251 (384)
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-------------ccccccCcccc------chhhHHH
Confidence 99999999999999999999877664 33333333322111 00000000000 1123689
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+++..++..+|..|.+..+... ++|....
T Consensus 252 ~~~~~~~~~~~~~~r~~~~~~~~-~~~~~~~ 281 (384)
T COG0515 252 SDLLKKLLAKDPKNRLSSSSDLS-HDLLAHL 281 (384)
T ss_pred HHHHHHHHhcCchhcCCHHHHhh-chHhhCc
Confidence 99999999999999999999998 7665553
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=223.20 Aligned_cols=189 Identities=24% Similarity=0.421 Sum_probs=148.1
Q ss_pred eccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC
Q psy10212 220 LEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE 299 (444)
Q Consensus 220 ~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~ 299 (444)
||||++.|.+++. ..+.++...+..++.|++.|+.|||+.|+.|+|+|++|+++. ..+.+||+|||.+.......
T Consensus 400 mE~~~~Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 400 MEYCPYDLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhcccHHHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-cCCceEEeecCcceeeccCc
Confidence 9999998888885 346899999999999999999999999999999999999999 78899999999987664443
Q ss_pred C-----CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC
Q psy10212 300 P-----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374 (444)
Q Consensus 300 ~-----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~ 374 (444)
. .....|+..|+|||.+.+...-....|+||.|+++..|.+|+.||......+....-..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------------- 539 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------------- 539 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---------------
Confidence 3 23457899999999998874456789999999999999999999986554432210000
Q ss_pred CCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 375 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 375 ~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+......... ...+-..++...+.+|.+||++||.+|.|+.+|++ .+||+++..
T Consensus 540 ----~~~~~~~~~~-~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~-d~W~~~i~~ 593 (601)
T KOG0590|consen 540 ----YSDQRNIFEG-PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN-DEWIRSIEC 593 (601)
T ss_pred ----cccccccccC-hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh-ChHhhhcce
Confidence 0000000000 01111246889999999999999999999999999 999999754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=192.16 Aligned_cols=165 Identities=25% Similarity=0.279 Sum_probs=109.8
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCC---CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQN---FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~---l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
.+++|+-+.++|.+++......... ........+..|+++.+++||+.|++|+||+|+|++++ .+|.+.|+||+..
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~-~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLD-QDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE--TTS-EEE--GGGE
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEc-CCCCEEEcChHHH
Confidence 6889999999998887543333322 22333455668999999999999999999999999999 7899999999877
Q ss_pred ccccCCCCCccccccccccCchhhccC-------CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCC
Q psy10212 293 KHLVRGEPNVSYICSRYYRAPELIFGA-------IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365 (444)
Q Consensus 293 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~ 365 (444)
......... ...+..|.|||..... ..++.+.|.|+||+++|.|+++..||......-....
T Consensus 193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------- 261 (288)
T PF14531_consen 193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------- 261 (288)
T ss_dssp EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------
T ss_pred eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------
Confidence 554322211 3345779999977432 3578999999999999999999999986543210000
Q ss_pred HHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 366 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
.+..+ .++|+.+++||..||+.||.+|
T Consensus 262 ----------------------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ----------------------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ----------------------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred ----------------------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 11122 2579999999999999999988
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=204.35 Aligned_cols=179 Identities=27% Similarity=0.446 Sum_probs=136.5
Q ss_pred cceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCC
Q psy10212 213 QVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291 (444)
Q Consensus 213 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~ 291 (444)
..++||+|++|. .+|.+|+.+. ......+....+.++.|++.|+.| ++.+|+|++|.||++. .+.+++|+|||+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc-cchhhhhhhhhh
Confidence 578999999999 5999999643 445678889999999999999999 9999999999999998 677999999999
Q ss_pred cccccCCC-------CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCC
Q psy10212 292 AKHLVRGE-------PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGT 363 (444)
Q Consensus 292 s~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~ 363 (444)
........ ..+...+|..||+||.+.+. .|+.++||||||++++|++. -.-.+... -....+.+ |.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~--g~ 476 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRD--GI 476 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhhc--CC
Confidence 87665444 45667899999999999998 89999999999999999996 22222110 01111111 11
Q ss_pred CCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
-++..+ .+ -+.-..|+.+||...|.+||++.+.-- |+|.
T Consensus 477 ip~~~~-------------------------~d-~p~e~~ll~~lls~~p~~RP~~~~~~~-~~~~ 515 (516)
T KOG1033|consen 477 IPPEFL-------------------------QD-YPEEYTLLQQLLSPSPEERPSAIEVAL-HEFL 515 (516)
T ss_pred CChHHh-------------------------hc-CcHHHHHHHHhcCCCcccCchHHHHhh-hhhc
Confidence 111111 11 355678999999999999998777666 6654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=194.30 Aligned_cols=171 Identities=19% Similarity=0.310 Sum_probs=126.2
Q ss_pred hhccccchhheecccceeEEEEeEecC-CCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLD-SGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
-+.++|.+.+.||+|+||+||+|+++. +++.+|||++... ...+.+|+++|++++|+||+..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 356789999999999999999999876 6788899987422 2347799999999999999852211 11
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (365)
T PRK09188 92 -------------------------------------------------------------------------------- 91 (365)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
..|+|||||+|..+..+. ... ...
T Consensus 92 ----------------------------------------------~~~LVmE~~~G~~L~~~~-------~~~---~~~ 115 (365)
T PRK09188 92 ----------------------------------------------KDGLVRGWTEGVPLHLAR-------PHG---DPA 115 (365)
T ss_pred ----------------------------------------------CcEEEEEccCCCCHHHhC-------ccc---hHH
Confidence 168999999974333221 111 146
Q ss_pred HHHHHHHHHHHHHHCCcccCCC-CCCcEEEcCCCCeEEEeecCCcccccCCCCC---------ccccccccccCchhhcc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDI-KPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---------VSYICSRYYRAPELIFG 318 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dL-kp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---------~~~~gt~~y~aPE~l~~ 318 (444)
++.|++++|.|||++|++|||| ||+||+++ .++.++|+|||+++........ ....+++.|++||.+..
T Consensus 116 ~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 116 WFRSAHRALRDLHRAGITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred HHHHHHHHHHHHHHCCCeeCCCCCcceEEEc-CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7899999999999999999999 99999998 6789999999999866443211 12345677899998742
Q ss_pred C-----CCCCcchhhh
Q psy10212 319 A-----IDYTTKIDVW 329 (444)
Q Consensus 319 ~-----~~~s~~sDiw 329 (444)
. ...+..+|-|
T Consensus 195 ~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 195 RERKILARKSLPSRIW 210 (365)
T ss_pred hhhccccccccccCcE
Confidence 2 2334455655
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=203.80 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=179.7
Q ss_pred cccccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchh---hHHHHhhhcCCCceeEe
Q psy10212 9 GFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKN---REMQIMRRLEHSNIVKL 80 (444)
Q Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~---~E~~~l~~l~h~~i~~~ 80 (444)
....--.||+++..++.-.+.||.+.|=+|.+|++.. |. |+||++-+.. +.+. +|++ ...++|||.+.+
T Consensus 10 Qi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 10 QISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPF 86 (1431)
T ss_pred ccchHHHHhhcCccceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccch
Confidence 3334446899999999999999999999999999853 44 9999984433 1222 3555 555689999976
Q ss_pred eeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 81 KYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
...-...
T Consensus 87 qk~~~t~------------------------------------------------------------------------- 93 (1431)
T KOG1240|consen 87 QKVLVTD------------------------------------------------------------------------- 93 (1431)
T ss_pred HHHHHhh-------------------------------------------------------------------------
Confidence 3321111
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCC
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQN 240 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~ 240 (444)
...|+|-+|+.-+|+|-+. ...-
T Consensus 94 -----------------------------------------------------kAAylvRqyvkhnLyDRlS----TRPF 116 (1431)
T KOG1240|consen 94 -----------------------------------------------------KAAYLVRQYVKHNLYDRLS----TRPF 116 (1431)
T ss_pred -----------------------------------------------------HHHHHHHHHHhhhhhhhhc----cchH
Confidence 3478999999999999772 2334
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc--cCCCCCc------cccccccccC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL--VRGEPNV------SYICSRYYRA 312 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~--~~~~~~~------~~~gt~~y~a 312 (444)
+...+.+.|+.||+.||..+|..||+|||||.+|||+. .=..+.|+||..=+-. ++..+.. +...-.+|+|
T Consensus 117 L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiA 195 (1431)
T KOG1240|consen 117 LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIA 195 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe-eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecC
Confidence 67778899999999999999999999999999999998 6778999999753322 1111110 1122456999
Q ss_pred chhhccC----------CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccC
Q psy10212 313 PELIFGA----------IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 381 (444)
Q Consensus 313 PE~l~~~----------~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 381 (444)
||.+... ...+++=||||+||+++||++ |++||.- .++-.....- .-.++.
T Consensus 196 PERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~-~~~~e~------------- 257 (1431)
T KOG1240|consen 196 PERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN-ADDPEQ------------- 257 (1431)
T ss_pred hHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-ccCHHH-------------
Confidence 9987431 125788999999999999996 7999962 1111111100 000000
Q ss_pred CCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 382 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 382 p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+..--++.++.+|..|++.||++|.+|.+.|.
T Consensus 258 ----------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 258 ----------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred ----------HHHhCcCccHHHHHHHHHccCchhccCHHHHHH
Confidence 011112568999999999999999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=168.76 Aligned_cols=74 Identities=18% Similarity=0.244 Sum_probs=61.6
Q ss_pred EEEEeccCCCcHH-HHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPETVY-KVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI-HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~~l~-~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
.+||||||+++.+ .... ...+++...+..++.|++.+|.+| |+.|++|+||||+||+++ .+.++|+|||++.
T Consensus 92 ~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~--~~~v~LiDFG~a~ 165 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH--DGKLYIIDVSQSV 165 (190)
T ss_pred CEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE--CCcEEEEEccccc
Confidence 3699999997533 2221 235788999999999999999999 799999999999999998 3689999999986
Q ss_pred cc
Q psy10212 294 HL 295 (444)
Q Consensus 294 ~~ 295 (444)
..
T Consensus 166 ~~ 167 (190)
T cd05147 166 EH 167 (190)
T ss_pred cC
Confidence 53
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=173.70 Aligned_cols=175 Identities=14% Similarity=0.163 Sum_probs=128.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccc---------hhhHHHHhhhcCCCceeEeeeEEe
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRF---------KNREMQIMRRLEHSNIVKLKYFFY 85 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~---------~~~E~~~l~~l~h~~i~~~~~~~~ 85 (444)
-+.++|.+++.||+|+||.||++.+ +++.+|||++... ... +.+|++.+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4689999999999999999999765 4778999998422 121 578999999999999999988876
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
....+..
T Consensus 106 ~~~~~~~------------------------------------------------------------------------- 112 (232)
T PRK10359 106 LAERKTL------------------------------------------------------------------------- 112 (232)
T ss_pred ecccccc-------------------------------------------------------------------------
Confidence 5431000
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCF 244 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~ 244 (444)
..+...+|+|||++| +|.++. ..++
T Consensus 113 ---------------------------------------------~~~~~~~lvmEyi~G~tL~~~~--------~~~~- 138 (232)
T PRK10359 113 ---------------------------------------------RYAHTYIMLIEYIEGVELNDMP--------EISE- 138 (232)
T ss_pred ---------------------------------------------cccCCeEEEEEEECCccHHHhh--------hccH-
Confidence 000237899999998 676652 1222
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCc
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
..+.+++.++..||+.|++|+|++|+||+++ +++ ++|+|||......... ... ...... .+..
T Consensus 139 ---~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-~~g-i~liDfg~~~~~~e~~-a~d----------~~vler-~y~~ 201 (232)
T PRK10359 139 ---DVKAKIKASIESLHQHGMVSGDPHKGNFIVS-KNG-LRIIDLSGKRCTAQRK-AKD----------RIDLER-HYGI 201 (232)
T ss_pred ---HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-CCC-EEEEECCCcccccchh-hHH----------HHHHHh-Hhcc
Confidence 2466999999999999999999999999998 566 9999999875542111 100 022333 4567
Q ss_pred chhhhhHHHHHHHHH
Q psy10212 325 KIDVWSAGCVLAELL 339 (444)
Q Consensus 325 ~sDiwSLGvil~eLl 339 (444)
++|+|+||+++..+.
T Consensus 202 ~~di~~lg~~~~~~~ 216 (232)
T PRK10359 202 KNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccceeEeehHHH
Confidence 899999999977554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=161.50 Aligned_cols=74 Identities=19% Similarity=0.199 Sum_probs=61.7
Q ss_pred EEEEeccCCCc-HHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPET-VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~~-l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
.++||||++|. +..... ...+++......++.|++.++.+||+ +|++|+||||+||+++ ++.++|+|||++.
T Consensus 92 ~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--~~~~~liDFG~a~ 165 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--DGKPYIIDVSQAV 165 (190)
T ss_pred CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--CCCEEEEEcccce
Confidence 46999999975 322211 12467888999999999999999999 9999999999999998 5789999999986
Q ss_pred cc
Q psy10212 294 HL 295 (444)
Q Consensus 294 ~~ 295 (444)
..
T Consensus 166 ~~ 167 (190)
T cd05145 166 EL 167 (190)
T ss_pred ec
Confidence 64
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=188.58 Aligned_cols=236 Identities=30% Similarity=0.480 Sum_probs=188.5
Q ss_pred eecccceeEEEEeEe---cCCCceeeeeeeecc------ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 29 VIGNGSFGIVYQAKL---LDSGELVAIKKVLQD------KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 29 ~lg~G~~g~Vy~~~~---~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.+|+|+||.|++++. .+.|+.||.|+.... +.....|..++..++ ||.++++.+.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k--------- 71 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK--------- 71 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc---------
Confidence 479999999999764 345778999987332 123335777888886 9999999988888765
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 72 -------------------------------------------------------------------------------- 71 (612)
T KOG0603|consen 72 -------------------------------------------------------------------------------- 71 (612)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCc-HHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPET-VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~-l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+++++++..++ |..-. .....+++...+.+...++.++
T Consensus 72 -------------------------------------l~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLal 110 (612)
T KOG0603|consen 72 -------------------------------------LYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALAL 110 (612)
T ss_pred -------------------------------------hhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHH
Confidence 88999998874 33222 3445678888999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
+++|+.+++|+|+|++||+++ ..|.+++.|||+++........ +|+.-|||||+..+ ...++|.||+|+++++
T Consensus 111 d~lh~l~iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~fe 183 (612)
T KOG0603|consen 111 DHLHKLGIAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIING---HLSAADWWSFGVLAFE 183 (612)
T ss_pred hhcchhHHHHhcccccceeec-ccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhhc---cCCcccchhhhhhHHH
Confidence 999999999999999999999 8999999999999876554433 88999999999984 3678999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 338 LltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
|++|-.||.+ +....|.+.. -.++...+..+++++..++..+|..|.
T Consensus 184 lltg~~pf~~----~~~~~Il~~~-----------------------------~~~p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 184 LLTGTLPFGG----DTMKRILKAE-----------------------------LEMPRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred HhhCCCCCch----HHHHHHhhhc-----------------------------cCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence 9999999987 4555554411 112335688999999999999999998
Q ss_pred CH-----HHHhccCchhhhhhhh
Q psy10212 418 SP-----LQVRSITPFLIELRAV 435 (444)
Q Consensus 418 s~-----~elL~~hpwf~~~~~~ 435 (444)
.. .|+++ |++|+.+...
T Consensus 231 g~~~~~~~eik~-h~f~~~i~~~ 252 (612)
T KOG0603|consen 231 GAGPDGVDEIKQ-HEFFQSIDWN 252 (612)
T ss_pred ccCcchhHHHhc-cchheeeeHh
Confidence 75 68888 9999886543
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=165.36 Aligned_cols=239 Identities=18% Similarity=0.197 Sum_probs=183.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
....++.+|...-.|..|+|+. .|..++.|++... .+.|+.|.-.|+-..||||+.+++.+-+..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp------- 260 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP------- 260 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-------
Confidence 4566788999999999999999 5667777877332 467778888888889999999887775542
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 261 -------------------------------------------------------------------------------- 260 (448)
T KOG0195|consen 261 -------------------------------------------------------------------------------- 260 (448)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+.++..||+ |||++.+.. ....-.+..++.+++.+|+
T Consensus 261 ---------------------------------------nlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldia 299 (448)
T KOG0195|consen 261 ---------------------------------------NLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIA 299 (448)
T ss_pred ---------------------------------------CceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHH
Confidence 2889999999 699998842 2333467788999999999
Q ss_pred HHHHHHHHCC--cccCCCCCCcEEEcCCCCeEE--EeecCCcccccCCCCCccccccccccCchhhccCC--CCCcchhh
Q psy10212 255 RSLAYIHVLG--ICHRDIKPQNLLLNPETGVLK--LCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI--DYTTKIDV 328 (444)
Q Consensus 255 ~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ik--L~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~s~~sDi 328 (444)
.|++|||+.. +.--.|+..++++| ++-..+ .+|-.++.. .......+.|++||.+.... ..-.++|+
T Consensus 300 rgmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadm 372 (448)
T KOG0195|consen 300 RGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADM 372 (448)
T ss_pred hhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhH
Confidence 9999999875 55567899999998 554443 344333322 12223478899999986542 23568999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||++++||+.|...||.+.++.+.-.++.- ..++-.+++.++..+..|+.-|
T Consensus 373 wsfaillwel~trevpfadlspmecgmkial---------------------------eglrv~ippgis~hm~klm~ic 425 (448)
T KOG0195|consen 373 WSFAILLWELNTREVPFADLSPMECGMKIAL---------------------------EGLRVHIPPGISRHMNKLMNIC 425 (448)
T ss_pred HHHHHHHHHhhccccccccCCchhhhhhhhh---------------------------ccccccCCCCccHHHHHHHHHH
Confidence 9999999999999999999988877665542 2344456778899999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy10212 409 LEYTPSSRISPLQVRS 424 (444)
Q Consensus 409 L~~DP~kRPs~~elL~ 424 (444)
+..||.+||...+++-
T Consensus 426 mnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 426 MNEDPGKRPKFDMIVP 441 (448)
T ss_pred hcCCCCcCCCcceehh
Confidence 9999999999887754
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=189.38 Aligned_cols=153 Identities=33% Similarity=0.554 Sum_probs=126.4
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------CCccccccccccCchhhc
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----------------PNVSYICSRYYRAPELIF 317 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----------------~~~~~~gt~~y~aPE~l~ 317 (444)
+.+++|||+.||+|+|+||+|.++. .-|++|++|||+++...... ...+.++|+.|.|||++.
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 7889999999999999999999999 89999999999986542211 112347899999999998
Q ss_pred cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
.. .|....|+|++|+|+|+.+-|..||.+.++++++.+.+...+. |.+. ..-+
T Consensus 232 rq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-------------------------wpE~-dea~ 284 (1205)
T KOG0606|consen 232 RQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-------------------------WPEE-DEAL 284 (1205)
T ss_pred hh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-------------------------cccc-CcCC
Confidence 77 7999999999999999999999999999999999888763221 1111 1235
Q ss_pred ChhHHHHHHHhcccCCCCCCC---HHHHhccCchhhhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRIS---PLQVRSITPFLIELRAV 435 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs---~~elL~~hpwf~~~~~~ 435 (444)
+++++++|.++|+.+|..|.- +.++-. |+||+.|...
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~-h~ff~~LDw~ 324 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQ-HGFFQLLDWK 324 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhh-ccceeecccc
Confidence 899999999999999999975 566777 9999997554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-17 Score=151.69 Aligned_cols=180 Identities=16% Similarity=0.160 Sum_probs=133.2
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeecccc--------chhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCC
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR--------FKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.+...|++|+||+||.+.. .+..++.+.+..... .+.+|+++|++|. |++|.+++++ .+
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~------ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DG------ 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cC------
Confidence 34678999999999998877 678888887754432 4678999999995 4778887664 11
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (218)
T PRK12274 73 -------------------------------------------------------------------------------- 72 (218)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||+.| +|..... . ....++.|+
T Consensus 73 -----------------------------------------~~lvmeyI~G~~L~~~~~-----~------~~~~~~~qi 100 (218)
T PRK12274 73 -----------------------------------------RHLDRSYLAGAAMYQRPP-----R------GDLAYFRAA 100 (218)
T ss_pred -----------------------------------------EEEEEeeecCccHHhhhh-----h------hhHHHHHHH
Confidence 6799999998 4543221 0 113478899
Q ss_pred HHHHHHHHHCCcccCCC-CCCcEEEcCCCCeEEEeecCCcccccCCCCC----c----------cccccccccCchhhcc
Q psy10212 254 FRSLAYIHVLGICHRDI-KPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----V----------SYICSRYYRAPELIFG 318 (444)
Q Consensus 254 l~aL~yLHs~givH~dL-kp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~----------~~~gt~~y~aPE~l~~ 318 (444)
+.+|.++|++|++|+|| +|+||+++ .++.++|+|||++......... . ....++.++.|+.-.-
T Consensus 101 ~~~L~~lH~~GIvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~ 179 (218)
T PRK12274 101 RRLLQQLHRCGVAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV 179 (218)
T ss_pred HHHHHHHHHCcCccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh
Confidence 99999999999999999 79999998 6789999999999754433211 0 0123666777765433
Q ss_pred CCCCC-cchhhhhHHHHHHHHHhCCCCCCC
Q psy10212 319 AIDYT-TKIDVWSAGCVLAELLLGQPMFPG 347 (444)
Q Consensus 319 ~~~~s-~~sDiwSLGvil~eLltG~~Pf~~ 347 (444)
....+ .+.+.++.|+-+|.++|+..|.-+
T Consensus 180 l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 180 LKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 22333 678888999999999999988643
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=180.81 Aligned_cols=124 Identities=25% Similarity=0.418 Sum_probs=106.4
Q ss_pred EEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc------CCCCeEEEee
Q psy10212 216 LNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLN------PETGVLKLCD 288 (444)
Q Consensus 216 ~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~------~~~~~ikL~D 288 (444)
-++|+||.+ |||++++. ...-+++..+..+..|+|..+.+||..+||||||||+|.++. .+..-++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 569999999 79999985 567799999999999999999999999999999999999993 3455789999
Q ss_pred cCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCC
Q psy10212 289 FGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPM 344 (444)
Q Consensus 289 fg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~P 344 (444)
||.+..+..-... ...++|-.+-.+|...|. .|+.+.|.|.|+-+++-|+.|++.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999766433333 334568889999999888 999999999999999999998753
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=157.10 Aligned_cols=188 Identities=24% Similarity=0.324 Sum_probs=134.2
Q ss_pred ceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC---CCeEEEeecC
Q psy10212 214 VFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE---TGVLKLCDFG 290 (444)
Q Consensus 214 ~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~---~~~ikL~Dfg 290 (444)
..+|+||.-...+|+.++- ....+......++.|+++|+.|||.+|+.|||+|.+||++.-+ -..+++.|||
T Consensus 316 ~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred ceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 4599999999999999984 3457777888899999999999999999999999999999432 2378999999
Q ss_pred CcccccCC-------CCCccccccccccCchhhccCCC-----CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q psy10212 291 SAKHLVRG-------EPNVSYICSRYYRAPELIFGAID-----YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEII 358 (444)
Q Consensus 291 ~s~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~-----~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~ 358 (444)
++-..... ......-|.-..||||+...... .=.++|.|+.|-+.||++....||-+....-+ ...
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~~r 468 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--DTR 468 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--chh
Confidence 87332211 11122345666899998854311 12489999999999999999999975221100 000
Q ss_pred HHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH---HHHhc-----cCchhh
Q psy10212 359 KVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP---LQVRS-----ITPFLI 430 (444)
Q Consensus 359 ~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~---~elL~-----~hpwf~ 430 (444)
. +....+|. ++..|++.+++++..+|+.||+||+++ +.+|. .|.|++
T Consensus 469 ~----------------Yqe~qLPa---------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vk 523 (598)
T KOG4158|consen 469 T----------------YQESQLPA---------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVK 523 (598)
T ss_pred h----------------hhhhhCCC---------CcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHH
Confidence 0 11112222 344689999999999999999999995 44444 455665
Q ss_pred hhh
Q psy10212 431 ELR 433 (444)
Q Consensus 431 ~~~ 433 (444)
.+.
T Consensus 524 a~~ 526 (598)
T KOG4158|consen 524 AMM 526 (598)
T ss_pred Hhc
Confidence 543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=148.40 Aligned_cols=134 Identities=19% Similarity=0.272 Sum_probs=103.7
Q ss_pred chhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhc-----CCCceeEeeeEEeecCCCCCCCC
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRL-----EHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.-...||+|+||.||. ++.++.. +||++... .+.+.+|+++++++ .||||+++++++..+...
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~----- 76 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT----- 76 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC-----
Confidence 3457899999999995 6666666 69988543 45677999999999 579999999999775310
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (210)
T PRK10345 77 -------------------------------------------------------------------------------- 76 (210)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccce-EEEEeccCC---CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVF-LNLVLEFMP---ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~iv~e~~~---~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+ +.+||||++ ++|.+++.. ..+++. ..++.
T Consensus 77 --------------------------------------g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~ 111 (210)
T PRK10345 77 --------------------------------------GYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLR 111 (210)
T ss_pred --------------------------------------eEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHH
Confidence 12 348899965 599999853 235555 36688
Q ss_pred HHHHHH-HHHHHCCcccCCCCCCcEEEcC---CCCeEEEeecCC
Q psy10212 252 QLFRSL-AYIHVLGICHRDIKPQNLLLNP---ETGVLKLCDFGS 291 (444)
Q Consensus 252 QIl~aL-~yLHs~givH~dLkp~NIll~~---~~~~ikL~Dfg~ 291 (444)
|++.++ +|||+++|+|+||||+||+++. ....++|+|++-
T Consensus 112 ~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 112 QLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 888888 9999999999999999999973 234899999443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=152.46 Aligned_cols=73 Identities=15% Similarity=0.151 Sum_probs=60.1
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG-ICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~g-ivH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
.++||||+++ ++.... ..........+..++.||+.++++||++| ++|+||+|+||+++ .+.++|+|||.+.
T Consensus 123 ~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~--~~~i~LiDFg~a~ 196 (237)
T smart00090 123 NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH--DGKVVIIDVSQSV 196 (237)
T ss_pred ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE--CCCEEEEEChhhh
Confidence 4699999998 444432 12345566677899999999999999999 99999999999998 6789999999875
Q ss_pred c
Q psy10212 294 H 294 (444)
Q Consensus 294 ~ 294 (444)
.
T Consensus 197 ~ 197 (237)
T smart00090 197 E 197 (237)
T ss_pred c
Confidence 4
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-15 Score=140.37 Aligned_cols=69 Identities=23% Similarity=0.375 Sum_probs=59.3
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.+++|||++| +|.+++... .. ....++.+++.+|.+||+.+++|+|++|+||+++ .+.++|+|||.+..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 6799999986 888877421 11 7888999999999999999999999999999998 57899999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.4e-15 Score=136.89 Aligned_cols=66 Identities=24% Similarity=0.419 Sum_probs=55.8
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.+++||||+| +|.+.+... .. .++.|++.+|.+||+.|++|+|++|+||+++ .+.++++|||.+..
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred CEEEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 5799999986 777765321 10 7899999999999999999999999999998 67899999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=154.17 Aligned_cols=183 Identities=28% Similarity=0.408 Sum_probs=136.1
Q ss_pred EEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCc-ccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGI-CHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~gi-vH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
+++|.+||+ |+|.+.+.. ....++..+...++++|+.||+|||...+ .|+.+++.|.+++ ....+||+|||+..
T Consensus 22 ~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd-~~w~lklt~~Gl~~ 97 (484)
T KOG1023|consen 22 MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD-SRWVLKLTDFGLNS 97 (484)
T ss_pred eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee-eeEEEEechhhhcc
Confidence 889999999 799999864 56678899999999999999999998765 9999999999999 88899999999986
Q ss_pred cccC---CCCCccccccccccCchhhccCC--C----CCcchhhhhHHHHHHHHHhCCCCCCCCChh----HHHHHHHHH
Q psy10212 294 HLVR---GEPNVSYICSRYYRAPELIFGAI--D----YTTKIDVWSAGCVLAELLLGQPMFPGDSGV----DQLVEIIKV 360 (444)
Q Consensus 294 ~~~~---~~~~~~~~gt~~y~aPE~l~~~~--~----~s~~sDiwSLGvil~eLltG~~Pf~~~~~~----e~~~~i~~~ 360 (444)
.... ............|.|||.+.... . .+.+.|+||+|++++|+++.+.||...... +.+..+.+
T Consensus 98 ~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~- 176 (484)
T KOG1023|consen 98 LLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK- 176 (484)
T ss_pred cccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-
Confidence 6432 11112223356699999987631 1 477899999999999999999999864322 23333222
Q ss_pred hCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 361 LGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 361 ~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+ .....|...... .+++++..++..||.-+|.+||++.++-.
T Consensus 177 ~~--------------~~~~rP~i~~~~-------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 177 GG--------------SNPFRPSIELLN-------ELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cC--------------CCCcCcchhhhh-------hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 01 011111111000 24568999999999999999999988765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.2e-15 Score=137.10 Aligned_cols=69 Identities=16% Similarity=0.284 Sum_probs=57.0
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.++||||++| +|.+... ......++.+++.++.++|+.|++|+||+|+||+++ .++.++|+|||.+..
T Consensus 106 ~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~-~~~~~~liDfg~~~~ 174 (198)
T cd05144 106 HAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD-DDEKIYIIDWPQMVS 174 (198)
T ss_pred ceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc-CCCcEEEEECCcccc
Confidence 4799999998 4433221 134567889999999999999999999999999999 688999999999854
Q ss_pred c
Q psy10212 295 L 295 (444)
Q Consensus 295 ~ 295 (444)
.
T Consensus 175 ~ 175 (198)
T cd05144 175 T 175 (198)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=154.06 Aligned_cols=65 Identities=25% Similarity=0.379 Sum_probs=56.7
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.++||||+++ +|.+++. ....++.|++.+|.+||+.|++||||||+||+++ ++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 5799999986 7777663 3467899999999999999999999999999995 67899999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.4e-14 Score=128.73 Aligned_cols=72 Identities=19% Similarity=0.253 Sum_probs=56.6
Q ss_pred EEEEeccCCC-cHH-HHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMPE-TVY-KVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~~-~l~-~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
.++||||+++ ++. ..+.... . ...++.++.+++.++.++|+ ++++|+||+|+||+++ ++.++|+|||.+
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--~~~~~liDfg~a 161 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--DGKVYIIDVPQA 161 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--CCcEEEEECccc
Confidence 5799999997 211 1111100 0 16688899999999999999 9999999999999998 778999999998
Q ss_pred ccc
Q psy10212 293 KHL 295 (444)
Q Consensus 293 ~~~ 295 (444)
...
T Consensus 162 ~~~ 164 (187)
T cd05119 162 VEI 164 (187)
T ss_pred ccc
Confidence 654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=5e-14 Score=147.13 Aligned_cols=258 Identities=24% Similarity=0.274 Sum_probs=199.7
Q ss_pred hhhhhhccccchhheecc--cceeEEEEeEe--cCCCceeeeeee--e----ccccchhhHHHHhhhc-CCCceeEeeeE
Q psy10212 15 TYFSDLDNSLAQKTVIGN--GSFGIVYQAKL--LDSGELVAIKKV--L----QDKRFKNREMQIMRRL-EHSNIVKLKYF 83 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~~aiK~~--~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 83 (444)
..++-+...|.+.+.+|. |++|.||.+.+ ..++..+|+|.= . ......++|+....++ .|++.++....
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 345666778889999999 99999999999 889999999983 1 2345556788777777 58999987777
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
|..++
T Consensus 187 ~e~~~--------------------------------------------------------------------------- 191 (524)
T KOG0601|consen 187 WEGSG--------------------------------------------------------------------------- 191 (524)
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 76665
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCCh
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPC 243 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~ 243 (444)
.+|+.+|+|+.+|.++.. .....+++
T Consensus 192 ---------------------------------------------------~lfiqtE~~~~sl~~~~~---~~~~~~p~ 217 (524)
T KOG0601|consen 192 ---------------------------------------------------ILFIQTELCGESLQSYCH---TPCNFLPD 217 (524)
T ss_pred ---------------------------------------------------cceeeeccccchhHHhhh---cccccCCc
Confidence 399999999988888764 34455889
Q ss_pred HHHHHHHHHHHH----HHHHHHHCCcccCCCCCCcEEEcCCC-CeEEEeecCCcccccCCCCCc------cccccccccC
Q psy10212 244 FYTKLYIYQLFR----SLAYIHVLGICHRDIKPQNLLLNPET-GVLKLCDFGSAKHLVRGEPNV------SYICSRYYRA 312 (444)
Q Consensus 244 ~~i~~i~~QIl~----aL~yLHs~givH~dLkp~NIll~~~~-~~ikL~Dfg~s~~~~~~~~~~------~~~gt~~y~a 312 (444)
..++..+.+... ||.++|+.+++|.|++|.||+.. .+ ..++++|||+...+....... ...+...|++
T Consensus 218 ~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~-~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ 296 (524)
T KOG0601|consen 218 NLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT-SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAA 296 (524)
T ss_pred hhhhhHHhhhhhcccccccccCCCcccccccchhheecc-cccceeecCCcceeEEccCCccccceeeeecCCCCceEeC
Confidence 999999999999 99999999999999999999998 55 789999999987765544221 1256677999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCC--ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD--SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 313 PE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~--~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
||...+ -++..+|++++|.++.+..++..+.... +......+ .+ ..
T Consensus 297 ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~------------------~~------------ip 344 (524)
T KOG0601|consen 297 KELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ------------------GY------------IP 344 (524)
T ss_pred hhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc------------------cc------------Cc
Confidence 999877 5789999999999999999888766543 22111110 00 11
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
..+-.+-+..+...+.+|++.+|-.|++++.++. |+++.+...+
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~-l~~i~s~~~~ 388 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA-LNVIHSKLFV 388 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc-cccccchhhh
Confidence 1112234677888999999999999999999999 9999875443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-13 Score=118.85 Aligned_cols=130 Identities=22% Similarity=0.253 Sum_probs=102.9
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeeccc--cchhhHHHHhhhcCC--CceeEeeeEEeecCCCCCCCCCCCCcc
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK--RFKNREMQIMRRLEH--SNIVKLKYFFYSSGDKKDEPTNYPPLE 101 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~~~~~~ 101 (444)
+++.||+|+++.||++.+. ++.+++|...... ..+.+|+.+++.++| ..+.+++.+....+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~------------- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDG------------- 66 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-------------
Confidence 5678999999999999984 4789999986554 367899999999976 47776655443321
Q ss_pred ccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCC
Q psy10212 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 181 (444)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (444)
T Consensus 67 -------------------------------------------------------------------------------- 66 (155)
T cd05120 67 -------------------------------------------------------------------------------- 66 (155)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 182 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
..+++|||+++...... +......++.+++.++++||
T Consensus 67 ---------------------------------~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh 103 (155)
T cd05120 67 ---------------------------------WSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLH 103 (155)
T ss_pred ---------------------------------ccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHh
Confidence 27899999987532211 45566778999999999999
Q ss_pred HC---CcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 262 VL---GICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 262 s~---givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.. +++|+|++|+||+++ +.+.++++||+.+..
T Consensus 104 ~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 104 QLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred CCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 85 699999999999999 578999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.9e-13 Score=127.20 Aligned_cols=69 Identities=19% Similarity=0.308 Sum_probs=56.7
Q ss_pred EEEEeccCCC--cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPE--TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
.++|||+++| +|.+++.. .++++. .+.||+.+|.+||++||+|+||+|.||+++ .++.++|+|||.+.
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~-~~~~v~LIDfg~~~ 190 (239)
T PRK01723 121 ADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD-PDGKFWLIDFDRGE 190 (239)
T ss_pred eeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc-CCCCEEEEECCCcc
Confidence 4699999996 77777642 334443 367899999999999999999999999998 56789999999885
Q ss_pred c
Q psy10212 294 H 294 (444)
Q Consensus 294 ~ 294 (444)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 5
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.4e-14 Score=154.62 Aligned_cols=189 Identities=28% Similarity=0.376 Sum_probs=142.0
Q ss_pred eEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCC-eEEEeecCC
Q psy10212 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETG-VLKLCDFGS 291 (444)
Q Consensus 215 ~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~-~ikL~Dfg~ 291 (444)
+.++.+++..| ++.+.+. .......+...+..++.|+..++.|+| ..++.|+|++|+|.+++ ..+ .+++.|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~-~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD-ESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc-cCCCcccCCCchh
Confidence 36788888765 5555442 122236778888999999999999999 99999999999999999 666 899999999
Q ss_pred cccccC-CCC---Cccccc-cccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCH
Q psy10212 292 AKHLVR-GEP---NVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366 (444)
Q Consensus 292 s~~~~~-~~~---~~~~~g-t~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~ 366 (444)
+..... ... .....| ++.|+|||...+.....+..|+||+|+++..+++|..||......+... ..
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~------- 242 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SS------- 242 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--ee-------
Confidence 977655 222 223467 8999999999885466789999999999999999999998655443110 00
Q ss_pred HHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 367 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
|. .. ........-...+....+++.+++..+|..|.+..++-. ++|+..
T Consensus 243 --~~---------~~----~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~-d~~~~~ 291 (601)
T KOG0590|consen 243 --WK---------SN----KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL-DNWLSS 291 (601)
T ss_pred --ec---------cc----ccccccCccccCChhhhhcccccccCCchhccccccccc-cccccc
Confidence 00 00 001011111235788999999999999999999999999 999988
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.5e-13 Score=132.79 Aligned_cols=181 Identities=18% Similarity=0.222 Sum_probs=132.3
Q ss_pred EEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
..+++||++ +++..++++.+.....+....-++|+.||+.||.|||+.. ++|+++..+.|++. .++-++++--.-.
T Consensus 147 viFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~ 225 (458)
T KOG1266|consen 147 VIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPD 225 (458)
T ss_pred eEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCcc
Confidence 568899998 7999999998888899999999999999999999999986 99999999999999 7888887643221
Q ss_pred cc-----ccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChhHHHHHHHHHhCCCCH
Q psy10212 293 KH-----LVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPM-FPGDSGVDQLVEIIKVLGTPTR 366 (444)
Q Consensus 293 ~~-----~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~P-f~~~~~~e~~~~i~~~~g~~~~ 366 (444)
.. ...........+.++|.+||.-... ..+.++|||++|+...+|..+..- -.+.+..+....+.+.....
T Consensus 226 s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-- 302 (458)
T KOG1266|consen 226 STHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-- 302 (458)
T ss_pred ccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec--
Confidence 11 0111122233557889999976544 667899999999999999977643 22222222222222211000
Q ss_pred HHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 367 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
-...-+++|..||+-.|..||++.++|. ||.+-+
T Consensus 303 ------------------------------en~lqr~~i~kcl~~eP~~rp~ar~llf-Hpllfe 336 (458)
T KOG1266|consen 303 ------------------------------ENGLQRGSITKCLEGEPNGRPDARLLLF-HPLLFE 336 (458)
T ss_pred ------------------------------cCccccCcCcccccCCCCCCcchhhhhc-Cceeee
Confidence 0233456899999999999999999999 997655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=122.21 Aligned_cols=73 Identities=23% Similarity=0.323 Sum_probs=54.6
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH-HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR-SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~-aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
-++||||++| +|.+..... . ... ....++.+++. .+..+|..|++|+|++|.||+++ .++.++++|||++.
T Consensus 233 ~vLvmE~i~G~~L~~~~~~~-~--~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~-~~g~i~liDfG~~~ 305 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAALD-E--AGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVL-KDGKIIALDFGIVG 305 (437)
T ss_pred ceEEEEeECCcccccHHHHH-h--cCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEEC-CCCcEEEEeCCCee
Confidence 5799999997 665554321 1 111 23445556655 47889999999999999999998 78899999999986
Q ss_pred cc
Q psy10212 294 HL 295 (444)
Q Consensus 294 ~~ 295 (444)
..
T Consensus 306 ~l 307 (437)
T TIGR01982 306 RL 307 (437)
T ss_pred EC
Confidence 65
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-11 Score=124.83 Aligned_cols=72 Identities=24% Similarity=0.273 Sum_probs=50.8
Q ss_pred eEEEEeccCCC-cHHHHHHhhhhcC---CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC----eEEE
Q psy10212 215 FLNLVLEFMPE-TVYKVAKHYSKSK---QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG----VLKL 286 (444)
Q Consensus 215 ~~~iv~e~~~~-~l~~~~~~~~~~~---~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~----~ikL 286 (444)
--+||||||+| .+.+... ....+ ..+.+..+..++.|++ ..|++|+|++|.||+++ .++ ++++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~-l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~-~~g~~~~~i~l 305 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAA-LRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVS-YDPPENPRYIA 305 (537)
T ss_pred CceEEEeeecCccHHhHHH-HHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEe-cCCCCCCeEEE
Confidence 36799999997 6655321 11111 1244445555556654 59999999999999998 555 9999
Q ss_pred eecCCcccc
Q psy10212 287 CDFGSAKHL 295 (444)
Q Consensus 287 ~Dfg~s~~~ 295 (444)
+|||++...
T Consensus 306 lDFGivg~l 314 (537)
T PRK04750 306 LDFGIVGSL 314 (537)
T ss_pred EecceEEEC
Confidence 999998665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.2e-11 Score=105.64 Aligned_cols=65 Identities=28% Similarity=0.412 Sum_probs=50.5
Q ss_pred EEEEeccCCCc-HHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCcEEEcCCCCeEEEeec
Q psy10212 216 LNLVLEFMPET-VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGI-----CHRDIKPQNLLLNPETGVLKLCDF 289 (444)
Q Consensus 216 ~~iv~e~~~~~-l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~gi-----vH~dLkp~NIll~~~~~~ikL~Df 289 (444)
.++|||+++|. +.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ .+.++++||
T Consensus 66 ~~lv~e~i~G~~l~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf 131 (170)
T cd05151 66 GVLITEFIEGSELLTE------------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDW 131 (170)
T ss_pred CeEEEEecCCCccccc------------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEec
Confidence 45999999984 3221 11123457899999999999985 9999999999998 457999999
Q ss_pred CCccc
Q psy10212 290 GSAKH 294 (444)
Q Consensus 290 g~s~~ 294 (444)
+.+..
T Consensus 132 ~~a~~ 136 (170)
T cd05151 132 EYAGM 136 (170)
T ss_pred ccccC
Confidence 98743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-09 Score=115.03 Aligned_cols=114 Identities=24% Similarity=0.351 Sum_probs=82.3
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
+|||+|-|.. |-..++. ++...+...+.||+.||.+|| ..+++|++|+.+.|+|+ ..|..+|++|.++..
T Consensus 84 ~ylvTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn-~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 84 LYLVTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN-ESGEWKLGGLELVSK 154 (690)
T ss_pred eEEEeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc-CCCcEEEeeeEEEec
Confidence 9999999874 1122221 226777888999999999998 67899999999999999 899999999998754
Q ss_pred ccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 295 LVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 295 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
...... .......-.|..|+.+... . -..|.|.|||++++++.|
T Consensus 155 ~~~~~~~~~~~~~~~s~~~P~~~~~s-~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 155 ASGFNAPAKSLYLIESFDDPEEIDPS-E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccCCcccccchhhhcccChhhcCcc-c--cchhhhhHHHHHHHHhCc
Confidence 322221 1112223335666654333 2 246999999999999998
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-11 Score=124.68 Aligned_cols=250 Identities=18% Similarity=0.151 Sum_probs=175.8
Q ss_pred hhhccccchhheecccceeEEEEeEec-CCCceeeeeeeeccccchh------hHHHHhhhc-CCCceeEeeeEEeecCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLL-DSGELVAIKKVLQDKRFKN------REMQIMRRL-EHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~------~E~~~l~~l-~h~~i~~~~~~~~~~~~ 89 (444)
+.+..+|.++..||.|.|+.|+.+... .++..|++|.+...-..+- .|+-+...+ .|.+++.++..|..-+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 456788999999999999999998865 5678899998855433222 566555555 58888888777766543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 341 -------------------------------------------------------------------------------- 340 (524)
T KOG0601|consen 341 -------------------------------------------------------------------------------- 340 (524)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.||..|||++....... .....+.+...+++
T Consensus 341 ----------------------------------------------~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~ 371 (524)
T KOG0601|consen 341 ----------------------------------------------GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRL 371 (524)
T ss_pred ----------------------------------------------ccCchhhhcCcchhhhh---HHHHhcCcchhhhh
Confidence 67999999863333222 23355788889999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcccccccccc-CchhhccCCCCCcchhh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-APELIFGAIDYTTKIDV 328 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~s~~sDi 328 (444)
..|++.++.++|+..++|+|++|+||++.+.++..+++||++.....- .........++. ..|.+.....+..+.|+
T Consensus 372 ~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~ 449 (524)
T KOG0601|consen 372 TAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADI 449 (524)
T ss_pred HHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--ecccccccccccccchhhcccccccccccc
Confidence 999999999999999999999999999985457889999998754211 111222233344 25555444478899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
++||+.+.+..++...-......- .+... ..| ...+.+.++..+...+
T Consensus 450 ~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~-------------------~~p----------~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 450 FSLGLSVDEAITGSPLSESGVQSL---TIRSG-------------------DTP----------NLPGLKLQLQVLLKVM 497 (524)
T ss_pred ccccccccccccCcccCcccccce---eeecc-------------------ccc----------CCCchHHhhhhhhhhh
Confidence 999999999998875432211110 00000 000 0122347888999999
Q ss_pred cccCCCCCCCHHHHhccCchhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
...++..||++.++.. |.=|..
T Consensus 498 ~~~~~~~~~l~~~l~~-~~~~~~ 519 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSL-HSEFYR 519 (524)
T ss_pred cCCccccchhhhhhcc-cchhhh
Confidence 9999999999999988 765544
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-09 Score=107.73 Aligned_cols=226 Identities=19% Similarity=0.223 Sum_probs=159.9
Q ss_pred ceeEEEEeEecCCCceeeeeeeecccc----chhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCccccccccCC
Q psy10212 34 SFGIVYQAKLLDSGELVAIKKVLQDKR----FKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFS 109 (444)
Q Consensus 34 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (444)
--.+.|++..+.+|..|++|+++..+. ....-++..+++.|+|||++.+.|....
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t--------------------- 346 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT--------------------- 346 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc---------------------
Confidence 346899999999999999999965543 3345688999999999999987776221
Q ss_pred CCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccC
Q psy10212 110 PRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 189 (444)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (444)
++
T Consensus 347 ----------------------------F~-------------------------------------------------- 348 (655)
T KOG3741|consen 347 ----------------------------FG-------------------------------------------------- 348 (655)
T ss_pred ----------------------------cC--------------------------------------------------
Confidence 00
Q ss_pred CcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC--cHHHHHHhh-----------hhcCCCCChHHHHHHHHHHHHH
Q psy10212 190 PPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE--TVYKVAKHY-----------SKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~~~~~-----------~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.-+++|++|.++ +|.+..-.- -..+...++..+|.++.|+..|
T Consensus 349 -----------------------D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaa 405 (655)
T KOG3741|consen 349 -----------------------DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAA 405 (655)
T ss_pred -----------------------cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHH
Confidence 1349999999985 787765221 1123446789999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
|.++|+.|+..+-|.+.+|++. .+.+++|...|......... .+| +. --.+.|.-.||.++.
T Consensus 406 L~sIHssGLAck~L~~~kIlv~-G~~RIriS~C~i~Dvl~~d~-----------~~~--le----~~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 406 LYSIHSSGLACKTLDLKKILVT-GKMRIRISGCGIMDVLQEDP-----------TEP--LE----SQQQNDLRDLGLLLL 467 (655)
T ss_pred HHHHHhcCceeecccHhHeEee-CcceEEEecccceeeecCCC-----------Ccc--hh----HHhhhhHHHHHHHHH
Confidence 9999999999999999999999 56689998888765543332 111 11 124679999999999
Q ss_pred HHHhCCCC-CCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 337 ELLLGQPM-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 337 eLltG~~P-f~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
.|.+|..- +......+...+.+. +.++.+++++|..+...++++
T Consensus 468 aLAt~~~ns~~~d~~~~s~~~~I~-----------------------------------~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 468 ALATGTENSNRTDSTQSSHLTRIT-----------------------------------TTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred HHhhcccccccccchHHHHHHHhh-----------------------------------hhhhHHHHHHHHHHHhcCccc
Confidence 99998642 222222222111111 246899999999999999996
Q ss_pred CCCHHHHhc--cCchhhhhhhh
Q psy10212 416 RISPLQVRS--ITPFLIELRAV 435 (444)
Q Consensus 416 RPs~~elL~--~hpwf~~~~~~ 435 (444)
-++.+++- ...||..+.++
T Consensus 513 -ksI~~llp~~~~~ff~vmes~ 533 (655)
T KOG3741|consen 513 -KSIQDLLPMIGSRFFTVMESV 533 (655)
T ss_pred -ccHHHHHHHHHHHHHHHHHhH
Confidence 66666665 12355544433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-09 Score=101.37 Aligned_cols=73 Identities=19% Similarity=0.238 Sum_probs=56.7
Q ss_pred EEEEeccCCCc-HHH-HHHhhhhcCCCCChHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMPET-VYK-VAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI-HVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~~~-l~~-~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
-+|||||++++ +.. .++ ...++......++.|++.+|..| |..|++||||++.||+++ .+.+.|+||+.+
T Consensus 99 ~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~--~~~v~iIDF~qa 171 (197)
T cd05146 99 HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH--DGKVWFIDVSQS 171 (197)
T ss_pred CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE--CCcEEEEECCCc
Confidence 56999999974 211 111 12345566778889999999988 899999999999999997 468999999988
Q ss_pred ccc
Q psy10212 293 KHL 295 (444)
Q Consensus 293 ~~~ 295 (444)
...
T Consensus 172 v~~ 174 (197)
T cd05146 172 VEP 174 (197)
T ss_pred eeC
Confidence 553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-10 Score=126.69 Aligned_cols=186 Identities=27% Similarity=0.414 Sum_probs=143.3
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
++++++|.++ +|...+. ..+..+...++.....+.+++++||+..+.|+|++|.|++.. ..+...+++|+....
T Consensus 879 ~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA-YDGHRPLTDFGTLSK 953 (1205)
T ss_pred cchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc-ccCCcccCccccccc
Confidence 7899999975 6666553 334677788888889999999999999999999999999998 788999999873211
Q ss_pred cc---------------------CC-----------CCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCC
Q psy10212 295 LV---------------------RG-----------EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ 342 (444)
Q Consensus 295 ~~---------------------~~-----------~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~ 342 (444)
.. .. .......+++.|.+||...+. .-...+|+|+.|+++++.++|.
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCC
Confidence 10 00 001123568899999999887 6677899999999999999999
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHH--
Q psy10212 343 PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL-- 420 (444)
Q Consensus 343 ~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~-- 420 (444)
+||....+......+..... .|... +...++.+.+++..+|..+|.+|..+.
T Consensus 1033 pp~na~tpq~~f~ni~~~~~-------------------------~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDI-------------------------PWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCCCcchhhhhhccccCCC-------------------------CCCCC-ccccChhhhhhhhhhhccCchhccCcccc
Confidence 99999888777665554211 11111 223588999999999999999999987
Q ss_pred -HHhccCchhhhhhh
Q psy10212 421 -QVRSITPFLIELRA 434 (444)
Q Consensus 421 -elL~~hpwf~~~~~ 434 (444)
++-. |+||++...
T Consensus 1087 ~e~k~-~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1087 AEVKG-HPFFQDVDW 1100 (1205)
T ss_pred ccccc-CCccCCCCc
Confidence 7777 999998543
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-08 Score=91.38 Aligned_cols=78 Identities=19% Similarity=0.190 Sum_probs=62.1
Q ss_pred EEEEeccCCC--cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeE--EEeecCC
Q psy10212 216 LNLVLEFMPE--TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVL--KLCDFGS 291 (444)
Q Consensus 216 ~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~i--kL~Dfg~ 291 (444)
-.|.|||++| ++.+++.. .-...........++.+|-..+.-||..+++||||..+||++.+...++ .++|||+
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~--~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILS--TMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred CeEEEEeccchhHHHHHHHH--HccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence 4599999998 78888753 2233344444478899999999999999999999999999997566655 9999999
Q ss_pred cccc
Q psy10212 292 AKHL 295 (444)
Q Consensus 292 s~~~ 295 (444)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=8e-08 Score=97.54 Aligned_cols=195 Identities=15% Similarity=0.174 Sum_probs=128.5
Q ss_pred EEEEeccCCC--cHHHHH--HhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCC
Q psy10212 216 LNLVLEFMPE--TVYKVA--KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291 (444)
Q Consensus 216 ~~iv~e~~~~--~l~~~~--~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~ 291 (444)
.-+.|+.+++ ....+. ...+.+-....+.+..+..+.++.+.+.||.+|.+-||++++|++++ +.+.+.|.|-..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs-d~~~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS-DDSKVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee-cCceEEEEcccc
Confidence 6788999987 444443 22334445577899999999999999999999999999999999999 889999988543
Q ss_pred cccccCCCCCccccccccccCchhhc-c---CCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChh-----HHHHHHHHHh
Q psy10212 292 AKHLVRGEPNVSYICSRYYRAPELIF-G---AIDYTTKIDVWSAGCVLAELLLG-QPMFPGDSGV-----DQLVEIIKVL 361 (444)
Q Consensus 292 s~~~~~~~~~~~~~gt~~y~aPE~l~-~---~~~~s~~sDiwSLGvil~eLltG-~~Pf~~~~~~-----e~~~~i~~~~ 361 (444)
-.....+.......+...|++||... + +-.-+...|.|.||+++++++.| +.||.+.... .....|....
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 33333334444567788999999874 1 11456789999999999999975 9999874210 1111111100
Q ss_pred CCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc--CCCCCCCHHHHhc
Q psy10212 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY--TPSSRISPLQVRS 424 (444)
Q Consensus 362 g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~--DP~kRPs~~elL~ 424 (444)
-. ..++......|.....+|. -+++++..|..+|+.. ++.-|||++-=+.
T Consensus 244 f~--------ya~~~~~g~~p~P~~~P~~-----~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a 295 (637)
T COG4248 244 FA--------YASDQRRGLKPPPRSIPLS-----MLPPDVQALFQQAFTESGVATPRPTAKAWVA 295 (637)
T ss_pred ee--------echhccCCCCCCCCCCChh-----hcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence 00 0011111111111111111 2589999999999974 4678999864333
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.8e-09 Score=111.81 Aligned_cols=155 Identities=19% Similarity=0.292 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--------Cc--cccccccccCchhhccC
Q psy10212 251 YQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------NV--SYICSRYYRAPELIFGA 319 (444)
Q Consensus 251 ~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------~~--~~~gt~~y~aPE~l~~~ 319 (444)
.+++.|+.++|. .+++|++|.|++|.++ ..+..||+.|+.+........ .. .......|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 345599999996 5899999999999999 889999999998754332111 00 01225569999999885
Q ss_pred CCCCcchhhhhHHHHHHHHH-hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLl-tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
..+.++|++|+|+++|.+. .|+..+...........-.... ..-....+.++|
T Consensus 185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-------------------------NAGAFGYSNNLP 238 (700)
T ss_pred -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-------------------------ccccccccccCc
Confidence 7899999999999999999 6777776654433222221110 011122235789
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+++++=|.++|..++..||++.+++. .|||.+-.
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~-~~ff~D~~ 272 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLS-IPFFSDPG 272 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhc-ccccCCch
Confidence 99999999999999999999999999 99999854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.2e-08 Score=90.15 Aligned_cols=72 Identities=21% Similarity=0.344 Sum_probs=48.2
Q ss_pred EEEEeccCC--CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY-IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~--~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y-LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
-+|||||++ |.....+.. ..++......++.+++..+.. +|..|++||||++.||+++ ++ .+.++|||.+
T Consensus 81 ~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~-~~-~~~iIDf~qa 153 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD-DG-KVYIIDFGQA 153 (188)
T ss_dssp TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE-TT-CEEE--GTTE
T ss_pred CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee-cc-eEEEEecCcc
Confidence 359999999 633333321 112255667788888885555 6799999999999999998 33 9999999987
Q ss_pred cc
Q psy10212 293 KH 294 (444)
Q Consensus 293 ~~ 294 (444)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.2e-08 Score=90.56 Aligned_cols=49 Identities=14% Similarity=0.243 Sum_probs=38.5
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCc
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSN 76 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~ 76 (444)
.+.|+.|..+.||++.... |+.+++|..... ...+.+|+++++.+.+.+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~ 56 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTG 56 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCC
Confidence 3678999999999998743 689999988543 346678999999997643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.4e-07 Score=85.17 Aligned_cols=66 Identities=21% Similarity=0.385 Sum_probs=53.2
Q ss_pred EEEEeccCCCcHH-HHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPETVY-KVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~~l~-~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
..|+|||++|.+. +.+... ...++..+-.-+.-||..||+||||.++||+++ .+.+.++|||++..
T Consensus 74 ~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe--CCcEEEEECCcccc
Confidence 4599999999554 465421 245677788888899999999999999999998 44599999999865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.6e-07 Score=87.07 Aligned_cols=76 Identities=18% Similarity=0.204 Sum_probs=63.1
Q ss_pred EEEEeccCCC--cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC------CCCeEEEe
Q psy10212 216 LNLVLEFMPE--TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP------ETGVLKLC 287 (444)
Q Consensus 216 ~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~------~~~~ikL~ 287 (444)
.+||||++++ +|.+++.... ..+.+......++.+++..+..||..|++|+|++++||+++. +...+.|+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 6799999997 6888874321 245567788899999999999999999999999999999973 24689999
Q ss_pred ecCCcc
Q psy10212 288 DFGSAK 293 (444)
Q Consensus 288 Dfg~s~ 293 (444)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999774
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=83.15 Aligned_cols=78 Identities=10% Similarity=0.070 Sum_probs=63.8
Q ss_pred ceEEEEeccCCC--cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe--EEEeec
Q psy10212 214 VFLNLVLEFMPE--TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGV--LKLCDF 289 (444)
Q Consensus 214 ~~~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~--ikL~Df 289 (444)
...+||+|-+++ +|.+++.. ..-.+.+......++.+++..+.-||..|+.|+|+.+.||+++ ..+. +.++||
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~-~~g~~~v~lIDl 174 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK-TEGKAEAGFLDL 174 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec-CCCCeeEEEEEh
Confidence 458899999984 88887642 1233567888889999999999999999999999999999997 3344 999999
Q ss_pred CCccc
Q psy10212 290 GSAKH 294 (444)
Q Consensus 290 g~s~~ 294 (444)
..++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-06 Score=84.27 Aligned_cols=70 Identities=17% Similarity=0.235 Sum_probs=55.2
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
-.+|||+++|-.+.- -+++......++..|+.-+..+-..|++|||+++-||+++ ++|.+.++||..+..
T Consensus 182 HaVvMe~ieG~eL~~--------~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~-~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 182 HAVVMEYIEGVELYR--------LRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT-EDGDIVVIDWPQAVP 251 (304)
T ss_pred ceeeeehcccceeec--------ccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe-cCCCEEEEeCccccc
Confidence 569999999843221 2235566777777888888778899999999999999999 788999999987643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-06 Score=78.40 Aligned_cols=75 Identities=23% Similarity=0.406 Sum_probs=62.3
Q ss_pred EEEEeccCCC--cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEEEeecCC
Q psy10212 216 LNLVLEFMPE--TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET--GVLKLCDFGS 291 (444)
Q Consensus 216 ~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~--~~ikL~Dfg~ 291 (444)
.++|+|.+++ +|.+++... ...+......++.+++..+.-||.+|++|+|+++.|||++.+. ..+.++||+.
T Consensus 92 s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~ 167 (206)
T PF06293_consen 92 SYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDR 167 (206)
T ss_pred EEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence 6899999997 688877531 2267778889999999999999999999999999999998332 2899999987
Q ss_pred ccc
Q psy10212 292 AKH 294 (444)
Q Consensus 292 s~~ 294 (444)
+..
T Consensus 168 ~~~ 170 (206)
T PF06293_consen 168 MRF 170 (206)
T ss_pred cee
Confidence 754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.6e-07 Score=94.28 Aligned_cols=76 Identities=24% Similarity=0.276 Sum_probs=50.8
Q ss_pred ceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH-HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCC
Q psy10212 214 VFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS-LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291 (444)
Q Consensus 214 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a-L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~ 291 (444)
.--+++|||++| .+.+..... . ...+...+ +..++.+ +..+-..|+.|+|.+|.||+++ .++++.+.|||+
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~-~--~g~d~k~i---a~~~~~~f~~q~~~dgffHaDpHpGNi~v~-~~g~i~~lDfGi 311 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALK-S--AGIDRKEL---AELLVRAFLRQLLRDGFFHADPHPGNILVR-SDGRIVLLDFGI 311 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHH-h--cCCCHHHH---HHHHHHHHHHHHHhcCccccCCCccceEEe-cCCcEEEEcCcc
Confidence 336799999999 555553221 1 22332222 2222222 3344458999999999999999 789999999999
Q ss_pred ccccc
Q psy10212 292 AKHLV 296 (444)
Q Consensus 292 s~~~~ 296 (444)
.....
T Consensus 312 ~g~l~ 316 (517)
T COG0661 312 VGRLD 316 (517)
T ss_pred eecCC
Confidence 86553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.8e-06 Score=78.02 Aligned_cols=65 Identities=15% Similarity=0.329 Sum_probs=49.6
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.+++|||++| .|.+... +++ .+...|.+++..||+.|++|||++|.|++++ ++.++++|++..+.
T Consensus 118 ~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~--~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS--NNGIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE--CCcEEEEECccccc
Confidence 6699999998 4544321 122 2445677889999999999999999999998 45599999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.8e-06 Score=91.71 Aligned_cols=179 Identities=19% Similarity=0.144 Sum_probs=116.8
Q ss_pred eEEEEeccCCCc--HHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 215 FLNLVLEFMPET--VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 215 ~~~iv~e~~~~~--l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
++.+++++|++. ....+. ...-.+..-....+++.-..++++||+..=+|+| ||+.. ++..+.++|+..
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s--~~~~~~~~~~v~ 378 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS--EEEVKLLDFAVP 378 (829)
T ss_pred ccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc--ccccccccccCC
Confidence 578999999864 222111 1111233334455566677889999988767887 77776 467899999988
Q ss_pred ccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhh
Q psy10212 293 KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM 372 (444)
Q Consensus 293 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~ 372 (444)
....+........+++.++|||....+ .+....|.|++|.-..+|.-|-+|-..... ...
T Consensus 379 ~~L~~~~~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~----------------~~~--- 438 (829)
T KOG0576|consen 379 PQLTRTMKPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA----------------VLP--- 438 (829)
T ss_pred cccCcccccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc----------------ccC---
Confidence 766555556677889999999988887 788999999999877777777777544110 000
Q ss_pred CCCCCcccCCCccC-CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 373 NPNYTEFKFPQIKS-HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 373 ~~~~~~~~~p~~~~-~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
.+.-.. ..+.... ..|...++ +++-..|+..-|..|+....++. |++|.-
T Consensus 439 ~~g~~p-~s~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacf-sKvfng 489 (829)
T KOG0576|consen 439 MIGNGP-NSPMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACF-SKVFNG 489 (829)
T ss_pred CCCCCC-CccccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHH-HHHhcc
Confidence 000000 0111111 22333322 15777889999999999999999 888865
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.1e-05 Score=88.74 Aligned_cols=170 Identities=22% Similarity=0.347 Sum_probs=114.3
Q ss_pred EEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCC---cEEEcCCCCeEEEe--ecCC
Q psy10212 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ---NLLLNPETGVLKLC--DFGS 291 (444)
Q Consensus 218 iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~---NIll~~~~~~ikL~--Dfg~ 291 (444)
+..++|.+ ++.+.+. .....+....+.+..+++.||.++|+..+.|.-+..+ +-..+ ..+....+ ||+.
T Consensus 263 v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~s 337 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVD-GEGVVAISLSDFDS 337 (1351)
T ss_pred HHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccC-ccceeecchhhhcc
Confidence 45577775 6666663 4577889999999999999999999997666666555 22223 33344444 7777
Q ss_pred cccccCCCCCccccccccccCchhhccC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHH
Q psy10212 292 AKHLVRGEPNVSYICSRYYRAPELIFGA-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370 (444)
Q Consensus 292 s~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~ 370 (444)
+.................+.++|..... ...+...|+|++|.....+..|..+-..... ......
T Consensus 338 s~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~---~~~~l~----------- 403 (1351)
T KOG1035|consen 338 SKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV---PVSLLD----------- 403 (1351)
T ss_pred cccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc---hhhhhc-----------
Confidence 7665444444444456667888877554 1233447999999999998877654321110 000000
Q ss_pred hhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 371 ~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
......+.+.+.+|+.-++++|+++.+++. |+|.+.
T Consensus 404 ------------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~-~~f~~~ 439 (1351)
T KOG1035|consen 404 ------------------------VLSTSELLDALPKCLDEDSEERLSALELLT-HPFLRF 439 (1351)
T ss_pred ------------------------cccchhhhhhhhhhcchhhhhccchhhhhh-chhccc
Confidence 011226888999999999999999999999 999875
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.2e-05 Score=80.39 Aligned_cols=77 Identities=73% Similarity=1.196 Sum_probs=73.0
Q ss_pred ccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccc
Q psy10212 138 VSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 214 (444)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (444)
-++|+++|+.++++.||.++++.+..|+|+|+++++++++.++|.+++.-+.+++..|+.+..+.+.|..+..+.+.
T Consensus 227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 35899999999999999999999999999999999999999999999999999999999999999999999987443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.5e-05 Score=71.55 Aligned_cols=75 Identities=17% Similarity=0.182 Sum_probs=56.2
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
-.|||||++.. ..-... -..-++....+..+..++++.+.-|-. .+++|+||+.-|||+. .+.+.++||+.+..
T Consensus 141 nVLvMEfIg~~-g~pAP~--LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--~~~p~iID~~QaV~ 215 (268)
T COG1718 141 NVLVMEFIGDD-GLPAPR--LKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--DGEPYIIDVSQAVT 215 (268)
T ss_pred CeEEEEeccCC-CCCCCC--cccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--CCeEEEEECccccc
Confidence 56999999864 111110 112233444688888999999998888 8999999999999998 78999999998855
Q ss_pred c
Q psy10212 295 L 295 (444)
Q Consensus 295 ~ 295 (444)
.
T Consensus 216 ~ 216 (268)
T COG1718 216 I 216 (268)
T ss_pred c
Confidence 3
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=66.98 Aligned_cols=47 Identities=19% Similarity=0.172 Sum_probs=37.0
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHS 75 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~ 75 (444)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.|...
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~ 50 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEH 50 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHT
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhc
Confidence 4678999999999999854 69999988554 45666899898888533
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00011 Score=78.25 Aligned_cols=73 Identities=21% Similarity=0.313 Sum_probs=49.1
Q ss_pred eEEEEeccCCC-cHH--HHHHhhhhcCCCCChHHHHHHHHHHHHH-HHHHHHCCcccCCCCCCcEEEcC---CCCeEEEe
Q psy10212 215 FLNLVLEFMPE-TVY--KVAKHYSKSKQNFPCFYTKLYIYQLFRS-LAYIHVLGICHRDIKPQNLLLNP---ETGVLKLC 287 (444)
Q Consensus 215 ~~~iv~e~~~~-~l~--~~~~~~~~~~~~l~~~~i~~i~~QIl~a-L~yLHs~givH~dLkp~NIll~~---~~~~ikL~ 287 (444)
--+++||||+| .+. +.++. ..++...+ +..+.++ +..|-..|++|+|-+|.||++.. .+..+.+.
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDK-----RGISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHH-----cCCCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEE
Confidence 47899999998 333 33321 23333333 3333333 23444678999999999999983 36799999
Q ss_pred ecCCcccc
Q psy10212 288 DFGSAKHL 295 (444)
Q Consensus 288 Dfg~s~~~ 295 (444)
|+|+....
T Consensus 348 DhGl~~~i 355 (538)
T KOG1235|consen 348 DHGLYAVI 355 (538)
T ss_pred cccccccc
Confidence 99998664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00023 Score=65.32 Aligned_cols=61 Identities=20% Similarity=0.271 Sum_probs=49.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeee--ccccchhhHHHHhhhcCCCceeEe
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVL--QDKRFKNREMQIMRRLEHSNIVKL 80 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~--~~~~~~~~E~~~l~~l~h~~i~~~ 80 (444)
+.....-.+.+.||+|.+|.||++.. .|..+|+|+-. ..+..+..|+++|..+...++..=
T Consensus 18 ~~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~ 80 (201)
T COG2112 18 EEGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPE 80 (201)
T ss_pred eccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCce
Confidence 33445566789999999999999998 57799999874 446788899999999988777653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00052 Score=65.70 Aligned_cols=43 Identities=23% Similarity=0.219 Sum_probs=32.3
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEH 74 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h 74 (444)
..||+|..+.||+. .|..+++|..... .....+|.++++.+..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~ 51 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFS 51 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHH
Confidence 57899999999984 2556889987542 2446789999988854
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.002 Score=60.65 Aligned_cols=66 Identities=21% Similarity=0.345 Sum_probs=47.3
Q ss_pred hccccchhheecccce-eEEEEeEecCCCceeeeeeeec--------------cc-----------cchhhHHHHhhhc-
Q psy10212 20 LDNSLAQKTVIGNGSF-GIVYQAKLLDSGELVAIKKVLQ--------------DK-----------RFKNREMQIMRRL- 72 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~aiK~~~~--------------~~-----------~~~~~E~~~l~~l- 72 (444)
....++.++.||.|+- |.||+++. .|+.||||++.. .. .-|..|-+..-+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3478999999999999 99999998 789999999300 00 1233566666665
Q ss_pred --CCCce--eEeeeEEeec
Q psy10212 73 --EHSNI--VKLKYFFYSS 87 (444)
Q Consensus 73 --~h~~i--~~~~~~~~~~ 87 (444)
.+.++ |+.++++.-.
T Consensus 113 e~~~e~~~Avkc~Gyl~L~ 131 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLT 131 (207)
T ss_pred hccccCceEEEeeEEEEEc
Confidence 34455 7888877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0023 Score=61.26 Aligned_cols=30 Identities=20% Similarity=0.293 Sum_probs=25.3
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
..++|+|+.|.||+++ +.+.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~-~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVD-PGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEe-CCcEEEEEEccccc
Confidence 3489999999999999 56667899998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0018 Score=73.50 Aligned_cols=52 Identities=19% Similarity=0.369 Sum_probs=38.1
Q ss_pred hhheecccceeEEEEeEecCCC--ceeeeeeeec-----cccchhhHHHHhhhcC-CCce
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSG--ELVAIKKVLQ-----DKRFKNREMQIMRRLE-HSNI 77 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~--~~~aiK~~~~-----~~~~~~~E~~~l~~l~-h~~i 77 (444)
.++.|+.|.++.+|+......+ ..+++|+... ....+.+|.++|+.|. |.+|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v 101 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV 101 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC
Confidence 3678899999999998875432 4688887632 2346779999999995 6654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0041 Score=59.10 Aligned_cols=51 Identities=12% Similarity=0.150 Sum_probs=35.0
Q ss_pred hheecccceeEEEEeEecC-CCceeeeeeeecccc---chhhHHHHhhhcCCCce
Q psy10212 27 KTVIGNGSFGIVYQAKLLD-SGELVAIKKVLQDKR---FKNREMQIMRRLEHSNI 77 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~---~~~~E~~~l~~l~h~~i 77 (444)
++.|..|-...+|++.... +++.|++|....... ...+|+.+++.+...++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl 57 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL 57 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC
Confidence 4567888889999997643 357899997744322 12378989998854443
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.011 Score=58.23 Aligned_cols=48 Identities=8% Similarity=-0.024 Sum_probs=35.4
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeec-cccchhhHHHHhhhcCCCc
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-DKRFKNREMQIMRRLEHSN 76 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~E~~~l~~l~h~~ 76 (444)
++.|..|....+|++.. ++..+++|+... .......|++++..|.+.+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g 67 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERG 67 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCC
Confidence 66788888899999865 456799998863 3445667898998885433
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.014 Score=58.21 Aligned_cols=56 Identities=9% Similarity=-0.058 Sum_probs=36.8
Q ss_pred hhhhccccch-----hheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCC
Q psy10212 17 FSDLDNSLAQ-----KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEH 74 (444)
Q Consensus 17 ~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h 74 (444)
+.++..+|.+ ++.++.|-...+|++.. ++..+++|+.... .+....|+.++..|..
T Consensus 12 l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~ 74 (307)
T TIGR00938 12 MSSFLDGYDLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAA 74 (307)
T ss_pred HHHHHHhcCCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHH
Confidence 3444445544 56677777789999875 3446888987542 3455678888888853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.015 Score=55.47 Aligned_cols=31 Identities=29% Similarity=0.426 Sum_probs=25.4
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.+++|+|+++.||+++ +.+...|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQ-DGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEE-CCCEEEEEeCcccCc
Confidence 4589999999999998 555567999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.043 Score=51.57 Aligned_cols=64 Identities=25% Similarity=0.296 Sum_probs=42.5
Q ss_pred EEEEeccCC---C----cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CC-eEE
Q psy10212 216 LNLVLEFMP---E----TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TG-VLK 285 (444)
Q Consensus 216 ~~iv~e~~~---~----~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~-~ik 285 (444)
+.+|+|.+. | ||.+++. .+.++. .... .+-.-..+|-+.+|+.+|++|+||++... .. .+.
T Consensus 92 ~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 92 LGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred eEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEE
Confidence 567777653 2 6777773 234544 3333 33344568889999999999999999522 22 678
Q ss_pred Eee
Q psy10212 286 LCD 288 (444)
Q Consensus 286 L~D 288 (444)
|+|
T Consensus 163 lID 165 (199)
T PF10707_consen 163 LID 165 (199)
T ss_pred EEe
Confidence 887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0026 Score=63.70 Aligned_cols=68 Identities=15% Similarity=0.221 Sum_probs=51.5
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
-++|||++.| .|...-. ...+..+...+..-+--|..+|++|||.+-=||++. +...++++||.....
T Consensus 183 H~Vvmelv~g~Pl~~v~~----------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~-dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 183 HCVVMELVDGYPLRQVRH----------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK-DDDKIVVIDFPQMVS 251 (465)
T ss_pred eeeHHHhhcccceeeeee----------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe-cCCCEEEeechHhhc
Confidence 5689999987 6554321 122344555666667789999999999999999999 788999999986543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.051 Score=54.20 Aligned_cols=31 Identities=26% Similarity=0.344 Sum_probs=25.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.+++|+|++++||+++ ++....++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~-~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE-GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE-CCceEEEEecccccC
Confidence 4899999999999998 555568999987743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.038 Score=53.44 Aligned_cols=45 Identities=16% Similarity=0.162 Sum_probs=31.7
Q ss_pred eecccceeEEEEeEecCCCceeeeeeeecccc----chhhHHHHhhhcCCC
Q psy10212 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR----FKNREMQIMRRLEHS 75 (444)
Q Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~E~~~l~~l~h~ 75 (444)
.+..|-.+.+|++.. +++.+++|....... ...+|.++++.+...
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~ 51 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSAL 51 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhc
Confidence 355677889999873 577899997644322 235799899988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.029 Score=57.29 Aligned_cols=74 Identities=19% Similarity=0.244 Sum_probs=54.0
Q ss_pred EEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
-+|||+++++.-|-.- +...-.++...+..+-.|++.-+-.|- ..+++|.||+--|+|+- .|.+.++|.+.+..
T Consensus 239 hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 239 HVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--DGKLYIIDVSQSVE 313 (520)
T ss_pred ceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE--CCEEEEEEcccccc
Confidence 4699999996422111 112345666677777777777776665 56899999999999997 78999999988744
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.0094 Score=62.98 Aligned_cols=91 Identities=21% Similarity=0.305 Sum_probs=68.0
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
+++|||++|.++.++..|...+......+....+.+....+........ ...+...++..+.+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~ 172 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLP 172 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHH
Confidence 5899999999999999999988877777766666654433332221110 00122346888999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+++.|+-..|..||...++.+ ++-|.+.
T Consensus 173 ~~~~c~~~~~~ir~l~~~~~k-~~i~~ev 200 (725)
T KOG1093|consen 173 LLKKCLWLEPIIRPLPMELSK-RCSFTEV 200 (725)
T ss_pred HhccCCccccccccchhHHhc-CccHHHH
Confidence 999999999999999999999 9988774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.029 Score=52.20 Aligned_cols=77 Identities=21% Similarity=0.193 Sum_probs=58.3
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCcEEEcCCCCeEEEeecCC
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV---LGICHRDIKPQNLLLNPETGVLKLCDFGS 291 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs---~givH~dLkp~NIll~~~~~~ikL~Dfg~ 291 (444)
-++|.||.+. +++... .....-...++..+..++.++++.+.+|+. ..+.-+|++++|+-++ ++++++++|...
T Consensus 31 ~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~ 108 (188)
T PF12260_consen 31 RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDD 108 (188)
T ss_pred CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe-CCCcEEEEechh
Confidence 3478899984 554220 000112346888999999999999999997 4588999999999999 788999999987
Q ss_pred ccc
Q psy10212 292 AKH 294 (444)
Q Consensus 292 s~~ 294 (444)
...
T Consensus 109 v~~ 111 (188)
T PF12260_consen 109 VFV 111 (188)
T ss_pred cch
Confidence 643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.23 Score=49.01 Aligned_cols=29 Identities=31% Similarity=0.616 Sum_probs=24.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
.+++|||+++.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~-~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK-D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe-C-CcEEEEECcccc
Confidence 5789999999999998 4 578999998663
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.15 Score=52.96 Aligned_cols=46 Identities=20% Similarity=0.351 Sum_probs=33.3
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeec-----------cccchhhHHHHhhhc
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-----------DKRFKNREMQIMRRL 72 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~E~~~l~~l 72 (444)
.+.||.|-+..||++.+...++.++||.-.. ..+....|.+.|+.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l 87 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQ 87 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHH
Confidence 4689999999999999864336899998531 122344677777775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.1 Score=52.02 Aligned_cols=30 Identities=20% Similarity=0.249 Sum_probs=26.1
Q ss_pred CcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 264 givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
++||+|+.++|++++ +++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
Confidence 699999999999998 677889999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.085 Score=53.34 Aligned_cols=30 Identities=33% Similarity=0.536 Sum_probs=26.2
Q ss_pred cccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 265 ICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 265 ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
++|+|+.+.||+++.+++.++++||+.+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 899999999999974567899999998854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.13 Score=50.77 Aligned_cols=51 Identities=25% Similarity=0.322 Sum_probs=34.7
Q ss_pred hheecccceeEEEEeEecC------CCceeeeeeeeccc---cchhhHHHHhhhcCCCce
Q psy10212 27 KTVIGNGSFGIVYQAKLLD------SGELVAIKKVLQDK---RFKNREMQIMRRLEHSNI 77 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i 77 (444)
++.|..|-...+|++.... .++.|++|+..... ....+|.++++.+...++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~ 62 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL 62 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC
Confidence 3556777778999998643 25889999875432 234578888888854333
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.017 Score=67.64 Aligned_cols=128 Identities=13% Similarity=0.001 Sum_probs=96.8
Q ss_pred EEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEEeec
Q psy10212 216 LNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG-----ICHRDIKPQNLLLNPETGVLKLCDF 289 (444)
Q Consensus 216 ~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~g-----ivH~dLkp~NIll~~~~~~ikL~Df 289 (444)
.+++++||. |.+.+.|....+...++.....-....+...+..-.|+.. .+|.++++-|.++. .+..++++++
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~ 1384 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee-cCCccccccc
Confidence 568899998 5788888766655556666666666666577777777543 78999999999998 6788999999
Q ss_pred CCcc-cccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCC
Q psy10212 290 GSAK-HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMF 345 (444)
Q Consensus 290 g~s~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf 345 (444)
|+.+ ............+++.|+.|++...- .++.++|+|..|+.+|....|..+|
T Consensus 1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccCchHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9987 22222222334567788888887766 7788899999999999999888776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.62 Score=47.40 Aligned_cols=32 Identities=28% Similarity=0.669 Sum_probs=26.9
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
..++|+|+++.||+++...+.+.++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 35899999999999984457899999998744
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.20 E-value=0.64 Score=48.16 Aligned_cols=30 Identities=27% Similarity=0.314 Sum_probs=25.2
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
..++|.|+.+.||+.+ +..+.++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~~--~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF--NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec--CCCEEEEEeccccC
Confidence 4689999999999986 45699999998744
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.33 Score=47.87 Aligned_cols=31 Identities=29% Similarity=0.527 Sum_probs=24.6
Q ss_pred CcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 264 givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.++|+|+++.||+++.+....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999983233457999998744
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.9 Score=46.65 Aligned_cols=30 Identities=20% Similarity=0.173 Sum_probs=24.5
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
..++|||+.+.||+++ + ..++++|+..+..
T Consensus 192 ~~llHGDl~~gNi~~~-~-~~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVS-E-HETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEc-C-CCCEEEcCccccc
Confidence 4589999999999997 3 3578999987744
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.45 Score=49.46 Aligned_cols=46 Identities=15% Similarity=0.142 Sum_probs=32.5
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhc
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRL 72 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l 72 (444)
.+.||.|--..||++.+...++-++||.-..- .+....|...|+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~ 89 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLE 89 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHH
Confidence 66889999999999998544678999976321 12223477777765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.03 E-value=0.32 Score=49.84 Aligned_cols=74 Identities=15% Similarity=0.214 Sum_probs=59.7
Q ss_pred cccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeec
Q psy10212 211 PLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDF 289 (444)
Q Consensus 211 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Df 289 (444)
....++|++|++-++++... ..-..+++..++++.+..+.-+..+ .+-|+++..+||+++ +|++-|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 34688999999998865422 2344677888999998888777765 589999999999998 789999999
Q ss_pred CCccc
Q psy10212 290 GSAKH 294 (444)
Q Consensus 290 g~s~~ 294 (444)
.+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.20 E-value=1.1 Score=44.54 Aligned_cols=59 Identities=7% Similarity=-0.016 Sum_probs=40.0
Q ss_pred cchhheecccceeEEEEeEecCCCceeeeeeeec--cccchhhHHHHhhhcCC---CceeEeeeEE
Q psy10212 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKNREMQIMRRLEH---SNIVKLKYFF 84 (444)
Q Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~E~~~l~~l~h---~~i~~~~~~~ 84 (444)
-.-.+-||.|..+.||+.... +..+.+|.... ....+.+|...|+.|.. -.|.++++.+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~ 79 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVM 79 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEe
Confidence 344667999999999999753 33577777543 24588899999998853 2344444433
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=89.75 E-value=0.11 Score=44.61 Aligned_cols=54 Identities=26% Similarity=0.393 Sum_probs=41.6
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhc
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRL 72 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l 72 (444)
+++++..|+ .+-||.||.|.||+|+.+. |+.||||+.... ...+..++.+|+.+
T Consensus 7 ~~~~F~~fd-~~PlasASiaQVh~a~l~~-g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 7 IDEIFDEFD-PEPLASASIAQVHRARLKD-GEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred HHHHHHHCC-cchhhheehhhheeeeecc-cchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 456666666 5789999999999999875 999999998655 34555677766654
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=89.62 E-value=4.3 Score=40.33 Aligned_cols=45 Identities=13% Similarity=0.203 Sum_probs=33.7
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeec-cccchhhHHHHhhhc
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-DKRFKNREMQIMRRL 72 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~E~~~l~~l 72 (444)
-.+.++.|....+|+.. .+++.+.+|.-.. ....+..|..-|+.|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L 66 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKAL 66 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHH
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHH
Confidence 36678999999999988 5788999998763 346778899888888
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2269|consensus | Back alignment and domain information |
|---|
Probab=87.40 E-value=1 Score=45.60 Aligned_cols=73 Identities=15% Similarity=0.113 Sum_probs=55.8
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
-++||-|++. .+.. -+-....++..+.+..-.|+..++..|. +.-++|.|++--|+|.. .|.+.++|...+.
T Consensus 358 hvLVMsFiGd~~~aA----PkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~--~gKvw~IDVsQsv 431 (531)
T KOG2269|consen 358 HVLVMSFIGDQGLAA----PKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWT--PGKVWVIDVSQSV 431 (531)
T ss_pred ceEEEEeecCCCCCC----ccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheec--CCceEEEechhcc
Confidence 4589999884 2211 1123345889999999999999888775 67899999999999998 4599999988774
Q ss_pred c
Q psy10212 294 H 294 (444)
Q Consensus 294 ~ 294 (444)
.
T Consensus 432 e 432 (531)
T KOG2269|consen 432 E 432 (531)
T ss_pred C
Confidence 4
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=86.90 E-value=0.91 Score=44.65 Aligned_cols=52 Identities=31% Similarity=0.379 Sum_probs=41.0
Q ss_pred ChHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 242 PCFYTKLYIYQLFRSLAYIHVL--GICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 242 ~~~~i~~i~~QIl~aL~yLHs~--givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
+.......+..+-.++.-++.. -++|+|+.|+|++.+ +.+.++|+||..+..
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t-~~~~l~LIDWEyAg~ 183 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT-DKGGLFLIDWEYAGL 183 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc-CCCcEEEEecccCCC
Confidence 4445555667777777777755 699999999999999 679999999998854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=86.19 E-value=3.1 Score=43.56 Aligned_cols=29 Identities=28% Similarity=0.446 Sum_probs=23.7
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeee
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVL 56 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~ 56 (444)
..+.||.|....||++.+ .++.++||.-.
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~ 64 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQAL 64 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCC
Confidence 467889999999999997 35679999774
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=85.42 E-value=0.89 Score=47.36 Aligned_cols=61 Identities=23% Similarity=0.258 Sum_probs=41.0
Q ss_pred cceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCcEEEc
Q psy10212 213 QVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL-AYIHVLGICHRDIKPQNLLLN 278 (444)
Q Consensus 213 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL-~yLHs~givH~dLkp~NIll~ 278 (444)
+.-..++=+|..| ++..+++. ...++...+.++.-...|+ ..|--.+++|.|++|.||++.
T Consensus 317 ~~~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 317 HTDLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cccceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 4446677778877 77777753 2334455555555555553 445567899999999999995
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.32 E-value=7.6 Score=41.04 Aligned_cols=53 Identities=13% Similarity=0.133 Sum_probs=35.2
Q ss_pred hhheecccceeEEEEeEecC--------CCceeeeeeeeccccch---hhHHHHhhhcCCCcee
Q psy10212 26 QKTVIGNGSFGIVYQAKLLD--------SGELVAIKKVLQDKRFK---NREMQIMRRLEHSNIV 78 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~---~~E~~~l~~l~h~~i~ 78 (444)
-++.|..|=.-.+|++.... .++.|.+++.....+.+ .+|..+++.+...+|.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~ 172 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIA 172 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCC
Confidence 56677778788999997642 25679999885443322 2488888877654444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.10 E-value=0.54 Score=43.96 Aligned_cols=31 Identities=42% Similarity=0.738 Sum_probs=21.1
Q ss_pred CcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 264 GICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 264 givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
-++|+|+.+.||+++...+.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 4899999999999943788999999998743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=84.43 E-value=0.97 Score=46.05 Aligned_cols=106 Identities=17% Similarity=0.191 Sum_probs=57.7
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcc--cceEEEEeccCCCcHHHHH-HhhhhcCCCCChHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL--QVFLNLVLEFMPETVYKVA-KHYSKSKQNFPCFYT 246 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~iv~e~~~~~l~~~~-~~~~~~~~~l~~~~i 246 (444)
+.++..+-+.+||++|..-.-+ |-.-.-+..+-.+.+-..+ +.--.||+++.-.+.-..- ....+.+-..-.+.+
T Consensus 200 ~~~Fvkl~SyFYp~~v~sniNv--IN~f~~mi~ffehekr~ny~y~rGnIIIfPLA~~Sadkv~~~~~~e~GF~s~~~Yv 277 (434)
T PF05445_consen 200 SEKFVKLLSYFYPKVVQSNINV--INNFNHMIHFFEHEKRANYSYDRGNIIIFPLARCSADKVTESNAAELGFKSNVEYV 277 (434)
T ss_pred hHHHHHHHHHHHHHHHHhhhHH--HHhHHHHHHHHHhhhhccceeccCcEEEEehhhcchhhcCHHHHHhcCchhHHHHH
Confidence 3445566677777776532211 1222223333232222221 2245689988765432211 111223333446678
Q ss_pred HHHHHHHHHHHHHHH----HCCcccCCCCCCcEEE
Q psy10212 247 KLYIYQLFRSLAYIH----VLGICHRDIKPQNLLL 277 (444)
Q Consensus 247 ~~i~~QIl~aL~yLH----s~givH~dLkp~NIll 277 (444)
+.++.||+.-.--+- ..+++|-||||+|||+
T Consensus 278 kfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi 312 (434)
T PF05445_consen 278 KFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILI 312 (434)
T ss_pred HHHHHHHHHHHeeeecCCCcceeeecccCcCcEEE
Confidence 889999976542232 3569999999999999
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 444 | ||||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-118 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-118 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-118 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-118 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-118 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-118 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-117 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-117 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-117 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-117 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-117 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-117 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-116 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-116 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-116 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-116 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-116 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-116 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-116 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-115 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-115 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-99 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-69 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-60 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-37 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-36 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-36 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-34 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-33 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-33 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-33 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-33 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-33 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-33 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-33 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-33 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-33 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-33 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-33 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-33 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-33 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-33 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-33 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-33 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-33 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-33 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-33 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-33 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-32 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-32 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-32 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-32 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-32 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-32 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-32 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-32 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-32 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-32 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-32 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-32 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-32 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-32 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-32 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-32 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-32 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-32 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-32 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-32 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-32 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-32 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-32 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-32 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-32 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-32 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-32 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-32 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-32 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-32 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-32 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-32 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-32 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-32 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-32 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-31 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-31 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-31 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-31 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-31 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-31 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-31 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-31 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-31 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-31 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-31 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-31 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-31 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-31 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-31 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-31 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-31 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-31 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-31 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-31 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-31 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-31 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-31 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-31 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-31 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-31 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-31 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-31 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-31 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-31 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-31 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-31 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-31 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-31 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-31 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-31 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-31 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-31 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-31 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-31 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-31 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-31 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-31 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-31 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-31 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-31 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-31 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-31 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-31 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-31 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-31 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-31 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-31 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-31 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-31 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-31 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-31 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-30 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-30 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-30 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-30 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-30 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-30 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-30 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-30 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-30 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-30 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-30 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-30 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-30 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-30 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-30 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-29 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-29 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-29 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-28 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-28 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-28 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-28 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-28 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-27 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-27 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-27 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-27 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-27 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-27 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-27 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-27 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-27 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-27 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-27 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-26 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-26 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-26 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-25 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-25 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-25 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-25 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-25 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-25 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-25 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-25 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-25 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-25 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-24 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-24 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-24 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-23 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-22 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-22 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-22 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-21 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-21 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-20 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-20 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-20 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-14 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-13 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-04 |
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 433 bits (1116), Expect = e-150
Identities = 222/362 (61%), Positives = 257/362 (70%), Gaps = 40/362 (11%)
Query: 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRV------- 138
S + MK+S +KVTTVVATPGQGPDRPQE+SYT+T+V
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 139 -------SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 191
DSG +LV I KVL R + RE+ + + H
Sbjct: 69 VVYQAKLCDSG--ELVAIKKVL-QDKRFKNREL-------QIMRKLDHCN---------- 108
Query: 192 DAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251
I RL + SS +V+LNLVL+++PETVY+VA+HYS++KQ P Y KLY+Y
Sbjct: 109 -----IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
QLFRSLAYIH GICHRDIKPQNLLL+P+T VLKLCDFGSAK LVRGEPNVSYICSRYYR
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
APELIFGA DYT+ IDVWSAGCVLAELLLGQP+FPGDSGVDQLVEIIKVLGTPTREQIRE
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431
MNPNYTEFKFPQIK+HPW+KVFR RTPP+AI L SRLLEYTP++R++PL+ + F E
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA-HSFFDE 342
Query: 432 LR 433
LR
Sbjct: 343 LR 344
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 56/65 (86%), Positives = 63/65 (96%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
VIGNGSFG+VYQAKL DSGELVAIKKVLQDKRFKNRE+QIMR+L+H NIV+L+YFFYSSG
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120
Query: 89 DKKDE 93
+KKDE
Sbjct: 121 EKKDE 125
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-145
Identities = 191/346 (55%), Positives = 237/346 (68%), Gaps = 36/346 (10%)
Query: 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSG-----------VDQLV 147
PL +K++ NKV V+A+ G+ + +EI+YTN +V +G V
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67
Query: 148 EIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 207
I KVL R + RE+ + +I HP + L + S+
Sbjct: 68 AIKKVL-QDKRFKNREL-------QIMRIVKHPN---------------VVDLKAFFYSN 104
Query: 208 RISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICH 267
+VFLNLVLE++PETVY+ ++HY+K KQ P KLY+YQL RSLAYIH +GICH
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164
Query: 268 RDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327
RDIKPQNLLL+P +GVLKL DFGSAK L+ GEPNVSYICSRYYRAPELIFGA +YTT ID
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID 224
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
+WS GCV+AEL+ GQP+FPG+SG+DQLVEIIKVLGTP+REQI+ MNPNY E KFPQI+ H
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
P+SKVFR RTPPDAIDLISRLLEYTPS+R++ ++ PF ELR
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC-HPFFDELR 329
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 50/65 (76%), Positives = 59/65 (90%), Gaps = 1/65 (1%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
VIGNGSFG+V+QAKL++S E VAIKKVLQDKRFKNRE+QIMR ++H N+V LK FFYS+G
Sbjct: 47 VIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 89 DKKDE 93
DKKDE
Sbjct: 106 DKKDE 110
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-141
Identities = 121/345 (35%), Positives = 185/345 (53%), Gaps = 45/345 (13%)
Query: 110 PRNKVTTVVATPGQGPDRPQEISYTNTRV------------SDSGVDQLVEIIKVLGTPT 157
P + ++ A R + + R+ + V I KV+ P
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 158 ---REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY-TPSSRISPLQ 213
RE ++ M + + HP I +L Y
Sbjct: 62 FRNRE-LQIM-------QDLAVLHHP---------------NIVQLQSYFYTLGERDRRD 98
Query: 214 VFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV--LGICHRDIK 271
++LN+V+E++P+T+++ ++Y + + P K++++QL RS+ +H+ + +CHRDIK
Sbjct: 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK 158
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
P N+L+N G LKLCDFGSAK L EPNV+YICSRYYRAPELIFG YTT +D+WS
Sbjct: 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
GC+ AE++LG+P+F GD+ QL EI++VLG P+RE +R++NP++T+ K PWS
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN 278
Query: 392 VFR---VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
VF ++ +A DL+S LL+Y P R+ P + P+ EL
Sbjct: 279 VFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC-HPYFDELH 322
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 32/68 (47%), Positives = 45/68 (66%), Gaps = 3/68 (4%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL---EHSNIVKLKYFFY 85
+ G G+FG V K +G VAIKKV+QD RF+NRE+QIM+ L H NIV+L+ +FY
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89
Query: 86 SSGDKKDE 93
+ G++
Sbjct: 90 TLGERDRR 97
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-137
Identities = 124/327 (37%), Positives = 184/327 (56%), Gaps = 22/327 (6%)
Query: 128 PQEISYTNTRV------------SDSGVDQLVEIIKVLGTPTREQ-----IREMN-PNYT 169
Y+ + D + + KVL P + ++ ++ N
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNII 63
Query: 170 EFK---FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPET 226
+ + P + +LN+++E++P+T
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 227 VYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKL 286
++KV K + +S ++ P +YIYQLFR++ +IH LGICHRDIKPQNLL+N + LKL
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 287 CDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFP 346
CDFGSAK L+ EP+V+YICSR+YRAPEL+ GA +YT ID+WS GCV EL+LG+P+F
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243
Query: 347 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406
G++ +DQLV II+++GTPT+EQ+ MNP+YTE +FP +K+ W K+ TP AIDL+
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 407 RLLEYTPSSRISPLQVRSITPFLIELR 433
++L Y P RI+P + + PF LR
Sbjct: 304 QILRYEPDLRINPYEAMA-HPFFDHLR 329
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 37/93 (39%), Positives = 56/93 (60%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
+G GSFGIV + ++SG+ A+KKVLQD R+KNRE+ IM+ L+H NI+KL +FY++G
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73
Query: 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATP 121
D++ +P P + + N V
Sbjct: 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVN 106
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-69
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L+LV E+ TV + ++ P K +Q +++ + H HRD+KP+N+
Sbjct: 77 LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L+ V+KLCDFG A+ L P+ Y + +R+YR+PEL+ G Y +DVW+ G
Sbjct: 134 LITKH-SVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG 190
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKS-HPW 389
CV AELL G P++PG S VDQL I K LG + N ++ K P + P
Sbjct: 191 CVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPL 250
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
F A+ L+ L P+ R++
Sbjct: 251 ELKFP-NISYPALGLLKGCLHMDPTERLT 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 19/74 (25%), Positives = 28/74 (37%), Gaps = 4/74 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKS-HPWSKVFRVRTPPDAIDL 196
S VDQL I K LG + N ++ K P + P F A+ L
Sbjct: 206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP-NISYPALGL 264
Query: 197 ISRLLEYTPSSRIS 210
+ L P+ R++
Sbjct: 265 LKGCLHMDPTERLT 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 21/58 (36%), Positives = 39/58 (67%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
IG GS+G+V++ + D+G++VAIKK L+ + RE++++++L+H N+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-68
Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 13/209 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
LV EF+ T+ + + + Y++Q+ + + H I HRDIKP+N+
Sbjct: 99 WYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L++ ++GV+KLCDFG A+ L P Y + +R+YRAPEL+ G + Y +DVW+ G
Sbjct: 156 LVS-QSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSH-PW 389
C++ E+ +G+P+FPGDS +DQL I+ LG NP + + P+IK P
Sbjct: 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPL 272
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ + + IDL + L P R
Sbjct: 273 ERRYP-KLSEVVIDLAKKCLHIDPDKRPF 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 20/74 (27%), Positives = 29/74 (39%), Gaps = 4/74 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREM--NPNYTEFKFPQIKSH-PWSKVFRVRTPPDAIDL 196
DS +DQL I+ LG NP + + P+IK P + + + IDL
Sbjct: 228 DSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYP-KLSEVVIDL 286
Query: 197 ISRLLEYTPSSRIS 210
+ L P R
Sbjct: 287 AKKCLHIDPDKRPF 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 21/58 (36%), Positives = 36/58 (62%), Gaps = 6/58 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLK 81
+G GS+G+V + + D+G +VAIKK L+ K RE++++++L H N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-66
Identities = 81/210 (38%), Positives = 121/210 (57%), Gaps = 16/210 (7%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV EFM + K ++K K+Y+YQL R +A+ H I HRD+KPQNL
Sbjct: 94 LTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150
Query: 276 LLNPETGVLKLCDFGSAKHLVR--GEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWS 330
L+N + G LKL DFG L R G P SY + + +YRAP+++ G+ Y+T +D+WS
Sbjct: 151 LINSD-GALKLADFG----LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHP 388
GC+ AE++ G+P+FPG + DQL +I +LGTP + ++ P + + F + P
Sbjct: 206 IGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKP 265
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
WS + + IDL+S +L + P+ RIS
Sbjct: 266 WSSIIP-GFCQEGIDLLSNMLCFDPNKRIS 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 5e-14
Identities = 22/73 (30%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
+ DQL +I +LGTP + ++ P + + F + PWS + + IDL+
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP-GFCQEGIDLL 281
Query: 198 SRLLEYTPSSRIS 210
S +L + P+ RIS
Sbjct: 282 SNMLCFDPNKRIS 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 11/60 (18%)
Query: 30 IGNGSFGIVYQAKLLDS-GELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
+G G++G+VY+AK DS G +VA+K++ D RE+ +++ L H NIV L
Sbjct: 29 VGEGTYGVVYKAK--DSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLI 85
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 213 bits (546), Expect = 5e-66
Identities = 85/208 (40%), Positives = 115/208 (55%), Gaps = 14/208 (6%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
++LV +FM + + K + + K Y+ + L Y+H I HRD+KP NL
Sbjct: 87 ISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
LL+ GVLKL DFG AK G PN +Y + +R+YRAPEL+FGA Y +D+W+ G
Sbjct: 144 LLDEN-GVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWS 390
C+LAELLL P PGDS +DQL I + LGTPT EQ +M P+Y F P
Sbjct: 201 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT--FKSFPGIPLH 258
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+F D +DLI L + P +RI+
Sbjct: 259 HIFS-AAGDDLLDLIQGLFLFNPCARIT 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 27/73 (36%), Positives = 36/73 (49%), Gaps = 5/73 (6%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
DS +DQL I + LGTPT EQ +M P+Y F P +F D +DLI
Sbjct: 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF--KSFPGIPLHHIFS-AAGDDLLDLI 272
Query: 198 SRLLEYTPSSRIS 210
L + P +RI+
Sbjct: 273 QGLFLFNPCARIT 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 9/61 (14%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVKL 80
+G G F VY+A+ ++ ++VAIKK+ R + RE+++++ L H NI+ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 81 K 81
Sbjct: 78 L 78
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 8e-66
Identities = 71/208 (34%), Positives = 115/208 (55%), Gaps = 12/208 (5%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV E++ + + + KL+++QL R LAY H + HRD+KPQNL
Sbjct: 75 LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L+N E G LKL DFG A+ P +Y + + +YR P+++ G+ DY+T+ID+W G
Sbjct: 132 LIN-ERGELKLADFGLARAK--SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWS 390
C+ E+ G+P+FPG + +QL I ++LGTPT E + + + +P+ ++
Sbjct: 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALL 248
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRIS 418
R D DL+++LL++ +RIS
Sbjct: 249 SHAP-RLDSDGADLLTKLLQFEGRNRIS 275
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 19/73 (26%), Positives = 36/73 (49%), Gaps = 3/73 (4%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
+ +QL I ++LGTPT E + + + +P+ ++ R D DL+
Sbjct: 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP-RLDSDGADLL 262
Query: 198 SRLLEYTPSSRIS 210
++LL++ +RIS
Sbjct: 263 TKLLQFEGRNRIS 275
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 18/61 (29%), Positives = 34/61 (55%), Gaps = 13/61 (21%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVKL 80
+G G++ VY+ K + LVA+K++ R ++ RE+ +++ L+H+NIV L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 81 K 81
Sbjct: 66 H 66
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-65
Identities = 76/210 (36%), Positives = 114/210 (54%), Gaps = 17/210 (8%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV E + + + K+ + K ++ QL +AY H + HRD+KPQNL
Sbjct: 75 LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 276 LLNPETGVLKLCDFGSAKHLVR--GEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWS 330
L+N E G LK+ DFG L R G P Y I + +YRAP+++ G+ Y+T ID+WS
Sbjct: 132 LINRE-GELKIADFG----LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHP 388
GC+ AE++ G P+FPG S DQL+ I ++LGTP + + P Y + F + P
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNFTVYEPLP 245
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
W + IDL+S++L+ P+ RI+
Sbjct: 246 WESFLK-GLDESGIDLLSKMLKLDPNQRIT 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
S DQL+ I ++LGTP + + P Y + F + PW + IDL+
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNFTVYEPLPWESFLK-GLDESGIDLL 261
Query: 198 SRLLEYTPSSRIS 210
S++L+ P+ RI+
Sbjct: 262 SKMLKLDPNQRIT 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 11/60 (18%)
Query: 30 IGNGSFGIVYQAKLLD-SGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG G++G+VY+A+ + GE A+KK+ +K RE+ I++ L+HSNIVKL
Sbjct: 10 IGEGTYGVVYKAQ--NNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLY 66
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 4/73 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
DS +DQL I + LGTP + P+Y + FP+ +SKV D L+
Sbjct: 207 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVP-PLDEDGRSLL 264
Query: 198 SRLLEYTPSSRIS 210
S++L Y P+ RIS
Sbjct: 265 SQMLHYDPNKRIS 277
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 59.8 bits (146), Expect = 4e-10
Identities = 23/59 (38%), Positives = 36/59 (61%), Gaps = 8/59 (13%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG G++G+VY+A+ +GE+VA+KK+ D RE+ +++ L H NIVKL
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLL 68
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 5e-65
Identities = 73/214 (34%), Positives = 113/214 (52%), Gaps = 20/214 (9%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L+L+ E+ + K Y + K ++YQL + + H HRD+KPQNL
Sbjct: 108 LHLIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163
Query: 276 LLN----PETGVLKLCDFGSAKHLVR--GEPNVSY---ICSRYYRAPELIFGAIDYTTKI 326
LL+ ET VLK+ DFG L R G P + I + +YR PE++ G+ Y+T +
Sbjct: 164 LLSVSDASETPVLKIGDFG----LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV 219
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQI 384
D+WS C+ AE+L+ P+FPGDS +DQL +I +VLG P + P++ + FP+
Sbjct: 220 DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS-FPKF 278
Query: 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ +V + +DL++ +LE P RIS
Sbjct: 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 22/73 (30%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
DS +DQL +I +VLG P + P++ + FP+ + +V + +DL+
Sbjct: 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS-FPKFRGKTLKRVLGALLDDEGLDLL 299
Query: 198 SRLLEYTPSSRIS 210
+ +LE P RIS
Sbjct: 300 TAMLEMDPVKRIS 312
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 19/59 (32%), Positives = 35/59 (59%), Gaps = 8/59 (13%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
+G G++G VY+A + E VAIK++ + + RE+ +++ L+H NI++LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELK 99
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-64
Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E+M + V + + + +L++YQL R L YIH + HRD+KP NL +
Sbjct: 99 IVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS----YICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N E VLK+ DFG A+ + + + +++YR+P L+ +YT ID+W+AGC
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSK 391
+ AE+L G+ +F G ++Q+ I++ + E +E+ + P ++
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ +A+D + ++L ++P R++
Sbjct: 274 LLP-GISREAVDFLEQILTFSPMDRLT 299
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 10/70 (14%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISRL 200
++Q+ I++ + E +E+ + P +++ +A+D + ++
Sbjct: 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP-GISREAVDFLEQI 289
Query: 201 LEYTPSSRIS 210
L ++P R++
Sbjct: 290 LTFSPMDRLT 299
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 12/78 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
+G G G+V+ A D + VAIKK++ + RE++I+RRL+H NIVK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIV----LTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 81 KYFFYSSGDKKDEPTNYP 98
SG + +
Sbjct: 74 FEILGPSGSQLTDDVGSL 91
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-63
Identities = 73/216 (33%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 216 LNLVLEFMPETVYKVAKHYS--KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV EFM + K + + + K + +QL + LA+ H I HRD+KPQ
Sbjct: 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ 137
Query: 274 NLLLNPETGVLKLCDFGSAKHLVR--GEPNVSY---ICSRYYRAPELIFGAIDYTTKIDV 328
NLL+N + G LKL DFG L R G P ++ + + +YRAP+++ G+ Y+T ID+
Sbjct: 138 NLLIN-KRGQLKLGDFG----LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDI 192
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKS 386
WS GC+LAE++ G+P+FPG + +QL I ++GTP + P Y Q
Sbjct: 193 WSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY-NPNIQQRPP 251
Query: 387 HPWSKVFRVRTPP----DAIDLISRLLEYTPSSRIS 418
+V + T + +D + LL+ P R+S
Sbjct: 252 RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 7/77 (9%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPP----DA 193
+ +QL I ++GTP + P Y Q +V + T +
Sbjct: 212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNL 270
Query: 194 IDLISRLLEYTPSSRIS 210
+D + LL+ P R+S
Sbjct: 271 MDFLHGLLQLNPDMRLS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 13/61 (21%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVKL 80
+GNG++ VY+ +G VA+K+V + + RE+ +M+ L+H NIV+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 81 K 81
Sbjct: 69 Y 69
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-62
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV E M + +V + + + ++Y + L +H G+ HRD+ P N+LL
Sbjct: 111 LVTELMRTDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337
+ + +CDF A+ Y+ R+YRAPEL+ +T +D+WSAGCV+AE
Sbjct: 168 A-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NP---NYTEFKFPQIKSHPWSKVF 393
+ + +F G + +QL +I++V+GTP E + +P +Y + + W+ V
Sbjct: 227 MFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV 286
Query: 394 RVRTPPDAIDLISRLLEYTPSSRIS 418
P A+DLI+++LE+ P RIS
Sbjct: 287 P-TADPVALDLIAKMLEFNPQRRIS 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 23/72 (31%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NP---NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 198
+QL +I++V+GTP E + +P +Y + + W+ V P A+DLI+
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP-TADPVALDLIA 298
Query: 199 RLLEYTPSSRIS 210
++LE+ P RIS
Sbjct: 299 KMLEFNPQRRIS 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 18/69 (26%)
Query: 29 VIGNGSFGIVYQAKLLDS-GELVAIKKV-------LQDKRFKN--------REMQIMRRL 72
I +GS+G V +DS G VAIK+V + RE++++
Sbjct: 29 FISSGSYGAVCAG--VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 73 EHSNIVKLK 81
H NI+ L+
Sbjct: 87 HHPNILGLR 95
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-62
Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 16/233 (6%)
Query: 197 ISRLLE--YTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
+ L+E T +S + + + LV +F + +A S F K + L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAK--HLVRGEPNVSY---ICSRY 309
L YIH I HRD+K N+L+ GVLKL DFG A+ L + Y + + +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQ- 368
YR PEL+ G DY ID+W AGC++AE+ P+ G++ QL I ++ G+ T E
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 369 --IREMNPNYTEFKFPQIKSHPWSKVFR-VRTPPDAIDLISRLLEYTPSSRIS 418
+ Y + + + + + P A+DLI +LL P+ RI
Sbjct: 254 PNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 17/75 (22%), Positives = 31/75 (41%), Gaps = 5/75 (6%)
Query: 140 DSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKSHPWSKVFR-VRTPPDAID 195
++ QL I ++ G+ T E + Y + + + + + P A+D
Sbjct: 232 NTEQHQLALISQLCGSITPEVWPNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 196 LISRLLEYTPSSRIS 210
LI +LL P+ RI
Sbjct: 291 LIDKLLVLDPAQRID 305
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 22/62 (35%), Positives = 36/62 (58%), Gaps = 14/62 (22%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLEHSNIVK 79
IG G+FG V++A+ +G+ VA+KKV +N RE++I++ L+H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 80 LK 81
L
Sbjct: 81 LI 82
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-62
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 17/211 (8%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV E + T +K + Y Q + + Y+Y++ ++L Y H +GI HRD+KP N+++
Sbjct: 110 LVFEHVNNTDFK--QLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337
+ E L+L D+G A+ G+ + SRY++ PEL+ Y +D+WS GC+LA
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223
Query: 338 LLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQI-----REMNPNYTEFKFPQIKSHPWSK 391
++ +P F G DQLV I KVLGT E++P + + + W +
Sbjct: 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND-ILGRHSRKRWER 282
Query: 392 VF----RVRTPPDAIDLISRLLEYTPSSRIS 418
+ P+A+D + +LL Y SR++
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 21/80 (26%), Positives = 34/80 (42%), Gaps = 10/80 (12%)
Query: 140 DSGVDQLVEIIKVLGTPTREQI-----REMNPNYTEFKFPQIKSHPWSKVF----RVRTP 190
DQLV I KVLGT E++P + + + W + +
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND-ILGRHSRKRWERFVHSENQHLVS 293
Query: 191 PDAIDLISRLLEYTPSSRIS 210
P+A+D + +LL Y SR++
Sbjct: 294 PEALDFLDKLLRYDHQSRLT 313
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 4/66 (6%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKV--LQDKRFKNREMQIMRRL-EHSNIVKLKYFFYS 86
+G G + V++A + + E V +K + ++ K+ K RE++I+ L NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITLADIVKD 102
Query: 87 SGDKKD 92
+
Sbjct: 103 PVSRTP 108
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-62
Identities = 78/211 (36%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV EF + + K + K +++QL + L + H + HRD+KPQNL
Sbjct: 76 LTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 276 LLNPETGVLKLCDFGSAKHLVR--GEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWS 330
L+N G LKL +FG L R G P Y + + +YR P+++FGA Y+T ID+WS
Sbjct: 133 LIN-RNGELKLANFG----LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 331 AGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSH 387
AGC+ AEL G+P+FPG+ DQL I ++LGTPT EQ M P+Y + +
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT- 246
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
V + DL+ LL+ P RIS
Sbjct: 247 SLVNVVP-KLNATGRDLLQNLLKCNPVQRIS 276
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 4/73 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
+ DQL I ++LGTPT EQ M P+Y + + V + DL+
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT-SLVNVVP-KLNATGRDLL 263
Query: 198 SRLLEYTPSSRIS 210
LL+ P RIS
Sbjct: 264 QNLLKCNPVQRIS 276
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 8/59 (13%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG G++G V++AK ++ E+VA+K+V D RE+ +++ L+H NIV+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLH 67
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-61
Identities = 74/208 (35%), Positives = 116/208 (55%), Gaps = 14/208 (6%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V + M +YK+ K Q+ + ++YQ+ R L YIH + HRD+KP NLLL
Sbjct: 107 IVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS----YICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N T LK+CDFG A+ + Y+ +R+YRAPE++ + YT ID+WS GC
Sbjct: 162 N-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWS 390
+LAE+L +P+FPG +DQL I+ +LG+P++E + + N + P PW+
Sbjct: 221 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 280
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRIS 418
++F A+DL+ ++L + P RI
Sbjct: 281 RLFP-NADSKALDLLDKMLTFNPHKRIE 307
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 20/71 (28%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL I+ +LG+P++E + + N + P PW+++F A+DL+ +
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP-NADSKALDLLDK 296
Query: 200 LLEYTPSSRIS 210
+L + P RI
Sbjct: 297 MLTFNPHKRIE 307
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 11/73 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
IG G++G+V A + VAIKK+ F++ RE++I+ R H NI+ +
Sbjct: 34 YIGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 81 KYFFYSSGDKKDE 93
+ ++ +
Sbjct: 91 NDIIRAPTIEQMK 103
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-60
Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV+ FM + K+ KH + +YQ+ + L YIH GI HRD+KP NL +
Sbjct: 107 LVMPFMGTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
N E LK+ DFG L R + Y+ +R+YRAPE+I + YT +D+WS GC++
Sbjct: 162 N-EDCELKILDFG----LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKV 392
AE++ G+ +F G +DQL EI+KV GTP E ++ + + + P+++ ++ +
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRIS 418
P A++L+ ++L R++
Sbjct: 277 LT-NASPLAVNLLEKMLVLDAEQRVT 301
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 17/71 (23%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL EI+KV GTP E ++ + + + P+++ ++ + P A++L+ +
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT-NASPLAVNLLEK 290
Query: 200 LLEYTPSSRIS 210
+L R++
Sbjct: 291 MLVLDAEQRVT 301
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 19/72 (26%), Positives = 36/72 (50%), Gaps = 10/72 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
+G+G++G V A +G VAIKK+ + F++ RE+++++ + H N++ L
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 81 KYFFYSSGDKKD 92
F D
Sbjct: 90 LDVFTPDETLDD 101
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-60
Identities = 69/205 (33%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV+ FM + K+ F + +YQ+ + L YIH G+ HRD+KP NL +
Sbjct: 106 LVMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS-YICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336
N E LK+ DFG A+H + ++ Y+ +R+YRAPE+I + Y +D+WS GC++A
Sbjct: 160 N-EDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVF 393
E+L G+ +F G +DQL +I+KV G P E ++++ + + PQ ++++F
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 394 RVRTPPDAIDLISRLLEYTPSSRIS 418
R P A DL+ ++LE R++
Sbjct: 276 P-RASPQAADLLEKMLELDVDKRLT 299
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 20/71 (28%), Positives = 38/71 (53%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL +I+KV G P E ++++ + + PQ ++++F R P A DL+ +
Sbjct: 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP-RASPQAADLLEK 288
Query: 200 LLEYTPSSRIS 210
+LE R++
Sbjct: 289 MLELDVDKRLT 299
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 21/73 (28%), Positives = 40/73 (54%), Gaps = 10/73 (13%)
Query: 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVK 79
T +G+G++G V A SGE VAIKK+ + F++ RE+ +++ ++H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 80 LKYFFYSSGDKKD 92
L F + ++
Sbjct: 88 LLDVFTPASSLRN 100
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-59
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 16/206 (7%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV M + + K + + IYQ+ R L YIH I HRD+KP NL +
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNV--SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
N E LK+ DFG L R + Y+ +R+YRAPE++ + Y +D+WS GC++
Sbjct: 166 N-EDCELKILDFG----LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKV 392
AELL G+ +FPG +DQL I++++GTP E ++++ + + + Q+ ++ V
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRIS 418
F P A+DL+ ++L RI+
Sbjct: 281 FI-GANPLAVDLLEKMLVLDSDKRIT 305
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 18/71 (25%), Positives = 38/71 (53%), Gaps = 4/71 (5%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+DQL I++++GTP E ++++ + + + Q+ ++ VF P A+DL+ +
Sbjct: 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEK 294
Query: 200 LLEYTPSSRIS 210
+L RI+
Sbjct: 295 MLVLDSDKRIT 305
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 17/72 (23%), Positives = 39/72 (54%), Gaps = 10/72 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
+G+G++G V A +G VA+KK+ + F++ RE+++++ ++H N++ L
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 81 KYFFYSSGDKKD 92
F + ++
Sbjct: 94 LDVFTPARSLEE 105
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-59
Identities = 71/216 (32%), Positives = 112/216 (51%), Gaps = 22/216 (10%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
++ E M +++V S + F IYQ R++ +H + HRD+KP NLL+
Sbjct: 91 IIQELMQTDLHRVISTQMLSDDHIQYF-----IYQTLRAVKVLHGSNVIHRDLKPSNLLI 145
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS-----------YICSRYYRAPELIFGAIDYTTKI 326
N LK+CDFG A+ + + S ++ +R+YRAPE++ + Y+ +
Sbjct: 146 N-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNYTEF--KFP 382
DVWS GC+LAEL L +P+FPG QL+ I ++GTP + +P E+ P
Sbjct: 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP 264
Query: 383 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ P K+F R P IDL+ R+L + P+ RI+
Sbjct: 265 MYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRIT 299
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 143 VDQLVEIIKVLGTPTREQIREM--NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAIDLIS 198
QL+ I ++GTP + +P E+ P + P K+F R P IDL+
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQ 287
Query: 199 RLLEYTPSSRIS 210
R+L + P+ RI+
Sbjct: 288 RMLVFDPAKRIT 299
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 19/73 (26%), Positives = 36/73 (49%), Gaps = 11/73 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
++G G++G+V A +GE+VAIKK+ + F RE++I++ +H NI+ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 81 KYFFYSSGDKKDE 93
+
Sbjct: 75 FNIQRPDSFENFN 87
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ LV E + + + P K + Q R L ++H I HRD+KP+N+
Sbjct: 94 VTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L+ G +KL DFG A+ ++ + + +YRAPE++ + Y T +D+WS G
Sbjct: 152 LVTSG-GTVKLADFGLARIY--SYQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVG 206
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWS 390
C+ AE+ +P+F G+S DQL +I ++G P + P FP P
Sbjct: 207 CIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA---FPPRGPRPVQ 263
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRIS 418
V L+ +L + P RIS
Sbjct: 264 SVVP-EMEESGAQLLLEMLTFNPHKRIS 290
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 18/73 (24%), Positives = 26/73 (35%), Gaps = 6/73 (8%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
+S DQL +I ++G P + P FP P V L+
Sbjct: 222 NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA---FPPRGPRPVQSVVP-EMEESGAQLL 277
Query: 198 SRLLEYTPSSRIS 210
+L + P RIS
Sbjct: 278 LEMLTFNPHKRIS 290
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 14/65 (21%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRL---EHSN 76
IG G++G VY+A+ SG VA+K V RE+ ++RRL EH N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 77 IVKLK 81
+V+L
Sbjct: 76 VVRLM 80
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-59
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV E + + + + P K ++QL R L ++H + HRD+KPQN+
Sbjct: 94 LTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAIDYTTKIDVWSAG 332
L+ +G +KL DFG A+ ++ + + +YRAPE++ + Y T +D+WS G
Sbjct: 152 LVT-SSGQIKLADFGLARIY--SFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVG 206
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPW 389
C+ AE+ +P+F G S VDQL +I+ V+G P E P F + P
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPI 262
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
K DL+ + L + P+ RIS
Sbjct: 263 EKFVT-DIDELGKDLLLKCLTFNPAKRIS 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 21/74 (28%), Positives = 29/74 (39%), Gaps = 8/74 (10%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDL 196
S VDQL +I+ V+G P E P F + P K DL
Sbjct: 222 SSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDL 276
Query: 197 ISRLLEYTPSSRIS 210
+ + L + P+ RIS
Sbjct: 277 LLKCLTFNPAKRIS 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 21/63 (33%), Positives = 35/63 (55%), Gaps = 12/63 (19%)
Query: 30 IGNGSFGIVYQAK-LLDSGELVAIKKVLQDKRFKN-------REMQIMRRL---EHSNIV 78
IG G++G V++A+ L + G VA+K+V + RE+ ++R L EH N+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 79 KLK 81
+L
Sbjct: 78 RLF 80
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-57
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V+E M + +V + +YQ+ + ++H GI HRD+KP N+++
Sbjct: 107 IVMELMDANLCQV------IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337
LK+ DFG A+ Y+ +RYYRAPE+I G Y +D+WS GC++ E
Sbjct: 161 K-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGE 218
Query: 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVF-- 393
++ G +FPG +DQ ++I+ LGTP E ++++ P + P+ + + K+F
Sbjct: 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 278
Query: 394 ---------RVRTPPDAIDLISRLLEYTPSSRIS 418
A DL+S++L S RIS
Sbjct: 279 VLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 13/81 (16%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVF-----------RVRT 189
+DQ ++I+ LGTP E ++++ P + P+ + + K+F
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK 291
Query: 190 PPDAIDLISRLLEYTPSSRIS 210
A DL+S++L S RIS
Sbjct: 292 ASQARDLLSKMLVIDASKRIS 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 10/72 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
IG+G+ GIV A VAIKK+ + F+N RE+ +M+ + H NI+ L
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 81 KYFFYSSGDKKD 92
F ++
Sbjct: 90 LNVFTPQKSLEE 101
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-57
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV+E M + +V + +YQ+ + ++H GI HRD+KP N+++
Sbjct: 144 LVMELMDANLCQV------IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337
LK+ DFG A+ Y+ +RYYRAPE+I G Y +D+WS GC++ E
Sbjct: 198 K-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGE 255
Query: 338 LLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVFR- 394
++ + +FPG +DQ ++I+ LGTP E ++++ P + P+ + K+F
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 315
Query: 395 ----------VRTPPDAIDLISRLLEYTPSSRIS 418
A DL+S++L P+ RIS
Sbjct: 316 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 13/81 (16%)
Query: 143 VDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVFR-----------VRT 189
+DQ ++I+ LGTP E ++++ P + P+ + K+F
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 190 PPDAIDLISRLLEYTPSSRIS 210
A DL+S++L P+ RIS
Sbjct: 329 ASQARDLLSKMLVIDPAKRIS 349
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 10/72 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
IG+G+ GIV A VAIKK+ + F+N RE+ +M+ + H NI+ L
Sbjct: 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 81 KYFFYSSGDKKD 92
F ++
Sbjct: 127 LNVFTPQKTLEE 138
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-54
Identities = 70/256 (27%), Positives = 116/256 (45%), Gaps = 47/256 (18%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV ++M ++ V + + +YQL + + Y+H G+ HRD+KP N+LL
Sbjct: 88 LVFDYMETDLHAVIRANILEPVHKQYV-----VYQLIKVIKYLHSGGLLHRDMKPSNILL 142
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS----------------------YICSRYYRAPEL 315
N +K+ DFG ++ V + Y+ +R+YRAPE+
Sbjct: 143 N-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI 201
Query: 316 IFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM-NP 374
+ G+ YT ID+WS GC+L E+L G+P+FPG S ++QL II V+ P+ E + + +P
Sbjct: 202 LLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSP 261
Query: 375 NYTEF--KFPQIKSHPWSKVFRVRTP---------------PDAIDLISRLLEYTPSSRI 417
+ S + T +A+DL+ +LL++ P+ RI
Sbjct: 262 FAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321
Query: 418 SPLQVRSITPFLIELR 433
S PF+
Sbjct: 322 SANDALK-HPFVSIFH 336
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 11/71 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRL-EHSNIVK 79
+G G++GIV+++ +GE+VA+KK+ F+N RE+ I+ L H NIV
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 80 LKYFFYSSGDK 90
L + D+
Sbjct: 74 LLNVLRADNDR 84
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 18/89 (20%)
Query: 143 VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTP--------- 190
++QL II V+ P+ E + + +P + S + T
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 191 ------PDAIDLISRLLEYTPSSRISPLQ 213
+A+DL+ +LL++ P+ RIS
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 7e-54
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQN-----FPCFYTKLYIYQLFRSLAYIHVLGICHRDI 270
+ L+ ++ ++ + K + SK N P K +YQ+ + Y+H + HRD+
Sbjct: 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154
Query: 271 KPQNLLLN---PETGVLKLCDFGSAKHLVRGEPNVSY------ICSRYYRAPELIFGAID 321
KP N+L+ PE G +K+ D G A+ P + + +YRAPEL+ GA
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAPELLLGARH 212
Query: 322 YTTKIDVWSAGCVLAELLLGQPMFPGDS---------GVDQLVEIIKVLGTPTREQ---I 369
YT ID+W+ GC+ AELL +P+F DQL I V+G P + I
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 272
Query: 370 REMNPNYTEFKFPQIKSHPWSKV--------FRVRTPPDAIDLISRLLEYTPSSRIS 418
++M P ++ + + ++ +V+ A L+ +LL P RI+
Sbjct: 273 KKM-PEHSTL-MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 21/66 (31%), Positives = 38/66 (57%), Gaps = 4/66 (6%)
Query: 30 IGNGSFGIVYQAKLLD--SGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFY 85
+G G++G VY+AK D + A+K++ + RE+ ++R L+H N++ L+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 86 SSGDKK 91
S D+K
Sbjct: 89 SHADRK 94
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 13/79 (16%)
Query: 143 VDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFPQIKSHPWSKV--------FRVRTPP 191
DQL I V+G P + I++M P ++ + + ++ +V+
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKM-PEHSTL-MKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 192 DAIDLISRLLEYTPSSRIS 210
A L+ +LL P RI+
Sbjct: 309 KAFHLLQKLLTMDPIKRIT 327
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 75/263 (28%), Positives = 112/263 (42%), Gaps = 68/263 (25%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+VLE K+ + + + K +Y L + Y+H GI HRD+KP N L+
Sbjct: 134 VVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS----------------------------YICSRY 309
N + +K+CDFG A+ + E S ++ +R+
Sbjct: 190 N-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLL-----------GQPMFPGDS--------- 349
YRAPELI +YT IDVWS GC+ AELL P+FPG S
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308
Query: 350 -----------GVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRV 395
DQL I +LGTP+ E I + + + FP+ + ++ F
Sbjct: 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP- 367
Query: 396 RTPPDAIDLISRLLEYTPSSRIS 418
+ DAI L+ R+L + P+ RI+
Sbjct: 368 ASSADAIHLLKRMLVFNPNKRIT 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 7/96 (7%)
Query: 121 PGQ---GPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFP 174
PG Q+ + DQL I +LGTP+ E I + + + FP
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355
Query: 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 210
+ + ++ F + DAI L+ R+L + P+ RI+
Sbjct: 356 KREGTDLAERFP-ASSADAIHLLKRMLVFNPNKRIT 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 10/61 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
+IG GS+G V +A +VAIKK+ + F++ RE+ I+ RL H ++VK+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 81 K 81
Sbjct: 118 L 118
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-52
Identities = 71/255 (27%), Positives = 110/255 (43%), Gaps = 60/255 (23%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+VLE + K+ K + + K +Y L +IH GI HRD+KP N LL
Sbjct: 107 IVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVS-----------------------YICSRYYRAPE 314
N + +K+CDFG A+ + + ++ +R+YRAPE
Sbjct: 163 N-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQ-----------PMFPGDSG------------- 350
LI +YT ID+WS GC+ AELL P+FPG S
Sbjct: 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVH 281
Query: 351 ----VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIKSHPWSKVFRVRTPPDAID 403
DQL I ++GTPT + ++ + P ++ FP K + + D I+
Sbjct: 282 EKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP-SISDDGIN 340
Query: 404 LISRLLEYTPSSRIS 418
L+ +L++ P+ RI+
Sbjct: 341 LLESMLKFNPNKRIT 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 121 PGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFPQIK 177
PG + S DQL I ++GTPT + ++ + P ++ FP K
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323
Query: 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 210
+ + D I+L+ +L++ P+ RI+
Sbjct: 324 PINLKQKYP-SISDDGINLLESMLKFNPNKRIT 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 22/61 (36%), Positives = 36/61 (59%), Gaps = 10/61 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIVKL 80
+IG GS+G VY A ++ + VAIKKV ++ F++ RE+ I+ RL+ I++L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 81 K 81
Sbjct: 91 Y 91
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+ E + +Y++ K Q F + + + + + L +H I H D+KP+N+LL
Sbjct: 176 MTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 278 -NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336
+K+ DFGS+ + + +YI SR+YRAPE+I G Y ID+WS GC+LA
Sbjct: 234 KQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILA 290
Query: 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR-----------EMNPNYTEFKFPQIK 385
ELL G P+ PG+ DQL +I++LG P+++ + + P Y
Sbjct: 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDG 350
Query: 386 SHPWSKVFRVRT----PPDA---------------IDLISRLLEYTPSSRISPLQ 421
S + R PP++ +D + + LE+ P+ R++P Q
Sbjct: 351 SVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 9/66 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRL------EHSNIVK 79
VIG GSFG V +A + VA+K V +KRF E++I+ L N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 80 LKYFFY 85
+ F
Sbjct: 164 MLENFT 169
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 43/242 (17%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV--LGICHRDIKPQNL 275
LV E + +Y + ++ + + T+ + Q+ +L ++ L I H D+KP+N+
Sbjct: 133 LVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 276 LL-NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL NP+ +K+ DFGS+ L G+ YI SR+YR+PE++ G + Y ID+WS GC+
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCI 247
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR-----------EMNPNYT------ 377
L E+ G+P+F G + VDQ+ +I++VLG P + + +
Sbjct: 248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKD 307
Query: 378 ---EFKFPQIKSHPWSKVFRVRTPPDA---------------IDLISRLLEYTPSSRISP 419
E+K P + P DLI R+L+Y P +RI P
Sbjct: 308 GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367
Query: 420 LQ 421
Sbjct: 368 YY 369
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 22/66 (33%), Positives = 30/66 (45%), Gaps = 9/66 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRL------EHSNIVK 79
+IG GSFG V +A E VAIK + K F N E++++ + IV
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 80 LKYFFY 85
LK F
Sbjct: 121 LKRHFM 126
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 53/237 (22%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+ E + + ++ K + Q +P + + YQL +L ++H + H D+KP+N+L
Sbjct: 99 IAFELLGKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 278 N------------------PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA 319
+ +++ DFGSA E + + + +R+YR PE+I
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILE- 213
Query: 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN------ 373
+ + DVWS GC+L E G +F + LV + K+LG I
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY 273
Query: 374 -------PNYTEFKFPQIKSHPWSKVFRVRTPPDA--IDLISRLLEYTPSSRISPLQ 421
N ++ ++ + P + DL+ R+LE+ P+ RI+ +
Sbjct: 274 KGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 16/85 (18%), Positives = 31/85 (36%), Gaps = 15/85 (17%)
Query: 144 DQLVEIIKVLGTPTREQIREMN-------------PNYTEFKFPQIKSHPWSKVFRVRTP 190
+ LV + K+LG I N ++ ++ + P +
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 191 PDA--IDLISRLLEYTPSSRISPLQ 213
DL+ R+LE+ P+ RI+ +
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 55/237 (23%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+V E + + Y K F + + YQ+ +S+ ++H + H D+KP+N+L
Sbjct: 94 IVFELLGLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 278 N------------------PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA 319
+K+ DFGSA + E + + + +R+YRAPE+I
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DDEHHSTLVSTRHYRAPEVILA- 208
Query: 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYT 377
+ ++ DVWS GC+L E LG +FP + L + ++LG + I++ +
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268
Query: 378 EFKFPQIKSHPWSKVFRVRTPP-------------DAIDLISRLLEYTPSSRISPLQ 421
+ + + P DLI ++LEY P+ RI+ +
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 46/245 (18%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
L+ E + ++Y++ + F KLY ++ ++L Y+ + + H D+KP+N+LL
Sbjct: 113 LIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 278 N------------------------PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAP 313
+ ++ +KL DFG A + + + S I +R YRAP
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAP 228
Query: 314 ELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM- 372
E+I + + D+WS GCVLAEL G +F ++ L + ++ + + E
Sbjct: 229 EVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEAT 287
Query: 373 --------NPNYTEFKFPQIKSHPWSKVFRVRTPPDA--------IDLISRLLEYTPSSR 416
N + + +P+ S S + P D + +L+ P+ R
Sbjct: 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347
Query: 417 ISPLQ 421
SP +
Sbjct: 348 PSPAE 352
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 17/65 (26%), Positives = 33/65 (50%), Gaps = 8/65 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRL-----EHSNIVKL 80
+G+G+FG V + +D+ + A+K V K++ E I++++ ++NIVK
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 81 KYFFY 85
F
Sbjct: 102 HGKFM 106
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-43
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 34/231 (14%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLL 276
+V E + E + + K Y + P Y K QL L Y+H GI H DIKP+N+L
Sbjct: 107 MVFEVLGENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 277 L-----NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
+ +K+ D G+A E + I +R YR+PE++ GA + D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGA-PWGCGADIWST 221
Query: 332 GCVLAELLLGQPMFPGDSG------VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385
C++ EL+ G +F D G D + +II++LG +R N YT F
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRG 279
Query: 386 SHPWSKVFRVRTPPDAI---------------DLISRLLEYTPSSRISPLQ 421
+ D + D +S +L+ P R
Sbjct: 280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 44/294 (14%), Positives = 81/294 (27%), Gaps = 33/294 (11%)
Query: 150 IKVLGTPTREQIREMNPNYTEFKFPQIKSHP----WSKVFRVRTPPDAIDLIS-RLLEYT 204
+KV E+ + R+ P DA+ + S
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 205 PSSRISPLQVFLNLVLEFMP---ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261
+ L++ E ++ + + + QL R A +
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG-AI 320
G+ H P NL + P+ G L L D + + G + Y E +
Sbjct: 212 SKGLVHGHFTPDNLFIMPD-GRLMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTA 268
Query: 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 380
+T ++ W G + + F + + L P +
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD------------- 315
Query: 381 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434
+ P LI R L + R+ PL+ TP ++L+
Sbjct: 316 -------SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME-TPEFLQLQN 361
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 7/63 (11%), Positives = 18/63 (28%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFK-------NREMQIMRRLEHSNIVKLK 81
+ G +V+ + ++ E A+K + RL + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 82 YFF 84
Sbjct: 129 DRR 131
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 41/199 (20%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ K K++ + K Y + ++ IH GI H D+KP N L+ G+LKL DFG A
Sbjct: 116 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIA 173
Query: 293 KHLVRGEPNV---SYICSRYYRAPELIFGA----------IDYTTKIDVWSAGCVLAELL 339
+ +V S + + Y PE I + K DVWS GC+L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399
G+ F + I ++PN+ E +FP I
Sbjct: 234 YGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDIPE------------K 267
Query: 400 DAIDLISRLLEYTPSSRIS 418
D D++ L+ P RIS
Sbjct: 268 DLQDVLKCCLKRDPKQRIS 286
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 14/69 (20%), Positives = 30/69 (43%), Gaps = 9/69 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKN--REMQIMRRLEH--SNIVKL 80
IG+G V+Q L + ++ AIK V ++ + E+ + +L+ I++L
Sbjct: 35 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 81 KYFFYSSGD 89
+ +
Sbjct: 94 YDYEITDQY 102
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 47/203 (23%), Positives = 71/203 (34%), Gaps = 36/203 (17%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L L E ++ +H + P Y+ +LA++H G+ H D+KP N+
Sbjct: 132 LYLQTELCGPSL---QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
L P G KL DFG L Y APEL+ G Y T DV+S G +
Sbjct: 189 FLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTI 245
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395
E+ + G G QL + P+ + S
Sbjct: 246 LEVACNMELPHGGEGWQQLRQGYLP---------------------PEFTAG-LS----- 278
Query: 396 RTPPDAIDLISRLLEYTPSSRIS 418
+ ++ +LE P R +
Sbjct: 279 ---SELRSVLVMMLEPDPKLRAT 298
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 16/68 (23%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL------QDKRFKNREMQIMRRL-EHSNIVKLK 81
+G+GS+G V++ + + G L A+K+ + +D+ K E+ ++ +H V+L+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 82 YFFYSSGD 89
+ G
Sbjct: 124 QAWEEGGI 131
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 32/181 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYIC- 306
+ Q+F +L Y+H GICHRDIKP+N L ++ +KL DFG +K + Y
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 307 ----SRYYRAPELIFGAID-YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ Y+ APE++ + Y K D WSAG +L LL+G FPG + D + +++
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-- 290
Query: 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
+ F + ++ + P A DL+S LL R ++
Sbjct: 291 ---------------KKLCFE---NPNYNVL-----SPLARDLLSNLLNRNVDERFDAMR 327
Query: 422 V 422
Sbjct: 328 A 328
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 9/65 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL---------QDKRFKNREMQIMRRLEHSNIVK 79
IG GS+G+V A + + AIK + +D E+++M++L H NI +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 80 LKYFF 84
L +
Sbjct: 93 LYEVY 97
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 29/176 (16%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
I Q+F + Y+H I HRD+KP+N+LL + +K+ DFG + + I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ YY APE++ G Y K DVWSAG +L LL G P F G + + +I+
Sbjct: 186 TAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL-------- 231
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+++ + W + DA DLI ++L + PS RI+ Q
Sbjct: 232 KRVETGKYAF--------DLPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 18/79 (22%), Positives = 36/79 (45%), Gaps = 6/79 (7%)
Query: 12 KNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------RE 65
+N + ++G GSFG V + K + + A+K + + RE
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 66 MQIMRRLEHSNIVKLKYFF 84
++++++L+H NI+KL
Sbjct: 72 VELLKKLDHPNIMKLFEIL 90
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 41/199 (20%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ K K++ + K Y + ++ IH GI H D+KP N L+ G+LKL DFG A
Sbjct: 97 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIA 154
Query: 293 KHLVRGEPNV---SYICSRYYRAPELIFG----------AIDYTTKIDVWSAGCVLAELL 339
+ +V S + + Y PE I + K DVWS GC+L +
Sbjct: 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
Query: 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399
G+ F + I ++PN+ E +FP I
Sbjct: 215 YGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDIPE------------K 248
Query: 400 DAIDLISRLLEYTPSSRIS 418
D D++ L+ P RIS
Sbjct: 249 DLQDVLKCCLKRDPKQRIS 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 9/69 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEH--SNIVKL 80
IG+G V+Q L + ++ AIK V ++ E+ + +L+ I++L
Sbjct: 16 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 81 KYFFYSSGD 89
+ +
Sbjct: 75 YDYEITDQY 83
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 29/189 (15%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAK 293
S++ F I Q+ + Y+H I HRD+KP+NLLL + +++ DFG +
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 294 HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ 353
H + I + YY APE++ G Y K DVWS G +L LL G P F G + +
Sbjct: 178 HFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY 233
Query: 354 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
+I+ +++ + + + W KV A DLI ++L Y P
Sbjct: 234 --DIL--------KKVEKGKYTF--------ELPQWKKV-----SESAKDLIRKMLTYVP 270
Query: 414 SSRISPLQV 422
S RIS
Sbjct: 271 SMRISARDA 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-------QDKRFKNREMQIMRRLEHSNIVKLK 81
V+G GSFG V K +G+ A+K + DK RE+Q++++L+H NI+KL
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 82 YFF 84
FF
Sbjct: 93 EFF 95
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-33
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 29/189 (15%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAK 293
+ F + I Q+ + Y+H I HRD+KP+NLLL + ++K+ DFG +
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 294 HLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ 353
+ + + YY APE++ Y K DVWS G +L LL G P F G + DQ
Sbjct: 188 VFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ 243
Query: 354 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
EI+ ++ + + S W V A DLI ++L++
Sbjct: 244 --EIL--------RKVEKGKYTF--------DSPEWKNV-----SEGAKDLIKQMLQFDS 280
Query: 414 SSRISPLQV 422
RIS Q
Sbjct: 281 QRRISAQQA 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 6/62 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
+G+G++G V + + AIK + + + E+ +++ L+H NI+KL
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 83 FF 84
FF
Sbjct: 104 FF 105
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 29/176 (16%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ Q+ + Y+H I HRDIKP+N+LL +K+ DFG + + +
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ YY APE++ Y K DVWS G ++ LL G P F G + DQ +II
Sbjct: 211 TAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-------- 256
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+++ + + + W + +A +LI +L Y + R + +
Sbjct: 257 KKVEKGKYYF--------DFNDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 17/76 (22%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----------------REMQIMRR 71
+G+G++G V K + AIK + + + K E+ +++
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 72 LEHSNIVKLKYFFYSS 87
L+H NI+KL F
Sbjct: 103 LDHPNIIKLFDVFEDK 118
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 49/239 (20%), Positives = 78/239 (32%), Gaps = 42/239 (17%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255
I RL+ Y R + + +L +L F T++ + + + R
Sbjct: 88 ILRLVAYCLRERGAKHEAWL--LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----------EPNVSYI 305
L IH G HRD+KP N+LL + G L D GS + +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 306 CSRYYRAPELIFGA--IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363
C+ YRAPEL + DVWS GCVL ++ G+ + V + V
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQN- 262
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ P + L++ ++ P R +
Sbjct: 263 --------------QLSIP-----QSPRH-----SSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 20/69 (28%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G F V + L G A+K++L QD+ RE + R H NI++L +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 85 YSSGDKKDE 93
K E
Sbjct: 96 LRERGAKHE 104
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 41/199 (20%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ K K++ + K Y + ++ IH GI H D+KP N L+ G+LKL DFG A
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIA 201
Query: 293 KHLVRGEPNV---SYICSRYYRAPELIFGA----------IDYTTKIDVWSAGCVLAELL 339
+ +V S + + Y PE I + K DVWS GC+L +
Sbjct: 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
Query: 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399
G+ F + I ++PN+ E +FP I
Sbjct: 262 YGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDIPE------------K 295
Query: 400 DAIDLISRLLEYTPSSRIS 418
D D++ L+ P RIS
Sbjct: 296 DLQDVLKCCLKRDPKQRIS 314
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 9/69 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEH--SNIVKL 80
IG+G V+Q L + ++ AIK V ++ E+ + +L+ I++L
Sbjct: 63 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 81 KYFFYSSGD 89
+ +
Sbjct: 122 YDYEITDQY 130
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 47/221 (21%), Positives = 77/221 (34%), Gaps = 44/221 (19%)
Query: 215 FLNLVLEFMPETV--YKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
F + +E T+ Y K ++ + Q LA++H L I HRD+KP
Sbjct: 92 FQYIAIELCAATLQEYVEQKDFAHLGLE-----PITLLQQTTSGLAHLHSLNIVHRDLKP 146
Query: 273 QNLLLNPETGV----LKLCDFGSAKHLVRGEPNVSY---IC-SRYYRAPELIFGAID--Y 322
N+L++ + DFG K L G + S + + + APE++
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 323 TTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 381
T +D++SAGCV ++ G F G + Q +
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQRQANILLGAC-SLDC 249
Query: 382 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P A +LI +++ P R S V
Sbjct: 250 LH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 18/63 (28%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RFKNREMQIMRRL-EHSNIVKLKYFF 84
K V+G+G+ G + + D VA+K++L + F +RE+Q++R EH N+++
Sbjct: 29 KDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 85 YSS 87
Sbjct: 88 KDR 90
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 51/235 (21%)
Query: 215 FLNLVLEFMPETVYKV---AKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
FL + LE + + ++ + + + Q+ +A++H L I HRD+K
Sbjct: 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 272 PQNLLLN------------PETGVLKLCDFGSAKHLVRGEPNVSY----IC-SRYYRAPE 314
PQN+L++ E + + DFG K L G+ + + +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 315 LIFGAID------YTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
L+ + + T ID++S GCV +L G+ F + II+
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRESNIIR-------- 252
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
F ++K + +A DLIS+++++ P R + ++V
Sbjct: 253 ---------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RFKNREMQIMRRL-EHSNIVKLKYFF 84
+ ++G GS G V G VA+K++L D E++++ +H N+++
Sbjct: 20 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 85 YSS 87
+
Sbjct: 79 TTD 81
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 34/222 (15%)
Query: 218 LVLEFMP-----ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIK 271
++ E+M + P K I + S +YIH ICHRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDY-TTKIDVW 329
P N+L++ + G +KL DFG ++++V + S + + PE Y K+D+W
Sbjct: 180 PSNILMD-KNGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389
S G L + F + +L I+ ++P ++H
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIR----------------TKNIEYPLDRNHFL 280
Query: 390 SKVFRVRTP-------PDAIDLISRLLEYTPSSRISPLQVRS 424
+ ++ + ID + L P+ RI+
Sbjct: 281 YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 8/80 (10%), Positives = 24/80 (30%), Gaps = 23/80 (28%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN----------------REMQ 67
+ G F + + + A+K + + + F E+Q
Sbjct: 38 TLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 68 IMRRLEHSNIVKLKYFFYSS 87
I+ +++ + + +
Sbjct: 96 IITDIKNEYCLTCEGIITNY 115
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 28/182 (15%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVS 303
KLY YQ+ ++ Y+H GI HRD+KP+N+LL E ++K+ DFG +K L +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 304 YICSRYYRAPELIFGAID--YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ Y APE++ Y +D WS G +L L G P F L + I
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-S 359
Query: 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
G ++ F W++V A+DL+ +LL P +R + +
Sbjct: 360 G---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEE 396
Query: 422 VR 423
Sbjct: 397 AL 398
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 12/68 (17%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------------REMQIMRRLEHSN 76
+G+G+ G V A + + VAI+ + + K E++I+++L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 77 IVKLKYFF 84
I+K+K FF
Sbjct: 202 IIKIKNFF 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 29/188 (15%)
Query: 237 SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKH 294
++ F I Q+F + Y+H I HRD+KP+N+LL + +K+ DFG +
Sbjct: 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 295 LVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQL 354
+ I + YY APE++ G Y K DVWSAG +L LL G P F G + D L
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 355 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414
+ ++ F W + DA DLI ++L + PS
Sbjct: 232 KRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPS 266
Query: 415 SRISPLQV 422
RI+ Q
Sbjct: 267 LRITATQC 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 6/62 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
++G GSFG V + K + + A+K + + RE++++++L+H NI+KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 83 FF 84
Sbjct: 89 IL 90
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 43/219 (19%), Positives = 75/219 (34%), Gaps = 18/219 (8%)
Query: 218 LVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L++EF P + + + P + + + + ++ GI HR+IKP N+
Sbjct: 86 LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 276 LLNP---ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID-------YTTK 325
+ V KL DFG+A+ L E VS + Y P++ A+ Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK--VLGTPTREQIREMNPNYTEFKFPQ 383
+D+WS G G F G + E++ + G P+ +
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS- 262
Query: 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P S +++ +LE Q
Sbjct: 263 -GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 5/68 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
++G G+ V++ + +G+L AIK + RE +++++L H NIVKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 84 FYSSGDKK 91
+ +
Sbjct: 76 EEETTTRH 83
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
LN+VLE + ++ KH+ K K+ P Y QL +L ++H + HRDIKP N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
+ + TGV+KL D G + S + + YY +PE I Y K D+WS GC
Sbjct: 167 VFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGC 224
Query: 334 VLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E+ Q F GD + L + I+ + +P + S +S+
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIE------------------QCDYPPLPSDHYSEE 266
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
R L++ + P R V
Sbjct: 267 LR--------QLVNMCINPDPEKRPDVTYV 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 7/67 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV-------LQDKRFKNREMQIMRRLEHSNIVKLK 81
IG G F VY+A L G VA+KKV + + +E+ ++++L H N++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 82 YFFYSSG 88
F
Sbjct: 99 ASFIEDN 105
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 44/232 (18%), Positives = 80/232 (34%), Gaps = 18/232 (7%)
Query: 218 LVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L++EF P + + + P + + + + ++ GI HR+IKP N+
Sbjct: 86 LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 276 LL---NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID-------YTTK 325
+ V KL DFG+A+ L E VS + Y P++ A+ Y
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK--VLGTPTREQIREMNPNYTEFKFPQ 383
+D+WS G G F G + E++ + G P+ +
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435
P S +++ +LE Q + T ++ +
Sbjct: 264 --DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVI 313
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 5/68 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
++G G+ V++ + +G+L AIK + RE +++++L H NIVKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 84 FYSSGDKK 91
+ +
Sbjct: 76 EEETTTRH 83
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 28/182 (15%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVS 303
KLY YQ+ ++ Y+H GI HRD+KP+N+LL E ++K+ DFG +K L +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 304 YICSRYYRAPELIFGAID--YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361
+ Y APE++ Y +D WS G +L L G P F L + I
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-S 234
Query: 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
G ++ F W++V A+DL+ +LL P +R + +
Sbjct: 235 G---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEE 271
Query: 422 VR 423
Sbjct: 272 AL 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 12/68 (17%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKN--------REMQIMRRLEHSN 76
+G+G+ G V A + + VAIK + + E++I+++L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 77 IVKLKYFF 84
I+K+K FF
Sbjct: 77 IIKIKNFF 84
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 43/229 (18%), Positives = 72/229 (31%), Gaps = 51/229 (22%)
Query: 218 LVLEFMPETVYKVAK---HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ M + + +S + ++ Q+ R LA +H G+ H ++P +
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI----------FGAIDYTT 324
++L+ + G + L F VR V SR + PEL T
Sbjct: 237 IVLD-QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 384
D W+ G V+ + D+ + E I F+ +
Sbjct: 293 SFDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSCK- 330
Query: 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
P L+ L Y R+ PLQ TP +LR
Sbjct: 331 -----------NIPQPVRALLEGFLRYPKEDRLLPLQAME-TPEYEQLR 367
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 7/43 (16%), Positives = 17/43 (39%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRR 71
V+G +A ++GE + +R + ++ M+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 27/179 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ + ++ ++H I HRD+KP+NLL + VLKL DFG AK + + C
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC 190
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ YY APE + G Y D+WS G ++ LL G P F ++G + +
Sbjct: 191 YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR------ 243
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+IR ++ FP + WS+V DA LI LL+ P+ R++ Q +
Sbjct: 244 --RIRLG-----QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 14/59 (23%), Positives = 26/59 (44%), Gaps = 2/59 (3%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFF 84
K V+G G G V + +G+ A+ K+L D +E+ + +IV + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCAL-KLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 29/178 (16%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ + ++AY H L + HRD+KP+N L + LKL DFG A G+ + +
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ YY +P+++ G Y + D WSAG ++ LL G P F + + +++I +
Sbjct: 171 TPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG------ 222
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
F FP W V P A LI RLL +P RI+ LQ
Sbjct: 223 -----------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
IG GS+G V A + A K ++D +E++IM+ L+H NI++L F
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 43/185 (23%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Q+ +L+YIH GI HRD+KP N+ ++ E+ +K+ DFG AK++ R +
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 309 ---------------YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ 353
Y A E++ G Y KID++S G + E++ P G
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME---- 233
Query: 354 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
V I+K ++R +FP +I L+++ P
Sbjct: 234 RVNILK--------KLRS-----VSIEFP---PDFDDNKM-----KVEKKIIRLLIDHDP 272
Query: 414 SSRIS 418
+ R
Sbjct: 273 NKRPG 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIVKLKYFFY 85
V+G G+FG V +A+ AIKK+ + + E+ ++ L H +V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 86 SSGDKKDEPTN 96
+ T
Sbjct: 73 ERRNFVKPMTA 83
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 66/214 (30%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
L+LE+ P TVY+ + F T YI +L +L+Y H + HRDIKP+NLL
Sbjct: 86 LILEYAPLGTVYR----ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141
Query: 277 LNPETGVLKLCDFGSAKHLVR-------GEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329
L G LK+ DFG + H G + Y PE+I G + K+D+W
Sbjct: 142 LG-SAGELKIADFGWSVHAPSSRRTDLCGTLD--------YLPPEMIEGR-MHDEKVDLW 191
Query: 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389
S G + E L+G+P F ++ + I +V EF FP +
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP-----DF 229
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR 423
A DLISRLL++ PS R +V
Sbjct: 230 -------VTEGARDLISRLLKHNPSQRPMLREVL 256
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 19/66 (28%), Positives = 34/66 (51%), Gaps = 7/66 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
+G G FG VY A+ S ++A+K ++ + RE++I L H NI++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 82 YFFYSS 87
+F+ +
Sbjct: 76 GYFHDA 81
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 22/177 (12%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ +L +++++H +G+ HRD+KP+NLL + +K+ DFG A+ + C
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ +Y APE + Y D+WS G +L +L GQ F ++++
Sbjct: 171 FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM---- 225
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
++I++ +F F W V +A DLI LL P+ R+ +
Sbjct: 226 -KKIKKG-----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 19/72 (26%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRL- 72
F + + +G GSF I + S + A+K + KR + +E+ ++
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCE 63
Query: 73 EHSNIVKLKYFF 84
H NIVKL F
Sbjct: 64 GHPNIVKLHEVF 75
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 38/223 (17%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-----VLGICHRD 269
L +V+E+ + V +K +Q + + QL +L H + HRD
Sbjct: 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 270 IKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDV 328
+KP N+ L+ +KL DFG A+ L + YY +PE + + Y K D+
Sbjct: 142 LKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDI 199
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388
WS GC+L EL P F S +L I+ + R + Y
Sbjct: 200 WSLGCLLYELCALMPPFTAFS-QKELAGKIR------EGKFRRIPYRY------------ 240
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431
+ ++I+R+L R S ++ P ++E
Sbjct: 241 ---------SDELNEIITRMLNLKDYHRPSVEEILE-NPLILE 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 15/69 (21%), Positives = 31/69 (44%), Gaps = 6/69 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVKLKY 82
IG GS+G + + G+++ K++ +K+ E+ ++R L+H NIV+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 83 FFYSSGDKK 91
+
Sbjct: 73 RIIDRTNTT 81
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 24/176 (13%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ + ++ Y+H + I HRD+KP+NLL +LKL DFG AK +
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ YY APE + G Y D+WS G ++ LL G P F + G+ +
Sbjct: 226 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------- 276
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+IR +++FP + WS+V + LI LL+ P+ R++ +
Sbjct: 277 TRIRM-----GQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFF 84
V+G G G V Q + E A+ K+LQD RE+++ R + +IV++ +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVY 124
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 31/182 (17%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
T+ + L + +H L I HRD+KP+N+LL+ + +KL DFG + L GE
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 306 CSRYYRAPELIFGAID-----YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV 360
+ Y APE+I +++ Y ++D+WS G ++ LL G P F + L I+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 361 LGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 420
++F S W DL+SR L P R +
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279
Query: 421 QV 422
+
Sbjct: 280 EA 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 15/70 (21%), Positives = 33/70 (47%), Gaps = 14/70 (20%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK------------KVLQDKRFK-NREMQIMRRL-EH 74
++G G +V + + + A+K + +Q+ R +E+ I+R++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 75 SNIVKLKYFF 84
NI++LK +
Sbjct: 84 PNIIQLKDTY 93
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 48/193 (24%), Positives = 75/193 (38%), Gaps = 34/193 (17%)
Query: 237 SKQNFPCFYT----KLYIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFG 290
+ + Y+ Y+ Q+ +L Y H I HRD+KP +LL + +KL FG
Sbjct: 119 KRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 291 SAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS 349
A L + ++ APE++ Y +DVW G +L LL G F G
Sbjct: 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK 237
Query: 350 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409
++L E I ++K WS + A DL+ R+L
Sbjct: 238 --ERLFEGII----------------KGKYKMN---PRQWSHI-----SESAKDLVRRML 271
Query: 410 EYTPSSRISPLQV 422
P+ RI+ +
Sbjct: 272 MLDPAERITVYEA 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 9/65 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVK 79
VIG G F +V + ++G+ A+K V K + RE I L+H +IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 80 LKYFF 84
L +
Sbjct: 91 LLETY 95
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 42/213 (19%)
Query: 215 FLNLVLEFMPE-TVYKVAKH-YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
F+ + +E +P ++ + + + K N Y Q+ L Y+H I HRDIK
Sbjct: 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQ--TIGFYTKQILEGLKYLHDNQIVHRDIKG 150
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAID-YTTKIDVWS 330
N+L+N +GVLK+ DFG++K L P ++ + Y APE+I Y D+WS
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP-- 388
GC + E+ G+P F +L E + FK K HP
Sbjct: 211 LGCTIIEMATGKPPFY------ELGEPQAAM-----------------FKVGMFKVHPEI 247
Query: 389 ---WSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
S +A I + E P R
Sbjct: 248 PESMS--------AEAKAFILKCFEPDPDKRAC 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 21/70 (30%), Positives = 38/70 (54%), Gaps = 7/70 (10%)
Query: 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKN---REMQIMRRLEHSNIVKLK 81
+ V+G G++GIVY + L + +AIK++ +D R+ E+ + + L+H NIV +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV--Q 83
Query: 82 YF-FYSSGDK 90
Y +S
Sbjct: 84 YLGSFSENGF 93
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 47/176 (26%), Positives = 71/176 (40%), Gaps = 30/176 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ Q+ +LAY H + H+D+KP+N+L +K+ DFG A+ E + +
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y APE+ D T K D+WSAG V+ LL G F G S + +
Sbjct: 189 TALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK------ 240
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
E + P A+DL+ ++L P R S QV
Sbjct: 241 -----------EPNYA---VECRP------LTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 5/61 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKNREMQIMRRLEHSNIVKLKYF 83
+G+G+FG V+ + SG IK + E+++++ L+H NI+K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 84 F 84
F
Sbjct: 89 F 89
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 27/177 (15%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
++ + +++ Y+H G+ HRD+KP N+L + +++CDFG AK L + C
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ + APE + Y D+WS G +L +L G F EI+
Sbjct: 182 YTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEIL------- 232
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+I +F W+ V A DL+S++L P R++ V
Sbjct: 233 -ARIGSG-----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFF 84
K IG GS+ + + + A+K + + KR E++I+ R +H NI+ LK +
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 28/176 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
I Q+ S+AY H GI HR++KP+NLLL + +KL DFG A + E +
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y +PE++ Y+ +D+W+ G +L LL+G P F + +I
Sbjct: 170 TPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------ 222
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ +P S W V P+A LI +L P RI+ Q
Sbjct: 223 -----------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQA 259
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 8e-10
Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
+G G+F +V + +G A K + K RE +I R+L+H NIV+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 83 FF 84
Sbjct: 73 SI 74
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 28/176 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
I Q+ S+AY H GI HR++KP+NLLL + +KL DFG A + E +
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y +PE + Y+ +D+W+ G +L LL+G P F + +I
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------ 245
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ +P S W V P+A LI +L P RI+ Q
Sbjct: 246 -----------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQA 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
+G G+F +V + +G A K + K RE +I R+L+H NIV+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 83 FF 84
Sbjct: 96 SI 97
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 29/177 (16%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
I Q+ ++ + H +G+ HR++KP+NLLL + +KL DFG A + +
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ Y +PE + Y +D+W+ G +L LL+G P F + +I
Sbjct: 175 GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------ 227
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ FP S W V P+A DLI+++L PS RI+ +
Sbjct: 228 -----------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEA 265
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
+G G+F +V + + +G+ A + K RE +I R L+H NIV+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 83 FF 84
Sbjct: 78 SI 79
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 62/216 (28%), Positives = 89/216 (41%), Gaps = 53/216 (24%)
Query: 218 LVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L+LEF P E ++ KH F + ++ +L +L Y H + HRDIKP+NL
Sbjct: 91 LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145
Query: 276 LLNPETGVLKLCDFGSAKHLVR-------GEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328
L+ G LK+ DFG + H G + Y PE+I G + K+D+
Sbjct: 146 LMG-YKGELKIADFGWSVHAPSLRRRTMCGTLD--------YLPPEMIEGK-THDEKVDL 195
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388
W AG + E L+G P F S + I+ V + KFP P
Sbjct: 196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKFP-----P 233
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+ + DLIS+LL Y P R+ V
Sbjct: 234 F-------LSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 17/66 (25%), Positives = 34/66 (51%), Gaps = 7/66 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
+G G FG VY A+ + ++A+K ++ ++ RE++I L H NI+++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 82 YFFYSS 87
+F+
Sbjct: 81 NYFHDR 86
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 31/177 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
I Q+ ++ Y+H GI HRD+KP+NLL E + + DFG +K G +S C
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC 168
Query: 307 -SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ Y APE + Y+ +D WS G + LL G P F ++ +I +
Sbjct: 169 GTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG----- 222
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
++F S W + A D I LLE P+ R + +
Sbjct: 223 ------------YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKA 259
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 17/60 (28%), Positives = 37/60 (61%), Gaps = 4/60 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----REMQIMRRLEHSNIVKLKYFF 84
V+G+G+F V+ K +G+L A+K + + F++ E+ ++++++H NIV L+ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 27/176 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ Q+ ++AY+H GI HRD+KP+NLL LK+ DFG +K + +
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y APE I Y ++D+WS G + LL G F + G + I
Sbjct: 213 TPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN------ 265
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
E+ F S W +V +A DL+ +L+ P R++ Q
Sbjct: 266 ----------CEYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 19/58 (32%), Positives = 31/58 (53%), Gaps = 2/58 (3%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFF 84
+G G+ IVY+ K + + A+K + + K E+ ++ RL H NI+KLK F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 37/197 (18%), Positives = 60/197 (30%), Gaps = 46/197 (23%)
Query: 247 KLYI-YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+L + Q+ R LA +H G+ H ++P +++L+ G + L F G VS I
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRD--GASAVSPI 269
Query: 306 CSRY----YRAPELIFGA----IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEI 357
+ A ++ T D W+ G + + D+ +
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG----- 324
Query: 358 IKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
E I P L+ L Y R+
Sbjct: 325 -------GSEWIFRSCK---------------------NIPQPVRALLEGFLRYPKEDRL 356
Query: 418 SPLQVRSITPFLIELRA 434
PLQ TP +LR
Sbjct: 357 LPLQAME-TPEYEQLRT 372
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 9/48 (18%), Positives = 20/48 (41%)
Query: 24 LAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRR 71
L + TV+G +A ++GE + +R + ++ M+
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 46/178 (25%), Positives = 69/178 (38%), Gaps = 31/178 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYI 305
++ Q+ + Y+H I H D+KP+N++L N +KL DFG A + G I
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNI 171
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ + APE I + D+WS G + LL G F G++ + L I V
Sbjct: 172 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV---- 226
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ F +S A D I RLL P R++ Q
Sbjct: 227 -------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 10/66 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----------KVLQDKRFKNREMQIMRRLEHSNIV 78
+G+G F IV + + +G+ A K + + RE+ I+R + H NI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 79 KLKYFF 84
L F
Sbjct: 72 TLHDIF 77
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGE-------P 300
+ + +L ++H GI HRD+KP+N+L + +K+CDF + P
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 301 NVSYIC-SRYYRAPELIFGAID----YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLV 355
+ C S Y APE++ + Y + D+WS G +L LL G P F G G D
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 356 EIIKVLGTPTR---EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412
+ + E I+E +++FP W+ + A DLIS+LL
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283
Query: 413 PSSRISPLQV 422
R+S QV
Sbjct: 284 AKQRLSAAQV 293
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 15/64 (23%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 26 QKTVIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKNREMQIMRRLE-HSNIVKL 80
Q+ V+G G+ V L + + A+K + + RE++++ + + H N+++L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 81 KYFF 84
FF
Sbjct: 77 IEFF 80
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 33/183 (18%)
Query: 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYI 305
T+ + L +++++H I HRD+KP+N+LL+ + ++L DFG + HL GE + +
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEK-LREL 259
Query: 306 C-SRYYRAPELIFGAID-----YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIK 359
C + Y APE++ ++D Y ++D+W+ G +L LL G P F + L I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 360 VLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419
+++F S W DLISRLL+ P +R++
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354
Query: 420 LQV 422
Q
Sbjct: 355 EQA 357
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 13/69 (18%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------------REMQIMRRL-EHS 75
VIG G +V + +G A+K + + RE I+R++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 76 NIVKLKYFF 84
+I+ L +
Sbjct: 161 HIITLIDSY 169
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 45/178 (25%), Positives = 70/178 (39%), Gaps = 31/178 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYI 305
++ Q+ + Y+H L I H D+KP+N++L N +K+ DFG A + G I
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNI 177
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ + APE I + D+WS G + LL G F GD+ + L + V
Sbjct: 178 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV---- 232
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
++F +S A D I RLL P R++
Sbjct: 233 -------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 13/66 (19%), Positives = 29/66 (43%), Gaps = 10/66 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----------KVLQDKRFKNREMQIMRRLEHSNIV 78
+G+G F +V + + +G A K + + RE+ I++ ++H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 79 KLKYFF 84
L +
Sbjct: 78 TLHEVY 83
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 45/178 (25%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+I Q+ + Y+H I H D+KP+N++L N +KL DFG A + G I
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ + APE I + D+WS G + LL G F GD+ + L I V
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ F +S A D I +LL R++ +
Sbjct: 234 -------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 10/66 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----------KVLQDKRFKNREMQIMRRLEHSNIV 78
+G+G F IV + + +G A K + + RE+ I+R++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 79 KLKYFF 84
L +
Sbjct: 79 TLHDVY 84
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 47/184 (25%), Positives = 71/184 (38%), Gaps = 31/184 (16%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL 295
+ F + Q+ +L ++H I HRDIK QN+ L + G ++L DFG A+ L
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVL 175
Query: 296 VRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQL 354
+ YY +PE+ Y K D+W+ GCVL EL + F S + L
Sbjct: 176 NSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNL 233
Query: 355 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414
V I ++ +Y D L+S+L + P
Sbjct: 234 VLKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPR 266
Query: 415 SRIS 418
R S
Sbjct: 267 DRPS 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 6/66 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVKLKY 82
IG GSFG K + G IK++ +++ RE+ ++ ++H NIV+ +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 83 FFYSSG 88
F +G
Sbjct: 91 SFEENG 96
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 43/214 (20%)
Query: 218 LVLEFMP------ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIK 271
L+LE+ + ++A+ S++ I Q+ + Y+H I H D+K
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 272 PQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDV 328
PQN+LL G +K+ DFG ++ + + I + Y APE++ TT D+
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYD-PITTATDM 216
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388
W+ G + LL F G+ + + I +V +
Sbjct: 217 WNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-----------------NVDYS---EET 256
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+S V A D I LL P R +
Sbjct: 257 FSSV-----SQLATDFIQSLLVKNPEKRPTAEIC 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 11/66 (16%), Positives = 27/66 (40%), Gaps = 7/66 (10%)
Query: 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHS-NIV 78
+G G F +V Q +G+ A K + + +R ++ E+ ++ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 79 KLKYFF 84
L +
Sbjct: 93 NLHEVY 98
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 31/178 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYI 305
+I Q+ + Y+H I H D+KP+N++L N +KL DFG A + G I
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 306 C-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ + APE I + D+WS G + LL G F GD+ + L I V
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ F +S+ A D I +LL R++ +
Sbjct: 234 -------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 10/66 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----------KVLQDKRFKNREMQIMRRLEHSNIV 78
+G+G F IV + + +G A K + + RE+ I+R++ H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 79 KLKYFF 84
L +
Sbjct: 79 TLHDVY 84
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 27/175 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y+ Q L ++H I H DIKP+N++ + +K+ DFG A L E +
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
+ APE++ D+W+ G + LL G F G+ ++ L + +
Sbjct: 214 AEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------- 265
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+++F +S V P+A D I LL+ P R++
Sbjct: 266 ----------DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 16/60 (26%), Positives = 28/60 (46%), Gaps = 4/60 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G+G+FG+V++ +G + K DK E+ IM +L H ++ L F
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 44/229 (19%), Positives = 81/229 (35%), Gaps = 40/229 (17%)
Query: 192 DAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250
D E + + L + +EF + T+ + + + +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELF 128
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ + + YIH + +RD+KP N+ L +T +K+ DFG L + Y
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQI 369
+PE I DY ++D+++ G +LAELL + F
Sbjct: 188 MSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAF------------------------ 222
Query: 370 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
E + +T+ + I + L+ +LL P R +
Sbjct: 223 -ETSKFFTDLRDGIISDI-FD--------KKEKTLLQKLLSKKPEDRPN 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 19/71 (26%), Positives = 34/71 (47%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
+IG+G FG V++AK G+ IK+V + RE++ + +L+H NIV +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 89 DKKDEPTNYPP 99
+ +
Sbjct: 78 YDPETSSKNSS 88
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 29/176 (16%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYIC- 306
Y++Q+ +L ++H I H DI+P+N++ + +K+ +FG A+ L G+ +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFT 165
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y APE + +T D+WS G ++ LL G F ++ +Q +II
Sbjct: 166 APEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII-------- 212
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
E I + E F +I S +A+D + RLL SR++ +
Sbjct: 213 ENIMNAEYTFDEEAFKEI-S------------IEAMDFVDRLLVKERKSRMTASEA 255
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 3/59 (5%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVA---IKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G FGIV++ S + +K D+ +E+ I+ H NI+ L F
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 52/217 (23%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
LVLE + + K+ K F + +++Q+ + Y+H GI HRD+ NLL
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL 144
Query: 277 LNPETGVLKLCDFGSAKHLVR---------GEPNVSYICSRYYRAPELIFGAIDYTTKID 327
L +K+ DFG A L G PN Y +PE+ + + + D
Sbjct: 145 LT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPN--------YISPEIATRS-AHGLESD 194
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
VWS GC+ LL+G+P F D+ + L +++ +++ P
Sbjct: 195 VWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-----------------DYEMP----- 232
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+ +A DLI +LL P+ R+S V
Sbjct: 233 SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 1e-10
Identities = 21/65 (32%), Positives = 35/65 (53%), Gaps = 7/65 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKN---REMQIMRRLEHSNIVKLKY 82
+G GSF VY+A+ + +G VAIK K + E++I +L+H +I++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 83 FFYSS 87
+F S
Sbjct: 79 YFEDS 83
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 41/182 (22%), Positives = 75/182 (41%), Gaps = 8/182 (4%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ + +L Y+H I HRD+KP+N++L P+ + K+ D G AK L +GE ++
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
+ Y APEL+ YT +D WS G + E + G F + Q ++
Sbjct: 186 TLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSIT 426
++ +F + S + + + +L + R + Q ++
Sbjct: 245 VVYDDLTGAV-KFSSVLPTPNHLSGILAGK----LERWLQCMLMWHQRQRGTDPQNPNVG 299
Query: 427 PF 428
F
Sbjct: 300 CF 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
+G G FG V + D+GE VAIK+ Q+ KN E+QIM++L H N+V +
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 84 FYSSGDKKDEPTNY 97
Sbjct: 81 PDGLQKLAPNDLPL 94
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 27/175 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y+ Q+ + L ++H H D+KP+N++ + LKL DFG HL + +
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
+ APE+ G D+WS G + LL G F G++ + T
Sbjct: 320 AEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLR 366
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
++ + N + F I D D I +LL P++R++ Q
Sbjct: 367 NVKSCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQA 408
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 4/60 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G+FG+V++ +G A K V DK +E+Q M L H +V L F
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 50/204 (24%), Positives = 78/204 (38%), Gaps = 49/204 (24%)
Query: 236 KSKQNFPCFYTKLYIYQLFRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAK 293
+S+ C YQ R++ ++H I HRD+K +NLLL+ G +KLCDFGSA
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSAT 186
Query: 294 HLVRG-------------EPNVSYICSRYYRAPELI--FGAIDYTTKIDVWSAGCVLAEL 338
+ E ++ + YR PE+I + K D+W+ GC+L L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 339 LLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398
Q F + + I+ ++ P VF
Sbjct: 247 CFRQHPFEDGA----KLRIVNG-----------------KYSIPP--HDTQYTVFH---- 279
Query: 399 PDAIDLISRLLEYTPSSRISPLQV 422
LI +L+ P R+S +V
Sbjct: 280 ----SLIRAMLQVNPEERLSIAEV 299
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRL-EHSNIVKLKYF 83
V+ G F VY+A+ + SG A+K++L + R +E+ M++L H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 84 FYSSGDKKDEPT 95
++ D
Sbjct: 95 ASIGKEESDTGQ 106
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 27/175 (15%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
++ Q+ + ++H + I H D+KP+N+L N + +K+ DFG A+ E +
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
+ APE++ + D+WS G + LL G F GD+ + L I+
Sbjct: 252 PEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------- 303
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ + + +A + IS+LL S RIS +
Sbjct: 304 ----------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 17/66 (25%), Positives = 39/66 (59%), Gaps = 4/66 (6%)
Query: 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKNREMQIMRRLEHSNIV 78
++++ ++G G FG V++ + +G +A K + ++DK E+ +M +L+H+N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 79 KLKYFF 84
+L F
Sbjct: 150 QLYDAF 155
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 44/211 (20%), Positives = 74/211 (35%), Gaps = 38/211 (18%)
Query: 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
++N+ +E + ++ ++ K P Y+ Q L Y+H I H D+K
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR------YYRAPELIFGAIDYTTKID 327
N+LL+ + LCDFG A L S + + APE++ G K+D
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVD 238
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
+WS+ C++ +L G + ++I P +I
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI----------------REIPPS 281
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ P I L P R S
Sbjct: 282 -CA--------PLTAQAIQEGLRKEPVHRAS 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 21/62 (33%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
+G GSFG V++ K +G A+KKV L+ F+ E+ L IV L Y G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPL-YGAVREG 122
Query: 89 DK 90
Sbjct: 123 PW 124
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 32/227 (14%), Positives = 69/227 (30%), Gaps = 63/227 (27%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ + E+ ++ + F K + Q+ R L YIH + + H DIKP N
Sbjct: 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145
Query: 275 LLLNPE------------------TGVLKLCDFGSAKHL-----VRGEPNVSYICSRYYR 311
+ ++ + K+ D G + G+ +
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS--------RFL 197
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
A E++ + K D+++ + +P+ ++ +
Sbjct: 198 ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG-------------- 243
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+ P+I S+ F +L+ ++ P R S
Sbjct: 244 --------RLPRIPQV-LSQEFT--------ELLKVMIHPDPERRPS 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 18/66 (27%), Positives = 33/66 (50%), Gaps = 11/66 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRL-EHSNIVKLK 81
IG+G FG V++ G + AIK+ D++ RE+ L +HS++V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR-- 75
Query: 82 YFFYSS 87
++S+
Sbjct: 76 --YFSA 79
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 43/235 (18%), Positives = 84/235 (35%), Gaps = 47/235 (20%)
Query: 202 EYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260
T + S +V+L + ++ E + + + Q+ ++ ++
Sbjct: 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR------------ 308
H G+ HRD+KP N+ V+K+ DFG + + E + +
Sbjct: 135 HSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 309 -YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
Y +PE I G Y+ K+D++S G +L ELL P F + + ++
Sbjct: 194 KLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTDVR-------- 241
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
KFP + + P ++ +L +P R + +
Sbjct: 242 ----------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 5/76 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR-----EMQIMRRLEHSNIVKLKYF 83
+G G FG+V++AK AIK++ R R E++ + +LEH IV+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 84 FYSSGDKKDEPTNYPP 99
+ + + P
Sbjct: 72 WLEKNTTEKLQPSSPK 87
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 31/208 (14%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLL 276
+ +E M ++ K K Q P + ++L ++H L + HRD+KP N+L
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID---YTTKIDVWSAGC 333
+N G +K+CDFG + +LV + Y APE I ++ Y+ K D+WS G
Sbjct: 143 IN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
+ EL + + + Q ++ + V PQ+ + +S F
Sbjct: 202 TMIELAILRFPYDSWGTPFQQLKQV-VEEPS-----------------PQLPADKFSAEF 243
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQ 421
D S+ L+ R + +
Sbjct: 244 V--------DFTSQCLKKNSKERPTYPE 263
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 15/69 (21%), Positives = 37/69 (53%), Gaps = 10/69 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKN--REMQI-MRRLEHSNIVKLKY 82
+G G++G+V + + + SG+++A+K++ + + K ++ I MR ++ V +
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV--TF 71
Query: 83 F--FYSSGD 89
+ + GD
Sbjct: 72 YGALFREGD 80
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 45/176 (25%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
+ + ++ Y+H + I HRD+KP+NLL +LKL DFG AK GE
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGEK------ 174
Query: 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
Y D+WS G ++ LL G P F + G+ +
Sbjct: 175 ---------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------- 211
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+IR +++FP + WS+V + LI LL+ P+ R++ +
Sbjct: 212 TRIRMG-----QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFF 84
V+G G G V Q + E A+ K+LQD RE+++ R + +IV++ +
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVY 80
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 30/226 (13%)
Query: 216 LNLVLEFMP----ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDI 270
+++ +E M + V K A P + + L Y+ I HRD+
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330
KP N+L+N G +KLCDFG + L+ N S++ +R Y +PE + G Y+ + D+WS
Sbjct: 159 KPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT-HYSVQSDIWS 215
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G L E+ +G+ P + + + E + S P
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 391 KVFRVRT---------------PPDAIDLISRLLEYTPSSRISPLQ 421
+F + + D +++ L P+ R Q
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 9/68 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKN--REMQIMRRLEHSNIVKLKYF 83
+G G+ G+V++ SG ++A K + ++ RE+Q++ IV ++
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV--GFY 97
Query: 84 --FYSSGD 89
FYS G+
Sbjct: 98 GAFYSDGE 105
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 53/217 (24%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+VLE ++ K ++ + Y+ Q+ Y+H + HRD+K NL
Sbjct: 92 VVLELCRRRSLL----ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147
Query: 277 LNPETGVLKLCDFG-SAKHLVRGE--------PNVSYICSRYYRAPELIFGAIDYTTKID 327
LN E +K+ DFG + K GE PN Y APE++ ++ ++D
Sbjct: 148 LN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPN--------YIAPEVLSKK-GHSFEVD 197
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
VWS GC++ LL+G+P F L E T +I++ E+ P
Sbjct: 198 VWSIGCIMYTLLVGKPPFETSC----LKE--------TYLRIKK-----NEYSIP----- 235
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
P A LI ++L+ P++R + ++ +
Sbjct: 236 KH-------INPVAASLIQKMLQTDPTARPTINELLN 265
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 7/67 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKN---REMQIMRRLEHSNIVKLKY 82
+G G F ++ D+ E+ A K +L + E+ I R L H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 83 FFYSSGD 89
FF +
Sbjct: 83 FFEDNDF 89
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 53/217 (24%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+VLE ++ K ++ + Y+ Q+ Y+H + HRD+K NL
Sbjct: 118 VVLELCRRRSLL----ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173
Query: 277 LNPETGVLKLCDFG-SAKHLVRGE--------PNVSYICSRYYRAPELIFGAIDYTTKID 327
LN E +K+ DFG + K GE PN Y APE++ ++ ++D
Sbjct: 174 LN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPN--------YIAPEVLSKK-GHSFEVD 223
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
VWS GC++ LL+G+P F L E T +I++ E+ P
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSC----LKE--------TYLRIKK-----NEYSIP----- 261
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
P A LI ++L+ P++R + ++ +
Sbjct: 262 KH-------INPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 7/65 (10%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKN---REMQIMRRLEHSNIVKLKY 82
+G G F ++ D+ E+ A K +L + E+ I R L H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 83 FFYSS 87
FF +
Sbjct: 109 FFEDN 113
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 31/178 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-S 307
Y L + + Y+H I HRDIKP NLL+ E G +K+ DFG + + +S +
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGT 200
Query: 308 RYYRAPELIFGAI-DYT-TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT 365
+ APE + ++ +DVW+ G L + GQ F + I L
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--------IMCL---- 248
Query: 366 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR 423
+I+ +FP P D DLI+R+L+ P SRI +++
Sbjct: 249 HSKIKS-----QALEFP---DQPD-------IAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 19/81 (23%), Positives = 33/81 (40%), Gaps = 30/81 (37%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--------------------- 63
IG GS+G+V A + A+K K+++ F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 64 ----REMQIMRRLEHSNIVKL 80
+E+ I+++L+H N+VKL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL 101
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
+ +V++ + + Y H ++ F KL+I +L +L Y+ I HRD+KP
Sbjct: 90 MFMVVDLLLGGDLRY----HLQQNVH-FKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF--GAIDYTTKIDVWSA 331
N+LL+ E G + + DF A L R + ++ Y APE+ Y+ +D WS
Sbjct: 145 NILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G ELL G+ + S EI+ +P WS
Sbjct: 204 GVTAYELLRGRRPYHIRSS-TSSKEIV--------HTFETTVV-----TYPS----AWS- 244
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421
+ + L+ +LLE P R S L
Sbjct: 245 -------QEMVSLLKKLLEPNPDQRFSQLS 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 23/63 (36%), Positives = 35/63 (55%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--REMQIMRRLEHSNIVKLK 81
IG GSFG V + D+ ++ A+K K ++ +N +E+QIM+ LEH +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 82 YFF 84
Y F
Sbjct: 82 YSF 84
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/273 (21%), Positives = 95/273 (34%), Gaps = 73/273 (26%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLL 276
+V E + + K + Q P K I Q+ + L Y+H I H DIKP+N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 277 L------------------------------------------------NPETGVLKLCD 288
L N E +K+ D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 289 FGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD 348
G+A + + I +R YR+ E++ G+ Y T D+WS C+ EL G +F
Sbjct: 240 LGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 349 SG------VDQLVEIIKVLGTPTREQIREM-------NPNYTEFKFPQIKSHPWSKVFRV 395
SG D + II++LG R+ I ++K +V
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 396 R---TPPDA---IDLISRLLEYTPSSRISPLQV 422
+ + +A D + +LE P R + +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 37/187 (19%), Positives = 75/187 (40%), Gaps = 45/187 (24%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL------------- 295
Q+ ++ ++H G+ HRD+KP N+ + V+K+ DFG +
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 296 VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLV 355
+ + ++ Y +PE I G +Y+ K+D++S G +L ELL
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM------- 277
Query: 356 EIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415
E ++++ +R + KFP + + + P ++ +L +P+
Sbjct: 278 ERVRII-----TDVRNL-------KFPLLFTQKY---------PQEHMMVQDMLSPSPTE 316
Query: 416 RISPLQV 422
R +
Sbjct: 317 RPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
+G G FG+V++AK AIK++ R RE++ + +LEH IV+
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 84 FYSSGDKKDEPTNYPPLEDMKISTFS 109
+ + +K + + + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 30/222 (13%), Positives = 67/222 (30%), Gaps = 43/222 (19%)
Query: 218 LVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
LV E + + + + ++ P + ++ + +H I H DIKP N
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203
Query: 276 LLNP----------ETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDY 322
+L + L L D G + + + + ++ E++ +
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPW 262
Query: 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 382
+ID + + +L G M + G + +
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEG--------------GECKPEGLFRRL------ 302
Query: 383 QIKSHPWSKVFRV------RTPPDAIDLISRLLEYTPSSRIS 418
W++ F V ++DL+ + L+ +
Sbjct: 303 -PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 10/67 (14%), Positives = 23/67 (34%), Gaps = 9/67 (13%)
Query: 27 KTVIGNGSFGIVYQAKLLD-----SGELVAIK----KVLQDKRFKNREMQIMRRLEHSNI 77
++G G+F VY+A D + + +K + + M+ ++
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 78 VKLKYFF 84
+K
Sbjct: 130 MKFYSAH 136
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 44/174 (25%), Positives = 67/174 (38%), Gaps = 38/174 (21%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYY 310
Q+ ++ + H G+ HRDIK +N+L++ G LKL DFGS L +R Y
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGTRVY 214
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
PE I + VWS G +L +++ G F D EII+
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----------- 257
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+ F Q S + LI L PS R + ++++
Sbjct: 258 ------GQVFFRQRVS------------SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 13/64 (20%), Positives = 28/64 (43%), Gaps = 12/64 (18%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN-----REMQIMRRLEHS--N 76
++G+G FG VY + VAIK ++ N E+ +++++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 77 IVKL 80
+++L
Sbjct: 110 VIRL 113
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 48/174 (27%), Positives = 67/174 (38%), Gaps = 38/174 (21%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYY 310
Q+ ++ + H G+ HRDIK +N+L++ G KL DFGS L +R Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--DGTRVY 204
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
PE I + VWS G +L +++ G F D EI++
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---------- 248
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
E FP S PD LI R L PSSR S ++
Sbjct: 249 -------ELHFPAHVS------------PDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 14/66 (21%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN-----REMQIMRRL----EH 74
++G G FG V+ L VAIK +VL + E+ ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 75 SNIVKL 80
+++L
Sbjct: 98 PGVIRL 103
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 37/202 (18%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+++ + + SK + P + Y+ ++ ++ +H L HRDIKP
Sbjct: 149 LYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-ICSRY-YRAPELI----FGAIDYTTKID 327
N+L++ G ++L DFGS L+ S Y +PE++ G Y + D
Sbjct: 205 NILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
WS G + E+L G+ F +S + + I MN F+FP
Sbjct: 264 WWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MNHK-ERFQFPT---- 304
Query: 388 PWSKVFRVRTPPDAIDLISRLL 409
+A DLI RL+
Sbjct: 305 -----QVTDVSENAKDLIRRLI 321
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDK--RFKNREMQIMRRLEHSNIVKLK 81
VIG G+FG V KL ++ ++ A+K ++L+ E ++ + I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 82 YFF 84
Y F
Sbjct: 141 YAF 143
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 23/222 (10%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQN 274
+ + +E M K+ + + P + ++L Y+ G+ HRD+KP N
Sbjct: 99 VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI----FGAIDYTTKIDVWS 330
+LL+ E G +KLCDFG + LV + Y APE I DY + DVWS
Sbjct: 156 ILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF----------- 379
G L EL GQ + +++ + P + ++ F
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 380 --KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419
K+ ++ H + K + D ++ T S R P
Sbjct: 275 RPKYNKLLEHSFIKRYE-TLEVDVASWFKDVMAKTESPRSGP 315
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 13/69 (18%), Positives = 35/69 (50%), Gaps = 10/69 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKN--REMQI-MRRLEHSNIVKLKY 82
+G+G+ G V++ + +G ++A+K++ + K ++ + ++ + IV +
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV--QC 89
Query: 83 F--FYSSGD 89
F F ++ D
Sbjct: 90 FGTFITNTD 98
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 26/229 (11%)
Query: 216 LNLVLEFMP---ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIK 271
+ +E M + YK YS P ++L ++ L I HRDIK
Sbjct: 96 CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 272 PQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID---YTTKIDV 328
P N+LL+ +G +KLCDFG + LV R Y APE I + Y + DV
Sbjct: 154 PSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEF------- 379
WS G L EL G+ +P + V + + P E P++ F
Sbjct: 213 WSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTK 272
Query: 380 ------KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
K+ ++ HP+ ++ + + ++L+ P++ SP+ V
Sbjct: 273 DESKRPKYKELLKHPFILMYE-ERAVEVACYVCKILDQMPATPSSPMYV 320
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 20/92 (21%), Positives = 44/92 (47%), Gaps = 11/92 (11%)
Query: 6 GELGFAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFK 62
G+L + + ++ L IG G++G V + SG+++A+K++ + +K K
Sbjct: 7 GKLKISPEQHWDFTAED-LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
Query: 63 N--REMQI-MRRLEHSNIVKLKYF--FYSSGD 89
++ + MR + IV +++ + GD
Sbjct: 66 QLLMDLDVVMRSSDCPYIV--QFYGALFREGD 95
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 7e-22
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 37/207 (17%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCF---YTKLYIYQLFRSLAYIHVLGICHRDI 270
L LV+ M + Y H ++ P F Y Q+ L ++H I +RD+
Sbjct: 260 LCLVMTIMNGGDIRY----HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 271 KPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVW 329
KP+N+LL+ + G +++ D G A L G+ + + APEL+ G +Y +D +
Sbjct: 316 KPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYF 373
Query: 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389
+ G L E++ + F + E+ +++ E +P S
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAV-----TYPDKFS--- 417
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSR 416
P + D LL+ P R
Sbjct: 418 ---------PASKDFCEALLQKDPEKR 435
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR--------EMQIMRRLEHSNIVKL 80
V+G G FG V+ ++ +G+L A K L KR K R E +I+ ++ IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 81 KYFF 84
Y F
Sbjct: 251 AYAF 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 1e-21
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 35/203 (17%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L+ +L+ M + Y +++H F + Y ++ L ++H + +RD+KP
Sbjct: 267 LSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 321
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
N+LL+ E G +++ D G A + +P+ + + + Y APE++ + Y + D +S GC
Sbjct: 322 NILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
+L +LL G F D+ EI M + P S
Sbjct: 380 MLFKLLRGHSPFRQHKTKDK-HEID--------RMTLTMAV-----ELPDSFS------- 418
Query: 394 RVRTPPDAIDLISRLLEYTPSSR 416
P+ L+ LL+ + R
Sbjct: 419 -----PELRSLLEGLLQRDVNRR 436
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 12/67 (17%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR--------EMQIMRRLEHSN---I 77
+IG G FG VY + D+G++ A+ K L KR K + E ++ + + I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 78 VKLKYFF 84
V + Y F
Sbjct: 255 VCMSYAF 261
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 53/217 (24%), Positives = 81/217 (37%), Gaps = 52/217 (23%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L LV+E+ + + SK + P + Y+ ++ ++ +H LG HRDIKP
Sbjct: 136 LYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVS--------YICSRYYRAPELI------FGA 319
N+LL+ G ++L DFGS L S Y+ +PE++ G
Sbjct: 192 NILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL------SPEILQAVGGGPGT 244
Query: 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 379
Y + D W+ G E+ GQ F DS + I ++
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI-------------VHYK-EHL 289
Query: 380 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
P P +A D I RLL P +R
Sbjct: 290 SLPL---------VDEGVPEEARDFIQRLLC-PPETR 316
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 15/63 (23%), Positives = 28/63 (44%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKK-----VLQDKR--FKNREMQIMRRLEHSNIVKLK 81
VIG G+F V K+ +G++ A+K +L+ E ++ + I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 82 YFF 84
+ F
Sbjct: 128 FAF 130
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 34/204 (16%)
Query: 216 LNLVLEFMP--ETVYKVAKH-YSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
L LVL M + + H Y + FP Y ++ L +H I +RD+KP
Sbjct: 259 LCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
+N+LL+ G +++ D G A H+ G+ + + Y APE++ YT D W+ G
Sbjct: 315 ENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALG 372
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
C+L E++ GQ F + E+ ++E+ Y+E
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVE--------RLVKEVPEEYSER------------- 411
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
P A L S+LL P+ R
Sbjct: 412 ----FSPQARSLCSQLLCKDPAER 431
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR--------EMQIMRRLEHSNIVKL 80
V+G G FG V ++ +G++ A K L+ KR K R E QI+ ++ +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 81 KYFF 84
Y +
Sbjct: 250 AYAY 253
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 38/206 (18%), Positives = 69/206 (33%), Gaps = 36/206 (17%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG--ICHRDIKP 272
+ LV E M T+ K + + + Q+ + L ++H I HRD+K
Sbjct: 104 IVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
N+ + TG +K+ D G A R + I + + APE+ Y +DV++ G
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFG 216
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+ E+ + + Q+ + G P
Sbjct: 217 MCMLEMATSEYPYSECQNAAQIYRRV-TSGVK-----------------PASFDKVAI-- 256
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRIS 418
P+ ++I + R S
Sbjct: 257 ------PEVKEIIEGCIRQNKDERYS 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 6/70 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG GSF VY+ ++ VA ++ K K+ E ++++ L+H NIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 83 FFYSSGDKKD 92
+ S+ K
Sbjct: 93 SWESTVKGKK 102
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 53/187 (28%), Positives = 72/187 (38%), Gaps = 50/187 (26%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAKHLVR---------- 297
Y QL L Y+H GI H+DIKP NLLL G LK+ G +
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 298 GEPNVSYICSRYYRAPELIFGAIDYT-TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVE 356
G P ++ PE+ G ++ K+D+WSAG L + G F GD+
Sbjct: 173 GSPA--------FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------- 217
Query: 357 IIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
I L E I + + P P DL+ +LEY P+ R
Sbjct: 218 -IYKL----FENIGK-----GSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKR 255
Query: 417 ISPLQVR 423
S Q+R
Sbjct: 256 FSIRQIR 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 16/60 (26%), Positives = 33/60 (55%), Gaps = 8/60 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN---REMQIMRRLEHSNIVKL 80
++G GS+G V + ++ A+K K+ + + +E+Q++RRL H N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 26/178 (14%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
+ QL ++Y H + ICHRD+K +N LL LK+CDFG +K V S + +
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180
Query: 308 RYYRAPELIFGAIDYT-TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR 366
Y APE++ +Y DVWS G L +L+G F T
Sbjct: 181 PAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTI 231
Query: 367 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
++I + ++ P +R P+ LISR+ P++RIS ++++
Sbjct: 232 QRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 5/56 (8%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKNREMQIMRRLEHSNIVKLK 81
IG+G+FG+ + + ELVA+K D+ + RE+ R L H NIV+ K
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFK 82
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 49/211 (23%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L L + E + + K F T+ Y ++ +L Y+H GI HRD+KP+
Sbjct: 105 LYFGLSYAKNGELLK----YIRKIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 159
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-------YRAPELIFGAIDYTTKI 326
N+LLN + +++ DFG+AK L S Y +PEL+
Sbjct: 160 NILLNED-MHIQITDFGTAKVL----SPESKQARANSFVGTAQYVSPELLTEK-SACKSS 213
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386
D+W+ GC++ +L+ G P F + + + I E+ FP+
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------------KLEYDFPE--- 253
Query: 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
+ P A DL+ +LL + R+
Sbjct: 254 ---------KFFPKARDLVEKLLVLDATKRL 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 20/63 (31%), Positives = 32/63 (50%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
++G GSF V A+ L + AIK ++++ + RE +M RL+H VKL
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 82 YFF 84
+ F
Sbjct: 97 FTF 99
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 17/163 (10%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
Q+ ++ Y H I HRD+K +NLLL+ +K+ DFG + G ++ + Y
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV--------LGT 363
APEL G ++DVWS G +L L+ G F G + + +L E + + T
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKYRIPFYMST 239
Query: 364 PTREQIREM---NPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403
++ NP QI W D +
Sbjct: 240 DCENLLKRFLVLNPI-KRGTLEQIMKDRW---INAGHEEDELK 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 7/61 (11%)
Query: 26 QKTVIGNGSFGIVYQAKLLDSGELVAIK----KVLQDKRFKN--REMQIMRRLEHSNIVK 79
KT IG G+F V A+ + +G VAIK L + RE++IM+ L H NIVK
Sbjct: 20 LKT-IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 80 L 80
L
Sbjct: 79 L 79
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 46/187 (24%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG--------SAKHLVR--- 297
+ +QL + Y+H +GI HRDIKP+NLLL+ E LK+ DFG + + L+
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 298 GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEI 357
G Y APEL+ + +DVWS G VL +L G+ + DQ +
Sbjct: 169 GTLP--------YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDS 214
Query: 358 IKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
+ + + + PW K+ + L+ ++L PS+RI
Sbjct: 215 CQEY----SDWKEK------KTYLN-----PWKKI-----DSAPLALLHKILVENPSARI 254
Query: 418 SPLQVRS 424
+ ++
Sbjct: 255 TIPDIKK 261
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 5/57 (8%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLK 81
+G G++G V A + E VA+K V + +E+ I + L H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 32/180 (17%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV--SYIC 306
+ +QL + Y+H +GI HRDIKP+NLLL+ E LK+ DFG A + +C
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 307 -SRYYRAPELIFGAIDYT-TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTP 364
+ Y APEL+ ++ +DVWS G VL +L G+ + DQ + +
Sbjct: 169 GTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEY--- 218
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+ + + PW K+ + L+ ++L PS+RI+ ++
Sbjct: 219 -SDWKEK------KTYLN-----PWKKI-----DSAPLALLHKILVENPSARITIPDIKK 261
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 5/57 (8%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLK 81
+G G++G V A + E VA+K V + +E+ I + L H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 36/206 (17%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L+L+L+++ E H S+ ++ F ++Y+ ++ +L ++H LGI +RDIK +
Sbjct: 134 LHLILDYINGGELFT----HLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSY-IC-SRYYRAPELIFGAID-YTTKIDVWS 330
N+LL+ G + L DFG +K V E +Y C + Y AP+++ G + +D WS
Sbjct: 189 NILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G ++ ELL G F D + EI +I + P +PQ S
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEIS--------RRILKSEP-----PYPQEMS---- 290
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSR 416
A DLI RLL P R
Sbjct: 291 --------ALAKDLIQRLLMKDPKKR 308
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L L+L+F+ + SK F K Y+ +L +L ++H LGI +RD+KP+
Sbjct: 101 LYLILDFLRGGDLFT----RLSKEVM-FTEEDVKFYLAELALALDHLHSLGIIYRDLKPE 155
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ E G +KL DFG +K + E C + Y APE++ +T D WS G
Sbjct: 156 NILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFG 213
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ E+L G F G + + +I + PQ S
Sbjct: 214 VLMFEMLTGTLPFQGKD-RKETMTMIL----------------KAKLGMPQFLS------ 250
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
P+A L+ L + P++R
Sbjct: 251 ------PEAQSLLRMLFKRNPANR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 11/66 (16%)
Query: 29 VIGNGSFGIVYQAKLL---DSGELVAIKKVLQDKRFKNR-------EMQIMRRLEHSNIV 78
V+G GSFG V+ K + D+ +L A+ KVL+ K R E I+ + H IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAM-KVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 79 KLKYFF 84
KL Y F
Sbjct: 90 KLHYAF 95
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E+ E + H S+ + F + Y ++ +L Y+H + +RDIK +
Sbjct: 80 LCFVMEYANGGELFF----HLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
NL+L+ + G +K+ DFG K + + C Y APE++ DY +D W G
Sbjct: 135 NLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLG 192
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
V+ E++ G+ F ++L E+I E +FP+ S
Sbjct: 193 VVMYEMMCGRLPFYNQD-HERLFELIL----------------MEEIRFPRTLS------ 229
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
P+A L++ LL+ P R
Sbjct: 230 ------PEAKSLLAGLLKKDPKQR 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 14/63 (22%), Positives = 28/63 (44%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--REMQIMRRLEHSNIVKLK 81
++G G+FG V + +G A+K ++ + E ++++ H + LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 82 YFF 84
Y F
Sbjct: 72 YAF 74
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L L+LE++ E + F Y+ ++ +L ++H GI +RD+KP+
Sbjct: 96 LYLILEYLSGGELFM----QLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPE 150
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
N++LN + G +KL DFG K + C Y APE++ + + +D WS G
Sbjct: 151 NIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLG 208
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ ++L G P F G++ + ++ I + P +
Sbjct: 209 ALMYDMLTGAPPFTGEN-RKKTIDKIL----------------KCKLNLPPYLT------ 245
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
+A DL+ +LL+ +SR
Sbjct: 246 ------QEARDLLKKLLKRNAASR 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-S 307
Y+ ++ +L+Y+H +G+ + D+KP+N++L E + KL D G+ + Y+ +
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QL-KLIDLGAVSRINS----FGYLYGT 240
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS 349
++APE++ T D+++ G LA L L P G
Sbjct: 241 PGFQAPEIVRTGPTVAT--DIYTVGRTLAALTLDLPTRNGRY 280
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 13/78 (16%)
Query: 29 VIGNGSFGIVYQAK--LLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVK 79
I +G G +Y A ++ G V +K L E Q + + H +IV+
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQ 143
Query: 80 LKYFFYSSGDKKDEPTNY 97
+ + F D+ +P Y
Sbjct: 144 I-FNFVEHTDRHGDPVGY 160
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 38/174 (21%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYY 310
QL ++ Y+ + I HRDIK +N+++ E +KL DFGSA +L RG+ C + Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKL-FYTFCGTIEY 195
Query: 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIR 370
APE++ G ++++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE----------- 238
Query: 371 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
P + S + + L+S LL+ P R + ++ +
Sbjct: 239 ------AAIHPPYLVS------------KELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 22/72 (30%), Positives = 39/72 (54%), Gaps = 12/72 (16%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN-------REMQIMRRLEHSNI 77
+G+G+FG V+ A + + V +K KVL+D ++ E+ I+ R+EH+NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 78 VKLKYFFYSSGD 89
+K+ F + G
Sbjct: 92 IKVLDIFENQGF 103
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E++ + +Y H + F Y ++ L ++H GI +RD+K
Sbjct: 93 LFFVMEYLNGGDLMY----HIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ + G +K+ DFG K + G+ + C Y APE++ G Y +D WS G
Sbjct: 148 NILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFG 205
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E+L+GQ F G ++L I+ +P+
Sbjct: 206 VLLYEMLIGQSPFHGQD-EEELFHSIR----------------MDNPFYPRWLE------ 242
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
+A DL+ +L P R
Sbjct: 243 ------KEAKDLLVKLFVREPEKR 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 51/208 (24%)
Query: 215 FLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
+L +V+E+MP + V + S + P + + Y ++ +L IH +G HRD+KP
Sbjct: 143 YLYMVMEYMPGGDLVNLM------SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVS--------YICSRYYRAPELIF---GAID 321
N+LL+ ++G LKL DFG+ + + YI +PE++ G
Sbjct: 197 DNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGY 249
Query: 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 381
Y + D WS G L E+L+G F DS V T +I MN F
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYSKI--MNHK-NSLTF 294
Query: 382 PQIKSHPWSKVFRVRTPPDAIDLISRLL 409
P +A +LI L
Sbjct: 295 P---DDND-------ISKEAKNLICAFL 312
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDK--RFKNREMQIMRRLEHSNIVKLK 81
VIG G+FG V + + ++ A+K ++++ F E IM +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 82 YFF 84
Y F
Sbjct: 136 YAF 138
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-19
Identities = 45/184 (24%), Positives = 71/184 (38%), Gaps = 46/184 (25%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFG-SAK----HLVR---GEP 300
Q+ ++ Y H + HRD+KP+N+LL+ K+ DFG S +R G P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSP 174
Query: 301 NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV 360
N Y APE+I G + ++D+WS G +L LL G F + +
Sbjct: 175 N--------YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPT 218
Query: 361 LGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 420
L ++IR F P + L+ +L+ P R +
Sbjct: 219 L----FKKIRG-----GVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIK 257
Query: 421 QVRS 424
+R
Sbjct: 258 DIRE 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 18/62 (29%), Positives = 33/62 (53%), Gaps = 10/62 (16%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIV 78
T +G G+FG V + +G VA+ K+L ++ ++ RE+Q ++ H +I+
Sbjct: 17 DT-LGVGTFGKVKIGEHQLTGHKVAV-KILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 79 KL 80
KL
Sbjct: 75 KL 76
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-S 307
+ Q+ ++ Y H I HRD+KP+NLLL+ + +K+ DFG + + G + C S
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNF-LKTSCGS 170
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
Y APE+I G + ++DVWS G VL +L+G+ F + + L + +
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR 423
+ P + P A LI R++ P RI+ ++R
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 10/62 (16%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIV 78
+T +G GSFG V A + + VA+ K + + K RE+ ++ L H +I+
Sbjct: 15 ET-LGEGSFGKVKLATHYKTQQKVAL-KFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 79 KL 80
KL
Sbjct: 73 KL 74
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 40/205 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKP 272
L V+E+ E + H S+ + F + Y ++ +L Y+H + +RD+K
Sbjct: 223 LCFVMEYANGGELFF----HLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSA 331
+NL+L+ + G +K+ DFG K ++ + C + Y APE++ DY +D W
Sbjct: 278 ENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGL 335
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G V+ E++ G+ F ++L E+I E +FP+
Sbjct: 336 GVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFPRTLG----- 373
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSR 416
P+A L+S LL+ P R
Sbjct: 374 -------PEAKSLLSGLLKKDPKQR 391
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 9/64 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR--------EMQIMRRLEHSNIVKL 80
++G G+FG V K +G A+ K+L+ + + E ++++ H + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAM-KILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 81 KYFF 84
KY F
Sbjct: 214 KYSF 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+EF+ + ++ H KS++ F + Y ++ +L ++H GI +RD+K
Sbjct: 99 LFFVMEFVNGGDLMF----HIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ E G KL DFG K + + C Y APE++ Y +D W+ G
Sbjct: 154 NVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMG 211
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E+L G F ++ D L E I E +P
Sbjct: 212 VLLYEMLCGHAPFEAEN-EDDLFEAIL----------------NDEVVYPTWLH------ 248
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
DA ++ + P+ R
Sbjct: 249 ------EDATGILKSFMTKNPTMR 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 52/211 (24%)
Query: 215 FLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
L +V+E++ E H + + F + + Y Q+ + Y+H L + +RD+KP
Sbjct: 115 NLYMVMEYVAGGEMFS----HLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVR------GEPNVSYICSRYYRAPELIFGAIDYTTKI 326
+NLL++ + G +++ DFG AK + G P APE+I Y +
Sbjct: 170 ENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLCGTPE--------ALAPEIILSK-GYNKAV 219
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386
D W+ G ++ E+ G P F D Q+ E I + +FP S
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SGKVRFPSHFS 262
Query: 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417
D DL+ LL+ + R
Sbjct: 263 ------------SDLKDLLRNLLQVDLTKRF 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
+G GSFG V K +SG A+K KV++ K+ + E +I++ + +VKL+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 82 YFF 84
+ F
Sbjct: 108 FSF 110
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E++ + +Y H + + F + Y ++ L ++ GI +RD+K
Sbjct: 96 LYFVMEYVNGGDLMY----HIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
N++L+ E G +K+ DFG K + C Y APE+I Y +D W+ G
Sbjct: 151 NVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFG 208
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E+L GQ F G+ D+L + I +P+ S
Sbjct: 209 VLLYEMLAGQAPFEGED-EDELFQSIM----------------EHNVAYPKSMS------ 245
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
+A+ + L+ P R
Sbjct: 246 ------KEAVAICKGLMTKHPGKR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 18/66 (27%), Positives = 29/66 (43%), Gaps = 12/66 (18%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKNREMQIMRR-LEHSN----IV 78
V+G GSFG V ++ + EL A+K V+QD + + +R L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC--TMVEKRVLALPGKPPFLT 84
Query: 79 KLKYFF 84
+L F
Sbjct: 85 QLHSCF 90
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E++ + +Y H + + F + Y ++ L ++ GI +RD+K
Sbjct: 417 LYFVMEYVNGGDLMY----HIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
N++L+ E G +K+ DFG K + C + Y APE+I Y +D W+ G
Sbjct: 472 NVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFG 529
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E+L GQ F G+ D+L + I +P+ S
Sbjct: 530 VLLYEMLAGQAPFEGED-EDELFQSIM----------------EHNVAYPKSMS------ 566
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
+A+ + L+ P R
Sbjct: 567 ------KEAVAICKGLMTKHPGKR 584
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L VL+++ E Y H + + F + Y ++ +L Y+H L I +RD+KP+
Sbjct: 114 LYFVLDYINGGELFY----HLQRERC-FLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 168
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-YRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ + G + L DFG K + S C Y APE++ Y +D W G
Sbjct: 169 NILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLG 226
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
VL E+L G P F + ++ + I + +
Sbjct: 227 AVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NKPLQLKPNIT------ 263
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
A L+ LL+ + R
Sbjct: 264 ------NSARHLLEGLLQKDRTKR 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 8/64 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFKN--REMQIM-RRLEHSNIVKL 80
VIG GSFG V A+ A+K +L+ K K+ E ++ + ++H +V L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 81 KYFF 84
+ F
Sbjct: 105 HFSF 108
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYI 305
+ Q+ +L H G HRD+KP+N+L++ L DFG A + + + +
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTV 196
Query: 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS 349
+ YY APE + T + D+++ CVL E L G P + GD
Sbjct: 197 GTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 35/206 (16%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNL 275
+V ++ ++Y H S++K + I Q R + Y+H I HRD+K N+
Sbjct: 96 IVTQWCEGSSLYHHL-HASETKFEMK---KLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAID--YTTKIDVWS 330
L+ E +K+ DFG A R + + S + APE+I Y+ + DV++
Sbjct: 152 FLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G VL EL+ GQ + + DQ II+++G + +
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSKVRSN-------------- 253
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSR 416
P L++ L+ R
Sbjct: 254 ------CPKRMKRLMAECLKKKRDER 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 11/66 (16%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEH 74
+ IG+GSFG VY+ K G+ VA+K + + FK E+ ++R+ H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRH 79
Query: 75 SNIVKL 80
NI+
Sbjct: 80 VNILLF 85
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E++ + ++ H + ++ P + + Y ++ +L Y+H GI +RD+K
Sbjct: 85 LFFVIEYVNGGDLMF----HMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ E G +KL D+G K +R S C + Y APE++ G DY +D W+ G
Sbjct: 140 NVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALG 197
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ E++ G+ F D P + + F I
Sbjct: 198 VLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYL--------FQVILEKQ--IR 237
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
A ++ L P R
Sbjct: 238 IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 10/65 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNRE----MQIMRR-LEHSN----IVK 79
VIG GS+ V +L + + A+ KV++ + + E +Q + E ++ +V
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAM-KVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 80 LKYFF 84
L F
Sbjct: 75 LHSCF 79
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---- 304
I ++L + H GI HRD+KP N++++ +K+ DFG A+ + +V+
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
I + Y +PE G + DV+S GCVL E+L G+P F GDS V
Sbjct: 180 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIH---VLGICHRDIKP 272
LV+E+ ++Y V H ++ + + Q + +AY+H + HRD+KP
Sbjct: 76 LVMEYAEGGSLYNVL-HGAEPLPYYT-AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
NLLL VLK+CDFG+A + S + APE+ G+ +Y+ K DV+S G
Sbjct: 134 PNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWG 190
Query: 333 CVLAELLLGQPMFPGDSGVDQLVE 356
+L E++ + F G +
Sbjct: 191 IILWEVITRRKPFDEIGGPAFRIM 214
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVK 79
+ + V+G G+FG+V +AK + VAIK++ + K E++ + R+ H NIVK
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 80 L 80
L
Sbjct: 66 L 66
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 52/210 (24%)
Query: 215 FLNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
+ ++++++ E KS++ FP K Y ++ +L Y+H I +RD+KP
Sbjct: 80 QIFMIMDYIEGGELFS----LLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVR------GEPNVSYICSRYYRAPELIFGAIDYTTKI 326
+N+LL+ G +K+ DFG AK++ G P+ Y APE++ Y I
Sbjct: 135 ENILLDKN-GHIKITDFGFAKYVPDVTYTLCGTPD--------YIAPEVVSTK-PYNKSI 184
Query: 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386
D WS G ++ E+L G F + + E I E +FP +
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------------NAELRFPPFFN 227
Query: 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
D DL+SRL+ S R
Sbjct: 228 ------------EDVKDLLSRLITRDLSQR 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 7/63 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIK-----KVLQDKRFK--NREMQIMRRLEHSNIVKLK 81
+G GSFG V+ + +G A+K V++ K+ + N E ++ + H I+++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 82 YFF 84
F
Sbjct: 73 GTF 75
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 216 LNLVLEFMP--ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L V+E++ + ++ H + ++ P + + Y ++ +L Y+H GI +RD+K
Sbjct: 128 LFFVIEYVNGGDLMF----HMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAG 332
N+LL+ E G +KL D+G K +R S C + Y APE++ G DY +D W+ G
Sbjct: 183 NVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALG 240
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ E++ G+ F D P + + F I
Sbjct: 241 VLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYL--------FQVILEKQ--IR 280
Query: 393 FRVRTPPDAIDLISRLLEYTPSSR 416
A ++ L P R
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKER 304
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 15/65 (23%), Positives = 30/65 (46%), Gaps = 10/65 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNRE----MQIMRR-LEHSN----IVK 79
VIG GS+ V +L + + A+ +V++ + + E +Q + E ++ +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAM-RVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 80 LKYFF 84
L F
Sbjct: 118 LHSCF 122
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 32/176 (18%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-S 307
Q+ + Y H + HRD+KP+N+LL+ K+ DFG + + GE + C S
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEF-LRTSCGS 178
Query: 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE 367
Y APE+I G + ++D+WS+G +L LL G F D + L +
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTL----FK 226
Query: 368 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR 423
+I + F P + P I L+ +L+ P R + +R
Sbjct: 227 KICD-----GIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIR 265
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 10/62 (16%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------REMQIMRRLEHSNIV 78
T +G G+FG V K +G VA+ K+L ++ ++ RE+Q ++ H +I+
Sbjct: 22 DT-LGVGTFGKVKVGKHELTGHKVAV-KILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 79 KL 80
KL
Sbjct: 80 KL 81
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 37/107 (34%), Positives = 59/107 (55%), Gaps = 8/107 (7%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY---- 304
+ Q+ + + H + I HRDIKPQN+L++ LK+ DFG AK L E +++
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKAL--SETSLTQTNHV 172
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV 351
+ + Y +PE G D++S G VL E+L+G+P F G++ V
Sbjct: 173 LGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 44/175 (25%), Positives = 66/175 (37%), Gaps = 39/175 (22%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSR 308
+ + L Y+H + HRDIK N+LLN G KL DFG A L + I +
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP----MFPGDSGVDQLVEIIKVLGTP 364
++ APE+I Y D+WS G E+ G+P + P ++ +
Sbjct: 190 FWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAI--- 234
Query: 365 TREQIREMNPNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
I P P + WS F D + + L +P R +
Sbjct: 235 --FMIPTNPP-------PTFRKPELWSDNFT--------DFVKQCLVKSPEQRAT 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 21/66 (31%), Positives = 40/66 (60%), Gaps = 6/66 (9%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFYSS 87
+G GS+G VY+A ++G++VAIK+V + + +E+ IM++ + ++VK +Y S
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVK----YYGS 92
Query: 88 GDKKDE 93
K +
Sbjct: 93 YFKNTD 98
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 34/135 (25%), Positives = 67/135 (49%), Gaps = 9/135 (6%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLG--ICHRDIKPQ 273
+V E++ ++Y++ H S +++ +L + Y + + + Y+H I HR++K
Sbjct: 111 IVTEYLSRGSLYRLL-HKSGAREQLD-ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
NLL++ + +K+CDFG ++ + S + + APE++ K DV+S G
Sbjct: 169 NLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFG 226
Query: 333 CVLAELLLGQPMFPG 347
+L EL Q +
Sbjct: 227 VILWELATLQQPWGN 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 10/66 (15%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEH 74
L K IG GSFG V++A+ G VA+K +++ F RE+ IM+RL H
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRH 93
Query: 75 SNIVKL 80
NIV
Sbjct: 94 PNIVLF 99
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 52/178 (29%), Positives = 73/178 (41%), Gaps = 42/178 (23%)
Query: 249 YI-YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYIC 306
YI ++ R L+++H + HRDIK QN+LL E +KL DFG + L R ++I
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 307 SRYYRAPELI----FGAIDYTTKIDVWSAGCVLAELLLGQP----MFPGDSGVDQLVEII 358
+ Y+ APE+I Y K D+WS G E+ G P M P +
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------M 240
Query: 359 KVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
+ L I P++KS WSK F+ I L S R
Sbjct: 241 RAL-----FLIPRNPA-------PRLKSKKWSKKFQ--------SFIESCLVKNHSQR 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 20/76 (26%), Positives = 41/76 (53%), Gaps = 8/76 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKNREMQIMRRL-EHSNIVKLKYFF 84
++GNG++G VY+ + + +G+L AIK + ++ +E+ ++++ H NI +
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT----Y 86
Query: 85 YSSGDKKDEPTNYPPL 100
Y + KK+ P L
Sbjct: 87 YGAFIKKNPPGMDDQL 102
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 39/174 (22%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRY 309
+ ++LAY+H G+ HRDIK ++LL G +KL DFG + + P S + + Y
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP----MFPGDSGVDQLVEIIKVLGTPT 365
+ APE+I + Y T++D+WS G ++ E++ G+P P ++ +
Sbjct: 207 WMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAM---- 250
Query: 366 REQIREMNPNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
+++R+ P P++K SH S V R D + R+L P R +
Sbjct: 251 -KRLRDSPP-------PKLKNSHKVSPVLR--------DFLERMLVRDPQERAT 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 8/68 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSNIVKLKYFFY 85
IG GS GIV A+ SG VA+K + Q + E+ IMR +H N+V+ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE----MY 108
Query: 86 SSGDKKDE 93
S +E
Sbjct: 109 KSYLVGEE 116
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 39/174 (22%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-VSYICSRY 309
+ ++L ++H + HRDIK N+LL G +KL DFG + + + + + Y
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP----MFPGDSGVDQLVEIIKVLGTPT 365
+ APE++ Y K+D+WS G + E++ G+P P ++ L
Sbjct: 182 WMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRAL---- 225
Query: 366 REQIREMNPNYTEFKFPQIKS-HPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
I P++++ S +FR D ++R LE R S
Sbjct: 226 -YLIATNGT-------PELQNPEKLSAIFR--------DFLNRCLEMDVEKRGS 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 21/68 (30%), Positives = 33/68 (48%), Gaps = 8/68 (11%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSNIVKLKYFFY 85
IG G+ G VY A + +G+ VAI+++ K E+ +MR ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN----YL 83
Query: 86 SSGDKKDE 93
S DE
Sbjct: 84 DSYLVGDE 91
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 41/175 (23%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY 309
+ + LAY+H + HRD+K N+LL+ E G++KL DFGSA + S++ + Y
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPY 215
Query: 310 YRAPELIFGA--IDYTTKIDVWSAGCVLAELLLGQP----MFPGDSGVDQLVEIIKVLGT 363
+ APE+I Y K+DVWS G EL +P M + L
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSAL-- 262
Query: 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS 418
I + P ++S WS+ FR + + L+ P R +
Sbjct: 263 ---YHIAQNES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPT 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 20/58 (34%), Positives = 35/58 (60%), Gaps = 7/58 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVK 79
IG+GSFG VY A+ + + E+VAIKK+ + N +E++ +++L H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSR 308
+ ++ + L Y+H HRDIK N+LL+ E G +KL DFG A L +++ +
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTP 183
Query: 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
++ APE+I + Y +K D+WS G EL G+P
Sbjct: 184 FWMAPEVIKQS-AYDSKADIWSLGITAIELARGEP 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 13/56 (23%), Positives = 28/56 (50%), Gaps = 5/56 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
IG GSFG V++ + ++VAIK + ++ +E+ ++ + + + K
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 32/143 (22%), Positives = 55/143 (38%), Gaps = 19/143 (13%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLG--ICHRDIK 271
+V+EF+P +Y + KL + + + Y+ I HRD++
Sbjct: 96 PRMVMEFVPCGDLYHR---LLDKAHPIK-WSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151
Query: 272 PQNLLLN----PETGVLKLCDFGSAKHLVRGEPNVSY--ICSRYYRAPELIFGAID-YTT 324
N+ L K+ DFG L + + + + + APE I + YT
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 325 KIDVWSAGCVLAELLLGQPMFPG 347
K D +S +L +L G+ F
Sbjct: 208 KADTYSFAMILYTILTGEGPFDE 230
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 13/71 (18%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------------KRFKNREMQIM 69
N + + IG G FG+V++ +L+ +VAIK ++ + F+ RE+ IM
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIM 77
Query: 70 RRLEHSNIVKL 80
L H NIVKL
Sbjct: 78 SNLNHPNIVKL 88
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 33/211 (15%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI----YQLFRSLAYIHVLGICHRDIKP 272
LV++ + +V + KH ++ + I ++ L Y+H G HRD+K
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR-------YYRAPELIFGAIDYTTK 325
N+LL E G +++ DFG + L G +++ R + APE++ Y K
Sbjct: 150 GNILLG-EDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK 207
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385
D+WS G EL G + + L+ ++ P+ E + +
Sbjct: 208 ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPPSLETGVQDKEMLKK------- 259
Query: 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
+ K FR +IS L+ P R
Sbjct: 260 ---YGKSFR--------KMISLCLQKDPEKR 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 19/56 (33%), Positives = 29/56 (51%), Gaps = 5/56 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
VIG+G+ +V A E VAIK++ +K + +E+Q M + H NIV
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSR 308
Q+ +L ++H I HRD+K N+L+ G ++L DFG + ++ + S+I +
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 309 YYRAPELIFGA----IDYTTKIDVWSAGCVLAELLLGQP 343
Y+ APE++ Y K D+WS G L E+ +P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 19/57 (33%), Positives = 32/57 (56%), Gaps = 4/57 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSNIVKLK 81
+G+G+FG VY+AK ++G L A K + ++ E++I+ +H IVKL
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 30/188 (15%)
Query: 255 RSLAYIH----------VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304
R LAY+H I HRDIK +N+LL + DFG A ++ E S
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLA---LKFEAGKSA 187
Query: 305 ICSRY------YRAPELIFGAI----DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQL 354
+ Y APE++ GAI D +ID+++ G VL EL G L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 355 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414
++ P+ E ++E+ + + K P ++ + W K + + I ++
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVH--KKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAE 301
Query: 415 SRISPLQV 422
+R+S V
Sbjct: 302 ARLSAGCV 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 5/62 (8%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVL-QDKR-FKN-REMQIMRRLEHSNIV 78
L V G FG V++A+L E VA+K QDK+ ++N E+ + ++H NI+
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 79 KL 80
+
Sbjct: 82 QF 83
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 30/142 (21%), Positives = 58/142 (40%), Gaps = 27/142 (19%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVL--------GICH 267
L+ + ++Y + + + L I + LA++H+ I H
Sbjct: 83 LITHYHEMGSLYDYLQLTTLD------TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 268 RDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS-----RYYRAPELIFGAI-- 320
RD+K +N+L+ + G + D G A + + + + Y APE++ I
Sbjct: 137 RDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 321 ---DYTTKIDVWSAGCVLAELL 339
D ++D+W+ G VL E+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVA 217
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 18/72 (25%), Positives = 30/72 (41%), Gaps = 8/72 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-QDKR-FKN-REMQIMRRLEHSNIVKLKYFFY 85
+G G +G V++ GE VA+K +D++ + E+ L H NI+ F
Sbjct: 15 CVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG---FIA 69
Query: 86 SSGDKKDEPTNY 97
S + T
Sbjct: 70 SDMTSRHSSTQL 81
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 19/103 (18%)
Query: 255 RSLAYIHVL--------GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
L ++H I HRD+K +N+L+ + G + D G A + V
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 307 S-----RYYRAPELIFGAI-----DYTTKIDVWSAGCVLAELL 339
+ + Y PE++ ++ D++S G +L E+
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 17/72 (23%), Positives = 27/72 (37%), Gaps = 8/72 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-QDKR-FKN-REMQIMRRLEHSNIVKLKYFFY 85
IG G +G V+ K GE VA+K ++ + E+ + H NI+ F
Sbjct: 44 QIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG---FIA 98
Query: 86 SSGDKKDEPTNY 97
+ T
Sbjct: 99 ADIKGTGSWTQL 110
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 23/149 (15%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQ 273
LN + E++ T+ + K +P + ++ + +AY+H + I HRD+
Sbjct: 82 LNFITEYIKGGTLRGIIK---SMDSQYP-WSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 274 NLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR---------------YYRAPELIFG 318
N L+ E + + DFG A+ +V + + S Y+ APE+I G
Sbjct: 138 NCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196
Query: 319 AIDYTTKIDVWSAGCVLAELLLGQPMFPG 347
Y K+DV+S G VL E++ P
Sbjct: 197 R-SYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 17/63 (26%), Positives = 38/63 (60%), Gaps = 4/63 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKN--REMQIMRRLEHSNI 77
+ L V+G G FG + ++GE++ +K++++ ++ + +E+++MR LEH N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 78 VKL 80
+K
Sbjct: 70 LKF 72
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 10/103 (9%)
Query: 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA--------KHLVRGEPN 301
+ + ++L YIH +G HR +K ++L++ G + L S + V +
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 302 VSYICSRYYRAPELIF-GAIDYTTKIDVWSAGCVLAELLLGQP 343
+ + +PE++ Y K D++S G EL G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 8/59 (13%)
Query: 29 VIGNG--SFGIVYQAKLLDSGELVAIKKV----LQDKRFKN--REMQIMRRLEHSNIVK 79
VIG G V A+ +GE V ++++ ++ E+ + + H NIV
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 255 RSLAYIHVLG---ICHRDIKPQNLLLN-------PETGVLKLCDFGSAKHLVRGEPNVSY 304
R + Y+H I HRD+K N+L+ +LK+ DFG A+ R +S
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSA 174
Query: 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPG 347
+ + APE+I + ++ DVWS G +L ELL G+ F G
Sbjct: 175 AGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 20/69 (28%), Positives = 34/69 (49%), Gaps = 12/69 (17%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRL 72
L + +IG G FG VY+A + G+ VA+K D + + +E ++ L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVR-QEAKLFAML 63
Query: 73 EHSNIVKLK 81
+H NI+ L+
Sbjct: 64 KHPNIIALR 72
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 27/145 (18%), Positives = 58/145 (40%), Gaps = 20/145 (13%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
++ T+Y V + +K T+ ++ + + Y+H GI H+D+K +N+
Sbjct: 106 IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162
Query: 277 LNPETGVLKLCDFGSA--KHLVRGEPNVSYICSR----YYRAPELIFGAID--------Y 322
+ G + + DFG +++ + + + APE+I +
Sbjct: 163 Y--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 323 TTKIDVWSAGCVLAELLLGQPMFPG 347
+ DV++ G + EL + F
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKT 245
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 22/66 (33%), Positives = 30/66 (45%), Gaps = 11/66 (16%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEH 74
L +IG G FG VY + GE VAI+ + + K FK RE+ R+ H
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW--HGE-VAIRLIDIERDNEDQLKAFK-REVMAYRQTRH 88
Query: 75 SNIVKL 80
N+V
Sbjct: 89 ENVVLF 94
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 23/144 (15%), Positives = 50/144 (34%), Gaps = 14/144 (9%)
Query: 210 SPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLG--I 265
SP L+ +MP ++Y V + + + + R +A++H L I
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS---QAVKFALDMARGMAFLHTLEPLI 134
Query: 266 CHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYT 323
+ ++++++ E ++ + + APE +
Sbjct: 135 PRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQKKPEDTNR 189
Query: 324 TKIDVWSAGCVLAELLLGQPMFPG 347
D+WS +L EL+ + F
Sbjct: 190 RSADMWSFAVLLWELVTREVPFAD 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 11/66 (16%), Positives = 24/66 (36%), Gaps = 10/66 (15%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEH 74
L T + G +++ + G + +K + + F N E +R H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDF-NEECPRLRIFSH 66
Query: 75 SNIVKL 80
N++ +
Sbjct: 67 PNVLPV 72
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 17/165 (10%), Positives = 37/165 (22%), Gaps = 50/165 (30%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311
L + H G+ P + ++ + G + L
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPA-------------------TM 176
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE 371
+ D+ G L LL+ + P L + E +
Sbjct: 177 PDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-PAD 227
Query: 372 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416
++ + P + +R ++ R
Sbjct: 228 IDRD---------------------IPFQISAVAARSVQGDGGIR 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 19/103 (18%)
Query: 255 RSLAYIHV--------LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC 306
LA++H+ I HRD+K +N+L+ + G + D G A +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 307 S-----RYYRAPELIFGAI-----DYTTKIDVWSAGCVLAELL 339
+ + Y APE++ +I + + D+++ G V E+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 21/72 (29%), Positives = 31/72 (43%), Gaps = 8/72 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-QDKR--FKNREMQIMRRLEHSNIVKLKYFFY 85
IG G FG V++ K GE VA+K +++R F+ E+ L H NI+ F
Sbjct: 49 SIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG---FIA 103
Query: 86 SSGDKKDEPTNY 97
+ T
Sbjct: 104 ADNKDNGTWTQL 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 1e-12
Identities = 64/404 (15%), Positives = 125/404 (30%), Gaps = 112/404 (27%)
Query: 61 FKNREMQIMRRLEHSNIVK--LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVV 118
F+ E Q ++ +I+ F + ++DM S S ++ ++
Sbjct: 9 FETGEHQ----YQYKDILSVFEDAF------VDNFDCKD--VQDMPKSILSKE-EIDHII 55
Query: 119 ATPGQGPDRPQEISYTNTRVSDSG---VDQLVEII-----KVLGTPTREQIREMNPNYTE 170
D + V + VE + K L +P + + R+ +
Sbjct: 56 ----MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 171 FKFPQIK----SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-- 224
+ + + + ++K R + L LLE P+ N++++ +
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSR-LQPYLKLRQALLELRPAK---------NVLIDGVLGS 161
Query: 225 -ETV--YKVAKHYS-KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRD---IKP-QNLL 276
+T V Y + K +F F+ L C+ ++ Q LL
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNL---------------KNCNSPETVLEMLQKLL 206
Query: 277 LNPETGVLKLCDFGSA----KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
+ D S H ++ E + S+ Y L+ + +V +A
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLLV---LL-----NVQNAK 257
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP---- 388
A F + K+L T TR T+F +H
Sbjct: 258 AWNA--------F--NLSC-------KILLT-TR------FKQVTDFLSAATTTHISLDH 293
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432
S TP + L+ + L+ P P +V + P + +
Sbjct: 294 HSMTL---TPDEVKSLLLKYLDCRPQD--LPREVLTTNPRRLSI 332
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 2e-08
Identities = 69/495 (13%), Positives = 149/495 (30%), Gaps = 139/495 (28%)
Query: 3 VVNGELGFAKNYTYFSDLDNSLAQ-KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRF 61
+++G LG K + + + V F I + L+
Sbjct: 154 LIDGVLGSGK-----TWVALDVCLSYKVQCKMDFKIFW----LNLKN------------- 191
Query: 62 KNREMQIMRRLEHSNIVKLKYFFYSSGDKK-DEPTNYP-PLEDMKISTFSPRNKVTTVVA 119
N ++ L+ KL Y + + D +N + ++ ++ ++
Sbjct: 192 CNSPETVLEMLQ-----KLLYQIDPNWTSRSDHSSNIKLRIHSIQ-------AELRRLLK 239
Query: 120 TPGQGPDRPQEISYTNT-----RVSDSGVDQLVEI-IKVLGTPTREQIREMNPNYTEFKF 173
+ Y N V ++ + K+L T TR T+F
Sbjct: 240 SK----------PYENCLLVLLNVQNAKAWNAFNLSCKILLT-TR------FKQVTDFLS 282
Query: 174 PQIKSHP----WSKVFRVRTPPDAIDLISRLLEYTPSS------RISPLQVFLNLVLEFM 223
+H S TP + L+ + L+ P +P + L+++ E +
Sbjct: 283 AATTTHISLDHHSMTL---TPDEVKSLLLKYLDCRPQDLPREVLTTNPRR--LSIIAESI 337
Query: 224 PETV--YKVAKHYSKSKQN--FPCFYTKL---YIYQLFRSLA------YI--HVLGICHR 268
+ + + KH + K L ++F L+ +I +L +
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 269 DIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328
D+ + V KL LV +P P + + K++
Sbjct: 398 DVIKS----DVMVVVNKLHK----YSLVEKQPK-----ESTISIPSIYL---ELKVKLEN 441
Query: 329 WSAGCVLAELLLGQ----PMFPGDSGVDQLVE--IIKVLG-----TPTREQIREMNPNYT 377
A L ++ F D + ++ +G E++ +
Sbjct: 442 EYA---LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 378 EFKFPQIK----SHPWSKVFRVRTPPDAIDLISRLLEY----TPSSRISPLQVRSITPFL 429
+F+F + K S W+ ++ + +L Y + V +I FL
Sbjct: 499 DFRFLEQKIRHDSTAWN------ASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 430 IE-----LRAVFENI 439
+ + + + ++
Sbjct: 553 PKIEENLICSKYTDL 567
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 36/181 (19%), Positives = 68/181 (37%), Gaps = 33/181 (18%)
Query: 218 LVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH---------VLGICH 267
LV+E+ P ++ K ++ + + + R LAY+H I H
Sbjct: 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTELPRGDHYKPAISH 143
Query: 268 RDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY---------YRAPELIFG 318
RD+ +N+L+ G + DFG + L Y APE++ G
Sbjct: 144 RDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 319 AID------YTTKIDVWSAGCVLAELLLGQPMFPGDSGVD--QLVEIIKVLGTPTREQIR 370
A++ ++D+++ G + E+ + V Q+ +V PT E ++
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ 262
Query: 371 E 371
Sbjct: 263 V 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKV-LQDKR-FKN-REMQIMRRLEHS 75
DLDN L +IG G +G VY+ L VA+K +++ F N + + + +EH
Sbjct: 11 DLDN-LKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHD 67
Query: 76 NIVKL 80
NI +
Sbjct: 68 NIARF 72
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 32/98 (32%), Positives = 46/98 (46%), Gaps = 18/98 (18%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLL----NPETGVLKLCDFGSAKHLVRGEPNVSYICSR-- 308
+ ++H HRDIK N+LL K+ DFG A+ + + + SR
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIV 196
Query: 309 --Y-YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQP 343
Y APE + G I T K D++S G VL E++ G P
Sbjct: 197 GTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIITGLP 232
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 18/73 (24%), Positives = 35/73 (47%), Gaps = 13/73 (17%)
Query: 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKK--------VLQ-DKRFKNREMQ 67
F + +G G FG+VY+ + + VA+KK + ++F E++
Sbjct: 27 FDE-RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQ-EIK 82
Query: 68 IMRRLEHSNIVKL 80
+M + +H N+V+L
Sbjct: 83 VMAKCQHENLVEL 95
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 24/124 (19%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y +Q+ + + ++ HRD+ +N+LL+ E V+K+CDFG A+ + +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP--------- 247
Query: 309 YYR------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLV 355
Y APE IF + YT + DVWS G +L E+ LG +PG ++
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 356 EIIK 359
+K
Sbjct: 307 RRLK 310
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 21/100 (21%)
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRY----- 309
R L Y+H I HRD+K N+LL+ E V K+ DFG +K E + +++ +
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISK--KGTELDQTHLSTVVKGTLG 206
Query: 310 YRAPELIFGAIDY------TTKIDVWSAGCVLAELLLGQP 343
Y PE Y T K DV+S G VL E+L +
Sbjct: 207 YIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSN 76
N+ K +IG+G FG VY+ L G VA+K+ + + F+ E++ + H +
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFET-EIETLSFCRHPH 96
Query: 77 IVKL 80
+V L
Sbjct: 97 LVSL 100
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 5e-09
Identities = 34/174 (19%), Positives = 57/174 (32%), Gaps = 23/174 (13%)
Query: 202 EYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261
Q+F+ L EF + ++ S K ++QL SLA
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAE 178
Query: 262 -VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320
L HRD+ N+LL + KL + K + I
Sbjct: 179 ASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGL-------------QVSII 224
Query: 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP 374
DYT V ++ + + +F GD D +I +++ + E +P
Sbjct: 225 DYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHP 276
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 6e-04
Identities = 20/92 (21%), Positives = 31/92 (33%), Gaps = 5/92 (5%)
Query: 17 FSDLDNSLAQKTV--IGNGSFGIVYQAKLLDSGELVAIKKV-LQDKRFKNREMQIMRRLE 73
FS + + IG G FG V+Q VAIK + ++ N Q
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 74 HSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKI 105
I+ K SG+ + + L +
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 23/101 (22%)
Query: 255 RSLAYIH---VLGICHRDIKPQNLLL----NPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
R LAY+H I HRD+K N+LL + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLM---DYKDTHVTT 193
Query: 308 RY-----YRAPE-LIFGAIDYTTKIDVWSAGCVLAELLLGQ 342
+ APE L G + K DV+ G +L EL+ GQ
Sbjct: 194 AVRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 23/83 (27%), Positives = 47/83 (56%), Gaps = 12/83 (14%)
Query: 7 ELGFAKNYTYFSDLD---NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR--- 60
LG K ++ +L ++ + K ++G G FG VY+ +L D G LVA+K++ +++
Sbjct: 13 HLGQLKRFSL-RELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGG 70
Query: 61 ---FKNREMQIMRRLEHSNIVKL 80
F+ E++++ H N+++L
Sbjct: 71 ELQFQT-EVEMISMAVHRNLLRL 92
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 39/170 (22%), Positives = 62/170 (36%), Gaps = 39/170 (22%)
Query: 218 LVLEFM-------------PETVYKVAKHYSKSKQNFPCFYTKL--YIYQLFRSLAYIHV 262
++ E+ + L + YQ+ + +A++
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR----------- 311
HRD+ +N+LL + K+CDFG A+ + Y
Sbjct: 164 KNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDS---------NYVVKGNARLPVKW 213
Query: 312 -APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIK 359
APE IF + YT + DVWS G L EL LG +PG + ++IK
Sbjct: 214 MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 22/90 (24%), Positives = 35/90 (38%), Gaps = 22/90 (24%)
Query: 13 NYTYFSDLD-----------NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV- 55
NY Y N L+ +G G+FG V +A + VA+K +
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 56 ----LQDKRFKNREMQIMRRL-EHSNIVKL 80
L ++ E++++ L H NIV L
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNL 92
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 28/154 (18%)
Query: 218 LVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
L+ + MP + Y + K N Y + Q+ + + Y+ + HRD+ +N+L
Sbjct: 93 LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APELIFGAIDYTTK 325
+ +K+ DFG AK L E Y A E I I YT +
Sbjct: 150 VK-TPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMALESILHRI-YTHQ 199
Query: 326 IDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
DVWS G + EL+ G + G + ++E
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKN-----REMQIMRRL 72
+ V+G+G+FG VY+ + GE VAIK++ + K E +M +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 73 EHSNIVKL 80
++ ++ +L
Sbjct: 75 DNPHVCRL 82
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Q+ +AY+ + HRD++ N+L+ E V K+ DFG A+ + E Y +
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNE----YTARQ 339
Query: 309 YYR------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
+ APE +T K DVWS G +L EL G+ +PG + VE
Sbjct: 340 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
SL + +G G FG V+ + VAIK + +E Q+M++L H +V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 79 KL 80
+L
Sbjct: 243 QL 244
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Q+ +AY+ + HRD++ N+L+ E V K+ DFG A+ + E Y +
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNE----YTARQ 422
Query: 309 YYR------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
+ APE +T K DVWS G +L EL G+ +PG + VE
Sbjct: 423 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
SL + +G G FG V+ + VAIK + +E Q+M++L H +V
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 79 KL 80
+L
Sbjct: 326 QL 327
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 9/69 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKN-----REMQIMRRL 72
L + +G G FG V + + +VA+K + D ++ +E+ I+R L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 73 EHSNIVKLK 81
H +I+K K
Sbjct: 91 YHEHIIKYK 99
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 35/123 (28%), Positives = 52/123 (42%), Gaps = 23/123 (18%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
L+ Q+ +AY+H HRD+ +N+LL+ ++K+ DFG AK + G
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH-------- 188
Query: 308 RYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQL 354
YYR APE + + DVWS G L ELL + +L
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 355 VEI 357
+ I
Sbjct: 248 IGI 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 24/122 (19%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
+Q+ + + ++ HRD+ +N+LL+ E V+K+CDFG A+ + + Y
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------DY 204
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
APE IF + YT + DVWS G +L E+ LG +PG ++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 358 IK 359
+K
Sbjct: 264 LK 265
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 11/70 (15%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV-----LQDKRFKNREMQIMRR 71
+ L +G G+FG V +A + VA+K + + R E++I+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 72 L-EHSNIVKL 80
+ H N+V L
Sbjct: 87 IGHHLNVVNL 96
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKV-----LQDKRFKNREMQIMRRL 72
L + +G G+FG V + G+ LVA+K++ Q + F+ RE+QI++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKAL 81
Query: 73 EHSNIVKLK 81
IVK +
Sbjct: 82 HSDFIVKYR 90
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
LY Q+ + + Y+ HRD+ +N+L+ +K+ DFG AK L +
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK-------- 181
Query: 308 RYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL 339
YY APE + I ++ + DVWS G VL EL
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELF 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 24/69 (34%), Positives = 38/69 (55%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLL----DSGELVAIKKVLQDKRFKN-----REMQIMRRL 72
L +G G+FG V + ++GE+VA+KK LQ ++ RE++I++ L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSL 68
Query: 73 EHSNIVKLK 81
+H NIVK K
Sbjct: 69 QHDNIVKYK 77
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 22/104 (21%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y Q+ + + Y+ HRD+ +N+L+ +K+ DFG K L + +
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE------- 169
Query: 308 RYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL 339
+++ APE + + ++ DVWS G VL EL
Sbjct: 170 -FFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 24/122 (19%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ + +A++ HRD+ +N+LL V K+ DFG A+ ++ Y
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS---------NY 220
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
APE IF + YT + DVWS G +L E+ LG +PG + ++
Sbjct: 221 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 358 IK 359
+K
Sbjct: 280 VK 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 11/70 (15%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV-----LQDKRFKNREMQIMRR 71
N+L +G G+FG V +A G+ VA+K + +K E++IM
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 72 L-EHSNIVKL 80
L +H NIV L
Sbjct: 106 LGQHENIVNL 115
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 9/69 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLL----DSGELVAIKKVLQDKRFKN-----REMQIMRRL 72
L + +G G FG V + ++GE VA+K + + + +E++I+R L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 73 EHSNIVKLK 81
H NIVK K
Sbjct: 81 YHENIVKYK 89
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 22/104 (21%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y Q+ + + Y+ HRD+ +N+L+ +K+ DFG K + +
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK-------- 180
Query: 308 RYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL 339
YY APE + + + DVWS G L ELL
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 35/145 (24%), Positives = 57/145 (39%), Gaps = 30/145 (20%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+V+E + + +++ T L + + Y+ HRD+ +N L
Sbjct: 189 IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APE-LIFGAIDYT 323
+ E VLK+ DFG ++ G Y APE L +G Y+
Sbjct: 246 VT-EKNVLKISDFGMSREEADGV---------YAASGGLRQVPVKWTAPEALNYGR--YS 293
Query: 324 TKIDVWSAGCVLAELL-LGQPMFPG 347
++ DVWS G +L E LG +P
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPN 318
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNR-----EMQIMRRLEHSN 76
L IG G+FG V+ +L LVA+K + + E +I+++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 77 IVKL 80
IV+L
Sbjct: 174 IVRL 177
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 35/123 (28%), Positives = 56/123 (45%), Gaps = 26/123 (21%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQ+ + + ++ HRD+ +N+L+ V+K+CDFG A+ ++ Y
Sbjct: 179 YQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDS---------NY 228
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAEL--LLGQPMFPGDSGVDQLVE 356
APE +F I YT K DVWS G +L E+ L P +PG +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFYK 286
Query: 357 IIK 359
+I+
Sbjct: 287 LIQ 289
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 16/96 (16%)
Query: 1 YNVVNGELGFAKNYTYFSDLD-----NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LV 50
+ E + Y DL +L V+G+G+FG V A + V
Sbjct: 19 TGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 78
Query: 51 AIKKV-----LQDKRFKNREMQIMRRL-EHSNIVKL 80
A+K + ++ E+++M +L H NIV L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 114
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 24/69 (34%), Positives = 38/69 (55%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLL----DSGELVAIKKVLQDKRFKN-----REMQIMRRL 72
L +G G+FG V + ++GE+VA+KK LQ ++ RE++I++ L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSL 99
Query: 73 EHSNIVKLK 81
+H NIVK K
Sbjct: 100 QHDNIVKYK 108
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 22/104 (21%)
Query: 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICS 307
Y Q+ + + Y+ HRD+ +N+L+ +K+ DFG K L + +
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDK-------- 199
Query: 308 RYYR------------APELIFGAIDYTTKIDVWSAGCVLAELL 339
YY+ APE + + ++ DVWS G VL EL
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 38/153 (24%), Positives = 62/153 (40%), Gaps = 26/153 (16%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
L+ + MP + + + K N Y + Q+ + + Y+ + HRD+ +N+L+
Sbjct: 93 LITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APELIFGAIDYTTKI 326
+K+ DFG AK L E Y A E I I YT +
Sbjct: 151 K-TPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMALESILHRI-YTHQS 200
Query: 327 DVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
DVWS G + EL+ G + G + ++E
Sbjct: 201 DVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKN-----REMQIMRRL 72
+ V+G+G+FG VY+ + GE VAIK++ + K E +M +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 73 EHSNIVKL 80
++ ++ +L
Sbjct: 75 DNPHVCRL 82
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKN------REMQIMRRL 72
++G G FG V +A+L VA+K + D + RE M+
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 73 EHSNIVKL 80
+H ++ KL
Sbjct: 83 DHPHVAKL 90
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 24/110 (21%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
+ + Y+ HRD+ +N +L E + + DFG ++ + G+ YY
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGD---------YY 193
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
R A E + + YT DVW+ G + E++ GQ + G
Sbjct: 194 RQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 16/62 (25%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
+ K +G G +G VY+ VA+K + +D +E +M+ ++H N+V
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 79 KL 80
+L
Sbjct: 73 QL 74
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 25/110 (22%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ ++ Y+ HRD+ +N L+ E ++K+ DFG ++ + Y
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSR----------LMTGDTY 166
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
APE + ++ K DVW+ G +L E+ G +PG
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 36/155 (23%), Positives = 62/155 (40%), Gaps = 30/155 (19%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV+E Y + ++ ++Q+ + Y+ HRD+ +N+LL
Sbjct: 94 LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 150
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APE-LIFGAIDYTT 324
K+ DFG +K L E YY+ APE + + +++
Sbjct: 151 V-TQHYAKISDFGLSKALRADEN--------YYKAQTHGKWPVKWYAPECINYYK--FSS 199
Query: 325 KIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
K DVWS G ++ E GQ + G G + ++E
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 15/60 (25%), Positives = 30/60 (50%), Gaps = 8/60 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGEL--VAIKKV---LQDKRFKN---REMQIMRRLEHSNIVKL 80
+G+G+FG V + + VA+K + D K+ E +M++L++ IV++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKN-----REMQIMRRLE 73
VIG G FG+VY + +D + AIK + + + RE +MR L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 74 HSNIVKL 80
H N++ L
Sbjct: 81 HPNVLAL 87
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 32/147 (21%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
++L +M + + +S Q P + Q+ R + Y+ HRD+ +N +
Sbjct: 100 VLLPYMC---HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM 156
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR--------------APE-LIFGAID 321
L+ E+ +K+ DFG A+ ++ E YY A E L
Sbjct: 157 LD-ESFTVKVADFGLARDILDRE---------YYSVQQHRHARLPVKWTALESLQTYR-- 204
Query: 322 YTTKIDVWSAGCVLAELL-LGQPMFPG 347
+TTK DVWS G +L ELL G P +
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 17/68 (25%), Positives = 27/68 (39%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL---VAIKKVLQDKRFKN------REMQIMRRL 72
N L ++G G FG V + L VA+K + D + E M+
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 73 EHSNIVKL 80
H N+++L
Sbjct: 94 SHPNVIRL 101
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 24/110 (21%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
+ + Y+ HRD+ +N +L + + + DFG +K + G+ YY
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGD---------YY 203
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
R A E + + YT+K DVW+ G + E+ G +PG
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 29/150 (19%), Positives = 50/150 (33%), Gaps = 27/150 (18%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
LV EF+ + Y K +N KL + QL ++ ++ + H ++ +N+L
Sbjct: 89 LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL 145
Query: 277 LNP-------ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------APELIFGAIDYT 323
L +KL D G + ++ + + PE I +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIPWVPPECIENPKNLN 196
Query: 324 TKIDVWSAGCVLAELL-LGQPMFPGDSGVD 352
D WS G L E+ G
Sbjct: 197 LATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 12/71 (16%), Positives = 26/71 (36%), Gaps = 13/71 (18%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL-------VAIKKV-----LQDKRFKNREMQIM 69
L +G G+F +++ + G+ V +K + + F +M
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EAASMM 66
Query: 70 RRLEHSNIVKL 80
+L H ++V
Sbjct: 67 SKLSHKHLVLN 77
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 29/115 (25%), Positives = 53/115 (46%), Gaps = 15/115 (13%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ ++ Y+ HR++ +N L+ E ++K+ DFG ++ + Y
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGA 379
Query: 311 R------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG--DSGVDQLVE 356
+ APE + ++ K DVW+ G +L E+ G +PG S V +L+E
Sbjct: 380 KFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 16/62 (25%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
+ K +G G +G VY+ VA+K + +D +E +M+ ++H N+V
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 79 KL 80
+L
Sbjct: 280 QL 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL----VAIKKVLQDKRFKN-----REMQIMRRL 72
L + V+G+G FG V++ + GE V IK + ++ M + L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 73 EHSNIVKL 80
+H++IV+L
Sbjct: 73 DHAHIVRL 80
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 18/149 (12%)
Query: 218 LVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
LV +++P + + + + Q+ + + Y+ G+ HR++ +N+L
Sbjct: 91 LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------APELIFGAIDYTTKIDVWS 330
L +++ DFG A L + + + A E I YT + DVWS
Sbjct: 148 LK-SPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWS 202
Query: 331 AGCVLAELL-LGQPMFPGDSGVD--QLVE 356
G + EL+ G + G + L+E
Sbjct: 203 YGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/83 (26%), Positives = 38/83 (45%), Gaps = 15/83 (18%)
Query: 13 NYTYFSDLD------NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV----LQ 57
N YFSD + K +G G+FG V+ A+ + LVA+K +
Sbjct: 26 NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES 85
Query: 58 DKRFKNREMQIMRRLEHSNIVKL 80
++ RE +++ L+H +IV+
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRF 108
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 33/116 (28%), Positives = 51/116 (43%), Gaps = 27/116 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ L HRD+ +N L+ + V+K+ DFG ++ + + YYR
Sbjct: 172 VYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTD---------YYRVGGRTM 221
Query: 312 ------APELIFGAIDYTTKIDVWSAGCVLAELL-LG-QPMFPGDSGVDQLVEIIK 359
PE I +TT+ DVWS G VL E+ G QP + S + ++ I
Sbjct: 222 LPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQP-WYQLS-NTEAIDCIT 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 35/156 (22%), Positives = 59/156 (37%), Gaps = 31/156 (19%)
Query: 218 LVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
LV+E + ++ P ++Q+ + Y+ HRD+ +N+L
Sbjct: 86 LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APE-LIFGAIDYT 323
L K+ DFG +K L + YY APE + F ++
Sbjct: 143 LV-NRHYAKISDFGLSKALGADDS--------YYTARSAGKWPLKWYAPECINFRK--FS 191
Query: 324 TKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
++ DVWS G + E L GQ + G + +E
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 19/61 (31%), Positives = 28/61 (45%), Gaps = 7/61 (11%)
Query: 27 KTVIGNGSFGIVYQAKLLDSGE--LVAIKKVLQDKRFKNR-----EMQIMRRLEHSNIVK 79
+G G+FG V Q + VAIK + Q + E QIM +L++ IV+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 80 L 80
L
Sbjct: 75 L 75
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 20/60 (33%), Positives = 27/60 (45%), Gaps = 8/60 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGE---LVAIK--KVLQDKRFKN---REMQIMRRLEHSNIVKL 80
VIG G FG VY LLD+ A+K + D + E IM+ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 30/146 (20%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+VL +M + +++ +++ + P + Q+ + + Y+ HRD+ +N +
Sbjct: 104 VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR--------------APELIFGAIDY 322
L+ E +K+ DFG A+ + E YY A E + +
Sbjct: 161 LD-EKFTVKVADFGLARDMYDKE---------YYSVHNKTGAKLPVKWMALESLQTQK-F 209
Query: 323 TTKIDVWSAGCVLAELL-LGQPMFPG 347
TTK DVWS G +L EL+ G P +P
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 29/144 (20%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+V E++ +Y +S L + Y + +A++ HRD+ +N L
Sbjct: 80 IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APE-LIFGAIDYTT 324
++ +K+ DFG ++++ + Y APE + Y++
Sbjct: 137 VD-RDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWSAPEVFHYFK--YSS 184
Query: 325 KIDVWSAGCVLAELL-LGQPMFPG 347
K DVW+ G ++ E+ LG+ +
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
+ +G+G FG+V K + VA+K + + ++ +E Q M +L H +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 79 KL 80
K
Sbjct: 67 KF 68
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 20/60 (33%), Positives = 27/60 (45%), Gaps = 8/60 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGE---LVAIK--KVLQDKRFKN---REMQIMRRLEHSNIVKL 80
VIG G FG VY LLD+ A+K + D + E IM+ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 33/143 (23%), Positives = 64/143 (44%), Gaps = 24/143 (16%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+VL +M + +++ +++ + P + Q+ + + ++ HRD+ +N +
Sbjct: 168 VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APELIFGAIDYTTK 325
L+ E +K+ DFG A+ + E + + A E + +TTK
Sbjct: 225 LD-EKFTVKVADFGLARDMYDKEFD------SVHNKTGAKLPVKWMALESLQTQK-FTTK 276
Query: 326 IDVWSAGCVLAELL-LGQPMFPG 347
DVWS G +L EL+ G P +P
Sbjct: 277 SDVWSFGVLLWELMTRGAPPYPD 299
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 31/155 (20%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+++E + + + ++ + + YQL +LAY+ HRDI +N+L
Sbjct: 92 IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APE-LIFGAIDYTT 324
++ +KL DFG ++++ YY+ APE + F +T+
Sbjct: 149 VS-SNDCVKLGDFGLSRYMEDST---------YYKASKGKLPIKWMAPESINFRR--FTS 196
Query: 325 KIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
DVW G + E+L G F G D +E
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 20/67 (29%), Positives = 26/67 (38%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKNR-----EMQIMRRLE 73
+ IG G FG V+Q + VAIK R E MR+ +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 74 HSNIVKL 80
H +IVKL
Sbjct: 75 HPHIVKL 81
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 33/150 (22%), Positives = 57/150 (38%), Gaps = 29/150 (19%)
Query: 218 LVLEFMPETVYKVAKHY-SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
LV+E + ++ P ++Q+ + Y+ HR++ +N+L
Sbjct: 412 LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------------APE-LIFGAIDYT 323
L K+ DFG +K L + YY APE + F ++
Sbjct: 469 LV-NRHYAKISDFGLSKALGADDS--------YYTARSAGKWPLKWYAPECINFRK--FS 517
Query: 324 TKIDVWSAGCVLAELL-LGQPMFPGDSGVD 352
++ DVWS G + E L GQ + G +
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 24/77 (31%), Positives = 34/77 (44%), Gaps = 7/77 (9%)
Query: 11 AKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGE--LVAIKKVLQDKRFKNR---- 64
K+ F DN L +G G+FG V Q + VAIK + Q +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 65 -EMQIMRRLEHSNIVKL 80
E QIM +L++ IV+L
Sbjct: 385 REAQIMHQLDNPYIVRL 401
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 25/122 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
++ +AY++ HRD+ +N ++ E +K+ DFG + + + YY
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETD---------YY 194
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
R +PE + + +TT DVWS G VL E+ L + + G S +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRF 252
Query: 358 IK 359
+
Sbjct: 253 VM 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKVLQDKRFKNR-----EMQIMRR 71
+ +G GSFG+VY+ + VAIK V + + R E +M+
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 72 LEHSNIVKL 80
++V+L
Sbjct: 85 FNCHHVVRL 93
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 25/122 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQ+ R + Y+ HRD+ +N+L+ E V+K+ DFG A+ + + YY
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHID---------YY 247
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
+ APE +F I YT + DVWS G +L E+ LG +PG V++L ++
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 305
Query: 358 IK 359
+K
Sbjct: 306 LK 307
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 18/72 (25%), Positives = 33/72 (45%), Gaps = 13/72 (18%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLL-------DSGELVAIKKV-----LQDKRFKNREMQIM 69
+ L +G G+FG V A+ + + VA+K + +D EM++M
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 70 RRL-EHSNIVKL 80
+ + +H NI+ L
Sbjct: 129 KMIGKHKNIINL 140
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIV 78
L IG G FG V G VA+K + D + F E +M +L HSN+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFL-AEASVMTQLRHSNLV 77
Query: 79 KL 80
+L
Sbjct: 78 QL 79
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 19/105 (18%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
+ ++ Y+ HRD+ +N+L++ E V K+ DFG L +
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFG----LTKEA----SSTQDTG 174
Query: 311 R------APE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
+ APE L ++TK DVWS G +L E+ G+ +P
Sbjct: 175 KLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 20/69 (28%), Positives = 36/69 (52%), Gaps = 11/69 (15%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV----LQDKR-FKNREMQIMRR 71
+ K +G G+FG V+ A+ + LVA+K + L ++ F+ RE +++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTN 73
Query: 72 LEHSNIVKL 80
L+H +IVK
Sbjct: 74 LQHEHIVKF 82
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 27/116 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ HRD+ +N L+ ++K+ DFG ++ + + YYR
Sbjct: 147 VYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTD---------YYRVGGHTM 196
Query: 312 ------APELIFGAIDYTTKIDVWSAGCVLAELL-LG-QPMFPGDSGVDQLVEIIK 359
PE I +TT+ DVWS G +L E+ G QP + S +++E I
Sbjct: 197 LPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQP-WFQLS-NTEVIECIT 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 25/110 (22%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
Q+ +A+I HRD++ N+L++ +T K+ DFG A+ + E Y
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE---------YT 165
Query: 311 R-----------APE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
APE + +G +T K DVWS G +L E++ G+ +PG
Sbjct: 166 AREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
+L +G G FG V+ + VA+K + Q + E +M++L+H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 79 KL 80
+L
Sbjct: 72 RL 73
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKNR-----EMQIMRRLE 73
+ + + +IG+G G V +L G+ VAIK + + R E IM + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 74 HSNIVKL 80
H NI++L
Sbjct: 109 HPNIIRL 115
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+V E+M + ++ + + + + Y+ LG HRD+ +N+L
Sbjct: 127 IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICS------RYYRAPE-LIFGAIDYTTKIDVW 329
++ V K+ DFG ++ ++ +P+ +Y + R+ APE + F +++ DVW
Sbjct: 184 VD-SNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWT-APEAIAFRT--FSSASDVW 238
Query: 330 SAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
S G V+ E+L G+ + + D VE
Sbjct: 239 SFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 17/97 (17%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ HRD+ +N+L++ E V K+ DFG K +
Sbjct: 303 EYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWT 353
Query: 312 APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
APE + ++TK DVWS G +L E+ G+ +P
Sbjct: 354 APEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 6/62 (9%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIV 78
L IG G FG V G VA+K + D + F E +M +L HSN+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFL-AEASVMTQLRHSNLV 249
Query: 79 KL 80
+L
Sbjct: 250 QL 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 25/122 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQL R + Y+ HRD+ +N+L+ E V+K+ DFG A+ + + YY
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNID---------YY 213
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
+ APE +F + YT + DVWS G ++ E+ LG +PG V++L ++
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 358 IK 359
+K
Sbjct: 272 LK 273
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 18/73 (24%), Positives = 33/73 (45%), Gaps = 15/73 (20%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-------LVAIKKV-----LQDKR-FKNREMQI 68
+ L +G G+FG V A+ + + VA+K + +D EM++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93
Query: 69 MRRL-EHSNIVKL 80
M+ + +H NI+ L
Sbjct: 94 MKMIGKHKNIINL 106
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 12/70 (17%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV-----LQDKR-FKNREMQIMR 70
+++ +G FG VY+ L VAIK + + F+ E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRA 67
Query: 71 RLEHSNIVKL 80
RL+H N+V L
Sbjct: 68 RLQHPNVVCL 77
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 27/116 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ + H+D+ +N+L+ + +K+ D G + + + YY+
Sbjct: 142 EYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLFREVYAAD---------YYKLLGNSL 191
Query: 312 ------APELIFGAIDYTTKIDVWSAGCVLAELL-LG-QPMFPGDSGVDQLVEIIK 359
APE I ++ D+WS G VL E+ G QP + G S +VE+I+
Sbjct: 192 LPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQP-YCGYS-NQDVVEMIR 244
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 25/122 (20%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
YQL R + Y+ HRD+ +N+L+ E V+K+ DFG A+ + + YY
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNID---------YY 259
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEI 357
+ APE +F + YT + DVWS G ++ E+ LG +PG V++L ++
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 317
Query: 358 IK 359
+K
Sbjct: 318 LK 319
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 18/73 (24%), Positives = 32/73 (43%), Gaps = 15/73 (20%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-------LVAIKKV-----LQDKR-FKNREMQI 68
+ L +G G FG V A+ + + VA+K + +D EM++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139
Query: 69 MRRL-EHSNIVKL 80
M+ + +H NI+ L
Sbjct: 140 MKMIGKHKNIINL 152
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 14/94 (14%)
Query: 1 YNVVNGELGFAKNYTYFSDL----DNSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVA 51
++ N FA + SDL ++ +G+G+FG VY+ ++ VA
Sbjct: 5 HHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 64
Query: 52 IKKV-----LQDKRFKNREMQIMRRLEHSNIVKL 80
+K + QD+ E I+ + H NIV+
Sbjct: 65 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 32/105 (30%), Positives = 42/105 (40%), Gaps = 25/105 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR---- 311
Y+ HRDI +N LL V K+ DFG A+ + R YYR
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YYRKGGC 204
Query: 312 --------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
PE I +T+K D WS G +L E+ LG +P
Sbjct: 205 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 20/69 (28%), Positives = 32/69 (46%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV-----LQDKRFKNREMQIMRR 71
N++ IG G+FG V+QA+ +VA+K + + RE +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 72 LEHSNIVKL 80
++ NIVKL
Sbjct: 107 FDNPNIVKL 115
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 33/116 (28%), Positives = 56/116 (48%), Gaps = 27/116 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
AY+ HRD+ +N L+ E V+K+ DFG ++++ + YY+
Sbjct: 188 AYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSAD---------YYKADGNDA 237
Query: 312 ------APELIFGAIDYTTKIDVWSAGCVLAELL-LG-QPMFPGDSGVDQLVEIIK 359
PE IF YTT+ DVW+ G VL E+ G QP + G + ++++ ++
Sbjct: 238 IPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 7e-07
Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 27/123 (21%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310
+Q+ + + Y+ + + HRD+ +N+L+ E +K+ DFG ++ + + Y
Sbjct: 157 WQISQGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEED---------SY 206
Query: 311 R------------APELIFGAIDYTTKIDVWSAGCVLAELL-LG-QPMFPGDSGVDQLVE 356
A E +F I YTT+ DVWS G +L E++ LG P +PG ++L
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YPGIP-PERLFN 263
Query: 357 IIK 359
++K
Sbjct: 264 LLK 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKV-----LQDKRFKNREMQIMRR 71
+L +G G FG V +A VA+K + + R E ++++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 72 LEHSNIVKL 80
+ H +++KL
Sbjct: 83 VNHPHVIKL 91
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 36/122 (29%), Positives = 53/122 (43%), Gaps = 25/122 (20%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Y YQL +LAY+ HRDI +N+L++ +KL DFG ++++
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDST--------- 545
Query: 309 YYR-----------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSG--VDQL 354
YY+ APE I +T+ DVW G + E+L G F G V
Sbjct: 546 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 355 VE 356
+E
Sbjct: 605 IE 606
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 20/67 (29%), Positives = 26/67 (38%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKNR-----EMQIMRRLE 73
+ IG G FG V+Q + VAIK R E MR+ +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 74 HSNIVKL 80
H +IVKL
Sbjct: 450 HPHIVKL 456
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 10/69 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL---VAIK-----KVLQDKRFKN--REMQIMRR 71
L +G+GSFG+V + + VA+K + Q + + RE+ M
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 72 LEHSNIVKL 80
L+H N+++L
Sbjct: 78 LDHRNLIRL 86
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 27/115 (23%), Positives = 44/115 (38%), Gaps = 27/115 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ HRD+ +NLLL ++K+ DFG + L + + +Y
Sbjct: 135 GYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDD--------HYVMQEHRK 185
Query: 312 ------APE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
APE L ++ D W G L E+ GQ + G +G ++
Sbjct: 186 VPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL---VAIKKVLQDKRFKNR-----EMQIMRRLE 73
+ ++G G FG VY+ + VA+K +D N+ E IM+ L+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 74 HSNIVKL 80
H +IVKL
Sbjct: 72 HPHIVKL 78
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 29/149 (19%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
+++E P Y HY + +N T + Q+ +++AY+ + HRDI +N+L
Sbjct: 89 IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APE-LIFGAIDYTT 324
+ +KL DFG ++++ + YY+ +PE + F +TT
Sbjct: 146 VA-SPECVKLGDFGLSRYIEDED---------YYKASVTRLPIKWMSPESINFRR--FTT 193
Query: 325 KIDVWSAGCVLAELL-LGQPMFPGDSGVD 352
DVW + E+L G+ F D
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 18/62 (29%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
+ L IG+G FG+V+ L+ + VAIK + + + E ++M +L H +V
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 79 KL 80
+L
Sbjct: 67 QL 68
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 29/144 (20%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
LV EFM + Y ++++ T L + + +AY+ + HRD+ +N L
Sbjct: 80 LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR-----------APE-LIFGAIDYTT 324
+ E V+K+ DFG + ++ + Y +PE F Y++
Sbjct: 137 VG-ENQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWASPEVFSFSR--YSS 184
Query: 325 KIDVWSAGCVLAELL-LGQPMFPG 347
K DVWS G ++ E+ G+ +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 25/113 (22%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
A+I HRD++ N+L++ + V K+ DFG A+ + E Y
Sbjct: 298 AFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 312 -----APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD--QLVE 356
APE I +T K DVWS G +L E++ G+ +PG S + + +E
Sbjct: 348 PIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
SL + +G G FG V+ A + VA+K + E +M+ L+H +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 79 KL 80
KL
Sbjct: 247 KL 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 31/154 (20%), Positives = 60/154 (38%), Gaps = 27/154 (17%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI-YQLFRSLAYIHVLGICHRDIKPQNLL 276
++ E+M + + K + + + + Y+ + HRD+ +N+L
Sbjct: 123 IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR----------APE-LIFGAIDYTTK 325
+N V K+ DFG ++ L Y APE + + +T+
Sbjct: 180 VN-SNLVCKVSDFGLSRVLEDDPEAT------YTTSGGKIPIRWTAPEAISYRK--FTSA 230
Query: 326 IDVWSAGCVLAELL-LGQPMFPGDSG--VDQLVE 356
DVWS G V+ E++ G+ + S V + +
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 9/68 (13%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKNR-----EMQIMRRL 72
+ + ++ VIG G FG VY+ L S VAIK + K R E IM +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 73 EHSNIVKL 80
H NI++L
Sbjct: 104 SHHNIIRL 111
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 25/103 (24%), Positives = 49/103 (47%), Gaps = 25/103 (24%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ HRD+ +N L+N + GV+K+ DFG +++++ E Y
Sbjct: 134 EYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDE---------YTSSVGSKF 183
Query: 312 -----APE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
PE L++ +++K D+W+ G ++ E+ LG+ +
Sbjct: 184 PVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIV 78
L +G G FG+V K + VAIK + + ++ E ++M L H +V
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 79 KL 80
+L
Sbjct: 83 QL 84
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 10/68 (14%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE--LVAIKKV-----LQDKR-FKNREMQIMRRL- 72
N + + VIG G+FG V +A++ G AIK++ D R F E++++ +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 83
Query: 73 EHSNIVKL 80
H NI+ L
Sbjct: 84 HHPNIINL 91
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 27/103 (26%)
Query: 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR------ 311
Y+ HRD+ +N+L+ E V K+ DFG L RG+ Y
Sbjct: 156 DYLSQKQFIHRDLAARNILVG-ENYVAKIADFG----LSRGQE--------VYVKKTMGR 202
Query: 312 ------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
A E + ++ YTT DVWS G +L E++ LG + G
Sbjct: 203 LPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 16/103 (15%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETG-VLKLCDFGSAKHLVRGEPNVSYICSRYY 310
++ L YIH H DIK NLLL + + L D+G + + Y
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----E 214
Query: 311 RAPELIFGAIDYTT-----------KIDVWSAGCVLAELLLGQ 342
+ G I++T+ + DV G + L G+
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 8/67 (11%)
Query: 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQDKRFKNR-----EMQIMRRLE 73
+++ V+G G FG V +L + VAIK + K R E IM + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 74 HSNIVKL 80
H NI++L
Sbjct: 105 HPNIIRL 111
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 23/109 (21%)
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR----- 311
+ Y+ +G HRD+ +N+L+N V K+ DFG + L E + Y
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVL---EDDPEA----AYTTRGGK 211
Query: 312 ------APE-LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVD 352
+PE + + +T+ DVWS G VL E++ G+ + S D
Sbjct: 212 IPIRWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 14/94 (14%)
Query: 1 YNVVNGELGFAKNYTYFSDL----DNSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVA 51
N FA + SDL ++ +G+G+FG VY+ ++ VA
Sbjct: 46 MTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA 105
Query: 52 IKKVLQDKRFKNR-----EMQIMRRLEHSNIVKL 80
+K + + ++ E I+ + H NIV+
Sbjct: 106 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 32/105 (30%), Positives = 42/105 (40%), Gaps = 25/105 (23%)
Query: 258 AYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR---- 311
Y+ HRDI +N LL V K+ DFG A+ + R YYR
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YYRKGGC 245
Query: 312 --------APELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPG 347
PE I +T+K D WS G +L E+ LG +P
Sbjct: 246 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 17/44 (38%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETG-VLKLCDFGSAKH 294
++ L YIH H DIK NLLLN + + L D+G A
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 10/44 (22%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPET-GVLKLCDFGSAKH 294
+L +L ++H H ++ +N+ ++PE + L +G A
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 29/111 (26%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETG----VLKLCDFGSAKHLVRGEPNVSYICS 307
Q+ + IH + +RDIKP N L+ ++ + DFG K Y
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDP 164
Query: 308 RY-----YRAPELIFGAIDYTT-----------KIDVWSAGCVLAELLLGQ 342
YR + + G Y + + D+ + G V L G
Sbjct: 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 16/57 (28%), Positives = 26/57 (45%), Gaps = 3/57 (5%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHS-NIVKLKYF 83
IG GSFG++++ L + + VAIK + E + + L I + YF
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 4/46 (8%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLL----NPETGVLKLCDFGSAK 293
QL + Y+H + +RD+KP+N L+ N V+ + DF AK
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 3/57 (5%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIK--KVLQDKRFKNREMQIMRRLEHS-NIVKLKYF 83
IG G+FG + K L + E VAIK + + E + ++L I ++ YF
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 16/57 (28%), Positives = 28/57 (49%), Gaps = 3/57 (5%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHS-NIVKLKYF 83
IG+GSFG +Y + +GE VAIK + E +I + ++ I +++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 17/105 (16%)
Query: 251 YQLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
Q+ + YIH HRD+KP N L+ + ++ + DFG AK R +I
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK-YRDARTHQHIP-- 168
Query: 309 YYRAPELIFGAIDYTT-----------KIDVWSAGCVLAELLLGQ 342
YR + + G Y + + D+ S G VL LG
Sbjct: 169 -YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 3/57 (5%)
Query: 30 IGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHS-NIVKLKYF 83
IG+GSFG +Y + + E VAIK + E +I R L+ I +++F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 15/44 (34%), Positives = 22/44 (50%), Gaps = 2/44 (4%)
Query: 252 QLFRSLAYIHVLGICHRDIKPQNLLL--NPETGVLKLCDFGSAK 293
Q+ + ++H HRDIKP N L+ + + DFG AK
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 444 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.49 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.41 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.03 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 90.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.45 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 85.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 82.75 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=429.31 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=205.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++.+++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~------ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD------ 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC------
Confidence 6899999999999999999999999999999998533 235678999999999999999999997764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (275)
T 3hyh_A 87 -------------------------------------------------------------------------------- 86 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+|+|.+.+. ..+++++..++.++.||+
T Consensus 87 ----------------------------------------~~~ivmEy~~g~L~~~l~----~~~~l~e~~~~~~~~qi~ 122 (275)
T 3hyh_A 87 ----------------------------------------EIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 122 (275)
T ss_dssp ----------------------------------------EEEEEEECCCEEHHHHHH----HSCSCCHHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHH
Confidence 399999999999999885 356899999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
.||+|||++||+||||||+||+++ .++.+||+|||+++............||+.|+|||++.+....+.++|||||||+
T Consensus 123 ~al~ylH~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvi 201 (275)
T 3hyh_A 123 SAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 201 (275)
T ss_dssp HHHHHHHHTTCCCCCCCTTTEEEC-TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHH
T ss_pred HHHHHHHHCCcccccCChHHeEEC-CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHH
Confidence 999999999999999999999999 7899999999999877665556677899999999999887445789999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+..+....+.+. ... ++..+|+++.+||.+||+.||+
T Consensus 202 ly~lltg~~PF~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~ 252 (275)
T 3hyh_A 202 LYVMLCRRLPFDDESIPVLFKNISNG-----------------VYT------------LPKFLSPGAAGLIKRMLIVNPL 252 (275)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHT-----------------CCC------------CCTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHHccCChh
Confidence 99999999999988877776666552 111 2335799999999999999999
Q ss_pred CCCCHHHHhccCchhhh
Q psy10212 415 SRISPLQVRSITPFLIE 431 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~ 431 (444)
+|||+.|+|+ ||||+.
T Consensus 253 ~R~s~~eil~-hpw~k~ 268 (275)
T 3hyh_A 253 NRISIHEIMQ-DDWFKV 268 (275)
T ss_dssp GSCCHHHHHH-CHHHHT
T ss_pred HCcCHHHHHc-Cccccc
Confidence 9999999999 999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=432.73 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=219.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
...|+++++||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-------- 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-------- 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--------
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--------
Confidence 46799999999999999999999999999999999533 356779999999999999999999998865
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 145 -------------------------------------------------------------------------------- 144 (346)
T 4fih_A 145 -------------------------------------------------------------------------------- 144 (346)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+|||||||+| +|.+++.+ +++++..++.++.||+.
T Consensus 145 --------------------------------------~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~ 181 (346)
T 4fih_A 145 --------------------------------------ELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQ 181 (346)
T ss_dssp --------------------------------------EEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHH
T ss_pred --------------------------------------EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHH
Confidence 39999999985 88888753 46999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++||+||||||+|||++ .++.+||+|||+++..... ......+||+.|+|||++.+. .|+.++|||||||+
T Consensus 182 aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvi 259 (346)
T 4fih_A 182 ALSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIM 259 (346)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHH
T ss_pred HHHHHHHCCcccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHH
Confidence 99999999999999999999999 7899999999999876443 334567899999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+..+.+..+.+.... .. .....+|+++.+||.+||+.||+
T Consensus 260 lyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------~~----------~~~~~~s~~~~dli~~~L~~dP~ 313 (346)
T 4fih_A 260 VIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------------RL----------KNLHKVSPSLKGFLDRLLVRDPA 313 (346)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHSSCC----------------CC----------SCGGGSCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHcCCCC----------------CC----------CccccCCHHHHHHHHHHcCCChh
Confidence 99999999999998888777766552100 00 01134699999999999999999
Q ss_pred CCCCHHHHhccCchhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELR 433 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~ 433 (444)
+|||+.|+|+ ||||++..
T Consensus 314 ~R~ta~e~l~-Hp~~~~~~ 331 (346)
T 4fih_A 314 QRATAAELLK-HPFLAKAG 331 (346)
T ss_dssp TSCCHHHHTT-CGGGGGCC
T ss_pred HCcCHHHHhc-CHhhcCCC
Confidence 9999999999 99998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=429.83 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=219.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++|+|||||+++++|.+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE------ 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC------
Confidence 5699999999999999999999999999999999532 245678999999999999999999997764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 106 -------------------------------------------------------------------------------- 105 (311)
T 4aw0_A 106 -------------------------------------------------------------------------------- 105 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|||||||+| +|.+++.. .+.+++..++.++.||
T Consensus 106 ----------------------------------------~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi 141 (311)
T 4aw0_A 106 ----------------------------------------KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEI 141 (311)
T ss_dssp ----------------------------------------EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 39999999985 99999853 4679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.||+|||++||+||||||+|||++ .++.+||+|||+++...... .....+||+.|+|||++.+. .++.++|+||
T Consensus 142 ~~al~ylH~~~IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWS 219 (311)
T 4aw0_A 142 VSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWA 219 (311)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHH
T ss_pred HHHHHHHHHCCCccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHH
Confidence 9999999999999999999999999 78999999999998764322 23456899999999999887 7899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..++..++.+. .+. ++..+|+++++||.+||+
T Consensus 220 lGvilyeml~G~~PF~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~dli~~lL~ 270 (311)
T 4aw0_A 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-----------------EYD------------FPEKFFPKARDLVEKLLV 270 (311)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------------CCC------------CCTTCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCcccCHHHHHHHHHHcc
Confidence 999999999999999998888888877762 112 233579999999999999
Q ss_pred cCCCCCCCHHHH------hccCchhhhhh
Q psy10212 411 YTPSSRISPLQV------RSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~el------L~~hpwf~~~~ 433 (444)
.||++|||+.|+ ++ ||||+++.
T Consensus 271 ~dp~~R~t~~e~~~~~~i~~-Hp~F~~id 298 (311)
T 4aw0_A 271 LDATKRLGCEEMEGYGPLKA-HPFFESVT 298 (311)
T ss_dssp SSGGGSTTSGGGTCHHHHHT-SGGGTTCC
T ss_pred CCHhHCcChHHHcCCHHHHC-CCCcCCCC
Confidence 999999999884 67 99999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=435.43 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=213.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++|+|||||++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~------- 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG------- 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-------
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-------
Confidence 6899999999999999999999999999999999543 245678999999999999999999998765
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 97 -------------------------------------------------------------------------------- 96 (350)
T 4b9d_A 97 -------------------------------------------------------------------------------- 96 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+ |+|.+++.. .....+++..++.|+.||+
T Consensus 97 ---------------------------------------~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~ 135 (350)
T 4b9d_A 97 ---------------------------------------SLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQIC 135 (350)
T ss_dssp ---------------------------------------EEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHH
Confidence 3999999998 599999863 3445689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||
T Consensus 136 ~aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGv 213 (350)
T 4b9d_A 136 LALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGC 213 (350)
T ss_dssp HHHHHHHHTTCEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHH
T ss_pred HHHHHHHHCCeeeccCCHHHEEEC-CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHH
Confidence 999999999999999999999999 78999999999997653322 12345799999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+.+.++.... +| .++.++|+++.+||.+||+.||
T Consensus 214 ilyemltG~~PF~~~~~~~~~~~i~~~~-------------------~~---------~~~~~~s~~~~~li~~~L~~dP 265 (350)
T 4b9d_A 214 VLYELCTLKHAFEAGSMKNLVLKIISGS-------------------FP---------PVSLHYSYDLRSLVSQLFKRNP 265 (350)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTC-------------------CC---------CCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------------CC---------CCCccCCHHHHHHHHHHccCCh
Confidence 9999999999999998888888777621 01 1123579999999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
++|||+.|+|+ ||||++
T Consensus 266 ~~R~s~~e~l~-hp~~~~ 282 (350)
T 4b9d_A 266 RDRPSVNSILE-KGFIAK 282 (350)
T ss_dssp GGSCCHHHHHT-SHHHHT
T ss_pred hHCcCHHHHhc-CHHhhc
Confidence 99999999999 999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=437.12 Aligned_cols=290 Identities=33% Similarity=0.587 Sum_probs=236.4
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++|+|||||++++++.......+
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~- 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE- 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT-
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc-
Confidence 457899999999999999999999999999999999533 2345689999999999999999998865432000
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 131 -------------------------------------------------------------------------------- 130 (398)
T 4b99_A 131 -------------------------------------------------------------------------------- 130 (398)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
...+|||||||+|+|.+++. ..+++++..++.++.||
T Consensus 131 ---------------------------------------~~~~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qi 167 (398)
T 4b99_A 131 ---------------------------------------FKSVYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQL 167 (398)
T ss_dssp ---------------------------------------CCCEEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHH
T ss_pred ---------------------------------------CCEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHH
Confidence 02489999999999999884 45789999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----CCCccccccccccCchhhccCCCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-----EPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+...++.++||
T Consensus 168 l~al~ylH~~~iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 168 LRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp HHHHHHHHHTTCBCCCCCGGGEEEC-TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHCcCcCCCcCccccccC-CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 9999999999999999999999999 7899999999999765332 233456899999999999876578999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC---cccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
||+||++|+|++|++||.+.+..+++..|.+..+.+....+........ ...++......|... .+++|+++.+||
T Consensus 247 WSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dLl 325 (398)
T 4b99_A 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETV-YPGADRQALSLL 325 (398)
T ss_dssp HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHH-STTCCHHHHHHH
T ss_pred ehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHh-CCCCCHHHHHHH
Confidence 9999999999999999999999999999999999988665433211100 001222222233332 246799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+||++||.+|||+.|+|+ ||||+++....
T Consensus 326 ~~mL~~dP~~R~ta~e~L~-Hp~f~~~~~p~ 355 (398)
T 4b99_A 326 GRMLRFEPSARISAAAALR-HPFLAKYHDPD 355 (398)
T ss_dssp HHHSCSSTTTSCCHHHHTT-SGGGTTTCCGG
T ss_pred HHHCcCChhHCcCHHHHhc-CHhhCcCCCCc
Confidence 9999999999999999999 99999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=434.61 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=219.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+.|+++++||+|+||.||+|+++.+|+.||||++... .+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-------- 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-------- 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--------
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--------
Confidence 46799999999999999999999999999999999533 356779999999999999999999998865
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 222 -------------------------------------------------------------------------------- 221 (423)
T 4fie_A 222 -------------------------------------------------------------------------------- 221 (423)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+|||||||+| +|.+++.. +++++..++.++.||+.
T Consensus 222 --------------------------------------~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~ 258 (423)
T 4fie_A 222 --------------------------------------ELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQ 258 (423)
T ss_dssp --------------------------------------EEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHH
T ss_pred --------------------------------------EEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHH
Confidence 39999999985 89888753 46999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++||+||||||+|||++ .++.+||+|||+++..... ......+||+.|||||++.+. .|+.++|||||||+
T Consensus 259 aL~ylH~~~IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvi 336 (423)
T 4fie_A 259 ALSVLHAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIM 336 (423)
T ss_dssp HHHHHHHTTEECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHH
T ss_pred HHHHHHHCCeecccCCHHHEEEc-CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHH
Confidence 99999999999999999999999 7899999999999876443 344567899999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+..+.+..+..... +. ......+|+++.+||.+||+.||.
T Consensus 337 lyeml~G~~PF~~~~~~~~~~~i~~~~~-------------------~~-------~~~~~~~s~~~~dli~~~L~~dP~ 390 (423)
T 4fie_A 337 VIEMVDGEPPYFNEPPLKAMKMIRDNLP-------------------PR-------LKNLHKVSPSLKGFLDRLLVRDPA 390 (423)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHSCC-------------------CC-------CSCTTSSCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHcCCC-------------------CC-------CcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999888877776655210 00 001235799999999999999999
Q ss_pred CCCCHHHHhccCchhhhh
Q psy10212 415 SRISPLQVRSITPFLIEL 432 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~ 432 (444)
+|||+.|+|+ ||||++.
T Consensus 391 ~R~ta~ell~-Hp~~~~~ 407 (423)
T 4fie_A 391 QRATAAELLK-HPFLAKA 407 (423)
T ss_dssp TSCCHHHHTT-CGGGGGC
T ss_pred HCcCHHHHhc-CHHhcCC
Confidence 9999999999 9999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=416.47 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=209.9
Q ss_pred ccc-chhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSL-AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+| ++.++||+|+||+||+|+++.+++.||+|++... ...+.+|+++|++|+|||||+++++|.+....
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~---- 100 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG---- 100 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT----
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC----
Confidence 344 6778899999999999999999999999999543 24577999999999999999999999764210
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (290)
T 3fpq_A 101 -------------------------------------------------------------------------------- 100 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
...+|||||||+ |+|.+++.. .+++++..++.|+.||
T Consensus 101 --------------------------------------~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi 138 (290)
T 3fpq_A 101 --------------------------------------KKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQI 138 (290)
T ss_dssp --------------------------------------EEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred --------------------------------------CcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHH
Confidence 135899999998 599999853 4679999999999999
Q ss_pred HHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||+|||+++ |+||||||+|||++..++.+||+|||+++.. .........||+.|||||++.+ .++.++|||||
T Consensus 139 ~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSl 215 (290)
T 3fpq_A 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAF 215 (290)
T ss_dssp HHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHH
T ss_pred HHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHH
Confidence 99999999999 9999999999999855789999999999753 2333456689999999998865 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+....+.+.+... .....++..+++++.+||.+||+.
T Consensus 216 Gvilyelltg~~Pf~~~~~~~~~~~~i~~~--------------------------~~~~~~~~~~~~~~~~li~~~L~~ 269 (290)
T 3fpq_A 216 GMCMLEMATSEYPYSECQNAAQIYRRVTSG--------------------------VKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--------------------------CCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--------------------------CCCCCCCccCCHHHHHHHHHHccC
Confidence 999999999999998766554443333210 011122345689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
||++|||+.|+|+ ||||++
T Consensus 270 dP~~R~s~~e~l~-Hp~~~~ 288 (290)
T 3fpq_A 270 NKDERYSIKDLLN-HAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHT-SGGGC-
T ss_pred ChhHCcCHHHHhc-CccccC
Confidence 9999999999999 999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=419.52 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=211.3
Q ss_pred cccchhheecccceeEEEEeEec---CCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||+||+|++. .+++.||||++... ...+.+|+++|++|+|||||++++++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence 67999999999999999999984 46789999998432 235668999999999999999999998765
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (304)
T 3ubd_A 100 -------------------------------------------------------------------------------- 99 (304)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|||||||+ |+|.+++.. .+++++..++.++.
T Consensus 100 ------------------------------------------~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~ 133 (304)
T 3ubd_A 100 ------------------------------------------KLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA 133 (304)
T ss_dssp ------------------------------------------EEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHH
Confidence 3999999998 599998853 46799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++|+||
T Consensus 134 qi~~aL~ylH~~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwS 211 (304)
T 3ubd_A 134 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWS 211 (304)
T ss_dssp HHHHHHHHHHHTTCCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHH
T ss_pred HHHHHHHHHHHCCCcCCCCCHHHeEEc-CCCCEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccc
Confidence 999999999999999999999999999 7899999999999765433 334566899999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+....+.+. ... ++..+|+++.+||.+||+
T Consensus 212 lGvilyemltG~~PF~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~ 262 (304)
T 3ubd_A 212 FGVLMFEMLTGTLPFQGKDRKETMTMILKA-----------------KLG------------MPQFLSPEAQSLLRMLFK 262 (304)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTC
T ss_pred hHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------CCC------------CCCcCCHHHHHHHHHHcc
Confidence 999999999999999999888888777651 111 233579999999999999
Q ss_pred cCCCCCCCH-----HHHhccCchhhhhh
Q psy10212 411 YTPSSRISP-----LQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~-----~elL~~hpwf~~~~ 433 (444)
.||++|||+ +|+++ ||||+++.
T Consensus 263 ~dP~~R~ta~~~~~~eil~-Hp~f~~id 289 (304)
T 3ubd_A 263 RNPANRLGAGPDGVEEIKR-HSFFSTID 289 (304)
T ss_dssp SSGGGSTTCSTTTHHHHHT-SGGGTTCC
T ss_pred cCHHHCCCCCcCCHHHHHc-CccccCCC
Confidence 999999995 79999 99999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=423.05 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=216.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCcc
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLE 101 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 101 (444)
+.|++.++||+|+||.||+|+++.+|+.||||++..+ ....+|+.+|++|+|||||++++++.+.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-~~~~~E~~il~~l~HpnIV~l~~~~~~~~------------- 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSSPRIVPLYGAVREGP------------- 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCTHHHHTTTTCCCTTBCCEEEEEEETT-------------
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-HhHHHHHHHHHhCCCCCCCcEEEEEEECC-------------
Confidence 5688999999999999999999999999999999654 34468999999999999999999998764
Q ss_pred ccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCC
Q psy10212 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 181 (444)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (444)
T Consensus 124 -------------------------------------------------------------------------------- 123 (336)
T 4g3f_A 124 -------------------------------------------------------------------------------- 123 (336)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHH
Q psy10212 182 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYI 260 (444)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yL 260 (444)
.+|||||||+ |+|.+++.. .+++++..++.++.||+.||+||
T Consensus 124 ---------------------------------~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl 166 (336)
T 4g3f_A 124 ---------------------------------WVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYL 166 (336)
T ss_dssp ---------------------------------EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------EEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4999999998 599999853 36799999999999999999999
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC------CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP------NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|++||+||||||+|||++.+...+||+|||+++....... .....||+.|||||++.+. .++.++|||||||+
T Consensus 167 H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvi 245 (336)
T 4g3f_A 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCM 245 (336)
T ss_dssp HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHH
T ss_pred HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHH
Confidence 9999999999999999993334799999999987643321 1234699999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+..+...++... .+ . ...+++++|+.+.+||.+||+.||.
T Consensus 246 lyemltG~~Pf~~~~~~~~~~~i~~~--~~---------------~---------~~~~~~~~s~~~~~li~~~L~~dP~ 299 (336)
T 4g3f_A 246 MLHMLNGCHPWTQYFRGPLCLKIASE--PP---------------P---------IREIPPSCAPLTAQAIQEGLRKEPV 299 (336)
T ss_dssp HHHHHHSSCSSTTTCCSCCHHHHHHS--CC---------------G---------GGGSCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCcCCCCCCCHHHHHHHHHcC--CC---------------C---------chhcCccCCHHHHHHHHHHccCCHh
Confidence 99999999999988877777766651 00 0 0123456899999999999999999
Q ss_pred CCCCHHHH-------------hccCchhhhhhhhh
Q psy10212 415 SRISPLQV-------------RSITPFLIELRAVF 436 (444)
Q Consensus 415 kRPs~~el-------------L~~hpwf~~~~~~~ 436 (444)
+|||+.|+ |+ |||+.+++.+-
T Consensus 300 ~R~sa~el~~~l~~~l~~~~~l~-hPw~~~~~~Pr 333 (336)
T 4g3f_A 300 HRASAMELRRKVGKALQEVGGLK-SPWKGEYKEPR 333 (336)
T ss_dssp GSCCHHHHHHHHHHHHHHTTSSC-SCSSSSCCCCC
T ss_pred HCcCHHHHHHHHHHHHhhhhhcc-CCCcCCCCCCC
Confidence 99999997 57 99998876654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=412.93 Aligned_cols=330 Identities=46% Similarity=0.875 Sum_probs=267.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++...++|++.+.||+|+||+||+|++..+|+.||||++..+.....+|++++++++||||+++++++...+.....+..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 34567899999999999999999999999999999999988888888999999999999999999999886541100000
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
. ......++... ...
T Consensus 82 ~-------------------------------------------------~~~~~~~~~~~----------------~~~ 96 (383)
T 3eb0_A 82 P-------------------------------------------------PDDHNKLGGKN----------------NGV 96 (383)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------ccccccccccc----------------ccc
Confidence 0 00000000000 000
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.++.. ..........++++|||||+++|.+.+......+..+++..++.++.||+.|
T Consensus 97 ~~~~~-----------------------~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 97 NNHHK-----------------------SVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp ------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccc-----------------------cccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 00000 0000012235799999999999999998777788899999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
|.|||++|++||||||+||+++..++.++|+|||.+.............+++.|+|||.+.+...++.++|+||+||++|
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99999999999999999999985688999999999987666665666788999999999987656899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
+|++|+.||.+.+..+.+..+++.++.+....+....+.+....+|......|...++..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCchhhhhhhh
Q psy10212 417 ISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 417 Ps~~elL~~hpwf~~~~~~ 435 (444)
||+.|+|+ ||||++++..
T Consensus 314 ~t~~e~l~-hp~f~~~~~~ 331 (383)
T 3eb0_A 314 INPYEAMA-HPFFDHLRNS 331 (383)
T ss_dssp CCHHHHHT-SGGGHHHHHC
T ss_pred CCHHHHhc-CHHHHHHHhh
Confidence 99999999 9999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=414.79 Aligned_cols=287 Identities=26% Similarity=0.429 Sum_probs=223.5
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEec---CCCceeeeeeeeccc--cchhhHHHHhhhc-CCCceeEeeeEEee
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQDK--RFKNREMQIMRRL-EHSNIVKLKYFFYS 86 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (444)
-|..+.++.++|+++++||+|+||+||+|+++ .+++.||||.+.... ..+.+|+++|+++ +||||++++++|.+
T Consensus 12 l~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 12 LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HHHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 35556778999999999999999999999875 357899999985543 3456899999998 69999999999977
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+
T Consensus 92 ~~------------------------------------------------------------------------------ 93 (361)
T 4f9c_A 92 ND------------------------------------------------------------------------------ 93 (361)
T ss_dssp TT------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 64
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHH
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~ 245 (444)
++|||||||+ ++|.+++ ..+++..
T Consensus 94 ------------------------------------------------~~~lvmE~~~g~~L~~~~-------~~l~~~~ 118 (361)
T 4f9c_A 94 ------------------------------------------------HVVIAMPYLEHESFLDIL-------NSLSFQE 118 (361)
T ss_dssp ------------------------------------------------EEEEEEECCCCCCHHHHH-------TTCCHHH
T ss_pred ------------------------------------------------EEEEEEeCCCcccHHHHH-------cCCCHHH
Confidence 4999999998 5898887 3589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--------------------------
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-------------------------- 299 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-------------------------- 299 (444)
++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++......
T Consensus 119 ~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLS 198 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-------------------
T ss_pred HHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999998556899999999996543221
Q ss_pred ---CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCC-CCChhHHHHHHHHHhCCCCHHHHHhhCCC
Q psy10212 300 ---PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFP-GDSGVDQLVEIIKVLGTPTREQIREMNPN 375 (444)
Q Consensus 300 ---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~-~~~~~e~~~~i~~~~g~~~~~~~~~~~~~ 375 (444)
......||+.|+|||++.+...++.++|+||+||++|+|++|+.||. +.+..+++..+.+.+|.+....+......
T Consensus 199 ~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~ 278 (361)
T 4f9c_A 199 RRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGK 278 (361)
T ss_dssp -------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTE
T ss_pred ccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccc
Confidence 11234689999999999876568999999999999999999999985 55677888899988886544333321100
Q ss_pred C---------------------CcccCCCccCC----CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 376 Y---------------------TEFKFPQIKSH----PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 376 ~---------------------~~~~~p~~~~~----~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
. .....|..... .........+|+++.|||.+||++||++|||+.|+|+ ||||+
T Consensus 279 ~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~-Hp~f~ 357 (361)
T 4f9c_A 279 SILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL-HPFFK 357 (361)
T ss_dssp EEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT-SGGGT
T ss_pred cccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc-CcccC
Confidence 0 00001110000 0001112457999999999999999999999999999 99999
Q ss_pred hhh
Q psy10212 431 ELR 433 (444)
Q Consensus 431 ~~~ 433 (444)
++.
T Consensus 358 ~i~ 360 (361)
T 4f9c_A 358 DMS 360 (361)
T ss_dssp TC-
T ss_pred CCC
Confidence 863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=414.50 Aligned_cols=297 Identities=78% Similarity=1.295 Sum_probs=268.9
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
...+|++++.||+|+||.||+|+++.+|+.||||++........+|++++++++||||++++++++..+...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~-------- 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK-------- 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTT--------
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCC--------
Confidence 345899999999999999999999999999999999888788889999999999999999999998754311
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 124 -------------------------------------------------------------------------------- 123 (420)
T 1j1b_A 124 -------------------------------------------------------------------------------- 123 (420)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
...++++|||||++++.+.+.........+++..++.++.||+.||.|
T Consensus 124 --------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (420)
T 1j1b_A 124 --------------------------------DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171 (420)
T ss_dssp --------------------------------TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 125688999999999999888777778899999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl 339 (444)
||++||+||||||+||+++.+.+.+||+|||+++............+++.|+|||++.+...++.++|||||||++|+|+
T Consensus 172 LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 251 (420)
T 1j1b_A 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251 (420)
T ss_dssp HHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999995567899999999987655555556678999999999977657899999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH
Q psy10212 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419 (444)
Q Consensus 340 tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~ 419 (444)
+|+.||.+.+..+.+.++++.+|.+....+....+.+....+|......|...++..+++++.+||.+||++||.+|||+
T Consensus 252 ~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~ 331 (420)
T 1j1b_A 252 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331 (420)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence 99999999999999999999999999999999999999999999888889888888999999999999999999999999
Q ss_pred HHHhccCchhhhhhhhhh
Q psy10212 420 LQVRSITPFLIELRAVFE 437 (444)
Q Consensus 420 ~elL~~hpwf~~~~~~~~ 437 (444)
.|+|+ ||||++++....
T Consensus 332 ~e~l~-hp~f~~~~~~~~ 348 (420)
T 1j1b_A 332 LEACA-HSFFDELRDPNV 348 (420)
T ss_dssp HHHHT-SGGGGGGGCTTC
T ss_pred HHHhC-CHhhcccccccc
Confidence 99999 999999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=400.03 Aligned_cols=268 Identities=21% Similarity=0.361 Sum_probs=197.7
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++|+|||||+++++|...+....
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~-- 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK-- 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc--
Confidence 346799999999999999999999999999999998532 2456689999999999999999999987653000
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (299)
T 4g31_A 81 -------------------------------------------------------------------------------- 80 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
........++|||||||+ |+|.+++.... .........++.++.||
T Consensus 81 --------------------------------~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi 127 (299)
T 4g31_A 81 --------------------------------LQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQI 127 (299)
T ss_dssp --------------------------------------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHH
T ss_pred --------------------------------ccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHH
Confidence 000011256999999998 58999885321 12234556789999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-------------CccccccccccCchhhccCC
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-------------NVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~ 320 (444)
+.||+|||++||+||||||+|||++ .++.+||+|||+++....... .....||+.|||||++.+.
T Consensus 128 ~~al~ylH~~~IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~- 205 (299)
T 4g31_A 128 AEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN- 205 (299)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC-
T ss_pred HHHHHHHHHCcCccccCcHHHeEEC-CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-
Confidence 9999999999999999999999999 788999999999976543321 1234699999999999887
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
.++.++|||||||++|+|++ ||.+. .+....+........+..+ ...++.
T Consensus 206 ~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p~~~-------------------------~~~~~~ 255 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFPPLF-------------------------TQKYPC 255 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCCHHH-------------------------HHHCHH
T ss_pred CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCCCCC-------------------------cccCHH
Confidence 89999999999999999996 77543 2222222222111111111 123678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.+||.+||+.||.+|||+.|+|+ ||||+++...
T Consensus 256 ~~~li~~~L~~dP~~Rps~~eil~-h~~~~~~~~p 289 (299)
T 4g31_A 256 EYVMVQDMLSPSPMERPEAINIIE-NAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT-SGGGCCC---
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc-CHhhCCCCCC
Confidence 899999999999999999999999 9999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=406.04 Aligned_cols=295 Identities=72% Similarity=1.195 Sum_probs=267.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
...+|.+.+.||+|+||+||+|++..+++ +|+|++..+.....+|++++++++||||+++++++...+...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~------- 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD------- 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS-------
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCC-------
Confidence 45789999999999999999999987665 9999998888888899999999999999999999987653111
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 110 -------------------------------------------------------------------------------- 109 (394)
T 4e7w_A 110 -------------------------------------------------------------------------------- 109 (394)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
..++++|||||++++...+.........+++..++.++.||+.||+|
T Consensus 110 ---------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 156 (394)
T 4e7w_A 110 ---------------------------------EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156 (394)
T ss_dssp ---------------------------------CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 25689999999999988887777778899999999999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHH
Q psy10212 260 IHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLl 339 (444)
||++|++||||||+||+++..++.++|+|||+++............+++.|+|||.+.+...++.++|+|||||++|+|+
T Consensus 157 LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp HHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999986688999999999987766655666788999999999987657999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCH
Q psy10212 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 419 (444)
Q Consensus 340 tG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~ 419 (444)
+|+.||.+.+..+.+..+.+.++.+....+....+.+....++......+...++..+++++.+||.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 99999999999999999999999999999999999888888888888888888888999999999999999999999999
Q ss_pred HHHhccCchhhhhhhhh
Q psy10212 420 LQVRSITPFLIELRAVF 436 (444)
Q Consensus 420 ~elL~~hpwf~~~~~~~ 436 (444)
.|+|+ ||||++++...
T Consensus 317 ~e~l~-hp~f~~~~~~~ 332 (394)
T 4e7w_A 317 IEALC-HPFFDELRTGE 332 (394)
T ss_dssp HHHHT-SGGGSTTTSSC
T ss_pred HHHhc-Chhhhhhcccc
Confidence 99999 99999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=397.49 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=213.4
Q ss_pred cccchhheecccceeEEEEeEec-----CCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|.+.++||+|+||+||+|++. .+++.||||++... .+.+.+|+++|++|+|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP--- 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE---
Confidence 57999999999999999999875 35788999999543 3567799999999999999999999987653
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (299)
T 4asz_A 90 -------------------------------------------------------------------------------- 89 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh---------hcCCCCC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS---------KSKQNFP 242 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~---------~~~~~l~ 242 (444)
++||||||+ |+|.+++.... .....++
T Consensus 90 -------------------------------------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~ 126 (299)
T 4asz_A 90 -------------------------------------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126 (299)
T ss_dssp -------------------------------------------EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCC
T ss_pred -------------------------------------------EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCC
Confidence 899999998 59999996532 2345799
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~ 319 (444)
+..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+.
T Consensus 127 ~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~ 205 (299)
T 4asz_A 127 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 205 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC
Confidence 999999999999999999999999999999999999 788999999999976533322 2234579999999999887
Q ss_pred CCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
.++.++|||||||++|||+| |+.||.+.+..+....+.+... ...+..+|
T Consensus 206 -~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~ 256 (299)
T 4asz_A 206 -KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV----------------------------LQRPRTCP 256 (299)
T ss_dssp -CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC----------------------------CCCCTTCC
T ss_pred -CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccch
Confidence 89999999999999999998 9999999888887776665210 01234679
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+++.+||.+||+.||++|||+.|++. |++++...
T Consensus 257 ~~~~~li~~cl~~dP~~RPs~~~i~~---~L~~~~~~ 290 (299)
T 4asz_A 257 QEVYELMLGCWQREPHMRKNIKGIHT---LLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH---HHHHHHhc
Confidence 99999999999999999999999977 99987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=393.78 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=207.4
Q ss_pred cccchhheecccceeEEEEeEec-----CCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|.+.++||+|+||+||+|++. .+++.||||++... .+.+.+|+++|++|+|||||++++++.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP--- 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE---
Confidence 56888899999999999999864 36889999999543 3567799999999999999999999987653
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 118 -------------------------------------------------------------------------------- 117 (329)
T 4aoj_A 118 -------------------------------------------------------------------------------- 117 (329)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh-----------cCCC
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK-----------SKQN 240 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-----------~~~~ 240 (444)
++||||||+ |+|.+++..... ...+
T Consensus 118 -------------------------------------------~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~ 154 (329)
T 4aoj_A 118 -------------------------------------------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154 (329)
T ss_dssp -------------------------------------------EEEEEECCTTCBHHHHHHTSSCC-----------CCS
T ss_pred -------------------------------------------EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCC
Confidence 899999999 599999864322 2357
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhc
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIF 317 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~ 317 (444)
+++..+..|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++...... ......+|+.|||||.+.
T Consensus 155 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhc
Confidence 99999999999999999999999999999999999999 88999999999997654332 223456899999999998
Q ss_pred cCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+... ...+..
T Consensus 234 ~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~----------------------------~~~p~~ 284 (329)
T 4aoj_A 234 YR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE----------------------------LERPRA 284 (329)
T ss_dssp TC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC----------------------------CCCCTT
T ss_pred CC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCccc
Confidence 87 89999999999999999998 8999999888877766655210 012346
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+|+++.+||.+||+.||++|||+.|+++ +++.+.+
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs~~ei~~---~L~~l~~ 319 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHSIKDVHA---RLQALAQ 319 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHH---HHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcCHHHHHH---HHHHHhh
Confidence 7999999999999999999999999998 7877654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=386.78 Aligned_cols=255 Identities=25% Similarity=0.318 Sum_probs=203.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+++++.++||+|+||+||+|++. ..||||++... .+.+.+|+++|++++|||||++++++..+.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~------ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN------ 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS------
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCe------
Confidence 467889999999999999999874 35999988432 245779999999999999999999764321
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 106 -------------------------------------------------------------------------------- 105 (307)
T 3omv_A 106 -------------------------------------------------------------------------------- 105 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++||||||+ |+|.+++. ....++++..+..|+.||
T Consensus 106 -----------------------------------------~~iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qi 141 (307)
T 3omv_A 106 -----------------------------------------LAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQT 141 (307)
T ss_dssp -----------------------------------------CEEEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHH
Confidence 789999999 59999885 345679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccC--CCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGA--IDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~s~~sDi 328 (444)
+.||+|||+++|+||||||+|||++ .++.+||+|||+++...... ......||+.|||||++.+. ..++.++||
T Consensus 142 a~gL~yLH~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDV 220 (307)
T 3omv_A 142 AQGMDYLHAKNIIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220 (307)
T ss_dssp HHHHHHHHHTTCBCSCCCSSSEEEE-TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHH
T ss_pred HHHHHHHHHCCccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHh
Confidence 9999999999999999999999999 78999999999997654322 23345789999999999643 258999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|||++|+.||.+.+..+.+..++... ...|.. ..++.++|+.+.+||.+|
T Consensus 221 wS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~-----------------~~~p~~------~~~~~~~~~~l~~li~~c 277 (307)
T 3omv_A 221 YSYGIVLYELMTGELPYSHINNRDQIIFMVGRG-----------------YASPDL------SKLYKNCPKAMKRLVADC 277 (307)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT-----------------CCCCCS------TTSCTTSCHHHHHHHHHH
T ss_pred HhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------------CCCCCc------ccccccchHHHHHHHHHH
Confidence 999999999999999999887766665554411 111111 122346899999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|+.||++|||+.|+++ .++.|+..
T Consensus 278 l~~dP~~RPs~~ei~~---~Le~l~~~ 301 (307)
T 3omv_A 278 VKKVKEERPLFPQILS---SIELLQHS 301 (307)
T ss_dssp TCSSSTTSCCHHHHHH---HHHHHHTT
T ss_pred cCCCHhHCcCHHHHHH---HHHHHhcc
Confidence 9999999999999988 44555443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=388.36 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=207.2
Q ss_pred cccchhheecccceeEEEEeEec-----CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.++++++||+|+||+||+|+.. .+++.||||++... .+.+.+|+.++++|+|||||++++++...+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~-- 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-- 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE--
Confidence 56778899999999999999863 36789999998433 3567899999999999999999999977653
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 104 -------------------------------------------------------------------------------- 103 (308)
T 4gt4_A 104 -------------------------------------------------------------------------------- 103 (308)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh------------hcC
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS------------KSK 238 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~------------~~~ 238 (444)
++||||||+ |+|.+++.... ...
T Consensus 104 --------------------------------------------~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~ 139 (308)
T 4gt4_A 104 --------------------------------------------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139 (308)
T ss_dssp --------------------------------------------CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEE
T ss_pred --------------------------------------------EEEEEEcCCCCcHHHHHHhhCccccccccccccccc
Confidence 889999998 59999986432 123
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchh
Q psy10212 239 QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPEL 315 (444)
Q Consensus 239 ~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~ 315 (444)
..+++..+..++.||+.||+|||+++++||||||+|||++ +++.+||+|||+++...... ......||+.|+|||.
T Consensus 140 ~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~ 218 (308)
T 4gt4_A 140 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEA 218 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHH
Confidence 5689999999999999999999999999999999999999 78999999999997653322 2334578999999999
Q ss_pred hccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 316 IFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 316 l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
+.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+... ...+
T Consensus 219 l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p 269 (308)
T 4gt4_A 219 IMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV----------------------------LPCP 269 (308)
T ss_dssp HHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC----------------------------CCCC
T ss_pred HhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCc
Confidence 9887 89999999999999999998 8999999888777665543110 0123
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.++|+.+.+||.+||+.||++|||+.||++
T Consensus 270 ~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 270 DDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 468999999999999999999999999988
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=422.20 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=223.4
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+.++|++++.||+|+||.||+|+++.+|+.||+|++... ...+.+|+++|++|+||||++++++|.+.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 227 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN------ 227 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS------
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC------
Confidence 3457899999999999999999999999999999998543 355678999999999999999999997764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 228 -------------------------------------------------------------------------------- 227 (573)
T 3uto_A 228 -------------------------------------------------------------------------------- 227 (573)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|||||||+| +|.+++. ...+.+++..++.++.||
T Consensus 228 ----------------------------------------~~~iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi 264 (573)
T 3uto_A 228 ----------------------------------------EMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQV 264 (573)
T ss_dssp ----------------------------------------EEEEEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHH
Confidence 49999999985 8988874 344679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPE-TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~-~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++||+||||||+||+++.+ .+.+||+|||+++...........+||+.|+|||++.+. .++.++||||||
T Consensus 265 ~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlG 343 (573)
T 3uto_A 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVG 343 (573)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHH
T ss_pred HHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHH
Confidence 999999999999999999999999743 479999999999887665555567899999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+.+..+...... + .......+|+++++||.+||+.|
T Consensus 344 vilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-----------------~--------~~~~~~~~s~~~~dli~~~L~~d 398 (573)
T 3uto_A 344 VLSYILLSGLSPFGGENDDETLRNVKSCDWN-----------------M--------DDSAFSGISEDGKDFIRKLLLAD 398 (573)
T ss_dssp HHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-----------------C--------CSGGGTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-----------------C--------CcccccCCCHHHHHHHHHHccCC
Confidence 9999999999999999888887777652111 1 11112357999999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~ 433 (444)
|.+|||+.|+|+ ||||+...
T Consensus 399 p~~R~t~~e~l~-Hpw~~~~~ 418 (573)
T 3uto_A 399 PNTRMTIHQALE-HPWLTPGN 418 (573)
T ss_dssp GGGSCCHHHHHH-STTTSCCC
T ss_pred hhHCcCHHHHhc-CcCcCCCC
Confidence 999999999999 99998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=372.66 Aligned_cols=281 Identities=33% Similarity=0.536 Sum_probs=232.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||+||+|+++.+|+.||+|++.... ..+.+|+.++++++||||+++++++.+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK------- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-------
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-------
Confidence 58999999999999999999999999999999995432 44568999999999999999999987764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (292)
T 3o0g_A 75 -------------------------------------------------------------------------------- 74 (292)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||||++++.+.+.. ..+.+++..++.++.||+.
T Consensus 75 ---------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~ 112 (292)
T 3o0g_A 75 ---------------------------------------KLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLK 112 (292)
T ss_dssp ---------------------------------------EEEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHH
Confidence 3899999999999888753 4567999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++|++|+||||+||+++ .++.++|+|||.+...... .......+|+.|+|||.+.+...++.++|+|||||+
T Consensus 113 ~l~~lH~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 191 (292)
T 3o0g_A 113 GLGFCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred HHHHHHhCCeecCCCCHHHEEEc-CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHH
Confidence 99999999999999999999999 7889999999999765432 223445779999999999877458999999999999
Q ss_pred HHHHHhCCCC-CCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPM-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~P-f~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|..| |.+.+..+.+..+.+..+.+....+............+..........+.+.+++.+++||.+||+.||
T Consensus 192 l~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 271 (292)
T 3o0g_A 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccCh
Confidence 9999987766 677788888999999888887766554332222222232222333333445789999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~ 433 (444)
++|||+.|+|+ ||||++..
T Consensus 272 ~~R~t~~e~l~-hp~f~~~~ 290 (292)
T 3o0g_A 272 VQRISAEEALQ-HPYFSDFC 290 (292)
T ss_dssp GGSCCHHHHHT-SGGGTTC-
T ss_pred hhCCCHHHHhc-CcccccCC
Confidence 99999999999 99999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=414.97 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=210.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhh---HHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNR---EMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.|+++++||+|+||+||+|+++.+|+.||||++.... ....+ ++.+++.++|||||+++++|.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--- 265 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--- 265 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS---
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC---
Confidence 67999999999999999999999999999999995431 12223 466777889999999999998765
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 266 -------------------------------------------------------------------------------- 265 (689)
T 3v5w_A 266 -------------------------------------------------------------------------------- 265 (689)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+|||||||+| +|.+++.. .+.+++..++.++
T Consensus 266 -------------------------------------------~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~ 298 (689)
T 3v5w_A 266 -------------------------------------------KLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYA 298 (689)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHH
Confidence 39999999985 99998853 4679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||+|||++||+||||||+|||++ .+|.+||+|||+++...... ....+||+.|+|||++.++..++.++|+||
T Consensus 299 ~qIl~aL~yLH~~gIiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWS 376 (689)
T 3v5w_A 299 AEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFS 376 (689)
T ss_dssp HHHHHHHHHHHTTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH
T ss_pred HHHHHHHHHHHHCCccccCCchHHeEEe-CCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHH
Confidence 9999999999999999999999999999 88999999999998764443 445689999999999975547999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHH---HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||++|+|++|++||.+.+..+. ...+.. ... .++..+|+++++||.+
T Consensus 377 LGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-----------------~~~------------~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------MAV------------ELPDSFSPELRSLLEG 427 (689)
T ss_dssp HHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-----------------CCC------------CCCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-----------------CCC------------CCCccCCHHHHHHHHH
Confidence 99999999999999986543322 222222 011 1234679999999999
Q ss_pred hcccCCCCCCC-----HHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRIS-----PLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs-----~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|++ +.|+++ ||||+++..
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~-HpfF~~idW 458 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKE-SPFFRSLDW 458 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTT-SGGGTTCCH
T ss_pred HccCCHhHCCCCCCCCHHHHhc-CccccCCCH
Confidence 99999999998 799999 999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=375.66 Aligned_cols=287 Identities=35% Similarity=0.640 Sum_probs=233.9
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
+...+.++|++++.||+|+||+||+|++. +|+.||+|++.... ..+.+|++++++++||||+++++++.+.+
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER- 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-
Confidence 45668899999999999999999999996 49999999985332 34668999999999999999999987654
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (311)
T 3niz_A 93 -------------------------------------------------------------------------------- 92 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+++|||||+++|.+.+.. ....+++..++.+
T Consensus 93 ---------------------------------------------~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~ 124 (311)
T 3niz_A 93 ---------------------------------------------CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIY 124 (311)
T ss_dssp ---------------------------------------------CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHH
T ss_pred ---------------------------------------------EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHH
Confidence 3899999999999988863 4466999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
+.||+.||.|||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+...++.++|+
T Consensus 125 ~~qi~~~l~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 125 LYQLLRGVAHCHQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCchHhEEEC-CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 99999999999999999999999999999 7889999999999765433 223345679999999999875578999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC--CcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY--TEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|||||++|+|++|+.||.+.+..+....+...++.+.+..+....... ....+.......+ ..+.+.+++++.+||.
T Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 282 (311)
T 3niz_A 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW-SSIIPGFCQEGIDLLS 282 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH-HHHSTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcH-HHhCcccCHHHHHHHH
Confidence 999999999999999999999999999999999888766554432100 0001111111111 2234567899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+||++||.+|||+.|+|+ ||||+++..+
T Consensus 283 ~~L~~dP~~Rpt~~ell~-hp~f~~~~~~ 310 (311)
T 3niz_A 283 NMLCFDPNKRISARDAMN-HPYFKDLDPQ 310 (311)
T ss_dssp HHSCSCTTTSCCHHHHHT-SGGGTTSCTT
T ss_pred HHcCCChhHCCCHHHHhc-CcccccCCcc
Confidence 999999999999999999 9999997643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.92 Aligned_cols=301 Identities=44% Similarity=0.826 Sum_probs=247.5
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecccc---chhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR---FKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.....++|++.+.||+|+||+||+|+++.+|+.||||++..... ...++++.+.+++||||+++++++...+..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~--- 94 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER--- 94 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS---
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc---
Confidence 34566899999999999999999999999999999999865543 334566677888999999999999875431
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (360)
T 3e3p_A 95 -------------------------------------------------------------------------------- 94 (360)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....++++|||||+++|...+.........+++..++.++.||
T Consensus 95 ------------------------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi 138 (360)
T 3e3p_A 95 ------------------------------------DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138 (360)
T ss_dssp ------------------------------------CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred ------------------------------------cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHH
Confidence 01125689999999999988887666677889999999999999
Q ss_pred HHHHHHHH--HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIH--VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLH--s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||.||| ++|++|+||||+||+++..++.++|+|||++.............+++.|+|||.+.+...++.++|+|||
T Consensus 139 ~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp HHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 99999999 9999999999999999844889999999999877665555666789999999999776568999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc---CCCChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR---VRTPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~s~~l~~LI~~~ 408 (444)
||++|+|++|+.||.+.+..+.+..+.+..+.+....+....+..............|...++ ..+++.+.+||.+|
T Consensus 219 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 999999999999999999999999999999999999999988877777666666655555543 33678999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
|+.||.+|||+.|+|+ ||||+++.....
T Consensus 299 L~~dP~~Rpt~~e~l~-hp~f~~~~~~~~ 326 (360)
T 3e3p_A 299 LQYLPEERMKPYEALC-HPYFDELHDPAT 326 (360)
T ss_dssp TCSSGGGSCCHHHHTT-SGGGGGGGCTTC
T ss_pred hccCccccCCHHHHhc-CccccccCCccc
Confidence 9999999999999999 999999876544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=366.09 Aligned_cols=278 Identities=35% Similarity=0.613 Sum_probs=223.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||+||+|++ .+|+.||+|++.... ..+.+|++++++++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR------ 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC------
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe------
Confidence 5799999999999999999999 579999999984332 345689999999999999999999876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (288)
T 1ob3_A 75 -------------------------------------------------------------------------------- 74 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+++|||||+++|.+++.. ..+.+++..++.++.||+.
T Consensus 75 ----------------------------------------~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~ 111 (288)
T 1ob3_A 75 ----------------------------------------LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLN 111 (288)
T ss_dssp ----------------------------------------EEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHH
Confidence 899999999999998863 3467999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++|++|+||||+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+|||||+
T Consensus 112 ~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 190 (288)
T 1ob3_A 112 GIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190 (288)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred HHHHHHHCCeecCCCCHHHEEEc-CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHH
Confidence 99999999999999999999999 7889999999998765322 223344679999999999776468999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC-CcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|+.||.+.+..+....+.+..+.+....++...... ....++......+ ..+...+++.+.+||.+||+.||
T Consensus 191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP 269 (288)
T 1ob3_A 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDP 269 (288)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccH-HHHhhhcCHHHHHHHHHHcCCCc
Confidence 999999999999999999999999888877655443321000 0001111111112 22335689999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
++|||+.|+|+ ||||++.
T Consensus 270 ~~Rpt~~e~l~-hp~f~~~ 287 (288)
T 1ob3_A 270 NQRITAKQALE-HAYFKEN 287 (288)
T ss_dssp TTSCCHHHHHT-SGGGGC-
T ss_pred ccCCCHHHHhc-Ccchhhc
Confidence 99999999999 9999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=367.47 Aligned_cols=287 Identities=28% Similarity=0.483 Sum_probs=229.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------cchhhHHHHhhhcC---CCceeEeeeEEeec
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------RFKNREMQIMRRLE---HSNIVKLKYFFYSS 87 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 87 (444)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+++++. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4689999999999999999999999999999999985332 24557888877774 99999999999775
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
...
T Consensus 87 ~~~----------------------------------------------------------------------------- 89 (308)
T 3g33_A 87 RTD----------------------------------------------------------------------------- 89 (308)
T ss_dssp CSS-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 420
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
...++++|||||+++|.+++.. .....+++..++
T Consensus 90 --------------------------------------------~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~ 123 (308)
T 3g33_A 90 --------------------------------------------REIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIK 123 (308)
T ss_dssp --------------------------------------------SEEEEEEEEECCCCBHHHHHHT--CCTTCSCHHHHH
T ss_pred --------------------------------------------CceeEEEEehhhhcCHHHHHhh--ccCCCCCHHHHH
Confidence 1145899999999999999864 223449999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchh
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
.++.||+.||+|||++|++|+||||+||+++ .++.++|+|||.+.............+|+.|+|||.+.+. .++.++|
T Consensus 124 ~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 201 (308)
T 3g33_A 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVD 201 (308)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC-TTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHH
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCEEEeeCccccccCCCcccCCccccccccCchHHcCC-CCCchHH
Confidence 9999999999999999999999999999998 7889999999999876655556667889999999999887 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|||||++|+|++|+.||.+.+..+...++.+..+.+....|...... ....++... ......+.+.+++.+.+||.+
T Consensus 202 iwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 279 (308)
T 3g33_A 202 MWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL-PRGAFPPRG-PRPVQSVVPEMEESGAQLLLE 279 (308)
T ss_dssp HHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSS-CGGGSCCCC-CCCHHHHSCSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhc-cccccCCCC-CCcHHHhCccccHHHHHHHHH
Confidence 999999999999999999999999999999998888776544321110 011111111 111222345789999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.|+|+ ||||++-..
T Consensus 280 ~L~~dP~~R~t~~e~l~-h~~~~~~~~ 305 (308)
T 3g33_A 280 MLTFNPHKRISAFRALQ-HSYLHKDEG 305 (308)
T ss_dssp HTCSSTTTSCCHHHHHT-STTC-----
T ss_pred HhcCCCccCCCHHHHhc-CccccCCCC
Confidence 99999999999999999 999997543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=383.99 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=209.3
Q ss_pred ccccchhheecccceeEEEEeEecCC-----Cceeeeeeeecc-----ccchhhHHHHhhhcCC-CceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQD-----KRFKNREMQIMRRLEH-SNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 89 (444)
.++|++.+.||+|+||+||+|++..+ ++.||||.+... .+.+.+|+++|.++.| ||||++++++...+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 46899999999999999999997654 367999998543 3457789999999965 999999999876542
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 143 -------------------------------------------------------------------------------- 142 (353)
T 4ase_A 143 -------------------------------------------------------------------------------- 142 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------ 236 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------ 236 (444)
.++||||||+ |+|.+++.....
T Consensus 143 ---------------------------------------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~ 177 (353)
T 4ase_A 143 ---------------------------------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177 (353)
T ss_dssp ---------------------------------------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------
T ss_pred ---------------------------------------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhh
Confidence 2889999999 599999975433
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCc
Q psy10212 237 SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAP 313 (444)
Q Consensus 237 ~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aP 313 (444)
....+++..+..++.||+.||+|||+++++||||||+|||++ .++.+||+|||+++....... .....+|+.||||
T Consensus 178 ~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 178 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred ccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 235589999999999999999999999999999999999999 788999999999986644332 2234679999999
Q ss_pred hhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccc
Q psy10212 314 ELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392 (444)
Q Consensus 314 E~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 392 (444)
|.+.+. .++.++|||||||++|||+| |+.||.+.+..+.+.+.+..-. . -.
T Consensus 257 E~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~---------------~------------~~ 308 (353)
T 4ase_A 257 ETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------R------------MR 308 (353)
T ss_dssp HHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---------------C------------CC
T ss_pred HHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCC---------------C------------CC
Confidence 999887 89999999999999999998 9999998765555544443110 0 01
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+..+++++.++|.+||+.||++|||+.|+++ | ++++.
T Consensus 309 ~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~-~--L~~ll 346 (353)
T 4ase_A 309 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-H--LGNLL 346 (353)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-H--HHHHH
T ss_pred CCccCCHHHHHHHHHHcCcChhHCcCHHHHHH-H--HHHHH
Confidence 23457999999999999999999999999999 4 55543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=383.79 Aligned_cols=288 Identities=32% Similarity=0.607 Sum_probs=226.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (444)
.+.++|++++.||+|+||+||+|+++.+|+.||||++... .....+|+.+++++. ||||+++++++...+.
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-- 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND-- 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS--
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC--
Confidence 4668999999999999999999999999999999998432 234558999999997 9999999999876542
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (388)
T 3oz6_A 84 -------------------------------------------------------------------------------- 83 (388)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..+|+|||||+++|.+++.. ..+++..++.++.
T Consensus 84 ------------------------------------------~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~ 116 (388)
T 3oz6_A 84 ------------------------------------------RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVY 116 (388)
T ss_dssp ------------------------------------------SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHH
T ss_pred ------------------------------------------CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHH
Confidence 24899999999999998853 4799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC----------------------CCCcccccccc
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----------------------EPNVSYICSRY 309 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~----------------------~~~~~~~gt~~ 309 (444)
||+.||+|||++|++||||||+||+++ .++.++|+|||+++..... .......+|+.
T Consensus 117 qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 195 (388)
T 3oz6_A 117 QLIKVIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195 (388)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGG
T ss_pred HHHHHHHHHHhCCEEeCCCCHHHeEEc-CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCC
Confidence 999999999999999999999999999 7889999999999764321 11233478999
Q ss_pred ccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCC------C
Q psy10212 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP------Q 383 (444)
Q Consensus 310 y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p------~ 383 (444)
|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+++..+...++.|....+......+...... .
T Consensus 196 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (388)
T 3oz6_A 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVE 275 (388)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC
T ss_pred cCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccccc
Confidence 9999999875579999999999999999999999999999999999999999999887775533221100000 0
Q ss_pred ccCCCCcccc------------cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 384 IKSHPWSKVF------------RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 384 ~~~~~~~~~~------------~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.....+...+ ...+++++.+||.+||++||.+|||+.|+|+ ||||+.+....+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~-Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 276 IRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK-HPFVSIFHNPNE 340 (388)
T ss_dssp -----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT-STTTTTTCCGGG
T ss_pred ccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC-CHHHHHhcCCcc
Confidence 0001111111 2367999999999999999999999999999 999998765543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=373.60 Aligned_cols=285 Identities=32% Similarity=0.606 Sum_probs=230.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++|.+++.||+|+||+||+|++..+++.||+|++.... ..+.+|++++++++||||+++++++...+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS------- 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC-------
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE-------
Confidence 58999999999999999999999999999999984332 245589999999999999999999876543
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (324)
T 3mtl_A 75 -------------------------------------------------------------------------------- 74 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+++|||||+++|.+++.. ....+++..++.++.||+.|
T Consensus 75 ---------------------------------------~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~a 112 (324)
T 3mtl_A 75 ---------------------------------------LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRG 112 (324)
T ss_dssp ---------------------------------------EEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 899999999999998863 45579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|.|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+...++.++|+|||||++
T Consensus 113 L~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 191 (324)
T 3mtl_A 113 LAYCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 191 (324)
T ss_dssp HHHHHHTTEEESSCCGGGEEEC-TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred HHHHHHCCccCCCcCHHHEEEC-CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999 78899999999987543322 223446799999999998755789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
|+|++|+.||.+.+..+....+.+..+.+....|+..... +.....+......+ ....+.+++++.+||.+||+.||
T Consensus 192 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP 270 (324)
T 3mtl_A 192 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEAL-LSHAPRLDSDGADLLTKLLQFEG 270 (324)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhh-hhhcCCCCHHHHHHHHHHcCcCc
Confidence 9999999999999999999999999998876655432111 01111222111111 11234679999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 414 SSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.+|||+.|+|+ ||||+++......
T Consensus 271 ~~R~t~~e~l~-hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 271 RNRISAEDAMK-HPFFLSLGERIHK 294 (324)
T ss_dssp GGSCCHHHHTT-SGGGGGGCSTTSS
T ss_pred ccCCCHHHHhc-Chhhhhccccccc
Confidence 99999999999 9999998766544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=368.25 Aligned_cols=286 Identities=32% Similarity=0.549 Sum_probs=218.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ..+.+|++++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN------- 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-------
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-------
Confidence 478999999999999999999999999999999985432 45668999999999999999999987654
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (317)
T 2pmi_A 77 -------------------------------------------------------------------------------- 76 (317)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhh--cCCCCChHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK--SKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~--~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||+++|.+++..... ....+++..++.++.||
T Consensus 77 ---------------------------------------~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi 117 (317)
T 2pmi_A 77 ---------------------------------------KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117 (317)
T ss_dssp ---------------------------------------EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHH
T ss_pred ---------------------------------------eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHH
Confidence 3899999999999999865432 23458999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++|++|+||||+||+++ .++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||||
T Consensus 118 ~~aL~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 196 (317)
T 2pmi_A 118 LQGLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG 196 (317)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HHHHHHHHHCCeeeCCCChHHeEEc-CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHH
Confidence 9999999999999999999999999 7889999999999765432 2233456799999999997754689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCC--CCCcccCCCccCCCC----cccccCCCChhHHHHHH
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKSHPW----SKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~p~~~~~~~----~~~~~~~~s~~l~~LI~ 406 (444)
|++|+|++|+.||.+.+..+....+.+..+.+....+..... .+. ..++......+ .......+++++.+||.
T Consensus 197 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 275 (317)
T 2pmi_A 197 CILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLH 275 (317)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHH
Confidence 999999999999999999999999999888876555443211 000 00111111111 11223467899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+||+.||.+|||+.|+|+ ||||++....
T Consensus 276 ~~L~~dP~~Rpt~~e~l~-hp~f~~~~~~ 303 (317)
T 2pmi_A 276 GLLQLNPDMRLSAKQALH-HPWFAEYYHH 303 (317)
T ss_dssp HHSCSSGGGSCCHHHHTT-SGGGGGGCC-
T ss_pred HHCCCCcccCCCHHHHhC-Chhhhcccch
Confidence 999999999999999999 9999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=391.69 Aligned_cols=286 Identities=29% Similarity=0.503 Sum_probs=228.7
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|++++.||+|+||+||+|++..+|+.||||++... ...+.+|++++++++||||+++++++...+..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~--- 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL--- 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST---
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc---
Confidence 468999999999999999999999999999999999542 24456899999999999999999998765420
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 137 -------------------------------------------------------------------------------- 136 (464)
T 3ttj_A 137 -------------------------------------------------------------------------------- 136 (464)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
......|+|||||+++|.+.+. ..+++..++.++.||
T Consensus 137 -------------------------------------~~~~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qi 173 (464)
T 3ttj_A 137 -------------------------------------EEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQM 173 (464)
T ss_dssp -------------------------------------TTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHH
T ss_pred -------------------------------------ccCCeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHH
Confidence 0012489999999999888763 358999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++||+||||||+||+++ .++.+||+|||+++............+|+.|+|||++.+. .++.++|||||||
T Consensus 174 l~aL~~lH~~~iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 251 (464)
T 3ttj_A 174 LCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 251 (464)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHH
T ss_pred HHHHHHHHHCCcccCCCChHhEEEe-CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHH
Confidence 9999999999999999999999999 7889999999999876655555667889999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc--cCCCccCCCCcccccCC-----------CChh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVFRVR-----------TPPD 400 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~-----------~s~~ 400 (444)
++|+|++|+.||.+.+..+++.++++.+|.+.+..+.........+ ..+......+...++.. .+++
T Consensus 252 il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 331 (464)
T 3ttj_A 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 331 (464)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHH
Confidence 9999999999999999999999999999999888775542111110 11111111111121111 1577
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+.+||.+||++||.+|||+.|+|+ ||||+....
T Consensus 332 ~~dLl~~mL~~dP~~R~ta~e~L~-Hp~~~~~~~ 364 (464)
T 3ttj_A 332 ARDLLSKMLVIDPAKRISVDDALQ-HPYINVWYD 364 (464)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT-STTTGGGCC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc-ChhhhhccC
Confidence 999999999999999999999999 999997543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.21 Aligned_cols=286 Identities=31% Similarity=0.568 Sum_probs=225.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|++++.||+|+||+||+|++..+|+.||+|++.... ..+.+|++++++++||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR------ 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT------
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC------
Confidence 478999999999999999999999999999999984432 34568999999999999999999987754
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (311)
T 4agu_A 76 -------------------------------------------------------------------------------- 75 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..++|||||++++...+. .....+++..++.++.||+
T Consensus 76 ----------------------------------------~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~ 112 (311)
T 4agu_A 76 ----------------------------------------RLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTL 112 (311)
T ss_dssp ----------------------------------------EEEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHH
T ss_pred ----------------------------------------eEEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHH
Confidence 389999999975444332 2456799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++|++|+||+|+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||||+
T Consensus 113 ~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 191 (311)
T 4agu_A 113 QAVNFCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191 (311)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred HHHHHHHHCCCcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence 999999999999999999999999 7889999999999765432 22344577999999999987557899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhC--CCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
++|+|++|+.||.+.+..+....+.+..+...+....... ..+.....+............+++++.+.+||.+||+.
T Consensus 192 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (311)
T 4agu_A 192 VFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM 271 (311)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccC
Confidence 9999999999999999999999998888887765544321 11222222222222111122246899999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
||.+|||+.|+|+ ||||++++...+
T Consensus 272 dP~~Rpt~~ell~-hp~f~~~~~~~~ 296 (311)
T 4agu_A 272 DPTERLTCEQLLH-HPYFENIREIED 296 (311)
T ss_dssp STTTSCCHHHHHT-SGGGTTCC----
T ss_pred ChhhcCCHHHHhc-ChHHHhccCHHH
Confidence 9999999999999 999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=372.31 Aligned_cols=293 Identities=30% Similarity=0.525 Sum_probs=229.3
Q ss_pred ccccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeE
Q psy10212 10 FAKNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYF 83 (444)
Q Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (444)
.......-....++|++++.||+|+||+||+|++..+|+.||||++... ...+.+|++++++++||||++++++
T Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (329)
T 3gbz_A 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101 (329)
T ss_dssp ----------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence 3333344456778999999999999999999999999999999998433 2345689999999999999999999
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+...+
T Consensus 102 ~~~~~--------------------------------------------------------------------------- 106 (329)
T 3gbz_A 102 IHHNH--------------------------------------------------------------------------- 106 (329)
T ss_dssp EEETT---------------------------------------------------------------------------
T ss_pred EecCC---------------------------------------------------------------------------
Confidence 87764
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCCh
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPC 243 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~ 243 (444)
.+++|||||+++|.+++. ....+++
T Consensus 107 ---------------------------------------------------~~~lv~e~~~~~L~~~~~----~~~~~~~ 131 (329)
T 3gbz_A 107 ---------------------------------------------------RLHLIFEYAENDLKKYMD----KNPDVSM 131 (329)
T ss_dssp ---------------------------------------------------EEEEEEECCSEEHHHHHH----HCTTCCH
T ss_pred ---------------------------------------------------EEEEEEecCCCCHHHHHh----hcCCCCH
Confidence 389999999999999885 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc----CCCCeEEEeecCCcccccCC-CCCccccccccccCchhhcc
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLN----PETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~----~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~ 318 (444)
..++.++.||+.||.|||++|++|+||||+||+++ ...+.++|+|||++...... .......+++.|+|||.+.+
T Consensus 132 ~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC
Confidence 99999999999999999999999999999999995 14557999999998765332 22334567999999999987
Q ss_pred CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC-CCcccCCCccCCCCcccccCCC
Q psy10212 319 AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 319 ~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
...++.++|+|||||++|+|++|+.||.+.+..+.+..+.+..+.+....+...... .....++......+...++..+
T Consensus 212 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
T 3gbz_A 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALL 291 (329)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGS
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhccccc
Confidence 646899999999999999999999999999999999999998888776554432110 0112233334444444555668
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
++++.+||.+||+.||.+|||+.|+|+ ||||++..
T Consensus 292 ~~~~~~li~~~L~~dP~~R~t~~e~l~-hp~f~~~~ 326 (329)
T 3gbz_A 292 DDEGLDLLTAMLEMDPVKRISAKNALE-HPYFSHND 326 (329)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT-SGGGSSSC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhC-CcccCCCC
Confidence 999999999999999999999999999 99998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=368.50 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=218.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..++|++++.||+|+||.||+|++..+|+.||||++.... ..+.+|++++++++||||+++++++...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK----- 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence 4578999999999999999999999999999999985432 34558999999999999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (328)
T 3fe3_A 88 -------------------------------------------------------------------------------- 87 (328)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||+ ++|.+++.. .+++++..++.++.|
T Consensus 88 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~q 122 (328)
T 3fe3_A 88 -----------------------------------------TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQ 122 (328)
T ss_dssp -----------------------------------------EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 3899999997 599998853 367999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++|++||||||+||+++ .++.++|+|||++.............+|+.|+|||.+.+....+.++|+||||
T Consensus 123 i~~al~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 201 (328)
T 3fe3_A 123 IVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201 (328)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHH
T ss_pred HHHHHHHHHHCCEeccCCCHHHEEEc-CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhH
Confidence 99999999999999999999999999 78899999999998766555556678899999999998873445899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+... ... ++..+++++.+||.+||+.|
T Consensus 202 ~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~d 252 (328)
T 3fe3_A 202 VILYTLVSGSLPFDGQNLKELRERVLRG-----------------KYR------------IPFYMSTDCENLLKRFLVLN 252 (328)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHHCCCC
Confidence 9999999999999998877776666541 111 12346899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~ 433 (444)
|.+|||+.|+|+ ||||+...
T Consensus 253 P~~R~t~~eil~-h~~~~~~~ 272 (328)
T 3fe3_A 253 PIKRGTLEQIMK-DRWINAGH 272 (328)
T ss_dssp TTTSCCHHHHTT-CTTTTTTC
T ss_pred hhHCcCHHHHhc-CHhhcCCC
Confidence 999999999999 99998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.14 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=221.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----------cchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----------RFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
.++.++|++.+.||+|+||+||+|+++.+|+.||+|.+.... +.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 467889999999999999999999999999999999995432 3467899999999999999999998765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 88 ~------------------------------------------------------------------------------- 88 (361)
T 2yab_A 88 T------------------------------------------------------------------------------- 88 (361)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
.+++|||||+ ++|.+++. ....+++..+
T Consensus 89 -----------------------------------------------~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~ 117 (361)
T 2yab_A 89 -----------------------------------------------DVVLILELVSGGELFDFLA----QKESLSEEEA 117 (361)
T ss_dssp -----------------------------------------------EEEEEEECCCSCBHHHHHT----TCSCCBHHHH
T ss_pred -----------------------------------------------EEEEEEEcCCCCcHHHHHH----hcCCCCHHHH
Confidence 3899999996 69999884 3567999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG---VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~---~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
+.++.||+.||.|||++|++|+||||+||+++.... .++|+|||++.............||+.|+|||.+.+. .++
T Consensus 118 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 196 (361)
T 2yab_A 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCC
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCC-CCC
Confidence 999999999999999999999999999999973332 7999999999877655555567899999999999877 789
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+|||||++|+|++|..||.+.+..+....+.......... +...+++.+.+
T Consensus 197 ~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~ 251 (361)
T 2yab_A 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE-------------------------FFSQTSELAKD 251 (361)
T ss_dssp THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-------------------------HHTTSCHHHHH
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch-------------------------hccCCCHHHHH
Confidence 99999999999999999999999988887777666532221111 12356899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||.+||..||.+|||+.|+|+ ||||+.+.
T Consensus 252 li~~~L~~dP~~R~t~~e~l~-hp~~~~~~ 280 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALR-HPWITPVD 280 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT-STTTSCSS
T ss_pred HHHHHCCCChhHCcCHHHHhc-CcCcCCCc
Confidence 999999999999999999999 99998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=382.79 Aligned_cols=290 Identities=35% Similarity=0.561 Sum_probs=220.9
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.+.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++.......
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~- 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK- 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT-
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc-
Confidence 3568999999999999999999999999999999998542 245668999999999999999999986653100
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 129 -------------------------------------------------------------------------------- 128 (458)
T 3rp9_A 129 -------------------------------------------------------------------------------- 128 (458)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...+|+|||||+++|.+++. ....+++..++.++.|
T Consensus 129 ----------------------------------------~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~q 164 (458)
T 3rp9_A 129 ----------------------------------------FDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYN 164 (458)
T ss_dssp ----------------------------------------CCCEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHH
T ss_pred ----------------------------------------CceEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHH
Confidence 02489999999999999885 4567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----------------------------CCccc
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----------------------------PNVSY 304 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----------------------------~~~~~ 304 (444)
|+.||.|||++||+||||||+|||++ .++.+||+|||+++...... .....
T Consensus 165 i~~aL~~LH~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (458)
T 3rp9_A 165 LLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243 (458)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSCTTCCCCCC--------------------------
T ss_pred HHHHHHHHHhCCcCCCCCChhhEEEC-CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCC
Confidence 99999999999999999999999999 78899999999997653221 12334
Q ss_pred cccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-----------CCCCCCCCC--------------------hhHH
Q psy10212 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-----------GQPMFPGDS--------------------GVDQ 353 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-----------G~~Pf~~~~--------------------~~e~ 353 (444)
.+|+.|+|||++.....++.++|||||||++|+|++ |+++|.+.+ ..++
T Consensus 244 ~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (458)
T 3rp9_A 244 VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323 (458)
T ss_dssp -CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHH
T ss_pred cccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHH
Confidence 679999999987555479999999999999999998 778887654 3577
Q ss_pred HHHHHHHhCCCCHHHHHhhCCCCC---cccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 354 LVEIIKVLGTPTREQIREMNPNYT---EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 354 ~~~i~~~~g~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
+..+.+.+|.+....+........ ...++......+...+ +.+++++.+||.+||++||.+|||+.|+|+ ||||+
T Consensus 324 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~-Hp~f~ 401 (458)
T 3rp9_A 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLA-HPFFK 401 (458)
T ss_dssp HHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-SGGGT
T ss_pred HHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhc-CHhhh
Confidence 888999999999887765432110 0012222223333333 356999999999999999999999999999 99999
Q ss_pred hhhhhh
Q psy10212 431 ELRAVF 436 (444)
Q Consensus 431 ~~~~~~ 436 (444)
+++...
T Consensus 402 ~~~~~~ 407 (458)
T 3rp9_A 402 EVRIAE 407 (458)
T ss_dssp TTCCGG
T ss_pred hcCCCc
Confidence 986544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=368.81 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=223.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++.++|++.+.||+|+||+||+|+++.+++.||+|.+... ...+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 74 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME------- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-------
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-------
Confidence 4678999999999999999999999999999999998543 345668999999999999999999997754
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (321)
T 1tki_A 75 -------------------------------------------------------------------------------- 74 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||||++ +|.+++. ....++++..++.++.||+
T Consensus 75 ---------------------------------------~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~ 112 (321)
T 1tki_A 75 ---------------------------------------ELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVC 112 (321)
T ss_dssp ---------------------------------------EEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHH
Confidence 38999999985 8988874 3445799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPE-TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~-~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++|++|+||||+||+++.. ++.++|+|||++.............+++.|+|||.+.+. .++.++|+||||+
T Consensus 113 ~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 191 (321)
T 1tki_A 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGT 191 (321)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHH
T ss_pred HHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHH
Confidence 99999999999999999999999832 689999999999876555544556789999999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|..||.+.+..+....+...........+ ..+|+++.+||.+||..||
T Consensus 192 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dp 246 (321)
T 1tki_A 192 LVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------------------------KEISIEAMDFVDRLLVKER 246 (321)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-------------------------TTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh-------------------------ccCCHHHHHHHHHHcCCCh
Confidence 999999999999998888877777764322222221 3468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+|||+.|+|+ ||||++...
T Consensus 247 ~~Rpt~~e~l~-hp~~~~~~~ 266 (321)
T 1tki_A 247 KSRMTASEALQ-HPWLKQKIE 266 (321)
T ss_dssp GGSCCHHHHHH-SHHHHSCGG
T ss_pred hHCcCHHHHhc-ChhhccCcc
Confidence 99999999999 999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=359.35 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=218.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..+..++|++++.||+|+||+||+|++..+|+.||||++... .+.+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 90 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC----
Confidence 455678999999999999999999999999999999998533 345668999999999999999999998764
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (297)
T 3fxz_A 91 -------------------------------------------------------------------------------- 90 (297)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++|||||+ ++|.+++.. ..+++..++.++.
T Consensus 91 ------------------------------------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ 123 (297)
T 3fxz_A 91 ------------------------------------------ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123 (297)
T ss_dssp ------------------------------------------EEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHH
Confidence 3899999996 599988853 3699999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||
T Consensus 124 qi~~~l~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 201 (297)
T 3fxz_A 124 ECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWS 201 (297)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHH
T ss_pred HHHHHHHHHHhCCceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHH
Confidence 999999999999999999999999999 78899999999987654332 23445789999999999887 7899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++|+|++|+.||.+.+..+....+...... ....+..+++.+.+||.+||+
T Consensus 202 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------------------------ELQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------------------------CCSCGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------------------CCCCccccCHHHHHHHHHHcc
Confidence 999999999999999988777666555442110 001123578999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||.+|||+.|+|+ ||||+..+
T Consensus 256 ~dp~~Rps~~ell~-h~~~~~~~ 277 (297)
T 3fxz_A 256 MDVEKRGSAKELLQ-HQFLKIAK 277 (297)
T ss_dssp SSTTTSCCHHHHTT-CGGGGGCC
T ss_pred CChhHCcCHHHHhh-ChhhcccC
Confidence 99999999999999 99999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=371.46 Aligned_cols=288 Identities=30% Similarity=0.564 Sum_probs=230.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|++++.||+|+||.||+|++..+|+.||||++... ...+.+|++++++++||||+++++++...+...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~- 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD- 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT-
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc-
Confidence 4678999999999999999999999999999999998432 234568999999999999999999987653200
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (367)
T 1cm8_A 101 -------------------------------------------------------------------------------- 100 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
....+|+|||||+++|.+++.. .++++..++.++.|
T Consensus 101 ---------------------------------------~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~q 136 (367)
T 1cm8_A 101 ---------------------------------------DFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQ 136 (367)
T ss_dssp ---------------------------------------TCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHH
T ss_pred ---------------------------------------cCceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHH
Confidence 0023789999998899998853 57999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||+++.... ......+|+.|+|||.+.+...++.++|+||+|
T Consensus 137 i~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 213 (367)
T 1cm8_A 137 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213 (367)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred HHHHHHHHHHCCccccCcCHHHEEEc-CCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHH
Confidence 99999999999999999999999999 788999999999976532 234457799999999998754799999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|++|+|++|+.||.+.+..+++..+.+..|.++...+......... ..++......+... ..++++.+.+||.+||
T Consensus 214 ~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL 292 (367)
T 1cm8_A 214 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKML 292 (367)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHc
Confidence 9999999999999999999999999999999988776554321100 01222223333322 3467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.||.+|||+.|+|+ ||||+++....
T Consensus 293 ~~dP~~R~t~~e~l~-hp~f~~~~~~~ 318 (367)
T 1cm8_A 293 VLDAEQRVTAGEALA-HPYFESLHDTE 318 (367)
T ss_dssp CSSTTTSCCHHHHHH-SGGGTTTC---
T ss_pred cCChhHCCCHHHHhc-ChHHHhhcCCc
Confidence 999999999999999 99999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=366.75 Aligned_cols=284 Identities=35% Similarity=0.584 Sum_probs=227.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
....++|++++.||+|+||+||+|++..+|+.||||++... ...+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34568999999999999999999999999999999998532 134568999999999999999999986654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 86 ~------------------------------------------------------------------------------- 86 (346)
T 1ua2_A 86 N------------------------------------------------------------------------------- 86 (346)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 2
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.++|||||+++|.+++. .....+++..++.
T Consensus 87 -----------------------------------------------~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~ 116 (346)
T 1ua2_A 87 -----------------------------------------------ISLVFDFMETDLEVIIK---DNSLVLTPSHIKA 116 (346)
T ss_dssp -----------------------------------------------CEEEEECCSEEHHHHHT---TCCSSCCSSHHHH
T ss_pred -----------------------------------------------eEEEEEcCCCCHHHHHH---hcCcCCCHHHHHH
Confidence 88999999999988874 3446799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchh
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+...++.++|
T Consensus 117 ~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 195 (346)
T 1ua2_A 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 195 (346)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHH
T ss_pred HHHHHHHHHHHHHHCCEECCCCCHHHEEEc-CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhh
Confidence 999999999999999999999999999999 78899999999997654332 3344578999999999977646899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|||||++|+|++|.+||.+.+..+.+..+.+..+.+....|...........+.......+. .+...+++++.+||.+
T Consensus 196 iwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 274 (346)
T 1ua2_A 196 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH-HIFSAAGDDLLDLIQG 274 (346)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHH-HHCTTCCHHHHHHHHH
T ss_pred hHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChH-HhhccCCHHHHHHHHH
Confidence 999999999999999999999999999999998888876655443321111111111111111 1224678999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
||+.||.+|||+.|+|+ ||||++..
T Consensus 275 ~L~~dP~~Rpt~~ell~-h~~f~~~~ 299 (346)
T 1ua2_A 275 LFLFNPCARITATQALK-MKYFSNRP 299 (346)
T ss_dssp HHCSSTTTSCCHHHHHT-SGGGTSSS
T ss_pred HhccChhhCCCHHHHhc-ChhhhcCC
Confidence 99999999999999999 99998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=365.77 Aligned_cols=261 Identities=28% Similarity=0.380 Sum_probs=217.5
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
.+.++|++.+.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.++++++||||+++++++...+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG- 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 3568899999999999999999999999999999998432 345679999999999999999999987754
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (351)
T 3c0i_A 100 -------------------------------------------------------------------------------- 99 (351)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+|+|||||+ ++|.+.+......+..+++..++.
T Consensus 100 ---------------------------------------------~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~ 134 (351)
T 3c0i_A 100 ---------------------------------------------MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134 (351)
T ss_dssp ---------------------------------------------EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHH
T ss_pred ---------------------------------------------EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHH
Confidence 3899999998 589888876666667799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.||+.||+|||++|++|+||||+||+++.. ...++|+|||++........ .....+|+.|+|||.+.+. .++.+
T Consensus 135 i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 213 (351)
T 3c0i_A 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKP 213 (351)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTH
T ss_pred HHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCch
Confidence 99999999999999999999999999999732 23599999999977644332 3345789999999999877 78999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|+|||||++|+|++|..||.+. ..+....+........+..+ ..+++.+.+||
T Consensus 214 ~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~-------------------------~~~s~~~~~li 267 (351)
T 3c0i_A 214 VDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW-------------------------SHISESAKDLV 267 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH-------------------------TTSCHHHHHHH
T ss_pred HhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc-------------------------ccCCHHHHHHH
Confidence 99999999999999999999874 33444444442111111111 24689999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+||+.||.+|||+.|+|+ ||||++..
T Consensus 268 ~~~L~~dP~~R~s~~e~l~-hp~~~~~~ 294 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALN-HPWLKERD 294 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHT-SHHHHTHH
T ss_pred HHHCCCChhHCcCHHHHhc-ChhhcCCc
Confidence 9999999999999999999 99999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=362.79 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=220.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
+.+.++|++.+.||+|+||.||+|+++.+|+.||+|++... .+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 35778999999999999999999999999999999998543 24467899999999999999999998765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 87 ~------------------------------------------------------------------------------- 87 (326)
T 2y0a_A 87 T------------------------------------------------------------------------------- 87 (326)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
.+++|||||+ ++|.+++. ....+++..+
T Consensus 88 -----------------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~ 116 (326)
T 2y0a_A 88 -----------------------------------------------DVILILELVAGGELFDFLA----EKESLTEEEA 116 (326)
T ss_dssp -----------------------------------------------EEEEEEECCCSCBHHHHHT----TSSCCBHHHH
T ss_pred -----------------------------------------------EEEEEEEcCCCCCHHHHHH----hcCCcCHHHH
Confidence 3899999997 59999884 3467999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC----eEEEeecCCcccccCCCCCccccccccccCchhhccCCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG----VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~----~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+.++.||+.||.|||++|++|+||+|+||+++ ..+ .++|+|||++.............+++.|+|||.+.+. .+
T Consensus 117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 194 (326)
T 2y0a_A 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PL 194 (326)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEES-CSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CC
T ss_pred HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe-cCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCC-CC
Confidence 99999999999999999999999999999998 444 8999999999876555445566789999999999876 78
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|+||||+++|+|++|..||.+.+..+....+......... .....+++.+.
T Consensus 195 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~ 249 (326)
T 2y0a_A 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-------------------------EYFSNTSALAK 249 (326)
T ss_dssp CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-------------------------cccccCCHHHH
Confidence 99999999999999999999999988877777666553211111 11235689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+||.+||+.||.+|||+.|+|+ ||||+...
T Consensus 250 ~li~~~L~~dP~~Rpt~~e~l~-hp~~~~~~ 279 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMTIQDSLQ-HPWIKPKD 279 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH-STTTSCCS
T ss_pred HHHHHHccCChhhCCCHHHHhc-CCCccCCc
Confidence 9999999999999999999999 99998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=378.44 Aligned_cols=292 Identities=34% Similarity=0.521 Sum_probs=230.7
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
--.+.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 345779999999999999999999999999999999999542 24566899999999999999999988765310
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (432)
T 3n9x_A 101 -------------------------------------------------------------------------------- 100 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
....+|+|||||+++|.+++. ....+++..++.++
T Consensus 101 -----------------------------------------~~~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~ 135 (432)
T 3n9x_A 101 -----------------------------------------KFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTIL 135 (432)
T ss_dssp -----------------------------------------TCCCEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHH
T ss_pred -----------------------------------------cCCeEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHH
Confidence 001389999999999999885 45679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----------------------CCcccccc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----------------------PNVSYICS 307 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----------------------~~~~~~gt 307 (444)
.||+.||.|||++|++||||||+||+++ .++.+||+|||+++...... ......+|
T Consensus 136 ~qil~aL~~LH~~givHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 214 (432)
T 3n9x_A 136 YNLLLGENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214 (432)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEEC-------------------------------CCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHeEEC-CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCC
Confidence 9999999999999999999999999999 78899999999997654322 12455789
Q ss_pred ccccCchhhccCCCCCcchhhhhHHHHHHHHHh-----------CCCCCCCCC-----------------hhHHHHHHHH
Q psy10212 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-----------GQPMFPGDS-----------------GVDQLVEIIK 359 (444)
Q Consensus 308 ~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-----------G~~Pf~~~~-----------------~~e~~~~i~~ 359 (444)
+.|+|||.+.....++.++|+|||||++|+|++ |.++|.+.+ ..+++..+.+
T Consensus 215 ~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~ 294 (432)
T 3n9x_A 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294 (432)
T ss_dssp CTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHH
T ss_pred ccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHH
Confidence 999999987555479999999999999999998 555565544 3678888999
Q ss_pred HhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 360 VLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 360 ~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+|.+....+......... ...+......+...+ +.+++++.+||.+||++||.+|||+.|+|+ ||||++++...
T Consensus 295 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-Hp~f~~~~~~~ 372 (432)
T 3n9x_A 295 IIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALD-HPYLKDVRKKK 372 (432)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT-CGGGTTTCCTT
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHhcCCcccCCCHHHHhc-ChhhhhccCcc
Confidence 9999998877653211000 011111111111222 457999999999999999999999999999 99999987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=364.57 Aligned_cols=297 Identities=28% Similarity=0.510 Sum_probs=233.4
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------------cchhhHHHHhhhcCCCce
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------------RFKNREMQIMRRLEHSNI 77 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~E~~~l~~l~h~~i 77 (444)
-...+..+.++|.+.+.||+|+||.||+|++.. |+.||||++.... ..+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345678899999999999999999999999875 9999999984321 446689999999999999
Q ss_pred eEeeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCc
Q psy10212 78 VKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPT 157 (444)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (444)
+++++++...+..
T Consensus 92 v~~~~~~~~~~~~------------------------------------------------------------------- 104 (362)
T 3pg1_A 92 LGLRDIFVHFEEP------------------------------------------------------------------- 104 (362)
T ss_dssp CCCSEEEEECCTT-------------------------------------------------------------------
T ss_pred cceeeeEEeccCC-------------------------------------------------------------------
Confidence 9999998765420
Q ss_pred hhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhc
Q psy10212 158 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKS 237 (444)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~ 237 (444)
....+++|||||+++|.+.+. ..
T Consensus 105 ------------------------------------------------------~~~~~~lv~e~~~~~l~~~~~---~~ 127 (362)
T 3pg1_A 105 ------------------------------------------------------AMHKLYLVTELMRTDLAQVIH---DQ 127 (362)
T ss_dssp ------------------------------------------------------TCCEEEEEEECCSEEHHHHHH---CT
T ss_pred ------------------------------------------------------CcceEEEEEccCCCCHHHHHH---hc
Confidence 013589999999999999886 34
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhc
Q psy10212 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF 317 (444)
Q Consensus 238 ~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~ 317 (444)
...+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+.............+++.|+|||.+.
T Consensus 128 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (362)
T 3pg1_A 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206 (362)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCTTC---------------CGGGCCHHHHT
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc-CCCCEEEEecCcccccccccccceecccceecCcHHhc
Confidence 55799999999999999999999999999999999999998 78899999999997655555555667899999999998
Q ss_pred cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC----CcccCCCccCCCCcccc
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY----TEFKFPQIKSHPWSKVF 393 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~ 393 (444)
+...++.++|+|||||++|+|++|+.||.+.+..+....+....+.+....+....... ............+ ..+
T Consensus 207 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 285 (362)
T 3pg1_A 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAV 285 (362)
T ss_dssp TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHH
T ss_pred CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-Hhh
Confidence 74478999999999999999999999999999999999999999988876554322100 0001111111111 223
Q ss_pred cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 394 ~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.+.+++.+.+||.+||+.||.+|||+.|+|+ ||||+++....+
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-hp~f~~~~~~~~ 328 (362)
T 3pg1_A 286 VPTADPVALDLIAKMLEFNPQRRISTEQALR-HPYFESLFDPLD 328 (362)
T ss_dssp STTSCHHHHHHHHHHTCSSGGGSCCHHHHHT-SGGGTTTCCGGG
T ss_pred CCCCCHHHHHHHHHHhcCChhhCCCHHHHHc-CchhhhccCccc
Confidence 4567999999999999999999999999999 999999755443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.74 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=213.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..+.++|.+.+.||+|+||+||+|++..+++.+|+|++.... +.+.+|++++++++||||+++++++...+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 93 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH---- 93 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC----
Confidence 467799999999999999999999999999999999996543 45678999999999999999999986654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (285)
T 3is5_A 94 -------------------------------------------------------------------------------- 93 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++|||||++ +|.+.+.........+++..++.++.
T Consensus 94 ------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 131 (285)
T 3is5_A 94 ------------------------------------------NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131 (285)
T ss_dssp ------------------------------------------EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHH
T ss_pred ------------------------------------------eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHH
Confidence 38999999985 99999977666778899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
||+.||+|||++|++|+||+|+||+++. ..+.++|+|||++.............+++.|+|||.+.+ .++.++|+|
T Consensus 132 qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~ 209 (285)
T 3is5_A 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIW 209 (285)
T ss_dssp HHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHH
T ss_pred HHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCee
Confidence 9999999999999999999999999952 457899999999977655554556678999999999864 689999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||.+.+..+....+..... ..+ .....+++.+.+||.+||
T Consensus 210 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~---------~~~~~~~~~~~~li~~~L 263 (285)
T 3is5_A 210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-----------------NYA---------VECRPLTPQAVDLLKQML 263 (285)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------CCC---------C--CCCCHHHHHHHHHHT
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----------------ccc---------cccCcCCHHHHHHHHHHc
Confidence 999999999999999998876665544433100 000 001236899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~ 431 (444)
+.||++|||+.|+|+ ||||++
T Consensus 264 ~~dP~~Rps~~e~l~-hp~f~~ 284 (285)
T 3is5_A 264 TKDPERRPSAAQVLH-HEWFKQ 284 (285)
T ss_dssp CSCTTTSCCHHHHHT-SGGGGC
T ss_pred cCChhhCcCHHHHhc-CHHhhc
Confidence 999999999999999 999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.10 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=215.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 78 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------ 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS------
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC------
Confidence 6899999999999999999999999999999998543 234568999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (337)
T 1o6l_A 79 -------------------------------------------------------------------------------- 78 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++.. .+.+++..++.++.||
T Consensus 79 ----------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi 114 (337)
T 1o6l_A 79 ----------------------------------------RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEI 114 (337)
T ss_dssp ----------------------------------------EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHH
Confidence 38999999985 88888753 4579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++||||||+||+++ .++.++|+|||++.... .........||+.|+|||.+.+. .++.++|+||||
T Consensus 115 ~~aL~~LH~~~ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 192 (337)
T 1o6l_A 115 VSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLG 192 (337)
T ss_dssp HHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHH
T ss_pred HHHHHHHHHCCeecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccch
Confidence 9999999999999999999999999 78899999999987543 23334556789999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+... ... ++..+++++.+||.+||+.|
T Consensus 193 ~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 193 VVMYEMMCGRLPFYNQDHERLFELILME-----------------EIR------------FPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTCSS
T ss_pred hHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999988777766655541 111 23457999999999999999
Q ss_pred CCCCC-----CHHHHhccCchhhhhh
Q psy10212 413 PSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRP-----s~~elL~~hpwf~~~~ 433 (444)
|.+|| ++.|+++ ||||+.+.
T Consensus 244 P~~R~g~~~~~~~ei~~-h~~f~~~~ 268 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVME-HRFFLSIN 268 (337)
T ss_dssp TTTSTTCSTTTHHHHHT-SGGGTTCC
T ss_pred HHHhcCCCCCCHHHHHc-CCCcCCCC
Confidence 99999 8999999 99998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=361.93 Aligned_cols=282 Identities=26% Similarity=0.448 Sum_probs=228.3
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcC-----CCceeEeeeEEeecC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLE-----HSNIVKLKYFFYSSG 88 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~ 88 (444)
...+.++|+++++||+|+||+||+|++..+++.||||++... .....+|+.+++++. ||||+++++++...+
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 355679999999999999999999999999999999998543 344567999999996 999999999998764
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 110 -------------------------------------------------------------------------------- 109 (360)
T 3llt_A 110 -------------------------------------------------------------------------------- 109 (360)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||||+++|.+++.. .....+++..++.
T Consensus 110 ----------------------------------------------~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ 141 (360)
T 3llt_A 110 ----------------------------------------------HMCLIFEPLGPSLYEIITR--NNYNGFHIEDIKL 141 (360)
T ss_dssp ----------------------------------------------EEEEEECCCCCBHHHHHHH--TTTCCCCHHHHHH
T ss_pred ----------------------------------------------eeEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHH
Confidence 3899999998899999864 2334699999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcC------------------------CCCeEEEeecCCcccccCCCCCccc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNP------------------------ETGVLKLCDFGSAKHLVRGEPNVSY 304 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~------------------------~~~~ikL~Dfg~s~~~~~~~~~~~~ 304 (444)
++.||+.||+|||++|++|+||||+||+++. ..+.++|+|||++..... .....
T Consensus 142 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~ 219 (360)
T 3llt_A 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSI 219 (360)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSC
T ss_pred HHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCc
Confidence 9999999999999999999999999999972 277899999999976433 23456
Q ss_pred cccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc------
Q psy10212 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE------ 378 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~------ 378 (444)
.+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+..+...+.........
T Consensus 220 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 298 (360)
T 3llt_A 220 INTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKD 298 (360)
T ss_dssp CSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETT
T ss_pred cCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcc
Confidence 789999999999887 7999999999999999999999999999999999988888887776665543221100
Q ss_pred ---ccCCCccCC--------CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 379 ---FKFPQIKSH--------PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 379 ---~~~p~~~~~--------~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
...|..... .....+....++.+.+||.+||+.||.+|||+.|+|+ ||||+
T Consensus 299 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~-hp~f~ 360 (360)
T 3llt_A 299 ELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK-HKFLE 360 (360)
T ss_dssp TTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT-SGGGC
T ss_pred cceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc-CcccC
Confidence 000000000 0001112234588999999999999999999999999 99996
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.62 Aligned_cols=297 Identities=31% Similarity=0.508 Sum_probs=237.2
Q ss_pred hhhhhccccchhheecccceeEEEEeEec-CCCceeeeeeeecc------ccchhhHHHHhhhc---CCCceeEeeeEEe
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLL-DSGELVAIKKVLQD------KRFKNREMQIMRRL---EHSNIVKLKYFFY 85 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~------~~~~~~E~~~l~~l---~h~~i~~~~~~~~ 85 (444)
.+..+.++|++++.||+|+||+||+|++. .+|+.||+|++... ...+.+|+.+++++ .||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34567799999999999999999999995 67899999998533 23455788887777 8999999999987
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
.....
T Consensus 85 ~~~~~--------------------------------------------------------------------------- 89 (326)
T 1blx_A 85 VSRTD--------------------------------------------------------------------------- 89 (326)
T ss_dssp EEECS---------------------------------------------------------------------------
T ss_pred ecccC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~ 245 (444)
....+++||||++++|.+++... ....+++..
T Consensus 90 ----------------------------------------------~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~ 121 (326)
T 1blx_A 90 ----------------------------------------------RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTET 121 (326)
T ss_dssp ----------------------------------------------SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHH
T ss_pred ----------------------------------------------CCceEEEEEecCCCCHHHHHHhc--ccCCCCHHH
Confidence 01358999999999999998642 234589999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcc
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+.............++..|+|||.+.+. .++.+
T Consensus 122 ~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 199 (326)
T 1blx_A 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATP 199 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc-CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcc
Confidence 999999999999999999999999999999999 7889999999998765443334455779999999999877 78999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|+||||+++|+|++|+.||.+.+..+....+.+..+.+....|...... ....+... .......+...+++.+.+||
T Consensus 200 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li 277 (326)
T 1blx_A 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL-PRQAFHSK-SAQPIEKFVTDIDELGKDLL 277 (326)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS-CGGGSCCC-CCCCGGGTCCSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc-chhhhccc-CcchhhhccccCCHHHHHHH
Confidence 99999999999999999999999999999999998887776554331110 00011111 11122334567899999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhhhccc
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVFENIC 440 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~~ 440 (444)
.+||+.||.+|||+.|+|+ ||||++++...+++.
T Consensus 278 ~~~L~~dP~~Rpt~~e~l~-hp~~~~~~~~~~~~~ 311 (326)
T 1blx_A 278 LKCLTFNPAKRISAYSALS-HPYFQDLERCKENLD 311 (326)
T ss_dssp HHHSCSSTTTSCCHHHHHT-SGGGTTCCCCCCC--
T ss_pred HHHcCCCcccCCCHHHHhc-Cccccccchhhhhhc
Confidence 9999999999999999999 999999887665543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=350.08 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=221.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+++.++|++.+.||+|+||+||+|.++.+|+.||+|++.... ..+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 78 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--- 78 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC---
Confidence 357899999999999999999999999999999999985442 44568999999999999999999986553
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (284)
T 3kk8_A 79 -------------------------------------------------------------------------------- 78 (284)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++|||||++ +|.+.+.. ...+++..++.++
T Consensus 79 -------------------------------------------~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~ 111 (284)
T 3kk8_A 79 -------------------------------------------FHYLVFDLVTGGELFEDIVA----REFYSEADASHCI 111 (284)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHH
Confidence 38999999985 88887753 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||++|++|+||+|+||+++.+ .+.++|+|||.+.............+++.|+|||.+.+. .++.++|+
T Consensus 112 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 190 (284)
T 3kk8_A 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDI 190 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHH
T ss_pred HHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccch
Confidence 999999999999999999999999999722 235999999999776555555556789999999999877 78999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|+.||.+.+..+....+...... .+. .....+++.+.+||.+|
T Consensus 191 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~~~~~~~~~li~~~ 245 (284)
T 3kk8_A 191 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----------------YPS--------PEWDTVTPEAKSLIDSM 245 (284)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------------CCT--------TTTTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-----------------CCc--------hhhcccCHHHHHHHHHH
Confidence 99999999999999999988877766666552111 110 01124689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
|+.||++|||+.|+|+ ||||++.+.....
T Consensus 246 l~~dp~~Rps~~~~l~-h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 246 LTVNPKKRITADQALK-VPWICNRERVASA 274 (284)
T ss_dssp SCSSTTTSCCHHHHTT-SHHHHSCCCGGGS
T ss_pred cccChhhCCCHHHHhc-CccccCChhHHhH
Confidence 9999999999999999 9999987665543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=357.33 Aligned_cols=281 Identities=31% Similarity=0.581 Sum_probs=229.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|++++.||+|+||.||+|++..+|+.||||++.... ..+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK------ 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT------
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC------
Confidence 478999999999999999999999999999999984432 33558999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (331)
T 4aaa_A 98 -------------------------------------------------------------------------------- 97 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..++|||||++++.+.+. .....+++..++.++.||+
T Consensus 98 ----------------------------------------~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~ 134 (331)
T 4aaa_A 98 ----------------------------------------RWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQII 134 (331)
T ss_dssp ----------------------------------------EEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHH
Confidence 389999999986655543 2446799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++|++|+||+|+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||||+
T Consensus 135 ~~l~~LH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~ 213 (331)
T 4aaa_A 135 NGIGFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGC 213 (331)
T ss_dssp HHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred HHHHHHHHCCEEccCcChheEEEc-CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHH
Confidence 999999999999999999999999 7889999999998765332 22334567999999999987657899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHh--hCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
++|+|++|+.||.+.+..+....+....+...+..... ..+.+.....+............+.+++.+.+||.+||+.
T Consensus 214 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 293 (331)
T 4aaa_A 214 LVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293 (331)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhcc
Confidence 99999999999999999999999998888877654432 2333334444444433333333457899999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~ 432 (444)
||.+|||+.|+|+ ||||+..
T Consensus 294 dP~~Rpt~~ell~-hp~f~~~ 313 (331)
T 4aaa_A 294 DPDKRPFCAELLH-HDFFQMD 313 (331)
T ss_dssp SGGGSCCGGGGGG-SHHHHGG
T ss_pred CcccCCCHHHHhc-CchhccC
Confidence 9999999999999 9999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.98 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=219.5
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..+.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ..+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 101 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--- 101 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC---
Confidence 456789999999999999999999999999999999995432 45668999999999999999999987654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 102 -------------------------------------------------------------------------------- 101 (362)
T 2bdw_A 102 -------------------------------------------------------------------------------- 101 (362)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..|+|||||++ +|.+.+. ....+++..++.++
T Consensus 102 -------------------------------------------~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~ 134 (362)
T 2bdw_A 102 -------------------------------------------FHYLVFDLVTGGELFEDIV----AREFYSEADASHCI 134 (362)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHH
Confidence 48999999985 8988874 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||++|++|+||||+||+++.. .+.++|+|||++.............+|+.|+|||.+.+. .++.++|+
T Consensus 135 ~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di 213 (362)
T 2bdw_A 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDI 213 (362)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHH
T ss_pred HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC-CCCchhhH
Confidence 999999999999999999999999999732 346999999999876655545566789999999999877 78999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|..||.+.+..+....+...... ++. .. ...+++.+.+||.+|
T Consensus 214 wslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~---~~-----~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----------------YPS---PE-----WDTVTPEAKSLIDSM 268 (362)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------------CCT---TG-----GGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------------CCc---cc-----ccCCCHHHHHHHHHH
Confidence 99999999999999999988877776666552111 110 00 124689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|+.||.+|||+.|+|+ ||||+...
T Consensus 269 L~~dP~~R~t~~e~l~-hp~~~~~~ 292 (362)
T 2bdw_A 269 LTVNPKKRITADQALK-VPWICNRE 292 (362)
T ss_dssp SCSSGGGSCCHHHHTT-SHHHHTHH
T ss_pred cCCChhhCcCHHHHhc-CcccCCCc
Confidence 9999999999999999 99998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=364.16 Aligned_cols=287 Identities=32% Similarity=0.581 Sum_probs=235.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.++|++++.||+|+||.||+|++..+++.||||++.... ..+.+|++++++++||||+++++++......
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 100 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE---- 100 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT----
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc----
Confidence 4579999999999999999999999999999999995332 4566899999999999999999988654310
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (364)
T 3qyz_A 101 -------------------------------------------------------------------------------- 100 (364)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.....++||||++++|.+++.. .++++..++.++.||+
T Consensus 101 -------------------------------------~~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~ 138 (364)
T 3qyz_A 101 -------------------------------------QMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQIL 138 (364)
T ss_dssp -------------------------------------TCCCEEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHH
T ss_pred -------------------------------------ccceEEEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHH
Confidence 0024899999999999998853 4699999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+|||++|++|+||||+||+++ .++.++|+|||.+........ .....+|+.|+|||.+.+...++.++|+||
T Consensus 139 ~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 217 (364)
T 3qyz_A 139 RGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217 (364)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHH
T ss_pred HHHHHHHHCCeecCCCChHhEEEC-CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHH
Confidence 999999999999999999999999 788999999999976543221 234578999999998876656899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC---CcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY---TEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||++|+|++|+.||.+.+..+.+..+...++.+....+....... .....+......+.. +.+++++++.+||.+
T Consensus 218 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 296 (364)
T 3qyz_A 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDK 296 (364)
T ss_dssp HHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999887765432100 001112212222222 234679999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||+.||.+|||+.|+|+ ||||++....
T Consensus 297 ~L~~dP~~R~t~~e~l~-hp~~~~~~~~ 323 (364)
T 3qyz_A 297 MLTFNPHKRIEVEQALA-HPYLEQYYDP 323 (364)
T ss_dssp HTCSSTTTSCCHHHHHT-SGGGTTTCCG
T ss_pred HcCCChhhCCCHHHHhc-CcchhhccCc
Confidence 99999999999999999 9999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.30 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=221.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++.++|++.+.||+|+||+||+|++..+++.+|+|++... .+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 79 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT----- 79 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence 46789999999999999999999999999999999998543 356778999999999999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (277)
T 3f3z_A 80 -------------------------------------------------------------------------------- 79 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++ +|.+++.. ...+++..++.++.|
T Consensus 80 -----------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~ 114 (277)
T 3f3z_A 80 -----------------------------------------DIYLVMELCTGGELFERVVH----KRVFRESDAARIMKD 114 (277)
T ss_dssp -----------------------------------------EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 38999999975 89888753 456999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll---~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
|+.||.|||++|++|+||+|+||++ + .++.++|+|||.+.............+++.|+|||.+.+ .++.++|+|
T Consensus 115 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~ 191 (277)
T 3f3z_A 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEW 191 (277)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHH
T ss_pred HHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhheh
Confidence 9999999999999999999999999 5 678999999999977665555556678999999999865 489999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||...+..+....+.......+...+ .++++.+.++|.+||
T Consensus 192 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l 246 (277)
T 3f3z_A 192 SAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------------------------LNVSPQAESLIRRLL 246 (277)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-------------------------TTSCHHHHHHHHHHT
T ss_pred hHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-------------------------hcCCHHHHHHHHHHc
Confidence 9999999999999999998887777776663322222211 246899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+.||.+|||+.++|+ ||||++...
T Consensus 247 ~~dp~~R~s~~~~l~-h~~~~~~~~ 270 (277)
T 3f3z_A 247 TKSPKQRITSLQALE-HEWFEKQLS 270 (277)
T ss_dssp CSSTTTSCCHHHHTT-SHHHHHHHC
T ss_pred cCChhhCcCHHHHhc-CHHHhcccc
Confidence 999999999999999 999998544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.80 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=214.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..++|.+.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.+++.++||||+++++++...+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 82 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT---- 82 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC----
Confidence 457899999999999999999999999999999998532 235678999999999999999999987754
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (336)
T 3h4j_B 83 -------------------------------------------------------------------------------- 82 (336)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+++|||||+++|.+++.. .+++++..++.++.|
T Consensus 83 ------------------------------------------~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~q 116 (336)
T 3h4j_B 83 ------------------------------------------DIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQ 116 (336)
T ss_dssp ------------------------------------------EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 3899999999999998853 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++.............|++.|+|||.+.+....++++|+||||
T Consensus 117 i~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 195 (336)
T 3h4j_B 117 IICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195 (336)
T ss_dssp HHHHHHHHHHHTCCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHH
T ss_pred HHHHHHHHHHCCeEecCCchhhEEEc-CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHH
Confidence 99999999999999999999999999 78899999999998766655556678999999999998773447899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||.+....+.... .......++..+|+.+.+||.+||+.|
T Consensus 196 ~il~~ll~g~~Pf~~~~~~~~~~~-----------------------------i~~~~~~~p~~~s~~~~~li~~~L~~d 246 (336)
T 3h4j_B 196 IVLYVMLVGRLPFDDEFIPNLFKK-----------------------------VNSCVYVMPDFLSPGAQSLIRRMIVAD 246 (336)
T ss_dssp HHHHHHHHSSCSSBCSSSTTCBCC-----------------------------CCSSCCCCCTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHHhCCCCCCCccHHHHHHH-----------------------------HHcCCCCCcccCCHHHHHHHHHHcCCC
Confidence 999999999999976543221100 000111234567999999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|.+|||+.|+++ ||||+.
T Consensus 247 P~~Rpt~~eil~-hp~~~~ 264 (336)
T 3h4j_B 247 PMQRITIQEIRR-DPWFNV 264 (336)
T ss_dssp GGGSCCHHHHTT-CHHHHT
T ss_pred hhHCcCHHHHHh-Chhhcc
Confidence 999999999999 999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=367.00 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=213.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+|..+++.+ +||||+++++++...+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----- 97 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD----- 97 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----
Confidence 6899999999999999999999999999999998543 23455799999988 7999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (353)
T 3txo_A 98 -------------------------------------------------------------------------------- 97 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||++ +|.+++.. .+.+++..++.++.|
T Consensus 98 -----------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~q 132 (353)
T 3txo_A 98 -----------------------------------------RLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAE 132 (353)
T ss_dssp -----------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 38999999985 89888853 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||+|||++|++||||||+||+++ .++.++|+|||++..... ........||+.|+|||.+.+. .++.++|+|||
T Consensus 133 i~~aL~~LH~~givHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 210 (353)
T 3txo_A 133 IISALMFLHDKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAM 210 (353)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHH
T ss_pred HHHHHHHHHHCCCcccCCCHHHEEEC-CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcc
Confidence 99999999999999999999999999 789999999999875332 2334456789999999999877 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+....+... .. .++..+++.+.+||.+||+.
T Consensus 211 G~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 211 GVLLYEMLCGHAPFEAENEDDLFEAILND-----------------EV------------VYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCS
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhhh
Confidence 99999999999999998888887777652 11 12234689999999999999
Q ss_pred CCCCCCCH------HHHhccCchhhhhhh
Q psy10212 412 TPSSRISP------LQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~------~elL~~hpwf~~~~~ 434 (444)
||.+||++ .|+++ ||||+++..
T Consensus 262 dP~~R~~~~~~~~~~~il~-hp~f~~~~w 289 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILR-HPFFKEIDW 289 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHT-SGGGTTCCH
T ss_pred CHHHccCCcccCCHHHHhh-CCcccCCCH
Confidence 99999998 89999 999998653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=373.04 Aligned_cols=284 Identities=31% Similarity=0.546 Sum_probs=231.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhc------CCCceeEeeeEEeecC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRL------EHSNIVKLKYFFYSSG 88 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 88 (444)
+.+..+|++++.||+|+||+||+|++..+++.||||++.... ..+.+|+++++.+ .|+||+++++.+...+
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 346678999999999999999999999999999999996543 4455788888877 5779999999987764
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 173 -------------------------------------------------------------------------------- 172 (429)
T 3kvw_A 173 -------------------------------------------------------------------------------- 172 (429)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||||+++|.+++.. .....+++..++.
T Consensus 173 ----------------------------------------------~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~~~ 204 (429)
T 3kvw_A 173 ----------------------------------------------HICMTFELLSMNLYELIKK--NKFQGFSLPLVRK 204 (429)
T ss_dssp ----------------------------------------------EEEEEECCCCCBHHHHHHH--TTTCCCCHHHHHH
T ss_pred ----------------------------------------------eEEEEEeccCCCHHHHHHh--ccCCCCCHHHHHH
Confidence 4899999999999999864 2334599999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe--EEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcch
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGV--LKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~--ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
++.||+.||+|||++|++||||||+||+++ ..+. ++|+|||++.... .......+|+.|+|||.+.+. .++.++
T Consensus 205 i~~qi~~aL~~LH~~~ivHrDlKp~NILl~-~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 280 (429)
T 3kvw_A 205 FAHSILQCLDALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPI 280 (429)
T ss_dssp HHHHHHHHHHHHHHHTEECSCCSGGGEEES-STTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHH
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHeEEc-cCCCcceEEeecccceecC--CcccccCCCCCccChHHHhCC-CCCchH
Confidence 999999999999999999999999999998 5555 9999999986543 233456789999999999887 799999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC---cccCC---------------------
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EFKFP--------------------- 382 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~---~~~~p--------------------- 382 (444)
|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+........ ....|
T Consensus 281 DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (429)
T 3kvw_A 281 DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSR 360 (429)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECT
T ss_pred HHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccc
Confidence 999999999999999999999999999999999999998876654211000 00000
Q ss_pred ------CccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 383 ------QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 383 ------~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
......|...++...++.+.+||.+||++||++|||+.|+|+ ||||++...
T Consensus 361 ~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~-Hpw~~~~~~ 417 (429)
T 3kvw_A 361 RGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR-HPWLRRRLP 417 (429)
T ss_dssp TCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT-STTTC----
T ss_pred hhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC-ChhhccCCC
Confidence 011223334445567899999999999999999999999999 999998543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.55 Aligned_cols=294 Identities=29% Similarity=0.473 Sum_probs=229.5
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
+....++|++++.||+|+||+||+|+++.+|+.||||++.... ..+.+|++++++++||||+++++++......
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 4445689999999999999999999999999999999884332 2455899999999999999999999875420
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
-
T Consensus 92 ~------------------------------------------------------------------------------- 92 (351)
T 3mi9_A 92 Y------------------------------------------------------------------------------- 92 (351)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
......+++|||||+++|.+.+. .....+++..++.++
T Consensus 93 ---------------------------------------~~~~~~~~lv~e~~~~~l~~~l~---~~~~~~~~~~~~~i~ 130 (351)
T 3mi9_A 93 ---------------------------------------NRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVM 130 (351)
T ss_dssp -------------------------------------------CEEEEEEECCSEEHHHHHH---CTTSCCCHHHHHHHH
T ss_pred ---------------------------------------ccCCceEEEEEeccCCCHHHHHh---hccCCCCHHHHHHHH
Confidence 00013589999999999988875 344579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----CCCccccccccccCchhhccCCCCCcc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-----EPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
.||+.||+|||++|++|+||||+||+++ .++.++|+|||++...... .......+|+.|+|||.+.+...++.+
T Consensus 131 ~qi~~~l~~LH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 209 (351)
T 3mi9_A 131 QMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 209 (351)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTH
T ss_pred HHHHHHHHHHHHCCeeCCCCCHHHEEEc-CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcH
Confidence 9999999999999999999999999999 7889999999998765322 222345679999999999876578999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC--CCcccCCCccCCCCcccc-cCCCChhHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKSHPWSKVF-RVRTPPDAI 402 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~-~~~~s~~l~ 402 (444)
+|+|||||++|+|++|+.||.+.+..+....+....+...+..++..... +................+ ....++.+.
T Consensus 210 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (351)
T 3mi9_A 210 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 289 (351)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHH
Confidence 99999999999999999999999999999999988887766544332110 000000000000000000 011378899
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+||.+||+.||.+|||+.|+|+ ||||++..
T Consensus 290 ~li~~~L~~dP~~R~t~~e~l~-hp~f~~~~ 319 (351)
T 3mi9_A 290 DLIDKLLVLDPAQRIDSDDALN-HDFFWSDP 319 (351)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT-SGGGGSSS
T ss_pred HHHHHHhcCChhhCCCHHHHhC-CCCcCCCC
Confidence 9999999999999999999999 99998743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=370.33 Aligned_cols=289 Identities=30% Similarity=0.562 Sum_probs=220.5
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|++++.||+|+||.||+|++..+|+.||||++... ...+.+|++++++++||||+++++++......
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-- 103 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL-- 103 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG--
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc--
Confidence 5678999999999999999999999999999999998532 24555899999999999999999998654310
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 104 -------------------------------------------------------------------------------- 103 (367)
T 2fst_X 104 -------------------------------------------------------------------------------- 103 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
......|+|||+++++|.+++.. ..+++..++.++.|
T Consensus 104 --------------------------------------~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~q 140 (367)
T 2fst_X 104 --------------------------------------EEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQ 140 (367)
T ss_dssp --------------------------------------GGCCCCEEEEECCCEECC----------CCCCHHHHHHHHHH
T ss_pred --------------------------------------ccCCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHH
Confidence 00023789999999999888752 57999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||+++.... ......+|+.|+|||.+.+...++.++|+||||
T Consensus 141 i~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 217 (367)
T 2fst_X 141 ILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217 (367)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHH
T ss_pred HHHHHHHHHHCCeeeCCCCHhhEEEC-CCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHH
Confidence 99999999999999999999999999 788999999999976432 234457899999999998755789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|++|+|++|+.||.+.+..+.+..+.+.+|.+....+......... ..++......+...+ .++++.+.+||.+||
T Consensus 218 ~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL 296 (367)
T 2fst_X 218 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKML 296 (367)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhC
Confidence 9999999999999999999999999999999988776543221000 011222222222222 367899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
++||.+|||+.|+|+ ||||+++....+
T Consensus 297 ~~dP~~R~t~~e~L~-hp~~~~~~~~~~ 323 (367)
T 2fst_X 297 VLDSDKRITAAQALA-HAYFAQYHDPDD 323 (367)
T ss_dssp CSSGGGSCCHHHHHT-SGGGTTTCCGGG
T ss_pred CCCcccCcCHHHHhc-ChhhhhccCCCC
Confidence 999999999999999 999998766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=369.57 Aligned_cols=287 Identities=29% Similarity=0.499 Sum_probs=220.6
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|++++.||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++||||+++++++...+..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--- 99 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL--- 99 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST---
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc---
Confidence 568999999999999999999999999999999998542 23456899999999999999999998765420
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (371)
T 2xrw_A 100 -------------------------------------------------------------------------------- 99 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
......++|||||+++|.+.+. ..+++..++.++.||
T Consensus 100 -------------------------------------~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi 136 (371)
T 2xrw_A 100 -------------------------------------EEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQM 136 (371)
T ss_dssp -------------------------------------TTCCEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHH
T ss_pred -------------------------------------ccccceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHH
Confidence 0012489999999999998874 358999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++|++|+||||+||+++ .++.++|+|||++.............+++.|+|||.+.+. .++.++|+|||||
T Consensus 137 ~~al~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 214 (371)
T 2xrw_A 137 LCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 214 (371)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHH
T ss_pred HHHHHHHHHCCeecccCCHHHEEEc-CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHH
Confidence 9999999999999999999999999 7889999999999776544444556789999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc--cCCCccCCCCcccc-----------cCCCChh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVF-----------RVRTPPD 400 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~-----------~~~~s~~ 400 (444)
++|+|++|+.||.+.+..+....+.+.++.+.+..+..+.+..... ..+......+...+ ....++.
T Consensus 215 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (371)
T 2xrw_A 215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 294 (371)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHH
Confidence 9999999999999999999999999988888877664432110000 00111111111111 0112578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.+||.+||+.||.+|||+.|+|+ ||||+.....
T Consensus 295 ~~~li~~mL~~dP~~R~t~~e~l~-hp~~~~~~~~ 328 (371)
T 2xrw_A 295 ARDLLSKMLVIDASKRISVDEALQ-HPYINVWYDP 328 (371)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH-SHHHHTTCCH
T ss_pred HHHHHHHHCcCChhhCCCHHHHhC-CcchhhhcCc
Confidence 999999999999999999999999 9999975443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=355.71 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=221.3
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
..+.++|++.+.||+|+||.||+|+++.+|+.||+|.+... .+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45778999999999999999999999999999999998543 23467899999999999999999998765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 88 ~------------------------------------------------------------------------------- 88 (321)
T 2a2a_A 88 T------------------------------------------------------------------------------- 88 (321)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
..++|||||+ ++|.+++. ....+++..+
T Consensus 89 -----------------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~ 117 (321)
T 2a2a_A 89 -----------------------------------------------DVVLILELVSGGELFDFLA----QKESLSEEEA 117 (321)
T ss_dssp -----------------------------------------------EEEEEECCCCSCBHHHHHH----TCSCEEHHHH
T ss_pred -----------------------------------------------EEEEEEEcCCCCcHHHHHH----hcCCCCHHHH
Confidence 3899999997 59999885 3467899999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC----eEEEeecCCcccccCCCCCccccccccccCchhhccCCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG----VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~----~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+.++.||+.||+|||++|++|+||+|+||+++ .++ .++|+|||++.............+++.|+|||.+.+. .+
T Consensus 118 ~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 195 (321)
T 2a2a_A 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PL 195 (321)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CC
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCChHHEEEe-cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCC-CC
Confidence 99999999999999999999999999999998 455 7999999999876555545566789999999999877 78
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|+||||+++|+|++|..||.+.+..+....+........ ..+...+++.+.
T Consensus 196 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~ 250 (321)
T 2a2a_A 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-------------------------EEFFSHTSELAK 250 (321)
T ss_dssp CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHH
T ss_pred CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-------------------------hhhhcccCHHHH
Confidence 9999999999999999999999998887776666554221111 112235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+||.+||+.||.+|||+.|+|+ ||||+.....
T Consensus 251 ~li~~~l~~dp~~Rps~~e~l~-hp~~~~~~~~ 282 (321)
T 2a2a_A 251 DFIRKLLVKETRKRLTIQEALR-HPWITPVDNQ 282 (321)
T ss_dssp HHHHTTSCSSTTTSCCHHHHHH-STTTSCSSHH
T ss_pred HHHHHHcCCChhhCcCHHHHhc-CccccCCCcc
Confidence 9999999999999999999999 9999875543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=366.63 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=195.5
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|.+.++||+|+||+||+|++ +|+.||||++.... ..+++|+..+.+++|||||++++++...+..
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~------- 72 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT------- 72 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-------
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC-------
Confidence 35788999999999999999998 69999999995442 2233577777889999999999999876520
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (303)
T 3hmm_A 73 -------------------------------------------------------------------------------- 72 (303)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
...+|||||||+ |+|.+++.. .++++..+..++.|++.|
T Consensus 73 -----------------------------------~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~g 112 (303)
T 3hmm_A 73 -----------------------------------WTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASG 112 (303)
T ss_dssp -----------------------------------SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHH
T ss_pred -----------------------------------ceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHH
Confidence 024899999998 699999853 468999999999999999
Q ss_pred HHHHHHC--------CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCC---
Q psy10212 257 LAYIHVL--------GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAI--- 320 (444)
Q Consensus 257 L~yLHs~--------givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~--- 320 (444)
|+|||++ +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+..
T Consensus 113 l~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~ 191 (303)
T 3hmm_A 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 191 (303)
T ss_dssp HHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTT
T ss_pred HHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccccc
Confidence 9999987 899999999999999 789999999999976543322 22347899999999987542
Q ss_pred --CCCcchhhhhHHHHHHHHHhCCCCCCCCChhH-----------HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 321 --DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD-----------QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 321 --~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e-----------~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
.++.++|||||||++|||++|..||......+ ....+.+.+. .......+|.
T Consensus 192 ~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------~~~~rp~~p~---- 256 (303)
T 3hmm_A 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC-----------EQKLRPNIPN---- 256 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT-----------TSCCCCCCCG----
T ss_pred CCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh-----------cccCCCCCCc----
Confidence 35679999999999999999987764322111 0111111100 0000000110
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
......++..+.+|+.+||+.||++|||+.|+++ -++++...
T Consensus 257 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~---~L~~l~~~ 298 (303)
T 3hmm_A 257 ---RWQSCEALRVMAKIMRECWYANGAARLTALRIKK---TLSQLSQQ 298 (303)
T ss_dssp ---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH---HHHHHHHC
T ss_pred ---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH---HHHHHHHH
Confidence 0001123467899999999999999999999999 57776543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.33 Aligned_cols=289 Identities=33% Similarity=0.592 Sum_probs=231.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|.+.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||+++++++...+...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~- 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR- 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST-
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc-
Confidence 4678999999999999999999999999999999999543 245568999999999999999999987654200
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 118 -------------------------------------------------------------------------------- 117 (371)
T 4exu_A 118 -------------------------------------------------------------------------------- 117 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....++|||||+++|.+.+ ...+++..++.++.|
T Consensus 118 ---------------------------------------~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~q 152 (371)
T 4exu_A 118 ---------------------------------------NFYDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQ 152 (371)
T ss_dssp ---------------------------------------TCCCCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHH
T ss_pred ---------------------------------------cceeEEEEEccccccHHHHh------hcCCCHHHHHHHHHH
Confidence 00226899999999988876 345999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++|++|+||||+||+++ .++.++|+|||++..... ......+++.|+|||.+.+...++.++|+||||
T Consensus 153 i~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (371)
T 4exu_A 153 MLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG 229 (371)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHH
T ss_pred HHHHHHHHHHCCCcCCCcCHHHeEEC-CCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHH
Confidence 99999999999999999999999999 788999999999975432 234456799999999998754889999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc---cCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|++|+|++|+.||.+.+..+.+..+.+..+.+....+..+....... ..+......+. .+.+.+++.+.+||.+||
T Consensus 230 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L 308 (371)
T 4exu_A 230 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKML 308 (371)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHC
Confidence 99999999999999999999999999999988876654432111000 11111111111 123467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+.||.+|||+.|+|+ ||||+.++...+.
T Consensus 309 ~~dP~~Rpt~~ell~-hp~f~~~~~~~~~ 336 (371)
T 4exu_A 309 ELDVDKRLTAAQALT-HPFFEPFRDPEEE 336 (371)
T ss_dssp CSCTTTSCCHHHHHT-SGGGTTTCCGGGC
T ss_pred CCChhhcCCHHHHhc-CcccccCCCcccc
Confidence 999999999999999 9999988765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=373.80 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=218.5
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
...+.++|++++.||+|+||+||+|+++.+|+.||+|++.... ..+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 83 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-- 83 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--
Confidence 4567899999999999999999999999999999999985432 45678999999999999999999987654
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (444)
T 3soa_A 84 -------------------------------------------------------------------------------- 83 (444)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..|+|||||++ +|.+.+.. ...+++..++.+
T Consensus 84 --------------------------------------------~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i 115 (444)
T 3soa_A 84 --------------------------------------------HHYLIFDLVTGGELFEDIVA----REYYSEADASHC 115 (444)
T ss_dssp --------------------------------------------EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHH
T ss_pred --------------------------------------------EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHH
Confidence 48999999985 89888853 467999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcch
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
+.||+.||.|||++|++||||||+||+++. .++.++|+|||++........ .....||+.|+|||.+.+. .++.++
T Consensus 116 ~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~ 194 (444)
T 3soa_A 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPV 194 (444)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHH
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCcc
Confidence 999999999999999999999999999974 357899999999976544322 2445789999999999877 789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|||||||++|+|++|..||.+.+..+....+...... ++. ..| ..+++.+.+||.
T Consensus 195 DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~---~~~-----~~~s~~~~~li~ 249 (444)
T 3soa_A 195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-----------------FPS---PEW-----DTVTPEAKDLIN 249 (444)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----------------CCT---TTT-----TTSCHHHHHHHH
T ss_pred ccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----------------CCc---ccc-----ccCCHHHHHHHH
Confidence 9999999999999999999998887777776652211 111 111 246899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+||+.||.+|||+.|+|+ ||||+...
T Consensus 250 ~~L~~dP~~Rpta~e~L~-hp~~~~~~ 275 (444)
T 3soa_A 250 KMLTINPSKRITAAEALK-HPWISHRS 275 (444)
T ss_dssp HHSCSSTTTSCCHHHHHH-SCTTHHHH
T ss_pred HHcCCChhHCCCHHHHhc-CccccCCc
Confidence 999999999999999999 99998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=349.00 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=204.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..++|++++.||+|+||+||+|++..+|+.||+|++.... ..+.++...++.++||||+++++++...+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~---- 80 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD---- 80 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS----
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC----
Confidence 4589999999999999999999999999999999985432 223345556888899999999999986643
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (290)
T 3fme_A 81 -------------------------------------------------------------------------------- 80 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.++|||||+++|.+++.........+++..++.++.||
T Consensus 81 ------------------------------------------~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi 118 (290)
T 3fme_A 81 ------------------------------------------VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118 (290)
T ss_dssp ------------------------------------------EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 89999999999999988777778899999999999999
Q ss_pred HHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhc---cCCCCCcchhhh
Q psy10212 254 FRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF---GAIDYTTKIDVW 329 (444)
Q Consensus 254 l~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~s~~sDiw 329 (444)
+.||+|||++ |++|+||||+||+++ ..+.++|+|||.+.............+++.|+|||.+. ....++.++|+|
T Consensus 119 ~~~l~~lH~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~ 197 (290)
T 3fme_A 119 VKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197 (290)
T ss_dssp HHHHHHHHHHSCCCCCCCSGGGCEEC-TTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHH
T ss_pred HHHHHHHhhcCCeecCCCCHHHEEEC-CCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHH
Confidence 9999999998 999999999999999 78899999999997765555455557899999999972 333789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLLGQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||+++|+|++|+.||.... ............ .+ ......+++.+.++|.+|
T Consensus 198 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~~~~~~li~~~ 250 (290)
T 3fme_A 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-------------------SP--------QLPADKFSAEFVDFTSQC 250 (290)
T ss_dssp HHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-------------------CC--------CCCTTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCccccCchHHHHHHHhccC-------------------CC--------CcccccCCHHHHHHHHHH
Confidence 99999999999999998643 333333333310 00 001134689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
|+.||.+|||+.|+|+ ||||+......
T Consensus 251 l~~~p~~Rpt~~e~l~-hp~f~~~~~~~ 277 (290)
T 3fme_A 251 LKKNSKERPTYPELMQ-HPFFTLHESKG 277 (290)
T ss_dssp TCSSGGGSCCHHHHTT-SHHHHHHHHSC
T ss_pred hhcChhhCcCHHHHHh-CcccccCcccc
Confidence 9999999999999999 99999865543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.91 Aligned_cols=293 Identities=28% Similarity=0.511 Sum_probs=216.7
Q ss_pred hhhhccccchh-heecccceeEEEEeEec--CCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 17 FSDLDNSLAQK-TVIGNGSFGIVYQAKLL--DSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 17 ~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
...+.+.|++. ++||+|+||+||+|+++ .+++.||||++... ...+.+|+.++++|+||||+++++++.....
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 92 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHAD-- 92 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT--
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC--
Confidence 34667788884 48999999999999976 46899999999544 3456789999999999999999999987543
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (405)
T 3rgf_A 93 -------------------------------------------------------------------------------- 92 (405)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhc-----CCCCChHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKS-----KQNFPCFYT 246 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~-----~~~l~~~~i 246 (444)
..+++|||||+++|.+++...... ...+++..+
T Consensus 93 ------------------------------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~ 130 (405)
T 3rgf_A 93 ------------------------------------------RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130 (405)
T ss_dssp ------------------------------------------TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHH
T ss_pred ------------------------------------------CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHH
Confidence 358999999999999988654332 235999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc---CCCCeEEEeecCCcccccCC----CCCccccccccccCchhhccC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLN---PETGVLKLCDFGSAKHLVRG----EPNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~---~~~~~ikL~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~l~~~ 319 (444)
+.++.||+.||.|||++||+||||||+||++. ...+.++|+|||++...... .......+|+.|+|||.+.+.
T Consensus 131 ~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (405)
T 3rgf_A 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210 (405)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC
Confidence 99999999999999999999999999999993 26789999999999765432 122345779999999999876
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCCh---------hHHHHHHHHHhCCCCHHHHHhhCCCCC---------cccC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSG---------VDQLVEIIKVLGTPTREQIREMNPNYT---------EFKF 381 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~---------~e~~~~i~~~~g~~~~~~~~~~~~~~~---------~~~~ 381 (444)
..++.++|||||||++|+|++|+.||.+.+. .+.+..+++.+|.+....|........ ....
T Consensus 211 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (405)
T 3rgf_A 211 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290 (405)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG
T ss_pred CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC
Confidence 4689999999999999999999999986554 478888999998887655543211000 0000
Q ss_pred CCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 382 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 382 p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.......+........++.+.+||.+||++||.+|||+.|+|+ ||||++...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~-hp~f~~~~~ 342 (405)
T 3rgf_A 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ-DPYFLEDPL 342 (405)
T ss_dssp TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT-SGGGTSSSC
T ss_pred CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc-ChhhccCCC
Confidence 0000000001112234789999999999999999999999999 999988543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=354.98 Aligned_cols=282 Identities=27% Similarity=0.505 Sum_probs=221.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeec-cccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ-DKRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.++|++++.||+|+||+||+|++..+++.||||++.. ....+.+|+++++++. ||||+++++++.....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~--------- 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS--------- 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---------
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---------
Confidence 3789999999999999999999999999999999854 3466779999999997 9999999999876432
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 106 -------------------------------------------------------------------------------- 105 (330)
T 3nsz_A 106 -------------------------------------------------------------------------------- 105 (330)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
...++|||||++ +|.+++. .+++..++.++.||+.||
T Consensus 106 -----------------------------------~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l 143 (330)
T 3nsz_A 106 -----------------------------------RTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKAL 143 (330)
T ss_dssp -----------------------------------CCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHH
T ss_pred -----------------------------------CceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHH
Confidence 248899999985 7766652 489999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
+|||++|++|+||||+||+++.+...++|+|||++.............++..|+|||.+.+...++.++|+|||||++|+
T Consensus 144 ~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 99999999999999999999855559999999999876655555566789999999999875478999999999999999
Q ss_pred HHhCCCCCC-CCChhHHHHHHHHHhCCCCHHHHHhh-CCCCCc---ccCCCccCCCCcccc----cCCCChhHHHHHHHh
Q psy10212 338 LLLGQPMFP-GDSGVDQLVEIIKVLGTPTREQIREM-NPNYTE---FKFPQIKSHPWSKVF----RVRTPPDAIDLISRL 408 (444)
Q Consensus 338 LltG~~Pf~-~~~~~e~~~~i~~~~g~~~~~~~~~~-~~~~~~---~~~p~~~~~~~~~~~----~~~~s~~l~~LI~~~ 408 (444)
|++|+.||. +.+..+.+..+.+..+.+....+... ...... ..........|...+ ...+++.+.+||.+|
T Consensus 224 ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred HHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 999999985 44556666666666554332221111 000000 000011111222111 233799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++||.+|||+.|+|+ ||||+++..
T Consensus 304 L~~dP~~Rpta~e~l~-hp~f~~~~~ 328 (330)
T 3nsz_A 304 LRYDHQSRLTAREAME-HPYFYTVVK 328 (330)
T ss_dssp SCSSGGGSCCHHHHHT-SGGGTTCC-
T ss_pred hcCCcccCCCHHHHhc-CccHhhhcc
Confidence 9999999999999999 999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=355.76 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=215.7
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||+|++... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~------ 79 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ------ 79 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS------
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC------
Confidence 6899999999999999999999999999999998543 234557999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (318)
T 1fot_A 80 -------------------------------------------------------------------------------- 79 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++.. ...+++..++.++.||
T Consensus 80 ----------------------------------------~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi 115 (318)
T 1fot_A 80 ----------------------------------------QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEV 115 (318)
T ss_dssp ----------------------------------------EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHH
Confidence 38999999985 99998853 4579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++|++||||||+||+++ .++.++|+|||++..... ......||+.|+|||.+.+. .++.++|+|||||
T Consensus 116 ~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 191 (318)
T 1fot_A 116 CLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGI 191 (318)
T ss_dssp HHHHHHHHTTTEECCCCCGGGEEEC-TTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHH
T ss_pred HHHHHHHHHCCccccCCChheEEEc-CCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHH
Confidence 9999999999999999999999999 789999999999976533 23456789999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+....+... ... ++..+++++.++|.+||+.||
T Consensus 192 il~ell~g~~pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~~~~~~~li~~lL~~dp 242 (318)
T 1fot_A 192 LIYEMLAGYTPFYDSNTMKTYEKILNA-----------------ELR------------FPPFFNEDVKDLLSRLITRDL 242 (318)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTCSCT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHHhccCH
Confidence 999999999999988877777766651 111 233578999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~~ 433 (444)
.+|| ++.++++ ||||+++.
T Consensus 243 ~~R~~~~~~~~~~i~~-hp~f~~~~ 266 (318)
T 1fot_A 243 SQRLGNLQNGTEDVKN-HPWFKEVV 266 (318)
T ss_dssp TTCTTSSTTTTHHHHT-SGGGSSCC
T ss_pred HHcCCCcCCCHHHHhc-CccccCCC
Confidence 9999 8999999 99998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=350.55 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=206.9
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------------------------cchhhHHHHhh
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------------------------RFKNREMQIMR 70 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------------------~~~~~E~~~l~ 70 (444)
.++|++.+.||+|+||.||+|++..+|+.||||++.... +.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999985432 44678999999
Q ss_pred hcCCCceeEeeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHH
Q psy10212 71 RLEHSNIVKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEII 150 (444)
Q Consensus 71 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (444)
+++||||+++++++.....
T Consensus 92 ~l~h~~iv~~~~~~~~~~~------------------------------------------------------------- 110 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNE------------------------------------------------------------- 110 (298)
T ss_dssp TCCCTTBCCEEEEEECSSS-------------------------------------------------------------
T ss_pred hCCCCCCCeEEEEEEcCCC-------------------------------------------------------------
Confidence 9999999999999876432
Q ss_pred HhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHH
Q psy10212 151 KVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYK 229 (444)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~ 229 (444)
..+++|||||++ +|.+
T Consensus 111 ---------------------------------------------------------------~~~~lv~e~~~~~~l~~ 127 (298)
T 2zv2_A 111 ---------------------------------------------------------------DHLYMVFELVNQGPVME 127 (298)
T ss_dssp ---------------------------------------------------------------SEEEEEEECCTTCBSCC
T ss_pred ---------------------------------------------------------------CEEEEEEecCCCCcHHH
Confidence 358999999985 6655
Q ss_pred HHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-Cccccccc
Q psy10212 230 VAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSR 308 (444)
Q Consensus 230 ~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~ 308 (444)
+. ...++++..++.++.||+.||+|||++|++|+||||+||+++ .++.++|+|||++........ .....+++
T Consensus 128 ~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 201 (298)
T 2zv2_A 128 VP-----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTP 201 (298)
T ss_dssp SS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCG
T ss_pred Hh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCc
Confidence 42 345799999999999999999999999999999999999999 788999999999976543322 23457899
Q ss_pred cccCchhhccCCC--CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccC
Q psy10212 309 YYRAPELIFGAID--YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386 (444)
Q Consensus 309 ~y~aPE~l~~~~~--~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~ 386 (444)
.|+|||.+.+... .+.++|+||||+++|+|++|+.||.+.+.......+... ...++.
T Consensus 202 ~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~~~~~--- 261 (298)
T 2zv2_A 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ-----------------ALEFPD--- 261 (298)
T ss_dssp GGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCCCCS---
T ss_pred cccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcc-----------------cCCCCC---
Confidence 9999999876522 478899999999999999999999887765554444331 111111
Q ss_pred CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 387 ~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
...+++.+.+||.+||+.||.+|||+.|+|+ ||||+.
T Consensus 262 -------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~-hp~~~~ 298 (298)
T 2zv2_A 262 -------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL-HPWVTR 298 (298)
T ss_dssp -------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT-CHHHHC
T ss_pred -------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc-CccccC
Confidence 1357899999999999999999999999999 999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=345.89 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=216.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
-+.++|++++.||+|+||+||+|++..+|+.||+|.+... .+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 3568899999999999999999999999999999998543 345678999999999999999999987654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (283)
T 3bhy_A 82 -------------------------------------------------------------------------------- 81 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..++|||||+ ++|.+++.. ...+++..++
T Consensus 82 ----------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~ 111 (283)
T 3bhy_A 82 ----------------------------------------------DVVLILELVSGGELFDFLAE----KESLTEDEAT 111 (283)
T ss_dssp ----------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHH
T ss_pred ----------------------------------------------eEEEEEeecCCCcHHHHHHh----cCCCCHHHHH
Confidence 3899999997 699998853 4579999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC----eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCC
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG----VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~----~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
.++.||+.||.|||++|++|+||+|+||+++ ..+ .++|+|||.+.............+++.|+|||.+.+. .++
T Consensus 112 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 189 (283)
T 3bhy_A 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLL-DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLG 189 (283)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEES-CSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTC-CCC
T ss_pred HHHHHHHHHHHHHHhCCccCCCCChHHEEEe-cCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCC-CCC
Confidence 9999999999999999999999999999998 444 8999999999776554444555789999999999877 789
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+||||+++|+|++|..||.+.+..+....+........ ......+++.+.+
T Consensus 190 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~ 244 (283)
T 3bhy_A 190 LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------------------EEYFSNTSELAKD 244 (283)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------------------------chhcccCCHHHHH
Confidence 999999999999999999999998877666655543211111 1122356899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+|.+||..||.+|||+.|+|+ ||||+.++...
T Consensus 245 li~~~l~~dp~~Rps~~~~l~-h~~~~~~~~~~ 276 (283)
T 3bhy_A 245 FIRRLLVKDPKRRMTIAQSLE-HSWIKAIRRRN 276 (283)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH-CHHHHHHHHCC
T ss_pred HHHHHccCCHhHCcCHHHHHh-CHHHHHHHHHh
Confidence 999999999999999999999 99999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.73 Aligned_cols=270 Identities=27% Similarity=0.420 Sum_probs=218.1
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEee
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYS 86 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (444)
.+.++.++|++.+.||+|+||+||+|++..+++.||+|++... .+.+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4678899999999999999999999999999999999998543 2456689999999999999999999876
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+
T Consensus 100 ~~------------------------------------------------------------------------------ 101 (345)
T 3hko_A 100 EQ------------------------------------------------------------------------------ 101 (345)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 54
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc--------
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS-------- 237 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-------- 237 (444)
..++|||||+ ++|.+++......
T Consensus 102 ------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~ 133 (345)
T 3hko_A 102 ------------------------------------------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133 (345)
T ss_dssp ------------------------------------------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEE
T ss_pred ------------------------------------------------eEEEEEeCCCCCcHHHHHHHhhcccccccccc
Confidence 4899999997 5898887421111
Q ss_pred ----------------------------CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEe
Q psy10212 238 ----------------------------KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG--VLKLC 287 (444)
Q Consensus 238 ----------------------------~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~ 287 (444)
...+++..++.++.||+.||+|||++|++|+||+|+||+++ .++ .++|+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~-~~~~~~~kl~ 212 (345)
T 3hko_A 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNKSFEIKLV 212 (345)
T ss_dssp EECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES-CSSSCCEEEC
T ss_pred cccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe-cCCCceEEEe
Confidence 11235778899999999999999999999999999999998 444 89999
Q ss_pred ecCCcccccCCC-----CCccccccccccCchhhccC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q psy10212 288 DFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGA-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVL 361 (444)
Q Consensus 288 Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~ 361 (444)
|||++....... ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.+.+..+....+....
T Consensus 213 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 292 (345)
T 3hko_A 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292 (345)
T ss_dssp CCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred eccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc
Confidence 999997653322 12345689999999998652 378999999999999999999999999988887777666521
Q ss_pred CCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 362 GTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 362 g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
.... ......+++.+.+||.+||+.||.+|||+.|+|+ ||||+++.....+
T Consensus 293 ~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~-hp~~~~~~~~~~~ 343 (345)
T 3hko_A 293 LCFE-------------------------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ-HPWISQFSDKIYK 343 (345)
T ss_dssp CCTT-------------------------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH-SHHHHTTSSCSSC
T ss_pred cccC-------------------------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc-ChhhccChHhhEe
Confidence 1100 0111246899999999999999999999999999 9999998766543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=349.25 Aligned_cols=299 Identities=28% Similarity=0.485 Sum_probs=225.3
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+.++|++++.||+|+||+||+|++..+|+.||+|++.... +.+.+|++++++++||||+++++++...+.....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~- 86 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD- 86 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc-
Confidence 45689999999999999999999999999999999985432 4566899999999999999999988665420000
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (320)
T 2i6l_A 87 -------------------------------------------------------------------------------- 86 (320)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
...........++|||||+++|.+++. .+++++..++.++.||+
T Consensus 87 -------------------------------~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~ 130 (320)
T 2i6l_A 87 -------------------------------DVGSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLL 130 (320)
T ss_dssp -----------------------------------CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHH
T ss_pred -------------------------------ccccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHH
Confidence 000001113589999999999999874 35799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC----CCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG----EPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+|||++|++|+||+|+||+++..++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||
T Consensus 131 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 210 (320)
T 2i6l_A 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210 (320)
T ss_dssp HHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred HHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHh
Confidence 99999999999999999999999856789999999998765322 12234456889999999876447899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCcc-CCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK-SHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||+++|+|++|+.||.+.+..+....+.............+.............. .......+...+++.+.+||.+||
T Consensus 211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 9999999999999999999888888888877666655544432111000000000 000111223467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.||.+|||+.|+|+ ||||++....
T Consensus 291 ~~dP~~Rpt~~ell~-hp~~~~~~~p 315 (320)
T 2i6l_A 291 TFSPMDRLTAEEALS-HPYMSIYSFP 315 (320)
T ss_dssp CSSGGGSCCHHHHHT-SHHHHTTCC-
T ss_pred CCCccccCCHHHHhC-CcccccccCc
Confidence 999999999999999 9999986543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=359.74 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=215.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (444)
-.++|++++.||+|+||+||+|+++.+|+.||||++... .....+|..++.++ +||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~--- 91 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--- 91 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS---
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC---
Confidence 347899999999999999999999999999999999543 23455788888877 9999999999987654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (345)
T 1xjd_A 92 -------------------------------------------------------------------------------- 91 (345)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+|+|||||+ ++|.+++.. .+.+++..++.++
T Consensus 92 -------------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~ 124 (345)
T 1xjd_A 92 -------------------------------------------NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYA 124 (345)
T ss_dssp -------------------------------------------EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHH
Confidence 3899999997 599988853 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
.||+.||+|||++|++||||||+||+++ .++.++|+|||+++.... ........||+.|+|||.+.+. .++.++|+|
T Consensus 125 ~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 202 (345)
T 1xjd_A 125 AEIILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWW 202 (345)
T ss_dssp HHHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHH
T ss_pred HHHHHHHHHHHHCCeEeCCCChhhEEEC-CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhH
Confidence 9999999999999999999999999999 788999999999876432 2334456789999999999887 789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
||||++|+|++|+.||.+.+..+....+... .. .++..+++++.+||.+||
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 203 SFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------------NP------------FYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------CC------------CCCcccCHHHHHHHHHHh
Confidence 9999999999999999988877776666541 11 122357899999999999
Q ss_pred ccCCCCCCCHH-HHhccCchhhhhh
Q psy10212 410 EYTPSSRISPL-QVRSITPFLIELR 433 (444)
Q Consensus 410 ~~DP~kRPs~~-elL~~hpwf~~~~ 433 (444)
+.||.+||++. ++++ ||||+++.
T Consensus 254 ~~dp~~R~~~~~~i~~-hp~f~~~~ 277 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQ-HPLFREIN 277 (345)
T ss_dssp CSSGGGSBTTBSCGGG-SGGGTTCC
T ss_pred cCCHhHcCCChHHHHc-CccccCCC
Confidence 99999999998 9999 99999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=357.88 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=213.9
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..+.++|++.+.||+|+||.||+|+++.+|+.||||++........+|++++.++ +||||+++++++.+.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-------- 89 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK-------- 89 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSS--------
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCC--------
Confidence 3577899999999999999999999999999999999988777778899999888 7999999999986653
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (342)
T 2qr7_A 90 -------------------------------------------------------------------------------- 89 (342)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+|+|||||++ +|.+.+. ..+.+++..++.++.||+.
T Consensus 90 --------------------------------------~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~ 127 (342)
T 2qr7_A 90 --------------------------------------YVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITK 127 (342)
T ss_dssp --------------------------------------EEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHH
T ss_pred --------------------------------------EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHH
Confidence 48999999975 8998885 3467999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCC---CeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPET---GVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~---~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+|||++|++||||||+||++.... +.++|+|||++...... .......+|+.|+|||.+.+. .++.++|+|||
T Consensus 128 al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 206 (342)
T 2qr7_A 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSL 206 (342)
T ss_dssp HHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHH
T ss_pred HHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeH
Confidence 99999999999999999999985333 35999999999765433 233455789999999999876 68899999999
Q ss_pred HHHHHHHHhCCCCCCCC---ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 332 GCVLAELLLGQPMFPGD---SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~---~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||++|+|++|..||.+. +..+....+... ...+ .......+|+.+.+||.+|
T Consensus 207 G~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----------------~~~~--------~~~~~~~~s~~~~~li~~~ 261 (342)
T 2qr7_A 207 GVLLYTMLTGYTPFANGPDDTPEEILARIGSG-----------------KFSL--------SGGYWNSVSDTAKDLVSKM 261 (342)
T ss_dssp HHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------------CCCC--------CSTTTTTSCHHHHHHHHHH
T ss_pred hHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------------Cccc--------CccccccCCHHHHHHHHHH
Confidence 99999999999999863 233333333321 0111 1111235799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|..||++|||+.++|+ ||||++..
T Consensus 262 L~~dP~~R~t~~~il~-hp~~~~~~ 285 (342)
T 2qr7_A 262 LHVDPHQRLTAALVLR-HPWIVHWD 285 (342)
T ss_dssp TCSSTTTSCCHHHHTT-SHHHHTGG
T ss_pred CCCChhHCcCHHHHhc-CCeecCcc
Confidence 9999999999999999 99997743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=354.18 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.++|+++++||+|+||+||+|+++.+|+.||||++.... ....+|+..+.++ +||||+++++++.+.+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~---- 130 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG---- 130 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC----
Confidence 4588999999999999999999999999999999884321 2223455555544 8999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 131 -------------------------------------------------------------------------------- 130 (311)
T 3p1a_A 131 -------------------------------------------------------------------------------- 130 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+++|||||+++|.+++.. .+..+++..++.++.|
T Consensus 131 ------------------------------------------~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~q 165 (311)
T 3p1a_A 131 ------------------------------------------ILYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRD 165 (311)
T ss_dssp ------------------------------------------EEEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHH
Confidence 4899999999999998864 3467999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||+++++|+||||+||+++ .++.++|+|||++.............+|+.|+|||.+.+ .++.++|+||||
T Consensus 166 i~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG 242 (311)
T 3p1a_A 166 TLLALAHLHSQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLG 242 (311)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEC-GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHH
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEEC-CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHH
Confidence 99999999999999999999999998 788999999999877655555555678999999998876 689999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|..|+.+.... ..+.. ......++..+++.+.+||.+||+.|
T Consensus 243 ~il~el~~g~~~~~~~~~~---~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 243 LTILEVACNMELPHGGEGW---QQLRQ---------------------------GYLPPEFTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp HHHHHHHHTCCCCSSHHHH---HHHTT---------------------------TCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHHhCCCCCCCccHH---HHHhc---------------------------cCCCcccccCCCHHHHHHHHHHcCCC
Confidence 9999999997766543221 11111 00111233457999999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|++|||+.|+|+ ||||++
T Consensus 293 P~~Rpt~~ell~-hp~~~~ 310 (311)
T 3p1a_A 293 PKLRATAEALLA-LPVLRQ 310 (311)
T ss_dssp TTTSCCHHHHHT-SGGGSC
T ss_pred hhhCcCHHHHHh-CccccC
Confidence 999999999999 999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=362.61 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=199.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
..++|++++.||+|+||+||+|+++.+++.||||++... ...+.+|+.++++++||||+++++++...+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------- 89 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 89 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--------
Confidence 458999999999999999999999999999999999543 355679999999999999999999997654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (361)
T 3uc3_A 90 -------------------------------------------------------------------------------- 89 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++|||||+ ++|.+++.. .+++++..++.++.||+.
T Consensus 90 --------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~ 127 (361)
T 3uc3_A 90 --------------------------------------HLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLS 127 (361)
T ss_dssp --------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHH
T ss_pred --------------------------------------EEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHH
Confidence 3899999997 599888853 357999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCC-cchhhhhHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETG--VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYT-TKIDVWSAG 332 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s-~~sDiwSLG 332 (444)
||.|||++|++||||||+||+++ ..+ .++|+|||++.............+|+.|+|||.+.+. .+. .++|+||||
T Consensus 128 ~L~~LH~~~ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG 205 (361)
T 3uc3_A 128 GVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ-EYDGKIADVWSCG 205 (361)
T ss_dssp HHHHHHHTTCCSCCCCGGGEEEC-SSSSCCEEECCCCCC---------------CTTSCHHHHHCS-SCCHHHHHHHHHH
T ss_pred HHHHHHHCCcccCCCCHHHEEEc-CCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCC-CCCCCeeeeehhH
Confidence 99999999999999999999997 444 5999999998755444444556789999999999877 454 459999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+.......+...... ....+|. ...+++.+.+||.+||+.|
T Consensus 206 ~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~----------~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 206 VTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-------------VKYSIPD----------DIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHHHHSSCSCC----CCCHHHHHHHHHT-------------TCCCCCT----------TSCCCHHHHHHHHHHSCSC
T ss_pred HHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-------------CCCCCCC----------cCCCCHHHHHHHHHHccCC
Confidence 9999999999999876554433333332110 0011111 1246899999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|.+|||+.|+++ ||||+.
T Consensus 263 P~~Rps~~ell~-hp~f~~ 280 (361)
T 3uc3_A 263 PATRISIPEIKT-HSWFLK 280 (361)
T ss_dssp TTTSCCHHHHHT-SHHHHT
T ss_pred hhHCcCHHHHHh-Ccchhc
Confidence 999999999999 999965
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.44 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=216.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++++.||+|+||+||+|+++.+|+.||+|++... .+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----- 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence 47899999999999999999999999999999998543 234567999999999999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 115 -------------------------------------------------------------------------------- 114 (350)
T 1rdq_E 115 -------------------------------------------------------------------------------- 114 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||+ ++|.+++.. .+.+++..++.++.|
T Consensus 115 -----------------------------------------~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~q 149 (350)
T 1rdq_E 115 -----------------------------------------NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQ 149 (350)
T ss_dssp -----------------------------------------EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 3899999997 599998853 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++...... .....||+.|+|||.+.+. .++.++|+||||
T Consensus 150 i~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 225 (350)
T 1rdq_E 150 IVLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALG 225 (350)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHH
T ss_pred HHHHHHHHHHCCcccccCccceEEEC-CCCCEEEcccccceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEeccc
Confidence 99999999999999999999999999 7889999999999765332 3456789999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+... ... ++..+++.+.+||.+||+.|
T Consensus 226 ~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 226 VLIYEMAAGYPPFFADQPIQIYEKIVSG-----------------KVR------------FPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTCCHHHHHHHHHHSCSC
T ss_pred HhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999988887777766651 111 23457999999999999999
Q ss_pred CCCCCC-----HHHHhccCchhhhhh
Q psy10212 413 PSSRIS-----PLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRPs-----~~elL~~hpwf~~~~ 433 (444)
|.+||+ +.|+++ ||||+.+.
T Consensus 277 p~~R~~~~~~~~~ei~~-h~~f~~~~ 301 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKN-HKWFATTD 301 (350)
T ss_dssp TTTCTTSSTTTTHHHHT-SGGGTTCC
T ss_pred HHhccCCccCCHHHHHh-CcCcCCCC
Confidence 999999 999999 99999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.43 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=203.3
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+.+.++|++.+.||+|+||+||+|+++.+++.||||++... .+.+.+|+.++++++||||+++++++...+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 121 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT------ 121 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSS------
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCC------
Confidence 456788999999999999999999999999999999999543 456778999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 122 -------------------------------------------------------------------------------- 121 (349)
T 2w4o_A 122 -------------------------------------------------------------------------------- 121 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||+ ++|.+++. ..+.+++..++.++.||
T Consensus 122 ----------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi 157 (349)
T 2w4o_A 122 ----------------------------------------EISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQI 157 (349)
T ss_dssp ----------------------------------------EEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------eEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHH
Confidence 3899999998 59988874 34569999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||.|||++|++|+||||+||+++. .++.++|+|||++.............+++.|+|||.+.+. .++.++|+|||
T Consensus 158 ~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 236 (349)
T 2w4o_A 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSV 236 (349)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHH
T ss_pred HHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHH
Confidence 99999999999999999999999972 3789999999999766544444556789999999999877 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhH-HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVD-QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||++|+|++|+.||.+....+ ....+.... ... ...+...++..+.+||.+||+
T Consensus 237 G~il~ell~g~~pf~~~~~~~~~~~~i~~~~-----------------~~~--------~~~~~~~~~~~~~~li~~~L~ 291 (349)
T 2w4o_A 237 GIITYILLCGFEPFYDERGDQFMFRRILNCE-----------------YYF--------ISPWWDEVSLNAKDLVRKLIV 291 (349)
T ss_dssp HHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-----------------CCC--------CTTTTTTSCHHHHHHHHTTSC
T ss_pred HHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-----------------Ccc--------CCchhhhCCHHHHHHHHHHcc
Confidence 999999999999998766554 333333210 000 011123568999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.||++|||+.|+|+ ||||+.....
T Consensus 292 ~dP~~Rpt~~e~l~-hp~~~~~~~~ 315 (349)
T 2w4o_A 292 LDPKKRLTTFQALQ-HPWVTGKAAN 315 (349)
T ss_dssp SSGGGSCCHHHHHH-STTTTSTTCC
T ss_pred CChhhCcCHHHHhc-CcccCCCccc
Confidence 99999999999999 9999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.65 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=217.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..+.++|++++.||+|+||+||+|+++.+++.||+|++... ...+.+|+.++++++||||+++++++...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 109 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--- 109 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC---
Confidence 45778999999999999999999999999999999998543 345668999999999999999999997654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 110 -------------------------------------------------------------------------------- 109 (494)
T 3lij_A 110 -------------------------------------------------------------------------------- 109 (494)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..|+|||||++ +|.+.+.. ..++++..++.++
T Consensus 110 -------------------------------------------~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~ 142 (494)
T 3lij_A 110 -------------------------------------------NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVII 142 (494)
T ss_dssp -------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHH
Confidence 38999999985 88888753 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||++|++||||||+||+++.. .+.++|+|||++.............+|+.|+|||.+.+ .++.++|+
T Consensus 143 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~Di 220 (494)
T 3lij_A 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDV 220 (494)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHH
T ss_pred HHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhH
Confidence 999999999999999999999999999732 45699999999987665555556678999999999864 68999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+||++|+|++|..||.+.+..+....+.......... ....+|+.+.+||.+|
T Consensus 221 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP-------------------------EWKNVSEGAKDLIKQM 275 (494)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-------------------------GGTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-------------------------hcccCCHHHHHHHHHH
Confidence 999999999999999999988888777766532111100 0134689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|+.||.+|||+.|+|+ ||||++....
T Consensus 276 L~~dp~~R~s~~e~l~-hp~~~~~~~~ 301 (494)
T 3lij_A 276 LQFDSQRRISAQQALE-HPWIKEMCSK 301 (494)
T ss_dssp TCSSTTTSCCHHHHHT-CHHHHHHHHH
T ss_pred CCCChhhCccHHHHhc-CcccccCccc
Confidence 9999999999999999 9999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.37 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=218.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..+.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++...+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 94 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--- 94 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC---
Confidence 45778999999999999999999999999999999998432 345668999999999999999999987654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (486)
T 3mwu_A 95 -------------------------------------------------------------------------------- 94 (486)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+++|||||++ +|.+.+.. ..++++..++.++
T Consensus 95 -------------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~ 127 (486)
T 3mwu_A 95 -------------------------------------------SFYIVGELYTGGELFDEIIK----RKRFSEHDAARII 127 (486)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHH
Confidence 38999999985 89888753 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||++|++||||||+||+++. ..+.++|+|||++.............+|+.|+|||.+.+ .++.++|+
T Consensus 128 ~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di 205 (486)
T 3mwu_A 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDV 205 (486)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHH
T ss_pred HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhH
Confidence 99999999999999999999999999952 355899999999987655555556678999999999876 58999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|..||.+.+..+.+..+........ .+ ....+|+.+.+||.+|
T Consensus 206 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------~~----------~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---------------LP----------QWRTISDDAKDLIRKM 260 (486)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---------------SG----------GGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------Cc----------ccCCCCHHHHHHHHHH
Confidence 9999999999999999999888877776665211110 00 0124689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.|+|+ ||||+....
T Consensus 261 L~~dp~~R~t~~~~l~-hp~~~~~~~ 285 (486)
T 3mwu_A 261 LTFHPSLRITATQCLE-HPWIQKYSS 285 (486)
T ss_dssp TCSSTTTSCCHHHHHH-CHHHHHTCC
T ss_pred cCCChhhCcCHHHHhc-CHhhccCcc
Confidence 9999999999999999 999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.91 Aligned_cols=290 Identities=19% Similarity=0.284 Sum_probs=214.1
Q ss_pred hhhhhccccchhheeccc--ceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 16 YFSDLDNSLAQKTVIGNG--SFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
.+..-.++|++++.||+| +||+||+|+++.+|+.||||++.... ..+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 344456899999999999 99999999999999999999995442 4556799999999999999999999876
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 99 ~------------------------------------------------------------------------------- 99 (389)
T 3gni_B 99 N------------------------------------------------------------------------------- 99 (389)
T ss_dssp T-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 5
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
.+++|||||+ ++|.+++.. .....+++..+
T Consensus 100 -----------------------------------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 130 (389)
T 3gni_B 100 -----------------------------------------------ELWVVTSFMAYGSAKDLICT--HFMDGMNELAI 130 (389)
T ss_dssp -----------------------------------------------EEEEEEECCTTCBHHHHHHH--TCTTCCCHHHH
T ss_pred -----------------------------------------------EEEEEEEccCCCCHHHHHhh--hcccCCCHHHH
Confidence 3899999998 589998864 23456999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC--------CCCccccccccccCchhhcc
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG--------EPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~--------~~~~~~~gt~~y~aPE~l~~ 318 (444)
+.++.||+.||+|||++|++||||||+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+
T Consensus 131 ~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 131 AYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc
Confidence 99999999999999999999999999999999 7889999999987543211 11223467889999999977
Q ss_pred C-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCC--------HHHHHhhCCC-----CC---cccC
Q psy10212 319 A-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPT--------REQIREMNPN-----YT---EFKF 381 (444)
Q Consensus 319 ~-~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~--------~~~~~~~~~~-----~~---~~~~ 381 (444)
. ..++.++|+|||||++|+|++|+.||.+.+..+....+........ .......... .. ....
T Consensus 210 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (389)
T 3gni_B 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289 (389)
T ss_dssp TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------------------
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCc
Confidence 3 3689999999999999999999999998777666555443211000 0000000000 00 0000
Q ss_pred CC-ccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 382 PQ-IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 382 p~-~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+. .........++..+++.+.+||.+||+.||.+|||+.|+|+ ||||++++..
T Consensus 290 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~-hp~f~~~~~~ 343 (389)
T 3gni_B 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN-HSFFKQIKRR 343 (389)
T ss_dssp ----------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT-SGGGGGC---
T ss_pred cccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc-CHHHHHHhhc
Confidence 00 00000111234567999999999999999999999999999 9999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=362.42 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=210.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|+++++||+|+||+||+|+++.+++.||+|++... ...+.+|..++.++ +||||+++++++...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---- 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence 36899999999999999999999999999999999543 23456799998887 8999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 127 -------------------------------------------------------------------------------- 126 (396)
T 4dc2_A 127 -------------------------------------------------------------------------------- 126 (396)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|+|||||++ +|..++.. .+.+++..++.++.
T Consensus 127 ------------------------------------------~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~ 160 (396)
T 4dc2_A 127 ------------------------------------------RLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSA 160 (396)
T ss_dssp ------------------------------------------EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHH
Confidence 39999999985 88888753 35799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccc-cCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++||+||||||+||+++ .++.++|+|||+++.. ..........||+.|+|||++.+. .++.++|+||
T Consensus 161 qi~~aL~~LH~~givHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~Diws 238 (396)
T 4dc2_A 161 EISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWA 238 (396)
T ss_dssp HHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHH
T ss_pred HHHHHHHHHHHCCEEeccCCHHHEEEC-CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHH
Confidence 999999999999999999999999999 7899999999999763 233445566889999999999887 8899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChh--------H-HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGV--------D-QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~--------e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
|||++|+|++|+.||...... + ....+.. ... .++..+++++
T Consensus 239 lGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------------~~~------------~~p~~~s~~~ 289 (396)
T 4dc2_A 239 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------KQI------------RIPRSLSVKA 289 (396)
T ss_dssp HHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-----------------CCC------------CCCTTSCHHH
T ss_pred HHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-----------------ccc------------CCCCcCCHHH
Confidence 999999999999999743221 1 1111221 011 1234579999
Q ss_pred HHHHHHhcccCCCCCCCH------HHHhccCchhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISP------LQVRSITPFLIELRA 434 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~------~elL~~hpwf~~~~~ 434 (444)
.+||.+||+.||.+||++ +|+++ ||||+++..
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~-Hpff~~i~w 327 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQG-HPFFRNVDW 327 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHH-STTTTTCCH
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhc-CccccCCCH
Confidence 999999999999999995 79999 999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.51 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=218.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++... ...+.+|+.++++++||||+++++++....
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 121 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY------ 121 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS------
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC------
Confidence 4667899999999999999999999999999999998543 346678999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 122 -------------------------------------------------------------------------------- 121 (387)
T 1kob_A 122 -------------------------------------------------------------------------------- 121 (387)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||++ +|.+++. .....+++..++.++.||
T Consensus 122 ----------------------------------------~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi 158 (387)
T 1kob_A 122 ----------------------------------------EMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQA 158 (387)
T ss_dssp ----------------------------------------EEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHH
Confidence 38999999985 8888774 234579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNP-ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~-~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++|+||||+||+++. ..+.++|+|||++.............+|+.|+|||.+.+. .++.++|+||||
T Consensus 159 ~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG 237 (387)
T 1kob_A 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIG 237 (387)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHH
T ss_pred HHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHh
Confidence 99999999999999999999999973 3468999999999876554444456789999999999876 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|..||.+.+..+....+.... ..++ ......+++++.+||.+||+.|
T Consensus 238 ~il~elltg~~Pf~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~s~~~~~li~~~L~~d 292 (387)
T 1kob_A 238 VLGYVLLSGLSPFAGEDDLETLQNVKRCD-----------------WEFD--------EDAFSSVSPEAKDFIKNLLQKE 292 (387)
T ss_dssp HHHHHHHHSCCSSCCSSHHHHHHHHHHCC-----------------CCCC--------SSTTTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------CCCC--------ccccccCCHHHHHHHHHHcCCC
Confidence 99999999999999888777766655421 0010 1112356999999999999999
Q ss_pred CCCCCCHHHHhccCchhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~ 432 (444)
|.+|||+.|+|+ ||||+..
T Consensus 293 P~~Rpt~~ell~-hp~~~~~ 311 (387)
T 1kob_A 293 PRKRLTVHDALE-HPWLKGD 311 (387)
T ss_dssp GGGSCCHHHHHT-STTTSSC
T ss_pred hhHCcCHHHHhh-CccccCC
Confidence 999999999999 9999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=354.47 Aligned_cols=250 Identities=23% Similarity=0.423 Sum_probs=208.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++++.||+|+||+||+|+++.+|+.||+|++.... ..+.+|+.+++++ +||||+++++++...+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----- 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----- 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-----
Confidence 68999999999999999999999999999999996432 3356799999888 8999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (345)
T 3a8x_A 84 -------------------------------------------------------------------------------- 83 (345)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||++ +|.+++.. .+.+++..++.++.|
T Consensus 84 -----------------------------------------~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~q 118 (345)
T 3a8x_A 84 -----------------------------------------RLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAE 118 (345)
T ss_dssp -----------------------------------------EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHH
Confidence 38999999975 89888853 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||+|||++|++||||||+||+++ .++.++|+|||+++... .........||+.|+|||.+.+. .++.++|+|||
T Consensus 119 i~~aL~~LH~~~ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 196 (345)
T 3a8x_A 119 ISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWAL 196 (345)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHH
T ss_pred HHHHHHHHHHCCceecCCCHHHEEEC-CCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHH
Confidence 99999999999999999999999999 78899999999997533 22334456789999999999887 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh---------hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 332 GCVLAELLLGQPMFPGDSG---------VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~---------~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
||++|+|++|+.||..... ......+.. ... .++..+++.+.
T Consensus 197 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-----------------~~~------------~~p~~~s~~~~ 247 (345)
T 3a8x_A 197 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------KQI------------RIPRSLSVKAA 247 (345)
T ss_dssp HHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-----------------CCC------------CCCTTSCHHHH
T ss_pred HHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-----------------CCC------------CCCCCCCHHHH
Confidence 9999999999999975321 111111211 001 12345799999
Q ss_pred HHHHHhcccCCCCCCCH------HHHhccCchhhhhh
Q psy10212 403 DLISRLLEYTPSSRISP------LQVRSITPFLIELR 433 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~------~elL~~hpwf~~~~ 433 (444)
+||.+||+.||.+||++ .|+++ ||||+++.
T Consensus 248 ~li~~lL~~dP~~R~~~~~~~~~~~i~~-hp~f~~~~ 283 (345)
T 3a8x_A 248 SVLKSFLNKDPKERLGCHPQTGFADIQG-HPFFRNVD 283 (345)
T ss_dssp HHHHHHTCSSTTTSTTCCTTTHHHHHHT-SGGGTTCC
T ss_pred HHHHHHhcCCHhHCCCCCCcCCHHHHhc-CCccCCCC
Confidence 99999999999999996 79999 99999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.82 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=215.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++++.||+|+||+||+|+++.+|+.||+|++... ...+.+|.+++..+ +||+|+++++++...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~---- 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---- 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC----
Confidence 47899999999999999999999999999999998543 23455789999887 8999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (353)
T 2i0e_A 95 -------------------------------------------------------------------------------- 94 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|+|||||++ +|.+++.. .+.+++..++.++.
T Consensus 95 ------------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ 128 (353)
T 2i0e_A 95 ------------------------------------------RLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAA 128 (353)
T ss_dssp ------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHH
Confidence 39999999975 99988853 35799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++|++||||||+||+++ .++.++|+|||++..... ........||+.|+|||.+.+. .++.++|+||
T Consensus 129 qi~~aL~~LH~~givHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 206 (353)
T 2i0e_A 129 EIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWA 206 (353)
T ss_dssp HHHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHH
T ss_pred HHHHHHHHHHHCCEEeccCCHHHEEEc-CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccc
Confidence 999999999999999999999999999 788999999999976432 2334456789999999999877 7899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+....+... ... ++..+++++.+||.+||+
T Consensus 207 lG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~lL~ 257 (353)
T 2i0e_A 207 FGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------------NVA------------YPKSMSKEAVAICKGLMT 257 (353)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTC
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHHhh
Confidence 999999999999999988887777766651 111 234579999999999999
Q ss_pred cCCCCCCC-----HHHHhccCchhhhhh
Q psy10212 411 YTPSSRIS-----PLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs-----~~elL~~hpwf~~~~ 433 (444)
.||.+||+ +.++++ ||||+.+.
T Consensus 258 ~dP~~R~~~~~~~~~~i~~-h~~f~~~~ 284 (353)
T 2i0e_A 258 KHPGKRLGCGPEGERDIKE-HAFFRYID 284 (353)
T ss_dssp SCTTSCTTCSTTHHHHHHT-SGGGTTCC
T ss_pred cCHHHcCCCCCCCHHHHhc-CccccCCC
Confidence 99999995 699999 99998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=372.02 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=219.3
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----------------ccchhhHHHHhhhcCCCceeEe
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----------------KRFKNREMQIMRRLEHSNIVKL 80 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------------~~~~~~E~~~l~~l~h~~i~~~ 80 (444)
..+.++|+++++||+|+||+||+|+++.+++.||+|++... .+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 56789999999999999999999999999999999998532 2346689999999999999999
Q ss_pred eeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 81 KYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
++++...+
T Consensus 112 ~~~~~~~~------------------------------------------------------------------------ 119 (504)
T 3q5i_A 112 FDVFEDKK------------------------------------------------------------------------ 119 (504)
T ss_dssp EEEEECSS------------------------------------------------------------------------
T ss_pred EEEEEcCC------------------------------------------------------------------------
Confidence 99987654
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCC
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQ 239 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~ 239 (444)
.+++|||||++ +|.+.+.. ..
T Consensus 120 ------------------------------------------------------~~~lv~e~~~gg~L~~~l~~----~~ 141 (504)
T 3q5i_A 120 ------------------------------------------------------YFYLVTEFYEGGELFEQIIN----RH 141 (504)
T ss_dssp ------------------------------------------------------EEEEEEECCTTCBHHHHHHH----HS
T ss_pred ------------------------------------------------------EEEEEEecCCCCcHHHHHHH----cC
Confidence 48999999985 89888853 35
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC--CeEEEeecCCcccccCCCCCccccccccccCchhhc
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET--GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF 317 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~--~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~ 317 (444)
.+++..++.++.||+.||.|||++|++||||||+||+++... ..++|+|||++.............+|+.|+|||.+.
T Consensus 142 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc
Confidence 799999999999999999999999999999999999998333 269999999998776555556678899999999987
Q ss_pred cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 318 ~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
+ .++.++|+|||||++|+|++|..||.+.+..+....+...........+ .++
T Consensus 222 ~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~ 274 (504)
T 3q5i_A 222 K--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW-------------------------KNI 274 (504)
T ss_dssp T--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-------------------------TTS
T ss_pred c--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc-------------------------CCC
Confidence 4 6899999999999999999999999998888877777663222221111 346
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.+.+||.+||++||.+|||+.|+|+ ||||+....
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~-h~~~~~~~~ 310 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALN-SRWIKKYAN 310 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT-SHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc-CHhhhhchh
Confidence 899999999999999999999999999 999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.70 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=213.4
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++++.||+|+||.||+|+++.+++.||+|++.... ..+.+|++++++++||||+++++++...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE----- 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 378999999999999999999999999999999985432 45568999999999999999999987764
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (384)
T 4fr4_A 89 -------------------------------------------------------------------------------- 88 (384)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||.+ +|.+++. ....+++..++.++.|
T Consensus 89 -----------------------------------------~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~q 123 (384)
T 4fr4_A 89 -----------------------------------------DMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICE 123 (384)
T ss_dssp -----------------------------------------EEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHH
Confidence 38999999975 8888875 3567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC--CCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA--IDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~s~~sDiwS 330 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++.............||+.|+|||++.+. ..++.++|+||
T Consensus 124 i~~aL~~LH~~givHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwS 202 (384)
T 4fr4_A 124 LVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202 (384)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHH
T ss_pred HHHHHHHHHHCCceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeec
Confidence 99999999999999999999999999 7899999999999877666656677899999999998642 25889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHH---HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||++|+|++|+.||...+.... ...+... . ..++..+++.+.+||.+
T Consensus 203 lG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------------~------------~~~p~~~s~~~~~li~~ 253 (384)
T 4fr4_A 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----------------V------------VTYPSAWSQEMVSLLKK 253 (384)
T ss_dssp HHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----------------C------------CCCCTTSCHHHHHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----------------c------------cCCCCcCCHHHHHHHHH
Confidence 99999999999999986443322 2211110 0 11234578999999999
Q ss_pred hcccCCCCCCC-HHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRIS-PLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs-~~elL~~hpwf~~~~~ 434 (444)
||+.||.+||+ +.++++ ||||+++..
T Consensus 254 lL~~dP~~R~s~~~~l~~-hp~f~~~~w 280 (384)
T 4fr4_A 254 LLEPNPDQRFSQLSDVQN-FPYMNDINW 280 (384)
T ss_dssp HSCSSGGGSCCSHHHHHT-SGGGTTCCH
T ss_pred HhcCCHhHhcccHHHHHc-ChhhhcCCH
Confidence 99999999999 888999 999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=353.64 Aligned_cols=255 Identities=27% Similarity=0.334 Sum_probs=210.2
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.++|++++.||+|+||+||+|++..+++.||+|++... .+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------ 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC------
Confidence 568899999999999999999999999999999998543 256678999999999999999999887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (323)
T 3tki_A 79 -------------------------------------------------------------------------------- 78 (323)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||++ +|.+++. ....+++..++.++.||
T Consensus 79 ----------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi 114 (323)
T 3tki_A 79 ----------------------------------------IQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQL 114 (323)
T ss_dssp ----------------------------------------EEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHH
T ss_pred ----------------------------------------eEEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHH
Confidence 48999999985 8877763 44579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+....+.++|+||
T Consensus 115 ~~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 193 (323)
T 3tki_A 115 MAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (323)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHH
T ss_pred HHHHHHHHHCCccccccchHHEEEe-CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHH
Confidence 9999999999999999999999999 78899999999997553222 2334578999999999987744578999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||...+.............. .. .....+++.+.+||.+||+
T Consensus 194 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------~~----------~~~~~~~~~~~~li~~~L~ 247 (323)
T 3tki_A 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------------YL----------NPWKKIDSAPLALLHKILV 247 (323)
T ss_dssp HHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT----------------TS----------TTGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc----------------cC----------CccccCCHHHHHHHHHHcc
Confidence 999999999999999876654333222221000 00 0012468999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.||.+|||+.|+|+ ||||++.
T Consensus 248 ~dP~~R~t~~eil~-h~~~~~~ 268 (323)
T 3tki_A 248 ENPSARITIPDIKK-DRWYNKP 268 (323)
T ss_dssp SSTTTSCCHHHHTT-CTTTTCC
T ss_pred CChhhCcCHHHHhh-Chhhccc
Confidence 99999999999999 9999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.04 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=212.7
Q ss_pred ccccch--hheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQ--KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+.|.+ .+.||+|+||.||+|++..+|+.||+|++... .+.+.+|++++++++||||+++++++...+
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 159 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN------ 159 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC------
Confidence 344555 67899999999999999999999999999643 456779999999999999999999987654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 160 -------------------------------------------------------------------------------- 159 (373)
T 2x4f_A 160 -------------------------------------------------------------------------------- 159 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||++ +|.+++.. ....+++..++.++.||
T Consensus 160 ----------------------------------------~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi 196 (373)
T 2x4f_A 160 ----------------------------------------DIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQI 196 (373)
T ss_dssp ----------------------------------------EEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHH
Confidence 38999999984 88888753 34568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEc-CCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLN-PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~-~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||++|++|+||||+||++. ...+.++|+|||++.............+|+.|+|||.+.+. .++.++|+||||
T Consensus 197 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 275 (373)
T 2x4f_A 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVG 275 (373)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHH
T ss_pred HHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHH
Confidence 9999999999999999999999993 25679999999999876555545556789999999999876 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+.+..+........ ......+++.+.+||.+||+.|
T Consensus 276 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 276 VIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-------------------------DEEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-------------------------SGGGTTSCHHHHHHHHTTSCSS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------------------------hhhhccCCHHHHHHHHHHcCCC
Confidence 999999999999999888887777765311110 0111356899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|.+|||+.|+|+ ||||++.+.
T Consensus 331 p~~Rps~~e~l~-hp~~~~~~~ 351 (373)
T 2x4f_A 331 KSWRISASEALK-HPWLSDHKL 351 (373)
T ss_dssp GGGSCCHHHHHH-SHHHHCHHH
T ss_pred hhhCCCHHHHhc-CcCcCCCch
Confidence 999999999999 999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.13 Aligned_cols=251 Identities=27% Similarity=0.508 Sum_probs=207.9
Q ss_pred ccccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
.++|++++.||+|+||.||+|++. .+|+.||+|++... ...+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 478999999999999999999985 57999999998542 2345689999999999999999999877543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 96 -------------------------------------------------------------------------------- 95 (327)
T 3a62_A 96 -------------------------------------------------------------------------------- 95 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
+|+|||||+ ++|.+++.. .+.+++..++.
T Consensus 96 ----------------------------------------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~ 125 (327)
T 3a62_A 96 ----------------------------------------------LYLILEYLSGGELFMQLER----EGIFMEDTACF 125 (327)
T ss_dssp ----------------------------------------------EEEEEECCTTEEHHHHHHH----HSSCCHHHHHH
T ss_pred ----------------------------------------------EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHH
Confidence 899999998 589888853 35789999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchh
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
++.||+.||.|||++|++||||||+||+++ .++.++|+|||++...... .......|++.|+|||.+.+. .++.++|
T Consensus 126 ~~~qi~~al~~lH~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 203 (327)
T 3a62_A 126 YLAEISMALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVD 203 (327)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHH
T ss_pred HHHHHHHHHHHHHhCCEEcccCCHHHeEEC-CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCccc
Confidence 999999999999999999999999999999 7889999999998654322 223445789999999999877 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||.+.+..+....+.+.. . .++..+++.+.+||.+
T Consensus 204 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~ 254 (327)
T 3a62_A 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----------------L------------NLPPYLTQEARDLLKK 254 (327)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHH
T ss_pred chhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHH
Confidence 9999999999999999999888777776666521 1 1223568999999999
Q ss_pred hcccCCCCCC-----CHHHHhccCchhhhhh
Q psy10212 408 LLEYTPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
||+.||.+|| ++.|+++ ||||+++.
T Consensus 255 ~L~~dp~~R~~~~~~~~~e~l~-hp~f~~~~ 284 (327)
T 3a62_A 255 LLKRNAASRLGAGPGDAGEVQA-HPFFRHIN 284 (327)
T ss_dssp HSCSCGGGSTTSSTTTHHHHHH-SGGGSSCC
T ss_pred HHhcCHhhccCCCCCCHHHHHc-CCcccCCC
Confidence 9999999999 8899999 99998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=356.99 Aligned_cols=287 Identities=33% Similarity=0.590 Sum_probs=229.1
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|.+.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||+++++++...+...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~- 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR- 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG-
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc-
Confidence 4678999999999999999999999999999999998542 235568999999999999999999887654200
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (353)
T 3coi_A 100 -------------------------------------------------------------------------------- 99 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....++|||||+++|.+++ ...+++..++.++.|
T Consensus 100 ---------------------------------------~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~q 134 (353)
T 3coi_A 100 ---------------------------------------NFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQ 134 (353)
T ss_dssp ---------------------------------------GCCCCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHH
T ss_pred ---------------------------------------cceeEEEEeccccCCHHHHh------cCCCCHHHHHHHHHH
Confidence 00236899999999887765 245999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++|+||+|+||+++ .++.++|+|||.+...... .....+++.|+|||.+.+...++.++|+||||
T Consensus 135 i~~al~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG 211 (353)
T 3coi_A 135 MLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211 (353)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEEC-TTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEeEC-CCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHH
Confidence 99999999999999999999999999 7889999999998764322 33456799999999998754789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
+++|+|++|+.||.+.+..+.+..+.+..+.+....+......... ...+......+. .+...+++.+.+||.+||
T Consensus 212 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L 290 (353)
T 3coi_A 212 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKML 290 (353)
T ss_dssp HHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHc
Confidence 9999999999999999999999999998888877655443211100 011111111121 123467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.||.+|||+.|+|+ ||||+.++...
T Consensus 291 ~~dp~~Rpt~~e~l~-hp~f~~~~~~~ 316 (353)
T 3coi_A 291 ELDVDKRLTAAQALT-HPFFEPFRDPE 316 (353)
T ss_dssp CSCTTTSCCHHHHHT-SGGGTTTCCGG
T ss_pred CCCcccCCCHHHHhc-CcchhhccCcc
Confidence 999999999999999 99999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=373.06 Aligned_cols=259 Identities=32% Similarity=0.508 Sum_probs=220.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
..+.++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||+++++++...+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 99 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-- 99 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 35678999999999999999999999999999999998432 345668999999999999999999987654
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (484)
T 3nyv_A 100 -------------------------------------------------------------------------------- 99 (484)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..++|||||. ++|.+.+. ...++++..++.+
T Consensus 100 --------------------------------------------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i 131 (484)
T 3nyv_A 100 --------------------------------------------YFYLVGEVYTGGELFDEII----SRKRFSEVDAARI 131 (484)
T ss_dssp --------------------------------------------EEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHH
T ss_pred --------------------------------------------EEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHH
Confidence 4899999998 58988875 3467999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEc--CCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLN--PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~--~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+.||+.||.|||++|++||||||+||+++ ...+.++|+|||++.............+|+.|+|||.+.+ .++.++|
T Consensus 132 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~D 209 (484)
T 3nyv_A 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCD 209 (484)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHH
T ss_pred HHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcce
Confidence 99999999999999999999999999994 2567999999999977655555555678999999999876 5899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+|||||++|+|++|..||.+.+..+....+........ .+ ....+|+.+.+||.+
T Consensus 210 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------~~----------~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 210 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---------------LP----------QWKKVSESAKDLIRK 264 (484)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------SG----------GGGGSCHHHHHHHHH
T ss_pred eHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---------------Cc----------ccccCCHHHHHHHHH
Confidence 99999999999999999999888887777665211110 00 012468999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.|+|+ ||||+....
T Consensus 265 ~L~~dp~~R~s~~e~l~-h~~~~~~~~ 290 (484)
T 3nyv_A 265 MLTYVPSMRISARDALD-HEWIQTYTK 290 (484)
T ss_dssp HTCSSGGGSCCHHHHHT-SHHHHHHTC
T ss_pred HCCCChhHCcCHHHHhh-Chhhccccc
Confidence 99999999999999999 999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=366.25 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=209.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----- 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence 47899999999999999999999999999999998542 234557999999999999999999998765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 222 -------------------------------------------------------------------------------- 221 (446)
T 4ejn_A 222 -------------------------------------------------------------------------------- 221 (446)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+++|||||++ +|.+++.. ...+++..++.++.|
T Consensus 222 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~q 256 (446)
T 4ejn_A 222 -----------------------------------------RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAE 256 (446)
T ss_dssp -----------------------------------------EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHH
Confidence 38999999985 88888753 457999999999999
Q ss_pred HHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 253 LFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|+.||+|||+ +||+||||||+||+++ .++.++|+|||++..... ........||+.|+|||++.+. .++.++|+||
T Consensus 257 i~~aL~~LH~~~giiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 334 (446)
T 4ejn_A 257 IVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWG 334 (446)
T ss_dssp HHHHHHHHHHHTCCCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHH
T ss_pred HHHHHHHHhhcCCEEECCCCHHHEEEC-CCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhh
Confidence 9999999998 9999999999999999 788999999999875332 2334456789999999999877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+....+... ... ++..+++.+.+||.+||+
T Consensus 335 lG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~~~~~~~li~~~L~ 385 (446)
T 4ejn_A 335 LGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EIR------------FPRTLGPEAKSLLSGLLK 385 (446)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTC
T ss_pred hHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCccCCHHHHHHHHHHcc
Confidence 999999999999999988877766666541 111 233578999999999999
Q ss_pred cCCCCCC-----CHHHHhccCchhhhhhh
Q psy10212 411 YTPSSRI-----SPLQVRSITPFLIELRA 434 (444)
Q Consensus 411 ~DP~kRP-----s~~elL~~hpwf~~~~~ 434 (444)
.||.+|| ++.|+|+ ||||+.+..
T Consensus 386 ~dP~~R~~~~~~t~~ell~-hp~f~~~~~ 413 (446)
T 4ejn_A 386 KDPKQRLGGGSEDAKEIMQ-HRFFAGIVW 413 (446)
T ss_dssp SSTTTSTTCSTTTHHHHHT-SGGGTTCCH
T ss_pred cCHHHhCCCCCCCHHHHHh-CccccCCCH
Confidence 9999999 9999999 999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.84 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=208.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
+.+.++|++++.||+|+||+||+|++..+++.||||++... ...+.+|+..+.++ +||||+++++++...+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-- 84 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-- 84 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--
Confidence 34779999999999999999999999999999999998542 24455789899998 9999999999987764
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (289)
T 1x8b_A 85 -------------------------------------------------------------------------------- 84 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..++|||||++ +|.+++.........+++..++.+
T Consensus 85 --------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 120 (289)
T 1x8b_A 85 --------------------------------------------HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120 (289)
T ss_dssp --------------------------------------------EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHH
T ss_pred --------------------------------------------eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHH
Confidence 38999999975 999999876666688999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcC------------------CCCeEEEeecCCcccccCCCCCcccccccccc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNP------------------ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~------------------~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~ 311 (444)
+.||+.||+|||++|++|+||||+||+++. ....++|+|||.+...... ....+++.|+
T Consensus 121 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~ 197 (289)
T 1x8b_A 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFL 197 (289)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGC
T ss_pred HHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCcccc
Confidence 999999999999999999999999999972 2347999999998765432 2345899999
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 391 (444)
|||.+.+...++.++|+||||+++|+|++|.+|+..... ...+... .. .
T Consensus 198 aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~-------------------~~---------~ 246 (289)
T 1x8b_A 198 ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-------------------RL---------P 246 (289)
T ss_dssp CHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-------------------CC---------C
T ss_pred ChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-------------------CC---------C
Confidence 999998765677899999999999999999987754322 2212110 00 1
Q ss_pred cccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 392 ~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.++..+++.+.++|.+||+.||.+|||+.|+|+ ||||++..
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~-h~~~~~~~ 287 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK-HSVLLSAS 287 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT-CTTC----
T ss_pred CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh-ChHhhhhc
Confidence 123467999999999999999999999999999 99998743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.08 Aligned_cols=312 Identities=20% Similarity=0.284 Sum_probs=207.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+++.++|++++.||+|+||.||+|+++.+|+.||||++... .+.+.+|++++++++||||++++++|.......
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~- 80 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK- 80 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH-
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch-
Confidence 46778999999999999999999999999999999998532 345678999999999999999999998765310
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
..+... .-+....
T Consensus 81 -----------------------------------------------------~~~~~~--------------~~~~~~~ 93 (332)
T 3qd2_B 81 -----------------------------------------------------WQEEMD--------------EIWLKDE 93 (332)
T ss_dssp -----------------------------------------------------HHHHHH--------------C------
T ss_pred -----------------------------------------------------hhhhhh--------------hhhhccc
Confidence 000000 0000000
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.....-...+............+.... .+....-.......++++|||||++ +|.+++.... .....++..++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~ 171 (332)
T 3qd2_B 94 STDWPLSSPSPMDAPSVKIRRMDPFST-KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFI 171 (332)
T ss_dssp ---------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHH
T ss_pred cccccccCCCcccccccceeeccccCc-ccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHH
Confidence 000000000000000000000000000 0000111112335679999999985 8999886422 223456667899999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-------------CCccccccccccCchhhcc
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-------------PNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-------------~~~~~~gt~~y~aPE~l~~ 318 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+
T Consensus 172 qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 250 (332)
T 3qd2_B 172 QIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250 (332)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred HHHHHHHHHHhCCeeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC
Confidence 999999999999999999999999999 78899999999997764432 2233468999999999988
Q ss_pred CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 319 AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 319 ~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
. .++.++|+||||+++|+|++|..|+. +....+........+... ...+
T Consensus 251 ~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~~~-------------------------~~~~ 299 (332)
T 3qd2_B 251 N-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPLLF-------------------------TQKY 299 (332)
T ss_dssp C-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCHHH-------------------------HHHC
T ss_pred C-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCccc-------------------------ccCC
Confidence 7 78999999999999999999876642 111111111111111111 1247
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+.+.+||.+||+.||.+|||+.|+|+ ||||+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~-~~~f~~~ 332 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE-NAIFENL 332 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH-STTCCCC
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh-chhhhcC
Confidence 88999999999999999999999999 9999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=352.90 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=215.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
++..++|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|++++++++||||+++++++...+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 127 (348)
T 1u5q_A 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 127 (348)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 345678999999999999999999999999999999985331 34668999999999999999999998764
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 128 -------------------------------------------------------------------------------- 127 (348)
T 1u5q_A 128 -------------------------------------------------------------------------------- 127 (348)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++|||||.|+|.+++.. ...++++..++.++
T Consensus 128 --------------------------------------------~~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~ 160 (348)
T 1u5q_A 128 --------------------------------------------TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVT 160 (348)
T ss_dssp --------------------------------------------EEEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHH
T ss_pred --------------------------------------------eEEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHH
Confidence 3899999999999988753 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc--CCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--AIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~s~~sDi 328 (444)
.||+.||.|||++|++|+||||+||+++ .++.++|+|||++..... .....+++.|+|||.+.+ ...++.++|+
T Consensus 161 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 236 (348)
T 1u5q_A 161 HGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 236 (348)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHH
T ss_pred HHHHHHHHHHHhCCeeeCCCCHHHEEEC-CCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHH
Confidence 9999999999999999999999999999 789999999999876532 234578999999999852 2368899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|+.||.+.+..+....+.... .+ ...+..+++.+.+||.+|
T Consensus 237 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------------SP--------ALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------CC--------CCCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------------CC--------CCCCCCCCHHHHHHHHHH
Confidence 999999999999999998887766665554410 00 011234689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|+.||.+|||+.++|+ ||||...
T Consensus 290 l~~dP~~Rps~~~ll~-h~~~~~~ 312 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLK-HRFVLRE 312 (348)
T ss_dssp TCSSGGGSCCHHHHTT-CHHHHSC
T ss_pred cccChhhCcCHHHHhh-Chhhhcc
Confidence 9999999999999999 9999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=351.21 Aligned_cols=289 Identities=30% Similarity=0.542 Sum_probs=225.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+|++++++++||||+++++++......
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--- 84 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE--- 84 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST---
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC---
Confidence 46789999999999999999999999999999999985322 3455899999999999999998877543210
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (353)
T 2b9h_A 85 -------------------------------------------------------------------------------- 84 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.....++|||||+++|.+++.. +.+++..++.++.||
T Consensus 85 --------------------------------------~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi 121 (353)
T 2b9h_A 85 --------------------------------------NFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQT 121 (353)
T ss_dssp --------------------------------------TCCCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHH
T ss_pred --------------------------------------ccceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHH
Confidence 0024899999999999998853 579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----------CccccccccccCchhhccCCCC
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----------NVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----------~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+.||+|||++|++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+...+
T Consensus 122 ~~~L~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (353)
T 2b9h_A 122 LRAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200 (353)
T ss_dssp HHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCC
T ss_pred HHHHHHHHHCCeecCCCCHHHeEEc-CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCc
Confidence 9999999999999999999999999 788999999999876543211 1224679999999988765478
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC----CcccCCCccCCCCcccccCCCC
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY----TEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~~s 398 (444)
+.++|+|||||++|+|++|+.||.+.+..+....+....+.+............ .....+......+. .+.+.++
T Consensus 201 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 279 (353)
T 2b9h_A 201 SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVN 279 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSC
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCC
Confidence 999999999999999999999999999888888888877765421110000000 00001111111111 1234679
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.+.+||.+||+.||++|||+.|+|+ ||||+......
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~-hp~~~~~~~~~ 316 (353)
T 2b9h_A 280 PKGIDLLQRMLVFDPAKRITAKEALE-HPYLQTYHDPN 316 (353)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT-SGGGTTTCCTT
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhc-CccccccCCcc
Confidence 99999999999999999999999999 99999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.76 Aligned_cols=251 Identities=33% Similarity=0.499 Sum_probs=212.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++.+.||+|+||+||+|++..+++.||+|++... ...+.+|+.++++++||||+++++++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----- 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-----
Confidence 47899999999999999999999999999999998443 245668999999999999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (279)
T 3fdn_A 83 -------------------------------------------------------------------------------- 82 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++ +|.+++.. ..++++..++.++.|
T Consensus 83 -----------------------------------------~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~q 117 (279)
T 3fdn_A 83 -----------------------------------------RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 117 (279)
T ss_dssp -----------------------------------------EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHH
Confidence 38999999985 88888853 356999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++|++|+||+|+||+++ .++.++|+|||++...... ......+++.|+|||.+.+. .++.++|+||||
T Consensus 118 i~~~l~~LH~~~i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 194 (279)
T 3fdn_A 118 LANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLG 194 (279)
T ss_dssp HHHHHHHHHTTTCEECCCCGGGEEEC-TTSCEEECSCCEESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHH
T ss_pred HHHHHHHHHhCCEecccCChHhEEEc-CCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHH
Confidence 99999999999999999999999999 7889999999988554332 23445789999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|..||...+..+....+.... . .++..+++.+.+||.+||+.|
T Consensus 195 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~ 245 (279)
T 3fdn_A 195 VLCYEFLVGKPPFEANTYQETYKRISRVE-----------------F------------TFPDFVTEGARDLISRLLKHN 245 (279)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----------------C------------CCCCcCCHHHHHHHHHHhccC
Confidence 99999999999999887776666554411 0 122346899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|.+|||+.|+|+ ||||++...
T Consensus 246 p~~Rps~~e~l~-h~~~~~~~~ 266 (279)
T 3fdn_A 246 PSQRPMLREVLE-HPWITANSS 266 (279)
T ss_dssp GGGSCCHHHHHH-CHHHHHHCS
T ss_pred hhhCCCHHHHhh-CccccCCcc
Confidence 999999999999 999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=353.54 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=220.4
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhc-CCCceeE
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRL-EHSNIVK 79 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l-~h~~i~~ 79 (444)
.+..+..+.++|++.+.||+|+||.||+|+++.+|+.||||++.... +.+.+|+.+++++ .||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34456778899999999999999999999999899999999985432 3456899999999 7999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+++++...+
T Consensus 165 ~~~~~~~~~----------------------------------------------------------------------- 173 (365)
T 2y7j_A 165 LIDSYESSS----------------------------------------------------------------------- 173 (365)
T ss_dssp EEEEEEBSS-----------------------------------------------------------------------
T ss_pred EEEEEeeCC-----------------------------------------------------------------------
Confidence 999887653
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcC
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSK 238 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~ 238 (444)
..++|||||++ +|.+++.. .
T Consensus 174 -------------------------------------------------------~~~lv~e~~~g~~L~~~l~~----~ 194 (365)
T 2y7j_A 174 -------------------------------------------------------FMFLVFDLMRKGELFDYLTE----K 194 (365)
T ss_dssp -------------------------------------------------------EEEEEECCCTTCBHHHHHHH----H
T ss_pred -------------------------------------------------------EEEEEEEeCCCCcHHHHHHh----c
Confidence 48999999986 89998853 3
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc
Q psy10212 239 QNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 239 ~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~ 318 (444)
..+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++.............+++.|+|||.+.+
T Consensus 195 ~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 195 VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccc
Confidence 5799999999999999999999999999999999999999 789999999999987665555556788999999999863
Q ss_pred C-----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccc
Q psy10212 319 A-----IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393 (444)
Q Consensus 319 ~-----~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 393 (444)
. ..++.++|+|||||++|+|++|..||.+.+.......+...........+
T Consensus 274 ~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------ 329 (365)
T 2y7j_A 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW------------------------ 329 (365)
T ss_dssp TTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH------------------------
T ss_pred cccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------
Confidence 2 25788999999999999999999999887777666665553221111111
Q ss_pred cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 394 ~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
..+++.+.+||.+||+.||.+|||+.|+|+ ||||+
T Consensus 330 -~~~~~~~~~li~~~L~~dP~~Rps~~ell~-hp~f~ 364 (365)
T 2y7j_A 330 -DDRSSTVKDLISRLLQVDPEARLTAEQALQ-HPFFE 364 (365)
T ss_dssp -SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH-SGGGC
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhc-CcccC
Confidence 246899999999999999999999999999 99997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.28 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=211.7
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.|+..+.||+|+||.||+|+++.+|+.||||++... .+.+.+|+.++++++||||+++++++...+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE---------- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----------
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----------
Confidence 477888999999999999999999999999998543 245668999999999999999999998764
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 116 -------------------------------------------------------------------------------- 115 (321)
T 2c30_A 116 -------------------------------------------------------------------------------- 115 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++|||||++ +|.+++. ...+++..++.++.||+.||
T Consensus 116 ------------------------------------~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L 154 (321)
T 2c30_A 116 ------------------------------------ELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQAL 154 (321)
T ss_dssp ------------------------------------EEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------EEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHH
Confidence 38999999985 8888763 35699999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLA 336 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~ 336 (444)
.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+. .++.++|+||||+++|
T Consensus 155 ~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ 232 (321)
T 2c30_A 155 AYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVI 232 (321)
T ss_dssp HHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHH
T ss_pred HHHHHCCeecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHH
Confidence 999999999999999999999 78899999999987654332 23455789999999999877 7899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 337 ELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 337 eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
+|++|+.||.+.+..+....+..... +. + .....+++.+.++|.+||+.||++|
T Consensus 233 el~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~-----~--~~~~~~~~~l~~li~~~l~~dp~~R 286 (321)
T 2c30_A 233 EMVDGEPPYFSDSPVQAMKRLRDSPP-------------------PK-----L--KNSHKVSPVLRDFLERMLVRDPQER 286 (321)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSSC-------------------CC-----C--TTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHhCCCCCCCCCHHHHHHHHhcCCC-------------------CC-----c--CccccCCHHHHHHHHHHccCChhhC
Confidence 99999999988877666555443110 00 0 0112468999999999999999999
Q ss_pred CCHHHHhccCchhhhhh
Q psy10212 417 ISPLQVRSITPFLIELR 433 (444)
Q Consensus 417 Ps~~elL~~hpwf~~~~ 433 (444)
||+.|+|+ ||||++..
T Consensus 287 ps~~ell~-hp~~~~~~ 302 (321)
T 2c30_A 287 ATAQELLD-HPFLLQTG 302 (321)
T ss_dssp CCHHHHHT-SGGGGGCC
T ss_pred cCHHHHhc-ChhhccCC
Confidence 99999999 99998743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=353.65 Aligned_cols=285 Identities=26% Similarity=0.404 Sum_probs=224.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcC--------CCceeEeeeEEeec
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLE--------HSNIVKLKYFFYSS 87 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~--------h~~i~~~~~~~~~~ 87 (444)
.+.++|+++++||+|+||+||+|++..+++.||||++... ...+.+|++++++++ |+||+++++.+...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4568999999999999999999999999999999999654 345668999999985 78899999998754
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+..
T Consensus 114 ~~~----------------------------------------------------------------------------- 116 (397)
T 1wak_A 114 GVN----------------------------------------------------------------------------- 116 (397)
T ss_dssp ETT-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 310
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..++++|||||+++|.+.+.. .....+++..++
T Consensus 117 ---------------------------------------------~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~ 149 (397)
T 1wak_A 117 ---------------------------------------------GTHICMVFEVLGHHLLKWIIK--SNYQGLPLPCVK 149 (397)
T ss_dssp ---------------------------------------------EEEEEEEECCCCCBHHHHHHH--TTTSCCCHHHHH
T ss_pred ---------------------------------------------CceEEEEEeccCccHHHHHHh--cccCCCCHHHHH
Confidence 135999999999999988864 233679999999
Q ss_pred HHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcCCC---------------------------------------------
Q psy10212 248 LYIYQLFRSLAYIHVL-GICHRDIKPQNLLLNPET--------------------------------------------- 281 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~-givH~dLkp~NIll~~~~--------------------------------------------- 281 (444)
.++.||+.||+|||++ |++||||||+||+++.+.
T Consensus 150 ~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999999998 999999999999998322
Q ss_pred ---CeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCC------hhH
Q psy10212 282 ---GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS------GVD 352 (444)
Q Consensus 282 ---~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~------~~e 352 (444)
..++|+|||.+...... .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+ ..+
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 306 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHH
T ss_pred ccccceEecccccccccccc--CccCCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHH
Confidence 27999999999765432 3445789999999999887 79999999999999999999999998655 456
Q ss_pred HHHHHHHHhCCCCHHHHHhhCCCCCcc----cCCCccCC-CC--------cccccCCCChhHHHHHHHhcccCCCCCCCH
Q psy10212 353 QLVEIIKVLGTPTREQIREMNPNYTEF----KFPQIKSH-PW--------SKVFRVRTPPDAIDLISRLLEYTPSSRISP 419 (444)
Q Consensus 353 ~~~~i~~~~g~~~~~~~~~~~~~~~~~----~~p~~~~~-~~--------~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~ 419 (444)
.+..+.+..+.++...+.......... ........ .+ ...++..+++.+.+||.+||+.||.+|||+
T Consensus 307 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 386 (397)
T 1wak_A 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386 (397)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH
T ss_pred HHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH
Confidence 777888888888776654321110000 00000000 00 001123346789999999999999999999
Q ss_pred HHHhccCchhhh
Q psy10212 420 LQVRSITPFLIE 431 (444)
Q Consensus 420 ~elL~~hpwf~~ 431 (444)
.|+|+ ||||++
T Consensus 387 ~e~l~-hp~~~~ 397 (397)
T 1wak_A 387 AECLR-HPWLNS 397 (397)
T ss_dssp HHHHT-SGGGGC
T ss_pred HHHhh-CccccC
Confidence 99999 999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.20 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=190.9
Q ss_pred hhccccchh---heecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQK---TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.++|++. +.||+|+||+||+|+++.+|+.||||++... .....+|+.+++++. ||||+++++++...+
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----- 79 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL----- 79 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Confidence 345667764 7899999999999999999999999999654 356678999999997 999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (325)
T 3kn6_A 80 -------------------------------------------------------------------------------- 79 (325)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..|+|||||++ +|.+++.. ...+++..++.++.|
T Consensus 80 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~q 114 (325)
T 3kn6_A 80 -----------------------------------------HTFLVMELLNGGELFERIKK----KKHFSETEASYIMRK 114 (325)
T ss_dssp -----------------------------------------EEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHH
Confidence 48999999985 99998853 467999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETG---VLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~---~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|+.||.|||++|++|+||||+||+++ ..+ .++|+|||++....... ......+++.|+|||.+.+. .++.++|+
T Consensus 115 i~~~l~~LH~~~ivH~Dlkp~NIll~-~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di 192 (325)
T 3kn6_A 115 LVSAVSHMHDVGVVHRDLKPENLLFT-DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDL 192 (325)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEE-C----CEEEECCCTTCEECCC----------------------C-CCCHHHHH
T ss_pred HHHHHHHHHHCCCeecCCCHHHEEEe-cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccch
Confidence 99999999999999999999999997 333 89999999997654332 23345679999999999877 79999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChh-------HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGV-------DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~-------e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
||||+++|+|++|+.||.+.+.. +....+..... .+......++++++
T Consensus 193 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~s~~~ 247 (325)
T 3kn6_A 193 WSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------------------------SFEGEAWKNVSQEA 247 (325)
T ss_dssp HHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------------------------CCCSHHHHTSCHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------------------------CCCcccccCCCHHH
Confidence 99999999999999999865432 22222211100 00111113469999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+||.+||+.||.+|||+.|+++ ||||++..
T Consensus 248 ~~li~~~L~~dP~~Rpt~~ell~-h~w~~~~~ 278 (325)
T 3kn6_A 248 KDLIQGLLTVDPNKRLKMSGLRY-NEWLQDGS 278 (325)
T ss_dssp HHHHHHHHCCCTTTCCCTTTSTT-CGGGCTTC
T ss_pred HHHHHHHCCCChhHCCCHHHHhc-ChhhccCc
Confidence 99999999999999999999999 99998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=362.81 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=217.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..++|++++.||+|+||+||+|+++.+++.||+|++... ...+.+|+.+++.++||||+++++++.+.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---- 142 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR---- 142 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----
Confidence 457899999999999999999999999999999998542 344668999999999999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 143 -------------------------------------------------------------------------------- 142 (410)
T 3v8s_A 143 -------------------------------------------------------------------------------- 142 (410)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|+|||||+ ++|.+++.. ..+++..++.++.
T Consensus 143 ------------------------------------------~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~ 175 (410)
T 3v8s_A 143 ------------------------------------------YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTA 175 (410)
T ss_dssp ------------------------------------------EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHH
Confidence 4999999996 589888752 4689999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCC---CCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAI---DYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~---~~s~~s 326 (444)
||+.||+|||++|++||||||+||+++ .++.++|+|||++....... ......||+.|+|||++.+.. .++.++
T Consensus 176 qi~~aL~~LH~~givHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~ 254 (410)
T 3v8s_A 176 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 254 (410)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHH
T ss_pred HHHHHHHHHHHCCeEeccCCHHHeeEC-CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcc
Confidence 999999999999999999999999999 78999999999997654332 123567899999999997652 178899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+|||||++|+|++|+.||.+.+..+...++..... ...+|. ...+|+++.+||.
T Consensus 255 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~ 309 (410)
T 3v8s_A 255 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------------SLTFPD----------DNDISKEAKNLIC 309 (410)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---------------HCCCCT----------TCCCCHHHHHHHH
T ss_pred eEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc---------------cccCCC----------cccccHHHHHHHH
Confidence 999999999999999999999888888877765310 011111 1246999999999
Q ss_pred HhcccCCCC--CCCHHHHhccCchhhhhhh
Q psy10212 407 RLLEYTPSS--RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 407 ~~L~~DP~k--RPs~~elL~~hpwf~~~~~ 434 (444)
+||+.+|.+ ||++.|+++ ||||+++..
T Consensus 310 ~lL~~~~~rlgR~~~~ei~~-Hp~f~~~~w 338 (410)
T 3v8s_A 310 AFLTDREVRLGRNGVEEIKR-HLFFKNDQW 338 (410)
T ss_dssp HHSSCGGGCTTSSCHHHHHT-SGGGCCSSC
T ss_pred HHccChhhhCCCCCHHHHhc-CccccCCCH
Confidence 999999988 999999999 999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=344.47 Aligned_cols=286 Identities=26% Similarity=0.450 Sum_probs=226.7
Q ss_pred hhhccccchhheecccceeEEEEeEe-cCCCceeeeeeeecc---ccchhhHHHHhhhcCCCc------eeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKL-LDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSN------IVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~ 87 (444)
+.+.++|++++.||+|+||+||+|++ ..+|+.||||++... .+.+.+|++++++++|++ |+++++++...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 34668999999999999999999998 567899999998643 245668999999887654 89999888765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 90 ~------------------------------------------------------------------------------- 90 (339)
T 1z57_A 90 G------------------------------------------------------------------------------- 90 (339)
T ss_dssp T-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.+++|||||+++|.+++.. ....++++..++
T Consensus 91 -----------------------------------------------~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~ 121 (339)
T 1z57_A 91 -----------------------------------------------HICIVFELLGLSTYDFIKE--NGFLPFRLDHIR 121 (339)
T ss_dssp -----------------------------------------------EEEEEEECCCCBHHHHHHH--TTTCCCCHHHHH
T ss_pred -----------------------------------------------cEEEEEcCCCCCHHHHHHh--cCCCCCcHHHHH
Confidence 4899999999999999864 233478999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC------------------CCeEEEeecCCcccccCCCCCcccccccc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE------------------TGVLKLCDFGSAKHLVRGEPNVSYICSRY 309 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~------------------~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~ 309 (444)
.++.||+.||+|||++|++|+||||+||+++.. .+.++|+|||.+..... ......+++.
T Consensus 122 ~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~ 199 (339)
T 1z57_A 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRH 199 (339)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGG
T ss_pred HHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCcc
Confidence 999999999999999999999999999999832 56799999999876432 2345578999
Q ss_pred ccCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc----ccCCCc-
Q psy10212 310 YRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE----FKFPQI- 384 (444)
Q Consensus 310 y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~----~~~p~~- 384 (444)
|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.+..+..+...+......... ...+..
T Consensus 200 y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
T 1z57_A 200 YRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278 (339)
T ss_dssp GCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTS
T ss_pred ccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccc
Confidence 9999999877 7899999999999999999999999999988888888888887776665543211000 000000
Q ss_pred --------cCCCCcc--cccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 385 --------KSHPWSK--VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 385 --------~~~~~~~--~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
....+.. .....+++.+.+||.+||+.||.+|||+.|+|+ ||||++++..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~-hp~f~~~~~~ 338 (339)
T 1z57_A 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK-HPFFDLLKKS 338 (339)
T ss_dssp HHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT-SGGGGGGGC-
T ss_pred cccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc-CHHHHHHhcc
Confidence 0000000 011234678999999999999999999999999 9999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=341.13 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=214.3
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc--------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
++.++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+|++++++++||||+++++++.....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK- 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC-
Confidence 4678999999999999999999999999999999998543 2456789999999999999999999865432
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (305)
T 2wtk_C 81 -------------------------------------------------------------------------------- 80 (305)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
...++|||||+++|.+++... ....+++..++.++
T Consensus 81 -------------------------------------------~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~ 115 (305)
T 2wtk_C 81 -------------------------------------------QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYF 115 (305)
T ss_dssp --------------------------------------------CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHH
T ss_pred -------------------------------------------CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHH
Confidence 248999999999988887643 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCC-CCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAI-DYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~s~~s 326 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+.. ..+.++
T Consensus 116 ~qi~~al~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 194 (305)
T 2wtk_C 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV 194 (305)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHH
T ss_pred HHHHHHHHHHHHCCeeecCCCcccEEEc-CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchh
Confidence 9999999999999999999999999999 78899999999987653221 122345799999999987641 347899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||||+++|+|++|+.||.+.+..+....+.+. .. .++..+++.+.++|.
T Consensus 195 Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 195 DIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-----------------SY------------AIPGDCGPPLSDLLK 245 (305)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------------CC------------CCCSSSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------------CC------------CCCCccCHHHHHHHH
Confidence 9999999999999999999987766655554431 00 123457899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+||+.||.+|||+.|+++ ||||++....
T Consensus 246 ~~l~~dp~~Rps~~~ll~-~~~~~~~~~~ 273 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQ-HSWFRKKHPP 273 (305)
T ss_dssp HHTCSSTTTSCCHHHHHH-SHHHHSCCCC
T ss_pred HHccCChhhCCCHHHHhc-CcccccCCCC
Confidence 999999999999999999 9999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.57 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=217.8
Q ss_pred chhhhhhccccchh-heecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhc-CCCceeEeeeEEe
Q psy10212 14 YTYFSDLDNSLAQK-TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRL-EHSNIVKLKYFFY 85 (444)
Q Consensus 14 ~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 85 (444)
|+..+.+.++|.+. +.||+|+||+||+|+++.+|+.||+|++... ...+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 45578899999998 8999999999999999999999999998543 24566899999999 5699999999987
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
..+
T Consensus 100 ~~~----------------------------------------------------------------------------- 102 (327)
T 3lm5_A 100 NTS----------------------------------------------------------------------------- 102 (327)
T ss_dssp CSS-----------------------------------------------------------------------------
T ss_pred eCC-----------------------------------------------------------------------------
Confidence 654
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCF 244 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~ 244 (444)
.+++|||||++ +|.+++.. .....+++.
T Consensus 103 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~ 131 (327)
T 3lm5_A 103 -------------------------------------------------EIILILEYAAGGEIFSLCLP--ELAEMVSEN 131 (327)
T ss_dssp -------------------------------------------------EEEEEEECCTTEEGGGGGSS--CC-CCCCHH
T ss_pred -------------------------------------------------eEEEEEEecCCCcHHHHHHH--hcccCCCHH
Confidence 38999999986 88777632 334679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCC
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
.++.++.||+.||+|||++|++|+||+|+||+++. ..+.++|+|||++.............+++.|+|||.+.+. .+
T Consensus 132 ~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 210 (327)
T 3lm5_A 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD-PI 210 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTC-CC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCC-CC
Confidence 99999999999999999999999999999999983 2679999999999876555445556789999999999877 78
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|+||||+++|+|++|+.||.+.+..+....+....... .......+++.+.
T Consensus 211 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY-------------------------SEETFSSVSQLAT 265 (327)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------------------------CTTTTTTSCHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc-------------------------CchhhcccCHHHH
Confidence 999999999999999999999999988877776665532111 1111235689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+||.+||+.||.+|||+.++|+ ||||+++.
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~-h~~~~~~~ 295 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLS-HSWLQQWD 295 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTT-CGGGCCCC
T ss_pred HHHHHHcCCChhhCcCHHHHhC-CHhhcccc
Confidence 9999999999999999999999 99998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=367.81 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=216.9
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|.+.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS----- 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence 47899999999999999999999999999999999543 235668999999999999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (476)
T 2y94_A 90 -------------------------------------------------------------------------------- 89 (476)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||+ ++|.+++. ..+++++..++.++.|
T Consensus 90 -----------------------------------------~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~q 124 (476)
T 2y94_A 90 -----------------------------------------DIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQ 124 (476)
T ss_dssp -----------------------------------------EEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHH
Confidence 3899999996 58988874 4567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++.............+++.|+|||.+.+....+.++|+||||
T Consensus 125 i~~aL~~LH~~givHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 203 (476)
T 2y94_A 125 ILSGVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203 (476)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCcccccHHHEEEe-cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhH
Confidence 99999999999999999999999999 78899999999998766555555678899999999998874457899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+......++.... . ..+..+++.+.+||.+||+.|
T Consensus 204 vil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~Li~~~L~~d 254 (476)
T 2y94_A 204 VILYALLCGTLPFDDDHVPTLFKKICDGI-----------------F------------YTPQYLNPSVISLLKHMLQVD 254 (476)
T ss_dssp HHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------------C------------CCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------c------------CCCccCCHHHHHHHHHHcCCC
Confidence 99999999999999887776666554411 0 112346899999999999999
Q ss_pred CCCCCCHHHHhccCchhhh
Q psy10212 413 PSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~ 431 (444)
|.+|||+.|+++ ||||++
T Consensus 255 P~~Rpt~~eil~-hp~~~~ 272 (476)
T 2y94_A 255 PMKRATIKDIRE-HEWFKQ 272 (476)
T ss_dssp TTTSCCHHHHHT-CHHHHT
T ss_pred chhCcCHHHHHh-CHHhhh
Confidence 999999999999 999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=342.78 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=216.2
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..+.++|.+.+.||+|+||+||+|++..+|+.||+|.+... ...+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 79 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT----- 79 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----
Confidence 35778999999999999999999999999999999999543 345678999999999999999999886654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (304)
T 2jam_A 80 -------------------------------------------------------------------------------- 79 (304)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||+ ++|.+++.. .+.+++..++.++.|
T Consensus 80 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~q 114 (304)
T 2jam_A 80 -----------------------------------------HYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQ 114 (304)
T ss_dssp -----------------------------------------EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHH
Confidence 3899999997 599888853 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEE---cCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll---~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
|+.||.|||++|++|+||+|+||++ + ..+.++|+|||.+..... .......+++.|+|||.+.+. .++.++|+|
T Consensus 115 i~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~ 191 (304)
T 2jam_A 115 VLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCW 191 (304)
T ss_dssp HHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHH
T ss_pred HHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcceecCC-CccccccCCCCccChHHhccC-CCCchhhHH
Confidence 9999999999999999999999999 5 678999999999865432 223345689999999999877 789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|..||.+.+..+....+.+... . +...+...+++.+.++|.+||
T Consensus 192 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----------------~--------~~~~~~~~~~~~~~~li~~~l 246 (304)
T 2jam_A 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYY-----------------E--------FESPFWDDISESAKDFICHLL 246 (304)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-----------------C--------CCTTTTTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------------C--------CCccccccCCHHHHHHHHHHc
Confidence 999999999999999998877776666554210 0 111122357899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..||.+|||+.|+|+ ||||+....
T Consensus 247 ~~dp~~Rps~~~~l~-h~~~~~~~~ 270 (304)
T 2jam_A 247 EKDPNERYTCEKALS-HPWIDGNTA 270 (304)
T ss_dssp CSSTTTSCCHHHHHT-SHHHHSSCS
T ss_pred CCChhHCcCHHHHhc-CccccCCCc
Confidence 999999999999999 999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=356.27 Aligned_cols=251 Identities=25% Similarity=0.455 Sum_probs=210.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHH-hhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQI-MRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++++.||+|+||.||+|+++.+++.||+|++.... ..+.+|..+ ++.++||||+++++++...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~---- 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD---- 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence 478999999999999999999999999999999995432 233456655 57789999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 113 -------------------------------------------------------------------------------- 112 (373)
T 2r5t_A 113 -------------------------------------------------------------------------------- 112 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|+|||||++ +|.+++.. .+.+++..++.++.
T Consensus 113 ------------------------------------------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ 146 (373)
T 2r5t_A 113 ------------------------------------------KLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAA 146 (373)
T ss_dssp ------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHH
Confidence 39999999985 89888753 45789999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++|++||||||+||+++ .++.++|+|||+++... .........||+.|+|||.+.+. .++.++|+||
T Consensus 147 qi~~aL~~LH~~givHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 224 (373)
T 2r5t_A 147 EIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWC 224 (373)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHH
T ss_pred HHHHHHHHHHHCCceecCCCHHHEEEC-CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHH
Confidence 999999999999999999999999999 78999999999997643 23344566889999999999877 7999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|..||.+.+..+....+... .. .++.++++.+.+||.+||+
T Consensus 225 lG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------PL------------QLKPNITNSARHLLEGLLQ 275 (373)
T ss_dssp HHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------------CC------------CCCSSSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------cc------------CCCCCCCHHHHHHHHHHcc
Confidence 999999999999999988887777766651 11 1234679999999999999
Q ss_pred cCCCCCCCH----HHHhccCchhhhhh
Q psy10212 411 YTPSSRISP----LQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~----~elL~~hpwf~~~~ 433 (444)
.||.+||++ .++++ ||||+.+.
T Consensus 276 ~dp~~R~~~~~~~~~i~~-h~~f~~~~ 301 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKS-HVFFSLIN 301 (373)
T ss_dssp SSGGGSTTTTTTHHHHHT-SGGGTTCC
T ss_pred cCHHhCCCCCCCHHHHhC-CccccCCC
Confidence 999999997 68999 99998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=364.80 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=219.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.-..++|+++++||+|+||+||+|+++.+++.||+|++... ...+.+|+.++.+++||||+++++++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-- 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-- 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 34468999999999999999999999999999999998542 234678999999999999999999987754
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 148 -------------------------------------------------------------------------------- 147 (437)
T 4aw2_A 148 -------------------------------------------------------------------------------- 147 (437)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+|+|||||+ |+|.+++.. ..+.+++..++.+
T Consensus 148 --------------------------------------------~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~ 180 (437)
T 4aw2_A 148 --------------------------------------------NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFY 180 (437)
T ss_dssp --------------------------------------------EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHH
T ss_pred --------------------------------------------EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHH
Confidence 3999999996 599998853 3567999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc----CCCCC
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG----AIDYT 323 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~s 323 (444)
+.||+.||.|||++||+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++.. ...++
T Consensus 181 ~~qi~~aL~~LH~~giiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~ 259 (437)
T 4aw2_A 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259 (437)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEEC
T ss_pred HHHHHHHHHHHHhCCeEecccCHHHeeEc-CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCC
Confidence 99999999999999999999999999999 789999999999976543332 223578999999999862 23689
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+|||||++|+|++|+.||.+.+..+...++..... ...+|.. ...+|+++.+
T Consensus 260 ~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~---------~~~~s~~~~d 315 (437)
T 4aw2_A 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---------------RFQFPTQ---------VTDVSENAKD 315 (437)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---------------HCCCCSS---------CCCSCHHHHH
T ss_pred CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc---------------cccCCcc---------cccCCHHHHH
Confidence 999999999999999999999999888888877764210 0111110 1246999999
Q ss_pred HHHHhcccCCCC--CCCHHHHhccCchhhhhh
Q psy10212 404 LISRLLEYTPSS--RISPLQVRSITPFLIELR 433 (444)
Q Consensus 404 LI~~~L~~DP~k--RPs~~elL~~hpwf~~~~ 433 (444)
||.+||..+|++ ||++.|+++ ||||+++.
T Consensus 316 Li~~lL~~~~~r~~r~~~~eil~-Hpff~~i~ 346 (437)
T 4aw2_A 316 LIRRLICSREHRLGQNGIEDFKK-HPFFSGID 346 (437)
T ss_dssp HHHTTSSCGGGCTTTTTTHHHHT-SGGGTTCC
T ss_pred HHHHHhcccccccCCCCHHHHhC-CCccCCCC
Confidence 999999999988 999999999 99999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=344.55 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=202.4
Q ss_pred hhhccccchh-heecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQK-TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (444)
+.+.++|++. +.||+|+||+||+|++..+++.||||++... ...+.+|+.++.++ +||||+++++++...+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--- 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--- 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC---
Confidence 4577899995 7899999999999999999999999999543 24566899999985 7999999999987754
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (316)
T 2ac3_A 85 -------------------------------------------------------------------------------- 84 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+++|||||+ ++|.+++.. ...+++..++.++
T Consensus 85 -------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~ 117 (316)
T 2ac3_A 85 -------------------------------------------RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVV 117 (316)
T ss_dssp -------------------------------------------EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHH
Confidence 3899999998 699998853 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC---eEEEeecCCcccccCCC--------CCccccccccccCchhhccC
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETG---VLKLCDFGSAKHLVRGE--------PNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~---~ikL~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~l~~~ 319 (444)
.||+.||+|||++|++|+||||+||+++ .++ .++|+|||++....... ......+++.|+|||.+.+.
T Consensus 118 ~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 196 (316)
T 2ac3_A 118 QDVASALDFLHNKGIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196 (316)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEES-CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHT
T ss_pred HHHHHHHHHHHhCCceeCCCCHHHEEEc-cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcc
Confidence 9999999999999999999999999998 444 39999999986543211 11233589999999998641
Q ss_pred ----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhH---------------HHHHHHHHhCCCCHHHHHhhCCCCCccc
Q psy10212 320 ----IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD---------------QLVEIIKVLGTPTREQIREMNPNYTEFK 380 (444)
Q Consensus 320 ----~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e---------------~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 380 (444)
..++.++|+|||||++|+|++|+.||.+.+..+ ....+.... ..
T Consensus 197 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-----------------~~ 259 (316)
T 2ac3_A 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-----------------YE 259 (316)
T ss_dssp SHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC-----------------CC
T ss_pred cccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC-----------------cc
Confidence 257899999999999999999999998764321 122222210 01
Q ss_pred CCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 381 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 381 ~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
++ ......+++.+.+||.+||+.||.+|||+.|+|+ ||||+....
T Consensus 260 ~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~-hp~~~~~~~ 304 (316)
T 2ac3_A 260 FP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ-HPWVQGCAP 304 (316)
T ss_dssp CC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-STTCC----
T ss_pred cC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc-ChhhcCCCC
Confidence 11 0111346899999999999999999999999999 999998543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=363.49 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=204.6
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhcCCCceeEeeeEE
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRLEHSNIVKLKYFF 84 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (444)
-..+.++|.+.+.||+|+||+||+|.++.+++.||||++.... ..+.+|+.++++++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3567899999999999999999999999999999999985432 2466899999999999999999987
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
..+
T Consensus 210 ~~~----------------------------------------------------------------------------- 212 (419)
T 3i6u_A 210 DAE----------------------------------------------------------------------------- 212 (419)
T ss_dssp ESS-----------------------------------------------------------------------------
T ss_pred ecC-----------------------------------------------------------------------------
Confidence 432
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCCh
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPC 243 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~ 243 (444)
..++|||||++ +|.+++. ....+++
T Consensus 213 --------------------------------------------------~~~lv~e~~~~g~L~~~l~----~~~~~~~ 238 (419)
T 3i6u_A 213 --------------------------------------------------DYYIVLELMEGGELFDKVV----GNKRLKE 238 (419)
T ss_dssp --------------------------------------------------EEEEEEECCTTCBGGGGTS----SSCCCCH
T ss_pred --------------------------------------------------ceEEEEEcCCCCcHHHHHh----ccCCCCH
Confidence 27899999985 8877663 4567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhcc--C
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--A 319 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--~ 319 (444)
..++.++.||+.||+|||++|++|+||||+||+++.. ...++|+|||++.............+|+.|+|||.+.+ .
T Consensus 239 ~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 318 (419)
T 3i6u_A 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318 (419)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCC
Confidence 9999999999999999999999999999999999732 34699999999987655555556678999999999853 2
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHH-hCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKV-LGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~-~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
..++.++|+|||||++|+|++|+.||........+...+.. .....+. ....++
T Consensus 319 ~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~ 373 (419)
T 3i6u_A 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE-------------------------VWAEVS 373 (419)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH-------------------------HHTTSC
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch-------------------------hhcccC
Confidence 36788999999999999999999999876544333332221 1111111 113468
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.+.+||.+||+.||.+|||+.|+|+ ||||++..
T Consensus 374 ~~~~~li~~~L~~dP~~Rps~~e~l~-hp~~~~~~ 407 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFTTEEALR-HPWLQDED 407 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH-SGGGCCHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhC-CcccCChh
Confidence 99999999999999999999999999 99998744
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.28 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=217.0
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------------ccchhhHHHHhhhcC-CCceeEeee
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------------KRFKNREMQIMRRLE-HSNIVKLKY 82 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------------~~~~~~E~~~l~~l~-h~~i~~~~~ 82 (444)
...+.++|++.+.||+|+||.||+|+++.+|+.||||++... .+.+.+|+++++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 456789999999999999999999999999999999998543 234568999999995 999999999
Q ss_pred EEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhh
Q psy10212 83 FFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIR 162 (444)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (444)
++...+
T Consensus 92 ~~~~~~-------------------------------------------------------------------------- 97 (298)
T 1phk_A 92 TYETNT-------------------------------------------------------------------------- 97 (298)
T ss_dssp EEECSS--------------------------------------------------------------------------
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 886543
Q ss_pred hcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCC
Q psy10212 163 EMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNF 241 (444)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l 241 (444)
..++|||||+ ++|.+++.. ...+
T Consensus 98 ----------------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~ 121 (298)
T 1phk_A 98 ----------------------------------------------------FFFLVFDLMKKGELFDYLTE----KVTL 121 (298)
T ss_dssp ----------------------------------------------------EEEEEEECCTTCBHHHHHHH----HSSC
T ss_pred ----------------------------------------------------eEEEEEeccCCCcHHHHHhc----cCCC
Confidence 4899999998 599998853 3579
Q ss_pred ChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc---
Q psy10212 242 PCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG--- 318 (444)
Q Consensus 242 ~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~--- 318 (444)
++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+.............+++.|+|||.+.+
T Consensus 122 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 200 (298)
T 1phk_A 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc-CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccc
Confidence 9999999999999999999999999999999999999 788999999999977655555556678999999999852
Q ss_pred --CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 319 --AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 319 --~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
...++.++|+||||+++|+|++|..||.+.+..+....+...... .+. .....
T Consensus 201 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~~ 255 (298)
T 1phk_A 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-----------------FGS--------PEWDD 255 (298)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------------CCT--------TTGGG
T ss_pred cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc-----------------cCc--------ccccc
Confidence 236789999999999999999999999888776666555542110 000 00124
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+++.+.++|.+||+.||.+|||+.|+|+ ||||++...
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~-h~~~~~~~~ 292 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALA-HPFFQQYVV 292 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTT-SGGGCTTC-
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHh-ChHhhhccc
Confidence 6899999999999999999999999999 999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=350.72 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=212.8
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------------ccchhhHHHHhhhcCCCceeEeeeE
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------------KRFKNREMQIMRRLEHSNIVKLKYF 83 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (444)
...++.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred CCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3456889999999999999999999999999999999998543 2356689999999999999999999
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+...+
T Consensus 98 ~~~~~--------------------------------------------------------------------------- 102 (335)
T 3dls_A 98 FENQG--------------------------------------------------------------------------- 102 (335)
T ss_dssp EECSS---------------------------------------------------------------------------
T ss_pred EeeCC---------------------------------------------------------------------------
Confidence 87654
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-C-cHHHHHHhhhhcCCCC
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-E-TVYKVAKHYSKSKQNF 241 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~-~l~~~~~~~~~~~~~l 241 (444)
.+++|||||. + +|.+++. ....+
T Consensus 103 ---------------------------------------------------~~~lv~e~~~~g~~l~~~~~----~~~~l 127 (335)
T 3dls_A 103 ---------------------------------------------------FFQLVMEKHGSGLDLFAFID----RHPRL 127 (335)
T ss_dssp ---------------------------------------------------EEEEEEECCTTSCBHHHHHH----TCCCC
T ss_pred ---------------------------------------------------EEEEEEEeCCCCccHHHHHH----hcCCC
Confidence 4899999986 4 8888875 45579
Q ss_pred ChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCC
Q psy10212 242 PCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 242 ~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 321 (444)
++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++.............+|+.|+|||.+.+...
T Consensus 128 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCB
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc-CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCC
Confidence 9999999999999999999999999999999999999 788999999999987666555556678999999999987744
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
.+.++|+||||+++|+|++|..||...... .. .....+..+++.+
T Consensus 207 ~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----------------------------~~~~~~~~~~~~l 251 (335)
T 3dls_A 207 RGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----------------------------AAIHPPYLVSKEL 251 (335)
T ss_dssp CSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----------------------------TCCCCSSCCCHHH
T ss_pred CCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----------------------------hccCCCcccCHHH
Confidence 488999999999999999999999652210 00 0001123468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+||.+||+.||.+|||+.++|+ ||||++.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~-hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVT-DPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH-CTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhc-CccccCC
Confidence 99999999999999999999999 9999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=335.99 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=204.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|.+.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT----- 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence 47899999999999999999999999999999998543 235668999999999999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (276)
T 2h6d_A 85 -------------------------------------------------------------------------------- 84 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||+ ++|.+++.. ...+++..++.++.|
T Consensus 85 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~q 119 (276)
T 2h6d_A 85 -----------------------------------------DFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQ 119 (276)
T ss_dssp -----------------------------------------EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHH
Confidence 3899999997 599998853 356899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++|+||+|+||+++ .++.++|+|||.+.............+++.|+|||.+.+....+.++|+||||
T Consensus 120 i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 198 (276)
T 2h6d_A 120 ILSAVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198 (276)
T ss_dssp HHHHHHHHHHHCSSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCChhhEEEC-CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHH
Confidence 99999999999999999999999999 78899999999997765544444557899999999998763446899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|+.||...+.......+.... . .++..++..+.++|.+||+.|
T Consensus 199 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~l~~li~~~l~~~ 249 (276)
T 2h6d_A 199 VILYALLCGTLPFDDEHVPTLFKKIRGGV-----------------F------------YIPEYLNRSVATLLMHMLQVD 249 (276)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------------c------------cCchhcCHHHHHHHHHHccCC
Confidence 99999999999998877665555443310 0 112346899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~ 432 (444)
|.+|||+.|+++ ||||++.
T Consensus 250 p~~Rps~~~~l~-h~~~~~~ 268 (276)
T 2h6d_A 250 PLKRATIKDIRE-HEWFKQD 268 (276)
T ss_dssp GGGSCCHHHHHH-SHHHHTT
T ss_pred hhhCCCHHHHHh-ChhhccC
Confidence 999999999999 9999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=339.53 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=191.0
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
+....++|++.+.||+|+||.||+|++..+|+.||+|.+.... ..+.+|++++++++||||+++++++...+
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 84 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN- 84 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-
Confidence 4445678999999999999999999999999999999995432 45678999999999999999999987653
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (278)
T 3cok_A 85 -------------------------------------------------------------------------------- 84 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
..++|||||++ +|.+++. ....++++..++.
T Consensus 85 ---------------------------------------------~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~ 116 (278)
T 3cok_A 85 ---------------------------------------------YVYLVLEMCHNGEMNRYLK---NRVKPFSENEARH 116 (278)
T ss_dssp ---------------------------------------------EEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHH
T ss_pred ---------------------------------------------eEEEEEecCCCCcHHHHHh---hccCCCCHHHHHH
Confidence 48999999975 8888875 2346799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchh
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|
T Consensus 117 ~~~qi~~~l~~lH~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 194 (278)
T 3cok_A 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESD 194 (278)
T ss_dssp HHHHHHHHHHHHHHTTEECSSCCGGGEEEC-TTCCEEECCCTTCEECC-----------------------------CTH
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhh
Confidence 999999999999999999999999999999 78899999999987654322 22345679999999999876 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||...+..+....+.. .. ..++..++.++.++|.+
T Consensus 195 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 195 VWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------------AD------------YEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp HHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------------SC------------CCCCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------------cc------------cCCccccCHHHHHHHHH
Confidence 99999999999999999987654432221110 00 11234578999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.++|+ ||||++...
T Consensus 246 ~l~~dp~~Rps~~~~l~-h~~~~~~~~ 271 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLD-HPFMSRNSS 271 (278)
T ss_dssp HSCSSGGGSCCHHHHTT-STTTC----
T ss_pred HcccCHhhCCCHHHHhc-CccccCCCC
Confidence 99999999999999999 999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.70 Aligned_cols=251 Identities=30% Similarity=0.487 Sum_probs=214.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK----- 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----
Confidence 37899999999999999999999999999999998543 245678999999999999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (284)
T 2vgo_A 88 -------------------------------------------------------------------------------- 87 (284)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++ +|.+++.. .+.+++..++.++.|
T Consensus 88 -----------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~q 122 (284)
T 2vgo_A 88 -----------------------------------------RIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEE 122 (284)
T ss_dssp -----------------------------------------EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHH
Confidence 38999999985 99998853 356999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||.|||++|++|+||+|+||+++ .++.++|+|||.+...... ......+++.|+|||.+.+. .++.++|+||||
T Consensus 123 i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 199 (284)
T 2vgo_A 123 LADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAG 199 (284)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHH
T ss_pred HHHHHHHHHHCCceecCCCHHHEEEc-CCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHH
Confidence 99999999999999999999999998 7889999999998654332 23345689999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
+++|+|++|..||...+..+....+... .. .++..+++.+.++|.+||+.|
T Consensus 200 ~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~ 250 (284)
T 2vgo_A 200 VLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL------------KFPPFLSDGSKDLISKLLRYH 250 (284)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC------------CCCTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------------cc------------CCCCcCCHHHHHHHHHHhhcC
Confidence 9999999999999887776655544431 00 123457899999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~ 434 (444)
|.+|||+.++++ ||||++...
T Consensus 251 p~~Rps~~~ll~-h~~~~~~~~ 271 (284)
T 2vgo_A 251 PPQRLPLKGVME-HPWVKANSR 271 (284)
T ss_dssp GGGSCCHHHHHT-CHHHHHHCC
T ss_pred HhhCCCHHHHhh-CHHHHhhcc
Confidence 999999999999 999997543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.64 Aligned_cols=284 Identities=30% Similarity=0.535 Sum_probs=223.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcC-CC-----ceeEeeeEEeecC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLE-HS-----NIVKLKYFFYSSG 88 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~ 88 (444)
+.+.++|++.+.||+|+||+||+|+++.+++.||||++.... ..+.+|+++++.+. |+ +|+++.+++...+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 567789999999999999999999999999999999996543 34557888888874 44 4999988887764
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 130 -------------------------------------------------------------------------------- 129 (382)
T 2vx3_A 130 -------------------------------------------------------------------------------- 129 (382)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||||+++|.+++... ....+++..++.
T Consensus 130 ----------------------------------------------~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~ 161 (382)
T 2vx3_A 130 ----------------------------------------------HLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRK 161 (382)
T ss_dssp ----------------------------------------------EEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHH
T ss_pred ----------------------------------------------ceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHH
Confidence 48999999999999998642 235689999999
Q ss_pred HHHHHHHHHHHHH--HCCcccCCCCCCcEEEcC-CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcc
Q psy10212 249 YIYQLFRSLAYIH--VLGICHRDIKPQNLLLNP-ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 249 i~~QIl~aL~yLH--s~givH~dLkp~NIll~~-~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.||+.||.||| +.||+||||||+||+++. ..+.++|+|||++..... ......+|+.|+|||.+.+. .++.+
T Consensus 162 i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~ 238 (382)
T 2vx3_A 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLA 238 (382)
T ss_dssp HHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTH
T ss_pred HHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCC-CCCcH
Confidence 9999999999999 578999999999999952 467899999999976533 23456789999999999887 79999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC---CCc-----ccCC----------CccCC
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN---YTE-----FKFP----------QIKSH 387 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~---~~~-----~~~p----------~~~~~ 387 (444)
+|+|||||++|+|++|+.||.+.+..+.+..+.+..+.++...+...... +.. .... .....
T Consensus 239 ~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (382)
T 2vx3_A 239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTR 318 (382)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCS
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchh
Confidence 99999999999999999999999999999999999988877665431100 000 0000 00000
Q ss_pred CCccccc-----------------CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 388 PWSKVFR-----------------VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 388 ~~~~~~~-----------------~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+...+. ...++.+.+||.+||++||++|||+.|+|+ ||||++..
T Consensus 319 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~-hp~f~~~~ 380 (382)
T 2vx3_A 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ-HSFFKKTA 380 (382)
T ss_dssp CHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT-SGGGCC--
T ss_pred hHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc-CcccccCC
Confidence 0000000 001147899999999999999999999999 99998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=341.50 Aligned_cols=269 Identities=24% Similarity=0.354 Sum_probs=196.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
..++|++.+.||+|+||+||+|++..+++.||||.+... ...+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE----- 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-----
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-----
Confidence 457999999999999999999999989999999998533 3456689999999999999999999877653
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (303)
T 2vwi_A 88 -------------------------------------------------------------------------------- 87 (303)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh----cCCCCChHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK----SKQNFPCFYTKLY 249 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~----~~~~l~~~~i~~i 249 (444)
.++|||||+ ++|.+++..... ....+++..++.+
T Consensus 88 -----------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i 126 (303)
T 2vwi_A 88 -----------------------------------------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126 (303)
T ss_dssp -----------------------------------------EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHH
T ss_pred -----------------------------------------cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHH
Confidence 889999997 599998865333 2456899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC------CCccccccccccCchhhccCCCCC
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE------PNVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
+.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+...++
T Consensus 127 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (303)
T 2vwi_A 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 205 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEEC-TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhEEEc-CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCC
Confidence 99999999999999999999999999999 78899999999886543221 122346799999999987633689
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+||||+++|+|++|+.||...+..+......... + +..........+...+++.+.+
T Consensus 206 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~-----------------~~~~~~~~~~~~~~~~~~~~~~ 266 (303)
T 2vwi_A 206 FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--P-----------------PSLETGVQDKEMLKKYGKSFRK 266 (303)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--C-----------------CCTTC-----CCCCCCCHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--C-----------------CccccccccchhhhhhhHHHHH
Confidence 99999999999999999999999877666554333210 0 0000011111223457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+|.+||+.||.+|||+.++++ ||||++.+..
T Consensus 267 li~~~l~~dp~~Rps~~~ll~-h~~~~~~~~~ 297 (303)
T 2vwi_A 267 MISLCLQKDPEKRPTAAELLR-HKFFQKAKNK 297 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT-STTC------
T ss_pred HHHHHccCChhhCcCHHHHhh-ChhhhcCCCC
Confidence 999999999999999999999 9999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.05 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=209.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
...|.+.+.||+|+||+||+|.+..+++.||+|.+... ...+.+|+.++++++||||+++++++......
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 100 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG---- 100 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS----
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC----
Confidence 45689999999999999999999999999999998543 24466899999999999999999998764320
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (290)
T 1t4h_A 101 -------------------------------------------------------------------------------- 100 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++++|||||++ +|.+++.. ...+++..++.++.||
T Consensus 101 --------------------------------------~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi 138 (290)
T 1t4h_A 101 --------------------------------------KKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQI 138 (290)
T ss_dssp --------------------------------------CEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred --------------------------------------CceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHH
Confidence 1458999999975 99998853 3679999999999999
Q ss_pred HHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||.|||+++ ++|+||+|+||+++...+.++|+|||++..... .......+++.|+|||.+.+ .++.++|+|||
T Consensus 139 ~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~sl 215 (290)
T 1t4h_A 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAF 215 (290)
T ss_dssp HHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHH
T ss_pred HHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHH
Confidence 99999999999 999999999999975688999999999865432 23344568999999998864 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|+.||............... ......++...++.+.++|.+||+.
T Consensus 216 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 216 GMCMLEMATSEYPYSECQNAAQIYRRVTS--------------------------GVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------------------------TCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCCCCCcCcHHHHHHHHhc--------------------------cCCccccCCCCCHHHHHHHHHHccC
Confidence 99999999999999876554443332221 0011123345689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
||.+|||+.|+|+ ||||++
T Consensus 270 dp~~Rps~~ell~-h~~f~~ 288 (290)
T 1t4h_A 270 NKDERYSIKDLLN-HAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHT-SGGGC-
T ss_pred ChhhCCCHHHHhh-Cccccc
Confidence 9999999999999 999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.06 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=208.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhcCCCceeEeeeEEe
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRLEHSNIVKLKYFFY 85 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (444)
..+.++|++.+.||+|+||.||+|+++.+++.||||++.... ..+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 457789999999999999999999999999999999985431 34668999999999999999998875
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
...
T Consensus 86 ~~~----------------------------------------------------------------------------- 88 (322)
T 2ycf_A 86 AED----------------------------------------------------------------------------- 88 (322)
T ss_dssp SSS-----------------------------------------------------------------------------
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 432
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCF 244 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~ 244 (444)
.++|||||++ +|.+++. ....+++.
T Consensus 89 --------------------------------------------------~~lv~e~~~~~~L~~~~~----~~~~~~~~ 114 (322)
T 2ycf_A 89 --------------------------------------------------YYIVLELMEGGELFDKVV----GNKRLKEA 114 (322)
T ss_dssp --------------------------------------------------EEEEEECCTTEETHHHHS----TTCCCCHH
T ss_pred --------------------------------------------------eEEEEecCCCCcHHHHHh----ccCCCCHH
Confidence 7899999985 8888774 45679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhc--cCC
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF--GAI 320 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~--~~~ 320 (444)
.++.++.||+.||.|||++|++|+||+|+||+++.. ...++|+|||++.............+++.|+|||.+. +..
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 194 (322)
T 2ycf_A 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCC
Confidence 999999999999999999999999999999999832 2259999999997654333233456899999999974 233
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHH-HHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVE-IIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~-i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|+|++|..||........+.. +........+ .....+++
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~ 249 (322)
T 2ycf_A 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP-------------------------EVWAEVSE 249 (322)
T ss_dssp TCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH-------------------------HHHTTSCH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc-------------------------hhhhhcCH
Confidence 688999999999999999999999987654433322 2221111111 11235689
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+.+||.+||+.||.+|||+.++|+ ||||++..
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~-h~~~~~~~ 282 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALR-HPWLQDED 282 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT-SGGGCCHH
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhh-CcCcCCHH
Confidence 9999999999999999999999999 99998744
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=348.58 Aligned_cols=279 Identities=22% Similarity=0.292 Sum_probs=211.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.++|.+.+.||+|+||+||+|++..+|+.||||++... .+.+.+|++++++++||||+++++++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---- 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT----
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC----
Confidence 3568999999999999999999999999999999998543 2455689999999999999999998876542
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (319)
T 4euu_A 82 -------------------------------------------------------------------------------- 81 (319)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...++|||||+ ++|.+++.... ....+++..++.++.|
T Consensus 82 ----------------------------------------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~q 120 (319)
T 4euu_A 82 ----------------------------------------RHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120 (319)
T ss_dssp ----------------------------------------CCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHH
T ss_pred ----------------------------------------ceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHH
Confidence 24899999997 59999886432 3344999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc-------CCC
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLL----NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG-------AID 321 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll----~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~ 321 (444)
|+.||+|||++|++|+||||+||++ + ..+.++|+|||++.............+++.|+|||.+.. ...
T Consensus 121 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 199 (319)
T 4euu_A 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199 (319)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCC
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCC
Confidence 9999999999999999999999998 5 667899999999987766555556678999999999862 237
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCCh----hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSG----VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~----~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
++.++|+|||||++|+|++|+.||..... .+.+.++.... +...+...... ....+.-.........+...+
T Consensus 200 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 275 (319)
T 4euu_A 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK---PSGAISGVQKA-ENGPIDWSGDMPVSCSLSRGL 275 (319)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC---CTTCCEEEECS-TTCCEEEESSCCTTCSSCHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC---Ccccchhhhcc-cCCccccCccCCcccccchhH
Confidence 89999999999999999999999975433 23333333321 11110000000 000000000011111223345
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCch
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPF 428 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpw 428 (444)
+..+.++|.+||+.||++|||+.|+|+ ||-
T Consensus 276 ~~~l~~ll~~~L~~dP~~R~s~~ell~-h~~ 305 (319)
T 4euu_A 276 QVLLTPVLANILEADQEKCWGFDQFFA-ETS 305 (319)
T ss_dssp HHHHHHHHHHHSCCCTTTSCCHHHHHH-HHH
T ss_pred HHHhHHHHHHhccCChhhhccHHHhhh-ccH
Confidence 678999999999999999999999999 763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.94 Aligned_cols=270 Identities=26% Similarity=0.374 Sum_probs=213.9
Q ss_pred chhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhc-CCCceeEeeeEEeecCC
Q psy10212 14 YTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 89 (444)
++.+....++|++++.||+|+||+||+|++..+|+.||||++... ...+.+|+.+++++ +||||+++++++.....
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344567789999999999999999999999999999999998543 35667899999999 89999999999987532
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
..
T Consensus 96 ~~------------------------------------------------------------------------------ 97 (326)
T 2x7f_A 96 PG------------------------------------------------------------------------------ 97 (326)
T ss_dssp -C------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
....+++|||||++ +|.+++... ....+++..++.
T Consensus 98 ------------------------------------------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 133 (326)
T 2x7f_A 98 ------------------------------------------MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAY 133 (326)
T ss_dssp ------------------------------------------CCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHH
T ss_pred ------------------------------------------ccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHH
Confidence 01358999999986 999998643 245789999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhcc----CCCCC
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFG----AIDYT 323 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~s 323 (444)
++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.. ...++
T Consensus 134 i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 212 (326)
T 2x7f_A 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212 (326)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSGGGEEEC-TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CC
T ss_pred HHHHHHHHHHHHHHCCccccCCcHHHEEEc-CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCC
Confidence 999999999999999999999999999999 78899999999987653322 2334568999999999862 22688
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+||||+++|+|++|..||.+.+.......+.... .+ ......+++.+.+
T Consensus 213 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~~~l~~ 265 (326)
T 2x7f_A 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-------------------AP--------RLKSKKWSKKFQS 265 (326)
T ss_dssp TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------CC--------CCSCSCSCHHHHH
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------cc--------cCCccccCHHHHH
Confidence 99999999999999999999998877665554433310 00 1112356899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||.+||..||.+|||+.++|+ ||||++...
T Consensus 266 li~~~l~~dp~~Rps~~~ll~-hp~~~~~~~ 295 (326)
T 2x7f_A 266 FIESCLVKNHSQRPATEQLMK-HPFIRDQPN 295 (326)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT-SHHHHCCTT
T ss_pred HHHHHhccChhhCCCHHHHhh-ChHHhhCcc
Confidence 999999999999999999999 999998543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=359.39 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=215.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..++|++++.||+|+||+||+|+++.+|+.||+|++... ...+.+|..++.+++||||+++++++.+.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~---- 134 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN---- 134 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS----
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC----
Confidence 458899999999999999999999999999999998542 245668999999999999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 135 -------------------------------------------------------------------------------- 134 (412)
T 2vd5_A 135 -------------------------------------------------------------------------------- 134 (412)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|+|||||+ ++|.+++.. .+..+++..++.++.
T Consensus 135 ------------------------------------------~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~ 169 (412)
T 2vd5_A 135 ------------------------------------------YLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLA 169 (412)
T ss_dssp ------------------------------------------EEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHH
Confidence 4999999996 599998863 345799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhcc------CCCCC
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFG------AIDYT 323 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~------~~~~s 323 (444)
||+.||+|||++|++||||||+||+++ .++.+||+|||++........ .....||+.|+|||++.. ...++
T Consensus 170 qi~~aL~~LH~~giiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~ 248 (412)
T 2vd5_A 170 EIVMAIDSVHRLGYVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248 (412)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEEC
T ss_pred HHHHHHHHHHHCCeeecccCHHHeeec-CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCC
Confidence 999999999999999999999999999 789999999999976544332 223578999999999873 22689
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
.++|+|||||++|+|++|+.||.+.+..+...++..... ...+|. +...+|+++++
T Consensus 249 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~---------~~~~~s~~~~d 304 (412)
T 2vd5_A 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---------------HLSLPL---------VDEGVPEEARD 304 (412)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---------------HCCCC-------------CCCHHHHH
T ss_pred hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------------CcCCCc---------cccCCCHHHHH
Confidence 999999999999999999999999888887777764210 001111 12357999999
Q ss_pred HHHHhcccCCCCC---CCHHHHhccCchhhhhh
Q psy10212 404 LISRLLEYTPSSR---ISPLQVRSITPFLIELR 433 (444)
Q Consensus 404 LI~~~L~~DP~kR---Ps~~elL~~hpwf~~~~ 433 (444)
||.+||. +|.+| |++.|+++ ||||+++.
T Consensus 305 li~~lL~-~p~~Rlgr~~~~ei~~-Hpff~~i~ 335 (412)
T 2vd5_A 305 FIQRLLC-PPETRLGRGGAGDFRT-HPFFFGLD 335 (412)
T ss_dssp HHHTTSS-CGGGCTTTTTHHHHHT-SGGGTTCC
T ss_pred HHHHHcC-ChhhcCCCCCHHHHhc-CCCcCCCC
Confidence 9999999 99998 58999999 99999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.84 Aligned_cols=284 Identities=15% Similarity=0.138 Sum_probs=197.1
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhc--CCCceeEee-------
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRL--EHSNIVKLK------- 81 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l--~h~~i~~~~------- 81 (444)
+.-...|.+.+.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++++.| +||||++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 344566999999999999999999999999999999996532 3344674444444 699988865
Q ss_pred eEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhh
Q psy10212 82 YFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQI 161 (444)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (444)
+.+...+.. .+..+.+..
T Consensus 138 d~~~~~~~~-------------~~~~~~~~~------------------------------------------------- 155 (371)
T 3q60_A 138 DAVAVQSQP-------------PFAQLSPGQ------------------------------------------------- 155 (371)
T ss_dssp EEEEETTSC-------------SSSBCSCC--------------------------------------------------
T ss_pred hheecCCCC-------------CeeeccCCc-------------------------------------------------
Confidence 333332210 000000000
Q ss_pred hhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCC
Q psy10212 162 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNF 241 (444)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l 241 (444)
.......+|+|||||+++|.+++... +..+
T Consensus 156 -----------------------------------------------~~~~~~~~~lv~e~~~~~L~~~l~~~---~~~~ 185 (371)
T 3q60_A 156 -----------------------------------------------DDYAVANYLLLMPAASVDLELLFSTL---DFVY 185 (371)
T ss_dssp -------------------------------------------------CCEEEEEEEECCCSEEHHHHHHHH---HHSC
T ss_pred -----------------------------------------------ccceeeeEEEEecCCCCCHHHHHHHh---cccc
Confidence 00011348999999999999999753 2234
Q ss_pred ChHHH------HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchh
Q psy10212 242 PCFYT------KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPEL 315 (444)
Q Consensus 242 ~~~~i------~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~ 315 (444)
..... ..++.||+.||+|||++|++||||||+||+++ .++.+||+|||++...... .....+++.|+|||.
T Consensus 186 ~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~ 262 (371)
T 3q60_A 186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM-PDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREF 262 (371)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEC-TTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHH
T ss_pred chhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEEC-CCCCEEEEecceeeecCCC--ccCccCCcCCcChhh
Confidence 55555 67779999999999999999999999999999 7889999999999764321 224566799999999
Q ss_pred hccC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 316 IFGA-IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 316 l~~~-~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
+.+. ..++.++|+|||||++|+|++|+.||.+...... ..+............+.....
T Consensus 263 ~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~ 322 (371)
T 3q60_A 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSC 322 (371)
T ss_dssp HTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTS
T ss_pred ccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc--------------------cchhhhhhhhccccccchhhc
Confidence 9761 2789999999999999999999999987643210 000111111111112222223
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.++++.+.+||.+||+.||++|||+.|+|+ ||||++++....
T Consensus 323 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-hp~f~~~~~~~~ 364 (371)
T 3q60_A 323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAME-TPEFLQLQNEIS 364 (371)
T ss_dssp SCCCHHHHHHHHHHTCSSTTTCCCHHHHTT-SHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcCCChhhCCCHHHHhc-CHHHHHHHHHHh
Confidence 468999999999999999999999999999 999999887643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=337.16 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=209.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
....++|++++.||+|+||+||+|++..+|+.||||.+... ...+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 97 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT------- 97 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-------
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-------
Confidence 45678899999999999999999999999999999999654 355678999999999999999999987754
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (314)
T 3com_A 98 -------------------------------------------------------------------------------- 97 (314)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+++|||||++ +|.+++.. ....+++..++.++.||+
T Consensus 98 ---------------------------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~ 135 (314)
T 3com_A 98 ---------------------------------------DLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTL 135 (314)
T ss_dssp ---------------------------------------EEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHH
Confidence 38999999986 89988852 456799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||||+
T Consensus 136 ~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 213 (314)
T 3com_A 136 KGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGI 213 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHH
Confidence 999999999999999999999999 78899999999987654332 23345679999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||...+.......+.... + + ....+..+++.+.+||.+||..||
T Consensus 214 il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----------------~-------~~~~~~~~~~~l~~li~~~l~~dp 267 (314)
T 3com_A 214 TAIEMAEGKPPYADIHPMRAIFMIPTNP--P-----------------P-------TFRKPELWSDNFTDFVKQCLVKSP 267 (314)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-----------------C-------CCSSGGGSCHHHHHHHHHHTCSCT
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcCC--C-----------------c-------ccCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999998877655444332210 0 0 001123468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~ 433 (444)
.+|||+.++|+ ||||++..
T Consensus 268 ~~Rpt~~~ll~-~~~~~~~~ 286 (314)
T 3com_A 268 EQRATATQLLQ-HPFVRSAK 286 (314)
T ss_dssp TTSCCHHHHTT-SHHHHTCC
T ss_pred hhCcCHHHHHh-CHHHhcCC
Confidence 99999999999 99999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.24 Aligned_cols=257 Identities=26% Similarity=0.327 Sum_probs=210.9
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+.++|++++.||+|+||.||+|++..+++.||+|++.... +.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------ 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT------
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC------
Confidence 5688999999999999999999999999999999985432 45668999999999999999999887654
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (276)
T 2yex_A 79 -------------------------------------------------------------------------------- 78 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
..++|||||++ +|.+++. ....+++..++.++.||
T Consensus 79 ----------------------------------------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i 114 (276)
T 2yex_A 79 ----------------------------------------IQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQL 114 (276)
T ss_dssp ----------------------------------------EEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHH
Confidence 38999999985 8887763 34579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+....+.++|+||
T Consensus 115 ~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 193 (276)
T 2yex_A 115 MAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (276)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHH
T ss_pred HHHHHHHHhCCeeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHH
Confidence 9999999999999999999999999 78899999999987543221 2334567999999999987634578999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++|+|++|+.||...+............. ... .....+++.+.++|.+||+
T Consensus 194 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------~~~----------~~~~~~~~~~~~li~~~l~ 247 (276)
T 2yex_A 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------------TYL----------NPWKKIDSAPLALLHKILV 247 (276)
T ss_dssp HHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----------------TTS----------TTGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----------------ccc----------CchhhcCHHHHHHHHHHCC
Confidence 99999999999999987665433222111000 000 0012468999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.||.+|||+.|+++ ||||++...
T Consensus 248 ~~p~~Rps~~~il~-~~~~~~~~~ 270 (276)
T 2yex_A 248 ENPSARITIPDIKK-DRWYNKPLK 270 (276)
T ss_dssp SSTTTSCCHHHHTT-CTTTTCCCC
T ss_pred CCchhCCCHHHHhc-CccccChhh
Confidence 99999999999999 999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.50 Aligned_cols=285 Identities=24% Similarity=0.441 Sum_probs=225.2
Q ss_pred hhccccchhheecccceeEEEEeEecCCC-ceeeeeeeecc---ccchhhHHHHhhhcCCCc------eeEeeeEEeecC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSG-ELVAIKKVLQD---KRFKNREMQIMRRLEHSN------IVKLKYFFYSSG 88 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~ 88 (444)
.+.++|++++.||+|+||+||+|++..++ +.||+|++... ...+.+|+.++++++|++ ++.+.+++...+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 35689999999999999999999998777 68999998643 345668999999997665 888888776654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 96 -------------------------------------------------------------------------------- 95 (355)
T 2eu9_A 96 -------------------------------------------------------------------------------- 95 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||||++++.+.+.. ....++++..++.
T Consensus 96 ----------------------------------------------~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~ 127 (355)
T 2eu9_A 96 ----------------------------------------------HMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRH 127 (355)
T ss_dssp ----------------------------------------------EEEEEEECCCCBHHHHHHH--TTTCCCCHHHHHH
T ss_pred ----------------------------------------------eEEEEEeccCCChHHHHHh--ccCCCCCHHHHHH
Confidence 4899999999999988854 2335799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcC------------------CCCeEEEeecCCcccccCCCCCccccccccc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNP------------------ETGVLKLCDFGSAKHLVRGEPNVSYICSRYY 310 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~------------------~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y 310 (444)
++.||+.||.|||++|++|+||||+||+++. ..+.++|+|||++..... ......+|+.|
T Consensus 128 i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y 205 (355)
T 2eu9_A 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHY 205 (355)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGG
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcc
Confidence 9999999999999999999999999999931 567899999999976432 23455789999
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc----cCCCc--
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF----KFPQI-- 384 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~----~~p~~-- 384 (444)
+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+.+..+..+...+.......... ..+..
T Consensus 206 ~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T 2eu9_A 206 RPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284 (355)
T ss_dssp CCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSH
T ss_pred cCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccc
Confidence 999999877 78999999999999999999999999999888888888888877766554432110000 00000
Q ss_pred -------cCCCCcc--cccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 385 -------KSHPWSK--VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 385 -------~~~~~~~--~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
....+.. ......++.+.+||.+||+.||.+|||+.|+|+ ||||+++...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~-hp~f~~~~~~ 343 (355)
T 2eu9_A 285 DGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL-HPFFAGLTPE 343 (355)
T ss_dssp HHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT-SGGGGGCCHH
T ss_pred hhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc-ChhhcCCChh
Confidence 0000000 001123568999999999999999999999999 9999997654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.90 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=214.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
...++|.+.+.||+|+||.||+|++..+++.||+|++... .+.+.+|+.++++++||||+++++++...+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--- 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC---
Confidence 3568999999999999999999999999999999998543 245668999999999999999999987654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (294)
T 2rku_A 89 -------------------------------------------------------------------------------- 88 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++|||||+ ++|.+++.. ...+++..++.++
T Consensus 89 -------------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~ 121 (294)
T 2rku_A 89 -------------------------------------------FVFVVLELCRRRSLLELHKR----RKALTEPEARYYL 121 (294)
T ss_dssp -------------------------------------------EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHH
Confidence 4899999998 588887753 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
.||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+. .++.++|+|
T Consensus 122 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~ 199 (294)
T 2rku_A 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVW 199 (294)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHH
T ss_pred HHHHHHHHHHHHCCccccCCChHhEEEc-CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHH
Confidence 9999999999999999999999999999 7889999999998765432 223345679999999999876 789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||...+..+....+... .. .++..+++.+.++|.+||
T Consensus 200 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------------EY------------SIPKHINPVAASLIQKML 250 (294)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC------------CCCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------------cC------------CCccccCHHHHHHHHHHc
Confidence 9999999999999999887766554443321 00 122356899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.||++|||+.|+|+ ||||++..
T Consensus 251 ~~~p~~Rps~~~ll~-~~~~~~~~ 273 (294)
T 2rku_A 251 QTDPTARPTINELLN-DEFFTSGY 273 (294)
T ss_dssp CSSGGGSCCGGGGGG-SHHHHTSC
T ss_pred ccChhhCcCHHHHhh-ChheecCC
Confidence 999999999999999 99998743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.42 Aligned_cols=260 Identities=30% Similarity=0.467 Sum_probs=216.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
-+.+.++|++++.||+|+||+||+|++..+++.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-- 94 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--
Confidence 356778999999999999999999999999999999998543 245668999999999999999999887654
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (287)
T 2wei_A 95 -------------------------------------------------------------------------------- 94 (287)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
..++|||||+ ++|.+.+.. ...+++..++.+
T Consensus 95 --------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i 126 (287)
T 2wei_A 95 --------------------------------------------SFYIVGELYTGGELFDEIIK----RKRFSEHDAARI 126 (287)
T ss_dssp --------------------------------------------EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHH
T ss_pred --------------------------------------------eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHH
Confidence 3899999997 588888753 347999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+.||+.||.|||++|++|+||+|+||+++.. ...++|+|||++.............+++.|+|||.+.+ .++.++|
T Consensus 127 ~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~D 204 (287)
T 2wei_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCD 204 (287)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHH
T ss_pred HHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchh
Confidence 9999999999999999999999999999732 34799999999876655444455568899999999876 4889999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|..||.+.+..+....+...... ...+ ....+++.+.++|.+
T Consensus 205 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~----------~~~~~~~~~~~li~~ 259 (287)
T 2wei_A 205 VWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA---------------FDLP----------QWRTISDDAKDLIRK 259 (287)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------CCSG----------GGTTSCHHHHHHHHH
T ss_pred hHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------CCch----------hhhhcCHHHHHHHHH
Confidence 999999999999999999988777666555441100 0000 013468999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.|+|+ ||||++...
T Consensus 260 ~l~~dp~~Rps~~ell~-hp~~~~~~~ 285 (287)
T 2wei_A 260 MLTFHPSLRITATQCLE-HPWIQKYSS 285 (287)
T ss_dssp HTCSSGGGSCCHHHHHH-SHHHHHHCC
T ss_pred HcccChhhCcCHHHHhc-CHHHhcccc
Confidence 99999999999999999 999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=344.88 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=215.0
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
+.-+.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 334667899999999999999999999999999999999995431 2456899999999999999999998776
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
...
T Consensus 85 ~~~----------------------------------------------------------------------------- 87 (311)
T 3ork_A 85 TPA----------------------------------------------------------------------------- 87 (311)
T ss_dssp ETT-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 430
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i 246 (444)
..+.|+|||||+ ++|.+++.. .+++++..+
T Consensus 88 ---------------------------------------------~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~ 118 (311)
T 3ork_A 88 ---------------------------------------------GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118 (311)
T ss_dssp ---------------------------------------------EEEEEEEEECCCEEEHHHHHHH----HCSCCHHHH
T ss_pred ---------------------------------------------CcccEEEEecCCCCCHHHHHHh----cCCCCHHHH
Confidence 024699999997 599998853 357999999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+.++.||+.||+|||++|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .+
T Consensus 119 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 196 (311)
T 3ork_A 119 IEVIADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SV 196 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTSCEEECCCSCC------------------CCTTCCHHHHHTC-CC
T ss_pred HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc-CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CC
Confidence 99999999999999999999999999999999 788999999999876543321 2234579999999999887 79
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|+||||+++|+|++|+.||.+.+..+....+......+. ......+++++.
T Consensus 197 ~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~ 251 (311)
T 3ork_A 197 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLD 251 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-------------------------HHHSTTCCHHHH
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-------------------------ccccCCCCHHHH
Confidence 9999999999999999999999998887776665554211111 011235799999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
++|.+||+.||.+||++.++|. |+|++....
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~-~~l~~~~~~ 282 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMR-ADLVRVHNG 282 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHH-HHHHHHHTT
T ss_pred HHHHHHHhcCHhhChhhHHHHH-HHHHHHhcC
Confidence 9999999999999999999999 999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.47 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred hhccccchh-heecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhh-hcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 19 DLDNSLAQK-TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMR-RLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 19 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+.++|.+. ++||+|+||+||+|+++.+|+.||||++.. .....+|+.++. .++||||+++++++.....
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~------- 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYA------- 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-------
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeeccc-------
Confidence 455677776 789999999999999999999999999864 345668888874 4589999999998865211
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 130 -------------------------------------------------------------------------------- 129 (400)
T 1nxk_A 130 -------------------------------------------------------------------------------- 129 (400)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
...++|+|||||++ +|.+++.. .....+++..++.++.||+.
T Consensus 130 -----------------------------------~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~ 172 (400)
T 1nxk_A 130 -----------------------------------GRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGE 172 (400)
T ss_dssp -----------------------------------TEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHH
T ss_pred -----------------------------------CCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHH
Confidence 01358999999985 99999863 22356999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
||.|||++|++||||||+||+++.. ++.+||+|||++.............+|+.|+|||++.+. .++.++|||||||
T Consensus 173 aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 251 (400)
T 1nxk_A 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGV 251 (400)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHH
T ss_pred HHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHH
Confidence 9999999999999999999999832 689999999999876554445566789999999999776 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhH----HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 334 VLAELLLGQPMFPGDSGVD----QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e----~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
++|+|++|+.||.+.+... ....+... ...++. .. ...+++++.+||.+||
T Consensus 252 il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-----------------~~~~~~---~~-----~~~~s~~~~~li~~~L 306 (400)
T 1nxk_A 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----------------QYEFPN---PE-----WSEVSEEVKMLIRNLL 306 (400)
T ss_dssp HHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----------------CCCCCT---TT-----TTTSCHHHHHHHHTTS
T ss_pred HHHHHHhCCCCCCCCccccccHHHHHHHHcC-----------------cccCCC---cc-----cccCCHHHHHHHHHHC
Confidence 9999999999998765432 22222220 111111 00 1346899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+.||.+|||+.|+|+ ||||.+.
T Consensus 307 ~~dP~~Rpt~~eil~-hp~~~~~ 328 (400)
T 1nxk_A 307 KTEPTQRMTITEFMN-HPWIMQS 328 (400)
T ss_dssp CSSGGGSCCHHHHHH-SHHHHTT
T ss_pred CCChhHCcCHHHHhc-CccccCC
Confidence 999999999999999 9999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.24 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=217.2
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..++|++++.||+|+||+||+|+++.+|+.||+|.+... ...+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 79 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---- 79 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG----
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC----
Confidence 457999999999999999999999999999999999543 2456689999999999999999998876432
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (279)
T 2w5a_A 80 -------------------------------------------------------------------------------- 79 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..+++|||||++ +|.+++.........+++..++.++.|
T Consensus 80 ----------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 119 (279)
T 2w5a_A 80 ----------------------------------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119 (279)
T ss_dssp ----------------------------------------TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ----------------------------------------ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHH
Confidence 358999999985 999999876666677999999999999
Q ss_pred HHHHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcch
Q psy10212 253 LFRSLAYIHVLG-----ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 253 Il~aL~yLHs~g-----ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
|+.||+|||+++ ++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++
T Consensus 120 i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 197 (279)
T 2w5a_A 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKS 197 (279)
T ss_dssp HHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHH
T ss_pred HHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchh
Confidence 999999999999 99999999999999 788999999999866533221 1234678999999999877 789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||||+++|+|++|+.||...+..+....+..... ..++..+++.+.++|.
T Consensus 198 Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~ 249 (279)
T 2w5a_A 198 DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------------------------RRIPYRYSDELNEIIT 249 (279)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHH
T ss_pred hHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----------------------------ccCCcccCHHHHHHHH
Confidence 999999999999999999998877666555544110 0122357899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+||+.||.+|||+.|+|+ |+|+..-.+
T Consensus 250 ~~l~~~p~~Rps~~~ll~-~~~~~~~~~ 276 (279)
T 2w5a_A 250 RMLNLKDYHRPSVEEILE-NPLILEHHH 276 (279)
T ss_dssp HHTCSSGGGSCCHHHHHT-STTCCGGGS
T ss_pred HHcCCCcccCCCHHHHHh-Chhhhhhcc
Confidence 999999999999999999 999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.69 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=203.0
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCC--CceeEeeeEEeecCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEH--SNIVKLKYFFYSSGD 89 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~ 89 (444)
+-..++|++++.||+|+||+||+|.+. +++.||||++.... ..+.+|+.++++++| +||+++++++...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~- 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ- 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-
Confidence 344588999999999999999999985 58999999985432 456689999999976 99999999987654
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (343)
T 3dbq_A 83 -------------------------------------------------------------------------------- 82 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
++++|||+++++|.+++.. ...+++..++.+
T Consensus 83 ---------------------------------------------~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i 113 (343)
T 3dbq_A 83 ---------------------------------------------YIYMVMECGNIDLNSWLKK----KKSIDPWERKSY 113 (343)
T ss_dssp ---------------------------------------------EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHH
T ss_pred ---------------------------------------------EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHH
Confidence 4899999888899999863 467999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhcc--------
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFG-------- 318 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~-------- 318 (444)
+.||+.||.|||++|++||||||+||+++ ++.++|+|||++........ .....+|+.|+|||.+.+
T Consensus 114 ~~qi~~al~~lH~~~iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 191 (343)
T 3dbq_A 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC------
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEEE--CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccccc
Confidence 99999999999999999999999999997 57899999999976543322 234568999999999864
Q ss_pred --CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 319 --AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 319 --~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
...++.++|||||||++|+|++|+.||...... .....+.. ......++.
T Consensus 192 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 244 (343)
T 3dbq_A 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------------------------PNHEIEFPD 244 (343)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---------------------------TTSCCCCCC
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---------------------------CCcccCCcc
Confidence 136889999999999999999999999865432 22222211 001112233
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
..+..+.+||.+||+.||.+|||+.|+|+ ||||+.-
T Consensus 245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~-hp~~~~~ 280 (343)
T 3dbq_A 245 IPEKDLQDVLKCCLKRDPKQRISIPELLA-HPYVQIQ 280 (343)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHT-SHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHHh-Ccccccc
Confidence 45789999999999999999999999999 9999853
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=362.16 Aligned_cols=273 Identities=19% Similarity=0.222 Sum_probs=202.3
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHH---HHhhhcCCCceeEee------
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREM---QIMRRLEHSNIVKLK------ 81 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~---~~l~~l~h~~i~~~~------ 81 (444)
....++|++.+.||+|+||+||+|+++.+|+.||||++... .+.+.+|+ +.+++++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34468999999999999999999999999999999998532 24566899 666677899999998
Q ss_pred -eEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhh
Q psy10212 82 -YFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQ 160 (444)
Q Consensus 82 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (444)
+++...+... ....+
T Consensus 149 ~~~~~~~~~~~------------~~~~~---------------------------------------------------- 164 (377)
T 3byv_A 149 FDLVKDPQKKK------------MIRVR---------------------------------------------------- 164 (377)
T ss_dssp SEEEECTTSCS------------EEEC-----------------------------------------------------
T ss_pred hhhhhccCCcc------------ccccc----------------------------------------------------
Confidence 4443332100 00000
Q ss_pred hhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhc---
Q psy10212 161 IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKS--- 237 (444)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~--- 237 (444)
+......-...|+|||||+|+|.+++......
T Consensus 165 ---------------------------------------------~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~ 199 (377)
T 3byv_A 165 ---------------------------------------------LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199 (377)
T ss_dssp --------------------------------------------------CEEESEEEEEECCSEEHHHHHHHHHHTTTT
T ss_pred ---------------------------------------------cCCCceEEEEEEEEEeccCCCHHHHHHhccccccc
Confidence 00000001248899999999999999653221
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhc
Q psy10212 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF 317 (444)
Q Consensus 238 ~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~ 317 (444)
...+++..++.++.||+.||+|||++|++||||||+||+++ .++.+||+|||++..... ......+ +.|+|||.+.
T Consensus 200 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~ 275 (377)
T 3byv_A 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEA 275 (377)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHH
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-CCCCEEEEechhheecCC--cccCCCC-cCccChhhhc
Confidence 11233478888999999999999999999999999999999 788999999999975322 2334456 8999999987
Q ss_pred cC----------CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 318 GA----------IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 318 ~~----------~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
+. ..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----------------------------- 326 (377)
T 3byv_A 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----------------------------- 326 (377)
T ss_dssp HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------------------------
T ss_pred ccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------------------------
Confidence 64 258999999999999999999999997654322111000
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.....+++.+.+||.+||+.||.+|||+.|+|+ ||||++++....
T Consensus 327 ----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~-hp~f~~~~~~~~ 371 (377)
T 3byv_A 327 ----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME-TPEYEQLRTELS 371 (377)
T ss_dssp ----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT-SHHHHHHHHHHH
T ss_pred ----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh-ChHHHHHHHHHH
Confidence 001357999999999999999999999999999 999999887654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=342.53 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=215.7
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
...++|.+.+.||+|+||.||+|++..+++.||+|++... .+.+.+|+.++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 114 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--- 114 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence 3568999999999999999999999999999999998543 245668999999999999999999987654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 115 -------------------------------------------------------------------------------- 114 (335)
T 2owb_A 115 -------------------------------------------------------------------------------- 114 (335)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+++|||||+ ++|.+++.. ...+++..++.++
T Consensus 115 -------------------------------------------~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~ 147 (335)
T 2owb_A 115 -------------------------------------------FVFVVLELCRRRSLLELHKR----RKALTEPEARYYL 147 (335)
T ss_dssp -------------------------------------------EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHH
T ss_pred -------------------------------------------eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHH
Confidence 4899999998 588888753 3579999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++...... .......++..|+|||.+.+. .++.++|+|
T Consensus 148 ~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~ 225 (335)
T 2owb_A 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVW 225 (335)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHH
T ss_pred HHHHHHHHHHHHCCCEecCCCchhEEEc-CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHH
Confidence 9999999999999999999999999999 7889999999999765432 223445689999999999877 789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||...+..+....+... .. .++..+++.+.+||.+||
T Consensus 226 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------------EY------------SIPKHINPVAASLIQKML 276 (335)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------------CC------------CCCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-----------------CC------------CCCccCCHHHHHHHHHHc
Confidence 9999999999999999887766655544431 01 122356899999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.||.+|||+.|+|+ ||||++..
T Consensus 277 ~~dp~~Rps~~ell~-~~~~~~~~ 299 (335)
T 2owb_A 277 QTDPTARPTINELLN-DEFFTSGY 299 (335)
T ss_dssp CSSGGGSCCGGGGGG-SHHHHTSC
T ss_pred cCChhHCcCHHHHhc-CccccCCC
Confidence 999999999999999 99998743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.49 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=210.9
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+..++|++++.||+|+||+||+|++..+|+.||+|++... ...+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK----- 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C-----
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe-----
Confidence 4668999999999999999999999999999999998543 2456689999999999999999999877543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (302)
T 2j7t_A 91 -------------------------------------------------------------------------------- 90 (302)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.++|||||++ +|.+++.. ....+++..++.++.||
T Consensus 91 -----------------------------------------~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i 126 (302)
T 2j7t_A 91 -----------------------------------------LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQM 126 (302)
T ss_dssp -----------------------------------------EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHH
Confidence 8999999986 78777653 34679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhc----cCCCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIF----GAIDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~----~~~~~s~~sDi 328 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||++...... .......+++.|+|||.+. ....++.++|+
T Consensus 127 ~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 205 (302)
T 2j7t_A 127 LEALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205 (302)
T ss_dssp HHHHHHHHHTTCCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHH
T ss_pred HHHHHHHhcCCcccCCCCHHHEEEC-CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhH
Confidence 9999999999999999999999999 7889999999986432111 1223446789999999984 23378899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|..||...+..+....+..... + ....+..++..+.++|.+|
T Consensus 206 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~-------~~~~~~~~~~~l~~li~~~ 259 (302)
T 2j7t_A 206 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-------------------P-------TLLTPSKWSVEFRDFLKIA 259 (302)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------------------C-------CCSSGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-------------------c-------ccCCccccCHHHHHHHHHH
Confidence 9999999999999999998877766655544110 0 0011235689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.++++ ||||+++..
T Consensus 260 l~~dp~~Rps~~~ll~-h~~~~~~~~ 284 (302)
T 2j7t_A 260 LDKNPETRPSAAQLLE-HPFVSSITS 284 (302)
T ss_dssp SCSCTTTSCCHHHHTT-STTTTTCCC
T ss_pred cccChhhCCCHHHHhc-ChHHhhhcc
Confidence 9999999999999999 999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=334.04 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=215.4
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
...++|++++.||+|+||.||+|++..+++.||||++... .+.+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 93 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT----- 93 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----
Confidence 4557899999999999999999999999999999998543 245678999999999999999999988754
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (303)
T 3a7i_A 94 -------------------------------------------------------------------------------- 93 (303)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++ +|.+++. ..++++..++.++.|
T Consensus 94 -----------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~q 127 (303)
T 3a7i_A 94 -----------------------------------------KLWIIMEYLGGGSALDLLE-----PGPLDETQIATILRE 127 (303)
T ss_dssp -----------------------------------------EEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHH
Confidence 38999999986 8888874 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+|||
T Consensus 128 i~~~l~~lH~~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl 205 (303)
T 3a7i_A 128 ILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSL 205 (303)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCChheEEEC-CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHH
Confidence 99999999999999999999999999 78899999999987654332 23345679999999999877 78999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
|+++|+|++|+.||...+..+....+.... ...++..+++.+.+||.+||+.
T Consensus 206 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 206 GITAIELARGEPPHSELHPMKVLFLIPKNN----------------------------PPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------------------------CCCCCSSCCHHHHHHHHHHCCS
T ss_pred HHHHHHHccCCCCCCCcCHHHHHHHhhcCC----------------------------CCCCccccCHHHHHHHHHHcCC
Confidence 999999999999998877665554433210 0112345789999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||.+|||+.++|+ ||||..-..
T Consensus 258 dp~~Rps~~~ll~-~~~~~~~~~ 279 (303)
T 3a7i_A 258 EPSFRPTAKELLK-HKFILRNAK 279 (303)
T ss_dssp SGGGSCCHHHHTT-CHHHHHHCC
T ss_pred ChhhCcCHHHHhh-ChhhhcCCC
Confidence 9999999999999 999977543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=365.90 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=214.8
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ..+.+|++++++++||||+++++++...+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT----- 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----
Confidence 478999999999999999999999999999999995432 34568999999999999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 259 -------------------------------------------------------------------------------- 258 (543)
T 3c4z_A 259 -------------------------------------------------------------------------------- 258 (543)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||+ ++|.+++.........+++..++.++.|
T Consensus 259 -----------------------------------------~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~q 297 (543)
T 3c4z_A 259 -----------------------------------------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297 (543)
T ss_dssp -----------------------------------------EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHH
Confidence 3899999998 5899988755445667999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||.|||++|++||||||+||+++ .++.++|+|||++........ .....||+.|+|||++.+. .++.++|+|||
T Consensus 298 i~~aL~~LH~~gIvHrDLKP~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSl 375 (543)
T 3c4z_A 298 IVSGLEHLHQRNIIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFAL 375 (543)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHH
T ss_pred HHHHHHHHHHcCCcccCCChHHEEEe-CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcc
Confidence 99999999999999999999999999 789999999999987654433 2345889999999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh----hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 332 GCVLAELLLGQPMFPGDSG----VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~----~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||++|+|++|+.||.+.+. .+....+... .. .++..+|+.+.+||.+
T Consensus 376 GvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~ 426 (543)
T 3c4z_A 376 GVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----------------AV------------TYPDKFSPASKDFCEA 426 (543)
T ss_dssp HHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----------------cc------------CCCcccCHHHHHHHHH
Confidence 9999999999999987542 2333333220 01 1234579999999999
Q ss_pred hcccCCCCCCC-----HHHHhccCchhhhhh
Q psy10212 408 LLEYTPSSRIS-----PLQVRSITPFLIELR 433 (444)
Q Consensus 408 ~L~~DP~kRPs-----~~elL~~hpwf~~~~ 433 (444)
||+.||.+||+ +.++++ ||||+++.
T Consensus 427 lL~~dP~~R~~~~~~~a~ei~~-Hpff~~i~ 456 (543)
T 3c4z_A 427 LLQKDPEKRLGFRDGSCDGLRT-HPLFRDIS 456 (543)
T ss_dssp HSCSSGGGSCCCBTTBSHHHHT-SGGGTTCC
T ss_pred hccCCHhHCCCCcccCHHHHHc-CccccCCC
Confidence 99999999996 488999 99999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=347.07 Aligned_cols=281 Identities=25% Similarity=0.406 Sum_probs=212.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|++++.||+|+||+||+|++..+|+.||+|++... ...+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 104 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------- 104 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-------
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-------
Confidence 47899999999999999999999999999999998543 245668999999999999999999988764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 105 -------------------------------------------------------------------------------- 104 (360)
T 3eqc_A 105 -------------------------------------------------------------------------------- 104 (360)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..++|||||++ +|.+++.. ...+++..++.++.||+
T Consensus 105 ---------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~ 141 (360)
T 3eqc_A 105 ---------------------------------------EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVI 141 (360)
T ss_dssp ---------------------------------------EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHH
Confidence 38999999985 99998853 35699999999999999
Q ss_pred HHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++ |++|+||+|+||+++ .++.++|+|||++...... ......+++.|+|||.+.+. .++.++|+||||+
T Consensus 142 ~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~ 218 (360)
T 3eqc_A 142 KGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGL 218 (360)
T ss_dssp HHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHH
T ss_pred HHHHHHHHhCCEEcCCccHHHEEEC-CCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHH
Confidence 999999996 999999999999999 7889999999998654322 23345789999999999887 7999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCH-HHHHhhCCCC--CcccC---CC---------ccCCCCcccccCCCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTR-EQIREMNPNY--TEFKF---PQ---------IKSHPWSKVFRVRTP 398 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~-~~~~~~~~~~--~~~~~---p~---------~~~~~~~~~~~~~~s 398 (444)
++|+|++|+.||...+..+....+......... .......... ..... +. .............++
T Consensus 219 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (360)
T 3eqc_A 219 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298 (360)
T ss_dssp HHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCccccc
Confidence 999999999999887765543322111100000 0000000000 00000 00 000000111123468
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+++.+||.+||+.||.+|||+.|+|+ ||||+.....
T Consensus 299 ~~~~~li~~~L~~dP~~Rpt~~ell~-hp~~~~~~~~ 334 (360)
T 3eqc_A 299 LEFQDFVNKCLIKNPAERADLKQLMV-HAFIKRSDAE 334 (360)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHT-SHHHHHHHHS
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhh-ChHhhcchHh
Confidence 99999999999999999999999999 9999986653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.34 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=213.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.++|++++.||+|+||.||+|+++.+|+.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----- 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence 46799999999999999999999999999999998543 234568999999999999999999887654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 258 -------------------------------------------------------------------------------- 257 (576)
T 2acx_A 258 -------------------------------------------------------------------------------- 257 (576)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||+ ++|.+++.. .....+++..++.++.|
T Consensus 258 -----------------------------------------~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~q 294 (576)
T 2acx_A 258 -----------------------------------------ALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAE 294 (576)
T ss_dssp -----------------------------------------EEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHH
Confidence 4999999997 589888853 22345999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++||+||||||+||+++ .++.++|+|||++.............||+.|+|||++.+. .++.++|+||||
T Consensus 295 Il~aL~yLH~~gIvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLG 372 (576)
T 2acx_A 295 ICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALG 372 (576)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHH
T ss_pred HHHHHHHHHHCCEeccCCchheEEEe-CCCCeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHH
Confidence 99999999999999999999999999 7899999999999876555544556889999999999877 789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+.......+...+ .. . ...++..+|+++.+||.+||+.|
T Consensus 373 vilyeLltG~~PF~~~~~~~~~~~i~~~i--------~~-----~------------~~~~p~~~s~~~~dLI~~lL~~d 427 (576)
T 2acx_A 373 CLLYEMIAGQSPFQQRKKKIKREEVERLV--------KE-----V------------PEEYSERFSPQARSLCSQLLCKD 427 (576)
T ss_dssp HHHHHHHHSSCSSSCSSSCCCHHHHHHHH--------HH-----C------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCcccccchhHHHHHHHh--------hc-----c------------cccCCccCCHHHHHHHHHhccCC
Confidence 99999999999998764321111121110 00 0 01123457999999999999999
Q ss_pred CCCCC-----CHHHHhccCchhhhhh
Q psy10212 413 PSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 413 P~kRP-----s~~elL~~hpwf~~~~ 433 (444)
|.+|| ++.|+++ ||||+++.
T Consensus 428 P~~R~g~~~~sa~eil~-HpfF~~i~ 452 (576)
T 2acx_A 428 PAERLGCRGGSAREVKE-HPLFKKLN 452 (576)
T ss_dssp GGGSTTCSSSHHHHHHT-SGGGTTCC
T ss_pred HHHcCCCCCCCHHHHHh-ChhhccCC
Confidence 99999 7899999 99999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=336.89 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=209.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
++|.+.+.||+|+||+||+|++..+++.||+|++... .+.+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--------- 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--------- 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT---------
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC---------
Confidence 7899999999999999999999999999999988432 355678999999999999999999998764
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (310)
T 3s95_A 81 -------------------------------------------------------------------------------- 80 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||++ +|.+++.. ....+++..++.++.||+.|
T Consensus 81 -------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~a 120 (310)
T 3s95_A 81 -------------------------------------RLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASG 120 (310)
T ss_dssp -------------------------------------EEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHH
T ss_pred -------------------------------------eeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHH
Confidence 38899999985 99998863 35679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---------------ccccccccccCchhhccCCC
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---------------VSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---------------~~~~gt~~y~aPE~l~~~~~ 321 (444)
|+|||++|++|+||||+||+++ .++.++|+|||++......... ....||+.|+|||.+.+. .
T Consensus 121 l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 198 (310)
T 3s95_A 121 MAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-S 198 (310)
T ss_dssp HHHHHHTTEECSCCSTTSEEEC-TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC-C
T ss_pred HHHHHhCCccCCCCCcCeEEEC-CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC-C
Confidence 9999999999999999999999 7889999999999765332211 144689999999999887 8
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
++.++||||||+++|+|++|..||............ ..... .....+.++++.+
T Consensus 199 ~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------~~~~~--------------------~~~~~~~~~~~~l 252 (310)
T 3s95_A 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NVRGF--------------------LDRYCPPNCPPSF 252 (310)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------CHHHH--------------------HHHTCCTTCCTTH
T ss_pred CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------hhhcc--------------------ccccCCCCCCHHH
Confidence 999999999999999999999998754322110000 00000 0111234678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.++|.+||+.||++|||+.++++ |++.++....
T Consensus 253 ~~li~~~l~~dP~~Rps~~~l~~---~L~~l~~~~~ 285 (310)
T 3s95_A 253 FPITVRCCDLDPEKRPSFVKLEH---WLETLRMHLA 285 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH---HHHHHHHhcc
Confidence 99999999999999999999999 9999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.21 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=202.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcC--CCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLE--HSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 92 (444)
..+|++++.||+|+||+||+|.+.. ++.||||++.... ..+.+|+.++++|. ||||+++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~---- 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---- 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC----
Confidence 4569999999999999999999875 9999999985432 45668999999996 599999999887654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 130 -------------------------------------------------------------------------------- 129 (390)
T 2zmd_A 130 -------------------------------------------------------------------------------- 129 (390)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||+++++|.+++.. ...+++..++.++.|
T Consensus 130 ------------------------------------------~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~q 163 (390)
T 2zmd_A 130 ------------------------------------------YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKN 163 (390)
T ss_dssp ------------------------------------------EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHH
Confidence 4899999877899999863 357899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccC----------
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGA---------- 319 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~---------- 319 (444)
|+.||.|||++||+||||||+||+++ ++.+||+|||++....... ......+|+.|+|||.+.+.
T Consensus 164 i~~aL~~lH~~~ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 241 (390)
T 2zmd_A 164 MLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241 (390)
T ss_dssp HHHHHHHHHTTTCCCCCCCGGGEEES--SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC----------
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEEE--CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccc
Confidence 99999999999999999999999997 4789999999997654332 12345789999999998651
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
..++.++|||||||++|+|++|+.||...... ..+..+... .....++...+
T Consensus 242 ~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~ 294 (390)
T 2zmd_A 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---------------------------NHEIEFPDIPE 294 (390)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT---------------------------TSCCCCCCCSC
T ss_pred cCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc---------------------------cccCCCCccch
Confidence 25889999999999999999999999865432 222222210 00111223457
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..+.+||.+||+.||.+|||+.|+|+ ||||+...
T Consensus 295 ~~~~~li~~~L~~dP~~Rps~~ell~-hp~~~~~~ 328 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRISIPELLA-HPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT-SHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhh-CcCccccC
Confidence 89999999999999999999999999 99998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=345.03 Aligned_cols=287 Identities=28% Similarity=0.453 Sum_probs=223.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcC-----------CCceeEeeeEEee
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLE-----------HSNIVKLKYFFYS 86 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~ 86 (444)
.++|++++.||+|+||+||+|++..+++.||||++... ...+.+|+++++++. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 47899999999999999999999999999999999644 345668999999886 8999999999887
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+..
T Consensus 98 ~~~~---------------------------------------------------------------------------- 101 (373)
T 1q8y_A 98 KGPN---------------------------------------------------------------------------- 101 (373)
T ss_dssp EETT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 5420
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHH
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i 246 (444)
..++++|||+++++|.+++... ....+++..+
T Consensus 102 ----------------------------------------------~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~ 133 (373)
T 1q8y_A 102 ----------------------------------------------GVHVVMVFEVLGENLLALIKKY--EHRGIPLIYV 133 (373)
T ss_dssp ----------------------------------------------EEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHH
T ss_pred ----------------------------------------------CceEEEEEecCCCCHHHHHHHh--hccCCcHHHH
Confidence 1358999999988999998643 3456999999
Q ss_pred HHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEcC-----CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 247 KLYIYQLFRSLAYIHVL-GICHRDIKPQNLLLNP-----ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~-givH~dLkp~NIll~~-----~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
+.++.||+.||+|||++ |++|+||||+||+++. ..+.++|+|||++...... .....+|+.|+|||.+.+.
T Consensus 134 ~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~- 210 (373)
T 1q8y_A 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA- 210 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-
T ss_pred HHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-
Confidence 99999999999999998 9999999999999951 3448999999999765432 3345789999999999887
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCC------hhHHHHHHHHHhCCCCHHHHHhhCCCC-------CcccCCCccCC
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDS------GVDQLVEIIKVLGTPTREQIREMNPNY-------TEFKFPQIKSH 387 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~------~~e~~~~i~~~~g~~~~~~~~~~~~~~-------~~~~~p~~~~~ 387 (444)
.++.++|+|||||++|+|++|+.||.+.+ ..+.+..+.+.++..+...+....... ...........
T Consensus 211 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (373)
T 1q8y_A 211 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290 (373)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccccccc
Confidence 78999999999999999999999998654 556778888888887766554321100 00000000000
Q ss_pred CC------cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 388 PW------SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 388 ~~------~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.. ...++..+++.+.+||.+||+.||.+|||+.|+|+ ||||++....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-hp~f~~~~~~ 343 (373)
T 1q8y_A 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN-HPWLKDTLGM 343 (373)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT-CGGGTTCTTC
T ss_pred chhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh-ChhhhcccCc
Confidence 00 01123345788999999999999999999999999 9999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=372.34 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=215.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++++.||+|+||+||+|+++.+++.||||++... .....+|..++..+ +||+|+++++++...+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~---- 415 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---- 415 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS----
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC----
Confidence 36799999999999999999999999999999998543 23455788888887 7999999998886654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 416 -------------------------------------------------------------------------------- 415 (674)
T 3pfq_A 416 -------------------------------------------------------------------------------- 415 (674)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+|||||||++ +|.+++.. .+.+++..++.++.
T Consensus 416 ------------------------------------------~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ 449 (674)
T 3pfq_A 416 ------------------------------------------RLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAA 449 (674)
T ss_dssp ------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHH
Confidence 39999999985 89888853 35799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc-CCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV-RGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++||+||||||+|||++ .++.++|+|||+++... .........||+.|+|||++.+. .++.++|+||
T Consensus 450 qi~~aL~~LH~~gIiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwS 527 (674)
T 3pfq_A 450 EIAIGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWA 527 (674)
T ss_dssp HHHHHHHHHHHTSEECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHH
T ss_pred HHHHHHHHHHhCCeEeccCChhhEEEc-CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEec
Confidence 999999999999999999999999999 78999999999997543 23334556789999999999877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++|+|++|+.||.+.+..++...+... ... ++..+++++.+||.+||+
T Consensus 528 lGvilyelltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 528 FGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------------NVA------------YPKSMSKEAVAICKGLMT 578 (674)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------------CCC------------CCTTSCHHHHHHHHHHSC
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCccCCHHHHHHHHHHcc
Confidence 999999999999999998888777766641 111 234579999999999999
Q ss_pred cCCCCCCCH-----HHHhccCchhhhhh
Q psy10212 411 YTPSSRISP-----LQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~-----~elL~~hpwf~~~~ 433 (444)
.||.+||++ .|+++ ||||+++.
T Consensus 579 ~dP~~R~~~~~~~~~ei~~-h~ff~~i~ 605 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKE-HAFFRYID 605 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHS-SGGGSSCC
T ss_pred CCHHHCCCCCCCcHHHHhc-CccccCCC
Confidence 999999998 99999 99999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=327.59 Aligned_cols=259 Identities=17% Similarity=0.202 Sum_probs=212.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+.++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|+++++++ +|+||+++++++....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-------- 79 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-------- 79 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--------
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--------
Confidence 457899999999999999999999999999999998543 45677899999999 8999999998886553
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (298)
T 1csn_A 80 -------------------------------------------------------------------------------- 79 (298)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+++|.+++.. .+.++++..++.++.||+.|
T Consensus 80 --------------------------------------~~~lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~ 118 (298)
T 1csn_A 80 --------------------------------------HNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLAR 118 (298)
T ss_dssp --------------------------------------EEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHH
T ss_pred --------------------------------------eeEEEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHH
Confidence 4899999998899999863 34569999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCC-----eEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCC
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETG-----VLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~-----~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
|+|||++|++|+||||+||+++ ..+ .++|+|||++........ .....+|+.|+|||.+.+. .++
T Consensus 119 l~~lH~~~ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 196 (298)
T 1csn_A 119 VQSIHEKSLVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQS 196 (298)
T ss_dssp HHHHHTTTEECCCCCGGGEEEC-CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCC
T ss_pred HHHHHhCCEecCCCCHHHEEec-cCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCC
Confidence 9999999999999999999997 444 399999999976544322 2345689999999999877 789
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~---~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
.++|+||||+++|+|++|+.||.+.+. .+....+......+... .+...+|+.
T Consensus 197 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~ 252 (298)
T 1csn_A 197 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR------------------------ELCAGFPEE 252 (298)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH------------------------HHTTTSCHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH------------------------HHHhhCcHH
Confidence 999999999999999999999987543 33333333321111111 112356899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.++|.+||+.||.+|||+.++++ .|+++....
T Consensus 253 l~~li~~~l~~dp~~RP~~~~l~~---~l~~~~~~~ 285 (298)
T 1csn_A 253 FYKYMHYARNLAFDATPDYDYLQG---LFSKVLERL 285 (298)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH---HHHHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHHH---HHHHHHHhc
Confidence 999999999999999999999999 788766543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.04 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=203.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++.++|++++.||+|+||+||+|++..+|+.||||.+.... ..+.+|+.++++++||||+++++++.....-...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~-- 80 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP-- 80 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh--
Confidence 56789999999999999999999999999999999995443 4566899999999999999999999875420000
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (303)
T 1zy4_A 81 -------------------------------------------------------------------------------- 80 (303)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
-........+++|||||++ +|.+++.. ....+++..++.++.||+
T Consensus 81 -------------------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~ 126 (303)
T 1zy4_A 81 -------------------------------MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQIL 126 (303)
T ss_dssp ------------------------------------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHH
T ss_pred -------------------------------hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHH
Confidence 0000112458999999975 99999863 345678899999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC---------------CCCccccccccccCchhhccC
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---------------EPNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~ 319 (444)
.||+|||++|++|+||+|+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+.
T Consensus 127 ~~l~~LH~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 127 EALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred HHHHHHHhCCeecccCCHHhEEEc-CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 999999999999999999999999 7889999999998765321 112334678999999999765
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTP 398 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s 398 (444)
..++.++|+||||+++|+|++ ||..... .+....+... ...+...++..++
T Consensus 206 ~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~ 257 (303)
T 1zy4_A 206 GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV-------------------------SIEFPPDFDDNKM 257 (303)
T ss_dssp SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHST-------------------------TCCCCTTCCTTTS
T ss_pred CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccc-------------------------ccccCccccccch
Confidence 478999999999999999998 5543222 2222222110 0111122344568
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 399 PDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 399 ~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
+.+.++|.+||+.||.+|||+.++|+ ||||+.
T Consensus 258 ~~~~~li~~~l~~dp~~Rps~~~ll~-h~~~~~ 289 (303)
T 1zy4_A 258 KVEKKIIRLLIDHDPNKRPGARTLLN-SGWLPV 289 (303)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH-SSCSCC
T ss_pred HHHHHHHHHHHhcCcccCcCHHHHhC-CCCcCC
Confidence 89999999999999999999999999 999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.60 Aligned_cols=264 Identities=26% Similarity=0.352 Sum_probs=191.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHH-HhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQ-IMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
-.++|++++.||+|+||.||+|.++.+|+.||||++.... ..+.+|+. +++.++||||+++++++...+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~----- 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG----- 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----
Confidence 3478999999999999999999999999999999995432 22334555 677889999999999997754
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (327)
T 3aln_A 95 -------------------------------------------------------------------------------- 94 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhh-cCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSK-SKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~-~~~~l~~~~i~~i~~Q 252 (444)
..++|||||+++|.+++..... ....+++..++.++.|
T Consensus 95 -----------------------------------------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~ 133 (327)
T 3aln_A 95 -----------------------------------------DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133 (327)
T ss_dssp -----------------------------------------EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHH
T ss_pred -----------------------------------------ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHH
Confidence 3899999999999988864332 3677999999999999
Q ss_pred HHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhc---cCCCCCcchhh
Q psy10212 253 LFRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIF---GAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~s~~sDi 328 (444)
++.||.|||++ |++|+||+|+||+++ .++.++|+|||++.............+++.|+|||.+. ....++.++|+
T Consensus 134 i~~~l~~lH~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di 212 (327)
T 3aln_A 134 TVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212 (327)
T ss_dssp HHHHHHHHHHHHSCCCSCCCGGGEEEE-TTTEEEECCCSSSCC------------------------------CCSHHHH
T ss_pred HHHHHHHHhccCCEeECCCCHHHEEEc-CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhH
Confidence 99999999999 999999999999999 78999999999997765444444457899999999983 22268999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++|+.||.+.+.. +....+ ..... ..+.......+++.+.+||.+
T Consensus 213 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------------~~~~~-----~~~~~~~~~~~~~~l~~li~~ 268 (327)
T 3aln_A 213 WSLGITLYELATGRFPYPKWNSVFDQLTQV-------------------VKGDP-----PQLSNSEEREFSPSFINFVNL 268 (327)
T ss_dssp HHHHHHHHHHHHSCCCSSCC-------CCC-------------------CCSCC-----CCCCCCSSCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchHHHHHHHH-------------------hcCCC-----CCCCCcccccCCHHHHHHHHH
Confidence 99999999999999999864321 111000 00000 111112234579999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||+.||.+|||+.++++ ||||.+....
T Consensus 269 ~l~~dp~~Rps~~ell~-hp~~~~~~~~ 295 (327)
T 3aln_A 269 CLTKDESKRPKYKELLK-HPFILMYEER 295 (327)
T ss_dssp HTCSSGGGSCCHHHHTT-SHHHHHHHHS
T ss_pred HhhCChhhCcCHHHHHh-ChHHHHhHhh
Confidence 99999999999999999 9999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.50 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=193.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.-.++|++++.||+|+||.||+|+++.+|+.||||++.... +.+.++..+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~---- 97 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT---- 97 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC----
Confidence 34578999999999999999999999999999999995432 22234455688889999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (318)
T 2dyl_A 98 -------------------------------------------------------------------------------- 97 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++.+..+... ....+++..++.++.|
T Consensus 98 ------------------------------------------~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~ 132 (318)
T 2dyl_A 98 ------------------------------------------DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVA 132 (318)
T ss_dssp ------------------------------------------EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHH
T ss_pred ------------------------------------------cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHH
Confidence 3899999997666655542 3567999999999999
Q ss_pred HHHHHHHHHHC-CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc----CCCCCcchh
Q psy10212 253 LFRSLAYIHVL-GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG----AIDYTTKID 327 (444)
Q Consensus 253 Il~aL~yLHs~-givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~s~~sD 327 (444)
|+.||.|||++ |++|+||+|+||+++ .++.++|+|||++.............+++.|+|||.+.+ ...++.++|
T Consensus 133 i~~~l~~lH~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 211 (318)
T 2dyl_A 133 IVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211 (318)
T ss_dssp HHHHHHHHHHHHCCCCCCCCGGGEEEC-TTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHH
T ss_pred HHHHHHHHHhhCCEEeCCCCHHHEEEC-CCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccc
Confidence 99999999995 999999999999999 788999999999876655444445678999999999852 236889999
Q ss_pred hhhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
+||||+++|+|++|+.||... ...+....+..... ...+ ...++++.+.++|.
T Consensus 212 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------~~~~----------~~~~~~~~l~~li~ 265 (318)
T 2dyl_A 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP----------------PLLP----------GHMGFSGDFQSFVK 265 (318)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC----------------CCCC----------SSSCCCHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC----------------CCCC----------ccCCCCHHHHHHHH
Confidence 999999999999999999874 34444444433100 0000 01246899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+||+.||.+|||+.++|+ ||||+++...
T Consensus 266 ~~l~~dp~~Rps~~~ll~-h~~~~~~~~~ 293 (318)
T 2dyl_A 266 DCLTKDHRKRPKYNKLLE-HSFIKRYETL 293 (318)
T ss_dssp HHTCSCTTTSCCHHHHTT-SHHHHHHHHS
T ss_pred HHccCChhHCcCHHHHhh-CHHHHhcccc
Confidence 999999999999999999 9999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.34 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=205.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.++|++++.||+|+||.||+|++..+++.||+|.+... ...+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 84 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD---- 84 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS----
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC----
Confidence 568899999999999999999999999999999998432 135668999999999999999999886654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (294)
T 4eqm_A 85 -------------------------------------------------------------------------------- 84 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++|||||++ +|.+++.. .+++++..++.++.
T Consensus 85 ------------------------------------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~ 118 (294)
T 4eqm_A 85 ------------------------------------------CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTN 118 (294)
T ss_dssp ------------------------------------------EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHH
T ss_pred ------------------------------------------eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHH
Confidence 48999999985 99998853 35799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+|
T Consensus 119 qi~~~l~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~ 196 (294)
T 4eqm_A 119 QILDGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIY 196 (294)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHH
T ss_pred HHHHHHHHHHHCCcccCCCCHHHEEEC-CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHH
Confidence 999999999999999999999999999 78899999999997654332 12334689999999999887 789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||.+.+..+...+..... . ......++..+|+.+.++|.+||
T Consensus 197 slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---~---------------------~~~~~~~~~~~~~~l~~li~~~l 252 (294)
T 4eqm_A 197 SIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS---V---------------------PNVTTDVRKDIPQSLSNVILRAT 252 (294)
T ss_dssp HHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC---C---------------------CCHHHHSCTTSCHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc---C---------------------CCcchhcccCCCHHHHHHHHHHh
Confidence 99999999999999999887766554443310 0 01111233457999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+.||.+||+..+.+. +.|..-+
T Consensus 253 ~~dp~~R~~~~~~l~-~~l~~~~ 274 (294)
T 4eqm_A 253 EKDKANRYKTIQEMK-DDLSSVL 274 (294)
T ss_dssp CSSGGGSCSSHHHHH-HHHHTSS
T ss_pred cCCHhHccccHHHHH-HHHHHHH
Confidence 999999996555555 5554433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.04 Aligned_cols=275 Identities=20% Similarity=0.295 Sum_probs=212.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---------------------cchhhHHHHhhhcCCCce
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---------------------RFKNREMQIMRRLEHSNI 77 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------------~~~~~E~~~l~~l~h~~i 77 (444)
.+.++|++++.||+|+||.||+|++ +|+.||||.+.... ..+.+|+.++++++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3458999999999999999999999 89999999984331 567799999999999999
Q ss_pred eEeeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCc
Q psy10212 78 VKLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPT 157 (444)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (444)
+++++++...+
T Consensus 106 ~~~~~~~~~~~--------------------------------------------------------------------- 116 (348)
T 2pml_X 106 LTCEGIITNYD--------------------------------------------------------------------- 116 (348)
T ss_dssp CCCSEEEESSS---------------------------------------------------------------------
T ss_pred ceEEEEEeeCC---------------------------------------------------------------------
Confidence 99999987654
Q ss_pred hhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHh---
Q psy10212 158 REQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKH--- 233 (444)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~--- 233 (444)
..++|||||++ +|.+++..
T Consensus 117 ---------------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~ 139 (348)
T 2pml_X 117 ---------------------------------------------------------EVYIIYEYMENDSILKFDEYFFV 139 (348)
T ss_dssp ---------------------------------------------------------EEEEEEECCTTCBSSEESSSEES
T ss_pred ---------------------------------------------------------eEEEEEeccCCCcHHHHHHHhhh
Confidence 38999999986 88877321
Q ss_pred -hhhcCCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCcccccccccc
Q psy10212 234 -YSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYR 311 (444)
Q Consensus 234 -~~~~~~~l~~~~i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~ 311 (444)
.......+++..++.++.||+.||.|||+ +|++|+||+|+||+++ .++.++|+|||.+...... ......++..|+
T Consensus 140 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~ 217 (348)
T 2pml_X 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFM 217 (348)
T ss_dssp SCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC-TTSCEEECCCTTCEECBTT-EECSSCSCGGGC
T ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc-CCCcEEEeccccccccccc-cccCCCCCcCcc
Confidence 11225789999999999999999999999 9999999999999999 7889999999999765333 234456799999
Q ss_pred CchhhccCCCCCc-chhhhhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCC
Q psy10212 312 APELIFGAIDYTT-KIDVWSAGCVLAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389 (444)
Q Consensus 312 aPE~l~~~~~~s~-~sDiwSLGvil~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~ 389 (444)
|||.+.+...++. ++|+||||+++|+|++|+.||...+. .+....+.......+ . . ... .........
T Consensus 218 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~-~-------~-~~~-~~~~~~~~~ 287 (348)
T 2pml_X 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP-L-------D-RNH-FLYPLTNKK 287 (348)
T ss_dssp CGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCC-C-------S-SSS-STTTTCC--
T ss_pred CchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCc-c-------c-hhh-hhccccccc
Confidence 9999977634555 99999999999999999999988766 444443332100000 0 0 000 000000001
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.......+++.+.+||.+||+.||.+|||+.|+|+ ||||++...
T Consensus 288 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~-hp~f~~~~~ 331 (348)
T 2pml_X 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK-HEWLADTNI 331 (348)
T ss_dssp ------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT-SGGGTTCCH
T ss_pred cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc-CccccCCCH
Confidence 11223567999999999999999999999999999 999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=324.98 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=209.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++++.||+|+||+||+|++. +++.||+|++... .+.+.+|++++++++||||+++++++...+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--------- 79 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--------- 79 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---------
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc---------
Confidence 68999999999999999999987 4788999999543 3567799999999999999999999876543
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (269)
T 4hcu_A 80 -------------------------------------------------------------------------------- 79 (269)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++|||||++ +|.+++.. ....+++..++.++.||+.||
T Consensus 80 -------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l 119 (269)
T 4hcu_A 80 -------------------------------------ICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGM 119 (269)
T ss_dssp -------------------------------------EEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHH
Confidence 8999999985 89888853 445799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||||+++
T Consensus 120 ~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l 197 (269)
T 4hcu_A 120 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLM 197 (269)
T ss_dssp HHHHHTTCCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHHHhCCeecCCcchheEEEc-CCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHH
Confidence 999999999999999999998 67899999999987543221 12233457789999999877 799999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |+.||.+.+..+....+.... ....+..+++.+.++|.+||+.||.
T Consensus 198 ~~ll~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~ 249 (269)
T 4hcu_A 198 WEVFSEGKIPYENRSNSEVVEDISTGF----------------------------RLYKPRLASTHVYQIMNHCWRERPE 249 (269)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHhcCc----------------------------cCCCCCcCCHHHHHHHHHHccCCcc
Confidence 99999 999999888777666554311 0111234689999999999999999
Q ss_pred CCCCHHHHhccCchhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~ 434 (444)
+|||+.++++ .++++.+
T Consensus 250 ~Rps~~~ll~---~l~~l~~ 266 (269)
T 4hcu_A 250 DRPAFSRLLR---QLAEIAE 266 (269)
T ss_dssp GSCCHHHHHH---HHHHHHH
T ss_pred cCcCHHHHHH---HHHHHHH
Confidence 9999999999 6776654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.93 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=210.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+.++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|++++++| +||||+++++++...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-------- 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-------- 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--------
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--------
Confidence 346899999999999999999999999999999998543 35677999999999 9999999999887754
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (330)
T 2izr_A 79 -------------------------------------------------------------------------------- 78 (330)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+.++|||||+++|.+++... ...+++..++.++.||+.|
T Consensus 79 --------------------------------------~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~ 117 (330)
T 2izr_A 79 --------------------------------------YNAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISR 117 (330)
T ss_dssp --------------------------------------EEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHH
T ss_pred --------------------------------------ccEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHH
Confidence 48999999988999998642 5689999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCe-----EEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCC
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGV-----LKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYT 323 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~-----ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s 323 (444)
|+|||++|++||||||+||+++ .++. ++|+|||++........ .....||+.|+|||.+.+. .++
T Consensus 118 l~~LH~~~iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 195 (330)
T 2izr_A 118 MEYVHSKNLIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQS 195 (330)
T ss_dssp HHHHHHTTEECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCC
T ss_pred HHHHHhCCeeccCCCHHHeeec-cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCC
Confidence 9999999999999999999998 5555 99999999976543322 2355789999999999887 789
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChhHH---HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~e~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
.++|+||||+++|+|++|+.||.+.+..+. ...+.......+... +...+| .
T Consensus 196 ~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~p-~ 250 (330)
T 2izr_A 196 RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV------------------------LCENFP-E 250 (330)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH------------------------HTTTCH-H
T ss_pred chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH------------------------HhccCh-H
Confidence 999999999999999999999988544333 333322111111110 111234 9
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.++|.+||+.||.+||++.++++ .|+++....
T Consensus 251 ~~~li~~~l~~~p~~RP~~~~l~~---~l~~~~~~~ 283 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPDYDYLRK---LFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH---HHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHH---HHHHHHHHc
Confidence 999999999999999999999998 787765543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.57 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=208.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeec--cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+.++|++.+.||+|+||+||+|++..+++.||||++.. ....+.+|++++++++|++++..+..+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-------- 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-------- 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEET--------
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCC--------
Confidence 456899999999999999999999999999999998743 3456778999999999988887777766554
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (296)
T 4hgt_A 78 -------------------------------------------------------------------------------- 77 (296)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+.++|||||+++|.+++.. ...++++..++.++.||+.|
T Consensus 78 -------------------------------------~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~ 117 (296)
T 4hgt_A 78 -------------------------------------DYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISR 117 (296)
T ss_dssp -------------------------------------TEEEEEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHH
T ss_pred -------------------------------------CceEEEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHH
Confidence 25899999998899999863 34579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEE---cCCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCCcc
Q psy10212 257 LAYIHVLGICHRDIKPQNLLL---NPETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll---~~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
|.|||++|++|+||||+||++ + ..+.++|+|||++........ .....+++.|+|||.+.+. .++.+
T Consensus 118 l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 195 (296)
T 4hgt_A 118 IEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRR 195 (296)
T ss_dssp HHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHH
T ss_pred HHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCch
Confidence 999999999999999999999 5 678999999999976544322 2345679999999999887 79999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChh---HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~---e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+|+|||||++|+|++|+.||.+.+.. .....+.......+. ..+...+|+.+.
T Consensus 196 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~l~ 251 (296)
T 4hgt_A 196 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI------------------------EVLCKGYPSEFA 251 (296)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH------------------------HHHTTTSCHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh------------------------hhhhccCCHHHH
Confidence 99999999999999999999875433 233333221111111 111235689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
++|.+||+.||++|||+.++++ .|+++....
T Consensus 252 ~li~~~l~~~p~~Rpt~~~l~~---~l~~~~~~~ 282 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPDYSYLRQ---LFRNLFHRQ 282 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHH---HHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHH---HHHHHHHHh
Confidence 9999999999999999999999 888876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=341.38 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=206.2
Q ss_pred cccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhc-CCCceeEeeeEEeecCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 89 (444)
++|++++.||+|+||+||+|++. .+|+.||||++... ...+.+|+++++++ +||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 132 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 132 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc-
Confidence 78999999999999999999984 47999999998432 24566899999999 7999999999887754
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 133 -------------------------------------------------------------------------------- 132 (355)
T 1vzo_A 133 -------------------------------------------------------------------------------- 132 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.+++|||||++ +|.+++.. ...+++..++.
T Consensus 133 ---------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~ 163 (355)
T 1vzo_A 133 ---------------------------------------------KLHLILDYINGGELFTHLSQ----RERFTEHEVQI 163 (355)
T ss_dssp ---------------------------------------------EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHH
T ss_pred ---------------------------------------------eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHH
Confidence 38999999985 99998853 35799999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccC-CCCCcc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGA-IDYTTK 325 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~s~~ 325 (444)
++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+. ..++.+
T Consensus 164 ~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 242 (355)
T 1vzo_A 164 YVGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242 (355)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEEC-CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCch
Confidence 999999999999999999999999999999 78899999999987543221 22345689999999999753 257899
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|+|||||++|+|++|+.||...........+.+... .. ...++..+++.+.+||
T Consensus 243 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~-----------------~~~~~~~~~~~~~~li 297 (355)
T 1vzo_A 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--------KS-----------------EPPYPQEMSALAKDLI 297 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--------HC-----------------CCCCCTTSCHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--------cc-----------------CCCCCcccCHHHHHHH
Confidence 9999999999999999999976543322222222110 00 0112345789999999
Q ss_pred HHhcccCCCCCC-----CHHHHhccCchhhhhh
Q psy10212 406 SRLLEYTPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 406 ~~~L~~DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
.+||..||.+|| |+.|+++ ||||+++.
T Consensus 298 ~~~L~~dP~~R~~~~~~s~~ell~-h~~f~~~~ 329 (355)
T 1vzo_A 298 QRLLMKDPKKRLGCGPRDADEIKE-HLFFQKIN 329 (355)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHT-SGGGTTCC
T ss_pred HHHhhhCHHHhcCCCCCCHHHHHc-CcchhcCC
Confidence 999999999999 9999999 99999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=325.05 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=212.4
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
++.++|++.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.++++++|++++..+..+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-------- 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-------- 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEET--------
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCC--------
Confidence 3568999999999999999999999999999999998543 356779999999999988777766665544
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (296)
T 3uzp_A 78 -------------------------------------------------------------------------------- 77 (296)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
...++|||||+++|.+++.. ...++++..++.++.||+.|
T Consensus 78 -------------------------------------~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~ 117 (296)
T 3uzp_A 78 -------------------------------------DYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISR 117 (296)
T ss_dssp -------------------------------------TEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHH
T ss_pred -------------------------------------CceEEEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHH
Confidence 25899999998899999863 34579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEc--CCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCCcch
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLN--PETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~--~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
|+|||++|++|+||+|+||+++ ...+.++|+|||.+........ .....+++.|+|||.+.+. .++.++
T Consensus 118 l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 196 (296)
T 3uzp_A 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRD 196 (296)
T ss_dssp HHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHH
T ss_pred HHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC-CCCcch
Confidence 9999999999999999999993 2678999999999976544322 2345689999999999887 789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~---~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
|+||||+++|+|++|+.||.+.+. .+....+.......+.. .+...+|+.+.+
T Consensus 197 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~ 252 (296)
T 3uzp_A 197 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------------------------VLCKGYPSEFAT 252 (296)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------------------------HHTTTSCHHHHH
T ss_pred hhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH------------------------HHHhhCCHHHHH
Confidence 999999999999999999987432 23333333321111111 112356899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+|.+||+.||.+|||+.++++ .|+++....
T Consensus 253 li~~~l~~dp~~Rps~~~l~~---~l~~~~~~~ 282 (296)
T 3uzp_A 253 YLNFCRSLRFDDKPDYSYLRQ---LFRNLFHRQ 282 (296)
T ss_dssp HHHHHHTSCTTCCCCHHHHHH---HHHHHHHHT
T ss_pred HHHHHHhcCcCcCCCHHHHHH---HHHHHHHhc
Confidence 999999999999999999999 788766543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=326.52 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=204.0
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
+|....+||+|+||+||+|++..+++.||||.+... ...+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------- 92 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG---------- 92 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----------
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----------
Confidence 445556999999999999999999999999998543 245668999999999999999999987654
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (295)
T 2clq_A 93 -------------------------------------------------------------------------------- 92 (295)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++|||||+ ++|.+++... .....+++..++.++.||+.||
T Consensus 93 ------------------------------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l 135 (295)
T 2clq_A 93 ------------------------------------FIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGL 135 (295)
T ss_dssp ------------------------------------EEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------cEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHH
Confidence 3899999997 5898888642 2234567889999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccC-CCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGA-IDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~s~~sDiwSLGvil 335 (444)
.|||++|++|+||+|+||+++..++.++|+|||.+....... ......+++.|+|||.+.+. ..++.++|+||||+++
T Consensus 136 ~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 215 (295)
T 2clq_A 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215 (295)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHH
T ss_pred HHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHH
Confidence 999999999999999999998448899999999987654322 23345679999999998654 2478999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|+.||................. ....++..+++.+.++|.+||+.||++
T Consensus 216 ~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 216 IEMATGKPPFYELGEPQAAMFKVGMFK--------------------------VHPEIPESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHHTSCTTGGGSSHHHHHHHHHHHC--------------------------CCCCCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred HHHHHCCCCccCCCchhHHHHhhcccc--------------------------ccccccccCCHHHHHHHHHHccCChhh
Confidence 999999999976543332211111100 011123457999999999999999999
Q ss_pred CCCHHHHhccCchhhhhhh
Q psy10212 416 RISPLQVRSITPFLIELRA 434 (444)
Q Consensus 416 RPs~~elL~~hpwf~~~~~ 434 (444)
|||+.++|+ ||||+....
T Consensus 270 Rps~~~ll~-~~~~~~~~~ 287 (295)
T 2clq_A 270 RACANDLLV-DEFLKVSSK 287 (295)
T ss_dssp SCCHHHHHT-SGGGCC---
T ss_pred CCCHHHHhc-Chhhhhccc
Confidence 999999999 999987554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=334.73 Aligned_cols=258 Identities=23% Similarity=0.284 Sum_probs=211.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..++|++.+.||+|+||.||+|++..+++ .||||++... ...+.+|+.++++++||||+++++++...+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR--- 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG---
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence 35789999999999999999999986665 4999999543 245678999999999999999999986654
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 124 -------------------------------------------------------------------------------- 123 (325)
T 3kul_A 124 -------------------------------------------------------------------------------- 123 (325)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++|||||++ +|.+++. .....+++..++.++
T Consensus 124 -------------------------------------------~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~ 157 (325)
T 3kul_A 124 -------------------------------------------LAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGML 157 (325)
T ss_dssp -------------------------------------------CCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHH
T ss_pred -------------------------------------------ccEEEeeCCCCCcHHHHHH---hcccCCCHHHHHHHH
Confidence 38899999975 9999885 344679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||.|||++|++|+||||+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++
T Consensus 158 ~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 235 (325)
T 3kul_A 158 RGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSAS 235 (325)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHH
T ss_pred HHHHHHHHHHHHCCeeCCCCCcceEEEC-CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHH
Confidence 9999999999999999999999999999 7889999999999765433221 122346789999999877 789999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |..||.+.+..+....+..... ...+..+++.+.+||
T Consensus 236 Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li 287 (325)
T 3kul_A 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----------------------------LPAPMGCPHALHQLM 287 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC----------------------------CCCCCCcCHHHHHHH
Confidence 99999999999998 9999998887776665543210 112235799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhhhcc
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~ 439 (444)
.+||..||.+|||+.++++ .++.+....+.+
T Consensus 288 ~~~l~~dp~~Rps~~eil~---~L~~l~~~~~~~ 318 (325)
T 3kul_A 288 LDCWHKDRAQRPRFSQIVS---VLDALIRSPESL 318 (325)
T ss_dssp HHHTCSSGGGSCCHHHHHH---HHHHHHHSCC--
T ss_pred HHHccCChhhCcCHHHHHH---HHHHHHhCcccc
Confidence 9999999999999999999 888876655543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=324.11 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=212.7
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
-+.+.++|++++.||+|+||.||+|++..+|+.||+|.+......+.+|++++++++||||+++++++......
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 79 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYD------ 79 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccC------
Confidence 35677899999999999999999999999999999999988888889999999999999999999988653210
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
+..
T Consensus 80 -------------~~~---------------------------------------------------------------- 82 (284)
T 2a19_B 80 -------------PET---------------------------------------------------------------- 82 (284)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------ccc----------------------------------------------------------------
Confidence 000
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
............+++|||||++ +|.+++... ....+++..++.++.||+.
T Consensus 83 ---------------------------~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~ 133 (284)
T 2a19_B 83 ---------------------------SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITK 133 (284)
T ss_dssp ---------------------------------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHH
T ss_pred ---------------------------ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHH
Confidence 0000001122468999999996 999998642 3467999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
||.|||++|++|+||+|+||+++ .++.++|+|||.+.............+++.|+|||.+.+. .++.++|+||||+++
T Consensus 134 ~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il 211 (284)
T 2a19_B 134 GVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLIL 211 (284)
T ss_dssp HHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHH
T ss_pred HHHHHHhCCeeeccCCHHHEEEc-CCCCEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHH
Confidence 99999999999999999999999 7889999999999776555555566789999999999877 789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|..|+... ......+.. ..++..+++.+.++|.+||+.||.+
T Consensus 212 ~~l~~~~~~~~~~--~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~ 258 (284)
T 2a19_B 212 AELLHVCDTAFET--SKFFTDLRD-------------------------------GIISDIFDKKEKTLLQKLLSKKPED 258 (284)
T ss_dssp HHHHSCCSSHHHH--HHHHHHHHT-------------------------------TCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhcCCcchhH--HHHHHHhhc-------------------------------ccccccCCHHHHHHHHHHccCChhh
Confidence 9999999887421 111111100 0012346899999999999999999
Q ss_pred CCCHHHHhccCchh
Q psy10212 416 RISPLQVRSITPFL 429 (444)
Q Consensus 416 RPs~~elL~~hpwf 429 (444)
|||+.|+++ |.|.
T Consensus 259 Rps~~e~l~-~l~~ 271 (284)
T 2a19_B 259 RPNTSEILR-TLTV 271 (284)
T ss_dssp SCCHHHHHH-HHHH
T ss_pred CcCHHHHHH-HHHH
Confidence 999999999 6544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=331.28 Aligned_cols=255 Identities=25% Similarity=0.307 Sum_probs=202.2
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
--.++|++.+.||+|+||+||+|++ +|+.||+|++.... +.+.+|++++++++||||+++++++...+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--- 108 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--- 108 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC---
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc---
Confidence 3457899999999999999999987 68999999985432 356689999999999999999999876543
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 109 -------------------------------------------------------------------------------- 108 (309)
T 3p86_A 109 -------------------------------------------------------------------------------- 108 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
+++|||||++ +|.+++.... ....+++..++.++.
T Consensus 109 -------------------------------------------~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~ 144 (309)
T 3p86_A 109 -------------------------------------------LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAY 144 (309)
T ss_dssp -------------------------------------------CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHH
T ss_pred -------------------------------------------eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHH
Confidence 7899999985 9999886321 123489999999999
Q ss_pred HHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||++| ++||||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+
T Consensus 145 qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di 222 (309)
T 3p86_A 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDV 222 (309)
T ss_dssp HHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHH
T ss_pred HHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhH
Confidence 9999999999999 99999999999999 78899999999986543322 23345789999999999887 78999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|+.||.+.+..+....+.... ....++..+++.+.+||.+|
T Consensus 223 wslG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~ 275 (309)
T 3p86_A 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---------------------------KRLEIPRNLNPQVAAIIEGC 275 (309)
T ss_dssp HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC---------------------------CCCCCCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------------------CCCCCCccCCHHHHHHHHHH
Confidence 999999999999999999887766555443210 01122346799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.++++ .++.+..
T Consensus 276 l~~dP~~Rps~~~ll~---~L~~~~~ 298 (309)
T 3p86_A 276 WTNEPWKRPSFATIMD---LLRPLIK 298 (309)
T ss_dssp TCSSGGGSCCHHHHHH---HHHHHHC
T ss_pred ccCChhhCcCHHHHHH---HHHHHHH
Confidence 9999999999999998 6666543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.43 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=214.8
Q ss_pred chhhhhhccccchhheecccceeEEEEeEec-----CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeE
Q psy10212 14 YTYFSDLDNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYF 83 (444)
Q Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (444)
+..++-..++|++++.||+|+||.||+|++. .+++.||||.+... ...+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4445566789999999999999999999997 34589999998543 2456789999999999999999999
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+...+.
T Consensus 119 ~~~~~~-------------------------------------------------------------------------- 124 (343)
T 1luf_A 119 CAVGKP-------------------------------------------------------------------------- 124 (343)
T ss_dssp ECSSSS--------------------------------------------------------------------------
T ss_pred EccCCc--------------------------------------------------------------------------
Confidence 866542
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc-----
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS----- 237 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~----- 237 (444)
.++|||||++ +|.+++......
T Consensus 125 ----------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 152 (343)
T 1luf_A 125 ----------------------------------------------------MCLLFEYMAYGDLNEFLRSMSPHTVCSL 152 (343)
T ss_dssp ----------------------------------------------------CEEEEECCTTCBHHHHHHHTCC------
T ss_pred ----------------------------------------------------eEEEEecCCCCcHHHHHHHhCccccccc
Confidence 8899999985 999998653221
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---
Q psy10212 238 ---------------KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--- 299 (444)
Q Consensus 238 ---------------~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--- 299 (444)
..++++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~ 231 (343)
T 1luf_A 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYK 231 (343)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC
T ss_pred ccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC-CCCeEEEeecCCCcccccCcccc
Confidence 26799999999999999999999999999999999999999 78899999999986543221
Q ss_pred CCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc
Q psy10212 300 PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 378 (444)
Q Consensus 300 ~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~ 378 (444)
......+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.+..
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 293 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN----------------- 293 (343)
T ss_dssp ----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------
T ss_pred ccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-----------------
Confidence 22334568889999999877 79999999999999999998 999999887766655444310
Q ss_pred ccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 379 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 379 ~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
. ..++..+++.+.++|.+||+.||.+|||+.++++ .|+++....+
T Consensus 294 --~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~---~L~~~~~~~~ 338 (343)
T 1luf_A 294 --I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR---ILQRMCERAE 338 (343)
T ss_dssp --C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHTTC---
T ss_pred --c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH---HHHHHHhhhh
Confidence 0 0123457899999999999999999999999999 8888765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.19 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=217.9
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
+|..++-..++|++.+.||+|+||+||+|+++.+++.||+|.+.... +.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45556667899999999999999999999999999999999996543 456689999999999999999998866542
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (288)
T 3kfa_A 84 -------------------------------------------------------------------------------- 83 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.++|||||+ ++|.+++.. .....+++..++.
T Consensus 84 ----------------------------------------------~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ 115 (288)
T 3kfa_A 84 ----------------------------------------------FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLY 115 (288)
T ss_dssp ----------------------------------------------EEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHH
T ss_pred ----------------------------------------------EEEEEEcCCCCcHHHHHHh--cccCCccHhHHHH
Confidence 899999998 599999864 2345699999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcch
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++
T Consensus 116 i~~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 193 (288)
T 3kfa_A 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKS 193 (288)
T ss_dssp HHHHHHHHHHHHHHHTCCCSCCSGGGEEEC-GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHH
T ss_pred HHHHHHHHHHHHHHCCccCCCCCcceEEEc-CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchh
Confidence 999999999999999999999999999998 788999999999876543321 1223457789999999877 789999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |..||.+.+..+....+.... ....+..+++.+.+||
T Consensus 194 Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li 245 (288)
T 3kfa_A 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------------------RMERPEGCPEKVYELM 245 (288)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------------------------CCCCCCCCCHHHHHHH
Confidence 99999999999999 999999877666554443310 1112245789999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+||..||.+|||+.++++ .|+.+...
T Consensus 246 ~~~l~~dp~~Rps~~~~~~---~l~~~~~~ 272 (288)
T 3kfa_A 246 RACWQWNPSDRPSFAEIHQ---AFETMFQE 272 (288)
T ss_dssp HHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred HHHhCCChhhCcCHHHHHH---HHHHHHHh
Confidence 9999999999999999998 77776544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=333.00 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=211.6
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcC--CCceeEeeeEE
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLE--HSNIVKLKYFF 84 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~--h~~i~~~~~~~ 84 (444)
.+.+.++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|+.+++++. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 456788999999999999999999999999999999998543 245668999999996 59999999998
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
...+
T Consensus 118 ~~~~---------------------------------------------------------------------------- 121 (320)
T 3a99_A 118 ERPD---------------------------------------------------------------------------- 121 (320)
T ss_dssp ECSS----------------------------------------------------------------------------
T ss_pred ecCC----------------------------------------------------------------------------
Confidence 7654
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC--CcHHHHHHhhhhcCCCCC
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP--ETVYKVAKHYSKSKQNFP 242 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~--~~l~~~~~~~~~~~~~l~ 242 (444)
..++|||++. ++|.+++.. ...++
T Consensus 122 --------------------------------------------------~~~lv~e~~~~~~~L~~~l~~----~~~l~ 147 (320)
T 3a99_A 122 --------------------------------------------------SFVLILERPEPVQDLFDFITE----RGALQ 147 (320)
T ss_dssp --------------------------------------------------EEEEEEECCSSEEEHHHHHHH----HCSCC
T ss_pred --------------------------------------------------cEEEEEEcCCCCccHHHHHhc----cCCCC
Confidence 3889999997 689998853 46799
Q ss_pred hHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCC
Q psy10212 243 CFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 243 ~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
+..++.++.||+.||.|||++|++|+||+|+||+++.+.+.++|+|||++...... ......+++.|+|||.+.+....
T Consensus 148 ~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 226 (320)
T 3a99_A 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYH 226 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCC
Confidence 99999999999999999999999999999999999866789999999998765433 23345689999999999776445
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
+.++|+||||+++|+|++|+.||.... .+... . ..++..+++.+.
T Consensus 227 ~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-----------------~------------~~~~~~~~~~~~ 271 (320)
T 3a99_A 227 GRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----------------Q------------VFFRQRVSSECQ 271 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----------------C------------CCCSSCCCHHHH
T ss_pred CccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-----------------c------------ccccccCCHHHH
Confidence 788999999999999999999996531 11110 0 012345799999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
+||.+||+.||.+|||+.|+++ ||||++.....+
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~-hp~~~~~~~~~~ 305 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQN-HPWMQDVLLPQE 305 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT-SGGGSSCCCHHH
T ss_pred HHHHHHccCChhhCcCHHHHhc-CHhhcCccCccc
Confidence 9999999999999999999999 999998765443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=321.22 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=208.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|++++.||+|+||+||+|++. +++.||+|++... ...+.+|++++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------- 76 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--------- 76 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---------
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---------
Confidence 379999999999999999999886 4778999999543 355778999999999999999999886554
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (268)
T 3sxs_A 77 -------------------------------------------------------------------------------- 76 (268)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+ ++|.+++.. ....+++..++.++.||+.|
T Consensus 77 -------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~ 116 (268)
T 3sxs_A 77 -------------------------------------PIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEG 116 (268)
T ss_dssp -------------------------------------SEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHH
T ss_pred -------------------------------------ceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHH
Confidence 2899999997 589998864 34569999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||++|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||||++
T Consensus 117 l~~lH~~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i 194 (268)
T 3sxs_A 117 MAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGIL 194 (268)
T ss_dssp HHHHHHTTEEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHH
T ss_pred HHHHHHCCeecCCcCcceEEEC-CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHH
Confidence 9999999999999999999999 788999999999876533321 1223446679999999876 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |..||...+..+....+..... ...+..+++.+.++|.+||+.||
T Consensus 195 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p 246 (268)
T 3sxs_A 195 MWEVFSLGKMPYDLYTNSEVVLKVSQGHR----------------------------LYRPHLASDTIYQIMYSCWHELP 246 (268)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHTTCSSG
T ss_pred HHHHHcCCCCCccccChHHHHHHHHcCCC----------------------------CCCCCcChHHHHHHHHHHcCCCh
Confidence 999998 9999998877766655443110 01123468999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+|||+.++++ .++.++..
T Consensus 247 ~~Rps~~~ll~---~L~~l~~~ 265 (268)
T 3sxs_A 247 EKRPTFQQLLS---SIEPLREK 265 (268)
T ss_dssp GGSCCHHHHHH---HHGGGCC-
T ss_pred hhCcCHHHHHH---HHHHhhhc
Confidence 99999999999 67776654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.58 Aligned_cols=267 Identities=23% Similarity=0.360 Sum_probs=187.6
Q ss_pred hhccccchhh-eecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 19 DLDNSLAQKT-VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 19 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.+.++|.+++ .||+|+||+||+|+++.+|+.||||++........+....++.+.||||+++++++......
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~------- 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHG------- 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT-------
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCC-------
Confidence 4678999965 69999999999999999999999999976655444445567778999999999998763210
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (336)
T 3fhr_A 98 -------------------------------------------------------------------------------- 97 (336)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++++|||||++ +|.+++.. .....+++..++.++.||+.|
T Consensus 98 -----------------------------------~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~ 140 (336)
T 3fhr_A 98 -----------------------------------KRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTA 140 (336)
T ss_dssp -----------------------------------EEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHH
T ss_pred -----------------------------------CceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHH
Confidence 1358999999986 99999863 233579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|.|||++|++|+||+|+||+++.. .+.++|+|||++...... ......+++.|+|||.+.+. .++.++|+||||++
T Consensus 141 l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~i 218 (336)
T 3fhr_A 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVI 218 (336)
T ss_dssp HHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------C-HHHHHHHHHHHHHH
T ss_pred HHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHH
Confidence 999999999999999999999732 456999999999765432 23345679999999998776 78899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+................ ....++ ......+++.+.+||.+||+.||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~ 277 (336)
T 3fhr_A 219 MYILLCGFPPFYSNTGQAISPGMKRRIRL-------------GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPT 277 (336)
T ss_dssp HHHHHHSSCCC----------------------------------CCC--------TTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHHCCCCCCCccchhhhhhHHHhhhc-------------cccccC--------chhhccCCHHHHHHHHHHCCCChh
Confidence 99999999999776544332211111000 000000 011135699999999999999999
Q ss_pred CCCCHHHHhccCchhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELR 433 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~ 433 (444)
+|||+.|+|+ ||||++..
T Consensus 278 ~Rpt~~ell~-hp~~~~~~ 295 (336)
T 3fhr_A 278 ERLTITQFMN-HPWINQSM 295 (336)
T ss_dssp GSCCHHHHHH-SHHHHTGG
T ss_pred HCcCHHHHhc-Cccccccc
Confidence 9999999999 99998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.35 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=212.9
Q ss_pred hhhhhccccchhheecccceeEEEEeE-----ecCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEE
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAK-----LLDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFF 84 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (444)
.++--.++|++.+.||+|+||.||+|+ +..+++.||||++... ...+.+|++++.++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 345567899999999999999999999 5567799999999543 23567899999999 899999999998
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
...+.
T Consensus 96 ~~~~~--------------------------------------------------------------------------- 100 (359)
T 3vhe_A 96 TKPGG--------------------------------------------------------------------------- 100 (359)
T ss_dssp CSTTS---------------------------------------------------------------------------
T ss_pred ecCCC---------------------------------------------------------------------------
Confidence 76542
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc------
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS------ 237 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~------ 237 (444)
.+++|||||++ +|.+++......
T Consensus 101 --------------------------------------------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~ 130 (359)
T 3vhe_A 101 --------------------------------------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130 (359)
T ss_dssp --------------------------------------------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC-
T ss_pred --------------------------------------------------ceEEEEEecCCCcHHHHHHhcccccccccc
Confidence 37899999985 999998654321
Q ss_pred --------------------------------------------------------CCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 238 --------------------------------------------------------KQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 238 --------------------------------------------------------~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
...+++..++.++.||+.||+|||
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH 210 (359)
T 3vhe_A 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 210 (359)
T ss_dssp -----------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH
Confidence 222889999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
++|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++||||||+++|+|
T Consensus 211 ~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el 288 (359)
T 3vhe_A 211 SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEI 288 (359)
T ss_dssp HTTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred HCCcccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHH
Confidence 99999999999999998 788999999999976533322 2234568889999999877 799999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |..||.+....+........... ...+..+++.+.++|.+||+.||.+||
T Consensus 289 lt~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp 341 (359)
T 3vhe_A 289 FSLGASPYPGVKIDEEFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRP 341 (359)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCCCCccchhHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 98 99999987765555444442110 011235689999999999999999999
Q ss_pred CHHHHhccCchhhhhhhh
Q psy10212 418 SPLQVRSITPFLIELRAV 435 (444)
Q Consensus 418 s~~elL~~hpwf~~~~~~ 435 (444)
|+.|+++ .++.+.+.
T Consensus 342 s~~ell~---~L~~~~~~ 356 (359)
T 3vhe_A 342 TFSELVE---HLGNLLQA 356 (359)
T ss_dssp CHHHHHH---HHHHHHHH
T ss_pred CHHHHHH---HHHHHHHH
Confidence 9999999 67776543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=339.09 Aligned_cols=253 Identities=21% Similarity=0.226 Sum_probs=205.0
Q ss_pred ccccchhheecccceeEEEEeE-----ecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAK-----LLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++++.||+|+||+||+|+ +..+++.||||++... ...+.+|+.++++++||||+++++++...+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~- 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP- 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence 4789999999999999999999 4557789999998432 2356689999999999999999999876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 149 -------------------------------------------------------------------------------- 148 (367)
T 3l9p_A 149 -------------------------------------------------------------------------------- 148 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh---cCCCCChHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK---SKQNFPCFYT 246 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~---~~~~l~~~~i 246 (444)
.++|||||++ +|.+++..... ....+++..+
T Consensus 149 ---------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 183 (367)
T 3l9p_A 149 ---------------------------------------------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183 (367)
T ss_dssp ---------------------------------------------CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHH
T ss_pred ---------------------------------------------CEEEEEeCCCCCHHHHHHhhccccCccccccHHHH
Confidence 7899999975 99999975442 2345899999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCC---CCCccccccccccCchhhccCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRG---EPNVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~ 321 (444)
+.++.||+.||+|||++|++||||||+||+++. ....++|+|||+++..... .......+++.|+|||.+.+. .
T Consensus 184 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~ 262 (367)
T 3l9p_A 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-I 262 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-C
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-C
Confidence 999999999999999999999999999999982 2235999999998654221 223345668899999999877 7
Q ss_pred CCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 322 YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
++.++|+|||||++|+|++ |..||.+.+..+....+..... ...+..+++.
T Consensus 263 ~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~ 314 (367)
T 3l9p_A 263 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR----------------------------MDPPKNCPGP 314 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccCCHH
Confidence 9999999999999999998 9999998887766655543110 0112457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf 429 (444)
+.+||.+||+.||.+|||+.++++ +.++
T Consensus 315 l~~li~~~l~~dP~~Rps~~eil~-~l~~ 342 (367)
T 3l9p_A 315 VYRIMTQCWQHQPEDRPNFAIILE-RIEY 342 (367)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH-HHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH-HHHH
Confidence 999999999999999999999999 4433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.08 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=204.1
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcC--CCceeEeeeEEee
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLE--HSNIVKLKYFFYS 86 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 86 (444)
..++-..++|++++.||+|+||.||+|++.. ++.||+|++.... ..+.+|++++++++ |+||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3455567889999999999999999999864 8999999985432 45568999999997 5999999998876
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+
T Consensus 100 ~~------------------------------------------------------------------------------ 101 (313)
T 3cek_A 100 DQ------------------------------------------------------------------------------ 101 (313)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 54
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHH
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i 246 (444)
++++|||+++++|.+++.. ...+++..+
T Consensus 102 ------------------------------------------------~~~lv~e~~~~~L~~~l~~----~~~~~~~~~ 129 (313)
T 3cek_A 102 ------------------------------------------------YIYMVMECGNIDLNSWLKK----KKSIDPWER 129 (313)
T ss_dssp ------------------------------------------------EEEEEECCCSEEHHHHHHH----CSSCCHHHH
T ss_pred ------------------------------------------------EEEEEEecCCCcHHHHHHh----cCCCCHHHH
Confidence 4899999888899999863 457899999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC----
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA---- 319 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~---- 319 (444)
+.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++........ .....+++.|+|||.+.+.
T Consensus 130 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (313)
T 3cek_A 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC---
T ss_pred HHHHHHHHHHHHHHHHCCceecCCCcccEEEE--CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccc
Confidence 99999999999999999999999999999997 48999999999876533321 2234679999999998651
Q ss_pred ------CCCCcchhhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccc
Q psy10212 320 ------IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392 (444)
Q Consensus 320 ------~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 392 (444)
..++.++|+||||+++|+|++|+.||...... .....+... .....
T Consensus 208 ~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~ 260 (313)
T 3cek_A 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---------------------------NHEIE 260 (313)
T ss_dssp -------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---------------------------TSCCC
T ss_pred ccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc---------------------------ccccC
Confidence 26788999999999999999999999865432 222211110 01111
Q ss_pred ccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhcc
Q psy10212 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 393 ~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~ 439 (444)
++..+++.+.++|.+||+.||.+|||+.|+|+ ||||+.-.......
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~-h~~~~~~~~~~~~~ 306 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA-HPYVQIQTHPVNQM 306 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT-SHHHHCC-------
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhc-CccccCCCCchhhh
Confidence 23345889999999999999999999999999 99999866555443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.30 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=210.6
Q ss_pred ccccchhheecccceeEEEEeEec-------CCCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeec
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLL-------DSGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSS 87 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (444)
.++|++.+.||+|+||+||+|++. .++..||||++.... ..+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999974 245679999985432 3566899999999 899999999998765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 160 ~~------------------------------------------------------------------------------ 161 (370)
T 2psq_A 160 GP------------------------------------------------------------------------------ 161 (370)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 43
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh----------
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK---------- 236 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~---------- 236 (444)
+|+|||||++ +|.+++.....
T Consensus 162 ------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 193 (370)
T 2psq_A 162 ------------------------------------------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193 (370)
T ss_dssp ------------------------------------------------CEEEEECCTTCBHHHHHHHTCCC---------
T ss_pred ------------------------------------------------EEEEEEcCCCCCHHHHHHhhCCcccccccccc
Confidence 8899999985 99999875332
Q ss_pred --cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccccccccc
Q psy10212 237 --SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYR 311 (444)
Q Consensus 237 --~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~ 311 (444)
....++...++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||++........ .....+++.|+
T Consensus 194 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~ 272 (370)
T 2psq_A 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 272 (370)
T ss_dssp --CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGC
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceE
Confidence 234588999999999999999999999999999999999999 788999999999976543321 22335578899
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.... .
T Consensus 273 aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------------~ 323 (370)
T 2psq_A 273 APEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH----------------------------R 323 (370)
T ss_dssp CHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------------------------C
T ss_pred CHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----------------------------C
Confidence 99999887 79999999999999999998 999999887766555443310 0
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
...+..+++.+.++|.+||+.||.+|||+.|+++ .++.+....
T Consensus 324 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~---~L~~il~~~ 366 (370)
T 2psq_A 324 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRILTLT 366 (370)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH---HHHHHHHHh
Confidence 1123457899999999999999999999999999 677765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.46 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=211.0
Q ss_pred hccccchhheecccceeEEEEeEe-----cCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSG 88 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 88 (444)
..++|++.+.||+|+||+||+|++ ..+++.||+|.+... .+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357999999999999999999985 456789999998543 35567899999999 9999999999987654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 101 ~------------------------------------------------------------------------------- 101 (313)
T 1t46_A 101 P------------------------------------------------------------------------------- 101 (313)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-----------
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK----------- 236 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~----------- 236 (444)
.++|||||++ +|.+++.....
T Consensus 102 -----------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 134 (313)
T 1t46_A 102 -----------------------------------------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134 (313)
T ss_dssp -----------------------------------------------CEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred -----------------------------------------------cEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 7899999985 99999865332
Q ss_pred ---cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccccc
Q psy10212 237 ---SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYY 310 (444)
Q Consensus 237 ---~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y 310 (444)
...++++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|
T Consensus 135 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 213 (313)
T 1t46_A 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213 (313)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGG
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc-CCCCEEEccccccccccccccceeccCCCCccee
Confidence 133589999999999999999999999999999999999999 789999999999876544332 1233457789
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCC
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~ 389 (444)
+|||.+.+. .++.++|+||||+++|+|++ |..||.+................
T Consensus 214 ~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------------------- 266 (313)
T 1t46_A 214 MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-------------------------- 266 (313)
T ss_dssp CCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC--------------------------
T ss_pred eChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC--------------------------
Confidence 999999877 79999999999999999998 99999887765555544442100
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
...+..+++.+.++|.+||+.||.+|||+.|+++ .++++...
T Consensus 267 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~---~L~~~~~~ 308 (313)
T 1t46_A 267 -MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ---LIEKQISE 308 (313)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred -CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH---HHHHHHHH
Confidence 0112356899999999999999999999999999 67765543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=330.61 Aligned_cols=269 Identities=23% Similarity=0.317 Sum_probs=211.3
Q ss_pred cchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 13 NYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
++..+....++|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 34567888899999999999999999999865 58999999985432 3567899999999999999999998765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 100 ~~------------------------------------------------------------------------------ 101 (326)
T 3uim_A 100 TE------------------------------------------------------------------------------ 101 (326)
T ss_dssp SC------------------------------------------------------------------------------
T ss_pred Cc------------------------------------------------------------------------------
Confidence 43
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYT 246 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i 246 (444)
.++|||||++ +|.+++........++++..+
T Consensus 102 ------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 133 (326)
T 3uim_A 102 ------------------------------------------------RLLVYPYMANGSVASCLRERPESQPPLDWPKR 133 (326)
T ss_dssp ------------------------------------------------CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHH
T ss_pred ------------------------------------------------eEEEEEeccCCCHHHHHHhccccCCCCCHHHH
Confidence 7899999985 999999766666677999999
Q ss_pred HHHHHHHHHHHHHHHHC---CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCC
Q psy10212 247 KLYIYQLFRSLAYIHVL---GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~---givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~ 321 (444)
+.++.||+.||+|||++ |++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .
T Consensus 134 ~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 211 (326)
T 3uim_A 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-K 211 (326)
T ss_dssp HHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC-TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-E
T ss_pred HHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC-CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC-C
Confidence 99999999999999999 999999999999999 788999999999976543322 2234589999999999877 7
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCC----ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGD----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~----~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
++.++|+||||+++|+|++|+.||... ........... ...................++...
T Consensus 212 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 3uim_A 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK--------------GLLKEKKLEALVDVDLQGNYKDEE 277 (326)
T ss_dssp ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT--------------TTTSSCCSTTSSCTTCTTSCCHHH
T ss_pred CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH--------------HHhhchhhhhhcChhhccccCHHH
Confidence 899999999999999999999999621 11111111111 111111122222222223333445
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
++.+.++|.+||+.||.+|||+.|+++
T Consensus 278 ~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 278 VEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp HHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 688999999999999999999999999
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.85 Aligned_cols=279 Identities=23% Similarity=0.231 Sum_probs=214.9
Q ss_pred hhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
..++...++|++.+.||+|+||+||+|++. +|+.||||++... .+.+.+|++++++++||||+++++++...+.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 109 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE- 109 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-
Confidence 346778899999999999999999999975 5899999988543 2456789999999999999999998865542
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 110 -------------------------------------------------------------------------------- 109 (321)
T 2qkw_B 110 -------------------------------------------------------------------------------- 109 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.++|||||+ ++|.+++.........+++..++.+
T Consensus 110 ---------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 144 (321)
T 2qkw_B 110 ---------------------------------------------MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144 (321)
T ss_dssp ---------------------------------------------CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHH
T ss_pred ---------------------------------------------EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHH
Confidence 789999998 4888887543334456899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcch
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
+.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++
T Consensus 145 ~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 222 (321)
T 2qkw_B 145 CIGAARGLHYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKS 222 (321)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCSTTEEEC-TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHH
T ss_pred HHHHHHHHHHhcCCCeecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCccc
Confidence 99999999999999999999999999999 78899999999987643222 22334579999999999877 789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|+||||+++|+|++|+.||.+..+.+........ .... ....+...........++..++..+.++|.
T Consensus 223 Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (321)
T 2qkw_B 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA--------VESH----NNGQLEQIVDPNLADKIRPESLRKFGDTAV 290 (321)
T ss_dssp HHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT--------HHHH----TTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred chHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh--------hhcc----ccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence 9999999999999999999865443221111000 0000 001111111222223334456788999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
+||+.||++|||+.|+++ .++.+....+
T Consensus 291 ~~l~~dP~~Rps~~ell~---~L~~~l~~~~ 318 (321)
T 2qkw_B 291 KCLALSSEDRPSMGDVLW---KLEYALRLQE 318 (321)
T ss_dssp HHTCSSGGGSCCHHHHHH---HHHHHHHSSC
T ss_pred HHcCCCcccCcCHHHHHH---HHHHHhhccc
Confidence 999999999999999999 6666655443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=326.50 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=203.8
Q ss_pred ccccchhheecccceeEEEEeE----ecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++++.||+|+||+||+|+ +..+++.||||++.... ..+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--- 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence 4899999999999999999998 56789999999985432 456789999999999999999998876432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (295)
T 3ugc_A 86 -------------------------------------------------------------------------------- 85 (295)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..+++|||||+ ++|.+++.. ...++++..++.++.
T Consensus 86 -----------------------------------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~ 121 (295)
T 3ugc_A 86 -----------------------------------------RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTS 121 (295)
T ss_dssp -----------------------------------------TSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHH
T ss_pred -----------------------------------------CceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHH
Confidence 23789999997 599999864 334699999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|
T Consensus 122 qi~~~l~~lH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 199 (295)
T 3ugc_A 122 QICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASD 199 (295)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHH
T ss_pred HHHHHHHHHhcCCcccCCCCHhhEEEc-CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHH
Confidence 999999999999999999999999999 788999999999976543321 2223456779999999887 7999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHH------HHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE------QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
+||||+++|+|++|..|+...... ..+..+..... ...... .......+..+++.+
T Consensus 200 i~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l 261 (295)
T 3ugc_A 200 VWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFHLIELLK-------------NNGRLPRPDGCPDEI 261 (295)
T ss_dssp HHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHHHHHHHH-------------TTCCCCCCTTCCHHH
T ss_pred HHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHHHHHHHh-------------ccCcCCCCcCcCHHH
Confidence 999999999999999998643211 11111111100 000000 000111234679999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.++|.+||+.||.+|||+.|+++ .+++++..
T Consensus 262 ~~li~~~l~~dp~~Rps~~el~~---~L~~l~~~ 292 (295)
T 3ugc_A 262 YMIMTECWNNNVNQRPSFRDLAL---RVDQIRDN 292 (295)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH---HHHHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHHH---HHHHHHHh
Confidence 99999999999999999999999 77777653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.83 Aligned_cols=264 Identities=20% Similarity=0.249 Sum_probs=194.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCc---eeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeec
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSS 87 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (444)
+.-..++|++.+.||+|+||+||+|++..+++ .||||++... .+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33446789999999999999999999987765 8999998543 24567899999999999999999999776
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
.....
T Consensus 98 ~~~~~--------------------------------------------------------------------------- 102 (323)
T 3qup_A 98 RAKGR--------------------------------------------------------------------------- 102 (323)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccC---------------------------------------------------------------------------
Confidence 43100
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh--cCCCCChH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK--SKQNFPCF 244 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~--~~~~l~~~ 244 (444)
....++|||||++ +|.+++..... ....+++.
T Consensus 103 ---------------------------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 137 (323)
T 3qup_A 103 ---------------------------------------------LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137 (323)
T ss_dssp -----------------------------------------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHH
T ss_pred ---------------------------------------------CCccEEEEEeccCCcHHHHHHhhhccccccccCHH
Confidence 0236899999986 99998865432 23368999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCC
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 321 (444)
.++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .
T Consensus 138 ~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~ 215 (323)
T 3qup_A 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-L 215 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTSCEEECCCCC-----------------CCGGGCCHHHHHHC-C
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-C
Confidence 9999999999999999999999999999999999 788999999999976543322 2233457789999999887 7
Q ss_pred CCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 322 YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
++.++|+||||+++|+|++ |+.||.+.+..+....+..... ...+..+++.
T Consensus 216 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 267 (323)
T 3qup_A 216 YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR----------------------------LKQPPECMEE 267 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHH
T ss_pred CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----------------------------CCCCCccCHH
Confidence 9999999999999999999 9999998887776665544110 1112457899
Q ss_pred HHHHHHHhcccCCCCCCC-------HHHHhccCchhhh
Q psy10212 401 AIDLISRLLEYTPSSRIS-------PLQVRSITPFLIE 431 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs-------~~elL~~hpwf~~ 431 (444)
+.+||.+||+.||.+||| ..+++. |+|+..
T Consensus 268 l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~-~~~~~~ 304 (323)
T 3qup_A 268 VYDLMYQCWSADPKQRPSFTCLRMELENILG-HLSVLS 304 (323)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH-C-----
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH-HhhhcC
Confidence 999999999999999999 666777 888766
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.04 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=208.6
Q ss_pred hccccchhheecccceeEEEEeEec-----CCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
-.++|.+.+.||+|+||.||+|++. .+++.||+|++.... ..+.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4589999999999999999999983 456899999985432 456689999999999999999998866543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 101 -------------------------------------------------------------------------------- 100 (314)
T 2ivs_A 101 -------------------------------------------------------------------------------- 100 (314)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------ 236 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------ 236 (444)
.++|||||+ ++|.+++.....
T Consensus 101 ----------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 134 (314)
T 2ivs_A 101 ----------------------------------------------LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134 (314)
T ss_dssp ----------------------------------------------CEEEEECCTTCBHHHHHHHTTTSTTEEC------
T ss_pred ----------------------------------------------eEEEEeecCCCCHHHHHHHHhhccCCcccccccc
Confidence 889999998 699999875432
Q ss_pred --------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccc
Q psy10212 237 --------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYI 305 (444)
Q Consensus 237 --------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~ 305 (444)
....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........ .....
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 213 (314)
T 2ivs_A 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGR 213 (314)
T ss_dssp ----------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCC
T ss_pred cccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc-CCCCEEEccccccccccccccceeccCCC
Confidence 123488999999999999999999999999999999999999 788999999999876543321 22335
Q ss_pred ccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCc
Q psy10212 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 384 (444)
Q Consensus 306 gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~ 384 (444)
+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+....
T Consensus 214 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------------- 269 (314)
T 2ivs_A 214 IPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH----------------------- 269 (314)
T ss_dssp SCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------------------
T ss_pred CcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-----------------------
Confidence 57889999999876 78999999999999999999 999999887766554433210
Q ss_pred cCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 385 ~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
....+..+++.+.++|.+||+.||.+|||+.++++ .++.+.
T Consensus 270 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~---~l~~~~ 310 (314)
T 2ivs_A 270 -----RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK---DLEKMM 310 (314)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHH
T ss_pred -----cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH---HHHHHH
Confidence 01122457999999999999999999999999998 566554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.47 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=209.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|.+.+.||+|+||.||+|+++.+++.||||.+... ...+.+|+++|++++||||+++++++...+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP------ 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS------
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC------
Confidence 46899999999999999999999989999999998543 2467789999999999999999999866543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 187 -------------------------------------------------------------------------------- 186 (377)
T 3cbl_A 187 -------------------------------------------------------------------------------- 186 (377)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
+++|||||+ ++|.+++.. .+..+++..++.++.||+
T Consensus 187 ----------------------------------------~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~ 223 (377)
T 3cbl_A 187 ----------------------------------------IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAA 223 (377)
T ss_dssp ----------------------------------------CEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHH
T ss_pred ----------------------------------------cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHH
Confidence 889999997 599998863 345689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
.||+|||++|++||||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+|||
T Consensus 224 ~~l~~LH~~~ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvwsl 301 (377)
T 3cbl_A 224 AGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSF 301 (377)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHH
T ss_pred HHHHHHHHCCcCCcccCHHHEEEc-CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHH
Confidence 999999999999999999999999 788999999999875432211 1112346779999999877 78999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++ |..||.+.+..+....+.... .. ..+..+++.+.+||.+||+
T Consensus 302 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~l~~li~~cl~ 353 (377)
T 3cbl_A 302 GILLWETFSLGASPYPNLSNQQTREFVEKGG------------------RL----------PCPELCPDAVFRLMEQCWA 353 (377)
T ss_dssp HHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------------------CC----------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCCCCCHHHHHHHHHHcC
Confidence 999999998 999999887665544333210 00 1234578999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.||++|||+.++++ .+++++..
T Consensus 354 ~dP~~Rps~~~i~~---~L~~i~~~ 375 (377)
T 3cbl_A 354 YEPGQRPSFSTIYQ---ELQSIRKR 375 (377)
T ss_dssp SSGGGSCCHHHHHH---HHHHHHHH
T ss_pred CCchhCcCHHHHHH---HHHHHHhh
Confidence 99999999999999 77777653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.73 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=201.3
Q ss_pred hhhhccccchhheecccceeEEEEeEecCC---Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
++-..++|++.+.||+|+||.||+|++..+ +..||+|.+... .+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN- 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC-
Confidence 455678999999999999999999998654 456999988542 34566899999999999999999887332
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (281)
T 1mp8_A 89 -------------------------------------------------------------------------------- 88 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..++|||||++ +|.+++.. ....+++..++
T Consensus 89 ----------------------------------------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~ 119 (281)
T 1mp8_A 89 ----------------------------------------------PVWIIMELCTLGELRSFLQV---RKYSLDLASLI 119 (281)
T ss_dssp ----------------------------------------------SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHH
T ss_pred ----------------------------------------------ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHH
Confidence 17899999995 99998863 34579999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.+
T Consensus 120 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 197 (281)
T 1mp8_A 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSA 197 (281)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHH
T ss_pred HHHHHHHHHHHHHHhCCeecccccHHHEEEC-CCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCc
Confidence 9999999999999999999999999999999 788999999999876543322 2223456789999999876 78999
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++ |..||.+.+..+....+.... ...++.++++.+.++
T Consensus 198 ~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------------------------RLPMPPNCPPTLYSL 249 (281)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHH
T ss_pred cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHH
Confidence 999999999999996 999999888777665554310 001234679999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+||+.||.+|||+.++++ .++++...
T Consensus 250 i~~~l~~~p~~Rps~~~l~~---~l~~~~~~ 277 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKA---QLSTILEE 277 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH---HHHHHHHH
Confidence 99999999999999999999 67776543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=320.81 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----------cchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----------RFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+|++++++++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3489999999999999999999999999999999984321 4566899999999999999999887432
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 96 -------------------------------------------------------------------------------- 95 (287)
T 4f0f_A 96 -------------------------------------------------------------------------------- 95 (287)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.++|||||+ ++|.+.+. ....++++..++
T Consensus 96 -----------------------------------------------~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~ 125 (287)
T 4f0f_A 96 -----------------------------------------------PRMVMEFVPCGDLYHRLL---DKAHPIKWSVKL 125 (287)
T ss_dssp -----------------------------------------------TEEEEECCTTCBHHHHHH---CTTSCCCHHHHH
T ss_pred -----------------------------------------------CeEEEEecCCCCHHHHHh---cccCCccHHHHH
Confidence 259999998 68988875 345679999999
Q ss_pred HHHHHHHHHHHHHHHCC--cccCCCCCCcEEEcCCCCe-----EEEeecCCcccccCCCCCccccccccccCchhhcc-C
Q psy10212 248 LYIYQLFRSLAYIHVLG--ICHRDIKPQNLLLNPETGV-----LKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG-A 319 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~g--ivH~dLkp~NIll~~~~~~-----ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~-~ 319 (444)
.++.||+.||+|||++| ++|+||||+||+++ ..+. ++|+|||++..... ......+++.|+|||.+.+ .
T Consensus 126 ~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 202 (287)
T 4f0f_A 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEE 202 (287)
T ss_dssp HHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSS
T ss_pred HHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCC
Confidence 99999999999999999 99999999999997 4444 99999999865432 2344578999999999843 2
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHH--HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
..++.++|+||||+++|+|++|+.||...+..+. ...+.. . .....++..+
T Consensus 203 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~--------------------------~~~~~~~~~~ 255 (287)
T 4f0f_A 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-E--------------------------GLRPTIPEDC 255 (287)
T ss_dssp CEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-S--------------------------CCCCCCCTTS
T ss_pred CCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-c--------------------------CCCCCCCccc
Confidence 2578999999999999999999999987655443 221211 0 1111233467
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCchhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
++.+.++|.+||+.||.+|||+.|+++ .+++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~---~L~~ 286 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVK---ELSE 286 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHT
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH---HHHh
Confidence 999999999999999999999999998 5544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=318.76 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=206.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.--.++|++++.||+|+||.||+|++. +++.||+|++... ...+.+|++++++++||||+++++++...+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP----- 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-----
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC-----
Confidence 344579999999999999999999886 5778999999543 4567799999999999999999998866542
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (283)
T 3gen_A 94 -------------------------------------------------------------------------------- 93 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.++|||||+ ++|.+++.. ....+++..++.++.||
T Consensus 94 -----------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi 129 (283)
T 3gen_A 94 -----------------------------------------IFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDV 129 (283)
T ss_dssp -----------------------------------------EEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHH
Confidence 899999997 589998853 34569999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+|||
T Consensus 130 ~~~l~~lH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl 207 (283)
T 3gen_A 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAF 207 (283)
T ss_dssp HHHHHHHHHTTCCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHH
T ss_pred HHHHHHHHHCCccCCCCccceEEEc-CCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHH
Confidence 9999999999999999999999999 78899999999987543221 12233457789999999877 78999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++ |+.||...+..+....+..... ...+..+++.+.++|.+||+
T Consensus 208 G~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~ 259 (283)
T 3gen_A 208 GVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------------------------LYRPHLASEKVYTIMYSCWH 259 (283)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHHhCCCCCccccChhHHHHHHhcccC----------------------------CCCCCcCCHHHHHHHHHHcc
Confidence 999999998 9999998887776665554211 11123468999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||.+|||+.++++ -++++.
T Consensus 260 ~~p~~Rps~~~ll~---~L~~~~ 279 (283)
T 3gen_A 260 EKADERPTFKILLS---NILDVM 279 (283)
T ss_dssp SSGGGSCCHHHHHH---HHHHHH
T ss_pred CChhHCcCHHHHHH---HHHHHh
Confidence 99999999999999 555544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=315.85 Aligned_cols=251 Identities=16% Similarity=0.202 Sum_probs=205.9
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|++.+.||+|+||+||+|++ +++.||+|++... .+.+.+|+.++++++||||+++++++.....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA----- 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS-----
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC-----
Confidence 47899999999999999999998 4899999998543 2456789999999999999999999876532
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (271)
T 3kmu_A 82 -------------------------------------------------------------------------------- 81 (271)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
...++|||||++ +|.+++.. .....+++..++.++.||
T Consensus 82 ---------------------------------------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi 120 (271)
T 3kmu_A 82 ---------------------------------------PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDM 120 (271)
T ss_dssp ---------------------------------------SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHH
T ss_pred ---------------------------------------CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHH
Confidence 237899999985 99999863 223368999999999999
Q ss_pred HHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC--CCCcchhhh
Q psy10212 254 FRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI--DYTTKIDVW 329 (444)
Q Consensus 254 l~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~s~~sDiw 329 (444)
+.||+|||++| ++|+||+|+||+++ .++.++|+||+++... ......+++.|+|||.+.+.. .++.++|+|
T Consensus 121 ~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 121 ARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp HHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred HHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeee----cccCccCCccccChhhhccCCCCCCCchhhHH
Confidence 99999999999 99999999999999 7888999988876442 223346789999999997651 233489999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||+++|+|++|+.||.+.+..+....+.... ....++..+++.+.++|.+||
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l 248 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEG---------------------------LRPTIPPGISPHVSKLMKICM 248 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC---------------------------CCCCCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCccccChHHHHHHHHhcC---------------------------CCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999999888776655554310 111223467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+.||.+|||+.++++ .++.+.+
T Consensus 249 ~~~p~~Rps~~~il~---~L~~l~~ 270 (271)
T 3kmu_A 249 NEDPAKRPKFDMIVP---ILEKMQD 270 (271)
T ss_dssp CSSGGGSCCHHHHHH---HHHHHCC
T ss_pred CCChhhCcCHHHHHH---HHHHhhc
Confidence 999999999999999 7777653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=328.78 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=207.6
Q ss_pred hccccchhheecccceeEEEEeEec-----CCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSG 88 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 88 (444)
-.++|++.+.||+|+||+||+|++. .+++.||+|.+... .+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3478999999999999999999973 35678999998533 34567899999999 9999999999987654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 123 ~------------------------------------------------------------------------------- 123 (344)
T 1rjb_A 123 P------------------------------------------------------------------------------- 123 (344)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc----------
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS---------- 237 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~---------- 237 (444)
+++|||||++ +|.+++......
T Consensus 124 -----------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 156 (344)
T 1rjb_A 124 -----------------------------------------------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156 (344)
T ss_dssp -----------------------------------------------CEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred -----------------------------------------------cEEEEecCCCCcHHHHHhhccccccccccchhh
Confidence 8899999975 999998643221
Q ss_pred ---------CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---cccc
Q psy10212 238 ---------KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYI 305 (444)
Q Consensus 238 ---------~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~ 305 (444)
...+++..++.++.||+.||+|||++|++|+||+|+||+++ .++.++|+|||++......... ....
T Consensus 157 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 235 (344)
T 1rjb_A 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNAR 235 (344)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEE
T ss_pred hcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCcc
Confidence 13478999999999999999999999999999999999999 7889999999999765433321 2334
Q ss_pred ccccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCc
Q psy10212 306 CSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 384 (444)
Q Consensus 306 gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~ 384 (444)
+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+.......+....
T Consensus 236 ~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------------- 291 (344)
T 1rjb_A 236 LPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----------------------- 291 (344)
T ss_dssp ECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-----------------------
T ss_pred CccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC-----------------------
Confidence 57789999999877 79999999999999999998 999998877655554444310
Q ss_pred cCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 385 ~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.....+..+++.+.+||.+||+.||.+|||+.++++ +++.+.+..
T Consensus 292 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~---~l~~~~~~~ 336 (344)
T 1rjb_A 292 ----FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS---FLGCQLADA 336 (344)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHC---
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH---HHHHHHHHH
Confidence 001122356899999999999999999999999999 777765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=321.18 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=202.4
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
..++|++.+.||+|+||.||+|++..+|+.||||++... ...+.+|++++++++||||+++++++...+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN---- 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence 346899999999999999999999999999999998532 245668999999999999999999998764
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 106 -------------------------------------------------------------------------------- 105 (310)
T 2wqm_A 106 -------------------------------------------------------------------------------- 105 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|||||++ +|.+++.........+++..++.++.
T Consensus 106 ------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 143 (310)
T 2wqm_A 106 ------------------------------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143 (310)
T ss_dssp ------------------------------------------EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred ------------------------------------------cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHH
Confidence 38999999986 99999987777778899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||
T Consensus 144 qi~~~l~~LH~~~i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s 221 (310)
T 2wqm_A 144 QLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWS 221 (310)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCC------------------CCSSCCHHHHTTC-CCCHHHHHHH
T ss_pred HHHHHHHHHhhCCeeCCCCcHHHEEEc-CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHH
Confidence 999999999999999999999999999 78899999999987653322 22334678999999999877 7899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChh--HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 331 AGCVLAELLLGQPMFPGDSGV--DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~--e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||+++|+|++|+.||.+.... .....+.. ...+. .....+++.+.++|.+|
T Consensus 222 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~--------~~~~~~~~~l~~li~~~ 274 (310)
T 2wqm_A 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------------CDYPP--------LPSDHYSEELRQLVNMC 274 (310)
T ss_dssp HHHHHHHHHHSSCTTC---CCHHHHHHHHHT-------------------TCSCC--------CCTTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcccchhHHHHHHHhhc-------------------ccCCC--------CcccccCHHHHHHHHHH
Confidence 999999999999999764322 21211111 00110 11135689999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
|+.||.+|||+.++++ .++++.+..
T Consensus 275 l~~dp~~Rps~~~il~---~l~~l~~~~ 299 (310)
T 2wqm_A 275 INPDPEKRPDVTYVYD---VAKRMHACT 299 (310)
T ss_dssp TCSSGGGSCCHHHHHH---HHHHHHHHH
T ss_pred cCCChhhCCCHHHHHH---HHHHHHHhh
Confidence 9999999999999999 888887654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=333.05 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=214.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCC-------Cceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEE
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDS-------GELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFF 84 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (444)
+-..++|.+.+.||+|+||+||+|++..+ ++.||+|++.... ..+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34458999999999999999999997543 3579999985432 4466899999999 999999999998
Q ss_pred eecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhc
Q psy10212 85 YSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREM 164 (444)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (444)
...+.
T Consensus 145 ~~~~~--------------------------------------------------------------------------- 149 (382)
T 3tt0_A 145 TQDGP--------------------------------------------------------------------------- 149 (382)
T ss_dssp CSSSS---------------------------------------------------------------------------
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 76543
Q ss_pred CCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh-------
Q psy10212 165 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK------- 236 (444)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~------- 236 (444)
+++|||||++ +|.+++.....
T Consensus 150 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 178 (382)
T 3tt0_A 150 ---------------------------------------------------LYVIVEYASKGNLREYLQARRPPGLEYSY 178 (382)
T ss_dssp ---------------------------------------------------CEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred ---------------------------------------------------eEEEEEecCCCcHHHHHHHhccccccccc
Confidence 8899999985 99999975432
Q ss_pred -----cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccc
Q psy10212 237 -----SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSR 308 (444)
Q Consensus 237 -----~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~ 308 (444)
....+++..++.++.||+.||+|||++|++|+||||+||+++ .++.++|+|||++....... ......+++
T Consensus 179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~ 257 (382)
T 3tt0_A 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257 (382)
T ss_dssp CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGG
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCc
Confidence 134699999999999999999999999999999999999999 78899999999997654332 223345678
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCC
Q psy10212 309 YYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387 (444)
Q Consensus 309 ~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~ 387 (444)
.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 258 ~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------------- 310 (382)
T 3tt0_A 258 KWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-------------------------- 310 (382)
T ss_dssp GGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--------------------------
T ss_pred ceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 89999999887 89999999999999999999 999999887766555443311
Q ss_pred CCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhcc
Q psy10212 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 388 ~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~ 439 (444)
....+..+++++.+||.+||+.||++|||+.|+++ .++.+.+...+.
T Consensus 311 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~---~L~~~~~~~~~~ 357 (382)
T 3tt0_A 311 --RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALTSNQ 357 (382)
T ss_dssp --CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHSCSC
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH---HHHHHHHHHhcC
Confidence 01122457999999999999999999999999999 677776655443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=314.92 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=208.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++.+.||+|+||.||+|++. +++.||+|.+... .+.+.+|++++++++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--------- 77 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--------- 77 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---------
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---------
Confidence 68999999999999999999987 5788999999543 3567789999999999999999998876542
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (267)
T 3t9t_A 78 -------------------------------------------------------------------------------- 77 (267)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++|||||+ ++|.+++.. ....+++..++.++.||+.||
T Consensus 78 -------------------------------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l 117 (267)
T 3t9t_A 78 -------------------------------------ICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGM 117 (267)
T ss_dssp -------------------------------------CEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHH
Confidence 889999997 589998853 345789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
.|||++|++|+||+|+||+++ .++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 118 ~~lH~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il 195 (267)
T 3t9t_A 118 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLM 195 (267)
T ss_dssp HHHHHTTCCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHHHhCCcccCCCchheEEEC-CCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHH
Confidence 999999999999999999998 78899999999987543211 12233457789999999876 789999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|+|++ |+.||...+..+....+.... ....+..+++.+.++|.+||+.||.
T Consensus 196 ~~l~~~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~ 247 (267)
T 3t9t_A 196 WEVFSEGKIPYENRSNSEVVEDISTGF----------------------------RLYKPRLASTHVYQIMNHCWRERPE 247 (267)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHhccCCCCCCCCCHHHHHHHHhcCC----------------------------cCCCCccCcHHHHHHHHHHccCChh
Confidence 99999 999999887766655544310 0111234689999999999999999
Q ss_pred CCCCHHHHhccCchhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~ 434 (444)
+|||+.++++ .++++.+
T Consensus 248 ~Rps~~~ll~---~L~~l~~ 264 (267)
T 3t9t_A 248 DRPAFSRLLR---QLAEIAE 264 (267)
T ss_dssp GSCCHHHHHH---HHHHHHH
T ss_pred hCcCHHHHHH---HHHHHHh
Confidence 9999999999 6777654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.30 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=199.9
Q ss_pred hhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhc----CCCceeEee
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRL----EHSNIVKLK 81 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l----~h~~i~~~~ 81 (444)
..+.+.++|++.+.||+|+||.||+|+++.+++.||||++... ...+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3567789999999999999999999999999999999998433 24556899999999 899999999
Q ss_pred eEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhh
Q psy10212 82 YFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQI 161 (444)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (444)
+++...+.
T Consensus 105 ~~~~~~~~------------------------------------------------------------------------ 112 (312)
T 2iwi_A 105 DWFETQEG------------------------------------------------------------------------ 112 (312)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred EEEecCCe------------------------------------------------------------------------
Confidence 98866542
Q ss_pred hhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEecc-CC-CcHHHHHHhhhhcCC
Q psy10212 162 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEF-MP-ETVYKVAKHYSKSKQ 239 (444)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~-~~-~~l~~~~~~~~~~~~ 239 (444)
.++|||+ +. ++|.+++.. ..
T Consensus 113 ------------------------------------------------------~~~v~e~~~~~~~L~~~l~~----~~ 134 (312)
T 2iwi_A 113 ------------------------------------------------------FMLVLERPLPAQDLFDYITE----KG 134 (312)
T ss_dssp ------------------------------------------------------CEEEEECCSSEEEHHHHHHH----HC
T ss_pred ------------------------------------------------------EEEEEEecCCCCCHHHHHHh----cC
Confidence 7899998 55 599998853 35
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~ 319 (444)
.+++..++.++.||+.||.|||++|++|+||+|+||+++..++.++|+|||++...... ......++..|+|||.+.+.
T Consensus 135 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 213 (312)
T 2iwi_A 135 PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRH 213 (312)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecC
Confidence 79999999999999999999999999999999999999866889999999998765433 23455689999999998776
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
...+.++|+||||+++|+|++|+.||.... .+... . ..++.++++
T Consensus 214 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-----------------~------------~~~~~~~~~ 258 (312)
T 2iwi_A 214 QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-----------------E------------LHFPAHVSP 258 (312)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-----------------C------------CCCCTTSCH
T ss_pred CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-----------------c------------cCCcccCCH
Confidence 344568999999999999999999996531 11110 0 012345789
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+.++|.+||+.||++|||+.|+|+ ||||++..+
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~-~~~~~~~~~ 292 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILL-DPWMQTPAE 292 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH-STTTCC---
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc-ChhhcCchh
Confidence 9999999999999999999999999 999998654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.83 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=208.3
Q ss_pred cccchhheecccceeEEEEeEecCCCcee--eeeeeec-----cccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELV--AIKKVLQ-----DKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--aiK~~~~-----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||.||+|+++.+|+.+ |+|.+.. ....+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-----
Confidence 79999999999999999999999888865 9998853 234567899999999 9999999999987654
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (327)
T 1fvr_A 100 -------------------------------------------------------------------------------- 99 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhh------------hcCCC
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYS------------KSKQN 240 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~------------~~~~~ 240 (444)
.+++|||||++ +|.+++.... .....
T Consensus 100 -----------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 138 (327)
T 1fvr_A 100 -----------------------------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138 (327)
T ss_dssp -----------------------------------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCS
T ss_pred -----------------------------------------ceEEEEecCCCCCHHHHHHhccccccccccccccccccc
Confidence 48999999975 9999986433 23457
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++.............+++.|+|||.+.+.
T Consensus 139 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 216 (327)
T 1fvr_A 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS- 216 (327)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-
Confidence 99999999999999999999999999999999999998 7889999999998654333333444568889999999876
Q ss_pred CCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|+|++ |..||.+.+..+....+... .....+..+++
T Consensus 217 ~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 268 (327)
T 1fvr_A 217 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----------------------------YRLEKPLNCDD 268 (327)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----------------------------CCCCCCTTBCH
T ss_pred cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC----------------------------CCCCCCCCCCH
Confidence 78999999999999999998 99999888766554433221 00112235689
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+.+||.+||+.||.+|||+.++++ .++.+...
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~ell~---~L~~~~~~ 301 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQILV---SLNRMLEE 301 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH---HHHHHHHh
Confidence 9999999999999999999999999 56665443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=315.71 Aligned_cols=242 Identities=29% Similarity=0.391 Sum_probs=193.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc--------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++.+.||+|+||+||+|++ +|+.||+|++... .+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP---- 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence 47899999999999999999998 4899999998432 245668999999999999999999987654
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (271)
T 3dtc_A 80 -------------------------------------------------------------------------------- 79 (271)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|||||++ +|.+++. ..++++..++.++.
T Consensus 80 ------------------------------------------~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ 112 (271)
T 3dtc_A 80 ------------------------------------------NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAV 112 (271)
T ss_dssp -------------------------------------------CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHH
T ss_pred ------------------------------------------ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHH
Confidence 27899999974 7877763 46799999999999
Q ss_pred HHHHHHHHHHHCC---cccCCCCCCcEEEcC-------CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCC
Q psy10212 252 QLFRSLAYIHVLG---ICHRDIKPQNLLLNP-------ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 252 QIl~aL~yLHs~g---ivH~dLkp~NIll~~-------~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 321 (444)
||+.||.|||++| ++|+||+|+||+++. ..+.++|+|||.+....... .....+++.|+|||.+.+. .
T Consensus 113 ~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~ 190 (271)
T 3dtc_A 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-M 190 (271)
T ss_dssp HHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-C
T ss_pred HHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-C
Confidence 9999999999999 899999999999984 26789999999987654332 2345689999999999877 7
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
++.++|+||||+++|+|++|+.||.+.+.......+... .....++..+++.+
T Consensus 191 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~ 243 (271)
T 3dtc_A 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN---------------------------KLALPIPSTCPEPF 243 (271)
T ss_dssp CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS---------------------------CCCCCCCTTCCHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC---------------------------CCCCCCCcccCHHH
Confidence 899999999999999999999999987766554443321 01111234678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.++|.+||+.||.+|||+.|+++
T Consensus 244 ~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.36 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=201.3
Q ss_pred cccchhheecccceeEEEEeEecCCCce----eeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL----VAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||+||+|++..+++. +|+|.+... ...+.+|+.++++++||||+++++++...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS----- 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-----
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 6899999999999999999999888887 566665322 24566899999999999999999987432
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (325)
T 3kex_A 88 -------------------------------------------------------------------------------- 87 (325)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|||||. ++|.+++.. ....+++..++.++.
T Consensus 88 ------------------------------------------~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~ 122 (325)
T 3kex_A 88 ------------------------------------------SLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGV 122 (325)
T ss_dssp ------------------------------------------SEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHH
T ss_pred ------------------------------------------ccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHH
Confidence 2889999998 589888853 345799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||.|||++|++||||||+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++|+
T Consensus 123 qi~~~l~~lH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 200 (325)
T 3kex_A 123 QIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDV 200 (325)
T ss_dssp HHHHHHHHHHHTTCCCSCCSSTTEEES-SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCccchheEEEC-CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHh
Confidence 999999999999999999999999998 788999999999977643322 2334567789999999877 79999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |..||.+.+..+....+.... ....+..+++.+.++|.+
T Consensus 201 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~ 252 (325)
T 3kex_A 201 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----------------------------RLAQPQICTIDVYMVMVK 252 (325)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----------------------------BCCCCTTBCTTTTHHHHH
T ss_pred HHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------------------CCCCCCcCcHHHHHHHHH
Confidence 999999999999 999999877665554443210 011123468899999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
||+.||.+|||+.++++ -|+.+
T Consensus 253 ~l~~dp~~Rps~~el~~---~l~~~ 274 (325)
T 3kex_A 253 CWMIDENIRPTFKELAN---EFTRM 274 (325)
T ss_dssp HTCSCTTTSCCHHHHHH---HHHHH
T ss_pred HcCCChhhCcCHHHHHH---HHHHH
Confidence 99999999999999999 45554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.97 Aligned_cols=273 Identities=24% Similarity=0.256 Sum_probs=206.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|+++++||+|+||+||+|++. ++.||||++.... ....+|+.++++++||||+++++++......
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-------- 93 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV-------- 93 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS--------
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC--------
Confidence 79999999999999999999984 8999999995432 3345689999999999999999999876520
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (322)
T 3soc_A 94 -------------------------------------------------------------------------------- 93 (322)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
...+++|||||++ +|.+++.. ..+++..++.++.||+.||
T Consensus 94 ----------------------------------~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al 134 (322)
T 3soc_A 94 ----------------------------------DVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGL 134 (322)
T ss_dssp ----------------------------------SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHH
T ss_pred ----------------------------------CceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHH
Confidence 1348999999985 99999853 4599999999999999999
Q ss_pred HHHHHC----------CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccC----C
Q psy10212 258 AYIHVL----------GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGA----I 320 (444)
Q Consensus 258 ~yLHs~----------givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~----~ 320 (444)
+|||++ |++|+||||+||+++ ..+.+||+|||++........ .....+|+.|+|||.+.+. .
T Consensus 135 ~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (322)
T 3soc_A 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213 (322)
T ss_dssp HHHTCCEEEETTEEECEEECSCCSGGGEEEC-TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCH
T ss_pred HHHHhhccccccccCCCEEeCCCChHhEEEC-CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCc
Confidence 999999 999999999999999 788999999999976543322 2335689999999999763 1
Q ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccc-cCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF-RVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~s~ 399 (444)
.++.++|||||||++|+|++|+.||.+..+.............+....+....... .........+ ...+++
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 286 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK-------KKRPVLRDYWQKHAGMA 286 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-------CCCCCCCGGGGSSHHHH
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc-------cCCCCccccccccchHH
Confidence 45668899999999999999999998765433222222222233333332211000 0001111111 112356
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+.+||.+||+.||++|||+.|+++ .++.+..
T Consensus 287 ~l~~li~~cl~~dP~~Rps~~ell~---~L~~l~~ 318 (322)
T 3soc_A 287 MLCETIEECWDHDAEARLSAGCVGE---RITQMQR 318 (322)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH---HHHHHHH
Confidence 6999999999999999999999999 7777654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=329.26 Aligned_cols=268 Identities=16% Similarity=0.138 Sum_probs=206.1
Q ss_pred hccccchhheecccceeEEEEeEecCC-----CceeeeeeeeccccchhhHH---------------HHhhhcCCCceeE
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDS-----GELVAIKKVLQDKRFKNREM---------------QIMRRLEHSNIVK 79 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~E~---------------~~l~~l~h~~i~~ 79 (444)
..++|++.+.||+|+||+||+|++..+ ++.||||++......+.+|+ ..+++++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456999999999999999999999764 58899999866554444444 4455667999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+++++......
T Consensus 113 ~~~~~~~~~~~--------------------------------------------------------------------- 123 (364)
T 3op5_A 113 YWGSGLHDKNG--------------------------------------------------------------------- 123 (364)
T ss_dssp EEEEEEEEETT---------------------------------------------------------------------
T ss_pred EEeeeeeccCC---------------------------------------------------------------------
Confidence 99998875320
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCC
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQ 239 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~ 239 (444)
..+.++|||||+++|.+++.. ...
T Consensus 124 -----------------------------------------------------~~~~~lv~e~~g~~L~~~~~~---~~~ 147 (364)
T 3op5_A 124 -----------------------------------------------------KSYRFMIMDRFGSDLQKIYEA---NAK 147 (364)
T ss_dssp -----------------------------------------------------EEEEEEEEECEEEEHHHHHHH---TTS
T ss_pred -----------------------------------------------------cceEEEEEeCCCCCHHHHHHh---ccC
Confidence 146899999998899999863 456
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEEeecCCcccccCCCC--------Cccccccccc
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP-ETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYY 310 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~-~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y 310 (444)
++++..++.++.||+.||+|||++|++||||||+||+++. ..+.++|+|||++........ .....+|+.|
T Consensus 148 ~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y 227 (364)
T 3op5_A 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEF 227 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCc
Confidence 7999999999999999999999999999999999999972 467999999999976533221 1234589999
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHH-HHHHhCCCCHHHHHhhCCCCCcccCCCccCCCC
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVE-IIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~-i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~ 389 (444)
+|||.+.+. .++.++|||||||++|+|++|+.||.+......... ............+....
T Consensus 228 ~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 290 (364)
T 3op5_A 228 TSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCF---------------- 290 (364)
T ss_dssp CCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHS----------------
T ss_pred cCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhc----------------
Confidence 999999887 799999999999999999999999986433332222 22211111111111100
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
...++++.+.++|..||..||.+||++.++++ .|+++...
T Consensus 291 ---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~---~l~~~~~~ 330 (364)
T 3op5_A 291 ---PAANAPGEIAKYMETVKLLDYTEKPLYENLRD---ILLQGLKA 330 (364)
T ss_dssp ---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH---HHHHHHHH
T ss_pred ---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH---HHHHHHHH
Confidence 01356899999999999999999999999998 77776554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=316.63 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=208.8
Q ss_pred hccccchhheecccceeEEEEeEecC---CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLD---SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..++|++.+.||+|+||+||+|++.. ++..||+|.+... ...+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP--- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS---
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC---
Confidence 45899999999999999999999754 3346999998543 355678999999999999999999875322
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (281)
T 3cc6_A 87 -------------------------------------------------------------------------------- 86 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.++|||||+ ++|.+++.. ....+++..++.++
T Consensus 87 --------------------------------------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ 119 (281)
T 3cc6_A 87 --------------------------------------------TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYS 119 (281)
T ss_dssp --------------------------------------------CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHH
T ss_pred --------------------------------------------CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHH
Confidence 579999998 589998863 34669999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||.+.+. .++.++|+
T Consensus 120 ~~i~~~l~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 197 (281)
T 3cc6_A 120 LQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDV 197 (281)
T ss_dssp HHHHHHHHHHHHTTCCCCCCSGGGEEEE-ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHH
T ss_pred HHHHHHHHHHHHCCcccCCCccceEEEC-CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccC-CCCchhcc
Confidence 9999999999999999999999999999 788999999999876543321 2233457789999999876 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||...+..+....+...... ..+..+++.+.++|.+
T Consensus 198 ~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~ 249 (281)
T 3cc6_A 198 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----------------------------PKPDLCPPVLYTLMTR 249 (281)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHH
Confidence 999999999998 99999887776665544431100 0123468999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhhhhcc
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAVFENI 439 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~ 439 (444)
||+.||.+|||+.|+++ .++++......|
T Consensus 250 ~l~~~p~~Rps~~ell~---~L~~~~~~~~~i 278 (281)
T 3cc6_A 250 CWDYDPSDRPRFTELVC---SLSDVYQMEKDI 278 (281)
T ss_dssp HTCSSGGGSCCHHHHHH---HHHHHHHHHHHH
T ss_pred HccCCchhCcCHHHHHH---HHHHHHHhhhhh
Confidence 99999999999999999 788877665554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.20 Aligned_cols=261 Identities=25% Similarity=0.323 Sum_probs=212.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCc-----eeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEee
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYS 86 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (444)
+-..++|++.+.||+|+||.||+|++..+++ .||+|.+... ...+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999999977664 7999998543 34567899999999 89999999999876
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+.
T Consensus 122 ~~~----------------------------------------------------------------------------- 124 (333)
T 2i1m_A 122 GGP----------------------------------------------------------------------------- 124 (333)
T ss_dssp SSS-----------------------------------------------------------------------------
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 543
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh---------
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK--------- 236 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~--------- 236 (444)
+++|||||++ +|.+++.....
T Consensus 125 -------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 155 (333)
T 2i1m_A 125 -------------------------------------------------VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155 (333)
T ss_dssp -------------------------------------------------CEEEEECCTTEEHHHHHHHHHHHHSCC----
T ss_pred -------------------------------------------------eEEEEecCCCCcHHHHHHHhccccccccccc
Confidence 8899999985 99999865432
Q ss_pred -cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccC
Q psy10212 237 -SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRA 312 (444)
Q Consensus 237 -~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~a 312 (444)
....+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|
T Consensus 156 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 234 (333)
T 2i1m_A 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 234 (333)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC-CCCeEEECccccccccccccceeecCCCCCCccccC
Confidence 145689999999999999999999999999999999999999 788999999999976543322 123345778999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcc
Q psy10212 313 PELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391 (444)
Q Consensus 313 PE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 391 (444)
||.+.+. .++.++|+||||+++|+|++ |..||.+.........+...... .
T Consensus 235 PE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~ 286 (333)
T 2i1m_A 235 PESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ---------------------------M 286 (333)
T ss_dssp HHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC---------------------------C
T ss_pred HHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC---------------------------C
Confidence 9999877 78999999999999999998 99999887766555554442100 0
Q ss_pred cccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 392 ~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
..+..+++.+.++|.+||+.||.+|||+.|+++ +++++....
T Consensus 287 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~---~L~~~~~~~ 328 (333)
T 2i1m_A 287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS---FLQEQAQED 328 (333)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH---HHHHHHHhh
Confidence 112346899999999999999999999999999 888876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=325.71 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred cccchhheecccceeEEEEeEecCCCcee----eeeeeec-----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELV----AIKKVLQ-----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||+||+|++..+++.+ |+|.+.. ....+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----
Confidence 78999999999999999999998888765 6776632 2345678999999999999999999987643
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (327)
T 3poz_A 91 -------------------------------------------------------------------------------- 90 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.++|++|+. ++|.+++.. ....+++..++.++.
T Consensus 91 -------------------------------------------~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~ 124 (327)
T 3poz_A 91 -------------------------------------------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCV 124 (327)
T ss_dssp -------------------------------------------EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHH
T ss_pred -------------------------------------------eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHH
Confidence 668888888 589988853 456799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||.|||++|++||||||+||+++ .++.++|+|||+++........ ....++..|+|||.+.+. .++.++|+
T Consensus 125 qi~~~l~~LH~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di 202 (327)
T 3poz_A 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDV 202 (327)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHH
T ss_pred HHHHHHHHHhhCCeeCCCCChheEEEC-CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhh
Confidence 999999999999999999999999999 7889999999998765433222 223457789999999887 89999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||.+.+..+....+..... ...+..++..+.++|.+
T Consensus 203 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~ 254 (327)
T 3poz_A 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------------------------LPQPPICTIDVYMIMVK 254 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCCCTTBCHHHHHHHHH
T ss_pred hhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHH
Confidence 999999999999 9999998776665443332110 01123568999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy10212 408 LLEYTPSSRISPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~ 424 (444)
||+.||.+|||+.++++
T Consensus 255 ~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 255 CWMIDADSRPKFRELII 271 (327)
T ss_dssp HTCSCGGGSCCHHHHHH
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=330.76 Aligned_cols=271 Identities=15% Similarity=0.115 Sum_probs=203.4
Q ss_pred hccccchhheecccceeEEEEeEecC---CCceeeeeeeecccc---------------chhhHHHHhhhcCCCceeEee
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLD---SGELVAIKKVLQDKR---------------FKNREMQIMRRLEHSNIVKLK 81 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~---------------~~~~E~~~l~~l~h~~i~~~~ 81 (444)
..++|++.+.||+|+||+||+|++.. +++.+|||++..... .+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34789999999999999999999987 788999999865432 233677778888999999999
Q ss_pred eEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhh
Q psy10212 82 YFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQI 161 (444)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (444)
+++......
T Consensus 115 ~~~~~~~~~----------------------------------------------------------------------- 123 (345)
T 2v62_A 115 GSGLTEFKG----------------------------------------------------------------------- 123 (345)
T ss_dssp EEEEEESSS-----------------------------------------------------------------------
T ss_pred cccccccCC-----------------------------------------------------------------------
Confidence 999874210
Q ss_pred hhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCC
Q psy10212 162 REMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNF 241 (444)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l 241 (444)
..+.++|||||+++|.+++.. .+.+
T Consensus 124 ---------------------------------------------------~~~~~lv~e~~~~~L~~~l~~----~~~~ 148 (345)
T 2v62_A 124 ---------------------------------------------------RSYRFMVMERLGIDLQKISGQ----NGTF 148 (345)
T ss_dssp ---------------------------------------------------CEEEEEEEECEEEEHHHHCBG----GGBC
T ss_pred ---------------------------------------------------CcEEEEEEeccCCCHHHHHHh----cCCC
Confidence 035999999997799998742 2389
Q ss_pred ChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEeecCCcccccCCCC--------Ccccccccccc
Q psy10212 242 PCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG--VLKLCDFGSAKHLVRGEP--------NVSYICSRYYR 311 (444)
Q Consensus 242 ~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~ 311 (444)
++..++.++.||+.||+|||++|++|+||||+||+++ .++ .++|+|||++........ .....+++.|+
T Consensus 149 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 227 (345)
T 2v62_A 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG-YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc-cCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence 9999999999999999999999999999999999998 455 999999999976532211 13446899999
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++|+|||||++|+|++|+.||.+. .................+..+....+
T Consensus 228 aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 290 (345)
T 2v62_A 228 SLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAP---------------- 290 (345)
T ss_dssp CHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSC----------------
T ss_pred CHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhcc----------------
Confidence 99999887 7999999999999999999999999653 22222222222211111121111110
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhccc
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENIC 440 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~~~ 440 (444)
...+++.+.++|.+||..||.+|||+.++++ .|+++......+.
T Consensus 291 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~---~L~~~~~~~~~~d 334 (345)
T 2v62_A 291 ---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK---ILNPHGIPLGPLD 334 (345)
T ss_dssp ---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH---HHCTTCCCCCCCC
T ss_pred ---ccccHHHHHHHHHHHhhcCcccCCCHHHHHH---HHhccCCcccCCC
Confidence 1146899999999999999999999999999 7877665544443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=319.14 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=202.6
Q ss_pred ccccchhheecccceeEEEEeE----ecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.++|++++.||+|+||.||+|+ +..+++.||+|++.... ..+.+|++++++++||||+++++++...+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG-- 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC--
Confidence 3679999999999999999999 56789999999985432 456789999999999999999999987642
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (302)
T 4e5w_A 98 -------------------------------------------------------------------------------- 97 (302)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..+++|||||++ +|.+++.. ....+++..++.++
T Consensus 98 ------------------------------------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ 132 (302)
T 4e5w_A 98 ------------------------------------------NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYA 132 (302)
T ss_dssp ------------------------------------------CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHH
T ss_pred ------------------------------------------ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHH
Confidence 238899999975 99998853 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||+|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++
T Consensus 133 ~~i~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 210 (302)
T 4e5w_A 133 VQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIAS 210 (302)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHH
T ss_pred HHHHHHHHHhhcCCcccCCCchheEEEc-CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcch
Confidence 9999999999999999999999999998 788999999999976544322 2234567789999999877 788999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHH-HHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQ-IREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++|..|+.... . ......+...... ..... ...........+..+++.+.+||
T Consensus 211 Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li 276 (302)
T 4e5w_A 211 DVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHGQMTVTRLV---------NTLKEGKRLPCPPNCPDEVYQLM 276 (302)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCGGGHHHHHH---------HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCcccccCHHHHH---------HHHhccCCCCCCCCCCHHHHHHH
Confidence 99999999999999998864321 1 1111111110000 00000 00000011122346799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+||+.||.+|||+.++++ .++.+
T Consensus 277 ~~~l~~dp~~Rps~~~ll~---~L~~l 300 (302)
T 4e5w_A 277 RKCWEFQPSNRTSFQNLIE---GFEAL 300 (302)
T ss_dssp HHTTCSSGGGSCCHHHHHH---HHHHH
T ss_pred HHHcCCCCCCCCCHHHHHH---HHHHH
Confidence 9999999999999999999 66664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=323.96 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=207.0
Q ss_pred hhhhccccchhheecccceeEEEEeEec-----CCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEee
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYS 86 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (444)
++-..++|++.+.||+|+||.||+|++. .+++.||||.+.... ..+.+|++++++++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 4556689999999999999999999886 357889999985432 346689999999999999999998866
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+.
T Consensus 100 ~~~----------------------------------------------------------------------------- 102 (322)
T 1p4o_A 100 GQP----------------------------------------------------------------------------- 102 (322)
T ss_dssp SSS-----------------------------------------------------------------------------
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 542
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc------CC
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS------KQ 239 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~------~~ 239 (444)
.++|||||++ +|.+++...... ..
T Consensus 103 -------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 133 (322)
T 1p4o_A 103 -------------------------------------------------TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133 (322)
T ss_dssp -------------------------------------------------CEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred -------------------------------------------------cEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence 7899999985 999998654321 25
Q ss_pred CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhh
Q psy10212 240 NFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELI 316 (444)
Q Consensus 240 ~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l 316 (444)
++++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc-CCCeEEECcCccccccccccccccccCCCCCCCccChhhh
Confidence 678999999999999999999999999999999999999 788999999999875533221 1223457889999999
Q ss_pred ccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 317 FGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 317 ~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.... . ...+.
T Consensus 213 ~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------~---------~~~~~ 263 (322)
T 1p4o_A 213 KDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-------------------L---------LDKPD 263 (322)
T ss_dssp HHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-------------------C---------CCCCT
T ss_pred ccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-------------------c---------CCCCC
Confidence 877 78999999999999999999 899998887766555444310 0 01123
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+++.+.++|.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 57899999999999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=342.68 Aligned_cols=276 Identities=22% Similarity=0.296 Sum_probs=207.2
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
.+.++|.+.++||+|+||+||+|++..+|+.||||++... .+.+.+|++++++++||||+++++++...+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---- 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT----
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC----
Confidence 3568999999999999999999999999999999998543 2455689999999999999999998876542
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (396)
T 4eut_A 82 -------------------------------------------------------------------------------- 81 (396)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...++|||||+ ++|.+++.... ....+++..++.++.|
T Consensus 82 ----------------------------------------~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~q 120 (396)
T 4eut_A 82 ----------------------------------------RHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120 (396)
T ss_dssp ----------------------------------------CCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHH
T ss_pred ----------------------------------------CeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHH
Confidence 24899999997 58988885322 2334999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEE----cCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC-------CC
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLL----NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA-------ID 321 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll----~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~ 321 (444)
|+.||+|||++|++||||||+||++ + ..+.++|+|||++.............+++.|+|||.+.+. ..
T Consensus 121 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 199 (396)
T 4eut_A 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199 (396)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHH
T ss_pred HHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccC
Confidence 9999999999999999999999998 5 6678999999999876555444556789999999998641 25
Q ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCC----hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCC
Q psy10212 322 YTTKIDVWSAGCVLAELLLGQPMFPGDS----GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRT 397 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLltG~~Pf~~~~----~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 397 (444)
++.++|+|||||++|+|++|+.||.... ..+.+.++... .+...+...... ....+.-.........++..+
T Consensus 200 ~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~ 275 (396)
T 4eut_A 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPSGAISGVQKA-ENGPIDWSGDMPVSCSLSRGL 275 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS---CCTTCCEEEECS-TTCCEEEESSCCTTCSSCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC---CCcccchhheec-cCCCcccCccCCcccccchHH
Confidence 7789999999999999999999997533 23333333331 111111000000 000000000001111222345
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
+..+.++|.+||+.||++|||+.|+++
T Consensus 276 ~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 276 QVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HhhchHHHHHhhccChhhhccHHHHHH
Confidence 678999999999999999999999977
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.99 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=195.7
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
..+.+.|.+.++||+|+||+||.+. ..+|+.||||++... .+.+.+|+++++++ +||||+++++++...+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~------- 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR------- 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-------
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-------
Confidence 4566778888999999999998754 457999999998654 34566899999886 8999999988876543
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (434)
T 2rio_A 83 -------------------------------------------------------------------------------- 82 (434)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCC---CChHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQN---FPCFYTKLYIYQ 252 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~---l~~~~i~~i~~Q 252 (444)
++|+|||||+++|.+++......... .++..++.++.|
T Consensus 83 ---------------------------------------~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~q 123 (434)
T 2rio_A 83 ---------------------------------------FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123 (434)
T ss_dssp ---------------------------------------EEEEEECCCSEEHHHHHHTC------------CCHHHHHHH
T ss_pred ---------------------------------------eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHH
Confidence 48999999999999999643322221 234457889999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcC------------CCCeEEEeecCCcccccCCCC-----CccccccccccCchh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNP------------ETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPEL 315 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~------------~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~ 315 (444)
|+.||+|||++|++||||||+||+++. ....++|+|||++........ .....+|+.|+|||.
T Consensus 124 i~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 203 (434)
T 2rio_A 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203 (434)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHH
T ss_pred HHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHH
Confidence 999999999999999999999999973 235899999999976643321 223468999999999
Q ss_pred hcc------CCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCC
Q psy10212 316 IFG------AIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388 (444)
Q Consensus 316 l~~------~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~ 388 (444)
+.+ ...++.++|+|||||++|+|++ |..||.+....+ ..+.... ...+..
T Consensus 204 ~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~-----------------~~~~~~---- 260 (434)
T 2rio_A 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGI-----------------FSLDEM---- 260 (434)
T ss_dssp HSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTC-----------------CCCCCC----
T ss_pred hccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCC-----------------CCcccc----
Confidence 965 1368999999999999999998 999997654433 2222211 011110
Q ss_pred CcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 389 ~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.......+++++.+||.+||+.||.+|||+.++|+ ||||...
T Consensus 261 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~-hp~f~~~ 302 (434)
T 2rio_A 261 -KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR-HPLFWPK 302 (434)
T ss_dssp -TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT-SGGGSCH
T ss_pred -cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh-CCccCCc
Confidence 00011234688999999999999999999999999 9999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=317.98 Aligned_cols=248 Identities=19% Similarity=0.227 Sum_probs=199.7
Q ss_pred ccccchhheecccceeEEEEeEecCCC-------ceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG-------ELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
.++|.+.+.||+|+||+||+|++..++ +.||+|.+... .+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 479999999999999999999998877 46999998543 2456689999999999999999999876543
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (289)
T 4fvq_A 87 -------------------------------------------------------------------------------- 86 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.++|||||+ ++|.+++.. ....+++..++.
T Consensus 87 ----------------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~ 117 (289)
T 4fvq_A 87 ----------------------------------------------NILVQEFVKFGSLDTYLKK---NKNCINILWKLE 117 (289)
T ss_dssp ----------------------------------------------CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHH
T ss_pred ----------------------------------------------CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHH
Confidence 789999998 599999863 334589999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCe--------EEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGV--------LKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~--------ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
++.||+.||.|||++|++|+||||+||+++ .++. ++|+|||.+..... .....++..|+|||.+.+..
T Consensus 118 i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 193 (289)
T 4fvq_A 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLI-REEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPK 193 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-ECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGG
T ss_pred HHHHHHHHHHHHhhCCeECCCcCcceEEEe-cCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCC
Confidence 999999999999999999999999999998 4554 99999999865321 23345788999999998744
Q ss_pred CCCcchhhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|+|++| .+||...+..... ..... . ..++..+++
T Consensus 194 ~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~-----------------~------------~~~~~~~~~ 243 (289)
T 4fvq_A 194 NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED-----------------R------------HQLPAPKAA 243 (289)
T ss_dssp GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT-----------------T------------CCCCCCSSC
T ss_pred CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc-----------------c------------CCCCCCCCH
Confidence 789999999999999999995 5555554443322 22220 0 011234578
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+.+||.+||+.||.+|||+.++++ .++++..
T Consensus 244 ~l~~li~~~l~~dp~~Rps~~~ll~---~l~~l~~ 275 (289)
T 4fvq_A 244 ELANLINNCMDYEPDHRPSFRAIIR---DLNSLFT 275 (289)
T ss_dssp TTHHHHHHHSCSSGGGSCCHHHHHH---HHHTCC-
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH---HHHHhcC
Confidence 8999999999999999999999999 6766544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.52 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=205.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.++|++++.||+|+||.||+|++..+|+.||||++... ...+.+|++++++++||||+++++++......
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------ 101 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA------ 101 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT------
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC------
Confidence 37999999999999999999999999999999988432 34567899999999999999999998754210
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 102 -------------------------------------------------------------------------------- 101 (317)
T 2buj_A 102 -------------------------------------------------------------------------------- 101 (317)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
....++|||||++ +|.+++.........+++..++.++.||+.
T Consensus 102 ------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 102 ------------------------------------KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp ------------------------------------EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred ------------------------------------CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 1358999999996 999999877777788999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----------ccccccccccCchhhccCC--CCC
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----------VSYICSRYYRAPELIFGAI--DYT 323 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----------~~~~gt~~y~aPE~l~~~~--~~s 323 (444)
||+|||++|++|+||+|+||+++ .++.++|+|||.+......... ....+++.|+|||.+.+.. .++
T Consensus 146 ~L~~LH~~~ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 224 (317)
T 2buj_A 146 GLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224 (317)
T ss_dssp HHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC
T ss_pred HHHHHHhCCcccCCCCHHHEEEc-CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCC
Confidence 99999999999999999999998 7889999999987654221111 1234588999999986542 368
Q ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChh-HHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHH
Q psy10212 324 TKIDVWSAGCVLAELLLGQPMFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 402 (444)
Q Consensus 324 ~~sDiwSLGvil~eLltG~~Pf~~~~~~-e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~ 402 (444)
.++|+||||+++|+|++|+.||...... +....... . ....+ ....+++.+.
T Consensus 225 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~------~~~~~----------~~~~~~~~l~ 277 (317)
T 2buj_A 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-----------N------QLSIP----------QSPRHSSALW 277 (317)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-----------C------C--CC----------CCTTSCHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-----------c------cCCCC----------ccccCCHHHH
Confidence 8999999999999999999999532110 00111111 0 00011 1235689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 403 DLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 403 ~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
++|.+||+.||.+|||+.++++ .++.+..
T Consensus 278 ~li~~~l~~dp~~Rps~~~ll~---~L~~~~~ 306 (317)
T 2buj_A 278 QLLNSMMTVDPHQRPHIPLLLS---QLEALQP 306 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH---HHHHTCC
T ss_pred HHHHHHhhcChhhCCCHHHHHH---HhhhcCC
Confidence 9999999999999999999999 6666543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.60 Aligned_cols=262 Identities=28% Similarity=0.390 Sum_probs=191.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 93 (444)
-...+|++.+.||+|+||.||+|++..+|+.||||++... ...+.+|+.+++++. ||||+++++++.......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~-- 102 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES-- 102 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS--
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc--
Confidence 3456999999999999999999999999999999998443 245668999999996 999999999987643200
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 103 -------------------------------------------------------------------------------- 102 (337)
T 3ll6_A 103 -------------------------------------------------------------------------------- 102 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
......+++|||||+++|.+++.... ..+++++..++.++.||
T Consensus 103 ------------------------------------~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi 145 (337)
T 3ll6_A 103 ------------------------------------DTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQT 145 (337)
T ss_dssp ------------------------------------TTSSEEEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHH
T ss_pred ------------------------------------ccCCceEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHH
Confidence 01114589999999999999986433 34579999999999999
Q ss_pred HHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-------------ccccccccccCchhhc-
Q psy10212 254 FRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-------------VSYICSRYYRAPELIF- 317 (444)
Q Consensus 254 l~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-------------~~~~gt~~y~aPE~l~- 317 (444)
+.||.|||++| ++|+||||+||+++ .++.++|+|||++......... ....+++.|+|||.+.
T Consensus 146 ~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (337)
T 3ll6_A 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224 (337)
T ss_dssp HHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTCBCCSSCC-------------------------------C
T ss_pred HHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence 99999999999 99999999999999 7889999999999765433211 1345789999999983
Q ss_pred -cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCC
Q psy10212 318 -GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVR 396 (444)
Q Consensus 318 -~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 396 (444)
....++.++|+||||+++|+|++|+.||............ ........
T Consensus 225 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-------------------------------~~~~~~~~ 273 (337)
T 3ll6_A 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK-------------------------------YSIPPHDT 273 (337)
T ss_dssp CTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------------------------------CCCCTTCC
T ss_pred cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc-------------------------------ccCCcccc
Confidence 2226889999999999999999999999765432211100 00011234
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 397 TPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 397 ~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+++.+.+||.+||+.||.+|||+.|+++ .++.+.+
T Consensus 274 ~~~~~~~li~~~l~~~p~~Rps~~e~l~---~l~~~~~ 308 (337)
T 3ll6_A 274 QYTVFHSLIRAMLQVNPEERLSIAEVVH---QLQEIAA 308 (337)
T ss_dssp SSGGGHHHHHHHSCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred cchHHHHHHHHHccCChhhCcCHHHHHH---HHHHHHh
Confidence 5788999999999999999999999999 5666544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=315.94 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=202.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.++|++.+.||+|+||+||+|++ +|+.||+|.+... .+.+.+|++++++++||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------- 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--------- 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----------
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC---------
Confidence 47899999999999999999988 5899999998643 3556789999999999999999998765431
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (278)
T 1byg_A 89 -------------------------------------------------------------------------------- 88 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..++|||||++ +|.+++... ....+++..++.++.||+.||
T Consensus 89 ------------------------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l 130 (278)
T 1byg_A 89 ------------------------------------GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAM 130 (278)
T ss_dssp ------------------------------------CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------ceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHH
Confidence 37899999986 999998642 223478999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
.|||++|++|+||+|+||+++ .++.++|+|||.+...... .....++..|+|||.+.+. .++.++|+||||+++|+
T Consensus 131 ~~lH~~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ 206 (278)
T 1byg_A 131 EYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWE 206 (278)
T ss_dssp HHHHHTTCCCSCCSGGGEEEC-TTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCccccCCCcceEEEe-CCCcEEEeecccccccccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHH
Confidence 999999999999999999999 7889999999998654322 2233567889999999876 78999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 338 LLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 338 Llt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
|++ |+.||...+..+....+... .....+..+++.+.++|.+||+.||.+|
T Consensus 207 l~t~g~~p~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (278)
T 1byg_A 207 IYSFGRVPYPRIPLKDVVPRVEKG----------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMR 258 (278)
T ss_dssp HHTTSCCSCTTSCGGGHHHHHTTT----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcC----------------------------CCCCCcccCCHHHHHHHHHHhcCChhhC
Confidence 998 99999887766554433221 0111234679999999999999999999
Q ss_pred CCHHHHhccCchhhhhhhhh
Q psy10212 417 ISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 417 Ps~~elL~~hpwf~~~~~~~ 436 (444)
||+.++++ .+++++...
T Consensus 259 ps~~~l~~---~L~~i~~~~ 275 (278)
T 1byg_A 259 PSFLQLRE---QLEHIKTHE 275 (278)
T ss_dssp CCHHHHHH---HHHHHHHHC
T ss_pred CCHHHHHH---HHHHHHhhh
Confidence 99999999 888876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.67 Aligned_cols=267 Identities=19% Similarity=0.221 Sum_probs=206.4
Q ss_pred hhhhhccccchhheecccceeEEEEeEecC---CCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEee
Q psy10212 16 YFSDLDNSLAQKTVIGNGSFGIVYQAKLLD---SGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYS 86 (444)
Q Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (444)
.+.--.++|.+.+.||+|+||+||+|++.. +++.||+|.+... .+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 344455899999999999999999998865 4568999998543 1446689999999999999999999887
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+...
T Consensus 108 ~~~~~--------------------------------------------------------------------------- 112 (313)
T 3brb_A 108 MSSQG--------------------------------------------------------------------------- 112 (313)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccC---------------------------------------------------------------------------
Confidence 54200
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhh--hcCCCCCh
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYS--KSKQNFPC 243 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~--~~~~~l~~ 243 (444)
....++|||||++ +|.+++.... .....+++
T Consensus 113 ----------------------------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 146 (313)
T 3brb_A 113 ----------------------------------------------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146 (313)
T ss_dssp ------------------------------------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCH
T ss_pred ----------------------------------------------CcccEEEEecccCCCHHHHHHHhhhhcCCccCCH
Confidence 0137899999985 9999885433 34567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCC
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~ 320 (444)
..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+.
T Consensus 147 ~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 224 (313)
T 3brb_A 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR- 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSS-
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-
Confidence 99999999999999999999999999999999999 78899999999987653332 12233557889999999877
Q ss_pred CCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|+|++ |..||.+.+..+....+.... ....+..+++
T Consensus 225 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 276 (313)
T 3brb_A 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH----------------------------RLKQPEDCLD 276 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------------------------CCCCBTTCCH
T ss_pred CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC----------------------------CCCCCccccH
Confidence 79999999999999999999 999999887776665544311 0112345789
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+.++|.+||..||.+|||+.++++ .++++....
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~---~L~~l~~~l 310 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRL---QLEKLLESL 310 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHH---HHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH---HHHHHHHhc
Confidence 9999999999999999999999999 777765544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.13 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=208.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.++|++.+.||+|+||.||+|.+ .|+.||||.+... ...+.+|+++|++++||||+++++++.....
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------- 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--------- 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS---------
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC---------
Confidence 47899999999999999999998 4889999999543 4567799999999999999999998876541
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 261 -------------------------------------------------------------------------------- 260 (450)
T 1k9a_A 261 -------------------------------------------------------------------------------- 260 (450)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.+++|||||++ +|.+++.. .....+++..++.++.||+.||
T Consensus 261 ------------------------------------~~~iv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l 302 (450)
T 1k9a_A 261 ------------------------------------GLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAM 302 (450)
T ss_dssp ------------------------------------CEEEEEECCTTCBHHHHHHH--HCTTTCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------ceEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHH
Confidence 38999999985 99999864 2233478999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
+|||++|++||||+|+||+++ .++.+||+|||+++..... .....++..|+|||.+.+. .++.++|+||||+++|+
T Consensus 303 ~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~e 378 (450)
T 1k9a_A 303 EYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWE 378 (450)
T ss_dssp HHHHHTTEECSCCCGGGEEEC-TTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCeeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHH
Confidence 999999999999999999999 7889999999998754322 2223567889999999887 89999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCC
Q psy10212 338 LLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSR 416 (444)
Q Consensus 338 Llt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kR 416 (444)
|++ |+.||.+.+..+....+.+.. ....+..+++.+.+||.+||+.||.+|
T Consensus 379 l~t~g~~P~~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~cl~~dp~~R 430 (450)
T 1k9a_A 379 IYSFGRVPYPRIPLKDVVPRVEKGY----------------------------KMDAPDGCPPAVYDVMKNCWHLDAATR 430 (450)
T ss_dssp HHTTTCCSSTTSCTTTHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 998 999999887766655443310 011234679999999999999999999
Q ss_pred CCHHHHhccCchhhhhhhh
Q psy10212 417 ISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 417 Ps~~elL~~hpwf~~~~~~ 435 (444)
||+.++++ .++++...
T Consensus 431 pt~~~l~~---~L~~i~~~ 446 (450)
T 1k9a_A 431 PTFLQLRE---QLEHIRTH 446 (450)
T ss_dssp CCHHHHHH---HHHHHHHT
T ss_pred cCHHHHHH---HHHHHHHh
Confidence 99999998 77776654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.13 Aligned_cols=256 Identities=26% Similarity=0.324 Sum_probs=195.1
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+-..++|++.+.||+|+||+||+|++. ..+|+|++.... ..+.+|+.++++++||||++++++....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 92 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---- 92 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC----
Confidence 334578999999999999999999874 359999985332 4567899999999999999998854222
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (289)
T 3og7_A 93 -------------------------------------------------------------------------------- 92 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+++|||||+ ++|.+++. .....+++..++.++
T Consensus 93 -------------------------------------------~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~ 126 (289)
T 3og7_A 93 -------------------------------------------QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIA 126 (289)
T ss_dssp -------------------------------------------SCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHH
T ss_pred -------------------------------------------ccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHH
Confidence 2789999998 58888874 345679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC---CCCccccccccccCchhhcc--CCCCCcc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG---EPNVSYICSRYYRAPELIFG--AIDYTTK 325 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~~s~~ 325 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++...... .......+++.|+|||.+.. ...++.+
T Consensus 127 ~qi~~~L~~lH~~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 205 (289)
T 3og7_A 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205 (289)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEE-TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHH
T ss_pred HHHHHHHHHHHhCCcccccCccceEEEC-CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcc
Confidence 9999999999999999999999999999 7889999999998654321 12233467999999999862 2268889
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|+||||+++|+|++|+.||.+....+............. ....+..++++.+.+||
T Consensus 206 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li 262 (289)
T 3og7_A 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-----------------------DLSKVRSNCPKRMKRLM 262 (289)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------------------CTTSSCTTSCHHHHHHH
T ss_pred cchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------------------chhhccccCCHHHHHHH
Confidence 9999999999999999999998777666555554211100 01112346789999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.+||+.||.+|||+.++++ .++++.
T Consensus 263 ~~~l~~~p~~Rps~~ell~---~L~~l~ 287 (289)
T 3og7_A 263 AECLKKKRDERPSFPRILA---EIEELA 287 (289)
T ss_dssp HHHTCSSGGGSCCHHHHHH---HHHHTT
T ss_pred HHHccCChhhCCCHHHHHH---HHHHHh
Confidence 9999999999999999998 666543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.14 Aligned_cols=251 Identities=23% Similarity=0.257 Sum_probs=204.6
Q ss_pred ccccchhh-eecccceeEEEEeEe--cCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 21 DNSLAQKT-VIGNGSFGIVYQAKL--LDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 21 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.++|.+.+ .||+|+||+||+|.+ ..+++.||||++... .+.+.+|++++++++||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 37899988 999999999999954 556789999998543 34567899999999999999999988 322
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (291)
T 1xbb_A 91 -------------------------------------------------------------------------------- 90 (291)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++|||||+ ++|.+++.. ...+++..++.++
T Consensus 91 -------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~ 123 (291)
T 1xbb_A 91 -------------------------------------------SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELV 123 (291)
T ss_dssp -------------------------------------------SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHH
T ss_pred -------------------------------------------CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHH
Confidence 2789999998 589998853 4569999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++
T Consensus 124 ~qi~~~l~~LH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 201 (291)
T 1xbb_A 124 HQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKS 201 (291)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHH
T ss_pred HHHHHHHHHHHhCCeEcCCCCcceEEEe-CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhh
Confidence 9999999999999999999999999999 7889999999998765433221 122346789999999876 788999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |+.||.+.+..+....+.... ...++..+++.+.++|
T Consensus 202 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li 253 (291)
T 1xbb_A 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------------------RMGCPAGCPREMYDLM 253 (291)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHH
Confidence 99999999999999 999999887766544433210 0112345799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+||+.||.+|||+.++++ .|+++-..
T Consensus 254 ~~~l~~dp~~Rps~~~l~~---~L~~~~~~ 280 (291)
T 1xbb_A 254 NLCWTYDVENRPGFAAVEL---RLRNYYYD 280 (291)
T ss_dssp HHHTCSSTTTSCCHHHHHH---HHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH---HHHHHHHH
Confidence 9999999999999999999 77776544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=323.00 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=200.2
Q ss_pred cccchhheecccceeEEEEeEecCCCcee----eeeeeec-----cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELV----AIKKVLQ-----DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++++.||+|+||+||+|++..+++.+ |+|.+.. ....+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC----
Confidence 78999999999999999999999888876 5555422 2345668999999999999999999987643
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (327)
T 3lzb_A 91 -------------------------------------------------------------------------------- 90 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++++++. ++|.+++.. ....+++..++.++.
T Consensus 91 -------------------------------------------~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~ 124 (327)
T 3lzb_A 91 -------------------------------------------VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCV 124 (327)
T ss_dssp -------------------------------------------EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHH
T ss_pred -------------------------------------------ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHH
Confidence 678888887 589998863 456799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||.|||++|++|+||||+||+++ ..+.++|+|||++......... ....+++.|+|||.+.+. .++.++|+
T Consensus 125 qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di 202 (327)
T 3lzb_A 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDV 202 (327)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHH
T ss_pred HHHHHHHHHhhCCCcCCCCCHHHEEEc-CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHH
Confidence 999999999999999999999999998 7889999999999765433222 223457789999999887 89999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |..||.+.+..+....+.... ....+..+++.+.++|.+
T Consensus 203 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~ 254 (327)
T 3lzb_A 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------------------------RLPQPPICTIDVYMIMRK 254 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------------------------CCCCCTTBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHH
Confidence 999999999999 999999887766554443311 001123568999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.|+++ .++.+..
T Consensus 255 ~l~~dp~~Rps~~ell~---~L~~~~~ 278 (327)
T 3lzb_A 255 CWMIDADSRPKFRELII---EFSKMAR 278 (327)
T ss_dssp HTCSSGGGSCCHHHHHH---HHHHHHT
T ss_pred HcCCChhHCcCHHHHHH---HHHHHHh
Confidence 99999999999999999 6776654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.21 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=211.2
Q ss_pred hhhhhhccccchhheecccceeEEEEeEe-----cCCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeE
Q psy10212 15 TYFSDLDNSLAQKTVIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYF 83 (444)
Q Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~ 83 (444)
..+.-..++|++.+.||+|+||+||+|++ ..+++.||||++... ...+.+|+++++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34455568999999999999999999985 456789999998543 23566899999999 79999999999
Q ss_pred EeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhh
Q psy10212 84 FYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIRE 163 (444)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (444)
+...+.
T Consensus 100 ~~~~~~-------------------------------------------------------------------------- 105 (316)
T 2xir_A 100 CTKPGG-------------------------------------------------------------------------- 105 (316)
T ss_dssp ECCTTS--------------------------------------------------------------------------
T ss_pred EecCCC--------------------------------------------------------------------------
Confidence 876432
Q ss_pred cCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhc-----
Q psy10212 164 MNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKS----- 237 (444)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~----- 237 (444)
.+++|||||++ +|.+++......
T Consensus 106 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (316)
T 2xir_A 106 ---------------------------------------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134 (316)
T ss_dssp ---------------------------------------------------CCEEEEECCTTEEHHHHHHTCTTSEECC-
T ss_pred ---------------------------------------------------ceEEEEEcCCCCcHHHHHHhccccccccc
Confidence 37899999985 999998643321
Q ss_pred -------CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---cccccc
Q psy10212 238 -------KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICS 307 (444)
Q Consensus 238 -------~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt 307 (444)
...+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++......... ....++
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t 213 (316)
T 2xir_A 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLP 213 (316)
T ss_dssp ------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred ccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-CCCCEEECCCccccccccCccceeccCCCcc
Confidence 22388999999999999999999999999999999999998 7889999999999765433221 233567
Q ss_pred ccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccC
Q psy10212 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386 (444)
Q Consensus 308 ~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~ 386 (444)
+.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+...........
T Consensus 214 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 269 (316)
T 2xir_A 214 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------- 269 (316)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-----------------------
T ss_pred eeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-----------------------
Confidence 889999999877 78999999999999999998 99999887655444433331100
Q ss_pred CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 387 ~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
...+..+++.+.++|.+||+.||.+|||+.|+++ .++++...
T Consensus 270 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~---~L~~~~~~ 311 (316)
T 2xir_A 270 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE---HLGNLLQA 311 (316)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH---HHHHHHhh
Confidence 0112346899999999999999999999999999 67766543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.07 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=195.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
.+|.+.++||+|+||+||. ....+|+.||||++... .....+|+++++++ +||||+++++++...+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~----------- 91 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ----------- 91 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETT-----------
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----------
Confidence 5799999999999999764 33457999999998543 35567899999999 7999999998886653
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (432)
T 3p23_A 92 -------------------------------------------------------------------------------- 91 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAY 259 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~y 259 (444)
++|+|||||+++|.+++.. ......+..++.++.||+.||.|
T Consensus 92 -----------------------------------~~~lv~E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~ 133 (432)
T 3p23_A 92 -----------------------------------FQYIAIELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAH 133 (432)
T ss_dssp -----------------------------------EEEEEEECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHH
T ss_pred -----------------------------------EEEEEEECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHH
Confidence 4899999999999999863 34456667788999999999999
Q ss_pred HHHCCcccCCCCCCcEEEcC----CCCeEEEeecCCcccccCCC----CCccccccccccCchhhcc--CCCCCcchhhh
Q psy10212 260 IHVLGICHRDIKPQNLLLNP----ETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFG--AIDYTTKIDVW 329 (444)
Q Consensus 260 LHs~givH~dLkp~NIll~~----~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~s~~sDiw 329 (444)
||++|++||||||+||+++. ....++|+|||++....... ......||+.|+|||.+.+ ...++.++|||
T Consensus 134 LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Diw 213 (432)
T 3p23_A 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF 213 (432)
T ss_dssp HHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHH
T ss_pred HHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHH
Confidence 99999999999999999952 22368899999987654332 2334568999999999874 22678899999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||++|+|++ |..||........ ..+. +... .+.. ......+..+.+||.+|
T Consensus 214 SlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~---------------~~~~-------~~~~~~~~~~~~li~~~ 267 (432)
T 3p23_A 214 SAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACS---------------LDCL-------HPEKHEDVIARELIEKM 267 (432)
T ss_dssp HHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCC---------------CTTS-------CTTCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCC---------------cccc-------CccccccHHHHHHHHHH
Confidence 99999999999 9999965443321 1111 1000 0000 00112356789999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.|+|+ ||||.++..
T Consensus 268 L~~dP~~Rps~~evl~-hp~f~~~~~ 292 (432)
T 3p23_A 268 IAMDPQKRPSAKHVLK-HPFFWSLEK 292 (432)
T ss_dssp SCSSGGGSCCHHHHHT-STTTCCHHH
T ss_pred HhCCHhhCCCHHHHHh-CccccChHH
Confidence 9999999999999999 999987554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.38 Aligned_cols=279 Identities=13% Similarity=0.107 Sum_probs=205.2
Q ss_pred ccccchhheecccceeEEEEeEecC--------CCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD--------SGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|++.+.||+|+||+||+|++.. .++.||+|.+... ..+.+|++++++++||||++++..+......
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL-- 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC--
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCcc--
Confidence 5899999999999999999999987 4889999998755 5677999999999999999853222111000
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
.-..++.+..
T Consensus 118 --------~i~~~~~~~~-------------------------------------------------------------- 127 (352)
T 2jii_A 118 --------AIPTCMGFGV-------------------------------------------------------------- 127 (352)
T ss_dssp --------SCCCCCEEEE--------------------------------------------------------------
T ss_pred --------Cccchhhccc--------------------------------------------------------------
Confidence 0000000000
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
......++|||||+++|.+++... ....+++..++.++.|
T Consensus 128 --------------------------------------~~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~q 167 (352)
T 2jii_A 128 --------------------------------------HQDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACR 167 (352)
T ss_dssp --------------------------------------ETTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHH
T ss_pred --------------------------------------cCCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHH
Confidence 001358999999988999999642 2467999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEeecCCcccccCCC--------CCccccccccccCchhhccCCCC
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETG--VLKLCDFGSAKHLVRGE--------PNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
|+.||.|||++|++|+||||+||+++ .++ .++|+|||++....... ......+++.|+|||.+.+. .+
T Consensus 168 i~~~L~~LH~~~ivH~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 245 (352)
T 2jii_A 168 LLDALEFLHENEYVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GP 245 (352)
T ss_dssp HHHHHHHHHHTTCBCSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CC
T ss_pred HHHHHHHHHhCCccCCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CC
Confidence 99999999999999999999999999 566 89999999997653321 12334789999999999887 78
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
+.++|+||||+++|+|++|+.||.... ..+......... .... +...... .....+++.+
T Consensus 246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~--------~~~~~~~---~~~~~~~~~l 306 (352)
T 2jii_A 246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF--------VDKP--------GPFVGPC---GHWIRPSETL 306 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH--------HHSC--------CCEECTT---SCEECCCHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc--------cCCh--------hhhhhhc---cccCCCcHHH
Confidence 999999999999999999999998764 333333222211 0000 0000000 0012468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+||.+||+.||.+|||+.++++ .|+++....
T Consensus 307 ~~li~~~l~~dp~~Rps~~~l~~---~L~~~~~~~ 338 (352)
T 2jii_A 307 QKYLKVVMALTYEEKPPYAMLRN---NLEALLQDL 338 (352)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHH---HHHHHHHHT
T ss_pred HHHHHHHHhCChhhCCCHHHHHH---HHHHHHHhc
Confidence 99999999999999999999999 787766543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.72 Aligned_cols=260 Identities=20% Similarity=0.317 Sum_probs=214.8
Q ss_pred ccchhhhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 12 KNYTYFSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
.++..++--.++|.+.++||+|+||.||+|+++.+++.||||.+... .+.+.+|+.+|++++||||+++++++...+
T Consensus 210 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 210 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34444555667899999999999999999999988999999999543 356779999999999999999999987654
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 290 ~------------------------------------------------------------------------------- 290 (495)
T 1opk_A 290 P------------------------------------------------------------------------------- 290 (495)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 3
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
++||||||+ ++|.+++.. .....+++..++
T Consensus 291 -----------------------------------------------~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~ 321 (495)
T 1opk_A 291 -----------------------------------------------FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLL 321 (495)
T ss_dssp -----------------------------------------------CEEEEECCTTCBHHHHHHH--SCTTTSCHHHHH
T ss_pred -----------------------------------------------EEEEEEccCCCCHHHHHHh--cCcCCCCHHHHH
Confidence 889999998 699999864 234568999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
.++.||+.||+|||++|++||||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.+
T Consensus 322 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 399 (495)
T 1opk_A 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 399 (495)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHH
T ss_pred HHHHHHHHHHHHHHhCCcccCCCChhhEEEC-CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcH
Confidence 9999999999999999999999999999998 788999999999976533221 1223346789999999877 78999
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+||||||+++|+|++ |..||.+.+..+....+.... ....+..+++.+.+|
T Consensus 400 sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------------------RMERPEGCPEKVYEL 451 (495)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHH
T ss_pred HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHH
Confidence 999999999999998 999999887766554433210 011234679999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
|.+||+.||.+|||+.++++ .|+.+
T Consensus 452 i~~cl~~dP~~RPs~~el~~---~L~~~ 476 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ---AFETM 476 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH---HHHTS
T ss_pred HHHHcCcChhHCcCHHHHHH---HHHHH
Confidence 99999999999999999998 66664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.94 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=194.3
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
....++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+|+.++++++||||+++++++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-- 107 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-- 107 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--
Confidence 34568999999999999999999999999999999998543 145668999999999999999999987754
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 108 -------------------------------------------------------------------------------- 107 (309)
T 2h34_A 108 -------------------------------------------------------------------------------- 107 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.+++|||||++ +|.+++.. ..++++..++.+
T Consensus 108 --------------------------------------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i 139 (309)
T 2h34_A 108 --------------------------------------------QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAI 139 (309)
T ss_dssp --------------------------------------------EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHH
T ss_pred --------------------------------------------eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHH
Confidence 38999999986 99998853 357999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchh
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|
T Consensus 140 ~~qi~~~l~~lH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 217 (309)
T 2h34_A 140 VRQIGSALDAAHAAGATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRAD 217 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCH
T ss_pred HHHHHHHHHHHHHCcCCcCCCChHHEEEc-CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCC-CCCchHh
Confidence 99999999999999999999999999999 78899999999986654332 12244678999999999877 7899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||||+++|+|++|+.||.+.+... ........ ......++.++|+.+.++|.+
T Consensus 218 i~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-------------------------~~~~~~~~~~~~~~l~~li~~ 271 (309)
T 2h34_A 218 IYALTCVLYECLTGSPPYQGDQLSV-MGAHINQA-------------------------IPRPSTVRPGIPVAFDAVIAR 271 (309)
T ss_dssp HHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSC-------------------------CCCGGGTSTTCCTHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccC-------------------------CCCccccCCCCCHHHHHHHHH
Confidence 9999999999999999998765442 22222210 001112335679999999999
Q ss_pred hcccCCCCCC-CHHHHhc
Q psy10212 408 LLEYTPSSRI-SPLQVRS 424 (444)
Q Consensus 408 ~L~~DP~kRP-s~~elL~ 424 (444)
||+.||++|| |+.++++
T Consensus 272 ~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 272 GMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HTCSSGGGSCSSHHHHHH
T ss_pred hccCCHHHHHHhHHHHHH
Confidence 9999999999 7888777
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.37 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=198.0
Q ss_pred ccccchhheecccceeEEEEeEec---CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
.++|.+.+.||+|+||.||+|+++ .+++.||||.+... ...+.+|+.++++++||||+++++++...+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP--- 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc---
Confidence 358999999999999999999987 45778999998543 2456789999999999999999999866542
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 121 -------------------------------------------------------------------------------- 120 (373)
T 2qol_A 121 -------------------------------------------------------------------------------- 120 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.++|||||+ ++|.+++. .....+++..++.++.
T Consensus 121 -------------------------------------------~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~ 154 (373)
T 2qol_A 121 -------------------------------------------VMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLR 154 (373)
T ss_dssp -------------------------------------------CEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHH
T ss_pred -------------------------------------------eEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHH
Confidence 889999997 59999885 3445799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||+|||++|++|+||||+||+++ .++.++|+|||++......... ....++..|+|||.+.+. .++.++|
T Consensus 155 qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 232 (373)
T 2qol_A 155 GIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASD 232 (373)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHH
T ss_pred HHHHHHHHHHHCCeeCCCCCcceEEEc-CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhc
Confidence 999999999999999999999999999 7889999999998765433211 112346789999999877 7999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
+||||+++|+|++ |+.||.+.+..+....+.... .. ..+..++..+.++|.
T Consensus 233 v~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------------------~~----------~~~~~~~~~l~~li~ 284 (373)
T 2qol_A 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------------------RL----------PPPMDCPAALYQLML 284 (373)
T ss_dssp HHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE------------------EC----------CCCTTCBHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCccccHHHHHHHH
Confidence 9999999999997 999998887766554443211 00 112356899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+||+.||.+||++.++++ .++.+....
T Consensus 285 ~cl~~dp~~RPs~~~i~~---~L~~~~~~~ 311 (373)
T 2qol_A 285 DCWQKDRNNRPKFEQIVS---ILDKLIRNP 311 (373)
T ss_dssp HHTCSSGGGSCCHHHHHH---HHHHHHHCG
T ss_pred HHhCcChhhCcCHHHHHH---HHHHHHhCc
Confidence 999999999999999999 777765443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.26 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=208.8
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
-..++|++++.||+|+||.||+|++. +++.||+|.+... .+.+.+|++++++++||||+++++++..+.
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 81 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP------- 81 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-------
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCC-------
Confidence 34589999999999999999999976 4778999998543 356778999999999999999998875321
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (279)
T 1qpc_A 82 -------------------------------------------------------------------------------- 81 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.++|||||+ ++|.+++.. .....+++..++.++.||+
T Consensus 82 ----------------------------------------~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~ 119 (279)
T 1qpc_A 82 ----------------------------------------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIA 119 (279)
T ss_dssp ----------------------------------------CEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHH
T ss_pred ----------------------------------------cEEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHH
Confidence 789999997 599998853 1223689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||||
T Consensus 120 ~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 197 (279)
T 1qpc_A 120 EGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFG 197 (279)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHH
T ss_pred HHHHHHHHCCeeccCCCHhhEEEc-CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHH
Confidence 999999999999999999999999 788999999999976543321 1223457789999999876 789999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|+|++ |+.||.+.+..+....+.+.. ....+..+++.+.++|.+||+.
T Consensus 198 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~ 249 (279)
T 1qpc_A 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------------------------RMVRPDNCPEELYQLMRLCWKE 249 (279)
T ss_dssp HHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCCcccCHHHHHHHHhccc----------------------------CCCCcccccHHHHHHHHHHhcc
Confidence 99999999 999999887766555443310 0112245789999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
||++|||+.++++ .++++....
T Consensus 250 ~p~~Rps~~~l~~---~l~~~~~~~ 271 (279)
T 1qpc_A 250 RPEDRPTFDYLRS---VLEDFFTAT 271 (279)
T ss_dssp SGGGSCCHHHHHH---HHHHHHHHC
T ss_pred ChhhCCCHHHHHH---HHHHHHHhc
Confidence 9999999999998 777765543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.14 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=208.6
Q ss_pred hccccchhheecccceeEEEEeEec-------CCCceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEee
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLL-------DSGELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYS 86 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (444)
-.++|.+.+.||+|+||+||+|++. .+++.||+|++.... ..+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3589999999999999999999985 457789999985432 3466899999999 89999999998866
Q ss_pred cCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCC
Q psy10212 87 SGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNP 166 (444)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (444)
.+.
T Consensus 113 ~~~----------------------------------------------------------------------------- 115 (334)
T 2pvf_A 113 DGP----------------------------------------------------------------------------- 115 (334)
T ss_dssp SSC-----------------------------------------------------------------------------
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 542
Q ss_pred CCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhh---------
Q psy10212 167 NYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSK--------- 236 (444)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~--------- 236 (444)
+++|||||++ +|.+++.....
T Consensus 116 -------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 146 (334)
T 2pvf_A 116 -------------------------------------------------LYVIVEYASKGNLREYLRARRPPGMEYSYDI 146 (334)
T ss_dssp -------------------------------------------------CEEEEECCTTCBHHHHHHTTSCTTCCSCC--
T ss_pred -------------------------------------------------eEEEEECCCCCcHHHHHHHhccccccccccc
Confidence 8899999985 99999865332
Q ss_pred ---cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Cccccccccc
Q psy10212 237 ---SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYY 310 (444)
Q Consensus 237 ---~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y 310 (444)
....+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........ .....+++.|
T Consensus 147 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 225 (334)
T 2pvf_A 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225 (334)
T ss_dssp ------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGG
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccce
Confidence 123588999999999999999999999999999999999999 788999999999876543321 2233457889
Q ss_pred cCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCC
Q psy10212 311 RAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389 (444)
Q Consensus 311 ~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~ 389 (444)
+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.....
T Consensus 226 ~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------------- 277 (334)
T 2pvf_A 226 MAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--------------------------- 277 (334)
T ss_dssp CCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---------------------------
T ss_pred eChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC---------------------------
Confidence 999999876 78999999999999999999 9999998877666554443110
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
...+..+++.+.++|.+||+.||.+|||+.|+++ .++.+....
T Consensus 278 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~---~L~~l~~~~ 320 (334)
T 2pvf_A 278 -MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRILTLT 320 (334)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH---HHHHHHhcc
Confidence 0122457899999999999999999999999999 677765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.75 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=205.4
Q ss_pred cccchhheecccceeEEEEeE----ecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++++.||+|+||.||+|+ +..+++.||||++.... +.+.+|++++++++||||++++++++..+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---- 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS----
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC----
Confidence 799999999999999999999 56789999999985442 446789999999999999999998875442
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 99 -------------------------------------------------------------------------------- 98 (327)
T 3lxl_A 99 -------------------------------------------------------------------------------- 98 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..+++|||||+ ++|.+++... ...+++..++.++.|
T Consensus 99 ----------------------------------------~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~q 135 (327)
T 3lxl_A 99 ----------------------------------------QSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQ 135 (327)
T ss_dssp ----------------------------------------CEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHH
T ss_pred ----------------------------------------ceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHH
Confidence 35899999996 5999988642 346999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|+.||+|||++|++|+||||+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+
T Consensus 136 i~~al~~lH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 213 (327)
T 3lxl_A 136 ICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDV 213 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEE-ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHH
T ss_pred HHHHHHHHHhCCccCCCCChhhEEEC-CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhH
Confidence 99999999999999999999999998 788999999999976543321 2233567789999999877 78999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||+++|+|++|..||............... ..+....+.... ........+..+++.+.+||.+|
T Consensus 214 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~ 280 (327)
T 3lxl_A 214 WSFGVVLYELFTYCDKSCSPSAEFLRMMGCER-DVPALSRLLELL------------EEGQRLPAPPACPAEVHELMKLC 280 (327)
T ss_dssp HHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHH------------HTTCCCCCCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCccccchhhhhccccc-ccccHHHHHHHh------------hcccCCCCCCcccHHHHHHHHHH
Confidence 99999999999999998654322111000000 000000000000 00011122346799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.|+++ .++.+..
T Consensus 281 l~~dP~~Rps~~ell~---~L~~~~~ 303 (327)
T 3lxl_A 281 WAPSPQDRPSFSALGP---QLDMLWS 303 (327)
T ss_dssp TCSSGGGSCCHHHHHH---HHHHC--
T ss_pred cCCChhhCcCHHHHHH---HHHHHHh
Confidence 9999999999999988 6666544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.02 Aligned_cols=263 Identities=23% Similarity=0.352 Sum_probs=198.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhh--cCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRR--LEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.+.++|++++.||+|+||+||+|++ +|+.||||++... ...+.+|.+++.. ++||||+++++++......
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~----- 77 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS----- 77 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT-----
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC-----
Confidence 4568999999999999999999998 6999999998554 3344566666666 7999999999988764320
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (301)
T 3q4u_A 78 -------------------------------------------------------------------------------- 77 (301)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
...+++|||||++ +|.+++. ...+++..++.++.||+
T Consensus 78 -------------------------------------~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~ 115 (301)
T 3q4u_A 78 -------------------------------------STQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIA 115 (301)
T ss_dssp -------------------------------------EEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHH
T ss_pred -------------------------------------CceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHH
Confidence 1348999999985 9999883 35799999999999999
Q ss_pred HHHHHHH--------HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCC-
Q psy10212 255 RSLAYIH--------VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAI- 320 (444)
Q Consensus 255 ~aL~yLH--------s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~- 320 (444)
.||+||| +++++|+||||+||+++ .++.++|+|||++........ .....+|+.|+|||.+.+..
T Consensus 116 ~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (301)
T 3q4u_A 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194 (301)
T ss_dssp HHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHhhhhccCCCCeecCCCChHhEEEc-CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCC
Confidence 9999999 99999999999999999 788999999999865543322 22347899999999997652
Q ss_pred ----CCCcchhhhhHHHHHHHHHhC----------CCCCCCCChhH-HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCcc
Q psy10212 321 ----DYTTKIDVWSAGCVLAELLLG----------QPMFPGDSGVD-QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385 (444)
Q Consensus 321 ----~~s~~sDiwSLGvil~eLltG----------~~Pf~~~~~~e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~ 385 (444)
.++.++|+||||+++|+|++| +.||......+ ....+...... ....+..
T Consensus 195 ~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~~- 259 (301)
T 3q4u_A 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV--------------DQQRPNI- 259 (301)
T ss_dssp TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--------------SCCCCCC-
T ss_pred CCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhc--------------cCCCCCC-
Confidence 234689999999999999999 88886543221 11111111100 0000000
Q ss_pred CCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 386 ~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
....++..+++.+.+||.+||+.||.+|||+.++++ .++++
T Consensus 260 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~---~L~~i 300 (301)
T 3q4u_A 260 ---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK---TLTKI 300 (301)
T ss_dssp ---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH---HHHHH
T ss_pred ---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH---HHhcc
Confidence 011122335688999999999999999999999998 55543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.26 Aligned_cols=250 Identities=26% Similarity=0.286 Sum_probs=204.1
Q ss_pred cccchhh-eecccceeEEEEeEec--CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKT-VIGNGSFGIVYQAKLL--DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.+++ .||+|+||.||+|.+. .+++.||+|.+... ...+.+|++++++++||||+++++++.. +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~----- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C-----
Confidence 6777777 9999999999999864 46788999999653 2456689999999999999999998832 2
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (287)
T 1u59_A 83 -------------------------------------------------------------------------------- 82 (287)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..++|||||++ +|.+++. .....+++..++.++.|
T Consensus 83 -----------------------------------------~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~q 118 (287)
T 1u59_A 83 -----------------------------------------ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 118 (287)
T ss_dssp -----------------------------------------SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHH
T ss_pred -----------------------------------------CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHH
Confidence 28899999986 8988874 24567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|+.||.|||++|++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+
T Consensus 119 i~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 196 (287)
T 1u59_A 119 VSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDV 196 (287)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHH
T ss_pred HHHHHHHHHHCCEeeCCCchheEEEc-CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhH
Confidence 99999999999999999999999999 788999999999976543321 1223457889999999876 78999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||+++|+|++ |+.||.+.+..+....+.... ...++..+++.+.++|.+
T Consensus 197 ~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~li~~ 248 (287)
T 1u59_A 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------------------RMECPPECPPELYALMSD 248 (287)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----------------------------cCCCCCCcCHHHHHHHHH
Confidence 999999999998 999998877766554443310 011234679999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||+.||.+|||+.++++ .++.+..
T Consensus 249 ~l~~~p~~Rps~~~l~~---~l~~~~~ 272 (287)
T 1u59_A 249 CWIYKWEDRPDFLTVEQ---RMRACYY 272 (287)
T ss_dssp TTCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred HcCCChhhCcCHHHHHH---HHHHHHH
Confidence 99999999999999999 5555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.49 Aligned_cols=259 Identities=24% Similarity=0.288 Sum_probs=207.2
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCC---ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSG---ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
+..-..+|++.+.||+|+||+||+|++..++ ..+|+|.+... ...+.+|+.++++++||||+++++++...+
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 3455678999999999999999999976433 35899988542 245668999999999999999999876543
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
.
T Consensus 100 ~------------------------------------------------------------------------------- 100 (298)
T 3f66_A 100 G------------------------------------------------------------------------------- 100 (298)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 2
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
..++|||||++ +|.+++. .....+++..++
T Consensus 101 ----------------------------------------------~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~ 131 (298)
T 3f66_A 101 ----------------------------------------------SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLI 131 (298)
T ss_dssp ----------------------------------------------CCEEEEECCTTCBHHHHHH---CTTCCCCHHHHH
T ss_pred ----------------------------------------------ceEEEEeCCCCCCHHHHHH---hcccCCCHHHHH
Confidence 37899999986 9999885 345678999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccCCCC
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGAIDY 322 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~ 322 (444)
.++.||+.||.|||++|++|+||||+||+++ .++.++|+|||.+....... ......+++.|+|||.+.+. .+
T Consensus 132 ~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~ 209 (298)
T 3f66_A 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KF 209 (298)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CC
T ss_pred HHHHHHHHHHHHHHhCCccCCCCchheEEEC-CCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CC
Confidence 9999999999999999999999999999999 78899999999987553321 12233557889999999877 78
Q ss_pred CcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 323 TTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 323 s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
+.++|+||||+++|+|++ +.+||.+.+..+....+..... ...+..+++.+
T Consensus 210 ~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l 261 (298)
T 3f66_A 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------------------------LLQPEYCPDPL 261 (298)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC----------------------------CCCCTTCCHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC----------------------------CCCCccCCHHH
Confidence 999999999999999999 7778887776666555443110 11123468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.++|.+||+.||.+|||+.|+++ .++.+....
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~---~L~~~~~~~ 293 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVS---RISAIFSTF 293 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHTS
T ss_pred HHHHHHHcCCChhhCcCHHHHHH---HHHHHHHhh
Confidence 99999999999999999999999 777766543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=316.53 Aligned_cols=273 Identities=23% Similarity=0.354 Sum_probs=210.0
Q ss_pred cchhhhhhccccchh------heecccceeEEEEeEecCCCceeeeeeeecc--------ccchhhHHHHhhhcCCCcee
Q psy10212 13 NYTYFSDLDNSLAQK------TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIV 78 (444)
Q Consensus 13 ~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h~~i~ 78 (444)
++..+.+++++|... +.||+|+||+||+|++ +++.||+|++... ...+.+|++++++++||||+
T Consensus 16 ~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 344567777777766 9999999999999987 6899999998532 24566899999999999999
Q ss_pred EeeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCch
Q psy10212 79 KLKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTR 158 (444)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (444)
++++++...+.
T Consensus 94 ~~~~~~~~~~~--------------------------------------------------------------------- 104 (307)
T 2nru_A 94 ELLGFSSDGDD--------------------------------------------------------------------- 104 (307)
T ss_dssp CEEEEECSSSS---------------------------------------------------------------------
T ss_pred EEEEEEecCCc---------------------------------------------------------------------
Confidence 99998876543
Q ss_pred hhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc
Q psy10212 159 EQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS 237 (444)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~ 237 (444)
.++|||||+ ++|.+++... ..
T Consensus 105 ---------------------------------------------------------~~lv~e~~~~~~L~~~l~~~-~~ 126 (307)
T 2nru_A 105 ---------------------------------------------------------LCLVYVYMPNGSLLDRLSCL-DG 126 (307)
T ss_dssp ---------------------------------------------------------CEEEEECCTTCBHHHHHHTG-GG
T ss_pred ---------------------------------------------------------eEEEEEecCCCcHHHHHHhc-cC
Confidence 789999997 5999988643 33
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCch
Q psy10212 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPE 314 (444)
Q Consensus 238 ~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE 314 (444)
..++++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....+++.|+|||
T Consensus 127 ~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 205 (307)
T 2nru_A 127 TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205 (307)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc-CCCcEEEeecccccccccccccccccccCCCcCcCChH
Confidence 46799999999999999999999999999999999999999 788999999999876543221 22346799999999
Q ss_pred hhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCccccc
Q psy10212 315 LIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394 (444)
Q Consensus 315 ~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 394 (444)
.+.+ .++.++|+||||+++|+|++|..||...........+.+.............. .. ....+
T Consensus 206 ~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~-~~~~~ 269 (307)
T 2nru_A 206 ALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID-------------KK-MNDAD 269 (307)
T ss_dssp HHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC-------------SS-CSCCC
T ss_pred HhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc-------------cc-ccccc
Confidence 8875 47899999999999999999999998765544333333322111100000000 00 01112
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 395 ~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..+++.+.++|.+||+.||.+|||+.++++ .++++.+
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~---~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQ---LLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHH---HHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHH---HHHHHhc
Confidence 234678999999999999999999999999 7776653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=318.68 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=201.9
Q ss_pred ccccchhheecccceeEEEEeEecCCC----ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG----ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.++|.+.+.||+|+||+||+|+++.++ ..||||.+... ...+.+|++++++++||||+++++++...+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC--
Confidence 467888999999999999999987654 35999998543 2346689999999999999999998865442
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 121 -------------------------------------------------------------------------------- 120 (333)
T 1mqb_A 121 -------------------------------------------------------------------------------- 120 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.++|||||++ +|.+++.. ....+++..++.++
T Consensus 121 --------------------------------------------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~ 153 (333)
T 1mqb_A 121 --------------------------------------------MMIITEYMENGALDKFLRE---KDGEFSVLQLVGML 153 (333)
T ss_dssp --------------------------------------------EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHH
T ss_pred --------------------------------------------cEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHH
Confidence 8999999986 99988853 44679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.++
T Consensus 154 ~qi~~aL~~LH~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 231 (333)
T 1mqb_A 154 RGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSAS 231 (333)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHH
T ss_pred HHHHHHHHHHHhCCeeCCCCChheEEEC-CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchh
Confidence 9999999999999999999999999999 788999999999876543221 1122346789999999877 789999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |+.||.+.+..+....+..... . ..+..+++.+.++|
T Consensus 232 Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~l~~li 283 (333)
T 1mqb_A 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------------------L----------PTPMDCPSAIYQLM 283 (333)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------------C----------CCCTTCBHHHHHHH
T ss_pred hhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc------------------C----------CCcccCCHHHHHHH
Confidence 99999999999998 9999988777665554433110 0 11235689999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.+||+.||.+||++.++++ .++++.....
T Consensus 284 ~~~l~~~p~~Rps~~~l~~---~L~~~~~~~~ 312 (333)
T 1mqb_A 284 MQCWQQERARRPKFADIVS---ILDKLIRAPD 312 (333)
T ss_dssp HHHTCSSTTTSCCHHHHHH---HHHHHHHSGG
T ss_pred HHHcCCChhhCcCHHHHHH---HHHHHHhcch
Confidence 9999999999999999999 6776654443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.05 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=209.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+--.++|++.+.||+|+||.||+|++.. ++.||||++... .+.+.+|+++|++++||||+++++++...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE------- 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSS-------
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC-------
Confidence 3345789999999999999999999864 788999999543 35677999999999999999999887522
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 256 -------------------------------------------------------------------------------- 255 (454)
T 1qcf_A 256 -------------------------------------------------------------------------------- 255 (454)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||+ ++|.+++... ....++...++.++.||
T Consensus 256 ----------------------------------------~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi 293 (454)
T 1qcf_A 256 ----------------------------------------PIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQI 293 (454)
T ss_dssp ----------------------------------------SCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHH
T ss_pred ----------------------------------------ccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHH
Confidence 1789999997 5999998632 23468889999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||+|||+++++||||||+||+++ .++.+||+|||+++...... ......++..|+|||.+... .++.++|+|||
T Consensus 294 ~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvwsl 371 (454)
T 1qcf_A 294 AEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSF 371 (454)
T ss_dssp HHHHHHHHHTTCCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHH
T ss_pred HHHHHHHHhCCccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhH
Confidence 9999999999999999999999999 78899999999997653221 11223456789999999877 79999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++ |+.||.+.+..+....+..... . ..+.++++.+.+||.+||+
T Consensus 372 G~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------~----------~~~~~~~~~l~~li~~cl~ 423 (454)
T 1qcf_A 372 GILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------------M----------PRPENCPEELYNIMMRCWK 423 (454)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC------------------C----------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------C----------CCCCCCCHHHHHHHHHHcc
Confidence 999999999 9999998887776665554211 1 1123579999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.||.+|||+.++++ .++++...
T Consensus 424 ~dp~~RPt~~~i~~---~L~~~~~~ 445 (454)
T 1qcf_A 424 NRPEERPTFEYIQS---VLDDFYTA 445 (454)
T ss_dssp SSGGGSCCHHHHHH---HHHTSSSS
T ss_pred CChhHCcCHHHHHH---HHHHHHhc
Confidence 99999999999998 77776543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.19 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=206.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
-...|.+.++||+|+||+||+|++..+++ .+|+|.+... .+.+.+|+.++++++||||+++++++...+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 96 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-- 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS--
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC--
Confidence 34567778999999999999999766554 7999998542 2456689999999999999999999876542
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 97 -------------------------------------------------------------------------------- 96 (298)
T 3pls_A 97 -------------------------------------------------------------------------------- 96 (298)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..++||||+. ++|.+++.. ....+++..++.++
T Consensus 97 -------------------------------------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~ 130 (298)
T 3pls_A 97 -------------------------------------------LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFG 130 (298)
T ss_dssp -------------------------------------------CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHH
T ss_pred -------------------------------------------CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHH
Confidence 2579999996 699998853 45678999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-----CCCccccccccccCchhhccCCCCCcc
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-----EPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
.||+.||+|||++|++|+||||+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+. .++.+
T Consensus 131 ~qi~~~l~~LH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 208 (298)
T 3pls_A 131 LQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTK 208 (298)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHH
T ss_pred HHHHHHHHHHHhCCcccCCCCcceEEEc-CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChh
Confidence 9999999999999999999999999999 7889999999998654321 222334568899999999877 78999
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++ +.+||...+..+....+..... ...+..+++.+.++
T Consensus 209 ~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~l 260 (298)
T 3pls_A 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----------------------------LPQPEYCPDSLYQV 260 (298)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHH
T ss_pred hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC----------------------------CCCCccchHHHHHH
Confidence 999999999999999 5566666666555544433110 11123568999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
|.+||+.||.+|||+.++++ .++++.....
T Consensus 261 i~~~l~~~p~~Rps~~~ll~---~l~~~~~~l~ 290 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVG---EVEQIVSALL 290 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHH---HHHHHHHHCC
T ss_pred HHHHccCChhhCcCHHHHHH---HHHHHHHHHh
Confidence 99999999999999999999 7887766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=319.01 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=201.6
Q ss_pred ccccchhheecccceeEEEEeE-----ecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAK-----LLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++++.||+|+||+||+|+ +..+++.||||.+... ...+.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP- 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC-
Confidence 5899999999999999999999 5567889999998432 2456689999999999999999999876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 108 -------------------------------------------------------------------------------- 107 (327)
T 2yfx_A 108 -------------------------------------------------------------------------------- 107 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhc---CCCCChHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKS---KQNFPCFYT 246 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~---~~~l~~~~i 246 (444)
.++|||||+ ++|.+++...... ...+++..+
T Consensus 108 ---------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 142 (327)
T 2yfx_A 108 ---------------------------------------------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142 (327)
T ss_dssp ---------------------------------------------CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHH
T ss_pred ---------------------------------------------cEEEEecCCCCcHHHHHHhhcccccccccccHHHH
Confidence 789999996 5999999754322 245889999
Q ss_pred HHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCC
Q psy10212 247 KLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAID 321 (444)
Q Consensus 247 ~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~ 321 (444)
+.++.||+.||.|||++|++|+||+|+||+++. ....++|+|||++....... ......+++.|+|||.+.+. .
T Consensus 143 ~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~ 221 (327)
T 2yfx_A 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-I 221 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-C
T ss_pred HHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-C
Confidence 999999999999999999999999999999972 23469999999986543222 22334568899999999877 7
Q ss_pred CCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 322 YTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 322 ~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
++.++|+||||+++|+|++ |..||...+..+....+.... ....+..+++.
T Consensus 222 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 273 (327)
T 2yfx_A 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG----------------------------RMDPPKNCPGP 273 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC----------------------------CCCCCCCCCHH
Confidence 8999999999999999998 999998877666554443310 00112457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
+.++|.+||+.||.+|||+.++++ |.|+-
T Consensus 274 l~~li~~~l~~dp~~Rps~~~ll~-~l~~~ 302 (327)
T 2yfx_A 274 VYRIMTQCWQHQPEDRPNFAIILE-RIEYC 302 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH-HHHHH
Confidence 999999999999999999999999 66654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.36 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=198.6
Q ss_pred ccccchhheecccceeEEEEeEecC-CCc--eeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-SGE--LVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++++.||+|+||+||+|++.. +++ .||+|.+... ...+.+|++++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 4789999999999999999998643 333 6899998532 245668999999999999999999886542
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 95 -------------------------------------------------------------------------------- 94 (291)
T 1u46_A 95 -------------------------------------------------------------------------------- 94 (291)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
.++||||++ ++|.+++.. ....+++..++.+
T Consensus 95 ---------------------------------------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~ 126 (291)
T 1u46_A 95 ---------------------------------------------MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRY 126 (291)
T ss_dssp ---------------------------------------------CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHH
T ss_pred ---------------------------------------------ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHH
Confidence 679999998 599998864 2356899999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcc
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
+.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.+
T Consensus 127 ~~~i~~~l~~lH~~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 204 (291)
T 1u46_A 127 AVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHA 204 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHH
T ss_pred HHHHHHHHHHHHhCCcccCCCchheEEEc-CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCch
Confidence 99999999999999999999999999998 788999999999876543322 1223457789999999876 78899
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++ |+.||.+.+..+....+.... ... ..+..+++.+.++
T Consensus 205 ~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~~l~~l 257 (291)
T 1u46_A 205 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----------------ERL----------PRPEDCPQDIYNV 257 (291)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----------------CCC----------CCCTTCCHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC-----------------CCC----------CCCcCcCHHHHHH
Confidence 999999999999999 999999887766655444310 000 1123578999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+||..||.+|||+.++++ +++++...
T Consensus 258 i~~~l~~~p~~Rps~~~l~~---~l~~~~~~ 285 (291)
T 1u46_A 258 MVQCWAHKPEDRPTFVALRD---FLLEAQPT 285 (291)
T ss_dssp HHHHTCSSGGGSCCHHHHHH---HHHHHC--
T ss_pred HHHHccCCcccCcCHHHHHH---HHHHhCcc
Confidence 99999999999999999999 88876554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=336.88 Aligned_cols=261 Identities=19% Similarity=0.234 Sum_probs=208.3
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
.+.++|+++++||+|+||.||+|++..+++.||||++... ...+.+|+++++.|.|.+++..+..+...+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-------- 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEG-------- 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEET--------
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeC--------
Confidence 3568999999999999999999999999999999987543 456778999999998755444444443333
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (483)
T 3sv0_A 76 -------------------------------------------------------------------------------- 75 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+.+||||||+++|.+++.. ....+++..++.++.||+.|
T Consensus 76 -------------------------------------~~~~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~a 115 (483)
T 3sv0_A 76 -------------------------------------DYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINR 115 (483)
T ss_dssp -------------------------------------TEEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHH
T ss_pred -------------------------------------CEEEEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHH
Confidence 24899999999999999863 34679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEc--CCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCCcch
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLN--PETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~--~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
|.|||++||+|+||||+|||++ ...+.++|+|||++........ .....++..|+|||.+.+. .++.++
T Consensus 116 L~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~s 194 (483)
T 3sv0_A 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRD 194 (483)
T ss_dssp HHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHH
T ss_pred HHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHH
Confidence 9999999999999999999993 2678999999999976644322 1245789999999999887 799999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhH---HHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVD---QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 403 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e---~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~ 403 (444)
|||||||++|+|++|+.||.+..... .+..+......... ..+...+++++.+
T Consensus 195 DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------------------------~~l~~~~p~~l~~ 250 (483)
T 3sv0_A 195 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI------------------------EALCRGYPTEFAS 250 (483)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH------------------------HHHHTTSCHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH------------------------HHHhcCCcHHHHH
Confidence 99999999999999999998765433 23333221111111 1122356899999
Q ss_pred HHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 404 LISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 404 LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||..||+.||.+||++.+|++ .|+++...
T Consensus 251 li~~cl~~dP~~RPs~~el~~---~L~~l~~~ 279 (483)
T 3sv0_A 251 YFHYCRSLRFDDKPDYSYLKR---LFRDLFIR 279 (483)
T ss_dssp HHHHHHTCCTTCCCCHHHHHH---HHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHH---HHHHHHHH
Confidence 999999999999999999998 77776543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=318.95 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=205.7
Q ss_pred hcccc-chhheecccceeEEEEeE----ecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCC
Q psy10212 20 LDNSL-AQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 20 ~~~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (444)
+.++| ++++.||+|+||+||++. +..+|+.||||++... ...+.+|++++++++||||+++++++...+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 55666 999999999999997764 4557899999999654 2456789999999999999999999987643
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 108 -------------------------------------------------------------------------------- 107 (318)
T 3lxp_A 108 -------------------------------------------------------------------------------- 107 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
..+++|||||++ +|.+++.. ..+++..++.
T Consensus 108 --------------------------------------------~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~ 138 (318)
T 3lxp_A 108 --------------------------------------------ASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLL 138 (318)
T ss_dssp --------------------------------------------TEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHH
T ss_pred --------------------------------------------ceEEEEEecccCCcHHHHHhh-----CCCCHHHHHH
Confidence 358999999985 99988742 4599999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|||.+.+. .++.
T Consensus 139 i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 216 (318)
T 3lxp_A 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYY 216 (318)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEH
T ss_pred HHHHHHHHHHHHHhCCccCCCCchheEEEc-CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC-CCCc
Confidence 999999999999999999999999999999 788999999999977644321 2233567789999999877 7889
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHH----HHHhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE----QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
++|+||||+++|+|++|..||....... ....+..... .+.... ........+..+++.
T Consensus 217 ~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~ 279 (318)
T 3lxp_A 217 ASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMTVLRLTELL------------ERGERLPRPDKCPAE 279 (318)
T ss_dssp HHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHHHHHHHHHH------------HTTCCCCCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchhHHHHHHHH------------hcccCCCCCccccHH
Confidence 9999999999999999999997532211 0000000000 000000 000111223467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
+.+||.+||+.||.+|||+.|+++ +++.+.+...
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~---~L~~l~~~~~ 313 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIP---ILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH---HHHHHHHhhc
Confidence 999999999999999999999999 8888876654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.81 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=192.1
Q ss_pred hhhccccchh-heecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHh-hhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 18 SDLDNSLAQK-TVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIM-RRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 18 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
..+.++|.++ +.||+|+||.||+|+++.+++.||+|++.. .....+|+.++ +.++||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~------ 85 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYA------ 85 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET------
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC------
Confidence 3567788888 789999999999999999999999999864 34566888887 66699999999999876211
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (299)
T 3m2w_A 86 -------------------------------------------------------------------------------- 85 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
....+++|||||++ +|.+++.. .....+++..++.++.||+
T Consensus 86 ------------------------------------~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~ 127 (299)
T 3m2w_A 86 ------------------------------------GRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIG 127 (299)
T ss_dssp ------------------------------------TEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHH
T ss_pred ------------------------------------CCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHH
Confidence 01358999999985 99999864 2345799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCC--CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPE--TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~--~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.||+|||++|++|+||+|+||+++.. ++.++|+|||++.... +. .++.++|+||||
T Consensus 128 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~-~~~~~~DiwslG 185 (299)
T 3m2w_A 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GE-KYDKSCDMWSLG 185 (299)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TC-GGGGHHHHHHHH
T ss_pred HHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cc-cCCchhhHHHHH
Confidence 99999999999999999999999832 6789999999885431 12 567899999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|+.||.+.+..+....+.. .. ......+.......+++.+.+||.+||+.|
T Consensus 186 ~il~el~tg~~pf~~~~~~~~~~~~~~------------------~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 244 (299)
T 3m2w_A 186 VIMYILLCGYPPFYSNHGLAISPGMKT------------------RI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 244 (299)
T ss_dssp HHHHHHHHSSCSCCC-------CCSCC------------------SS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHCCCCCCCCcchhhhHHHHH------------------HH---hhccccCCchhcccCCHHHHHHHHHHcccC
Confidence 999999999999976543321110000 00 000001111112457999999999999999
Q ss_pred CCCCCCHHHHhccCchhhhhhhh
Q psy10212 413 PSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 413 P~kRPs~~elL~~hpwf~~~~~~ 435 (444)
|.+|||+.|+|+ ||||++....
T Consensus 245 P~~Rps~~e~l~-hp~~~~~~~~ 266 (299)
T 3m2w_A 245 PTQRMTITEFMN-HPWIMQSTKV 266 (299)
T ss_dssp TTTSCCHHHHHT-SHHHHTGGGS
T ss_pred hhhCCCHHHHhc-ChhhcccccC
Confidence 999999999999 9999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=333.07 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=204.5
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
--.++|++.+.||+|+||.||+|++.. ++.||||++... .+.+.+|+++|++++||||+++++++.. +.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~------ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP------ 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS------
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc------
Confidence 345789999999999999999999875 567999998643 3567899999999999999999988754 21
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 253 -------------------------------------------------------------------------------- 252 (452)
T 1fmk_A 253 -------------------------------------------------------------------------------- 252 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.++|||||+ ++|.+++.. ..+..+++..+..++.||+
T Consensus 253 ----------------------------------------~~iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~ 290 (452)
T 1fmk_A 253 ----------------------------------------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIA 290 (452)
T ss_dssp ----------------------------------------CEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHH
T ss_pred ----------------------------------------eEEEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHH
Confidence 789999998 599999853 2345689999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.||+|||++|++||||+|+||+++ .++.+||+|||++........ .....++..|+|||.+.+. .++.++|+||||
T Consensus 291 ~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG 368 (452)
T 1fmk_A 291 SGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFG 368 (452)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHH
T ss_pred HHHHHHHhCCeeCCCCChhhEEEC-CCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHH
Confidence 999999999999999999999998 788999999999976543221 1223456789999999877 799999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|+|++ |+.||.+.+..+....+.... .. ..+..+++.+.+||.+||+.
T Consensus 369 ~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------~~----------~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 369 ILLTELTTKGRVPYPGMVNREVLDQVERGY------------------RM----------PCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp HHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------CC----------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------CC----------CCCCCCCHHHHHHHHHHccC
Confidence 99999999 999999888776665544311 00 12345799999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||++|||+.++++ .++++..
T Consensus 421 dP~~Rpt~~~l~~---~L~~~~~ 440 (452)
T 1fmk_A 421 EPEERPTFEYLQA---FLEDYFT 440 (452)
T ss_dssp SGGGSCCHHHHHH---HHHTTTS
T ss_pred ChhhCcCHHHHHH---HHHHHhc
Confidence 9999999999998 6776543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.73 Aligned_cols=291 Identities=23% Similarity=0.279 Sum_probs=210.6
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
...++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|++++++++||||+++++++.......
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~-- 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA-- 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC--
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc--
Confidence 3458899999999999999999999999999999998543 345668999999999999999987764422100
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (676)
T 3qa8_A 89 -------------------------------------------------------------------------------- 88 (676)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....++|||||+ ++|.+++... .....+++..++.++.|
T Consensus 89 --------------------------------------~~~~~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~Q 129 (676)
T 3qa8_A 89 --------------------------------------PNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSD 129 (676)
T ss_dssp --------------------------------------TTSSCCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHH
T ss_pred --------------------------------------CCCeEEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHH
Confidence 0023789999996 5999988642 22346999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCC--eEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETG--VLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~--~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|+.||+|||++|++|+||+|+||+++.+.. .++|+|||.+.............+++.|+|||.+.+. .++.++|+||
T Consensus 130 Ll~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwS 208 (676)
T 3qa8_A 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWS 208 (676)
T ss_dssp HHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHH
T ss_pred HHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccC-CCCchhHHHH
Confidence 999999999999999999999999983322 4899999999877666555667889999999999877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
||+++|+|++|..||............. ........ .....................+...+++.+.++|.+||.
T Consensus 209 LGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~--~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~ 283 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHI--VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM 283 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------C--CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhh--hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHcc
Confidence 9999999999999997654332111000 00000000 000000000111111122233445568999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
+||.+|||+.|+|+ ||||+.+.....
T Consensus 284 ~DP~kRPTa~elL~-hp~F~~l~~iL~ 309 (676)
T 3qa8_A 284 WHQRQRGTDPQNPN-VGCFQALDSILS 309 (676)
T ss_dssp SSCC---CCTTCCC-CTTHHHHHHHHC
T ss_pred CCHhhCcCHHHHhc-CHHHHHHHHHHh
Confidence 99999999999999 999999876654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.92 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=194.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++|++.+.||+|+||+||+|++ .++.||+|++... ...+.+|++++++++||||+++++++.+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------------ 73 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP------------ 73 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT------------
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------------
Confidence 6899999999999999999998 4889999998543 35677899999999999999998765421
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (307)
T 2eva_A 74 -------------------------------------------------------------------------------- 73 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.++|||||++ +|.+++... .....++...++.++.||+.||+
T Consensus 74 ------------------------------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~ 116 (307)
T 2eva_A 74 ------------------------------------VCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVA 116 (307)
T ss_dssp ------------------------------------TEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------cEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHH
Confidence 6799999975 999988632 12234788999999999999999
Q ss_pred HHHH---CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 259 YIHV---LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 259 yLHs---~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
|||+ +|++|+||||+||+++.+...++|+|||.+...... .....+++.|+|||.+.+. .++.++|+||||+++
T Consensus 117 ~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il 193 (307)
T 2eva_A 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIIL 193 (307)
T ss_dssp HHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHH
T ss_pred HHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHH
Confidence 9999 899999999999999844445899999998654322 2334689999999999877 789999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCC
Q psy10212 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSS 415 (444)
Q Consensus 336 ~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~k 415 (444)
|+|++|+.||................+ ....+..++++.+.++|.+||+.||.+
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~ 247 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNG--------------------------TRPPLIKNLPKPIESLMTRCWSKDPSQ 247 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTT--------------------------CCCCCBTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcC--------------------------CCCCcccccCHHHHHHHHHHhcCChhh
Confidence 999999999986543221111111000 001123457899999999999999999
Q ss_pred CCCHHHHhccCchhhhhhhhh
Q psy10212 416 RISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 416 RPs~~elL~~hpwf~~~~~~~ 436 (444)
|||+.++++ .++.+...+
T Consensus 248 Rps~~ell~---~L~~~~~~~ 265 (307)
T 2eva_A 248 RPSMEEIVK---IMTHLMRYF 265 (307)
T ss_dssp SCCHHHHHH---HHHHHGGGC
T ss_pred CcCHHHHHH---HHHHHHHhc
Confidence 999999999 777766544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.46 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=206.1
Q ss_pred hccccchhheecccceeEEEEeE----ecCCCceeeeeeeeccc----cchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAK----LLDSGELVAIKKVLQDK----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
..++|++++.||+|+||.||+|+ +..+|+.||||++.... ..+.+|++++++++||||+++++++...+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR-- 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC--
Confidence 34679999999999999999998 46689999999985432 456789999999999999999998876542
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 117 -------------------------------------------------------------------------------- 116 (326)
T 2w1i_A 117 -------------------------------------------------------------------------------- 116 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..+++|||||++ +|.+++.. ....+++..++.++
T Consensus 117 ------------------------------------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~ 151 (326)
T 2w1i_A 117 ------------------------------------------RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 151 (326)
T ss_dssp -------------------------------------------CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHH
T ss_pred ------------------------------------------CceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHH
Confidence 237899999985 99999863 34569999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||.+||++|++|+||+|+||+++ .++.++|+|||++........ .....++..|+|||.+.+. .++.++
T Consensus 152 ~qi~~aL~~LH~~~ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 229 (326)
T 2w1i_A 152 SQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVAS 229 (326)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHH
T ss_pred HHHHHHHHHHHhCCEeccCCCcceEEEc-CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchh
Confidence 9999999999999999999999999999 788999999999976543322 1223457779999999877 789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHH-----HH-HhhCCCCCcccCCCccCCCCcccccCCCChh
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTRE-----QI-REMNPNYTEFKFPQIKSHPWSKVFRVRTPPD 400 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~-----~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~ 400 (444)
|+||||+++|+|++|..||..... ...+..+..... .+ ..... ......+..+++.
T Consensus 230 Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~ 291 (326)
T 2w1i_A 230 DVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIVFHLIELLKN-------------NGRLPRPDGCPDE 291 (326)
T ss_dssp HHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHHHHHHHHHHT-------------TCCCCCCTTCCHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhHHHHHHHhhc-------------CCCCCCCCcccHH
Confidence 999999999999999999864211 111111111100 00 00000 0001123467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
+.++|.+||+.||.+|||+.|+++ .+++++...
T Consensus 292 l~~li~~cl~~dP~~Rps~~el~~---~L~~l~~~l 324 (326)
T 2w1i_A 292 IYMIMTECWNNNVNQRPSFRDLAL---RVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH---HHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH---HHHHHHHHh
Confidence 999999999999999999999999 888877654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.54 Aligned_cols=268 Identities=20% Similarity=0.294 Sum_probs=198.2
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-cchhhHHHHhhh--cCCCceeEeeeEEeecCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RFKNREMQIMRR--LEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
-..+.++|++++.||+|+||.||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++......
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~--- 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS--- 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG---
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC---
Confidence 355678999999999999999999998 48999999985543 333445555444 4999999999998876420
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 107 -------------------------------------------------------------------------------- 106 (337)
T 3mdy_A 107 -------------------------------------------------------------------------------- 106 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...+++|||||++ +|.+++.. ..+++..++.++.|
T Consensus 107 ---------------------------------------~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~ 142 (337)
T 3mdy_A 107 ---------------------------------------WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYS 142 (337)
T ss_dssp ---------------------------------------GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHH
T ss_pred ---------------------------------------CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHH
Confidence 0248999999985 99999853 46999999999999
Q ss_pred HHHHHHHHHHC--------CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC-----ccccccccccCchhhccC
Q psy10212 253 LFRSLAYIHVL--------GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN-----VSYICSRYYRAPELIFGA 319 (444)
Q Consensus 253 Il~aL~yLHs~--------givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~-----~~~~gt~~y~aPE~l~~~ 319 (444)
++.||.|||++ |++|+||||+||+++ .++.++|+|||++......... ....+|+.|+|||.+.+.
T Consensus 143 i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 221 (337)
T 3mdy_A 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221 (337)
T ss_dssp HHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHhhhhhccCCCEEecccchHHEEEC-CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc
Confidence 99999999999 999999999999999 7889999999998665333221 244689999999999776
Q ss_pred CCCCcc------hhhhhHHHHHHHHHhC----------CCCCCCCChhH-HHHHHHHHhCCCCHHHHHhhCCCCCcccCC
Q psy10212 320 IDYTTK------IDVWSAGCVLAELLLG----------QPMFPGDSGVD-QLVEIIKVLGTPTREQIREMNPNYTEFKFP 382 (444)
Q Consensus 320 ~~~s~~------sDiwSLGvil~eLltG----------~~Pf~~~~~~e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p 382 (444)
..... +|+|||||++|+|++| +.||....... ....+...... ......++
T Consensus 222 -~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 289 (337)
T 3mdy_A 222 -LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI-----------KKLRPSFP 289 (337)
T ss_dssp -CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----------SCCCCCCC
T ss_pred -cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhh-----------hccCcccc
Confidence 44443 9999999999999999 77776532211 11111111000 00000000
Q ss_pred CccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 383 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 383 ~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.......+++.+.+||.+||+.||.+|||+.++++ .++.+.+..
T Consensus 290 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~---~L~~l~~~~ 333 (337)
T 3mdy_A 290 -------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK---TLAKMSESQ 333 (337)
T ss_dssp -------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH---HHHHHHHTT
T ss_pred -------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH---HHHHHHhhc
Confidence 00111245788999999999999999999999999 677766543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=310.43 Aligned_cols=257 Identities=20% Similarity=0.264 Sum_probs=202.1
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
++--.++|++.+.||+|+||+||+|++.. .+|+|++... ...+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH- 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC-
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc-
Confidence 44456899999999999999999999843 5999998532 2456789999999999999999999876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 104 -------------------------------------------------------------------------------- 103 (319)
T 2y4i_B 104 -------------------------------------------------------------------------------- 103 (319)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHH
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLY 249 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i 249 (444)
+++|||||+ ++|.+++. .....+++..++.+
T Consensus 104 ---------------------------------------------~~iv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i 135 (319)
T 2y4i_B 104 ---------------------------------------------LAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQI 135 (319)
T ss_dssp ---------------------------------------------EEEECBCCCSEEHHHHTT---SSCCCCCSHHHHHH
T ss_pred ---------------------------------------------eEEEeecccCCcHHHHHH---hcCCCCCHHHHHHH
Confidence 899999998 58988874 23457999999999
Q ss_pred HHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC------CCCccccccccccCchhhcc-----
Q psy10212 250 IYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG------EPNVSYICSRYYRAPELIFG----- 318 (444)
Q Consensus 250 ~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~------~~~~~~~gt~~y~aPE~l~~----- 318 (444)
+.||+.||+|||++|++|+||+|+||+++ ++.++|+|||++...... .......+++.|+|||.+.+
T Consensus 136 ~~qi~~al~~lH~~~i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 213 (319)
T 2y4i_B 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213 (319)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC-
T ss_pred HHHHHHHHHHHHhCCccccCCChhhEEEe--CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccc
Confidence 99999999999999999999999999998 578999999987654211 12223457899999999865
Q ss_pred ---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccC
Q psy10212 319 ---AIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395 (444)
Q Consensus 319 ---~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 395 (444)
...++.++|+||||+++|+|++|+.||...+.......+..... + .....
T Consensus 214 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------------~--------~~~~~ 266 (319)
T 2y4i_B 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK-------------------P--------NLSQI 266 (319)
T ss_dssp -CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC-------------------C--------CCCCS
T ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC-------------------C--------CCCcC
Confidence 22578999999999999999999999998877665554433100 0 01112
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 396 ~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.++..+.++|.+||..||.+|||+.++++ .++++.....
T Consensus 267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~---~l~~l~~~~~ 305 (319)
T 2y4i_B 267 GMGKEISDILLFCWAFEQEERPTFTKLMD---MLEKLPKRNR 305 (319)
T ss_dssp SCCTTHHHHHHHHHCSSTTTSCCHHHHHH---HHTTC-----
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH---HHHHHHHhhc
Confidence 46889999999999999999999999999 8888766543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.94 Aligned_cols=255 Identities=24% Similarity=0.288 Sum_probs=197.9
Q ss_pred ccccchhheecccceeEEEEeEecCCC---ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG---ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
...|.+.+.||+|+||+||+|++..++ ..+|+|.+... .+.+.+|+.++++++||||+++++++...+.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--- 164 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--- 164 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS---
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC---
Confidence 346788899999999999999986433 46899988432 2456789999999999999999998765431
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 165 -------------------------------------------------------------------------------- 164 (373)
T 3c1x_A 165 -------------------------------------------------------------------------------- 164 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..++|||||++ +|.+++. .....+++..++.++.
T Consensus 165 ------------------------------------------~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~ 199 (373)
T 3c1x_A 165 ------------------------------------------SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 199 (373)
T ss_dssp ------------------------------------------CCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHH
T ss_pred ------------------------------------------CeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHH
Confidence 27899999985 9999885 3445688999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCCCCCcch
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
||+.||.|||++|++||||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.++
T Consensus 200 qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 277 (373)
T 3c1x_A 200 QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKS 277 (373)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC---------------------CCGGGSCHHHHHHC-CCCHHH
T ss_pred HHHHHHHHHHHCCEecCccchheEEEC-CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC-CCCcHH
Confidence 999999999999999999999999999 788999999999975533221 1233457789999999877 899999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|+||||+++|+|++ |.+||.+.+..+....+.... ....+..+++.+.++|
T Consensus 278 DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----------------------------~~~~p~~~~~~l~~li 329 (373)
T 3c1x_A 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------------------------RLLQPEYCPDPLYEVM 329 (373)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----------------------------CCCCCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHH
Confidence 99999999999999 788998877666554443310 0011235789999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRAVF 436 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~ 436 (444)
.+||+.||.+|||+.|+++ .++.+....
T Consensus 330 ~~cl~~dp~~RPs~~ell~---~L~~i~~~~ 357 (373)
T 3c1x_A 330 LKCWHPKAEMRPSFSELVS---RISAIFSTF 357 (373)
T ss_dssp HHHTCSSGGGSCCHHHHHH---HHHHHHHTC
T ss_pred HHHcCCChhhCcCHHHHHH---HHHHHHHhc
Confidence 9999999999999999999 677765443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.49 Aligned_cols=185 Identities=21% Similarity=0.261 Sum_probs=150.0
Q ss_pred EEEEeccCCCcHHHHHHhh---hhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCc
Q psy10212 216 LNLVLEFMPETVYKVAKHY---SKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292 (444)
Q Consensus 216 ~~iv~e~~~~~l~~~~~~~---~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s 292 (444)
.+++|+++.++|.+++... .....++++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus 180 ~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~-~~~~~kL~DFG~a 258 (413)
T 3dzo_A 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGVFLTGFEHL 258 (413)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCGGGC
T ss_pred eEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEe-cCCeEEEEeccce
Confidence 7899999999999988543 23345577888999999999999999999999999999999999 7888999999998
Q ss_pred ccccCCCCCccccccccccCchhhc---------cCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCC
Q psy10212 293 KHLVRGEPNVSYICSRYYRAPELIF---------GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGT 363 (444)
Q Consensus 293 ~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~ 363 (444)
+..... .....+ +.|+|||.+. ....++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 259 ~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~------ 329 (413)
T 3dzo_A 259 VRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------ 329 (413)
T ss_dssp EETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG------
T ss_pred eecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH------
Confidence 764333 334466 9999999983 2226888999999999999999999999865533211100
Q ss_pred CCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 364 PTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+. -...+|+.+.+||.+||+.||.+|||+.++|+ ||||++++.....
T Consensus 330 -----------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~-~~~~~~~~~~~~~ 376 (413)
T 3dzo_A 330 -----------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME-TPEYEQLRTELSA 376 (413)
T ss_dssp -----------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT-SHHHHHHHHHHHH
T ss_pred -----------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh-CHHHHHHHHHHHH
Confidence 00 01256899999999999999999999999999 9999998876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.14 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=207.8
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+--.++|++.++||+|+||.||+|++.. ++.||||++... .+.+.+|+++|++|+|+||+++++++.. +.
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~----- 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP----- 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS-----
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc-----
Confidence 3345789999999999999999999875 567999999543 3567899999999999999999988754 21
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 336 -------------------------------------------------------------------------------- 335 (535)
T 2h8h_A 336 -------------------------------------------------------------------------------- 335 (535)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++||||||++ +|.+++.. ..+..+++..++.++.||
T Consensus 336 -----------------------------------------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi 372 (535)
T 2h8h_A 336 -----------------------------------------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQI 372 (535)
T ss_dssp -----------------------------------------CEEEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHH
T ss_pred -----------------------------------------ceEeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHH
Confidence 7899999985 99999853 234568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||+|||+++++||||+|+||+++ .++.+||+|||++....... ......++..|+|||.+.+. .++.++|||||
T Consensus 373 ~~~L~~LH~~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSl 450 (535)
T 2h8h_A 373 ASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSF 450 (535)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHH
T ss_pred HHHHHHHHhCCeeCCCCCHhhEEEc-CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHH
Confidence 9999999999999999999999998 78899999999997653211 11223456789999999877 79999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 332 GCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 332 Gvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|+++|+|++ |+.||.+.+..+....+.... . ...+..+++.+.+||.+||+
T Consensus 451 Gv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------~----------~~~~~~~~~~l~~li~~cl~ 502 (535)
T 2h8h_A 451 GILLTELTTKGRVPYPGMVNREVLDQVERGY------------------R----------MPCPPECPESLHDLMCQCWR 502 (535)
T ss_dssp HHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------------------C----------CCCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------C----------CCCCCCCCHHHHHHHHHHcC
Confidence 999999999 999999888776665544311 0 01234579999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
.||++|||+.++++ .++++.
T Consensus 503 ~dP~~RPt~~~l~~---~L~~~~ 522 (535)
T 2h8h_A 503 KEPEERPTFEYLQA---FLEDYF 522 (535)
T ss_dssp SSGGGSCCHHHHHH---HHHTSS
T ss_pred CChhHCcCHHHHHH---HHHHHh
Confidence 99999999999998 666653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.02 Aligned_cols=249 Identities=25% Similarity=0.279 Sum_probs=200.6
Q ss_pred ccchhh-eecccceeEEEEeEecC--CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 23 SLAQKT-VIGNGSFGIVYQAKLLD--SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 23 ~y~~~~-~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++.+.+ .||+|+||.||+|.++. ++..||||++... .+.+.+|+++|++++||||+++++++..+.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------ 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSS------
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCC------
Confidence 344444 89999999999998763 4567999998542 356779999999999999999999885422
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 410 -------------------------------------------------------------------------------- 409 (613)
T 2ozo_A 410 -------------------------------------------------------------------------------- 409 (613)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+++|||||++ +|.+++. .....+++..++.++.||
T Consensus 410 -----------------------------------------~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi 445 (613)
T 2ozo_A 410 -----------------------------------------LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQV 445 (613)
T ss_dssp -----------------------------------------EEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHH
Confidence 8899999985 8988874 245679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcchhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
+.||+|||++|++||||||+||+++ .++.+||+|||+++........ ....+++.|+|||.+.+. .++.++|||
T Consensus 446 ~~~L~~LH~~~iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvw 523 (613)
T 2ozo_A 446 SMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVW 523 (613)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHH
T ss_pred HHHHHHHHHCCEEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHH
Confidence 9999999999999999999999999 7889999999999765332211 122345789999999877 899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 330 SAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 330 SLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
||||++|+|++ |+.||.+.+..+....+.... ...++..+++.+.+||.+|
T Consensus 524 SlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~c 575 (613)
T 2ozo_A 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------------------RMECPPECPPELYALMSDC 575 (613)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHH
Confidence 99999999998 999999888777665554311 0112346799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+||++.++++ .++++..
T Consensus 576 l~~dP~~RPs~~~l~~---~L~~~~~ 598 (613)
T 2ozo_A 576 WIYKWEDRPDFLTVEQ---RMRACYY 598 (613)
T ss_dssp TCSSTTTSCCHHHHHH---HHHHHHH
T ss_pred cCCChhHCcCHHHHHH---HHHHHHH
Confidence 9999999999999988 6666543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=310.66 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=203.9
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhh--cCCCceeEeeeEEeecCCCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRR--LEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
-..+.++|.+.+.||+|+||+||+|++ +|+.||||++... ...+.+|++++.. ++||||+++++++.......
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~-- 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW-- 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC--
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc--
Confidence 355678999999999999999999998 5999999999543 3455678888887 79999999999987754200
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 113 -------------------------------------------------------------------------------- 112 (342)
T 1b6c_B 113 -------------------------------------------------------------------------------- 112 (342)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
..+++|||||++ +|.+++.. .++++..++.++.|
T Consensus 113 ----------------------------------------~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~ 147 (342)
T 1b6c_B 113 ----------------------------------------TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALS 147 (342)
T ss_dssp ----------------------------------------CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHH
T ss_pred ----------------------------------------ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHH
Confidence 138999999986 99999853 46899999999999
Q ss_pred HHHHHHHHH--------HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccC
Q psy10212 253 LFRSLAYIH--------VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 253 Il~aL~yLH--------s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~ 319 (444)
|+.||.||| +++++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+.
T Consensus 148 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp HHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC-TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred HHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC-CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 999999999 89999999999999999 78899999999987654433 12344689999999998765
Q ss_pred CC-----CCcchhhhhHHHHHHHHHhC----------CCCCCCCChhH-HHHHHHHHhCCCCHHHHHhhCCCCCcccCCC
Q psy10212 320 ID-----YTTKIDVWSAGCVLAELLLG----------QPMFPGDSGVD-QLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 383 (444)
Q Consensus 320 ~~-----~s~~sDiwSLGvil~eLltG----------~~Pf~~~~~~e-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~ 383 (444)
.. ++.++|+||||+++|+|++| ..||......+ ....+.+.... ......++.
T Consensus 227 ~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 295 (342)
T 1b6c_B 227 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-----------QKLRPNIPN 295 (342)
T ss_dssp CCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----------SCCCCCCCG
T ss_pred ccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHH-----------HHhCCCCcc
Confidence 22 22689999999999999999 78887643211 11111111100 000000000
Q ss_pred ccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 384 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 384 ~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
......++..+.+||.+||+.||++|||+.++++ .++++...
T Consensus 296 -------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~---~L~~i~~~ 337 (342)
T 1b6c_B 296 -------RWQSCEALRVMAKIMRECWYANGAARLTALRIKK---TLSQLSQQ 337 (342)
T ss_dssp -------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH---HHHHHHHT
T ss_pred -------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHH---HHHHHHHH
Confidence 0011234578999999999999999999999999 67776654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=317.41 Aligned_cols=247 Identities=17% Similarity=0.226 Sum_probs=196.3
Q ss_pred hhhhccccchhheecccceeEEEEe-----EecCCCceeeeeeeecc-ccchhhHHHHhhhcC---CCceeEeeeEEeec
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQA-----KLLDSGELVAIKKVLQD-KRFKNREMQIMRRLE---HSNIVKLKYFFYSS 87 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 87 (444)
+.-..++|.+.+.||+|+||+||+| .+..+++.||||++... ...+.+|++++++++ |+||+++++.+...
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 3445688999999999999999999 46778999999999543 456678888888886 99999999999876
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 140 ~~------------------------------------------------------------------------------ 141 (365)
T 3e7e_A 140 NG------------------------------------------------------------------------------ 141 (365)
T ss_dssp SC------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 53
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh-cCCCCChHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK-SKQNFPCFY 245 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~l~~~~ 245 (444)
.++|||||+ ++|.+++..... ....+++..
T Consensus 142 ------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~ 173 (365)
T 3e7e_A 142 ------------------------------------------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173 (365)
T ss_dssp ------------------------------------------------EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHH
T ss_pred ------------------------------------------------cEEEEeccCCCcHHHHHHHhhcccccCCCHHH
Confidence 889999998 699999975444 456799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCC-----------CCeEEEeecCCcccccC---CCCCcccccccccc
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPE-----------TGVLKLCDFGSAKHLVR---GEPNVSYICSRYYR 311 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~-----------~~~ikL~Dfg~s~~~~~---~~~~~~~~gt~~y~ 311 (444)
++.++.||+.||+|||++||+||||||+||+++ . .+.++|+|||++..... ........||+.|+
T Consensus 174 ~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~-~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 252 (365)
T 3e7e_A 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG-NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ 252 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCC
T ss_pred HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec-ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCC
Confidence 999999999999999999999999999999998 4 78999999999965432 22233456899999
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 391 (444)
|||.+.+. .++.++|+|||||++|+|++|+.||....... ... ......
T Consensus 253 aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------------------------~~~----~~~~~~ 301 (365)
T 3e7e_A 253 CVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------------------------CKP----EGLFRR 301 (365)
T ss_dssp CHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------------------------EEE----CSCCTT
T ss_pred ChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc--------------------------eee----chhccc
Confidence 99999887 79999999999999999999999996432210 000 000000
Q ss_pred cccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 392 ~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
...++.+.+++..||+.+|.+|++..+.|.
T Consensus 302 ---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 302 ---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 023678999999999999999977666555
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.03 Aligned_cols=243 Identities=23% Similarity=0.266 Sum_probs=197.9
Q ss_pred heecccceeEEEEeEe--cCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKL--LDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
+.||+|+||+||+|.+ +.+++.||||++... .+.+.+|+++|++++||||+++++++..+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----------- 443 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES----------- 443 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----------
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----------
Confidence 4799999999999955 456789999998543 245678999999999999999999874321
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 444 -------------------------------------------------------------------------------- 443 (635)
T 4fl3_A 444 -------------------------------------------------------------------------------- 443 (635)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.++|||||++ +|.+++. ....+++..++.++.||+.||+
T Consensus 444 ------------------------------------~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~ 483 (635)
T 4fl3_A 444 ------------------------------------WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMK 483 (635)
T ss_dssp ------------------------------------EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------EEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHH
Confidence 7899999985 8999885 3467999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|||++||+||||||+||+++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||+
T Consensus 484 yLH~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 484 YLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVL 561 (635)
T ss_dssp HHHHTTCCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHH
T ss_pred HHHHCCEeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHH
Confidence 99999999999999999999 788999999999876543321 1223456789999999877 79999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++ |+.||.+.+..+....+.... ....+..+++++.+||.+||+.||
T Consensus 562 l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~cl~~dP 613 (635)
T 4fl3_A 562 MWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------------------RMGCPAGCPREMYDLMNLCWTYDV 613 (635)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSST
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCH
Confidence 999998 999999888776655554311 011234679999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~ 434 (444)
++|||+.++++ .++++..
T Consensus 614 ~~RPs~~~l~~---~L~~~~~ 631 (635)
T 4fl3_A 614 ENRPGFAAVEL---RLRNYYY 631 (635)
T ss_dssp TTSCCHHHHHH---HHHHHHH
T ss_pred hHCcCHHHHHH---HHHHHHH
Confidence 99999999998 6666543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.58 Aligned_cols=279 Identities=22% Similarity=0.336 Sum_probs=195.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-cchh--hHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RFKN--REMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~--~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|++++.||+|+||.||+|++ +++.||||++.... ..+. +|+..+..++||||+++++.+......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~------- 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD------- 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT-------
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccC-------
Confidence 47899999999999999999987 78999999985432 2333 344455668999999998766543210
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (336)
T 3g2f_A 83 -------------------------------------------------------------------------------- 82 (336)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
....+++|||||+ ++|.+++.. ...++..++.++.||+.|
T Consensus 83 ----------------------------------~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~ 123 (336)
T 3g2f_A 83 ----------------------------------GRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRG 123 (336)
T ss_dssp ----------------------------------SCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHH
T ss_pred ----------------------------------CCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHH
Confidence 0134789999997 599999853 345889999999999999
Q ss_pred HHHHHHC---------CcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---------CCccccccccccCchhhcc
Q psy10212 257 LAYIHVL---------GICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---------PNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 257 L~yLHs~---------givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---------~~~~~~gt~~y~aPE~l~~ 318 (444)
|.|||++ |++|+||||+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+
T Consensus 124 L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp HHHHHCCBCCGGGCBCCEECSSCSGGGEEEC-TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred HHHHHhhhccccccccceeecccccceEEEc-CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9999999 999999999999999 78899999999997653321 1223468999999999976
Q ss_pred C------CCCCcchhhhhHHHHHHHHHhCCCCC-CCCChhHHHHHHHHHh-CCCCHHHHHhhC-CCCCcccCCCccCCCC
Q psy10212 319 A------IDYTTKIDVWSAGCVLAELLLGQPMF-PGDSGVDQLVEIIKVL-GTPTREQIREMN-PNYTEFKFPQIKSHPW 389 (444)
Q Consensus 319 ~------~~~s~~sDiwSLGvil~eLltG~~Pf-~~~~~~e~~~~i~~~~-g~~~~~~~~~~~-~~~~~~~~p~~~~~~~ 389 (444)
. ..++.++|||||||++|+|++|..|| .+....+....+.... ..+....+.... .......+|. .+
T Consensus 203 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 278 (336)
T 3g2f_A 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AW 278 (336)
T ss_dssp CCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TC
T ss_pred CcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cc
Confidence 2 24567899999999999999996654 3332221111111111 112222221110 0000001110 00
Q ss_pred cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 390 ~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
.. ...+++.+.+||.+||+.||++|||+.|+++ .++++....+
T Consensus 279 ~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~---~L~~ll~~~~ 321 (336)
T 3g2f_A 279 KE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEE---RMAELMMIWE 321 (336)
T ss_dssp CC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH---HHHHHHHCCC
T ss_pred cc--ccchHHHHHHHHHHHhcCChhhCcchHHHHH---HHHHHHHHHH
Confidence 00 1124568999999999999999999999988 7777665443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=332.19 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=207.5
Q ss_pred hhhhccccchhheecccceeEEEEeEecCC---Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDS---GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
++-..++|++.+.||+|+||+||+|++..+ +..+|||.+... .+.+.+|+.++++++||||+++++++..+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN- 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 344567899999999999999999998654 457999988542 25667899999999999999999887332
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 464 -------------------------------------------------------------------------------- 463 (656)
T 2j0j_A 464 -------------------------------------------------------------------------------- 463 (656)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.+++|||||+ ++|.+++.. ....+++..++
T Consensus 464 ----------------------------------------------~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~ 494 (656)
T 2j0j_A 464 ----------------------------------------------PVWIIMELCTLGELRSFLQV---RKFSLDLASLI 494 (656)
T ss_dssp ----------------------------------------------SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHH
T ss_pred ----------------------------------------------ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHH
Confidence 1789999998 599998863 34568999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
.++.||+.||.|||++|++||||||+||+++ .++.++|+|||++........ .....+++.|+|||.+.+. .++.+
T Consensus 495 ~i~~qi~~aL~~LH~~givHrDikp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~ 572 (656)
T 2j0j_A 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSA 572 (656)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHH
T ss_pred HHHHHHHHHHHHHHhCCccccccchHhEEEe-CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCch
Confidence 9999999999999999999999999999999 788999999999976543322 1223456789999999877 89999
Q ss_pred hhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 326 IDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 326 sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
+|+||||+++|+|++ |..||.+.+..+....+..... ..++.++++.+.++
T Consensus 573 ~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------------LPMPPNCPPTLYSL 624 (656)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHH
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccccHHHHHH
Confidence 999999999999997 9999998887777666554210 01234679999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|.+||+.||.+|||+.++++ .++++.+
T Consensus 625 i~~~l~~dP~~RPs~~el~~---~L~~il~ 651 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKA---QLSTILE 651 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH---HHHHHHH
Confidence 99999999999999999998 6776643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=315.16 Aligned_cols=269 Identities=17% Similarity=0.130 Sum_probs=192.1
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhcC---------CCceeE
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRLE---------HSNIVK 79 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l~---------h~~i~~ 79 (444)
.++|++++.||+|+||+||+|++ +|+.||||++.... +.+.+|+.++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 78999999996542 45678999999885 999999
Q ss_pred eeeEEeecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchh
Q psy10212 80 LKYFFYSSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTRE 159 (444)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (444)
+.+.+...+..+ ..+++.++
T Consensus 97 l~~~~~~~~~~h-------------------------------------------------------p~iv~~~~----- 116 (336)
T 2vuw_A 97 LNSVHCVQGSYP-------------------------------------------------------PLLLKAWD----- 116 (336)
T ss_dssp EEEEEEEESSCC-------------------------------------------------------HHHHHHHH-----
T ss_pred hcceeEecCCCc-------------------------------------------------------HHHHHHHH-----
Confidence 998887654210 00111110
Q ss_pred hhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCC---cccceEEEEeccCCC-cHHHHHHhhh
Q psy10212 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRIS---PLQVFLNLVLEFMPE-TVYKVAKHYS 235 (444)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~iv~e~~~~-~l~~~~~~~~ 235 (444)
-+....++.... .....+|||||||++ ++.+.+.
T Consensus 117 ---------------------------------------~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--- 154 (336)
T 2vuw_A 117 ---------------------------------------HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--- 154 (336)
T ss_dssp ---------------------------------------HHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---
T ss_pred ---------------------------------------HHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---
Confidence 000000000000 012459999999975 5665552
Q ss_pred hcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCC--------------------eEEEeecCCccc
Q psy10212 236 KSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETG--------------------VLKLCDFGSAKH 294 (444)
Q Consensus 236 ~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~--------------------~ikL~Dfg~s~~ 294 (444)
...+++..++.++.||+.||+||| ++||+||||||+||+++ ..+ .+||+|||+++.
T Consensus 155 --~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 231 (336)
T 2vuw_A 155 --TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL 231 (336)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence 256899999999999999999999 99999999999999998 444 899999999976
Q ss_pred ccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH-HHHHHhCCCCCCCCCh-hHHHHHHHHHhCCCCHHHHHhh
Q psy10212 295 LVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV-LAELLLGQPMFPGDSG-VDQLVEIIKVLGTPTREQIREM 372 (444)
Q Consensus 295 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi-l~eLltG~~Pf~~~~~-~e~~~~i~~~~g~~~~~~~~~~ 372 (444)
... ....||+.|+|||++.+. . +.++||||++++ .++++.|..||.+... ......+.....
T Consensus 232 ~~~----~~~~gt~~y~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 295 (336)
T 2vuw_A 232 ERD----GIVVFCDVSMDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT---------- 295 (336)
T ss_dssp EET----TEEECCCCTTCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC----------
T ss_pred cCC----CcEEEeecccChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc----------
Confidence 543 245789999999999876 3 899999998777 6778889998843211 111112221000
Q ss_pred CCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHh-ccCchhh
Q psy10212 373 NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVR-SITPFLI 430 (444)
Q Consensus 373 ~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL-~~hpwf~ 430 (444)
.+ ..........+|+++.+||.+||+.| |+.|+| + ||||+
T Consensus 296 --------~~----~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~-Hp~f~ 336 (336)
T 2vuw_A 296 --------FK----TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQ-HSLFK 336 (336)
T ss_dssp --------CS----SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHH-CGGGC
T ss_pred --------cC----cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhc-CCCcC
Confidence 00 00001112346899999999999977 999999 9 99995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=335.18 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=200.1
Q ss_pred hhhccccchhheecccceeEEEEeEecC-CCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLD-SGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
+.+.++|++++.||+|+||+||+|++.. +|+.||||++... ...+.+|++++++++||||+++++++...+...
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 4566899999999999999999999976 7899999988533 235568999999999999999999998765310
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 156 -------------------------------------------------------------------------------- 155 (681)
T 2pzi_A 156 -------------------------------------------------------------------------------- 155 (681)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
..+.|||||||++ +|.+++. .++++..++.++
T Consensus 156 -----------------------------------------~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~ 188 (681)
T 2pzi_A 156 -----------------------------------------DPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYL 188 (681)
T ss_dssp -----------------------------------------CEEEEEEEECCCCEECC----------CCCCHHHHHHHH
T ss_pred -----------------------------------------CceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHH
Confidence 0247999999985 7776653 279999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||.|||++||+|+||||+||+++ . +.++|+|||++...... ....||+.|+|||.+.+. ++.++||||
T Consensus 189 ~qi~~aL~~lH~~giiHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~s 261 (681)
T 2pzi_A 189 LEILPALSYLHSIGLVYNDLKPENIMLT-E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYT 261 (681)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEC-S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCeecccChHHeEEe-C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhh
Confidence 9999999999999999999999999998 3 48999999999765332 455789999999998775 489999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|..||.+..... .+. ......+++.+.+||.+||+
T Consensus 262 lG~~l~~l~~g~~~~~~~~~~~----------------------------~~~-------~~~~~~~~~~l~~li~~~l~ 306 (681)
T 2pzi_A 262 VGRTLAALTLDLPTRNGRYVDG----------------------------LPE-------DDPVLKTYDSYGRLLRRAID 306 (681)
T ss_dssp HHHHHHHHHSCCCEETTEECSS----------------------------CCT-------TCHHHHHCHHHHHHHHHHTC
T ss_pred hHHHHHHHHhCCCCCccccccc----------------------------ccc-------cccccccCHHHHHHHhhhcc
Confidence 9999999999999886521110 000 00001236889999999999
Q ss_pred cCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.||.+||+..+.+. |+|+.-++..
T Consensus 307 ~dP~~R~~~~~~l~-~~l~~~~~~~ 330 (681)
T 2pzi_A 307 PDPRQRFTTAEEMS-AQLTGVLREV 330 (681)
T ss_dssp SSGGGSCSSHHHHH-HHHHHHHHHH
T ss_pred CChhhCCCHHHHHH-HHHHHHHHHh
Confidence 99999999999999 9999877654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=293.22 Aligned_cols=232 Identities=13% Similarity=0.036 Sum_probs=183.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
+.++|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+|++.+.+++||||+++++++...+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~---- 104 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA---- 104 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC----
Confidence 4578999999999999999999999999999999995432 45678999999999999999999987764
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 105 -------------------------------------------------------------------------------- 104 (286)
T 3uqc_A 105 -------------------------------------------------------------------------------- 104 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
..|+|||||++ +|.+++.. ......+..++.
T Consensus 105 ------------------------------------------~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ 136 (286)
T 3uqc_A 105 ------------------------------------------GGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQ 136 (286)
T ss_dssp ------------------------------------------EEEEEEECCCEEEHHHHHTT------CCCHHHHHHHHH
T ss_pred ------------------------------------------cEEEEEEecCCCCHHHHHhc------CCChHHHHHHHH
Confidence 38999999985 89888732 245667888999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
||+.||+|||++|++|+||||+||+++ .++.++|++++ |++ .++.++|+|||
T Consensus 137 ql~~aL~~lH~~givH~Dikp~NIll~-~~g~~kl~~~~-------------------~~~--------~~~~~~Di~sl 188 (286)
T 3uqc_A 137 SLAAAADAAHRAGVALSIDHPSRVRVS-IDGDVVLAYPA-------------------TMP--------DANPQDDIRGI 188 (286)
T ss_dssp HHHHHHHHHHHTTCCCCCCSGGGEEEE-TTSCEEECSCC-------------------CCT--------TCCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCccCCCCcccEEEc-CCCCEEEEecc-------------------ccC--------CCCchhHHHHH
Confidence 999999999999999999999999999 78899987443 222 36889999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+.+....+ .. .........+..++++.+.++|.+||+.
T Consensus 189 G~il~elltg~~Pf~~~~~~~~~~~~~~---------------------~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 189 GASLYALLVNRWPLPEAGVRSGLAPAER---------------------DT-AGQPIEPADIDRDIPFQISAVAARSVQG 246 (286)
T ss_dssp HHHHHHHHHSEECSCCCSBCCCSEECCB---------------------CT-TSCBCCHHHHCTTSCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHCCCCCCcCCcchhhHHHHH---------------------Hh-ccCCCChhhcccCCCHHHHHHHHHHccc
Confidence 9999999999999987654321100000 00 0000111123456899999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
||.+| |+.|+++ .++++.....
T Consensus 247 dP~~R-s~~el~~---~L~~~~~~~~ 268 (286)
T 3uqc_A 247 DGGIR-SASTLLN---LMQQATAVAD 268 (286)
T ss_dssp TSSCC-CHHHHHH---HHHHHHC---
T ss_pred CCccC-CHHHHHH---HHHHHhccCC
Confidence 99999 9999999 7877665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=260.80 Aligned_cols=179 Identities=18% Similarity=0.071 Sum_probs=127.1
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeecc--------------ccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------------KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 92 (444)
..++.|++|.+..++....|+.||+|.+..+ .+.+.+|+++|+++ .|+||+++++++.+++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~--- 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS--- 316 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE---
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE---
Confidence 3567888888888888889999999999543 13577899999999 79999999999987753
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 317 -------------------------------------------------------------------------------- 316 (569)
T 4azs_A 317 -------------------------------------------------------------------------------- 316 (569)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
+|||||||+| +|.+.+. ..+++++. .|+.
T Consensus 317 -------------------------------------------~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~ 346 (569)
T 4azs_A 317 -------------------------------------------GWLVMEKLPGRLLSDMLA----AGEEIDRE---KILG 346 (569)
T ss_dssp -------------------------------------------EEEEEECCCSEEHHHHHH----TTCCCCHH---HHHH
T ss_pred -------------------------------------------EEEEEecCCCCcHHHHHH----hCCCCCHH---HHHH
Confidence 9999999997 9999985 34566654 5789
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
||+.||+|||++||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. +..++|+|+
T Consensus 347 QIl~AL~ylH~~GIIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s 423 (569)
T 4azs_A 347 SLLRSLAALEKQGFWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRS 423 (569)
T ss_dssp HHHHHHHHHHHTTCEESCCCGGGEEEC-TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------
T ss_pred HHHHHHHHHHHCCceeccCchHhEEEC-CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccc
Confidence 999999999999999999999999999 7899999999999765433 234456789999999999874 567899999
Q ss_pred HHHHHHHHHhCC
Q psy10212 331 AGCVLAELLLGQ 342 (444)
Q Consensus 331 LGvil~eLltG~ 342 (444)
+|++++.+.++.
T Consensus 424 ~g~~~~~l~~~~ 435 (569)
T 4azs_A 424 APVHPFNLPQPW 435 (569)
T ss_dssp -----CCCCTTH
T ss_pred cccchhhhcccc
Confidence 999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=223.80 Aligned_cols=177 Identities=15% Similarity=0.194 Sum_probs=135.9
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeeccc------------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK------------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
..+.||+|+||+||+|.. .++.+|+|+...+. +.+.+|++++++++||||+++..+......
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---- 413 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---- 413 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT----
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc----
Confidence 466899999999999954 68899999874321 235789999999999999966555554432
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 414 -------------------------------------------------------------------------------- 413 (540)
T 3en9_A 414 -------------------------------------------------------------------------------- 413 (540)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.|||||||+ ++|.+++.. +..++.|
T Consensus 414 ------------------------------------------~~lVmE~~~ggsL~~~l~~------------~~~i~~q 439 (540)
T 3en9_A 414 ------------------------------------------KRIMMSYINGKLAKDVIED------------NLDIAYK 439 (540)
T ss_dssp ------------------------------------------TEEEEECCCSEEHHHHSTT------------CTHHHHH
T ss_pred ------------------------------------------cEEEEECCCCCCHHHHHHH------------HHHHHHH
Confidence 689999998 699988742 5689999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--------CccccccccccCchhhcc--CCCC
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFG--AIDY 322 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~--~~~~ 322 (444)
|+.||.|||++|++||||||+||+++ . .++|+|||+++....... .....+|+.|+|||++.. . .|
T Consensus 440 i~~aL~~LH~~gIiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-~Y 515 (540)
T 3en9_A 440 IGEIVGKLHKNDVIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLE-GY 515 (540)
T ss_dssp HHHHHHHHHHTTEECTTCCTTSEEES-S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-HH
T ss_pred HHHHHHHHHHCcCccCCCCHHHEEEC-C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHH-HH
Confidence 99999999999999999999999999 4 999999999987643221 124578999999999975 3 56
Q ss_pred CcchhhhhHHHHHHHHHhCCCCCC
Q psy10212 323 TTKIDVWSAGCVLAELLLGQPMFP 346 (444)
Q Consensus 323 s~~sDiwSLGvil~eLltG~~Pf~ 346 (444)
+...|+|+..+-..+.+.++.+|.
T Consensus 516 ~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 516 KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHhHHHHHHHHHHHHHhccccC
Confidence 778899998888888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-21 Score=187.03 Aligned_cols=78 Identities=15% Similarity=0.200 Sum_probs=64.8
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
.++|||||+| +|.+ + .......++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++..
T Consensus 175 ~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~--~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 175 NAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--EEGIWIIDFPQSVE 241 (282)
T ss_dssp TEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--TTEEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE--CCcEEEEECCCCeE
Confidence 6899999986 7766 3 1234567999999999999999999999999999999 78999999999854
Q ss_pred ccCCCCCccccccccccCchhhcc
Q psy10212 295 LVRGEPNVSYICSRYYRAPELIFG 318 (444)
Q Consensus 295 ~~~~~~~~~~~gt~~y~aPE~l~~ 318 (444)
+..+.|||.+..
T Consensus 242 ------------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ------------VGEEGWREILER 253 (282)
T ss_dssp ------------TTSTTHHHHHHH
T ss_pred ------------CCCCCHHHHHHH
Confidence 334678887743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.5e-19 Score=169.16 Aligned_cols=69 Identities=16% Similarity=0.281 Sum_probs=57.9
Q ss_pred EEEEeccCCC------cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEcCCCCeEEEee
Q psy10212 216 LNLVLEFMPE------TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQNLLLNPETGVLKLCD 288 (444)
Q Consensus 216 ~~iv~e~~~~------~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH-s~givH~dLkp~NIll~~~~~~ikL~D 288 (444)
.++|||||++ +|.+... ..++..+..++.||+.+|.+|| ++|++||||||+||+++ . .++|+|
T Consensus 143 ~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~-~--~~~liD 212 (258)
T 1zth_A 143 NVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI-D--KVYFID 212 (258)
T ss_dssp TEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEES-S--SEEECC
T ss_pred CEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEc-C--cEEEEE
Confidence 5799999953 6665532 1235678899999999999999 99999999999999999 4 899999
Q ss_pred cCCccc
Q psy10212 289 FGSAKH 294 (444)
Q Consensus 289 fg~s~~ 294 (444)
||++..
T Consensus 213 FG~a~~ 218 (258)
T 1zth_A 213 MGQAVT 218 (258)
T ss_dssp CTTCEE
T ss_pred Cccccc
Confidence 999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=154.29 Aligned_cols=69 Identities=14% Similarity=0.190 Sum_probs=54.4
Q ss_pred EEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCC----------eE
Q psy10212 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETG----------VL 284 (444)
Q Consensus 216 ~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~----------~i 284 (444)
.+||||||+| +|..+ ........++.||+.+|.+||++|++||||||.|||++ +++ .+
T Consensus 186 ~~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~-~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR-EEKDAEDPSSITLTP 254 (397)
T ss_dssp TEEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-EEECSSCTTSEEEEE
T ss_pred ceEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe-CCCCcccccccccce
Confidence 3699999997 44322 12234567889999999999999999999999999997 333 48
Q ss_pred EEeecCCcccc
Q psy10212 285 KLCDFGSAKHL 295 (444)
Q Consensus 285 kL~Dfg~s~~~ 295 (444)
.|+||+.+...
T Consensus 255 ~iID~~Q~V~~ 265 (397)
T 4gyi_A 255 IIIXFPQMVSM 265 (397)
T ss_dssp EECCCTTCEET
T ss_pred EEEEeCCcccC
Confidence 99999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-10 Score=109.47 Aligned_cols=66 Identities=20% Similarity=0.031 Sum_probs=51.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeec----cccchhhHHHHhhhcC-CCceeEeeeEEeec
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ----DKRFKNREMQIMRRLE-HSNIVKLKYFFYSS 87 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 87 (444)
....|++...++.|+.+.||++.. .++.+++|.... ....+.+|+.+++.|. +..+.+++++....
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 82 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence 445688999999999999999986 478999999853 3456789999999984 55666666665443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=4.9e-09 Score=98.61 Aligned_cols=67 Identities=9% Similarity=-0.034 Sum_probs=44.6
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhcCCCce--eEeeeEEe
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRLEHSNI--VKLKYFFY 85 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~h~~i--~~~~~~~~ 85 (444)
......+.+..+.+.|+.+.||++.. .+|+.+++|..... ...+.+|+.+++.+.+.++ .+++.+..
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~ 85 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT 85 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc
Confidence 34445566655555666799999975 45788999987543 2456789999999865443 44555443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.7e-08 Score=100.69 Aligned_cols=58 Identities=12% Similarity=0.169 Sum_probs=40.5
Q ss_pred chhheecccceeEEEEeEecCCCceeeeeeee--c-----cccchhhHHHHhhhcCC--CceeEeeeEE
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVL--Q-----DKRFKNREMQIMRRLEH--SNIVKLKYFF 84 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~--~-----~~~~~~~E~~~l~~l~h--~~i~~~~~~~ 84 (444)
..++.|+.|.++.||++.. .+..+++|+.. . ....+.+|+.+++.|.. ..+.+++.+.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~ 107 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALC 107 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEEC
Confidence 3577899999999999987 35789999876 2 23567789999999974 3455555444
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.60 E-value=3.8e-08 Score=95.95 Aligned_cols=122 Identities=17% Similarity=0.166 Sum_probs=75.6
Q ss_pred eEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH-------------------------------
Q psy10212 215 FLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV------------------------------- 262 (444)
Q Consensus 215 ~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs------------------------------- 262 (444)
+-|+||++++| ++..... ..++......++.|++..|..||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp CSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 35789999998 4433221 245666667777777777777775
Q ss_pred ---------------------------CCcccCCCCCCcEEEcCC-CCeEEEeecCCcccccCCCCCccccccccc---c
Q psy10212 263 ---------------------------LGICHRDIKPQNLLLNPE-TGVLKLCDFGSAKHLVRGEPNVSYICSRYY---R 311 (444)
Q Consensus 263 ---------------------------~givH~dLkp~NIll~~~-~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y---~ 311 (444)
..++|+|+++.||+++.+ ...+.|+||+.+...... ......... .
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~ 240 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEY 240 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSC
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhcccc
Confidence 137999999999999833 456789999987543111 111001111 1
Q ss_pred Cchhhc----cCC---------CCCcchhhhhHHHHHHHHHhCCCCC
Q psy10212 312 APELIF----GAI---------DYTTKIDVWSAGCVLAELLLGQPMF 345 (444)
Q Consensus 312 aPE~l~----~~~---------~~s~~sDiwSLGvil~eLltG~~Pf 345 (444)
.|+... ... ......+.|+++.++|.+.+|..+|
T Consensus 241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222110 000 0122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=7.5e-05 Score=70.66 Aligned_cols=44 Identities=16% Similarity=0.062 Sum_probs=32.2
Q ss_pred eccccee-EEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhcC
Q psy10212 30 IGNGSFG-IVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRLE 73 (444)
Q Consensus 30 lg~G~~g-~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~ 73 (444)
+..|..| +||+......+..+++|.-... ...+.+|...|+.|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~ 77 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLT 77 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHT
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhc
Confidence 4445444 7999988777888999987443 345678999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=9.3e-05 Score=72.19 Aligned_cols=43 Identities=14% Similarity=0.066 Sum_probs=33.2
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEH 74 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h 74 (444)
++.++.|....||++ |+.+++|+-... ...+.+|..+|+.|.+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~ 68 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVG 68 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTT
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHh
Confidence 567889999999998 577899985322 2456789999999965
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00011 Score=73.89 Aligned_cols=48 Identities=17% Similarity=0.176 Sum_probs=33.3
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeecc-----------ccchhhHHHHhhhcC
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----------KRFKNREMQIMRRLE 73 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------~~~~~~E~~~l~~l~ 73 (444)
.++.||.|..+.||++.+..+++.+++|..... .+...+|.++++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~ 92 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 92 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence 366899999999999987666789999976321 123457888888773
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00023 Score=69.31 Aligned_cols=45 Identities=13% Similarity=0.197 Sum_probs=28.7
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLE 73 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~ 73 (444)
++.|+.|..+.||++.. .+..+++|+..........|+.+++.|.
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~ 81 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLA 81 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHH
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHH
Confidence 44566678999999986 3446999999765545556777777663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00032 Score=69.25 Aligned_cols=48 Identities=4% Similarity=0.023 Sum_probs=34.9
Q ss_pred hhhee-cccceeEEEEeEec--C----CCceeeeeeeeccc-------cchhhHHHHhhhcC
Q psy10212 26 QKTVI-GNGSFGIVYQAKLL--D----SGELVAIKKVLQDK-------RFKNREMQIMRRLE 73 (444)
Q Consensus 26 ~~~~l-g~G~~g~Vy~~~~~--~----~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~ 73 (444)
.++.| +.|....+|++... . +++.+++|...... ..+.+|+.+++.|.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~ 85 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVG 85 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHH
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHh
Confidence 45677 88989999998763 1 16789999874432 45678999988884
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0051 Score=57.30 Aligned_cols=97 Identities=14% Similarity=0.028 Sum_probs=63.2
Q ss_pred cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccc
Q psy10212 226 TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSY 304 (444)
Q Consensus 226 ~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~ 304 (444)
||.+.+. ..+.+++++++|.++.|.+.+|.-+-. +.-...-+.|..|++. .+|.+.+.+ ..+.
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW-RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe-cCCceeccc-cccc-----------
Confidence 6888776 467899999999999999999877632 2222344556888888 677776654 1110
Q ss_pred cccccccCchhhccCCCCCcchhhhhHHHHHHHHHh
Q psy10212 305 ICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340 (444)
Q Consensus 305 ~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt 340 (444)
.....+.|||.... ..+.+.=|||||+++|..+.
T Consensus 98 ~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSSS--SSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhh
Confidence 11234667876532 45788899999999998884
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0035 Score=60.42 Aligned_cols=42 Identities=12% Similarity=0.070 Sum_probs=30.3
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecccc---chhhHHHHhhhcCC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR---FKNREMQIMRRLEH 74 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~E~~~l~~l~h 74 (444)
++.|+.|....+|++ +.+++|+...... ...+|+.+++.+..
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~ 67 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAK 67 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHH
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHH
Confidence 788999999999999 5689998754322 22468888887743
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.008 Score=60.88 Aligned_cols=32 Identities=9% Similarity=0.181 Sum_probs=26.7
Q ss_pred HHCCcccCCCCCCcEEEcCCCCeEEEeecCCccc
Q psy10212 261 HVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKH 294 (444)
Q Consensus 261 Hs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~ 294 (444)
+...++|||+++.||+++ .++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~-~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT-QDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEEC-SSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEe-CCC-CEEEeCccccc
Confidence 346799999999999998 444 99999998855
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.011 Score=57.71 Aligned_cols=32 Identities=41% Similarity=0.556 Sum_probs=26.3
Q ss_pred CCcccCCCCCCcEEEcCC---CCeEEEeecCCccc
Q psy10212 263 LGICHRDIKPQNLLLNPE---TGVLKLCDFGSAKH 294 (444)
Q Consensus 263 ~givH~dLkp~NIll~~~---~~~ikL~Dfg~s~~ 294 (444)
..++|||+++.||+++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999832 26789999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.20 E-value=0.021 Score=55.01 Aligned_cols=45 Identities=11% Similarity=0.031 Sum_probs=30.8
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeec--cccchhhHHHHhhhcC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKNREMQIMRRLE 73 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~E~~~l~~l~ 73 (444)
++.|+.|....+|++... +..+++|.... ....+..|+.+++.|.
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLA 73 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHH
Confidence 456777888999999863 34789998865 4556678888888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.027 Score=53.67 Aligned_cols=50 Identities=18% Similarity=0.179 Sum_probs=39.5
Q ss_pred ccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcC
Q psy10212 23 SLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLE 73 (444)
Q Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~ 73 (444)
+..-++.+|.|..+.||++... +|+.|++|+.... ...+.+|...|+.|.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 4556788999999999999864 6899999986432 245678999998884
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.66 E-value=0.035 Score=56.64 Aligned_cols=52 Identities=13% Similarity=0.229 Sum_probs=37.1
Q ss_pred hhheecccceeEEEEeEecC-------CCceeeeeeeec-cc-cchhhHHHHhhhcCCCce
Q psy10212 26 QKTVIGNGSFGIVYQAKLLD-------SGELVAIKKVLQ-DK-RFKNREMQIMRRLEHSNI 77 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~-~~-~~~~~E~~~l~~l~h~~i 77 (444)
.++.|+.|-...||++.... +++.+++|+... .. ..+.+|..+++.|...++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~ 137 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHL 137 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 35678888889999998753 257899998844 22 455579988888853333
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.038 Score=54.03 Aligned_cols=46 Identities=13% Similarity=0.118 Sum_probs=35.9
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhcC
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRLE 73 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~ 73 (444)
-++.|+.|....+|++.. +++.+++|..... ...+.+|...|+.|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~ 86 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLA 86 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHH
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHH
Confidence 356789999999999986 5778999987543 345678988888873
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.17 Score=52.08 Aligned_cols=53 Identities=21% Similarity=0.154 Sum_probs=36.0
Q ss_pred hhheecccceeEEEEeEecCCCceeeeeeeeccccch---hhHHHHhhhcCCCcee
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFK---NREMQIMRRLEHSNIV 78 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~E~~~l~~l~h~~i~ 78 (444)
-++.|+.|-...+|++.....++.+++|+.......+ .+|..+++.|...++.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~ 167 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA 167 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC
Confidence 3567888889999999875445789999874433222 4799999998655543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.051 Score=54.67 Aligned_cols=47 Identities=13% Similarity=0.070 Sum_probs=29.6
Q ss_pred hheecccceeEEEEeEecC-------CCceeeeeeeec---cccchhhHHHHhhhcC
Q psy10212 27 KTVIGNGSFGIVYQAKLLD-------SGELVAIKKVLQ---DKRFKNREMQIMRRLE 73 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~---~~~~~~~E~~~l~~l~ 73 (444)
++.|..|-...+|++.... +++.|++|+... ......+|.++++.|.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~ 111 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILA 111 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHH
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHH
Confidence 5678888899999998742 357899998733 2234458999888874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.12 E-value=0.081 Score=51.00 Aligned_cols=44 Identities=18% Similarity=-0.006 Sum_probs=32.4
Q ss_pred heecccceeEEEEeEecCCCceeeeeeeec---cccchhhHHHHhhhcC
Q psy10212 28 TVIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKNREMQIMRRLE 73 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~---~~~~~~~E~~~l~~l~ 73 (444)
..|+ |....||++... +|+.+++|.... ....+..|..+++.|.
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLV 78 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHH
Confidence 4566 778899998753 467899999863 2455667888888884
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.86 E-value=0.053 Score=53.59 Aligned_cols=50 Identities=10% Similarity=0.079 Sum_probs=30.9
Q ss_pred hheecccceeEEEEeEecC--------CCceeeeeeeeccccc---hhhHHHHhhhcCCCc
Q psy10212 27 KTVIGNGSFGIVYQAKLLD--------SGELVAIKKVLQDKRF---KNREMQIMRRLEHSN 76 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~---~~~E~~~l~~l~h~~ 76 (444)
+..|+.|-...+|++.... .++.+++|+....... ..+|..+++.|...+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g 98 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYK 98 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTT
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcC
Confidence 5677888889999998643 1368999987543332 247888888874333
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=90.36 E-value=0.2 Score=50.45 Aligned_cols=72 Identities=86% Similarity=1.392 Sum_probs=67.1
Q ss_pred CCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCc
Q psy10212 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211 (444)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (444)
++..+++.+.++.+|.++.+...++.++|.+..++++...+|.+.+....+..++|+++.++.+.|..+...
T Consensus 260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~ 331 (420)
T 1j1b_A 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331 (420)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence 445588999999999999999999999999999999999999999999999999999999999999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.45 E-value=1.7 Score=44.08 Aligned_cols=48 Identities=10% Similarity=0.114 Sum_probs=33.9
Q ss_pred hhheecccceeEEEEeEecCC-------Cceeeeeeeeccccch---hhHHHHhhhcC
Q psy10212 26 QKTVIGNGSFGIVYQAKLLDS-------GELVAIKKVLQDKRFK---NREMQIMRRLE 73 (444)
Q Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~~~~---~~E~~~l~~l~ 73 (444)
-++.|..|-...+|++..... ++.|++++.....+.+ .+|.++++.|.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~ 131 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLS 131 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHH
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHH
Confidence 356778888899999987521 5789999874432222 37888888884
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=85.98 E-value=0.48 Score=47.09 Aligned_cols=73 Identities=78% Similarity=1.262 Sum_probs=67.5
Q ss_pred cCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCc
Q psy10212 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISP 211 (444)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (444)
+.+..+++.++++.+|.+..+....+.++|.+..++++...++++.+....++..+|++..++.+.|+.+...
T Consensus 244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 3455688999999999999999999999999999999999999999999999999999999999999998864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=82.75 E-value=0.92 Score=44.61 Aligned_cols=73 Identities=48% Similarity=0.935 Sum_probs=65.6
Q ss_pred CCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcc
Q psy10212 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPL 212 (444)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (444)
.+..+++...++.+|.++.+....+.++|++..++.+....|.+.+....+....|+++.++.+.|+.+....
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 4455889999999999999999999999999999999999999999999999999999999999999998653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 444 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-81 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-10 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-09 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-07 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-07 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-14 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-04 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-11 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-07 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-12 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-08 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-07 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-11 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-12 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-07 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-11 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-08 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-12 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-12 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-13 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-08 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-08 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-12 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-12 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-13 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-13 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-08 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-07 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 0.003 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-06 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-10 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-11 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-12 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-09 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-11 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-12 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-10 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-12 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-09 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-10 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-09 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-10 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-11 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-23 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-11 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-08 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-07 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-10 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-09 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-21 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-12 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-21 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-11 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-10 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-10 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-09 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-20 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-10 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-10 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-20 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-08 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-20 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-13 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-10 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-06 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-15 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-04 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 1e-81
Identities = 213/334 (63%), Positives = 247/334 (73%), Gaps = 36/334 (10%)
Query: 112 NKVTTVVATPGQGPDRPQEISYTNTRV------------SDSGVDQLVEIIKVLGTPTRE 159
+KVTTVVATPGQGPDRPQE+SYT+T+V +LV IK + R
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV-AIKKVLQDKRF 59
Query: 160 QIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLV 219
+ RE+ + + H I RL + SS +V+LNLV
Sbjct: 60 KNREL-------QIMRKLDHCN---------------IVRLRYFFYSSGEKKDEVYLNLV 97
Query: 220 LEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNP 279
L+++PETVY+VA+HYS++KQ P Y KLY+YQLFRSLAYIH GICHRDIKPQNLLL+P
Sbjct: 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 280 ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELL 339
+T VLKLCDFGSAK LVRGEPNVSYICSRYYRAPELIFGA DYT+ IDVWSAGCVLAELL
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 340 LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399
LGQP+FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK+HPW+KVFR RTPP
Sbjct: 218 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277
Query: 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
+AI L SRLLEYTP++R++PL+ + F ELR
Sbjct: 278 EAIALCSRLLEYTPTARLTPLEACA-HSFFDELR 310
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 3e-22
Identities = 57/75 (76%), Positives = 66/75 (88%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88
VIGNGSFG+VYQAKL DSGELVAIKKVLQDKRFKNRE+QIMR+L+H NIV+L+YFFYSSG
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 89 DKKDEPTNYPPLEDM 103
+KKDE L+ +
Sbjct: 87 EKKDEVYLNLVLDYV 101
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-44
Identities = 80/208 (38%), Positives = 108/208 (51%), Gaps = 6/208 (2%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
++LV +FM + + + K Y+ + L Y+H I HRD+KP NL
Sbjct: 75 ISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL+ E GVLKL DFG AK ++ +R+YRAPEL+FGA Y +D+W+ GC+
Sbjct: 132 LLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
LAELLL P PGDS +DQL I + LGTPT EQ +M F P +F
Sbjct: 191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQV 422
D +DLI L + P +RI+ Q
Sbjct: 251 -AAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 4e-12
Identities = 20/70 (28%), Positives = 36/70 (51%), Gaps = 9/70 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---------REMQIMRRLEHSNIVK 79
+G G F VY+A+ ++ ++VAIKK+ R + RE+++++ L H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 80 LKYFFYSSGD 89
L F +
Sbjct: 65 LLDAFGHKSN 74
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (137), Expect = 8e-10
Identities = 26/76 (34%), Positives = 34/76 (44%), Gaps = 1/76 (1%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 198
DS +DQL I + LGTPT EQ +M F P +F D +DLI
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQ 261
Query: 199 RLLEYTPSSRISPLQV 214
L + P +RI+ Q
Sbjct: 262 GLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-43
Identities = 73/242 (30%), Positives = 115/242 (47%), Gaps = 8/242 (3%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
+ RL + SR + + L LV E + + + + P K ++QL R
Sbjct: 72 VVRLFDVCTVSR-TDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLLRG 128
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
L ++H + HRD+KPQN+L+ +G +KL DFG A+ S + + +YRAPE++
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
+ Y T +D+WS GC+ AE+ +P+F G S VDQL +I+ V+G P E +
Sbjct: 188 LQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR-DVAL 245
Query: 377 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVF 436
F + P K DL+ + L + P+ RIS S P+ +L
Sbjct: 246 PRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSALS-HPYFQDLERCK 303
Query: 437 EN 438
EN
Sbjct: 304 EN 305
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 22/74 (29%), Positives = 38/74 (51%), Gaps = 10/74 (13%)
Query: 29 VIGNGSFGIVYQAK-LLDSGELVAIKKVLQDKRFKN------REMQIMRRL---EHSNIV 78
IG G++G V++A+ L + G VA+K+V + RE+ ++R L EH N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 79 KLKYFFYSSGDKKD 92
+L S ++
Sbjct: 74 RLFDVCTVSRTDRE 87
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 6e-07
Identities = 20/75 (26%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 199
S VDQL +I+ V+G P E + F + P K DL+ +
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDWPR-DVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLK 275
Query: 200 LLEYTPSSRISPLQV 214
L + P+ RIS
Sbjct: 276 CLTFNPAKRISAYSA 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 12/228 (5%)
Query: 203 YTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV 262
T +S + + + LV +F + S F K + L L YIH
Sbjct: 79 RTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 263 LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-----SYICSRYYRAPELIF 317
I HRD+K N+L+ GVLKL DFG A+ + + + + + +YR PEL+
Sbjct: 136 NKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
Query: 318 GAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 377
G DY ID+W AGC++AE+ P+ G++ QL I ++ G+ T E ++
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 378 EFKFPQIKSHP---WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
K +K ++ P A+DLI +LL P+ RI
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 3e-12
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 6/75 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG G+FG V++A+ +G+ VA+KKVL + + RE++I++ L+H N+V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 83 FFYSSGDKKDEPTNY 97
+ +
Sbjct: 77 ICRTKASPYNRCKGS 91
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 5e-07
Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 3/79 (3%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP---WSKVFRVRTPPDAID 195
++ QL I ++ G+ T E ++ K +K ++ P A+D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 196 LISRLLEYTPSSRISPLQV 214
LI +LL P+ RI
Sbjct: 284 LIDKLLVLDPAQRIDSDDA 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-41
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 22/223 (9%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH-VLGICHRDIKPQN 274
+++ +E M K P + + L Y+ I HRD+KP N
Sbjct: 79 ISICMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+L+N G +KLCDFG + L+ N S++ +R Y +PE + G Y+ + D+WS G
Sbjct: 136 ILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLS 192
Query: 335 LAELLLGQPMFPG-DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF------------ 381
L E+ +G+ P D+ +L+ +V G R P +
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 382 --PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
I + P K+ + D +++ L P+ R Q+
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (170), Expect = 9e-14
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
+G G+ G+V++ SG ++A K + + + RE+Q++ IV
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 84 FYSSGD 89
FYS G+
Sbjct: 73 FYSDGE 78
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (94), Expect = 3e-04
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 14/90 (15%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF--------------PQIKSHPWSKV 184
D+ +L+ +V G R P + I + P K+
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 185 FRVRTPPDAIDLISRLLEYTPSSRISPLQV 214
+ D +++ L P+ R Q+
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 144 bits (364), Expect = 3e-40
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 15/222 (6%)
Query: 210 SPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRD 269
P+ LV E + T +K + Q + + Y+Y++ ++L Y H +GI HRD
Sbjct: 101 DPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 154
Query: 270 IKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVW 329
+KP N++++ E L+L D+G A+ G+ + SRY++ PEL+ Y +D+W
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 214
Query: 330 SAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI---- 384
S GC+LA ++ + P F G DQLV I KVLGT + + +F I
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274
Query: 385 KSHPWSKVFRVRT----PPDAIDLISRLLEYTPSSRISPLQV 422
W + P+A+D + +LL Y SR++ +
Sbjct: 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 60.6 bits (146), Expect = 9e-11
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 2/64 (3%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFK-NREMQIMRRL-EHSNIVKLKYFFYS 86
+G G + V++A + + E V +K + K+ K RE++I+ L NI+ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 87 SGDK 90
+
Sbjct: 102 PVSR 105
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 49.8 bits (118), Expect = 3e-07
Identities = 21/84 (25%), Positives = 32/84 (38%), Gaps = 8/84 (9%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI----KSHPWSKVFRVRT----P 190
DQLV I KVLGT + + +F I W +
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 191 PDAIDLISRLLEYTPSSRISPLQV 214
P+A+D + +LL Y SR++ +
Sbjct: 293 PEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-40
Identities = 79/221 (35%), Positives = 120/221 (54%), Gaps = 9/221 (4%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV EF+ + + K + + P K Y++QL + LA+ H + HRD+KPQNL
Sbjct: 76 LYLVFEFLHQDLKKF--MDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 276 LLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
L+N E G +KL DFG A+ V + + +YRAPE++ G Y+T +D+WS GC+
Sbjct: 134 LINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKV 392
AE++ + +FPGDS +DQL I + LGTP + P+Y + FP+ +SKV
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKV 251
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
D L+S++L Y P+ RIS + PF ++
Sbjct: 252 VP-PLDEDGRSLLSQMLHYDPNKRISAKAALA-HPFFQDVT 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 4e-12
Identities = 23/66 (34%), Positives = 39/66 (59%), Gaps = 6/66 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG G++G+VY+A+ +GE+VA+KK+ D + RE+ +++ L H NIVKL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 83 FFYSSG 88
++
Sbjct: 69 VIHTEN 74
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (123), Expect = 6e-08
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 4/77 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
DS +DQL I + LGTP + P+Y + FP+ +SKV D L+
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVP-PLDEDGRSLL 263
Query: 198 SRLLEYTPSSRISPLQV 214
S++L Y P+ RIS
Sbjct: 264 SQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 8e-40
Identities = 71/212 (33%), Positives = 111/212 (52%), Gaps = 7/212 (3%)
Query: 213 QVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
+ L LV E + + + K + K ++ QL +AY H + HRD+KP
Sbjct: 72 KKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128
Query: 273 QNLLLNPETGVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
QNLL+N E G LK+ DFG A+ + I + +YRAP+++ G+ Y+T ID+WS
Sbjct: 129 QNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKSHPWS 390
GC+ AE++ G P+FPG S DQL+ I ++LGTP + + + F + PW
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+ IDL+S++L+ P+ RI+ Q
Sbjct: 248 SFLK-GLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 60.7 bits (146), Expect = 6e-11
Identities = 24/64 (37%), Positives = 40/64 (62%), Gaps = 7/64 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG G++G+VY+A+ + GE A+KK+ +K + RE+ I++ L+HSNIVKL
Sbjct: 9 KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 83 FFYS 86
++
Sbjct: 68 VIHT 71
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 50.7 bits (120), Expect = 1e-07
Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 2/77 (2%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 197
S DQL+ I ++LGTP + + + F + PW + IDL+
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK-GLDESGIDLL 261
Query: 198 SRLLEYTPSSRISPLQV 214
S++L+ P+ RI+ Q
Sbjct: 262 SKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-39
Identities = 79/244 (32%), Positives = 126/244 (51%), Gaps = 16/244 (6%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
I + + + I ++ LV M +YK+ K Q+ + ++YQ+ R
Sbjct: 68 IIGINDIIRAPTIEQMKDVY-LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRG 121
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYICSRYYRA 312
L YIH + HRD+KP NLLLN T LK+CDFG A+ + Y+ +R+YRA
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 313 PELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREM 372
PE++ + YT ID+WS GC+LAE+L +P+FPG +DQL I+ +LG+P++E + +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 373 ---NPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
P PW+++F A+DL+ ++L + P RI Q + P+L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALA-HPYL 298
Query: 430 IELR 433
+
Sbjct: 299 EQYY 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 1e-11
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 5/70 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV--LQDKRFKN---REMQIMRRLEHSNIVKLKYF 83
IG G++G+V A + VAIKK+ + + + RE++I+ R H NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 84 FYSSGDKKDE 93
+ ++ +
Sbjct: 75 IRAPTIEQMK 84
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 1e-08
Identities = 25/121 (20%), Positives = 49/121 (40%), Gaps = 8/121 (6%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREM---NPNYTEFKFPQIKSHPWSKVFRVRTPPDAID 195
+DQL I+ +LG+P++E + + P PW+++F A+D
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP-NADSKALD 273
Query: 196 LISRLLEYTPSSRISPLQV----FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIY 251
L+ ++L + P RI Q +L + E + + + + P K I+
Sbjct: 274 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIF 333
Query: 252 Q 252
+
Sbjct: 334 E 334
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-38
Identities = 71/240 (29%), Positives = 121/240 (50%), Gaps = 13/240 (5%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
+ LL+ LV+ FM + K+ KH + + +YQ+ +
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKG 133
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
L YIH GI HRD+KP NL +N E LK+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
+ YT +D+WS GC++AE++ G+ +F G +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 377 TEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
+ P+++ ++ + P A++L+ ++L R++ + + P+ L
Sbjct: 251 AKNYMKGLPELEKKDFASILT-NASPLAVNLLEKMLVLDAEQRVTAGEALA-HPYFESLH 308
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 4e-12
Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKN---REMQIMRRLEHSNIVKLKY 82
+G+G++G V A +G VAIKK+ Q + F RE+++++ + H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 83 FFYSSGDKKDEPTNYPPLEDM 103
F D Y + M
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM 105
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 4e-07
Identities = 17/79 (21%), Positives = 38/79 (48%), Gaps = 4/79 (5%)
Query: 139 SDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAID 195
+DQL EI+KV GTP E ++ + + + P+++ ++ + P A++
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT-NASPLAVN 279
Query: 196 LISRLLEYTPSSRISPLQV 214
L+ ++L R++ +
Sbjct: 280 LLEKMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-38
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 4/214 (1%)
Query: 222 FMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET 281
+ K++ + K +++QL + L + H + HRD+KPQNLL+N
Sbjct: 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN- 137
Query: 282 GVLKLCDFGSAKHL-VRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL 340
G LKL +FG A+ + + + + +YR P+++FGA Y+T ID+WSAGC+ AEL
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 341 G-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399
+P+FPG+ DQL I ++LGTPT EQ M +P + +
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
DL+ LL+ P RIS + P+ +
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQ-HPYFSDFC 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (151), Expect = 1e-11
Identities = 22/64 (34%), Positives = 39/64 (60%), Gaps = 6/64 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG G++G V++AK ++ E+VA+K+V D + RE+ +++ L+H NIV+L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 83 FFYS 86
+S
Sbjct: 69 VLHS 72
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (123), Expect = 5e-08
Identities = 21/75 (28%), Positives = 30/75 (40%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 199
+ DQL I ++LGTPT EQ M +P + + DL+
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 200 LLEYTPSSRISPLQV 214
LL+ P RIS +
Sbjct: 266 LLKCNPVQRISAEEA 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-38
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L LE+ + P + + +QL + Y+H +GI HRDIKP+N
Sbjct: 77 IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSA 331
LLL+ E LK+ DFG A + Y APEL+ + +DVWS
Sbjct: 134 LLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G VL +L G+ + S Q K + +PW K
Sbjct: 193 GIVLTAMLAGELPWDQPSDSCQEYSDW---------------------KEKKTYLNPWKK 231
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
+ + L+ ++L PS+RI+ ++
Sbjct: 232 I-----DSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 1e-12
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 5/65 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
+G G++G V A + E VA+K V + +E+ I + L H N+VK
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 84 FYSSG 88
Sbjct: 72 RREGN 76
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 7e-37
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ L+LE+ P + F T YI +L +L+Y H + HRDIKP+N
Sbjct: 80 RVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LLL G LK+ DFG + H + + Y PE+I G + + K+D+WS G +
Sbjct: 137 LLLG-SAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVL 193
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
E L+G+P F ++ + I +V EF FP
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPD----------- 225
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
A DLISRLL++ PS R +V P++
Sbjct: 226 -FVTEGARDLISRLLKHNPSQRPMLREVLE-HPWI 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 1e-12
Identities = 20/67 (29%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
+G G FG VY A+ S ++A+K + + + K RE++I L H NI++L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 82 YFFYSSG 88
+F+ +
Sbjct: 73 GYFHDAT 79
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (340), Expect = 1e-36
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 30/220 (13%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ ++ EFM ++ + + Y+ Q+ + L ++H H D+KP+N+
Sbjct: 98 MVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155
Query: 276 LLNP-ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+ + LKL DFG HL + + + APE+ G D+WS G +
Sbjct: 156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVL 214
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
LL G F G++ + L ++ + N + F I
Sbjct: 215 SYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSGI---------- 252
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434
D D I +LL P++R++ Q P+L A
Sbjct: 253 ---SEDGKDFIRKLLLADPNTRMTIHQALE-HPWLTPGNA 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 69.7 bits (170), Expect = 1e-13
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL----QDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G+FG+V++ +G A K V+ DK +E+Q M L H +V L F
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 85 YSSGD 89
+
Sbjct: 93 EDDNE 97
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (335), Expect = 1e-36
Identities = 54/222 (24%), Positives = 84/222 (37%), Gaps = 35/222 (15%)
Query: 213 QVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKP 272
F LV + M Y K T+ + L + +H L I HRD+KP
Sbjct: 82 NTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP 138
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID-----YTTKID 327
+N+LL+ + +KL DFG + L GE + Y APE+I +++ Y ++D
Sbjct: 139 ENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
+WS G ++ LL G P F + L I N + ++
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQMLML------------RMIMSGNYQFGSPEWDDY--- 242
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
DL+SR L P R + + + PF
Sbjct: 243 ----------SDTVKDLVSRFLVVQPQKRYTAEEALA-HPFF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 52.0 bits (124), Expect = 4e-08
Identities = 13/72 (18%), Positives = 32/72 (44%), Gaps = 14/72 (19%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV-------------LQDKRFKNREMQIMRRL-EH 74
++G G +V + + + A+K + + + +E+ I+R++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 75 SNIVKLKYFFYS 86
NI++LK + +
Sbjct: 70 PNIIQLKDTYET 81
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-36
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 35/219 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L +++EF + ++ ++ Q +L Y+H I HRD+K N+
Sbjct: 84 LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141
Query: 276 LLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAID----YTTKIDVWS 330
L + G +KL DFG + R + S+I + Y+ APE++ Y K DVWS
Sbjct: 142 LFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200
Query: 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G L E+ +P + + L++I KS P +
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKI--------------------------AKSEPPT 234
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
R + D + + LE +R + Q+ PF+
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ-HPFV 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.0 bits (158), Expect = 2e-12
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G+G+FG VY+A+ ++ L A K + ++ E+ I+ +H NIVKL F
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 85 YSSGD 89
Y +
Sbjct: 79 YYENN 83
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-36
Identities = 73/240 (30%), Positives = 120/240 (50%), Gaps = 13/240 (5%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
+ LL+ +R + LV M + + K Q + + IYQ+ R
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRG 133
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
L YIH I HRD+KP NL +N E LK+ DFG A+H + Y+ +R+YRAPE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIM 190
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
+ Y +D+WS GC++AELL G+ +FPG +DQL I++++GTP E +++++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 377 TEF---KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
Q+ ++ VF P A+DL+ ++L RI+ Q + + +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALA-HAYFAQYH 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 5e-12
Identities = 18/91 (19%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV------LQDKRFKNREMQIMRRLEHSNIVKLKY 82
+G+G++G V A +G VA+KK+ + + RE+++++ ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 83 FFYSSGDKKDEPTNYPPLEDMKISTFSPRNK 113
F + ++ Y M +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC 115
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 8e-08
Identities = 19/78 (24%), Positives = 37/78 (47%), Gaps = 4/78 (5%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIKSHPWSKVFRVRTPPDAIDL 196
+DQL I++++GTP E +++++ Q+ ++ VF P A+DL
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI-GANPLAVDL 280
Query: 197 ISRLLEYTPSSRISPLQV 214
+ ++L RI+ Q
Sbjct: 281 LEKMLVLDSDKRITAAQA 298
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 6e-35
Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 216 LNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG-----ICHRD 269
L +V+E+ + V +K +Q + + QL +L H + HRD
Sbjct: 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139
Query: 270 IKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV-SYICSRYYRAPELIFGAIDYTTKIDV 328
+KP N+ L+ + +KL DFG A+ L +++ + YY +PE + Y K D+
Sbjct: 140 LKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDI 197
Query: 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388
WS GC+L EL P F S + +I E KF +I
Sbjct: 198 WSLGCLLYELCALMPPFTAFSQKELAGKIR-------------------EGKFRRIPYR- 237
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
+ ++I+R+L R S ++ P +
Sbjct: 238 --------YSDELNEIITRMLNLKDYHRPSVEEILE-NPLI 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 1e-12
Identities = 15/69 (21%), Positives = 31/69 (44%), Gaps = 6/69 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL------QDKRFKNREMQIMRRLEHSNIVKLKY 82
IG GS+G + + G+++ K++ +K+ E+ ++R L+H NIV+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 83 FFYSSGDKK 91
+
Sbjct: 71 RIIDRTNTT 79
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 40/217 (18%), Positives = 74/217 (34%), Gaps = 35/217 (16%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLG--ICHRDIKP 272
+ LV E M K Y K + + + Q+ + L ++H I HRD+K
Sbjct: 86 CIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 142
Query: 273 QNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
N+ + TG +K+ D G A L R + I + + APE+ Y +DV++ G
Sbjct: 143 DNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFG 199
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+ E+ + + Q+ + F ++
Sbjct: 200 MCMLEMATSEYPYSECQNAAQIYRRVT--------------SGVKPASFDKVAI------ 239
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
P+ ++I + R S + + F
Sbjct: 240 ------PEVKEIIEGCIRQNKDERYSIKDLLN-HAFF 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (153), Expect = 7e-12
Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 6/70 (8%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG GSF VY+ ++ VA ++ K K+ E ++++ L+H NIV+
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 83 FFYSSGDKKD 92
+ S+ K
Sbjct: 76 SWESTVKGKK 85
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 28/220 (12%)
Query: 215 FLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQ 273
L +V+E + ++ + + Q F + + ++ Y+H + I HRD+KP+
Sbjct: 83 CLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140
Query: 274 NLLLN--PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
NLL +LKL DFG AK + + YY APE++ Y D+WS
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSL 199
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G ++ LL G P F + G+ + + +IR + ++ ++
Sbjct: 200 GVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWSEV------- 244
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431
+ LI LL+ P+ R++ + + P++++
Sbjct: 245 ------SEEVKMLIRNLLKTEPTQRMTITEFMN-HPWIMQ 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 3e-12
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 2/65 (3%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSS 87
V+G G G V Q + E A+ K+LQD RE+++ R + +IV++ + +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 77
Query: 88 GDKKD 92
+
Sbjct: 78 YAGRK 82
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (323), Expect = 3e-34
Identities = 44/209 (21%), Positives = 79/209 (37%), Gaps = 29/209 (13%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ L+LEF+ ++ + Y+ Q L ++H I H DIKP+N
Sbjct: 100 EMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 275 LLL-NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
++ + +K+ DFG A L E + + APE++ D+W+ G
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGV 216
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
+ LL G F G+ ++ L + ++ + + E F +
Sbjct: 217 LGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSV--------- 255
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P+A D I LL+ P R++
Sbjct: 256 ----SPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 68.2 bits (166), Expect = 3e-13
Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G+G+FG+V++ +G + K + DK E+ IM +L H ++ L F
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 85 YSSGD 89
+
Sbjct: 96 EDKYE 100
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 6e-34
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 37/220 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
LV+E+ + K+ + + LAY+H + HRD+K N+
Sbjct: 90 AWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAID--YTTKIDVWSAGC 333
LL+ E G++KL DFGSA + P S++ + Y+ APE+I + Y K+DVWS G
Sbjct: 147 LLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
EL +P + + L I + + P ++S WS
Sbjct: 203 TCIELAERKPPLFNMNAMSALYHIAQ-------------------NESPALQSGHWS--- 240
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
+ + L+ P R + + F++ R
Sbjct: 241 -----EYFRNFVDSCLQKIPQDRPTSEVLLK-HRFVLRER 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.4 bits (172), Expect = 4e-14
Identities = 41/253 (16%), Positives = 78/253 (30%), Gaps = 77/253 (30%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
IG+GSFG VY A+ + + E+VAIKK+ + N +E++ +++L H N ++ +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 82 YFFYSS------------GDKKDEPTNYPPLE---------------------------- 101
+ + PL+
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 102 -----------DMKISTF---SPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQ-- 145
+K+ F S + V TP P+ I + D VD
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMA--PEVILAMDEGQYDGKVDVWS 199
Query: 146 ----LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 201
+E+ + + + + P ++S WS + + L
Sbjct: 200 LGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS--------EYFRNFVDSCL 251
Query: 202 EYTPSSRISPLQV 214
+ P R + +
Sbjct: 252 QKIPQDRPTSEVL 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-34
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 30/217 (13%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L ++ EF+ + + + S Y++Q+ +L ++H I H DI+P+N+
Sbjct: 76 LVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133
Query: 276 LL-NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+ + +K+ +FG A+ L G+ + Y APE+ +T D+WS G +
Sbjct: 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTL 192
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
+ LL G F ++ + E I + E F +I
Sbjct: 193 VYVLLSGINPFLAETNQQII------------ENIMNAEYTFDEEAFKEI---------- 230
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIE 431
+A+D + RLL SR++ + P+L +
Sbjct: 231 ---SIEAMDFVDRLLVKERKSRMTASEALQ-HPWLKQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (164), Expect = 5e-13
Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV---LQDKRFKNREMQIMRRLEHSNIVKLKYFFY 85
+G G FGIV++ S + K V D+ +E+ I+ H NI+ L F
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 86 SSGD 89
S +
Sbjct: 72 SMEE 75
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-32
Identities = 44/215 (20%), Positives = 81/215 (37%), Gaps = 31/215 (14%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
L +V ++ + + H + F Q + + Y+H I HRD+K N
Sbjct: 77 QLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSY---ICSRYYRAPELIFGAID--YTTKIDVW 329
+ L+ E +K+ DFG A R + + S + APE+I Y+ + DV+
Sbjct: 135 IFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 389
+ G VL EL+ GQ + + DQ++ ++ + ++ N
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVG--RGYLSPDLSKVRSNC------------- 238
Query: 390 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
P L++ L+ R Q+ +
Sbjct: 239 --------PKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (126), Expect = 3e-08
Identities = 19/62 (30%), Positives = 30/62 (48%), Gaps = 11/62 (17%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLK 81
IG+GSFG VY+ K VA+K + + FK E+ ++R+ H NI+
Sbjct: 15 RIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNILLFM 70
Query: 82 YF 83
+
Sbjct: 71 GY 72
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-32
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L L + Y + +F T+ Y ++ +L Y+H GI HRD+KP+N+
Sbjct: 83 LYFGLSYAKNGELL---KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
LLN E +++ DFG+AK L S++ + Y +PEL+ D+W+ G
Sbjct: 140 LLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALG 197
Query: 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
C++ +L+ G P F + +IIK+ E+ FP+
Sbjct: 198 CIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------------EYDFPE--------- 231
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
+ P A DL+ +LL + R+ ++ P
Sbjct: 232 ---KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 2e-12
Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVL-------QDKRFKNREMQIMRRLEHSNIVKLK 81
++G GSF V A+ L + AIK + + RE +M RL+H VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 82 YFFYSSGD 89
+ F
Sbjct: 75 FTFQDDEK 82
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 22/250 (8%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256
I LL + + LV+E M + +V + ++ +YQ+
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCG 131
Query: 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELI 316
+ ++H GI HRD+KP N+++ + LK+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 317 FGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 376
G + Y +D+WS GC++ E++ + +FPG +DQ ++I+ LGTP E ++++ P
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 377 TEF--KFPQIKSHPWSKVFR-----------VRTPPDAIDLISRLLEYTPSSRISPLQVR 423
+ P+ + K+F A DL+S++L P+ RIS
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 424 SITPFLIELR 433
P++
Sbjct: 310 Q-HPYINVWY 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.5 bits (148), Expect = 5e-11
Identities = 23/81 (28%), Positives = 37/81 (45%), Gaps = 6/81 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN------REMQIMRRLEHSNIVKLKY 82
IG+G+ GIV A VAIKK+ + + + RE+ +M+ + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 83 FFYSSGDKKDEPTNYPPLEDM 103
F ++ Y +E M
Sbjct: 84 VFTPQKTLEEFQDVYLVMELM 104
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 8e-07
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 13/88 (14%)
Query: 140 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPWSKVFR----------- 186
+DQ ++I+ LGTP E ++++ P + P+ + K+F
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 187 VRTPPDAIDLISRLLEYTPSSRISPLQV 214
A DL+S++L P+ RIS
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 4e-31
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 34/215 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L +V+E++ ++ + ++L ++H + HRDIK N+
Sbjct: 92 LWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCV 334
LL + G +KL DFG + + S + + Y+ APE++ Y K+D+WS G +
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIM 205
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
E++ G+P + ++ + L I GTP E + P+
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------ELQNPE----------- 240
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
+ D ++R L+ R S ++ FL
Sbjct: 241 -KLSAIFRDFLNRCLDMDVEKRGSAKELLQ-HQFL 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.7 bits (165), Expect = 3e-13
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
IG G+ G VY A + +G+ VAI+++ K E+ +MR ++ NIV +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 85 YSSGD 89
+
Sbjct: 87 LVGDE 91
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 4e-30
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 32/226 (14%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L L+++ + K + I+Q+ ++ Y+H LGI HRD+KP+NL
Sbjct: 82 LYLIMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138
Query: 276 LLN--PETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
L E + + DFG +K G + + Y APE++ Y+ +D WS G
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGV 197
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
+ LL G P F ++ +I+K ++
Sbjct: 198 IAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI--------------------- 236
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENI 439
A D I L+E P R + Q P++ A+ +NI
Sbjct: 237 ----SDSAKDFIRHLMEKDPEKRFTCEQALQ-HPWIAGDTALDKNI 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 68.1 bits (166), Expect = 3e-13
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKLKYF 83
V+G G+F V A+ + +LVAIK + + E+ ++ +++H NIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 84 FYSSGD 89
+ S G
Sbjct: 76 YESGGH 81
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.9 bits (85), Expect = 0.003
Identities = 39/232 (16%), Positives = 77/232 (33%), Gaps = 42/232 (18%)
Query: 32 NGSFGIVYQAKLLDSGELVAI---KKVLQDKRFKNREMQIMRRLEH---SNIVKLKYFFY 85
G ++ Q L+ GEL K ++ Q++ +++ IV
Sbjct: 79 GGHLYLIMQ--LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136
Query: 86 SSGDKKDEPTNYPPLEDMKISTF-SPRNKVTTVVATPGQGPDRPQEISYTN-TRVSDSGV 143
+ + + + D +S P + ++T TPG P+ ++ ++ D
Sbjct: 137 NLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA--PEVLAQKPYSKAVDCWS 194
Query: 144 DQLVEIIKVLGTP---------TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAI 194
++ I + G P EQI + + + I A
Sbjct: 195 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-------------SDSAK 241
Query: 195 DLISRLLEYTPSSRISPLQV----FLN----LVLEFMPETVYKVAKHYSKSK 238
D I L+E P R + Q ++ L ++ K+++KSK
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 4e-29
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 28/233 (12%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHV-LGICHRDIKPQ 273
+++V+ F +A + P Y K QL L Y+H GI H DIKP+
Sbjct: 96 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 155
Query: 274 NLLLNPE-----TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328
N+L+ +K+ D G+A E + I +R YR+PE++ GA + D+
Sbjct: 156 NVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADI 212
Query: 329 WSAGCVLAELLLGQPMFPGDSG------VDQLVEIIKVLGTPTREQIREMNPNYTEF--- 379
WS C++ EL+ G +F D G D + +II++LG +R T F
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272
Query: 380 ----KFPQIKSHPWSKVFRVRT------PPDAIDLISRLLEYTPSSRISPLQV 422
++K P V + + D +S +L+ P R +
Sbjct: 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 58.1 bits (139), Expect = 6e-10
Identities = 15/58 (25%), Positives = 29/58 (50%), Gaps = 3/58 (5%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIVKLKYF 83
+G G F V+ AK + + VA+K V DK + E+++++R+ ++ K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 13/93 (13%)
Query: 135 NTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF-------KFPQIKSHPWSKVFRV 187
D + +II++LG +R T F ++K P V
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292
Query: 188 RTP------PDAIDLISRLLEYTPSSRISPLQV 214
+ + D +S +L+ P R +
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 4e-29
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 36/207 (17%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ ++++++ + Q FP K Y ++ +L Y+H I +RD+KP+N
Sbjct: 78 QIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334
+LL+ + G +K+ DFG AK++ + + + Y APE++ Y ID WS G +
Sbjct: 135 ILLD-KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGIL 190
Query: 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
+ E+L G F + + +I+ E +FP
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKILN-----------------AELRFPP----------- 222
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQ 421
D DL+SRL+ S R+ LQ
Sbjct: 223 -FFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 64.7 bits (157), Expect = 4e-12
Identities = 15/67 (22%), Positives = 29/67 (43%), Gaps = 7/67 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV-------LQDKRFKNREMQIMRRLEHSNIVKLK 81
+G GSFG V+ + +G A+K + L+ N E ++ + H I+++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 82 YFFYSSG 88
F +
Sbjct: 71 GTFQDAQ 77
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 6e-29
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 39/214 (18%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L+LE + + + + + +Q+ ++ + H G+ HRDIK +N+
Sbjct: 84 FVLILERPEP--VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
L++ G LKL DFGS L++ + +R Y PE I + VWS G +L
Sbjct: 142 LIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395
+++ G F D EII+ FR
Sbjct: 201 YDMVCGDIPFEHDE------EIIR-----------------------------GQVFFRQ 225
Query: 396 RTPPDAIDLISRLLEYTPSSRISPLQVRSITPFL 429
R + LI L PS R + ++++ P++
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN-HPWM 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 3e-10
Identities = 16/72 (22%), Positives = 32/72 (44%), Gaps = 12/72 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRL--EHSN 76
++G+G FG VY + VAIK V +D+ E+ +++++ S
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 77 IVKLKYFFYSSG 88
+++L +F
Sbjct: 71 VIRLLDWFERPD 82
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (285), Expect = 8e-29
Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 31/203 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L+ +L+ M ++ F + Y ++ L ++H + +RD+KP N+
Sbjct: 82 LSFILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
LL+ E G +++ D G A + +P+ S + Y APE++ + Y + D +S GC+L
Sbjct: 139 LLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCML 196
Query: 336 AELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRV 395
+LL G F D+ EI + +
Sbjct: 197 FKLLRGHSPFRQHKTKDKH-EIDR--------------------MTLTMAVELPDSF--- 232
Query: 396 RTPPDAIDLISRLLEYTPSSRIS 418
P+ L+ LL+ + R+
Sbjct: 233 --SPELRSLLEGLLQRDVNRRLG 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.4 bits (151), Expect = 3e-11
Identities = 19/71 (26%), Positives = 32/71 (45%), Gaps = 12/71 (16%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-----------REMQIMRRLEHSNI 77
+IG G FG VY + D+G++ A+ K L KR K + ++ + I
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 78 VKLKYFFYSSG 88
V + Y F++
Sbjct: 70 VCMSYAFHTPD 80
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-28
Identities = 46/211 (21%), Positives = 77/211 (36%), Gaps = 32/211 (15%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ L+LE + + K++ ++ Q+ + Y+H L I H D+KP+N
Sbjct: 87 DVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143
Query: 275 LLL---NPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
++L N +K+ DFG A + G + + + APE++ + D+WS
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSI 202
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G + LL G F GD+ + L + V E
Sbjct: 203 GVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT------------------- 243
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
A D I RLL P R++
Sbjct: 244 ------SALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 3e-12
Identities = 14/71 (19%), Positives = 33/71 (46%), Gaps = 10/71 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN----------REMQIMRRLEHSNIV 78
+G+G F +V + + +G A K + + + + RE+ I++ ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 79 KLKYFFYSSGD 89
L + + D
Sbjct: 77 TLHEVYENKTD 87
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (277), Expect = 3e-28
Identities = 33/203 (16%), Positives = 68/203 (33%), Gaps = 19/203 (9%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
LV++ + ++ + F + Q+ + IH + +RDIKP N L+
Sbjct: 78 LVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134
Query: 278 N----PETGVLKLCDFGSAKHL--------VRGEPNVSYICSRYYRAPELIFGAIDYTTK 325
++ + DFG K + + + Y + G + + +
Sbjct: 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRR 193
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385
D+ + G V L G + G + ++ +RE+ + E +F +
Sbjct: 194 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE-EFYKYM 252
Query: 386 SHPWSKVFRVRTPPDAIDLISRL 408
+ + F PD L
Sbjct: 253 HYARNLAFDAT--PDYDYLQGLF 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 16/64 (25%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFYS 86
IG GSFG++++ L + + VAIK + E + + L + Y+F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 87 SGDK 90
G
Sbjct: 72 EGLH 75
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 232 KHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGS 291
++ +S F Y ++ L ++H GI +RD+K N+LL+ + G +K+ DFG
Sbjct: 91 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGM 149
Query: 292 AKHLVRGEPNVSYIC-SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSG 350
K + G+ + C + Y APE++ G Y +D WS G +L E+L+GQ F G
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
Query: 351 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410
+ IR NP Y + +A DL+ +L
Sbjct: 209 EELF------------HSIRMDNPFYPRW-----------------LEKEAKDLLVKLFV 239
Query: 411 YTPSSRIS 418
P R+
Sbjct: 240 REPEKRLG 247
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 3e-11
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 8/68 (11%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKL 80
++G GSFG V+ A+ + + AIK + +D + + + EH + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 81 KYFFYSSG 88
F +
Sbjct: 69 FCTFQTKE 76
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 105 bits (264), Expect = 2e-26
Identities = 49/230 (21%), Positives = 87/230 (37%), Gaps = 39/230 (16%)
Query: 210 SPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRD 269
+P +V+E++ + ++ I ++L + H GI HRD
Sbjct: 80 TPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 136
Query: 270 IKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNV----SYICSRYYRAPELIFGAIDYTTK 325
+KP N++++ V K+ DFG A+ + +V + I + Y +PE G +
Sbjct: 137 VKPANIMISATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDAR 194
Query: 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385
DV+S GCVL E+L G+P F GDS V + ++ P + +
Sbjct: 195 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL------------- 241
Query: 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435
D ++ + L P +R + +L V
Sbjct: 242 ------------SADLDAVVLKALAKNPENRYQ-----TAAEMRADLVRV 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 66.7 bits (162), Expect = 6e-13
Identities = 19/74 (25%), Positives = 28/74 (37%), Gaps = 9/74 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQD--------KRFKNREMQIMRRLEHSNIVKL 80
++G G V+ A+ L VA+K + D RF+ RE Q L H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 72
Query: 81 KYFFYSSGDKKDEP 94
+ P
Sbjct: 73 YDTGEAETPAGPLP 86
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 3e-26
Identities = 36/218 (16%), Positives = 71/218 (32%), Gaps = 35/218 (16%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL- 276
+V+E + ++ ++ + F L Q+ + YIH HRD+KP N L
Sbjct: 80 MVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 136
Query: 277 -LNPETGVLKLCDFGSAKHLVRGEPNV--------SYICSRYYRAPELIFGAIDYTTKID 327
L + ++ + DFG AK + + + Y + G I+ + + D
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDD 195
Query: 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 387
+ S G VL LG + G + + ++ I + Y
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY----------- 244
Query: 388 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P + ++ + +R +
Sbjct: 245 ----------PSEFATYLNFCRSLRFDDKPDYSYLRQL 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 65.2 bits (158), Expect = 2e-12
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 2/64 (3%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFYS 86
IG+GSFG +Y + +GE VAIK + E +I + ++ + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 87 SGDK 90
GD
Sbjct: 74 EGDY 77
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-26
Identities = 39/187 (20%), Positives = 71/187 (37%), Gaps = 30/187 (16%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ ++ F + Y ++ +L Y+H + +RDIK +NL+L+ + G +K+ DFG
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC 152
Query: 293 KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD 352
K + + C + DY +D W G V+ E++ G+ F
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 353 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412
I+ E +FP+ P+A L++ LL+
Sbjct: 213 LFELILM-----------------EEIRFPR------------TLSPEAKSLLAGLLKKD 243
Query: 413 PSSRISP 419
P R+
Sbjct: 244 PKQRLGG 250
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 1e-10
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 7/67 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
++G G+FG V + +G A+K + ++ E ++++ H + LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 82 YFFYSSG 88
Y F +
Sbjct: 72 YAFQTHD 78
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 8e-26
Identities = 41/210 (19%), Positives = 74/210 (35%), Gaps = 34/210 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L +V E+M + S+ + + + ++ Y+ HRD+ +N+
Sbjct: 76 LYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 134
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335
L++ E V K+ DFG K + + APE + ++TK DVWS G +L
Sbjct: 135 LVS-EDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILL 190
Query: 336 AELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFR 394
E+ G+ +P D + + K +
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC------------------------- 225
Query: 395 VRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
PP +++ + R S LQ+R
Sbjct: 226 ---PPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (155), Expect = 4e-12
Identities = 19/64 (29%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--REMQIMRRLEHSNIVKLKYFFYS 86
IG G FG V G VA+K + D + E +M +L HSN+V+L
Sbjct: 14 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 87 SGDK 90
Sbjct: 72 EKGG 75
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 41/222 (18%), Positives = 79/222 (35%), Gaps = 37/222 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ +V E P + K + +F Y Q+ + Y+ HRD+ +NL
Sbjct: 85 MKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAG 332
LL ++K+ DFG + L + + + + + ++ D W G
Sbjct: 143 LLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 333 CVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
L E+ GQ + G +G L +I K + P+ +
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKIDK-----------------EGERLPRPED----- 239
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
P D +++ + + P R + + +R FL+E +
Sbjct: 240 -----CPQDIYNVMVQCWAHKPEDRPTFVALRD---FLLEAQ 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (135), Expect = 2e-09
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 12/69 (17%)
Query: 29 VIGNGSFGIVYQAKLLDS---GELVAIKKVLQD--------KRFKNREMQIMRRLEHSNI 77
+G+GSFG+V + + VA+K + D F RE+ M L+H N+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHRNL 73
Query: 78 VKLKYFFYS 86
++L +
Sbjct: 74 IRLYGVVLT 82
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 43/213 (20%), Positives = 74/213 (34%), Gaps = 34/213 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ +V E+M + K Q+ +AY+ + HRD++ N+
Sbjct: 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQ-LVDMAAQIASGMAYVERMNYVHRDLRAANI 144
Query: 276 LLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
L+ E V K+ DFG A+ + E + APE +T K DVWS G
Sbjct: 145 LVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGI 202
Query: 334 VLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L EL G+ +PG + L ++ + P +
Sbjct: 203 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------------------- 239
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P DL+ + P R + +++
Sbjct: 240 -----PESLHDLMCQCWRKEPEERPTFEYLQAF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (138), Expect = 7e-10
Identities = 17/61 (27%), Positives = 29/61 (47%), Gaps = 6/61 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G FG V+ + VAIK + + + F +E Q+M++L H +V+L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL-QEAQVMKKLRHEKLVQLYAVV 81
Query: 85 Y 85
Sbjct: 82 S 82
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-25
Identities = 49/189 (25%), Positives = 77/189 (40%), Gaps = 29/189 (15%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ ++ F ++Y+ ++ +L ++H LGI +RDIK +N+LL+ G + L DFG +
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS 176
Query: 293 KHLVRGEPNVSYIC---SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDS 349
K V E +Y Y + G + +D WS G ++ ELL G F D
Sbjct: 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236
Query: 350 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409
+ EI + +E +PQ A DLI RLL
Sbjct: 237 EKNSQAEISR-------------RILKSEPPYPQ------------EMSALAKDLIQRLL 271
Query: 410 EYTPSSRIS 418
P R+
Sbjct: 272 MKDPKKRLG 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 9e-09
Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 11/86 (12%)
Query: 29 VIGNGSFGIVYQAKLL---DSGELVAIKKV--------LQDKRFKNREMQIMRRLEHSNI 77
V+G G++G V+ + + D+G+L A+K + + E Q++ + S
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 78 VKLKYFFYSSGDKKDEPTNYPPLEDM 103
+ ++ + + K +Y ++
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGEL 116
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 8e-24
Identities = 34/241 (14%), Positives = 87/241 (36%), Gaps = 24/241 (9%)
Query: 197 ISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKL---YIYQ 252
I + + Q++L V ++ +++ Y+ + + +
Sbjct: 59 ILGFIAADNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS-----YICS 307
+ I HRD+K +N+L+ + G + D G A + + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 308 RYYRAPELIFGAI-----DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLG 362
+ Y APE++ +I + + D+++ G V E+ G QL V
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS-IGGIHEDYQLPYYDLVPS 234
Query: 363 TPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P+ E++R++ +++ + ++ ++ ++R++ L++
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 423 R 423
+
Sbjct: 289 K 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 3e-10
Identities = 18/68 (26%), Positives = 26/68 (38%), Gaps = 5/68 (7%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKR---FKNREMQIMRRLEHSNIVKLKYFFY 85
IG G FG V++ K GE VA+K + F+ E+ L H NI+
Sbjct: 10 SIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 86 SSGDKKDE 93
+
Sbjct: 68 KDNGTWTQ 75
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 43/229 (18%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
L LV+E + K ++ P ++Q+ + Y+ HRD+ +N+
Sbjct: 83 LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR----YYRAPELIFGAIDYTTKIDVWSA 331
LL K+ DFG +K L + + + + APE I ++++ DVWS
Sbjct: 141 LLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSY 198
Query: 332 GCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G + E L GQ + G + + I + +
Sbjct: 199 GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC--------------------- 237
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAVFENI 439
PP+ L+S Y R L V +RA + ++
Sbjct: 238 -------PPELYALMSDCWIYKWEDRPDFLTVEQ------RMRACYYSL 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (145), Expect = 9e-11
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 9/81 (11%)
Query: 16 YFSDLDNSLAQKTVIGNGSFGIVYQA--KLLDSGELVAIKKVLQD------KRFKNREMQ 67
F DN L +G G+FG V Q ++ VAIK + Q + RE Q
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQ 61
Query: 68 IMRRLEHSNIVKLKYFFYSSG 88
IM +L++ IV+L +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA 82
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 2e-23
Identities = 40/213 (18%), Positives = 76/213 (35%), Gaps = 34/213 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ ++ E+M + S Q+ +A+I HRD++ N+
Sbjct: 82 IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYIC--SRYYRAPELIFGAIDYTTKIDVWSAGC 333
L++ +T K+ DFG A+ + E + APE I +T K DVWS G
Sbjct: 141 LVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGI 198
Query: 334 VLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
+L E++ G+ +PG + + + + + +
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC----------------------- 235
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P + L+ + P R + +RS+
Sbjct: 236 -----PEELYQLMRLCWKERPEDRPTFDYLRSV 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.6 bits (149), Expect = 3e-11
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 4/59 (6%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIVKLKYFF 84
+G G FG V+ + VA+K + Q + E +M++L+H +V+L
Sbjct: 20 RLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 41/181 (22%), Positives = 71/181 (39%), Gaps = 33/181 (18%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
+ YQ+ + + ++ HRD+ +N+L+ V+K+CDFG A+ ++ V +R
Sbjct: 169 FAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNAR 227
Query: 309 ---YYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTP 364
+ APE +F I YT K DVWS G +L E+ LG +PG ++I+
Sbjct: 228 LPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----- 281
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
N + P + ++ + R S + S
Sbjct: 282 ----------NGFKMDQPF------------YATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 425 I 425
Sbjct: 320 F 320
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 3e-08
Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 11/72 (15%)
Query: 29 VIGNGSFGIVYQAKLLDSGEL-----VAIKKVLQDKRFKN-----REMQIMRRLE-HSNI 77
V+G+G+FG V A + VA+K + + E+++M +L H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 78 VKLKYFFYSSGD 89
V L SG
Sbjct: 104 VNLLGACTLSGP 115
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 42/213 (19%), Positives = 73/213 (34%), Gaps = 34/213 (15%)
Query: 217 NLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLL 276
+ V + A+ S C Q+ +AY+ HRD+ +N L
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172
Query: 277 LNPETGVLKLCDFGSAKHLVRGEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
+ E V+K+ DFG ++++ + + + PE IF YTT+ DVW+ G
Sbjct: 173 VG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGV 230
Query: 334 VLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
VL E+ G + G + + + + I N
Sbjct: 231 VLWEIFSYGLQPYYGMAHEEVIYYVRD-------GNILACPENC---------------- 267
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P + +L+ P+ R S + I
Sbjct: 268 -----PLELYNLMRLCWSKLPADRPSFCSIHRI 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.6 bits (120), Expect = 1e-07
Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 12/71 (16%)
Query: 29 VIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNI 77
IG G+FG V+QA+ + +VA+K + ++ F+ RE +M ++ NI
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNPNI 78
Query: 78 VKLKYFFYSSG 88
VKL
Sbjct: 79 VKLLGVCAVGK 89
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.8 bits (240), Expect = 9e-23
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 33/189 (17%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+ + F + + Y Q+ + Y+H L + +RD+KP+NLL++ + G +++ DFG A
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA 188
Query: 293 KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVD 352
K + + APE+I Y +D W+ G ++ E+ G P F D +
Sbjct: 189 KR--VKGRTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 353 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412
+I+ + +FP D DL+ LL+
Sbjct: 246 IYEKIVS-----------------GKVRFPS------------HFSSDLKDLLRNLLQVD 276
Query: 413 PSSRISPLQ 421
+ R L+
Sbjct: 277 LTKRFGNLK 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.4 bits (143), Expect = 2e-10
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 7/64 (10%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN-------REMQIMRRLEHSNIVKLK 81
+G GSFG V K +SG A+K + + K K E +I++ + +VKL+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 82 YFFY 85
+ F
Sbjct: 108 FSFK 111
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 2e-21
Identities = 41/215 (19%), Positives = 69/215 (32%), Gaps = 38/215 (17%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
LV+E Y + ++ ++Q+ + Y+ HRD+ +N+
Sbjct: 82 WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331
LL + K+ DFG +K L E + APE I +++K DVWS
Sbjct: 139 LLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSF 196
Query: 332 GCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390
G ++ E GQ + G G + + K
Sbjct: 197 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC--------------------- 235
Query: 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P + DL++ Y +R V
Sbjct: 236 -------PREMYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (134), Expect = 2e-09
Identities = 15/65 (23%), Positives = 30/65 (46%), Gaps = 8/65 (12%)
Query: 29 VIGNGSFGIVYQAKLLD--SGELVAIKKV---LQDKRFKN---REMQIMRRLEHSNIVKL 80
+G+G+FG V + + VA+K + D K+ E +M++L++ IV++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 81 KYFFY 85
Sbjct: 74 IGICE 78
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 3e-21
Identities = 37/209 (17%), Positives = 75/209 (35%), Gaps = 33/209 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ LV EFM ++ + + F + +AY+ + HRD+ +N
Sbjct: 75 ICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYIC--SRYYRAPELIFGAIDYTTKIDVWSAGC 333
L+ E V+K+ DFG + ++ + S + +PE+ + Y++K DVWS G
Sbjct: 133 LVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGV 190
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
++ E+ + + ++VE I R P
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDI-------STGFRLYKPRL----------------- 226
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQV 422
+++ + P R + ++
Sbjct: 227 ---ASTHVYQIMNHCWKERPEDRPAFSRL 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 2e-12
Identities = 18/65 (27%), Positives = 32/65 (49%), Gaps = 6/65 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
IG+G FG+V+ L+ + VAIK + + ++ F E ++M +L H +V+L
Sbjct: 12 EIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYGVC 69
Query: 85 YSSGD 89
Sbjct: 70 LEQAP 74
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 5e-21
Identities = 32/212 (15%), Positives = 77/212 (36%), Gaps = 35/212 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ ++ E+M + + + + F + ++ Y+ HRD+ +N
Sbjct: 74 IFIITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVS--YICSRYYRAPELIFGAIDYTTKIDVWSAGC 333
L+N + GV+K+ DFG +++++ E S + PE++ + +++K D+W+ G
Sbjct: 132 LVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGV 189
Query: 334 VLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKV 392
++ E+ LG+ + + + I + L P +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYRPHL-------- 225
Query: 393 FRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
++ R + + S
Sbjct: 226 ----ASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (151), Expect = 1e-11
Identities = 17/64 (26%), Positives = 26/64 (40%), Gaps = 6/64 (9%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKV----LQDKRFKNREMQIMRRLEHSNIVKLKYFF 84
+G G FG+V K VAIK + + + F E ++M L H +V+L
Sbjct: 11 ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLYGVC 68
Query: 85 YSSG 88
Sbjct: 69 TKQR 72
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.6 bits (224), Expect = 5e-21
Identities = 38/214 (17%), Positives = 73/214 (34%), Gaps = 39/214 (18%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ ++ EFM ++ F + + + Y+ + HRD+ +N+
Sbjct: 102 VMIITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR------YYRAPELIFGAIDYTTKIDVW 329
L+N V K+ DFG ++ L + +Y + + APE I +T+ DVW
Sbjct: 160 LVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVW 217
Query: 330 SAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHP 388
S G V+ E++ G+ + + D + I + P
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC------------------- 258
Query: 389 WSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P L+ + + R Q+
Sbjct: 259 ---------PSALHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.8 bits (144), Expect = 1e-10
Identities = 21/69 (30%), Positives = 29/69 (42%), Gaps = 10/69 (14%)
Query: 29 VIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD------KRFKNREMQIMRRLEHSNIVK 79
VIG G FG V L G+ VAIK + + F E IM + +H N++
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQFDHPNVIH 91
Query: 80 LKYFFYSSG 88
L+ S
Sbjct: 92 LEGVVTKST 100
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 7e-21
Identities = 41/211 (19%), Positives = 76/211 (36%), Gaps = 36/211 (17%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ L+ + MP + + + K N Y + Q+ + + Y+ + HRD+ +N+
Sbjct: 85 VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR---YYRAPELIFGAIDYTTKIDVWSAG 332
L+ +K+ DFG AK L E + + A E I I YT + DVWS G
Sbjct: 143 LVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYG 200
Query: 333 CVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
+ EL+ G + G ++ I++ + + P
Sbjct: 201 VTVWELMTFGSKPYDGIP-ASEISSILE------KGERLPQPPIC--------------- 238
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
D ++ + SR ++
Sbjct: 239 ------TIDVYMIMVKCWMIDADSRPKFREL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 3e-10
Identities = 18/69 (26%), Positives = 34/69 (49%), Gaps = 9/69 (13%)
Query: 29 VIGNGSFGIVYQAKLLDSGEL----VAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
V+G+G+FG VY+ + GE VAIK++ + K E +M +++ ++ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 80 LKYFFYSSG 88
L +S
Sbjct: 76 LLGICLTST 84
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 3e-20
Identities = 36/214 (16%), Positives = 70/214 (32%), Gaps = 35/214 (16%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
+ ++ E+M K + F + + + Y+ + HRD+ +N+
Sbjct: 84 MMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYIC----SRYYRAPELIFGAIDYTTKIDVWSA 331
L+N V K+ DFG ++ L + APE I + DVWS
Sbjct: 142 LVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSF 199
Query: 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
G V+ E++ + ++++ I + R P
Sbjct: 200 GIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFRLPTP----------------- 235
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
+ P L+ + + + R + SI
Sbjct: 236 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 22/70 (31%), Positives = 28/70 (40%), Gaps = 9/70 (12%)
Query: 29 VIGNGSFGIVYQAKLLDSGE----LVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVK 79
VIG G FG VY+ L S VAIK + K E IM + H NI++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 80 LKYFFYSSGD 89
L+
Sbjct: 74 LEGVISKYKP 83
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 4e-20
Identities = 41/211 (19%), Positives = 78/211 (36%), Gaps = 38/211 (18%)
Query: 218 LVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLL 277
+VL +M + N + Q+ + + ++ HRD+ +N +L
Sbjct: 106 VVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 163
Query: 278 NPETGVLKLCDFGSAKHLVRGEPNVSYICSRY-----YRAPELIFGAIDYTTKIDVWSAG 332
+ E +K+ DFG A+ + E + + + + A E + +TTK DVWS G
Sbjct: 164 D-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFG 221
Query: 333 CVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
+L EL+ G P +P + D V +++ R + P Y
Sbjct: 222 VLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLLQPEYC-------------- 259
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P +++ + R S ++
Sbjct: 260 ------PDPLYEVMLKCWHPKAEMRPSFSEL 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 20/70 (28%), Positives = 27/70 (38%), Gaps = 8/70 (11%)
Query: 29 VIGNGSFGIVYQAKLLDS---GELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIVKL 80
VIG G FG VY LLD+ A+K + + E IM+ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 81 KYFFYSSGDK 90
S
Sbjct: 94 LGICLRSEGS 103
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 6e-20
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR 308
+ YQ+ + +A++ HRD+ +N+LL + K+CDFG A+ + V +R
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 309 ---YYRAPELIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTP 364
+ APE IF + YT + DVWS G L EL LG +PG + ++IK
Sbjct: 209 LPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----- 262
Query: 365 TREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
E R ++P + P + D++ + P R + Q+
Sbjct: 263 --EGFRMLSPEH--------------------APAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 3e-10
Identities = 18/72 (25%), Positives = 28/72 (38%), Gaps = 11/72 (15%)
Query: 29 VIGNGSFGIVYQAKLL-----DSGELVAIKKVLQDKRFKN-----REMQIMRRLE-HSNI 77
+G G+FG V +A D+ VA+K + E++++ L H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 78 VKLKYFFYSSGD 89
V L G
Sbjct: 90 VNLLGACTIGGP 101
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 7e-20
Identities = 49/305 (16%), Positives = 98/305 (32%), Gaps = 45/305 (14%)
Query: 137 RVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF-PQIKSHPW-SKVFRVRTPPDAI 194
R+ G+ I ++ +++ R+ E + ++ HP + +
Sbjct: 30 RIKKDGLRMDAAIKRMKEYASKDDHRDF---AGELEVLCKLGHHPNIINLLGACEHRGYL 86
Query: 195 DLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254
L + L+ + + + + + +
Sbjct: 87 YLAIEYAPHGN---------LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137
Query: 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPE 314
R + Y+ HRD+ +N+L+ E V K+ DFG ++ + A E
Sbjct: 138 RGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 196
Query: 315 LIFGAIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMN 373
+ ++ YTT DVWS G +L E++ LG + G + ++ E
Sbjct: 197 SLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------------CAELYEKL 239
Query: 374 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433
P + P + DL+ + P R S Q+ ++E R
Sbjct: 240 PQGYRLEKPL------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 434 AVFEN 438
+ N
Sbjct: 288 KTYVN 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (127), Expect = 2e-08
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 15 TYFSDLD-NSLAQKTVIGNGSFGIVYQAKLLDSGEL--VAIKKV-----LQDKRFKNREM 66
T + LD N + + VIG G+FG V +A++ G AIK++ D R E+
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 61
Query: 67 QIMRRLE-HSNIVKLKYFFYSSG 88
+++ +L H NI+ L G
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRG 84
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 7e-20
Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 33/189 (17%)
Query: 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR 297
K + Y +Q+ + + ++ HRD+ +N+LL+ E V+K+CDFG A+ + +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYK 186
Query: 298 GEPNV---SYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG-QPMFPGDSGVDQ 353
V + APE IF + YT + DVWS G +L E+ +PG ++
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 354 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413
+K E R P+Y T P+ + P
Sbjct: 246 FCRRLK-------EGTRMRAPDY--------------------TTPEMYQTMLDCWHGEP 278
Query: 414 SSRISPLQV 422
S R + ++
Sbjct: 279 SQRPTFSEL 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 7e-08
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 11/73 (15%)
Query: 29 VIGNGSFGIVYQAKL-----LDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNI 77
+G G+FG V +A + VA+K + + + + ++ H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 78 VKLKYFFYSSGDK 90
V L G
Sbjct: 80 VNLLGACTKPGGP 92
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.1 bits (215), Expect = 8e-20
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 32/212 (15%)
Query: 216 LNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNL 275
++ EFM ++Q Q+ ++ Y+ HRD+ +N
Sbjct: 88 FYIITEFMTYGNLL-DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146
Query: 276 LLNPETGVLKLCDFGSAKHLVRGEPNVSYICSR--YYRAPELIFGAIDYTTKIDVWSAGC 333
L+ E ++K+ DFG ++ + + APE + ++ K DVW+ G
Sbjct: 147 LVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGV 204
Query: 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393
+L E+ + Q+ E+++ + P+
Sbjct: 205 LLWEIATYGMSPYPGIDLSQVYELLE---------------KDYRMERPE---------- 239
Query: 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSI 425
P +L+ ++ PS R S ++
Sbjct: 240 --GCPEKVYELMRACWQWNPSDRPSFAEIHQA 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.0 bits (168), Expect = 1e-13
Identities = 36/243 (14%), Positives = 72/243 (29%), Gaps = 57/243 (23%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN---REMQIMRRLEHSNIVKLKYFFY 85
+G G +G VY+ VA+K + +D +E +M+ ++H N+V+L
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVA-------TPGQGPDRPQEI------- 131
+ R +V+ VV + +
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 143
Query: 132 ------SYTNTRVSDSGVDQLV-EIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS-- 182
+V+D G+ +L+ + I+ P + IKS W+
Sbjct: 144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 183 --------------------KVFRV-----------RTPPDAIDLISRLLEYTPSSRISP 211
+V+ + P +L+ ++ PS R S
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 263
Query: 212 LQV 214
++
Sbjct: 264 AEI 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 1e-19
Identities = 45/213 (21%), Positives = 77/213 (36%), Gaps = 35/213 (16%)
Query: 215 FLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQN 274
+ +++E + K + LY YQL +LAY+ HRDI +N
Sbjct: 81 PVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138
Query: 275 LLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC--SRYYRAPELIFGAIDYTTKIDVWSAG 332
+L++ +KL DFG ++++ + + APE I +T+ DVW G
Sbjct: 139 VLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFG 196
Query: 333 CVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSK 391
+ E+L+ G F G D + I P
Sbjct: 197 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC---------------------- 234
Query: 392 VFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424
PP L+++ Y PS R ++++
Sbjct: 235 ------PPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 9e-10
Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 10/65 (15%)
Query: 29 VIGNGSFGIVYQAKLL---DSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVK 79
IG G FG V+Q + + VAIK ++F +E MR+ +H +IVK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVK 72
Query: 80 LKYFF 84
L
Sbjct: 73 LIGVI 77
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 2e-19
Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 47/225 (20%)
Query: 215 FLNLVLEFM-------------PETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261
L +++E+ P + ++ YQ+ R + Y+
Sbjct: 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVS---YICSRYYRAPELIFG 318
HRD+ +N+L+ + V+K+ DFG A+ + + + APE +F
Sbjct: 153 SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211
Query: 319 AIDYTTKIDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 377
I YT + DVWS G +L E+ LG +PG V++L +++K
Sbjct: 212 RI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLK------------------ 251
Query: 378 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
E S+ + ++ PS R + Q+
Sbjct: 252 EGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 2e-06
Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 13/73 (17%)
Query: 29 VIGNGSFGIVYQAKLL-------DSGELVAIKKVLQDKRFKN-----REMQIMRRL-EHS 75
+G G+FG V A+ + + VA+K + D K+ EM++M+ + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 76 NIVKLKYFFYSSG 88
NI+ L G
Sbjct: 80 NIINLLGACTQDG 92
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 2e-15
Identities = 39/218 (17%), Positives = 77/218 (35%), Gaps = 41/218 (18%)
Query: 216 LNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYT------KLYIYQLFRSLAYIHVLGICHR 268
+++E M + + + N P ++ +AY++ HR
Sbjct: 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157
Query: 269 DIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYIC---SRYYRAPELIFGAIDYTTK 325
D+ +N ++ E +K+ DFG + + + + +PE + + +TT
Sbjct: 158 DLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTY 215
Query: 326 IDVWSAGCVLAELL-LGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 384
DVWS G VL E+ L + + G S L +++ + + N
Sbjct: 216 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-------GGLLDKPDNC-------- 260
Query: 385 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQV 422
P +L+ +Y P R S L++
Sbjct: 261 -------------PDMLFELMRMCWQYNPKMRPSFLEI 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (123), Expect = 6e-08
Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 10/70 (14%)
Query: 29 VIGNGSFGIVYQAKL-----LDSGELVAIKKVLQDKRFKN-----REMQIMRRLEHSNIV 78
+G GSFG+VY+ + VAIK V + + E +M+ ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 79 KLKYFFYSSG 88
+L
Sbjct: 87 RLLGVVSQGQ 96
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.8 bits (144), Expect = 3e-11
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 233 HYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSA 292
+K + + +A + GI H D+ N+L++ E + + DF +
Sbjct: 92 IDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQS 149
Query: 293 KHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337
+ GE I R R F Y T+ D+ SA + +
Sbjct: 150 VEV--GEEGWREILERDVRNIITYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 37.8 bits (87), Expect = 9e-04
Identities = 8/69 (11%), Positives = 14/69 (20%), Gaps = 15/69 (21%)
Query: 29 VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKN--------------REMQIMRRLEH 74
++G G V+ +K R E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 75 SNIVKLKYF 83
+ KL+
Sbjct: 66 RALQKLQGL 74
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 444 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.51 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=434.88 Aligned_cols=295 Identities=79% Similarity=1.303 Sum_probs=263.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCCcc
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPPLE 101 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 101 (444)
.+|..+++||+|+||+||+|+++.+|+.||||++..+.....+|+++|++++||||++++++|...+...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~---------- 89 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK---------- 89 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CC----------
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccC----------
Confidence 4799999999999999999999999999999999888888889999999999999999999998765311
Q ss_pred ccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCCCC
Q psy10212 102 DMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPW 181 (444)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (444)
T Consensus 90 -------------------------------------------------------------------------------- 89 (350)
T d1q5ka_ 90 -------------------------------------------------------------------------------- 89 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHH
Q psy10212 182 SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIH 261 (444)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLH 261 (444)
...+++||||||++++...+.........+++..++.++.||+.||+|||
T Consensus 90 ------------------------------~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 90 ------------------------------DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp ------------------------------SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 12579999999999988888777777889999999999999999999999
Q ss_pred HCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHHHhC
Q psy10212 262 VLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLG 341 (444)
Q Consensus 262 s~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG 341 (444)
++||+||||||+|||++.+...+||+|||++.............+++.|+|||.+.+...++.++||||+||++|+|++|
T Consensus 140 ~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g 219 (350)
T d1q5ka_ 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219 (350)
T ss_dssp TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence 99999999999999998555689999999998876666666778999999999987765799999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHH
Q psy10212 342 QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQ 421 (444)
Q Consensus 342 ~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~e 421 (444)
+.||...+..+.+..+.+..|.+....+....+.+....++......+.......+++++.+||.+||++||.+|||+.|
T Consensus 220 ~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999999999999999999999999999888888888888888877777889999999999999999999999999
Q ss_pred HhccCchhhhhhhhhh
Q psy10212 422 VRSITPFLIELRAVFE 437 (444)
Q Consensus 422 lL~~hpwf~~~~~~~~ 437 (444)
+|+ ||||++++....
T Consensus 300 ~L~-Hp~f~~~~~~~~ 314 (350)
T d1q5ka_ 300 ACA-HSFFDELRDPNV 314 (350)
T ss_dssp HHT-SGGGGGGGCTTC
T ss_pred Hhc-CHhhccccCCCC
Confidence 999 999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=408.31 Aligned_cols=247 Identities=34% Similarity=0.528 Sum_probs=215.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||+|++... ...+.+|++++++++||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT------ 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC------
Confidence 5799999999999999999999999999999998532 245668999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 80 -------------------------------------------------------------------------------- 79 (263)
T d2j4za1 80 -------------------------------------------------------------------------------- 79 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|||||||+ |+|.+++.. ..++++..++.++.||
T Consensus 80 ----------------------------------------~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi 115 (263)
T d2j4za1 80 ----------------------------------------RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITEL 115 (263)
T ss_dssp ----------------------------------------EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHH
Confidence 3899999998 599888853 4579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++|++||||||+||+++ .++.+||+|||++...... ......||+.|+|||.+.+. .++.++|||||||
T Consensus 116 ~~al~~lH~~~ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGv 192 (263)
T d2j4za1 116 ANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGV 192 (263)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHH
T ss_pred HHHHHHHHHCCeeeeeeccccceec-CCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhH
Confidence 9999999999999999999999999 7889999999999765433 34456789999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+....+.+. .. .++..+|+++.+||.+||+.||
T Consensus 193 ilyell~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~L~~dp 243 (263)
T d2j4za1 193 LCYEFLVGKPPFEANTYQETYKRISRV-----------------EF------------TFPDFVTEGARDLISRLLKHNP 243 (263)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------CC------------CCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------CC------------CCCccCCHHHHHHHHHHccCCH
Confidence 999999999999988877776655441 11 1234579999999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
.+|||+.|+|+ ||||+.
T Consensus 244 ~~R~t~~eil~-hp~~~~ 260 (263)
T d2j4za1 244 SQRPMLREVLE-HPWITA 260 (263)
T ss_dssp GGSCCHHHHHT-CHHHHH
T ss_pred hHCcCHHHHHc-CcCcCC
Confidence 99999999999 999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=412.66 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=217.9
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
..++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|++++++++||||+++++++.+.+
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------- 90 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD------- 90 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-------
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-------
Confidence 456899999999999999999999999999999998543 345679999999999999999999998765
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (293)
T d1yhwa1 91 -------------------------------------------------------------------------------- 90 (293)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||++ +|.+++.. .++++..++.++.||+
T Consensus 91 ---------------------------------------~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~ 126 (293)
T d1yhwa1 91 ---------------------------------------ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECL 126 (293)
T ss_dssp ---------------------------------------EEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHH
Confidence 38999999985 88877642 4699999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++||+||||||+||+++ .++.+||+|||+++..... .......||+.|+|||.+.+. .++.++|||||||
T Consensus 127 ~aL~yLH~~~iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGv 204 (293)
T d1yhwa1 127 QALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGI 204 (293)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHH
T ss_pred HHHHHHHHCCCcccCCcHHHeEEC-CCCcEeeccchhheeeccccccccccccCCCccChhhhcCC-CCCchhceehHhH
Confidence 999999999999999999999999 7889999999999876443 334456789999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+.+..+..... + ....+..+|+.+++||.+||+.||
T Consensus 205 ilyemltG~~Pf~~~~~~~~~~~~~~~~~-~-------------------------~~~~~~~~s~~~~~li~~~L~~dP 258 (293)
T d1yhwa1 205 MAIEMIEGEPPYLNENPLRALYLIATNGT-P-------------------------ELQNPEKLSAIFRDFLNRCLDMDV 258 (293)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHHCS-C-------------------------CCSSGGGSCHHHHHHHHHHTCSST
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHhCCC-C-------------------------CCCCcccCCHHHHHHHHHHccCCh
Confidence 99999999999998888777766655210 0 001234579999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
.+|||+.|+|+ ||||+.-
T Consensus 259 ~~R~s~~eil~-Hp~~~~~ 276 (293)
T d1yhwa1 259 EKRGSAKELLQ-HQFLKIA 276 (293)
T ss_dssp TTSCCHHHHTT-CGGGGGC
T ss_pred hHCcCHHHHhc-CHhhCCC
Confidence 99999999999 9999853
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=410.95 Aligned_cols=253 Identities=27% Similarity=0.331 Sum_probs=211.3
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
.++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~------- 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------- 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-------
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-------
Confidence 46799999999999999999999999999999998543 346779999999999999999999998764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (271)
T d1nvra_ 77 -------------------------------------------------------------------------------- 76 (271)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||++ +|.+++. ....+++..++.++.||+
T Consensus 77 ---------------------------------------~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~ 113 (271)
T d1nvra_ 77 ---------------------------------------IQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLM 113 (271)
T ss_dssp ---------------------------------------EEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHH
T ss_pred ---------------------------------------eeEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHH
Confidence 48999999985 8888773 456799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
.||+|||++||+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+...++.++|||||
T Consensus 114 ~al~ylH~~~IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl 192 (271)
T d1nvra_ 114 AGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192 (271)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred HHHHHHHHcCCccCcccHHHEEEC-CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence 999999999999999999999999 78899999999997654322 23456789999999999877345788999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||...+............... ......+|+++.+||.+||+.
T Consensus 193 Gvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~ 246 (271)
T d1nvra_ 193 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------------------LNPWKKIDSAPLALLHKILVE 246 (271)
T ss_dssp HHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------------------STTGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------------------CCccccCCHHHHHHHHHHcCC
Confidence 999999999999998766544333332210000 001134689999999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
||++|||+.|+|+ ||||++
T Consensus 247 dP~~R~t~~eil~-hpwf~~ 265 (271)
T d1nvra_ 247 NPSARITIPDIKK-DRWYNK 265 (271)
T ss_dssp STTTSCCHHHHTT-CTTTTC
T ss_pred ChhHCcCHHHHhc-CHhhCc
Confidence 9999999999999 999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-53 Score=416.08 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=207.8
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
-+++.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++.+.+
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 80 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--- 80 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 356889999999999999999999999999999999998532 345678999999999999999999997664
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (307)
T d1a06a_ 81 -------------------------------------------------------------------------------- 80 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+|||||||+ ++|.+++. ..+++++..++.++
T Consensus 81 -------------------------------------------~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~ 113 (307)
T d1a06a_ 81 -------------------------------------------HLYLIMQLVSGGELFDRIV----EKGFYTERDASRLI 113 (307)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHH
Confidence 3899999998 59999985 35689999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||+.||+|||++|++||||||+||++.. +++.+||+|||+++............||+.|+|||.+.+. .++.++||
T Consensus 114 ~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~Di 192 (307)
T d1a06a_ 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDC 192 (307)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTC-CCCTHHHH
T ss_pred HHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHh
Confidence 99999999999999999999999999952 4679999999999876555555667899999999999887 79999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|+.||.+.+..+....+.+... . .......++|+++.+||.+|
T Consensus 193 wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-----------------~--------~~~~~~~~~s~~~~~li~~~ 247 (307)
T d1a06a_ 193 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-----------------E--------FDSPYWDDISDSAKDFIRHL 247 (307)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-----------------C--------CCTTTTTTSCHHHHHHHHHH
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-----------------C--------CCCccccCCCHHHHHHHHHH
Confidence 9999999999999999998888777766655211 0 11112346799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~ 431 (444)
|+.||.+|||+.|+|+ ||||+.
T Consensus 248 L~~dP~~R~s~~eil~-hp~~~~ 269 (307)
T d1a06a_ 248 MEKDPEKRFTCEQALQ-HPWIAG 269 (307)
T ss_dssp SCSSGGGSCCHHHHHH-STTTTS
T ss_pred ccCCHhHCcCHHHHhc-CHhhCC
Confidence 9999999999999999 999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=408.74 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=208.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++.+..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN------ 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---------
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC------
Confidence 5799999999999999999999999999999998433 2346689999999999999999999976542
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (269)
T d2java1 78 -------------------------------------------------------------------------------- 77 (269)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
..+|||||||+ |+|.+++.........+++..++.++.||+
T Consensus 78 --------------------------------------~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~ 119 (269)
T d2java1 78 --------------------------------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119 (269)
T ss_dssp ---------------------------------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHH
T ss_pred --------------------------------------CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHH
Confidence 23899999998 599999987777788999999999999999
Q ss_pred HHHHHHHHCC-----cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhh
Q psy10212 255 RSLAYIHVLG-----ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 255 ~aL~yLHs~g-----ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
.||.|||+++ |+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||
T Consensus 120 ~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DI 197 (269)
T d2java1 120 LALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDI 197 (269)
T ss_dssp HHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHH
T ss_pred HHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHH
Confidence 9999999976 99999999999999 78999999999997764432 23456789999999999877 79999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|+|++|+.||.+.+..+....+.... . ..++.++|+++.+||.+|
T Consensus 198 wSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------------------~---------~~~~~~~s~~l~~li~~~ 249 (269)
T d2java1 198 WSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------------------F---------RRIPYRYSDELNEIITRM 249 (269)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------------------C---------CCCCTTSCHHHHHHHHHH
T ss_pred HhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------------C---------CCCCcccCHHHHHHHHHH
Confidence 999999999999999999988877776665421 0 012345799999999999
Q ss_pred cccCCCCCCCHHHHhccCchh
Q psy10212 409 LEYTPSSRISPLQVRSITPFL 429 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf 429 (444)
|+.||.+|||++|+|+ |||+
T Consensus 250 L~~dp~~Rps~~ell~-hp~i 269 (269)
T d2java1 250 LNLKDYHRPSVEEILE-NPLI 269 (269)
T ss_dssp TCSSGGGSCCHHHHHT-STTC
T ss_pred cCCChhHCcCHHHHHh-CCcC
Confidence 9999999999999999 9995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=408.94 Aligned_cols=279 Identities=36% Similarity=0.600 Sum_probs=229.7
Q ss_pred chhheecccceeEEEEeEecCCCceeeeeeeecc---------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+.+++||+|+||+||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++..++.
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~------ 74 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN------ 74 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC------
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc------
Confidence 3568999999999999999999999999998432 1346689999999999999999999977653
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (299)
T d1ua2a_ 75 -------------------------------------------------------------------------------- 74 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
+|+|||||.+++...+. .....+++..++.++.||+.
T Consensus 75 ----------------------------------------~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~ 111 (299)
T d1ua2a_ 75 ----------------------------------------ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQ 111 (299)
T ss_dssp ----------------------------------------CEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHH
T ss_pred ----------------------------------------eeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHH
Confidence 88999999987766553 35677999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++|++||||||+||+++ ..+.+||+|||.++...... ......+|+.|+|||.+.+...++.++||||+||+
T Consensus 112 aL~~lH~~~iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi 190 (299)
T d1ua2a_ 112 GLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190 (299)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHH
T ss_pred HHHHhhccceecccCCcceEEec-CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchH
Confidence 99999999999999999999999 78999999999997664433 33445789999999998766578999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|++||.+.++.+++..+.+..+.+....+...........+.......+... ...+++++.+||.+||+.||+
T Consensus 191 l~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~ 269 (299)
T d1ua2a_ 191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPC 269 (299)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTT
T ss_pred HHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999888765544332222222222222222222 246799999999999999999
Q ss_pred CCCCHHHHhccCchhhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~~ 435 (444)
+|||+.|+|+ ||||++....
T Consensus 270 ~R~sa~e~L~-Hp~f~~~p~p 289 (299)
T d1ua2a_ 270 ARITATQALK-MKYFSNRPGP 289 (299)
T ss_dssp TSCCHHHHHT-SGGGTSSSCC
T ss_pred hCcCHHHHhC-CHhhCCCCCC
Confidence 9999999999 9999986644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=406.15 Aligned_cols=283 Identities=34% Similarity=0.607 Sum_probs=233.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||++++++|.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~------- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN------- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-------
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-------
Confidence 4799999999999999999999999999999998432 345668999999999999999999998865
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (298)
T d1gz8a_ 75 -------------------------------------------------------------------------------- 74 (298)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+|+|||||++++.+.+.. .....+++..++.++.||+.
T Consensus 75 ---------------------------------------~~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~ 113 (298)
T d1gz8a_ 75 ---------------------------------------KLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQ 113 (298)
T ss_dssp ---------------------------------------EEEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHH
T ss_pred ---------------------------------------ceeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHH
Confidence 3899999999988877643 34567999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++||+||||||+||+++ .++.+||+|||.++..... .......+|+.|+|||.+.....++.++|+||+||+
T Consensus 114 ~L~yLH~~~IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvi 192 (298)
T d1gz8a_ 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192 (298)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHhhcCCEEccccCchheeec-ccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchh
Confidence 99999999999999999999999 7889999999999766443 334455789999999998776567899999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCC-CcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|+.||.+.+..+.+.++.+..+.+....+....... .....+......... ....+|+++.+||.+||+.||
T Consensus 193 ly~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP 271 (298)
T d1gz8a_ 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDP 271 (298)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSST
T ss_pred hhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhh-hccCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999988887655443321110 011111111211111 234678999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+|||+.|+|+ ||||+++...
T Consensus 272 ~~R~t~~ell~-H~ff~~~~~p 292 (298)
T d1gz8a_ 272 NKRISAKAALA-HPFFQDVTKP 292 (298)
T ss_dssp TTSCCHHHHHT-SGGGTTCCCC
T ss_pred hHCcCHHHHhC-CHhhccCCCC
Confidence 99999999999 9999998665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=403.89 Aligned_cols=292 Identities=32% Similarity=0.514 Sum_probs=236.4
Q ss_pred hhhccccchhheecccceeEEEEeEecCC-Cceeeeeeeecc------ccchhhHHHHhhhc---CCCceeEeeeEEeec
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDS-GELVAIKKVLQD------KRFKNREMQIMRRL---EHSNIVKLKYFFYSS 87 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~------~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~ 87 (444)
.+..++|+++++||+|+||+||+|++..+ ++.||||++... ...+.+|+.+++.| +||||+++++++...
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 34568999999999999999999999655 678999998432 23455788887776 799999999998754
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
..
T Consensus 83 ~~------------------------------------------------------------------------------ 84 (305)
T d1blxa_ 83 RT------------------------------------------------------------------------------ 84 (305)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 31
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
+....++++||||++++...... .....+++..++
T Consensus 85 -------------------------------------------~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~ 119 (305)
T d1blxa_ 85 -------------------------------------------DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIK 119 (305)
T ss_dssp -------------------------------------------SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHH
T ss_pred -------------------------------------------ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHH
Confidence 00146899999999987665532 355678999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchh
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
.++.||+.||+|||++||+||||||+|||++ ..+.++|+|||.+.............||+.|+|||.+.+. .++.++|
T Consensus 120 ~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~D 197 (305)
T d1blxa_ 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVD 197 (305)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHH
T ss_pred HHHHHHHHHHHHHHhCCEEecCCCccEEEEc-CCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChheh
Confidence 9999999999999999999999999999999 7889999999998776555555667899999999999887 8999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||+||++|+|++|+.||.+.+..+.+..+.+..+.+....+....... ...+.. ........+...+++.+.+||.+
T Consensus 198 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~s~~~~dli~~ 275 (305)
T d1blxa_ 198 LWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP-RQAFHS-KSAQPIEKFVTDIDELGKDLLLK 275 (305)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC-GGGSCC-CCCCCGGGTCCSCCHHHHHHHHH
T ss_pred hhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch-hhhhcc-ccccchhhccccCCHHHHHHHHH
Confidence 9999999999999999999999999999999999988766554321111 011111 11112233456789999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
||++||++|||+.|+|+ ||||+++..--+
T Consensus 276 mL~~dP~~R~sa~e~L~-Hpff~~i~~~ke 304 (305)
T d1blxa_ 276 CLTFNPAKRISAYSALS-HPYFQDLERCKE 304 (305)
T ss_dssp HSCSSTTTSCCHHHHHT-SGGGTTCCCCCC
T ss_pred HCcCChhHCcCHHHHhc-ChhhcCchhhCC
Confidence 99999999999999999 999999865444
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=406.49 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=221.1
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcCCCceeEeeeEEeecC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLEHSNIVKLKYFFYSSG 88 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (444)
.+.++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++++||||+++++++.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4678999999999999999999999999999999998432 234668999999999999999999997764
Q ss_pred CCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCC
Q psy10212 89 DKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNY 168 (444)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (293)
T d1jksa_ 87 -------------------------------------------------------------------------------- 86 (293)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHH
Q psy10212 169 TEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTK 247 (444)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~ 247 (444)
.+|||||||+ |+|.+++.. .+++++..++
T Consensus 87 ----------------------------------------------~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~ 116 (293)
T d1jksa_ 87 ----------------------------------------------DVILILELVAGGELFDFLAE----KESLTEEEAT 116 (293)
T ss_dssp ----------------------------------------------EEEEEEECCCSCBHHHHHHH----HSSCCHHHHH
T ss_pred ----------------------------------------------EEEEEEEcCCCccccchhcc----ccccchhHHH
Confidence 4899999998 589998853 3579999999
Q ss_pred HHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCC---CeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCc
Q psy10212 248 LYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPET---GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 248 ~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~---~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
.++.||+.||+|||+++++||||||+||+++..+ ..+||+|||++.............+++.|+|||.+.+. .++.
T Consensus 117 ~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~ 195 (293)
T d1jksa_ 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGL 195 (293)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCT
T ss_pred HHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCC
Confidence 9999999999999999999999999999997332 26999999999877665556667889999999999877 7899
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDL 404 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~L 404 (444)
++||||+||++|+|++|+.||.+.+..+....+....... ...+..++|+.+++|
T Consensus 196 ~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-------------------------EDEYFSNTSALAKDF 250 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-------------------------CHHHHTTSCHHHHHH
T ss_pred cccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------------CchhcCCCCHHHHHH
Confidence 9999999999999999999999988888777665532111 122234679999999
Q ss_pred HHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 405 ISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 405 I~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
|.+||+.||.+|||++|+|+ ||||+...
T Consensus 251 i~~~L~~dP~~R~s~~eil~-hp~~~~~~ 278 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQ-HPWIKPKD 278 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHH-STTTCC--
T ss_pred HHHHccCChhHCcCHHHHhc-CcccCCCC
Confidence 99999999999999999999 99998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=406.14 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=214.6
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+.|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++++||||+++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--------- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--------- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT---------
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---------
Confidence 5699999999999999999999999999999998543 256678999999999999999999998765
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (288)
T d2jfla1 83 -------------------------------------------------------------------------------- 82 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
.+++|||||++ +|.+++.. ..+++++..++.++.||+.|
T Consensus 83 -------------------------------------~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~g 122 (288)
T d2jfla1 83 -------------------------------------NLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDA 122 (288)
T ss_dssp -------------------------------------EEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHH
Confidence 38999999985 88877653 45679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhcc----CCCCCcchhhhhH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFG----AIDYTTKIDVWSA 331 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~s~~sDiwSL 331 (444)
|.|||++||+||||||+||+++ .++.+||+|||++...... .......||+.|+|||.+.. ...++.++|||||
T Consensus 123 L~ylH~~~ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl 201 (288)
T d2jfla1 123 LNYLHDNKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201 (288)
T ss_dssp HHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred HHHHHHCCEEEeecChhheeEC-CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence 9999999999999999999999 7889999999998654322 12234578999999999842 2368899999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+.+.++.+.. + + ....+.++|+++.+||.+||+.
T Consensus 202 Gvilyemltg~~Pf~~~~~~~~~~~i~~~~--~-----------------~-------~~~~~~~~s~~~~~li~~~L~~ 255 (288)
T d2jfla1 202 GITLIEMAEIEPPHHELNPMRVLLKIAKSE--P-----------------P-------TLAQPSRWSSNFKDFLKKCLEK 255 (288)
T ss_dssp HHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C-----------------C-------CCSSGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C-----------------C-------CCCccccCCHHHHHHHHHHccC
Confidence 999999999999999988888877776521 0 0 0011245799999999999999
Q ss_pred CCCCCCCHHHHhccCchhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~ 431 (444)
||.+|||+.|+|+ ||||+.
T Consensus 256 dp~~R~t~~ell~-hp~~~~ 274 (288)
T d2jfla1 256 NVDARWTTSQLLQ-HPFVTV 274 (288)
T ss_dssp STTTSCCHHHHTT-SGGGCC
T ss_pred ChhHCcCHHHHhc-CcccCC
Confidence 9999999999999 999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=398.63 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=208.6
Q ss_pred ccc-chhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSL-AQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.+| ++.++||+|+||+||+|+++.+++.||+|++... .+.+.+|+++|++++||||++++++|.+....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~---- 83 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG---- 83 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS----
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc----
Confidence 444 5677899999999999999999999999998543 24567899999999999999999998764320
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (270)
T d1t4ha_ 84 -------------------------------------------------------------------------------- 83 (270)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
...+|+|||||++ +|.+++.. ...+++..++.++.||
T Consensus 84 --------------------------------------~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi 121 (270)
T d1t4ha_ 84 --------------------------------------KKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQI 121 (270)
T ss_dssp --------------------------------------CEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred --------------------------------------CCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHH
Confidence 0358999999985 89888853 4679999999999999
Q ss_pred HHHHHHHHHCC--cccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLG--ICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~g--ivH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||+|||+++ |+||||||+||+++.+++.+||+|||+++... ........||+.|+|||.+.+ .++.++|||||
T Consensus 122 ~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSl 198 (270)
T d1t4ha_ 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAF 198 (270)
T ss_dssp HHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHH
T ss_pred HHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhH
Confidence 99999999999 99999999999997467899999999997542 233445689999999999865 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+......+.+.+.. + .....++..+++++.+||.+||+.
T Consensus 199 Gvilyel~~g~~Pf~~~~~~~~~~~~i~~-~-------------------------~~~~~~~~~~~~~~~~li~~~l~~ 252 (270)
T d1t4ha_ 199 GMCMLEMATSEYPYSECQNAAQIYRRVTS-G-------------------------VKPASFDKVAIPEVKEIIEGCIRQ 252 (270)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-------------------------CCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCcccHHHHHHHHHc-C-------------------------CCCcccCccCCHHHHHHHHHHccC
Confidence 99999999999999876655444333221 0 011123345789999999999999
Q ss_pred CCCCCCCHHHHhccCchhh
Q psy10212 412 TPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~ 430 (444)
||++|||+.|+|+ |||||
T Consensus 253 dp~~R~s~~ell~-Hp~fk 270 (270)
T d1t4ha_ 253 NKDERYSIKDLLN-HAFFQ 270 (270)
T ss_dssp SGGGSCCHHHHHT-SGGGC
T ss_pred CHhHCcCHHHHhC-CcccC
Confidence 9999999999999 99996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=406.06 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=213.2
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
....|++++.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++|++|+|||||++++++.+.+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~---- 88 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH---- 88 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC----
Confidence 4467999999999999999999999999999999985432 34668999999999999999999998764
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 89 -------------------------------------------------------------------------------- 88 (309)
T d1u5ra_ 89 -------------------------------------------------------------------------------- 88 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|+|||||.+++.+.+. ....++++..++.++.|
T Consensus 89 ------------------------------------------~~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~q 123 (309)
T d1u5ra_ 89 ------------------------------------------TAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHG 123 (309)
T ss_dssp ------------------------------------------EEEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHH
Confidence 389999999976555433 23568999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccC--CCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA--IDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~s~~sDiwS 330 (444)
|+.||.|||++||+||||||+|||++ .++.+||+|||++..... .....||+.|+|||.+.+. ..++.++||||
T Consensus 124 i~~aL~yLH~~~iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwS 199 (309)
T d1u5ra_ 124 ALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 199 (309)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHH
T ss_pred HHHHHHHHHhCCEeccCCCcceEEEC-CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhh
Confidence 99999999999999999999999999 789999999999976533 3345789999999998642 25889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+.+.++.... .+ ...+..+|+.+.+||.+||+
T Consensus 200 lGvilyel~~g~~Pf~~~~~~~~~~~i~~~~-------------------~~--------~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 200 LGITCIELAERKPPLFNMNAMSALYHIAQNE-------------------SP--------ALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------CC--------CCSCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------------------CC--------CCCCCCCCHHHHHHHHHHCc
Confidence 9999999999999999888877776665521 00 01123578999999999999
Q ss_pred cCCCCCCCHHHHhccCchhhh
Q psy10212 411 YTPSSRISPLQVRSITPFLIE 431 (444)
Q Consensus 411 ~DP~kRPs~~elL~~hpwf~~ 431 (444)
.||.+|||++|+|+ ||||+.
T Consensus 253 ~dP~~Rpt~~ell~-Hp~~~~ 272 (309)
T d1u5ra_ 253 KIPQDRPTSEVLLK-HRFVLR 272 (309)
T ss_dssp SSGGGSCCHHHHTT-CHHHHS
T ss_pred CChhHCcCHHHHHh-CHHhcC
Confidence 99999999999999 999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=404.65 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=213.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++.+++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE------ 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS------
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC------
Confidence 5799999999999999999999999999999998532 245678999999999999999999987764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (288)
T d1uu3a_ 82 -------------------------------------------------------------------------------- 81 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++. ..+.+++..++.++.||
T Consensus 82 ----------------------------------------~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi 117 (288)
T d1uu3a_ 82 ----------------------------------------KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEI 117 (288)
T ss_dssp ----------------------------------------EEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHH
Confidence 38999999985 8988875 34679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
+.||+|||++||+||||||+||+++ +++.++|+|||+++...... ......||+.|+|||++.+. .++.++||||
T Consensus 118 ~~al~ylH~~~iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwS 195 (288)
T d1uu3a_ 118 VSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWA 195 (288)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHH
T ss_pred HHHHHhhccccEEcCcCCccccccC-CCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceeh
Confidence 9999999999999999999999999 78899999999997764332 23345789999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+...++.+. ... ++..+|+++++||.+||+
T Consensus 196 lGvilyell~g~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------------EYD------------FPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----------------CCC------------CCTTCCHHHHHHHHTTSC
T ss_pred hhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----------------CCC------------CCccCCHHHHHHHHHHcc
Confidence 999999999999999998887777766541 111 234579999999999999
Q ss_pred cCCCCCCCHHHH------hccCchhhhhh
Q psy10212 411 YTPSSRISPLQV------RSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs~~el------L~~hpwf~~~~ 433 (444)
.||++|||+.|+ ++ ||||+++.
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~-Hpff~~i~ 274 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKA-HPFFESVT 274 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHT-SGGGTTCC
T ss_pred CCHhHCcCHHHHcCCHHHHc-CCccCCCC
Confidence 999999999884 67 99998863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-52 Score=416.56 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=223.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+-++|++++.||+|+||.||+|+++.+|+.||||++... .+.+.+|+++|++|+||||+++++++.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------- 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN------- 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-------
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-------
Confidence 456899999999999999999999999999999998543 345678999999999999999999998764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 97 -------------------------------------------------------------------------------- 96 (350)
T d1koaa2 97 -------------------------------------------------------------------------------- 96 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+ |+|.+++. ...+++++..++.++.||+
T Consensus 97 ---------------------------------------~~~ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~ 134 (350)
T d1koaa2 97 ---------------------------------------EMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVC 134 (350)
T ss_dssp ---------------------------------------EEEEEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHH
Confidence 3999999998 48988874 2456799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNP-ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~-~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||.|||++|++||||||+||+++. .++.+||+|||+++............||+.|+|||++.+. .++.++|||||||
T Consensus 135 ~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGv 213 (350)
T d1koaa2 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGV 213 (350)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHH
T ss_pred HHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhH
Confidence 9999999999999999999999963 3578999999999887666656667889999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+.+..+....... ......++|+++++||.+||+.||
T Consensus 214 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP 268 (350)
T d1koaa2 214 LSYILLSGLSPFGGENDDETLRNVKSCDWNM-------------------------DDSAFSGISEDGKDFIRKLLLADP 268 (350)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------------------------CCGGGGGCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------------------CcccccCCCHHHHHHHHHHccCCh
Confidence 9999999999999988888887776632111 111223579999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~ 433 (444)
++|||++|+|+ ||||++..
T Consensus 269 ~~R~t~~eil~-hp~~~~~~ 287 (350)
T d1koaa2 269 NTRMTIHQALE-HPWLTPGN 287 (350)
T ss_dssp GGSCCHHHHHH-STTTSCTT
T ss_pred hHCcCHHHHhc-CcccCCCC
Confidence 99999999999 99998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-51 Score=397.15 Aligned_cols=277 Identities=34% Similarity=0.569 Sum_probs=227.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|+++++||+|+||+||+|+++ +|+.||||++... ...+.+|+.+|++++||||+++++.+...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~------ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR------ 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC------
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc------
Confidence 58999999999999999999996 6899999999443 2456689999999999999999999987753
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (286)
T d1ob3a_ 75 -------------------------------------------------------------------------------- 74 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
.+++||++.+++...+. ...+.+++..++.++.||+.
T Consensus 75 ----------------------------------------~~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~ 111 (286)
T d1ob3a_ 75 ----------------------------------------LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLN 111 (286)
T ss_dssp ----------------------------------------EEEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHH
T ss_pred ----------------------------------------eeEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHH
Confidence 89999999998877775 34578999999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++||+||||||+||+++ .++.+||+|||.+........ .....+++.|+|||.+.+...++.++|+|||||+
T Consensus 112 ~L~~LH~~~IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~ 190 (286)
T d1ob3a_ 112 GIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190 (286)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred HHHHhccCcEEecCCCCceeeEc-CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcH
Confidence 99999999999999999999999 789999999999876544332 3344678999999999876578999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC-cccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT-EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|+.||.+.+..+...++.+..+.+....+........ ....... .......+...+++.+.+||.+||++||
T Consensus 191 l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP 269 (286)
T d1ob3a_ 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDP 269 (286)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC-CCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc-cCcchhhhcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999988887665543221110 1111111 1111233446789999999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
++|||+.|+|+ ||||++
T Consensus 270 ~~R~s~~ell~-Hp~f~~ 286 (286)
T d1ob3a_ 270 NQRITAKQALE-HAYFKE 286 (286)
T ss_dssp TTSCCHHHHHT-SGGGGC
T ss_pred hHCcCHHHHhc-CcccCc
Confidence 99999999999 999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-51 Score=414.32 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=222.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
+.+.|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|+++|++|+||||++++++|.+++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~------- 99 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY------- 99 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-------
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-------
Confidence 457899999999999999999999999999999998543 345668999999999999999999998764
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 100 -------------------------------------------------------------------------------- 99 (352)
T d1koba_ 100 -------------------------------------------------------------------------------- 99 (352)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+| +|.+.+. ..+.++++..++.++.||+
T Consensus 100 ---------------------------------------~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~ 137 (352)
T d1koba_ 100 ---------------------------------------EMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQAC 137 (352)
T ss_dssp ---------------------------------------EEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHH
Confidence 38999999985 8877653 3456799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcC-CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNP-ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~-~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++||+||||||+|||++. ..+.+||+|||++.............+|+.|+|||++.+. .++.++|||||||
T Consensus 138 ~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv 216 (352)
T d1koba_ 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGV 216 (352)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHH
T ss_pred HHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHH
Confidence 9999999999999999999999973 4679999999999887666556667889999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+.+..+..... .+ ......++|+++.+||.+||+.||
T Consensus 217 ilyelltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~--------~~~~~~~~s~~~~~li~~~L~~dp 271 (352)
T d1koba_ 217 LGYVLLSGLSPFAGEDDLETLQNVKRCDW-----------------EF--------DEDAFSSVSPEAKDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----------------CC--------CSSTTTTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------CC--------CcccccCCCHHHHHHHHHHccCCh
Confidence 99999999999999988888877766211 11 111224579999999999999999
Q ss_pred CCCCCHHHHhccCchhhhh
Q psy10212 414 SSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~ 432 (444)
.+|||+.|+|+ ||||+..
T Consensus 272 ~~R~s~~eil~-Hp~~~~~ 289 (352)
T d1koba_ 272 RKRLTVHDALE-HPWLKGD 289 (352)
T ss_dssp GGSCCHHHHHT-STTTSSC
T ss_pred hHCcCHHHHhc-CHhhCCC
Confidence 99999999999 9999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-52 Score=410.47 Aligned_cols=281 Identities=26% Similarity=0.402 Sum_probs=211.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
..++|+++++||+|+||+||+|+++.+|+.||+|++..+ ...+.+|+++|++++||||++++++|.+.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------ 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS------
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC------
Confidence 357899999999999999999999999999999998543 245668999999999999999999998765
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (322)
T d1s9ja_ 78 -------------------------------------------------------------------------------- 77 (322)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|||||||++ +|.+++.. .+.+++..++.++.||
T Consensus 78 ----------------------------------------~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi 113 (322)
T d1s9ja_ 78 ----------------------------------------EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113 (322)
T ss_dssp ----------------------------------------EEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------EEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHH
Confidence 38999999995 89888853 3579999999999999
Q ss_pred HHHHHHHHH-CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHV-LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs-~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||.|||+ +||+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.+. .++.++||||+|
T Consensus 114 l~aL~yLH~~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlG 190 (322)
T d1s9ja_ 114 IKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMG 190 (322)
T ss_dssp HHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHH
T ss_pred HHHHHHHHHhCCEEccccCHHHeeEC-CCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHH
Confidence 999999997 4999999999999999 7899999999999765433 23456899999999999987 899999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHH-HHHHHHHhCCCCHHHHHhhCCCC-----CcccCCCc---------cCCCCcccccCCC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNY-----TEFKFPQI---------KSHPWSKVFRVRT 397 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~-~~~i~~~~g~~~~~~~~~~~~~~-----~~~~~p~~---------~~~~~~~~~~~~~ 397 (444)
|++|+|++|+.||.+.+..+. ........+.............. .....+.. ............+
T Consensus 191 vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (322)
T d1s9ja_ 191 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270 (322)
T ss_dssp HHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTB
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccC
Confidence 999999999999987665432 21122211111110000000000 00000000 0000001111235
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 398 PPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 398 s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+++.+||.+||+.||.+|||+.|+|+ ||||++..+
T Consensus 271 s~~~~dli~~~L~~dP~~R~ta~e~L~-Hpf~~~~~~ 306 (322)
T d1s9ja_ 271 SLEFQDFVNKCLIKNPAERADLKQLMV-HAFIKRSDA 306 (322)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT-SHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhh-CHhhCcCCc
Confidence 899999999999999999999999999 999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=407.65 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=223.9
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++.++|++++.||+|+||+||+|+++.+|+.||||++..+. ..+.+|+++|++++||||++++++|.+.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~------- 74 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME------- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-------
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-------
Confidence 57899999999999999999999999999999999995443 35669999999999999999999998765
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (321)
T d1tkia_ 75 -------------------------------------------------------------------------------- 74 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.+|||||||+| +|.+++. ..+.++++..++.++.||+
T Consensus 75 ---------------------------------------~~~lvmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~ 112 (321)
T d1tkia_ 75 ---------------------------------------ELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVC 112 (321)
T ss_dssp ---------------------------------------EEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHH
T ss_pred ---------------------------------------EEEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHH
Confidence 39999999995 8998884 3455799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCC-CCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPE-TGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~-~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
.||+|||++||+||||||+||+++.+ ...++|+|||++.............+++.|+|||.+.+. .++.++|+|||||
T Consensus 113 ~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGv 191 (321)
T d1tkia_ 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGT 191 (321)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCC-CCCchhhcccHHH
Confidence 99999999999999999999999732 458999999999876555555566789999999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|..||.+.+..+....+.+.....+... .+.+|+++.+||.+||+.||
T Consensus 192 ily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp 246 (321)
T d1tkia_ 192 LVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------------------------FKEISIEAMDFVDRLLVKER 246 (321)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------------------------HTTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------------------------ccCCCHHHHHHHHHHccCCh
Confidence 99999999999999998888888876432222222 13469999999999999999
Q ss_pred CCCCCHHHHhccCchhhh
Q psy10212 414 SSRISPLQVRSITPFLIE 431 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~ 431 (444)
.+|||+.|+|+ ||||++
T Consensus 247 ~~R~s~~eil~-hp~~~~ 263 (321)
T d1tkia_ 247 KSRMTASEALQ-HPWLKQ 263 (321)
T ss_dssp GGSCCHHHHHH-SHHHHS
T ss_pred hHCcCHHHHhc-CHhhcc
Confidence 99999999999 999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=404.87 Aligned_cols=249 Identities=25% Similarity=0.446 Sum_probs=218.0
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+++|++++||||++++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 78 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------ 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS------
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc------
Confidence 5799999999999999999999999999999998532 244568999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 79 -------------------------------------------------------------------------------- 78 (337)
T d1o6la_ 79 -------------------------------------------------------------------------------- 78 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||++ +|.+++. ..+.+++..++.++.||
T Consensus 79 ----------------------------------------~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qi 114 (337)
T d1o6la_ 79 ----------------------------------------RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEI 114 (337)
T ss_dssp ----------------------------------------EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHH
T ss_pred ----------------------------------------ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHH
Confidence 49999999995 8888875 35679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccC-CCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVR-GEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
+.||+|||++|++||||||+||+++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|+||||
T Consensus 115 l~al~ylH~~~iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlG 192 (337)
T d1o6la_ 115 VSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLG 192 (337)
T ss_dssp HHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHH
T ss_pred hhhhhhhhhcCccccccCHHHeEec-CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchh
Confidence 9999999999999999999999999 789999999999986543 3344556899999999999887 889999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccC
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYT 412 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~D 412 (444)
|++|+|++|++||.+.+..+....+... ... ++.++|+++.+||.+||++|
T Consensus 193 vilyeml~G~~pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~dli~~~L~~d 243 (337)
T d1o6la_ 193 VVMYEMMCGRLPFYNQDHERLFELILME-----------------EIR------------FPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHTCSS
T ss_pred hHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------------CCC------------CCccCCHHHHHHHHhhccCC
Confidence 9999999999999998887777666551 111 23467999999999999999
Q ss_pred CCCCCC-----HHHHhccCchhhhh
Q psy10212 413 PSSRIS-----PLQVRSITPFLIEL 432 (444)
Q Consensus 413 P~kRPs-----~~elL~~hpwf~~~ 432 (444)
|.+||+ +.|+++ ||||+++
T Consensus 244 P~~R~~~~~~~~~eil~-Hp~f~~i 267 (337)
T d1o6la_ 244 PKQRLGGGPSDAKEVME-HRFFLSI 267 (337)
T ss_dssp TTTSTTCSTTTHHHHHT-SGGGTTC
T ss_pred chhhcccccccHHHHHc-CcccccC
Confidence 999995 899999 9999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-50 Score=394.79 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=220.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------------cchhhHHHHhhhcC-CCceeEeeeEEe
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------------RFKNREMQIMRRLE-HSNIVKLKYFFY 85 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~E~~~l~~l~-h~~i~~~~~~~~ 85 (444)
|.++|++++.||+|+||+||+|+++.+|+.||||++.... +.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4578999999999999999999999999999999985432 24668999999997 999999999998
Q ss_pred ecCCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcC
Q psy10212 86 SSGDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMN 165 (444)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (444)
+++
T Consensus 81 ~~~----------------------------------------------------------------------------- 83 (277)
T d1phka_ 81 TNT----------------------------------------------------------------------------- 83 (277)
T ss_dssp CSS-----------------------------------------------------------------------------
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 764
Q ss_pred CCCcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChH
Q psy10212 166 PNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCF 244 (444)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~ 244 (444)
.+|||||||+ ++|.+++.. .+++++.
T Consensus 84 -------------------------------------------------~~~ivmE~~~~g~L~~~l~~----~~~l~e~ 110 (277)
T d1phka_ 84 -------------------------------------------------FFFLVFDLMKKGELFDYLTE----KVTLSEK 110 (277)
T ss_dssp -------------------------------------------------EEEEEEECCTTCBHHHHHHH----HSSCCHH
T ss_pred -------------------------------------------------ceEEEEEcCCCchHHHHHHh----cCCCCHH
Confidence 4999999998 599999853 4579999
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhcc-----C
Q psy10212 245 YTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFG-----A 319 (444)
Q Consensus 245 ~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~-----~ 319 (444)
.++.++.||+.||+|||++|++||||||+||+++ .++.+||+|||+++............||+.|+|||.+.+ .
T Consensus 111 ~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~ 189 (277)
T d1phka_ 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred HHHHHHHHHHHHHHHHHHcCCcccccccceEEEc-CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccC
Confidence 9999999999999999999999999999999999 789999999999988766655666788999999999863 2
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
..++.++|+||+||++|+|++|+.||.+.+..+....+...-. .. ......++|+
T Consensus 190 ~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~-----------------~~--------~~~~~~~~s~ 244 (277)
T d1phka_ 190 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-----------------QF--------GSPEWDDYSD 244 (277)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------------CC--------CTTTGGGSCH
T ss_pred CCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC-----------------CC--------CCcccccCCH
Confidence 3568899999999999999999999999988887776665211 00 1111235799
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
++++||.+||+.||.+|||+.|+|+ ||||++.
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~-h~~~~~~ 276 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALA-HPFFQQY 276 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT-SGGGCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHc-CHHHHHh
Confidence 9999999999999999999999999 9999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-50 Score=399.96 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=216.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ------ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS------
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC------
Confidence 5699999999999999999999999999999998532 245668999999999999999999998764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (316)
T d1fota_ 78 -------------------------------------------------------------------------------- 77 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+|+|||||+| +|..++. ....+++..++.++.||
T Consensus 78 ----------------------------------------~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi 113 (316)
T d1fota_ 78 ----------------------------------------QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEV 113 (316)
T ss_dssp ----------------------------------------EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHH
T ss_pred ----------------------------------------eeeeEeeecCCcccccccc----ccccccccHHHHHHHHH
Confidence 49999999996 6666664 45678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||+|||++||+||||||+||+++ .++.+||+|||+++..... .....||+.|+|||++.+. .++.++|+|||||
T Consensus 114 ~~al~~lH~~~iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGv 189 (316)
T d1fota_ 114 CLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGI 189 (316)
T ss_dssp HHHHHHHHTTTEECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHH
T ss_pred HHhhhhhccCcEEccccCchheeEc-CCCCEEEecCccceEeccc--cccccCcccccCHHHHcCC-CCCchhhccccch
Confidence 9999999999999999999999999 7899999999999775433 3456899999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+..+...++... .. .++..+|+++.++|.+||+.||
T Consensus 190 ilyemltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 190 LIYEMLAGYTPFYDSNTMKTYEKILNA-----------------EL------------RFPPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSCT
T ss_pred hHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhhhCH
Confidence 999999999999998888887777652 11 1234579999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~~ 433 (444)
.+|+ |++++|+ ||||+++.
T Consensus 241 ~~R~~~~r~t~~~il~-Hp~f~~i~ 264 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKN-HPWFKEVV 264 (316)
T ss_dssp TTCTTSSTTTTHHHHT-SGGGSSCC
T ss_pred HhccccchhhHHHHHc-CcccccCC
Confidence 9996 8999999 99999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=401.09 Aligned_cols=287 Identities=30% Similarity=0.566 Sum_probs=230.5
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||++++++|...+.-
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~-- 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL-- 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST--
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc--
Confidence 3679999999999999999999999999999999998532 23456899999999999999999999765420
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 93 -------------------------------------------------------------------------------- 92 (346)
T d1cm8a_ 93 -------------------------------------------------------------------------------- 92 (346)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.....+|+|||||+.+|..++.+ .++++..++.++.|
T Consensus 93 --------------------------------------~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~q 129 (346)
T d1cm8a_ 93 --------------------------------------DDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQ 129 (346)
T ss_dssp --------------------------------------TTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHH
T ss_pred --------------------------------------cccceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHH
Confidence 00134899999998888887642 57999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++||+||||||+||+++ .++.++++|||.+..... ......+|+.|+|||.+.+...++.++|+||+|
T Consensus 130 i~~aL~~LH~~~IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 206 (346)
T d1cm8a_ 130 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG 206 (346)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred HHHHHHHHHhCCCcccccCcchhhcc-cccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcch
Confidence 99999999999999999999999999 789999999999976533 344567899999999998765789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCC---cccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|++|+|++|+.||.+.+..+.+..+....+.++...+........ ....+......+... ..++++++.+||.+||
T Consensus 207 vil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL 285 (346)
T d1cm8a_ 207 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKML 285 (346)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHC
Confidence 999999999999999999999999999998888766554321110 011222223333322 3567999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.||.+|||+.|+|+ ||||+++...
T Consensus 286 ~~dP~~R~ta~eiL~-Hp~f~~~~~~ 310 (346)
T d1cm8a_ 286 VLDAEQRVTAGEALA-HPYFESLHDT 310 (346)
T ss_dssp CSSTTTSCCHHHHHH-SGGGTTTC--
T ss_pred cCChhHCcCHHHHhc-ChhhCcCCCc
Confidence 999999999999999 9999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=400.01 Aligned_cols=247 Identities=24% Similarity=0.438 Sum_probs=215.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
++|++++.||+|+||.||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------ 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc------
Confidence 6899999999999999999999999999999998532 234568999999999999999999997764
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 115 -------------------------------------------------------------------------------- 114 (350)
T d1rdqe_ 115 -------------------------------------------------------------------------------- 114 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
.+++|||||.+ +|...+.. .+.+++..++.++.||
T Consensus 115 ----------------------------------------~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi 150 (350)
T d1rdqe_ 115 ----------------------------------------NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQI 150 (350)
T ss_dssp ----------------------------------------EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHH
Confidence 38999999985 88887753 3579999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ......||+.|+|||++.+. .++.++|+|||||
T Consensus 151 ~~aL~yLH~~~iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGv 226 (350)
T d1rdqe_ 151 VLTFEYLHSLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGV 226 (350)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHH
T ss_pred HHHHHHHHhCCEecCcCCHHHcccC-CCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhH
Confidence 9999999999999999999999999 788999999999987643 23456899999999999887 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
++|+|++|+.||.+.+......++.... .. ++..+|+++.+||.+||+.||
T Consensus 227 ilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------~~------------~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 227 LIYEMAAGYPPFFADQPIQIYEKIVSGK-----------------VR------------FPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------CC------------CCTTCCHHHHHHHHHHSCSCT
T ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------------CC------------CCccCCHHHHHHHHHHhhhCH
Confidence 9999999999999988887777766521 11 123579999999999999999
Q ss_pred CCCC-----CHHHHhccCchhhhh
Q psy10212 414 SSRI-----SPLQVRSITPFLIEL 432 (444)
Q Consensus 414 ~kRP-----s~~elL~~hpwf~~~ 432 (444)
.+|+ |++++++ ||||++.
T Consensus 278 ~kR~~~~r~t~~ell~-Hp~f~~~ 300 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKN-HKWFATT 300 (350)
T ss_dssp TTCTTSSTTTTHHHHT-SGGGTTC
T ss_pred HhccccccccHHHHHc-CccccCC
Confidence 9995 9999999 9999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-49 Score=400.55 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=209.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhh---HHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNR---EMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
++|++++.||+|+||.||+|+++.+|+.||||++.... ..+.+ |+++++.++||||+++++++...+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--- 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--- 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS---
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC---
Confidence 57999999999999999999999999999999985321 22233 467778889999999999987764
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (364)
T d1omwa3 81 -------------------------------------------------------------------------------- 80 (364)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
.+|||||||+ ++|.+++.. ...+++..++.++
T Consensus 81 -------------------------------------------~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~ 113 (364)
T d1omwa3 81 -------------------------------------------KLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYA 113 (364)
T ss_dssp -------------------------------------------EEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHH
T ss_pred -------------------------------------------EEEEEEEecCCCcHHHHHHh----cccccHHHHHHHH
Confidence 3899999998 589988853 4678999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+.||.|||++|++||||||+|||++ ..+.+||+|||+++..... ......||+.|+|||.+.+...++.++||||
T Consensus 114 ~qi~~aL~ylH~~~iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwS 191 (364)
T d1omwa3 114 AEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFS 191 (364)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEC-SSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHH
T ss_pred HHHHHHHHHHHHCCccceeeccceeEEc-CCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhH
Confidence 9999999999999999999999999999 7899999999999876443 3445679999999999976547899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcc
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLE 410 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~ 410 (444)
|||++|+|++|+.||.+.+..+... +.+... .....++.++|+++.+||.+||+
T Consensus 192 lGvilyemltG~~Pf~~~~~~~~~~-~~~~~~-------------------------~~~~~~~~~~s~~~~~li~~~L~ 245 (364)
T d1omwa3 192 LGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL-------------------------TMAVELPDSFSPELRSLLEGLLQ 245 (364)
T ss_dssp HHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSS-------------------------SCCCCCCSSSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcc-------------------------cCCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999999998765544332 221110 00112234679999999999999
Q ss_pred cCCCCCCC-----HHHHhccCchhhhhh
Q psy10212 411 YTPSSRIS-----PLQVRSITPFLIELR 433 (444)
Q Consensus 411 ~DP~kRPs-----~~elL~~hpwf~~~~ 433 (444)
.||.+||| ++|+++ ||||+++.
T Consensus 246 ~dP~~R~t~~~~~a~eil~-Hp~f~~i~ 272 (364)
T d1omwa3 246 RDVNRRLGCLGRGAQEVKE-SPFFRSLD 272 (364)
T ss_dssp SSTTTSTTTSSSTHHHHHT-SGGGTTCC
T ss_pred cCHHHhCCCcccCHHHHHc-CccccCCC
Confidence 99999999 799999 99999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=385.86 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=209.0
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc----------ccchhhHHHHhhhcC--CCceeEeeeEEeec
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----------KRFKNREMQIMRRLE--HSNIVKLKYFFYSS 87 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 87 (444)
+.++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 468999999999999999999999999999999998543 133568999999996 89999999999776
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+
T Consensus 82 ~------------------------------------------------------------------------------- 82 (273)
T d1xwsa_ 82 D------------------------------------------------------------------------------- 82 (273)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 4
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC--cHHHHHHhhhhcCCCCChHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE--TVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~--~l~~~~~~~~~~~~~l~~~~ 245 (444)
..++|||||.+ ++.+++. ....+++..
T Consensus 83 -----------------------------------------------~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~ 111 (273)
T d1xwsa_ 83 -----------------------------------------------SFVLILERPEPVQDLFDFIT----ERGALQEEL 111 (273)
T ss_dssp -----------------------------------------------EEEEEEECCSSEEEHHHHHH----HHCSCCHHH
T ss_pred -----------------------------------------------eEEEEEEeccCcchHHHHHh----ccCCCCHHH
Confidence 38999999974 6777764 346799999
Q ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcc
Q psy10212 246 TKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTK 325 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~ 325 (444)
++.++.||+.||+|||++|++||||||+||+++.+.+.++|+|||++...... ......||+.|+|||.+.+...++.+
T Consensus 112 ~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~ 190 (273)
T d1xwsa_ 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRS 190 (273)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHH
T ss_pred HHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcc
Confidence 99999999999999999999999999999999856689999999999765333 34456789999999999876456788
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|||||||++|+|++|+.||.+.+ .+.+. . ..++..+|+++.+||
T Consensus 191 ~DiwSlGvilyell~g~~Pf~~~~------~i~~~-----------------~------------~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 191 AAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----------------Q------------VFFRQRVSSECQHLI 235 (273)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----------------C------------CCCSSCCCHHHHHHH
T ss_pred cccccceeeehhHhhCCCCCCCch------HHhhc-----------------c------------cCCCCCCCHHHHHHH
Confidence 999999999999999999997531 12220 0 112346799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+||+.||++|||+.|+|+ ||||+++..
T Consensus 236 ~~~L~~dp~~R~s~~eil~-hp~~~~~~~ 263 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQN-HPWMQDVLL 263 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHT-SGGGSSCCC
T ss_pred HHHccCCHhHCcCHHHHhc-CHhhCCCCC
Confidence 9999999999999999999 999998643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=398.46 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=212.3
Q ss_pred hccccchhh-eecccceeEEEEeEecCCCceeeeeeeeccccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 20 LDNSLAQKT-VIGNGSFGIVYQAKLLDSGELVAIKKVLQDKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 20 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+.++|++++ .||+|+||+||+|+++.+|+.||||++.. ...+.+|+.++.++ +||||++++++|.+....
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~------- 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAG------- 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT-------
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC-------
Confidence 557899886 59999999999999999999999999854 45567899987655 899999999998753210
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (335)
T d2ozaa1 81 -------------------------------------------------------------------------------- 80 (335)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||||+ |+|.+++.. ....++++..++.++.||+.|
T Consensus 81 -----------------------------------~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~a 123 (335)
T d2ozaa1 81 -----------------------------------RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEA 123 (335)
T ss_dssp -----------------------------------EEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHH
T ss_pred -----------------------------------CCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHH
Confidence 145999999998 599999863 234579999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||++|++||||||+||+++. +.+.+||+|||+++............||+.|+|||++.+. .++.++|+|||||+
T Consensus 124 l~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvi 202 (335)
T d2ozaa1 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVI 202 (335)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHH
T ss_pred HHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchh
Confidence 99999999999999999999973 3467999999999877666666677899999999999877 79999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 335 LAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 335 l~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
+|+|++|+.||.+.+..+....+..... .....+| .....++|+++.+||.+||+.||+
T Consensus 203 ly~lltg~~Pf~~~~~~~~~~~~~~~i~-------------~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 203 MYILLCGYPPFYSNHGLAISPGMKTRIR-------------MGQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp HHHHTTSSCSCEETTCC--------CCC-------------SCSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHh-------------cCCCCCC--------CcccccCCHHHHHHHHHHccCChh
Confidence 9999999999987765554443332110 0011111 111234799999999999999999
Q ss_pred CCCCHHHHhccCchhhh
Q psy10212 415 SRISPLQVRSITPFLIE 431 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~ 431 (444)
+|||+.|+|+ ||||++
T Consensus 262 ~R~s~~eil~-hp~~~~ 277 (335)
T d2ozaa1 262 QRMTITEFMN-HPWIMQ 277 (335)
T ss_dssp TSCCHHHHHH-SHHHHT
T ss_pred HCcCHHHHHc-CHHhhC
Confidence 9999999999 999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-49 Score=392.39 Aligned_cols=282 Identities=27% Similarity=0.491 Sum_probs=226.0
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc-ccchhhHHHHhhhcC-CCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-KRFKNREMQIMRRLE-HSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+++. ||||++++++|.....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~--------- 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS--------- 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---------
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---------
Confidence 37899999999999999999999999999999998543 456779999999995 9999999999876542
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 105 -------------------------------------------------------------------------------- 104 (328)
T d3bqca1 105 -------------------------------------------------------------------------------- 104 (328)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
.++++|||||++ +|... .+.+++..++.++.||+.||
T Consensus 105 -----------------------------------~~~~~v~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL 142 (328)
T d3bqca1 105 -----------------------------------RTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKAL 142 (328)
T ss_dssp -----------------------------------CSEEEEEECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHH
T ss_pred -----------------------------------CceeEEEeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHH
Confidence 248999999996 55432 35799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAE 337 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~e 337 (444)
+|||++||+||||||+|||++.+++.++|+|||++.............+|+.|+|||.+.+...++.++|+||+||++|+
T Consensus 143 ~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 222 (328)
T d3bqca1 143 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222 (328)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHH
Confidence 99999999999999999999856678999999999877666666677889999999999877568999999999999999
Q ss_pred HHhCCCCCCCCC-hhHHHHHHHHHhCCCCHHHHHhhCCCCCcccC----CCccCCCCccc----ccCCCChhHHHHHHHh
Q psy10212 338 LLLGQPMFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKF----PQIKSHPWSKV----FRVRTPPDAIDLISRL 408 (444)
Q Consensus 338 LltG~~Pf~~~~-~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~~----~~~~~s~~l~~LI~~~ 408 (444)
|++|+.||.... ..+....+...++.+....+...........+ +......+... ....+++++.+||.+|
T Consensus 223 ~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 302 (328)
T d3bqca1 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302 (328)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHH
T ss_pred hccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHH
Confidence 999999997654 45666677777766554444432211111111 11111111111 1234789999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|++||.+|||+.|+|+ ||||+++..
T Consensus 303 L~~dP~~R~ta~e~L~-Hp~F~~v~~ 327 (328)
T d3bqca1 303 LRYDHQSRLTAREAME-HPYFYTVVK 327 (328)
T ss_dssp SCSSGGGSCCHHHHHT-SGGGTTSCC
T ss_pred ccCChhHCcCHHHHhc-CcccCCCCC
Confidence 9999999999999999 999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=392.83 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=214.3
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-------cchhhHHHHhh-hcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-------RFKNREMQIMR-RLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++++.||+|+||+||+|+++.+|+.||||++.... +.+.+|..++. .++||||+++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----- 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----- 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence 46999999999999999999999999999999995431 23446666655 689999999999998765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 77 -------------------------------------------------------------------------------- 76 (320)
T d1xjda_ 77 -------------------------------------------------------------------------------- 76 (320)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+|||||||++ +|.+++. ....+++..++.++.|
T Consensus 77 -----------------------------------------~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~q 111 (320)
T d1xjda_ 77 -----------------------------------------NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAE 111 (320)
T ss_dssp -----------------------------------------EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHH
T ss_pred -----------------------------------------ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHH
Confidence 39999999985 8998885 3467899999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC-CCCccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG-EPNVSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
|+.||+|||++|++||||||+||+++ ..+.+||+|||+++..... .......||+.|+|||++.+. .++.++|+|||
T Consensus 112 i~~al~ylH~~~iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSl 189 (320)
T d1xjda_ 112 IILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSF 189 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCcccceeec-CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhh
Confidence 99999999999999999999999999 7899999999999765433 334456789999999999987 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|+.||.+.+..+....+... ... ++..+|+++.+||.+||+.
T Consensus 190 GvilyemltG~~PF~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 190 GVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------------NPF------------YPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------CCC------------CCTTSCHHHHHHHHHHSCS
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------CCC------------CCccCCHHHHHHHHHhccc
Confidence 99999999999999998888777766541 111 2345799999999999999
Q ss_pred CCCCCCCHH-HHhccCchhhhhh
Q psy10212 412 TPSSRISPL-QVRSITPFLIELR 433 (444)
Q Consensus 412 DP~kRPs~~-elL~~hpwf~~~~ 433 (444)
||.+|||+. ++++ ||||+++.
T Consensus 241 dP~~R~s~~~~l~~-hpff~~~~ 262 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQ-HPLFREIN 262 (320)
T ss_dssp SGGGSBTTBSCGGG-SGGGTTCC
T ss_pred CCCCCcCHHHHHHh-CchhccCC
Confidence 999999995 8999 99999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=381.79 Aligned_cols=281 Identities=33% Similarity=0.535 Sum_probs=228.8
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPT 95 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 95 (444)
++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||+++++++....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK------- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-------
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-------
Confidence 5899999999999999999999999999999998433 245568999999999999999999997765
Q ss_pred CCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCC
Q psy10212 96 NYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 175 (444)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (292)
T d1unla_ 75 -------------------------------------------------------------------------------- 74 (292)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHH
Q psy10212 176 IKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFR 255 (444)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~ 255 (444)
..++|++++.+.+...+. ...+.+++..++.++.|++.
T Consensus 75 ---------------------------------------~~~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~ 112 (292)
T d1unla_ 75 ---------------------------------------KLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLK 112 (292)
T ss_dssp ---------------------------------------EEEEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHH
T ss_pred ---------------------------------------ceeEEeeecccccccccc---ccccccchhHHHHHHHHHHH
Confidence 388999999986554443 34578899999999999999
Q ss_pred HHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 256 SLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 256 aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
||+|||++||+||||||+||+++ ..+.++|+|||.+........ .....+++.|.|||.+.+...++.++|+||+||+
T Consensus 113 aL~~lH~~~IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~i 191 (292)
T d1unla_ 113 GLGFCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred HHHHhhcCCEeeecccCcccccc-cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchH
Confidence 99999999999999999999999 678999999999987654432 3334567889999998776567999999999999
Q ss_pred HHHHHhCCCC-CCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLGQPM-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG~~P-f~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|+|++|+.| |.+.+..+....+....+.+....+............+..............+++.+.+||.+||+.||
T Consensus 192 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (292)
T d1unla_ 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCCh
Confidence 9999999987 556667778888888888776655444322222222333333333444456789999999999999999
Q ss_pred CCCCCHHHHhccCchhhhhh
Q psy10212 414 SSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 414 ~kRPs~~elL~~hpwf~~~~ 433 (444)
.+|||++|+|+ ||||+++.
T Consensus 272 ~~R~sa~e~L~-Hp~f~~~~ 290 (292)
T d1unla_ 272 VQRISAEEALQ-HPYFSDFC 290 (292)
T ss_dssp GGSCCHHHHTT-SGGGSSCS
T ss_pred hHCcCHHHHhc-ChhhcCCC
Confidence 99999999999 99999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=384.38 Aligned_cols=289 Identities=29% Similarity=0.456 Sum_probs=222.6
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++......-.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~-- 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN-- 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc--
Confidence 58999999999999999999999999999999998433 2345689999999999999999999876532000
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 87 -------------------------------------------------------------------------------- 86 (318)
T d3blha1 87 -------------------------------------------------------------------------------- 86 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
.....+++|||||++++..... .....+++..++.++.||+
T Consensus 87 ------------------------------------~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil 127 (318)
T d3blha1 87 ------------------------------------RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLL 127 (318)
T ss_dssp ----------------------------------------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHH
T ss_pred ------------------------------------ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHH
Confidence 0002489999999988777653 3556799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccCCCCCcchhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGAIDYTTKIDVW 329 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiw 329 (444)
.||.|||++||+||||||+||+++ .++.++|+|||++....... ......+|+.|+|||.+.+...++.++|+|
T Consensus 128 ~~l~~lH~~~ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw 206 (318)
T d3blha1 128 NGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206 (318)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEEC-TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHhccCCEEecCcCchheeec-CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence 999999999999999999999999 78899999999996553221 223346899999999998765789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCc--cCCCCcccc-cCCCChhHHHHHH
Q psy10212 330 SAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KSHPWSKVF-RVRTPPDAIDLIS 406 (444)
Q Consensus 330 SLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~~~-~~~~s~~l~~LI~ 406 (444)
|+||++|+|++|+.||.+.++.+....+.+..+.+.+..+............... ........+ ....++.+.+||.
T Consensus 207 SlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 207 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred cCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHH
Confidence 9999999999999999999999999999998887765443222111000000000 000000000 1124788999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
+||++||++|||+.|+|+ ||||++.
T Consensus 287 ~mL~~dP~~R~sa~elL~-Hpff~~~ 311 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALN-HDFFWSD 311 (318)
T ss_dssp HHSCSSTTTSCCHHHHHH-SGGGSSS
T ss_pred HHCcCChhHCcCHHHHHc-ChhhccC
Confidence 999999999999999999 9999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-48 Score=381.76 Aligned_cols=257 Identities=19% Similarity=0.293 Sum_probs=210.5
Q ss_pred hhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 18 SDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+--.++|++.+.||+|+||+||+|+++.+|+.||||++..+ .+.+.+|+++|++++|||||++++++.+.+.
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----- 87 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----- 87 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-----
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe-----
Confidence 33357899999999999999999999999999999998543 3557799999999999999999999976543
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 88 -------------------------------------------------------------------------------- 87 (287)
T d1opja_ 88 -------------------------------------------------------------------------------- 87 (287)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++||||||+ |+|.+++.. .....+++..++.++.||
T Consensus 88 -----------------------------------------~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi 124 (287)
T d1opja_ 88 -----------------------------------------FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQI 124 (287)
T ss_dssp -----------------------------------------CEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHH
T ss_pred -----------------------------------------eEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHH
Confidence 889999999 588888753 345678999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSA 331 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSL 331 (444)
+.||+|||++||+||||||+|||++ .++.+||+|||+++........ ....+++.|+|||.+.+. .++.++|||||
T Consensus 125 ~~gL~yLH~~~iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~ 202 (287)
T d1opja_ 125 SSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAF 202 (287)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHH
T ss_pred HHHHHHHHHCCcccCccccCeEEEC-CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhH
Confidence 9999999999999999999999999 7889999999999775443222 223568899999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 332 GCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 332 Gvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
||++|+|++|..||....+...+.+++.. . ....++..+|+.+.+||.+||+.
T Consensus 203 Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-----------------~----------~~~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 203 GVLLWEIATYGMSPYPGIDLSQVYELLEK-----------------D----------YRMERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----------------T----------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhCCCCCCCcchHHHHHHHHhc-----------------C----------CCCCCCccchHHHHHHHHHHcCC
Confidence 99999999966655444433333333321 0 01112346799999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
||.+|||+.|+++ +|+.+..
T Consensus 256 dP~~Rps~~ei~~---~L~~~~~ 275 (287)
T d1opja_ 256 NPSDRPSFAEIHQ---AFETMFQ 275 (287)
T ss_dssp SGGGSCCHHHHHH---HHHHTTS
T ss_pred CHhHCcCHHHHHH---HHHHHHH
Confidence 9999999999988 7877643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=392.08 Aligned_cols=285 Identities=29% Similarity=0.489 Sum_probs=221.3
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
+.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+.++++++||||++++++|...+..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~--- 91 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL--- 91 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST---
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc---
Confidence 347899999999999999999999999999999999543 23466899999999999999999999766420
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (355)
T d2b1pa1 92 -------------------------------------------------------------------------------- 91 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
+...++|+|||||.+++.+.+ ...+++..++.++.||
T Consensus 92 -------------------------------------~~~~~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qi 128 (355)
T d2b1pa1 92 -------------------------------------EEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQM 128 (355)
T ss_dssp -------------------------------------TTCCEEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHH
T ss_pred -------------------------------------ccCceeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHH
Confidence 001359999999999888765 3568999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHH
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGC 333 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGv 333 (444)
+.||.|||++|++||||||+||+++ .++.++++|||++.............+|+.|+|||.+.+. .+++++|+||+||
T Consensus 129 l~gl~~LH~~giiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 129 LCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGC 206 (355)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHH
T ss_pred HHHHHHhhhcccccccCCccccccc-cccceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccc
Confidence 9999999999999999999999999 7889999999998777666666667889999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcc--cCCCccCCCC-----------cccccCCCChh
Q psy10212 334 VLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKSHPW-----------SKVFRVRTPPD 400 (444)
Q Consensus 334 il~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~--~~p~~~~~~~-----------~~~~~~~~s~~ 400 (444)
++++|++|+.||.+.+......++....+.+.+..+.......... ..+......+ ........+++
T Consensus 207 ~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 286 (355)
T d2b1pa1 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286 (355)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHH
T ss_pred hHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHH
Confidence 9999999999999999999999999999988887665433211100 0000000010 11112234788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 401 AIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 401 l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+.+||.+||.+||++||||+|+|+ ||||+...
T Consensus 287 ~~dll~~mL~~dP~~R~ta~elL~-Hpw~~~~~ 318 (355)
T d2b1pa1 287 ARDLLSKMLVIDPAKRISVDDALQ-HPYINVWY 318 (355)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT-STTTGGGC
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc-CcccCCCC
Confidence 999999999999999999999999 99999754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=385.60 Aligned_cols=289 Identities=33% Similarity=0.573 Sum_probs=229.8
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
+..+|+++++||+|+||+||+|+++.+|+.||||++.... ..+.+|+.+|++|+||||+++++.+......
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~---- 81 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE---- 81 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT----
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc----
Confidence 5578999999999999999999999999999999995432 3556899999999999999999988664310
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (345)
T d1pmea_ 82 -------------------------------------------------------------------------------- 81 (345)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLF 254 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl 254 (444)
...+.++++++++++|.+++.. .++++..++.++.||+
T Consensus 82 -------------------------------------~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil 119 (345)
T d1pmea_ 82 -------------------------------------QMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQIL 119 (345)
T ss_dssp -------------------------------------TCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHH
T ss_pred -------------------------------------ccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHH
Confidence 0124778888888899999853 4799999999999999
Q ss_pred HHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 255 RSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 255 ~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
.||+|||++||+||||||+||+++ ..+.+||+|||++....... ......+++.|+|||.+.....++.++|+||
T Consensus 120 ~al~yLH~~~iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwS 198 (345)
T d1pmea_ 120 RGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHH
T ss_pred HHHHHHHHCCCcCCCCCcceEEEC-CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhc
Confidence 999999999999999999999999 78899999999987653322 2334568999999999866557899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCC---CCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 331 AGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPN---YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 331 LGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
+||++|+|++|+.||.+.+..+.........+.+........... ......+......+... .+++++.+++||.+
T Consensus 199 lG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDK 277 (345)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHH
T ss_pred cCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHH
Confidence 999999999999999999988888888888887776544321100 00112222223333322 34678999999999
Q ss_pred hcccCCCCCCCHHHHhccCchhhhhhhhhh
Q psy10212 408 LLEYTPSSRISPLQVRSITPFLIELRAVFE 437 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~hpwf~~~~~~~~ 437 (444)
||+.||.+|||+.|+|+ ||||++.....+
T Consensus 278 ~L~~dP~~R~ta~e~L~-hpf~~~~~~~~~ 306 (345)
T d1pmea_ 278 MLTFNPHKRIEVEQALA-HPYLEQYYDPSD 306 (345)
T ss_dssp HSCSSTTTSCCHHHHHT-SGGGTTTCCGGG
T ss_pred HccCChhHCcCHHHHhc-CHhhccCCCCcc
Confidence 99999999999999999 999997665443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-48 Score=374.72 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=208.0
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
.+.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|++++++++||||+++++++...+..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~- 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA- 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS-
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC-
Confidence 4678999999999999999999999999999999998432 13467899999999999999999999876531
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (277)
T d1o6ya_ 83 -------------------------------------------------------------------------------- 82 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
...+|||||||+| +|.+++. ..+++++..++.++
T Consensus 83 -----------------------------------------~~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~ 117 (277)
T d1o6ya_ 83 -----------------------------------------GPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVI 117 (277)
T ss_dssp -----------------------------------------SEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHH
T ss_pred -----------------------------------------CceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHH
Confidence 1358999999995 7887764 34679999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC----CCccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE----PNVSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||+|||++|++||||||+||+++ ..+.++++|||.+....... ......||+.|+|||.+.+. .+++++
T Consensus 118 ~qi~~al~~lH~~~iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~ 195 (277)
T d1o6ya_ 118 ADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARS 195 (277)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEE-TTSCEEECCCTTCEECC----------------TTCCHHHHTTC-CCCHHH
T ss_pred HHHHHHHHHHHhCCccCccccCcccccC-ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCC-CCCcce
Confidence 9999999999999999999999999999 78899999999886543322 23345789999999999877 799999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 327 DVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 327 DiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
|||||||++|+|++|+.||.+.+..+...++...... .......++|+.+.+||.
T Consensus 196 DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-------------------------PPSARHEGLSADLDAVVL 250 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------------------------CGGGTSSSCCHHHHHHHH
T ss_pred ecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-------------------------CCchhccCCCHHHHHHHH
Confidence 9999999999999999999998888777766652110 111223467999999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhh
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLI 430 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~ 430 (444)
+||+.||.+||+.++.|. |+|++
T Consensus 251 ~~L~~dp~~R~~sa~~l~-~~l~r 273 (277)
T d1o6ya_ 251 KALAKNPENRYQTAAEMR-ADLVR 273 (277)
T ss_dssp HHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred HHccCCHhHCHhHHHHHH-HHHHH
Confidence 999999999996555555 67775
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=369.59 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=201.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++++.||+|+||+||+|+++ +++.||||++... .+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--------- 74 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--------- 74 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---------
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc---------
Confidence 57999999999999999999987 4788999998543 4567799999999999999999999977653
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (263)
T d1sm2a_ 75 -------------------------------------------------------------------------------- 74 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+++|||||+ |+|.+++. .....+++..+..++.||+.||
T Consensus 75 -------------------------------------~~lv~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl 114 (263)
T d1sm2a_ 75 -------------------------------------ICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGM 114 (263)
T ss_dssp -------------------------------------CEEEEECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHH
Confidence 889999998 58888875 3446789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC--ccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN--VSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||+++++||||||+||+++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++|||||||++
T Consensus 115 ~~lH~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil 192 (263)
T d1sm2a_ 115 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLM 192 (263)
T ss_dssp HHHHHTTCCCTTCSGGGEEEC-GGGCEEECSCC------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHH
T ss_pred Hhhhccceeecccchhheeec-CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHH
Confidence 999999999999999999999 7889999999999765443322 234678999999999887 799999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|||++ |.+||...+..+....+..... ...+..+++.+.+||.+||+.||+
T Consensus 193 ~el~t~~~~~~~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~p~ 244 (263)
T d1sm2a_ 193 WEVFSEGKIPYENRSNSEVVEDISTGFR----------------------------LYKPRLASTHVYQIMNHCWKERPE 244 (263)
T ss_dssp HHHHTTSCCTTCSCCHHHHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHhcCC----------------------------CCCccccCHHHHHHHHHHccCCHh
Confidence 99998 5777777776666665554211 112345789999999999999999
Q ss_pred CCCCHHHHhccCchhhhhhh
Q psy10212 415 SRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 415 kRPs~~elL~~hpwf~~~~~ 434 (444)
+|||+.|+|+ -++++.+
T Consensus 245 ~Rps~~~il~---~L~~i~e 261 (263)
T d1sm2a_ 245 DRPAFSRLLR---QLAEIAE 261 (263)
T ss_dssp GSCCHHHHHH---HHHHHHH
T ss_pred HCcCHHHHHH---HHHHHHh
Confidence 9999999999 4776643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=384.80 Aligned_cols=287 Identities=30% Similarity=0.556 Sum_probs=226.9
Q ss_pred hhccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 19 DLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+++|++++||||+++++++.......
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~- 93 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE- 93 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT-
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc-
Confidence 3578999999999999999999999999999999998543 234568999999999999999999886543200
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 94 -------------------------------------------------------------------------------- 93 (348)
T d2gfsa1 94 -------------------------------------------------------------------------------- 93 (348)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
...+.++++++++++|.+++. .+++++..++.++.|
T Consensus 94 ---------------------------------------~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~q 129 (348)
T d2gfsa1 94 ---------------------------------------EFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQ 129 (348)
T ss_dssp ---------------------------------------TCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHH
T ss_pred ---------------------------------------cCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHH
Confidence 002356667766789998873 357999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
|+.||+|||++||+||||||+||+++ .++.++++|||.+.... .......+++.|+|||.+.+...++.++|+||||
T Consensus 130 il~aL~~LH~~giiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlG 206 (348)
T d2gfsa1 130 ILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206 (348)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEC-TTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHH
T ss_pred HHHHHHHHHhCCCcccccCCcccccc-ccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhh
Confidence 99999999999999999999999999 78999999999986542 2234557899999999987765678999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCc---ccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 333 CVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 333 vil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|++|+|++|+.||.+.+.......+.+..+.+.............. ...+......+... ..++++++++||.+||
T Consensus 207 v~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL 285 (348)
T d2gfsa1 207 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 285 (348)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHC
Confidence 9999999999999999999999999998888776654332111000 01112222222222 2467999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
+.||.+|||+.|+|+ ||||+++...
T Consensus 286 ~~dP~~R~ta~elL~-Hp~f~~~~~~ 310 (348)
T d2gfsa1 286 VLDSDKRITAAQALA-HAYFAQYHDP 310 (348)
T ss_dssp CSSGGGSCCHHHHHT-SGGGTTTCCT
T ss_pred cCChhhCcCHHHHhc-CHhhCCCCCC
Confidence 999999999999999 9999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=370.19 Aligned_cols=254 Identities=25% Similarity=0.299 Sum_probs=203.2
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEP 94 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 94 (444)
.++|++.+.||+|+||+||+|+.+ ..||||++... .+.+.+|+++|++++||||+++++++.+..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~------ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ------ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS------
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccE------
Confidence 368999999999999999999863 46999998432 245668999999999999999998764321
Q ss_pred CCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCC
Q psy10212 95 TNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 174 (444)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (444)
T Consensus 78 -------------------------------------------------------------------------------- 77 (276)
T d1uwha_ 78 -------------------------------------------------------------------------------- 77 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHH
Q psy10212 175 QIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQL 253 (444)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QI 253 (444)
++||||||+ |+|.+++. ....++++..+..++.||
T Consensus 78 -----------------------------------------~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi 113 (276)
T d1uwha_ 78 -----------------------------------------LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQT 113 (276)
T ss_dssp -----------------------------------------CEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHH
T ss_pred -----------------------------------------EEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHH
Confidence 789999999 59999885 345679999999999999
Q ss_pred HHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccccccccCchhhccC--CCCCcchhh
Q psy10212 254 FRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYICSRYYRAPELIFGA--IDYTTKIDV 328 (444)
Q Consensus 254 l~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~s~~sDi 328 (444)
+.||+|||+++|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+. ..++.++||
T Consensus 114 ~~gl~yLH~~~ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDi 192 (276)
T d1uwha_ 114 AQGMDYLHAKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192 (276)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEEE-TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHH
T ss_pred HHHHHHHhcCCEeccccCHHHEEEc-CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhh
Confidence 9999999999999999999999999 78999999999997654322 22345789999999998643 257899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHh
Q psy10212 329 WSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRL 408 (444)
Q Consensus 329 wSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~ 408 (444)
|||||++|||++|+.||.+.+....+...+.....+ | ....++.++|+.+.+||.+|
T Consensus 193 wS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----------------p------~~~~~~~~~~~~l~~li~~c 249 (276)
T d1uwha_ 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-----------------P------DLSKVRSNCPKAMKRLMAEC 249 (276)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC-----------------C------CGGGSCTTCCHHHHHHHHHH
T ss_pred hhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC-----------------C------cchhccccchHHHHHHHHHH
Confidence 999999999999999999887776665555421111 0 01123456799999999999
Q ss_pred cccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 409 LEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 409 L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
|+.||.+|||+.|+++ -++.++.
T Consensus 250 l~~dp~~RPt~~~il~---~Le~l~~ 272 (276)
T d1uwha_ 250 LKKKRDERPLFPQILA---SIELLAR 272 (276)
T ss_dssp TCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred cCCCHhHCcCHHHHHH---HHHHHHH
Confidence 9999999999999999 4555543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-47 Score=373.79 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=197.1
Q ss_pred cccchhheecccceeEEEEeEecCCCc---eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE---LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.++||+|+||+||+|+++.+|+ .||||.+... .+.+.+|+++|++++|||||++++++..++.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~---- 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP---- 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS----
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE----
Confidence 678899999999999999999987765 5889987432 2457799999999999999999999976653
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 102 -------------------------------------------------------------------------------- 101 (299)
T d1jpaa_ 102 -------------------------------------------------------------------------------- 101 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
+++|||||++ +|.+++. ...+.+++..+..++.|
T Consensus 102 ------------------------------------------~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~q 136 (299)
T d1jpaa_ 102 ------------------------------------------VMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRG 136 (299)
T ss_dssp ------------------------------------------CEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHH
Confidence 8899999995 7888765 34557999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC------ccccccccccCchhhccCCCCCcch
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN------VSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
|+.||.|||+++++||||||+|||++ .++.+||+|||+++........ ....+++.|+|||.+.+. .++.++
T Consensus 137 ia~gl~yLH~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~s 214 (299)
T d1jpaa_ 137 IAAGMKYLADMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSAS 214 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCC-----------------------CGGGSCHHHHHSC-CCCHHH
T ss_pred HHHHHHHHhhCCCccCccccceEEEC-CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCccc
Confidence 99999999999999999999999999 7889999999999765433221 123468899999999887 899999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
|||||||++|||++ |+.||.+.+..+....+..... ...+.++|+.+.+||
T Consensus 215 DvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li 266 (299)
T d1jpaa_ 215 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR----------------------------LPPPMDCPSALHQLM 266 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHH
T ss_pred ccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHH
Confidence 99999999999997 8999998887776665543110 012345799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+||+.||.+|||+.|+++ .++.+
T Consensus 267 ~~cl~~~P~~RPs~~ei~~---~L~~~ 290 (299)
T d1jpaa_ 267 LDCWQKDRNHRPKFGQIVN---TLDKM 290 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHH---HHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH---HHHHH
Confidence 9999999999999999998 45544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=365.17 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=208.4
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeec---cccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ---DKRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++++.||+|+||+||+|+++ +++.||||++.. ..+.+.+|++++++++||||+++++++.+++.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~--------- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--------- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS---------
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc---------
Confidence 68899999999999999999985 688999999954 34677899999999999999999999876543
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 74 -------------------------------------------------------------------------------- 73 (258)
T d1k2pa_ 74 -------------------------------------------------------------------------------- 73 (258)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+++|||||+ |+|..++. .....+++..++.++.||++||
T Consensus 74 -------------------------------------~~iv~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl 113 (258)
T d1k2pa_ 74 -------------------------------------IFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAM 113 (258)
T ss_dssp -------------------------------------EEEEEECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHH
Confidence 899999998 57777764 3456789999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++||||||+||+++ .++.+||+|||+++....... .....+++.|+|||.+.+. .++.++||||||+++
T Consensus 114 ~~LH~~~iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l 191 (258)
T d1k2pa_ 114 EYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLM 191 (258)
T ss_dssp HHHHHTTBCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHHhhcCcccccccceeEEEc-CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhh
Confidence 999999999999999999999 788999999999976543322 2235678999999999887 799999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|||++ |+.||.+.+..+....+.+... ...+..+++.+.+||.+||+.||+
T Consensus 192 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~ 243 (258)
T d1k2pa_ 192 WEIYSLGKMPYERFTNSETAEHIAQGLR----------------------------LYRPHLASEKVYTIMYSCWHEKAD 243 (258)
T ss_dssp HHHHTTSCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HhHHhcCCCCCCCCCHHHHHHHHHhCCC----------------------------CCCcccccHHHHHHHHHHccCCHh
Confidence 99998 8999999988877766654211 011235789999999999999999
Q ss_pred CCCCHHHHhccC
Q psy10212 415 SRISPLQVRSIT 426 (444)
Q Consensus 415 kRPs~~elL~~h 426 (444)
+|||+.++|+ |
T Consensus 244 ~RPt~~eil~-~ 254 (258)
T d1k2pa_ 244 ERPTFKILLS-N 254 (258)
T ss_dssp GSCCHHHHHH-H
T ss_pred HCcCHHHHHH-H
Confidence 9999999998 5
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=377.61 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=205.5
Q ss_pred cccchhheecccceeEEEEeEecCCCc-----eeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE-----LVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|++.+.||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~- 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP- 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe-
Confidence 689999999999999999999876554 6999988432 34566899999998 89999999999977653
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 116 -------------------------------------------------------------------------------- 115 (325)
T d1rjba_ 116 -------------------------------------------------------------------------------- 115 (325)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh-------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------- 236 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------- 236 (444)
+|+|||||+ |+|.+++...+.
T Consensus 116 ---------------------------------------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 150 (325)
T d1rjba_ 116 ---------------------------------------------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150 (325)
T ss_dssp ---------------------------------------------CEEEEECCTTCBHHHHHHTTTTCC-----------
T ss_pred ---------------------------------------------EEEEEEcCCCCcHHHHHHhccCCCcchhhhhcccc
Confidence 899999998 599999864321
Q ss_pred ------cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---cccccc
Q psy10212 237 ------SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICS 307 (444)
Q Consensus 237 ------~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt 307 (444)
....+++..++.++.||+.||+|||+++|+||||||+||+++ .++.+||+|||+++........ ....+|
T Consensus 151 ~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred ccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCC
Confidence 234589999999999999999999999999999999999999 7899999999999766544332 234568
Q ss_pred ccccCchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccC
Q psy10212 308 RYYRAPELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 386 (444)
Q Consensus 308 ~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~ 386 (444)
+.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+.+.+++... .
T Consensus 230 ~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~-----------------~------- 284 (325)
T d1rjba_ 230 VKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-----------------F------- 284 (325)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-----------------C-------
T ss_pred CccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------------C-------
Confidence 999999999887 89999999999999999997 899999877766666665411 0
Q ss_pred CCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 387 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 387 ~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
....+..+|+++.+||.+||+.||++|||++||++
T Consensus 285 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 285 ---KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123467999999999999999999999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=369.66 Aligned_cols=249 Identities=26% Similarity=0.299 Sum_probs=203.9
Q ss_pred cccchhhe-ecccceeEEEEeEecCC--Cceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTV-IGNGSFGIVYQAKLLDS--GELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~-lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|.+... ||+|+||+||+|.++.+ +..||||++... .+.+.+|+++|++++|||||++++++.++.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----- 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA----- 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe-----
Confidence 56777774 99999999999987643 457999998432 245678999999999999999999875432
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 83 -------------------------------------------------------------------------------- 82 (285)
T d1u59a_ 83 -------------------------------------------------------------------------------- 82 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
+|||||||++ +|.+++. .....+++..+..++.|
T Consensus 83 ------------------------------------------~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~q 117 (285)
T d1u59a_ 83 ------------------------------------------LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 117 (285)
T ss_dssp ------------------------------------------EEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHH
T ss_pred ------------------------------------------EEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHH
Confidence 7899999995 8888764 34567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
|+.||+|||+++++||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||
T Consensus 118 i~~gL~ylH~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV 195 (285)
T d1u59a_ 118 VSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDV 195 (285)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHH
T ss_pred HHHHHHHHHhCCeecCcCchhheeec-cCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchh
Confidence 99999999999999999999999999 788999999999977644322 2234578899999999877 79999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||||++|||++ |+.||.+.+..+....+.+.. ...++.++|+++.+||.+
T Consensus 196 wS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~ 247 (285)
T d1u59a_ 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------------------RMECPPECPPELYALMSD 247 (285)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHH
T ss_pred hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHH
Confidence 999999999997 999999888777665554311 011235689999999999
Q ss_pred hcccCCCCCCCHHHH---hccCchhhh
Q psy10212 408 LLEYTPSSRISPLQV---RSITPFLIE 431 (444)
Q Consensus 408 ~L~~DP~kRPs~~el---L~~hpwf~~ 431 (444)
||+.||++|||+.++ |+ |+|+.-
T Consensus 248 cl~~~p~~RPs~~~i~~~L~-~~~~~~ 273 (285)
T d1u59a_ 248 CWIYKWEDRPDFLTVEQRMR-ACYYSL 273 (285)
T ss_dssp TTCSSGGGSCCHHHHHHHHH-HHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHH-HHHHHh
Confidence 999999999999888 55 666643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=366.92 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=203.7
Q ss_pred ccccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
.++|++++.||+|+||+||+|+++ +++.||||++... .+.+.+|++++++++|||||++++++.++.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--------- 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP--------- 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---------
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCC---------
Confidence 478999999999999999999986 5788999999543 356789999999999999999999764422
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (272)
T d1qpca_ 82 -------------------------------------------------------------------------------- 81 (272)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
+++|||||+ |+|.+++.. ....++++..+..++.||+.|
T Consensus 82 --------------------------------------~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~g 121 (272)
T d1qpca_ 82 --------------------------------------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEG 121 (272)
T ss_dssp --------------------------------------CEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHH
T ss_pred --------------------------------------eEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHH
Confidence 689999998 588887632 234469999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|+|||+++++||||||+||+++ +++.+||+|||+++...... ......+++.|+|||.+.+. .++.++|||||||+
T Consensus 122 l~~lH~~~ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvv 199 (272)
T d1qpca_ 122 MAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGIL 199 (272)
T ss_dssp HHHHHHTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHH
T ss_pred HHHHHhCCcccCccchhheeee-cccceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHH
Confidence 9999999999999999999999 78999999999998764432 22345678899999999877 78999999999999
Q ss_pred HHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|||++| .+|+...+..+....+.... ....+.++|+++.+||.+||+.||
T Consensus 200 l~ellt~~~~~~~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~cl~~~P 251 (272)
T d1qpca_ 200 LTEIVTHGRIPYPGMTNPEVIQNLERGY----------------------------RMVRPDNCPEELYQLMRLCWKERP 251 (272)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcC----------------------------CCCCcccChHHHHHHHHHHcCCCH
Confidence 9999995 56666666665555443311 011234679999999999999999
Q ss_pred CCCCCHHHHhcc-Cchhh
Q psy10212 414 SSRISPLQVRSI-TPFLI 430 (444)
Q Consensus 414 ~kRPs~~elL~~-hpwf~ 430 (444)
++|||+.++++. |+||.
T Consensus 252 ~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 252 EDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHhhhhhh
Confidence 999999999871 34543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=367.11 Aligned_cols=241 Identities=23% Similarity=0.276 Sum_probs=196.5
Q ss_pred heecccceeEEEEeEec--CCCceeeeeeeecc------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 28 TVIGNGSFGIVYQAKLL--DSGELVAIKKVLQD------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 28 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++||+|+||+||+|.+. .+++.||||++... .+.+.+|+++|++++||||+++++++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~----------- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES----------- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----------
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----------
Confidence 47999999999999864 35678999998432 245779999999999999999999874322
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 82 -------------------------------------------------------------------------------- 81 (277)
T d1xbba_ 82 -------------------------------------------------------------------------------- 81 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+||||||++ +|.+++. ...++++..+..++.||+.||+
T Consensus 82 ------------------------------------~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ 121 (277)
T d1xbba_ 82 ------------------------------------WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMK 121 (277)
T ss_dssp ------------------------------------EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------EEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHh
Confidence 6799999985 8988875 3567999999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchhhhhHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvi 334 (444)
|||+++++||||||+||+++ .++.++|+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||+
T Consensus 122 ylH~~~iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~ 199 (277)
T d1xbba_ 122 YLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVL 199 (277)
T ss_dssp HHHHTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHH
T ss_pred hHHhCCcccCCCcchhhccc-ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhh
Confidence 99999999999999999999 789999999999976543322 2234578999999999877 78999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCC
Q psy10212 335 LAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTP 413 (444)
Q Consensus 335 l~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP 413 (444)
+|||++ |+.||.+.+..+....+.+.. ...++.++|+++.+||.+||+.||
T Consensus 200 l~ellt~g~~Pf~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~~~~li~~cl~~dp 251 (277)
T d1xbba_ 200 MWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------------------RMGCPAGCPREMYDLMNLCWTYDV 251 (277)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSST
T ss_pred hhHHhhCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCcccCHHHHHHHHHHcCCCH
Confidence 999997 899999888776655444310 011234679999999999999999
Q ss_pred CCCCCHHHHh---ccCchhh
Q psy10212 414 SSRISPLQVR---SITPFLI 430 (444)
Q Consensus 414 ~kRPs~~elL---~~hpwf~ 430 (444)
.+|||+++++ + |+|++
T Consensus 252 ~~RPs~~~i~~~L~-~~~~~ 270 (277)
T d1xbba_ 252 ENRPGFAAVELRLR-NYYYD 270 (277)
T ss_dssp TTSCCHHHHHHHHH-HHHHH
T ss_pred hHCcCHHHHHHHhh-CHHhh
Confidence 9999999984 5 54443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=359.12 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=199.3
Q ss_pred cccchhheecccceeEEEEeEecCCC----ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSG----ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|++.++||+|+||.||+|.++.++ ..||||++... ...+.+|++++++++|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~--- 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP--- 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc---
Confidence 57999999999999999999987655 46999998433 2356789999999999999999999977653
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 84 -------------------------------------------------------------------------------- 83 (283)
T d1mqba_ 84 -------------------------------------------------------------------------------- 83 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
+++|||||.+ ++.+.+. .....+++..+..++.
T Consensus 84 -------------------------------------------~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~ 117 (283)
T d1mqba_ 84 -------------------------------------------MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLR 117 (283)
T ss_dssp -------------------------------------------EEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHH
T ss_pred -------------------------------------------eEEEEEecccCcchhhhh---cccccccHHHHHHHHH
Confidence 8899999996 6666554 3556799999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC----CccccccccccCchhhccCCCCCcchh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP----NVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
||+.||+|||+++++||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|
T Consensus 118 ~i~~gl~~lH~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sD 195 (283)
T d1mqba_ 118 GIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASD 195 (283)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHH
T ss_pred HHHHhhhhccccccccCccccceEEEC-CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCccc
Confidence 999999999999999999999999999 789999999999976543321 2234578899999999887 8999999
Q ss_pred hhhHHHHHHHHHhCC-CCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLIS 406 (444)
Q Consensus 328 iwSLGvil~eLltG~-~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~ 406 (444)
||||||++|||+++. +|+...+..+....+.+.. ....+.++++.+.+||.
T Consensus 196 I~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~li~ 247 (283)
T d1mqba_ 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----------------------------RLPTPMDCPSAIYQLMM 247 (283)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------------------------CCCCCTTCBHHHHHHHH
T ss_pred ccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----------------------------CCCCchhhHHHHHHHHH
Confidence 999999999999855 5555555555444333210 11123457899999999
Q ss_pred HhcccCCCCCCCHHHHhccCchhhhhhhhhhc
Q psy10212 407 RLLEYTPSSRISPLQVRSITPFLIELRAVFEN 438 (444)
Q Consensus 407 ~~L~~DP~kRPs~~elL~~hpwf~~~~~~~~~ 438 (444)
+||+.||++|||+.|+++ .++.+...-+.
T Consensus 248 ~cl~~~p~~RPt~~eil~---~L~~l~~~p~~ 276 (283)
T d1mqba_ 248 QCWQQERARRPKFADIVS---ILDKLIRAPDS 276 (283)
T ss_dssp HHTCSSTTTSCCHHHHHH---HHHHHHHSGGG
T ss_pred HHCcCCHhHCcCHHHHHH---HHHHHhhCccc
Confidence 999999999999999998 77766554443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=359.70 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=198.5
Q ss_pred cccchhheecccceeEEEEeEecCCC---ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSG---ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||+||+|++..++ ..||||.+... ...+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------ 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence 68999999999999999999986544 46889988432 34577899999999999999999988432
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 81 -------------------------------------------------------------------------------- 80 (273)
T d1mp8a_ 81 -------------------------------------------------------------------------------- 80 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHH
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQ 252 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~Q 252 (444)
.+++|||||++ +|.+++. .....+++..++.++.|
T Consensus 81 -----------------------------------------~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~q 116 (273)
T d1mp8a_ 81 -----------------------------------------PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQ 116 (273)
T ss_dssp -----------------------------------------SCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHH
T ss_pred -----------------------------------------eEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHH
Confidence 27899999995 7777654 34567999999999999
Q ss_pred HHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC--CCccccccccccCchhhccCCCCCcchhhhh
Q psy10212 253 LFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE--PNVSYICSRYYRAPELIFGAIDYTTKIDVWS 330 (444)
Q Consensus 253 Il~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwS 330 (444)
|+.||.|||+++++||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||
T Consensus 117 i~~gl~ylH~~~iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwS 194 (273)
T d1mp8a_ 117 LSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWM 194 (273)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHH
T ss_pred HHHHhhhhcccCeeccccchhheeec-CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCcccccc
Confidence 99999999999999999999999999 78899999999997654332 22344568899999999877 8999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhc
Q psy10212 331 AGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLL 409 (444)
Q Consensus 331 LGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L 409 (444)
|||++|||++ |.+||.+.+..+....+.+... ..+++++|+.+.+||.+||
T Consensus 195 lGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl 246 (273)
T d1mp8a_ 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------------LPMPPNCPPTLYSLMTKCW 246 (273)
T ss_dssp HHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred chHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999997 8999999888887776654210 1123568999999999999
Q ss_pred ccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 410 EYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 410 ~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
+.||.+|||+.|+++ .++.+.+
T Consensus 247 ~~dp~~Rps~~ei~~---~L~~i~~ 268 (273)
T d1mp8a_ 247 AYDPSRRPRFTELKA---QLSTILE 268 (273)
T ss_dssp CSSGGGSCCHHHHHH---HHHHHHH
T ss_pred CCCHhHCcCHHHHHH---HHHHHHH
Confidence 999999999999999 4666544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=364.04 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=199.4
Q ss_pred cccchhheecccceeEEEEeEecCCCc----eeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGE----LVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKD 92 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 92 (444)
++|+++++||+|+||+||+|++..+|+ .||+|++... .+.+.+|++++++++|||||++++++.++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 469999999999999999999988887 4777777432 245779999999999999999999987643
Q ss_pred CCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccC
Q psy10212 93 EPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 172 (444)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (317)
T d1xkka_ 85 -------------------------------------------------------------------------------- 84 (317)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHH
Q psy10212 173 FPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIY 251 (444)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~ 251 (444)
.+++|++|. ++|.+.+. .....+++..++.++.
T Consensus 85 -------------------------------------------~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~ 118 (317)
T d1xkka_ 85 -------------------------------------------VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCV 118 (317)
T ss_dssp -------------------------------------------EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHH
T ss_pred -------------------------------------------eeEEEEeccCCccccccc---ccccCCCHHHHHHHHH
Confidence 556777776 68888775 3567899999999999
Q ss_pred HHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---ccccccccccCchhhccCCCCCcchhh
Q psy10212 252 QLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYRAPELIFGAIDYTTKIDV 328 (444)
Q Consensus 252 QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~s~~sDi 328 (444)
||+.||+|||+++++||||||+||+++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++||
T Consensus 119 qi~~gl~yLH~~~iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDv 196 (317)
T d1xkka_ 119 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDV 196 (317)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHH
T ss_pred HHHHHHHHHHHcCcccCcchhhcceeC-CCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhh
Confidence 999999999999999999999999999 7889999999999776443322 233578999999999887 89999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 329 WSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 329 wSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
|||||++|||+| |..||.+.+..+....+.+... ...+..+++.+.+||.+
T Consensus 197 wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------------------------LPQPPICTIDVYMIMVK 248 (317)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC----------------------------CCCCTTBCHHHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCcccCHHHHHHHHH
Confidence 999999999998 8999998887776655544210 01134579999999999
Q ss_pred hcccCCCCCCCHHHHhccC
Q psy10212 408 LLEYTPSSRISPLQVRSIT 426 (444)
Q Consensus 408 ~L~~DP~kRPs~~elL~~h 426 (444)
||+.||.+|||+.|+++ |
T Consensus 249 cl~~dP~~RPs~~eil~-~ 266 (317)
T d1xkka_ 249 CWMIDADSRPKFRELII-E 266 (317)
T ss_dssp HTCSSGGGSCCHHHHHH-H
T ss_pred hCCCChhhCcCHHHHHH-H
Confidence 99999999999999999 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=356.78 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=203.9
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYPP 99 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 99 (444)
++|++++.||+|+||.||+|++ +|+.||||++..+ .+.+.+|++++++++||||+++++++.++..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---------- 74 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---------- 74 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------------
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC----------
Confidence 5789999999999999999998 5889999999544 4667799999999999999999999876432
Q ss_pred ccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCCC
Q psy10212 100 LEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSH 179 (444)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (262)
T d1byga_ 75 -------------------------------------------------------------------------------- 74 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHH
Q psy10212 180 PWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLA 258 (444)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~ 258 (444)
.+++|||||+ |+|.+++... ....+++..++.++.||+.||+
T Consensus 75 -----------------------------------~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ 117 (262)
T d1byga_ 75 -----------------------------------GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117 (262)
T ss_dssp -----------------------------------CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------cEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcc
Confidence 2789999998 5899988532 2345899999999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCCCCCcchhhhhHHHHHHHH
Q psy10212 259 YIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVLAEL 338 (444)
Q Consensus 259 yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil~eL 338 (444)
|||+++++||||+|+||+++ .++.++|+|||+++..... .....++..|+|||.+.+. .++.++|||||||++|||
T Consensus 118 ylH~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 118 YLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp HHHHTTCCCSCCSGGGEEEC-TTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred ccccCceeccccchHhheec-CCCCEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHH
Confidence 99999999999999999999 7899999999999764332 3345678899999999887 899999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCCCCC
Q psy10212 339 LL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRI 417 (444)
Q Consensus 339 lt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRP 417 (444)
++ |++||...+..+....+.+. ....++..+++.+.+||.+||+.||.+||
T Consensus 194 ~t~~~~p~~~~~~~~~~~~i~~~----------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rp 245 (262)
T d1byga_ 194 YSFGRVPYPRIPLKDVVPRVEKG----------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245 (262)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTT----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHCCCCCCCCCCHHHHHHHHHcC----------------------------CCCCCCccCCHHHHHHHHHHcccCHhHCc
Confidence 98 79999888777766554321 11123446789999999999999999999
Q ss_pred CHHHHhccCchhhhhhhh
Q psy10212 418 SPLQVRSITPFLIELRAV 435 (444)
Q Consensus 418 s~~elL~~hpwf~~~~~~ 435 (444)
|+.++++ ++++++..
T Consensus 246 s~~~l~~---~L~~i~~~ 260 (262)
T d1byga_ 246 SFLQLRE---QLEHIKTH 260 (262)
T ss_dssp CHHHHHH---HHHHHHHH
T ss_pred CHHHHHH---HHHHHHhC
Confidence 9999999 78887653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=365.75 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=208.9
Q ss_pred cccchhheecccceeEEEEeEec---CCCceeeeeeeecc--------ccchhhHHHHhhhcCC-CceeEeeeEEeecCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLL---DSGELVAIKKVLQD--------KRFKNREMQIMRRLEH-SNIVKLKYFFYSSGD 89 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 89 (444)
++|+++++||+|+||+||+|++. .+|+.||||++... .+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 66999999999999999999974 46899999998432 2456689999999966 89999999987764
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 103 -------------------------------------------------------------------------------- 102 (322)
T d1vzoa_ 103 -------------------------------------------------------------------------------- 102 (322)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHH
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKL 248 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~ 248 (444)
.++++||||.+ +|.+.+. ..+.+++..++.
T Consensus 103 ---------------------------------------------~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~ 133 (322)
T d1vzoa_ 103 ---------------------------------------------KLHLILDYINGGELFTHLS----QRERFTEHEVQI 133 (322)
T ss_dssp ---------------------------------------------EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHH
T ss_pred ---------------------------------------------ceeeeeecccccHHHHHHH----hcccccHHHHHH
Confidence 49999999995 8888875 345788999999
Q ss_pred HHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCC--CCCccccccccccCchhhccC-CCCCcc
Q psy10212 249 YIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRG--EPNVSYICSRYYRAPELIFGA-IDYTTK 325 (444)
Q Consensus 249 i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~s~~ 325 (444)
++.||+.||+|||++|++||||||+||+++ .++.++|+|||++...... .......+++.|++||.+.+. ..++.+
T Consensus 134 ~~~Qi~~al~~lH~~~ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~k 212 (322)
T d1vzoa_ 134 YVGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 212 (322)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred HHHHHHHHHHHhhcCCEEeccCCccceeec-CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCch
Confidence 999999999999999999999999999999 7789999999998765332 223455789999999998654 247889
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 326 IDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 326 sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
+|||||||++|+|++|+.||.+.+..+....+.+..... ...++.++|+.+.+||
T Consensus 213 sDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li 267 (322)
T d1vzoa_ 213 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------------------------EPPYPQEMSALAKDLI 267 (322)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------------------------CCCCCTTSCHHHHHHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-------------------------CCCCcccCCHHHHHHH
Confidence 999999999999999999998877666655555421000 0012346799999999
Q ss_pred HHhcccCCCCCC-----CHHHHhccCchhhhhh
Q psy10212 406 SRLLEYTPSSRI-----SPLQVRSITPFLIELR 433 (444)
Q Consensus 406 ~~~L~~DP~kRP-----s~~elL~~hpwf~~~~ 433 (444)
.+||++||.+|| |++|+|+ ||||+++.
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~-Hpff~~i~ 299 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKE-HLFFQKIN 299 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHT-SGGGTTCC
T ss_pred HHHcccCHHHcCCCCcccHHHHHc-CHhhcCCC
Confidence 999999999999 4899999 99998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=357.26 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=198.9
Q ss_pred cccchhheecccceeEEEEeEecCC-C--ceeeeeeeecc-------ccchhhHHHHhhhcCCCceeEeeeEEeecCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDS-G--ELVAIKKVLQD-------KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKK 91 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~aiK~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (444)
++|++++.||+|+||.||+|++..+ + ..||||++... .+.+.+|+++|++++||||+++++++.+..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~--- 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--- 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc---
Confidence 6799999999999999999987543 3 36899998432 245679999999999999999999886532
Q ss_pred CCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCccc
Q psy10212 92 DEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 171 (444)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (273)
T d1u46a_ 85 -------------------------------------------------------------------------------- 84 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHH
Q psy10212 172 KFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYI 250 (444)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~ 250 (444)
+++|||||+ +++.+.+.. ..+++++..++.++
T Consensus 85 --------------------------------------------~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~ 117 (273)
T d1u46a_ 85 --------------------------------------------MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYA 117 (273)
T ss_dssp --------------------------------------------CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHH
T ss_pred --------------------------------------------hheeeeeecCcchhhhhhc---ccCCCCHHHHHHHH
Confidence 679999998 588877653 34569999999999
Q ss_pred HHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC----ccccccccccCchhhccCCCCCcch
Q psy10212 251 YQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN----VSYICSRYYRAPELIFGAIDYTTKI 326 (444)
Q Consensus 251 ~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~s~~s 326 (444)
.||+.||.|||+++++||||||+||+++ .++.+||+|||+++........ ....++..|+|||.+.+. .++.++
T Consensus 118 ~qi~~gl~ylH~~~iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 195 (273)
T d1u46a_ 118 VQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHAS 195 (273)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHH
T ss_pred HHHHHHHHHhhhCCEeeeeecHHHhccc-cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcch
Confidence 9999999999999999999999999999 6789999999999876444322 223467789999999887 899999
Q ss_pred hhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHH
Q psy10212 327 DVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLI 405 (444)
Q Consensus 327 DiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI 405 (444)
||||||+++|||++ |+.||.+.+..+....+.+. .... ..+.++|+.+.+||
T Consensus 196 Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-----------------~~~~----------~~~~~~~~~l~~li 248 (273)
T d1u46a_ 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----------------GERL----------PRPEDCPQDIYNVM 248 (273)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----------------CCCC----------CCCTTCCHHHHHHH
T ss_pred hhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----------------CCCC----------CCcccccHHHHHHH
Confidence 99999999999997 89999998888877766541 1111 12346799999999
Q ss_pred HHhcccCCCCCCCHHHHhccCchhhhh
Q psy10212 406 SRLLEYTPSSRISPLQVRSITPFLIEL 432 (444)
Q Consensus 406 ~~~L~~DP~kRPs~~elL~~hpwf~~~ 432 (444)
.+||+.||++|||+.|+++ ++++.
T Consensus 249 ~~cl~~dp~~RPt~~ei~~---~L~~~ 272 (273)
T d1u46a_ 249 VQCWAHKPEDRPTFVALRD---FLLEA 272 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHH---HHHHH
T ss_pred HHHcCCChhHCcCHHHHHH---HHHhc
Confidence 9999999999999999988 77764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=357.24 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
++|++.+.||+|+||.||+|+++. ++.||||++... .+.+.+|+.++++++|||||++++++.++.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~---------- 85 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------- 85 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----------
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCC----------
Confidence 689999999999999999999875 467999998543 356779999999999999999999874322
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 86 -------------------------------------------------------------------------------- 85 (285)
T d1fmka3 86 -------------------------------------------------------------------------------- 85 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
+++|||||++ +|..++.. .....+++..++.++.||+.||
T Consensus 86 -------------------------------------~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl 126 (285)
T d1fmka3 86 -------------------------------------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGM 126 (285)
T ss_dssp -------------------------------------CEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHH
T ss_pred -------------------------------------eEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHH
Confidence 6799999995 77777643 3345799999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC--CccccccccccCchhhccCCCCCcchhhhhHHHHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP--NVSYICSRYYRAPELIFGAIDYTTKIDVWSAGCVL 335 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLGvil 335 (444)
+|||++|++||||||+||+++ .++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++
T Consensus 127 ~~LH~~~ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil 204 (285)
T d1fmka3 127 AYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILL 204 (285)
T ss_dssp HHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred HHHhhhheecccccceEEEEC-CCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHH
Confidence 999999999999999999999 788999999999976543322 2335678999999999887 889999999999999
Q ss_pred HHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhcccCCC
Q psy10212 336 AELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPS 414 (444)
Q Consensus 336 ~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~DP~ 414 (444)
|||++| .+|+.+....+.+..+.+.. ....+..+|+++.+||.+||+.||+
T Consensus 205 ~el~t~~~p~~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~dP~ 256 (285)
T d1fmka3 205 TELTTKGRVPYPGMVNREVLDQVERGY----------------------------RMPCPPECPESLHDLMCQCWRKEPE 256 (285)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcC----------------------------CCCCCcccCHHHHHHHHHHcccCHh
Confidence 999995 55566666666555544311 0112346799999999999999999
Q ss_pred CCCCHHHHhc-cCchhhh
Q psy10212 415 SRISPLQVRS-ITPFLIE 431 (444)
Q Consensus 415 kRPs~~elL~-~hpwf~~ 431 (444)
+|||+.++++ -++||..
T Consensus 257 ~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 257 ERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp GSCCHHHHHHHHHTTTSC
T ss_pred HCcCHHHHHHHHhhhhcC
Confidence 9999999876 1344444
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-45 Score=358.74 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=208.5
Q ss_pred ccccchhheecccceeEEEEeEec-----CCCceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++++.||+|+||+||+|+.+ .+++.||||++... ...+.+|++++++++||||+++++++...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~- 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP- 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc-
Confidence 478999999999999999999975 35678999998543 3457799999999999999999999977653
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 91 -------------------------------------------------------------------------------- 90 (301)
T d1lufa_ 91 -------------------------------------------------------------------------------- 90 (301)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh--------------
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS-------------- 235 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~-------------- 235 (444)
++++||||+ ++|.+++....
T Consensus 91 ---------------------------------------------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 125 (301)
T d1lufa_ 91 ---------------------------------------------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125 (301)
T ss_dssp ---------------------------------------------CEEEEECCTTCBHHHHHHHTCC-------------
T ss_pred ---------------------------------------------eEEEEEecCCCcHHHHHHhcCccccccccccccch
Confidence 889999998 58998885321
Q ss_pred ------hcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC---CCccccc
Q psy10212 236 ------KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE---PNVSYIC 306 (444)
Q Consensus 236 ------~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~---~~~~~~g 306 (444)
.....+++..+..++.||+.||+|||+++++||||||+||+++ .++.+||+|||+++...... ......+
T Consensus 126 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred hhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCc
Confidence 1233588999999999999999999999999999999999999 78899999999987553322 2234467
Q ss_pred cccccCchhhccCCCCCcchhhhhHHHHHHHHHhCC-CCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCcc
Q psy10212 307 SRYYRAPELIFGAIDYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 385 (444)
Q Consensus 307 t~~y~aPE~l~~~~~~s~~sDiwSLGvil~eLltG~-~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~ 385 (444)
++.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+....+.+.. .+
T Consensus 205 ~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-------------------~~--- 261 (301)
T d1lufa_ 205 PIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-------------------IL--- 261 (301)
T ss_dssp CGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------------CC---
T ss_pred CcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-------------------CC---
Confidence 8899999999887 8999999999999999999885 6898888887776654411 00
Q ss_pred CCCCcccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 386 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 386 ~~~~~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..+.++|+++.+||.+||+.||++|||+.||++ +++.+.
T Consensus 262 ------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~---~L~~i~ 300 (301)
T d1lufa_ 262 ------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR---ILQRMC 300 (301)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHTT
T ss_pred ------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH---HHHHhc
Confidence 123467999999999999999999999999988 777654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=358.58 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=208.6
Q ss_pred cccchhheecccceeEEEEeEecCCCce--eeeeeeec-----cccchhhHHHHhhhc-CCCceeEeeeEEeecCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGEL--VAIKKVLQ-----DKRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDKKDE 93 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~-----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 93 (444)
++|++.+.||+|+||.||+|+++.+|.. ||||++.. ..+.+.+|+++|+++ +||||+++++++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence 7899999999999999999999988874 67887732 234677999999999 7999999999998765
Q ss_pred CCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCC
Q psy10212 94 PTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 173 (444)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (444)
T Consensus 85 -------------------------------------------------------------------------------- 84 (309)
T d1fvra_ 85 -------------------------------------------------------------------------------- 84 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhh------------hhcCCC
Q psy10212 174 PQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHY------------SKSKQN 240 (444)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~------------~~~~~~ 240 (444)
.+++|||||+ |+|.+++... ......
T Consensus 85 -----------------------------------------~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 123 (309)
T d1fvra_ 85 -----------------------------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123 (309)
T ss_dssp -----------------------------------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCS
T ss_pred -----------------------------------------eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCC
Confidence 3999999999 5999988542 234577
Q ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCCccccccccccCchhhccCC
Q psy10212 241 FPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 241 l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 320 (444)
+++..+..++.||+.||.|||+++++||||||+|||++ ..+.+||+|||+++............+|..|+|||.+.+.
T Consensus 124 l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~- 201 (309)
T d1fvra_ 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS- 201 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-
T ss_pred CCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc-CCCceEEccccccccccccccccceecCCcccchHHhccC-
Confidence 99999999999999999999999999999999999999 7889999999999766555555556789999999999887
Q ss_pred CCCcchhhhhHHHHHHHHHhCC-CCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLGQ-PMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG~-~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|||||||++|+|++|. +||.+.+..+....+.+.. ....+.++++
T Consensus 202 ~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~ 253 (309)
T d1fvra_ 202 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------------------------RLEKPLNCDD 253 (309)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC----------------------------CCCCCTTBCH
T ss_pred CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----------------------------CCCCCccCCH
Confidence 7999999999999999999965 6788877766655443310 0112345799
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
++.+||.+||+.||++|||+.|+++ | ++++.
T Consensus 254 ~~~~li~~cl~~dP~~RPs~~eil~-~--L~~i~ 284 (309)
T d1fvra_ 254 EVYDLMRQCWREKPYERPSFAQILV-S--LNRML 284 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH-H--HHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH-H--HHHHH
Confidence 9999999999999999999999999 4 55544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=355.68 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=197.3
Q ss_pred cccchhheecccceeEEEEeEecC-----CCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 90 (444)
++|+++++||+|+||.||+|++.. +++.||||++... .+.+.+|+..+.++ +|+||+.+.+++.+.+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~- 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC-
Confidence 789999999999999999999754 3478999998532 23455677777776 78999999888866542
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 92 -------------------------------------------------------------------------------- 91 (299)
T d1ywna1 92 -------------------------------------------------------------------------------- 91 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------c
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------S 237 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------~ 237 (444)
.+++|||||+ |+|.+++..... .
T Consensus 92 --------------------------------------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 127 (299)
T d1ywna1 92 --------------------------------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127 (299)
T ss_dssp --------------------------------------------CCEEEEECCTTCBHHHHHHHTGGGBCC---------
T ss_pred --------------------------------------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhh
Confidence 3889999998 699999865432 2
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCch
Q psy10212 238 KQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPE 314 (444)
Q Consensus 238 ~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE 314 (444)
...+++..++.++.||+.||+|||+++|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||
T Consensus 128 ~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206 (299)
T ss_dssp --CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence 34588999999999999999999999999999999999999 788999999999976543322 23456899999999
Q ss_pred hhccCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccc
Q psy10212 315 LIFGAIDYTTKIDVWSAGCVLAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVF 393 (444)
Q Consensus 315 ~l~~~~~~s~~sDiwSLGvil~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 393 (444)
.+.+. .++.++||||+||++|+|++| .+||.+.+..+.+...+.... . ...
T Consensus 207 ~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~---------------~------------~~~ 258 (299)
T d1ywna1 207 TIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------R------------MRA 258 (299)
T ss_dssp HHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC---------------C------------CCC
T ss_pred HhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------C------------CCC
Confidence 99887 899999999999999999986 578887766555555444210 0 012
Q ss_pred cCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 394 RVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 394 ~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
+..+++++.+||.+||+.||.+|||+.|+++ | ++++.
T Consensus 259 ~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~-~--L~~il 295 (299)
T d1ywna1 259 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE-H--LGNLL 295 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-H--HHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHH-H--HHHHH
Confidence 3357999999999999999999999999999 4 66553
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=351.08 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=203.8
Q ss_pred ccccchhheecccceeEEEEeEecCCC-------ceeeeeeeeccc-----cchhhHHHHhhhc-CCCceeEeeeEEeec
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLDSG-------ELVAIKKVLQDK-----RFKNREMQIMRRL-EHSNIVKLKYFFYSS 87 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~~-----~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (444)
.++|++++.||+|+||.||+|++..++ ..||||++..+. ..+.+|+..+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 379999999999999999999986554 379999995442 4455788888888 899999999999876
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 92 ~~------------------------------------------------------------------------------ 93 (299)
T d1fgka_ 92 GP------------------------------------------------------------------------------ 93 (299)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred Ce------------------------------------------------------------------------------
Confidence 53
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhh-----------
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYS----------- 235 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~----------- 235 (444)
+++|||||+ |+|.+++....
T Consensus 94 ------------------------------------------------~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~ 125 (299)
T d1fgka_ 94 ------------------------------------------------LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125 (299)
T ss_dssp ------------------------------------------------CEEEECCCTTCBHHHHHHTTSCC---------
T ss_pred ------------------------------------------------EEEEEEccCCCcHHHHHHhhcCCccccccccc
Confidence 889999998 58999986432
Q ss_pred -hcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---Ccccccccccc
Q psy10212 236 -KSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYR 311 (444)
Q Consensus 236 -~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~ 311 (444)
.....+++..++.++.||+.||+|||+++++||||||+|||++ .++.+||+|||++........ .....+++.|+
T Consensus 126 ~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 204 (299)
T d1fgka_ 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 204 (299)
T ss_dssp ---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGS
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhh
Confidence 1245689999999999999999999999999999999999999 788999999999976644332 23356788999
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++||||||+++|+|++ |.+||.+.+..+....+.... .
T Consensus 205 aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~----------------------------~ 255 (299)
T d1fgka_ 205 APEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH----------------------------R 255 (299)
T ss_dssp CHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------------------C
T ss_pred hhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC----------------------------C
Confidence 99999887 89999999999999999997 799998877765554333210 0
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
..++.++|+++.+||.+||+.||++|||+.|+|+ .++.+-+
T Consensus 256 ~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~---~L~~i~a 296 (299)
T d1fgka_ 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVA 296 (299)
T ss_dssp CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH---HHHHHhh
Confidence 1123467999999999999999999999999999 7776644
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-44 Score=349.73 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=201.4
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeecc--ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD--KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNY 97 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 97 (444)
+.++|++++.||+|+||.||+|+++.+|+.||||++..+ ...+.+|++++++++|++++..+..+...+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~--------- 75 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG--------- 75 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEET---------
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecC---------
Confidence 447899999999999999999999999999999987543 456778999999998877666655554443
Q ss_pred CCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcC
Q psy10212 98 PPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 177 (444)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (444)
T Consensus 76 -------------------------------------------------------------------------------- 75 (299)
T d1ckia_ 76 -------------------------------------------------------------------------------- 75 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 178 SHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
...++|||||++++.+.+. .....+++..+..++.|++.||
T Consensus 76 ------------------------------------~~~~ivme~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l 116 (299)
T d1ckia_ 76 ------------------------------------DYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRI 116 (299)
T ss_dssp ------------------------------------TEEEEEEECCCCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CEEEEEEEEcCCchhhhhh---hccCCCcHHHHHHHHHHHHHHH
Confidence 2488999999999887764 3456899999999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcC--CCCeEEEeecCCcccccCCCC--------CccccccccccCchhhccCCCCCcchh
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNP--ETGVLKLCDFGSAKHLVRGEP--------NVSYICSRYYRAPELIFGAIDYTTKID 327 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~--~~~~ikL~Dfg~s~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~s~~sD 327 (444)
+|||++||+||||||+||+++. .+..++|+|||+++....... .....||+.|+|||.+.+. .++.++|
T Consensus 117 ~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 195 (299)
T d1ckia_ 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDD 195 (299)
T ss_dssp HHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHH
T ss_pred HHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhh
Confidence 9999999999999999999852 345799999999987643321 2344789999999999887 7999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHH
Q psy10212 328 VWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISR 407 (444)
Q Consensus 328 iwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~ 407 (444)
||||||++|+|++|+.||......+....+.+..... +. . -...+..++|+++.++|.+
T Consensus 196 iwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----~~----------~-------~~~~~~~~~p~~~~~li~~ 254 (299)
T d1ckia_ 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----MS----------T-------PIEVLCKGYPSEFATYLNF 254 (299)
T ss_dssp HHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH----HH----------S-------CHHHHTTTSCHHHHHHHHH
T ss_pred EEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc----CC----------C-------ChhHhccCCCHHHHHHHHH
Confidence 9999999999999999998876655444333211000 00 0 0011224679999999999
Q ss_pred hcccCCCCCCCHHHH---hccCchhh
Q psy10212 408 LLEYTPSSRISPLQV---RSITPFLI 430 (444)
Q Consensus 408 ~L~~DP~kRPs~~el---L~~hpwf~ 430 (444)
||+.||.+||++.++ |+ |+|.+
T Consensus 255 cl~~~p~~RP~~~~i~~~l~-~~~~~ 279 (299)
T d1ckia_ 255 CRSLRFDDKPDYSYLRQLFR-NLFHR 279 (299)
T ss_dssp HHHSCTTCCCCHHHHHHHHH-HHHHH
T ss_pred HccCChhHCcCHHHHHHHHH-HHHHH
Confidence 999999999998755 55 55543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=349.83 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=210.5
Q ss_pred ccccchhheecccceeEEEEeEec-----CCCceeeeeeeecc-----ccchhhHHHHhhhc-CCCceeEeeeEEeecCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLL-----DSGELVAIKKVLQD-----KRFKNREMQIMRRL-EHSNIVKLKYFFYSSGD 89 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 89 (444)
.++|++.+.||+|+||.||+|++. .+++.||||++... ...+.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 379999999999999999999863 45678999999543 24567899999999 69999999999977643
Q ss_pred CCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCc
Q psy10212 90 KKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYT 169 (444)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (444)
T Consensus 102 -------------------------------------------------------------------------------- 101 (311)
T d1t46a_ 102 -------------------------------------------------------------------------------- 101 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------------
Q psy10212 170 EFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------------ 236 (444)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------------ 236 (444)
+++|||||+ ++|.+++.....
T Consensus 102 ----------------------------------------------~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~ 135 (311)
T d1t46a_ 102 ----------------------------------------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135 (311)
T ss_dssp ----------------------------------------------CEEEEECCTTEEHHHHHHHTTTTC----------
T ss_pred ----------------------------------------------EEEEEEcCCCCCHHHHHHhccccccccccccccc
Confidence 889999998 588888864332
Q ss_pred --cCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCCC---cccccccccc
Q psy10212 237 --SKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEPN---VSYICSRYYR 311 (444)
Q Consensus 237 --~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~~---~~~~gt~~y~ 311 (444)
....+++..+..++.||+.||+|||+++++||||||+||+++ ..+.++++|||.++........ ....+|+.|+
T Consensus 136 ~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~ 214 (311)
T d1t46a_ 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214 (311)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred cccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHc
Confidence 334689999999999999999999999999999999999999 7889999999999876543322 2346799999
Q ss_pred CchhhccCCCCCcchhhhhHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCc
Q psy10212 312 APELIFGAIDYTTKIDVWSAGCVLAELLL-GQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWS 390 (444)
Q Consensus 312 aPE~l~~~~~~s~~sDiwSLGvil~eLlt-G~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 390 (444)
|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+.+.++++.-. .
T Consensus 215 aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~---------------------------~ 266 (311)
T d1t46a_ 215 APESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF---------------------------R 266 (311)
T ss_dssp CHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC---------------------------C
T ss_pred CHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------------------C
Confidence 99999877 89999999999999999998 7777877777676666665210 0
Q ss_pred ccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 391 KVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 391 ~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
...+..+|+.+.+||.+||+.||.+|||+.|+|+ .++..-..
T Consensus 267 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~---~L~~~i~~ 308 (311)
T d1t46a_ 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ---LIEKQISE 308 (311)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH---HHHHhhcc
Confidence 1112356899999999999999999999999998 77665443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=349.07 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=205.7
Q ss_pred ccccchhheecccceeEEEEeEecC-----CCceeeeeeeeccc-----cchhhHHHHhhhcCCCceeEeeeEEeecCCC
Q psy10212 21 DNSLAQKTVIGNGSFGIVYQAKLLD-----SGELVAIKKVLQDK-----RFKNREMQIMRRLEHSNIVKLKYFFYSSGDK 90 (444)
Q Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (444)
.++|++.++||+|+||+||+|.++. +++.||||++.... ..+.+|++++++++||||+++++.+.....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~- 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP- 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc-
Confidence 3899999999999999999999853 35789999995432 346799999999999999999999876543
Q ss_pred CCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcc
Q psy10212 91 KDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 170 (444)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (444)
T Consensus 98 -------------------------------------------------------------------------------- 97 (308)
T d1p4oa_ 98 -------------------------------------------------------------------------------- 97 (308)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhh------cCCCCCh
Q psy10212 171 FKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSK------SKQNFPC 243 (444)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~------~~~~l~~ 243 (444)
.++|||||+ |+|.+++...+. .-..+++
T Consensus 98 ---------------------------------------------~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~ 132 (308)
T d1p4oa_ 98 ---------------------------------------------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132 (308)
T ss_dssp ---------------------------------------------CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCH
T ss_pred ---------------------------------------------eeEEEeecCCCCHHHHHHhcccccccccccCCCCH
Confidence 889999998 589888854332 1234688
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC---CccccccccccCchhhccCC
Q psy10212 244 FYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP---NVSYICSRYYRAPELIFGAI 320 (444)
Q Consensus 244 ~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~---~~~~~gt~~y~aPE~l~~~~ 320 (444)
..+..++.|++.||.|||+++++||||||+|||++ .++++||+|||+++....... .....+++.|+|||.+.+.
T Consensus 133 ~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~- 210 (308)
T d1p4oa_ 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG- 210 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-
Confidence 89999999999999999999999999999999999 889999999999976543322 2334678999999999887
Q ss_pred CCCcchhhhhHHHHHHHHHhC-CCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 DYTTKIDVWSAGCVLAELLLG-QPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 ~~s~~sDiwSLGvil~eLltG-~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|+||||+++|||++| ..||.+.+..+....+.+... ...+.++|+
T Consensus 211 ~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~ 262 (308)
T d1p4oa_ 211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----------------------------LDKPDNCPD 262 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCH
T ss_pred CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC----------------------------CCCcccchH
Confidence 889999999999999999997 588988888777766554110 112345789
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhc
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRS 424 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~ 424 (444)
.+.++|.+||+.||.+|||+.++++
T Consensus 263 ~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 263 MLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.4e-43 Score=341.67 Aligned_cols=258 Identities=17% Similarity=0.210 Sum_probs=209.1
Q ss_pred hccccchhheecccceeEEEEeEecCCCceeeeeeeec--cccchhhHHHHhhhcCC-CceeEeeeEEeecCCCCCCCCC
Q psy10212 20 LDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKNREMQIMRRLEH-SNIVKLKYFFYSSGDKKDEPTN 96 (444)
Q Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~ 96 (444)
+.++|++++.||+|+||+||+|+++.+|+.||||++.. ....+.+|++.++.|.| +||+.+++++...+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-------- 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-------- 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--------
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--------
Confidence 34789999999999999999999999999999998844 34567789999999965 89999988876654
Q ss_pred CCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCc
Q psy10212 97 YPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 176 (444)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (444)
T Consensus 75 -------------------------------------------------------------------------------- 74 (293)
T d1csna_ 75 -------------------------------------------------------------------------------- 74 (293)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHH
Q psy10212 177 KSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRS 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~a 256 (444)
..++|||||+++|.+++. ..+..++...+..++.|++.|
T Consensus 75 --------------------------------------~~~~vme~~~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~ 113 (293)
T d1csna_ 75 --------------------------------------HNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLAR 113 (293)
T ss_dssp --------------------------------------EEEEEEECCCCBHHHHHH---HTTTCCCHHHHHHHHHHHHHH
T ss_pred --------------------------------------ccEEEEEecCCCHHHHHH---hhccchhhHHHHHHHHHHHHH
Confidence 489999999999999875 345679999999999999999
Q ss_pred HHHHHHCCcccCCCCCCcEEEcC----CCCeEEEeecCCcccccCCC--------CCccccccccccCchhhccCCCCCc
Q psy10212 257 LAYIHVLGICHRDIKPQNLLLNP----ETGVLKLCDFGSAKHLVRGE--------PNVSYICSRYYRAPELIFGAIDYTT 324 (444)
Q Consensus 257 L~yLHs~givH~dLkp~NIll~~----~~~~ikL~Dfg~s~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~s~ 324 (444)
|+|||++|++||||||+||+++. ..+.++|+|||+++...... ......||+.|+|||.+.+. .++.
T Consensus 114 l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~ 192 (293)
T d1csna_ 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSR 192 (293)
T ss_dssp HHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCH
T ss_pred HHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCCh
Confidence 99999999999999999999963 35689999999997654321 22345689999999999887 8999
Q ss_pred chhhhhHHHHHHHHHhCCCCCCCCChhHH---HHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhH
Q psy10212 325 KIDVWSAGCVLAELLLGQPMFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDA 401 (444)
Q Consensus 325 ~sDiwSLGvil~eLltG~~Pf~~~~~~e~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l 401 (444)
++|+||||+++|+|++|+.||.+.+.... ..++......++.. .+..++|+++
T Consensus 193 ~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~l~~~~p~~l 248 (293)
T d1csna_ 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR------------------------ELCAGFPEEF 248 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH------------------------HHTTTSCHHH
T ss_pred HHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH------------------------HhcCCCCHHH
Confidence 99999999999999999999987554333 22232211111111 1224578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhccCchhhhhhh
Q psy10212 402 IDLISRLLEYTPSSRISPLQVRSITPFLIELRA 434 (444)
Q Consensus 402 ~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~ 434 (444)
.+++..|+..+|++||+.+.+.+ +|+++..
T Consensus 249 ~~ii~~~~~~~~~~rP~y~~l~~---~l~~~~~ 278 (293)
T d1csna_ 249 YKYMHYARNLAFDATPDYDYLQG---LFSKVLE 278 (293)
T ss_dssp HHHHHHHHHCCTTCCCCHHHHHH---HHHHHHH
T ss_pred HHHHHHHhcCCcccCcCHHHHHH---HHHHHHH
Confidence 99999999999999999988877 7777543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=342.91 Aligned_cols=248 Identities=23% Similarity=0.251 Sum_probs=195.4
Q ss_pred hheecccceeEEEEeEecCCC---ceeeeeeeecc-----ccchhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSG---ELVAIKKVLQD-----KRFKNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
.++||+|+||+||+|++..++ ..||||++... .+.+.+|+++|++++||||+++++++....
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---------- 101 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---------- 101 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----------
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----------
Confidence 467999999999999986643 25899998432 245779999999999999999999987653
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 102 -------------------------------------------------------------------------------- 101 (311)
T d1r0pa_ 102 -------------------------------------------------------------------------------- 101 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCCC-cHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMPE-TVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
..+++|||||++ +|.+++. ......+...+..++.|++.||
T Consensus 102 -----------------------------------~~~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL 143 (311)
T d1r0pa_ 102 -----------------------------------GSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM 143 (311)
T ss_dssp -----------------------------------TEEEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHH
T ss_pred -----------------------------------CceEEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhh
Confidence 238899999995 7777764 3455677888999999999999
Q ss_pred HHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCCC-----CccccccccccCchhhccCCCCCcchhhhhHH
Q psy10212 258 AYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGEP-----NVSYICSRYYRAPELIFGAIDYTTKIDVWSAG 332 (444)
Q Consensus 258 ~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~s~~sDiwSLG 332 (444)
.|||+++++||||||+||+++ +++.+||+|||+++....... .....++..|+|||.+.+. .++.++||||||
T Consensus 144 ~~lH~~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfG 221 (311)
T d1r0pa_ 144 KFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFG 221 (311)
T ss_dssp HHHHHTTCCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHH
T ss_pred hhhcccCcccCCccHHhEeEC-CCCCEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhH
Confidence 999999999999999999999 789999999999976543322 2224578999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCC-ChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCChhHHHHHHHhccc
Q psy10212 333 CVLAELLLGQPMFPGD-SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEY 411 (444)
Q Consensus 333 vil~eLltG~~Pf~~~-~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~~l~~LI~~~L~~ 411 (444)
+++|||++|..||... +..+....+.... ....+.++++.+.+||.+||+.
T Consensus 222 ivl~El~t~~~p~~~~~~~~~~~~~i~~g~----------------------------~~~~p~~~~~~l~~li~~cl~~ 273 (311)
T d1r0pa_ 222 VLLWELMTRGAPPYPDVNTFDITVYLLQGR----------------------------RLLQPEYCPDPLYEVMLKCWHP 273 (311)
T ss_dssp HHHHHHHTTSCCSCC------CHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCcccCcHHHHHHHHHHcCC
Confidence 9999999977776543 3333333222210 0112346789999999999999
Q ss_pred CCCCCCCHHHHhccCchhhhhhhh
Q psy10212 412 TPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 412 DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
||++|||+.|+++ .++.+.+.
T Consensus 274 dP~~RPs~~ei~~---~L~~i~~~ 294 (311)
T d1r0pa_ 274 KAEMRPSFSELVS---RISAIFST 294 (311)
T ss_dssp SGGGSCCHHHHHH---HHHHHHHT
T ss_pred CHhHCcCHHHHHH---HHHHHHHh
Confidence 9999999999999 47776654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-42 Score=347.50 Aligned_cols=282 Identities=27% Similarity=0.437 Sum_probs=211.2
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc---cchhhHHHHhhhcC-----------CCceeEeeeEEeec
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK---RFKNREMQIMRRLE-----------HSNIVKLKYFFYSS 87 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~ 87 (444)
++|+++++||+|+||+||+|+++.+|+.||||++..+. +.+.+|++++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46999999999999999999999999999999996542 55678999998885 47888888888765
Q ss_pred CCCCCCCCCCCCccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCC
Q psy10212 88 GDKKDEPTNYPPLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPN 167 (444)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (444)
+.
T Consensus 93 ~~------------------------------------------------------------------------------ 94 (362)
T d1q8ya_ 93 GP------------------------------------------------------------------------------ 94 (362)
T ss_dssp ET------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 43
Q ss_pred CcccCCCCcCCCCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccC--CCcHHHHHHhhhhcCCCCChHH
Q psy10212 168 YTEFKFPQIKSHPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFM--PETVYKVAKHYSKSKQNFPCFY 245 (444)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~--~~~l~~~~~~~~~~~~~l~~~~ 245 (444)
...+++|.++ .++...... ......+++..
T Consensus 95 ----------------------------------------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 126 (362)
T d1q8ya_ 95 ----------------------------------------------NGVHVVMVFEVLGENLLALIK--KYEHRGIPLIY 126 (362)
T ss_dssp ----------------------------------------------TEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHH
T ss_pred ----------------------------------------------cceeeeeeecccccccccccc--cccccCCcHHH
Confidence 2344555554 445444432 34566789999
Q ss_pred HHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEcCCC-----CeEEEeecCCcccccCCCCCccccccccccCchhhccC
Q psy10212 246 TKLYIYQLFRSLAYIHV-LGICHRDIKPQNLLLNPET-----GVLKLCDFGSAKHLVRGEPNVSYICSRYYRAPELIFGA 319 (444)
Q Consensus 246 i~~i~~QIl~aL~yLHs-~givH~dLkp~NIll~~~~-----~~ikL~Dfg~s~~~~~~~~~~~~~gt~~y~aPE~l~~~ 319 (444)
++.++.||+.||+|||+ +||+||||||+||+++... ..++++|||.+..... ......+++.|+|||.+.+.
T Consensus 127 i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhcccc
Confidence 99999999999999998 8999999999999997322 1589999999876433 33456789999999999877
Q ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCC------hhHHHHHHHHHhCCCCHHHHHhhCCCC---Ccc----cCCCccC
Q psy10212 320 IDYTTKIDVWSAGCVLAELLLGQPMFPGDS------GVDQLVEIIKVLGTPTREQIREMNPNY---TEF----KFPQIKS 386 (444)
Q Consensus 320 ~~~s~~sDiwSLGvil~eLltG~~Pf~~~~------~~e~~~~i~~~~g~~~~~~~~~~~~~~---~~~----~~p~~~~ 386 (444)
.++.++|+||+||++++|++|+.||...+ ..+........+|.++...+....... ... .......
T Consensus 205 -~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
T d1q8ya_ 205 -PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283 (362)
T ss_dssp -CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred -CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC
Confidence 78999999999999999999999997532 445677778888887766554321100 000 0011011
Q ss_pred CCC------cccccCCCChhHHHHHHHhcccCCCCCCCHHHHhccCchhhhhh
Q psy10212 387 HPW------SKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVRSITPFLIELR 433 (444)
Q Consensus 387 ~~~------~~~~~~~~s~~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~ 433 (444)
..+ ...+....++.+.+||.+||.+||.+|||+.|+|+ ||||++..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~-Hp~f~~~~ 335 (362)
T d1q8ya_ 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN-HPWLKDTL 335 (362)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT-CGGGTTCT
T ss_pred CchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc-CcccCCCC
Confidence 111 01112334788999999999999999999999999 99999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=339.19 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=195.5
Q ss_pred cccchhheecccceeEEEEeEecCCCceeeeeeeeccc-cc--hhhHHHHhhhcCCCceeEeeeEEeecCCCCCCCCCCC
Q psy10212 22 NSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQDK-RF--KNREMQIMRRLEHSNIVKLKYFFYSSGDKKDEPTNYP 98 (444)
Q Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~--~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 98 (444)
..|.+.+.||+|+||+||+|++ +|+.||||++..+. .. .++|+..+.+++||||+++++++...+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~-------- 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-------- 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS--------
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc--------
Confidence 5688899999999999999997 68999999995443 22 33566677788999999999999876531
Q ss_pred CccccccccCCCCCceeEEecCCCCCCCCccccccccccccCCChhhHHHHHHhhCCCchhhhhhcCCCCcccCCCCcCC
Q psy10212 99 PLEDMKISTFSPRNKVTTVVATPGQGPDRPQEISYTNTRVSDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKS 178 (444)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (444)
T Consensus 73 -------------------------------------------------------------------------------- 72 (303)
T d1vjya_ 73 -------------------------------------------------------------------------------- 72 (303)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCcccccccCCcchHHHHHHhhccCCCCCCCcccceEEEEeccCC-CcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHH
Q psy10212 179 HPWSKVFRVRTPPDAIDLISRLLEYTPSSRISPLQVFLNLVLEFMP-ETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSL 257 (444)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL 257 (444)
...+++|||||+ |+|.+++.. .++++..++.++.|++.||
T Consensus 73 ----------------------------------~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl 113 (303)
T d1vjya_ 73 ----------------------------------WTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGL 113 (303)
T ss_dssp ----------------------------------SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHH
T ss_pred ----------------------------------ceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHH
Confidence 034899999998 599999853 4689999999999999999
Q ss_pred HHHHH--------CCcccCCCCCCcEEEcCCCCeEEEeecCCcccccCCC-----CCccccccccccCchhhccCC----
Q psy10212 258 AYIHV--------LGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLVRGE-----PNVSYICSRYYRAPELIFGAI---- 320 (444)
Q Consensus 258 ~yLHs--------~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~---- 320 (444)
+|||+ +||+||||||+||+++ .++.+||+|||++....... ......||+.|+|||.+.+..
T Consensus 114 ~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 192 (303)
T d1vjya_ 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192 (303)
T ss_dssp HHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTC
T ss_pred HHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccC
Confidence 99996 5999999999999999 78999999999987664432 123456899999999986541
Q ss_pred -CCCcchhhhhHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhCCCCHHHHHhhCCCCCcccCCCccCCCCcccccCCCCh
Q psy10212 321 -DYTTKIDVWSAGCVLAELLLGQPMFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKSHPWSKVFRVRTPP 399 (444)
Q Consensus 321 -~~s~~sDiwSLGvil~eLltG~~Pf~~~~~~e~~~~i~~~~g~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~s~ 399 (444)
.++.++|||||||++|||++|..||......+...... ....+....+..... .....|... ....+...+.
T Consensus 193 ~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~ 265 (303)
T d1vjya_ 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALR 265 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHH
T ss_pred CCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-ccccchHHHHHHHHh--ccccCCCCC----cccCChHHHH
Confidence 25678999999999999999998875432211000000 000001111110000 000000000 0011122345
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhccCchhhhhhhh
Q psy10212 400 DAIDLISRLLEYTPSSRISPLQVRSITPFLIELRAV 435 (444)
Q Consensus 400 ~l~~LI~~~L~~DP~kRPs~~elL~~hpwf~~~~~~ 435 (444)
.+.+|+.+||+.||++|||+.|+++ .++++..+
T Consensus 266 ~l~~li~~cl~~dp~~Rps~~ei~~---~L~~i~~~ 298 (303)
T d1vjya_ 266 VMAKIMRECWYANGAARLTALRIKK---TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTCCSSGGGSCCHHHHHH---HHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHH---HHHHHHHh
Confidence 6999999999999999999999998 77777643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.6e-21 Score=177.27 Aligned_cols=97 Identities=18% Similarity=0.153 Sum_probs=70.5
Q ss_pred EEEeccCCCcHHHHHHhhhhcCCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcCCCCeEEEeecCCccccc
Q psy10212 217 NLVLEFMPETVYKVAKHYSKSKQNFPCFYTKLYIYQLFRSLAYIHVLGICHRDIKPQNLLLNPETGVLKLCDFGSAKHLV 296 (444)
Q Consensus 217 ~iv~e~~~~~l~~~~~~~~~~~~~l~~~~i~~i~~QIl~aL~yLHs~givH~dLkp~NIll~~~~~~ikL~Dfg~s~~~~ 296 (444)
+++|||+++... ..++...+..++.|++.+|.|||++|++||||||+||+++ + ..++|+|||.+....
T Consensus 86 ~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~-~-~~~~liDFG~a~~~~ 153 (191)
T d1zara2 86 AVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFPQSVEVG 153 (191)
T ss_dssp EEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCTTCEETT
T ss_pred EEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee-C-CCEEEEECCCcccCC
Confidence 599999997421 2356677788999999999999999999999999999998 3 468999999986643
Q ss_pred CCCCCccccccccccC------chhhccCCCCCcchhhhhHHHH
Q psy10212 297 RGEPNVSYICSRYYRA------PELIFGAIDYTTKIDVWSAGCV 334 (444)
Q Consensus 297 ~~~~~~~~~gt~~y~a------PE~l~~~~~~s~~sDiwSLGvi 334 (444)
.... ..|.. .+.+ .. .++.++|+||+.--
T Consensus 154 ~~~~-------~~~l~rd~~~~~~~f-~r-~y~~~~d~~s~~~~ 188 (191)
T d1zara2 154 EEGW-------REILERDVRNIITYF-SR-TYRTEKDINSAIDR 188 (191)
T ss_dssp STTH-------HHHHHHHHHHHHHHH-HH-HHCCCCCHHHHHHH
T ss_pred CCCc-------HHHHHHHHHHHHHHH-cC-CCCCcccHHHHHHH
Confidence 2211 11111 1222 22 57788999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.99 E-value=2.3e-05 Score=71.62 Aligned_cols=55 Identities=20% Similarity=0.043 Sum_probs=40.0
Q ss_pred hhhhccccchhheecccceeEEEEeEecCCCceeeeeeeecc----ccchhhHHHHhhhcC
Q psy10212 17 FSDLDNSLAQKTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD----KRFKNREMQIMRRLE 73 (444)
Q Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~E~~~l~~l~ 73 (444)
+.++...|++.+..+.++.+.||++.. +++.+++|..... ...+.+|..+++.|.
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~ 67 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLE 67 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHT
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHh
Confidence 556667888888777777789999864 6777889987433 234568888887774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.10 E-value=0.0016 Score=58.51 Aligned_cols=28 Identities=18% Similarity=0.274 Sum_probs=23.8
Q ss_pred cccCCCCCCcEEEcCCCCeEEEeecCCcc
Q psy10212 265 ICHRDIKPQNLLLNPETGVLKLCDFGSAK 293 (444)
Q Consensus 265 ivH~dLkp~NIll~~~~~~ikL~Dfg~s~ 293 (444)
++|+|+.|.||+++ ++..+.|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~-~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVE-NGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEe-CCceEEEEEchhcc
Confidence 89999999999998 55556799998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.05 E-value=0.0015 Score=63.59 Aligned_cols=46 Identities=17% Similarity=0.190 Sum_probs=30.6
Q ss_pred hheecccceeEEEEeEecCCCceeeeeeeecc-----------ccchhhHHHHhhhc
Q psy10212 27 KTVIGNGSFGIVYQAKLLDSGELVAIKKVLQD-----------KRFKNREMQIMRRL 72 (444)
Q Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------~~~~~~E~~~l~~l 72 (444)
.+.+|.|....||++.+...++.+++|..... .+...+|...|+.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~ 87 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ 87 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHH
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHh
Confidence 45789999999999998877889999965321 11233588888766
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.42 E-value=0.028 Score=51.84 Aligned_cols=59 Identities=8% Similarity=0.018 Sum_probs=36.7
Q ss_pred hhhhhccccchh-----heecccceeEEEEeEecCCCceeeeeeeec--cccchhhHHHHhhhcCCCc
Q psy10212 16 YFSDLDNSLAQK-----TVIGNGSFGIVYQAKLLDSGELVAIKKVLQ--DKRFKNREMQIMRRLEHSN 76 (444)
Q Consensus 16 ~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~E~~~l~~l~h~~ 76 (444)
.+..+..+|.+. +.|..|---+.|+++.. +..|++|++.. +......|++++..|...+
T Consensus 7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp HHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhcc
Confidence 355566667653 33446666889999863 45699999854 3455567888888885433
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.63 E-value=0.037 Score=53.08 Aligned_cols=54 Identities=13% Similarity=0.179 Sum_probs=34.7
Q ss_pred chhheecccceeEEEEeEecC-------CCceeeeeeeecccc--chhhHHHHhhhcCCCcee
Q psy10212 25 AQKTVIGNGSFGIVYQAKLLD-------SGELVAIKKVLQDKR--FKNREMQIMRRLEHSNIV 78 (444)
Q Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~--~~~~E~~~l~~l~h~~i~ 78 (444)
-.++.|+.|-.-.+|++.... .++.|.+++...... ...+|..+++.+.-.+++
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~ 107 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLG 107 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSS
T ss_pred eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 346788999999999998753 235577776642222 233688888877433433
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.51 E-value=0.055 Score=50.39 Aligned_cols=38 Identities=18% Similarity=0.040 Sum_probs=29.4
Q ss_pred eEEEEeEecCCCceeeeeeeecc---ccchhhHHHHhhhcCC
Q psy10212 36 GIVYQAKLLDSGELVAIKKVLQD---KRFKNREMQIMRRLEH 74 (444)
Q Consensus 36 g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~E~~~l~~l~h 74 (444)
-+||++... +|+.|++|+.... .+.+..|..++..|..
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~ 76 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVN 76 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHH
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHh
Confidence 589999874 5899999998553 3556789988888853
|